{
  "nbformat": 4,
  "nbformat_minor": 0,
  "metadata": {
    "colab": {
      "name": "Big_Data_EDA_PySpark.ipynb",
      "provenance": [],
      "collapsed_sections": []
    },
    "kernelspec": {
      "name": "python3",
      "display_name": "Python 3"
    }
  },
  "cells": [
    {
      "cell_type": "code",
      "metadata": {
        "id": "lTeztkcacPb1"
      },
      "source": [
        "!apt-get install openjdk-8-jdk-headless -qq > /dev/null\n",
        "!wget -q https://downloads.apache.org/spark/spark-3.0.1/spark-3.0.1-bin-hadoop2.7.tgz\n",
        "!tar -xvf spark-3.0.1-bin-hadoop2.7.tgz\n",
        "!pip install -q findspark\n",
        "!pip install pyspark"
      ],
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "L1cXfnfIcw-r"
      },
      "source": [
        "import os\n",
        "os.environ[\"JAVA_HOME\"] = \"/usr/lib/jvm/java-8-openjdk-amd64\"\n",
        "os.environ[\"SPARK_HOME\"] = \"/content/spark-3.0.1-bin-hadoop2.7\""
      ],
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "ykt5i4Pnc_8_",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "c7e515f1-f44a-4f38-d717-b15bc792ef22"
      },
      "source": [
        "import numpy as np\n",
        "import pandas as pd\n",
        "#import os\n",
        "import json\n",
        "#import re\n",
        "import matplotlib\n",
        "import matplotlib.pyplot as plt\n",
        "#from matplotlib.patches import ConnectionPatch\n",
        "#import plotly.express as px\n",
        "#import plotly.figure_factory as ff\n",
        "#import pycountry\n",
        "#import copy\n",
        "import seaborn as sns\n",
        "from pandas_profiling import ProfileReport\n",
        "from collections import Counter\n",
        "from matplotlib import style\n",
        "#from tqdm import tqdm\n",
        "from google.colab import drive\n",
        "drive.mount('/content/drive')\n",
        "\n",
        "import findspark\n",
        "findspark.init()\n",
        "from pyspark.sql import *\n",
        "\n",
        "spark = SparkSession.builder.master(\"local[*]\").getOrCreate()"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "text": [
            "Mounted at /content/drive\n"
          ],
          "name": "stdout"
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "WSs3uX5PdMq-"
      },
      "source": [
        "#style.use(\"ggplot\")\n",
        "#drive.mount('/content/gdrive',force_remount=True)\n",
        "#base_dir = 'gdrive/My Drive/EDA_Big_Data_Dataset/'\n"
      ],
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "uTxnsevkda--",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "0036b279-c985-4203-ec6b-5ce6459e7404"
      },
      "source": [
        "docs=[]\n",
        "counts=0\n",
        "drive.mount('/content/gdrive',force_remount=True)\n",
        "path = 'gdrive/My Drive/EDA_Big_Data_Dataset/'\n",
        "dirs = os.listdir(path)\n",
        "\n",
        "# This would print all the files and directories\n",
        "for file in dirs:\n",
        "  #print(file)\n",
        "  file_path = f\"/content/gdrive/My Drive/EDA_Big_Data_Dataset/{file}\"\n",
        "  j = json.load(open(file_path,\"rb\"))\n",
        "  #Taking last 7 characters. it removes the 'PMC' appended to the beginning\n",
        "  #also paperid in pdf_json are guids and hard to plot in the graphs hence the substring\n",
        "  paper_id = j['paper_id']\n",
        "  paper_id = paper_id[-7:]\n",
        "  title = j['metadata']['title']\n",
        "  try:#sometimes there are no abstracts\n",
        "    abstract = j['abstract'][0]['text']\n",
        "  except:\n",
        "    abstract = \"\"\n",
        "  full_text = \"\"\n",
        "  bib_entries = []\n",
        "  for text in j['body_text']:\n",
        "    full_text += text['text']\n",
        "    for csp in text['cite_spans']:\n",
        "      try:\n",
        "        title = j['bib_entries'][csp['ref_id']]['title']\n",
        "        bib_entries.append(title)\n",
        "      except:\n",
        "        pass        \n",
        "  docs.append([paper_id, title, abstract, full_text, bib_entries])\n",
        "  counts = counts + 1\n",
        "  if(counts >= 10000):\n",
        "    break   \n",
        "df=pd.DataFrame(docs,columns=['paper_id','title','abstract','full_text','bib_entries']) \n",
        "df_sp = spark.createDataFrame(df)"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "text": [
            "Mounted at /content/gdrive\n"
          ],
          "name": "stdout"
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "gsOlgDdndlNl",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "9a1dedaa-dcb4-4b6d-afd7-eb47da1059d0"
      },
      "source": [
        "print(df_sp)\n",
        "df_sp.show(10)\n",
        "df_sp.head(10)"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "text": [
            "DataFrame[paper_id: string, title: string, abstract: string, full_text: string, bib_entries: array<string>]\n",
            "+--------+--------------------+--------------------+--------------------+--------------------+\n",
            "|paper_id|               title|            abstract|           full_text|         bib_entries|\n",
            "+--------+--------------------+--------------------+--------------------+--------------------+\n",
            "| 8d11bbb|Submit your next ...|Background: Médec...|Médecins Sans Fro...|[Innovation médic...|\n",
            "| 141ea7b|Viral infection i...|Of 7,772 laborato...|The human respira...|[Respiratory sync...|\n",
            "| a290117|A critical role o...|Background: Vario...|Plasmodium falcip...|[The pathogenic b...|\n",
            "| 35452b9|Implementation of...|The smallest know...|In contrast to th...|[Evolutionary pri...|\n",
            "| 9eff92d|FDA draft guidanc...|                    |Two pathways are ...|[FDA guidance for...|\n",
            "| f2845f7|Full Title: A sys...|                    |Since the first h...|                  []|\n",
            "| 3e2fa78|Supplementary Inf...|                    |- Figure S1 : Phy...|                  []|\n",
            "| 3a6b4ad|Diagnosis and tre...|Reçu et accepté l...|Les pathologies i...|[Epidemiology of ...|\n",
            "| 6edff6d|Early sexual init...|                    |Letter to the edi...|[Behavioral inter...|\n",
            "| d9112fa|SUPPLEMENTAL INFO...|                    |. More than 60 tu...|                  []|\n",
            "+--------+--------------------+--------------------+--------------------+--------------------+\n",
            "only showing top 10 rows\n",
            "\n"
          ],
          "name": "stdout"
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "[Row(paper_id='8d11bbb', title='Submit your next manuscript to BioMed Central and take full advantage of: • Convenient online submission • Thorough peer review • No space constraints or color figure charges • Immediate publication on acceptance • Inclusion in PubMed, CAS, Scopus and Google Scholar • Research which is freely available for redistribution', abstract=\"Background: Médecins Sans Frontières (MSF) is one of the world's leading humanitarian medical organizations. The increased emphasis in MSF on research led to the creation of an ethics review board (ERB) in 2001. The ERB has encouraged innovation in the review of proposals and the interaction between the ERB and the organization. This has led to some of the advances in ethics governance described in this paper. Discussion: We first update our previous work from 2009 describing ERB performance and then highlight five innovative practices:\", full_text='Médecins Sans Frontières (MSF) is one of the world\\'s leading humanitarian medical organizations. It provides emergency medical assistance to populations in danger in more than 70 countries. The foundational and animating values of MSF as a humanitarian medical organization are rooted in ethics [1] . Historically, research was not seen as core to the mission of MSF. However, during its history, MSF has constantly developed innovative protocols and tools, in response to unmet field needs [2] . It now initiates, sponsors or participates in numerous research projects in multiple field sites. In 2013 alone, 253 research papers were published [3] . The results of MSF research have had substantial impact on global health policy and provide benefits to populations served by MSF and elsewhere as presented later in this paper. MSF has also shown leadership in operational research initiatives in the humanitarian NGO sector [4] . As a result, research has become increasingly integral to MSF activities, both in the field and in global health advocacy. The increased emphasis on research led to the creation of an ethics review board (ERB) in 2001. From the outset independence of the ERB from the organisation was perceived as essential. To avoid conflict of interest and ensure independence, ERB members cannot have a working relationship with MSF during their tenure. The ERB has now been in place for thirteen years. The ERB\\'s dialogue with MSF has enhanced sensitivities towards research ethics and lead to gradual improvements in developing ethically sound proposals. The consistent use of an ethics framework has helped in standardizing the review process and guiding field research teams in addressing ethical issues. The way that the ERB functions and the challenging ethical issues addressed by the ERB since its inception have been described previously [5] . The ERB strives to take a constructive approach to both research proposals and the field of research ethics itself. The ERB has encouraged innovation in both the review of proposals and the interaction between the ERB and the organization.In the view of the ERB ethics review should not be dogmatic and ought to be proportionate in terms of benefit and harms. The ethics review procedure and its stringency should be commensurate with the type of research based on an approximate estimation of potential harm ( Figure 1 ).This has led to some of the advances in ethics governance further described in this paper. Some of the innovations implemented by the ERB may run counter to standard operating procedures and guidance documents that are utilized in various jurisdictions. We argue that much standard practice in research ethics review ought to be open to challenge and revision, and this irrespectively of the actors and the context of the research.Research ethics is a field that should not be regarded as a set of rigid standards fixed for all time and in all contexts. Much of current research ethics practice lacks an empirical basis, and many recommended standards are based on historical practice. From our perspective, research ethics and research ethics practices are capable of being examined through research and a quality improvement approach. Any genuine ethics review requires critical reflection and discussion, not the pedestrian adoption of legalistic rules, and it should result in a learning process for both the researchers and the reviewers. Fostering a spirit of innovation and evaluation in research ethics practice demonstrates that research ethics itself is an active and essential component of global health research. In this paper we describe innovations that we think challenge accepted practices and thus hope to stimulate a more vigorous debate in this area, beyond the realm of research carried out by MSF.To contextualise our proposals for changes in research ethics governance, we will first update our previous work from 2009 [5] describing ERB performance and then highlight five innovative practices:A new framework to guide ethics review The introduction of a policy exempting a posteriori analysis of routinely collected data The preapproval of \"emergency\" protocols General ethical approval of \"routine surveys\" Evaluating the impact of approved studiesBefore describing the five areas of innovation, we will briefly give an overview of ERB activities and performance focusing on the past four years. Since its inception, the volume of ERB activity has increased considerably, as reflected in the number of protocols received. Overall 248 research protocols were reviewed by the ERB between 2002 and 2013 with an almost ten-fold increase in the number of protocols across that period ( Figure 2 ). Protocols are always submitted to the ERB and to the Ethics Committees in the study country, and the approval from the local Ethics Committee is a fundamental prerequisite to the ERB approval. In very rare instances, the ERB may waive this request if, for example, no ethics committee or national body able to play a similar function is available, or if it is justified not to collaborate with the legal authorities, as this could be detrimental to the population served by MSF (e.g. working in a conflict zone with a population group persecuted by national authorities).In 2010-2011, 56 requests for review were received in 24 months. This increased to 72 requests during the two-year period 2012-13, despite the fact that during this time research based on a posteriori analyses of routinely collected clinical data was no longer submitted to the ERB for review. Of this number 61 were expedited reviews and 11 were full board reviews a .The Board is also evaluating the timeliness of its reviews. An audit of proposals from 2010-2013 (four-year period) demonstrated an average time to approval of twelve weeks (Figure 3) . Figure 3 shows that, on average, the ERB needs more time for doing the first review (time between MSF request and finalizing ERB review) than researchers for responding (time between ERB review and MSF reply) in the case of expedited review. However, the ERB is faster than the investigators in case of full review. Once a satisfactory reply and revisions from the researchers are received, approval is usually granted quickly. Overall the procedure is faster for expedited review than for full review. This is mainly due to the fact that proposals submitted for expedited review are judged to be of minimal risk of harm, that study design is often less complex and that a smaller number of reviewers is involved. Assessing the timeline of the review procedure is a relevant indicator of ERB performance and dispels the myth that the ERB is responsible for a slow review process. Also, the overall time to approval should not be seen as the \"time to getting a stamp\", but as a time of dialogue and critical reflection on both sides. In addition, ERB timelines are shortened in case of extraordinarily urgent situations and turnaround can occur within a few days.To further improve its decentralized and very reactive way of functioning, a web-based platform was created exclusively for the MSF ERB. This platform provides access for ERB members to all routine communications, active files and ERB archives including all past ERB reviews, protocol amendments, research reports, ERB decisions, relevant MSF or ERB policies.In the rest of this paper we outline five different innovations that have resulted in proportionate ethics review, without compromising on the fundamental role of the ERB.A new framework to help guide ethics review was adopted by MSF in November 2013. This replaced a previous ethics framework that had been adapted from the work of Emanuel et al. [6] . In this section we will explain both what is different about the new framework and why the changes were made. However, we will begin by explaining why a framework is necessary at all. What is an ethics framework? What is its role? How does it work?An ethics framework can serve many purposes. First, it seeks to articulate and make explicit the kinds of values or other ethical considerations that are taken to be of crucial importance in relation to the topic in hand, in this case, the ethics of research conducted in the course of humanitarian medicine. Any framework will be the product of a particular time, influenced by the knowledge and experience of those involved in producing it. Articulating the considerations that are held to be relevant allows for transparent discussion, critique and development of the framework over time in the light of evolving situations. Second, and perhaps most crucially, an ethics framework provides assistance to researchers and others that evaluate and/or make decisions about the ethics of research. This means that a framework will often be an aid to research design and deliberation, not just a theoretical expression of ideals. On this view, it ought to be of use to members of the ethics board, but also of aid to researchers and anyone else thinking about the relevant issues (as the document is publicly available on the MSF website [7] ). Third, it is also important to recognise what a framework does not do. It does not, for example, determine what should or should not be done. It is not a piece of legal or quasi-legal regulation. Rather, its intent is clearly expressed by the metaphor of \\'framing\\'; it aims to \\'frame\\' , or provide an outline or structure for a focused and relevant discussion and eventual decision, not to provide a list of necessary and absolute principles or statements.The original MSF ERB framework was based on the work of Emanuel et al. This was used, because at the time it was the most practically orientated of the various frameworks, guidelines and documents available. It provided a coherent summary of the issues that were central to discussions of research ethics, building upon the many documents then available [8] [9] [10] . The Emanuel framework seemed to synthesize these diverse guidelines into something tangible. Despite its limitations briefly described below, it provided a focus for both reviewers and researchers. It is fair to say that the new ethics framework is a development from the work of Emanuel et al., but it is significantly different in a number of ways.There were three main motivations for developing a new framework. First, and perhaps most importantly, the Emanuel framework actually provides little practical guidance. It is more of a checklist of important considerations than a framework that facilitates making ethical judgments. For example, the framework is structured in terms of a series of ethical \\'principles\\' and related \\'benchmarks\\'. However, it is unclear what a benchmark is. How do the different \\'benchmarks\\' relate to each other? What is the moral status of a benchmark? Is it an ethical principle, a value or just a statement? What practical priority is to be given to each principle or benchmark? How do the different principles and benchmarks relate to each other and what should we do if they conflict? Is the presented order of the principles and benchmarks important or not? For example, the old framework\\'s first stated \\'principle\\' is \\'Collaborative Partnership\\' , followed by \\'Social Value\\' and then \\'Scientific Validity\\'. In what sense are these supposed to be principles? They might be things that researchers and the ERB are supposed to \\'take into account\\' , but how do they do this? Is \"Collaborative Partnership\" the most important \\'principle\\'? Is that why it is first? Emanuel et al. [8] suggest that their requirements are presented in chronological order, although the detail of the order could be questioned. For example, why is a procedural requirement (independent review) in the list, and why does it appear where it does? Why is informed consent prior to, and separate from, respect for potential and enrolled subjects? If we consider the \\'benchmarks\\' the first thing that is noticeable is that they are very didactic ( Table 1) .The benchmarks state what should happen in a firm and clear way. There is a mixture of useful advice about engaging with local communities and researchers, although it remains unclear why this should be done. Is it for practical reasons e.g., because this is the best way to get the study results? Or is it for ethical reasons? If so, it is unclear what they might be, especially as \\'collaborative partnership\\' is not an ethical principle. For example, you might expect some possible commitment to ideas of respect, or equality and justice. Second, the benchmarks are not always helpful. For example, consider the benchmark: \\'Respect the community\\'s values, culture, traditions, and social practices\\'. What does this mean? Does this relate to the kinds of issues just mentioned, such as a commitment to equal respect and value of persons? Are we to take it literally as a general didactic statement? Is it a commitment to some form of relativism? Are we to commit ourselves to engage with and effectively endorse any existing injustices in the population of study? If women have a marginalised role in that society, should we \\'respect\\' this? At the very least, these are complex matters where the benchmarks often fail to capture the nuances relevant to thinking about ethics. Similar kinds of questions can be asked of many other research ethics frameworks and guidelines, as it is often left obscure how they are to be used as practical tools [11, 12] . Second, the academic literature and debates have proliferated and developed over the last ten years, especially in relation to post-research benefits for host populations. Many of these discussions are of particular importance for research conducted by MSF. MSF as a medical organisation is providing health care to vulnerable and destitute populations and is devoting limited resources to research with the sole aim of improving health care. Third, there has been a growing awareness that the kind of research conducted by MSF may not be well served by traditional research ethics for several reasons: the chosen method is only rarely one of a randomised clinical trial of novel medicines (the model that has dominated research ethics) and is more likely to use retrospective analysis of previously collected clinical data, surveys, needs assessment or case control methods; the context for research is distinctive, in that much research is conducted in contexts of disaster, conflict, poverty, social exclusion and lack of access to care, disrupted health systems or other difficult circumstances, where there is great vulnerability and pressing humanitarian needs.We believe that the new ethics framework [13] is an improvement in a number of ways. First, the overall structure of the framework is clearer. The issues are now placed into three groups (Research Question and Methodology; Respecting and Protecting Research Participants and Communities; Implications and Implementation of the Research Findings) to reflect a logical temporal order of things to consider before, during and after the research has been conducted. Second, this structure and, in particular, the use of questions should aid deliberation by anyone using the framework. Formulating the content of the framework in terms of questions very deliberately \\'frames\\' the discussion about research ethics. It provides an open and flexible approach, rather than seeking to articulate a number of general statements. Table 2 illustrates this by focusing on the issue of informed consent.The old framework sets out a set of commands as if they were absolute rules that must be followed. The new framework covers much of the same ground, but approaches the issues in a different spirit. It seeks to invite researchers to justify their approach. It accepts that sometimes it is inappropriate or impossible to gain a fully informed consent from every individual. Help is offered to the researcher, but the aim is to encourage a conversation about ethical issues, rather than impose quasi-legalistic rules. The questions help potential researchers to see what the ERB wishes to see in a protocol and ethics application, but can also help researchers come to understand ethical issues in more detail, and how ethical issues are intertwined with methodological issues. The use of open questions requires researchers to engage with the framework and outline and defend how they will address the relevant issues that they have identified. Ethics review is more of an active process, with the researcher as a participant, rather than the victim of an alien and abstract set of rules. Third, the new framework is more engaged with the specific MSF research context. This means that certain values/principles/issues are given much greater prominence than they ever have before. For example, it is now much clearer how methodological and ethical issues interact and the obligations that arise once research has been completed are much more prominent and require greater attention b .The new framework has been implemented since November 2013 and has been well received by MSF researchers. It will be evaluated after 12 to 18 months\\' use from the researchers and the ERB\\'s perspective.Exempting research based on a posteriori analysis of routinely collected data from review MSF collects a vast amount of data as part of its routine clinical procedures. At a later stage these data may be useful to evaluate programme outcomes, analyse predictors of treatment outcomes, or assess factors influencing programme or treatment effectiveness. As the number of protocols aimed at generating this kind of data submitted to the ERB for review was steadily increasing, the possibility of delegating ethical responsibility for this type of study to the MSF medical directors under certain conditions was discussed at a joint meeting of the ERB and medical directors in June 2010. Primary considerations concerned (1) how these data were collected and (2) how patients were informed of the potential uses of their health data. Collecting routine clinical data should presumably follow universal ethical principles and thus might be thought to require consent. The ERB thus encouraged MSF to establish a policy on routine collection of data in clinical settings. The uses of such data may carry a low risk of harm, informing each patient may be difficult to implement and it is arguable that consent to at least some uses is implicit in clinical care. It was thus suggested that MSF consider a variety of ways of informing people about the possible uses of their data (e.g. well displayed posters describing the potential uses of health data collected in the clinic).It was agreed that a posteriori analyses of routinely collected clinical data do not require ERB review, if MSF as an organization through the medical directors (who are overseeing research) takes responsibility for addressing the ethical issues. The following seven criteria must be fulfilled to qualify for exemption from ERB review:1. Studies/articles are based on routinely-collected programme and clinical data. 2. They are either descriptive or targeted evaluations. 3. Confidentiality is respected; no individual patient identifiers are revealed. 4. Harm is minimal but acknowledged where relevant. 5. Potential benefits to both the programme and the community are described. Since the goal is publication, the relevance to a wider audience is described. 6. Collaborative involvement and, if applicable, authorship from a local medical or public health Table 2 An example of the difference between the two frameworks: consentOld framework New framework 1) Involve the study community in establishing appropriate recruitment procedures and incentives for the participants.(2.2) What are your plans for obtaining consent? A requirement to inform participants is often seen as being an important way to show respect and promote patient autonomy and welfare. 2) Ensure that consent procedures are acceptable within the study community (may include supplementary community and familial consent procedures).a. What information ought to be provided? This will usually include the following elements: the reasons for doing research, details about who is doing the research, why the potential participant is being asked to be involved, details about what any intervention might involve and any on-going commitments of participation, details about anticipated risks and benefits, the fact that participants are free to refuse or withdraw, that any findings will be communicated back to the participants etc. The information given should be proportionate to any risks, but this does not mean that the higher the risk, the more information ought to be provided. Sometimes, calling attention clearly to a common or significant particular risk is more important than listing every possible remote risk.3) Disclose information in culturally and linguistically appropriate formats. This implies that• any information given during the informed consent process must be pretested with people of a similar cultural and educational background as potential study participants;• the information provided on the consent form must be in simple language, avoiding technical terms;b. Providing information does not guarantee it has been understood. How can information be provided at an appropriate linguistic level, without jargon or technical terms, and appropriate to the local language and culture?• the consent form must be translated into the local language and then back-translated into the \"international\" language used to get a sense of the accuracy of the translation and correct mistakes;c. Should information be provided in oral and/or written form? 4) Ensure that participants fully comprehend the research objectives and procedures:d. How will the consent process be conducted? You may want to consider issues such as: who will consent, where they will do so (is the place appropriate to allow a confidential discussion), will a witness to the consent be required, how much time will be offered to consider whether to be involved? Prior engagement with communities can be a useful way to ensure that the consent process meets local expectations and sensitivities. How will the act of consent be recorded (e.g. signed and witnessed document, thumb print etc.)?• if needed, the person should get time to discuss the information received with members of the community or family before deciding on consent;e. Alternative or additional consent procedures may need to be developed where potential participants are minors, minor parents, or suffering from short or long-term incapacities etc.• in addition, community information or \"schooling\" on the research to be done and on the purpose and process of seeking informed consent will raise pre-enrolment awareness and thus help people to decide if they want to participate in the study.f. It should not be assumed that a long and complicated information sheet is always necessary and in exceptional cases it may be justifiable not to seek informed consent. Where researchers believe that this is appropriate, they should be careful to providereasons for this in the protocol.6) Ensure that potential participants are free to refuse or withdraw from the research at any stage without penalty.. authority or partner (Ministry of Health, DHO, other NGO) is encouraged. If relevant and possible, consultation with a body representing the community is desirable. 7. If the decision for exemption from review is taken by the medical directors, the MSF responsibility to ensure that ethical requirements are met is similar to reviewed projects. This exemption, in addition, does not exempt MSF from compliance with regulatory requirements in the country from where the data originate. National or institutional ethical review may still be required.Consequently between June 2010 and December 2013, 127 protocols involving exclusively a posterior analysis of routinely collected data were directly exempted from review by the medical directors. In case of doubt protocols are submitted to the ERB to ensure all criteria are met. This was the case six times in 2013. In all instances the ERB confirmed that exemption criteria were met. The list of exempted studies is provided to the ERB at the end of each calendar year. The ERB retains the right to audit exempted studies to verify that exemption criteria are respected.There is considerable uncertainty about optimal intervention in many dimensions of humanitarian medicine. Humanitarian interventions, as already noted, occur in an unpredictable manner and in uncertain contexts. Often the response must be implemented quickly and not according to the time table of meetings for established research ethics boards.The need for rapid, yet robust, research ethics review has been noted in the literature. Experiences with SARS and pandemic influenza have demonstrated that existing research ethics structures are poorly tailored for rapid assessment and feedback in a sufficiently timely manner and may hinder legitimate research with potential benefits [14] . Recommendations for addressing these deficiencies have been tabled [15] .MSF frequently carries out research in emergency situations which do not allow sufficient time for prior ethics review. In a paper on MSF emergency research \"external ethical review\" is briefly mentioned with no indication if and how it is implemented [16] . The ERB has repeatedly been asked to conduct a posteriori reviews of emergency research in form of draft papers prior to publication. As emergency research may have serious implications for research participants, the issue of ethics review was revisited.One recommendation that was adopted and passed by the MSF ERB was for pre-approval of generic protocols. Infectious disease outbreaks are a good example of the type of situation where such pre-approval can take place. There are often well structured research questions that are supported by the evidence as being a priority for answering through rigorous research. Protocols have been developed, but there is uncertainty about where the next outbreak will occur.MSF ERB approved the following process:1. When researchers have decided what topic to research in the next emergency, a \"generic\" research protocol is submitted to the ERB for review and pre-approval before the exact location is known. 2. Once the location is known, the final research protocol must be submitted to local ethics committee/authorities for approval. 3. At the same time, the final proposal is submitted to the MSF ERB, including details pertinent to the chosen location. 4. This review can be expedited by decision of the chair. In this case, the chair plus two members will pledge to provide a review and decision within 48 hours. 5. This decision can, however, be challenged by one or more ERB members, leading to full ERB review. It is expected that if this occurs, all members will provide input within an additional 24 hours.This process has been successfully used in assessing the validity of new rapid diagnostic tests during a meningitis outbreak with no reported harms to participants and enhanced ability of researchers to respond in a timely manner. Until recently this was the only instance in which this process was used since it was agreed upon in 2008. The procedure has, however, been applied to a qualitative research protocol to understand local considerations and practices related to Ebola Virus Disease (EVD).Emergency ethics review was also discussed for research to be carried out in the next Ebola fever outbreak. Previously, a review of research on filovirus haemorrhagic fever outbreaks (Ebola/Marburg) published between 1999 and 2007, had shown that among 34 research interventions, individual consent was sought in fifteen cases and ethics review (international and local) was mentioned only in three cases [17] . As MSF wished to carry out research on supportive treatments in major outbreak settings, the ERB suggested in 2010 a \"generic\" protocol be prepared, taking into consideration how to involve potential victims (or survivors) of these outbreaks in the development of such protocols. As outbreaks are unpredictable in terms of timing and location, finding individuals at the time might be unrealistic. However, some survivors are health workers and it may be possible to involve them in protocol development. In this specific case the \"generic\" research protocol could also be pre-approved by the relevant ethics committees of the countries concerned such as DRC, Republic of Congo, Gabon, South Sudan, and Uganda. This had not been taken forward by MSF before the recent Ebola outbreak in West Africa. ERB members, MSF medical directors and researchers met in October 2014, and subsequent decisions to conduct clinical trials in the Ebola outbreak were informed by the interaction of the ERB and MSF. The virtual structure of the ERB provided rapid and thorough expert review. It may also be noteworthy that a number of the MSF ERB members have also advised WHO on this issue.One major question has repeatedly been where to draw the line between research and activities such as prospective disease prevalence surveys and rapid health assessments. MSF routinely carries out vaccination coverage surveys, nutritional surveys and retrospective mortality surveys. These surveys and assessments often have to be done in emergency settings for the purposes of program planning and emergency response, and historically have rarely been submitted to the ERB. Although these could be considered low-risk surveys, the same survey may be more sensitive in certain populations, such as a mortality survey in Iraq or in Syrian refugees, mapping of water quality in slums during the cholera epidemic in Haiti or assessing access to health services for undocumented migrants. Surveys cannot be presumed upfront to be of minimal risk. Many sensitive and morally problematic issues can be disclosed by surveys. Examples include discrimination or blaming of population groups, psychological distress, dealing with uncovered child abuse, or providing demographic characteristics of a community that may enhance their attractiveness as targets by combatants.It was decided recently that the ERB should provide guidance without reviewing every survey, adopting a similar approach to that related to the retrospective analysis of routinely collected data. The ERB would trust researchers to deliberate about potential risks and whether they may want advice or review, within the following frame of reference:Standard vaccination coverage, nutrition and mortality survey instruments will be examined by the ERB and review exemption granted under certain conditions; Criteria for review exemption will be similar to those for a posteriori analysis of routinely collected data; Adding (or removing) a question from the standard protocol means that it is not a standard protocol anymore. Consequently an ERB review will be needed.Sensitive survey research, such as sexual activity, illegal behaviour or mental health, can never be exempted from ethics review. As for a posteriori analysis of routinely collected data, national or institutional ethical review in the country from where the data originate may still be required.Implementation of this new policy will start in 2014, including submission of generic survey protocols to the ERB.While Principle 34 of the Declaration of Helsinki [8] only requests researchers to make provisions for posttrial access for all participants who still need an intervention identified as beneficial in the trial, the general wording in principle 20 (\"… this group should stand to benefit from the knowledge, practices or interventions that result from the research\"), might be interpreted in the sense of post-research access to a broader population. The CIOMS guidelines (Guideline 10) emphasise that \"investigators must make every effort to ensure that the research is responsive to the health needs and the priorities of the population or community in which it is to be carried out; and that any intervention or product developed, or knowledge generated, will be made reasonably available for the benefit of that population or community\" [9] . More recently, global actors have highlighted the need to ensure that the outcomes and benefits of publically-funded research are understood and mapped, and that a strategic approach to harnessing research results is taken by those seeking to improve healthcare delivery [18, 19] . MSF as a global humanitarian actor doing research clearly has to ensure that the benefits of the research are made available to the study community. However, the responsibility of MSF goes beyond responding to the health needs of the research population, using positive results of research to improve policy and practice at the national and international level [20] .The ERB has always closely examined the social value of research, meaning its potential benefits for research participants, the community and beyond during the review process. To assess if claims made in research protocols have translated into practice, the ERB requested MSF for the first time in 2010 to report on the dissemination of research results and programmatic impact of all research approved since the inception of the ERB. We distinguish between impact in the literature (scholarly impact) and impact in the field of intervention. Although examining impact in the literature may have some value, one should not forget that what happens after publication is what is important with operational research and for organisations such as MSF. Changes in policy and practice at the national and international level and real effects on programme performance (changes to programme outcomes, decrease in morbidity and mortality) are more relevant than scholarly impact.Dissemination of research results was categorized as (1) internal MSF report only, (2) limited sharing of results at national or international level and (3) peerreviewed publication. The ERB received feedback on 234 protocols out of 248 reviewed between 2002 and 2013. Overall 11 studies had been refused by the ERB and 38 protocols had to been cancelled after approval. 80 research protocols were still ongoing at the end of 2013. Of the remaining 105 studies, 76 lead to one or several publications, 9 to a more limited dissemination of results (i.e. poster or oral presentations), while the results of 20 studies were only shared internally through a report.To assess impact at the programmatic and/or policy level four broad categories were proposed: local project impact, impact in the country where the study was done, impact within MSF, (potential) changes on a global scale. Given the fact that MSF research spans from opportunistic analyses of collected data to clinical trials, these categories do not necessarily imply a hierarchy. Some studies may be designed for local impact only; others may from the outset have the ambition to change therapeutic protocols internationally [21] . In Figure 4 below, each subsequent category encompasses the previous one. For example, impact at national level includes impact at the local level, and impact at a global scale comprises impact on MSF operations. Table 3 provides some examples for each of the four impact categories [22] [23] [24] [25] [26] [27] [28] [29] [30] .The new framework explicitly asks for the dissemination strategy at community and global level, including dissemination if the research findings are negative. In addition, post-research obligations must be articulated at the level of research participants, the community, others in the same situation elsewhere, and should include an (advocacy) plan in place to assure access to benefits of the study results beyond MSF\\'s and MSF partners\\' engagement. Impact reporting has been systematised on an annual basis for all research protocols approved by the ERB. It is important to note that this approach to impact does not just follow orthodox approaches such as, for example, citation counts. The ERB has also encouraged MSF to share negative findings arising from MSF research as well as positive findings. However, this has not been explicitly assessed.This paper shares the experience of an independently functioning ethics review board serving a large medical humanitarian organisation and shows how it has evolved over time to face the growing challenges of research carried out with vulnerable communities in resource-constrained or emergency settings. First and foremost, we have noted over the years the importance of the dialogue between MSF researchers and independent ERB members. Continued interaction has allowed for progressive innovations based on a trustful and respectful partnership between the ERB and the researchers. During those years we have learned to work together and to better serve each other\\'s needs thus leading to a co-evolution of researchers and the research ethics board. And most importantly we have come to understand that research ethics should be seen as an iterative evolving process. Our experience shows that ethics review can be a constructive learning process, and a time of reflection and critical debate. We think research ethics review should take this format. This, of course, differs from the ordinary perception of institutional ethics review as legalistic, formulaic and at times obstructive.While pursuing developments in various areas as described in this paper in the coming years, we would particularly like to focus our attention on three areas.First, the impact of any new framework should be continuously assessed. While, in this case, we can already sense after six months implementation, that it has been adopted very easily and seems to be much more \"intuitive\" than the previous framework, a more rigorous evaluation of its acceptance, implementation and impact on the quality of research protocols would be useful not only for MSF, but also for other organisations that are facing the same challenges and might wish to adopt and/or adapt it.Second, the impact of research needs to be defined more precisely to be meaningfully assessed. One must also consider that impact changes over time -short, medium and long term cumulative impact. The latency of the impact may be shown in a meta-analysis or metasynthesis at a later time, or demonstrated by uptake of the results into guidelines. It is impossible to predict upfront when key impact will occur. Another important question will be how sustainable changes implemented based on research outcomes are over time. Finally, the dialogue between the MSF ERB and the ethics committees in the study countries should be enhanced [31] . Until now this relationship has been limited to seeing each other\\'s approvals and sometimes the full comments. A more structured and continuous exchange could, for example, be initiated with national ethics committees in countries where MSF has been present a long time and is repeatedly carrying out research activities.We hope that the innovations in research ethics governance described in this paper may be relevant for other organisations carrying out research in fragile contexts and for ethics committees reviewing such research.Endnotes a Full review requiring participation of all ERB members, is warranted if the effectiveness, efficacy or safety of a given procedure or therapy is tested on human subjects and/or if the research involves collecting body/tissue samples with hypothesis testing (e.g. all clinical trials and some operational research projects). Expedited review, requiring participation of two or three ERB members, is deemed sufficient if the research carries only minimal risks to human subjects. b A research ethics framework for similar contexts was produced by R2HC [32] after we had revised our framework. It will take us too far from the purpose of this paper to offer any detailed comparative analysis but it should be noted that the RCHC framework largely summarizes existing literature and follows our revised framework in many respects.A case study of a collaborative initiative between an HIV/AIDS Clinic and a Community Non-Governmental Organization Network in Mumbai, India (2010) The Mumbai team learned an important lesson regarding followup of defaulters: not to approach the homes, but to contact by other means. To avoid stigma.Errol L et al. Tracing patients on antiretroviral treatment lost-to-follow-up in an urban slum in India. J Adv Nurs 2012; 68(11); 2399-409.', bib_entries=['Innovation médicales en situations humanitaires: le travail de Médecins Sans Frontières', 'Conducting operational research within a non governmental organization: the example of Médecins Sans Frontières', 'Research ethics review in humanitarian contexts: the experience of the independent ethics review board of Medecins Sans Frontieres', 'Research ethics review in humanitarian contexts: the experience of the independent ethics review board of Medecins Sans Frontieres', 'What makes clinical research in developing countries ethical? The benchmarks of ethical research', 'MSF Field research', 'World Medical Association Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects', 'Council for International Organizations of Medical Sciences (CIOMS) in collaboration with the World Health Organization (WHO)', 'Council for International Organizations of Medical Sciences (CIOMS) in collaboration with the World Health Organization (WHO)', 'World Medical Association Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects', 'Theory and practice in public health ethics: a complex relationship', \"Relief of oppression': an organizing principle for researchers' obligations to participants in observational studies in the developing world\", 'A framework for ethics review during public emergencies', 'Research ethics governance in disaster situations', 'Research in complex humanitarian emergencies: the médecins sans frontières/epicentre experience', 'Research ethics and international epidemic response: the case of Ebola and Marburg hemorrhagic fevers', 'World Medical Association Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects', 'Council for International Organizations of Medical Sciences (CIOMS) in collaboration with the World Health Organization (WHO)', 'Making an Impact: A Preferred Framework and Indicators to Measure Returns on Investment in Health Research', 'What is the purpose of medical research?', 'Is operational research delivering the goods? The journey to success in low-income countries', 'Making sure that clinical trial results make a difference: operational research and the hierarchy of evidence', 'Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo', 'Mental health treatment outcomes in a humanitarian emergency: a pilot model for the integration of mental health into primary care in Habilla', 'Practicing medicine without borders: tele-consultations and tele-mentoring for improving paediatric care in a conflict setting in Somalia', 'Treating 4,000 diabetic patients in Cambodia, a high-prevalence but resource-limited setting: a 5-year study', 'Low referral completion of rapid diagnostic test-negative patients in community-based treatment of malaria in Sierra Leone', 'Cesarean section rates and indications in sub-Saharan Africa: a multi-country study from Medecins sans Frontieres', 'Efficacy of three artemisinin combination therapies for the treatmentof uncomplicated Plasmodium falciparum malaria in the Republic of Congo', 'Lost to follow up from tuberculosis treatment in an urban informal settlement (Kibera)', 'Tracing patients on antiretroviral treatment lost-to-follow-up in an urban slum in India', 'Double ethical review of North-south collaborative clinical research: hidden paternalism or real partnership', 'Submit your next manuscript to BioMed Central and take full advantage of: • Convenient online submission • Thorough peer review • No space constraints or color figure charges • Immediate publication on acceptance • Inclusion in PubMed, CAS, Scopus and Google Scholar • Research which is freely available for redistribution']),\n",
              " Row(paper_id='141ea7b', title='Viral infection is not uncommon in adult patients with severe hospital-acquired pneumonia', abstract='Of 7,772 laboratory-confirmed cases of respiratory viral infection among hospitalized patients, 22.8% were categorized as having hospital-acquired infection. The overall incidence of hospital-acquired respiratory viral infection was 3.9 (95% confidence interval, 3.7-4.1) cases per 1,000 admitted patients. Rhinovirus was the most common virus (30.3%), followed by influenza virus (17.6%) and parainfluenza virus (15.6%).', full_text='The human respiratory viruses include adenovirus, bocavirus, human coronaviruses, enterovirus, influenza viruses, human metapneumovirus, parainfluenza virus, respiratory syncytial virus, and rhinovirus. Although respiratory viruses are mainly recognized as causes of community-acquired infections, they can also cause serious hospital-acquired respiratory infections 1 and may be responsible for hospital outbreaks. [2] [3] [4] Their relatively short incubation times and efficient transmission via small droplets among comorbid patients highlight the need for better understanding of respiratory viral infections in hospital settings. However, very limited published data are available on the overall epidemiologic characteristics of hospital-acquired infection caused by respiratory viruses, especially by viruses other than influenza viruses. Therefore, using laboratory-based surveillance, we investigated the overall incidence and related factors of hospital-acquired respiratory virus infections.This study was performed at a 2,700-bed, tertiary care, universityaffiliated hospital between January 2012 and December 2015. All admitted patients who had positive test results for respiratory virus polymerase chain reaction (PCR) were prospectively identified and monitored until their discharge or release from isolation. Performance of the PCR test for respiratory viruses was at the discretion of the attending physician. Outpatients and patients discharged in the emergency room were not included. Respiratory viruses were detected by multiplex reverse-transcription PCR assay using a Seeplex RV15 ACE Detection kit (Seegene, Seoul, Korea) (January 2012-October 2013) or Anyplex II RV16 Detection kit (Seegene) (November 2013-December 2015). The performance of those PCR kits used in this study has been evaluated in a published study. 5 6, 7 The proportion of hospital-acquired respiratory viral infections was calculated for all viruses. The incidence of such infections was calculated as the number of cases per 1,000 admissions and as cases per 10,000 patient days. This study was approved by the Institutional Review Board of Asan Medical Center.During the study period, there were 453,075 admissions, and a total of 21,288 respiratory viral PCR tests were conducted. Table 1 shows the variation of the number of study subjects from year to year. A total of 7,772 nonduplicative PCR-positive cases were identified. Of these, 1,770 (22.8%) were categorized as having hospital-acquired infections. A total of 1,888 viruses were identified: 2 viruses were identified in 101 patients, 3 viruses were identified in 7 patients, and 4 viruses were identified in 1 patient. Of the 1,888 viruses identified, 573 (30.3%) were positive for rhinovirus, 333 (17.6%) were positive for influenza virus comprising 254 with influenza A and 79 with influenza B, 294 (15.6%) were positive for parainfluenza virus, 240 (12.7%) were positive for respiratory syncytial virus, 230 (12.2%) were positive for human coronavirus, 91 (4.8%) were positive for human metapneumovirus, 54 (2.9%) were positive for bocavirus, 43 (2.3%) were positive for adenovirus, and 30 (1.6%) were positive for enterovirus. The proportion of hospital-acquired infections was highest in human coronavirus (30.2%), followed by parainfluenza virus (29.8%), influenza virus (28.1%), rhinovirus (24.5%), respiratory syncytial virus (21.4%), bocavirus (21.1%), human metapneumovirus (20.5%), entero-virus (14.0%), and adenovirus (9.1%). The median length of hospital stay prior to contracting a respiratory viral infection was 16 days (interquartile range, 9-32 days).The overall incidence of hospital-acquired respiratory virus infections was 3.9 cases per 1,000 admissions (95% confidence interval, 3.7-4.1) and 4.9 cases per 10,000 patient days (95% confidence interval, 4.7-5.2). The incidences of such infections according to the year, sex, age group, ward, and virus type are summarized in Table 1 . The incidences ranged from 3.6-4.3 cases per 1,000 admissions, with the highest incidence in the year 2015. Patients ≤15 years were more likely to develop hospital-acquired respiratory virus infections. The incidence of such infections was highest in intensive care units (ICUs), followed by medical wards and surgical wards. Of the ICU cases, the median days of ICU stay before viral infection was 4 days (interquartile range, 1-12). All-cause 30-day mortality, 60-day mortality, and in-hospital mortality were 11.3%, 16.5%, and 12.9%, respectively.The seasonal distribution of hospital-acquired respiratory viruses among hospitalized patients was similar to that of communityacquired infections (Supplementary Fig S1) .We found that hospital-acquired respiratory viral infections commonly occurred in a tertiary care hospital. Despite the inherent limitations of laboratory-based surveillance, which underestimated the disease burden, >20% of respiratory viral infections of hospitalized patients were categorized as hospital-acquired events, and various respiratory viruses were responsible. Our study is notable in that we included year-round data from 4 consecutive years and provided the admission days-adjusted incidence for each infection. Data on hospital-acquired respiratory virus infections are still very scarce, mostly confined to influenza virus infections. A Canadian group reported that among hospitalized patients in 51 Canadian hospitals, 23.2%-23.6% of influenza virus infections were health careassociated infections. 8 A German group recently reported the proportion of hospital-acquired influenza virus infection as 20.5%-24.6%. 9 Our rate of such infections (28.1%) was somewhat higher than prior reports. Our inclusion of pediatric patients may have been responsible for this. Of note, the influenza virus was responsible for only 13.9% of all hospital-acquired respiratory viral infections. That is, most cases were caused by respiratory viruses other than the influenza virus and which have received much less attention. These findings highlight the importance of year-round surveillance and infection control measures for various respiratory viruses beyond the influenza virus.According to our results, the incidence of hospital-acquired respiratory virus infections has increased in recent years. We speculate that increased numbers of prescriptions for PCR tests for hospitalized patients are responsible for this finding. That means that clinicians are increasingly aware of respiratory viral infection as one of the important causes of hospital-acquired infection. The use of more sensitive PCR kits in recent years may also have affected the incidence of respiratory viral infection. However, because the reported sensitivities of the 2 assays (93.3% and 95.2%, respectively) are similar, 5 the impact of changes in the PCR kits is not likely to have been substantial. Surprisingly, the incidence of respiratory virus infections was highest in ICUs. Considering the brevity of ICU stays (median, 4 days) before the detection of viruses, it is probable that most of the cases were hospital-acquired lower respiratory tract infections that occurred in wards, not in the ICUs. These findings are consistent with those of a Spanish group, which showed that during the influenza season, 29.5% of critical patients with suspected lower respiratory tract infections had influenza, 42% of which were hospital acquired. 10 It has also been reported that respiratory viruses were responsible for 22.5% of cases of severe hospital-acquired pneumonia requiring ICU admission in adults. 11 These results strongly suggest that hospital-acquired infections caused by respiratory viruses could lead to serious consequences.This study had several limitations. First, it was performed at a single, large tertiary care hospital. Our study population included a substantial number of immunocompromised patients who were susceptible to infection, which likely biased our results. Second, some patients categorized as having hospital-acquired infections may have been already carrying respiratory viruses at the time of admission. Finally, the indications for conducting PCR tests for respiratory viruses were not standardized across the hospital, and the detailed significance of PCR-positive cases was not analyzed.In conclusion, hospital-acquired respiratory viral infections are commonly encountered among hospitalized patients. Hospital surveillance of respiratory viruses should be considered to identify infected patients early and to prevent intrahospital transmission of respiratory viruses.', bib_entries=['Respiratory syncytial virus infections on an adult medical ward', 'Outbreak of human parainfluenza virus 3 infections in a hematopoietic stem cell transplant population', 'Possible role of aerosol transmission in a hospital outbreak of influenza', 'Comparison of Anyplex II RV16 with the xTAG respiratory viral panel and Seeplex RV15 for detection of respiratory viruses', 'Red book: 2015 report of the committee on infectious diseases', 'Case definitions for national notifiable infectious diseases. Osong: KCDC', 'Understanding the burden of influenza infection among adults in Canadian hospitals: a comparison of the 2009-2010 pandemic season with the prepandemic and postpandemic seasons', 'Characterisation of nosocomial and community-acquired influenza in a large university hospital during two consecutive influenza seasons', 'Should lower respiratory tract secretions from intensive care patients be systematically screened for influenza virus during the influenza season', 'Viral infection is not uncommon in adult patients with severe hospital-acquired pneumonia']),\n",
              " Row(paper_id='a290117', title='A critical role of perinuclear fliamentous actin in spatial repositioning and mutually exclusive expression of virulence genes in malaria parasites', abstract='Background: Various transcription factors are involved in the process of mutually exclusive expression and clonal variation of the Plasmodium multigene (var) family. Recent studies revealed that a P. falciparum SWI/SNF-related matrix-associated actin-dependent regulator of chromatin (PfSWIB) might trigger stage-specific programmed cell death (PCD), and was not only crucial for the survival and development of parasite, but also had profound effects on the parasite by interacting with other unknown proteins. However, it remains unclear whether PfSIWB is involved in transcriptional regulation of this virulence gene and its functional properties.', full_text='Plasmodium falciparum, which causes malignant malaria such as cerebral malaria (CM) or pregnancy-associated malaria (PAM) [1, 2] , is the cause of death to 435,000 individuals annually [3] . Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1), which is encoded by the var gene family comprising approximately 60 members, is the major virulence factor involved in the antigenic variation and clinical pathogenicity of falciparum malaria [4, 5] . It is remarkable that the expression of var family members is mutually exclusive. For each parasite at a time, only one or a few var genes are expressed, while the remaining members are silenced [6, 7] . In each generation, P. falciparum is able to express different var genes, and the switches in var gene expression lead to antigenic variation of PfEMP1, which results in immune evasion and chronic infection [8] [9] [10] [11] . This process has proven to be mediated by epigenetic mechanisms, including chromatin modification, nuclear architecture and gene relocation [12, 13] .It has been shown that the single active var gene is enriched in euchromatic modifications, such as histone 3 lysine 9 acetylation (H3K9ac) and histone 3 lysine 4 trimethylation (H3K4me3), particularly near the transcriptional start site (TSS) [14] , while the silent var genes are usually enriched in the heterochromatin marker (histone 3 lysine9 trimethylation, H3K9me3) in the 5\\'UTR or the coding sequence [14] [15] [16] [17] . In this process, histone modifying enzymes such as PfMYST, PfGCN5, PfSIR2 and PfSET, have been considered important for epigenetic control of reversible histone modifications, according to previous studies [12, 13] . PfMYST, a putative histone acetyltransferases (HATs) in P. falciparum, is capable of acetylating multiple lysines on H4 [18, 19] , while an orthologue of the yeast HAT PfGCN5 influences acetylation of H3K9 and K14, both are essential marks of gene activation [18, 20] . Two paralogues of the class III HDAC (histone deacetylases) Sir2, play key roles in maintaining heterochromatin and mutually exclusive var gene expression [15, 21, 22] . PfSir2A deacetylates H3K9ac, H3K14ac and H4K16ac [23] , and is more important in silencing subtelomeric var genes such as upsA-, upsEand upsC-subtype vars. In contrast, PfSir2B silences upsB vars [22] . Furthermore, a total of ten P. falciparum histone lysine methyltransferases (HKMTs) belonging to the SET domain family have been found in P. falciparum [18, 24, 25] . PfSET10 localizes to a specialized region at the nuclear periphery with the active vars such as H3K4me4 transferase [26] .Plasmodium falciparum variant-silencing SET gene (PfSETvs) controls the H3K36me3 on var genes (silencing var genes) [27] . Moreover, subnuclear architecture contributes to the regulation of var gene expression [13] .var genes are by default silent since they are located at the nuclear periphery [28] . However, active var promoters seem to occupy a privileged expression site of this region, making it permissive to transcribe [21] . PF11_0091, an ApiAP2 member, binds a conserved motif in var introns, mediates episomal anchoring towards the nuclear periphery, and recruiting an actin protein complex and polymerized nuclear actin de-represses silent var genes [29] .On the other hand, various trans factors are intimately involved in regulating chromatin structure and gene activity. PfAlbas contribute to heterochromatin structure and regulation of var gene expression [30] . PfSIP2, another ApiAP2 member, is involved in the recruitment and organization of subtelomeric heterochromatin through binding to SPE2 [31] , and induces a comprehensive silencing of a var promoter. Particularly, four major classes of ATP-dependent chromatin remodelers had been found in P. falciparum, facilitating the spatial and temporal remodeling of chromatin [13] . All these remodeler families consist of a SWI2/SNF2family ATPase subunit featuring an ATPase domain [32, 33] , which includes an HSA (helicase-SANT), a post-HSA, and a C-terminal bromodomain. Some other conserved subunits carry extra conserved domains, such as hBAF155/170 (SANT, SWIRM), hBAF60 (SWIB) and human polybromo (multiple bromodomains). BAF60b is generally known as SWI-B or SWIB, an alternative form of the SWI/SNF complex (Complex B) [34] , while human BAF60a protein of SWI/SNF complex is responsible for facilitating cell cycle halting and has the ability to tune the balance between repair and apoptosis induction [35] [36] [37] . Recently, a SWI/ SNF-related matrix-associated actin-dependent regulator of chromatin, PfSWIB (GenBank: PF3D7_0611400), which is characterized by its SWIB/MDM2 domain (SWI complex, BAF60b domain), has been identified in P. falciparum. PfSWIB might trigger stage-specific PCD by which transient nuclear localization causes removal of these parasites [38] . Further studies revealed that PfSWIB was not only crucial for the survival and growth of the parasite, but also had profound effects on the parasite by interacting with other unknown proteins [38] [39] [40] . However, it remains unclear whether PfSWIB is involved in transcriptional regulation of virulence gene, especially vars, and its functional properties.To address the molecular mechanism of PfSWIB, we propose a new conditional knockdown system to study the function and mechanism of chromatin remodeler PfSWIB in regulating var gene expression. We found that the dysfunction of PfSWIB might lead to a significant downregulation of upsA, upsC and partial upsB var genes at the ring stage in a PfSWIB-knockdown line, as well as the aberrant expression of certain var genes at the mature stage in a single 48-h life-cycle of P. falciparum, which was characterized by the reversion of transcriptional downregulation of upsA and partial upsB/ upsC var genes, suggesting that PfSWIB might play a key role on var gene regulating. In addition, PfSWIB knockdown could affect the growth and development of parasite. This study provides a better understanding of the regulatory function of chromatin remodeling complexes (CRCs) in regulating the clonal variation of var genes, and an essential insight into the regulation of the major virulence gene family contributing to the pathogenesis in malaria parasites.Plasmodium falciparum lines 3D7, PfSWIB and PfSWIB∆ were first thawed and established for continuous cultivation in vitro according to standard procedures [41] . The cultivation was as follows: thawed isolates were cultured in RPMI 1640 medium (Invitrogen/Thermo Fisher Scientific, Carlsbad, CA, USA) containing 25 mM Hepes, 2 mM l-glutamine, 0.1 mM hypoxanthine (Sigma-Aldrich, Shanghai, China), 20 mg/ml gentamicin (Sigma-Aldrich, Shanghai, China), 0.5% Albumax II (Invitrogen/Thermo Fisher Scientific) and 2% human serum (type AB+; Changhai Hospital, The Second Military Medical University, Shanghai, China). Cultures were grown in media with type O+ erythrocytes at a 3% hematocrit under 2% O 2 , 5.5% CO 2 , 92.5% N 2 at 37 °C. To obtain tightly synchronized ring stage parasites, a standard percoll/sorbitol synchronization method was performed [42, 43] . In brief, schizonts were isolated over a 40 and 60% percoll cushion and allowed to invade fresh RBCs for 0 to 6 h. The resulting rings were subjected to 5% sorbitol treatment for 5 min at 37 °C. This process was repeated twice. The culture was washed and re-suspended in complete medium containing 2% RBC after the final sorbitol treatment.All transfected parasite lines originated from the 3D7 clone. DNA extraction was performed using the QIAamp DNA Mini Kit (Qiagen, Hilden, Germany). The high fidelity KOD-plus-Neo enzyme (Toyobo, Osaka, Japan) was used for PCR amplification to detect the endogenous PfSWIB locus or integration of the PfSWIB locus (PfSWIB-HA-FKBP-LID). PCR amplification reaction conditions are as follows: 95 °C for 3 min, followed by 32 cycles of 95 °C for 30 s, 50 °C for 30 s, 62 °C for 1 min, and a final extension cycle of 65 °C for 10 min. The specific primers used for PCR are listed in Additional file 1: Table S1 .pLN-ENR-GFP [44] (GenBank: DQ813653.3) was modified by deleting the whole pfenr-gfp cassette, which was then used to clone various DNA fragments in ApaI/BamHI multicloning site. For the pLN-HA-FKBP-LID construct (6900 bp), the calmodulin promoter (5\\' CaM fragment) was initially substituted by a 1.5 kb C terminus of PfSWIB in the ApaI/ASCI multicloning site. Three duplicates of HA tag (YPYDVPDYA) and FKBP-LID tag were ligated towards the C terminus of PfSWIB via a linker sequence (AAAAVDAAAA). The resulting vector pLN-PfSWIB-HA-FKBP-LID was used to transfect the 3D7 clone. The HA tag consists of three tandem repeat sequences of influenza hemagglutinin, whereas the FKBP-LID tag is comprised of the FK506-and rapamycin-binding protein and a 19-amino-acid degron fused towards the C terminus of FKBP ( Fig. 1a ) [45] .Transfections were performed on synchronized ringstage parasites of 3D7 in a 2 mm BioRad Gene Pulser ® cuvettes (Bio-Rad Laboratories, Hercules, CA 94547, USA). A minimum of 100 μg recombinated plasmid DNA was initially purified and used for electroporation using the Bio-Rad GenePulse Xcell ™ electroporator (BioRad Laboratories, Hercules, CA 94547, USA), at 310 V, with a resistance of 950 μF and a transfection time of less than 15 ms. Positive BSD drug selection at the final concentration of 2 nM, was subsequently applied and maintained after the first growth cycle. Those parasites that adopted the pLN-PfSWIB-HA-FKBP-LID construct carrying the bsd gene would offer a level of resistance to the drug. The transfected parasites were subjected to in vitro culturing for 25 to 40 days and subsequent BSD drug cycling to select stable single-crossover parasites. The initial obtained transfected parasite line was a mixture of the episomal and integrated form. Therefore, a \"3 + 2\" mode of drug screening process was subsequently introduced to enrich the integrated lines. In this process, the original transfected parasites were first cultured in vitro in the absence of BSD for 3 weeks, followed by 2 weeks of culture with BSD (2.5 µg/ml), therefore integrated lines of PfSWIB-HA-FKBP-LID could possibly be further sorted after 2-3 rounds of drug cycling (Fig. 1b) . After two cycles of BSD \"off \" (3 weeks) and BSD \"on\" (2 weeks), PCR was applied to detect the integration events of PfSWIB-HA-FKBP-LID in transfected parasites lines by using specific primers (Additional file 1: Table S1 ). Primers P2, P4 and P5 are specific to 3\\'UTR of endogenous PfSWIB, the upstream sequence of PfSWIB C-terminus and downstream plasmid sequence of HA-FKBP-LID fusion expression system, respectively, while Fn is the forward primer used for PCR amplification of PfSWIB C-terminus.In order to obtain purified integrated parasites clones, we utilized a clone screening assay by serial dilution of parasites in 96-well plates, as detailed previously [46] . Two stable transfections of PfSWIB-FKBP-LID integrated parasites clones, PfSWIB-C2 and PfSWIB-B10 were obtained. The integration events were detected on screened clones after extended the culture to 24-well plates. The primers used for testing the clones are described above (see also Additional file 1: Table S1 ). PCR amplification reaction conditions were as follows: 94 °C for 5 min, followed by 32 cycles of 94 °C for 30 s, 54 °C for 30 s, 65 °C for 2 min, and a final extension cycle of 65 °C for 10 min.To analyze the expression of the PfSWIB fusion system in integrated parasites lines, total parasite extracts were prepared by treatment with 0.15% saponin and re-suspended in SDS-loading buffer (Bio-Rad), then separated on a 12% SDS-PAGE gel (Bio-Rad) and subjected to western blot analysis. Total proteins from the 3D7 clone were used as controls. An antibody to aldolase (1:1000 dilution; Roche, Indianapolis, USA) was used as a positive control. Rabbit anti-HA (1:1000 dilution; Abcam, Cambridge, UK) was used to identify PfSWIB fusion proteins in different parasite lines. An enhanced chemiluminescence (ECL) western blotting kit (GE Healthcare, Uppsala, Sweden) was used to develop western blots. The theoretical molecular weight of endogenous PfSWIB, HA tag and HA-FKBP-LID tag is 92kD, 3.5kD and 22kD, respectively. The graylevel image analysis procedure was implemented with ImageJ software. Statistical significance was determined (*P < 0.05, **P < 0.01).Synchronized ring parasites (0-6 h after re-invasion) of the PfSWIB integrated clone (PfSWIB-HA-FKBP-LID) and the 3D7 clone were collected and diluted to 0.2% parasitemia. Each diluted parasite clone was divided into two wells of parasite cultures in the 24-well plate (50 µl RBC pellets/1 ml medium). Shield1 (0.5 mM (diluted in ethanol); Clontech, Mountain View, USA) was added into one of the two wells (final concentration: 0.5 μM). Consequently, four parasite lines including PfSWIB, PfSWIBΔ, 3D7 (shield1 induced) and 3D7 sh− (shield1 not induced) were subject to in vitro culture for 4-5 days. The parasitemia of each parasite line was counted every 12 h up to 96 h and repeated twice. The rate of parasitemia (%) of different lines were compared statistically by a one-way ANOVA followed by Bonferroni\\'s multiple comparison test (*P < 0.05, **P < 0.01). Growth curve analysis was performed in triplicate.For the transcription level assay of individual var genes, we used the var primer pairs published elsewhere [47] and listed in Additional file 2: Table S2 . qPCR assays were performed as described previously [10] . In brief, total RNA of synchronous parasite culture was extracted using TRIzol reagent (Invitrogen/Thermo Fisher Scientific, Carlsbad, CA, USA) [48] . cDNA was prepared in accordance with the manufacturer\\'s recommendations (Thermofisher Scientific, Carlsbad, CA, USA). The fold change between the experimental and reference groups was calculated as 2 −ΔΔCq . qPCR was performed on a QuantStudio 6 Flex Real-Time PCR System (Applied Biosystems, Singapore) using a program of 1 cycle of 15 s at 95 °C and 40 cycles of 30 s at 95 °C, 30 s at 54 °C, 30 s at 60 °C. Seryl-tRNA synthetase was applied as an endogenous control gene and to normalize the transcriptional level of each var gene. For the qPCR data, statistical significance was determined with the two-tailed Student\\'s t-test (*P < 0.05, **P < 0.01).RNA-seq was used to screen differentially expressed genes in three parasite lines and was carried out in duplicate. The reference genome and transcript information (P. falciparum 3D7) were obtained from PlasmoDB (http://plasm odb.org/). The RNA-seq aligner STAR v2.5.3a [49] was used to create a genome catalog, based on two data files including a genome sequence fasta file and GFF3 annotation file (PlasmoDB-34_Pfalcipa-rum3D7_Genome.fasta, PlasmoDB-34_Pfalciparum3D7. gff ). FastQC v0.11.5 was subsequently used to analyze the quality of the RNA-seq reads. The qualified reads were subsequently mapped and aligned to the reference genome. Reads with a minimum mapping quality of 20 (− q 20) were further screened out by using SAM tools. Heatmaps of gene expression profiles in different lines were created by using the R package edgeR [50] . Hierarchical clustering was performed by using one minus Pearson\\'s correlation metric and average linkage method. Line plots were generated with ggplot2 [51] . In order to carry out an analysis of variance (ANOVA)-like differential gene expression analysis, a statistical analysis of summarized read counts per genomic feature obtained from feature Counts function [52] was performed by using the R package ALDEx2 [53, 54] . A fold change greater than 1.5 or lower than − 1.5, FDR < 0.05, and P < 0.05 were selected as filters for defining the sets of differentially expressed genes. [44] , which harbored an antibiotic selection marker (bsd for Blasticidin S resistance, pink). HA tags (red) and FKBP-LID tag (blue and green) were ligated towards the 1.5 kb C terminus of PfSWIB. b Drug screening of the PfSWIB fusion expression system. The integration events and expression of PfSWIB modified locus were identified by PCR. \\'BSD+\\' and \\'BSD-\\' indicate that the transfected parasites were cultured in the presence or absence of BSD. Day 24: in vitro culturing in the absence of BSD for 24 days. Day 5, 10 and 15: in vitro culturing in the presence of BSD for 5, 10 and 15 days, respectively. The details of specific primers used for detecting the endogenous, episomal and integrated PfSWIB locus are provided in \"Methods\"Due to the low transfection proficiency after inserting the full-length PfSWIB gene, we subsequently selected a 1.5 kb C terminal sequence of PfSWIB and cloned this into the modified recombinant plasmids pLN-ENR-GFP forming fusion gene expression system pLN-PfSWIB (C-terminus)-HA-FKBP-LID. Through homologous recombination caused by a single crossover event, a transfected parasite clone known as PfSWIB-HA-FKBP-LID was obtained by transfecting the recombinant plasmid pLN-PfSWIB (C-terminus)-HA-FKBP-LID into the 3D7 strain, which was selected by Blasticidin S deaminase (BSD). The HA tag contains three tandem repeat sequences of influenza hemagglutinin, whereas FKBP-LID tag is comprised of the FK506and rapamycin-binding protein and a 19-amino-acid degron (ligand-induced degradation domain) fused to the C terminus of FKBP (Fig. 1a) [45] . A drug cycling process was subsequently introduced to enrich the integrated lines. The integration events and expression of PfSWIB-HA-FKBP-LID fusion gene were first identified by PCR (Fig. 1b) . The specific primers designed for detecting the transfection proficiency of the PfSWIB modified locus are listed in Additional file 1: Table S1 . Additional file 3: Figure S1 shows the screening of integrated clones which were performed by serial dilution and identification of integration events by PCR. Stable transfections of PfSWIB-FKBP-LID integrated parasites clones PfSWIB-C2 and PfSWIB-B10 were finally obtained from the cloning and screening process in 96-well plates. Since the PfSWIB-C2 clone exhibited stability and reproducibility in the subsequent assays, such as PCR detection and qPCR analysis, we selected clone PfSWIB-C2 rather than clone PfSWIB-B10 for the present study.Western blotting was subsequently performed to detect the expression of PfSWIB-HA-FKBP-LID fusion protein in the presence and absence of shield1 (1:2000, 0.5 μM). According to the previous study, PfSWIB is theoretically stable in the absence of the small molecule shield1 [45] . Alternatively, shield1 binds tightly to FKBP thereby substituting the degron and triggering rapid, continuous degradation of the LID domain and PfSWIB [45] . As shield1 may take time to exert its inhibition function, we selected the in vitro culturing ring and trophozoite parasite stage within their third life-cycle (> 96 h) as testing samples, according to the GCA results (Fig. 2a) . The results indicated that although the PfSWIB-HA-FKBP-LID (114 kDa) fusion gene could be successfully expressed in both stages in the presence or absence of shield1 (Fig. 2b , Additional file 4: Figure S2a) , there was still a significant difference of PfSWIB fusion protein expression between PfSWIB∆ and PfSWIB lines in the trophozoite stage, the expression of PfSWIB fusion protein decreased in PfSWIB∆ line (t (2) = 4.890, P = 0.0394). In contrast, no significant difference had been found in the ring stage parasite (t (2) = 1.006, P = 0.4205) (Fig. 2b, Additional file 4: Figure S2b) .To study the specific functions of PfSWIB, we subsequently analyzed the growth curve by counting parasitemia of different groups within 96 h (Fig. 2 , Additional file 5: Table S3 ). Both PfSWIB-C2 and 3D7 parasite clones were initially synchronized into 0-6 h ring stage parasites and equally divided into two groups. One group contained shield1 in the culture medium, whereas the other group was lacking shield1. Thus, four groups of lines including PfSWIB∆ (PfSWIB shield1 induced), PfSWIB (PfSWIB sh− shield1 not induced), 3D7 sh+ and 3D7 sh− were subject into the in vitro culture, with exactly the same preliminary parasitemia of 0.2%.The results of GCA revealed no significant difference in parasitemia between these lines during the first 48 h life-cycle (F (3, 6) Based on the GCA result, we subsequently performed RNA-seq analysis in duplicate with synchronized 0-6 h ring stage parasites of three P. falciparum lines within their third life-cycle, to study the change of expression profiling when knocking down PfSWIB. The scatter plot illustrates the comparison of screening of differentially expressed genes in three parasite lines, including 3D7, PfSWIB and PfSWIB∆ (Additional file 6: Figure S3a ). Among all differentially expressed genes, 112 and 450 were upregulated in the PfSWIB∆ line when compared with the PfSWIB and 3D7 line, respectively, whereas 1 and 616 genes were downregulated (fold change, FC > 1.5, P < 0.05, FDR < 0.05). We further performed hierarchical clustering of the individual gene expression profiles by using the R package edgeR. RNA-seq data were normalized for sequencing depth and gene length using log 2 -transformed FPKM values (Additional file 6: Figure  S3b ). According to the special characteristics of differentially expressed proteins in each line, we further screened out transcription factors such as PfApiAP2 family and PfSir2B, as well as certain histone modification enzymes, which proved to be involved in regulating on var gene transcription. These genes were significantly upregulated in the PfSWIB∆ line, suggesting the existence of their different transcription profiling when knocking down PfSWIB. In addition, a number of vars also exhibited differential expression among different lines (Additional file 2: Table S2 ).To further study the transcription patterns of upsA-, upsB-and upsC-subtype var genes in different parasite lines, we first selected 44 differentially expressed vars among different lines based on the RNA-seq results (fold change, FC > 1.5, P < 0.05, FDR < 0.05), and tested the expression patterns of these preferred vars in each comparison group at the ring stage (0-10 h after re-invasion in 3rd life-cycle, > 96 h) by real-time PCR (Additional file 2: Table S2 ). upsB or upsA corresponds to subtelomeric and upsC corresponds to chromosome internal var gene members [55, 56] . Figure 3 shows the fold change of var gene expression profiling between shield1 pre-and post-induced lines PfSWIB∆ vs PfSWIB. Most upsA-and upsC-type vars were significantly downregulated in the PfSWIB∆ line, especially the upsA vars, when compared to the PfSWIB line (Fig. 3 , Additional file 7: Figure S4 ). However, the expression pattern of partial upsB vars presented a distinct change in the PfSWIB∆ line. A group of 9 upsB vars exhibited a high level of expression (Fig. 3 , red asterisk) (fold change ≥ 2.0, P < 0.05), while 5 upsB vars present an extremely low expression level (Fig. 3 , black asterisk) (fold change ≤ − 2.0, P < 0.05), when compared the PfSWIB∆ line to other lines.We subsequently re-analyzed the RNA-seq results of vars in these lines by using the R package edgeR, to identify similarities and differences in expression patterns for different var variants. The heatmap representing the hierarchical clustering of the var genes is shown in Fig. 4 and Additional file 8: Figure S5 . Figure 4 indicates two major clusters of 44 selected vars in relation to the expression pattern: one major cluster consisting of 37 var variants covered most of upsA, upsB and all upsC vars, while the other cluster covered only 5 upsB and 2 upsA vars. In addition, there were 24 and 20 vars variants showed an expression maximum in the 3D7 line and PfSWIB∆ line, respectively (red box). Additional linear regression analysis of the correlation between qPCR and RNA-seq data was performed to investigate the transcriptome data accuracy on 44 var genes (Additional file 9: Figure S6 , Additional file 10: Table S4 ). In the PfSWIB vs PfSWIB∆ comparison, the qPCR data showed a significant linear correlation with the RNA-seq data (r (44) = 0.6281, P < 0.0001). The RNA-seq results of 9 upregulated and 5 downregulated upsB vars (described above by qPCR analysis in the PfSWIB∆ line), were also re-analyzed by computing the log 2 fold change of FPKM values in different lines. Of these, 5 out of 9 upregulated upsB vars (except for PF3D7_1300100, PF3D7_1200100, PF3D7_0900100 and PF3D7_0712300) (Fig. 4, red arrow) , and 4 out of 5 downregulated (except for PF3D7_1240300) (Fig. 4 , black arrow) showed consistency with the qPCR results. Additional file 8: Figure S5 shows the expression pattern and hierarchical clustering of all the 60 vars in the three lines.According to previous studies, var genes were highly expressed in the ring stage, while drastically downregulated in the trophozoite stage [6, 10, 11] . To confirm this, we initially collected RNA samples from the ring and trophozoite stages of the 3D7 clone within the third . Approximately all of the var genes, were downregulated at the mature stage of 3D7 sh+ and 3D7 sh− parasite lines, except for PF3D7-0632500 (upsA), and PF3D7_1219300 and PF3D7_0712900 (upsB), suggesting that shield1 may have no influence on the expression of most var genes in a single 48 hour-life cycle of P. falciparum (Additional file 11: Figure S7) .We subsequently analyzed the log 2 ratio of T/R in invitro cultured PfSWIB∆ and PfSWIB lines within their third life-cycle after collecting RNA samples from their synchronized ring and trophozoite parasites. Among these parasite lines, PfSWIB exhibited a quite similar log 2 ratio of T/R to 3D7, which was characterized by the downregulation of most var genes at the mature stage (Fig. 5) . In contrast, approximately all of the upsA vars, as well as partial upsB (PF3D7_1200400, PF3D7_0632500, PF3D7_1219300, PF3D7_1240300 and PF3D7_1240400) and upsC (PF3D7_0412900, PF3D7_0420900 and PF3D7_0617400) vars were activated at the mature stage of P. falciparum in the PfSWIB∆ line (Fig. 5 ).The interplay between altered histone modification, chromatin modifying machinery, and general or sequence-specific transcription factors results in var gene regulation by modulating chromatin structure [57] . In this process, ATP-dependent chromatin remodeling complexes (CRCs) play a key role in chromatin remodeling through removal and movements of nucleosomes and deposition of alternative histones [13] . There are at least 11 proteins containing putative SWI2/SNF2 ATPase catalytic domains in P. falciparum [58] , seven of which are predicted to be chromatin-modifying proteins, including ISWI, Swr1, CHD1, SNF2L, MAL8P1.65, PFB0730w, PFF0225w and PF13_0308 [18] . However, it remains unclear how these PfCRCs regulate var gene expression by remodeling certain chromatin and therefore resulting in a high level of antigenic variation, immunity evasion and pathopoiesis.The SWI/SNF complex, originally revealed in yeasts, allows for transcriptional activation by remodeling chromatin [59] . It has also been demonstrated previously that mammalian SWI/SNF homologs complexes, also known as BRG1-associated factors (BAFs), can be found in multiple forms which consist of 9-12 proteins. Among these BAFs, BAF60b exists in an alternative form of the SWI/ SNF complex (Complex B), which is generally known as SWI-B or SWIB [34] . In humans, the BAF60a protein of the SWI/SNF complex is responsible for p53 binding and regulates its activities via an N-terminal region of the SWIB/MDM2 domain [35] , as well as facilitating cell cycle halting and tune the balance between repair and apoptosis induction [35] [36] [37] . SWIB/MDM2 domains have in fact been shown to participate in protein-protein [60] and chromatin-related interactions [61] , but their functional roles in other species are poorly understood. Similarly, the SWI/SNF complex is composed of constant units and includes the Swp73p/SNF12 protein comprising a SWIB/MDM2 domain, proposed to facilitate specificity and/or functionality to some extent [38, 62] . According to recent studies, the P. falciparum genome encodes two putative SWIB/MDM2 domain-containing proteins: PfMDM2 (PF3D70518200, SWIB/MDM2 domaincontaining protein) and PfSWIB (PF3D70611400, SWI/ SNF-related matrix-associated actin-dependent regulator of chromatin) [38] , and PfSWIB was not only crucial for the survival and growth of the parasite, but additionally had profound effects on the parasite by interacting with other unknown proteins [38] [39] [40] . Bioinformatics analysis demonstrated that PfSWIB is characterized by its SWIB domain (BAF60b domain, PlasmoDB, http://plasm odb. org/). Bonger et al. [45] have recently developed a new technique by which the degradation of a specific protein is definitely induced by way of a small molecule, shield1. Hence, an in-depth functional analysis of PfSWIB based on the conditional knock-down assay was implemented in the present study. By using a transgenic assay, drug screening and subsequent screening of the clones, we obtained two integrated parasite clones PfSWIB-C2 and B10, with a stable transfection of the modified locus PfSWIB-FKBP-LID into the Plasmodium parasites (Fig. 1 , Additional file 3: Figure S1 ). Western blot analysis confirmed that the fusion expression protein was successfully expressed in the transfected parasite lines, and there was a significant decrease of PfSWIB fusion protein expression in the PfSWIB∆ line (t (2) = 4.890, P = 0.0394), at its trophozoite stage within third life-cycle of P. falciparum. However, it should be noted that no significant change was detected in the protein expression level of PfSWIB fusion system during the ring stage, either in the presence or absence of drug pressure (t (2) = 1.006, P = 0.4205) (Fig. 2b , Additional file 4: Figure S2 ). This could be due to at least two reasons. First, it takes time for shield1 to work at full capacity through binding to LID, therefore, a portion or slight loss of fused PfSWIB protein could not be identified. Secondly, this protein might be expressed predominantly at the mature stage of P. falciparum.It is worth noting that PfSWIB may lead to stage-specific PCD, in the same way as BAF60a of the mammalian SWI/SNF complex induces p53-directed apoptosis, by which transient nuclear localization results in removal of these parasites, as previously described [35] . Vieira et al. [38] further demonstrated that PfSWIB could have a stage-specific, pro-survival function and takes part in the heat stress response of the Plasmodium parasite. They discovered that PfSWIB and PfARK3 participate in preventing p53-mediated apoptosis within the nucleus in reaction to heat stress [38] . Alternatively, human Aurora kinase B and its yeast homologue play key roles during gene transcription through histone H3 phosphorylation [39, 40] . Likewise, PfSWIB could also have an effect on parasite survival through transcriptional regulation by guiding the PfARK3\\'s phosphorylation activities [39, 40] . In our study, growth curve analysis of P. falciparum revealed that a relatively low parasitemia was observed in the PfSWIB knockdown line (PfSWIB∆) when compared to other parasite lines during their second life-cycle. Significant change was observed after 96 hours, when the parasites developed into the third life-cycle. The parasitemia of PfSWIB∆ showed a sharp decline (Fig. 2a) , suggesting that PfSWIB might play a key role in the proliferation and survival of P. falciparum.On the other hand, Jiang et al. [27] proved that knocking out the P. falciparum variant-silencing SET gene, which encodes an ortholog of Drosophila melanogaster ASH1 and controls histone H3 lysine 36 trimethylation (H3K36me3) on var genes, leads to expression of all vars. In another study focused on a novel chromatin-associated exoribonuclease, termed PfRNase II, Zhang et al. [63] revealed that this PfRNase II controls the silencing of upsA var genes, by marking their transcription start site and intron promoter regions leading to short-lived cryptic RNA. Depletion of PfRNase II specifically removes the silencing of upsA vars. Similarly, in the present study, knocking down of PfSWIB results in the silencing of upsA, upsC and partial upsB var genes, as well as removes the silencing of partial upsB vars (Fig. 3 , Additional file 7: Figure S4 ). Therefore, PfSWIB might be one of the trans factors activating var genes, especially the upsA vars, and silencing partial upsB vars. In addition, a few var genes exhibited inconsistent RNA-seq results with qPCR, especially the upsA vars. They are more likely to be conditionally activated in the PfSWIB knockdown line, according to the RNA-seq analysis (Fig. 4 , Additional file 8: Figure  S5 ). The minor inconsistency between the RNA-seq and the qPCR results for partial vars could be due to false positives/negatives resulting from either of these two methods, or experimental variation caused by different parasite lines or other unidentified factors. Nevertheless, by comparing the log 2 fold change data from qPCR and RNA-seq on 44 var genes, we confirmed that the linear regression and linear correlation analysis showed a significant linear correlation between the two methods (r (44) =v0.6281, P < 0.0001) (Additional file 9: Figure S6) .Furthermore, previous studies have demonstrated that var genes were highly expressed in the ring stage of P. falciparum, while drastically downregulated in the trophozoite stage. The var transcriptional levels in trophozoites are usually 10-100 times less than those in rings [6, 7, 10, 11] . A single P. falciparum parasite simultaneously transcribes multiple var genes but selects only one PfEMP-1 to attain the surface of the host cell by way of a developmentally regulated process [6, 7] . In order to test whether the transcription pattern had been disrupted when knocking down PfSWIB, we subsequently compared the transcription level of selected var genes between ring and trophozoite stage parasites, by testing the log 2 fold change of T/R in each group during a single life-cycle of P. falciparum (Fig. 5 , Additional file 11: Figure S7 ). Strikingly, we discovered that most of the upsA, upsB and upsC vars were downregulated in PfSWIB and 3D7 lines, while virtually all the upsA vars and partial upsB/upsC vars were significantly upregulated at the trophozoite-stage of the PfSWIB∆ line within the third life-cycle of P. falciparum (Fig. 5) , suggesting that PfSWIB might be involved in temporal regulation of var genes, particularly group A vars. The dysfunction of PfSWIB could disrupt the interactions between PfSWIB and other transcription factors which are essential for gene silencing or inhibit PfSWIB activity through unknown mechanisms.As we mentioned previously, P. falciparum varies its surface protein expression, particularly the var gene family-encoded clonally variant surface protein expression, to evade host immune responses [6] . In the process of monoallelic expression, specific silent var genes are usually retained at unique perinuclear sites and relocated to transcriptionally active zones [21, 28] . Nuclear actin has been discovered complexed with PfSET10, which has been suggested to play a role in the movement of the locus during activation and heterochromatic silencing [26, 29] . Actin and actin-related proteins (Arps) are common components of chromatin remodeling complexes and are involved in nuclear positioning. According to biological characteristics, PfSWIB may be involved in the process of relocating episomes, as an actin-dependent regulator of chromatin. Further studies regarding the possible role of PfSWIB and actin interaction would be worthwhile.In the present study, we revealed that actin-related chromatin remodeling factor PfSWIB is involved in the process of clonal variation in var gene expression, and is crucial for the survival and growth of the Plasmodium parasite. Depletion of PfSWIB not only silences upsA, upsC and partial upsB var genes and removes the silencing of partial upsB var genes, but also leads to the aberrant expression of upsA and partial upsB/upsC var genes at the mature stage of P. falciparum, during a single 48-hour life-cycle. These findings could provide a better understanding of the regulatory function of PfCRCs in regulating the clonal variation of the var gene family contributing to the pathogenesis in malaria parasites.', bib_entries=['The pathogenic basis of malaria', 'Variant surface antigens, virulence, genes and the pathogenesis of malaria', 'WHO Global Malaria Programme. Geneva: World Health Organization', 'The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of Plasmodium falciparum infected erythrocytes', 'Receptorspecific adhesion and clinical disease in Plasmodium falciparum', 'Developmental selection of var gene expression in Plasmodium falciparum', 'Antigenic variation in malaria: in situ switching, relaxed and mutually exclusive transcription of var genes during intra-erythrocytic development in Plasmodium falciparum', 'Switches in expression of Plasmodium falciparumvar genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes', 'A highly conserved segmental duplication in the subtelomeres of Plasmodium falciparum chromosomes varies in copy number', 'A well-conserved Plasmodium falciparumvar gene shows an unusual stagespecific transcript pattern', 'A study of var gene transcription in vitro using universal var gene primers', 'Chromatin-mediated epigenetic regulation in the malaria parasite Plasmodium falciparum', 'The role of chromatin in Plasmodium gene expression', \"5' flanking region of var genes nucleate histone modification patterns linked to phenotypic inheritance of virulence traits in malaria parasites\", \"5' flanking region of var genes nucleate histone modification patterns linked to phenotypic inheritance of virulence traits in malaria parasites\", 'Telomeric heterochromatin propagation and histone acetylation control mutually exclusive expression of antigenic variation genes in malaria parasites', 'Epigenetic memory at malaria virulence genes', 'Plasmodium falciparum heterochromatin protein 1 marks genomic loci linked to phenotypic variation of exported virulence factors', 'Chromatin-mediated epigenetic regulation in the malaria parasite Plasmodium falciparum', 'The role of chromatin in Plasmodium gene expression', 'In silico and biological survey of transcriptionassociated proteins implicated in the transcriptional machinery during the erythrocytic development of Plasmodium falciparum', 'The MYST family histone acetyltransferase regulates gene expression and cell cycle in malaria parasite Plasmodium falciparum', 'In silico and biological survey of transcriptionassociated proteins implicated in the transcriptional machinery during the erythrocytic development of Plasmodium falciparum', 'PfGCN5-mediated histone H3 acetylation plays a key role in gene expression in Plasmodium falciparum', 'Telomeric heterochromatin propagation and histone acetylation control mutually exclusive expression of antigenic variation genes in malaria parasites', 'Heterochromatin silencing and locus repositioning linked to regulation of virulence genes in Plasmodium falciparum', 'Sir2 paralogues cooperate to regulate virulence genes and antigenic variation in Plasmodium falciparum', 'Plasmodium falciparum Sir2 is an NAD+-dependent deacetylase and an acetyllysine-dependent and acetyllysineindependent NAD+ glycohydrolase', 'Sir2 paralogues cooperate to regulate virulence genes and antigenic variation in Plasmodium falciparum', 'In silico and biological survey of transcriptionassociated proteins implicated in the transcriptional machinery during the erythrocytic development of Plasmodium falciparum', 'Histone lysine methyltransferases and demethylases in Plasmodium falciparum', 'Potential epigenetic regulatory proteins localise to distinct nuclear subcompartments in Plasmodium falciparum', 'Plasmodium falciparum methyltransferase, maintains the active var gene in a poised state during parasite division', 'PfSETvs methylation of histone H3K36 represses virulence genes in Plasmodium falciparum', 'The role of chromatin in Plasmodium gene expression', 'Dynamic histone H3 epigenome marking during the intraerythrocytic cycle of Plasmodium falciparum', 'Heterochromatin silencing and locus repositioning linked to regulation of virulence genes in Plasmodium falciparum', 'A critical role of perinuclear fliamentous actin in spatial repositioning and mutually exclusive expression of virulence genes in malaria parasites', 'Identification and molecular characterization of an Alba-family protein from human malaria parasite Plasmodium falciparum', 'A major role for the Plasmodium falciparum ApiAP2 protein PfSIP2 in chromosome end biology', 'The role of chromatin in Plasmodium gene expression', 'Control of gene expression in Plasmodium falciparum-ten years on', 'Composition and functional specificity of SWI2/ SNF2 class chromatin remodeling complexes', 'Gene structure of rat BAF60b, a component of mammalian SWI/SNF complexes, and its physical linkage to the growth hormone gene and transcription factor SUG/proteasome p45 gene', 'BAF60a interacts with p53 to recruit the SWI/SNF complex', 'Mammalian SWI/SNF chromatin remodeling complexes are required to prevent apoptosis after DNA damage', 'SWI/SNF complex interacts with tumor suppressor p53 and is necessary for the activation of p53-mediated transcription', 'Localization and interactions of Plasmodium falciparum SWIB/MDM2 homologues', 'Localization and interactions of Plasmodium falciparum SWIB/MDM2 homologues', 'Mitotic phosphorylation of histone H3 Is governed by Ipl1/aurora kinase and Glc7/PP1 phosphatase in budding yeast and nematodes', 'Aurora-B phosphorylates Histone H3 at serine28 with regard to the mitotic chromosome condensation', 'Human malaria parasites in continuous culture', 'Synchronization of Plasmodium falciparum erythrocytic stages in culture', 'An alternative protocol for Plasmodium falciparum culture synchronization and a new method for synchrony confirmation', 'Efficient site-specific integration in Plasmodium falciparum chromosomes mediated by mycobacteriophage Bxb1 integrase', 'Small-molecule displacement of a cryptic degron causes conditional protein degradation', 'Cloning of naturally occurring mixed infections of malaria parasites', 'Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancyassociated malaria', 'A well-conserved Plasmodium falciparumvar gene shows an unusual stagespecific transcript pattern', 'A simple RNA analysis method shows var and rif multigene family expression patterns in Plasmodium falciparum', 'STAR: ultrafast universal RNA-seq aligner', 'Complex heatmaps reveal patterns and correlations in multidimensional genomic data', 'Ggplot2: elegant graphics for data analysis', 'featureCounts: an efficient general purpose program for assigning sequence reads to genomic features', 'ANOVA like differential expression (ALDEx) analysis for mixed population RNAseq', 'Unifying the analysis of high-throughput sequencing datasets: characterizing RNA-seq, 16S rRNA gene sequencing and selective growth experiments by compositional data analysis', 'Efficient site-specific integration in Plasmodium falciparum chromosomes mediated by mycobacteriophage Bxb1 integrase', 'Small-molecule displacement of a cryptic degron causes conditional protein degradation', 'Small-molecule displacement of a cryptic degron causes conditional protein degradation', 'Small-molecule displacement of a cryptic degron causes conditional protein degradation', 'WHO Global Malaria Programme. Geneva: World Health Organization', 'Developmental selection of var gene expression in Plasmodium falciparum', 'Sub-grouping of Plasmodium falciparum 3D7 var genes based on sequence analysis of coding and non-coding regions', 'Genome sequence of the human malaria parasite Plasmodium falciparum', 'Efficient site-specific integration in Plasmodium falciparum chromosomes mediated by mycobacteriophage Bxb1 integrase', 'Developmental selection of var gene expression in Plasmodium falciparum', 'A well-conserved Plasmodium falciparumvar gene shows an unusual stagespecific transcript pattern', 'A study of var gene transcription in vitro using universal var gene primers', 'Chromatin modifications, epigenetics, and how protozoan parasites regulate their lives', 'The role of chromatin in Plasmodium gene expression', 'Comparative analysis of apicomplexa and genomic diversity in eukaryotes', 'In silico and biological survey of transcriptionassociated proteins implicated in the transcriptional machinery during the erythrocytic development of Plasmodium falciparum', 'Diversity and specialization of mammalian SWI/SNF complexes', 'Gene structure of rat BAF60b, a component of mammalian SWI/SNF complexes, and its physical linkage to the growth hormone gene and transcription factor SUG/proteasome p45 gene', 'BAF60a interacts with p53 to recruit the SWI/SNF complex', 'BAF60a interacts with p53 to recruit the SWI/SNF complex', 'Mammalian SWI/SNF chromatin remodeling complexes are required to prevent apoptosis after DNA damage', 'SWI/SNF complex interacts with tumor suppressor p53 and is necessary for the activation of p53-mediated transcription', 'The SWIB and the MDM2 domains are homologous and share a common fold', 'The core of chloroplast nucleoids contains architectural SWIB domain proteins', 'Localization and interactions of Plasmodium falciparum SWIB/MDM2 homologues', 'SWI/SNF nucleosome remodellers and cancer', 'Localization and interactions of Plasmodium falciparum SWIB/MDM2 homologues', 'Localization and interactions of Plasmodium falciparum SWIB/MDM2 homologues', 'Mitotic phosphorylation of histone H3 Is governed by Ipl1/aurora kinase and Glc7/PP1 phosphatase in budding yeast and nematodes', 'Aurora-B phosphorylates Histone H3 at serine28 with regard to the mitotic chromosome condensation', 'Small-molecule displacement of a cryptic degron causes conditional protein degradation', 'BAF60a interacts with p53 to recruit the SWI/SNF complex', 'Localization and interactions of Plasmodium falciparum SWIB/MDM2 homologues', 'Localization and interactions of Plasmodium falciparum SWIB/MDM2 homologues', 'Mitotic phosphorylation of histone H3 Is governed by Ipl1/aurora kinase and Glc7/PP1 phosphatase in budding yeast and nematodes', 'Aurora-B phosphorylates Histone H3 at serine28 with regard to the mitotic chromosome condensation', 'Mitotic phosphorylation of histone H3 Is governed by Ipl1/aurora kinase and Glc7/PP1 phosphatase in budding yeast and nematodes', 'Aurora-B phosphorylates Histone H3 at serine28 with regard to the mitotic chromosome condensation', 'PfSETvs methylation of histone H3K36 represses virulence genes in Plasmodium falciparum', 'Exonucleasemediated degradation of nascent RNA silences genes linked to severe malaria', 'Efficient site-specific integration in Plasmodium falciparum chromosomes mediated by mycobacteriophage Bxb1 integrase', 'Developmental selection of var gene expression in Plasmodium falciparum', 'Antigenic variation in malaria: in situ switching, relaxed and mutually exclusive transcription of var genes during intra-erythrocytic development in Plasmodium falciparum', 'A well-conserved Plasmodium falciparumvar gene shows an unusual stagespecific transcript pattern', 'A study of var gene transcription in vitro using universal var gene primers', 'Developmental selection of var gene expression in Plasmodium falciparum', 'Antigenic variation in malaria: in situ switching, relaxed and mutually exclusive transcription of var genes during intra-erythrocytic development in Plasmodium falciparum', 'Developmental selection of var gene expression in Plasmodium falciparum', 'Heterochromatin silencing and locus repositioning linked to regulation of virulence genes in Plasmodium falciparum', 'Dynamic histone H3 epigenome marking during the intraerythrocytic cycle of Plasmodium falciparum', 'Plasmodium falciparum methyltransferase, maintains the active var gene in a poised state during parasite division', 'A critical role of perinuclear fliamentous actin in spatial repositioning and mutually exclusive expression of virulence genes in malaria parasites']),\n",
              " Row(paper_id='35452b9', title='Implementation of nondeterministic finite automata for approximate pattern matching', abstract='The smallest known biological organisms are, by far, the viruses. One of the unique adaptations that many viruses have aquired is the compression of the genes in their genomes. In this paper we study a formalized model of gene compression in viruses. Specifically, we define a set of constraints that describe viral gene compression strategies and investigate the properties of these constraints from the point of view of genomes as languages. We pay special attention to the finite case (representing real viral genomes) and describe a metric for measuring the level of compression in a real viral genome. An efficient algorithm for establishing this metric is given along with applications to real genomes including automated classification of viruses and prediction of horizontal gene transfer between host and virus.', full_text='In contrast to the lengthy, often redundant, genomes of higher organisms, the genomes of viruses are extremely efficient in the encoding of their genes. Where mammalian genomes, for example, possess lengthy introns which code for no genes at all, any given segment of a viral genome may be a coding region for several genes. In addition to prefix and suffix overlap of viral genes, some genes may also be encoded in a retrograde fashion (that is, the gene would be read in a direction opposite to other genes). These systems provide evidence that viruses have evolved a special type of information compression technique. Studying this natural compression system in a rigorous setting could yield insight into the structure of viral genomes and may contribute to a basis for classifying such structures.In this paper, we will specifically consider the types of compression seen in two small double-stranded DNA virus families, Papillomavirus and Polyomavirus, and single-stranded RNA viruses from the Bornavirus, Coronavirus and, to a lesser extent, the Filovirus and Retrovirus families.The importance of this genetic compression becomes obvious when considering the structure of viruses. Viruses generally consist of two principal components: a protein capsid, and genetic material inside the capsid. The capsid serves as protection for the genetic material and also as a mechanism for inserting the genetic material into a host cell. The genetic material may consist of single-or double-stranded DNA or RNA and, in some rare cases, a mixture of the former possibly also including proteins.The need for compression stems from the fact that the size of the capsid limits the amount of room for genetic information inside the virus. In the case of Polyomaviruses, the genome is constrained to be approximately 5kbp (5,000 basepairs) of DNA (compare to the human genome of size 3,150,000 kb), yet still manages to encode 6 distinct genes.We exposit here a formal model of the viral compression techniques in terms of constraints on languages. For example, we would say that a language satisfies the \"viral overlapping compression\" property if some prefix of some word in the language is also a suffix of some other word in the language. We can likewise define constraints for other viral compression techniques, including retrograde encodings. We will focus here on deterministic modeling of the gene-level mechanics, in contrast to the probabilistic analysis of [8] , which addresses gene compression from the point of view of evolutionary pressures and constraints on entire genomes.The organization of the paper is as follows: In section 2 we consider basic notation and prerequisites. In section 3 we define formal versions of the basic viral compression techniques and investigate relationships and dependencies between them. We consider also the question of for which families of languages it is possible to decide these properties. Section 4 focuses on the finitary case of the problem as this is the most interesting from the point of view of applied viral genetics. We present efficient algorithms to decide each of the properties for real viral genomes. Section 5 contains our conclusions and a discussion of practical applications.For a general introduction to virology, we refer the reader to [3] and [10] ; for formal language theory preliminaries, we refer to [9] . Let Σ be a finite alphabet. We denote, by Σ * and Σ + , the sets of words and non-empty words, respectively, over Σ and the empty word by λ. A language L is any subset of Σ * . For a word w ∈ Σ * , we denote the length of w by |w| and the reversal of w by w R . Let N be the set of positive integers. Furthermore, for k ∈ N, define Σ ≥k = {w ∈ Σ * | |w| ≥ k}.A full trio is a language family closed under homomorphism, inverse homomorphism and intersection with regular sets. A full trio is also referred to as a cone. It is known that every full trio is closed under arbitrary a-transductions 1 and hence arbitrary gsm mappings. We refer to [1, 4] for the theory of AFL\\'s.For a binary relation ⊆ Σ * × Σ * and a language L ⊆ Σ * , we defineWe will consider the following well-known relations. Let w, v ∈ Σ * .Also, for each of the relations above, we prepend the word \"proper\", which will be denoted by < p , < s , < i where we enforce that x, y ∈ Σ + above.For example,Before formally stating the definitions of the viral properties, we will define the following sets which will be used for the conditions.Let L ⊆ Σ * be a language, and let n ∈ N such that 1 ≤ n ≤ 6 and let k ∈ N. Then we define the following sets:So, for example, Z(i, L, k) consists of all words w ∈ L such that there exists a word u of length at least k, a non-empty word x and a word v whereby xu is in L and w = uv which is also in L.We now define the properties that we will study.Let L ⊆ Σ * , let n satisfy 1 ≤ n ≤ 6 and let k, l ∈ N. We say that L satisfies condition W (n, k, l) if |Z(n, L, k)| ≥ l.We also call condition W (1, k, l) the l-weak k-prefix overlapping property, condition W (2, k, l) the l-weak k-suffix overlapping property, condition W (3, k, l) the l-weak k-overlapping property, condition W (4, k, l) the l-weak k-double-sided overlapping property, condition W (5, k, l) the l-weak k-retrograde overlapping property and condition W (6, k, l) the l-weak k-concatenated retrograde overlapping property.For example, a language L satisfies W (1, k, l) if and only if there exists l distinct words w ∈ L whereby w = uv for some u, v, x ∈ Σ * , with u of length at least k,x non-empty and xu ∈ L.We also define a strong version of the properties above.We also refer to each of these properties by replacing the prefix \"l-weak\" of each condition above with \"strong\". 2 We now consider the relationships of these properties to each other. The following is immediate from the definitions.Then the following are true:Also, we note the following:Then the following are true:Proof. The first three statements are straightforward. For the fourth statement,Combining Lemma 1, 2, we obtain:Then the following statements are true:We see, however that if L 1 = {abc, aa} andWe also define the following sets which we will use for a characterization.Hence, there exists x ∈ Σ + such that xu ∈ L. Let i = 2. \"⊆\" Let w ∈ U (2, L, k). Thus, there exists v ∈ Σ ≥k , u ∈ Σ * , y ∈ Σ + , vy ∈ L, w = uv. Therefore, v ∈< −1 p (L) ∩ Σ ≥k and w ∈≤ s (< −1 p (L) ∩ Σ ≥k ). \"⊇\" Let w ∈≤ s (< −1 p (L) ∩ Σ ≥k ). Thus, there exists u, v ∈ Σ * such that w = uv with v ∈< −1 p (L) ∩ Σ ≥k . Hence, there exists x ∈ Σ + such that vx ∈ L.Let i = 3. Immediate from case 1, 2. Let i = 4. \"⊆\" Let w ∈ U (4, L, k). Thus, there exists u, v ∈ Σ ≥k , x, y ∈ Σ + , w = uv, (xu ∈ L∧vy ∈ L). Therefore, u ∈< −1Hence, there exists x, y ∈ Σ + such that xu ∈ L and vy ∈ L.Let i = 5. \"⊆\" Let w ∈ U (5, L, k) .This leads naturally to some decision problems. One would like to provide algorithms to test whether languages (or genomes) satisfy these properties. Namely, can we decide whether a given language satisfies one of the properties, depending on the language family that the given language is in? For each weak condition, this amounts to deciding whether |Z(i, L, k)| ≥ l and for each strong condition, it amounts to deciding whether Z(i, L, k) = L. Proposition 3. Let L 1 , L 2 be language families effectively closed under intersection and the full trio operations with L 1 being effectively semilinear and L 2 having a decidable equality problem. Then the following are true:1. For each k, l ∈ N and i, 1 ≤ i ≤ 4, it is decidable whether L ∈ L 1 satisfies W (i, k, l) and it is decidable whether L ∈ L 2 satisfies V (i, k). 2. If L 1 , L 2 are also effectively closed under reversal, then it is decidable whether L ∈ L 1 satisfies W (5, k, l) and it is decidable whether L ∈ L 2 satisfies V (5, k). 3. If L 1 , L 2 are also effectively closed under reversal and +, then it is decidable whether L ∈ L 1 satisfies W (6, k, l) and it is decidable whether L ∈ L 2 satisfies V (6, k).Also, every intersectionclosed full trio is closed under union and concatenation since L 1 $Σ * ∩ Σ * $L 2 is in L 1 and L 2 , there is an a-transducer which outputs L 1 ∪ L 2 and there is a homomorphism which outputs L 1 L 2 . Thus, Z(1, L, k), Z(2, L, k), Z(3, L, k), Z(4, L, k) are in L 1 and L 2 . Additionally, if L 1 , L 2 are closed under reversal, then Z(5, L, k) is in L 1 and L 2 and if L 1 , L 2 are closed under reversal and +, then Z(6, L, k) is in L 1 and L 2 . Since L 1 is effectively semilinear, we can decide if L ∈ L 1 is infinite [5] and if it is not, then we can effectively find the length of the longest word in L. Then, we can test membership of every word of length less than or equal to that length to determine whether |Z(i, L, k)| ≥ l (emptiness is always decidable for semilinear sets, and since L 1 is closed under intersection with regular languages, we can decide whether w ∈ L by testing whether L∩{w} = ∅). Also, by the decidability of equality for L 2 , the proposition follows.We denote by NCM the family of languages defined by one-way nondeterministic, reversal-bounded multicounter machines. It is known that NCM is an intersection and reversal closed full trio effectively closed under semilinearity [7] . Also, it is known that the family of regular languages is closed under all of the operations above and has a decidable equality problem.For each L ∈ NCM, each i, 1 ≤ i ≤ 5 and each k, l ∈ N, it is decidable whether L satisfies W (i, k, l). In addition, for each L ∈ REG, each i, 1 ≤ i ≤ 6 and each k, l ∈ N, it is decidable whether L satisfies W (i, k, l) and V (i, k).Ideally, one would like to apply the formal definitions given here to real viral genomes as a method for classifying viruses based on gene compression. In this section we will consider fast algorithms to do exactly this, and their complexity. Since all real viral genomes are finite, we will restrict ourselves to dealing with finite input languages here. We will describe algorithms which will verify each of the viral properties for a given input viral genome. A viral genome is a finite language in which the words are the genes of the virus.For a finite language L ⊆ Σ + , we let s L be the sum of the lengths of every word of L (the length of the genome).We recall a well-known and important result from [2] . A partial deterministic finite automaton is a deterministic finite automaton in which each state need not have a transition on every letter. The smallest partial DFA for a given regular language is the partial DFA that recognizes the language and has the smallest number of states. In [2] , it is demonstrated that, for each word w ∈ Σ * , the smallest partial DFA accepting For each algorithm in this section, we assume that we have some encoding of L as input, whereby there is only one copy of each word given. We have discussed above how to perform the method suffix dfa. It is easy to pass in the reversal of a language to suffix dfa, in time linear in s L . Then, in line 5 of Algorithm 1, we can check to see if the intersection is empty by keeping a counter starting at k and running w through the transition function of M , decreasing the counter at each step. Then, when the counter reaches 0, we test every state we hit on input w to see whether it is a final state. If it is, we increase l 1 and set v 1 indicating that w ∈ Z(1, L, k). Also, in line 8, we are testing whether w R ∈ Z(1, L R , k). Indeed, by Lemma 2(3), w R ∈ Z(1, L R , k) if and only if w ∈ Z(2, L, k). Thus, if this is true, we increase l 2 and set v 2 to true. In addition, w ∈ Z (3, L, k) if and only if w ∈ Z(1, L, k) ∪ Z(2, L, k) and so we increase l 3 if and only if either v 1 or v 2 is true, and we reset each to false. In this way, when the method completes, l 1 , l 2 and l 3 will be the maximum such that L satisfies W (1, k, l 1 ), W (2, k, l 2 ) and W (3, k, l 3 ), respectively. Furthermore, this method runs in time O(s L ) time. In addition, it is well-known that we can test whether a word w is in the language generated by an NFA in time O(|Q||w|) (see [6] ). Thus, to find the largest integer l 6 such that L satisfies W (6, k, l), we construct the NFA from L and decide membership of w R for each w ∈ L. This takes time O(|w 1 ||Q| + · · · + |w m ||Q|) = O(|Q|s L ). Thus, one can decide whether a finite language L satisfies W (6, k, l) in time O(s 2 L ). Finally, the strong properties can also be verified straightforwardly using the algorithms presented above. Indeed, they are just a special case where l = |L|. We summarize the preceding thusly: Proposition 4. Let i satisfy 1 ≤ i ≤ 5 and let Σ be some fixed alphabet. Then given a finite language L ⊆ Σ + as input without duplicates and k ∈ N, we can both find the largest integer l such that L satisfies W (i, k, l) and we can decide whether L satisfies V (i, k) in time O(s L ). Furthermore, we can both find the largest l whereby L satisfies W (6, k, l) and we can decide whether L satisfies V (6, k) in time O(s 2 L ).We have presented here a formalization of the process of gene compression that occurs in many viral genomes. We have shown dependencies and relationships between these properties and demonstrated that, in general, most of the weak versions of the properties can be decided for languages defined by nondeterministic finite automata augmented with reversal-bounded counters while the strong versions can be decided for regular languages. Most significantly, we have given algorithms which can efficiently decide these properties for real viral genomes and provide information which is immediately useful to virologists. These algorithms give us the ability to study the relative amount of gene compression between related viruses in a quantifiable way. It may be possible to infer evolutionary relationships between viruses using this information. The fact that genes overlap one another provides a very serious constraint for viral genome evolution. It is known that viruses occasionally aquire genes horizontally (that is, a gene from an infected host becomes part of the virus\\'s own genome). Clearly, only those genes which meet very specific constraints (e.g. those that are \"compressible\" relative to the virus\\'s genome) will be able to be incorporated into the virus. Using the algorithms presented here and real viral genome data, we can find target genes in the host organism which, due to their structure, have the greatest probability of being incorporated into the viral genome.Finally, the formal properties here also present a framework for automated classification of a virus given only its genome. The family of Coronaviruses, for example, has a very regular genomic structure: a single strand of +-sense RNA of length 27-30kb. The beginning of this RNA strand always encodes a viral polymerase (often as part of a polyprotein) and the remainder encodes a series of \"nested\" genes. Each of these nested genes is a proper suffix of the previous gene.This structure can obviously be formally encoded using the properties given here. Similar compression regularities can be found in other viral genomes and encoded using our properties. Classification of a new virus is then simply a matter of verifying compliance to our properties and then checking to see if this matches any known structures.By formalizing this ancient form of data compression, we have provided tools which will allow for further insight in the molecular evolution of viruses and assist in the automated classification of new viruses by reference to only their genomes.', bib_entries=['Evolutionary principles of genome compression', 'Principles of Molecular Virology, 3e', 'Basic Virology', 'Formal Languages', 'Transductions and Context-Free Languages', 'Algebraic and Automata-Theoretic Properties of Formal Languages', 'The smallest automaton recognizing the subwords of a text', 'Bounded algol-like languages', 'Reversal-bounded multicounter machines and their decision problems', 'The smallest automaton recognizing the subwords of a text', 'The smallest automaton recognizing the subwords of a text', 'Implementation of nondeterministic finite automata for approximate pattern matching']),\n",
              " Row(paper_id='9eff92d', title='FDA draft guidance for industry and FDA staff: in vitro diagnostic (IVD) device studies-frequently asked questions', abstract='', full_text=\"Two pathways are described for submission to FDA for clearance of a diagnostic device: a Premarket Application (PMA), which can lead to approval of a diagnostic device, and a Premarket Notification, which can lead to clearance. The latter is often called a 510(k), named for the statute providing for this path. Recent FDA clearance of molecular-based multiplex panels represents the beginning of a new era for the diagnosis of respiratory infections. The ability to test for multiple pathogens simultaneously, accompanied by the increasing availability of molecular-based assays for newly recognized respiratory pathogens will likely have a major impact on patient care, drug development, and public health epidemiology. We provide a general overview of how FDA evaluates new diagnostics for respiratory tract infections and the agency's expectations for sponsors developing new tests in this area.The Food and Drug Administration (FDA) has regulatory responsibility in the United States for review and oversight of the products that form the backbone of modern medical practice. FDA premarket and postmarket activities are administratively organized around centers, with the Center for Drug Evaluation and Research (CDER), Center for Biologics, Evaluation, and Research (CBER), and Center for Devices and Radiological Health (CDRH) bearing most of the responsibility for patient diagnosis and treatment. CDRH, through the Division of Microbiology Devices, in the Office of In Vitro Diagnostic Device Evaluation and Safety has regulatory responsibility for in vitro diagnostic devices (IVDs) intended for use in the diagnosis of almost all infectious diseases, including respiratory tract infections. The specific regulations that guide FDA are defined under Title 21 of the Code of Federal Regulations (CFR); in this overview, we highlight both the elements of the CFR relevant to in vitro microbiology diagnostic devices as well as how FDA approaches the review of microbiology device applications for respiratory infections. (Specific regulations cited are included in brackets when referenced.)IVDs are defined as ''reagents, instruments, and systems intended for use in the diagnosis of disease or other conditions, including a determination of the state of health, in order to cure, mitigate, treat, or prevent disease or its sequelae.for use in the collection, preparation, and examination of specimens from the human body'' [21 CFR 809.3] . Similar to drug and biological products, new in vitro devices must undergo FDA review prior to marketing. For a new IVD, both ''safety'' and ''effectiveness'' of a device must be demonstrated. The broad criteria for evaluating the safety and effectiveness of new IVD are also defined by regulation: Requirements for marketing also include the need for labeling that includes, among other requirements, product performance characteristics ''as appropriate . . . describing such things as accuracy, precision, specificity, and sensitivity'' [21 CFR 809.10].The following discussion provides an overview of how FDA approaches these requirements during the development and review of a new microbiology diagnostic device.FDA regularly issues guidances in an effort to make the FDA submission and review process more consistent. Guidances are not rules but provide FDA's current thinking on a topic. Guidances may be applicable to all of FDA (eg, see [1] ), to a center within FDA, to a class of products, or tied to a novel product (often called Special Controls Guidance; eg, see [2, 3] ). Some are initially issued as draft guidances where the public has an opportunity to comment for a prespecified period. In this article, we provide references to several FDA guidances.The FDA drug approval process is more familiar to physiciansadequate and well-controlled trials to establish safety and efficacy [21 CFR 314.50] are required as the standard for regulatory approval, usually conducted as randomized, comparative trials. In contrast, study designs used to support device applications are typically not randomized, controlled trials; most often, clinical performance is documented by a single prospective multicenter study in the intended use population, supported by extensive nonclinical analytical studies. For diseases of low prevalence, prospective studies may not be feasible.One major difference between drugs and devices is the existence of two distinct pathways for the marketing of devices: devices may be ''cleared'' through the 510(k) process when a new device is determined to be substantially equivalent to a previously marketed product. Devices for entirely new indications or higher-risk intended use are ''approved'' by the Premarket Application (PMA) process. It is important that clinical and analytical requirements for submissions are more aligned with the technology and the clinical settings for use of the device rather than the specific pathway used to go to market. Some devices are novel, but may be considered to be moderate risk in the context of how they are used. These devices may still may be cleared via the 510(k) process using what is called a de novo 510(k). However, the potential for a de novo pathway should be discussed with FDA well in advance of a formal submission.Essential elements considered in the review of a new in vitro diagnostic device for a respiratory pathogen are outlined in Table 1 and discussed in more detail below.How diagnostic devices are evaluated is strongly influenced by the intended use (IU) and the risks associated with that use. The proposed IU for a device is an explicit statement of the analyte that the device is measuring or detecting (eg, a specific organism or a biomarker for that organism, and the clinical disease resulting from infection). The IU also describes how the results are reported: qualitative assays most often report whether a specific pathogen is detected or not (eg, culture or direct antigen tests); less commonly (for respiratory pathogens), the results may be quantitative (eg, viral load assays or antibody titers).The specimen type (also referred to as the sample matrix) that can be tested is also an important component of the IU of the device. Typical specimens for an upper respiratory tract infection diagnostic device are nasal swabs, nasopharyngeal swabs, nasal washes; or for lower respiratory tract specimens, bronchoalveolar lavage or sputum. Less obvious matrices for respiratory pathogens include urine or gastric lavage specimens. Evaluation of an analyte in a specific matrix may be critical for a proposed IU as test performance may significantly vary across different matrices.The setting (and/or timing) where test specimens should be collected may also be part of the IU; for example, some devices (including several rapid influenza tests) are cleared for point-ofcare settings (ie, used near the patients while under the auspices of a laboratory with professional laboratorians). Timing may be equally critical to test performance; for example, sensitivity of certain rapid antigen tests may drop dramatically as an illness evolves.New devices must be compared with a benchmark for establishing whether or not a specific target condition is present. FDA recognizes two major situations for assessing the diagnostic performance of new qualitative diagnostic tests: when a clinical reference method is available or when a comparator other than a reference method is used. In the former circumstance, a clinical reference method is considered to be the best available method for establishing the presence or absence of the target organism [1] but the reference method cannot incorporate results reported by the new device; for example, a new enzyme- linked immunosorbent assay (ELISA) could not be used as one of the diagnostic criteria for the reference method in a study used to evaluate the performance of the assay. Confusion may sometimes arise when distinguishing between analytical and clinical reference method since these may be identical or separate in different contexts; for example, the performance characteristics for a new assay for group A streptococcus against an analytical reference method such as culture on appropriate media may only be valid in the clinical setting of pharyngitis, since group A streptococcus may be a normal colonizer and performance may be different in the setting of colonization versus infection. In contrast, the analytical and clinical reference methods for influenza A are identical since the presence of influenza A is always considered abnormal. Determining the appropriate clinical reference methods may be particularly complex in the setting of multiplex assays for diseases with multiple etiologies such as community-acquired pneumonia, and where two or more possible pathogens may be isolated.Newly identified organisms introduce different challenges in selecting the appropriate reference method; for example, more recently identified pathogens such as metapneumovirus may be difficult to isolate or confirm by traditional methods such as culture. Because a clinical reference method cannot include the new device in its ascertainment, methods such as polymerase chain reaction (PCR) followed by bidirectional DNA sequencing may be necessary to confirm test performance. Similar concerns exist for assays that differentiate subtypes of novel influenza, a disease where diagnostics are essential but where relatively few clinical specimens are available for confirming performance. There are recent FDA guidances that are useful in aiding companies in developing valid comparators. One is a draft guidance on establishing the performance of an influenza IVD [4] , whereas the other two guidances are special controls guidances: one for multiplex devices for respiratory viral pathogens [2] and the other for multiplex devices for influenza A subtyping [3] .Another common issue that arises in clinical studies for new devices is result discordance; that is, when discrepancies occur between the result with the new device and the reference method. The objective of a pivotal study is to ascertain performance of the new device. Retesting discrepant samples tends to result in an overly optimistic view of performance of the new device. If the new device is truly better than the current clinical reference method, companies should consider contacting FDA to discuss an alternative comparator prior to beginning their pivotal trial.Clinical studies for evaluating new devices should support the intended use of the device and be conducted in a manner that will yield results consistent with how the device would be integrated into US clinical practice. New devices under study may include foreign sites depending on the specific analyte and the specific intended use for the device; however, clinical studies with foreign sites must include a justification for why similar performance is expected in the United States. Study protocols should include clear inclusion and exclusion criteria, case report forms, and testing procedures. Sample sizes should be sufficient to ensure that the clinical performance is acceptable in its IU setting. See section on Assay performance characteristics: Statistics 101 for Diagnostic Devices for further discussion.The interpretation of results from a new investigational device should be determined prior to conducting 'pivotal' clinical studies. For a qualitative assay, this includes the criteria for scoring device results (eg, as either analyte detected, analyte not detected, equivocal, or invalid). Invalid results may occur when one or more test parameters fail to meet the expected criteria. For equivocal results, rules for retesting specimens should be specified. Assay Performance Characteristics: Statistics 101 for Diagnostic Devices Sensitivity/specificity. The simplest approach to describing diagnostic performance characteristics is when every test result can be described qualitatively (eg, analyte detected or not detected), and where a reference method exists. For a prospectively enrolled study where patients meet the inclusion/exclusion criteria for the IU of the device, agreement of the test results with the reference method establishes sensitivity and specificity of the test device.Sensitivity is the probability that the new device will have a positive test result given that the clinical reference method is positive; it is estimated in a clinical study as the fraction of patients that are positive by the new test among those that are positive by the clinical reference method. For example, in a study of novel H1N1 influenza, it is the percent of patients that both test positive by the new device and are positive via the reference assay divided by the number of patients positive by the reference assay. Low test sensitivity reflects less security with the results of a negative test; that is, patients with the disease may be falsely labeled as negative by the new assay. (This fundamental consideration, i.e., -equating ''analyte not detected'' with the absence of disease [or the analyte]-is a common misinterpretation that bedevils the clinical use of devices with imperfect sensitivity.). Specificity is the converse; that is, the probability that the new device will have a negative test result given that the clinical reference method is negative. Specificity is estimated in the pivotal study by the fraction of subjects that are negative by the new test among those that are negative by the clinical reference method. Higher specificity yields greater confidence in a positive result. It is important to recognize that although patients included in specificity calculations do not have the disease of interest, in most cases they are still symptomatic (depending on the specific IU for the test); asymptomatic subjects would not be considered part of the IU population for such a device and therefore would not be appropriate for use in a specificity calculation.There are examples where a new device is not compared with a reference but to a previously cleared/approved device. In this setting, sensitivity and specificity cannot be estimated due to the lack of known infected status. (For example, a benchmark reference standard for aspergillosis infection may include galactomannan as part of the definition of aspergillosis infection in certain populations, even in the absence of invasive procedures to document infection.). Identical statistical calculations can be used in this setting but are interpreted as being positive and negative percent agreement rather than sensitivity and specificity; these considerations are also described in FDA guidance [1] . Percent agreement estimates may be misleading as similar devices can both be in error; for example, 100% agreement between two similar devices would be unlikely to indicate the new device has perfect clinical sensitivity/specificity were the clinical truth available.There may be significant challenges with estimating the sensitivity of a new assay if the prevalence of the disease being tested for is low. As Table 2 illustrates, estimates of sensitivity are dependent both on the true underlying sensitivity and sample size. In a clinical study with only 5 specimens positive for a specific pathogen (via the reference method) and an observed sensitivity of 5/5 (100%) results in a lower confidence bound of only 55.6%, meaning diagnostic performance is very uncertain. Even for a test with perfect sensitivity, at least 35 patients with the condition of interest would be needed to yield a 95% lower bound greater than 90%. In a pivotal study for devices to detect more common conditions, it is not uncommon to see a sample size of 50 or more patients that are positive via the reference method. FDA considers the observed sensitivity and specificity and their respective 95% lower confidence bounds as part of device performance.When sensitivity, specificity, and prevalence are known, one can calculate positive and negative predictive values (PPV and NPV, respectively). PPV and NPV ask an alternative question: given a positive or negative test result, what is the probability that the patient has (or does not have) the condition being tested for? In a prospective study, this would be estimated as the percentage of patients with the condition of interest from all patients that test positive; similarly, the negative predictive value is estimated as the percentage of patients without the condition of interest among those that test negative.The relationship between sensitivity, specificity, prevalence, PPV, and NPV is illustrated in Table 3 . As can be seen, PPV and NPV are expressed as percentages; ideally, both will be close to 100%. The importance of test prevalence is illustrated in Table 4 where, despite high sensitivity and specificity, test utility is extremely limited in the context of ruling in a diagnosis as the PPV of the test result is still only 8%, underscoring the value of tests as an adjunct to diagnosis rather than the sole means for diagnosis.However, tests may still have substantial clinical value even when only the NPV is very high. A high NPV indicates that if the patient tests negative, it is very unlikely that the disease is present and the physician may want to pursue further work up to obtain a diagnosis.However, the formulas for NPV and PPV in Table 3 are inappropriate when prevalence is unknown (e.g., when representative cases and controls are selected for study). Instead, a more complex set of formulas found in Pepe [5] provides a means of estimating NPV and PPV under various scenarios for prevalence.Assuming one believes reasonable estimates of sensitivity and specificity are available, these equations can be used to illustrate what impact prevalence has on PPV and NPV: a Lower limit of a two-sided 95% score confidence interval (see [1] ). The lower confidence bound is influenced by the number of specimens with pathogen of interest and how good the device is. FN 1 TN 1 FP) 5 100% x (N 1 /N) , positive predictive value (PPV) is 100% x TP/(TP 1 FP), negative predictive value (NPV) is 100% x TN/(TN 1 FN) . In these equations, prevalence is assumed known (ie, measured without error). So if we had a device with a sensitivity of 90% and a specificity of 90% as in Table 4 , but the prevalence of the target condition of interest was now 10% rather than the 1% in Table 4 , the PPV would be 0.50 or 50% rather than 8.33% as in Table 3 , and NPV would be 0.99 or 99%. NPV is negligibly lower than in Table 3 .When a clinical study only assesses agreement to another previously cleared device rather than to a reference method, reporting NPV and PPV would be inappropriate.Prospective studies in the IU population provide the best estimate of real-world performance for a diagnostic device. However, clinical performance of devices for detecting rare conditions, such as potential bioterrorism agents (eg, anthrax) may be impossible to ascertain.Low prevalence often mandates the use of retrospective or banked specimens as clinical specimens for new devices. With banked specimens and/or enriched studies, prevalence usually cannot be estimated. (Retrospective samples that were prospectively archived [e.g., all patients meeting a prespecified inclusion/exclusion criteria are included] can still be representative provided storage conditions do not impact the assay results. However, banked [repository] specimens may not be representative and should be considered separately.). As an alternative, the PPV and NPV can be calculated for a set of plausible prevalence estimates so that the clinical impact of a different disease prevalence can be understood. It is also important to appreciate that including a nontrivial proportion of banked specimens or substantial enrichment of specimens can change the disease spectrum in the study, which in turn changes the estimates of sensitivity and specificity and not just prevalence; in this situation, sensitivity, specificity, PPV, and NPV could all be biased and misleading.Given the critical role of study design in determining performance characteristics for a new test, companies are strongly encouraged to discuss their study proposals with FDA prior to initiation of studies essential for device clearance or approval.To evaluate the performance of the assay in multiple settings, precision studies must be conducted to confirm the reproducibility of assay results. These studies usually include multiple days or multiple runs across clinical sites. Studies should be designed to capture all major sources of variability, including site-to-site variation, the effect of different operators, and instrument-specific variability. Detailed guidance regarding precision studies for in vitro diagnostic devices is available in the Clinical and Laboratory Standards Institute (CLSI) guideline EP5-2A [6] .For qualitative assays, test panels used for precision/reproducibility studies should not only include both positive and negative samples, but particularly samples close to assay cutoffs; that is, thresholds for distinguishing positive from negative or equivocal. For quantitative assays, panels should include samples that are at the extremes of the analytical measurement range as well as values near key clinical decision points.Analytical sensitivity (limit of detection) for each detected pathogen (analyte) and each specimen type (ie, matrix) need to be assessed [2-4, 7, 8] . Analytical specificity, including crossreactivity with other possible respiratory pathogens, should be assessed, as well as interference by common substances such as blood, medications, and so forth.For some quantitative assays, it may be necessary to rule out a possible hook effect with high positive samples. For studies utilizing banked specimens to establish clinical or analytical performance, it would be necessary to provide evidence that storage conditions do not impact assay results. Other analytical studies may be requested depending on the type of technology used.A recent major advance for respiratory in vitro diagnostic testing has been FDA clearance of multiplex devices that can test for multiple pathogens simultaneously. The technical definition of a multiplex assay is ''two or more targets simultaneously detected via a common process of sample preparation, target or signal amplification, allele discrimination, and collective interpretation'' [7] . Essentially, a multiplex assay takes a single sample and then provides more than one output (eg, adenovirus present or absent and influenza A present or absent).There are several known hurdles to developing a multiplex assay with many pathogens, as illustrated by the multiplex respiratory viral infection panel example [2] . Adequate performance must be demonstrated for each viral pathogen included Adding a high-risk pathogen such as severe acute respiratory syndrome (SARS) coronavirus to a multiplex assay would mean submitting a PMA for approval. Thus, the regulatory path may be a consideration when designing a multiplex device.An FDA special controls guidance for respiratory viral panel multiplex devices has been recently published [2] and addresses some of these issues. FDA also publishes special control guidance on devices detecting new pathogens, which can be either standalone tests or part of multiplex assays.The Clinical Laboratory Improvement Amendments of 1988 (CLIA) defines categorization for a subset of devices sufficiently simple to use in a CLIA-waived settings, thus in essence permitting the use of these diagnostic tests outside of a clinical laboratory [9] . (A CLIA-waived test is different from ''home use devices'' [eg, pregnancy tests] which can be used with no medical oversight, or ''point-of-care'' tests [eg, tests performed in an emergency room, which remains under the auspices of the hospital laboratory]. ''Point-of-care'' tests may or may not be CLIA-waived depending on the specific device.) Upon application by a sponsor, FDA has the authority to designate a specific in vitro diagnostic test as a waived test. Waived tests such as urine dipsticks or group A streptococcal throat swab tests have widespread clinical use due to their availability at sites such as physician offices or commercial pharmacies.Devices being considered for a CLIA waiver are first subject to the same regulatory process as other diagnostic devices; that is, the device must demonstrate it has adequate performance characteristics in the hands of a trained laboratorian. However, beyond the demonstration that the device has adequate performance characteristics, the device must perform well in a CLIA-waived setting. This can be done either after a device is cleared or approved, or the initial study of the device can be designed to support a CLIA waiver application, which can be submitted after clearance/approval is granted.As part of an application for a CLIA waiver, sponsors are required to include studies to show the outcomes of not following the ''instructions for use'' provided with the device (e.g., prolonging the incubation of reagents, adding reagents in the wrong order, etc). These are studies designed to ensure that the device is robust and simple enough to operate without a trained laboratorian. By this definition, a sample that required centrifugation for processing, for example, would not be eligible for a waiver.The study participants in a CLIA-waiver study represent end users typical of those who would perform the test in a waived setting (eg, nurses or aides in a doctor's office or nursing home). Three or more sites should be included in the study, with 1-3 users per site for a minimum of 9 intended users. Testing must also include specimens with results close to the test cutoff values (ie, specimens that may be the most challenging to nonlaboratorians). Detailed information regarding the design of studies for a CLIA waiver application, including the minimal performance criteria acceptable for a CLIA-waived device, is described in ''FDA guidance for industry and FDA staff: recommendations for Clinical Laboratory Improvement Amendments of 1988 (CLIA) waiver applications for manufacturers of in vitro diagnostic devices'' [9] .It is highly recommended that sponsors seeking to market a device for use in a waived setting consult with FDA early in the regulatory process, especially for new products under development. It is important to note that CLIA-waiver requirements are very stringent; sponsors should consider the value of device use in CLIA-waived settings before pursuing the waiver process.Most pivotal studies for IVDs do not involve managing the patient based on the result of the investigational device; thus, IVD companies are rarely required to have an investigational device exemption (IDE) to start their pivotal study. However, FDA Center for Devices and Radiological Health, including the Division of Microbiology Devices, provides advice to sponsors on whether an IDE is required and other issues regarding the pre-IDE submission consultative process. Given the extensive number of diagnostic indications, the evolving technologies, and potential regulatory pathways, FDA strongly recommends that companies consider participating in the pre-IDE submission process early in the device development cycle and especially prior to conducting pivotal studies. The pre-IDE process allows FDA to evaluate if the proposed study designs are appropriate to support the IU of a device. For new instrumentation that have not been reviewed by the FDA, documentation of hardware, software, and manufacturing processes will need to be assessed, and could be topics for discussion in a pre-IDE submission [10, 11] .As an aid to sponsors developing new diagnostic devices, FDA posts summaries of the review decisions for cleared devices on the FDA Web site (http://www.accessdata.fda.gov/scripts/cdrh/ cfdocs/cfpmn/pmn.cfm). Companies may want to examine these summaries for recently cleared devices that are similar to the ones they are proposing to submit. In addition, substantial advice concerning the device development process is available through published FDA guidance [12] .The previous discussion has only briefly reviewed some of the concerns manufacturers of new in vitro diagnostic tests should consider during their development. The extensive number of diagnostic indications, evolving technologies, increasing use of multiplex instruments in microbiology, and potential regulatory pathways mandate careful planning by sponsors when developing new diagnostic assays. It is essential that sponsors plan for clinical and analytical studies that consider the device performance needed to support the proposed intended use. The use of appropriate statistical methods in both planning and evaluating these studies is also highly recommended. Interactive dialogue with FDA during the device development process is strongly encouraged.\", bib_entries=['FDA guidance for industry and FDA staff: class II special controls guidance documents: respiratory virus panel multiplex nucleic acid assay', 'FDA guidance for industry and FDA staff: class II special controls guidance document: testing for detection and differentiation of influenza A virus subtypes using multiplex nucleic acid tests', 'FDA guidance for industry and FDA staff: class II special controls guidance documents: respiratory virus panel multiplex nucleic acid assay', 'FDA draft guidance: establishing performance characteristics of in vitro diagnostic devices for the detection or detection and differentiation of influenza viruses', 'FDA guidance for industry and FDA staff: class II special controls guidance document: testing for detection and differentiation of influenza A virus subtypes using multiplex nucleic acid tests', 'FDA guidance for industry and FDA staff: class II special controls guidance documents: respiratory virus panel multiplex nucleic acid assay', 'The statistical evaluation of medical tests for classification and prediction', 'FDA guidance for industry and FDA staff: class II special controls guidance documents: respiratory virus panel multiplex nucleic acid assay', '2A: establishment of precision of quantitative measurement procedures', 'A: verification and validation of multiplex nucleic acid assays', 'FDA guidance for industry and FDA staff: recommendations for Clinical Laboratory Improvement Amendments of 1988 (CLIA) waiver applications for manufacturers of in vitro diagnostic devices', 'FDA guidance for industry and FDA staff: recommendations for Clinical Laboratory Improvement Amendments of 1988 (CLIA) waiver applications for manufacturers of in vitro diagnostic devices', 'FDA guidance for industry and FDA staff: guidance for the content of premarket submissions for software contained in medical devices', 'FDA guidance for industry, FDA reviewers and compliance on off-the-shelf software use in medical devices', 'FDA draft guidance for industry and FDA staff: in vitro diagnostic (IVD) device studies-frequently asked questions']),\n",
              " Row(paper_id='f2845f7', title='Full Title: A systematic review of MERS-CoV (Middle East Respiratory Syndrome Coronavirus) 2 seroprevalence and viral RNA prevalence in dromedary camels: implications for animal vaccination', abstract='', full_text='Since the first human case of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 53 was detected in 2012 (1), a substantial evidence base has built up showing dromedary camels to be the 54 zoonotic source of this virus (2) . MERS-CoV circulates extensively in dromedary populations causing 55 no impactful disease. Human infection, however, is associated with a measured case fatality ratio of 56 around 35% (3). Following spillover events, human-to-human transmission of MERS-CoV is 57 relatively inefficient and limited to close, unprotected contact environments such as hospitals (4, 5) .Phylogenetic analysis of viral sequences isolated from dromedaries and humans indicates that 59 hundreds of camel-to-human spillover events are likely to have occurred since 2012 (6). Taken 60 together, recurring dromedary-to-human transmission is driving ongoing human infection.The key role of dromedaries in human MERS-CoV infection has led decision-makers to consider 62 dromedary vaccination as part of MERS-CoV prevention interventions (2) . Dromedary-targeted Additionally, although whole-virus isolation and culture is necessary to confirm whether the shedding 78 is infectious, detection of viral RNA through RT-PCR can be used as a proxy for the prevalence and 79 distribution of infectious dromedaries (8-10).By conducting a qualitative synthesis of the study findings, considering reported heterogeneities, and 81 summarising the results of longitudinal studies of infection and immunity, we aim to assess the extent 82 of current understanding of MERS-CoV epidemiology in dromedaries, implications for control, and 83 gaps to be addressed going forward. We note that a similar systematic review of the literature up untilMay 2018 was unknowingly carried out in parallel to our own (11), with no discussion between the 85 two groups. Here, we confirm and update the results of the parallel review, discussing our results in 86 the context of potential animal vaccination and mathematical modelling of MERS-CoV in dromedary 87 camels. f. neutralisation at dilution >1:80 gave 15% seropositivity but regional range only available for ELISA results -reported accordingly 138 g. study also tested different site-types but measured RNA in serum sample rather than nasal swab so this was not included 139 h. range is across weeks rather than regions 140 i. both (66) and (65) Fig 3) .(67) UAE 2012 - - - - 4% 1113 farm (68) UAE 2014 - - - - 100% j 6 j - - (69) UAE 2015 100% 8 - 1:40 100% 8 - -(70Although seroprevalence was 80-100% in adult dromedaries in most populations across the Middle Three studies have found dromedaries to be shedding MERS-CoV RNA despite having high 266 antibody titres months or weeks prior to detectable infection. Both older animals whose 267 antibodies reflect past exposure (29, 76, 79) , and young calves whose high antibody titres 268 were maternally-acquired immediately post-partum, became infected (79).One study directly observed recurring infection amongst a herd of dromedaries in Egypt.Four animals were shedding 1-3 months prior to a herd-wide epidemic in which they were Age-dependent seroprevalence patterns suggest that the higher prevalence of viral shedding 311 in juveniles compared with adults is likely due to immunological naivety. The age-312 distribution of reported infections synthesised here, suggests that contact with juveniles may 313 pose greater risks of human transmission than adults, making them potential targets for 314 vaccination. However, frequency of human contact with dromedaries may also be animal- respiratory syndrome coronavirus specific antibodies in naturally exposed Israeli llamas, 543 alpacas and camels. One Health. 2018;5:65-8. 544', bib_entries=[]),\n",
              " Row(paper_id='3e2fa78', title='Supplementary Information An eco-epidemiological study of Morbilli-related paramyxovirus infection in Madagascar bats reveals host-switching as the dominant macro-evolutionary mechanism', abstract='', full_text='- Figure S1 : Phylogeny of all sequences belonging to the UMRV phylogroup. - Table S4 : Bats cytochrome b sequences data set. -Table S5 : Test of host-parasite co-evolution using global fit methods ParaFit. Figure S1 . Phylogeny of all sequences belonging to the UMRV phylogroup. A global phylogeny of 308 partial L-gene sequences calculated in 10,000,000 iterations in MrBayes with the GTR + G + I evolutionary model and a 10% burn-in rooted with an Aquaparamyxovirus sequence (GenBank number EF646380). All Malagasy bat paramyxoviruses sequences obtained within this study fell within group of Unclassified Morbillivirus-Related viruses. Genbank accession numbers used for each virus genera are indicated in Table S6 . ', bib_entries=[]),\n",
              " Row(paper_id='3a6b4ad', title='Diagnosis and treatment of rhinovirus respiratory infections', abstract='Reçu et accepté le 7 février 2004', full_text=\"Les pathologies infectieuses respiratoires sont fréquemment rencontrées dans la communauté et généralement de gravité légère ou modérée. Les agents responsables sont, dans la plupart des cas, de type viral avec parmi eux : les virus influenza et para-influenza, le virus respiratoire syncytial, les rhinovirus, les coronavirus, et les adénovirus ; les herpès virus ne sont que très rarement rencontrés dans ce contexte. Parmi ces pathogènes, seuls quelques uns sont capables d'induire des tableaux sévères dont le diagnostic comme la prise en charge sont assez difficiles à réaliser. S'il est relativement aisé d'obtenir un diagnostic étiologique pour une infection bactérienne, cette étape est délicate en cas d'infection virale et rend d'autant plus difficile la prise en charge de ces pathologies. Ces pneumonies restent malgré tout rares chez l'immunocompétent, et doivent systématiquement faire rechercher une pathologie ou un traitement immunosuppresseur si le diagnostic est confirmé : en dehors de la grippe et de la pneumonie à SRAS-coronavirus, une infection par un herpès virus, un rhinovirus ou autre est relativement exceptionnelle chez l'immunocompétent. Le rôle des virus dans les pneumonies graves est toujours difficile à confirmer. Cette revue va se focaliser sur les différents agents pouvant être impliqués et les caractéristiques, tant cliniques que biologiques, permettant de les caractériser.Le CMV est un membre de la famille des herpès virus ; ce virus à ADN possède un génome constitué de 230 kb qui en fait le plus important des herpès virus. L'infection à CMV est fréquente dans la population générale avec un niveau de séroprévalence reporté entre 40 à 100 % ; la distribution en fonction de l'âge est bimodale et deux pics sont décrits : le premier dans la petite enfance témoigne d'une transmission verticale qui peut être rattachée à l'allaitement maternel [1, 2] . Le second pic de séroconversion survient chez le jeune adulte, la transmission est essentiellement d'origine sexuelle [3] . La réponse à l'infection liée au CMV fait intervenir à la fois l'immunité cellulaire et l'immunité humorale ; cependant l'absence d'immunité cellulaire représente le facteur prédisposant le plus important des infections liées à ce pathogène. Pour cette raison, l'infection à CMV est généralement rencontrée en pathologie hématologique, dans un contexte de transplantation ou en cas d'infection VIH évoluée. Comme pour les autres infections à herpès virus, au décours de la primo-infection, le CMV demeure indéfiniment latent chez l'hôte, pouvant être à l'origine de réactivation et de réinfections successives dans le temps [4, 5] . Le mécanisme exact de la réactivation n'est pas encore totalement élucidé mais résulte le plus souvent d'une altération de la balance entre les défenses de l'hôte et le virus latent expliquant le caractère exceptionnel des infections respiratoires à CMV chez l'adulte immunocompétent [6] . Dans la greffe de moelle allogénique, la pneumonie à CMV survient dans 10 à 20 % des cas avec une mortalité estimée à 50 % [7] .Le patient hospitalisé en réanimation pose néanmoins un problème particulier car ne pouvant être considéré comme totalement immunocompétent. Différentes études ont essayé d'évaluer la fréquence de survenue des infections à CMV au sein de ce sous-groupe de patients : Papazian et al. rapportent les résultats obtenus sur une série de 60 nécropsies et 26 biopsies pulmonaires de patients atteints de pneumonies nosocomiales ou présentant une détresse respiratoire aiguë [8] . La pneumonie à CMV a été confirmée chez 25 patients, la symptomatologie clinique était totalement atypique dans la plupart des cas, ce sous-groupe de patients présentait néanmoins une hypoxémie plus sévère et une atteinte radiologique plus importante. La force de cette étude repose sur l'utilisation de critères histologiques dans le diagnostic de l'infection à CMV. En concordance avec ces résultats, Heninger et al., dans une unité de réanimation chirurgicale ont suivi 56 patients porteurs d'IgG anti-CMV au cours de leur hospitalisation [9] . Une fois par semaine, la recherche de CMV était réalisée par PCR et culture virale à partir d'échantillons sanguins et respiratoires. Vingt patients ont développé une infection active ; pour sept d'entre eux, le virus fut isolé des sécrétions respiratoires. Le seul facteur de risque mis en évidence par l'analyse multivariée était l'existence d'un sepsis (Odds ratio : 4,62). D'autres publications avaient aussi retrouvé le sepsis comme facteur favorisant d'une réactivation de l'infection à CMV avec des pourcentages variant entre 45 et 97 % [10, 11] . Le mécanisme responsable de la réactivation d'une infection à CMV latente impliquerait l'existence d'un déséquilibre de la réponse immune induit par une augmentation de production du TNF-a [10] . D'autres facteurs pourraient aussi être mis en cause comme l'existence d'une chirurgie ou d'une anesthésie qui ont toutes deux montré leur capacité à altérer la réponse immunitaire [12, 13] . De la même manière, la transfusion de produits sanguins contenant des leucocytes a été impliquée [14] .En dehors de la rétinite à CMV, les infections dues à ce virus ne peuvent être diagnostiquées sur une présentation clinique isolée. La symptomatologie clinique est aspécifique, rendant la pneumonie à CMV difficilement discernable d'une pneumonie nosocomiale d'étiologie bactérienne. Dans le travail de Papazian et al., les infections à CMV survenaient au décours d'une période de ventilation prolongée (médiane 18 jours), et les images radiologiques associaient des opacités interstitielles et alvéolaires bilatérales [8] .De façon classique, le virus doit être individualisé sur un prélèvement tissulaire, un liquide céphalorachidien ou dans le sang par une technique d'histopathologie, de cytologie ou en culture, l'isolement du virus à partir de sécrétions respiratoires ou en urinaire ne suffisant pas à poser le diagnostic.Plusieurs [17] . Elle constitue actuellement la technique de référence mais risque probablement d'être rapidement supplantée par les techniques de PCR. Son rendement est optimal sur le sang et le LCR, sa sensibilité initialement rapportée à 100 % pour le LBA a été depuis revue à la baisse [15] .Les inclusions intranucléaires sont pathognomoniques d'infection à CMV, elles peuvent être retrouvées au niveau du poumon, du côlon, de l'oesophage, ou du foie. Le caractère invasif de cette méthode en limite l'utilisation. La recherche de ces inclusions sur les cellules obtenues par un LBA a été proposée par Cordonnier et al., ces auteurs retrouvant une supériorité de cette analyse comparée à la biopsie pulmonaire [18] .2.1.3.6. La sérologie. D'un intérêt très limité, la sérologie peut trouver une place dans la primo-infection. La présence d'IgM peut aussi être observée dans une réactivation, manquer chez l'immunodéprimé, ou enfin persister jusqu'à une année chez certains patients. L'ensemble de ces facteurs limite donc considérablement l'intérêt de cette technique.La prise en charge d'une infection à CMV repose sur l'utilisation d'une chimiothérapie spécifique, trois produits sont actuellement disponibles :• le ganciclovir est un analogue nucléosidique inhibiteur de l'HCMV DNA polymérase. Il est généralement administré à la dose de 5 mg/kg par 12 heures en traitement d'attaque ; • le foscarnet est un inhibiteur de la DNA polymérase, il est administré à la dose de 90 mg/kg par 12 heures en traitement d'attaque en intraveineux ;• le cidofovir est un analogue nucléosidique inhibant la DNA polymérase virale. Sa demi-vie particulièrement importante permet une administration hebdomadaire ou bi-hebdomadaire. Il n'existe pas de recommandation précise sur l'utilisation respective de ces molécules chez le patient de réanimation. Dans le travail de Papazian et al., l'utilisation de ganciclovir a permis chez quatre des huit patients traités une amélioration de l'oxygénation dans les cinq jours [8] . Chez les patients dont le tableau clinique est particulièrement évolué, d'autres auteurs ont montré la faible efficacité de l'administration de ganciclovir [9] . Le problème de la résistance du CMV aux produits habituellement utilisés ne survient pas encore en réanimation avec la fréquence observée dans les secteurs de transplantation [19, 20] .En conclusion, il est important de souligner que la pneumonie à CMV de l'adulte immunocompétent est une pathologie rare et doit faire rechercher en première intention un facteur au moins transitoire d'immunodépression. La prise en charge n'est pas codifiée et repose sur des molécules dont la toxicité limite l'emploi. La guérison pourrait correspondre à la sortie de cette immunodépression relative, il est en effet difficile d'affirmer sur les données de la littérature qu'un traitement médicamenteux est le seul responsable de l'amélioration clinique.HSV1 est un membre de la famille des herpès virus. C'est un virus ubiquitaire dont la primo-infection peut s'étaler de l'enfance à l'âge adulte. À 20 ans, environ 40 % de la population « riche » et 60 % de la population « pauvre » ont été en contact avec le virus de l'herpès. Vers 40 ans, quasiment tout le monde a rencontré le virus.La contamination se fait par contact direct à partir des lésions cutanéomuqueuses. HSV1 possède un tropisme neurotrope, et va rester quiescent, l'évolution se faisant par résurgences cutanéomuqueuses. L'atteinte pulmonaire chez le sujet immunocompétent est exceptionnelle, de l'ordre du cas clinique dans la littérature.Dans les jours précédant l'atteinte respiratoire il est fréquemment retrouvé une réactivation cutanéomuqueuse. En dehors de cette éruption, la présentation clinique de la pneumonie à HSV1 ne permet pas de la discerner d'une pneumonie d'autre étiologie, bactérienne ou virale. Toutefois, certains auteurs ont retrouvé des hémoptysies et des dysphagies potentiellement liées à des atteintes muqueuses trachéales et oesophagiennes [21] . Des signes de défaillance neurologique peuvent être présents et s'expliquent facilement par le tropisme du virus. Une seule étude [22] , en réanimation, a recherché systématiquement HSV-1 par cultures virales sur des prélèvements distaux protégés chez des patients polytraumatisés. Quatre pneumonies dues à HSV1 ont été diagnostiquées sur 71 patients (5,4 %). Il est intéressant de noter que d'une part aucun des patients n'a présenté d'éruption cutanéomuqueuse et que d'autre part deux des quatre patients présentaient une co-infection bactérienne. Enfin la pneumonie à HSV1 peut se révéler en réanimation par un échec de sevrage de la ventilation mécanique. Ceci a été rapporté sous la forme d'un cas clinique [23] , la culture virale s'est avérée positive pour HSV1 et une fois traitée la patiente avait pu être sevrée de la ventilation mécanique.La radiographie du thorax peut révéler un infiltrat focalisé faisant évoquer une contamination par les voies aériennes, mais montre le plus souvent un infiltrat interstitiel diffus reflet d'une infection par voie hématogène.L'aspect histologique d'un poumon infecté par HSV1 comporte une nécrose parenchymateuse, des hémorragies et un infiltrat de cellules inflammatoires mononucléées.Classiquement le diagnostic est obtenu par culture virale telle que décrit précédemment pour le CMV. HSV1 est le virus ayant la plus grande vitesse de croissance, avec une réplication virale de 24 à 48 heures. En culture HSV1 produit un effet cytopathogène, son identification est confirmée par immunofluorescence. La méthode par centrifugation déjà décrite pour le CMV est aussi sensible que la culture traditionnelle et permet d'obtenir des résultats dans les 20 heures suivant l'inoculation. La PCR peut être obtenue rapidement (24 heures) et procure des résultats ayant une sensibilité et une spécificité respectivement de 95 et 100 %.Le traitement de référence est l'aciclovir intraveineux à une posologie pouvant aller de 5 à 10 mg/kg toutes les huit heures. Certains nouveaux antiviraux, qui sont bien absorbés par voie orale, tel le valaciclovir et le famciclovir, peuvent représenter une alternative à l'utilisation de l'aciclovir par voie intraveineuse.Des résistances à l'aciclovir ont été décrites. Elles se font généralement par le biais d'une mutation de la thymidine kinase, ou plus rarement de la DNA polymérase. Les HSV résistant à l'aciclovir présentent le plus souvent une résistance croisée au ganciclovir qui utilise également la voie de la thymidine kinase. Le traitement fait alors appel au foscarnet.Il n'existe pas de mesure préventive particulière chez les sujets immunocompétents. En revanche, la prévention est importante pour certains patients de réanimation immunodéficitaires et notamment les patients porteurs d'une maladie hématologique ou en aplasie, sous réserve de leur statut sérologique vis-à-vis d'HSV1. La prévention fait appel à l'aciclovir, au valaciclovir ou au famciclovir sans qu'il n'y ait actuellement de recommandations précises en terme de dose et de durée de traitement.Le virus de la varicelle et du zona est un virus ubiquitaire et strictement humain de la famille des herpès virus. Il se transmet par voie aérienne ou contact cutané. Le VZV est responsable de la varicelle chez l'enfant et du zona chez l'adulte (qui correspond à une réactivation du VZV). En 1980, près de 99 % des sujets adultes présentaient des anticorps anti-VZV, en 2001, on observe une baisse de ce pourcentage : près de 25 % des jeunes femmes sont actuellement séronégatives. Aux États-Unis et au Royaume-Uni, la proportion des cas chez les sujets de plus de 15 ans est passée de 7 % en 1967 à 20 % en 1995, avec une augmentation du taux de mortalité. Le risque de décès chez l'adulte est multiplié par 25 par rapport à l'enfant [24] . La pneumonie varicelleuse a été identifiée dès 1942, elle touche les enfants de moins de six mois et les adultes. Elle est responsable de 30 % des décès liés à la varicelle. Le seul facteur de risque identifié pour la pneumopathie varicelleuse chez l'adulte sain est le tabagisme [25, 26] .La présentation clinique est aspécifique et très variable : fièvre, toux, dyspnée, douleur thoracique. La présence des lésions cutanées de varicelle est un élément clé dans l'orientation du diagnostic. Dans les groupes prédisposés (déficit de l'immunité cellulaire, néoplasie, nouveau-nés, femme enceinte) la pneumonie varicelleuse prend volontiers l'aspect d'une détresse respiratoire aiguë hypoxémiante avec radiologiquement un infiltrat nodulaire bilatéral et des épanchements pleuraux modérés réactionnels [27, 28] . À l'extrême des formes pulmonaires abcédées ont été décrites chez l'enfant [29] .Le cas particulier de la femme enceinte a été bien étudié. La grossesse n'augmente pas en soi le risque de pneumopathie varicelleuse, en revanche, la varicelle grave de la femme enceinte et en particulier les formes avec pneumonies sont associées à une augmentation du nombre de morts in utero et d'accouchements prématurés. Les facteurs de risque de pneumonie varicelleuse retrouvés chez la femme enceinte sont le tabagisme mais également un nombre de lésions cutanées supérieur à 100, ce qui pourrait être le reflet d'une charge virale élevée [26] .La confirmation virologique rapide du diagnostic de pneumonie à VZV est difficile. La culture virale sur fibroblaste est longue, et seuls les prélèvements précoces contiennent du virus. L'effet cytopathogène se développe en trois à sept jours. L'immunofluorescence après centrifugation peut permettre d'accélérer le diagnostic (48 heures) .La recherche des anticorps anti-VZV ne semble pas présenter d'intérêt dans les formes aiguës puisque nécessitant un sérum précoce et un sérum tardif.Là encore c'est l'analyse par PCR qui semble être la plus à même d'apporter un diagnostic positif précoce. Le test permet d'identifier une séquence nucléotidique de 287 paires de bases qui ne présente pas de réaction croisée avec les autres herpès virus, le diagnostic peut ainsi être obtenu en 48 heures [28] .Nous aborderons uniquement le traitement des formes respiratoires. Il convient toutefois de rappeler que des mesures d'éviction des collectivités sont réglementaires ; de même il faut mettre en oeuvre des mesures de prévention de la surinfection des lésions cutanées. Il convient de proscrire l'utilisation d'aspirine en cas de fièvre en raison du risque de syndrome de Reye.Compte tenu de la sévérité de la pathologie et de l'évolution vers un syndrome de détresse respiratoire aiguë, il semble licite de proposer une surveillance en réanimation pour les patients présentant des facteurs de risque.La pneumonie à VZV repose sur l'aciclovir par voie intraveineuse (indication hors AMM) [24] . La posologie habituellement utilisée est de 10 à 15 mg/kg toutes les huit heures pour une durée de dix jours. Chez le nouveau-né la dose recommandée est de 20 mg/kg toutes les huit heures.Les immunoglobulines spécifiques réduisaient la gravité de la maladie chez les patients immunodéprimés mais ne sont plus disponibles. Les immunoglobulines polyvalentes n'ont aucune efficacité démontrée. Plusieurs auteurs ont retrouvé une diminution de mortalité après administration de corticoïdes chez les patients atteints de pneumonie à VZV hospitalisés en réanimation. Il s'agit cependant soit de cas cliniques [30] soit de petites séries observationnelles [31] . Ces données méritent donc d'être interprétées avec précaution. Il semble important de pouvoir préciser à quel groupe de patients et à quelle période de la maladie cette corticothérapie doit être instaurée. Cette possibilité thérapeutique ne fait en tout état de cause pas partie des recommandations de la conférence de consensus de 1998.En grande partie responsable de la fin de la première guerre mondiale, la grippe espagnole atteint la France en deux vagues successives, la première par Bordeaux en avril 1918, la seconde par Brest en août 1918. On estime actuellement que 25 à 40 millions de personnes sont mortes de cette grippe qui envahit les États-Unis en sept jours et traversa la planète en trois mois [32, 33] . Le responsable était le virus influenza A H1N1 qui continua de circuler jusqu'en 1957 où il fut finalement supplanté par un sous-type H2N2 avant d'être à son tour remplacé en 1968 par un nouveau sous-type H3N2.L'histoire s'est répétée : la grippe asiatique de 1957 (H2N2) et la grippe de Hongkong de 1968 (H3N2) firent à elles deux 1,5 million de victimes.Plus proche de nous, en 1997, à Hongkong, un nouveau sous-type, le virus influenza A H5N1 était isolé chez un enfant décédé de pneumonie, ce sous-type étant auparavant confiné au genre aviaire [34] . À la fin de cette même année, toujours à Hongkong, 17 nouveaux cas étaient recensés, avec six décès, laissant craindre l'arrivée d'une nouvelle pandémie [35] . Des mesures furent rapidement prises car ce nouveau virus était retrouvé chez près de 20 % des poulets vendus sur les marchés. Le 28 décembre 1997, 1,5 million de poulets furent ainsi exterminés sur l'ensemble du territoire endiguant la propagation potentielle de l'épidémie. En mars 1999, le système de surveillance mis en place détecta la présence de H5N1 sur une cargaison d'oies en provenance de la province de Guangdong, la souche étant similaire à celle de 1997. En février et mai 2001, H5N1 était à nouveau détecté sur des poulets décédés sur le marché à Hong Kong. Le gouvernement a ainsi décidé de réaliser une seconde extermination de poulets sur le territoire [36] .L'impossibilité d'éradiquer le virus influenza, les données historiques et les connaissances actuelles de la biologie, l'épidémiologie et l'écologie de ce virus laissent présager une future pandémie, incitant à une surveillance accrue des modifications du virus grippal.Le virus influenza a un génome constitué d'un ARN monocaténaire fragmenté en huit segments dont chacun code pour une protéine. Ces segments d'ARN peuvent à partir de deux virus grippaux différents se recombiner et produire un virus nouveau. La capside est constituée de protéines antigéniques déterminant le type A ou le type B. Les deux types de glycoprotéines virales de surface, l'hémagglutinine (H) et le neuraminidase (N), sont insérés sur l'enveloppe.À titre d'exemple, si l'on se focalise sur la dernière épidémie de 1997, les études épidémiologiques ont montré que les responsables de l'épidémie étaient les volailles, avec un taux d'infection proche de 20 % du parc, le virus provenant de Chine, de la province du Guangdong. Il n'y a pas eu lors de cette épidémie de transmission interhumaine de la maladie, même si une séroconversion asymptomatique a été mise en évidence parmi 3,7 % du personnel soignant et 10 % des sujets contacts [37, 38] . Une étude cas-témoin, comprenant 15 patients touchés par l'épidémie, a par ailleurs montré que seule l'exposition aux volailles la semaine précédant l'installation des symptômes, était un facteur de risque. Le fait de voyager en zone épidémique, de manger des volailles, ou de préparer des produits dérivés, n'était pas associé à un risque plus important [39] .Concernant la contamination interhumaine d'un virus humain ou adapté à celui-ci, la grippe se transmet par l'intermédiaire des microgouttelettes respiratoires et évolue par vagues successives pendant la saison hivernale. Des épidémies de grippe A surviennent tous les deux à trois ans, seule la grippe A pouvant se présenter sous forme de pandémies tous les 10 à 20 ans. Nous ne reviendrons pas sur le syndrome grippal habituel. Les paramètres cliniques décrits chez les patients infectés à Hong Kong en 1997 par H5N1 étaient marqués par l'existence d'une pneumonie avec hypoxémie sévère chez la moitié des patients avec évolution vers un SDRA ou un syndrome de défaillance multiviscérale chez six d'entre eux. Le seul critère qui prédisait l'évolution vers une forme sévère était une lymphopénie précoce sévère [36] . Les données biologiques objectivaient une lymphopénie, une altération du bilan hépatique, des troubles de coagulation et une insuffisance rénale. Une rhabdomyolyse peut être observée en particulier chez le patient âgé, sans retentissement apparent sur le pronostic même si le nombre de cas décrits reste faible [40] .Le diagnostic repose habituellement sur la symptomatologie clinique et un contexte épidémiologique adéquat. L'isolement du virus, la sérologie par hémagglutination sont possibles, toutefois une confirmation rapide peut être obtenue par RT-PCR sur liquide de LBA [41] .L'efficacité des antiviraux n'a pu être définie. L'amantadine a été essayée chez la majorité des patients, à un stade toutefois trop évolué pour juger de son efficacité.Depuis cet épisode, des mesures encore plus strictes de surveillance, de détection, et d'isolement des poulets venant de chine (isolement obligatoire pendant cinq jours), puis de destruction rapide d'élevage en cas de contamination ont pour l'instant permis d'enrayer cette épidémie.De ces données, il semble évident que la source principale de contamination, le poulet, a été éradiquée, cependant le virus H5N1 circule toujours en Chine. La démographie propre à ce pays constitue, comme pour le coronavirus, un milieu optimal pouvant permettre un réassortiment de cette souche avec les souches humaines, voire une adaptation progressive par transmissions interhumaines successives. Ce passage à l'homme se traduirait alors, comme par le passé, par une pandémie dont la vitesse serait accentuée par les moyens de communication actuels. Les armes face à un tel scénario seraient alors une réponse internationale coordonnée [42] , les antiviraux, et la vaccination avec un délai important lié à sa fabrication.Sur l'ensemble des pneumonies communautaires de l'adulte, un pathogène est isolé dans environ la moitié des cas. De la même manière, en pédiatrie, dans la pathologie respiratoire en général, un agent responsable est retrouvé dans seulement deux tiers des cas. Les pathogènes les plus couramment isolés sont le virus respiratoire syncitial (VRS), les virus parainfluenza et influenza [43] . Un nouveau pathogène, le métapneumovirus, a récemment été isolé aux Pays-Bas chez des enfants souffrant d'infections aiguës des voies aériennes [44] . Ce virus a par ailleurs été mis en évidence chez certains patients atteints du SARS, laissant supposer qu'une co-infection puisse être responsable de ce syndrome [45, 46] .Ce virus isolé uniquement par des techniques de biologie moléculaire appartient aux paramyxovirus (tout comme le VRS et parainfluenza). Proche du pneumovirus d'origine aviaire, c'est le premier pathogène humain du genre métapneumovirus.Les signes respiratoires miment ceux d'une affection à VRS, et vont de la simple affection des voies respiratoires supérieures à la bronchiolite ou à la pneumonie nécessitant la ventilation mécanique. Les formes les plus sévères surviennent chez les sujets les plus jeunes [44] . Esper et al., dans une étude réalisée chez des enfants de moins de cinq ans, retrouvaient chez plus de 50 % d'entre eux : toux, rhinorrhée, fièvre et sibilants [47] , une hypoxie était présente chez un tiers d'entre eux. Chez le sujet âgé, le métapneumovirus peut aussi être responsable d'une symptomatologie respiratoire associant toux, fièvre et dyspnée [48, 49] .Depuis son identification au Pays-Bas, le métapneumovirus a été retrouvé sur plusieurs continents, en Europe [50] , en Australie [51] , en Asie [52] , et en Amérique du Nord [47] . Bien que ce virus ait été récemment identifié, son incidence parmi les enfants hospitalisés pour infection des voies aériennes n'est pas négligeable, que ce soit en Europe ou aux États-Unis [47, 53] : 6 % de ces enfants présentent une PCR positive au métapneumovirus et sont négatifs aux autres virus habituellement responsables de cette pathologie. Une étude séro-épidémiologique réalisée aux Pays-Bas a montré qu'audelà de l'âge de cinq ans, la grande majorité des individus était porteuse d'anticorps spécifiques dirigés contre le métapneumovirus [54] . Ce pathogène est aussi rencontré chez l'adulte : une étude a rapporté la présence du métapneumovirus dans les prélèvements nasaux de 2,2 % d'adultes souffrant d'infection des voies aériennes [50] . Des pneumonies à métapneumovirus ont par ailleurs été décrites chez des immunodéprimés [55] .Il n'existe pas de traitement spécifique à ce jour.De façon rétrospective, le premier cas de SARS a pu être daté au 16 L'agent responsable du SARS est un nouveau coronavirus, il fut obtenu à partir d'un collectif de 50 patients. Les auteurs ont collecté des aspirats nasopharyngés et du sérum et ont comparé ces patients à un groupe témoin hospitalisé pour une autre pathologie [57] . Deux autres travaux publiés ont permis de confirmer l'hypothèse du coronavirus [58, 59] .Le SARS-CoV se transmet de façon prédominante par voie respiratoire par l'intermédiaire de « gouttelettes » émises par le patient infecté [58, 60] . Les données de l'épidémie de Singapour ont permis de confirmer que cet agent n'est que modérément transmissible dans la plupart des cas ; la notion de « superspreader » probablement à l'origine de l'épidémie n'est que rarement retrouvée [61, 62] . Dans le cas du SARS, les premières analyses montrent que la contamination nécessite un contact prolongé et répété avec un malade présentant une symptomatologie pulmonaire. Ceci est étayé par les explorations préliminaires de Poutanen et Tsang, ainsi que celles de l'OMS et du CDC [45, 63] . Tous les patients ont eu un contact avec un sujet atteint. Une très grande proportion des cas initiaux de SARS survenait chez du personnel soignant, là encore en faveur d'un contact rapproché et prolongé [64] .La présence de virus dans les selles suggère la possibilité d'une transmission orofécale [57, 58] . À Hong Kong, 321 personnes ont été contaminées au sein d'un même immeuble (cluster Amoy garden) dont 41 % résidant dans le même bloc. Parmi ces patients, 66 % ont présenté une diarrhée (contre 2 à 7 % dans les tableaux décrits habituellement).Dans une faible proportion de cas le SARS-CoV pourrait aussi se propager par voie aérienne, ce mode de transmission permettrait d'expliquer le cluster initial de Hong Kong ainsi que certains cas nosocomiaux secondaires à une aérosolisation lors de procédures à risque.L'épidémie de SARS a débuté le 21 février 2003 à l'hôtel Métropole de Hong Kong. Avant la fin du mois de février, les différentes personnes contaminées au 9 e étage de cet hôtel ont essaimé à Hong Kong [63, 64] , au Vietnam et à Singapour [65] . De façon simultanée l'épidémie s'est poursuivie autour du monde essentiellement par le biais des voyages aériens internationaux vers d'autres villes et d'autres pays, dont le Canada qui fut particulièrement touché [45, 66] . L'origine de ce virus n'est pas encore clairement définie, plusieurs équipes à Hong Kong et Shenzhen ont identifié des souches de coronavirus génétiquement proches du SARS-CoV. Ces souches ont été recueillies à partir de prélèvements réalisés sur des animaux sauvages revendus pour la consommation humaine obtenus sur des marchés du sud de la Chine. Le virus a été individualisé sur la civette (Paguma larvata) [67] . Il n'existe actuellement aucune preuve du rôle de la civette dans l'histoire naturelle de l'épidémie de SARS.La période d'incubation peut varier de 1 à 11 jours avec une moyenne à six jours. Le signe clinique le plus fréquem-ment retrouvé dans l'ensemble des séries est la fièvre, elle peut cependant être absente dans la phase très précoce de la maladie. La symptomatologie est rassemblée dans le Tableau 1 en fonction des différentes séries déjà publiées.On notera que dans la forme du cluster Amoy Garden précédemment décrite, la diarrhée est présente chez 60 % des patients. [68] . Une lymphopénie progressive est observée chez 98 % des patients atteignant son maximum lors de la deuxième semaine. La récupération s'amorce dès la 3 e semaine mais peut persister jusqu'à cinq semaines. La plupart des patients ont un taux de CD4 et CD8 diminué à la phase précoce de la maladie et ceci est associé à un plus mauvais pronostic. Une leucopénie transitoire a été observée chez 64 % des patients lors de la 1 re semaine, l'augmentation des neutrophiles survient ensuite possiblement liée à la corticothérapie.Sur le plan biologique, les anomalies les plus souvent rencontrées sont : une augmentation des LDH, des ASAT, des ALAT et des CPK [45, 57, 63, 64, 66] . Quelques patients ont présenté une baisse du calcium, phosphore, magnésium, sodium et potassium.Radiologie. La radiographie de thorax est anormale dans plus de 70 % des cas. Typiquement l'évolution radiologique débute par une opacité unilatérale qui en un à deux jours progresse vers une atteinte bilatérale généralisée [69] .L'étude de Hong Kong sur 156 SARS a permis d'individualiser trois facteurs associés à un pronostic défavorable : l'âge, un taux élevé de LDH, un taux élevé de neutrophiles à l'admission.La définition du SARS a été revue le 16 juillet 2003, elle repose sur trois séries de critères : cliniques, épidémiologiques, et biologiques.• Patient asymptomatique ou symptomatologie respiratoire minime. • Symptomatologie respiratoire modérée : fièvre supérieure à 38°C ET un ou plusieurs signes d'atteinte respiratoire basse (toux, dyspnée, gêne respiratoire, hypoxie).• Symptomatologie respiratoire sévère : fièvre supérieure à 38°C ET un ou plusieurs signes d'atteinte respiratoire basse (toux, dyspnée, gêne respiratoire, hypoxie), ET pneumonie radiologique.• Détresse respiratoire aiguë.Des données autopsiques confirmant une pneumonie ou un ARDS sans autre cause identifiable.• Voyage dans les dix jours précédant le début des signes dans une zone de transmission actuelle ou antérieure du SARS. • Contact dans les dix jours précédents avec un patient atteint de SARS. Le traitement le plus efficace est actuellement encore inconnu. Deux produits ont été administrées de façon relativement courante lors de l'épidémie, les corticoïdes et le ribavirine. La ribavirine est un anti-viral qui a montré une activité contre les virus à ARN et en particulier dans l'hépatite C. Son activité sur le SARS-CoV est relativement modeste et obtenue seulement à fortes concentrations. Les effets secondaires en particulier hématologiques en limitent rapidement l'utilité [66] . L'administration de corticoïdes a été Fièvre  100  100  94  99  Frissons  73  74  65  28  Toux  57  62  50  69  Myalgie  61  54  51  49  Malaise  50  64  31  Rhinorrhée 23  24  25  2  Pharyngite  23  20  23  12  Dyspnée  20  31  Diarrhée  20  10  27  24  Céphalées  56  20  50  35 réalisée de façon très large mais est actuellement de plus en plus contestée, rendue responsable de rebonds et d'activation de la réplication virale [70] . Des données préliminaires non encore publiées de l'équipe de Hong Kong montrent un rôle potentiellement intéressant du lopinavir.L'hospitalisation d'un patient porteur de SRAS en réanimation doit conduire à la limitation d'un certain nombre de gestes et procédures à risque. La liste suivante constitue une série de recommandations qui n'engage que les auteurs de ce travail.Utilisation d'une sonde à oxygène. Pas d'humification (limitant ainsi le débit à 5 L/min). Si le patient nécessite des FiO 2 supérieures à 50 %, un masque sans effet venturi peut être proposé.Toute procédure de ventilation non invasive par CPAP ou BiPAP est à proscrire formellement.Toute procédure impliquant une aérosolisation est strictement contre-indiquée.Les médications inhalées doivent être délivrées dans la mesure du possible par des dispositifs de type turbuhaler ou en cas d'impossibilité en utilisant une chambre d'inhalation.Proscrire la ventilation à haute fréquence. Utilisation d'un filtre type PALL 50 entre le tube et le ventilateur.Récupération et élimination des gaz à la sortie du ventilateur (pratique recommandée dont la mise en place reste obscure...) : une solution est la mise en place de deux filtres en série sur la valve expiratoire : le premier à la connexion circuit expiratoire-ventilateur, le second à la sortie du respirateur. L'idéal est un système de récupération fermé des gaz.Utilisation pour les aspirations d'un système clos. Pas d'instillation de sérum salé isotonique avant les aspirations.Limiter au maximum les aspirations.La ventilation au ballon doit être limitée au maximum. Le transport d'un patient ventilé au ballon est à proscrire, l'intubation est souhaitable.La ventilation au ballon pré-intubation doit s'accompagner de l'administration de curares pour limiter les fuites.Le ballon doit être équipé d'un filtre au niveau de la valve expiratoire.En cas d'arrêt cardiorespiratoire : le bouche-à-bouche est strictement contre-indiqué ; le massage cardiaque est en revanche, à débuter sans retard ; la ventilation au masque doit être rapidement mise en place, l'intubation la plus rapide possible.Aucun équipement ne doit être partagé avec les autres patients (radiologie portable).Rien ne doit être bu ou mangé à proximité du poste de surveillance infirmier.Papiers, crayons, photos ne doivent pas être sortis de la chambre une fois entrés.• la réalisation d'écouvillonnage nasal ou pharyngé ;• la kinésithérapie respiratoire du patient non intubé ;• l'extubation.Le virus respiratoire syncitial (VRS) est responsable d'une grande variété de pathologies respiratoires incluant des infections peu sévères et pouvant, chez certains sujets, induire des tableaux extrêmement sévères de bronchiolites ou de pneumonies. Cette pathologie affecte en général l'enfant et survient fréquemment dans un contexte d'immunodépression associée la sortant ainsi du cadre de cette revue [71, 72] . La radiologie de thorax est totalement atypique, pouvant être normale dans près de 30 % des cas [73] .Due à un paramyxovirus dénommé Morbilivirus, la rougeole se complique rarement de pneumonie, cette complication est cependant associée à une forte mortalité pouvant atteindre 60 %. En dehors de la surinfection, les atteintes respiratoires correspondent soit à une pneumonie interstitielle à cellules géantes, soit à une rougeole maligne pouvant évoluer vers la défaillance multiviscérale. Il n'existe aucun traitement spécifique, certains auteurs ont proposé l'administration de NO [74] , ou de corticostéroïdes et de vitamines A [75] .Le parvovirus B19 est un petit virus à ADN découvert en 1975 dans le sérum de donneurs de sang asymptomatiques [76, 77] . Cette infection est très courante avec un taux de séroconversion dans la population générale qui est de 50 % à 15 ans et passe à 90 % chez le sujet âgé. Quelques rapports ont montré l'existence de syndromes infectieux liés à une infection à Parvovirus B19 mais touchant généralement un hôte immunodéprimé [77] . L'infection du sujet immunocompétent est très rare [78] .Les rhinovirus sont habituellement responsables de pathologies peu sévères des voies respiratoires ; plusieurs auteurs suggèrent toutefois leur implication dans des tableaux plus aigus [79, 80] . Chez les personnes âgées, une atteinte des voies respiratoires inférieures peut être observée dans environ 60 % des cas [81, 82] . Dans la plupart des cas une immunodépression sous-jacente est observée : dans une étude rétrospective portant sur l'ensemble des prélèvements respiratoires réalisés sur une période de dix ans, Malcolm et al. ont analysé 431 échantillons de façon systématique [83] . Le CMV et HSV étaient le plus fréquemment isolés, le rhinovirus a pu être individualisé dans 20 cas, tous avaient une radiologie de thorax anormale, 60 % ont été admis en réanimation, et 25 % sont décédés. Tous ces patients avaient une pathologie ou un traitement responsable d'immunodépression. Les possibilités thérapeutiques sont limitées, seul le pléconaril pourrait présenter un intérêt, il agit comme compétiteur de la liaison du pathogène à la cellule épithéliale [84] , un inhibiteur de protéase est aussi actuellement en développement (AG7088).Les pneumonies virales représentent en secteur de réanimation un enjeu diagnostique majeur. Probablement sousestimée, l'incidence des pneumonies sévères directement liées à un virus est vraisemblablement associée à une morbimortalité importante. Les méthodes diagnostiques disponibles sont particulièrement lourdes et faisaient appel, dans un grand nombre de cas, soit à la culture cellulaire, soit à une sérologie dont le délai de réalisation est incompatible avec une mise en place rapide d'un traitement efficace. La généralisation et l'amélioration des techniques de biologie moléculaire avec une disponibilité maintenant accrue de la PCR sont en train de radicalement modifier notre pratique courante. En dehors de la grippe et du SRAS, une pneumonie sévère virale est rare chez le sujet immunocompétent et doit, à ce titre, si le diagnostic est confirmé, initier une enquête à la recherche d'un facteur immunosuppresseur sous-jacent que ce soit une pathologie (néoplasie, VIH, ...) ou un traitement (corticothérapie). L'arsenal thérapeutique antiviral est beaucoup moins développé que dans la pathologie bactérienne avec des molécules dont les effets secondaires sont souvent importants ; pour cette raison, le développement de techniques sensibles et spécifiques représente un espoir important dans la prise en charge de ces infections.\", bib_entries=['Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding', 'Current aspects of diagnosis and treatment of cytomegalovirus infections in infants', 'Cytomegalovirus infections in homosexual men. An epidemiological study', 'Summary of the International Consensus Symposium on Advances in the Diagnosis, Treatment and Prophylaxis and Cytomegalovirus Infection', 'Immune evasion by cytomegalovirus -survival strategies of a highly adapted opportunist', 'Cytomegalovirus infection', 'Cytomegalovirus pneumonia: presentation, diagnosis, and treatment', 'An unexpected cause of ventilator-associated pneumonia', 'Human cytomegalovirus infections in non-immunosuppressed critically ill patients', 'Cytomegalovirus reactivation and tumour necrosis factor', 'High incidence of active cytomegalovirus infection among septic patients', 'Cytomegalovirus reactivation and tumour necrosis factor', 'Changes in lymphocyte subpopulations and adhesion/activation molecules following endotoxemia and major surgery', 'The effect of anesthetic agents on the human immune response', 'Evaluation by polymerase chain reaction of cytomegalovirus reactivation in intensive care patients under mechanical ventilation', 'An unexpected cause of ventilator-associated pneumonia', 'Comparison between viremia and antigenemia for detection of cytomegalovirus in blood', 'Comparison of standard tube and shell vial cell culture techniques for the detection of cytomegalovirus in clinical specimens', 'Evaluation of three assays on alveolar lavage fluid in the diagnosis of cytomegalovirus pneumonitis after bone marrow transplantation', 'An unexpected cause of ventilator-associated pneumonia', 'Human cytomegalovirus infections in non-immunosuppressed critically ill patients', 'Ganciclovir resistance as a result of oral ganciclovir in a heart transplant recipient with multiple human cytomegalovirus strains in blood', 'Human cytomegalovirus resistance to antiviral drugs: diagnosis, monitoring and clinical impact', 'Pneumonia caused by herpesviruses in recipients of hematopoietic cell transplants', 'Herpes simplex virus pneumonia in trauma patients', 'Herpes simplex virus pneumonia presenting as failure to wean from a ventilator', 'Prise en charge des infections à VZV', 'Varicella pneumonitis: clinical presentation and experience with acyclovir treatment in immunocompetent adults', 'Risk factors and outcome of varicella-zoster virus pneumonia in pregnant women', 'Varicella pneumonia in patients with HIV/AIDS', 'Varicella-zoster virus detection by polymerase chain reaction using bronchoalveolar lavage specimens', 'Lung abscess complicating post-varicella pneumonia', 'Risk factors and outcome of varicella-zoster virus pneumonia in pregnant women', 'Varicella-zoster virus detection by polymerase chain reaction using bronchoalveolar lavage specimens', 'Prise en charge des infections à VZV', 'Varicella pneumonia: another ″steroid responsive″ pneumonia?', 'Corticosteroids in life-threatening varicella pneumonia', 'The chronicle of influenza epidemics', 'The origin of influenza pandemics', 'Update: Isolation of Avian Influenza A(H5N1) Viruses From Human Beings -Hong Kong, 1997-1998', 'Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus', 'Outbreak of avian influenza A(H5N1) virus infection in Hong Kong in 1997', 'Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong', 'Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts', 'Case-control study of risk factors for avian influenza A (H5N1) disease, Hong Kong', 'Outbreak of avian influenza A(H5N1) virus infection in Hong Kong in 1997', 'Influenza A pneumonia with rhabdomyolysis', 'Two cases of severe bronchopneumonia due to influenza A (H3N2) virus: detection of influenza virus gene using reverse transcription polymerase chain reaction', 'Influenza pandemic planning', 'Prospective comparative study of viral, bacterial and atypical organisms identified in pneumonia and bronchiolitis in hospitalized Canadian infants', 'A newly discovered human pneumovirus isolated from young children with respiratory tract disease', 'Identification of Severe Acute Respiratory Syndrome in Canada', 'Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome', 'A newly discovered human pneumovirus isolated from young children with respiratory tract disease', 'Human metapneumovirus infection in the United States: clinical manifestations associated with a newly emerging respiratory infection in children', 'Human metapneumovirus infections in hospitalized children', 'Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden', 'Human metapneumovirus as a cause of community-acquired respiratory illness', 'Australian find suggests worldwide reach for metapneumovirus', 'Children with respiratory disease associated with metapneumovirus in Hong Kong', 'Human metapneumovirus infection in the United States: clinical manifestations associated with a newly emerging respiratory infection in children', 'Human metapneumovirus infection in the United States: clinical manifestations associated with a newly emerging respiratory infection in children', 'Presence of the new human metapneumovirus in French children with bronchiolitis', 'Human metapneumovirus: a newly emerging respiratory pathogen', 'Human metapneumovirus as a cause of community-acquired respiratory illness', 'Osterhaus AD. Human metapneumovirus in a haematopoietic stem cell transplant recipient with fatal lower respiratory tract disease', 'Clinical utility of capillary polymerase chain reaction for diagnosis of Cytomegalovirus pneumonia', 'Coronavirus as a possible cause of severe acute respiratory syndrome', 'Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome', 'A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome', 'Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome', 'Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS)', 'Severe acute respiratory syndrome -Singapore', 'Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions', 'Identification of Severe Acute Respiratory Syndrome in Canada', 'A Cluster of Cases of Severe Acute Respiratory Syndrome in Hong Kong', 'A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong', 'Coronavirus as a possible cause of severe acute respiratory syndrome', 'Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome', 'A Cluster of Cases of Severe Acute Respiratory Syndrome in Hong Kong', 'A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong', 'Severe acute respiratory syndrome (SARS) in Singapore: clinical features of index patient and initial contacts', 'Identification of Severe Acute Respiratory Syndrome in Canada', 'Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area', 'Infectious diseases. Clues to the animal origins of SARS', 'Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis', 'Identification of Severe Acute Respiratory Syndrome in Canada', 'Coronavirus as a possible cause of severe acute respiratory syndrome', 'A Cluster of Cases of Severe Acute Respiratory Syndrome in Hong Kong', 'A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong', 'Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area', 'Severe acute respiratory syndrome: radiographic appearances and pattern of progression in 138 patients', 'Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area', 'The use of corticosteroids in SARS', 'Severe respiratory syncytial virus pneumonia associated with primary Epstein-Barr virus infection', 'Respiratory syncytial virus infection in patients with phagocyte defects', 'Respiratory syncytial virus infection of the lower respiratory tract: radiological findings in 108 children', 'Measles pneumonia: treatment of a near-fatal case with nitric oxide inhalation', 'Measles pneumonia. Treatment of a near-fatal case with corticosteroids and vitamin A', 'Role of parvovirus B19 in human disease', 'Parvovirus B19 in human disease', 'Parvovirus B19 in human disease', 'Acute lung injury due to parvovirus pneumonia', 'Conventional respiratory viruses recovered from immunocompromised patients: clinical considerations', 'Editorial response: rhinovirus pneumonia--a clinical entity?', 'Acute viral infections of upper respiratory tract in elderly people living in the community: comparative, prospective, population based study of disease burden', 'Risk factors for lower respiratory complications of rhinovirus infections in elderly people living in the community: prospective cohort study', 'Clinical features of patients with acute respiratory illness and rhinovirus in their bronchoalveolar lavages', 'Diagnosis and treatment of rhinovirus respiratory infections']),\n",
              " Row(paper_id='6edff6d', title='Early sexual initiation: The role of peer norms', abstract='', full_text='Letter to the editor Lessons Learned: Achieving Critical Mass in Masking Among Youth in Congregate LivingCovenant House is a nonprofit organization that provides housing and support services to youth facing homelessness. Homeless services are provided in congregate settings, which can facilitate the spread of infection. Recommendations to prevent COVID-19 may be difficult for a person experiencing homelessness to follow. For many, it is not possible to avoid crowded locations, such as shelters. However, once sheltered, some measures become more feasible, such as frequent handwashing with soap and water and wearing a face mask. Maintaining a distance of six feet from others may be more or less feasible depending on the limitations of spacing at the shelter but can be addressed with processes that make it possible. Covenant House staff members have been tirelessly working to maintain standard measures to protect our youth and to be able to sustain the shelters\\' mission during this unprecedented time.We serve at the health center within the Covenant House of Pennsylvania. Our first programmatic changes related to COVID-19 transmission were made in early March. While presented sequentially, many of our efforts happened simultaneously. Each new effort was introduced as it was developed with often overlapping time frames. We tried to minimize crowds by expanding mealtime and shower hours, thereby allowing fewer residents into those spaces at any time. We expanded access to hand sanitizers and required all youth to sanitize before entering public spaces. When we asked youth to abide by universal masking, many were initially resistant. Committed to avoiding punitive measures for youth not wearing their masks, we focused on methods of positive reinforcement. Our efforts were based on a diffusion of innovation model which has been successfully used with adolescents and young adults to achieve behavioral change [1e4] .A new idea is adopted slowly during the early stages of the diffusion process until a critical mass of early adopters is achieved [1e3]. We first worked to encourage staff to wear masks and, within a couple of weeks, mandated usage. We created posters of staff and celebrities wearing masks and placed them in public locations, but adult modeling had minimal impact on the youth. We took an informal poll to assess how the youth felt about masking and perceived barriers and made changes using the philosophy of rapid process innovation. Surgical masks, which were first available and recommended, were considered the most invasive, uncomfortable, and disruptive of all the interventions. Lack of personal experience with COVID-19, misinformation about their own susceptibility, conspiracy rumors, and general mistrust of government made it difficult for youth to appreciate real risks or the protective benefits of masking. In response, we set out to educate our youth and created customizable pins with the statement \"I wear my mask for.\" and distributed them around the shelter. We tried to harness the protective nature and compassion of the youth as motivation to adopt this new behavior change. The pins yielded few new adopters.Diffusion of innovation theory depends on early adopters\\' perception of the innovation as advantageous [1, 4] . We were able to identify an early adopter in shelter who was considered a leader among her peers. We met with her in the middle of March to better understand her motivations. She suggested that we allow the youth to decorate their masks, a subtle gesture that would celebrate individuality. We created a mask training session for the residents and provided them with space and materials to decorate the masks. We saw some improvement in the rate of adoption as our early adopter shared her positive experiences with other residents. However, by the end of March, we still had a minority of youth complying with universal masking.In mid-April, a little over 6 weeks after we began our initial efforts, we reached a critical mass. Cloth masks were introduced as an option for the youth, largely made possible by the charitable contributions of local donors. The cloth masks allowed residents the opportunity to express their personal styles. Here we saw the biggest change thus far in the rate of adoption. It was, however, the eventual donation of masks with the logos of Philadelphia sports teams that enabled us to reach our critical mass. This provided youth with the ability to champion their home sports team in a way similar to wearing a jersey or baseball cap while abiding by universal masking. We are now proudly at a point where on average about three-quarters of the residents wear their masks at any time while inside the shelter. We are aware that cloth masks do not offer the same protection as surgical masks but do decrease transmission rates. Nevertheless, the lesson we would draw from this process is that we would start next time with the decorative cloth masks e and be well supplied with team logos e to engage more early adopters.At Covenant House, we were faced with a nearly impossible mission of staying true to our core values during this www.jahonline.org pandemic. How do we keep our doors open to youth in need of shelter, support, and loving-kindness, while closing the doors to the virus in order to keep those inside safe and protected? Our open-door policy was perhaps what we both valued and feared most. What we discovered through our efforts is not a surprise to those familiar with adolescents. Diffusion of innovation, in this case universal masking, is largely dependent on the influence of early adopters [1, 2] . We also know that perceptions about peer behaviors motivate change [5] . Decisions made in adolescence are intimately bound to social context and the perception of normative behaviors. Once we reached critical mass in our universal masking, youth perception of peer behavior shifted and redefined what was considered normative. Innovations that involve a behavior change among youth need early adoption from a few prominent individuals. However, we must accept the power of peer influence and use it to our advantage, by first learning from youth what attracts and engages them. ', bib_entries=['Behavioral interventions for prevention and control of sexually transmitted diseases', 'HIV immunization: Acceptability and anticipated effects of sexual behavior among adolescents', 'Behavioral interventions for prevention and control of sexually transmitted diseases', 'HIV risk behavior reduction following intervention with key opinion leaders of population: An experimental analysis', 'Early sexual initiation: The role of peer norms']),\n",
              " Row(paper_id='d9112fa', title='SUPPLEMENTAL INFORMATION Integrating and updating wildlife conservation in China', abstract='', full_text=\". More than 60 turtle species from all over the world have been found being sold in the Yuehe Pet Market, the largest pet market in China. Over 60 % of the species are CITES listed species (e.g. Astrochelys radiata, Platysternon megacephalum), over 20 species as critically endangered (e.g. Cuora galbinifrons, Cuora picturata) or endangered (e.g.Cuora mouhotii, Geoemyda spengleri) on the IUCN Red List [S1, S2] . Due to lax law enforcement, wildlife trade in this market has existed for many years, posing a serious threat to endagered species in China and throughout the world. Table S1 . Number of threatened species of China's vertebrate in each category (birds [S3] , mammals [S4] , reptiles [S5] , amphibians [S6] , continental fishes [S7] ) and number of protected species of each category on the national key-protected species list of China \", bib_entries=[])]"
            ]
          },
          "metadata": {
            "tags": []
          },
          "execution_count": 5
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "J9xNLgNXfbNG",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 927
        },
        "outputId": "c2a9c8c2-2323-4972-8dbe-a141ffff27c5"
      },
      "source": [
        "df_abstract = df.loc[df['abstract'] != '']\n",
        "with pd.option_context('display.max_colwidth', -1):\n",
        "    display(df_abstract[['paper_id','title','abstract','bib_entries']].head(2))"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/html": [
              "<div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>paper_id</th>\n",
              "      <th>title</th>\n",
              "      <th>abstract</th>\n",
              "      <th>bib_entries</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>8d11bbb</td>\n",
              "      <td>Submit your next manuscript to BioMed Central and take full advantage of: • Convenient online submission • Thorough peer review • No space constraints or color figure charges • Immediate publication on acceptance • Inclusion in PubMed, CAS, Scopus and Google Scholar • Research which is freely available for redistribution</td>\n",
              "      <td>Background: Médecins Sans Frontières (MSF) is one of the world's leading humanitarian medical organizations. The increased emphasis in MSF on research led to the creation of an ethics review board (ERB) in 2001. The ERB has encouraged innovation in the review of proposals and the interaction between the ERB and the organization. This has led to some of the advances in ethics governance described in this paper. Discussion: We first update our previous work from 2009 describing ERB performance and then highlight five innovative practices:</td>\n",
              "      <td>[Innovation médicales en situations humanitaires: le travail de Médecins Sans Frontières, Conducting operational research within a non governmental organization: the example of Médecins Sans Frontières, Research ethics review in humanitarian contexts: the experience of the independent ethics review board of Medecins Sans Frontieres, Research ethics review in humanitarian contexts: the experience of the independent ethics review board of Medecins Sans Frontieres, What makes clinical research in developing countries ethical? The benchmarks of ethical research, MSF Field research, World Medical Association Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects, Council for International Organizations of Medical Sciences (CIOMS) in collaboration with the World Health Organization (WHO), Council for International Organizations of Medical Sciences (CIOMS) in collaboration with the World Health Organization (WHO), World Medical Association Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects, Theory and practice in public health ethics: a complex relationship, Relief of oppression': an organizing principle for researchers' obligations to participants in observational studies in the developing world, A framework for ethics review during public emergencies, Research ethics governance in disaster situations, Research in complex humanitarian emergencies: the médecins sans frontières/epicentre experience, Research ethics and international epidemic response: the case of Ebola and Marburg hemorrhagic fevers, World Medical Association Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects, Council for International Organizations of Medical Sciences (CIOMS) in collaboration with the World Health Organization (WHO), Making an Impact: A Preferred Framework and Indicators to Measure Returns on Investment in Health Research, What is the purpose of medical research?, Is operational research delivering the goods? The journey to success in low-income countries, Making sure that clinical trial results make a difference: operational research and the hierarchy of evidence, Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo, Mental health treatment outcomes in a humanitarian emergency: a pilot model for the integration of mental health into primary care in Habilla, Practicing medicine without borders: tele-consultations and tele-mentoring for improving paediatric care in a conflict setting in Somalia, Treating 4,000 diabetic patients in Cambodia, a high-prevalence but resource-limited setting: a 5-year study, Low referral completion of rapid diagnostic test-negative patients in community-based treatment of malaria in Sierra Leone, Cesarean section rates and indications in sub-Saharan Africa: a multi-country study from Medecins sans Frontieres, Efficacy of three artemisinin combination therapies for the treatmentof uncomplicated Plasmodium falciparum malaria in the Republic of Congo, Lost to follow up from tuberculosis treatment in an urban informal settlement (Kibera), Tracing patients on antiretroviral treatment lost-to-follow-up in an urban slum in India, Double ethical review of North-south collaborative clinical research: hidden paternalism or real partnership, Submit your next manuscript to BioMed Central and take full advantage of: • Convenient online submission • Thorough peer review • No space constraints or color figure charges • Immediate publication on acceptance • Inclusion in PubMed, CAS, Scopus and Google Scholar • Research which is freely available for redistribution]</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>141ea7b</td>\n",
              "      <td>Viral infection is not uncommon in adult patients with severe hospital-acquired pneumonia</td>\n",
              "      <td>Of 7,772 laboratory-confirmed cases of respiratory viral infection among hospitalized patients, 22.8% were categorized as having hospital-acquired infection. The overall incidence of hospital-acquired respiratory viral infection was 3.9 (95% confidence interval, 3.7-4.1) cases per 1,000 admitted patients. Rhinovirus was the most common virus (30.3%), followed by influenza virus (17.6%) and parainfluenza virus (15.6%).</td>\n",
              "      <td>[Respiratory syncytial virus infections on an adult medical ward, Outbreak of human parainfluenza virus 3 infections in a hematopoietic stem cell transplant population, Possible role of aerosol transmission in a hospital outbreak of influenza, Comparison of Anyplex II RV16 with the xTAG respiratory viral panel and Seeplex RV15 for detection of respiratory viruses, Red book: 2015 report of the committee on infectious diseases, Case definitions for national notifiable infectious diseases. Osong: KCDC, Understanding the burden of influenza infection among adults in Canadian hospitals: a comparison of the 2009-2010 pandemic season with the prepandemic and postpandemic seasons, Characterisation of nosocomial and community-acquired influenza in a large university hospital during two consecutive influenza seasons, Should lower respiratory tract secretions from intensive care patients be systematically screened for influenza virus during the influenza season, Viral infection is not uncommon in adult patients with severe hospital-acquired pneumonia]</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>"
            ],
            "text/plain": [
              "  paper_id  ...                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 bib_entries\n",
              "0  8d11bbb  ...  [Innovation médicales en situations humanitaires: le travail de Médecins Sans Frontières, Conducting operational research within a non governmental organization: the example of Médecins Sans Frontières, Research ethics review in humanitarian contexts: the experience of the independent ethics review board of Medecins Sans Frontieres, Research ethics review in humanitarian contexts: the experience of the independent ethics review board of Medecins Sans Frontieres, What makes clinical research in developing countries ethical? The benchmarks of ethical research, MSF Field research, World Medical Association Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects, Council for International Organizations of Medical Sciences (CIOMS) in collaboration with the World Health Organization (WHO), Council for International Organizations of Medical Sciences (CIOMS) in collaboration with the World Health Organization (WHO), World Medical Association Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects, Theory and practice in public health ethics: a complex relationship, Relief of oppression': an organizing principle for researchers' obligations to participants in observational studies in the developing world, A framework for ethics review during public emergencies, Research ethics governance in disaster situations, Research in complex humanitarian emergencies: the médecins sans frontières/epicentre experience, Research ethics and international epidemic response: the case of Ebola and Marburg hemorrhagic fevers, World Medical Association Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects, Council for International Organizations of Medical Sciences (CIOMS) in collaboration with the World Health Organization (WHO), Making an Impact: A Preferred Framework and Indicators to Measure Returns on Investment in Health Research, What is the purpose of medical research?, Is operational research delivering the goods? The journey to success in low-income countries, Making sure that clinical trial results make a difference: operational research and the hierarchy of evidence, Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo, Mental health treatment outcomes in a humanitarian emergency: a pilot model for the integration of mental health into primary care in Habilla, Practicing medicine without borders: tele-consultations and tele-mentoring for improving paediatric care in a conflict setting in Somalia, Treating 4,000 diabetic patients in Cambodia, a high-prevalence but resource-limited setting: a 5-year study, Low referral completion of rapid diagnostic test-negative patients in community-based treatment of malaria in Sierra Leone, Cesarean section rates and indications in sub-Saharan Africa: a multi-country study from Medecins sans Frontieres, Efficacy of three artemisinin combination therapies for the treatmentof uncomplicated Plasmodium falciparum malaria in the Republic of Congo, Lost to follow up from tuberculosis treatment in an urban informal settlement (Kibera), Tracing patients on antiretroviral treatment lost-to-follow-up in an urban slum in India, Double ethical review of North-south collaborative clinical research: hidden paternalism or real partnership, Submit your next manuscript to BioMed Central and take full advantage of: • Convenient online submission • Thorough peer review • No space constraints or color figure charges • Immediate publication on acceptance • Inclusion in PubMed, CAS, Scopus and Google Scholar • Research which is freely available for redistribution]\n",
              "1  141ea7b  ...  [Respiratory syncytial virus infections on an adult medical ward, Outbreak of human parainfluenza virus 3 infections in a hematopoietic stem cell transplant population, Possible role of aerosol transmission in a hospital outbreak of influenza, Comparison of Anyplex II RV16 with the xTAG respiratory viral panel and Seeplex RV15 for detection of respiratory viruses, Red book: 2015 report of the committee on infectious diseases, Case definitions for national notifiable infectious diseases. Osong: KCDC, Understanding the burden of influenza infection among adults in Canadian hospitals: a comparison of the 2009-2010 pandemic season with the prepandemic and postpandemic seasons, Characterisation of nosocomial and community-acquired influenza in a large university hospital during two consecutive influenza seasons, Should lower respiratory tract secretions from intensive care patients be systematically screened for influenza virus during the influenza season, Viral infection is not uncommon in adult patients with severe hospital-acquired pneumonia]                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \n",
              "\n",
              "[2 rows x 4 columns]"
            ]
          },
          "metadata": {
            "tags": []
          }
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "DenQy9y5fmnI"
      },
      "source": [
        "def countOccurences(str, targets, paperkey):\n",
        "  target=[]\n",
        "  dictonary={}\n",
        "  dictonary[paperkey] = {} \n",
        "  target=targets\n",
        "  a=str.split(\" \")\n",
        "  count=0\n",
        "  for targetword in target:\n",
        "    for i in range(0,len(a)):\n",
        "      if(targetword==a[i]):\n",
        "        count=count+1\n",
        "    #print(paperkey,count)\n",
        "    dictonary[paperkey]['paper_id']=paperkey\n",
        "    dictonary[paperkey][targetword]=count\n",
        "    #print(dictonary)\n",
        "    count=0\n",
        "  return dictonary"
      ],
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "hOoWjyv4fyEs",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "outputId": "8c329968-ec65-4c07-93d9-72949fbc05ce"
      },
      "source": [
        "targets = ['vaccine','vaccination','vaccines','vaccinations'] \n",
        "a={}\n",
        "for line,paperid in df_sp.select(\"abstract\",\"paper_id\").toLocalIterator():\n",
        "  b=countOccurences(line,targets,paperid)\n",
        "  a.update(b)\n",
        "#print(a)\n",
        "df2=pd.DataFrame(a)\n",
        "df2=df2.transpose()\n",
        "#abstract_dataframe_spark=spark.createDataFrame(df2)\n",
        "#print('Count of Targeted Words in an Abstract')\n",
        "#abstract_dataframe_spark.sort('vaccine', ascending=False).show(40,False)\n",
        "\n",
        "temp_df=df2.sort_values(by=['vaccine'],ascending=False)\n",
        "temp_df=temp_df.head(15)\n",
        "#print(temp_df)\n",
        "\n",
        "%matplotlib inline\n",
        "temp_df.plot(kind='bar',x='paper_id',y='vaccine',figsize=(20,8),title='Count of vaccine in Abstracts')\n",
        "temp_df.plot(kind='bar',figsize=(20,8),title='Paper wise distribution of words (Vertically)',stacked=True)\n",
        "#temp_df.plot.barh(figsize=(20,8),title='Paper wise distribution of words (Horizantally)',stacked=True)"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "<matplotlib.axes._subplots.AxesSubplot at 0x7f4fc7c22a20>"
            ]
          },
          "metadata": {
            "tags": []
          },
          "execution_count": 8
        },
        {
          "output_type": "display_data",
          "data": {
            "image/png": "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\n",
            "text/plain": [
              "<Figure size 1440x576 with 1 Axes>"
            ]
          },
          "metadata": {
            "tags": [],
            "needs_background": "light"
          }
        },
        {
          "output_type": "display_data",
          "data": {
            "image/png": "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\n",
            "text/plain": [
              "<Figure size 1440x576 with 1 Axes>"
            ]
          },
          "metadata": {
            "tags": [],
            "needs_background": "light"
          }
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "CxGaAqXro5L8",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "outputId": "320e9716-e455-4680-c059-78c098b2614c"
      },
      "source": [
        "targets = ['vaccine','vaccination','vaccines','vaccinations'] \n",
        "d={}\n",
        "for line,paperid in df_sp.select(\"full_text\",\"paper_id\").toLocalIterator():\n",
        "  c=countOccurences(line,targets,paperid)\n",
        "  d.update(c)\n",
        "\n",
        "df3=pd.DataFrame(d)\n",
        "df3=df3.transpose()\n",
        "\n",
        "temp_df=df3.sort_values(by=['vaccine'],ascending=False)\n",
        "temp_df=temp_df.head(30)\n",
        "#print(temp_df)\n",
        "%matplotlib inline\n",
        "temp_df.plot(kind='bar',x='paper_id',y='vaccine',figsize=(20,8),title='Top 30 papers for count of keyword: vaccine in Full Text')\n",
        "temp_df.plot(kind='bar',figsize=(20,8),title='Paper wise distribution of words (Vertically)',stacked=True)\n",
        "temp_df.plot.barh(figsize=(20,8),title='Paper wise distribution of words (Horizantally)',stacked=True)"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "<matplotlib.axes._subplots.AxesSubplot at 0x7f4fc7382d30>"
            ]
          },
          "metadata": {
            "tags": []
          },
          "execution_count": 9
        },
        {
          "output_type": "display_data",
          "data": {
            "image/png": "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\n",
            "text/plain": [
              "<Figure size 1440x576 with 1 Axes>"
            ]
          },
          "metadata": {
            "tags": [],
            "needs_background": "light"
          }
        },
        {
          "output_type": "display_data",
          "data": {
            "image/png": "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\n",
            "text/plain": [
              "<Figure size 1440x576 with 1 Axes>"
            ]
          },
          "metadata": {
            "tags": [],
            "needs_background": "light"
          }
        },
        {
          "output_type": "display_data",
          "data": {
            "image/png": "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\n",
            "text/plain": [
              "<Figure size 1440x576 with 1 Axes>"
            ]
          },
          "metadata": {
            "tags": [],
            "needs_background": "light"
          }
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "dej403Fz9M0N",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "outputId": "5c3ee755-ebf1-4ffc-dd54-3deda6880062"
      },
      "source": [
        "targets = ['anti-viral','anti viral','genome','genome data','strain'] \n",
        "e={}\n",
        "for line,paperid in df_sp.select(\"full_text\",\"paper_id\").toLocalIterator():\n",
        "  f=countOccurences(str(line),targets,str(paperid))\n",
        "  e.update(f)\n",
        "\n",
        "df4=pd.DataFrame(e)\n",
        "df4=df4.transpose()\n",
        "\n",
        "temp_df=df4.sort_values(by=['anti-viral'],ascending=False)\n",
        "temp_df=temp_df.head(15)\n",
        "\n",
        "%matplotlib inline\n",
        "temp_df.plot(kind='bar',x='paper_id',y='anti-viral',figsize=(20,8),title='Top 15 papers for count of keyword: anti-viral in Full Text')\n",
        "temp_df.plot(kind='bar',figsize=(20,8),title='Paper wise distribution of words',stacked=True)\n",
        "temp_df.plot.barh(figsize=(20,8),title='Paper wise distribution of words',stacked=True)\n"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "<matplotlib.axes._subplots.AxesSubplot at 0x7f4fc6fc8400>"
            ]
          },
          "metadata": {
            "tags": []
          },
          "execution_count": 10
        },
        {
          "output_type": "display_data",
          "data": {
            "image/png": "iVBORw0KGgoAAAANSUhEUgAABHcAAAITCAYAAACNGvBtAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4yLjIsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+WH4yJAAAgAElEQVR4nOzdebxtdV038M+XSVRwCG6W4vVSqeEQIFdFU9PUHFBJS8HU5zEzsudxzCzKyqEySq204VEywxnNgZxyKnEGBQUV0JxQrgMiiqJGinyfP9Y6eO7h3Hv2wXvuPuvyfr9e53XPXsPe3/1b65xz12f/fr9V3R0AAAAApmm3eRcAAAAAwJUn3AEAAACYMOEOAAAAwIQJdwAAAAAmTLgDAAAAMGHCHQAAAIAJE+4AwIRV1Z9V1deq6ivzrmVequr+VXVeVX27qg5dZn1X1c/Mo7YfVVWdXFWPnNNrP6+q/vhK7LdxPBa7X8nXvXNVbdnO+m9X1U9dmee+kvU8vKreu+jxZM8nAHZdwh0A1sR4AbbwdVlV/feixw/ZQa/xoKp6f1V9t6pOXmZ9V9V3Fr3uC3bE664XVbUxyROT3Ky7f2Le9VxZO+Bi+VlJHt3d+3T3R3ZUXVclSwOMJOnuR3X3n672ubr7C+Ox+MGOq3Cr59+nuz+72v2qatN4ri3+3XTmjqqrqs5a9Lw/qKpLFj3+wx+h3j12VI0A7Lr8sQBgTXT3PgvfV9W5SR7Z3e/YwS/z9SR/m+Rnk/ziNrY5uLs/vYNfd81U1e6ruCjemOTC7v7qlXidPbr70tXut07dKMlZ8y7iR1FVlaS6+7J517KW1sn7vM5anPvdffOF78ew+aXdvUsFygCsX3ruALBTVdXVqupvq+pL49ffVtXVxnV3rqotVfWH41Cjc7fXy6e739Hdr0rypR1Q18lV9RdV9cGq+lZV/VtV/dii9f9aVV+pqm9W1buravGF3AnjEJa3V9XFVfWuqrrRovU/O677elV9sqoetGTf/1dVb66q7yS5S1Xdu6rOHp/ri1X1u8vUe7ckb09y/bFnwAnj8vuNPQguGt/TQYv2Obeqfr+qPprkO8v1CKiqmy+q9fyFHgcrHLcr9PpY3BtnfI//UFVvGt/TqVX10+O6d4+7nDm+j6OWqWm3qvqjqvp8VX21ql5cVdcea/p2kt3H/T+z7SN8+XPdoYYhXHceHz+iqs6pqm9U1VsXjttY77OX7Pv6qnpCVf16Vb1h0fJPVdW/Lnp8XlUdMn5/+6r60HjefKiqbr9ou5Or6s+r6n1Jvpvkp6rq7lX1iXH7v09SK72nRc93m6r6wHjsv1xVf19Vey1a31X1qLHei8b3WOM58rwktxuPwUXj9idU1Z9t47XOqar7LHq8R1VdUFW3qiU9TrbxPn99fI6Lq+qzVfVbq3ifM51bq3i+K/SQqR08HG4759nvjzUvtNVv1/Dzu3eShZ+Ni8bjcrsdVQ8Aux7hDgA725OTHJ7kkCQHJ7lNkj9atP4nkuyf5AZJ/neS46vqpj/C6727hlDmtVW1aYVt/1eSRyT5ySSXJnnuonX/nuTGSX48yYeTvGzJvg9J8qdj7WcsrK+qa2YIYV4+7nt0kn+sqpst2vfXkvx5kn2TvDfJPyf5re7eN8ktkvzn0kLHXlD3SvKlcZjKw6vqJklekeTxSTYkeXOSNyy+wE/y4CRHZJneC1W1b5J3JHlLkusn+Zkk/zGuXum4reToJE9Lct0knx7fb7r7TuP6g8f38cpl9n34+HWXJD+VZJ8kf9/d/7Ooh9jB3b3di/qqumeG9vmV7j65qo5M8odJHpChvd4zrk+SFyV5cFXtNu67f5K7ZTiO70pyxzF0un6SvZLcbtxuob6P1hAOvinDebRfkr9O8qaq2m9RWQ9LckyGY//NJK/N0K77J/lMkp9fVP/GMZTZuI23+IMkTxj3vV2Suyb5P0u2uU+SWyf5uSQPSnKP7j4nyaOSfGA8BtfZXjuOXpHhXFpwjyRf6+4Pb2P7xe/z80m+OtZyrSS/nuRvqupWM7zucpY9t9aLFc6zZyb5nyR/VFU3TvKMJA/t7kuSLPxsXGc8Lh/YuZUDMCXCHQB2tockeXp3f7W7L8hwUfawJdv88Xjh/q4MF8cPWvokM/qFJJsyDNv6UpI31vbnr3hJd3+8u7+T5I+TPKjGSWG7+4XdfXF3/0+SpyY5uKquvWjfN3X3u8f1T87QC+KGGS5gz+3uf+nuS8c5YV6T5IGL9v237n5fd182XtR9P8nNqupa3f2N7VwwL3XUWMfbu/v7GeaiuXqS2y/a5rndfV53//cy+98nyVe6+9ndfcn4fk8d181y3Lbndd39wTFQelmGkGhWD0ny19392e7+dpI/SHL0CsdyqQcmeX6Se3X3B8dlj0ryF919zljXM5IcUlU3Grf5ZoaAJBkChJO7+/xxvpeLx/dwpyRvTfKlqvrZDOfce8ZhR0ck+VR3v2Q89q9I8okk911U1wndfdb4+vdKclZ3v3o8fn+b5PKJsse5bK7T3V9Y7g129+ndfcr4WueO7/cXlmx2XHdfND7HO7O647DYy5Pcr6quMT7+tfwwsFjO5e+zu7/f3W/q7s/04F1J3pbkjleyltWeW18bQ7KLaplecWtge+fZZRlC5ccmeX2SvzJvFABXhnAHgJ3t+hk+uV/w+XHZgm+M4cq21s9sDFu+190XJXlckgOTHLSdXc5b8rp7Jtm/qnavquOq6jNV9a0k547b7L/cvmMA8fWx7hslue2ii8mLMoQVP7HcvqNfSXLvJJ+vYYjXrMMxtmrb8cLxvAy9oLb1WovdMENvkRWfO6s/Lovv5vXdDL1bZrXca++R5HqreI7HJ3lVd3980bIbJXnOouPy9QzDoBba60VJHjp+/9AkL1m077uS3DlDuPOuJCdnCFJ+YXy8XN0LtW/reFw/W59Hne0fr61U1U2q6o1jT7VvZQgR9l+y2ZU6DlX177VoQvRxHqtzktx3DHjulyHw2Zat3kdV3auqTqlh+N9FGc73pbXOarXvaf8xJLtOdz/rSr7mamz3PBuDuHdmCKL/YSfUA8AuSLgDwM72pQwXOws2Zus5c647DmXa1vofRWf7c5jccMnrfj/J1zL0Sjgyw7Cca2e4CMuS57p836raJ8mPZaj7vCTvWnQxuTDE4reX1PXDB90f6u4jMwzjOinJq2Z8f1u1bVXVWNcXt/VaS5yXYdjTis+drY/Ld5Is9OBIVe3oO3ct99qXJjl/Fc/xwCS/XFWPW7TsvAzD3xYfm6t39/vH9S9NcmRVHZwhFDxp0b4L4c4dx+/flSuGO0vrXqh9W8fjy9n6PKpsfU6u5P9l6Bl04+6+VoahQLPO2bO98yLdfa/xvN2nuxeGJC4MzToyydm9/YnLL3/+GuZqek2GnmXXG4eBvXkVte5oC2HyNRYt25Hn8HbPs6o6IsMwuv/IMExrwXaPCQAsJtwBYGd7RYb5JTaM85j8SYaL6MWeVlV7VdUdMwwV+telT5IMd5YaJx7dI8luVbV3Ve05rrt5VR0ybrNPkmdnuKg+Zzu1PbSqbjb2RHh6klf3cOeqfTPMi3FhhgvAZyyz771rmKx3rwxz75zS3ecleWOSm1TVw6pqz/Hr1rVoouMl72mvqnpIVV17HJrzrSSz3lnoVUmOqKq7ju3wxLHu929/t8u9MclPVtXja5iseN+quu24bnvH7cwkC+29d4Zha6txfrYdKi289hOq6sDxWD4jySt7dXc8+lKGIVaPq6qFYO15Sf6gxsmxa5ik+fLhct29JcmHMvTYec2SoWzvyjAH0NXH7d6T5J4Z5tZZGFbz5gzH/tdqmHD4qCQ3y9DOy3lThnZ8wDjk7LFZXciwb4bz5dvjELHfXmH7xc5PcsCS+ZlWcmKSXxpfZ3u9dpbaK8nVklyQ5NKqutf4PHMxDjP8Yoaf/92r6hFJVjUp8wq2eZ6NP0svSPLIDHOM3beq7j3ud0GGn/3t/WwAQBLhDgA7358lOS3JR5N8LMPkxIvvyPOVJN/IcDH+siSP6u5PbOO5HpbkvzP0WLjj+P0/jeuul+SVGS52P5uht819xsBkW16S5ISxhr0zXFwnyYszDKf5YpKzk5yyzL4vT/KUDEMuDss4nKe7L85w4Xr0+J6+kuQvM1zcbsvDkpw7Dq15VIZhXCvq7k+Or/t3GXoc3TfJfbv7ezPuf3GSu4/7fSXJpzIEGMl2jlt3/1eGMOwd4z5b3TlrBk9N8qJx2Mpy8yu9MMOxeXeSzyW5JMljVvkaGeeZuWuSY6vqkd39ugzH4sSxrT+eYd6bxV6U5JbZekjWwnv+doZQJ929cJ69bwwE090XZggnn5ghGPy9DOfg17ZR39cy9DA6btz+xknet7B+nFD529uZUPl3M/QyuzjDz8Fyk1Nvy39muJ38V6pq2fqWqffLST6QYU6nmV9rPM8emyGM/MZY8+tXUeta+M0kT8rQ7jfP7IHoilY4z47PMOfWm8fz5TeSvKCq9uvu72aYHPp948/G4TuqJgB2PTUM5waA+avh9tQv7e4D5vDaJ4+v/YIrse8JSbZ092ruHsUEVNWdMvRQulH7TxMAsE7puQMAsIxxaNvjkrxAsAMArGfCHQCAJcY5kS5K8pMZbkkOALBuGZYFAAAAMGF67gAAAABMmHAHAAAAYML2WIsn3X///XvTpk1r8dQAAAAAV0mnn37617p7w9LlaxLubNq0KaeddtpaPDUAAADAVVJVfX655YZlAQAAAEyYcAcAAABgwoQ7AAAAABO2JnPuAAAAAFdd3//+97Nly5Zccskl8y5lkvbee+8ccMAB2XPPPWfaXrgDAAAA7FBbtmzJvvvum02bNqWq5l3OpHR3LrzwwmzZsiUHHnjgTPsYlgUAAADsUJdcckn2228/wc6VUFXZb7/9VtXrSbgDAAAA7HCCnStvtW0n3AEAAACu8k466aScffbZlz/+kz/5k7zjHe+Yef/nPe95efGLX7yq1zzhhBPy6Ec/elX7LMecOwAAAMCa2nTsm3bo85173BE79PmSIdy5z33uk5vd7GZJkqc//emr2v9Rj3rUsssvvfTS7LHH2sYveu4AAAAAu6Rf/uVfzmGHHZab3/zmOf7445Mk++yzT5785Cfn4IMPzuGHH57zzz8/73//+/P6178+T3rSk3LIIYfkM5/5TB7+8Ifn1a9+9VbPd9lll2XTpk256KKLLl924xvfOOeff36e+tSn5lnPelaS5M53vnMe//jHZ/PmzXnOc56TN7zhDbntbW+bQw89NHe7291y/vnn79D3KdwBAAAAdkkvfOELc/rpp+e0007Lc5/73Fx44YX5zne+k8MPPzxnnnlm7nSnO+Wf/umfcvvb3z73u9/98sxnPjNnnHFGfvqnf3rZ59ttt91y5JFH5nWve12S5NRTT82NbnSjXO9617vCtt/73vdy2mmn5YlPfGLucIc75JRTTslHPvKRHH300fmrv/qrHfo+hTsAAADALum5z33u5T10zjvvvHzqU5/KXnvtlfvc5z5JksMOOyznnnvuqp7zqKOOyitf+cokyYknnpijjjpqm9st2LJlS+5xj3vklre8ZZ75zGfmrLPOunJvaBuEOwAAAMAu5+STT8473vGOfOADH8iZZ56ZQw89NJdcckn23HPPy+9Gtfvuu+fSSy/d7vOceuqpOeSQQ3LIIYfk9a9/fW53u9vl05/+dC644IKcdNJJecADHrDsfte85jUv//4xj3lMHv3oR+djH/tYnv/856/qNuezMKEyAAAAsMv55je/mete97q5xjWukU984hM55ZRTtrv9vvvum4svvvgKy29729vmjDPO2GrZ/e9///zO7/xODjrooOy3334z1XKDG9wgSfKiF71oFe9iNnruAAAAALuce97znrn00ktz0EEH5dhjj83hhx++3e2PPvroPPOZz8yhhx6az3zmM9vd9qijjspLX/rSbQ7JWuqpT31qHvjAB+awww7L/vvvP/N7mFV198obVT0hySOTdJKPJfn17t5mH6LNmzf3aaedtsOKBAAAAKbjnHPOyUEHHTTvMiZtuTasqtO7e/PSbVfsuVNVN0jy2CSbu/sWSXZPcvQOqhUAAACAH8Gsw7L2SHL1qtojyTWSfGntSgIAAABgVitOqNzdX6yqZyX5QpL/TvK27n7b0u2q6pgkxyTJxo0bd0hxm4590w55nh3p3OOOmHcJAAAAAJebZVjWdZMcmeTAJNdPcs2qeujS7br7+O7e3N2bN2zYsOMrBQAAACZjljl+Wd5q226WYVl3S/K57r6gu7+f5LVJbn8lagMAAACuAvbee+9ceOGFAp4robtz4YUXZu+99555nxWHZWUYjnV4VV0jw7CsuyZxKywAAABgWQcccEC2bNmSCy64YN6lTNLee++dAw44YObtZ5lz59SqenWSDye5NMlHkhx/pSsEAAAAdml77rlnDjzwwHmXcZUxS8+ddPdTkjxljWsBAAAAYJVmvRU6AAAAAOuQcAcAAABgwoQ7AAAAABMm3AEAAACYMOEOAAAAwIQJdwAAAAAmTLgDAAAAMGHCHQAAAIAJE+4AAAAATJhwBwAAAGDChDsAAAAAEybcAQAAAJgw4Q4AAADAhAl3AAAAACZMuAMAAAAwYcIdAAAAgAkT7gAAAABMmHAHAAAAYMKEOwAAAAATJtwBAAAAmDDhDgAAAMCECXcAAAAAJky4AwAAADBhwh0AAACACRPuAAAAAEyYcAcAAABgwoQ7AAAAABMm3AEAAACYMOEOAAAAwIQJdwAAAAAmTLgDAAAAMGHCHQAAAIAJE+4AAAAATJhwBwAAAGDChDsAAAAAEybcAQAAAJgw4Q4AAADAhAl3AAAAACZMuAMAAAAwYcIdAAAAgAkT7gAAAABMmHAHAAAAYMKEOwAAAAATtmK4U1U3raozFn19q6oevzOKAwAAAGD79lhpg+7+ZJJDkqSqdk/yxSSvW+O6AAAAAJjBaodl3TXJZ7r782tRDAAAAACrs9pw5+gkr1huRVUdU1WnVdVpF1xwwY9eGQAAAAArmjncqaq9ktwvyb8ut767j+/uzd29ecOGDTuqPgAAAAC2YzU9d+6V5MPdff5aFQMAAADA6qwm3HlwtjEkCwAAAID5mCncqaprJrl7kteubTkAAAAArMaKt0JPku7+TpL91rgWAAAAAFZptXfLAgAAAGAdEe4AAAAATJhwBwAAAGDChDsAAAAAEybcAQAAAJgw4Q4AAADAhAl3AAAAACZMuAMAAAAwYcIdAAAAgAkT7gAAAABMmHAHAAAAYMKEOwAAAAATJtwBAAAAmDDhDgAAAMCECXcAAAAAJky4AwAAADBhwh0AAACACRPuAAAAAEyYcAcAAABgwoQ7AAAAABMm3AEAAACYMOEOAAAAwIQJdwAAAAAmTLgDAAAAMGHCHQAAAIAJE+4AAAAATJhwBwAAAGDChDsAAAAAEybcAQAAAJgw4Q4AAADAhAl3AAAAACZMuAMAAAAwYcIdAAAAgAkT7gAAAABMmHAHAAAAYMKEOwAAAAATJtwBAAAAmDDhDgAAAMCECXcAAAAAJky4AwAAADBhwh0AAACACRPuAAAAAEzYTOFOVV2nql5dVZ+oqnOq6nZrXRgAAAAAK9tjxu2ek+Qt3f2rVbVXkmusYU0AAAAAzGjFcKeqrp3kTkkeniTd/b0k31vbsgAAAACYxSzDsg5MckGSf6mqj1TVC6rqmmtcFwAAAAAzmGVY1h5JbpXkMd19alU9J8mxSf548UZVdUySY5Jk48aNO7pOVrDp2DfNu4QrOPe4I+ZdwhVoJwAAAHY1s/Tc2ZJkS3efOj5+dYawZyvdfXx3b+7uzRs2bNiRNQIAAACwDSuGO939lSTnVdVNx0V3TXL2mlYFAAAAwExmvVvWY5K8bLxT1meT/PralQQAAADArGYKd7r7jCSb17gWAAAAAFZpljl3AAAAAFinhDsAAAAAEybcAQAAAJgw4Q4AAADAhAl3AAAAACZMuAMAAAAwYcIdAAAAgAkT7gAAAABMmHAHAAAAYMKEOwAAAAATJtwBAAAAmDDhDgAAAMCECXcAAAAAJky4AwAAADBhwh0AAACACRPuAAAAAEyYcAcAAABgwoQ7AAAAABMm3AEAAACYMOEOAAAAwIQJdwAAAAAmTLgDAAAAMGHCHQAAAIAJE+4AAAAATJhwBwAAAGDChDsAAAAAEybcAQAAAJgw4Q4AAADAhAl3AAAAACZMuAMAAAAwYcIdAAAAgAkT7gAAAABMmHAHAAAAYMKEOwAAAAATJtwBAAAAmDDhDgAAAMCECXcAAAAAJky4AwAAADBhwh0AAACACRPuAAAAAEyYcAcAAABgwoQ7AAAAABMm3AEAAACYsD1m2aiqzk1ycZIfJLm0uzevZVEAAAAAzGamcGd0l+7+2ppVAgAAAMCqGZYFAAAAMGGzhjud5G1VdXpVHbOWBQEAAAAwu1mHZd2hu79YVT+e5O1V9YnufvfiDcbQ55gk2bhx4w4uEwAAAIDlzNRzp7u/OP771SSvS3KbZbY5vrs3d/fmDRs27NgqAQAAAFjWiuFOVV2zqvZd+D7JLyX5+FoXBgAAAMDKZhmWdb0kr6uqhe1f3t1vWdOqAAAAAJjJiuFOd382ycE7oRYAAAAAVsmt0AEAAAAmTLgDAAAAMGHCHQAAAIAJE+4AAAAATJhwBwAAAGDChDsAAAAAEybcAQAAAJgw4Q4AAADAhAl3AAAAACZMuAMAAAAwYcIdAAAAgAkT7gAAAABMmHAHAAAAYMKEOwAAAAATJtwBAAAAmDDhDgAAAMCECXcAAAAAJky4AwAAADBhwh0AAACACRPuAAAAAEyYcAcAAABgwoQ7AAAAABMm3AEAAACYMOEOAAAAwIQJdwAAAAAmTLgDAAAAMGHCHQAAAIAJE+4AAAAATJhwBwAAAGDChDsAAAAAEybcAQAAAJgw4Q4AAADAhAl3AAAAACZMuAMAAAAwYcIdAAAAgAkT7gAAAABMmHAHAAAAYMKEOwAAAAATJtwBAAAAmDDhDgAAAMCECXcAAAAAJky4AwAAADBhwh0AAACACZs53Kmq3avqI1X1xrUsCAAAAIDZrabnzuOSnLNWhQAAAACwejOFO1V1QJIjkrxgbcsBAAAAYDVm7bnzt0l+L8lla1gLAAAAAKu0YrhTVfdJ8tXuPn2F7Y6pqtOq6rQLLrhghxUIAAAAwLbN0nPn55Pcr6rOTXJikl+sqpcu3ai7j+/uzd29ecOGDTu4TAAAAACWs2K4091/0N0HdPemJEcn+c/ufuiaVwYAAADAilZztywAAAAA1pk9VrNxd5+c5OQ1qQQAAACAVdNzBwAAAGDChDsAAAAAEybcAQAAAJgw4Q4AAADAhAl3AAAAACZMuAMAAAAwYcIdAAAAgAkT7gAAAABMmHAHAAAAYMKEOwAAAAATJtwBAAAAmDDhDgAAAMCECXcAAAAAJky4AwAAADBhwh0AAACACRPuAAAAAEyYcAcAAABgwoQ7AAAAABMm3AEAAACYMOEOAAAAwIQJdwAAAAAmTLgDAAAAMGHCHQAAAIAJE+4AAAAATJhwBwAAAGDChDsAAAAAEybcAQAAAJgw4Q4AAADAhAl3AAAAACZMuAMAAAAwYcIdAAAAgAkT7gAAAABMmHAHAAAAYMKEOwAAAAATJtwBAAAAmDDhDgAAAMCECXcAAAAAJky4AwAAADBhwh0AAACACRPuAAAAAEyYcAcAAABgwoQ7AAAAABMm3AEAAACYsBXDnarau6o+WFVnVtVZVfW0nVEYAAAAACvbY4Zt/ifJL3b3t6tqzyTvrap/7+5T1rg2AAAAAFawYrjT3Z3k2+PDPcevXsuiAAAAAJjNLD13UlW7Jzk9yc8k+YfuPnWZbY5JckySbNy4cUfWCOxkm45907xLWNa5xx0x7xIAAADWnZkmVO7uH3T3IUkOSHKbqrrFMtsc392bu3vzhg0bdnSdAAAAACxjVXfL6u6LkrwzyT3XphwAAAAAVmOWu2VtqKrrjN9fPcndk3xirQsDAAAAYGWzzLnzk0leNM67s1uSV3X3G9e2LAAAAABmMcvdsj6a5NCdUAsAAAAAq7SqOXcAAAAAWF+EOwAAAAATJtwBAAAAmDDhDgAAAMCECXcAAAAAJky4AwAAADBhwh0AAACACRPuAAAAAEyYcAcAAABgwoQ7AAAAABMm3AEAAACYMOEOAAAAwIQJdwAAAAAmTLgDAAAAMGHCHQAAAIAJE+4AAAAATJhwBwAAAGDChDsAAAAAEybcAQAAAJgw4Q4AAADAhAl3AAAAACZMuAMAAAAwYcIdAAAAgAkT7gAAAABMmHAHAAAAYMKEOwAAAAATJtwBAAAAmDDhDgAAAMCECXcAAAAAJky4AwAAADBhwh0AAACACRPuAAAAAEyYcAcAAABgwoQ7AAAAABMm3AEAAACYMOEOAAAAwIQJdwAAAAAmTLgDAAAAMGHCHQAAAIAJE+4AAAAATJhwBwAAAGDChDsAAAAAEybcAQAAAJiwFcOdqrphVb2zqs6uqrOq6nE7ozAAAAAAVrbHDNtcmuSJ3f3hqto3yelV9fbuPnuNawMAAABgBSv23OnuL3f3h8fvL05yTpIbrHVhAAAAAKxslp47l6uqTUkOTXLqMuuOSXJMkmzcuHEHlAaw/m069k3zLuEKzj3uiHmXcAXaaXbaajbaaTbrsZ2S9dlWADBlM0+oXFX7JHlNksd397eWru/u47t7c3dv3rBhw46sEQAAAIBtmCncqao9MwQ7L+vu165tSQAAAADMapa7ZVWSf05yTnf/9dqXBAAAAMCsZum58/NJHpbkF6vqjPHr3mtcFwAAAAAzWHFC5e5+b5LaCbUAAAAAsEozT6gMAAAAwPoj3AEAAACYMOEOAAAAwIQJdwAAAAAmTLgDAAAAMGHCHQAAAIAJE+4AAAAATJhwBwAAAGDChDsAAAAAEybcAQAAAJgw4Q4AAADAhAl3AAAAACZMuAMAAAAwYcIdAAAAgAkT7gAAAABMmHAHAAAAYMKEOwAAAAATJtwBAAAAmDDhDgAAAMCECXcAADKHTS8AACAASURBVAAAJky4AwAAADBhwh0AAACACRPuAAAAAEyYcAcAAABgwoQ7AAAAABMm3AEAAACYMOEOAAAAwIQJdwAAAAAmTLgDAAAAMGHCHQAAAIAJE+4AAAAATJhwBwAAAGDChDsAAAAAEybcAQAAAJgw4Q4AAADAhAl3AAAAACZMuAMAAAAwYcIdAAAAgAkT7gAAAABMmHAHAAAAYMKEOwAAAAATJtwBAAAAmLAVw52qemFVfbWqPr4zCgIAAABgdrP03DkhyT3XuA4AAAAAroQVw53ufneSr++EWgAAAABYJXPuAAAAAEzYHjvqiarqmCTHJMnGjRt31NMCAMCa23Tsm+ZdwhWce9wR8y7hCrTT7LTVbLTTbNZjOyXaalY7o512WM+d7j6+uzd39+YNGzbsqKcFAAAAYDsMywIAAACYsFluhf6KJB9IctOq2lJVv7H2ZQEAAAAwixXn3OnuB++MQgAAAABYPcOyAAAAACZMuAMAAAAwYcIdAAAAgAkT7gAAAABMmHAHAAAAYMKEOwAAAAATJtwBAAAAmDDhDgAAAMCECXcAAAAAJky4AwAAADBhwh0AAACACRPuAAAAAEyYcAcAAABgwoQ7AAAAABMm3AEAAACYMOEOAAAAwIQJdwAAAAAmTLgDAAAAMGHCHQAAAIAJE+4AAAAATJhwBwAAAGDChDsAAAAAEybcAQAAAJgw4Q4AAADAhAl3AAAAACZMuAMAAAAwYcIdAAAAgAkT7gAAAABMmHAHAAAAYMKEOwAAAAATJtwBAAAAmDDhDgAAAMCECXcAAAAAJky4AwAAADBhwh0AAACACRPuAAAAAEyYcAcAAABgwoQ7AAAAABMm3AEAAACYMOEOAAAAwIQJdwAAAAAmTLgDAAAAMGHCHQAAAIAJmyncqap7VtUnq+rTVXXsWhcFAAAAwGxWDHeqavck/5DkXkluluTBVXWztS4MAAAAgJXN0nPnNkk+3d2f7e7vJTkxyZFrWxYAAAAAs5gl3LlBkvMWPd4yLgMAAABgzqq7t79B1a8muWd3P3J8/LAkt+3uRy/Z7pgkx4wPb5rkkzu+3B/J/km+Nu8iJkA7zU5bzUY7zUY7zU5bzUY7zU5bzUY7zUY7zU5bzUY7zU5bzUY7zWa9ttONunvD0oV7zLDjF5PccNHjA8ZlW+nu45Mcf6XLW2NVdVp3b553HeuddpqdtpqNdpqNdpqdtpqNdpqdtpqNdpqNdpqdtpqNdpqdtpqNdprN1NpplmFZH0py46o6sKr2SnJ0ktevbVkAAAAAzGLFnjvdfWlVPTrJW5PsnuSF3X3WmlcGAAAAwIpmGZaV7n5zkjevcS1rbd0OGVtntNPstNVstNNstNPstNVstNPstNVstNNstNPstNVstNPstNVstNNsJtVOK06oDAAAAMD6NcucOwAAAACsU8IdAAAAgAkT7gAAAKwDVfXA8d8D510LMC275Jw7VfVTSR6Q5IZJfpDkv5K8vLu/NdfC1rmqulaSGyf5bHd/Y971MH1VtX93f23edaxHVVVJbpPkBuOiLyb5YO+Kv5R3oKr68e7+6rzrWM+q6roZfpfvvbCsu989v4qYqqraLUm6+7Kq2ivJLZKc291fn29l61NV3SLJzbL1z96L51fR+lRVP5YkzqPlVdWHu/tWC//Ou56pGMOwQ5Oc3d2fmHc9U1FV+3T3t+ddx3pSVXt29/eXLJvENc0u13Onqh6b5HkZ/rDeOsnVMoQ8p1TVnedY2rpTVS+tqv3H7++R5ONJ/jLJGQufGrB9VfWxedewXlTVvarqc1X13qo6tKrOSnJqVW2pqrvOu771pKp+Kcmnkjw1yb3Hr6cl+dS4jgwXAEu+9kvywaq67sLFAVurqkcmeXeSt2Y4p96a4TxjGeO5dK1517EeVdUvJ/lyki9W1ZFJ3pPkmUk+WlX3nWtx61BVPSXJ341fd0nyV0nuN9ei1pGq2lhVJ1bVBUlOzfC7/Kvjsk3zrW7dubCq3pbkwKp6/dKveRe3XlTVSYu+PzLJfya5b5J/q6qHz6uuCTp73gWsF1V1l6rakuTLVfW2Jb+b3jafqlZnl+u5M15sH9LdP6iqayR5c3ffuao2Jvm37j50ziWuG1X1se6+5fj9+5P8WnefOwY+/9HdB8+3wvWhqh6wrVVJntfdG3ZmPetVVZ2R5MFJrpPkjUmO6O5TquqgJC/z6dMPVdU5Se7V3ecuWX5ght9ZB82lsHWmqi5L8vkliw9IsiVJd/dP7fyq1rfxb+Ctk5zS3YdU1c8meUZ3b+v32FVOVV0/yXFJjkyyT4Zec0nywiR/vvTTuquqqvpIknsluXqSM5Pcurs/WVU3SvKa7t481wLXmfFn7+AkH+nug6vqekle2t13n3Np60JVfSDJ3yZ5dXf/YFy2e5IHJnl8dx8+z/rWk7GX3K2SvCTJI5eu7+537fSi1qGq+sjCdd14HfOQ7v6c65grqqrf2daqJE/ubh+YJamqDyV5eHefVVW/muQvkjxsvJ75yBRyhD3mXcAa2SPDcKyrZfiPW7r7C1W151yrWn92q6prjcPVLkvyhSTp7q9V1a56blwZr0zysiTLJaF7L7Psquqy7j4nSarqu919SpJ09zkLXfu53B4ZAoqlvpjE76kfelKSuyd5Und/LEmq6nPdbR6Cbbukuy+pqlTV1br7E1V103kXtc68NMnTu/t/jeH9HZP8UZI/SPIPSY6ZZ3HrSXd/JUmq6gvd/clx2ef9Tl/Wf4/D1y4de4N9NUPPcQb7d/crFy8YQ54Tq+pP51TTutTd38sw4uD23X3BvOtZxxb/v3yP7v5ccvl1zGVzqmm9ekaGnpeXLrPO7/Mf2qu7z0qS7n71+GHsa6vq97P8deC6sytewL8gyYeq6tQM/2H7yySpqg1JjO3d2tOSvLOq/iHJ+5L869jd8y5J3jLXytaXjyZ5Vnd/fOmKqrrbHOpZry6qqt9Kcq0k36iqJyR5VZK7JTGWd2svzPB76sQk543Lbpjk6CT/PLeq1pnufnZVvTLJ31TVeUmekon8cZ2jLVV1nSQnJXl7VX0jV+z9dFW3X3efnCTd/dqqenJ3fyfJH1WVeRoWqarduvuyJI9YtGz3JHvNr6p167TxZ++fkpye4e/eB+Zb0rpyelX9Y5IXZeu/e/87yUfmVtU6V1XPyhXncfrF+VW0rhxcVd/K0PvkalX1k9395bHn0+5zrm29+XCSk7r79KUrxuHcDL5fVT+x8MHG2IPnrhlGJPz0fEubzS43LCtJqurmSQ5K8nETam1fVf1Mkt9McpP8sDfBSd391rkWto5U1R2TfL67v7DMus3dfdocylp3quqGGT79vixDcPjgJL+R4cLydxd69TAYh6sdma0nVH59dxv7vIyqul+SP0yyqbt/Yt71TEFV/UKSayd5y/hJMEmq6h1JTkjyzgw3X7hzd/9KVVWST3b3TeZZ33pRVbdO8rHuvmTJ8k1J7tDdL51HXVMwttG1uvujcy5l3RgvuH8jy/zdS/LP3f0/86ptvRrn3Xllkt9N8qgMQdgF3f37cy1snRtD1oO6W7g6GnvwXrjchMBVdb3uPn8OZa0744f2F3T3mUuWXyfJ/+3uP59PZbPbJcOdparq/3T3P867DgCuvKq6epKfXq4XHe5sNKtxDr6FT8PPyDDs78s1TNh95+5+zVwLZFLGn7XvL9zpsKrukmG+lLO7+9/nWhyTVlWnd/dhVfXR7v65cdmHuvvW864Nriqq6lbd/eF51zGrXW5Y1jITRlWSP6iqvZOku/9651c1HVX1Xz61XN54Dv1Gkptn6+6xj9jmTldxzqflVdWHk7w2ycu7+7PzrmdCDktym6q6fndP4q4FO0sNdzZ6fpLLqupRGXo5fTvJTavqt7v7DXMtcB0Ze2E+aJnlFyYR7Iyqap8kv5fkVzJMZP69JJ/JcCOBE+ZY2nrzoSR3zjAc+UlJ7p/kzUl+p6p+obuPnWdx601V/VSS5yQ5PMMw2w8keYK/hctamNz9y1V1RJIvJTHx7QwW3zSGH6qqtyd5YHdfND6+bpITu/se861sfaiqpTd/qQx3X7tvhk4x6z7k2eXCnQzDQd6c5KwMByQZxl3uO7eK1qmqujjDH9ZatPgaC8u72+1ht/aSJJ9Ico8kT0/ykCSGGo2cT6ty3Qx3FTu5qr6S5BVJXtndX5pvWetLVX2wu28zfv+bSf5vktclecr4Scpxcy1wfXlKhjv1LHtnoyTCne0QRC/rZRl+3u6RIQy7ZpITM8xNdJPu/sN5FreO7N7d3xi/PyrJHbv7v6vquAzzXAh3tvbyDBOX3398fHSGv4G3nVtF69efVdW1kzwxyd9lmNPwCfMtaf2o7d/N1vDt5e2/EOwkSXd/o6p+fJ4FrTOnJTklyeJhovsl+esM1zjrfr6rXW5Y1tjd+tlJPpvkad393ar6rFvmXlFVPTfDBeaTFsZauhPNti3cAm+he+x497X3uH3nwPk0u6r6cI+3hh/ndHpwhrk/zknyiu4+fp71rRe19W1OP5Tk3t19QVVdM8Otvn0qN1rSVh/v7lssWnf5+ca2g+gk340g+nJVdebiWwkvDAcZh/+d3d0/O8fy1o0absF8THd/vKrekuTB4wXT3klOW/yzSLJ4iNGiZVudazCLqvp+tn0321/tbh/sL1FVpye5/8I8ouMHQK/zf4RBVf1KkscmOW5hWO3UrmV2uZ4748n6wKo6MsOdQv5m3jWtV9392Ko6LMkrquqkJH8fd6LZnoXusRdV1S2SfCWJtHvkfLpyuvs9Sd5TVY/JcNvvo5IIdwa7jV2Gd8vwYcQFSdLd36mq5W7neZXmzkYz+5cIomfxnaq6Q3e/d5zQ/OvJ5XM61Qr7XpU8KsnLqurMDLc/P62q3p3klhluP0ySqloYTvTvVXVshl5gneFv3pvnVtg6VlUvSvK4JUNonm06gMu5m+3qPTnJe6vqXRk+4LhjkmPmW9L60d2vqaq3JvnTqnpEhl5zk7qW2eV67iw2frr71CS37e47zbmcdWv8FO7RSR6YYbLS68+5pHWphlsFvibDf9hOSLJPkj/u7ufPs671xvm0sqo6sbuPnncd611VnZvh7muV4Y/rz48T3+6T5L3dfcg861tP3NlodcYg+pkZbhn/90k+rYfv1qrq55K8IMPdND+e5BHd/V9VtSFD75TnzrXAdWQMUX8pW9959K2Lhz9c1VXV53LFHnML2s/fFS3ukbm9ZVdV5W62V0pV7Z9hzqtk6AV9hTtocfn8O89OcvPunsyH+f+/vfsOl7Os9j7+/dEJLUgTUKRJE0MLhKZSBQQReSkqwkHQIx1fPCIqrwgqB1ARjhQFIVQBQQTOEaQXBWkhEEpAPRFClxqkQ/J7/1j3ZM9uYe8AuZ/ZWZ/rmiszz+xwrQx7Zu5nPetea0gnd1okLVQaJaZpkLQ4sIbtvIKSBk3SjrYvlLSM7X/k71N6v0gaBixm+x+1Y0mdKxPRKaUmK9VgG7V6OpXqpxtzS3IaLEkjbI+rHUenKVWq89l+qXYsAzVL7QDea5KOKhlJJI2UNAG4VdIjkj5VObymmwuYS1Luo28j6QBJH64dRwf4TvnzdwC2n8zEzrRJWkzSaZJa+3pXkbRn7biazvarwDO142gSSfNKOkLS/ZImSXpG0q2Sdq8dW1PZnlKqT3YCvlo7niaStJKkTUu1XPvxLWvF1DT53hs8SatK2knSbq1b7Zga6mfAXyT9UNKPgFuAYyrH1BiSjpW0Qe04OsRYSX8rv0ur1A6m6SStIOlaoiL6JUkjJB1aO66BGHKVO2obfSfpeuBg23dIWoEYOzyyboTNIekS29uV+58DjgNuANYH/jNHnQZJk4BXiBGw5wEXtnp/pC6K8YoG1gb+1PN529vO8KAariR1RgPfs72apNmAsXlV7p1Jmmh7qdpxNIWkS4nJRtfQY7IR8HhONuqtVIB9E1jK9tckfRRY0fb/VA6tESQdQEyoGw+sTvT+uLQ8l026i3zvDY6kw4jR8asQvXa2IrbZ7lAzrqYqJ+KtCT3X2X6gZjxNIukZ4BFgEeACYiDF2LpRNZOkscCuxACPnYnzmvOIMegPVwytkUpPom8Bv+pvWEVTDcXkznjg47bflnRr+ySj9sRP6jVd5RZgl7KdZmHg2pxcEMoH4lrAZsQH4rbAGOJD8WLb/6oYXmNImgNYkxgZ3+squO0bZ3hQDaeu6TPt78W7s5dMkHRQf08RCbEP9PP8TEc52WjQJF1AfJbvZnvVkuy5Jd9/QdK9wHq2Xy69my4CzrZ9fPb96JLvvcEpv1erERcyVpO0GHCO7c0rh9ZokvaxfVLtOJpEXVNsVyDW518AZiXW5+fZ/mvVABukZ0Je0jrE67UTMNH2+tWCa6BOXp8PuWlZwEnA5ZKOAv4o6XjgYiLrfXfVyJqnPbM3W6t/he1nJU2pFFMTuUyguQq4SjECfSsi+/1T4orBTM/2m8QWyPWzsmnAXpG0EOW9KGldYFLdkBrlSKLpbV+TsYbctuJ3KScbDd5ytneW9EWI7X75WnUzi+2XAWw/LGkj4CLF6Nx8nbrke29wXiuvzduS5icmjOXW9zb9XNj4rqS5AGwfO4NDaioDlCTOD4kJRyOI9fnlwPIVY2uabp9Ftm8Hbpf0TSCHDvX2rKTl6Fqf7wA8WTekgRlyyR3bvyhXBfama2rBCkTJ7I9qxtZAq0l6iXjDzylp8TKJZg4i851Czw/Et4DLgMvKld7Upq/EjqRTbOeoxd4OIn6XlpN0M5EozNL0LncBl9ge0/MJxfS61GUv4NflCuZ9wJ4AislGJ9YMrMHelDQ3XYu35YA36obUKE9LWt323QClgmcb4HRiamQKewOn5ntvwO6UNBw4laicexn4S92QGudwIjlxP11r0FmB+apF1Ey9kqelafA4uvpApvCTvg46tvBkZX1v+wKnACtJehz4B7BL3ZAGZshty0rvXvnSXdl2ftkSTbWytPOdKaY49PkUcI/tD83IeDpF6bOzIvE6PVSShwmQtCLwfD8Jw8VsP10hrDRESNqc6IuyClGZuQGwu+0basbVFJI+BLxt+6k+ntvA9s0VwkpDSNnuN39O8elO0lJEM+UJwOGlqnBCjovvTtK8rerClN4PkuYhqlg7pgXHkEzuSFoW2J4o85wM/JVoptwxY8xmpLLfecny8PE8Yeqt7J1vlVnPAawKPGz7+bqRNYekyURju/YrKS6Pl7Q9R5XAGkoxfWZLun9OXVW2AKY0KCW5uh/wOFFZ8V1gPaIZ7pGtUbqpu7Itcl3ic+pW289WDqmxJC1KTNUEwPbEiuE0xjR6gwG5haadpAWI772pa07gStsv1ouqucqwk4OBnwPHZHJn2sq6agVgQv5OdVd2tfR70m97xAwMp7Ha1lJPAKcRFWDr00FrqSHXs6BMd/gVsQBZG5iTOHm6tewXT4WkNSTdSkzIOqbcblSM8MxGiYWk7Yh9lo+XL9o/EeWN4yR9tmpwzTIB2Mj2Mm23ZW0vA2TCsI2knYDriEXufsRn1a7A3ZJyu0MhaQFJR0l6UNLzkp6TNL4cG147voY5h5jSMxK4HvggcDTwGnBGvbCaq/RD2QpYq0zIGlaaTKY2kraV9DeiLP1G4GHgiqpBNct85TaS2KK1ZLntRQwZSIBi3PldxKSsYeW2MTBGOQq9T2U63aeBUcBjlcNpHEkntd3fEHiAqHi6V9JnqgXWTNsAnwX+WG67lNvl5ZZCay21FrGWWpwOW0sNucqdkplc3fbk0g/lctsblRLHS3O6QxdJdwNft31bj+PrEqPfcloWU6dlbQXMDdwDrG37odJU8ne2R1YNsCEk7UuMM72nj+f2t/2LCmE1kqRxwLql1Hph4FzbW5RGgL/MqQVB0pVEEuzM1tYQSR8E/g3Y1Pana8bXJK0pDiVh8ZjtJXs+VzG8RpJ0MjAF2MT2ypIWJKrn1q4cWqNIuocYSnFNmUyzMfBl23tWDq1RJN0EbN0q35c0H/AH29msFJD0EDCqZ0VFed/dZnuFOpGlTqW2CVCSrge+afuusoPjt7k+7019TDpUj0laM7OhsJYacpU7RatR9JzAvDC1fHj2ahE10zw9EzsAtm8lspapsP1UmSY20fZD5dgjDN330KDZPrGvxE55LhM73Ym4CgDwCrAoTG0EOH+toBpoadtHt/f8KO/Fo4GPVIyriWYpJ0kfBuYtvSxa245yS2TfRtneF3gdoJRb52vV21u2nyN+x2axfT1RpZK6Wwx4s+3xm+VYCqLvbSFTyOlr3UhaSdIVkv4gaTlJZ0h6QdLtklauHV9DzW/7LgDbE8j1eX8kaYO2B+uTr1W7jl9LDblpWcCvgTsk3QZ8giilak0tyP4o3V0h6Q/AWcCj5diHgd2Ikr1UlAXtFGCPtmOz0iFv9Bkl+8gM2OXAH8uV3i2BC2HqXt9c5HZ5RNLBROXO0zC1R9judH1mpfCfwIPl/h7E5CwTzYIPrxZVs71VPsdb07IWIU40U3cvls/2m4BzJf2TSEqn7s4iRgv/nvgc/xwdUsY/g/wYuEvSVXR9fi8FbE6MsU5dTiG2/89LVK9+G/gKsbXmBGDTeqE1ykqlElrA0pIWtP1C6ZOZ6/O+7QGMLv2vAF6k7dwmdf5aashtywKQ9DFgZeA+2w++08/PzCRtRSxA2pvbXWY7918WktYG7rX9eo/jSwMb2j6nRlxNU/rI/AcxgnJj4BbiasDHiRL+nIbRpuwHX4WYJHZ1OTYLMLvtHMfM1HL9Q4jPqMWIk/CnifHxR2dD8+5KokK231ZMYVudaJL/ZOXQGknSLsDORF+UM4EdgENtX1g1sIZRTAt5jfg83wVYgNhK+lzVwBpI0prEhUWAm2yPrRlP05TP9C3o3VC58U1KZ6T2rTOS/m57+bbncgtNUdojtHvS9ptlu/snbV9cI64mknSg7eNVJh22kju2J9WOrWk6fS01JJM7MLVvzP1te5/nJ8Z799qGlFJ697KPzOApJ9Wl95ikzwPXtRZspfH0RrYvqRtZM0laibgKLuBa2+Mrh5Q6UOnr+JLtF8uFn5HAg7bvqxpYQ5XeaesQCfs72rfeplhPtaYXSdrHdnvj4Ptsr1ovumYqlc/kRZ++tfWSyeTgAHTyWmooJ3fGAmu6/APLFfE78xe6t1KKfjDwMbqPOd2kWlANJOmjRLneKnR/nXI0JVObmY+wbUlzA7e0XXnKxUgbSasDvySugD9eDn+IKI/dp7VvPAVJRxJjYF8sjxckGiceWjey5umr4V9fDRRnZq2TgP7kyUGQ9DxwMXAescgdmgvGd0nSIcDXgTeAnxIVrDcD6wKnOUehdyPpq8D3ie1GAj4FHGH79KqBNYikrxMXyF7ucXx5YD/b36gTWbOUpOoxRIL+ReL3aX7id+sQ2w/Xi65ZJJ1HJJ2XAP63/SnAzlHo3XTyWmoo9txpUftCxPaUUlqVejsXuIDYy7sXMYnmmaoRNdNo4DDg58S2o6+QTcjaZR+ZgTuD/ifVjQZyUl13W9n+butB2VP/GSCTO7319ZmU333djSEqBkT0/Hih3B8OTASWqRdaozwD3A0cAZwl6SLgvDJ0IXXZlbjoM4wYE7+s7WfKdrbbgEzudPctYI3Wtr7SqPQWIJM7he1f9XP870AmdrpcABwH7GJ7MkzdUrMjcD6RYE2A7S+WirkrgW1rx9MBOnYtNZRPTCdIOkDS7OV2IDChdlANtZDt04iJGDfa3oMYe5q6m9v2tUTi8BHbPwC2rhxTY9j+NnA8cfXyCNtHlqdeJHpapC45qW5wZpU0Z+tBqQybcxo/PzO7U9KxZcLKcpKOJZIZqbC9TKm4vAb4rO2FbS9EXOC4qm50jfKK7RNsbwCsR1QZniRpQqmmS2Gy7deI77rXgOcAbGfT6b49B/yr7fG/yrFUSFpW0umSfiRpXkmnSrpP0oWt6T0JgIVtX9BK7ADYnmz7fGChinE1Upk2ulo5h+l2qx1bA3XsWmooJ3f2AtYnFiOPAaOAf68aUXO9Vf58UtLWktYAplm2PpN6o2zv+5uk/cp+zHlrB9Ukti+3/dNWg+BybEo2CO6lNeJ0Z0nrl9vOiul1Oamut3OBayXtKWlP4GqiAW7qbX9iBPMFxJXL14F9q0bUXOu2Dw+wfQWxbkhhasWl7Ym2jylb2z9DJPFTuEvSb4gtbNcCZ0raRdJpwAN1Q2sOSQdJOgj4O3CbpB9IOgy4lZismbqcAdwBvEy8Pg8CWxHrg6xw6jJG0kmSRklaotxGSToJyGbmbSRt2XZ/AUmnSRon6Tel/2Pqbn/i/PiCcnuDDllLDdmeO2ngJG0D/IkYX/0LYr/q4bYvqxpYwyimZo0nSvd/SLxOP8kS9SDpw8ToziWBK4jX5q3y3CW2t6sZX9MoJ9UNSlmYbFYeXm37yprxpM4n6Uriu6818XAXYsLKFvWiag5Jx9o+qHYcTVe2/O9IbPW7iLiY+EVii9+JWcETSiKnX7Y7YszwjKDu07Im2l6qr+dmdpLmAPakj7UU0e8qk9BFeyNlSb8GngJOBbYHPpVr9KFjyCV3StnU72zfXDuWlGYmkq4GfkdcZdoTWIvY8vBcLkamTdIw26/WjqOpJC1DjDh9vTyeG1gsmyV2kXQxUTlwSc8mnKlvpR/YYcAny6EbiS2l2VA5pVSNpDFEgnA40c9wS9t3lobKF2fz2zRYPZI73ZoF99U8eGalGBH/HWA7YFEiaf9P4FLgqNZgjybriMZAg7Qr8MkyAeoCovlfluZNg6S5iJPxntOy9qgWVIeQdIrt3O4XFrH9y3J/f0lfBm6StC3x4Zh6kLQecBqxvW8pSasRjZb3qRtZ41xI9+0yk8uxteuE00ijgCnAf0m6hphw9Afbb9YNq7lKEufA2nE0ValI2RP4PDFhBeKq+KXEVfG3+vu756ml0AAACtVJREFUM6OcqDltpZnr94n1wPeJbQ/bE1uODrT9ZMXwmuZg4L+Jz/TtgO9IGkFM2PxazcCaRNKyxGCFx4GjiYEn6xFV9t/KC0DdLFq2RQqYX1L74KGh3KZlsH5LTFvbyPZTMPWza/fy3KfrhTYwQ/F/5mO2RwKbE03azpH0oKTDJK1QObamOhv4ILAFceXyQ3RvdjdTk/SBfm4LEb0HUpi9JAoBsH0OceJ0JbB4taia7TjifddqwHkPXVUEqcts7UmKcn+OivE00T9t7wAsTZwUfA14XNJoSY1fjMxIpd/AUWVt8Lyk5ySNL8eG146vQc4GVgd+QHzXfQY4nJjmd07/f22mNRo4GXibmKh5Fvk6tTuDOOl+FLieaD69NbE18pf9/7WZTxnesR3RW24n4Ilyf1Pbl9aMrWHOIHoTvUJUjT9E9ibqz6nAfMTFxDOBhWFq4uLuinE1zdK2j24ldmBqI+qjgI9UjGvAhuK2rKllZ23HRhDljTvaXr5OZM3V2jIjaZztEZJmB/5kO0cIApImA4/QfZx3a4zukrbzJBOQ9H+Bu2zf2OP4GsAxtjevE1lzSbrN9qge++vvsZ2j0NuULX+/aPUBk/Q54ADbm9aNrDn6+e5bGNgB2Ml2TkAsSq+d64Az+7gyt4ntTIYBkv5qu8+LYtN6bmYlaYzttSTda/vj7cdqx9YE79BHJreFtJF0MHHecj5RlQJx4fULwPnlRHOml72JBk7SKOBB25MkDQMOAdYgmr4faXtS1QAbQtJVxCTNM20/XY4tRqwPNre92TT+eiMMxW1Z6nnA9jhgHLGHLvXWKq1+UdKqRJOtRSvG0zQTiKslE3s+IenRCvE0ku2fA0g6kyixbu1LfZi4Upd6e1TS+oBLUvVA4spm6m4v4FxJJ5THjwG7VYyniXr12bH9LHFFPK+Kd7e07aPbD5Qkz1GSvlIppiZ6XtKORB/DKQCKiZE7Ai9UjayZuk3UJE7Kc6Jml/bdAmf1eG7WGRlIB/gq8LGeWx9LX9H7gUzuhCllV8ZwYJikkW29ifJ3qrvTiapLiKrxV4mtbJsSVYfbV4qraXYmEl83lqSOgaeJJt071QxsoIZicucTAJJETL5Y1vYRkpYCPmj79qrRNdMpkhYk9q1eRixG/l/dkBrlOGBBYvJFT8fM4Fg6wYj2hmO2XyjVO6m3vYDjiSkPjwNXAdlvp03ZU/954HZgGHAPcUXlpaqBNYztT8LUHmr7ABsSi5I/Aye3mlEnAB4pV8b7ujKXieguXyAW/ydKan2mDye21HyhWlQNI+ls27sClxCfUQcQEzU3Af6tZmwNc6mkeW2/bPvQ1sFyIv5QxbiaaArR5+qRHscXL8+lkL2JBm4W22+X+yPbKn3/LCm3ZXXZFTjB9rdrBzK9hty2rBZJJxNv9k1sr1ySF1fZzgacRWms1etw+dO2j52R8TSVpDmJTO4Ttq+R9CWiuet44JRsKtmdpHuIRmQvlMcfAG5slamnLqXK6Rttr9WCwM+ymXmQdACwDXAT0e9jLPAikezZx/YN9aJrJkm/pfSbK4e+BAy3vWO9qJqlvM8OIcbntqpUW1fmjmq9H2d2ijHDXyT6fdwFbAlsQFQO5HdfIekBYDPgCmAjelSQ5/S1IOmbTGO4Qq45u0jaEjgB+BtdCeelgOWB/Wz/sVZsTSNpZeKzfAnivfc0cKnte6sG1jCSLgQutz1a0mjgxFLltAJwbp4fB0mTiB5O/wv8BriwVEF3jKGc3LnL9prZy6J/kg4rd1ckps5cVh5/Frjd9perBNYwks4lqtyGESeW8xIjhzcl3kN5Za6NpN2A7xLTjCBK+H9s++x6UTVTX3vCc594F0n3Aqvbnlz2iF9ue6NSiXlpvk69SXrA9irvdCz1TdJXbI+uHUcTtH33zQ1MAuYBfk9+93VTktB7A8sSFZiiqy+fc1pWyDXn4JQtfusQlb0Qv1t32J5cL6pmyd5EA6cY8X08scPlWWBNInH4KNHD8J6K4TWGpLHAWkTCfmdgW2AMMYH0YtuNHzg0lJM7txHVFXeUJM8iROVOngz0IOkmYOvWL6yk+YgRujm1B2hrND0b8eWxRDnZFHCP7RGVQ2wcSasQJekA19l+oGY8TZVVTtNWkjsjbb9Rqi2uLtMQkXSf7VXrRtg8ks4hSopvLY9HAfvazh5FA9CzKefMLL/7BkfSybb3rh1H0+WaM71XJP2VvnsTzQHcb/ujdSJrLknzA8sQifvHWluTU+g5nKL0w9yKSCJuZnuRasEN0FDsudPyX8QVpkUl/ZiYGHLotP/KTGsx4M22x2+WYynMUr4o5iGqdxYAngfmBGavGVhTlWROJnTe2c+Av5RyWShVThXjaZpfA3eUZP0niP4flGR9bnVoUxJhJj6TbpE0sTz+CPBgzdiaRtK4/p4iv/va5XffIGRiZ8ByzZneK9mbaJBKv8Ks0ulfz221bxFVhpeVCvLGG7LJHdvnShpDKR8GtrOdU2j6dhZwu6Tfl8fbAWfUC6dxTiNOjmYFvgdcKGkCsC5RCprSdLF9lqQ76apy2j6rnLrYPl7SNcDKRC+iB8vxZ4C8ytvdNrUD6CCLAVvQe+KTgFtmfDiNld996f2Qa870XvkGcK2kPnsTVYsqdbKd+3vC9qszMpDpNWS3ZaXBkbQmZdIYcJPtsTXjaRpJSwDYfkLScGIv5sScvpZSSp1F0mnAaNt/7uO539j+UoWwGim/+9L7Idec6b2SvYlS6i6TOymllFJKKaWUUkodbJbaAaSUUkoppZRSSiml6ZfJnZRSSimllFJKKaUOlsmdlFJKKaWUUkoppQ6WyZ2UUkoppUGQtISki/p57gZJI2d0TCmllFKauWVyJ6WUUkqpD5Jm6+u47Sds7zCj40kppZRS6k8md1JKKaXUMSQtLelBSedKGi/pIknDJH1f0h2S7pN0iiSVn79B0vGS7i7PrVOOzyPpdEm3Sxor6XPl+O6SLpN0HXDtNGK4r9yfW9L5JZbfA3PPmFcipZRSSqlLJndSSiml1GlWBE6yvTLwErAPcILttW2vSiRYtmn7+WG2Vy8/d3o59j3gOtvrABsDP5E0T3luTWAH258aQCx7A6+WWA4D1nqX/7aUUkoppUHL5E5KKaWUOs2jtm8u988BNgQ2lnSbpHuBTYCPtf38eQC2bwLmlzQc+DRwiKS7gRuAuYClys9fbfv5AcbyyRIDtscB46b7X5VSSimlNJ363EueUkoppdRg7uPxScBI249K+gGRrJnWzwv4P7Yfan9C0ijglfc23JRSSiml91dW7qSUUkqp0ywlab1y/0vAn8v9ZyXNC/RsdrwzgKQNgUm2JwFXAvu39eZZYzpjuanEgKRVgRHT+d9JKaWUUppuWbmTUkoppU7zELCvpNOBB4CTgQWB+4CngDt6/PzrksYCswN7lGM/BI4DxkmaBfgH3fv0DNTJwGhJ44HxwJjp+G+klFJKKb0rsntWKqeUUkopNZOkpYH/KY2TB/LzNwD/YfvO9zGslFJKKaWqcltWSimllFJKKaWUUgfLyp2UUkoppT5I+jhwdo/Db9geVSOelFJKKaX+ZHInpZRSSimllFJKqYPltqyUUkoppZRSSimlDpbJnZRSSimllFJKKaUOlsmdlFJKKaWUUkoppQ6WyZ2UUkoppZRSSimlDpbJnZRSSimllFJKKaUO9v8BmbJ1s9VIvrUAAAAASUVORK5CYII=\n",
            "text/plain": [
              "<Figure size 1440x576 with 1 Axes>"
            ]
          },
          "metadata": {
            "tags": [],
            "needs_background": "light"
          }
        },
        {
          "output_type": "display_data",
          "data": {
            "image/png": "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\n",
            "text/plain": [
              "<Figure size 1440x576 with 1 Axes>"
            ]
          },
          "metadata": {
            "tags": [],
            "needs_background": "light"
          }
        },
        {
          "output_type": "display_data",
          "data": {
            "image/png": "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\n",
            "text/plain": [
              "<Figure size 1440x576 with 1 Axes>"
            ]
          },
          "metadata": {
            "tags": [],
            "needs_background": "light"
          }
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "xoyydFGBAcRW",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "outputId": "b77eb0eb-3bf4-451a-ac8f-8f768324f5fe"
      },
      "source": [
        "targets = ['vaccine','vaccination','vaccines','vaccinations','anti-viral','anti viral','genome','genome data','strain'] \n",
        "g={}\n",
        "for line,paperid in df_sp.select(\"full_text\",\"paper_id\").toLocalIterator():\n",
        "  h=countOccurences(str(line),targets,str(paperid))\n",
        "  g.update(h)\n",
        "#print(g)\n",
        "df5=pd.DataFrame(g)\n",
        "df5=df5.transpose()\n",
        "\n",
        "%matplotlib inline\n",
        "df5.plot.barh(figsize=(20,300),title='Global distribution of keywords in the papers',stacked=True)"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "<matplotlib.axes._subplots.AxesSubplot at 0x7f4fc6e1e8d0>"
            ]
          },
          "metadata": {
            "tags": []
          },
          "execution_count": 11
        },
        {
          "output_type": "display_data",
          "data": {
            "image/png": "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\n",
            "text/plain": [
              "<Figure size 1440x21600 with 1 Axes>"
            ]
          },
          "metadata": {
            "tags": [],
            "needs_background": "light"
          }
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "7Ys5LOOkJTBY"
      },
      "source": [
        "def countOccurencesIgnoreKey(str, targets, paperkey):\n",
        "  target=[]\n",
        "  dictonary={}\n",
        "  dictonary[paperkey] = {} \n",
        "  target=targets\n",
        "  a=str.split(\" \")\n",
        "  count=0\n",
        "  for targetword in target:\n",
        "    for i in range(0,len(a)):\n",
        "      if(targetword==a[i]):\n",
        "        count=count+1\n",
        "    #print(paperkey,count)\n",
        "    #dictonary[paperkey]['paper_id']=paperkey\n",
        "    dictonary[paperkey][targetword]=count\n",
        "    #print(dictonary)\n",
        "    count=0\n",
        "  return dictonary"
      ],
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "kF881VqGL_wr",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "928dabb8-fee5-4c11-8cdd-f60d95130e76"
      },
      "source": [
        "targets=['Chile', 'Brazil', 'Iran', 'Canada', 'England', 'France', 'Colombia','turkey', 'Niger', 'China', 'Pakistan', \n",
        "         'India', 'Peru', 'USA', 'Russia', 'Mexico', 'South Africa', 'Spain', 'Argentina']\n",
        "j={}\n",
        "for line,paperid in df_sp.select(\"full_text\",\"paper_id\").toLocalIterator():\n",
        "  i=countOccurencesIgnoreKey(str(line),targets,str(paperid))\n",
        "  j.update(i)\n",
        "\n",
        "df6=pd.DataFrame(j)\n",
        "df6=df6.transpose()\n",
        "CountryCount_df=df6.sum(axis = 0, skipna = True) \n",
        "#CountryCount_df=CountryCount_df.sort_values(ascending=False)\n",
        "print(CountryCount_df)\n",
        "CountryCount_Dict=CountryCount_df.to_dict()\n",
        "Country_name=[]\n",
        "Country_count=[]\n",
        "for key in CountryCount_Dict.keys():\n",
        "  Country_name.append(key)\n",
        "for value in CountryCount_Dict.values():\n",
        "  Country_count.append(value)\n"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "text": [
            "Chile            25\n",
            "Brazil           45\n",
            "Iran             37\n",
            "Canada           33\n",
            "England          39\n",
            "France           77\n",
            "Colombia          1\n",
            "turkey           47\n",
            "Niger            26\n",
            "China           424\n",
            "Pakistan         18\n",
            "India           104\n",
            "Peru              3\n",
            "USA              88\n",
            "Russia           12\n",
            "Mexico           26\n",
            "South Africa      0\n",
            "Spain            72\n",
            "Argentina         7\n",
            "dtype: int64\n"
          ],
          "name": "stdout"
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "lBvWEu6BWAYB",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "outputId": "3e8c1484-4ef9-4311-f151-754397554418"
      },
      "source": [
        "%matplotlib inline\n",
        "fig = plt.figure(figsize =(15, 10)) \n",
        "plt.pie(Country_count, labels = Country_name, autopct='%1.0f%%', pctdistance=1.1, labeldistance=1.2) "
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "([<matplotlib.patches.Wedge at 0x7fdb715cfeb8>,\n",
              "  <matplotlib.patches.Wedge at 0x7fdb71576b00>,\n",
              "  <matplotlib.patches.Wedge at 0x7fdb71476eb8>,\n",
              "  <matplotlib.patches.Wedge at 0x7fdb7141e748>,\n",
              "  <matplotlib.patches.Wedge at 0x7fdb71c3a780>,\n",
              "  <matplotlib.patches.Wedge at 0x7fdb719ba5c0>,\n",
              "  <matplotlib.patches.Wedge at 0x7fdb711b6fd0>,\n",
              "  <matplotlib.patches.Wedge at 0x7fdb710a51d0>,\n",
              "  <matplotlib.patches.Wedge at 0x7fdb6cb03da0>,\n",
              "  <matplotlib.patches.Wedge at 0x7fdb70f63ef0>,\n",
              "  <matplotlib.patches.Wedge at 0x7fdb6d543ba8>,\n",
              "  <matplotlib.patches.Wedge at 0x7fdb71ed64a8>,\n",
              "  <matplotlib.patches.Wedge at 0x7fdb70bef9b0>,\n",
              "  <matplotlib.patches.Wedge at 0x7fdb71e4afd0>,\n",
              "  <matplotlib.patches.Wedge at 0x7fdb71b6e7f0>,\n",
              "  <matplotlib.patches.Wedge at 0x7fdb71f16080>,\n",
              "  <matplotlib.patches.Wedge at 0x7fdb719f1780>,\n",
              "  <matplotlib.patches.Wedge at 0x7fdb70f14e80>,\n",
              "  <matplotlib.patches.Wedge at 0x7fdb7137dc18>],\n",
              " [Text(1.196851654125981, 0.08686839480445722, 'Chile'),\n",
              "  Text(1.1548045751932199, 0.32623058273682265, 'Brazil'),\n",
              "  Text(1.0455476189395827, 0.5889228952331271, 'Iran'),\n",
              "  Text(0.9054486601510531, 0.7875041103579478, 'Canada'),\n",
              "  Text(0.7226717151729241, 0.9579903924826303, 'England'),\n",
              "  Text(0.3661867818676043, 1.1427629853934924, 'France'),\n",
              "  Text(0.10073688298745236, 1.1957642244213413, 'Colombia'),\n",
              "  Text(-0.06604437549024336, 1.1981811801501907, 'turkey'),\n",
              "  Text(-0.31617799349091613, 1.1575972859470853, 'Niger'),\n",
              "  Text(-1.1999999999999997, -1.931051837059921e-08, 'China'),\n",
              "  Text(-0.34292968287919884, -1.1499561872525284, 'Pakistan'),\n",
              "  Text(0.07645934424154768, -1.1975616763566512, 'India'),\n",
              "  Text(0.43825513164659363, -1.1171089649561616, 'Peru'),\n",
              "  Text(0.7143153570246293, -0.964237300003882, 'USA'),\n",
              "  Text(0.9600808229707486, -0.7198922234361265, 'Russia'),\n",
              "  Text(1.0333858208253264, -0.6100112665493698, 'Mexico'),\n",
              "  Text(1.0763754722491443, -0.5304864208822234, 'South Africa'),\n",
              "  Text(1.162920002287937, -0.2960018045192037, 'Spain'),\n",
              "  Text(1.1997530720001115, -0.024342683218888602, 'Argentina')],\n",
              " [Text(1.0971140162821493, 0.07962936190408579, '2%'),\n",
              "  Text(1.058570860593785, 0.29904470084208745, '4%'),\n",
              "  Text(0.9584186506946176, 0.5398459872970333, '3%'),\n",
              "  Text(0.8299946051384655, 0.7218787678281188, '3%'),\n",
              "  Text(0.6624490722418471, 0.8781578597757446, '4%'),\n",
              "  Text(0.3356712167119706, 1.0475327366107015, '7%'),\n",
              "  Text(0.092342142738498, 1.0961172057195632, '0%'),\n",
              "  Text(-0.06054067753272309, 1.0983327484710081, '4%'),\n",
              "  Text(-0.2898298273666731, 1.061130845451495, '2%'),\n",
              "  Text(-1.0999999999999999, -1.7701308506382613e-08, '39%'),\n",
              "  Text(-0.31435220930593233, -1.0541265049814845, '2%'),\n",
              "  Text(0.07008773222141872, -1.0977648699935971, '10%'),\n",
              "  Text(0.40173387067604416, -1.024016551209815, '0%'),\n",
              "  Text(0.654789077272577, -0.8838841916702252, '8%'),\n",
              "  Text(0.8800740877231863, -0.6599012048164493, '1%'),\n",
              "  Text(0.9472703357565494, -0.5591769943369224, '2%'),\n",
              "  Text(0.9866775162283824, -0.4862792191420382, '0%'),\n",
              "  Text(1.0660100020972756, -0.27133498747593676, '7%'),\n",
              "  Text(1.0997736493334358, -0.02231412628398122, '1%')])"
            ]
          },
          "metadata": {
            "tags": []
          },
          "execution_count": 14
        },
        {
          "output_type": "display_data",
          "data": {
            "image/png": "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\n",
            "text/plain": [
              "<Figure size 1080x720 with 1 Axes>"
            ]
          },
          "metadata": {
            "tags": []
          }
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "8G4LhPKorxzg",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "17258988-8078-40ce-f234-71dbfa501474"
      },
      "source": [
        "#Add all the references in a single list and find the count of the repeats\n",
        "bibs=[]\n",
        "for item in df['bib_entries']:\n",
        "    for eachbib in item:\n",
        "        bibs.append(eachbib)\n",
        "a = dict(Counter(bibs))\n",
        "print(a)\n",
        "#del a['']\n",
        "df_a=pd.DataFrame.from_dict(a, orient='index',columns=['no. of times cited'])\n",
        "df_a['no. of times cited'] = df_a['no. of times cited'].astype(str).astype(int)\n",
        "sorted_df_a=df_a.sort_values(by='no. of times cited', ascending=False)\n",
        "new_df = sorted_df_a.loc[sorted_df_a['no. of times cited'] >= 5] #5 here is the minimum no. of times the paper has been cited\n",
        "new_df['title'] = new_df.index.str.slice(0,40)#truncated the title"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "text": [
            "{'Innovation médicales en situations humanitaires: le travail de Médecins Sans Frontières': 1, 'Conducting operational research within a non governmental organization: the example of Médecins Sans Frontières': 1, 'Research ethics review in humanitarian contexts: the experience of the independent ethics review board of Medecins Sans Frontieres': 2, 'What makes clinical research in developing countries ethical? The benchmarks of ethical research': 1, 'MSF Field research': 1, 'World Medical Association Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects': 3, 'Council for International Organizations of Medical Sciences (CIOMS) in collaboration with the World Health Organization (WHO)': 3, 'Theory and practice in public health ethics: a complex relationship': 1, \"Relief of oppression': an organizing principle for researchers' obligations to participants in observational studies in the developing world\": 1, 'A framework for ethics review during public emergencies': 1, 'Research ethics governance in disaster situations': 1, 'Research in complex humanitarian emergencies: the médecins sans frontières/epicentre experience': 1, 'Research ethics and international epidemic response: the case of Ebola and Marburg hemorrhagic fevers': 1, 'Making an Impact: A Preferred Framework and Indicators to Measure Returns on Investment in Health Research': 1, 'What is the purpose of medical research?': 1, 'Is operational research delivering the goods? The journey to success in low-income countries': 1, 'Making sure that clinical trial results make a difference: operational research and the hierarchy of evidence': 1, 'Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo': 1, 'Mental health treatment outcomes in a humanitarian emergency: a pilot model for the integration of mental health into primary care in Habilla': 1, 'Practicing medicine without borders: tele-consultations and tele-mentoring for improving paediatric care in a conflict setting in Somalia': 1, 'Treating 4,000 diabetic patients in Cambodia, a high-prevalence but resource-limited setting: a 5-year study': 1, 'Low referral completion of rapid diagnostic test-negative patients in community-based treatment of malaria in Sierra Leone': 1, 'Cesarean section rates and indications in sub-Saharan Africa: a multi-country study from Medecins sans Frontieres': 1, 'Efficacy of three artemisinin combination therapies for the treatmentof uncomplicated Plasmodium falciparum malaria in the Republic of Congo': 1, 'Lost to follow up from tuberculosis treatment in an urban informal settlement (Kibera)': 1, 'Tracing patients on antiretroviral treatment lost-to-follow-up in an urban slum in India': 1, 'Double ethical review of North-south collaborative clinical research: hidden paternalism or real partnership': 1, 'Submit your next manuscript to BioMed Central and take full advantage of: • Convenient online submission • Thorough peer review • No space constraints or color figure charges • Immediate publication on acceptance • Inclusion in PubMed, CAS, Scopus and Google Scholar • Research which is freely available for redistribution': 2, 'Respiratory syncytial virus infections on an adult medical ward': 1, 'Outbreak of human parainfluenza virus 3 infections in a hematopoietic stem cell transplant population': 1, 'Possible role of aerosol transmission in a hospital outbreak of influenza': 1, 'Comparison of Anyplex II RV16 with the xTAG respiratory viral panel and Seeplex RV15 for detection of respiratory viruses': 2, 'Red book: 2015 report of the committee on infectious diseases': 1, 'Case definitions for national notifiable infectious diseases. Osong: KCDC': 1, 'Understanding the burden of influenza infection among adults in Canadian hospitals: a comparison of the 2009-2010 pandemic season with the prepandemic and postpandemic seasons': 1, 'Characterisation of nosocomial and community-acquired influenza in a large university hospital during two consecutive influenza seasons': 1, 'Should lower respiratory tract secretions from intensive care patients be systematically screened for influenza virus during the influenza season': 1, 'Viral infection is not uncommon in adult patients with severe hospital-acquired pneumonia': 1, 'The pathogenic basis of malaria': 1, 'Variant surface antigens, virulence, genes and the pathogenesis of malaria': 1, 'WHO Global Malaria Programme. Geneva: World Health Organization': 2, 'The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of Plasmodium falciparum infected erythrocytes': 1, 'Receptorspecific adhesion and clinical disease in Plasmodium falciparum': 1, 'Developmental selection of var gene expression in Plasmodium falciparum': 6, 'Antigenic variation in malaria: in situ switching, relaxed and mutually exclusive transcription of var genes during intra-erythrocytic development in Plasmodium falciparum': 3, 'Switches in expression of Plasmodium falciparumvar genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes': 1, 'A highly conserved segmental duplication in the subtelomeres of Plasmodium falciparum chromosomes varies in copy number': 1, 'A well-conserved Plasmodium falciparumvar gene shows an unusual stagespecific transcript pattern': 4, 'A study of var gene transcription in vitro using universal var gene primers': 3, 'Chromatin-mediated epigenetic regulation in the malaria parasite Plasmodium falciparum': 2, 'The role of chromatin in Plasmodium gene expression': 5, \"5' flanking region of var genes nucleate histone modification patterns linked to phenotypic inheritance of virulence traits in malaria parasites\": 2, 'Telomeric heterochromatin propagation and histone acetylation control mutually exclusive expression of antigenic variation genes in malaria parasites': 2, 'Epigenetic memory at malaria virulence genes': 1, 'Plasmodium falciparum heterochromatin protein 1 marks genomic loci linked to phenotypic variation of exported virulence factors': 1, 'In silico and biological survey of transcriptionassociated proteins implicated in the transcriptional machinery during the erythrocytic development of Plasmodium falciparum': 4, 'The MYST family histone acetyltransferase regulates gene expression and cell cycle in malaria parasite Plasmodium falciparum': 1, 'PfGCN5-mediated histone H3 acetylation plays a key role in gene expression in Plasmodium falciparum': 1, 'Heterochromatin silencing and locus repositioning linked to regulation of virulence genes in Plasmodium falciparum': 3, 'Sir2 paralogues cooperate to regulate virulence genes and antigenic variation in Plasmodium falciparum': 2, 'Plasmodium falciparum Sir2 is an NAD+-dependent deacetylase and an acetyllysine-dependent and acetyllysineindependent NAD+ glycohydrolase': 1, 'Histone lysine methyltransferases and demethylases in Plasmodium falciparum': 1, 'Potential epigenetic regulatory proteins localise to distinct nuclear subcompartments in Plasmodium falciparum': 1, 'Plasmodium falciparum methyltransferase, maintains the active var gene in a poised state during parasite division': 2, 'PfSETvs methylation of histone H3K36 represses virulence genes in Plasmodium falciparum': 2, 'Dynamic histone H3 epigenome marking during the intraerythrocytic cycle of Plasmodium falciparum': 2, 'A critical role of perinuclear fliamentous actin in spatial repositioning and mutually exclusive expression of virulence genes in malaria parasites': 2, 'Identification and molecular characterization of an Alba-family protein from human malaria parasite Plasmodium falciparum': 1, 'A major role for the Plasmodium falciparum ApiAP2 protein PfSIP2 in chromosome end biology': 1, 'Control of gene expression in Plasmodium falciparum-ten years on': 1, 'Composition and functional specificity of SWI2/ SNF2 class chromatin remodeling complexes': 1, 'Gene structure of rat BAF60b, a component of mammalian SWI/SNF complexes, and its physical linkage to the growth hormone gene and transcription factor SUG/proteasome p45 gene': 2, 'BAF60a interacts with p53 to recruit the SWI/SNF complex': 4, 'Mammalian SWI/SNF chromatin remodeling complexes are required to prevent apoptosis after DNA damage': 2, 'SWI/SNF complex interacts with tumor suppressor p53 and is necessary for the activation of p53-mediated transcription': 2, 'Localization and interactions of Plasmodium falciparum SWIB/MDM2 homologues': 7, 'Mitotic phosphorylation of histone H3 Is governed by Ipl1/aurora kinase and Glc7/PP1 phosphatase in budding yeast and nematodes': 4, 'Aurora-B phosphorylates Histone H3 at serine28 with regard to the mitotic chromosome condensation': 4, 'Human malaria parasites in continuous culture': 1, 'Synchronization of Plasmodium falciparum erythrocytic stages in culture': 1, 'An alternative protocol for Plasmodium falciparum culture synchronization and a new method for synchrony confirmation': 1, 'Efficient site-specific integration in Plasmodium falciparum chromosomes mediated by mycobacteriophage Bxb1 integrase': 4, 'Small-molecule displacement of a cryptic degron causes conditional protein degradation': 5, 'Cloning of naturally occurring mixed infections of malaria parasites': 1, 'Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancyassociated malaria': 1, 'A simple RNA analysis method shows var and rif multigene family expression patterns in Plasmodium falciparum': 1, 'STAR: ultrafast universal RNA-seq aligner': 1, 'Complex heatmaps reveal patterns and correlations in multidimensional genomic data': 1, 'Ggplot2: elegant graphics for data analysis': 1, 'featureCounts: an efficient general purpose program for assigning sequence reads to genomic features': 2, 'ANOVA like differential expression (ALDEx) analysis for mixed population RNAseq': 1, 'Unifying the analysis of high-throughput sequencing datasets: characterizing RNA-seq, 16S rRNA gene sequencing and selective growth experiments by compositional data analysis': 1, 'Sub-grouping of Plasmodium falciparum 3D7 var genes based on sequence analysis of coding and non-coding regions': 1, 'Genome sequence of the human malaria parasite Plasmodium falciparum': 1, 'Chromatin modifications, epigenetics, and how protozoan parasites regulate their lives': 1, 'Comparative analysis of apicomplexa and genomic diversity in eukaryotes': 1, 'Diversity and specialization of mammalian SWI/SNF complexes': 1, 'The SWIB and the MDM2 domains are homologous and share a common fold': 1, 'The core of chloroplast nucleoids contains architectural SWIB domain proteins': 1, 'SWI/SNF nucleosome remodellers and cancer': 1, 'Exonucleasemediated degradation of nascent RNA silences genes linked to severe malaria': 1, 'Evolutionary principles of genome compression': 1, 'Principles of Molecular Virology, 3e': 1, 'Basic Virology': 1, 'Formal Languages': 1, 'Transductions and Context-Free Languages': 1, 'Algebraic and Automata-Theoretic Properties of Formal Languages': 1, 'The smallest automaton recognizing the subwords of a text': 3, 'Bounded algol-like languages': 1, 'Reversal-bounded multicounter machines and their decision problems': 1, 'Implementation of nondeterministic finite automata for approximate pattern matching': 1, 'FDA guidance for industry and FDA staff: class II special controls guidance documents: respiratory virus panel multiplex nucleic acid assay': 4, 'FDA guidance for industry and FDA staff: class II special controls guidance document: testing for detection and differentiation of influenza A virus subtypes using multiplex nucleic acid tests': 2, 'FDA draft guidance: establishing performance characteristics of in vitro diagnostic devices for the detection or detection and differentiation of influenza viruses': 1, 'The statistical evaluation of medical tests for classification and prediction': 1, '2A: establishment of precision of quantitative measurement procedures': 1, 'A: verification and validation of multiplex nucleic acid assays': 1, 'FDA guidance for industry and FDA staff: recommendations for Clinical Laboratory Improvement Amendments of 1988 (CLIA) waiver applications for manufacturers of in vitro diagnostic devices': 2, 'FDA guidance for industry and FDA staff: guidance for the content of premarket submissions for software contained in medical devices': 1, 'FDA guidance for industry, FDA reviewers and compliance on off-the-shelf software use in medical devices': 1, 'FDA draft guidance for industry and FDA staff: in vitro diagnostic (IVD) device studies-frequently asked questions': 1, 'Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding': 1, 'Current aspects of diagnosis and treatment of cytomegalovirus infections in infants': 1, 'Cytomegalovirus infections in homosexual men. An epidemiological study': 1, 'Summary of the International Consensus Symposium on Advances in the Diagnosis, Treatment and Prophylaxis and Cytomegalovirus Infection': 1, 'Immune evasion by cytomegalovirus -survival strategies of a highly adapted opportunist': 1, 'Cytomegalovirus infection': 1, 'Cytomegalovirus pneumonia: presentation, diagnosis, and treatment': 1, 'An unexpected cause of ventilator-associated pneumonia': 3, 'Human cytomegalovirus infections in non-immunosuppressed critically ill patients': 2, 'Cytomegalovirus reactivation and tumour necrosis factor': 2, 'High incidence of active cytomegalovirus infection among septic patients': 1, 'Changes in lymphocyte subpopulations and adhesion/activation molecules following endotoxemia and major surgery': 1, 'The effect of anesthetic agents on the human immune response': 1, 'Evaluation by polymerase chain reaction of cytomegalovirus reactivation in intensive care patients under mechanical ventilation': 1, 'Comparison between viremia and antigenemia for detection of cytomegalovirus in blood': 1, 'Comparison of standard tube and shell vial cell culture techniques for the detection of cytomegalovirus in clinical specimens': 1, 'Evaluation of three assays on alveolar lavage fluid in the diagnosis of cytomegalovirus pneumonitis after bone marrow transplantation': 1, 'Ganciclovir resistance as a result of oral ganciclovir in a heart transplant recipient with multiple human cytomegalovirus strains in blood': 1, 'Human cytomegalovirus resistance to antiviral drugs: diagnosis, monitoring and clinical impact': 1, 'Pneumonia caused by herpesviruses in recipients of hematopoietic cell transplants': 1, 'Herpes simplex virus pneumonia in trauma patients': 1, 'Herpes simplex virus pneumonia presenting as failure to wean from a ventilator': 1, 'Prise en charge des infections à VZV': 2, 'Varicella pneumonitis: clinical presentation and experience with acyclovir treatment in immunocompetent adults': 1, 'Risk factors and outcome of varicella-zoster virus pneumonia in pregnant women': 2, 'Varicella pneumonia in patients with HIV/AIDS': 1, 'Varicella-zoster virus detection by polymerase chain reaction using bronchoalveolar lavage specimens': 2, 'Lung abscess complicating post-varicella pneumonia': 1, 'Varicella pneumonia: another ″steroid responsive″ pneumonia?': 1, 'Corticosteroids in life-threatening varicella pneumonia': 1, 'The chronicle of influenza epidemics': 1, 'The origin of influenza pandemics': 1, 'Update: Isolation of Avian Influenza A(H5N1) Viruses From Human Beings -Hong Kong, 1997-1998': 1, 'Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus': 1, 'Outbreak of avian influenza A(H5N1) virus infection in Hong Kong in 1997': 2, 'Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong': 1, 'Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts': 1, 'Case-control study of risk factors for avian influenza A (H5N1) disease, Hong Kong': 1, 'Influenza A pneumonia with rhabdomyolysis': 1, 'Two cases of severe bronchopneumonia due to influenza A (H3N2) virus: detection of influenza virus gene using reverse transcription polymerase chain reaction': 1, 'Influenza pandemic planning': 1, 'Prospective comparative study of viral, bacterial and atypical organisms identified in pneumonia and bronchiolitis in hospitalized Canadian infants': 1, 'A newly discovered human pneumovirus isolated from young children with respiratory tract disease': 12, 'Identification of Severe Acute Respiratory Syndrome in Canada': 4, 'Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome': 2, 'Human metapneumovirus infection in the United States: clinical manifestations associated with a newly emerging respiratory infection in children': 3, 'Human metapneumovirus infections in hospitalized children': 4, 'Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden': 1, 'Human metapneumovirus as a cause of community-acquired respiratory illness': 8, 'Australian find suggests worldwide reach for metapneumovirus': 1, 'Children with respiratory disease associated with metapneumovirus in Hong Kong': 8, 'Presence of the new human metapneumovirus in French children with bronchiolitis': 1, 'Human metapneumovirus: a newly emerging respiratory pathogen': 1, 'Osterhaus AD. Human metapneumovirus in a haematopoietic stem cell transplant recipient with fatal lower respiratory tract disease': 1, 'Clinical utility of capillary polymerase chain reaction for diagnosis of Cytomegalovirus pneumonia': 1, 'Coronavirus as a possible cause of severe acute respiratory syndrome': 14, 'Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome': 3, 'A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome': 1, 'Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS)': 2, 'Severe acute respiratory syndrome -Singapore': 1, 'Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions': 3, 'A Cluster of Cases of Severe Acute Respiratory Syndrome in Hong Kong': 3, 'A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong': 3, 'Severe acute respiratory syndrome (SARS) in Singapore: clinical features of index patient and initial contacts': 1, 'Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area': 5, 'Infectious diseases. Clues to the animal origins of SARS': 1, 'Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis': 1, 'Severe acute respiratory syndrome: radiographic appearances and pattern of progression in 138 patients': 1, 'The use of corticosteroids in SARS': 1, 'Severe respiratory syncytial virus pneumonia associated with primary Epstein-Barr virus infection': 1, 'Respiratory syncytial virus infection in patients with phagocyte defects': 1, 'Respiratory syncytial virus infection of the lower respiratory tract: radiological findings in 108 children': 1, 'Measles pneumonia: treatment of a near-fatal case with nitric oxide inhalation': 1, 'Measles pneumonia. Treatment of a near-fatal case with corticosteroids and vitamin A': 1, 'Role of parvovirus B19 in human disease': 1, 'Parvovirus B19 in human disease': 2, 'Acute lung injury due to parvovirus pneumonia': 1, 'Conventional respiratory viruses recovered from immunocompromised patients: clinical considerations': 1, 'Editorial response: rhinovirus pneumonia--a clinical entity?': 1, 'Acute viral infections of upper respiratory tract in elderly people living in the community: comparative, prospective, population based study of disease burden': 1, 'Risk factors for lower respiratory complications of rhinovirus infections in elderly people living in the community: prospective cohort study': 1, 'Clinical features of patients with acute respiratory illness and rhinovirus in their bronchoalveolar lavages': 1, 'Diagnosis and treatment of rhinovirus respiratory infections': 1, 'Behavioral interventions for prevention and control of sexually transmitted diseases': 2, 'HIV immunization: Acceptability and anticipated effects of sexual behavior among adolescents': 1, 'HIV risk behavior reduction following intervention with key opinion leaders of population: An experimental analysis': 1, 'Early sexual initiation: The role of peer norms': 1, 'Epidemiology of multidrug-resistant bacteria in patients with long hospital stays': 2, 'Antimicrobial susceptibility patterns of unusual nonfermentative Gram-negative bacilli isolated from Latin America: report from the SENTRY Antimicrobial Surveillance Program': 1, 'NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention': 1, 'Guidelines for the treatment of methicillin-resistant Staphylococcus aureus infections in Taiwan': 1, 'Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis': 1, 'Nationwide surveillance in Taiwan of the in-vitro activity of tigecycline against clinical isolates of Gram-positive cocci': 1, 'Daptomycin 98-01 and 99-01 Investigators. The safety and efficacy of daptomycin for the treatment of complicated skin and skinstructure infections': 1, 'Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus': 1, 'Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci at a university hospital in Taiwan from 1991 to 2003: resistance trends, antibiotic usage and in vitro activities of newer antimicrobial agents': 2, 'Correlation between antimicrobial consumption and resistance among Staphylococcus aureus and enterococci causing healthcare-associated infections at a university hospital in Taiwan from': 4, 'Wayne: CLSI; 2009. 23. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility tests: approved standard (Document M2-A9)': 4, 'CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting': 1, 'Secular trends of healthcare-associated infections at a teaching hospital in Taiwan': 1, 'Community surveillance of respiratory viruses among families in the Utah Better Identification of Germs Longitudinal Viral Epidemiology (BIG-LoVE) Study': 1, 'A study of illness in a group of Cleveland families. I. Plan of study and certain general observations': 1, 'The Tecumseh study of respiratory illness. I. Plan of study and observations on syndromes of acute respiratory disease': 1, 'The Seattle Virus Watch program. I. Infection and illness experience of Virus Watch families during a communitywide epidemic of echovirus type 30 aseptic meningitis': 1, 'The Virus Watch program: a continuing surveillance of viral infections in metropolitan New York families. II. Laboratory methods and preliminary report on infections revealed by virus isolation': 1, 'Community epidemiology of human metapneumovirus, human coronavirus NL63, and other respiratory viruses in healthy preschool-aged children using parent-collected specimens': 2, 'an automated nested multiplex PCR system for multi-pathogen detection: development and application to respiratory tract infection': 1, 'Symptomatic and asymptomatic respiratory viral infections in the first year of life: association with acute otitis media development': 2, 'Duration of rhinovirus shedding in the upper respiratory tract in the first year of life': 1, 'Human rhinoviruses: the cold wars resume': 2, 'Detecting respiratory viruses in asymptomatic children': 1, 'Gene expression patterns in blood leukocytes discriminate patients with acute infections': 1, 'Gene expression profiles in febrile children with defined viral and bacterial infection': 1, 'Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans': 1, 'A hostbased rt-PCR gene expression signature to identify acute respiratory viral infection': 1, 'Superiority of transcriptional profiling over procalcitonin for distinguishing bacterial from viral lower respiratory tract infections in hospitalized adults': 2, 'Excessive antibiotic use for acute respiratory infections in the United States': 1, 'Teaching machines to read and comprehend': 9, 'A conceptual theory of question answering': 2, 'Populating the semantic web by macro-reading internet text': 1, 'Procedures as a representation for data in a computer program for understanding natural language': 1, 'The lunar sciences natural language system: final report': 1, 'Baseball: an automatic question-answerer': 1, 'Deep read: A reading comprehension system': 3, 'A rule-based question answering system for reading comprehension tests': 1, 'Searching the world wide web': 1, 'Estimating search engine index size variability: a 9-year longitudinal study': 1, 'SQuAD: 100,000+ questions for machine comprehension of text': 1, 'HotpotQA: A dataset for diverse, explainable multi-hop question answering': 2, 'WordNet: An Electronic Lexical Database. Language, Speech, and Communication': 1, 'Wikidata: A Free Collaborative Knowledgebase': 1, 'On what there is. The review of metaphysics': 1, 'Ontological promiscuity': 1, 'Freebase: A collaboratively created graph database for structuring human knowledge': 2, 'Freebase data dumps': 1, \"The Goldilocks Principle: Reading Children's Books with Explicit Memory Representations\": 3, 'Introducing the knowledge graph: things, not strings. Official Google blog': 1, 'WikiQA: A challenge dataset for open-domain question answering': 1, 'Triviaqa: A large scale distantly supervised challenge dataset for reading comprehension': 1, 'The narrativeqa reading comprehension challenge': 1, 'The Stanford CoreNLP Natural Language Processing Toolkit': 1, 'Accurate unlexicalized parsing': 1, 'Lucene in Action, Second Edition': 1, 'MCTest: A challenge dataset for the open-domain machine comprehension of text': 1, 'Machine comprehension with syntax, frames, and semantics': 1, 'Emergent predication structure in hidden state vectors of neural readers': 1, 'End-to-end memory networks': 2, 'Attention-over-attention neural networks for reading comprehension': 3, 'Reformer: The efficient transformer': 1, 'Attention is all you need': 2, 'Token-level dynamic self-attention network for multi-passage reading comprehension': 1, 'Xception: Deep learning with depthwise separable convolutions': 1, 'Generalized autoregressive pretraining for language understanding': 1, 'Transformer-XL: Attentive language models beyond a fixed-length context': 1, 'Question answering by reasoning across documents with graph convolutional networks': 1, 'Deep contextualized word representations': 2, 'Multi-hop question answering via reasoning chains': 1, 'Pointer networks': 1, 'Coarse-grain finegrain coattention network for multi-evidence question answering': 1, 'Learning phrase representations using RNN encoder-decoder for statistical machine translation': 1, 'Neural models for reasoning over multiple mentions using coreference': 1, 'BERT: Pretraining of deep bidirectional transformers for language understanding': 1, 'Dropout: A simple way to prevent neural networks from overfitting': 1, 'Yangqing Jia, and Kaiming He. Accurate, large minibatch SGD: training imagenet in 1 hour. The Computing Research Repository (CoRR)': 1, 'Adam: A method for stochastic optimization': 1, 'Relation extraction with weakly supervised learning based on process-structure-property-performance reciprocity': 1, 'Cybermaterials: Materials by design and accelerated insertion of materials': 2, 'Designing a new material world': 1, 'Inorganic materials database for exploring the nature of material': 1, 'Distant supervision for relation extraction without labeled data': 1, 'Knowledge-based weak supervision for information extraction of overlapping relations': 2, 'Modeling Relations and Their Mentions without Labeled Text': 1, 'Deep residual learning for weakly-supervised relation extraction': 2, 'Distant supervision for relation extraction via piecewise convolutional neural networks': 1, 'Neural relation extraction with selective attention over instances': 1, 'Distant Supervision for Relation Extraction with Sentence-Level Attention and Entity Descriptions': 1, 'A soft-label method for noise-tolerant distantly supervised relation extraction': 1, 'GloVe: Global vectors for word representation': 1, 'The role of \"condition\": A novel scientific knowledge graph representation and construction model': 1, 'An information extraction and knowledge graph platform for accelerating biochemical discoveries': 1, 'propnet: A knowledge graph for materials science. Matter, 2': 1, 'Multi-task identification of entities, relations, and coreference for scientific knowledge graph construction': 1, 'The SOFC-exp corpus and neural approaches to information extraction in the materials science domain': 1, 'The materials science procedural text corpus: Annotating materials synthesis procedures with shallow semantic structures': 1, 'Text-mined dataset of inorganic materials synthesis recipes. Scientific Data': 1, 'Automatically extracting action graphs from materials science synthesis procedures': 1, 'Mise en place: Unsupervised interpretation of instructional recipes': 1, 'Named entity recognition and normalization applied to largescale information extraction from the materials science literature': 2, 'Machine-learned and codified synthesis parameters of oxide materials. Scientific Data': 1, 'Efficient estimation of word representations in vector space': 1, 'Unsupervised word embeddings capture latent knowledge from materials science literature': 1, 'Imagenet: A large-scale hierarchical image database': 2, 'Learning to detect unseen object classes by between-class attribute transfer': 1, 'One-shot learning of object categories': 1, 'Object classification from a single example utilizing class relevance metrics': 1, 'Diverse few-shot text classification with 110 multiple metrics': 1, 'Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome': 1, 'Hepatitis C virus: types, subtypes and beyond': 1, 'Comparative studies of the core gene products of two different hepatitis C virus isolates: two alternative forms determined by a single amino acid substitution': 4, 'Differential subcellular localization of hepatitis C virus core gene products': 6, 'Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo ®broblasts to tumorigenic phenotype': 2, 'Interaction between hepatitis C virus core protein and E1 envelope protein': 6, 'Genetic organization and diversity of the hepatitis C virus': 1, 'A dual-luciferase reporter system for studying recoding signals': 3, 'Conservation of polyamine regulation by translational frameshifting from yeast to mammals': 2, 'Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA': 2, 'Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee': 2, 'Transcripts of a chimeric cDNA clone of hepatitis C virus genotype 1b are infectious in vivo': 2, 'Hepatitis C virus: an infectious molecular clone of a second major genotype (2a) and lack of viability of intertypic 1a and 2a chimeras': 1, 'An infectious molecular clone of a Japanese genotype 1b hepatitis C virus': 2, 'Reduction of synonymous substitutions in the core protein gene of hepatitis C virus': 1, 'Expression and dimerization of hepatitis C virus core protein in E.coli': 3, 'Expression, identi®cation and subcellular localization of the proteins encoded by the hepatitis C viral genome': 1, 'Reading two bases twice: mammalian antizyme frameshifting in yeast': 1, 'Programmed frameshifting in the synthesis of mammalian antizyme is +1 in mammals, predominantly +1 in ®ssion yeast, but ±2 in budding yeast': 1, 'Internal ribosomal entry sitemediated translation in hepatitis C virus replication': 1, 'Expression of the Rous sarcoma virus pol gene by ribosomal frameshifting': 1, 'Characterization of an ef®cient coronavirus ribosomal frameshifting signal: requirement for an RNA pseudoknot': 1, 'The human astrovirus RNA-dependent RNA polymerase coding region is expressed by ribosomal frameshifting': 1, 'Ef®cient initiation of HCV RNA replication in cell culture': 1, 'Translating old drugs into new treatments: ribosomal frameshifting as a target for antiviral agents': 1, 'Genotyping by type-speci®c primers that can type HCV types 1±6': 1, 'Activation of p53 tumor suppressor by hepatitis C virus core protein': 2, 'Posttranslational modi®cation and subcellular localization of the p12 capsid protein of herpes simplex virus type 1': 1, 'and respiratory syncytial virus in the United States': 2, 'inhibitors of influenza virus meuraminidase are effective at a once-weekly': 1, 'Rational design of potent sialidase-based obstructive pulmonary disease': 2, 'Comparison of the Directigen flu A+B test, dosing regimen': 1, 'Managing influenza in primary care': 1, 'The contribution of influenza to combined acute respiratory infec': 1, 'Influenza-A infection in children': 1, 'Characterization of temperature sensitive NDA21-087 Tamiflu (Oseltamivir Phosphate) capsule [online': 1, 'Structure and diversity of influenza virus neuraminidase': 1, 'Textbook of children treated with oseltamivir': 1, 'The efficacy of influenza vaccination in impact of age, severity of infections and specific risk factors': 1, \"Comparison of elderly people's editors. Textbook of influenza\": 1, 'Synthesis and anti-influenza evaluation of 48. CDC. Update on Influenza A(H5N1) and SARS: interim recommendations for orally active bicyclic ether derivatives related to zanamivir': 1, 'Potent and long-acting dimeric': 1, 'Zanamivir for the treatment of clinically of influenza A in elderly nursing home patients': 1, 'Emergence and transmission of influenza A viruses resistant a patient perspective assessed by questionnaire': 1, 'and rimantadine-resistant influenza A viruses in symptomatic immunocom-40': 1, 'Influence of amantadine resistance mutations on prevention and treatment': 1, 'Amantadine-resistant influenza A in 42. McCullers JA, Bartmess KC. Role of neuraminidase in lethal synergism between nursing homes: identification of a resistant virus prior to drug use. Arch Intern influenza virus and streptococcus pneumoniae': 1, 'Low incidence of rimantadine resisanalysis and susceptibilities of influenza virus clinical isolates to zanamivir and tance in field isolates of influenza A viruses': 1, 'Neuraminidase inhibitors for the treatment and prevention': 2, 'Oseltamivir: a review of its use in influenza': 2, 'Neuraminidase inhibitors: zanamivir and oseltamivir': 2, 'Efficacy and safety of zanamivir in patients with influenza': 2, 'Existing antivirals are effective ing a novel hydrophobic interaction in the enzyme active site: design, synthesis, against influenza viruses with genes from the 1918 pandemic virus. Proc Natl and structural analysis of carbocyclic sialic acid analogues with potent anti-Acad Sci': 1, 'BCX-1812 (RWJ-270201): discovery of a influenza A viruses that possess genes encoding H5N1 internal proteins and are novel, highly potent, orally active, and selective influenza neuraminidase pathogenic in mammals': 1, 'Efficacy and safety of inhaled zanamivir for the treatment of influenza in patients with asthma or chronic': 1, 'Influenza neuraminidase inhibitors: struc-(oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) ture-based design of a novel inhibitor series': 1, 'In vitro characterization of A-315675, a 47. CSIRO. CSIRO based drug effective against bird flu': 1, 'Zanamivir for the treatment of clinically': 1, 'Neuraminidase sequence': 3, 'Efficacy of zanamivir against avian': 1, 'The neuraminidase inhibitor GS4104': 1, 'Oral oseltamivir treatment of': 2, 'Management of influenza: use of new subtype H5N1 disease': 1, 'Evaluation of neuraminidase enzyme influenza A (H5N1) virus infection in cynomolgus macaques (Macaca fascicuassays using different substrates to measure susceptibility of influenza virus laris)': 1, 'Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial': 1, 'Inhaled zanamivir for the prevention of influenza in families: Zanamivir Family Study Group': 1, 'Zanamivir prophylaxis: an effective strategy for the prevention of influenza types A and B within house-71': 1, 'Zanamivir use during transmission of amantadineresistant influenza A in a nursing home': 1, 'Cost-effectiveness of newer treatment strategies for influceptibility network': 1, 'Influenza virus carrying an R292K mutation in influenza B infection': 1, 'Use of the selective oral neuraminidase': 1, 'Effectiveness of oseltamivir in preventneuraminidase active site following oseltamivir phosphate treatment leave virus ing influenza in household contacts: a randomized controlled trial': 1, 'Experience with oseltamivir in the control of influenza viruses resistant to the antiviral oseltamivir': 1, 'Long-term use of oseltamivir for the 76. Vogel GE. Neuraminidase inhibitors in the management of influenza: experience prophylaxis of influenza in a vaccinated frail older population. J Am Geriatr of an outpatient practice': 1, 'Resistance of influenza viruses to neuraminidase inhibiload during treatment in military conscripts with influenza. Scand J Infect Dis tors: a review': 6, 'Logistic issues and potential prescribing resistance in an immunocompromised child infected with influenza B virus. J costs associated with use of neuraminidase inhibitors for the treatment of': 2, 'Characterization of 2 influenza A(H3N2)': 1, 'Generation and characteers': 1, 'Overexpression of the alpha-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to Correspondence and offprints: Dr Jennifer L. McKimm-Breschkin, CSIRO neuraminidase inhibitors': 1, 'Drug design against a shifting target: a Australia': 1, 'The H274Y mutation in the influenza A/H1N1': 1, 'Transmission studies in ferrets of': 1, 'In vitro selection and characterization of 282: 31-5 influenza A (A/N9) virus variants resistant to a novel neuraminidase inhibitor, A-315675': 1, 'Characterization of mutants of influenza A 343: 1282-9 virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en': 1, 'Molecular mechanisms of influenza virus resistance to 21: 700-4 neuraminidase inhibitors': 1, 'Zanamivir: a significant reduction in viral': 1, 'Coadministration of orally inhaled clinical isolates with reduced susceptibility to neuraminidase inhibitors due to zanamivir with inactivated trivalent influenza vaccine does not adversely affect mutations in the hemagglutinin gene': 1, 'Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China': 29, 'Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response': 4, 'Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region': 3, 'Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study': 12, 'Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State': 5, 'COVID-19; patient zero in the Netherlands': 1, 'Nationale Intensive Care Evaluatie (NICE) COVID-19 in Dutch Intensive Care Units; patient characteristics and outcomes': 1, 'Acute respiratory distress syndrome: the Berlin Definition': 2, 'Prone positioning in severe acute respiratory distress syndrome': 2, 'Respiratory mechanics to understand ARDS and guide mechanical ventilation': 1, 'Incidence of thrombotic complications in critically ill ICU patients with COVID-19': 6, 'The interactions between inflammation and coagulation': 1, 'Inflammation as a cause of venous thromboembolism': 1, 'Prevalence and Localization of Pulmonary Embolism in Unexplained Acute Exacerbations of COPD: A Systematic Review and Meta-analysis': 1, 'Pneumonia and risk of venous thrombosis: results from the MEGA study': 1, 'Acute infection as a trigger for incident venous thromboembolism: Results from a population-based case-crossover study': 1, 'Kinins and Cytokines in COVID-19: A Comprehensive Pathophysiological Approach': 1, 'Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease': 7, 'Immunization against influenza a virus: comparison of conventional in activated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system': 1, 'Baculovirus-based vaccination vectors allow for efficient induction of immune responses against plasmodium falciparum circumsporozoite protein': 1, 'Localization of VP28 on the baculovirus envelope and its immunogenicity against white spot syndrome virus in Penaeus monodon': 1, 'Induction of natural killer cell-dependent antitumor immunity by the Autographa californica multiple nuclear polyhedrosis virus': 1, 'Baculovirus activates murine dendritic cells and induces non-specific NK cell and T cell immune responses': 1, 'Induction of antitumor immunity against mouse carcinoma by baculovirus-infected dendritic cells': 2, 'Antitumor effects of baculovirus-infected dendritic cells against human pancreatic carcinoma': 2, 'Baculovirus directly activates murine NK cells via TLR9': 2, 'Baculovirusmediated interferon alleviates dimethylnitrosamine-induced liver cirrhosis symptoms in a murine model': 1, 'Baculovirus capsid display potentiates OVA cytotoxic and innate immune responses': 1, 'Baculovirus surface display of SARS coronavirus (SARS-CoV) spike protein and immunogenicity of the displayed protein in mice models': 1, 'Baculovirus surface display of E2 envelope glycoprotein of classical swine fever virus and immunogenicity of the displayed proteins in a mouse model': 1, 'Hemagglutinin displayed baculovirus protects against highly pathogenic influenza': 1, 'Potential cancer gene therapy by baculoviral transduction': 1, 'Baculovirus vectors for antiangiogenesis-based cancer gene therapy': 1, 'Development of the hybrid sleeping beauty: baculovirus vector for sustained gene expression and cancer therapy': 1, 'DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma': 1, 'Ovalbumin-specific, MHC class Irestricted, αβ-positive, Tc1 and Tc0 CD8 T cell clones mediate the in vivo inhibition of rat IgE': 1, 'Gene therapy for cancer treatment: past, present and future': 2, 'Cancer gene therapy: present and future': 2, 'Cancer gene-therapy: clinical trials': 2, 'Adeno-associated virusmediated cancer gene therapy: current status': 1, 'Adeno-associated virus (AAV) vectors in cancer gene therapy': 1, 'Baculovirus-mediated gene transfer into mammalian cells': 1, 'Transient and stable gene expression in mammalian cells transduced with a recombinant baculovirus vector': 1, 'Combination treatment for osteosarcoma with baculoviral vector mediated gene therapy (p53) and chemotherapy (adriamycin)': 1, 'Gene transfer as a tool to induce therapeutic vascular growth': 1, 'Baculovirus-based vaccine displaying respiratory syncytial virus glycoprotein induces protective immunity against RSV infection without vaccine-enhanced disease': 1, 'Direct vaccination with pseudotype baculovirus expressing murine telomerase induces anti-tumor immunity comparable with RNA-electroporated dendritic cells in a murine glioma model': 2, 'In vitro and in vivo gene delivery by recombinant baculoviruses': 1, 'Characterization of cell-surface determinants important for baculovirus infection': 1, 'Baculovirus vectors elicit antigenspecific immune responses in mice': 1, 'Truncated vesicular stomatitis virus G protein improves baculovirus transduction efficiency in vitro and in vivo': 1, 'Inhibition of HIV-1 replication by vesicular stomatitis virus envelopegly coprotein pseudotyped baculovirus vector-transduced ribozyme in mammalian cells': 1, 'Liganddirected gene targeting to mammalian cells by pseudotype baculoviruses': 1, 'Suppression of porcine arterivirus replication by baculovirus-delivered shRNA targeting nucleoprotein': 1, 'Enhanced baculovirus-mediated transduction of human cancer cells by tumor-homing peptides': 1, 'Tumor targeting of baculovirus displaying a lymphatic homing peptide': 1, 'Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice': 2, 'Baculovirus stimulates antiviral effects in mammalian cells': 1, 'Involvement of the toll-like receptor 9 signaling pathway in the induction of innate immunity by baculovirus': 1, 'Efficient gene transfer into various mammalian cells, including non-hepatic cells, by baculovirus vectors': 1, 'Autographa californica nuclear polyhedrosis virus (AcNPV) DNA does not persist in mass cultures of mammalian cells': 1, 'HIV-1 Gag-virus-like particles induce natural killer cell immune responses via activation and maturation of dendritic cells': 1, 'e epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China: the novel coronavirus pneumonia emergency response epidemiology': 1, 'Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia': 10, 'A pneumonia outbreak associated with a new coronavirus of probable bat origin': 18, 'A new coronavirus associated with human respiratory disease in China': 5, 'Initial cluster of novel coronavirus (2019-nCoV) infections in Wuhan, China is consistent with substantial human-to-human transmission': 1, '2019-nCoV (Wuhan virus), a novel coronavirus: human-to-human transmission, travelrelated cases, and vaccine readiness': 1, 'Comparison of the clinical characteristics between RNA positive and negative patients clinically diagnosed with 2019 novel coronavirus pneumonia': 1, 'Clinical and epidemiological characteristics of 34 children with 2019 novel coronavirus infection in Shenzhen': 2, 'Clinical characteristics of 50466 hospitalized patients with 2019-nCoV infection': 1, 'Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2': 5, 'Development of genetic diagnostic methods for novel coronavirus 2019 (nCoV-2019) in Japan': 1, 'Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR': 4, 'Comparison of different samples for 2019 novel coronavirus detection by nucleic acid amplification tests': 2, 'Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases': 7, 'Use of chest CT in combination with negative RT-PCR assay for the 2019 novel coronavirus but high clinical suspicion': 1, 'Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing': 1, 'Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients': 3, 'A mathematical model for simulating the phase-based transmissibility of a novel coronavirus': 3, 'Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts': 5, 'A familial cluster of infection associated with the 2019 novel coronavirus indicating potential person-to-person transmission during the incubation period': 2, 'Prediction of epidemic spread of the 2019 novel coronavirus driven by spring festival transportation in China: a population-based study': 1, 'Potential presymptomatic transmission of SARS-CoV-2': 3, 'Epidemiological analysis on a family cluster of COVID-19': 1, 'A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)': 6, 'Real-time forecasts of the COVID-19 epidemic in China from': 1, 'Estimation of the transmission risk of the 2019-nCoV and its implication for public health interventions': 4, 'Lack of vertical transmission of severe acute respiratory syndrome coronavirus 2, China': 1, 'Genomic Characterisation and Phylogenetic Analysis of SARS-CoV-2 in Italy': 1, 'An Emergent Clade of SARS-CoV-2 Linked to Returned Travellers from Iran': 1, 'Cryptic Transmission of SARS-CoV-2 in Washington State': 1, 'MAFFT: A Novel Method for Rapid Multiple Sequence Alignment Based on Fast Fourier Transform': 1, 'Maximum Likelihood Phylogenetic Estimation from DNA Sequences with Variable Rates over Sites: Approximate Methods': 1, 'Ultrafast Approximation for Phylogenetic Bootstrap': 1, 'Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet': 2, 'Novel 2019 Coronavirus SARS-CoV-2 (COVID-19): An Updated Overview for Emergency Clinicians. EB Medicine': 1, 'Handbook of COVID-19 Prevention and Treatment': 1, 'Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). 2020. Available at': 1, 'Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan': 2, 'Recommendations for the diagnosis, prevention and control of the 2019 novel coronavirus infection in children (first interim edition). (The Society of Pediatrics': 2, 'Diagnosis and Treatment of Novel Coronavirus Pneumonia (the 7th edition)': 2, 'Diagnosis and treatment of pleural effusion caused by Mycoplasma pneumoniae in children': 1, 'Mycoplasma pneumoniaerelated community-acquired pneumonia and parapneumonic pleural effusion in children and adolescents': 1, 'The COVID-19 pandemic, personal reflections on editorial responsibility': 1, 'Responding to health emergencies in the Eastern Mediterranean region in times of conflict': 1, \"The coronavirus has brought out the ugly side of Hong Kong's protest movement\": 2, 'China has a post-pandemic dream for Hong Kong': 1, 'Hong Kong police are using coronavirus restrictions to clamp down on protesters': 1, 'Police pepper spray Hong Kongers defying ban to mark Tiananmen': 2, 'Treatment of complex PTSD: Results of the ISTSS expert clinician survey on best practices': 2, 'Template integrity is essential for PCR amplification of 20-to 30-kb sequences from genomic DNA': 1, 'Hypertension in 2011: New insights-From risk factors to treatment implications': 3, 'Oscillation patterns in negative feedback loops': 1, 'Physiologic parameters as biomarkers: What can we learn from physiologic variables and variation?': 4, 'Circadian clock and cardiovascular disease': 2, 'Basic notions of heart rate variability and its clinical applicability': 6, 'Neurophysiological and computational principles of cortical rhythms in cognition': 1, 'Clinical review: A review and analysis of heart rate variability and the diagnosis and prognosis of infection': 5, 'Weaning from mechanical ventilation: a retrospective analysis leading to a multimodal perspective': 7, 'Breathing pattern in humans: Diversity and individuality': 3, 'Reduced breathing variability as a predictor of unsuccessful patient separation from mechanical ventilation': 6, 'Heart Rate Variability': 4, 'Breathing pattern variability: A weaning predictor in postoperative patients recovering from systemic inflammatory response syndrome': 9, 'Comparisons of predictive performance of breathing pattern variability measured during t-piece, automatic tube compensation, and pressure support ventilation for weaning intensive care unit patients from mechanical ventilation': 10, 'Approximate entropy of respiratory rate and tidal volume during weaning from mechanical ventilation': 3, 'Effect of weight and age on respiratory complexity in premature neonates': 2, 'Physiology of circadian entrainment': 1, 'Derivation of respiratory signals from multi-lead ecgs': 1, 'Synchrosqueezed wavelet transforms: An empirical mode decomposition-like tool': 7, 'Nonparametric and adaptive modeling of dynamic seasonality and trend with heteroscedastic and dependent errors': 14, 'Instantaneous frequency and wave shape functions (I)': 6, 'The synchrosqueezing algorithm for time-varying spectral analysis: Robustness properties and new paleoclimate applications': 9, 'Analysis of time-varying signals with small bt values': 2, 'Time-frequency/timescale reassignment': 3, 'A nonlinear squeezing of the continuous wavelet transform based on auditory nerve models': 2, 'Complications associated with mechanical ventilation': 3, 'Qualitative studies on the patientÕs experience of weaning from mechanical ventilation': 3, 'A prospective study of indexes predicting the outcome of trials of weaning from mechanical ventilation': 1, 'Instability of spontaneous breathing patterns in patients with persistent vegetative state': 2, 'One or two frequencies? The synchrosqueezing answers': 1, 'Recent advances in time-frequency reassignment and synchrosqueezing': 3, 'Differential reassignment': 1, 'Society for Industrial and Applied Mathematics': 1, 'Improving the readability of time-frequency and time-scale representations by the reassignment method': 1, 'Generalized Function Theory': 1, 'Predicting the ultimate outcome of the COVID-19 outbreak in Italy': 5, 'Age-structured impact of social distancing on the COVID-19 epidemic in India': 1, 'COVID-19 epidemic: Power law spread and flattening of the curve': 1, 'Methods of categorizing emergency department visit urgency: a survey of pediatric emergency medicine physicians': 1, 'Pediatric emergency departments': 1, 'Nonurgent pediatric emergency department visits: care-seeking behavior and parental knowledge of insurance': 1, 'Appropriate use of a pediatric emergency department: is the pediatrician called before the visit?': 1, 'Emergency department utilization in an urban community: implications for community ambulatory care': 1, 'Day care and illness: evidence, costs, and public policy': 1, 'The effects of day care: a critical review': 1, 'Welfare, the earned income tax credit, and the labor supply of single mothers': 1, 'Factors associated with emergency department utilization for nonurgent pediatric problems': 1, 'Acute illness in day care: how much does it cost?': 2, 'Childhood upper respiratory tract infections: to what degree is incidence affected by day-care attendance?': 1, 'Respiratory illness in preschool children with different forms of day care': 1, 'Diarrheal illness among infants and toddlers in day care centers': 1, 'Public health considerations of infectious diseases in child day care centers': 1, 'Human rhinovirus species associated with hospitalizations for acute respiratory illness in young US children': 1, 'Recognition, investigation, and control of communicable-disease outbreaks in child day-care settings': 1, 'Respiratory illness in children attending daycare': 1, 'Epidemiology of viral respiratory tract infections in a prospective cohort of infants and toddlers attending daycare': 3, 'Frequency and severity of infections in day care': 1, 'Frequency and severity of infections in day care: three-year follow-up': 1, 'Epidemiology of multiple respiratory viruses in childcare attendees': 4, 'High rate of viral identification and coinfections in infants with acute bronchiolitis': 1, 'Single versus dual respiratory virus infections in hospitalized infants: impact on clinical course of disease and interferon-gamma response': 4, 'Human metapneumovirus in severe respiratory syncytial virus bronchiolitis': 3, 'The impact of dual viral infection in infants admitted to a pediatric intensive care unit associated with severe bronchiolitis': 1, 'Role of rhinovirus in hospitalized infants with respiratory tract infections in Spain': 3, 'Detection of viruses identified recently in children with acute wheezing': 1, 'Frequent and prolonged shedding of bocavirus in young children attending daycare': 7, 'Respiratory tract infections in children in day care': 1, 'Infection control challenges in child-care centers': 4, 'Control of infections in child care': 2, 'Contagious diseases of child day care': 1, 'US Bureau of the Census. Trends in child care arrangements of working mothers': 1, 'A longitudinal study of the occurrence of diarrheal disease in day care centers': 1, \"Assessment of gastroenteric viruses frequency in a children's day care center in Rio De Janeiro, Brazil: a fifteen year study\": 1, 'Rotavirus and severe childhood diarrhea': 2, 'Trends in otitis media among children in the United States': 1, 'Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis': 1, 'Otitis media-related antibiotic prescribing patterns, outcomes, and expenditures in a pediatric Medicaid population': 1, 'Otitis media in children': 1, 'Behavior and cognitive outcomes from middle ear disease': 1, 'Otitis media in infancy and intellectual ability, school achievement, speech, and language at age 7 years': 1, 'Consequences of unremitting middle-ear disease in early life': 1, 'Otitis media in young children: medical, developmental, and educational considerations': 1, 'Language learning in a prospective study of otitis media with effusion in the first two years of life': 1, 'Otitis media and the social behavior of daycare attending children': 1, 'The effects of otitis media on the attention skills of day-care attending toddlers': 1, 'Otitis media: models of effects and implications for interventions': 1, 'Otitis media with effusion during the first three years of life and development of speech and language': 1, 'Otitis media and language performance in a cohort of Apache Indian children': 1, 'Otitis media in early childhood and its relationship to later verbal and academic performance': 1, 'Child care arrangements and repeated ear infections in young children': 2, 'A meta-analytic review of the risk factors for acute otitis media': 2, 'Increasing prevalence of recurrent otitis media among children in the United States': 3, 'Microbiology of recently treated acute otitis media compared with previously untreated acute otitis media': 1, 'Will reduction of antibiotic use reduce antibiotic resistance? The pneumococcal paradigm': 1, 'Acute otitis media in children: association with day care centersantibiotic resistance, treatment and prevention': 2, 'Epidemiology of Moraxella catarrhalis in children during the first two years of life: relationship to otitis media': 1, 'Pacifiers and dental structure as risk factors for otitis media': 2, 'Diagnosis and management of acute otitis media': 1, 'Illness associated with child day care: a study of incidence and cost': 1, 'Childhood antecedents of allergic sensitization in young British adults': 1, 'Cross sectional study of the relation between sibling number and asthma, hay fever, and eczema': 1, 'Do infections in infancy affect sensitization to airborne allergens and development of atopic disease? A retrospective study of seven-year-old children': 1, 'Day care attendance, recurrent respiratory tract infections and asthma': 2, 'Development of allergen-specific T-cell memory in atopic and normal children': 3, 'Peak flow variability, methacholine responsiveness and atopy as markers for detecting different wheezing phenotypes in childhood': 1, 'Age of entry to day nursery and allergy in later childhood': 1, 'Maturation of immune responses at the beginning of asthma': 1, 'Speculations on the cause of childhood acute lymphoblastic leukemia': 2, 'Aetiology of acute leukemia': 2, 'Evidence for an infective cause of childhood leukaemia: comparison of a Scottish new town with nuclear reprocessing sites in Britain': 1, 'Infection, immune responses and the aetiology of childhood leukaemia': 1, 'Infectious etiologies of childhood leukemia: plausibility and challenges to proof': 1, 'Daycare attendance and the risk of childhood acute lymphoblastic leukaemia': 1, 'Patterns of infection and day care utilization and risk of childhood acute lymphoblastic leukaemia': 1, 'Infections, vaccinations, and the risk of childhood leukaemia': 1, 'Day care in infancy and risk of childhood acute lymphoblastic leukaemia: findings from UK case-control study': 2, 'Infectious diseases in the first year of life, perinatal characteristics and childhood acute leukaemia': 2, 'A metaanalysis of the association between day-care attendance and childhood acute lymphoblastic leukaemia': 1, 'Prevention of pneumococcal disease among infants and childrenuse of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine': 3, 'Effect of a conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotic use is day-care center attendees': 2, 'Vaccination of day-care center attendees reduces carriage of Streptococcus pneumoniae among their younger siblings': 1, 'Reduction of frequent otitis media and pressure-equalizing tubes insertions in children after introduction of pneumococcal conjugate vaccine': 1, 'Efficacy of a pneumococcal conjugate vaccine against acute otitis media': 2, 'Influenza vaccination in the prevention of acute otitis media in children': 1, 'Influenza A vaccine decreases incidence of otitis media in 6-to-30-month-old children in day care': 2, 'The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine in children': 3, 'Studies of the 1996-1997 inactivated influenza vaccine among children attending day care: immunologic response, protection against infections, and clinical effectiveness': 1, 'Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial': 2, 'Prevention of otitis media in children with live attenuated influenza vaccine given intranasally': 2, 'Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day care': 1, 'Hand-washing and diapering equipment reduces disease among children in out-of-home child care centers': 2, 'Effect of washing hands with soap on diarrhoea risk in the community: a systematic review': 1, 'Effect of infection control measures on the frequency of upper respiratory infection in child care: a randomized controlled trial': 1, 'Hand washing practices among various school age students': 1, 'Reduction of illness absenteeism in elementary schools using an alcohol-free instant hand sanitizer': 1, 'Comparing hand washing to hand sanitizers in reducing elementary school students absenteeism': 2, 'A randomized, controlled trial of a multifaceted intervention including alcohol-based hand sanitizer and hand-hygiene education to reduce illness transmission in the home': 1, 'Efficacy of waterless hand hygiene compared with handwashing with soap: a field study': 1, \"Infant daycare and otitis media: multiple influences on children's later development\": 1, 'Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after vaccination with a 9-valent pneumococcal conjugate vaccine in toddlers attending day care centers': 1, 'Reduction in nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine': 1, 'Recommendations for the prevention of Streptococcus pneumoniae infections in infants and children: use of 13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23)': 1, 'Systematic review of covid-19 in children shows milder cases and a better prognosis than adults': 1, 'SARS-Cov-2 Infection in children': 1, 'Age-dependent effects in the transmission and control of COVID-19 epidemics': 4, 'Relationship between ABO and Secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individuals': 1, 'Serum Alpha 2 Makroglobulin concentration and its variation with age and sex': 1, \"Reference Distributions for a2-Macroglobulin: A Comparison of a Large Cohort to the World's Literature\": 1, 'Maturation of the hemostatic system during childhood, Blood': 1, 'Macromolecular Protein Complexes. Subcellular Biochemistry': 1, 'Role for alpha 2 Makroglobulin in haemostatic balance': 1, 'Thrombophilie: XVIII. Hamburger Symposium über Blutgerinnung': 1, 'Comparison of Progressive Antithrombin Activity and the Concentrations of three Thrombin Inhibitors in Human plasma': 1, 'Alpha-2-Macroglobulin Is a Major Determinant Of a Lower Thrombin Generation In Infants and Children Compared To Adults Blood': 1, 'Alpha 2 Makroglobulin may provide protection from thromboembolic events in Antithrombin III deficient children Blood': 1, 'The psychological impact of SARS on health care providers': 6, 'Impact of Ebola experiences and risk perceptions on mental health in Sierra Leone': 1, 'Mental health strategies to combat the psychological impact of COVID-19 beyond paranoia and panic': 3, 'Psychological status of medical workforce during the COVID-19 pandemic: a cross-sectional study': 2, 'Psychological symptoms among frontline healthcare workers during COVID-19 outbreak in Wuhan': 1, 'Coronavirus disease 2019 (COVID-19) and beyond: micropractices for burnout prevention and emotional wellness': 2, 'COVID-19 and experiences of moral injury in front-line key workers': 2, 'Supporting clinicians during the COVID-19 pandemic': 1, 'Outcomes of SARS survivors in China: not only physical and psychiatric co-morbidities': 1, 'Understanding and addressing sources of anxiety among health care professionals during the COVID-19 pandemic': 2, 'Exploring the associations between resilience, dispositional hope, subjective well-being, and psychological health among adults during early stage of COVID-19': 1, 'The immediate psychological and occupational impact of the 2003 SARS outbreak in a teaching hospital': 1, 'Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed': 4, 'Preferred reporting items for systematic reviews and metaanalyses: the PRISMA statement': 1, \"Joanna Briggs Institute reviewer's manual. The Joanna Briggs Institute\": 1, 'International Classification of Health Interventions-ICHI Beta': 1, 'Standard quality assessment criteria for evaluating': 2, 'Developing delirium best practice: a systematic review of education interventions for healthcare professionals working in inpatient settings': 1, 'Training peers to treat Ebola centre workers with anxiety and depression in Sierra Leone': 5, 'A qualitative study assessing the feasibility of implanting a group cognitive-behavioural therapy-based intervention in Sierra Leone': 7, \"Effects of a SARS prevention programme in Taiwan on nursing staff's anxiety, depression and sleep quality: a longitudinal survey\": 5, 'Impact on mental health and perceptions of psychological care among medical and nursing staff in Wuhan during the 2019 novel coronavirus disease outbreak: a cross-sectional study': 13, 'Factors associated with mental health outcomes among health care workers exposed to Coronavirus disease 2019': 11, 'Effectiveness of small group cognitive behavioural therapy for anxiety and depression in Ebola treatment centre staff in Sierra Leone': 9, 'Analysis of psychological and sleep status and exercise rehabilitation of front-line clinical staff in the fight against COVID-19 in China': 6, 'Computer-assisted resilience training to prepare healthcare workers for pandemic influenza: a randomized trial of the optimal dose of training': 5, 'Receptive music therapy to reduce stress and improve wellbeing in Italian clinical staff involved in COVID-19 pandemic: a preliminary study': 7, 'The myth of the 1-day training: the effectiveness of psychosocial support capacity-building during the Ebola outbreak in West Africa': 10, 'The effect of psychological first aid training on knowledge and understanding about psychosocial support principles: a clusterrandomized controlled trial': 7, 'Psychological support system for hospital workers during thre Covid-19 outgreak: rapid design and implementationof the Covid-Psy hotline': 3, 'Effects of progressive muscle relaxation on anxiety and sleep quality in patients with COVID-19': 8, 'Efficacy of internet-based integrated intervention on depression and anxiety symptoms in patients with COVID-19': 8, 'The effect of brief crisis intervention package on improving quality of life and mental health in patients with COVID-19': 5, 'Feasibility and preliminary results of effectiveness of social media-based intervention on the psychological well-being of suspected COVID-19 cases during quarantine': 6, 'Playing to live: outcome evaluation of a community-based psychosocial expressive arts program for children during the Liberian Ebola epidemic': 11, 'The impact of COVID-19 epidemic declaration on psychological consequences: a study of active Weibo users': 8, 'How an epidemic outbreak impacts happiness: Factors that worsen S. Soklaridis, et al. General Hospital Psychiatry': 2, 'System effectiveness of detection, brief intervention and refer to treatment for the people with post-traumatic emotional distress by MERS: a case report of community-based proactive intervention in South Korea': 3, 'Prevalence of psychiatric disorders among Toronto hospital workers one to two years after the SARS outbreak': 1, 'Applying the lessons of SARS to pandemic influenza: an evidence-based approach to mitigating the stress experienced by healthcare workers': 2, 'The psychological impact of the SARS epidemic on hospital employees in China: exposure, risk perception, and altruistic acceptance of risk': 3, 'A potent antimicrobial protein from onion seeds showing sequence homology to plant lipid transfer protein': 4, 'Biochemical and molecular characterization of three barley seed proteins with antifungal properties': 4, 'Isolation and purification of ribosome-inactivating proteins from bitter melon seeds by ion exchange chromatographic columns in series': 4, 'A chitinbinding lectin from stinging nettle rhizomes with antifungal properties': 4, 'Antifungal properties of lectin and new chitinases from potato tuber': 3, 'Isolation of a novel deoxyribonuclease with antifungal activity from Asparagus officinalis seeds': 2, 'Cysteine protease inhibitor from pearl millet: a new class of antifungal protein': 4, 'A Bowman-Birk-type trypsin-chymotrypsin inhibitor from broad beans': 8, 'Antimicrobial peptides in insects; structure and function': 1, 'Eryngin, a novel antifungal peptide from fruiting bodies of the edible mushroom Pleurotus eryngii': 1, 'Ascalin, a new antifungal peptide with human immunodeficiency virus type 1 reverse transcriptase inhibitory activity from shallot bulbs': 3, 'Two isoforms of NP24: a thaumatin-like protein in tomato fruit': 2, 'Characteristics and antifungal activity of a chitin binding protein from Ginkgo biloba': 2, 'Isolation of a small chitinase-like antifungal protein from Panax notoginseng (sanchi ginseng) roots': 2, 'Antifungal proteins': 1, 'Purification, characterization and differential hormonal regulation of a β-1, 3-glucanase and two chitinases from chickpea': 2, 'First isolation of an antifungal lipid transfer peptide from seeds of a Brassica species': 4, 'Isolation of a large thaumatin-like antifungal protein from seeds of the Kweilin chestnut Castanopsis chinensis': 2, 'Ginkbilobin, a novel antifungal protein from Ginkgo biloba seeds with sequence similarity to embryo-abundant protein': 3, 'Gymnin, a potent defensin-like antifungal peptide from the Yunnan bean Gymnocladus chinensis Baill': 7, 'Isolation of a napin-like polypeptide with potent translation-inhibitory activity from Chinese cabbage (Brassica parachinensis cv green-stalked) seeds': 2, 'Cloning and characterization of Arabidopsis and Brassica juncea flavin-containing amine oxidases': 1, 'Purification and characterization of cytosolic pyruvate kinase from Brassica napus (rapeseed) suspension cell cultures: implications for the integration of glycolysis with nitrogen assimilation': 1, 'Purification and characterization of phosphoenolpyruvate carboxylase from Brassica napus (rapeseed) suspension cell cultures: implications for phosphoenolpyruvate carboxylase regulation during phosphate starvation, and the integration of glycolysis with nitrogen assimilation': 1, 'Functional expression and characterization of the myrosinase MYR1 from Brassica napus in Saccharomyces cerevisiae': 1, 'Glyoxalase I from Brassica juncea is a calmodulin stimulated protein': 1, 'A novel and exploitable antifungal peptide from kale (Brassica alboglabra) seeds': 4, 'Brassiparin, an antifungal peptide from Brassica parachinensis seeds': 2, 'Lipid transfer proteins from Brassica campestris and mung bean surpass mung bean chitinase in exploitability': 9, 'Cicerin and arietin, novel chickpea peptides with different antifungal potencies': 2, 'Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of protein in the range from 1 to 100 kDa': 1, 'Inhibitory effects of antifungal proteins on human immunodeficiency virus type 1 reverse transcriptase, protease and integrase': 4, 'Concurrent purification of two defense proteins from French bean seeds: a defensin-like antifungal peptide and a hemagglutinin': 3, 'Interaction of a nonspecific wheat lipid transfer protein with phospholipid monolayers imaged by fluorescence microscopy and studied by infrared spectroscopy': 2, 'Solution structure and lipid binding of a nonspecific lipid transfer protein extracted from maize seeds': 1, 'Lipid-transfer proteins in plants': 1, 'Germination-specific lipid transfer protein cDNAs in Brassica napus L': 2, 'The defensive role of non specific lipid-transfer proteins in plants': 1, 'Cabbage cryoprotectin is a member of the nonspecific plant lipid transfer protein gene family': 1, 'Cabbage lipid transfer protein Bra o 3 is a major allergen responsible for cross-reactivity between plant foods and pollens': 1, 'The promoter of a Brassica napus lipid transfer protein gene is active in a range of tissues and stimulated by light and viral infection in transgenic Arabidopsis': 2, 'Antifungal proteins production in Maize suspension cultures': 1, 'Characterization of a new antifungal lipid transfer protein from wheat': 1, 'Plants express a lipid transfer protein with high similarity to mammalian sterol carrier protein-2': 1, 'Stress induction and antimicrobial properties of a lipid transfer protein in germinating sunflower seeds': 1, 'Identification of pathogen-responsive regions in the promoter of a pepper lipid transfer protein gene (CALTPI) and the enhanced resistance of the CALTPI transgenic Arabidopsis against pathogen and environmental stresses': 1, 'Resistance function of rice lipid transfer protein LTP110': 1, 'Purification and characterization of three antifungal proteins from cheeseweed (Malva parviflora)': 1, 'Characterization of a new antifungal non-specific lipid transfer protein (nsLTP) from sugar beet leaves': 1, 'In vitro antifungal activity of a radish (Raphanus sativus L.) seed protein homologous to nonspecific lipid transfer proteins': 1, 'Nonspecific lipid-transfer protein genes expression in grape (Vitis sp.) cells in response to fungal elicitor treatments': 2, 'The EU General Data Protection Regulation (GDPR) is the most important change in data privacy regulation in 20 years.eugdpr.org. EU: c2019': 4, 'General Data Protection Regulation (GDPR). Recitals. Key Issues. gdpr-info': 2, 'GDPR: an impediment to research?': 3, ')) (Health Research) Regulations 2018. irishstatutebook': 2, 'Health Research Consent Declaration Committee. Hrcdc.ie. Ireland: c2019': 2, 'Health Research Board Decision Tree. hrb.ie. Ireland: c2019': 1, 'Guidance notes to support and application to process or further process personal data for the purposes of health research commencing before 8 August 2018 (re-consenting). hrcdc.ie. Ireland. c2019': 2, 'Researchers: consent rules put future medical trials at risk. Sunday Business Post (Ireland)': 3, 'Various Data Protection Acts, HSE National Consent Policy (revised 2019), Guide to Professional Conduct and Ethics for Registered Medical Practitioners': 2, 'National Quality Improvement Division. National Consent Policy -Quality Improvement Programmes': 3, 'Article 29 working party guidelines on consent under regulation 2016/679': 4, 'Opinion 3/2019 concerning the Questions and Answers on the interplay between the Clinical Trials Regulation (CTR) and the General Data Protection regulation (GDPR)(art. 70.1.b)). European Commission': 5, 'Question and Answers on the interplay between the Clinical Trials Regulation and the General Data Protection Regulation': 2, 'European Data Protection Supervisor. A preliminary opinion on data protection and scientific research': 3, 'EDPB opinion raises questions over Irish Health Research Regulations': 1, 'Health research, consent and the GDPR exemption': 3, 'Should consent for data processing be privileged in health research? A comparative legal analysis. Int Data Priv Law': 4, 'Survey of NCHDs in Ireland to assess their views and opinions in relation to participation in health research and the impact of new Irish data protection regulations': 3, 'General data protection regulation': 2, 'And The Health Service (Control of Patient Information) Regulations': 1, \"Subcommittee on Privacy and Confidentiality. Susan Ehringhaus's testimony on behalf of the Association of American Medical Colleges\": 1, 'Negative impact of HIPAA on population-based cancer registry research: a brief survey. Springfield: North American Association of Central Cancer Registries': 1, 'Influence of the HIPAA privacy rule on Health Research': 1, 'Committee on Health Research and the Privacy of Health Information: The HIPAA Privacy Rule': 1, 'Guidance for using data in health research in the context of COVID-19 research': 1, 'Guidelines 03/2020 on the processing of data concerning health for the purpose of scientific research in the context of the COVID-19 outbreak': 2, 'Use of functional genomics to understand influenza-host interactions': 1, 'Large-scale monitoring of host cell gene expression during HIV-1 infection using cDNA microarrays': 1, 'Insights into host responses against pathogens from transcriptional profiling': 1, 'Virus infection and the interferon response: a global view through functional genomics': 1, 'Early days: genomics and human responses to infection': 1, 'Hijacking of the host-cell response and translational control during influenza virus infection': 2, 'Type 1 interferons and the virus-host relationship: a lesson in detente': 2, 'Viral regulation and evasion of the host response': 1, 'Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures': 1, 'Interferon-inducible antiviral effectors': 1, 'The role of the Type I interferon response in the resistance of mice to filovirus infection': 2, 'Inhibition of interferon-mediated antiviral responses by influenza A viruses and other negative-strand RNA viruses': 1, 'Identification and characterization of viral antagonists of type I interferon in negative-strand RNA viruses': 1, 'Antiviral response in pandemic influenza viruses': 1, 'Ebola virus selectively inhibits responses to interferons, but not to interleukin-1beta, in endothelial cells': 1, 'Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection': 1, 'Genomic analysis reveals age-dependent innate immune responses to severe acute respiratory syndrome coronavirus': 1, 'Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome': 1, 'Functional genomics highlights differential induction of antiviral pathways in the lungs of SARS-CoVinfected macaques': 1, 'Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome': 1, 'Host gene expression profiling of dengue virus infection in cell lines and patients': 1, 'Differences in global gene expression in peripheral blood mononuclear cells indicate a significant role of the innate responses in progression of dengue fever but not dengue hemorrhagic fever': 1, 'Dengue virus induces novel changes in gene expression of human umbilical vein endothelial cells': 3, 'The host response to West Nile Virus infection limits viral spread through the activation of the interferon regulatory factor 3 pathway': 1, 'Gene expression in mice infected with West Nile virus strains of different neurovirulence': 1, 'Using high-throughput genomics to study hepatitis C: what determines the outcome of infection?': 2, 'Principles of intracellular viral recognition': 2, 'Interferons, interferon-like cytokines, and their receptors': 2, 'Interferons at age 50: past, current and future impact on biomedicine': 1, 'IFN-lambda: novel antiviral cytokines': 1, 'An important role for type III interferon (IFNlambda/IL-28) in TLR-induced antiviral activity': 1, 'IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex': 1, 'Interferonlambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses': 1, 'Viral infections activate types I and III interferon genes through a common mechanism': 2, 'IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes': 1, 'IFN-lambda (IFN-lambda) is expressed in a tissuedependent fashion and primarily acts on epithelial cells in vivo': 1, 'PKR in innate immunity, cancer, and viral oncolysis': 1, 'MDA5/RIG-I and virus recognition': 1, 'STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling': 1, 'The multifunctional NS1 protein of influenza A viruses': 1, 'The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3': 3, 'The Ebola virus VP35 protein functions as a type I IFN antagonist': 2, 'VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice': 1, 'Inhibition of IRF-3 activation by VP35 is critical for the high level of virulence of ebola virus': 3, 'Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication': 2, 'Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation': 2, 'Comparisons of highly virulent H5N1 influenza A viruses isolated from humans and chickens from Hong Kong': 2, 'Virulent avian influenza A viruses: their effect on avian lymphocytes and macrophages in vivo and in vitro': 1, 'Mortality associated with influenza and respiratory syncytial virus in the United States': 2, 'The origin and virulence of the 1918 \"Spanish\" influenza virus': 1, 'Discovery and characterization of the 1918 pandemic influenza virus in historical context': 1, 'Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes': 1, 'Origin and evolution of the 1918 \"Spanish\" influenza virus hemagglutinin gene': 1, 'Novel origin of the 1918 pandemic influenza virus nucleoprotein gene': 1, 'Characterization of the 1918 \"Spanish\" influenza virus matrix gene segment': 1, '1918 influenza pandemic caused by highly conserved viruses with two receptor-binding variants': 1, 'Initial genetic characterization of the 1918': 1, 'Characterization of the 1918 influenza virus polymerase genes': 1, 'Characterization of the reconstructed 1918 Spanish influenza pandemic virus': 4, 'Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus': 4, 'Global host immune response: pathogenesis and transcriptional profiling of type A influenza viruses expressing the hemagglutinin and neuraminidase genes from the 1918 pandemic virus': 1, 'Cellular transcriptional profiling in influenza A virusinfected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza': 1, 'Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus': 2, 'Isolation of avian influenza A(H5N1) viruses from humans--Hong Kong': 2, 'Update on avian influenza A (H5N1) virus infection in humans': 1, 'Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus': 1, 'Emerging influenza': 1, 'Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from humans in Hong Kong': 1, 'Characterization of influenza A/HongKong/ 156/97 (H5N1) virus in a mouse model and protective effect of zanamivir on H5N1 infection in mice': 1, 'A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans': 1, 'Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness': 1, 'Gene expression analysis of host innate immune responses during Lethal H5N1 infection in ferrets': 1, 'Cell number and cell characteristics of the normal human lung': 1, 'H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice': 2, 'Ebolavirus and other filoviruses': 1, 'Ebola virus: unravelling pathogenesis to combat a deadly disease': 1, 'Filoviruses and the balance of innate, adaptive, and inflammatory responses': 1, 'Molecular characterization of an isolate from the 1989/90 epizootic of Ebola virus Reston among macaques imported into the United States': 1, 'Multiplex analysis of cytokines in the blood of cynomolgus macaques naturally infected with Ebola virus (Reston serotype)': 1, 'Experimental infection of cynomolgus macaques with Ebola-Reston filoviruses from the 1989-1990 U.S. epizootic': 1, 'Current knowledge on lower virulence of Reston Ebola virus (in French: Connaissances actuelles sur la moindre virulence du virus Ebola Reston)': 1, 'Global suppression of the host antiviral response by Ebola-and Marburgviruses: increased antagonism of the type I interferon response is associated with enhanced virulence': 3, 'Whole-genome expression profiling reveals that inhibition of host innate immune response pathways by Ebola virus can be reversed by a single amino acid change in the VP35 protein': 1, 'The temporal program of peripheral blood gene expression in the response of nonhuman primates to Ebola hemorrhagic fever': 1, 'Functional classification of interferon-stimulated genes identified using microarrays': 1, 'The interferon-stimulated genes: targets of direct signaling by interferons, doublestranded RNA, and viruses': 1, 'Toll-like receptormediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycinsensitive PI(3)K-mTOR-p70S6K pathway': 1, 'Microarray analysis during adipogenesis identifies new genes altered by antiretroviral drugs': 1, 'Transcriptional profiles in CD8+ T cells from HIV+ progressors on HAART are characterized by coordinated up-regulation of oxidative phosphorylation enzymes and interferon responses': 1, 'Cytokine gene expression profiles in human lymphocytes induced by a formula of traditional Chinese medicine, vigconic VI-28': 1, 'Genomic and genetic biomarkers of toxicity': 1, 'Microarrays and toxicology: the advent of toxicogenomics': 1, 'Application of DNA microarray technology to influenza A/Vietnam/1194/2004 (H5N1) vaccine safety evaluation': 1, 'Molecular and cellular signatures of human vaccine adjuvants': 1, 'Drosophila RNAi screen identifies host genes important for influenza virus replication': 1, 'Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1': 14, 'Geographical tracking and mapping of coronavirus disease COVID-19/severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic and associated events around the world: how 21 st century GIS technologies are supporting the global fight against outbreaks and epidemics': 1, 'Origin and evolution of pathogenic coronaviruses': 3, 'Molecular immune pathogenesis and diagnosis of COVID-19': 5, 'Mechanisms by which ambient humidity may affect viruses in aerosols': 2, 'Absolute humidity modulates influenza survival, transmission, and seasonality': 3, 'Mechanical properties of viral capsids': 1, 'Determination of prestress and elastic properties of virus capsids': 1, 'Evaporation-Induced Crumpling of Graphene Oxide Nanosheets in Aerosolized Droplets: Confinement Force Relationship': 1, 'Mechanical properties of suspended graphene sheets': 1, 'Dynamic vaccination in partially overlapped multiplex network': 1, 'Features of evaporation of an ensemble of femto-picoliter droplets on a substrate. Experiment and simulation': 3, 'Highly efficient antiviral and antibacterial activities of solid-state cuprous compounds': 1, 'Inactivation of influenza A virus on copper versus stainless steel surfaces': 2, 'Survival of two avian respiratory viruses on porous and nonporous surfaces': 1, 'An Essay on the Principle of Population': 1, 'The size and concentration of droplets generated by coughing in human subjects': 1, 'Characterizations of particle size distribution of the droplets exhaled by sneeze': 2, 'Temperature distributions in the human leg for VLF-VHF exposures at the ANSIrecommended safety levels': 1, 'European union regulations on algorithmic decisionmaking and a \"right to explanation': 1, \"Asking 'Why' in AI: explainability of intelligent systems-perspectives and challenges\": 1, 'Explainability in human-agent systems': 1, 'Agent-based simulation of unmanned aerial vehicles in civilian applications: a systematic literature review and research directions': 1, 'Intelligent agents: theory and practice': 2, 'Explanations of black-box model predictions by contextual importance and utility': 1, 'Explanation in artificial intelligence: insights from the social sciences': 1, 'JS-son-A minimal JavaScript BDI agent library': 1, 'Best practice recommendations for designing and implementing experimental vignette methodology studies': 1, 'WebRTC: APIs and RTCWEB Protocols of the HTML5 Real-Time Web': 1, 'Comparison of agent-based simulation frameworks for unmanned aerial transportation applications': 1, 'General Guidelines for Methodologies on Research and Evaluation of Traditional Medicines': 1, 'FDA Guidance for Industry-Botanical Drug Products (Draft Guidance), US Food and Drug Administration': 2, 'Note for Guidance on Quality of Herbal Medicinal Products': 1, 'Guidelines for the Assessment of Herbal Medicine, World Health Organization': 1, 'State Food and Drug Administration of China': 1, \"China Pharmacopoeia Committee, Pharmacopoeia of the People's Republic of China\": 3, 'Chromatogr': 1, 'Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities': 1, 'Antiviral actions of interferons': 3, 'How cells respond to interferons': 1, 'Interferon signalling network in innate defence': 7, 'The human 2′-5′oligoadenylate synthetase family: unique interferon-inducible enzymes catalyzing 2′-5′ instead of 3′-5′ phosphodiester bond formation': 4, 'Gene structure and function of the 2′-5′-oligoadenylate synthetase family': 2, 'Gene structure of the murine 2′-5′-oligoadenylate synthetase family': 1, 'Expansion and molecular evolution of the interferon-induced 2′-5′ oligoadenylate synthetase gene family': 1, 'Cleavage of oligoribonucleotides by the 2′,5′-oligoadenylate-dependent ribonuclease L': 2, 'Interferon action: RNA cleavage pattern of a (2′-5′)oligoadenylate-dependent endonuclease': 2, 'Interferon action-sequence specificity of the ppp(A2′p)nA-dependent ribonuclease': 2, 'Control of the ppp(a2′p)nA system in HeLa cells. Effects of interferon and virus infection': 1, 'p59OASL, a 2′-5′ oligoadenylate synthetase like protein: a novel human gene related to the 2′-5′ oligoadenylate synthetase family': 1, '2′5′ oligoadenylate synthetase, an interferon induced enzyme: direct assay methods for the products, 2′5′ oligoadenylates and 2′5′ co-oligonucleotides': 2, 'The 2′5′ oligoadenylate synthetase has a multifunctional 2′5′ nucleotidyl-transferase activity': 6, 'A study of the interferon antiviral mechanism: apoptosis activation by the 2-5A system': 2, 'Cloning and characterization of a RNAse L inhibitor. A new component of the interferon-regulated 2-5A pathway': 1, 'Identification of 2′-phosphodiesterase, which plays a role in the 2-5A system regulated by interferon': 5, 'Characterization of human phosphodiesterase 12 and identification of a novel 2′-5′ oligoadenylate nuclease -The ectonucleotide pyrophosphatase/ phosphodiesterase 1': 3, 'Murine AKAP7 has a 2′,5′-phosphodiesterase domain that can complement an inactive murine coronavirus ns2 gene': 2, 'Antagonism of the interferon-induced OAS-RNase L pathway by murine coronavirus ns2 protein is required for virus replication and liver pathology': 2, 'Homologous 2′,5′-phosphodiesterases from disparate RNA viruses antagonize antiviral innate immunity': 2, 'Human 2′-phosphodiesterase localizes to the mitochondrial matrix with a putative function in mitochondrial RNA turnover': 4, 'Murine plasma cell membrane antigen PC-1: molecular cloning of cDNA and analysis of expression': 1, 'AKAP7gamma is a nuclear RI-binding AKAP': 1, '5′-Oligoadenylate-dependent RNAse located in nuclei: biochemical characterization and subcellular distribution of the nuclease in human and murine cells': 1, 'Ultrastructural localization of interferon-inducible double-stranded RNA-activated enzymes in human cells': 1, 'Four different forms of interferon-induced 2′,5′-oligo(A) synthetase identified by immunoblotting in human cells': 1, 'Identification of 69-kd and 100-kd forms of 2-5A synthetase in interferontreated human cells by specific monoclonal antibodies': 1, 'Simian virus 40-infected, interferon-treated cells contain 2′,5′-oligoadenylates which do not activate cleavage of RNA': 1, '2-5A accumulates to high levels in interferontreated, vaccinia virus-infected cells in the absence of any inhibition of virus replication': 1, 'An efficient chemical synthesis of adenylyl(2′ goes to 5′)adenylyl(2′ goes to 5′)adenosine': 1, 'Synthesis of 2-5As possessing base-modified adenosines and their activities to human recombinant RNase L': 1, 'High yield synthesis, purification and characterisation of the RNase L activators 5′-triphosphate 2′-5′-oligoadenylates': 4, 'Monitoring activation of ribonuclease L by 2′,5′-oligoadenylates using purified recombinant enzyme and intact malignant glioma cells': 1, 'Small-molecule activators of RNase L with broad-spectrum antiviral activity': 1, 'Induction, purification, and properties of 2′5′ oligoadenylate synthetase': 2, 'Evolution of the 2′-5′-oligoadenylate synthetase family in eukaryotes and bacteria': 2, 'Isolation of two interferoninduced translational inhibitors: a protein kinase and an oligo-isoadenylate synthetase': 2, 'Accumulation of 2′,5′-oligoadenylates in encephalomyocarditis virus-infected mice': 2, 'An interferon-induced phosphodiesterase degrading (2′-5′) oligoisoadenylate and the C-C-A terminus of tRNA': 3, 'Regulation of 2-5 A phosphodiesterase activity by cAMP-dependent phosphorylation: mechanism and biological role': 2, 'Nerve growth factor induces changes in (2′-5′)oligo(A) synthetase and 2′-phosphodiesterase activities during differentiation of PC12 pheochromocytoma cells': 2, 'Intrinsic molecular activities of the interferon-induced 2-5A-dependent RNase': 2, '2′-phosphodiesterase and 2′,5′-oligoadenylate synthetase activities in the lowest metazoans, sponge': 1, 'Structural mechanism of sensing long dsRNA via a noncatalytic domain in human oligoadenylate synthetase 3': 1, 'The 2′-5′-oligoadenylate synthetase 3 enzyme potently synthesizes the 2′-5′-oligoadenylates required for RNase L activation': 1, 'Characterization of the 2′-5′-oligoadenylate synthetase ubiquitin-like family': 2, 'Synthesis, characterisation and biological significance of (2′-5′)oligoadenylate derivatives of NAD+, ADP-ribose and adenosine(5′)tetraphospho(5′)adenosine': 3, 'Purification and characterization of a 2′-phosphodiesterase from bovine spleen': 1, 'Viral phosphodiesterases that antagonize doublestranded RNA signaling to RNase L by degrading 2-5A': 1, 'The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide': 1, 'After Ebola in West Africa-Unpredictable Risks, Preventable Epidemics': 1, 'Worldwide Outbreak Database: the largest collection of nosocomial outbreaks': 1, 'Prevention and control of hospital-related infections in low and middle income countries': 1, 'World Health Organization. WHO guidelines on hand hygiene in health care. First global patient safety challenge: clean care is safer care. Geneva: World Health Organization': 3, 'Bacterial contamination of the hands of doctors: a study in the medicine and dermatology wards': 1, 'Decreasing operating room environmental pathogen contamination through improved cleaning practice': 1, 'Costs of diarrhea and acute respiratory infection attributable to not handwashing: the cases of India and China': 1, 'Challenges to sustainability of hand hygiene at a rural hospital in Rwanda': 1, 'Risk of organism acquisition from prior room occupants: a systematic review and meta-analysis': 1, 'Hospital cleaning in the 21st century': 1, 'Environmental Cleaning and Disinfection of Patient Areas': 1, 'Personal protective equipment solution for UK military medical personnel working in an Ebola virus disease treatment unit in Sierra Leone': 1, 'Infection prevention and control measures and tools for the prevention of entry of carbapenem-resistant Enterobacteriaceae into healthcare settings: guidance from the European Centre for Disease Prevention and Control': 1, 'Impact of barrier precautions and antibiotic consumption on the incidence rate of acquired cases of infection or colonization with Acinetobacter baumannii: a 10-year multi-department study': 1, \"Burden, spectrum, and impact of healthcare-associated infection at a South African children's hospital\": 1, 'Receipt of antibiotics in hospitalized patients and risk for Clostridium difficile infection in subsequent patients who occupy the same bed': 1, 'Carbapenem-resistant Enterobacteriaceae at a low prevalence tertiary care center: Patientlevel risk factors and implications for an infection prevention strategy': 1, 'The impact of infectious disease specialists on antibiotic prescribing in hospitals': 1, 'Correlation of Aminoglycoside Consumption and Amikacin-or Gentamicin-Resistant Pseudomonas aeruginosa in Long-Term Nationwide Analysis: Is Antibiotic Cycling an Effective Policy for Reducing Antimicrobial Resistance?': 1, 'Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America': 1, 'Influenza Vaccination of Healthcare Workers: Critical Analysis of the Evidence for Patient Benefit Underpinning Policies of Enforcement': 2, 'Advisory Committee on Immunization Practices. Recommended Immunization Schedule for Adults Aged 19 Years or Older, United States': 1, 'Use of ward closure to control outbreaks among hospitalized patients in acute care settings: a systematic review': 2, 'Impact of intervention on healthcare waste management practices in a tertiary care governmental hospital of Nepal': 1, 'The potential of social media and internetbased data in preventing and fighting infectious diseases: from internet to twitter': 1, 'New technologies in predicting, preventing and controlling emerging infectious diseases. Virulence': 1, 'Model-informed risk assessment and decision making for an emerging infectious disease in the Asia-Pacific region': 1, 'The Respiratory Protection Effectiveness Clinical Trial (ResPECT): a cluster randomized comparison of respirator and medical mask effectiveness against respiratory infections in healthcare personnel': 1, 'Assessment of Hospital Emergency Department Response to Potentially Infectious Diseases Using Unannounced Mystery Patient Drills': 1, 'Outbreak Response and Incident Management: SHEA Guidance and Resources for Healthcare Epidemiologists in United States Acute-Care Hospitals': 1, 'Comparing nonpharmaceutical interventions for containing emerging epidemics': 1, 'Detection of turkey coronavirus in commercial turkey poults in Brazil': 3, 'Visual detection of turkey coronavirus RNA in tissues and feces by reverse-transcription loop-mediated isothermal amplification (RT-LAMP) with hydroxynaphthol blue dye': 1, 'Detection of Turkey astrovirus in young poults affected with poult enteritis complex in Brazil': 1, 'Pathology and tissue distribution of turkey coronavirus in experimentally infected chicks and turkey poults': 5, 'Enteric viruses in Brazilian turkey flocks: single and multiple virus infection frequency according to age and clinical signs of intestinal disease': 2, 'Virus taxonomy: classification and nomenclature of viruses: Ninth Report of the International Committee on Taxonomy of Viruses': 1, 'Structure of the carboxy-terminal receptor-binding domain of avian reovirus fibre sigmaC': 2, 'Pathology and virus tissue distribution of Turkey origin reoviruses in experimentally infected Turkey poults': 6, 'Enteric Viruses Detected by Molecular Methods in Commercial Chicken and Turkey Flocks in the United States Between': 1, 'Isolation of a reovirus from poult enteritis and mortality syndrome and its pathogenicity in turkey poults': 5, 'Sequence and phylogenetic analysis of the S1 genome segment of turkey-origin reoviruses': 2, 'Sequence analysis of the S3 gene from a turkey reovirus': 2, 'Initial characterization of an avian reovirus isolate from turkey poults with poult enteritis and mortality syndrome': 2, 'Validation of an immunohistochemistry assay to detect turkey coronavirus: a rapid and simple screening tool for limited resource settings': 4, 'Coronaviruses in poultry and other birds': 1, 'Establishment and characterization of a chicken hepatocellular carcinoma cell line, LMH': 1, 'Avian reovirus: structure and biology': 2, 'U-net: Convolutional networks for biomedical image segmentation': 1, 'Improving the segmentation of anatomical structures in chest radiographs using u-net with an imagenet pretrained encoder': 1, 'Deep residual learning for image recognition': 1, 'Grad-cam: Visual explanations from deep networks via gradient-based localization': 1, 'Plant-produced vaccines: promise and reality': 4, 'Plant molecular pharming for the treatment of chronic and infectious diseases': 2, 'Plant-produced candidate countermeasures against emerging and reemerging infections and bioterror agents': 2, 'Broadly neutralizing HIV antibodies define a glycandependent epitope on the prefusion conformation of gp41 on cleaved envelope trimers': 1, 'Plant Molecular Farming: Much More than Medicines': 2, 'Plant-derived pharmaceuticals for the developing world': 1, 'Realising the value of plant molecular pharming to benefit the poor in developing countries and emerging economies': 1, 'Developing country applications of molecular farming: case studies in South Africa and Argentina': 1, 'Molecular farming on rescue of pharma industry for next generations': 1, 'Protein modifications in the plant secretory pathway: current status and practical implications in molecular pharming': 1, 'Glyco-engineering in plants to produce human-like N-glycan structures': 1, 'In planta protein sialylation through overexpression of the respective mammalian pathway': 2, \"Designing tomorrow's vaccines\": 6, 'Vaccines through centuries: major cornerstones of global health': 1, 'Plant-made vaccines and reagents for the One Health initiative': 3, 'Endoplasmic reticulum stress responses in plants': 1, 'Engineering and expression of a human rotavirus candidate vaccine in Nicotiana benthamiana': 5, 'Endoplasmic reticulum protein quality control and its relationship to environmental stress responses in plants': 1, 'Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice': 9, 'Plant-based rapid production of recombinant subunit hemagglutinin vaccines targeting H1N1 and H5N1 influenza': 3, 'A plant-derived quadrivalent virus like particle influenza vaccine induces cross-reactive antibody and T cell response in healthy adults': 1, 'Coexpression of molecular chaperone BiP improves immunoglobulin solubility and IgG secretion from Trichoplusia ni insect cells': 1, 'In vitro folding of inclusion body proteins': 1, 'Structure of influenza haemagglutinin at the pH of membrane fusion': 4, 'ER degradation of a misfolded luminal protein by the cytosolic ubiquitin-proteasome pathway': 1, 'Multiple proteolytic systems, including the proteasome, contribute to CFTR processing': 1, 'Degradation from the endoplasmic reticulum: disposing of newly synthesized proteins': 1, 'A protein translocation defect linked to ubiquitin conjugation at the endoplasmic reticulum': 1, 'Degradation of CFTR by the ubiquitin-proteasome pathway': 1, 'The surprising complexity of signal sequences': 1, 'Enzyme digests eliminate nonfunctional Env from HIV-1 particle surfaces, leaving native Env trimers intact and viral infectivity unaffected': 1, 'Folding of HIV-1 envelope glycoprotein involves extensive isomerization of disulfide bonds and conformation-dependent leader peptide cleavage': 1, 'Effects of inefficient cleavage of the signal sequence of HIV-1 gp 120 on its association with calnexin, folding, and intracellular transport': 1, 'The HIV-1 Env protein signal sequence retards its cleavage and down-regulates the glycoprotein folding': 1, 'Enhanced secretion from insect cells of a foreign protein fused to the honeybee melittin signal peptide': 1, 'The development of Rift Valley fever virus candidate vaccines and reagents produced in Nicotiana benthamiana': 3, 'Plant-derived hemagglutinin protects ferrets against challenge infection with the A/Indonesia/05/05 strain of avian influenza': 4, 'High level expression of surface glycoprotein of rabies virus in tobacco leaves and its immunoprotective activity in mice': 3, 'Expression of the rabies virus glycoprotein in transgenic tomatoes': 4, 'Biological and biochemical characterization of HIV-1 Gag/dgp41 virus-like particles expressed in Nicotiana benthamiana': 1, 'Co-expression of the protease furin in Nicotiana benthamiana leads to efficient processing of latent transforming growth factor-beta1 into a biologically active protein': 3, 'Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles': 1, 'Glycoprotein sialylation in plants?': 2, 'Setting up a platform for plant-based influenza virus vaccine production in South Africa': 3, 'Plant-based technologies to enable rapid response to Ebola outbreak': 1, 'Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns': 2, 'Virus-induced humoral immunity: on how B cell responses are initiated': 2, 'The N276 glycosylation site is required for HIV-1 neutralization by the CD4 binding site specific HJ16 monoclonal antibody': 2, 'A plant-derived human monoclonal antibody induces an anticarbohydrate immune response in rabbits': 1, 'Controlled glycosylation of plant-produced recombinant proteins': 2, 'Implications of plant glycans in the development of innovative vaccines': 1, 'Iterative structure-based improvement of a fusion-glycoprotein vaccine against RSV': 2, 'Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein': 1, 'Crystal structure of a soluble cleaved HIV-1 envelope trimer': 2, 'Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies': 1, 'A Prominent Site of Antibody Vulnerability on HIV Envelope Incorporates a Motif Associated with CCR5 Binding and Its Camouflaging Glycans': 1, 'Antibody neutralization and escape by HIV-1': 3, 'Addition of N-glycosylation sites on the globular head of the H5 hemagglutinin induces the escape of highly pathogenic avian influenza A H5N1 viruses from vaccineinduced immunity': 1, 'Addition of glycosylation to influenza A virus hemagglutinin modulates antibody-mediated recognition of H1N1 2009 pandemic viruses': 1, 'A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody': 1, 'Cross-neutralization of 1918 and 2009 influenza viruses: role of glycans in viral evolution and vaccine design': 1, 'Biochemical composition of haemagglutinin-based influenza virus-like particle vaccine produced by transient expression in tobacco plants': 2, 'Human antibody response to N-glycans present on plant-made influenza virus-like particle (VLP) vaccines. Vaccine': 2, 'Global site-specific N-glycosylation analysis of HIV envelope glycoprotein': 1, 'SSR alpha and associated calnexin are major calcium binding proteins of the endoplasmic reticulum membrane': 1, 'Structure and immune recognition of the HIV Glycan shield': 1, 'An oligosacchyaryl transferase from Leishmania major increases the N-glycan occupancy on recombinant glycoproteins produced in Nicotiana benthamiana': 1, 'Glycosylation of plant produced human antibodies': 1, 'Identification of common features in prototype broadly neutralizing antibodies to HIV envelope V2 apex to facilitate vaccine design': 1, 'Structural delineation of a quaternary, cleavagedependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers': 1, 'Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design': 1, 'Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120': 1, 'Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer': 1, 'The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120': 1, 'The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1->2 mannose residues on the outer face of gp120': 1, 'Promiscuous glycan site recognition by antibodies to the high-mannose patch of gp120 broadens neutralization of HIV': 1, 'Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1': 1, 'Rapid high-level production of functional HIV broadly neutralizing monoclonal antibodies in transient plant expression systems': 6, 'The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade': 2, 'Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens': 2, 'Structural constraints determine the glycosylation of HIV-1 envelope trimers': 1, 'Glycans function as anchors for antibodies and help drive HIV broadly neutralizing antibody development': 1, 'Generation of biologically active multi-sialylated recombinant human EPOFc in plants': 1, 'Engineering of complex protein sialylation in plants': 1, 'Engineering of a sialic acid synthesis pathway in transgenic plants by expression of bacterial Neu5Ac-synthesizing enzymes': 1, 'The convertases furin and PC1 can both cleave the human immunodeficiency virus (HIV)-1 envelope glycoprotein gp160 into gp120 (HIV-1 SU) and gp41 (HIV-I TM)': 1, 'Furin is important but not essential for the proteolytic maturation of gp160 of HIV-1': 1, 'Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160': 1, 'Comparative cellular processing of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp160 by the mammalian subtilisin/kexin-like convertases': 1, 'Cleavage strongly influences whether soluble HIV-1 envelope glycoprotein trimers adopt a native-like conformation': 3, 'Vaccine-elicited primate antibodies use a distinct approach to the HIV-1 primary receptor binding site informing vaccine redesign': 1, 'Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteins': 2, 'A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure': 1, 'Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1': 1, 'Influenza HA subtypes demonstrate divergent phenotypes for cleavage activation and pH of fusion: implications for host range and adaptation': 4, 'Cleavage-independent HIV-1 Env trimers engineered as soluble native spike mimetics for vaccine design': 3, 'Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches': 1, 'The human immunodeficiency virus type 1 envelope glycoprotein precursor acquires aberrant intermolecular disulfide bonds that may prevent normal proteolytic processing': 2, 'Role of hemagglutinin cleavage for the pathogenicity of influenza virus': 1, 'Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease': 1, 'A plant-produced influenza subunit vaccine protects ferrets against virus challenge. Influenza Other Respir': 3, 'Plant-derived H7 VLP vaccine elicits protective immune response against H7N9 influenza virus in mice and ferrets': 3, 'Chaperone machines for protein folding, unfolding and disaggregation': 1, 'Protein Quality Control in the Endoplasmic Reticulum of Plants': 1, 'Review/N-glycans: the making of a varied toolbox': 1, 'N-linked glycans direct the cotranslational folding pathway of influenza hemagglutinin': 1, 'ERp57 is a multifunctional thiol-disulfide oxidoreductase': 1, 'Interaction of the thiol-dependent reductase ERp57 with nascent glycoproteins': 1, 'ERp57 functions as a subunit of specific complexes formed with the ER lectins calreticulin and calnexin': 1, 'Enhanced catalysis of ribonuclease B folding by the interaction of calnexin or calreticulin with ERp57': 1, 'Functional relationship between protein disulfide isomerase family members during the oxidative folding of human secretory proteins': 1, 'Glycosylation and disulfide bond analysis of transiently and stably expressed clade C HIV-1 gp140 trimers in 293T cells identifies disulfide heterogeneity present in both proteins and differences in O-linked glycosylation': 1, 'Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells': 2, 'Estimates of global seasonal influenza-associated respiratory mortality: a modelling study': 1, 'Update: Influenza Activity -United States': 1, 'The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza': 2, 'Progress in developing virus-like particle influenza vaccines': 1, 'Egg-Independent Influenza Vaccines and Vaccine Candidates. Vaccines': 1, 'A plant-based system for rapid production of influenza vaccine antigens': 2, 'Plant-expressed HA as a seasonal influenza vaccine candidate': 2, 'Safety and immunogenicity of a plant-produced recombinant hemagglutinin-based influenza vaccine (HAI-05) derived from A/ Indonesia/05/2005 (H5N1) influenza virus: a phase 1 randomized, doubleblind, placebo-controlled, dose-escalation study in healthy adults': 1, 'Safety and immunogenicity of a plantproduced recombinant monomer hemagglutinin-based influenza vaccine derived from influenza A (H1N1)pdm09 virus: a Phase 1 dose-escalation study in healthy adults': 1, 'Preclinical and clinical development of plant-made viruslike particle vaccine against avian H5N1 influenza': 1, 'Influenza virus-like particle vaccines made in Nicotiana benthamiana elicit durable, poly-functional and cross-reactive T cell responses to influenza HA antigens': 1, 'The HIV-1 epidemic: low-to middle-income countries. Cold Spring Harb': 2, 'Effectiveness of UNAIDS targets and HIV vaccination across 127 countries': 1, 'Native-like Env trimers as a platform for HIV-1 vaccine design': 1, 'The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus': 2, 'Advantageous features of plant-based systems for the development of HIV vaccines': 1, \"Taking forward a 'One Health' approach for turning the tide against the Middle East respiratory syndrome coronavirus and other zoonotic pathogens with epidemic potential\": 1, 'Are we prepared for emerging flaviviruses in Europe? Challenges for vaccination': 1, 'Zika virus outbreak in the Americas: the need for novel mosquito control methods': 1, 'Plant expression systems, a budding way to confront chikungunya and Zika in developing countries?': 1, 'A plantproduced antigen elicits potent immune responses against West Nile virus in mice': 2, 'Strategies for the plant-based expression of dengue subunit vaccines': 1, 'Cholera toxin B subunit-domain III of dengue virus envelope glycoprotein E fusion protein production in transgenic plants': 2, 'Expression of a consensus dengue virus envelope protein domain III in transgenic callus of rice': 1, 'Exploring different strategies to express Dengue virus envelope protein in a plant system': 2, 'Production of dengue 2 envelope domain III in plant using TMV-based vector system': 2, 'Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein': 1, 'Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells': 1, 'Structural Basis of Zika Virus-Specific Antibody Protection': 1, 'Expression of dengue-3 premembrane and envelope polyprotein in lettuce chloroplasts': 1, 'Production of Japanese encephalitis virus antigens in plants using bamboo mosaic virus-based vector': 1, 'Plant-produced subunit vaccine candidates against yellow fever induce virus neutralizing antibodies and confer protection against viral challenge in animal models': 2, 'Nanoparticles target distinct dendritic cell populations according to their size': 1, 'Plant-produced Zika virus envelope protein elicits neutralizing immune responses that correlate with protective immunity against Zika virus in mice': 1, 'Virus-like particles that display Zika virus envelope protein domain III induce potent neutralizing immune responses in mice': 1, 'Plant-made vaccines for humans and animals': 1, 'Arabidopsis thaliana plants expressing Rift Valley fever virus antigens: mice exhibit systemic immune responses as the result of oral administration of the transgenic plants': 1, 'Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challenge': 1, 'Mice orally immunized with a transgenic plant expressing the glycoprotein of Crimean-Congo hemorrhagic fever virus': 1, 'Development of an edible rabies vaccine in maize using the Vnukovo strain': 1, 'Generation of the transgenic potato expressing fulllength spike protein of infectious bronchitis virus': 1, 'Expression of the Newcastle disease virus fusion protein in transgenic maize and immunological studies': 1, 'Accumulation of recombinant SARS-CoV spike protein in plant cytosol and chloroplasts indicate potential for development of plant-derived oral vaccines': 1, 'A protease activity-depleted environment for heterologous proteins migrating towards the leaf cell apoplast': 1, 'Modulating secretory pathway pH by proton channel co-expression can increase recombinant protein stability in plants': 1, 'N-glyco-engineering in plants: update on strategies and major achievements': 1, 'Cloning, characterization and expression of cDNA containing major histocompatibility complex class II α and II β genes of Japanese flounder Paralichtys olivaceus': 8, 'Identification of MHC class II β resistance/susceptibility alleles to Aernmonas salmonicida in brook charr (Salvelinus fontinalis)': 2, 'Interactions between immunogenetic peptides and MHC proteins': 1, 'The evolutionary ecology of the major histocompatibility complex': 2, 'Human Streptococcus agalactiae isolate in Nile tilapia (Oreochromis niloticus)': 1, 'Nolinkage of major histocompatibility complex class I and class II loci in bony fishes': 1, 'MHC polymorphism and disease resistance in Atlantic salmon (Salmo salar); facing pathogens with single expressed major histocompatibility class I and class II loci': 2, 'How specific MHC class I and class II combinations affect disease resistance against infectious salmon anaemia in Atlantic salmon (Salmo salar)': 1, 'Molecular identification, polymorphism, and expression analysis of major histocompatibility complex class IIA and B genes of turbot (Scophthalmus maximus)': 4, 'Characterization of the major histocompatibility complex class II genes in miiuy croaker': 1, 'Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1': 2, 'The importance of immune gene variability (MHC) in evolutionary ecology and conservation': 1, 'Resistance ranking of some common inbred mouse strains to Mycobacterium tuberbulosis and relationship to major histocompatibility complex haplotype and Nramp1 genotype': 1, 'Major histocompatibility complex variation associated with juvenile survival and parasite resistance in a large unmanaged ungulate population': 1, 'Association of polymorphisms in non-classic MHC genes with susceptibility to autoimmune hepatitis': 2, 'Resistance to a malignant lymphoma in chickens is mapped to subregion of major histocompatibility (B) complex': 1, 'The role of MHC polymorphism in anti-microbial resistance': 1, 'Major histocompatibility complex class IIB allele polymorphismand its association with resistance/susceptibility to Vibrio anguillarum': 2, 'Major histocompatibility polymorphism associated with resistance towards amoebic gill disease in Atlantic salmon (Salmo salar L.)': 2, 'MHC polymorphism and disease resistance to Vibrio anguillarum in 8 families of half-smooth tongue sole (Cynoglossus semilaevis)': 2, 'Isolation of carp genes encoding major histocompatibility complex antigens': 1, 'Coding sequences of the MHC II β chain of homozygous rainbow trout (Oncorhynchus mykiss)': 2, 'Molecular cloning, genomic structure, polymorphism and expression analysis of major histocompatibility complex class IIA and IIB genes of half-smooth tongue sole (Cynoglossus semilaevis). Fish Shellfish Immunol': 12, 'Molecular cloning, genomic structure, polymorphism and expression analysis of major histocompatibility complex class II B gene of Nile tilapia (Oreochromis niloticus)': 9, 'Major histocompatibility complex class IIA and IIB genes of Nile tilapia Oreochromis niloticus, genomic structure, molecular polymorphism and expression patterns. Fish Shellfish Immunol': 12, 'Organization of MHC class IIB genes in the zebrafish (Brachydanio rerio)': 2, 'Molecular polymorphism and expression analysis of MHC class II B gene from red sea bream (Chrysophrys major)': 3, 'Major histocompatibility complex class IIA and IIB genes of the spotted halibut Verasper variegatus, genomic structure, molecular polymorphism, and expression analysis': 10, 'SRY-related genes in the genome of the rice field eel (Monopterus albus)': 1, 'Study on pathogen of bacterial hemorrhagic septicemia of rice eel (Monopterus albus)': 1, 'Identity and virulence properties of Aeromonas isolates from diseased fish, healthy controls and water environment in China': 1, 'Cloning and comparative expression of IRF4 and IRF10 in the Asian swamp eel (Monopterus albus)': 1, 'Nomenclature for themajor histocompatibility complexes of different species, a proposal': 1, 'Sequence analysis of MHC DRB alleles in domestic cats from the United Kingdom': 1, 'Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0': 1, 'The neighbor-joining method, a new method for reconstructing phylogenetic trees': 1, 'Role of transmembrane domain interactions in the assembly of class II MHC molecules': 1, 'MHC class II B genes in the channel catfish (Ictalurus punctatus)': 1, 'Molecular characterization and expression analysis of MHC class II α and β genes in large yellow croaker (Pseudosciaena crocea)': 2, 'Molecular cloning, expression pattern, and 3D structural analysis of the MHC class IIB gene in the Chinese longsnout catfish (Leiocassis longirostris)': 1, 'A general strategy for cloning double-stranded RNA: Nucleotide sequence of the simian-l 1 rotavirus gene 8': 1, 'Serotypespecific glycoprotein of simian 11 rotavirus: Coding assignment and gene sequence. froc': 1, 'Cloning of bovine rotavirus (RF strain): Nucleotide sequence of the gene coding for the major capsid protein': 1, 'Marked sequence variation between segment 4 genes of human RV-5 and simian SAl 1 rotaviruses': 1, 'Nucleotide sequence and expression in Escherichia co/i of the gene encoding the nonstructural protein NCVP2 of bovine rotavirus': 1, 'ldentificatlon of the simian rotavirus SAl 1 genome segment 3 product': 1, 'RNA-binding proteins of bovine rotavirus': 1, 'Assignment of simian rotavirus SAl 1 temperature-sensitive mutant groups A, C, F, and G to genome segments': 1, 'In vitro culture of a rotavirus associated with neonatal calf scours': 1, 'A Manual of Methods for Baculovirus Vectors and Insect Cell Culture Procedures': 1, 'Molecular Cloning. A Laboratory Manual': 1, 'DNA sequencing with chain-terminating inhibitors': 1, 'The complete nucleotide sequence of an infectious clone of cauliflower mosaic virus by': 1, 'Two types of glycoprotein precursors are produced by the simian rotavirus SAI 1': 2, 'Slmlan rotavirus SAl 1 replication In cell cultures': 1, 'Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs': 1, 'A putative signal peptidase recognition site and sequence in eukaryotic and prokaryotic signal peptides': 1, 'Analysis of the accuracy and implications of simple methods for predicting secondary structure of globular proteins': 1, 'Rapid protein sequence slmilartty searches': 1, 'Los Alamos sequence analysis package for nucleic acids and proteins': 1, 'Primary structural comparison of RNA-dependent polymerases from plant, animal and bacterial viruses': 1, 'Birnavirus RNA polymerase is related to polymerases of positive strand RNA viruses': 2, 'Baculovirus expression vectors: The requirements for high level expression of proteins, including glycoproteins': 1, 'novel coronavirus (COVID-19) outbreak: a review of the current literature': 1, 'Short-term stability study of RNA at room temperature. Biopreservation and biobanking': 2, 'RNA preservation and stabilization': 1, 'Stability of Middle East respiratory syndrome coronavirus (MERS-CoV) under different environmental conditions': 2, 'Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity': 1, 'Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome': 1, 'Impact of RNA Degradation on Viral Diagnosis: An Understated but Essential Step for the Successful Establishment of a Diagnosis Network': 1, 'The use of carrier RNA to enhance DNA extraction from microfluidic-based silica monoliths': 1, 'Molecular detection and serotyping of infectious bronchitis virus from FTA® filter paper. Avian diseases': 1, 'Evolving epidemiology and impact of non-pharmaceutical interventions on the outbreak of coronavirus disease 2019 in Wuhan, China': 1, 'Early spread of SARS-Cov-2 in the Icelandic population': 1, 'Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship': 8, 'Presumed asymptomatic carrier transmission of COVID-19': 2, 'Asymptomatic and presymptomatic SARS-CoV-2 infections in residents of a long-term care skilled nursing facility': 1, 'Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2)': 14, \"General's remarks at the media briefing on 2019-nCoV on 11 February. Available at:. 2020\": 1, 'Co-infection with SARS-CoV-2 and influenza A virus in patient with pneumonia': 1, 'Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China': 15, 'Clinical features of patients infected with 2019 novel coronavirus in Wuhan': 31, 'Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study': 29, 'Utility of Ferritin, Procalcitonin, and C-reactive Protein in Severe Patients with 2019 Novel Coronavirus Disease': 1, 'Hydroxychloroquine and Azithromycin as a treatment of COVID-19: preliminary results of an open-label non-randomized clinical trial': 1, 'A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19': 7, 'connectivity and degree distributions: Exponential random graph (p*) models for directed social networks': 2, 'Naming the coronavirus disease (COVID-19) and the virus that causes it': 3, 'COVID-19: what is next for public health?': 3, 'Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study': 2, 'Risk assessment of novel coronavirus COVID-19 outbreaks outside China': 1, 'Effect of delay in diagnosis on transmission of COVID-19': 1, 'Epidemic analysis of COVID-19 in China by dynamical modeling': 1, 'Risk for transportation of 2019 novel coronavirus disease from Wuhan to other cities in China': 1, 'A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating personto-person transmission: a study of a family cluster': 1, 'Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72,314 cases from the Chinese Center for Disease Control and Prevention': 1, 'Notice on strengthening community prevention and control about COVID-19': 2, 'National Health Commission (NHC)': 5, 'Coronavirus disease': 3, 'World Health Organization. Coronavirus disease (COVID-2019) situation reports': 1, 'Transmission dynamics of 2019 novel coronavirus (2019-nCoV)': 2, 'Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22': 1, 'Pneumonia of unknown etiology in Wuhan, China: potential for international spread via commercial air travel': 1, 'Genomic analysis of nCoV spread': 1, 'New SARS-like virus in China triggers alarm': 1, 'Clinical characteristics of coronavirus disease 2019 in China': 19, 'Nowcasting and forecasting the potential domestic and international spread of the 2019-ncov outbreak originating in Wuhan, China: a modelling study': 1, \"COVID-19: Study estimates rate of 'silent transmission\": 3, 'Indirect virus transmission in cluster of COVID-19 cases': 2, 'How coronavirus spreads so quickly and how you can slow it down': 2, 'The vaccines and drugs in development to treat COVID-19': 1, 'COVID-19: how to treat coronavirus at home': 2, 'World Health Organization. Summary of probable SARS cases with onset of illness from 1': 1, 'A novel coronavirus outbreak of global health concern': 6, 'Modeling the control of COVID-19: impact of policy interventions and meteorological factors': 4, 'Modelling the epidemic trend of the 2019 novel coronavirus outbreak in China': 2, 'Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak': 2, 'Estimating the effective reproduction number of the 2019-nCoV in China': 1, 'The transmissibility of novel coronavirus in the early stages of the 2019-20 outbreak in Wuhan: exploring initial point-source exposure sizes and durations using scenario analysis': 2, 'Studies of the strategies for controlling the COVID-19 epidemic in China: estimation of control efficacy and suggestions for policy makers (in Chinese)': 1, 'Pattern of early human-to-human transmission of Wuhan': 1, 'Early transmissibility assessment of a novel coronavirus in Wuhan': 2, 'Stochastic discrete epidemic modeling of COVID-19 transmission in the Province of Shaanxi incorporating public health intervention and case importation. medRxiv': 2, 'Serial interval of COVID-19 among publicly reported confirmed cases': 2, 'Early dynamics of transmission and control of 2019-nCoV: a mathematical modelling study': 1, 'Reproduction numbers and subthreshold endemic equilibria for compartmental models of disease transmission': 2, 'Notice on printing and distributing Diagnosis and Treatment Protocol for COVID-19': 1, 'Interpretation of Diagnosis and Treatment Protocol for COVID-19 (trial version 6)': 1, \"Wuhan Municipal People's Government, Wuhan's resident population exceeds 11 million\": 1, \"The 10th Report of Wuhan's Economic and Social Development Achievements on the 70th Anniversary of the Founding of New China\": 1, 'Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China': 6, 'SARS outbreaks in Ontario, Hong Kong and Singapore: the role of diagnosis and isolation as a control mechanism': 1, 'Partial immunity and vaccination for influenza': 1, 'The data fitting and optimal control of a hand, foot and mouth disease (HFMD) model with stage structure': 1, 'A methodology for performing global uncertainty and sensitivity analysis in systems biology': 1, 'Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond princess cruise ship: a data-driven analysis': 1, 'An absolutely necessary piece\": A qualitative study of legal perspectives on medical affidavits in the asylum process': 1, 'Asylum medicine: Standard and best practices. Health and human rights': 1, 'Detention Management: Detention Statistics': 1, 'USCIS to take action to address asylum backlog': 1, 'Practice Pointer: AILA frequently asked questions (FAQs) on changes to the asylum office affirmative scheduling system. Doc. no. 18020233: American Immigration Lawyers Association': 1, 'Assessing the efficacy and': 1, 'Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study': 4, 'Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington state': 4, 'Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a singlecentered, retrospective, observational study': 9, 'Clinical features and short-term outcomes of 18 patients with corona virus disease 2019 in intensive care unit': 2, 'Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study': 28, 'Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China': 9, 'Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention': 7, 'Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China': 8, 'Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China': 8, 'A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias': 1, 'Global surveillance for COVID-19 caused by human infection with COVID-19 virus: interim guidance': 2, 'Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1': 8, 'Detection of SARS-CoV-2 in different types of clinical specimens': 5, 'SARS in a hospital visitor and her intensivist': 1, 'Group of Interventional Respiratory Medicine, Chinese Thoracic Society. Expert consensus for bronchoscopy during the epidemic of 2019 novel coronavirus infection': 1, 'Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore': 4, 'Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)': 2, 'Evaluation of droplet dispersion during non-invasive ventilation, oxygen therapy, nebuliser treatment and chest physiotherapy in clinical practice: implications for management of pandemic influenza and other airborne infections': 2, 'Exhaled air dispersion during highflow nasal cannula therapy versus CPAP via different masks': 2, 'Comparison of highflow nasal cannula versus oxygen face mask for environmental bacterial contamination in critically ill pneumonia patients: a randomized controlled crossover trial': 2, 'Noninvasive ventilation in acute hypoxemic nonhypercapnic respiratory failure: a systematic review and meta-analysis': 1, 'Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries': 5, 'Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection': 8, 'Failure of high-flow nasal cannula therapy may delay intubation and increase mortality': 1, 'Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review': 3, 'Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients': 6, 'An official American Thoracic Society/European Society of Intensive Care Medicine/ Society of Critical Care Medicine clinical practice guideline: Mechanical ventilation in adult patients with acute respiratory distress syndrome': 1, 'Treatment for severe acute respiratory distress syndrome from COVID-19': 1, 'Assessment of therapeutic interventions and lung protective ventilation in patients with moderate to severe acute respiratory distress syndrome: a systematic review and network meta-analysis': 1, 'Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus': 1, 'Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases': 2, 'Preparing for the most critically ill patients with COVID-19: the potential role of extracorporeal membrane oxygenation': 2, 'Conservative fluid management or deresuscitation for patients with sepsis or acute respiratory distress syndrome following the resuscitation phase of critical illness: a systematic review and meta-analysis': 1, 'Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a metaanalysis': 1, 'Impact of complicated myocardial injury on the clinical outcome of severe or critically ill COVID-19 patients': 1, 'Co-infections of SARS-CoV-2 with multiple common respiratory pathogens in infected patients': 1, 'The clinical characteristics of pneumonia patients co-infected with 2019 novel coronavirus and influenza virus in Wuhan': 1, 'COVID-19: consider cytokine storm syndromes and immunosuppression': 10, 'SARS: systematic review of treatment effects': 5, 'Corticosteroid therapy for critically ill patients with Middle East Respiratory Syndrome': 1, 'Corticosteroids as adjunctive therapy in the treatment of influenza': 1, 'Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance': 4, 'Safe patient transport for COVID-19': 1, 'Novel coronavirus infection during the 2019-2020 epidemic: preparing intensive care units-the experience in Sichuan Province, China': 2, 'Chinese Critical Care Ultrasound Study Group. Findings of lung ultrasonography of novel corona virus pneumonia during the 2019-2020 epidemic': 1, 'Viral dynamics in mild and severe cases of COVID-19': 2, 'Informal consultation on prioritization of candidate therapeutic agents for use in novel coronavirus 2019 infection': 2, 'Discovering drugs to treat coronavirus disease 2019 (COVID-19)': 3, 'COVID-19: An update on the epidemiological, clinical, preventive and therapeutic evidence and guidelines of integrative Chinese-Western medicine for the management of 2019 novel coronavirus disease': 1, 'XueBiJing injection versus placebo for critically ill patients with severe community-acquired pneumonia: a randomized controlled trial': 1, 'Ethical considerations for use of unregistered interventions for Ebola viral disease: report of an advisory panel to WHO': 1, 'Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study': 3, 'Rational use of personal protective equipment for coronavirus disease 2019 (COVID-19): interim guidance': 1, 'Expanding ICU facilities in an epidemic: recommendations based on experience from the SARS epidemic in Hong Kong and Singapore': 4, 'Strategies for optimizing the supply of n95 respirators: crisis/alternate strategies': 1, 'Performance of a novel non-fit-tested HEPA filtering face mask': 2, 'Contamination: a comparison of 2 personal protective systems': 1, 'A randomized, controlled trial of Ebola virus disease therapeutics': 2, 'Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV': 5, 'Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro': 13, 'Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses': 3, 'Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies': 8, 'Chloroquine is a potent inhibitor of SARS coronavirus infection and spread': 4, 'Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial': 6, 'Safety and tolerability of a novel, polyclonal human anti-MERS coronavirus antibody produced from transchromosomic cattle: a phase 1 randomised, double-blind, single-dose-escalation study': 1, 'Treatment of 5 critically ill patients with COVID-19 with convalescent plasma': 2, 'Advances in the research of cytokine storm mechanism induced by corona virus disease 2019 and the corresponding immunotherapies': 1, 'Transmission of SARS to healthcare workers. The experience of a Hong Kong ICU': 1, 'Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient': 2, 'Extensive viable Middle East respiratory syndrome (MERS) coronavirus contamination in air and surrounding environment in MERS isolation wards': 2, 'Interim infection prevention and control recommendations for patients with suspected or confirmed coronavirus disease 2019 (COVID-19) in healthcare settings': 1, 'Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected: interim guidance': 2, 'Structure, organization, and delivery of critical care in Asian ICUs': 1, 'A controlled crossover human volunteer study of the in vivo filtration efficacy of a high-efficiency particulate air-filtering oxygen mask': 1, 'The global community needs to swiftly ramp up the response to contain COVID-19': 1, 'Critical care bed capacity in Asian countries and regions': 3, 'The variability of critical care bed numbers in Europe': 2, 'Intensive care unit capacity in low-income countries: a systematic review': 1, 'Surge capacity logistics: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement': 1, 'Are high nurse workload/staffing ratios associated with decreased survival in critically ill patients? A cohort study': 1, 'A systematic review of short courses for nonspecialist education in intensive care': 1, 'Preparing for COVID-19: early experience from an intensive care unit in Singapore': 1, 'Supporting the health care workforce during the COVID-19 global epidemic': 4, \"Facing Covid-19 in Italy-ethics, logistics, and therapeutics on the epidemic's front line\": 1, 'Triage: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement': 2, 'Effect of intravenous interferon beta-1a on death and days free from mechanical ventilation among patients with moderate to severe acute respiratory distress syndrome: a randomized clinical trial': 1, 'InFACT: a global critical care research response to H1N1': 1, 'placebocontrolled clinical trial of the safety and efficacy of investigational therapeutics for the treatment of COVID-19 in hospitalized patients': 1, 'Preprints: an underutilized mechanism to accelerate outbreak science': 1, 'Control and prevention of canine rabies: the need for building laboratory-based surveillance capacity': 2, 'Rabies in Iraq: trends in human cases 2001-2010 and characterisation of animal rabies strains from Baghdad': 1, 'Eliminating the scourge of dog-transmitted rabies': 1, 'The feasibility of canine rabies elimination in Africa: dispelling doubts with data': 1, 'The changing scenario of rabies in India: are we moving towards its prevention and control?': 1, 'Re-evaluating the burden of rabies in Africa and Asia': 3, 'Evaluation of cost-eff ective strategies for rabies post-exposure vaccination in low-income countries': 1, 'and the Africa Rabies Expert Bureau (AfroREB). Fighting rabies in Africa: the Africa Rabies Expert Bureau (AfroREB)': 1, 'Potential economic benefi ts of eliminating canine rabies': 3, 'Eliminating canine rabies, the principal source of human infection: what will it take?': 1, 'Control of rabies in Jaipur, India, by the sterilisation and vaccination of neighbourhood dogs': 1, 'Stray dog population demographics in Jodhpur, India following a population control/ rabies vaccination program': 1, 'Virus Taxonomy: Ninth Report of the International Committee on Taxonomy of Viruses': 2, 'Rabies virus vaccines: is there a need for a pan-lyssavirus vaccine?': 3, \"Rabies remains a 'neglected disease'\": 2, 'Phylogenetic relationships of Irkut and West Caucasian bat viruses within the Lyssavirus genus and suggested quantitative criteria based on the N gene sequence for lyssavirus genotype defi nition': 1, 'Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses': 1, 'Effi cacy of rabies biologics against new lyssaviruses from Eurasia': 1, 'Quantifying antigenic relationships among the lyssaviruses': 1, 'Host switching in Lyssavirus history from the Chiroptera to the Carnivora orders': 2, 'Lagos bat virus virulence in mice inoculated by the peripheral route': 1, 'Comparison of pathogenic domains of rabies and African rabies-related lyssaviruses and pathogenicity observed in mice': 1, 'Rabies: scientifi c basis of the disease and its management': 5, 'Bats and lyssaviruses': 3, 'Crystal structure of the rabies virus nucleoprotein-RNA complex': 1, 'Is there an advantage to including the nucleoprotein in a rabies glycoprotein subunit vaccine?': 1, 'Rabies virus transcription and replication': 2, 'Rabies virus receptors': 1, 'Rabies virus interaction with various cell lines is independent of the acetylcholine receptor': 1, 'Characterization of protein involvement in rabies virus binding to BHK-21 cells': 2, 'Mechanism of rabies virus entry into CER cells': 1, 'Involvement of gangliosides in rabies virus infection': 1, 'Functional characterization of Negri bodies (NBs) in rabies virus-infected cells: Evidence that NBs are sites of viral transcription and replication': 2, 'Toll-like receptor 3 (TLR3) plays a major role in the formation of rabies virus Negri Bodies': 1, \"Contributo allow studio dell'eziologia dell rabia\": 1, 'Protein expression redirects vesicular stomatitis virus RNA synthesis to cytoplasmic inclusions': 1, 'Tracking fl uorescencelabeled rabies virus: enhanced green fl uorescent protein-tagged phosphoprotein P supports virus gene expression and formation of infectious particles': 1, 'Diff erential transcription attenuation of rabies virus genes by intergenic regions: generation of recombinant viruses overexpressing the polymerase gene': 1, 'Dissociation of rabies virus matrix protein functions in regulation of viral RNA synthesis and virus assembly': 2, 'Rabies virus matrix protein regulates the balance of virus transcription and replication': 2, 'Rabies Virus Neurovirulence In: Singh SK, Ruzek D': 1, 'Management and outcomes after multiple corneal and solid organ transplantations from a donor infected with rabies virus': 1, 'Possible human-to-human transmission of rabies in Ethiopia': 1, 'Airborne rabies transmission in a laboratory worker': 1, 'Airborne transmission of lyssaviruses': 1, 'Revealing the secrets of neuronal circuits with recombinant rabies virus technology': 1, 'Interferon in rabies virus infection': 1, 'Rabies viral mechanisms to escape the IFN system: the viral protein P interferes with IRF-3, Stat1, and PML nuclear bodies': 1, 'Inhibition of interferon signaling by rabies virus phosphoprotein P: activation-dependent binding of STAT1 and STAT2': 1, 'A novel nuclear traffi cking module regulates the nucleocytoplasmic localization of the rabies virus interferon antagonist, P protein': 1, 'Conservation of a unique mechanism of immune evasion across the Lyssavirus genus': 2, 'Neuronal apoptosis does not play a important role in human rabies encephalitis': 1, 'Comparative pathogenesis of rabies and rabies-like viruses: infection of the central nervous system and centrifugal spread of virus to peripheral tissues': 1, 'Extraneural organ involvement in human rabies': 1, 'Experimental infection of serotine bats (Eptesicus serotinus) with European bat lyssavirus type 1a': 1, 'Nervous control of salivary glands': 1, 'Experimental oral and nasal transmission of rabies virus in mice': 1, 'Comparative pathological study of the murine brain after experimental infection with classical rabies virus and European bat lyssaviruses': 1, 'The immune response to rabies virus infection and vaccination': 3, 'Intracerebral administration of recombinant rabies virus expressing GM-CSF prevents the development of rabies after infection with street virus': 1, 'Infl ammatory response in the nervous system of mice infected with a street isolate of rabies virus': 1, 'Immunovirological correlates in human rabies treated with therapeutic coma': 3, 'Evasive strategies in rabies virus infection': 1, 'Human rabies: neuropathogenesis, diagnosis, and management': 4, 'Human rabies due to lyssavirus infection of bat origin': 1, 'Passive immunity in the prevention of rabies': 1, 'An unusual case of human rabies thought to be of chiropteran origin': 1, 'Fatal human infection with rabies-related Duvenhage virus': 1, 'Fatal human rabies due to Duvenhage virus from a bat in Kenya: failure of treatment with coma-induction, ketamine, and antiviral drugs': 1, 'A fatal human infection with Mokola virus': 1, 'A fatal case of bat lyssavirus infection in Primorskiy Territory of the Russian Far East': 1, 'A human case of encephalitis due to a lyssavirus recently identifi ed in fruit bats': 1, 'Australian bat lyssavirus infection: a second human case, with a long incubation period': 1, 'Australian bat lyssavirus in a child: the fi rst reported case': 1, 'Evidence of rabies virus exposure among humans in the Peruvian Amazon': 1, 'Rabies encephalitis in malaria-endemic area': 1, 'Evaluation of a direct, rapid immunohistochemical test for rabies diagnosis': 1, 'Emerging technologies for the detection of rabies virus: challenges and hopes in the 21st century': 1, 'A reliable diagnosis of human rabies based on analysis of skin biopsy specimens': 2, 'Case report: rapid ante-mortem diagnosis of a human case of rabies imported into the UK from the Philippines': 1, 'Management of rabies in humans': 2, 'Recovery from rabies: a call to arms (editorial)': 1, 'Survival after treatment of rabies with induction of coma': 1, 'Recovery from rabies': 1, 'Current and future approaches to the therapy of human rabies': 3, 'Neuroprotection for ischaemic stroke: translation from the bench to the bedside': 1, 'Current rabies vaccines and prophylaxis schedules: preventing rabies before and after exposure': 6, 'Risk factors associated with travel to rabies endemic countries': 1, 'Rabies vaccination for international travelers': 2, 'Rabies vaccines: WHO position paper-recommendations': 2, 'Rabies vaccines. WHO position paper': 1, 'Jha P, and the Million Death Study Collaborators. Deaths from symptomatically identifi able furious rabies in India: a nationally representative mortality survey': 1, 'Preventative childhood vaccination to rabies': 1, 'Encephalitis following purifi ed chick embryo rabies vaccination': 1, 'Developments in rabies vaccines': 2, 'WHO. WHO expert consultation on rabies-second report': 1, 'Human rabies prevention-United States': 2, 'The Louis Pasteur Oration. Kolkatta India Association for the Prevention of Rabies': 1, 'Development of a murine monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans': 1, 'First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity': 1, 'A human monoclonal antibody cocktail as a novel component of rabies postexposure prophylaxis': 1, 'Production, characterization, and antigen specifi city of recombinant 62-71-3, a candidate monoclonal antibody for rabies prophylaxis in humans': 1, 'Monoclonal antibodies for prophylactic and therapeutic use against viral infections': 1, 'Protective vaccine-induced CD4(+) T cell-independent B cell responses against rabies infection': 1, 'Eff ective preexposure and postexposure prophylaxis of rabies with a highly attenuated recombinant rabies virus': 1, 'Intramuscular inoculation of mice with the live-attenuated recombinant rabies virus TriGAS results in a transient infection of the draining lymph nodes and a robust, long-lasting protective immune response against rabies': 1, \"Rabies-the need for a 'one medicine' approach\": 1, 'Can rabies be eradicated?': 1, 'Current status of human rabies transmitted by dogs in Latin America': 1, 'The Pan American Health Organization (PAHO) role in the control of rabies in Latin America': 1, 'Progress towards eliminating canine rabies: policies and perspectives from Latin America and the Caribbean': 2, 'Rabies update for Latin America and the Caribbean': 1, 'Eliminating canine rabies: the role of public-private partnerships': 1, 'Renewed global partnerships and redesigned roadmaps for rabies prevention and control': 1, 'Current and future tools for global canine rabies elimination': 1, 'OIE activities to support sustainable rabies control: vaccine banks, OIE twinning and evaluation of the performance of veterinary services': 2, 'Molecular tools for rabies diagnosis in animals': 1, 'Impact of the Coronavirus (COVID-19) pandemic on surgical practice -Part 1': 2, 'Fourteenth World Congress on Diseases of Callie I; Dublin': 1, 'Emerging or re-emerging bacterial zoonoses: factors of emergence, surveillance and control': 1, 'The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2': 3, 'The outbreak of COVID-19: an overview': 1, 'Bats and Human Health: Ebola, SARS, Rabies and Beyond': 1, 'Discovery of a novel coronavirus, China Rattus coronavirus HKU24, from Norway rats supports the murine origin of Betacoronavirus 1 has implications for the ancestor of Betacoronavirus lineage A': 1, 'Animal source of the coronavirus continues to elude scientists': 1, 'Peptidyl dipeptidase A: angiotensin I-converting enzyme': 1, 'Potentiation of bradykinin actions by ACE inhibitors': 1, 'Angiotensin-(1-7) prevents systemic hypertension, attenuates oxidative stress and tubulointerstitial fibrosis, and normalizes renal angiotensin-converting enzyme 2 and Mas receptor expression in diabetic mice': 1, 'Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection': 1, 'Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein': 5, 'Structural and functional basis of SARS-CoV-2 entry by using human ACE2': 3, 'Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2': 1, 'Creating the CIPRES Science Gateway for inference of large phylogenetic trees': 1, 'Evolutionary trees from DNA sequences: a maximum likelihood approach': 1, 'The EMBL-EBI search and sequence analysis tools APIs in 2019': 2, 'Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2': 1, 'Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega': 1, 'Updating the accounts: global mortality of the 1918-1920 \"Spanish\" influenza pandemic': 2, 'Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918-20 pandemic: a quantitative analysis': 4, 'Mortality burden of the 1918-1919 influenza pandemic in Europe. Influenza Other Respir Viruses': 2, 'A review of the 1918 herald pandemic wave: importance for contemporary pandemic response strategies': 4, 'Dating the emergence of pandemic influenza viruses': 3, 'A hypothesis: the conjunction of soldiers, gas, pigs, ducks, geese and horses in northern France during the Great War provided the conditions for the emergence of the \"Spanish\" influenza pandemic of 1918-1919': 1, 'Genesis and pathogenesis of the 1918 pandemic H1N1 influenza A virus': 1, 'The signature features of influenza pandemics-implications for policy': 3, 'Pandemic versus epidemic influenza mortality: a pattern of changing age distribution': 4, 'Spanish influenza seen from Spain': 5, 'Spanish flu\" in Spain': 3, 'Spatial-temporal excess mortality patterns of the 1918-1919 influenza pandemic in Spain': 10, 'The Spanish influenza pandemic in occidental Europe (1918-1920) and victim age. Influenza Other Respir Viruses': 1, 'Estimating reproduction numbers for the 1889-90 and 1918-20 influenza pandemics in the city of Madrid. Presented at the IX Congreso de la Asociación de Demografía Histórica': 1, 'La Pandemia de 1918-19': 4, 'Mortality patterns associated with the 1918 influenza pandemic in Mexico: evidence for a spring herald wave and lack of preexisting immunity in older populations': 6, 'The 1918-19 influenza pandemic in Boyaca, Colombia. Emerg Infect Dis': 5, 'The 1918-1920 influenza pandemic in Peru': 4, 'Death patterns during the 1918 influenza pandemic in Chile': 3, 'Epidemiological evidence of an early wave of the 1918 influenza pandemic in New York City': 6, 'Epidemiologic characterization of the 1918 influenza pandemic summer wave in Copenhagen: implications for pandemic control strategies': 4, 'Age-and sex-specific mortality associated with the 1918-1919 influenza pandemic in Kentucky': 4, 'Excess mortality patterns during 1918-1921 influenza pandemic in the state of Arizona, USA': 2, 'The 1918 influenza pandemic: insights for the 21st century': 2, 'Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness': 2, 'Demographic Statistical Yearly Books of the City of Madrid': 1, 'El Declive de la Mortalidad en España': 1, 'Methods for current statistical analysis of excess pneumonia-influenza deaths': 1, 'Mortality and transmissibility patterns of the 1957 influenza pandemic in Maricopa County': 2, 'An Introduction to the': 1, 'A socially neutral disease? Individual social class, household wealth and mortality from Spanish influenza in two socially contrasting parishes in Kristiania 1918-19': 1, 'La Gripe de 1889-1890 en Madrid': 1, 'Age-specific excess mortality patterns and transmissibility during the 1889-1890 influenza pandemic in Madrid, Spain': 2, 'Excess pneumonia-influenza mortality by age and sex in three major influenza A2 epidemics': 1, 'Geography may explain adult mortality from the 1918-20 influenza pandemic': 1, 'Cross-protection between successive waves of the 1918-1919 influenza pandemic: epidemiological evidence from US Army camps and from Britain': 1, 'Mortality risk factors during the 1918-1919 influenza pandemic in the Australian army': 1, 'Qualitative analysis of the level of cross-protection between epidemic waves of the 1918-1919 influenza pandemic': 1, 'Prior immunity helps to explain wave-like behaviour of pandemic influenza in 1918-19': 1, 'The Spanish Flu: Narrative and Cultural Identity in Spain': 1, 'The transmissibility of influenza pandemics of 1889-1890 and 1918-1920 in a large urban environment: Age-specific excess mortality': 1, 'Recrudescent wave of pandemic A/H1N1 influenza in Mexico, winter 2011-2012: age shift and severity': 1, 'Whole-genome analysis of human influenza A virus reveals multiple persistent lineages and reassortment among recent H3N2 viruses': 1, 'Autopsy series of 68 cases dying before and during the 1918 influenza pandemic peak': 1, 'Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis': 2, 'Novel Coronavirus -Saudi Arabia: Human Isolate': 2, 'Severe respiratory illness caused by a novel coronavirus': 5, 'As Outbreak Continues, Confusion Reigns Over Virus Patents': 1, 'Middle East respiratory syndrome coronavirus (MERS-CoV) RNA and neutralising antibodies in milk collected according to local customs from dromedary camels': 8, 'MERS-CoV Daily, Monthly and Cumulative Numbers Over Time': 1, 'Middle East respiratory syndrome coronavirus: Implications for health care facilities': 1, 'Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study': 14, 'epidemiological findings from a retrospective investigation': 9, 'Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia': 20, 'First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-tohuman transmission': 3, 'Family cluster of Middle East respiratory syndrome coronavirus infections': 8, 'Middle East respiratory syndrome coronavirus: epidemic potential or a storm in a teacup?': 4, 'A family cluster of Middle East Respiratory Syndrome Coronavirus infections related to a likely unrecognized asymptomatic or mild case': 8, 'Middle East respiratory syndrome coronavirus (MERS-CoV) infections in two returning travellers in the Netherlands': 10, 'Laboratory-confirmed case of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in Malaysia: preparedness and response': 11, 'Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans': 19, 'Stillbirth During Infection With Middle East Respiratory Syndrome Coronavirus': 2, 'Is MERS another SARS?': 2, 'Screening for Middle East respiratory syndrome coronavirus infection in hospital patients and their healthcare worker and family contacts: a prospective descriptive study': 1, 'A case of long-term excretion and subclinical infection with Middle East respiratory syndrome coronavirus in a healthcare worker': 2, 'Contact investigation for imported case of Middle East respiratory syndrome': 5, 'In-vitro renal epithelial cell infection reveals a viral kidney tropism as a potential mechanism for acute renal failure during Middle East Respiratory Syndrome (MERS) Coronavirus infection': 6, 'Acute renal impairment in coronavirus-associated severe acute respiratory syndrome': 1, 'Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection': 5, 'Middle East respiratory syndrome coronavirus not detected in children hospitalized with acute respiratory illness in': 1, 'MERS: emergence of a novel human coronavirus': 2, 'Spread, circulation, and evolution of the Middle East respiratory syndrome coronavirus': 8, 'Assessing activity and inhibition of Middle East respiratory syndrome coronavirus papain-like and 3C-like proteases using luciferase-based biosensors': 4, 'Structural and functional characterization of MERS coronavirus papain-like protease': 5, 'Full-genome deep sequencing and phylogenetic analysis of novel human betacoronavirus': 1, 'Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections': 5, 'Reliable typing of MERS-CoV variants with a small genome fragment': 2, 'Full-genome sequence of human betacoronavirus 2c jordan-n3/2012 after serial passage in Mammalian cells': 1, 'Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study': 2, 'Isolation of MERS Coronavirus from a Dromedary Camel': 3, 'Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development': 1, 'Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26': 3, 'The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies': 1, 'Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4': 1, 'Evidence for camel-to-human transmission of MERS coronavirus': 9, 'Prevalence of MERS-CoV Nasal Carriage and Compliance With the Saudi Health Recommendations Among Pilgrims Attending the': 2, 'Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction': 1, 'Viral respiratory infections among Hajj pilgrims in 2013': 1, 'Lack of nasal carriage of novel corona virus (HCoV-EMC) in French Hajj pilgrims returning from the Hajj 2012, despite a high rate of respiratory symptoms': 2, 'Co-circulation of four human coronaviruses (HCoVs) in Queensland children with acute respiratory tract illnesses in 2004': 1, 'CDC Concludes Indiana MERS Patient did not Spread Virus to Illinois Business Associate': 4, 'Middle East respiratory syndrome coronavirus (MERS-CoV) viral shedding in the respiratory tract: an observational analysis with infection control implications': 2, 'Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?': 3, 'Respiratory Tract Samples, Viral Load and Genome Fraction Yield in patients with Middle East Respiratory Syndrome': 2, 'Investigation of anti-middle East respiratory syndrome antibodies in blood donors and slaughterhouse workers in Jeddah and Makkah, Saudi Arabia, fall 2012': 3, \"Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests\": 2, 'Middle East respiratory syndrome: what clinicians need to know': 1, 'A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV': 1, 'Middle East respiratory syndrome (MERS) coronavirus seroprevalence in domestic livestock in Saudi Arabia': 8, 'MERS coronavirus in dromedary camel herd, Saudi Arabia': 8, 'Lack of Middle East respiratory syndrome coronavirus transmission from infected camels': 2, 'Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt': 4, 'Middle East Respiratory Syndrome coronavirus (MERS-CoV) serology in major livestock species in an affected region in Jordan': 1, 'Lack of MERS coronavirus neutralizing antibodies in humans, eastern province, Saudi Arabia': 1, 'Specific serology for emerging human coronaviruses by protein microarray': 3, 'Human cell tropism and innate immune system interactions of human respiratory coronavirus EMC compared to those of severe acute respiratory syndrome coronavirus': 4, 'Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines': 4, 'Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications for disease pathogenesis and clinical manifestation': 1, 'Human Infection with MERS Coronavirus after Exposure to Infected Camels': 9, 'Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC': 3, 'Increased expression of plasma and CD4+ T lymphocyte costimulatory molecule CD26 in adult patients with allergic asthma': 1, 'Wild-type and innate immune-deficient mice are not susceptible to the Middle East respiratory syndrome coronavirus': 5, 'Receptor variation and susceptibility to Middle East respiratoy syndrome coronavirus infection': 3, 'The multifunctional or moonlighting protein CD26/DPPIV': 1, 'Loss of dipeptidylpeptidase IV activity in chronic rhinosinusitis contributes to the neurogenic inflammation induced by substance P in the nasal mucosa': 2, 'Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures': 7, 'Generation of transgenic mouse model of middle east respiratory syndrome-coronavirus infection and disease': 1, 'An animal model of MERS produced by infection of rhesus macaques with MERS coronavirus': 5, 'Efficient replication of the novel human betacoronavirus EMC on primary human epithelium highlights its zoonotic potential': 8, 'Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment': 2, 'Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus': 6, 'Active replication of middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis': 3, 'IL-10 family of cytokines': 1, 'Recovery from severe novel coronavirus infection': 1, 'Community Case Clusters of Middle East Respiratory Syndrome Coronavirus in Hafr Al-Batin, Kingdom of Saudi Arabia: A Descriptive Genomic study': 1, 'Detection of the Middle East respiratory syndrome coronavirus genome in an air sample originating from a camel barn owned by an infected patient': 1, 'Taking stock of the first 133 MERS coronavirus cases globally -Is the epidemic changing?': 4, 'Human-Dromedary camel interactions and the risk of acquiring zoonotic Middle East respiratory syndrome coronavirus infection': 4, 'Emerging infectious diseases associated with bat viruses': 1, 'Bats and their virome: an important source of emerging viruses capable of infecting humans': 2, 'Coronavirus diversity, phylogeny and interspecies jumping': 1, 'Beneficial effect of camel milk in diabetic nephropathy': 1, 'Camel milk as an adjuvant therapy for the treatment of type 1 diabetes: verification of a traditional ethnomedical practice': 1, 'The antiplatelet activity of camel urine': 1, 'Camel urine components display anti-cancer properties in vitro': 1, 'Geographic distribution of MERS Coronavirus among dromedary camels': 1, 'Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia': 7, 'Middle East respiratory syndrome coronavirus antibody reactors among camels in Dubai': 3, 'Antibodies against MERS coronavirus in dromedary camels': 3, 'Serologic Assessment of Possibility for MERS-CoV Infection in Equids': 1, 'MERS coronaviruses in dromedary camels': 1, 'Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation': 5, 'Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels': 5, 'Replication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels': 5, 'Missing information in animal surveillance of MERS-CoV': 1, 'Investigation of an imported case of Middle East Respiratory Syndrome Coronavirus (MERS-CoV': 1, 'Viability of Pseudomonas aeruginosa in cough aerosols generated by persons with cystic fibrosis': 2, 'Age-specific and sex-specific morbidity and mortality from avian influenza A(H7N9)': 5, 'Call for infection control to stem MERS': 2, 'Infection control and MERS-CoV in health workers': 2, 'First confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in the United States, updated information on the epidemiology of MERS-CoV infection': 1, 'Survival of coronaviruses in water and wastewater': 1, 'The effects of temperature and relative humidity on the viability of the SARS coronavirus': 1, 'Assessing the pandemic potential of MERS-CoV': 1, 'Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk': 1, 'Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility': 4, 'Assessment of the MERS-CoV Epidemic Situation in the Middle East Region. Program for Monitoring Emerging Diseases': 3, 'Synthesizing data and models for the spread of MERS-CoV, 2013: key role of index cases and hospital transmission': 1, 'Virology Down Under. 21-6-2014a': 4, 'Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture': 7, 'Repurposing of clinically developed drugs for treatment of Middle East Respiratory Coronavirus Infection': 3, 'Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus': 1, 'The safety of dipeptidyl peptidase-4 (DPP-4) inhibitors or sodium-glucose cotransporter 2 (SGLT-2) inhibitors added to metformin background therapy in patients with type 2 diabetes mellitus: a systematic review and meta-analysis': 2, 'Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice': 3, 'Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution': 2, 'Engineering a replication-competent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidate': 2, 'A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines': 1, 'A highly conserved WDYPKCDRA epitope in the RNA directed RNA polymerase of human coronaviruses can be used as epitope-based universal vaccine design': 1, 'Ribavirin and interferon (IFN)-alpha-2b as primary and preventive treatment for Middle East respiratory syndrome coronavirus (MERS-CoV): a preliminary report of two cases': 1, 'Novel coronavirus: the challenge of communicating about a virus which one knows little about': 2, 'MERS-CoV enigma deepens as reported cases surge': 1, 'Saudi Arabia Replaces Health Minister Amid MERS Virus Fears': 1, \"H5N1: Crawford Kilian's Infectious Disease Blog\": 1, \"Avian Flu Diary: Michael Coston's Blog on Emerging Infectious Diseases\": 1, \"Mens et Manus: Maia Majumder's Blog. 8-6-2014\": 1, 'Influenza A (H7N9) and the importance of digital epidemiology': 1, 'The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak': 1, 'An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China': 4, 'The effect of human mobility and control measures on the COVID-19 epidemic in China': 4, 'Early dynamics of transmission and control of COVID-19: a mathematical modelling study': 4, 'Effect of non-pharmaceutical interventions for containing the COVID-19 outbreak in China. medRxiv': 1, 'Open access epidemiological data from the COVID-19 outbreak': 1, 'Epidemiological data from the COVID-19 outbreak, realtime case information': 1, 'An interactive web-based dashboard to track COVID-19 in real time': 11, 'Early epidemiological analysis of the coronavirus disease 2019 outbreak based on crowdsourced data: a population-level observational study': 1, 'The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application': 9, 'Epidemiological research priorities for public health control of the ongoing global novel coronavirus (2019-nCoV) outbreak': 1, 'Serial Interval of COVID-19 among Publicly Reported Confirmed Cases': 1, 'Temporal dynamics in viral shedding and transmissibility of COVID-19': 4, 'Report of the Ebola Interim Assessment Panel': 1, \"What we've learned about fighting Ebola\": 1, 'Digital disease detection: harnessing the Web for public health surveillance': 1, 'History of biological warfare and bioterrorism': 1, 'Molecular characterization of a variant rhinovirus from an outbreak associated with uncommonly high mortality': 1, 'Rhinovirus and the lower respiratory tract': 1, 'Rhinoviruses infect the lower airways': 2, 'VP1 sequencing of all human rhinovirus serotypes: Insights into genus phylogeny and susceptibility to antiviral capsid-binding compounds': 3, 'Two groups of rhinoviruses revealed by a panel of antiviral compounds present sequence divergence and differential pathogenicity': 2, 'Alignment of capsid protein VP1 sequences of all human rhinovirus prototype strains: conserved motifs and functional domains': 2, 'Genetic clustering of all 102 human rhinovirus prototype strains: serotype 87 is close to human enterovirus 70': 1, 'Cell recognition and entry by rhino-and enteroviruses': 2, 'Very-low-density lipoprotein receptor fragment shed from HeLa cells inhibits human rhinovirus infection': 1, 'Members of the low density lipoprotein receptor family mediate cell entry of a minor group common cold virus': 3, 'The Minor Receptor Group of Human Rhinovirus (HRV) Includes HRV23 and HRV25, but the Presence of a Lysine in the VP1 HI Loop Is Not Sufficient for Receptor Binding': 2, 'The cellular receptor to human rhinovirus 2 binds around the 5-fold axis and not in the canyon: a structural view': 2, 'Human rhinovirus type 54 infection via heparan sulfate is less efficient and strictly dependent on low endosomal pH': 1, 'Structure of a human common cold virus and functional relationship to other picornaviruses': 2, 'Structure of human rhinovirus serotype 2 (HRV2)': 1, 'Comparison of the three-dimensional structure of two human rhinoviruses (HRV2 and HRV14)': 1, 'Enterovirus 68 is associated with respiratory illness and shares biological features with both the enteroviruses and the rhinoviruses': 1, 'Interaction of coxsackievirus A21 with its cellular receptor, ICAM-1': 1, 'Determination of the structure of a decay accelerating factor-binding clinical isolate of echovirus 11 allows mapping of mutants with altered receptor requirements for infection': 1, 'The structure of echovirus type 12 bound to a two-domain fragment of its cellular attachment protein decay-accelerating factor (CD 55)': 2, 'Three-dimensional structure of poliovirus receptor bound to poliovirus': 2, 'Interaction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptor': 1, 'Subclassification of picornaviruses': 1, 'Picornaviridae: The viruses and their replication': 2, 'New complete genome sequences of human rhinoviruses shed light on their phylogeny and genomic features': 2, 'Genomewide diversity and selective pressure in the human rhinovirus': 5, 'Recombination in circulating human enterovirus B: independent evolution of structural and non-structural genome regions': 1, 'Frequency and dynamics of recombination within different species of human enteroviruses': 1, 'Polymerase chain reaction and sequencing for typing rhinovirus RNA': 1, 'A collaborative report: Rhinoviruses -extension of the numbering system from 89 to 100': 1, 'Characterisation of a newly identified human rhinovirus, HRV-QPM, discovered in infants with bronchiolitis': 12, 'Pan-viral screening of respiratory tract infections in adults with and without asthma reveals unexpected human coronavirus and human rhinovirus diversity': 4, 'Clinical and molecular epidemiology of human bocavirus in respiratory and fecal samples from children in Hong Kong': 10, 'Frequent detection of human rhinoviruses, paramyxoviruses, coronaviruses, and bocavirus during acute respiratory tract infections': 7, 'Sequence analysis of human rhinoviruses in the RNA-dependent RNA polymerase coding region reveals within-species variation': 1, 'Complete genomic sequencing shows that polioviruses and members of human enterovirus species C are closely related in the noncapsid coding region': 1, 'Full-length human iummunodeficiency virus type 1 genomes from subtype Cinfected seroconverters in India, with evidence of intersubtype recombination': 2, 'Alignments and comparative profiles of picornavirus genera': 1, 'Molecular relationships between 21 human rhinovirus serotypes': 1, 'Structural studies of two rhinovirus serotypes complexed with fragments of their cellular receptor': 1, 'Family Picornaviridae': 2, 'Presence of the newly discovered human polyomaviruses KI and WU in Australian patients with acute respiratory tract infection': 5, 'Insights into the genetic basis for natural phenotypic resistance of human rhinoviruses to pleconaril': 1, 'Cellular receptors of picornaviruses': 1, 'The BC loop in poliovirus coat protein VP1: an ideal acceptor site for major insertions': 1, 'A cellular receptor of human rhinovirus type 2, the very-low-density lipoprotein receptor, binds to two neighboring proteins of the viral capsid': 1, 'Sequence and structure of human rhinoviruses reveal the basis of receptor discrimination': 1, 'Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation': 1, 'Amplification of rhinovirus specific nucleic acids from clinical samples using the polymerase chain reaction': 1, 'A diverse group of previously unrecognized human rhinoviruses are common causes of respiratory illness in infants': 1, 'MassTag Polymerase-Chain-Reaction Detection of Respiratory Pathogens, Including a New Rhinovirus Genotype, That Caused Influenza-Like Illness in New York State during': 1, 'Role of respiratory viruses in acute upper and lower respiratory tract illness in the first year of life': 1, 'Cleavage site analysis in picornaviral polyproteins: Discovering cellular targets by neural networks': 1, 'UCSF chimera-A visualization system for exploratory research and analysis': 2, 'Bioedit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT': 1, 'MEGA3: Integrated software for molecular evolutionary genetic analysis and sequence alignment': 1, 'SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modelling': 1, 'The structure of human rhinovirus 16': 1, 'Clinical evaluation of the efficacy of Haemophilus somnus and Pasteurella sp. bacterins': 2, 'Efficacy of a Pasteurella haemolytica vaccine/bacterial extract in the prevention of bovine respiratory disease in recently shipped feedlot calves': 1, 'Shipping fever pneumonia in yearling feedlot cattle': 1, 'Reactivation of temperature sensitive and nontemperature sensitive infectious bovine rhinotracheitis vaccine virus with dexamethasone': 1, 'Immunosuppression and immunomodulation in bovine respiratory disease': 3, 'Potentiation of bovine respiratory syncytial virus infection in calves by bovine viral diarrhoea virus': 1, 'Viral-bacterial interactions': 1, 'Experimental production of bovine respiratory tract disease with bovine viral diarrhea virus': 1, 'Suppression of neutrophil and lymphocyte function induced by a vaccinal strain of bovine viral diarrhea virus with and without the concurrent administration of ACTH': 1, 'Coronavirus isolation from nasal swab samples in cattle with signs of respiratory tract disease after shipping': 2, 'Synergism between Mycoplasma bovis and Pasteurella haemolytica in calf pneumonia': 2, 'Alteration of neutrophil function associated with coccidiosis in cattle: Influence of decoquinate and dexamethasone': 1, \"Intranasal vaccination of pigs against Aujeszky's disease: Comparison with one or two doses of attenuated vaccines in pigs with high maternal antibody titres\": 1, 'Stimulation of bovine herpesvirus-1 specific T lymphocyte and antibody responses in cattle following immunization with a polyvalent vaccine': 1, 'Lymphocyte blastogenesis and neutrophil function in cattle persistently infected with bovine viral diarrhea virus': 1, 'Reactivation of infectious bovine rhinotracheitis virus by transport': 1, 'Genetic diversity and BVD virus': 2, 'Molecular biology of bovine viral diarrhea virus and its interactions with the host': 1, 'Serologic detection and practical consequences of antigenic diversity among bovine viral diarrhea viruses in a vaccinated herd': 1, 'Protection of the bovine fetus from bovine viral diarrhoea virus by means of a new inactivated vaccine': 1, 'Immunity to human and bovine respiratory syncytial virus': 1, 'Priming for local and systemic antibody memory responses to bovine respiratory syncytial virus: Effect of amount of virus, virus replication, route of administration and maternal antibodies': 1, 'In vitro lymphocyte proliferative responses and gamma-interferon production as measures of cell-mediated immunity of cattle exposed to Pasteurella haemolytica': 1, 'Cloning and sequencing of the gene encoding a 31-kilodalton antigen of Haemophilus somnus': 1, 'A field trial to evaluate an intranasal infectious bovine rhinotracheitis vaccine': 1, 'Studies on transplacental transmissibility of a bovine virus diarrhoea (BVD) vaccine virus in cattle. II. Inoculation of pregnant cows without detectable neutralizing antibodies to BVD virus 90-229 days before parturition (51st to 190th day of gestation)': 1, 'Agriculture. Pestivirus Infections of Ruminants. Luxembourg': 1, 'Effects of dietary supplemental protein source and a Pasteurella haemalytica toxoid on performance and health of newly received calves': 1, 'Respiratory tract disease and mucosal colonization by Pasteurella haemolytica in transported calves': 1, 'Clinical management of respiratory disease in feedlot cattle': 1, 'Isolation of Haemophilus somnus antigens and their use as vaccines for prevention of bovine thromboembolic meningoencephalitis': 1, 'Factors associated with mortality and treatment costs in feedlot calves': 1, 'The effect of route and dosage of immunization on the serological response to a Pasteurella haemolytica and Haemophilus somnus vaccine in feedlot calves': 1, 'Characterization of a panel of monoclonal antibodies and their use in the study of the antigenic diversity of bovine viral diarrhea virus': 1, 'Investigation of bovine viral diarrhea virus infections in a range of beef cattle herd': 1, 'Proper Injection Procedures for Cattle. University of Nebraska NEB Guide G92-1992': 1, 'Ragweed (Ambrosia) progression and its health risks: will Switzerland resist this invasion?': 1, 'Ambrosia artemisiifolia -a motivation for European-wide control': 1, 'Common ragweed: A threat to environmental health in Europe': 2, 'Ragweed pollen source inventory for France -The second largest centre of Ambrosia in Europe': 4, 'Biological weed control to relieve millions from Ambrosia allergies in Europe': 1, 'Localization, release and bioavailability of pollen allergens: the influence of environmental factors': 1, 'Aerobiological studies -current state and future challenges': 1, 'Pollen grains are efficient cloud condensation nuclei': 1, 'Pollen Rupture and Its Impact on Precipitation in Clean Continental Conditions': 1, 'Ice nucleating behavior of different tree pollen in the immersion mode': 1, 'Effect of coarse biogenic aerosol on downwelling infrared flux at the surface': 1, 'Climate warming drives invasion history of Ambrosia artemisiifolia in central Europe': 1, 'Production of allergenic pollen by ragweed (Ambrosia artemisiifolia L.) is increased in CO2-enriched atmospheres': 1, 'Recent warming by latitude associated with increased length of ragweed pollen season in central North America': 1, 'Airborne Pollen Transport': 1, 'Forecasting ragweed pollen characteristics with nonparametric regression methods over the most polluted areas in Europe': 1, 'Numerical ragweed pollen forecasts using different source maps: a comparison for France': 1, 'Morphometric Analysis of Pollen from Four Species of Ambrosia (compositae)': 2, 'Pollen Terminology: An Illustrated Handbook': 2, 'Inherent optical properties of pollen particles: a case study for the morning glory pollen': 2, 'An automatic volumetric spore trap': 1, 'Pollen Grain Recognition Using Deep Learning': 1, 'Dual-excitation-wavelength fluorescence spectra and elastic scattering for differentiation of single airborne pollen and fungal particles': 1, 'A flash-lamp based device for fluorescence detection and identification of individual pollen grains': 1, 'Spectral Intensity Bioaerosol Sensor (SIBS): an instrument for spectrally resolved fluorescence detection of single particles in real time': 1, 'Generation of aerosol-particle light-scattering patterns from digital holograms': 1, 'Real-time pollen monitoring using digital holography': 1, 'Digital holographic imaging of aerosol particles in flight': 1, 'Application of polarization effects in light scattering: a new biophysical tool': 1, 'Biological Particles as Irregularly Shaped Scatterers': 2, 'Scattering matrix elements of biological particles measured in a flow through system: theory and practice': 1, 'Pollen characterization and identification by elastically scattered light': 1, 'Polarization Analysis of Light Scattered by Pollen Grains of Cryptomeria japonica': 1, 'Polarization signatures of airborne particulates': 1, 'Development of an angle-scanning spectropolarimeter: Preliminary results': 1, 'Relationship between laser light scattering and physical properties of airborne pollen': 1, 'Simultaneous two-color, two-dimensional angular optical scattering patterns from airborne particulates: Scattering results and exploratory analysis': 1, 'Scattering, Absorption, and Emission of Light by Small Particles': 2, 'Lidar polarization discrimination of bioaerosols': 1, 'Boreal tree pollen sensed by polarization lidar: Depolarizing biogenic chaff': 1, 'Influence of biogenic pollen on optical properties of atmospheric aerosols observed by lidar over Gwangju, South Korea': 1, 'Atmospheric non-spherical particles optical properties from UV-polarization lidar and scattering matrix': 1, \"Investigating the size, shape and surface roughness dependence of polarization lidars with light-scattering computations on real mineral dust particles: Application to dust particles' external mixtures and dust mass concentration retrievals\": 1, 'Optics of Biological Particles: Proceedings of the NATO Advanced Research Workshop on Fluorescence and Other Optical Properties of Biological Particles for Biological Warfare Agent Sensors': 1, 'T-matrix approach to calculating circular polarization of aggregates made of optically active materials': 1, 'Light scattering from biological cells: dependence of backscatter radiation on membrane thickness and refractive index': 1, 'Absorption and Scattering of Light by Small Particles': 2, 'Photopolarimetrical properties of coronavirus model particles: Spike proteins number influence': 3, 'Electromagnetic scattering by nonspherical particles: A tutorial review': 1, 'Transfer of Polarized Light in Planetary Atmospheres': 1, 'Laboratory evaluation of the scattering matrix elements of mineral dust particles from 176.0° up to 180.0°-exact backscattering angle': 5, 'Subpollen particles: Carriers of allergenic proteins and oxidases': 1, 'Particle Morphology and Density Characterization by Combined Mobility and Aerodynamic Diameter Measurements. Part 1: Theory': 1, 'Conditions of applicability of the single-scattering approximation': 1, 'Average nearest-neighbor distances between uniformly distributed finite particles': 1, 'Three-dimensional label-free imaging and analysis of Pinus pollen grains using optical diffraction tomography': 1, 'Cell refractive index tomography by digital holographic microscopy': 1, 'Review: Model particles in atmospheric optics': 1, 'Electromagnetic wave scattering from particles of arbitrary shapes': 1, 'Light scattering by arbitrary shaped particles with rough surfaces: Shmatrices approach': 1, 'Single Scattering Properties of Atmospheric Ice Crystals': 1, 'Optical properties of aggregate particles comparable in size to the wavelength': 1, 'Adhesion of mineral and soot aerosols can strongly affect their scattering and absorption properties': 1, 'Spectra of light reflected by aggregate structures of submicron particles': 1, 'Characterization and remote sensing of biological particles using circular polarization': 1, 'Funds of knowledge for teaching: Using a qualitative approach to connect homes and classrooms': 1, 'Research, reform, and equity in US mathematics education': 1, 'Principles and standards for school mathematics. Author: National Council of Teachers of Mathematics': 1, 'Preface to a socio-political look at equity in school organization of mathematics': 1, 'Considering the rights of learners in the classroom: The importance of mistakes and growth assessment practices': 1, 'Overlooked, misunderstood and at-risk: exploring the lives and HIV risk of ethnic minority male-to-female transgender youth': 1, 'A needs assessment of transgender people of color living in Washington DC': 1, 'The health and social service needs of transgender people in Philadelphia': 1, 'Transgender stigma and health: a critical review of stigma determinants, mechanisms, and interventions': 1, 'Experiences of transgender-related discrimination and implications for health: results from the Virginia Transgender Health Initiative Study': 1, 'The time is now: attention increases to transgender health in the United States but scientific knowledge gaps remain': 1, 'Estimating HIV prevalence and risk behavior of transgendered persons in the United States': 1, 'An intersectional perspective on access to HIV-related healthcare for transgender women': 2, 'Legal immigration status is associated with depressive symptoms among Latina transgender women in Washington, DC': 1, 'HIV infection risk factors among male-to-female transgender persons: a review of the literature': 2, 'Barriers and facilitators to engagement and retention in care among transgender women living with human immunodeficiency virus': 2, 'Transgender non-inclusive healthcare and delaying care because of fear: connections to general health and mental health among transgender adults. Transgend Health': 1, 'Recruiting, linking, and retaining high-risk transgender women into HIV prevention and care services: an overview of barriers, strategies, and lessons learned': 1, 'Behavioral interventions to prevent HIV transmission and acquisition for transgender women: a critical review': 1, 'Healing our women for transgender women: adaptation, acceptability, and pilot testing': 1, 'Resource guide for adapting SISTA for transgender women': 1, \"HIV/AIDS Programming in the United States: considerations affecting transgender women and girls. Women's Health Issues\": 1, 'Healthy Divas. Improving Engagement in HIV Care for High-risk Women. clinicaltrials': 1, 'The transgender women of color initiative: implementing and evaluating innovative interventions to enhance engagement and retention in HIV care': 1, 'SPNS Transgender Women of Color Initiative Intervention Manuals': 1, 'Gender affirmation: a framework for conceptualizing risk behavior among transgender women of color': 2, '/Cross ing-the-Quali ty-Chasm /Quali ty%20Cha sm%20200 1%20%20rep ort%20 bri ef': 1, 'Culturally responsive integrated health care: key issues for medical education': 1, 'The Gender Affirmative Model: what we know and what we aim to learn': 1, 'The role of gender affirmation in psychological well-being among transgender women': 1, 'Gender affirmation and resiliency among Black transgender women with and without HIV infection': 1, 'Integrated and gender-affirming transgender clinical care and research': 1, 'Evidence for the model of gender affirmation: the role of gender affirmation and healthcare empowerment in viral suppression among transgender women of color living with HIV': 2, 'Evolving trends in medical carecoordination for patients with HIV and AIDS': 2, 'HIV System navigation: an emerging model to improve HIV care access': 1, 'Implementation and operational research: the navigation program: an intervention to reengage lost patients at 7 HIV clinics in Los Angeles County': 1, 'Patient navigation that helps to engage people in HIV care': 1, 'Unpacking linkage and reengagement in care: a day in the life of a positive charge care coordinator': 1, 'The role of patient navigators in building a medical home for multiply diagnosed HIV-positive homeless populations': 1, 'Lost to care and back again: patient and navigator perspectives on HIV care reengagement': 1, 'Patient navigation facilitates medical and social services engagement among HIVinfected individuals leaving jail and returning to the community': 1, 'Qualitative data analysis for applied policy research': 1, 'Using the framework method for the analysis of qualitative data in multi-disciplinary health research': 1, 'Dedoose Version 7.0.23, web application for managing, analyzing, and presenting qualitative and mixed method research data': 1, 'Considerations for a new definition of health literacy': 1, 'Discussing the effects of poor health literacy on patients facing HIV: a narrative literature review': 1, 'Fostering a \"feeling of worth\" among vulnerable HIV populations: the role of linkage to care specialists': 1, 'No estas solo\": navigation programs support engagement in HIV care for Mexicans and Puerto Ricans living in the continental U': 1, 'Patient navigators effectively support HIVinfected individuals returning to the community from jail settings': 1, \"Patient-physician social concordance, medical visit communication and patients' perceptions of health care quality\": 1, 'HIV risk and social networks among male-to-female transgender sex workers in': 1, 'Male-to-female transgender individuals building social support and capital from within a gender-focused network': 2, 'Transgender people of color at the center: conceptualizing a new intersectional model': 1, 'Center for Integrated Health Solutions': 1, 'Creating environments of care with transgender communities. Assoc Nurses AIDS Care': 1, 'Prognostic factors of non-HIV immunocompromised patients with pulmonary infiltrates': 4, 'Pulmonary complications in the non-HIV immunocompromised patient': 1, 'IDSA clinical practice guideline for vaccination of the immunocompromised host': 2, 'Pulmonary disease in the immunocompromised host (first of two parts)': 1, 'British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults': 2, 'Cancer Therapy Evaluation Program Protocol Development Website for Common Terminology Criteria for Adverse Events': 1, 'A new method of classifying prognostic comorbidity in longitudinal studies: development and validation': 1, 'The continuing utility of bronchoalveolar lavage to diagnose opportunistic infection in AIDS patients': 1, 'Pulmonary infiltrates in immunosuppressed patients: analysis of a diagnostic protocol': 1, 'Diagnostic accuracy of bronchoalveolar lavage samples in immunosuppressed patients with suspected pneumonia: analysis of a protocol': 1, 'Association of bronchoalveolar lavage yield with chest computed tomography findings and symptoms in immunocompromised patients': 1, 'Bending the curve -ending TB: Annual report': 1, 'Role of bronchoalveolar lavage in immunocompromised patients with pneumonia treated with a broad spectrum antibiotic and antifungal regimen': 1, 'Safety, diagnostic yield, and therapeutic implications of flexible bronchoscopy in patients with febrile neutropenia and pulmonary infiltrates': 1, 'Performance of a standardized bronchoalveolar lavage protocol in a comprehensive cancer center': 1, 'Growth in emission transfers via international trade from': 2, \"Assessment of China's energy-saving and emission-reduction accomplishments and opportunities during the 11th Five Year Plan\": 1, 'The five-year plan: A new tool for energy saving and emissions reduction in China': 1, \"Growth and structural change in China's energy economy\": 1, 'Energy and air emissions embodied in China-US trade: Eastbound assessment using adjusted bilateral trade data': 1, 'Energy embodied in the international trade of China: An energy input-output analysis': 1, \"The driving forces of China's energy use from 1992 to 2010: An empirical study of input-output and structural decomposition analysis\": 1, 'Trade-off analysis between embodied energy exports and employment creation in China': 1, \"What drive the changes in China's energy consumption and intensity during 12 th Five-Year Plan period?\": 1, \"Embodied energy, export policy adjustment and China's sustainable development: A multi-regional input-output analysis\": 1, 'The estimation of domestic value-added and employment induced by exports: An application to Chinese exports to the United States': 1, 'Interprovincial transfer of embodied primary energy in China: A complex network approach': 1, 'Driving forces of energy embodied in China-EU manufacturing trade from': 1, 'Energy, CO 2 emissions, and value added flows embodied in the J o u r n a l P r e -p r o o f Journal Pre-proof -28 -international trade of the BRICS group: A comprehensive assessment': 1, \"China's energy saving potential from the perspective of energy efficiency advantages of foreign-invested enterprises\": 3, \"Trade, production fragmentation, and China's carbon dioxide emissions\": 5, \"Assessing the impact of foreign content in China's exports on the carbon outsourcing hypothesis\": 3, \"China's carbon emissions embodied in (normal and processing) exports and their driving forces\": 7, 'Emissions embodied in Chinese exports taking into account of the special export structure of China': 2, \"Firm ownership, China's export related emissions, and the responsibility\": 2, 'Structural decomposition analysis applied to energy and emissions: Some recent developments': 3, 'Assessing drivers of economy-wide energy use and emissions: IDA versus SDA': 1, \"Analysis of CO 2 emissions embodied in China's bilateral trade: A non-competitive import input-output approach\": 2, \"China's emissions embodied in exports: How regional and trade heterogeneity matter\": 1, \"Production globalization makes China's exports cleaner\": 1, 'Regional disparity in energy intensity of China and the role of industrial and export structure': 2, \"Input-output and structural decomposition analysis of India's carbon emissions and intensity\": 1, \"Demand contributors and driving factors of Singapore's aggregate carbon intensities\": 1, \"Who shapes China's carbon intensity and how? A demand-side decomposition analysis\": 1, 'LMDI decomposition approach: A guide for implementation': 2, 'Multiplicative decomposition of aggregate carbon intensity change using input-output analysis': 2, 'From production-based to consumption-based national emission inventories': 3, 'Multi-region input-output analysis of CO 2 emissions embodied in trade: The feedback effects': 1, 'Structural decomposition analysis applied to energy and emissions: Aggregation issues': 1, 'A multi-region structural decomposition analysis of global CO2 emission intensity': 1, 'Impacts of international export on global and regional carbon intensity': 1, 'Spatial differences in energy performance among four municipalities of China: From both the aggregate and final demand perspectives': 1, 'Prevalence of infectious bronchitis and Newcastle disease virus among domestic and wild birds in H5N1 outbreaks areas': 1, 'Molecular evolution and emergence of avian gammacoronaviruses': 3, 'Detection of infectious bronchitis virus with the use of real-time quantitative reverse transcriptase-PCR and correlation with virus detection in embryonated eggs': 1, 'Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction': 1, 'MEGA6: molecular evolutionary genetics analysis version 6.0': 3, 'Development and evaluation of a real-time Taqman RT-PCR assay for the detection of infectious bronchitis virus from infected chickens': 1, 'Further development and use of a molecular serotype identification test for infectious bronchitis virus': 1, 'Relationship between serotypes and genotypes based on the hypervariable region of the S1 gene of infectious bronchitis virus': 1, 'Rapid virulence prediction and identification of Newcastle disease virus genotypes using third-generation sequencing': 1, 'Rapid multiplex small DNA sequencing on the MinION nanopore sequencing platform': 1, 'The immune response to pneumococcal proteins during experimental human carriage': 3, 'Serum immunoglobulin G response to candidate vaccine antigens during experimental human pneumococcal colonization': 3, 'Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae': 1, 'Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae': 1, 'Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection': 2, 'Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae': 2, 'Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae': 2, 'Limited role of antibody in clearance of Streptococcus pneumoniae in a murine model of colonization': 2, 'The immunising effect of pneumococcal nasopharyngeal colonisation; protection against future colonisation and fatal invasive disease': 2, 'Antibodyindependent, CD4+ T-cell-dependent protection against pneumococcal colonization elicited by intranasal immunization with purified pneumococcal proteins': 2, 'Opsonic function of bronchoalveolar lavage IgG after pneumococcal vaccination in HIV-infected and uninfected adults': 2, 'Inhaled delivery of 23-valent pneumococcal polysaccharide vaccine does not result in enhanced pulmonary mucosal immunoglobulin responses. Vaccine': 2, 'Pneumococcal conjugate vaccine is immunogenic in lung fluid of HIV-infected and immunocompetent adults': 2, 'Commentary: Understanding practical lot quality assurance sampling': 2, 'Pneumococcal vaccination in developing countries': 1, 'The protective efficacy of polyvalent pneumococcal polysaccharide vaccine': 1, 'A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection': 1, 'Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study': 3, 'Continuous Electroencephalography Monitoring in Adults in the Intensive Care Unit': 1, 'Electrodes and Montages': 2, 'The standardized EEG electrode array of the IFCN': 1, 'PROSEVA Study Group. Prone positioning in severe acute respiratory distress syndrome': 1, 'Prone positioning in acute respiratory distress syndrome (ARDS): when and how': 1, 'Does prone positioning increase intracranial pressure? A retrospective analysis of patients with acute brain injury and acute respiratory failure': 2, 'Prone ventilation for adult patients with acute respiratory distress syndrome': 2, 'Adult Electroencephalography Artifact': 2, 'Electroencephalography and Artifact in the Intensive Care Unit': 2, 'Artifact: recording EEG in special care units': 2, 'Respiratory artifact on EEG independent of the respirator': 2, 'Atlas of EEG patterns': 2, 'Electroencephalography Predicts Poor and Good Outcomes After Cardiac Arrest: A Two-Center Study': 1, 'Recommendations for the use of electroencephalography and evoked potentials in comatose patients': 1, 'Neurology and Critical Care. Atlas of Electroencephalography': 5, 'An Electroencephalographic Voyage in search of Triphasic Waves (TWs) -the Sirens and Corsairs on the Encephalopathy/EEG horizon: a survey of TWs': 2, 'Obesity in the critically ill: a narrative review': 1, \"American Clinical Neurophysiology Society's Standardized Critical Care EEG Terminology: 2012 version\": 1, 'EEG patterns and imaging correlations in encephalopathy: encephalopathy part II': 2, 'EEG patterns in hypoxic encephalopathies (post-cardiac arrest syndrome): fluctuations, transitions, and reactions': 1, 'Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children': 2, 'Neurologic Features in Severe SARS-CoV-2 Infection': 1, 'Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease': 4, 'Coronavirus disease (COVID-19) Pandemic. Geneva: WHO 2020': 1, 'The paramount importance of serological surveys of SARS-CoV-2 infection and immunity': 2, 'Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention': 1, 'Why Only Test Symptomatic Patients? Consider Random Screening for COVID-19': 1, 'The epidemiology, diagnosis and treatment of COVID-19': 1, 'Characteristics of COVID-19 pandemic and public health consequences': 1, 'SARS-CoV-2 and COVID-19: The most important research questions': 1, 'Data-based analysis, modelling and forecasting of the COVID-19 outbreak': 1, 'Communication from the Commission -Guidelines on COVID-19 in vitro diagnostic tests and their performance': 2, 'FIND. COVID-19 Diagnostics Resource Center': 1, 'medicaldevices/emergency-situations-medical-devices/eua-authorized-serology-test-performance': 1, 'Vitro Diagnostic Assays for COVID-19: Recent Advances and Emerging Trends': 1, 'The Role of Antibody Testing for SARS-CoV-2: Is There One?': 5, 'Test performance evaluation of SARS-CoV-2 serological assays': 3, 'Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG': 2, 'Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases': 4, 'Successful containment of Covid-19 outbreak in a large maternity and perinatal center while continuing clinical service': 1, 'COVID-19: immunopathology and its implications for therapy': 2, 'Comparison of the Elecsys(R) Anti-SARS-CoV-2 immunoassay with the EDI enzyme linked immunosorbent assays for the detection of SARS-CoV-2 antibodies in human plasma': 2, 'Clinical Performance of the Roche SARS-CoV-2 Serologic Assay': 2, 'Clinical performance of the Elecsys electrochemiluminescent immunoassay for the detection of SARS-CoV-2 total antibodies': 1, 'SARS-CoV-2 Serology: Much Hype, Little Data': 2, 'Diagnostic performance of COVID-19 serology assays': 1, 'Serological assays for emerging coronaviruses: challenges and pitfalls': 2, 'Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses': 3, 'Teaching pediatric dermoscopy in a resource-limited setting': 1, 'Screencasts: how effective are they and how do students engage with them?': 1, 'The role of Toll-like receptors in the host response to viruses': 2, 'Shared and unique functions of the Dexd/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity': 3, 'The RNA helicase RIG-I has an essential function in double-stranded RNAinduced innate antiviral responses': 2, 'The V proteins of Paramyxoviruses bind the IFN-inducible RNA helicase, MDA-5, and inhibit its activation of the IFN-Beta promoter': 1, 'Differential roles of MDA5 and RIG-I Helicases in the recognition of RNA viruses': 4, \"The C-terminal regulatory domain is the RNA 5'-triphosphate sensor of RIG-I\": 1, 'Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses': 1, \"5'-Triphosphate RNA is the ligand for RIG-I\": 1, 'Inhibition of beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3': 2, 'Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5': 1, 'Flavivirus induces interferon-beta gene expression through a pathway involving RIG-I-dependent IRF-3 and PI3K-dependent NF-Kappab activation': 1, 'Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity': 4, 'West Nile virus evades activation of interferon regulatory factor 3 through RIG-I-dependent and -independent pathways without antagonizing host defense signaling': 2, 'Establishment and maintenance of the innate antiviral response to West Nile virus involves both RIG-I and MDA5 signaling through IPS-1': 5, 'Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans': 1, 'A protective role of Interleukin-15 in a mouse model for systemic infection with Herpes Simplex virus': 2, 'Toll-like receptors and type I interferons': 2, 'Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA': 1, 'Recognition of single-stranded RNA viruses by Toll-like receptor 7': 1, 'Flavivirus activation of plasmacytoid dendritic cells delineates key elements of TLR7 signaling beyond endosomal recognition': 4, 'TLR-mediated activation of type I IFN during antiviral immune responses: fighting the battle to win the war': 1, 'Human TLR3 recognizes Dengue virus and modulates viral replication In Vitro': 2, 'Flaviviruses induce pro-inflammatory and anti-inflammatory cytokines from murine dendritic cells through Myd88-dependent pathway': 2, 'Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis': 3, 'Toll-like receptor 3 has a protective role against West Nile virus infection': 3, 'Toll-like receptor 7 induced immune response to cutaneous West Nile Virus infection': 2, 'Yellow fever vaccine YF-17D Activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity': 2, 'Analysis of genes induced by Sendai virus infection of mutant cell lines reveals essential roles of interferon regulatory factor 3, NF-kappaB, and interferon but not Toll-like receptor 3': 1, 'Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases: report of the interorganizational task force on nucleic acid amplification testing of blood donors': 1, 'Pathologic studies of fatal cases in outbreak of hand, foot, and mouth disease': 1, 'Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/P300': 1, 'Activation of TBK1 and ikkvarepsilon kinases by vesicular stomatitis virus infection and the role of viral ribonucleoprotein in the development of interferon antiviral immunity': 1, 'Activation of the interferon-beta promoter during Hepatitis C virus RNA replication': 1, 'Cell-specific IRF-3 responses protect against West Nile virus infection by interferon-dependent and -independent mechanisms': 3, 'Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays': 1, 'Interferon inhibits Dengue Virus infection by preventing translation of viral RNA through a PKR-independent mechanism': 2, 'Nile virus replication interferes with both Poly(I:C)-induced interferon gene transcription and response to interferon treatment': 2, 'Resistance to alpha/beta interferon is a determinant of West Nile virus replication fitness and virulence': 7, 'West Nile Virus inhibits the signal transduction pathway of alpha interferon': 3, 'Differential induction of antiviral effects against West Nile Virus in primary mouse macrophages derived from flavivirus-susceptible and congenic resistant mice by alpha/beta interferon and Poly(I-C)': 2, 'Alpha/Beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival': 3, 'Role of type I and Type II interferon responses in recovery from infection with an encephalitic flavivirus': 1, 'New Mouse Model For Dengue Virus Vaccine Testing': 1, 'Murine model for dengue virus-induced lethal disease with increased vascular permeability': 1, 'Critical roles for both STAT1-dependent and STAT1-independent pathways in the control of primary Dengue virus infection in mice': 1, 'Interleukin-4 inhibits indoleamine 2,3-dioxygenase expression in human monocytes': 1, 'Efficient Dengue virus (DENV) Infection of human muscle satellite cells upregulates type I interferon response genes and differentially modulates MHC I expression on bystander and DENV-infected cells': 1, 'Differential expression of interferon (IFN-) regulatory factors and IFN-stimulated genes at early times after West Nile virus infection of mouse embryo fibroblasts': 1, 'Interferon regulatory factor IRF-7 induces the antiviral alpha interferon response and protects against lethal West Nile virus infection': 1, 'Transcriptional activation of interferonstimulated genes but not of cytokine genes after primary infection of rhesus macaques with Dengue virus type 1. Clin. Vaccine Immunol': 1, 'Host gene expression profiling of Dengue virus infection in cell lines and patients': 1, 'Differences in global gene expression in peripheral blood mononuclear cells indicate a significant role of the innate responses in progression of Dengue fever but not Dengue hemorrhagic fever': 1, 'High circulating levels of the Dengue Virus nonstructural protein NS1 early in Dengue illness correlate with the development of Dengue Hemorrhagic fever': 1, 'Human dendritic cells are activated by Dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis': 1, 'A blunted blood plasmacytoid dendritic cell response to an acute systemic viral infection is associated with increased disease severity': 1, 'Inhibition of interferon signaling by Dengue virus': 4, 'A. inhibition of alpha/beta interferon signaling by the NS4B protein of Flaviviruses': 5, 'Topology of the membraneassociated Hepatitis C virus protein NS4B': 1, 'Isolation and characterization of noncytopathic pestivirus mutants reveals a role for nonstructural protein NS4B in viral cytopathogenicity': 1, 'Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile Virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins': 2, 'Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression': 1, 'NS5 of Dengue virus mediates STAT2 binding and degradation': 2, 'Dengue virus NS5 inhibits interferon-alpha signaling by blocking signal transducer and activator of transcription 2 phosphorylation': 1, 'Dengue virus type 2 antagonizes IFN-alpha but not IFN-gamma antiviral effect via downregulating Tyk2-STAT signaling in the human dendritic cell': 1, 'Blocking of the alpha interferon-induced Jak-Stat signaling pathway by japanese encephalitis virus infection': 1, 'Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne Flavivirus and identification of NS5 as an interferon antagonist': 1, 'Efficient transcomplementation of the Flavivirus Kunjin NS5 protein but not of the NS1 Protein requires its coexpression with other components of the viral replicase': 1, 'Toll-like receptors and RNA helicases: Two parallel ways to trigger antiviral responses': 1, 'Negative regulation of the retinoic acid-inducible gene I-induced antiviral state by the ubiquitin-editing protein A20': 1, 'Analysis of adaptive mutations in Kunjin virus replicon RNA reveals a novel role for the flavivirus nonstructural protein NS2A In inhibition of beta interferon promoter-driven transcription': 1, 'Estimation of COVID-2019 burden and potential for international dissemination of infection from Iran': 1, 'COVID-19 Coronavirus Outbreak': 1, 'Coronavirus in Iran: Warning -Level': 1, \"More Int'l Medical Aid Arrives in Iran\": 2, 'Novel 2019 coronavirus genome': 1, 'No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity': 4, 'Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials': 1, 'Hirulog and Early Reperfusion or Occlusion (HERO': 1, 'Beta blockade during and after myocardial infarction: an overview of the randomized trials': 3, 'Metabolic modulation of acute myocardial infarction: the ECLA glucose-insulin-potassium pilot trial': 2, 'The CREATE Study : rationale, design and methods': 1, 'Randomized comparison of enoxaparin, a low-molecular-weight heparin, with unfractionated heparin adjunctive to recombinant tissue plasminogen activator thrombolysis and aspirin: second trial of Heparin and Aspirin Reperfusion Therapy (HART II)': 1, 'The role of infections in autoimmune disease': 2, 'Editorial: Microbial and Environmental Factors in Autoimmune and Inflammatory Diseases': 1, 'Microbes and Viruses Are Bugging the Gut in Celiac Disease. Are They Friends or Foes? Front': 7, 'Viruses and autoimmunity': 2, 'Viral trigger for type 1 diabetes: Pros and cons': 6, 'Seasonal Incidence of Diabetes Mellitus': 1, 'Enterovirus and type 1 diabetes: What is the matter?': 2, 'Evidence of association between type 1 diabetes and exposure to enterovirus in Cuban children and adolescents': 2, 'A Prospective Study of the Role of Coxsackie B and Other Enterovirus Infections in the Pathogenesis of IDDM': 2, 'The first signs of beta-cell autoimmunity appear in infancy in genetically susceptible children from the general population: The Finnish Type 1 Diabetes Prediction and Prevention Study': 1, 'Enterovirus infection as a risk factor for beta-cell autoimmunity in a prospectively observed birth cohort: The Finnish Diabetes Prediction and Prevention Study': 1, 'Effects on isolated human pancreatic islet cells after infection with strains of enterovirus isolated at clinical presentation of type 1 diabetes': 1, 'Detection of enteroviruses in the intestine of type 1 diabetic patients': 1, 'Enterovirus infection and type 1 diabetes mellitus: Systematic review and meta-analysis of observational molecular studies': 1, 'Coxsackie B virus infection and onset of childhood diabetes': 1, 'Detection of Coxsackie B Virus RNA sequences in whole blood samples from adult patients at the onset of type I diabetes mellitus': 1, 'Coxsackie B virus infection and beta cell autoantibodies in newly diagnosed IDDM adult patients': 1, 'Enterovirus RNA in blood is linked to the development of type 1 diabetes': 1, 'T-cell responses to enterovirus antigens in children with type 1 diabetes': 2, 'Isolation of a virus from the pancreas of a child with diabetic ketoacidosis': 2, 'Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients': 1, 'Lessons from the mouse: Potential contribution of bystander lymphocyte activation by viruses to human type 1 diabetes': 4, 'Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets': 1, 'A dual role for TNF-alpha in type 1 diabetes: Islet-specific expression abrogates the ongoing autoimmune process when induced late but not early during pathogenesis': 1, 'Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus': 2, 'Antibodies to Glutamic Acid Decarboxylase and P2-C Peptides in Sera from Coxsackie Virus B4-Infected Mice and IDDM Patients': 1, 'Enteroviruses and the pathogenesis of type 1 diabetes revisited: Cross-reactivity of enterovirus capsid protein (VP1) antibodies with human mitochondrial proteins': 1, 'Coxsackie B virus serology and Type 1 diabetes mellitus: A systematic review of published case-control studies': 1, 'Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes': 1, 'Rotavirus infections and development of diabetes-associated autoantibodies during the first 2 years of life': 1, 'Rotavirus Activates Lymphocytes from Non-Obese Diabetic Mice by Triggering Toll-Like Receptor 7 Signaling and Interferon Production in Plasmacytoid Dendritic Cells': 2, 'Rotavirus Infection Accelerates Type 1 Diabetes in Mice with Established Insulitis': 2, 'Rotavirus acceleration of murine type 1 diabetes is associated with a T helper 1-dependent specific serum antibody response and virus effects in regional lymph nodes': 1, 'The expression of influenza virus hemagglutinin in the pancreatic beta cells of transgenic mice results in autoimmune diabetes': 1, 'Influenza A viruses grow in human pancreatic cells and cause pancreatitis and diabetes in an animal model': 4, 'National Heart, Lung, Blood Institute Retrovirus Epidemiology Donor Study-II (REDS-II). Influenza viremia and the potential for blood-borne transmission': 1, 'Evidence of viremia in 2 cases of severe pandemic influenza A H1N1/09': 1, 'The Trigger of Diabetic Ketoacidosis in a Young Woman with Ketosis-Prone Diabetes': 1, 'Conversion to type 1 diabetes after H1N1 influenza infection: A case report': 1, 'Detection of Respiratory Viruses in the 2009 Winter Season in Rome: 2009 Influenza a (H1N1) Complications in Children and Concomitant Type 1 Diabetes Onset': 1, 'Respiratory infections are temporally associated with initiation of type 1 diabetes autoimmunity: The TEDDY study': 1, 'A Type I Interferon Transcriptional Signature Precedes Autoimmunity in Children Genetically at Risk for Type 1 Diabetes': 1, 'Increased IFN-α-producing Plasmacytoid Dendritic Cells (pDCs) in Human Th1-mediated Type 1 Diabetes: pDCs Augment Th1 Responses through IFN-α Production1': 2, 'Influenza A Virus Infection Induces Viral and Cellular Defective Ribosomal Products Encoded by Alternative Reading Frames': 1, 'Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2': 1, 'Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy': 2, 'Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in china': 1, 'Risk of Narcolepsy after AS03 Adjuvanted Pandemic A/H1N1 2009 Influenza Vaccine in Adults: A Case-Coverage Study in England': 1, 'AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland': 1, 'Adjuvanted Seasonal and Pandemic Influenza Vaccines': 1, 'Update on Narcolepsy Cases Associated with Pandemrix Vaccination in 2009 in the Netherlands': 1, 'Narcolepsy and influenza vaccination-induced autoimmunity': 1, 'Viruses and multiple sclerosis': 4, 'Epstein-Barr Virus in Systemic Autoimmune Diseases': 3, 'Detecting Epstein-Barr virus DNA from peripheral blood mononuclear cells in adult patients with systemic lupus erythematosus in Taiwan': 1, 'Patients with systemic lupus erythematosus have abnormally elevated Epstein-Barr virus load in blood': 1, 'A New Perspective': 1, 'Epstein-Barr virus early antigen diffuse (EBV-EA/D)-directed immunoglobulin A antibodies in systemic lupus erythematosus patients': 1, 'Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus': 1, 'Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from Toll-like receptor 3': 1, 'Herpes Simplex Virus in Postmortem Multiple Sclerosis Brain Tissue': 1, 'Microglia-induced IL-6 protects against neuronal loss following HSV-1 infection of neural progenitor cells': 1, 'Epstein-Barr virus in multiple sclerosis: A continuing conundrum': 1, 'Molecular Mimicry by Herpes Simplex Virus-Type 1: Autoimmune Disease After Viral Infection': 1, 'Herpes simplex virus-specific T cells infiltrate the cornea of patients with herpetic stromal keratitis: No evidence for autoreactive T cells': 1, 'Association of cytomegalovirus infection with autoimmune type 1 diabetes': 1, 'Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells': 1, 'Factors That Increase Risk of Celiac Disease Autoimmunity after a Gastrointestinal Infection in Early Life': 1, 'Infections and Autoimmunity-Good or Bad?': 3, 'Infections May Have a Protective Role in the Etiopathogenesis of Celiac Disease': 3, 'Herpesvirus Infections and Transglutaminase Type 2 Antibody Positivity in Childhood: The Generation R Study': 1, 'Ethnic differences in coeliac disease autoimmunity in childhood: The Generation R Study': 1, 'Duodenal Bacteria from Patients With Celiac Disease and Healthy Subjects Distinctly Affect Gluten Breakdown and Immunogenicity': 1, 'Parasitic infection and autoimmunity': 1, 'Association between parasite infection and immune responses in multiple sclerosis': 1, 'The impact of parasite infections on the course of multiple sclerosis': 1, 'Helminth Products Protect against Autoimmunity via Innate Type 2 Cytokines IL-5 and IL-33, Which Promote Eosinophilia': 1, 'Type 1 diabetes and measles, mumps and rubella childhood infections within the Italian Insulin-dependent Diabetes Registry': 1, 'Mumps and Coxsackie B3 Virus Infection of Human Fetal Pancreatic Islet-like Cell Clusters': 1, 'Infection by human cytomegalovirus and rubella virus of cultured human fetal islets of Langerhans': 1, 'Autoimmunity in Guillain-Barré syndrome associated with Zika virus infection and beyond': 1, 'Dengue fever triggering systemic lupus erythematosus and lupus nephritis: A case report': 1, 'Virus infection, antiviral immunity, and autoimmunity': 1, 'Peptide Sharing Between Viruses and DLX Proteins: A Potential Cross-Reactivity Pathway to Neuropsychiatric Disorders': 3, 'NMDA receptor function, memory, and brain aging': 1, 'Understanding Neuropsychiatric Diseases, Analyzing the Peptide Sharing between Infectious Agents and the Language-Associated NMDA 2A Protein': 1, 'The comparative biochemistry of viruses and humans: An evolutionary path towards autoimmunity': 1, 'Enteroviruses, type 1 diabetes and hygiene: A complex relationship': 1, 'Do viral infections protect from or enhance type 1 diabetes and how can we tell the difference?': 1, 'El Registro Civil de 1841-1870, 30 años de provisionalidad': 1, 'La autopsia medico-legal': 1, '¿Firmo el certificado de defunción? Legalidad y ética': 2, 'Catástrofes: conceptos, perfil epidemiológico e introducción a la identificación de víctimas': 1, \"Updating the Accounts: Global Mortality of the 1918-1920 'Spanish' Influenza Pandemic\": 1, 'Un reto para la sociedad madrileña: la epidemia de gripe de 1918-19': 1, 'La gripe española: la pandemia de 1918-1919 Madrid': 1, 'Comunicado del GCCOM sobre las Certificaciones de Defunción en general y en los casos con Covid-19': 1, 'Coronavirus Act -excess death provisions: information and guidance for medical practitioners 31': 1, 'COVID-19: death certification and cremation during the coronavirus pandemic': 1, 'Covid-19: risk factors for severe disease and death': 1, 'COVID-19 coding in ICD-10': 1, 'El número de licencias de enterramiento expedidas por los registros civiles de Castilla-La Mancha en marzo de 2020 aumenta un 96,3 % respecto al mismo mes del año anterior. TSJ Castilla-La Mancha': 1, 'A small round virus associated with enteritis in turkey poults': 2, 'Characterization of two Escherichia coli isolates associated with poult enteritis and mortality syndrome': 2, 'Virus infections of the gastrointestinal tract of poultry': 2, 'Prevalence of enteropathogenic Escherichia coli in naturally occurring cases of poult enteritis-mortality syndrome': 2, 'Pathogenicity of turkey coronavirus in turkeys and chickens': 2, 'Electron microscopic identification of viruses associated with poult enteritis in turkeys grown in California': 1, 'Poult enteritis-mortality syndrome. Pages 1171-1180 in Diseases of Poultry': 1, 'Spiking mortality of turkey poults. 1. Experimental reproduction in isolation facilities': 5, 'Experimental reproduction of a spiking mortality syndrome of turkeys': 4, 'Poult malabsorption syndrome. I. Malabsorption in poult enteritis': 2, 'Comparison of electron microscopy with three commercial tests for the detection of rotavirus in animal feces': 1, 'Veterinary Clinical Parasitology': 1, 'Periodic monitoring of commercial turkeys for enteric viruses indicates continuous presence of astrovirus and rotavirus on the farms': 1, 'Development of an RT-PCR diagnostic test for avian astrovirus': 1, 'Development of a multiplex reverse transcriptionpolymerase chain reaction diagnostic test specific for turkey astrovirus and coronavirus': 1, 'Pathogenesis of type 2 turkey astroviruses with variant capsid genes in 2-day-old specific pathogen free poults': 3, 'Pathogenesis of rotavirus infection in turkey poults': 2, 'Viral agents associated with poult enteritis and mortality syndrome: The role of a small round virus and a turkey coronavirus': 1, 'A novel \"small round virus\" inducing poult enteritis and mortality syndrome and associated immune alterations': 1, 'Identifying agent(s) associated with poult enteritis mortality syndrome: Importance of the thymus': 2, 'Skeletal lesions associated with a naturally occurring poult enteritis': 1, 'High mortality and growth depression experimentally produced in young turkeys by dual infection with enteropathogenic Escherichia coli and turkey coronavirus': 1, 'Effect of combined rotavirus and Escherichia coli in neonatal gnotobiotic calves': 1, 'Cholecalciferol requirements of young turkeys under normal conditions and during recovery from rickets': 1, 'Virus Taxonomy: Classification and Nomenclature of Viruses: Seventh Report of the International Committee on Taxonomy of Viruses': 1, 'The electron microscopical and physical characteristics of small round human fecal viruses: An interim scheme for classification': 1, 'Avian astroviruses': 1, 'Antigenic and genomic characterization of turkey enterovirus-like virus (North Carolina, 1988 isolate): Identification of the virus as turkey astrovirus 2': 1, 'Hemorrhagic enteritis of turkeys': 1, 'Pathogenesis of type II avian adenovirus infection in turkeys: In vivo immune cell tropism and tissue distribution of the virus': 1, 'Pathophysiology of viral diarrhoea. Pages 27-52 in Viral Infections of the Gastrointestinal Tract': 1, 'Rotavirus infection in avian species': 1, 'Isolation and cell culture propagation of rotaviruses from turkeys and chickens': 1, 'Enteric viruses in diarrheic turkey poults': 3, 'Age-related infections with rotavirus, rotaviruslike virus, and atypical rotavirus in turkey flocks': 1, 'Detection of rotaviruses and intestinal lesions in broiler chicks from flocks with runting and stunting syndrome (RSS)': 1, 'Detection of astroviruses in turkey faeces by direct electron microscopy': 1, 'Astrovirus: A cause of an enteric disease in turkey poults': 2, 'Molecular characterization of an avian astrovirus': 2, 'Inactivation of an astrovirus associated with poult enteritis mortality syndrome': 1, 'Astrovirus infections. Pages 320-325 in Diseases of Poultry': 1, 'Astrovirus induces diarrhea in the absence of inflammation and cell death': 1, 'Astrovirus increases epithelial barrier permeability independently of viral replication': 1, 'Astrovirus infection in hatchling turkeys: Alterations in intestinal maltase activity': 1, 'Enteric viral infections of turkey poults: Incidence of infection': 1, 'Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention': 1, 'Taking a ″good″ look at free radicals in the aging process': 1, 'The role of antioxidants in the chemistry of oxidative stress: A review': 1, '2020) Prevalence of comorbidities and its effects in coronavirus disease 2019 patients: A systematic review and meta-analysis': 2, 'Therapeutic Modulation of Virus-Induced Oxidative Stress via the Nrf2-Dependent Antioxidative Pathway': 1, 'Glutathione: overview of its protective roles, measurement, and biosynthesis': 2, 'Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan': 1, 'Vitamin D and L-cysteine levels correlate positively with GSH and negatively with insulin resistance levels in the blood of type 2 diabetic patients': 1, 'Can L-Cysteine and Vitamin D Rescue Vitamin D and Vitamin D Binding Protein Levels in Blood Plasma of African American Type 2 Diabetic Patients?': 1, 'L-cysteine supplementation upregulates glutathione (GSH) and vitamin D binding protein (VDBP) in hepatocytes cultured in high glucose and in vivo in liver, and increases blood levels of GSH, VDBP, and 25-hydroxy-vitamin D in Zucker diabetic fatty rats': 1, 'Glutathione deficiency induces epigenetic alterations of vitamin D metabolism genes in the livers of high-fat diet-fed obese mice': 1, 'Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment': 1, 'Efficacy of glutathione therapy in relieving dyspnea associated with COVID-19 pneumonia: A report of 2 cases': 1, \"Strombeck's small animal gastroenterology\": 2, 'Helicobacter infection in dogs and cats: fact and fiction': 1, 'Gastric function in dogs with naturally acquired Helicobacter spp. infection': 1, 'Occurrence and characterization of gastric Helicobacter spp. in naturally infected dogs': 1, 'Canine gastritis, associated with Helicobacter spp. infection. Buletinul Universitatii de Stiinte Agricole Cluj Napoca Seria Zootehnie si': 1, 'Canine gastritis associated with Helicobacter felis': 1, 'Role of Helicobacter felis in chronic canine gastritis': 2, 'Gastritis in dogs and its therapy': 1, 'Diseases of the canine stomach': 1, 'Canine gastric hyperplasia': 1, 'Duodenogastric reflux in the dog, a clinicopathological study': 1, 'Zollinger-Ellison syndrome and myelofibrosis in a dog': 1, 'Gastritis associated with gastric bacteria in asymptomatic, random source dogs': 1, 'Endoscopic assessment of mucosal hemodynamic changes in a canine model of gastric ulcer': 1, 'Effects of fluoride on structure and function of canine gastric mucosa': 1, 'Development of erosive gastritis in a canine model of esophageal varices': 1, 'Lysolecithin-lipid interactions in disruption of the canine gastric mucosal barrier': 1, 'Effect of local acid-base status on gastric mucosal blood flow and surface cell injury by bile acid': 1, 'Gastric mucosal blood flow in misoprostol pretreated aspirin-induced ulceration': 1, 'Gastric mucosal integrity: gastric mucosal blood flow and microcirculation. An overview': 1, 'Role of mucosal blood flow: a conceptional review in gastric mucosal injury and protection': 1, 'The role of blood flow in gastric mucosal defense, damage and healing': 1, 'The cellular and molecular basis of gastric mucosal defence': 1, 'Present views on restitution of gastrointestinal epithelium': 1, 'Pathways, mediators and mechanisms of gastroduodenal mucosal injury': 1, 'Mechanisms of gastric mucosal injury and protection': 1, 'Inflammatory mediators in gastrointestinal defense and injury': 3, 'Role of oxygen radicals in ischemia-induced lesions in the cat stomach': 1, 'Circulatory mechanisms of gastric mucosal damage and protection': 1, 'Food sensitivity in cats with chronic idiopathic gastrointestinal problems': 1, 'Correlation between Helicobacter pylori infection and food allergy in chronic gastritis': 1, 'Mucosal pathology of the foregut associated with food allergy and recurrent abdominal pains in children': 1, 'Macroscopic picture of gastric mucosa in endoscopic examination of patients with chronic gastritis and food allergy': 1, 'Gastrointestinal syndromes associated with food sensitivity': 1, 'Allergy and the gut': 1, 'Gastrointestinal allergy': 2, 'Awakenings to the pathogenicity of urease and the requirement for continuous long term therapy': 1, 'NSAID toxicity: where are we and how do we go forward?': 1, 'Nonsteroidal anti-inflammatory drug toxicosis in dogs and cats: 240 cases (1989-1990)': 1, 'Effect on gastric secretion, parietal cell populations, and ulcer provocation in the dog': 1, 'Mechanisms of gastric damage by non-steroidal antiinflammatory drugs': 1, 'Gastric mucosal blood flow and neutrophil activation in aspirin-induced gastric mucosal damage in man': 1, 'Effects of flunixin and flunixin plus prednisone on the gastrointestinal tract of dogs': 2, 'Understanding NSAIDs: from aspirin to COX-2': 1, 'Comparison of the upper gastrointestinal effects of etodolac and aspirin in healthy dogs': 1, 'The gastroduodenal effects of buffered aspirin, carprofen, and etodolac in healthy dogs': 1, 'Endoscopy of the gastroduodenal mucosa after carprofen, meloxicam and ketoprofen administration in dogs': 1, 'In vitro effects of nonsteroidal antiinflammatory drugs on cyclooxygenase activity in dogs': 1, 'Evaluation of selective inhibition of canine cyclooxygenase 1 and 2 by carprofen and other nonsteroidal anti-inflammatory drugs': 1, 'Role of cyclooxygenase-2 in gastric mucosal defense': 1, 'One hundred years of NSAID gastropathy: are coxibs the answer?': 1, 'Effects of dexamethasone and surgical hypotension on the stomach of dogs: clinical, endoscopic, and pathologic evaluations': 1, 'Diagnosing emerging bacterial infections: salmonellosis, campylobacteriosis, clostridial toxicosis, and helicobacteriosis': 1, 'Helicobacter pylori virulence and genetic geography': 1, 'Chronic gastritis and Helicobacter pylori': 1, 'Helicobacter salomonis sp. nov., a canine gastric Helicobacter sp. related to Helicobacter felis and Helicobacter bizzozeronii': 1, 'Serological discrimination of dogs infected with gastric Helicobacter spp. and uninfected dogs': 1, 'Prevalence and varieties of Helicobacter species in dogs from random sources and pet dogs: animal and public health implications': 1, 'Helicobacter-like organisms: histopathological examination of gastric biopsies from dogs and cats': 1, 'Comparison of gastric lesions in dogs and cats with and without gastric spiral organisms': 2, 'Gastric function in dogs with naturally acquired gastric Helicobacter spp. infection': 2, 'The treatment of Helicobacter pylori infection in the management of peptic ulcer disease': 1, 'The relationship of Helicobacter spp. infection to gastric disease in dogs and cats': 1, 'Canine parvovirus': 1, 'Influence of thyroid states on stress gastric ulcer formation': 1, 'Stress-induced gastric ulceration: its aetiology and clinical implications': 1, 'Role of epidermal growth factor, prostaglandin, and sulfhydryls in stress-induced gastric lesions': 1, 'Gastric ulceration: critical events at the neutrophil-endothelium interface': 1, 'Gastrointestinal myoelectric activity disturbances in gastric ulcer disease in rats and dogs': 1, 'Gastric neoplasia': 1, 'Infection with the stomach worm Physaloptera as a cause of chronic vomiting in the dog': 1, 'Diseases of the stomach': 1, 'Superior mesenteric artery syndrome: an unusual cause of intestinal obstruction in brain-injured children': 1, 'Intestinal pseudo-obstruction followed by major clinical features of Kawasaki disease: report of one case': 1, 'Bile reflux gastritis': 1, 'Postgastrectomy syndromes': 1, 'Mechanism by which bile salt disrupts the gastric mucosal barrier in the dog': 1, 'Alkaline reflux gastritis. Late results on a controlled trial of diagnosis and treatment': 1, 'The endocrine ulcer concept': 1, 'Canine Zollinger-Ellison syndrome': 1, 'Current veterinary therapy XIII. Philadelphia: WB Saunders': 1, 'Gastric intramucosal acidosis in patients with chronic kidney failure': 1, 'New strategies for the prevention and treatment of Helicobacter pylori infection': 1, 'Gastric mucosal lesions in dogs with acute intervertebral disc disease: characterization and effects of omeprazole or misoprostol': 1, 'Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial': 1, 'Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 -United States': 1, 'Current smoking is not associated with COVID-19': 1, 'Risk factors of critical & mortal COVID-19 cases: a systematic literature review and metaanalysis': 1, 'Use of reninangiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study': 1, 'Position Statement of the ESC Council on hypertension on ACE-inhibitors and angiotensin receptor blockers. 2020': 1, 'Lamina propria lymphocytes: a unique population of mucosal lymphocytes': 2, 'Mansbach CM. 2nd, Nutrient absorption': 1, 'Regionalized immune function of tonsils and adenoids': 1, 'Organization of mucosal lymphoid tissue': 1, 'Mammary lymphoid tissue: a unique component of the mucosal immune system': 1, 'Pulmonary host defenses. Implications for therapy': 1, 'Mucosal immune system of the human genitat tract': 1, 'The indigenous gastrointestinal microflora': 1, 'Intestinal microflora and the interaction with immunocompetent cells': 1, 'The Bcell system of human mucosae and exocrine glands': 1, 'Lymphocyte trafficking and regional immunity': 1, 'T cell and cytokine regulation of the IgA response': 1, 'Effector and regulatory lymphoid cells and cytokines in mucosal sites': 1, 'Membrane traffic in polarized epithelial cells': 1, 'Antibody-mediated protection of mucosal surfaces': 1, 'Current concepts in mucosal immunity. IV. How epithelial transport of IgA antibodies relates to host defense': 1, 'Intestinal IgA: novel views on its function in the defence of the largest mucosal surface': 1, 'Structure and function of human IgA Fc receptors (Fc alpha R)': 1, 'Special features of the intestinal lymphocytic system': 1, 'Intestinal intraepithelial T lymphocytes. Our T cell horizons are expanding': 1, 'Human immunodeficiency virus type 1 and mucosal humoral defense': 1, 'Cells as ports of entry for enteroinvasive pathogens: mechanisms of interaction, consequences for the disease process': 1, 'Immunophenotypage des leucocytes. Clusters de differenciation humains. Application & la caracterisation des h~mopathies': 1, 'Secretory immunity in defense against cariogenic mutans streptococci': 1, 'Helicobacter pylori infection and host cell responses': 1, 'Current concepts of celiac disease pathogenesis': 1, 'Current theories on the causes of inflammatory bowel disease': 1, 'Cells and cytokines in mucosal immunity and inflammation': 1, 'Immunotherapy for food allergies. Past, present, future': 1, 'A rational basis for mucosal vaccination against HIV infection': 1, 'Plants for delivery of edible vaccines': 1, 'Interleukin 12 and innate molecules for enhanced mucosal immunity': 1, 'Relevant targets of ANCA in primary vasculitits : which tests should be used in clinical practice?': 1, 'Nanobioimaging and sensing of infectious diseases': 1, 'Molecular diagnostics of infectious diseases': 1, 'Microarray-based molecular detection of foot-and-mouth disease, vesicular stomatitis and swine vesicular disease viruses, using padlock probes': 1, 'Diagnostic evaluation of multiplexed reverse transcription-PCR microsphere array assay for detection of footand-mouth and look-alike disease viruses': 1, 'Microarray-based detection of viruses causing vesicular or vesicular-like lesions in livestock animals': 1, 'DNA microarrays for virus detection in cases of central nervous system infection': 1, 'Conventional and molecular diagnostic testing for the acute neurologic patient': 1, 'DNA microarray technology for simultaneous detection and species identification of seven human herpes viruses': 3, 'Rapid diagnosis of herpetic encephalitis in children by PCR-microarray technology for simultaneous detection of seven human herpes viruses': 2, 'Diagnosis of neurological herpesvirus infections: real time PCR in cerebral spinal fluid analysis': 1, 'Rapid detection and quantification of Japanese encephalitis virus by real-time reverse transcription loop-mediated isothermal amplification': 1, 'Evaluation of the Cobas 4800 CT NG test for detecting Chlamydia trachomatis and Neisseria gonorrhoeae': 1, 'An oligonucleotide microarray for multiplex real-time PCR identification of HIV-1, HBV, and HCV': 1, 'Direct visual detection of DNA based on the light scattering of silica nanoparticles on a human papillomavirus DNA chip': 2, 'Detection and genotyping of human papillomavirus DNA using polymerase chain reaction short PCR fragment 10-line probe assay in abnormal Papanicolaou-stained cervicovaginal smears': 1, 'Visual DNA microarrays for simultaneous detection of human immunodeficiency virus type-1 and Treponema pallidum coupled with multiplex asymmetric polymerase chain reaction': 1, 'Rapid and simultaneous detection of Ureaplasma parvum and Chlamydia trachomatis antibodies based on visual protein microarray using gold nanoparticles and silver enhancement': 1, 'Viral hemorrhagic fevers': 1, 'Development of single-tube mutiplex RT-PCR for dengue virus typing': 1, 'Comprehensive panel of real-time TaqMan polymerase chain reaction assays for detection and absolute quantification of filoviruses, arenaviruses, and New World hantaviruses': 1, 'Automated multiplex assay system for simultaneous detection of hepatitis B virus DNA, hepatitis C virus RNA, and human immunodeficiency virus type 1 RNA': 1, 'Poor performance of hepatitis C antibody tests in hospital patients in Uganda': 1, 'Simultaneous determination of five-type hepatitis virus antigens in 5 min using an integrated automatic electrochemical immunosensor array': 1, 'Development of an RNA extraction protocol for detection of waterborne viruses by reverse transcriptase quantitative PCR (RT-qPCR)': 1, 'QDs-DNA nanosensor for the detection of hepatitis B virus DNA and the single-base mutants': 1, 'Development of a DNA microarray for detection and serotyping of enterotoxigenic Escherichia coli': 1, 'A novel DNA microarray for rapid diagnosis of enteropathogenic bacteria in stool specimens of patients with diarrhea': 1, 'Simultaneous detection of six human diarrheal pathogens by using DNA microarray combined with tyramide signal amplification': 1, 'Reverse transcription-multiplex PCR assay for simultaneous detection of Escherichia coli O157:H7, Vibrio cholerae O1, and Salmonella typhi': 1, 'Development of a serotype-specific DNA microarray for identification of some Shigella and pathogenic Escherichia coli strains': 1, 'The treatment of HSV1 ocular infections using quantitative real-time PCR results': 1, 'Prevalence and features of keratitis with quantitative polymerase chain reaction positive for cytomegalovirus': 1, 'Performance of a modified HIV-1 p24 antigen assay for early diagnosis of HIV-1 infection in infants and prediction of mother-to-infant transmission of HIV-1 in Dar es Salaam, Tanzania': 1, 'A quick and parallel analytical method based on quantum dots labeling for TORCH-related antibodies': 1, 'Microarray-based genotyping of Salmonella: inter-laboratory evaluation of reproducibility and standardization potential': 1, 'Development of a consensus microarray method for identification of some highly pathogenic viruses': 1, 'Real-time reverse transcription loopmediated isothermal amplification for rapid detection of West Nile virus': 2, 'Rapid detection and differentiation of dengue virus serotypes by a real-time reverse transcription-loop-mediated isothermal amplification assay': 1, 'Real-time detection of virus particles and viral protein expression with two-color nanoparticle probes': 1, 'A multiplex PCR-based reverse line blot hybridization (mPCR RLB) assay for detection of bacterial respiratory pathogens in children with pneumonia': 1, 'Utility of DNA microarrays for detection of viruses in acute respiratory tract infections in children': 2, 'Respiratory viral infections detected by multiplex PCR among pediatric patients with lower respiratory tract infections seen at an urban hospital in Delhi from': 1, 'Rapid diagnosis of H5N1 avian influenza virus infection by newly developed influenza H5 hemagglutinin gene-specific loop-mediated isothermal amplification method': 1, 'The use of Computational Docking to estimate the effects of Montelukast on potential viral main protease catalytic site': 1, \"Montelukast's ability to fight COVID-19 infection\": 1, 'Comparison of single genome and allele 771 frequency data reveals discordant demographic histories': 1, 'The effect of linkage on limits to artificial selection': 1, 'Libsequence: a C++ class library for evolutionary genetic analysis': 1, 'Inferring human population size and separation history from 938 multiple genome sequences': 1, 'Drastic 857 population fluctuations explain the rapid extinction of the passenger pigeon': 1, 'Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding': 13, 'Pangolin homology associated with 2019-nCoV': 1, 'Decoding the evolution and transmissions of the novel pneumonia coronavirus (SARS-CoV-2 / HCoV-19) using whole genomic data': 1, 'The Genome sequence of the SARS-associated coronavirus': 2, 'ACE2: from vasopeptidase to SARS virus receptor': 3, 'Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus': 4, 'The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. bioRxiv': 1, 'Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme': 1, 'ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia': 2, 'Identification of bronchioalveolar stem cells in normal lung and lung cancer': 3, 'MicroRNome analysis unravels the molecular basis of SARS infection in bronchoalveolar stem cells': 1, 'Severe acute respiratory syndrome: clinical outcome and prognostic correlates': 2, 'Lung pathology of fatal severe acute respiratory syndrome': 4, 'Detecting specific cytotoxic T lymphocytes against SARS-coronavirus with DimerX HLA-A2:Ig fusion protein': 2, 'Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges': 3, 'Clinical review: Stem cell therapies for acute lung injury/acute respiratory distress syndrome -hope or hype?': 2, 'Stem cells and repair of lung injuries': 1, 'Lineage-negative progenitors mobilize to regenerate lung epithelium after major injury': 1, 'Establishment and operation of a Good Manufacturing Practice-compliant allogeneic Epstein-Barr virus (EBV)-specific cytotoxic cell bank for the treatment of': 1, 'Enhancing T Cell Receptor Stability in Rejuvenated iPSC-Derived T Cells Improves Their Use in Cancer Immunotherapy': 2, 'Generation of rejuvenated antigen-specific T cells by reprogramming to pluripotency and redifferentiation': 2, 'Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation': 2, 'Fever with thrombocytopenia associated with a novel bunyavirus in China': 4, 'Metagenomic analysis of fever, thrombocytopenia and leukopenia syndrome (FTLS) in Henan Province, China: discovery of a new bunyavirus': 2, 'Hemorrhagic fever caused by a novel Bunyavirus in China: pathogenesis and correlates of fatal outcome': 6, 'Clinical and laboratory findings of a sandfly fever Turkey Virus outbreak in Ankara': 1, 'Hemorrhagic fever with renal syndrome in the Dolenjska region of Slovenia--a 10-year survey': 1, 'The 2007 Rift Valley fever outbreak in Sudan': 3, 'Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy': 2, 'Guideline for prevention and treatment of severe fever with thrombocytopenia syndrome (2010 version)': 1, 'The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination': 2, 'Multiple organ failure. Pathophysiology and potential future therapy': 1, 'Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock': 1, 'Antineuronal Antibodies and Infectious Pathogens in Severe Acute Pediatric Encephalitis': 1, 'Infectious encephalitis in france in 2007: a national prospective study': 1, 'Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation': 1, 'Early diagnosis of novel SFTS bunyavirus infection by quantitative real-time RT-PCR assay': 1, 'Critical epitopes in the nucleocapsid protein of SFTS virus recognized by a panel of SFTS patients derived human monoclonal antibodies': 1, 'Relaxing the rule of ten events per variable in logistic and Cox regression': 1, 'A case of a male presenting with fever, myalgia, leucopenia, thrombocytopenia and acute kidney injury': 2, 'Clinical Progress and Risk Factors for Death in Severe Fever with Thrombocytopenia Syndrome Patients': 2, 'Hemorrhagic fever caused by a novel tick-borne Bunyavirus in Huaiyangshan': 2, 'Sporadic case infected by severe fever with thrombocytopenia syndrome bunyavirus in a nonepidemic region of China': 1, 'Epidemiologic analysis on severe fever with thrombocytopenia syndrome in Hubei province': 1, 'A Family Cluster of Infections by a Newly Recognized Bunyavirus in Eastern China': 2, 'Person-to-Person Transmission of Severe Fever with Thrombocytopenia Syndrome Virus': 1, 'The neglected arboviral infections in mainland China': 1, 'Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited': 1, 'Severity of acute hepatitis and its outcome in patients with dengue fever in a tertiary care hospital Karachi': 1, 'Blood chemistry measurements and D-Dimer levels associated with fatal and nonfatal outcomes in humans infected with Sudan Ebola virus': 1, 'Cytokine and chemokine levels in patients with severe Fever with thrombocytopenia syndrome virus': 2, 'Hemorrhagic Fever Caused by a Novel Bunyavirus in China: Pathogenesis and Correlates of Fatal Outcome': 1, 'Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever': 1, 'Hantavirus pulmonary syndrome due to Andes virus in Temuco, Chile: clinical experience with 16 adults': 1, 'Nephropathia epidemica in Finland: a retrospective study of 126 cases': 1, 'Hyponatremia, convulsions, respiratory arrest, and permanent brain damage after elective surgery in healthy women': 1, 'Postoperative hyponatremic encephalopathy in menstruant women': 1, 'Ionized calcium concentration and outcome in critical illness': 1, 'Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome': 1, 'Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)': 3, 'Economic burden of smoking in Korea': 1, 'Smoking and atherosclerotic cardiovascular disease in men with low levels of serum cholesterol; the Korea Medical Insurance Corporation Study': 1, 'A comparative study of the health care delivery system of Korea and Thailand': 1, 'Antibodyresponse to three recombinant hepatitis B vaccines: comparative evaluation of multicenter travel-clinic based experience': 2, 'Immunogenicity of combined hepatitis A and B vaccine in elderly persons': 2, 'European Consensus Group on Hepatitis B Immunity. Are booster immunizations needed for lifelong hepatitis B immunity': 1, 'Highly conserved protective epitopes on influenza B viruses': 1, 'Vaccine-induced antibodies that neutralize Group 1 and Group 2 Influenza A viruses': 1, 'A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins': 1, 'Antibody recognition of a highly conserved influenza virus epitope': 1, 'Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses': 1, 'Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection': 2, 'A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen': 2, 'Influenza H7N9 virus neuraminidase-specific human monoclonal antibodies inhibit viral egress and protect from lethal influenza infection in mice': 1, 'Structural basis of protection against H7N9 influenza virus by human anti-N9 neuraminidase antibodies': 1, 'A site of vulnerability on the influenza virus hemagglutinin head domain trimer interface': 1, 'Memory B cells that cross-react with group 1 and group 2 influenza A viruses are abundant in adult human repertoires': 1, 'Conserved epitope on influenza-virus hemagglutinin head defined by a vaccine-induced antibody': 1, 'Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation': 6, 'Identification of bacteria using mass spectrometry': 1, 'The rapid identification of intact microorganisms using mass spectrometry': 1, 'Rapid identification of intact whole bacteria based on spectral patterns using matrix-assisted laser desorption/ionization with time-offlight mass spectrometry': 1, 'Compilation of a MALDI-TOF mass spectral database for the rapid screening and characterisation of bacteria implicated in human infectious diseases': 1, 'Microbial fingerprinting using matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) applications and challenges': 1, 'Application and use of various mass spectrometry methods in clinical microbiology': 1, \"Biomedical mass spectrometry in today's and tomorrow's clinical microbiology laboratories\": 1, 'Ibis T5000: a universal biosensor approach for microbiology': 1, 'High-throughput MALDI-TOF discovery of genomic sequence polymorphisms': 1, 'Automated comparative sequence analysis by base-specific cleavage and mass spectrometry for nucleic acid-based microbial typing': 1, 'Comparative DNA sequence analysis and typing using mass spectrometry': 1, 'Molecular genotyping of microbes by multilocus PCR and mass spectrometry: a new tool for hospital infection control and public health surveillance': 1, 'Multiplex detection of human herpes viruses from archival specimens by using matrix-assisted laser desorption ionization-time of flight mass spectrometry': 1, 'Multiplexed flow cytometry immunoassay for influenza virus detection and differentiation': 1, 'Experimental evaluation of the FluChip diagnostic microarray for influenza virus surveillance': 1, 'Mass spectrometry analysis of the influenza virus': 1, 'Rapid and specific influenza virus detection by functionalized magnetic nanoparticles and mass spectrometry': 1, 'Develoment of a multiplex polymerase chain reaction assay for simultaneous identification of human enterovirus 71 and coxsackievirus A16': 1, 'Simultaneous detection and identification of enteric viruses by PCR-mass assay': 1, 'Sensitive and rapid detection of viruses associated with hand foot and mouth disease using multiplexed MALDI-TOF analysis': 1, 'Robust hepatitis B virus genotyping by mass spectrometry': 1, 'Detection of hepatitis B virus YMDD variants using mass spectrometry analysis of oligonucleotide fragments': 2, 'Multiplex detection of 60 hepatitis B virus variants by MALDI-TOF mass spectrometry': 2, 'Dynamics of hepatitis B virus quasispecies heterogeneity in association with nucleos(t)ide analogue treatment determined by MALDI-TOF MS': 1, 'Characterisation of single nucleotide polymorphisms in the genome of JC polyomavirus using MALDI TOF mass spectrometry': 1, 'Early detection of influenza A (H5) viruses with affinity for the human sialic acid receptor by MALDI-TOF mass spectrometry based mutation detection': 1, 'Sensitive and rapid detection of ganciclovir resistance by PCR based MALDI-TOF analysis': 1, 'Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry': 1, 'Comparison of two matrix-assisted laser desorption ionization-time of flight mass spectrometry methods with conventional phenotypic identification for routine identification of bacteria to the species level': 1, 'Proteomics for routine identification of microorganisms': 1, 'Sistema Nacional de Vigilancia Epidemiológica': 1, 'Is There Still Room for Novel Viral Pathogens in Pediatric Respiratory Tract Infections?': 1, 'The Geographic Structure of Viruses in the Cuatro Ciénegas Basin, a Unique Oasis in Northern Mexico, Reveals a Highly Diverse Population on a Small Geographic Scale': 1, 'Electrochemical Methods. 2 edn': 1, 'Electrochemical and chemical synthesis of different types of sulfonamide derivatives of N,Ndimethyl-1,4-benzenediamine using 4-nitroso-N,N-dimethylaniline': 1, 'Electrochemical synthesis of sulfonamide derivatives based on the oxidation of 2,5-diethoxy-4-morpholinoaniline in the presence of arylsulfinic acids': 1, \"Product diversity by changing the electrode potential. Synthesis, kinetic evaluation and antibacterial activity of arylsulfonyl-4,4'-biphenol and bis-arylsulfonyl-4,4'-biphenol derivatives\": 1, 'Electrochemical synthesis of 1-N-phenyl-4-(sulfonyl)benzene-1,2-diamine derivatives. A mild and regioselective protocol': 1, 'Electrochemical behavior of 2-aminodiphenylamine and efficient factors on the site-selectivity of sulfonylation reaction: Experimental and theoretical studies': 1, 'Unsymmetrical diaryl sulfones through electrochemical oxidation of fast violet b in the presence of aryl sulfinic acids': 1, 'ChemBioDraw Ultra 12.0, Cambridgesoft': 1, 'Catalytic enantioselective dihalogenation and the selective synthesis of (−)-deschloromytilipin A and (−)-danicalipin A': 1, 'Electrochemical oxidation of some dihydroxybenzene derivatives in the presence of indole': 1, 'Real estimates of mortality following COVID-19 infection': 2, 'Coronavirus Disease 2019 (COVID-19): Protecting Hospitals From the Invisible. Ann Intern Medm': 1, 'Coronavirus Disease 2019 (COVID-19): What we know': 1, 'Diagnostic Testing for the Novel Coronavirus': 2, 'Chest CT for Typical 2019-nCoV Pneumonia: Relationship to Negative RT-PCR Testing. Radiology, in press': 2, 'The transmission and diagnosis of 2019 novel coronavirus infection disease (COVID-19): A Chinese perspective': 2, 'Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes': 3, 'World Health Organization. Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases': 2, 'CT Features of Coronavirus Disease 2019 (COVID-19) Pneumonia in 62 Patients in Wuhan, China': 2, 'COVID-19): A Perspective from China. Radiology, in press': 1, 'Early Clinical and CT Manifestations of Coronavirus Disease 2019 (COVID-19) Pneumonia': 1, 'Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review': 3, 'Imaging Features of Coronavirus disease 2019 (COVID-19): Evaluation on Thin-Section CT': 1, 'Interrater reliability: the kappa statistic': 1, 'COVID-19 Standardized Reporting\" Working Group of the Dutch Radiological Society. CO-RADS -A categorical CT assessment scheme for patients with suspected COVID-19: definition and evaluation': 1, 'Temporal Changes of CT Findings in 90 Patients with COVID-19 Pneumonia: A Longitudinal Study': 1, 'International Diabetes Federation. IDF Diabetes Atlas-7th Edition': 1, 'Executive summary: standards of medical care in diabetes-2012': 1, 'Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)': 1, 'Initial combination therapy for type 2 diabetes mellitus: is it ready for prime time?': 1, 'Standards of medical care in diabetes-2016: summary of revisions': 1, 'Consensus Recommendations on GLP-1 RA Use in the Management of Type 2 Diabetes Mellitus: South Asian Task Force': 1, 'Bone loss in diabetes: use of antidiabetic thiazolidinediones and secondary osteoporosis': 2, 'RSSDI clinical practice recommendations for the management of type 2 diabetes mellitus 2017': 1, 'The effectiveness of hydroxychloroquine in patients with type 2 diabetes mellitus who are refractory to sulfonylureas-a randomized trial': 1, 'Efficacy and safety of hydroxychloroquine in the treatment of type 2 diabetes mellitus: a double blind, randomized comparison with pioglitazone': 4, 'Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy': 1, 'Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision)': 1, 'Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)': 1, 'Sitagliptin: a novel drug for the treatment of type 2 diabetes': 1, 'Insulin-sparing effect of hydroxychloroquine in diabetic rat is concentration dependent': 1, 'Inhibition of insulin metabolism by hydroxychloroquine and its enantiomers in cytosolic fraction of liver homogenates from healthy and diabetic rats': 1, 'C-reactive protein, interleukin-6, and risk of developing type-2 diabetes mellitus': 1, 'Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients': 1, 'Antidiabetogenic effects of hydroxychloroquine on insulin sensitivity and beta cell function: a randomised trial': 1, 'Changes in glycated hemoglobin after initiation of hydroxychloroquine or methotrexate in diabetic patients with rheumatic diseases': 1, 'Hydroxychloroquine improves insulin sensitivity in obese non-diabetic individuals': 1, 'Effect of hydroxychloroquine on type 2 diabetes mellitus unresponsive to more than two oral antidiabetic agents': 1, 'Efficacy and safety of substituting teneligliptin with hydroxychloroquine in inadequately controlled type 2 diabetes subjects with combination therapy of teneligliptin, metformin and glimepiride with or without other antidiabetic therapy: The TENE-HYQ SHIFT Study': 1, 'Efficacy of maximum and optimum doses of hydroxychloroquine added to patients with poorly controlled type 2 diabetes on stable insulin therapy along with glimepiride and metformin: association of high-sensitive c-reactive protein (hs-crp) and glycosylated haemoglobin (HbA1c)': 1, 'Real-world clinical effectiveness and tolerability of /hydroxychloroquine 400 mg in uncontrolled type 2 diabetes subjects who are not willing to initiate insulin therapy (HYQ-Real-World Study)': 1, 'Hydroxychloroquine in decompensated, treatment-refractory noninsulin-dependent diabetes mellitus: a new job for an old drug': 1, 'Hydroxychloroquine reduces heart rate by modulating the hyperpolarization-activated current If: Novel electrophysiological insights and therapeutic potential': 1, 'Type 2-diabetes is associated with elevated levels of TNF-alpha, IL-6 and adiponectin and low levels of leptin in a population of Mexican Americans: a cross-sectional study': 1, 'Chloroquine and hydroxychloroquine for COVID-19: implications for cardiac safety': 1, 'Hydroxychloroquine use is associated with decreased incident cardiovascular events in rheumatoid arthritis patients': 2, 'Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine': 2, 'Hydroxychloroquine use associated with improvement in lipid profiles in rheumatoid arthritis patients': 1, 'Associations of hydroxychloroquine use with lipid profiles in rheumatoid arthritis: pharmacologic implications': 1, 'Efficacy and safety of fixed dose combination of atorvastatin and hydroxychloroquine: a randomized, double-blind comparison with atorvastatin alone among Indian patients with dyslipidemia': 1, 'Prophylaxis of deep venous thrombosis by hydroxychloroquine sulfate and heparin': 1, 'Prevention of postoperative deep venous thrombosis in legs by orally administered hydroxychloroquine sulphate': 1, 'Hydroxychloroquine sulphate in prevention of deep venous thrombosis following fracture of the hip, pelvis, or thoracolumbar spine': 1, 'Use of hydroxychloroquine to prevent thrombosis in systemic lupus erythematosus and in antiphospholipid antibody-positive patients': 1, 'Hydroxychloroquine reduces heart rate by modulating the hyperpolarization-activated current I f : Novel electrophysiological insights and therapeutic potential': 1, 'Covid-19 in critically Ill patients in the Seattle region -case series': 2, 'Incidence of blindness in a population of rheumatic patients treated with hydroxychloroquine': 1, 'Comorbidity and it is impact on 1590 patients with Covid-19 in China: a Nationwide Analysis': 1, 'Diabetes is a risk factor for the progression and prognosis of COVID-19': 1, 'Prevalence and impact of diabetes among people infected with SARS-C0v-2': 1, 'Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia -a systematic review, meta-analysis, and metaregression': 1, 'Endocrine and metabolic link to coronavirus infection': 1, 'COVID-19 pandemic, Corona Viruses, and diabetes mellitus': 1, '2020) Coronavirus infections and type 2 diabetesshared pathways with therapeutic implications': 1, 'Antihyperglycemic properties of hydroxychloroquine in patients with diabetes: risk and benefits at the time of COVID-19 pandemic': 1, 'COVID-19 and diabetes management: what should be considered?': 1, 'Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?': 1, 'Chloroquine or hydroxychloroquine in the treatment of COVID-19 with or without diabetes: a systematic search and a narrative review with special reference to India and other developing countries': 1, 'Role of adjunctive treatment strategies in COVID-19 and a review of International and national clinical guidelines': 1, 'condition or disease\": COVID \"other terms\" hydroxychloroquine). Accessed': 2, 'National consumption of antimalarial drugs and covid-19 deaths dynamics: can ecological study': 1, 'Lombardy Section Italian Society Infectious And Tropical Diseases (2020) Vademecum for the treatment of people with COVID-19': 1, 'Bench-to-bedside review: Rhabdomyolysis -an overview for clinicians': 1, 'Rhabdomyolysis: A review': 1, 'Current epidemiological and clinical features of COVID-19; a global perspective from': 1, 'Extrapulmonary manifestations of COVID-19: Radiologic and clinical overview': 1, 'Rhabdomyolysis: A review of the literature': 1, 'Acute renal failure due to rhabdomyolysis associated with echovirus 9 infection: A case report and review of literature': 1, 'Severe rhabdomyolysis and acute renal failure following recent coxsackie B virus infection': 1, 'Rhabdomyolysis complicating acute Epstein Barr virus infection': 1, 'Viral rhabdomyolysis': 1, 'Rhabdomyolysis in Ebola virus disease. Results of an observational study in a treatment center in Guinea': 1, 'Rhabdomyolysis as potential late complication associated with COVID-19': 1, 'Rhabdomyolysis as a presentation of 2019 novel coronavirus disease': 1, 'Rhabdomyolysis associated with dengue virus infection': 1, 'Tumor necrosis factor and coxsackie B4 rhabdomyolysis': 1, 'The syndrome of rhabdomyolysis: Pathophysiology and diagnosis': 1, 'Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus -infected pneumonia in Wuhan, China': 1, 'Rhabdomyolysis: Historical background, clinical, diagnostic and therapeutic features': 1, 'Rhabdomyolysis: Pathogenesis of renal injury and management': 1, 'Rhabdomyolysis: an evaluation of 475 hospitalized patients': 2, 'Liver aminotransferases are elevated with rhabdomyolysis in the absence of significant liver injury': 1, 'Rhabdomyolysis and acute kidney injury': 3, 'Clinical role of lung ultrasound for the diagnosis and monitoring of COVID-19 pneumonia in pregnant women': 1, 'Clinical application of Lung Ultrasound for the management of pregnant women with suspicion of COVID-19: a review of literature': 1, 'COVID-19 outbreak: less stethoscope, more ultrasound': 1, 'How to perform lung ultrasound in pregnant women with suspected COVID-19 infection': 1, 'From the Centres for Disease Control and Prevention. Update: outbreak of severe acute respiratory syndrome -worldwide 2003': 1, 'Clinical course and management of SARS in health care workers in Toronto: a case series': 1, 'Severe Acute Respiratory Syndrome (SARS) -multi-country outbreak -update': 1, 'A cluster of cases of severe acute respiratory syndrome in Hong Kong': 7, 'SARS: health care work can be hazardous to health': 1, 'Advisors of Expert SARS group of Hospital Authority. Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS)': 1, 'SARS coronavirus: a new challenge for prevention and therapy': 3, 'World Health Organization Multicentre Collaborative Network for Severe Acute Respiratory Syndrome Diagnosis. A multicentre collaboration to investigate the cause of severe acute respiratory syndrome': 1, 'Investigations continue as SARS claims more lives': 1, 'Three cases reported but no link to outbreak of atypical pneumonia established yet (Press release). Ministry of Health': 1, 'Update on SARS (Press release)': 1, 'Hiding in the bunker: challenges for a radiation oncology department operating in the Severe Acute Respiratory Syndrome outbreak': 1, \"Prime Minister's Goh Chok Tong's Address. Fighting SARS together (Press release)\": 1, \"Singapore is off WHO's SARS list (Press release)\": 1, 'Responsibility of Health Care Institutions. Ministry of Health': 1, \"Patients' perceptions of care: measurement of quality and satisfaction\": 1, \"Physicians' attitudes toward using patient reports to assess quality of care\": 2, 'What do patients think about during their consultations? A qualitative study': 2, \"Patients' ratings of outpatient visits in different practice settings: Results from the medical outcomes study\": 2, 'Patient satisfaction with health care: intentions and change in plan': 1, 'Behavioural consequences of consumer dissatisfaction with medical care': 1, 'Development and testing of a visit-specific patient satisfaction questionnaire: the Princess Margaret Hospital Satisfaction With Doctor Questionnaire': 2, 'Improving interpretation of clinical studies by use of confidence levels, clinical significance curves, and risk-benefit contours': 1, \"Shakespeare's Confidence Calculator v1.0. [downloadable software; cited\": 1, 'Physician conduct and other factors that affect consumer satisfaction with medical care': 1, 'The relationship of patient satisfaction with care and clinical outcomes': 1, 'South Korean MERS outbreak spotlights lack of research': 1, 'A new virus isolated from the human respiratory tract': 2, 'Fatal outcome of human coronavirus NL63 infection despite successful viral elimination by IFN-alpha in a patient with newly diagnosed ALL': 1, 'Characterization of human coronavirus OC43 and human coronavirus NL63 infections among hospitalized children < 5 years of age': 1, 'Enterovirus D68. A focused review and clinical highlights from the': 1, 'Intricacies of cardiac damage in coxsackievirus B3 infection: implications for therapy': 1, 'Rhinovirus-induced asthma exacerbations and risk populations': 1, 'A novel outbreak enterovirus D68 strain associated with acute flaccid myelitis cases in the USA (2012−14): a retrospective cohort study': 1, 'Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease': 1, 'The distribution of inflammation and virus in human enterovirus 71 encephalomyelitis suggests possible viral spread by neural pathways': 1, 'Cysteine proteases of positive strand RNA viruses and chymotrypsin-like serine proteases. A distinct protein superfamily with a common structural fold': 1, 'Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra alpha-helical domain': 8, 'Phase II, randomized, double-blind, placebo-controlled studies of rupintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers': 1, 'Reversal of the progression of fatal coronavirus infection in cats by a broad-spectrum coronavirus protease inhibitor': 1, '3C protease of enterovirus 68: structurebased design of Michael acceptor inhibitors and their broad-spectrum antiviral effects against picornaviruses': 4, 'A Gquadruplex-binding macrodomain within the ″SARS-unique domain″ is essential for the activity of the SARS-coronavirus replicationtranscription complex': 2, 'Coronavirus main proteinase (3CL pro ) structure: basis for design of anti-SARS drugs': 2, 'Enterovirus 71 and Coxsackievirus A16 3C proteases: binding to rupintrivir and their substrates and antihand, foot, and mouth disease virus drug design': 3, 'Hilgenfeld, R. pH-dependent conformational flexibility of the SARS-CoV main proteinase M pro dimer: molecular dynamics simulations and multiple X-ray structure analyses': 1, 'Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease': 3, 'The molecular basis of drug resistance against hepatitis C virus NS3/4A protease inhibitors': 1, 'Discovery of (1R,5S)-N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl': 1, 'Potent inhibition of norovirus 3CL protease by peptidyl alphaketoamides and alpha-ketoheterocycles': 1, 'Synthesis and structure-activity relationship of alpha-keto amides as enterovirus 71 3C protease inhibitors': 1, 'Potent inhibition of enterovirus D68 and human rhinoviruses by dipeptidyl aldehydes and alpha-ketoamides': 1, 'Broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, noroviruses, and coronaviruses': 2, 'Design, synthesis, and bioevaluation of viral 3C and 3C-like protease inhibitors': 1, 'Structural basis of inhibition specificities of 3C and 3C-like proteases by zinc-coordinating and peptidomimetic compounds': 2, 'Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor': 1, 'Production of authentic SARS-CoV M(pro) with enhanced activity: application as a novel tag-cleavage endopeptidase for protein overproduction': 1, 'A structural view of the inactivation of the SARS coronavirus main proteinase by benzotriazole esters': 2, 'Overview of the CCP4 suite and current developments': 3, 'Molecular replacement with MOLREP': 1, 'JLigand: a graphical tool for the CCP4 template-restraint library': 1, 'Features and development of Coot': 2, 'MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-alpha treatment': 4, 'Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex': 4, 'Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by nonimmunosuppressive cyclosporine A-derivatives including Alisporivir': 1, 'Situation Report -51. (World Health Organization': 1, \"Seasonality of infectious diseases and severe acute respiratory syndromewhat we don't know can hurt us\": 1, 'Global patterns in monthly activity of influenza virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus: a systematic analysis': 1, 'Preliminary evidence that higher temperatures are associated with lower incidence of COVID-19, for cases reported globally up to 29th': 2, 'Association between ambient temperature and COVID-19 infection in 122 cities from China': 2, 'Effects of temperature variation and humidity on the mortality of COVID-19 in Wuhan': 1, 'Effects of temperature on COVID-19 transmission. medRxiv': 1, 'The impact of temperature and absolute humidity on the coronavirus disease 2019 (COVID-19) outbreak -evidence from China. medRxiv': 1, 'The role of absolute humidity on transmission rates of the COVID-19 outbreak. medRxiv': 2, 'Temperature significant change COVID-19 Transmission in 429 cities. medRxiv': 3, 'Spread of SARS-CoV-2 Coronavirus likely constrained by climate. medRxiv': 1, 'High Temperature and High Humidity Reduce the Transmission of COVID-19': 1, 'A practical information-theoretic approach. Model selection and multimodel inference': 2, 'Mixed effects models and extensions in ecology with R': 1, 'Core Team (2019) nlme: linear and nonlinear mixed effects models': 1, 'Pulmonary dysfunction in pediatric hematopoietic stem cell transplant patients: overview, diagnostic considerations, and infectious complications': 2, 'Pulmonary complications after bone marrow transplantation in children: twenty-four years of experience in a single pediatric center': 3, 'Natural history of pulmonary complications in children after bone marrow transplantation': 1, 'Utility of bronchoalveolar lavage in the diagnosis of pulmonary infection in children with haematological malignancies': 5, 'Utility of bronchoalveolar lavage in immunocompromised children: diagnostic yield and complications': 2, 'Fiberoptic bronchoscopy and bronchoalveolar lavage for the evaluation of pulmonary disease in children with primary immunodeficiency and cancer': 2, 'Flexible bronchoscopy and bronchoalveolar lavage in pediatric patients with lung disease': 1, 'Clinical utility of bronchoalveolar lavage in pediatric cancer patients': 2, 'Evaluation of persistent pulmonary infiltrates in pediatric oncology patients': 2, 'Diagnostic yield of bronchoalveolar lavage is low in allogeneic hematopoietic stem cell recipients receiving immunosuppressive therapy or with acute graft-versus-host disease: the St': 2, 'Diagnosis of invasive pulmonary aspergillosis in children with bronchoalveolar lavage galactomannan': 1, 'Yield of bronchoalveolar lavage in ventilated and non-ventilated children after bone marrow transplantation': 1, 'Fiberoptic bronchoscopy and bronchoalveolar lavage for the evaluation of pulmonary infiltrates after BMT in children': 1, 'Prophylaxis of pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials': 1, 'Paediatric interstitial lung disease: classification and definitions': 1, 'Pulmonary infections diagnosed by BAL: a 12-year experience in 1066 immunocompromised patients': 1, 'Bronchoscopy with bronchoalveolar lavage in the evaluation of pulmonary complications of bone marrow transplantation in children': 1, 'Clinical utility of bronchoalveolar lavage and respiratory tract biopsies in diagnosis and management of suspected invasive respiratory fungal infections in children': 2, 'Bronchoalveolar lavage and lung biopsy in patients with cancer and hematopoietic stem-cell transplantation recipients: a systematic review and meta-analysis': 1, 'A comparison of bronchoalveolar lavage versus lung biopsy in pediatric recipients after stem cell transplantation': 1, 'Physical interventions to interrupt or reduce the spread of respiratory viruses: Systematic review': 1, 'Face masks, respirators might help during pandemic fl u outbreak': 1, 'Plague vaccines': 1, 'Disease and destiny-mystery and mastery': 1, 'Smallpox and vaccinia': 1, 'Bioterrorism and smallpox planning: Information and voluntary vaccination': 1, 'Updating the accounts: Global mortality of the 1918-1920 \"Spanish\" in fl uenza pandemic': 1, 'Ethics and infectious disease': 1, 'WHO estimates of the causes of death in children': 2, 'Virology: Molecular biology and pathogenesis': 1, 'Impact of regional climate change on human health': 1, 'Global trends in emerging infectious diseases': 3, 'Institutes of medicine: The threat of pandemic in fl uenza: Are we ready?': 1, 'Historical comparisons of morbidity and mortality for vaccinepreventable diseases in the United States': 1, 'The looming threat of bioterrorism': 1, 'Smallpox revisited?': 1, 'Costing infectious disease outbreaks for economic evaluation: A review for hepatitis A': 1, \"Society's failure to protect a precious resource\": 1, 'Antibiotic-resistant bugs in the 21st century -A clinical superchallenge': 1, 'Transmission of measles (Online) Available': 1, 'Belgian parents are sentenced to prison for not vaccinating children': 1, 'Intimidation, coercion and resistance in the fi nal stages of the South Asian smallpox eradication campaign 1973-1975': 1, 'HIV man guilty of infecting lovers (Online)': 1, 'Celstraf voor Opzettelijke Hiv-besmetting (Online': 1, 'Immunization, equity, and human rights': 1, 'Obligatory precautions against infection': 3, 'Infectious disease. Polio eradication effort adds new weapon to its armory': 1, 'Is there a moral obligation not to infect others?': 2, 'What are the moral obligations of the traveller in relation to vaccination?': 1, 'Bezwaren tegen Vaccinaties: Het Perspectief van de Weigeraar . Bithoven: Rijksinstituut voor Volksgezondheid en Milieu': 1, 'The moral justi fi cation for a compulsory human papillomavirus vaccination program': 1, 'Vaccines against drugs of abuse: A viable treatment option?': 1, 'The principles of disease elimination and eradication': 1, 'Freedom and resentment': 1, 'Famine, af fl uence, and morality': 1, 'Zika virus. I. Isolations and serological specificity': 1, 'Lipophilic statins inhibit Zika virus production in Vero cells': 1, 'Full-length sequencing and genomic characterization of Bagaza, Kedougou, and Zika viruses': 1, 'Antiviral activity of pinocembrin against Zika virus replication': 1, 'Outcomes of congenital Zika disease depend on timing of infection and maternal-fetal interferon action': 1, 'Zika virus infection in pregnancy: a systematic review of disease course and complications': 1, 'Zika virus infections imported to Italy: clinical, immunological and virological findings, and public health implications': 1, 'Zika virus in Brazil and macular atrophy in a child with microcephaly': 1, 'Zika virus infection: global update on epidemiology and potentially associated clinical manifestations': 1, 'Natural products isolated from oriental medicinal herbs inactivate Zika virus': 1, 'Homoharringtonine and omacetaxine for myeloid hematological malignancies': 1, 'Effect of cantharidin, cephalotaxine and homoharringtonine on \"in vitro\" models of hepatitis B virus (HBV) and bovine viral diarrhoea virus (BVDV) replication': 6, 'Cephalotaxus alkaloids': 1, 'Molecular modes of action of cephalotaxine and homoharringtonine from the coniferous tree Cephalotaxus hainanensis in human tumor cell lines': 2, 'Anti-varicella-zoster virus activity of cephalotaxine esters in vitro': 4, 'Micafungin is a novel anti-viral agent of chikungunya virus through multiple mechanisms': 2, 'Palmatine inhibits Zika virus infection by disrupting virus binding, entry, and stability': 5, 'Synergistic effects of combination treatment using EGCG and suramin against the chikungunya virus': 1, 'Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay': 1, 'Zika virus: quantification, propagation, detection, and storage': 1, 'Inhibition of translation in eukaryotic systems by harringtonine': 2, 'Inhibition of chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expression': 3, 'Identification of inhibitory compounds against Singapore grouper iridovirus infection by cell viability-based screening assay and droplet digital PCR': 1, 'A screen of the NIH Clinical Collection small molecule library identifies potential anti-coronavirus drugs': 1, 'Harringtonine, an inhibitor of initiation of protein biosynthesis': 1, 'Homoharringtonine: an effective new natural product in cancer chemotherapy': 1, 'Stroke incidence and prevalence in Europe: a review of available data': 1, 'Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials': 1, 'Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the': 1, 'Seasonal variations in neurological severity and outcomes of ischemic stroke: 5-year singlecenter observational study': 2, 'WHO declares COVID-19 a pandemic': 1, 'Covid-19 -Navigating the uncharted': 1, 'Covid-19: doctors are told not to perform CPR on patients in cardiac arrest': 1, 'Situación COVID-19 en España': 1, 'Likely increase in the risk of death or disability from stroke during the COVID-19 pandemic. European Stroke Organization': 1, 'Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: A Retrospective Case Series Study': 1, 'Neurological manifestations of the coronavirus (SARS-CoV-2) pandemic 2019-2020': 1, 'Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19': 1, 'EXPRESS: COVID-19 and Stroke -A Global World Stroke Organisation perspective': 1, 'Global burden of stroke and risk factors in 188 countries, during 1990-2013: a systematic analysis for the Global Burden of Disease Study': 1, 'Resultados provisionales a 30 de abril de 2020 para las 26 principales ciudades. Propuestas para una desescalada con aire limpio. Madrid: Ecologistas en acción': 1, 'Seasonality of stroke in Finland': 1, 'Stroke seasonality associations with subtype, etiology and laboratory results in the Ludwigshafen stroke study (LuSSt)': 1, 'Acute Cerebrovascular Disease Following COVID-19: A Single Center, Retrospective, Observational Study': 1, 'The coronavirus nucleocapsid protein is 851 ADP-ribosylated': 1, 'DGHO. Coronavirus-Infektion (COVID-19) bei Patienten mit Blut-und Krebserkrankungen': 1, 'Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal': 1, 'A War on Two Fronts: Cancer Care in the Time of COV-ID-19': 1, 'International Myeloma Society Recommendations for the Management of Myeloma Patients during the COVID-19 Pandemic Examples': 1, \"COVID-19: Global radiation oncology's targeted response for pandemic preparedness\": 1, 'Guidance on the Management of Clinical Trials during the COVID-19 (Coronavirus) pandemic': 1, 'Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol': 1, 'WHO Coronavirus Disease (COVID-19) Dashboard': 1, 'The natural history of progressive fibrosing interstitial lung diseases': 1, 'Pulmonary fibrosis secondary to COVID-19: a call to arms': 1, 'Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic': 1, 'Factors Associated With Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus Disease': 1, 'Salmonella: a model for bacterial pathogenesis': 1, 'Of mice, calves, and men. Comparison of the mouse typhoid model with other Salmonella infections': 1, 'Animal models of Salmonella infections: enteritis versus typhoid fever': 1, \"Salmonella typhimurium initiates murine infection by penetrating and destroying the specialized epithelial M cells of the Peyer's patches\": 1, 'Cell tropism of Salmonella enterica': 1, 'Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria': 4, 'Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol': 2, 'Assembly and function of type III secretory systems': 2, 'Topology and organization of the Salmonella typhimurium type III secretion needle complex components': 1, 'Protein delivery into eukaryotic cells by type III secretion machines': 1, 'Type III protein secretion mechanism in mammalian and plant pathogens': 1, 'Salmonella interactions with host cells: type III secretion at work': 1, 'Salmonella pathogenicity islands encoding type III secretion systems': 1, 'Salmonella pathogenicity island 2': 1, 'The invasion-associated type III secretion system of Salmonella enterica serovar Typhimurium is necessary for intracellular proliferation and vacuole biogenesis in epithelial cells': 1, 'Functions and effectors of the Salmonella pathogenicity island 2 type III secretion system': 1, 'Cytoskeletal rearrangements accompanying Salmonella entry into epithelial cells': 2, 'Ruffles induced by Salmonella and other stimuli direct macropinocytosis of bacteria': 1, 'Requirement of CDC42 for Salmonella-induced cytoskeletal and nuclear responses': 1, 'typhimurium encodes an activator of Rho GTPases that induces membrane ruffling and nuclear responses in host cells': 1, 'Salmonellacontaining vacuoles: directing traffic and nesting to grow': 1, 'Maturation steps of the Salmonellacontaining vacuole': 1, 'Taking possession: biogenesis of the Salmonella-containing vacuole': 1, 'Membrane dynamics and spatial distribution of Salmonella-containing vacuoles': 1, 'The Salmonella-containing vacuole: moving with the times': 1, 'Biogenesis of Salmonella typhimuriumcontaining vacuoles in epithelial cells involves interactions with the early endocytic pathway': 1, 'Functional dissection of SseF, a type III effector protein involved in positioning the Salmonella-containing vacuole': 1, 'The translocated Salmonella effector proteins SseF and SseG interact and are required to establish an intracellular replication niche': 2, 'SseG, a virulence protein that targets Salmonella to the Golgi network': 4, 'The SPI-2 type III secretion system restricts motility of Salmonella-containing vacuoles': 1, 'Intracellular Salmonella enterica redirect exocytic transport processes in a Salmonella pathogenicity island 2-dependent manner': 1, 'Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics': 3, 'Identification of host factors involved in coronavirus replication by quantitative proteomics analysis': 7, 'Salmonella maintains the integrity of its intracellular vacuole through the action of SifA': 1, 'Reconstitution of the transport of protein between successive compartments of the Golgi measured by the coupled incorporation of N-acetylglucosamine': 3, 'Evidence for segregation of sphingomyelin and cholesterol during formation of COPI-coated vesicles': 4, 'Sphingomyelin-enriched microdomains at the Golgi complex': 3, 'A major transmembrane protein of Golgi-derived COPI-coated vesicles involved in coatomer binding': 1, 'Mass spectrometric analysis of the Schistosoma mansoni tegumental sub-proteome': 1, 'The International Protein Index: an integrated database for proteomics experiments': 1, 'Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999': 1, 'A novel proteomic screen for peptide-protein interactions': 2, 'StatQuant: a post-quantification analysis toolbox for improving quantitative mass spectrometry': 2, 'Infection of epithelial cells with Salmonella enterica': 1, 'PANTHER: a library of protein families and subfamilies indexed by function': 1, 'Effector proteins encoded by Salmonella pathogenicity island 2 interfere with the microtubule cytoskeleton after translocation into host cells': 1, 'Remodelling of the actin cytoskeleton is essential for replication of intravacuolar Salmonella': 1, 'Salmonella effectors translocated across the vacuolar membrane interact with the actin cytoskeleton': 1, 'Peroxiredoxin 6, a 1-Cys peroxiredoxin, functions in antioxidant defense and lung phospholipid metabolism. Free Radic': 1, 'Lung phospholipid metabolism in transgenic mice overexpressing peroxiredoxin 6': 1, 'Cloning and expression of rat lung acidic Ca(21)-independent PLA2 and its organ distribution': 1, 'Identification of a human cDNA clone for lysosomal type Ca 21 -independent phospholipase A2 and properties of the expressed protein': 2, 'Peroxiredoxin 6 phosphorylation and subsequent phospholipase A2 activity are required for agonist-mediated activation of NADPH oxidase in mouse pulmonary microvascular endothelium and alveolar macrophages': 1, 'The hemidesmosomal protein bullous pemphigoid antigen 1 and the integrin beta 4 subunit bind to ERBIN. Molecular cloning of multiple alternative splice variants of ERBIN and analysis of their tissue expression': 1, \"LAP proteins: what's up with epithelia?\": 1, 'Role for erbin in bacterial activation of Nod2': 2, 'Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection': 1, 'Membrane recruitment of NOD2 in intestinal epithelial cells is essential for nuclear factor-kappaB activation in muramyl dipeptide recognition': 1, 'A role for Erbin in the regulation of Nod2-dependent NF-kappaB signaling': 1, 'Identification and characterization of a novel Tre-2/Bub2/Cdc16 (TBC) protein that possesses Rab3A-GAP activity': 1, 'A network of Rab GTPases controls phagosome maturation and is modulated by Salmonella enterica serovar Typhimurium': 2, 'Association of stomatin with lipid-protein complexes in the plasma membrane and the endocytic compartment': 1, 'Isolation and partial characterization of the human erythrocyte band 7 integral membrane protein': 1, 'Purification of band 7.2b, a 31-kDa integral phosphoprotein absent in hereditary stomatocytosis': 1, 'Stomatin: A putative cation transport regulator in the red cell membrane': 1, 'Isolation of cDNA coding for an ubiquitous membrane protein deficient in high Na1, low K1stomato-cytic erythrocytes': 1, 'Association of stomatin with lipid bodies': 1, 'Esterification of cholesterol by a type III secretion effector during intracellular Salmonella infection': 1, 'Higher PEEP improves outcomes in ARDS patients with clinically objective positive oxygenation response to PEEP: a systematic review and meta-analysis': 1, 'Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network': 1, 'Emergence of SARS-like coronavirus poses new challenge in China': 2, 'Rolling Updates on Coronavirus Disease (COVID-19)': 3, 'Overview of COVID-19 Surveillance': 2, 'Understanding Markov Chains': 2, 'Baseline Sensitivity of Fusarium virguliforme to Fluopyram Fungicide': 2, 'Endemic shrimp Macrobrachium pantanalense as a test species to assess potential contamination by pesticides in Pantanal (Brazil)': 2, 'Nonlinear Regression': 1, 'Dose-Response Analysis Using R': 1, 'R: A Language and Environment for Statistical Computing; R Foundation for Statistical Computing': 1, 'Coronavirus Testing: Criteria and Numbers by Country': 4, 'South Korean Government Raised COVID-19 Alert to Its \"Highest\" Level as Confirmed Cases Surpass 600': 1, 'COVID-19 and Italy: What next? Lancet 2020': 3, \"South Korea's Drive Through Testing for Coronavirus is Fast-and Free\": 1, 'Italy Orders Closure of all Schools and Universities Due to Coronavirus': 2, \"Here's How Utahns Are Changing Plans and Taking Precautions to Avoid Coronavirus. The Salt Lake Tribune\": 1, 'Italy has Put the Entire Country Under Travel Restriction': 1, \"Italy's Coronavirus Crisis Could be America's\": 1, 'Things Have Changed\": Government Leaders, Schools Limit Public Gatherings to Slow Virus\\' Spread; KSL News': 1, 'How South Korea Triumphed, and the US Flounderd, Over the Pandemic': 1, 'Utah K-12 Schools Dismissed for a Two-Week \"soft Closure\" Due to Coronavirus. The Salt Lake Tribune': 1, \"South Korea's Rapid Intrusive Measures\": 2, 'As State Cases Rise to 21, Summit County Announces Closure Order. The Salt Lake Tribune': 1, 'Spencer Cox Sets Record Straight on Coronavirus \"Crazy Rumors': 1, 'McAdams Tests Positive for COVID-19, Housing Lenders Suspend Evictions. The Salt Lake Tribune': 1, \"What the World Can Learn from South Korea's Coronavirus Strategy\": 1, 'Announces Rent Deferments, Eviction Freezes until May 15 in Utah': 1, 'Population Ages and Above (% of Total Population-Italy': 1, 'Similarities and Evolutionary Relationships of COVID-19 and Related Viruses': 1, \"Countries' Responses to the Coronavirus Are Revealing Which Strategies Work and Which Fall Short. Widespread Testing Is Crucial, While Lockdowns Can Buy Time\": 2, 'The Fractal Time Growth of COVID-19 Pandemic: An Accurate Self-Similar Model, and Urgent Conclusions': 1, 'A Mathematical prediction of the time evolution of the Covid-19 pandemic in some countries of the European Union using Monte Carlo simulations': 2, 'Modellierung von Beispielszenarien der SARS-CoV-2-Epidemie 2020 in Deutschland': 4, 'A SIDARTHE Model of COVID-19 Epidemic in Italy': 1, 'Modeling projections for COVID-19 pandemic by combining epidemiological, statistical, and neural network approaches': 1, 'Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures': 2, 'Estimating in real time the efficacy of measures to control emerging communicable diseases': 2, 'caucheme A new framework and software to estimate time-varying reproduction numbers during epidemics': 5, 'Solvable delay model for epidemic spreading: the case of Covid-19 in Italy': 2, 'Global stability analysis for a generalized delayed SIR model with vaccination and treatment': 2, 'Dynamic models for Coronavirus Disease 2019 and data analysis': 1, 'COVID-19: What proportion are asymptomatic?': 1, 'How generation intervals shape the relationship between growth rates and reproductive numbers': 2, 'Estimating the number of infections and the impact of nonpharmaceutical interventions on COVID-19 in 11 European countries': 1, 'Stochastic epidemics in dynamic populations: quasi-stationarity and extinction': 1, 'An application of queuing theory to SIS and SEIS epidemic models': 1, 'On the integral equation of renewal theory': 1, 'A contribution to the mathematical theory of epidemics': 5, 'The mathematics of infectious diseases': 6, 'Dynamic behaviors of a modified SIR model in epidemic diseases using nonlinear incidence and recovery rates': 1, 'Some epidemiological models with delays': 1, 'Time Delays in Epidemic Models': 1, 'Epidemiological Research: Terms and Concepts': 1, 'The end of social confinement and COVID-19 re-emergence risk': 1, \"Off the podium: why public health concerns for global spread of zika virus means that Rio de Janeiro's 2016 Olympic Games must not proceed\": 1, 'Tourism development on Bali and Lombok: analysis, comparison and possible reasons for the diverging development': 3, 'Dengue fever, hawaii': 1, 'Notes from the field: outbreak of locally acquired cases of dengue fever-Hawaii': 1, 'Surge of dengue virus infection and chikungunya Fever in Bali in 2010: the burden of mosquito-borne infectious diseases in a tourist destination': 5, 'The bilateral relationship between tourism and dengue occurrence: evidence from Aruba': 1, 'Dengue: a literature review and case study of travelers from the United States, 1986-1994': 1, 'Prevalence of infection with dengue virus among international travelers': 1, 'The outbreak: find out how authorities prepared for the inevitable arrival of the Zika virus in Singapore in 2016': 1, 'Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study': 1, 'Tracing the path of Chikungunya virus-evolution and adaptation': 1, 'Horizontal and vertical dispersal of dengue vector mosquitoes, Aedes aegypti and Aedes albopictus': 3, 'Role of tourism in economy of Bali and Indonesia': 2, 'Adat in Balinese discourse and practice: locating citizenship and the commonweal': 1, 'Marketing for hospitality and tourism': 1, 'Indonesia in transition: concluding reflections on engaged research and the critique of local knowledge': 1, 'Off the market? Elusive links in community-based sustainable development initiatives in Bali': 1, 'Bali tourism': 1, 'Terrorism and tourism': 5, 'regional autonomy, electoral democracy and entrenched identities': 2, 'Bali: a paradise created': 1, 'Tourism market recovery in the Maldives after the 2004 Indian Ocean Tsunami': 1, 'Renewing bonds in an age of Asian travel: Indian tourists in Bali': 1, 'Viremic dengue virus infections in travellers: potential for local outbreak in Northern Italy': 1, 'Miscarriage following dengue virus 3 infection in the first 6 weeks of pregnancy of a dengue virus-naive traveller returning from Bali to Italy': 1, 'Dengue sentinel traveler surveillance: monthly and yearly notification trends among Japanese travelers': 1, 'Situation of dengue virus infection and Chikungunya virus infection in Bali, Indonesia in 2010': 1, 'Emergence of a new lineage of dengue virus type 2 identified in travelers entering Western Australia from Indonesia': 1, 'Sources of dengue viruses imported into Queensland, australia': 1, 'Human health as precondition for achieving sustainable development': 1, 'The changing incidence of dengue haemorrhagic fever in Indonesia: a 45-year registry-based analysis': 1, 'Dengue/dengue hemorrhagic fever: the emergence of a global health problem': 1, 'Temepos resistance in Aedes aegypti in Colombia compromises dengue vector control': 1, \"Relationships among residents' image, evaluation of the stay and post-purchase behaviour\": 1, 'Tourism image, evaluation variables and after purchase behaviour: inter-relationship': 1, 'A model of destination branding: Integrating the concepts of the branding and destination image': 1, 'Collaborative communication networks: an application in Indonesia': 1, 'Innate immunity to influenza virus infection': 6, 'Increased lung neutrophil apoptosis and inflammation resolution in nonresponding pneumonia': 1, 'Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection': 3, 'Endothelial activation and dysfunction in the pathogenesis of influenza A virus infection': 3, 'Into the eye of the cytokine storm': 4, 'Switch from protective to adverse inflammation during influenza: viral determinants and hemostasis are caught as culprits': 2, 'Evasion of influenza A viruses from innate and adaptive immune responses': 2, 'Innate immune recognition in infectious and noninfectious diseases of the lung': 2, 'A simple method of estimating fifty per cent endpoints': 2, 'Clinical response to pandemic H1N1 influenza virus from a fatal and mild case in ferrets': 1, 'Technical considerations for developing enzyme immunohistochemical staining procedures on formalin-fixed paraffin-embedded tissues for diagnostic pathology': 1, 'Experimental infection with H1N1 European swine influenza virus protects pigs from an infection with the 2009 pandemic H1N1 human influenza virus': 1, 'Molecular characterization of in vivo adjuvant activity in ferrets vaccinated against influenza virus': 1, 'NCBI. NCBI nucleotide database': 1, 'Respiratory epithelial cells in innate immunity to influenza virus infection': 1, 'Critical role of natural killer cells in lung immunopathology during influenza infection in mice': 1, 'Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand': 1, 'Comparison of temporal and spatial dynamics of seasonal H3N2, pandemic H1N1 and highly pathogenic avian influenza H5N1 virus infections in ferrets': 1, 'Severe seasonal influenza in ferrets correlates with reduced interferon and increased IL-6 induction': 1, 'Protection from lethal influenza virus challenge by oral type 1 interferon': 1, 'Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques': 1, 'The pathogenesis of influenza virus infections: the contributions of virus and host factors': 2, 'Activation of the RIG-I pathway during influenza vaccination enhances the germinal center reaction, promotes T follicular helper cell induction, and provides a dose-sparing effect and protective immunity': 1, 'Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus': 1, 'Cytokine response patterns in severe pandemic 2009 H1N1 and seasonal influenza among hospitalized adults': 1, 'CCR2+ monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality': 1, 'Modeling host responses in ferrets during A/California/07/2009 influenza infection': 1, 'Recognition of double-stranded RNA and activation of NF-κB by toll-like receptor 3': 1, 'Detrimental contribution of the toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia': 4, 'Matrix metalloprotease 9 mediates neutrophil migration into the airways in response to influenza virus-induced toll-like receptor signaling': 1, 'Sensing of viral infection and activation of innate immunity by toll-like receptor 3': 1, 'Role of human toll-like receptors in naturally occurring influenza A infections': 1, 'Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus': 2, 'Toll-like receptor 3 gene polymorphisms and severity of pandemic A/H1N1/2009 influenza in otherwise healthy children': 2, 'Attenuation of the influenza virus sickness behavior in mice deficient in toll-like receptor 3': 2, 'Does toll-like receptor 3 play a biological role in virus infections': 1, 'Pathogen recognition and innate immunity': 2, 'RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates': 1, 'The cellular RNA helicase UAP56 is required for prevention of doublestranded RNA formation during influenza A virus infection': 2, 'Impact of defective interfering particles on virus replication and antiviral host response in cell culture-based influenza vaccine production': 1, 'The lung microvascular endothelium as a therapeutic target in severe influenza': 1, 'Extracellular RNA promotes leukocyte recruitment in the vascular system by mobilising proinflammatory cytokines': 1, 'In search for stability in crypto-assets: Are stablecoins the solution? ECB Occasional Paper No': 2, 'The blockchain folk theorem': 2, 'Designing stable coins. Duo Network Academic Whitepaper': 2, 'An analysis of the stability characteristics of Celo': 2, 'Competitive equilibria between staking and on-chain lending. Crypto Economic Systems': 2, 'Distribution function inequalities for martingales': 3, 'An analysis of Uniswap markets': 2, 'Altered Ribostasis: RNA-Protein Granules in Degenerative Disorders': 4, 'The P Granules of C. elegans: A Genetic Model for the Study of RNA-Protein Condensates': 1, 'Stress Granules and Processing Bodies in Translational Control': 3, 'Eukaryotic Stress Granules: The Ins and Outs of Translation': 1, 'The Role of RNA in Biological Phase Separations': 1, 'Protein Phase Separation as a Stress Survival Strategy': 2, 'Controlling compartmentalization by non-membrane-bound organelles': 2, 'Getting RNA and protein in phase': 2, 'Mammalian stress granules and processing bodies': 3, 'G3BP-Caprin1-USP10 complexes mediate stress granule condensation and associate with 40S subunits': 2, 'Both G3BP1 and G3BP2 contribute to stress granule formation': 1, 'Diversion of stress granules and P-bodies during viral infection': 3, 'Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS': 2, 'Mutant KRAS Enhances Tumor Cell Fitness by Upregulating Stress Granules': 2, 'Acetylation of intrinsically disordered regions regulates phase separation': 3, 'Histone arginine demethylase JMJD6 is linked to stress granule assembly through demethylation of the stress granule nucleating protein G3BP1': 1, 'NEDDylation promotes stress granule assembly': 1, 'A functional RNAi screen links O-GlcNAc modification of ribosomal proteins to stress granule and processing body assembly': 1, 'ADP-ribose) regulates stress responses and microRNA activity in the cytoplasm': 8, 'Friend or foe -post-translational modifications as regulators of phase separation and RNP granule dynamics': 2, 'Dual Specificity Kinase DYRK3 Couples Stress Granule Condensation/Dissolution to mTORC1 Signaling': 1, 'PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes': 2, 'SnapShot: ADP-Ribosylation Signaling. Molecular Cell': 2, 'ADP-ribosylation: new facets of an ancient modification': 2, 'PARylation regulates stress granule dynamics, phase separation, and neurotoxicity of disease-related RNA-binding proteins': 7, 'ADP-Ribose) Prevents Pathological Phase Separation of TDP-43 by Promoting Liquid Demixing and Stress Granule Localization': 8, 'Liquid demixing of intrinsically disordered proteins is seeded by poly(ADP-ribose)': 3, 'ADP-ribose) engages the TDP-43 nuclear-localization sequence to regulate granulo-filamentous aggregation': 2, 'PARP1-produced poly-ADP-ribose causes the PARP12 translocation to stress granules and impairment of Golgi complex functions': 2, 'Nuclear poly(ADP-ribose) activity is a therapeutic target in amyotrophic lateral sclerosis': 2, 'Dynamic oscillation of translation and stress granule formation mark the cellular response to virus infection': 1, 'Cytoplasmic RNA granules and viral infection': 6, 'Antiviral innate immunity and stress granule responses': 1, 'Translation inhibition and stress granules in the antiviral immune response': 6, 'Viral and cellular proteins containing FGDF motifs bind G3BP to block stress granule formation': 4, 'Chikungunya virus nsP3 blocks stress granule assembly by recruitment of G3BP into cytoplasmic foci': 8, 'The nsP3 macro domain is important for Sindbis virus replication in neurons and neurovirulence in mice': 1, 'ADPribosylhydrolase activity of Chikungunya virus macrodomain is critical for virus replication and virulence': 6, 'The Enigmatic Alphavirus Non-Structural Protein 3 (nsP3) Revealing Its Secrets at Last. Viruses': 6, 'New World and Old World Alphaviruses Have Evolved to Exploit Different Components of Stress Granules, FXR and G3BP Proteins, for Assembly of Viral Replication Complexes': 9, 'Sequestration of G3BP coupled with efficient translation inhibits stress granules in Semliki Forest virus infection': 7, 'SNAP-tagged Chikungunya Virus Replicons Improve Visualisation of Non-Structural Protein 3 by Fluorescence Microscopy. Sci Rep': 4, 'Hypervariable Domain of Eastern Equine Encephalitis Virus nsP3 Redundantly Utilizes Multiple Cellular Proteins for Replication Complex Assembly. Perlman S, editor': 1, 'The C-terminal repeat domains of nsP3 from the Old World alphaviruses bind directly to G3BP': 3, 'The conserved macrodomains of the non-structural proteins of Chikungunya virus and other pathogenic positive strand RNA viruses function as mono-ADP-ribosylhydrolases. Sci Rep': 3, 'The Conserved Coronavirus Macrodomain Promotes Virulence and Suppresses the Innate Immune Response during Severe Acute Respiratory Syndrome Coronavirus Infection': 1, 'Viral Macro Domains Reverse Protein ADP-ribosylation': 2, 'Nuclear localization sequence of FUS and induction of stress granules by ALS mutants': 2, 'Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules': 2, 'Tracking and elucidating alphavirus-host protein interactions': 3, 'Different types of nsP3-containing protein complexes in Sindbis virus-infected cells': 4, 'Formation of nsP3-specific protein complexes during Sindbis virus replication': 2, 'Multiple Host Factors Interact with Hypervariable Domain of Chikungunya Virus nsP3 and Determine Viral Replication in Cell-Specific Mode. López S, editor': 1, 'Context-Dependent and Disease-Specific Diversity in Protein Interactions within Stress Granules': 1, 'High-Density Proximity Mapping Reveals the Subcellular Organization of mRNA-Associated Granules and Bodies': 1, 'Host factors associated with the Sindbis virus RNA-dependent RNA polymerase: role for G3BP1 and G3BP2 in virus replication': 1, 'Stress granules as crucibles of ALS pathogenesis': 1, 'RNA Granules and Diseases: A Case Study of Stress Granules in ALS and FTLD': 1, 'Stress Granules and ALS: A Case of Causation or Correlation? Adv Neurobiol': 1, 'Amyotrophic lateral sclerosis-linked FUS/TLS alters stress granule assembly and dynamics': 1, 'Quantitative proteomics identifies proteins that resist translational repression and become dysregulated in ALS-FUS': 1, 'Stress granule components G3BP1 and G3BP2 play a proviral role early in Chikungunya virus replication': 2, 'Phase Separation of C9orf72 Dipeptide Repeats Perturbs Stress Granule Dynamics. Molecular Cell': 1, 'Endogenous TDP-43, but not FUS, contributes to stress granule assembly via G3BP': 1, 'ALS mutant SOD1 interacts with G3BP1 and affects stress granule dynamics': 1, 'Macrodomain ADP-ribosylhydrolase and the pathogenesis of infectious diseases. Dutch RE, editor': 1, 'Viral Macrodomains: Unique Mediators of Viral Replication and Pathogenesis': 1, 'Sindbis Virus Infection Causes Cell Death by nsP2-Induced Transcriptional Shutoff or by nsP3-Dependent Translational Shutoff. López S, editor': 1, 'ADP-ribosyl-binding and hydrolase activities of the alphavirus nsP3 macrodomain are critical for initiation of virus replication': 3, 'ADP-ribose): An organizer of cellular architecture': 2, 'ADPriboDB: The database of ADPribosylated proteins': 1, 'The C-terminal domain of p53 orchestrates the interplay between non-covalent and covalent poly(ADPribosyl)ation of p53 by PARP1': 1, 'The rise and fall of poly(ADP-ribose): An enzymatic perspective': 1, 'Structures and Mechanisms of Enzymes Employed in the Synthesis and Degradation of PARP-Dependent Protein ADP-Ribosylation. Molecular Cell': 1, \"ADP-ribose) drives pathologic α-synuclein neurodegeneration in Parkinson's disease\": 1, 'Loss of poly(ADPribose) glycohydrolase causes progressive neurodegeneration in Drosophila melanogaster': 1, 'CRISPRs for Optimal Targeting: Delivery of CRISPR Components as DNA, RNA, and Protein into Cultured Cells and Single-Cell Embryos': 1, 'Mechanisms of Methods for Hepatitis C Virus Inactivation': 1, 'Ebola Virus Inactivation by Detergents Is Annulled in Serum': 1, 'CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel': 1, 'A novel coronavirus associated with severe acute respiratory syndrome': 7, 'Identification of a novel coronavirus in patients with severe acute respiratory syndrome': 8, 'A novel coronavirus from patients with pneumonia in China': 19, \"National Health Commission of the People's Republic of China\": 2, 'COVID-19 global cases': 1, 'Covid-19: preparedness, decentralisation, and the hunt for patient zero': 1, 'Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China': 12, 'Efficient management of novel coronavirus pneumonia by efficient prevention and control in scientific manner': 2, \"State Council's Joint Prevention and Control Mechanism for New Coronavirus Infected Pneumonia introduce the latest progress of epidemic prevention and control, especially the measures of caring for medical staff. www.nhc.gov.cn/xwzb/webcontrollerdo? titleSeq=11231&gecstype=1 Date last updated\": 1, 'International Severe Acute Respiratory and emerging Infection Consortium. COVID-19 Case Record Forms (CRF)': 1, 'World Health Organization. Household transmission investigation protocol for 2019-novel coronavirus (2019-nCoV) infection. www.who.int/publications-detail/household-transmission-investigation-protocol-for-2019-novel-coronavirus-(2019-ncov)-infection Date last updated: 25': 1, 'Real-time RT-PCR panel for detection of 2019-novel coronavirus': 1, 'SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing': 1, 'Prokka: rapid prokaryotic genome annotation': 1, 'C-Sibelia: an easy-to-use and highly accurate tool for bacterial genome comparison': 1, 'A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3': 2, 'MAFFT online service: multiple sequence alignment, interactive sequence choice and visualization': 1, 'RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies': 1, 'Clustal Omega. www.ebi. ac.uk/Tools/msa/clustalo/ Date last accessed': 1, 'RNA chaperones and the RNA folding problem': 2, 'RNA chaperones exist and DEAD box proteins get a life': 2, 'The ubiquitous nature of RNA chaperone proteins': 3, 'Strategies for RNA folding and assembly': 1, 'Assays for the RNA chaperone activity of proteins': 2, 'Intrinsically unstructured proteins and their functions': 1, 'Disordered RNA chaperone proteins: from functions to disease': 1, 'The role of structural disorder in the function of RNA and protein chaperones': 2, 'Investigation by fluorescence correlation spectroscopy of the chaperoning interactions of HIV-1 nucleocapsid protein with the viral DNA initiation sequences': 2, 'Nucleic acid conformational changes essential for HIV-I nucleocapsid protein-mediated inhibition of self-priming in minus-strand transfer': 4, 'Insights on the role of nucleic acid/protein interactions in chaperoned nucleic acid rearrangements of HIV-1 reverse transcription': 1, 'Investigating the mechanism of the nucleocapsid protein chaperoning of the second strand transfer during HIV-1 DNA synthesis': 2, 'The annealing mechanism of HIV-1 reverse transcription primer onto the viral genome': 2, 'Probing nucleation, reverse annealing, and chaperone function along the reaction path of HIV-1 single-strand transfer': 3, 'The hepatitis C virus core protein is a potent nucleic acid chaperone that directs dimerization of the viral (+) strand RNA in vitro': 5, 'Poliovirus protein 3AB displays nucleic acid chaperone and helix-destabilizing activities': 3, 'Vif is a RNA chaperone that could temporally regulate RNA dimerization and the early steps of HIV-1 reverse transcription': 4, 'Selective strand annealing and selective strand exchange promoted by the N-terminal domain of hepatitis delta antigen': 2, 'RNA chaperoning and intrinsic disorder in the core proteins of Flaviviridae': 2, 'Rapid assembly and disassembly of complementary DNA strands through as equilibrium': 3, 'DNA strand exchange and selective DNA annealing promoted by the human immunodeficiency virus type I nucleocapsid protein': 3, 'Mechanistic studies of mini-TAR RNA/DNA annealing in the absence and presence of HIV-1 nucleocapsid protein': 3, 'Coronavirus nucleocapsid protein is an RNA chaperone': 3, 'Facilitation of hammerhead ribozyme catalysis by the nucleocapsid protein of HIV-1 and the heterogeneous nuclear ribonucleoprotein A1': 2, 'A chloroplast protein binds a viroid RNA in vivo and facilitates its hammerhead-mediated self-cleavage': 2, 'An RNA chaperone activity of non-specific RNA binding proteins in hammerhead ribozyme catalysis': 1, 'RNA chaperone activity of protein components of human Ro RNPs': 4, 'Escherichia coli proteins, including ribosomal protein S12, facilitate in vitro splicing of phage T4 introns by acting as RNA chaperones': 1, 'Probing the mechanisms of DEAD-box proteins as general RNA chaperones: the C-terminal domain of CYT-19 mediates general recognition of RNA': 1, 'Folding of the td pre-RNA with the help of the RNA chaperone StpA': 1, 'RNA chaperone activity of large ribosomal subunit proteins from Escherichia coli': 1, 'Escherichia coli protein StpA stimulates self-splicing by promoting RNA assembly in vitro': 1, 'Human immunodeficiency virus type 1 nucleocapsid protein promotes efficient strand transfer and specific viral DNA synthesis by inhibiting TAR-dependent self-priming from minus-strand strong-stop DNA': 2, 'Subtle alterations of the native zinc finger structures have dramatic effects on the nucleic acid chaperone activity of human immunodeficiency virus type 1 nucleocapsid protein': 2, 'Alteration of nucleic acid structure and stability modulates the efficiency of minus-strand transfer mediated by the HIV-1 nucleocapsid protein': 1, 'Effects of nucleic acid local structure and magnesium ions on minus-strand transfer mediated by the nucleic acid chaperone activity of HIV-1 nucleocapsid protein': 1, 'Assaying RNA chaperone activity in vivo using a novel RNA folding trap': 3, 'Escherichia coli CspA-family RNA chaperones are transcription antiterminators': 1, 'A DEAD-box protein functions as an ATP-dependent RNA chaperone in group I intron splicing': 1, 'Hepatitis delta antigens enhance the ribozyme activities of hepatitis delta virus RNA in vivo': 2, 'Zinc finger domain of murine leukemia virus nucleocapsid protein enhances the rate of viral DNA synthesis in vivo': 1, 'HIV-1: fifteen proteins and an RNA': 3, 'Small finger protein of avian and murine retrovirus has nucleic acid annealing activity and positions the replication primer tRNA onto genomic RNA': 1, 'Nucleocapsid protein chaperoning of nucleic acids at the heart of HIV structure, assembly and cDNA synthesis': 1, 'Nucleic acid chaperone activity of HIV-1 nucleocapsid protein: critical role in reverse transcription and molecular mechanism': 10, 'The HIV-1 transcriptional activator Tat has potent nucleic acid chaperoning activities in vitro': 3, 'Predicting intrinsic disorder from aminoacid sequence': 2, 'Optimizing intrinsic disorder predictors with protein evolutionary information': 2, 'Cis elements and trans-acting factors involved in the RNA dimerization of the human immunodeficiency virus HIV-1': 1, 'Effect of human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein on HIV-1 reverse transcriptase activity in vitro': 2, 'Human immunodeficiency virus type 1 nucleocapsid protein reduces reverse transcriptase pausing at a secondary structure near the murine leukemia virus polypurine tract': 2, 'Molecular requirements for human immunodeficiency virus type 1 plus-strand transfer: analysis in reconstituted and endogenous reverse transcription systems': 2, 'Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles': 1, 'Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with vif-negative human immunodeficiency virus type 1': 1, 'Monomeric APOBEC3G is catalytically active and has antiviral activity': 1, 'A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins': 1, 'Transcription of HIV: Tat and cellular chromatin': 1, 'The hepatitis delta (d) virus possesses a circular RNA': 1, 'Structure, sequence and expression of the hepatitis delta (d) viral genome': 1, 'Determination of the multimerization state of the hepatitis delta virus antigens in vivo': 1, 'Initiation of replication of the human hepatitis delta virus genome from cloned DNA: role of delta antigen': 1, 'Identification and characterization of the RNA chaperone activity of hepatitis delta antigen peptides': 1, 'Nucleic acid binding properties of the nucleic acid chaperone domain of hepatitis delta antigen': 1, 'Flaviviridae: the viruses and their replication': 1, 'Replication of hepatitis C virus': 2, 'Analysis of hepatitis C virus RNA dimerization and core-RNA interactions': 2, 'Nidovirales: evolving the largest RNA virus genome': 1, 'Coronavirus transcription: a perspective': 1, 'A contemporary view of coronavirus transcription': 5, 'Role of nucleotides immediately flanking the transcription-regulating sequence core in coronavirus subgenomic mRNA synthesis': 4, 'Sequence motifs involved in the regulation of discontinuous coronavirus subgenomic RNA synthesis': 4, 'Identification of a coronavirus transcription enhancer': 1, 'The nucleoprotein is required for efficient coronavirus genome replication': 3, 'Biochemical aspects of coronavirus replication and virus-host interaction': 1, 'Sequence comparison of the N genes of five strains of the coronavirus mouse hepatitis virus suggests a three domain structure for the nucleocapsid protein': 1, 'Proteomics analysis unravels the functional repertoire of coronavirus nonstructural protein 3': 1, 'Hantaviruses: molecular biology, evolution and pathogenesis': 1, 'Hantaviruses: genome structure, expression and evolution': 2, 'Role of the conserved nucleotide mismatch within 3 -and 5 -terminal regions of Bunyamwera virus in signaling transcription': 1, 'The hantavirus nucleocapsid protein recognizes specific features of the viral RNA panhandle and is altered in conformation upon RNA binding': 1, 'The bunyavirus nucleocapsid protein is an RNA chaperone: possible roles in viral RNA panhandle formation and genome replication': 2, 'Molecular mechanisms of poliovirus variation and evolution': 1, 'Structure and function of nuclear and cytoplasmic ribonucleoprotein particles': 1, 'hnRNP proteins and the biogenesis of mRNA': 1, 'RNA annealing activities in HeLa nuclei': 1, 'Formation of a ribonucleoprotein complex of mouse hepatitis virus involving heterogeneous nuclear ribonucleoprotein A1 and transcription-regulatory elements of viral RNA': 1, 'Interactions between the cytoplasmic proteins and the intergenic (promoter) sequence of mouse hepatitis virus RNA: correlation with the amounts of subgenomic mRNA transcribed': 1, 'Heterogeneous nuclear ribonucleoprotein A1 binds to the 3 -untranslated region and mediates potential 5 -3 -end cross talks of mouse hepatitis virus RNA': 1, 'Viral and cellular proteins involved in coronavirus replication': 4, 'Evaluation of the role of heterogeneous nuclear ribonucleoprotein A1 as a host factor in murine coronavirus discontinuous transcription and genome replication': 1, 'Characterization of cDNAs encoding the polypyrimidine tract-binding protein': 1, 'Differential alternative splicing activity of isoforms of polypyrimidine tract binding protein (PTB)': 1, 'hnRNP I, the polypyrimidine tract-binding protein: distinct nuclear localization and association with hnRNAs': 1, 'The polypyrimidine tract binding protein is required for efficient picornavirus gene expression and propagation': 1, 'Evidence for an RNA chaperone function of polypyrimidine tract-binding protein in picornavirus translation': 2, 'Role of La autoantigen and polypyrimidine tract-binding protein in HCV replication': 5, 'Feline calicivirus replication: requirement for polypyrimidine tract-binding protein is temperature-dependent': 2, 'Internal initiation of translation from the human rhinovirus-2 internal ribosome entry site requires the binding of Unr to two distinct sites on the 5 untranslated region': 2, 'Transient expression of cellular polypyrimidine-tract binding protein stimulates cap-independent translation directed by both picornaviral and flaviviral internal ribosome entry sites in vivo': 1, 'Polypyrimidine-tract-binding protein is a component of the HCV RNA replication complex and necessary for RNA synthesis': 1, 'The polypyrimidine tract-binding protein (PTB) is required for efficient replication of hepatitis C virus (HCV) RNA': 1, 'Recognition of nascent RNA by the human La antigen: conserved and divergent features of structure and function': 1, 'A role for the yeast La protein in U6 snRNP assembly: evidence that the La protein is a molecular chaperone for RNA polymerase III transcripts': 1, 'La autoantigen enhances and corrects aberrant translation of poliovirus RNA in reticulocyte lysate': 1, 'All five cold-shock domains of unr (upstream of Nras) are required for stimulation of human rhinovirus RNA translation': 1, 'The Apaf-1 internal ribosome entry segment attains the correct structural conformation for function via interactions with PTB and Unr': 1, 'Transcription termination at intrinsic terminators: the role of the RNA hairpin': 1, 'Terminating transcription in eukaryotes: lessons learned from RNA polymerase I': 1, 'Strand transfer events during HIV-1 reverse transcription': 6, 'Role of the reverse transcriptase, nucleocapsid protein, and template structure in the two-step transfer mechanism in retroviral recombination': 1, 'Torovirus non-discontinuous transcription: mutational analysis of a subgenomic mRNA promoter': 1, 'A complex network of RNA-RNA interactions controls subgenomic mRNA transcription in a tombusvirus': 1, 'The premature termination model: a possible third mechanism for subgenomic mRNA transcription in (+)-strand RNA viruses': 1, 'Advances in the molecular biology of tombusviruses: gene expression, genome replication, and recombination': 2, 'Downstream sequences influence the choice between a naturally occurring noncanonical and closely positioned upstream canonical heptameric fusion motif during bovine coronavirus subgenomic mRNA synthesis': 1, 'Insights into the multiple roles of pausing in HIV-1 reverse transcriptase-promoted strand transfers': 1, 'Mechanistic analysis of pause site-dependent and -independent recombinogenic strand transfer from structurally diverse regions of the HIV genome': 1, 'Copy-choice recombination by reverse transcriptases: reshuffling of genetic markers mediated by RNA chaperones': 3, 'Factors regulating template switch in vitro by viral RNAdependent RNA polymerases: implications for RNA-RNA recombination': 1, 'New insights into the mechanisms of RNA recombination': 1, 'Dissecting RNA recombination in vitro: role of RNA sequences and the viral replicase': 1, 'Discontinuous subgenomic RNA synthesis in arteriviruses is guided by an RNA hairpin structure located in the genomic leader region': 3, 'Coronavirus replication and reverse genetics': 1, 'Expression, purification, and characterization of SARS coronavirus RNA polymerase': 1, 'Time-resolved NMR studies of RNA folding': 1, \"Specific zinc-finger architecture required for HIV-1 nucleocapsid protein's nucleic acid chaperone functions\": 1, 'Mechanism for nucleic acid chaperone activity of HIV-1 nucleocapsid protein revealed by single molecule stretching': 1, 'Out of sight but not out of mind: an answer set programming based online abduction framework for visual sensemaking in autonomous driving': 1, 'Lars: a logic-based framework for analytic reasoning over streams': 2, 'Ticker: a system for incremental ASP-based stream reasoning': 1, 'A distributed approach to LARS stream reasoning (System paper)': 2, 'Expressive stream reasoning with laser': 7, 'Foundations of Databases': 2, 'EP-SPARQL: a unified language for event processing and stream reasoning': 4, \"It's a streaming world! reasoning upon rapidly changing information\": 5, 'Stream reasoning: a survey and outlook': 2, 'Reasoning over streaming data in metric temporal datalog': 2, 'An incremental reasoning algorithm for large scale knowledge graph': 2, 'SRBench: a streaming RDF/SPARQL benchmark': 3, 'A first step towards stream reasoning': 1, 'Streaming the web: reasoning over dynamic data': 1, 'C-SPARQL: a continuous query language for RDF data streams': 1, 'Streaming SPARQL -extending SPARQL to process data streams': 1, 'C-Sprite: efficient hierarchical reasoning for rapid RDF stream processing': 1, 'Enabling ontology-based access to streaming data sources': 1, 'A native and adaptive approach for unified processing of linked streams and linked data': 1, 'Answer set programming for stream reasoning': 1, 'Web stream reasoning using probabilistic answer set programming': 1, 'StreamRule: a nonmonotonic stream reasoning system for the semantic web': 1, 'High-performance distributed stream reasoning using S4': 1, 'Enhancing the scalability of expressive stream reasoning via input-driven parallelization': 1, 'Strider R: massive and distributed RDF graph stream reasoning': 1, 'Operator-aware approach for boosting performance in RDF stream processing': 1, 'Seven commandments for benchmarking semantic flow processing systems': 1, 'Heaven: a framework for systematic comparative research approach for RSP engines': 1, 'RSPLab: RDF stream processing benchmarking made easy': 1, 'Ontology-based query answering for probabilistic temporal data': 1, 'Stream reasoning using temporal logic and predictive probabilistic state models': 1, 'Approximate stream reasoning with metric temporal logic under uncertainty': 1, 'The window validity problem in rule-based stream reasoning': 1, 'Optimised maintenance of datalog materialisations': 1, 'Incremental update of datalog materialisation: the backward/forward algorithm': 1, 'Maintenance of datalog materialisations revisited': 1, 'Optimising ontology stream reasoning with truth maintenance system': 1, 'DynamiTE: parallel materialization of dynamic RDF data': 1, 'China coronavirus: WHO declares international emergency as death toll exceeds 200': 1, 'Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China': 3, 'Clinical characteristics of 2019 novel coronavirus infection in China': 5, 'Emerging 2019 novel coronavirus (2019-nCoV) pneumonia': 2, 'Evolution of computed tomography manifestations in five patients who recovered from coronavirus disease 2019 (COVID-19) pneumonia': 1, 'Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China': 1, 'Shape \"breakand-repair\" strategy and its application to automated medical image segmentation': 2, 'Severe acute respiratory syndrome: temporal lung changes at thin-section CT in 30 patients': 1, 'Diagnosis and treatment protocols of pneumonia caused by a novel coronavirus (trial version 6). National Health Commission of the PRC': 1, 'Glossary of terms for thoracic imaging--German version of the Fleischner Society recommendations': 1, 'Fleischner Society: glossary of terms for thoracic imaging': 2, 'An automated CT based lung nodule detection scheme using geometric analysis of signed distance field': 1, 'Robust semi-automatic segmentation of pulmonary subsolid nodules in chest computed tomography scans': 1, 'Usual interstitial pneumonia: correlation of CT with clinical, functional, and radiologic findings': 2, 'Pulmonary sequelae in convalescent patients after severe acute respiratory syndrome: evaluation with thin-section CT': 1, 'CT correlation with outcomes in 15 patients with acute Middle East respiratory syndrome coronavirus': 1, 'Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia': 1, 'China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China': 2, 'Multiple organ infection and the pathogenesis of SARS': 3, 'Early prediction of disease progression in 2019 novel coronavirus pneumonia patients outside Wuhan with CT and clinical characteristics': 2, 'Clinical pathology of critical patient with novel coronavirus pneumonia (COVID-19)': 1, 'Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China': 2, 'Pathological findings of COVID-19 associated with acute respiratory distress syndrome': 8, 'The international Ebola emergency': 1, 'WHO Director-General summarizes the outcome of the Emergency Committee regarding clusters of microcephaly and Guillain-Barré syndrome': 1, 'Senior appointments and new facilities announced as the ECDC is inaugurated': 1, 'The surveillance of communicable diseases in the European Union--a long-term strategy': 1, 'Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study': 1, 'Secondary attack rate and superspreading events for SARS-CoV-2': 1, 'Estimating the overdispersion in COVID-19 transmission using outbreak sizes outside China': 3, 'What settings have been linked to SARS-CoV-2 transmission clusters?': 1, 'The Effectiveness of Contact Tracing in Emerging Epidemics': 1, 'Bidirectional contact tracing is required for reliable COVID-19 control': 2, 'Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan': 2, 'A high-resolution human contact network for infectious disease transmission': 2, 'The role of directionality, heterogeneity and correlations in epidemic risk and spread': 1, 'Superspreading and the effect of individual variation on disease emergence': 1, 'Characterizing super-spreading events and age-specific infectivity of COVID-19 transmission in Georgia': 1, 'Clustering and superspreading potential of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in Hong Kong. Prepr (Version 1) available Res Sq': 1, 'Prevalence of Asymptomatic SARS-CoV-2 Infection': 1, 'Scientific Pandemic Influenza Group on Modelling Operational sub-group. SPI-M-O: Consensus Statement on COVID-19': 1, 'Efficacy of contact tracing for the containment of the 2019 novel coronavirus (COVID-19)': 1, 'Systems biology of persistent infection: tuberculosis as a case study': 3, 'Form follows function: lymphoid tissue microarchitecture in antimicrobial immune defence': 1, 'Plasmacytoid dendritic cells in immunity': 1, 'Antigen-presentation properties of plasmacytoid dendritic cells': 2, 'Plasmacytoid dendritic cells-virus experts of innate immunity': 3, 'Coronavirus infection of the central nervous system: host-virus stand-off': 12, 'Coronaviruses post-SARS: update on replication and pathogenesis': 3, 'Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon': 9, 'Hematopoietic cell-derived interferon controls viral replication and virusinduced disease': 2, 'Type I IFN-mediated protection of macrophages and dendritic cells secures control of murine coronavirus infection': 6, 'A mathematical approach for optimizing dendritic cell-based immunotherapy': 1, \"A systems biologist's view on dendritic cellcytotoxic T lymphocyte interaction\": 1, 'Identification of Coronavirus Non-Structural Protein 1 as a Major Pathogenicity Factor -Implications for the Rational Design of Live Attenuated Coronavirus Vaccines': 2, 'Interferon and cytokine responses to SARS-coronavirus infection': 2, 'Adaptive mutations resulting in enhanced polymerase activity contribute to high virulence of influenza A virus in mice': 1, 'Immunopathogenesis of coronavirus infections: implications for SARS': 1, 'Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells': 1, 'Protective T cell-independent antiviral antibody responses are dependent on complement': 1, 'Unraveling the complexities of the interferon response during SARS-CoV infection': 1, 'Interferon-beta pretreatment of conventional and plasmacytoid human dendritic cells enhances their activation by influenza virus': 1, 'Steady-state and inflammatory dendritic-cell development': 1, 'Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases': 1, 'Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen': 1, 'CCR9 is a homing receptor for plasmacytoid dendritic cells to the small intestine': 1, 'Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon': 1, 'Evidence for recruitment of plasmacytoid dendritic cell precursors to inflamed lymph nodes through high endothelial venules': 1, 'Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development': 1, 'Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance': 1, 'Mouse hepatitis virus liver pathology is dependent on ADP-ribose-10-phosphatase, a viral function conserved in the alpha-like supergroup': 1, 'The Fgl2/ fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis': 1, 'The art of the probable: system control in the adaptive immune system': 1, 'Systems biology and the host response to viral infection': 1, 'Enabling a systems biology approach to immunology: focus on innate immunity': 1, 'Systems biology of innate immunity': 2, 'Mathematical and computational approaches can complement experimental studies of host-pathogen interactions': 1, 'Multiscale modeling for biologists': 1, 'Modelling viral and immune system dynamics': 1, 'The role of models in understanding CD8+ T-cell memory': 1, 'Analysing immune cell migration': 1, 'Mathematical model of antiviral immune response. III. Influenza A virus infection': 1, 'Modelling dynamics of the type I interferon response to in vitro viral infection': 1, 'Recombinant mouse hepatitis virus strain A59 from cloned, full-length cDNA replicates to high titers in vitro and is fully pathogenic in vivo': 2, 'Model selection in ecology and evolution': 1, 'When a good fit can be bad': 1, 'Determining control parameters for dendritic cell-cytotoxic T lymphocyte interaction': 2, 'Numerical solution by LMMs of stiff delay differential systems modelling an immune response': 1, 'Dynamic modelling and analysis of biochemical networks: mechanism-based models and model-based experiments': 1, 'Identifiability of nonlinear systems with applications to HIV/AIDS models': 1, 'Parameter identifiability and estimation of HIV/AIDS dynamic models': 1, 'S1 gene-based phylogeny of infectious bronchitis virus: an attempt to harmonize virus classification': 2, 'Detection of different genotypes of infectious bronchitis virus and of infectious bursal disease virus in European broilers during an epidemiological study in 2013 and the consequences for the diagnostic approach': 1, 'The replicase gene of avian coronavirus infectious bronchitis virus is a determinant of pathogenicity': 1, 'Infection of the tracheal epithelium by infectious bronchitis virus is sialic acid dependent': 1, 'Differences in the tissue tropism to chicken oviduct epithelial cells between avian coronavirus IBV strains Qx and B1648 are not related to the sialic acid binding properties of their spike proteins': 1, 'Binding of avian coronavirus spike proteins to host factors reflects virus tropism and pathogenicity': 3, 'Identification of N-linked glycosylation sites in the spike protein and their functional impact on the replication and infectivity of coronavirus infectious bronchitis virus in cell culture': 3, 'Unexpected receptor functional mimicry elucidates activation of coronavirus fusion': 3, 'Structural basis for human coronavirus attachment to sialic acid receptors': 2, 'Cryo-Electron microscopy structure of porcine deltacoronavirus spike protein in the prefusion': 1, 'Specific asparagine-linked glycosylation sites are critical for DC-SIGN-and L-SIGN-Mediated severe acute respiratory syndrome coronavirus entry': 1, 'A single asparagine-linked glycosylation site of the severe acute respiratory syndrome coronavirus spike glycoprotein facilitates inhibition by mannose-binding lectin through multiple mechanisms': 2, 'Cryo-Em structure of infectious bronchitis coronavirus spike protein reveals structural and functional evolution of coronavirus spike proteins': 3, 'Mapping of the receptor-binding domain and amino acids critical for attachment in the spike protein of avian coronavirus infectious bronchitis virus': 1, 'Glycosylation of the viral attachment protein of avian coronavirus is essential for host cell and receptor binding': 6, 'A reverse genetics system for avian coronavirus infectious bronchitis virus based on targeted RNA recombination': 8, 'Plaque formation by infectious bronchitis virus in chicken embryo kidney cell cultures': 1, 'Glycomics-based analysis of chicken red blood cells provides insight into the selectivity of the viral agglutination assay': 1, 'A rapid-plate hemagglutination assay for the detection of infectious bronchitis virus': 1, 'Crystal structure of bovine coronavirus spike protein lectin domain': 1, 'Human coronaviruses OC43 and HKU1 bind to 9-O -acetylated sialic acids via a conserved receptor-binding site in spike protein domain A': 1, 'Exploitation of glycosylation in enveloped virus pathobiology': 1, 'Glycan-protein interactions in viral pathogenesis': 2, 'Synthetic carbohydrate antigens for HIV vaccine design': 1, 'World Health Organization. Coronavirus disease 2019 (COVID-19): situation report': 1, 'Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention': 4, 'Coronavirus disease 2019: What we know': 2, 'Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: a single arm meta-analysis': 1, 'Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis': 4, 'Laboratory findings of COVID-19 infection are conflicting in different age groups and pregnant women: a literature review': 1, 'Diagnostic value of blood parameters for community-acquired pneumonia': 1, 'Lymphocyte-C-reactive protein ratio as promising new marker for predicting surgical and oncological outcomes in colorectal cancer': 2, 'Neutrophil-to-lymphocyte ratio relation to sepsis severity scores and inflammatory biomarkers in patients with community-acquired pneumonia: a case series': 1, '2019-nCoV pneumonia in a normal work infectious diseases hospital besides Hubei Province': 2, 'Clinical Features of Patients Infected with the 2019 Novel Coronavirus (COVID-19) in Shanghai, China. medRxiv': 2, 'Clinical features and laboratory inspection of novel coronavirus pneumonia (COVID-19) in Xiangyang': 2, 'Study of the lymphocyte change between COVID-19 and non-COVID-19 pneumonia cases suggesting other factors besides uncontrolled inflammation contributed to multi-organ injury': 4, 'Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the': 1, 'Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: Interim guidance2020': 1, 'Linking a role of lncRNAs (long non-coding RNAs) with insulin resistance, accelerated senescence, and inflammation in patients with type 2 diabetes': 1, 'Acute respiratory distress syndrome': 2, 'Clinical characteristics of 51 patients discharged from hospital with COVID-19 in Chongqing, China. medRxiv': 1, 'Myocardial injury is associated with in-hospital mortality of confirmed or suspected COVID-19 in Wuhan, China: a single center retrospective cohort study. medRxiv': 2, 'Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan': 6, 'Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis. medRxiv': 2, 'Macrophage activation-like syndrome: a distinct entity leading to early death in sepsis': 1, 'Adult haemophagocytic syndrome': 1, 'Dysregulation of immune response in patients with COVID-19 in Wuhan': 1, 'The clinical and chest CT features associated with severe and critical COVID-19 pneumonia': 1, 'Lymphopenic community acquired pneumonia as signature of severe COVID-19 infection': 1, 'The role of neutrophil to lymphocyte count ratio in the differential diagnosis of pulmonary tuberculosis and bacterial community-acquired pneumonia: a cross-sectional study at Ayder and Mekelle Hospitals': 1, 'Lymphocyte-to-monocyte ratio effectively predicts survival outcome of patients with obstructive colorectal cancer': 1, 'Neutrophil-to-lymphocyte ratio and lymphocyteto-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis': 1, 'Characteristics and Associations with Severity in COVID-19 Patients: a Multicentre Cohort Study from Jiangsu Province': 1, 'Intracellular RNAs of the feline infectious peritonitis virus strain 791146': 1, 'Coronavirus gene expression: genome organization and protein expression': 1, 'An overview of feline enteric coronavirus and infectious peritonitis virus infections': 2, 'Feline coronavirus type II strains 79-1683 and 79-1146 originate from a double recombination between feline coronavirus type I and canine coronavirus': 2, 'The prevalence of types I and II feline coronavirus infections in cats': 1, 'Risk factors for feline infectious peritonitis among cats in multiple-cat environments with endemic feline enteric coronavirus': 3, 'A review of feline infectious peritonitis virus: molecular biology, immunopathogenesis, clinical aspects, and vaccination': 1, 'Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization': 4, 'An uncommon intestinal manifestation of feline infectious peritonitis: 26 cases (1986-1993)': 1, 'Placebo-controlled evaluation of a modified life virus vaccine against feline infectious peritonitis: safety and efficacy under field conditions': 1, 'Patterns of feline coronavirus infection and fecal shedding from cats in multiple-cat environments': 3, 'Feline infectious peritonitis viruses arise by mutation from endemic feline enteric coronaviruses': 6, 'The molecular genetics of feline coronaviruses: comparative sequence analysis of the ORF7a/7b transcription unit of different biotypes': 2, 'Two related strains of feline infectious peritonitis virus isolated from immunocompromised cats infected with a feline enteric coronavirus': 5, 'Rapid and simple method for purification of nucleic acid': 1, 'Rapid and sensitive method for detection of hepatitis C virus RNA by using silica particles': 1, 'Primary structure of the membrane and nucleocapsid protein genes of feline infectious peritonitis virus and immunogenicity of recombinant vaccinia viruses in kittens': 1, 'Experiences on the application of the polymerase chain reaction in a diagnostic laboratory': 1, 'Mutation analysis of genetic diseases by asymmetric-PCR SSCP and ethidium bromide staining: application to neurofibromatosis and cystic fibrosis': 1, 'Genomic organization and expression of the 3′ end of the canine and feline enteric coronaviruses': 1, 'Persistence and evolution of feline coronavirus in a closed cat-breeding colony': 1, 'An enteric coronavirus infection of cats and its relationship to feline infectious peritonitis': 4, 'High-frequency RNA recombination of murine coronaviruses': 1, 'Establishing a genetic recombination map of murine coronavirus strain A59 complementation groups': 1, 'RNA virus populations as quasispecies': 1, 'Recombination in large RNA viruses: Coronaviruses': 1, 'The potential role of IL-6 in monitoring severe case of coronavirus disease2019. medRxiv': 1, 'Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology': 9, 'Ribavirin and interferon alfa-2a for severe middle east respiratory syndrome coronavirus infection: a retrospective cohort study': 1, 'Tocilizumab: a new opportunity in the possible therapeutic arsenal against COVID-19': 1, 'Why tocilizumab could be an effective treatment for severe COVID-19?': 3, 'Effective treatment of severe COVID-19 patients with Tocilizumab': 2, 'Role of LOPINAVIR/RITONAVIR in the treatment of SARS: initial virological and clinical findings': 1, 'The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies': 1, 'Pharmacokinetics and pharmacodynamics of Tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, following single-dose administration by subcutaneous and intravenous routes to healthy subjects': 1, 'Nucleocapsid protein of SARS-CoV activates interleukin-6 expression through cellular transcription factor NF-kappaB': 1, 'FDA approval summary: tocilizumab for treatment of chimeric antigen receptor T cell-induced severe or life-threatening cytokine release syndrome': 1, 'IL-6 inhibitor for the treatment of rheumatoid arthritis: a comprehensive review': 1, 'Laboratory abnormalities in patients with COVID-2019 infection': 2, 'Coronavirus infections and immune responses': 5, 'Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?': 1, 'Intrinsically disordered proteins in overcrowded milieu: membrane-less organelles, phase separation, and intrinsic disorder': 2, 'Controlling compartmentalization by nonmembrane-bound organelles': 1, 'The centrosome is a selective condensate that nucleates microtubules by concentrating tubulin': 1, 'Noise reduction in the intracellular pom1p gradient by a dynamic clustering mechanism': 1, 'Protein disorder, prion propensities, and self-organizing macromolecular collectives': 1, 'Altered ribostasis: RNA-protein granules in degenerative disorders': 1, 'Decoding ALS: from genes to mechanism': 1, 'Viruses as hijackers of PML nuclear bodies': 1, 'Inhibition of stress granule formation by middle east respiratory syndrome coronavirus 4a accessory protein facilitates viral translation, leading to efficient virus replication': 1, 'Understanding protein non-folding': 2, 'Triggering the interferon antiviral response through an IKKrelated pathway': 1, 'Atg9a controls dsDNA-driven dynamic translocation of STING and the innate immune response': 1, 'MAP4-regulated dynein-dependent trafficking of BTN3A1 controls the TBK1-IRF3 signaling axis': 1, 'TBK1 and IKKepsilon prevent TNF-induced cell death by RIPK1 phosphorylation': 1, 'dynamics and mitosis': 3, 'TBK1 suppresses RIPK1-driven apoptosis and inflammation during development and in aging': 1, 'Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth': 1, 'Zika virus disrupts phospho-TBK1 localization and mitosis in human neuroepithelial stem cells and radial glia': 1, 'The TBK1 adaptor and autophagy receptor NDP52 restricts the proliferation of ubiquitin-coated bacteria': 2, 'RIP2 filament formation is required for NOD2 dependent NF-kappaB signalling': 1, 'The molecular mechanisms of signaling by cooperative assembly formation in innate immunity pathways': 1, 'An aberrant phase transition of stress granules triggered by misfolded protein and prevented by chaperone function': 2, 'A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells': 1, 'Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin': 1, 'Hsp90 regulates activation of interferon regulatory factor 3 and TBK-1 stabilization in Sendai virus-infected cells': 1, 'Dynamic recruitment and activation of ALS-associated TBK1 with its target optineurin are required for efficient mitophagy': 1, 'The Golgi apparatus acts as a platform for TBK1 activation after viral RNA sensing': 3, 'Kinase-inactivated ULK proteins inhibit autophagy via their conserved C-terminal domains using an Atg13-independent mechanism': 2, 'Kinase-controlled phase transition of membraneless organelles in mitosis': 2, 'SINTBAD, a novel component of innate antiviral immunity, shares a TBK1-binding domain with NAP1 and TANK': 2, 'Severe fever with thrombocytopenia syndrome phlebovirus non-structural protein activates TPL2 signalling pathway for viral immunopathogenesis': 3, 'Phase transition of a disordered nuage protein generates environmentally responsive membraneless organelles': 1, 'Structural insights into linear tri-ubiquitin recognition by A20-binding inhibitor of NF-kappaB': 1, 'A20-binding inhibitor of nuclear factor-kappaB (NF-kappaB)-2 (ABIN-2) is an activator of inhibitor of NF-kappaB (IkappaB) kinase alpha (IKKalpha)-mediated NF-kappaB transcriptional activity': 1, 'ABIN2 function is required to suppress DSS-induced colitis by a Tpl2-independent mechanism': 1, 'Molecular basis of Tank-binding kinase 1 activation by transautophosphorylation': 1, 'Identification of a splice variant of optineurin which is defective in autophagy and phosphorylation': 1, 'Metabolic regulation of innate and adaptive lymphocyte effector responses': 1, 'Metabolism as a guiding force for immunity': 1, 'Distinct functions of Ulk1 and Ulk2 in the regulation of lipid metabolism in adipocytes': 1, 'IL-1 plays an important role in lipid metabolism by regulating insulin levels under physiological conditions': 1, 'TRAF6 and A20 regulate lysine 63-linked ubiquitination of Beclin-1 to control TLR4-induced autophagy': 1, 'Dissection of TBK1 signaling via phosphoproteomics in lung cancer cells': 1, 'The intricate interplay between RNA viruses and NF-kappaB': 1, 'Identification of a novel A20-binding inhibitor of nuclear factor-kappa B activation termed ABIN-2': 1, 'Activation of ULK Kinase and Autophagy by GABARAP Trafficking from the Centrosome Is Regulated by WAC and GM130': 1, 'GCN5 is a required cofactor for a ubiquitin ligase that targets NF-kappaB/RelA': 1, 'SUMO modification of TBK1 at the adaptor-binding C-terminal coiled-coil domain contributes to its antiviral activity': 1, 'Genome engineering using the CRISPR-Cas9 system': 2, 'CDK1-mediated phosphorylation at H2B serine 6 is required for mitotic chromosome segregation': 2, 'Stop and go extraction tips for matrixassisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics': 1, 'MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification': 1, 'Instant Clue: A Software Suite for Interactive Data Visualization and': 1, 'ESpritz: accurate and fast prediction of protein disorder': 1, 'Coronavirus en diarrea neonatal de los terneros': 1, 'Enterovirus bovino. Caracterizaci6n de un aislamiento realizado en el pafs': 1, 'Infecci6n experimental en ovinos con virus de leucemia bovina enzo6tica (BLV)': 1, 'Developmental aspects of the fetal bovine immune response: a review': 2, 'Viral infection of the bovine fetus and its environment': 3, 'Methods for detection and frequency of contamination of fetal calf serum with bovine viral diarrhea virus and antibodies against bovine viral diarrhea virus': 1, 'Detection of bovine herpesvirus type 1 via an immunoperoxidase method using monoclonal antibodies': 1, 'Immunologic response of the bovine fetus to infectious bovine rhinotracheitis-infectious pustular vulvovaginitis virus': 1, 'In Herpesvirus Diseases of Cattle, Horses and Pigs. Developments in Veterinary Virology': 2, 'Bovine viral diarrhea-mucosal disease virus infection in pregnant cows': 1, 'The pathogenesis of bovine viral diarrhoea virus infection. Revue Scientifique et Technique de l': 1, 'Immunofluorescence and cell culture techniques in the diagnosis of viral infections of aborted bovine fetuses': 2, 'Diagnostic studies of the fetus, placenta and materual blood from 265 abortions': 2, 'Pdrdidas reproductivas y abortos ocasionados por el virus de la diarrea viral bovina en un rodeo de la provincia de': 1, 'Pestivirus fetopathogenicity in cattle: Changing sequelae with fetal maturation': 1, 'Antibodies against several viruses in sera from normal bovine fetuses and precolostral calves': 1, 'Inhibitors of bovine parvovirus, coronavirus and rotavirus in precoloslral and fetal bovine sera': 2, 'Fiebre aftosa': 1, 'Las enfermedadas animales por retrovirus: leucosis bovina enzo6tica, anemia infecciosa de los 6quidos, artritis/encefalitis caprina': 1, \"The public's response to severe acute respiratory syndrome in Toronto and the United States\": 1, 'The creation and resolution of market uncertainty: the impact of information releases on implied volatility': 1, 'Economic freedom and the stability of stock prices: A cross-country analysis': 5, 'COVID-19 Crisis Poses Threat to Financial Stability': 2, 'Bid, ask and transaction prices in a specialist market with heterogeneously informed traders': 1, 'Trades, quotes, inventories, and information': 1, 'Annual report readability and stock liquidity. Financial Markets': 1, 'Deciphering the liquidity and credit crunch': 1, 'Coronavirus and financial volatility: 40 days of fasting and fear': 2, 'Financial contagion during COVID-19 crisis': 1, 'Death and contagious infectious diseases: Impact of the COVID-19 virus on stock market returns': 1, '#Flattenthecurve and Stock Market Liquidity -An Inquiry into Emerging Economies. Emerging Markets Finance and Trade': 1, 'COVID-19: Media coverage and financial markets behavior-A sectoral inquiry': 1, 'A model of investor sentiment': 1, 'Social trust and the liquidity of cross-listed securities': 3, 'Price clustering and economic freedom: The case of cross-listed securities': 1, 'Free trade and the efficiency of financial markets': 1, 'Does religiosity affect liquidity in financial markets': 2, 'Exchange rate volatility and the stability of stock prices': 1, 'Illiquidity and stock returns: cross-section and time-series effects': 6, 'Range-based estimation of stochastic volatility models': 2, 'Price clustering and sentiment in bitcoin': 1, 'Stock prices and geographic proximity of information: Evidence from the Ebola outbreak': 1, 'Dangerous infectious diseases: Bad news for Main Street, good news for Wall Street?': 2, 'Economic Freedom and Financial Market Liquidity: Evidence from ADRs. Available at SSRN 2708519': 1, 'Aerosol box, an operating room security measure in COVID-19 pandemic': 2, 'A multipurpose portable negative air flow isolation chamber for aerosol-generating procedures during the COVID-19 pandemic': 4, 'Reducing droplet spread during airway manipulation: lessons from the COVID-19 pandemic in Singapore': 1, 'Barrier enclosure during endotracheal intubation': 3, 'Should we continue using laparoscopy amid the COVID-19 pandemic?': 1, 'A review on recent progress in observations, and health effects of bioaerosols': 1, 'Evaluating the colonization and distribution of fungal and bacterial bioaerosol in Rajkot, western India using multi-proxy approach': 1, 'Spatial variation of airborne allergenic fungal spores in the ambient PM2.5-A study in Rajkot City, Western Part of India': 1, 'Global implications of bio-aerosol in pandemic. Environmental Development and Sustainability': 1, 'Treatment of fungal bioaerosols by a high-temperature, short-time process in a continuous-flow system': 1, 'Coronavirus disease 2019 (COVID-19): Situation report-58. World Health Organization': 1, 'Evolution and taxonomy of positive-strand RNA viruses: implications of comparative analysis of amino acid sequences': 3, 'Alphaviruses': 1, 'The alphaviruses: gene expression, replication and evolution': 2, 'Sindbis virus proteins nsP1 and nsP2 contain homology to non-structural proteins from several RNA plant viruses': 1, 'Striking similarities in amino acid sequence among non-structural proteins encoded by RNA viruses that have dissimilar genomic organisation': 1, 'Phosphorylation site analysis of Semliki Forest virus nonstructural protein 3': 1, 'Formation of nsP3 specific protein complexes during Sindbis virus replication': 1, 'Deletions in the hypervariable domain of the nsP3 gene attenuates Semliki Forest virus virulence': 1, 'In vitro synthesis of infectious Venezuelan Equine Encephalitis virus RNA from a cDNA clone: analysis of a viable deletion mutant': 4, \"Nonstructural proteins nsP3 and nsP4 of Ross River and O'Nyong-nyong viruses: sequence and comparison with those of oyther alphaviruses\": 2, 'Sequencing of protype viruses in the Venezuelan equine encephalitis antigenic complex': 2, 'Complete sequence of Venezuelan equine encephalitis virus subtype 1E reveals conserved and hypervariable domains within the C terminus of nsP3': 2, 'Ross River virus: ecology and distribution': 1, 'Molecular evolutionary dynamics of Ross River virus and implications for vaccine efficacy': 4, 'An epidemic of Ross River virus in Fiji': 1, 'Ross River virus: epidemic polyarthritis': 2, 'Venezuelan encephalitis emergence mediated by a phylogenetically predicted viral mutation': 2, 'Epistatic roles of E2 glycoprotein mutations in adaption of Chikungunya virus to Aedes albopictus and Ae. Aegypti mosquitoes': 2, 'Isolation of Ross River virus from epidemic polyarthritis patients in Australia': 1, 'New insights into the mechanism of RNA recombination': 1, 'Evolutionary relationships and systematics of the alphaviruses': 1, 'Evolutionary patterns of Eastern Equine Encephalitis virus in North versus South America suggest ecological differences and taxonomic revision': 1, '18S defective interfering RNA of Semliki Forest virus contains a triplicated linear repeat': 2, 'Studies of defective interfering RNAs of Sindbis virus with and without tRNA Asp sequences at their 5′ termini': 2, 'Increased fidelity reduces poliovirus fitness and virulence under selective pressure in mice': 1, 'Noninvasive ventilation for chest wall and neuromuscular disorders': 1, 'British Thoracic Society guideline for respiratory management of children with neuromuscular weakness': 1, 'Foundation for Infantile Paralysis-March of Dimes': 1, 'Intermittent positive pressure ventilation via the mouth as an alternative to tracheostomy for 257 ventilator users': 1, 'Nocturnal mechanical ventilation for chronic hypoventilation in patients with neuromuscular and chest wall disorders': 1, '228th ENMC International Workshop:: Airway clearance techniques in neuromuscular disorders': 2, 'Airway clearance techniques in neuromuscular disorders: A state of the art review': 2, 'Pneumobelt for sleep in the ventilator user: clinical experience': 1, 'Evaluation of ventilators for mouthpiece ventilation in neuromuscular disease': 8, 'Mouthpiece ventilation and complementary techniques in patients with neuromuscular disease: A brief clinical review and update': 3, 'An evaluation of home volume ventilators that support opencircuit mouthpiece ventilation': 2, 'Noninvasive Ventilation for Neuromuscular Disease': 2, 'Accuracy of tidal volume delivered by home mechanical ventilation during mouthpiece ventilation: A bench evaluation': 3, 'Home ventilator performances with mouthpiece ventilation: Does resistance change effectiveness?': 2, 'Home monitoring of daytime mouthpiece ventilation effectiveness in patients with neuromuscular disease': 4, 'Diurnal ventilation via mouthpiece: survival in end-stage Duchenne patients': 2, 'Are home ventilators able to guarantee a minimal tidal volume?': 1, 'Harms of unintentional leaks during volume targeted pressure support ventilation': 1, 'Effect of dynamic random leaks on the monitoring accuracy of home mechanical ventilators: a bench study': 1, 'The configuration of bi-level ventilator circuits may affect compensation for non-intentional leaks during volume-targeted ventilation': 1, 'Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement': 1, 'Daytime Mouthpiece for Continuous Noninvasive Ventilation in Individuals With Amyotrophic Lateral Sclerosis': 4, 'Twenty-four hour noninvasive ventilation in Duchenne muscular dystrophy: a safe alternative to tracheostomy': 2, 'Noninvasive Respiratory Management of Patients With Neuromuscular Disease': 1, 'Open circuit mouthpiece ventilation: Concise clinical review': 5, 'Tidal volume during mouthpiece non-invasive home ventilation: When the choice is the right answer': 1, 'Mouthpiece ventilation: Individualized patient care is the key to success': 1, 'On sleep and an apparatus for promoting artificial respiration': 1, 'Management of end stage respiratory failure in Duchenne muscular dystrophy': 1, 'Intermittent daytime mouthpiece ventilation successfully augments nocturnal non-invasive ventilation, controlling ventilatory failure and maintaining patient independence': 2, 'Mouthpiece Ventilation in Patients with Neuromuscular Disease: A Brief Clinical Review': 3, 'Preference of neuromuscular patients regarding equipment for daytime mouthpiece ventilation: A randomized crossover study': 1, 'Lung volume effects on pharyngeal swallowing physiology': 1, 'Breathing-swallowing interaction in neuromuscular patients: a physiological evaluation': 1, 'Noninvasive Mechanical Ventilation Improves Breathing-Swallowing Interaction of Ventilator Dependent Neuromuscular Patients: A Prospective Crossover Study': 1, 'Swallowing with Noninvasive Positive-Pressure Ventilation (NPPV) in Individuals with Muscular Dystrophy: A Qualitative Analysis': 1, 'Experiences of Speaking With Noninvasive Positive Pressure Ventilation: A Qualitative Investigation': 1, 'Noninvasive ventilation using a mouthpiece in patients with chronic obstructive pulmonary disease and acute respiratory failure': 1, 'Extubation of patients with neuromuscular weakness: a new management paradigm': 1, 'Increased exercise tolerance using daytime mouthpiece ventilation for patients with diaphragm paralysis': 1, 'The patient experience and health outcomes': 1, 'Clinical development of gene therapy for colorectal cancer': 1, 'Research evolution of colorectal cancer in China': 1, 'Angiogenesis in cancer, vascular, rheumatoid and other disease': 1, 'Angiogenesis and tumor metastasis': 1, 'Vascular endothelial growth factor is a secreted angiogenic mitogen': 1, 'Research of micro blood vessel density and expression of vascular endothelial growth factor': 1, 'Research development of VEGF and its effect on angiogenesis in tumour': 1, 'Research status and prospect of gene therapy for colorectal cancer': 1, 'Role of the double-stranded RNA-activated protein kinase (PKR) in cell regulation': 1, 'Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans': 1, 'Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells': 1, 'A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics': 1, 'Vascular endothelial growth factor mRNA isoform expression is correlated with liver metastasis and poor prognosis in colon cancer': 1, 'The biology of vascular endothelial growth factor': 1, 'A simple and cost effective method for producing small interfering RNAs with high efficacy': 1, 'Identification of essential genes in cultured mammalian cells using small interfering RNAs': 1, 'RNA interference in mammalian cells using siRNAs synthesized with T7 RNA polymerase': 1, 'Synthetic small inhibiting RNAs: efficient tools to inactivate oncogenic mutations and restore p53 pathways': 1, 'Coronavirus: organisation, replication and expression of genome': 1, 'Feline infectious peritonitis and feline enteric coronavirus infections': 1, 'Antibody, immune complexes and complement activity fluctuations in kittens with experimentally induced feline infectious peritonitis': 1, 'Monoclonal antibodies to the spike protein of feline infectious peritonitis virus mediate antibody-dependent enhancement of infection of feline macrophages': 2, 'Feline infectious peritonitis. Veterinary Clinics of North America': 1, 'Feline infectious peritonitis in a closed breeding colony': 1, 'Naturally occurring infectious peritonitis: signs and clinical diagnosis': 1, 'Feline infectious peritonitis: something old, something new': 1, 'Isolation of feline coronaviruses from two cats with diverse manifestations': 1, 'The Viruses of Laboratory Rodents and Lagomorphs. British Veterinary Association': 1, 'Models@run.time: a guided tour of the state of the art and research challenges': 1, 'Digital twin-based smart production management and control framework for the complex product assembly shop-floor': 1, 'A multi-paradigm modelling approach to live modelling': 1, 'Runtime failure prevention and reaction': 4, 'CoMA: conformance monitoring of Java programs by abstract state machines': 1, 'Formal methods @ runtime': 1, 'Software monitoring through formal specification animation': 1, 'Runtime enforcement of cyber-physical systems': 1, 'Analysis of safety-critical computer failures in medical devices': 1, 'Formal design and verification of selfadaptive systems with decentralized control': 1, 'ActivFORMS: a model-based approach to engineer selfadaptive systems': 1, 'Time for a new era of science diplomacy': 1, 'States of knowledge: The co-production of science and the social order': 1, 'Knowledge actors and transnational governance: The public-private policy nexus in the global Agora': 3, 'Transgovernmental policy networks in the anglosphere': 1, 'Science diplomacy: Investigating the perspective of scholars on politics-science collaboration in international affairs': 2, 'Sustainable diplomacies': 1, 'Policy diffusion and policy transfer': 1, 'New public diplomacy in the 21st century: A comparative study of policy and practice': 1, 'Theorising the role of cultural products in cultural diplomacy from a cultural studies perspective': 1, 'European Union economic diplomacy: The role of the EU in external economic relations': 1, 'Environmental diplomacy: negotiating more effective global agreements': 1, 'Water diplomacy: A negotiated approach to managing complex water networks': 1, 'The four horsemen of the apocalypse: tropical medicine in the fight against plague, death, famine, and war': 1, 'Privatizing diplomacy? International Studies Perspectives': 1, 'Epistemic communities, constructivism, and international environmental politics': 1, 'Advancing science diplomacy: Indonesia and the US Naval Medical Research Unit': 2, 'Research policy and academic performativity: Compliance, contestation and complicity': 1, 'Scholarship with impact': 1, 'A realist theory of science': 1, 'Science et société: les trois traductions': 1, \"Impact' in the proposals for the UK's research excellence framework: Shifting the boundaries of academic autonomy\": 1, 'The new philanthropy: Private power in international development policy': 1, 'The administration of informal intergovernmental organisations': 2, 'Interpreting territory and power': 1, 'Science diplomacy at the intersection of S&T policies and foreign affairs: Towards a typology of national approaches': 1, 'Global policy advisory systems: Patterns, trajectories and impacts': 3, 'Soft power: The means to success in world politics': 1, 'South Korea pushes the envelope in science diplomacy': 1, 'The EU, structural diplomacy and the challenge of learning': 1, 'Science and technology in global cooperation: The case of the United Nations and UNESCO': 1, 'The newton fund: Science and innovation for development and diplomacy, science and diplomacy': 2, 'From Clinton to Blair: the Democratic (Party) origins of welfare to work': 1, 'The Americanization of British welfare: a case study of policy transfer': 1, 'The political uses of expert knowledge: Immigration policy and social research': 1, 'Evidence-based policymaking-speaking truth to power?': 1, 'Science advice to governments: An emerging dimension of science diplomacy': 2, 'Assessing 30 years of Westminster policy advisory system experience': 1, 'Advances to the study of international public administration': 1, 'The politics of expertise in international organizations: How international bureaucracies produce and mobilize knowledge': 1, 'Global public policy and transnational administration': 1, 'The relevance of political science': 1, 'Complications of seasonal and pandemic influenza': 1, 'Pulmonary embolism hospitalization, readmission, and mortality rates in US older adults': 1, 'Our recommendations for acute management of COVID-19': 1, 'Prevention and treatment of venous thromboembolism associated with coronavirus disease 2019 infection: a consensus statement before guidelines': 1, 'Clinical analysis of 31 cases of 2019 novel coronavirus infection in children from six provinces (autonomous region) of northern China': 1, 'Innate immunity to respiratory infection in early life': 1, 'Middle East respiratory syndrome coronavirus disease in children': 2, 'Middle East respiratory syndrome coronavirus in children': 1, 'World Health Organization. Coronavirus disease (COVID-19) situation report-41': 1, 'Korea Centers for Disease Control & Prevention. The updates of COVID-19 in the Republic of Korea': 1, 'Modification of an outbreak of influenza in Tecumseh, Michigan by vaccination of schoolchildren': 1, 'Analysis of CT features of 15 children with 2019 novel coronavirus infection': 1, 'Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. The Lancet Infectious Diseases': 1, 'Vaccine Effectiveness Against Laboratory-Confirmed Influenza in Children 6 to 59 Months of Age During the': 1, 'Cost-effectiveness of Palivizumab for Respiratory Syncytial Virus Infection in High-risk Children, Based on Long-term Epidemiologic Data From Austria': 1, 'Influenza: Epidemiology, Clinical Features, Therapy, and Prevention': 1, 'Rates of hospitalization for respiratory syncytial virus infection among children in medicaid': 1, 'Molecular characterization of a nosocomial outbreak of human respiratory syncytial virus on an adult leukemia/lymphoma ward': 2, 'Typespecific identification of influenza viruses A, B and C by the polymerase chain reaction': 1, 'Type-specific identification of human adenovirus 3, 7 and 21 by a multiplex pcr assay': 1, 'Comparison of quantitative reverse transcription-PCR to viral culture for assessment of respiratory syncytial virus shedding': 2, 'Simultaneous detection and identification of human parainfluenza viruses 1, 2, and 3 from clinical samples by multiplex PCR': 1, 'RT-PCR (rRTPCR) Protocol for Detection and Characterization of Swine Influenza': 1, 'Secretaria de Vigilância em Saú de, Departamento de Vigilância Epidemioló gica': 1, 'Resolução SS n8 249, de 13 de julho de 2007. Norma Té cnica que estabelece as diretrizes para prevenção da infecção pelo Vírus Sincicial Respirató rio -VSR no âmbito do Sistema Ú nico do Estado de São Paulo': 1, 'Diretrizes para o Manejo da Infecção Causada pelo Vírus Sincicial Respirató rio (VSR)': 2, 'Vainionpä ä R. Human metapneumovirus infections in children': 1, 'Very Young Infants Severity of Acute Bronchiolitis Depends On Carried Viruses. Morty RE': 1, 'Risk Factors in Children Hospitalized With RSV Bronchiolitis Versus Non-RSV Bronchiolitis': 1, 'Correlation of viral load of respiratory pathogens and co-infections with disease severity in children hospitalized for lower respiratory tract infection': 2, 'Epidemiological profile and clinical associations of human bocavirus and other human parvoviruses': 1, 'Etiology of bronchiolitis in a hospitalized pediatric population: Prospective multicenter study': 1, 'Adenovirus respiratory infection: significant increase in diagnosis using PCR comparing with antigen detection and culture methods': 1, 'Há rsi CM. Molecular epidemiology of human adenovirus isolated from children hospitalized with acute respiratory infection in São Paulo': 1, 'Viral and Atypical Bacterial Detection in Acute Respiratory Infection in Children Under Five Years': 1, 'Hospital admissions in children with Down syndrome: experience of a population-based cohort followed from birth': 1, 'Down syndrome and hospitalizations due to respiratory syncytial virus: a population-based study': 1, \"Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study\": 1, 'Sr: Mortality and morbidity among infants at high risk for severe respiratory syncytial virus infection receiving prophylaxis with palivizumab: A systematic literature review and meta-analysis': 1, 'Epidemiology and Prevention of Respiratory Syncytial Virus Infections Among Infants and Young Children': 1, 'Bordetella pertussis Infection Is Common in Nonvaccinated Infants Admitted for Bronchiolitis': 1, 'Viral Infections of the Lower Respiratory Tract: Old Viruses, New Viruses, and the Role of Diagnosis': 1, 'Telomeric repeat containing RNA structure in living cells': 5, 'G quadruplexes: the beginning and end of UTRs': 2, 'DNA secondary structures: stability and function of G quadruplex structures': 1, 'G quadruplex struc tures: in vivo evidence and function': 2, 'G4 motifs affect origin positioning and efficien cy in two vertebrate replicators': 2, 'Characterizing and controlling intrinsic biases of lambda exonuclease in nascent strand sequencing reveals phasing between nucleosomes and G quadruplex motifs around a subset of human replication origins': 1, 'Telomerase recruit ment by the telomere end binding protein beta facilitates G quadruplex DNA unfolding in ciliates': 1, 'Targeting G quadruplexes in gene promoters: a novel anti cancer strategy?': 4, 'Mutagenic capa city of endogenous G4 DNA underlies genome instabi lity in FANCJ defective C. elegans': 1, 'Genome wide study predicts promoter G4 DNA motifs regulate selective functions in bacteria: radioresistance of D. radio durans involves G4 DNA mediated regulation': 2, 'An alternative DNA structure is necessary for pilin antigenic variation in Neisseria gonorrhoeae': 2, 'Genomes and G quadruplexes: for better or for worse': 1, 'Determinants of G quadruplex induced epigenetic instability in REV1 deficient cells': 1, '5′ UTR G quadruplex structures acting as translational repressors': 2, 'Exploring mRNA 3′ UTR G quadruplexes: evidence of roles in both alternative polyadenylation and mRNA shortening': 2, 'G quadruplex nucleic acids and human disease': 1, 'G quadruplexes: emerging roles in neurodegenerative diseases and the non coding transcrip tome': 3, 'Molecular dynamics simulations reveal the balance of forces governing the formation of a guanine tetrad -a common structural unit of G quadruplex DNA': 1, 'A structural analysis of G quadruplex/ligand interactions': 3, 'Structure of a left handed DNA G quadruplex': 2, 'A sequence independent study of the influence of short loop lengths on the stability and topology of intramolecular DNA G quadruplexes': 6, 'Classification of G quadruplex DNA on the basis of the quadruplex twist angle and planarity of G quartets': 1, 'Polyelectrolyte effects in G quadruplexes': 2, 'Structural polymorphism of intramolecular quadru plex of human telomeric DNA: effect of cations, quadru plex binding drugs and flanking sequences': 2, 'Cation binding to 15 TBA quadruplex DNA is a multiple pathway cation dependent process': 4, 'The exception that confirms the rule: a higher order telomeric G quadruplex structure more stable in sodium than in potassium': 3, 'Strand directionality affects cation binding and movement within tetramolecular G quadruplexes': 1, 'Stacking and not solely topology of T3 loops controls rigidity and ammo nium ion movement within d(G 4 T 3 G 4 ) 2 G quadruplex': 2, 'Assessment of selectivity of G quadruplex ligands via an optimised FRET melting assay': 4, 'Effects of salt on the stability of a G quadruplex from the human c MYC promoter': 2, 'Crystal structure of a DNA/Ba 2+ G quadruplex containing a water mediated C tetrad': 1, 'Kinetics and mechanism of G quadruplex formation and conformational switch in a G quadruplex of PS2.M induced by Pb 2+': 1, 'Metallo responsive switching between hexadecameric and octamer ic supramolecular G quadruplexes': 1, 'Quadruplex turncoats: cation dependent folding and stability of quadruplex DNA double switches': 4, 'Linkage of cation binding and folding in human telomeric quadruplex DNA': 1, 'Stacking of G quadruplexes: NMR struc ture of a G rich oligonucleotide with potential anti HIV and anticancer activity': 4, 'Parallel G quadruplexes formed by guanine rich microsatellite repeats inhibit human topoisomerase I': 3, 'Sequence effects in single base loops for quadruplexes': 6, 'Structures, folding pat terns, and functions of intramolecular DNA G quadru plexes found in eukaryotic promoter regions': 2, 'Effect of loop sequence and loop length on the intrinsic fluorescence of G quadruplexes': 2, 'Structure of the human telomere in K + solution: a stable basket type G quadruplex with only two G tetrad layers': 3, 'Formation of G quadruplexes in poly G sequences: structure of a pro peller type parallel stranded G quadruplex formed by a G 15 stretch': 2, 'Explaining the varied glycosidic conformational, G tract length and sequence preferences for anti parallel G quadruplexes': 1, 'Unfolding thermodynamics of intramolecular G quadru plexes: base sequence contributions of the loops': 2, 'G quadruplex structure: a target for anticancer therapy and a probe for detection of potassium': 1, 'Resolution and characterization of the structural polymorphism of a single quadruplex forming sequence': 5, ') d(CGGTGGT) forms an octameric parallel G quadruplex via stacking of unusual G(:C):G(:C):G(:C):G(:C) octads': 2, 'DNA based nanostructures: the effect of the base sequence on octamer formation from d(XGGYGGT) tetramolecular G quadruplexes': 2, 'RecA binding pilE G4 sequence essential for pilin antigenic variation forms monomeric and 5′ end stacked dimeric parallel G quadruplexes': 2, 'Structure and conformational dynamics of a stacked dimeric G quadruplex formed by the human CEB1 minisatellite': 4, 'Human telomeric G quadruplex: struc tures of DNA and RNA sequences': 7, 'Engineering of inter locked DNA G quadruplexes as a robust scaffold': 2, 'Mapping the sequences of potential guanine quadruplex motifs': 1, 'QuadBase: genome wide data base of G4 DNA occurrence and conservation in human, chimpanzee, mouse and rat promoters and 146 microbes': 1, 'GRSDB2 and GRS_UTRdb: databases of quadru plex forming G rich sequences in pre mRNAs and mRNAs': 1, 'The G4 genome': 1, 'Human telomeric G quadruplex: the current status of telomeric G quadruplexes as therapeutic targets in human cancer': 4, 'Formation of pearl necklace monomorphic G quadruplexes in the human CEB25 minisatellite': 3, 'Microsatellite tandem repeats are abundant in human pro moters and are associated with regulatory elements': 1, 'Quadruplex forming sequences occupy discrete regions inside plant LTR retro transposons': 2, 'Making sense of G quadruplex and i motif functions in oncogene promoters': 4, 'Genome wide analysis reveals regulatory role of G4 DNA in gene transcription': 1, 'Unraveling cell type specific and reprogrammable human replication origin signatures associated with G quadruplex consensus motifs': 1, 'New insights into repli cation origin characteristics in metazoans': 1, 'Potential G quadruplex formation at breakpoint regions of chromosomal translocations in cancer may explain their fragility': 1, 'Genome wide analyses of recombination prone regions predict role of DNA structural motif in recombina tion': 1, 'Solution structure of a unique G quadruplex scaffold adopted by a guanosine rich human intronic sequence': 1, 'Genome wide colo nization of gene regulatory elements by G4 DNA motifs': 1, 'Association of G quadruplex form ing sequences with human mtDNA deletion breakpoints': 1, 'Structure, location and interactions of G quadruplexes': 3, 'Structure of human telomeric RNA (TERRA): stacking of two G quadruplex blocks in K + solution': 4, 'A potassium ion dependent RNA structural switch regulates human pre miRNA 92b maturation': 3, 'Potential G quadruplexes in the human long non coding transcriptome': 2, 'QGRS Conserve: a computational method for dis covering evolutionarily conserved G quadruplex motifs': 1, 'G4 quadruplexes and genome instability': 2, 'G quadru plexes in promoters throughout the human genome': 1, 'DNA G quadruplex formation in response to remote downstream transcription activity: long range sens ing and signal transducing in DNA double helix': 4, 'The major G quadruplex formed in the human BCL 2 proximal promoter adopts a parallel structure with a 13 nt loop in K + solution': 4, 'G4 DNA: at risk in the genome': 1, 'G4 motifs correlate with promoter proximal transcriptional pausing in human genes': 1, 'G quadruplex DNA sequences are evolutionarily conserved and associated with distinct genomic features in Saccharomyces cerevisiae': 1, 'A stable RNA G quadruplex with in the 5′ UTR of Arabidopsis thaliana ATR mRNA inhibits translation': 1, 'High throughput sequencing of DNA G quadruplex structures in the human genome': 1, 'How long is too long? Effects of loop size on G quadru plex stability': 4, 'Bulges in G quadruplexes: broadening the definition of G quadruplex forming sequences': 1, 'New scoring system to identify RNA G quadruplex fold ing': 2, 'Effect of loops and G quartets on the stability of RNA G quadru plexes': 5, 'Re eval uation of G quadruplex propensity with G4Hunter': 1, 'The genome wide distribution of non B DNA motifs is shaped by oper on structure and suggests the transcriptional importance of non B DNA structures in Escherichia coli': 2, 'Role for G quadruplex RNA binding by Epstein-Barr virus nuclear antigen 1 in DNA replication and metaphase chromosome attachment': 1, 'G quadruplexes regulate Epstein-Barr virus encoded nuclear antigen 1 mRNA translation': 2, 'Human papillo mavirus G quadruplexes': 1, 'G quadruplex forming oligonucleotides as anti HIV agents': 1, 'Circular dichroism and guanine quadruplexes': 2, 'Monitoring the temperature unfolding of G quadruplexes by UV and cir cular dichroism spectroscopies and calorimetry tech niques': 1, 'Stability of telomeric G quadruplexes': 4, 'Folding thermodynamics of the hybrid 1 type intramolecular human telomeric G quadruplex': 3, 'Structure and stability of higher order human telo meric quadruplexes': 8, 'Duplex quadruplex motifs in a peculiar structural organization cooperatively contribute to throm bin binding of a DNA aptamer': 3, 'A dynamic G quadruplex region regulates the HIV 1 long terminal repeat promoter': 1, 'The importance of neg ative superhelicity in inducing the formation of G quadru plex and i motif structures in the c Myc promoter: impli cations for drug targeting and control of gene expression': 9, 'Evidence of the formation of G quadruplex structures in the promoter region of the human vascular endothelial growth factor gene': 2, 'A fluorescence based helicase assay: application to the screening of G quadruplex ligands': 1, 'G quadruplex formation in double strand DNA probed by NMM and CV fluores cence': 4, 'G quadruplex conformation and dynamics are determined by loop length and sequence': 2, 'Mechanical unfolding of human telomere G quadruplex DNA probed by integrated fluorescence and magnetic tweezers spectroscopy': 2, 'G quadruplex formation in telomeres enhances POT1/TPP1 protection against RPA binding': 2, 'Polymorphism of human telomeric quadruplex structure controlled by DNA concentration: a Raman study': 4, 'Conformations of human telomeric G quadru plex studied using a nucleotide independent nitroxide label': 1, 'Conformations of individual quadruplex units stud ied in the context of extended human telomeric DNA': 1, 'Electrospray mass spec trometry of telomeric RNA (TERRA) reveals the forma tion of stable multimeric G quadruplex structures': 3, 'NMR spec troscopy of G quadruplexes': 2, 'Structure of the human telomere in Na + solution: an antiparallel (2+2) G quadruplex scaffold reveals additional diversity': 2, 'Stability and kinetics of G quadruplex structures': 7, 'Human telomeric G quadruplex: thermodynamic and kinetic studies of telomeric quadru plex stability': 3, 'Predicting and understanding the sta bility of G quadruplexes': 2, 'The stability of intramolecular DNA G quadruplexes compared with other macromolecules': 3, 'Self dissociative primers for nucleic acid amplification and detection based on DNA quadru plexes with intrinsic fluorescence': 1, 'G quadruplexes with (4n-1) guanines in the G tetrad core: formation of a G triad water complex and implication for small molecule bind ing': 1, 'G triplex structure and formation propensity': 2, 'The abasic site lesions in the human telomeric sequence d[TA(G) 3 (T) 2 (A) 3 (G) 3 ]: a thermodynamic point of view': 1, 'G reg ister exchange dynamics in guanine quadruplexes': 1, 'Thermal sta bility of quadruplex primers for highly versatile isothermal DNA amplification': 2, 'Thermodynamic stability and folding kinetics of the major G quadruplex and its loop isomers formed in the nuclease hypersensitive element in the human c Myc promoter: effect of loops and flanking segments on the stability of parallel stranded intramolecular G quadruplexes': 4, 'Short loop length and high ther mal stability determine genomic instability induced by G quadruplex forming minisatellites': 3, 'MYC promoter G quadruplex formed at the 5′ end of NHE III1 element: insights into biological relevance and parallel stranded G quadruplex stability': 2, 'Exploded view of higher order G quadruplex structures through click chemistry assisted single molecule mechanical unfolding': 6, 'Solution structures of all parallel stranded monomeric and dimeric G quadruplex scaffolds of the human c kit2 promoter': 2, 'Reevaluation of the stability of G quadruplex structures under crowding conditions': 2, 'Hydration is required in DNA G quadruplex-pro tein binding': 1, 'Molecular crowding and hydration regulating of G quadruplex formation': 1, 'Dynamics and stability of polymorphic human telomeric G quadruplex under ten sion': 3, 'Energetics and kinetics of a conformational switch in G quadruplex DNA': 1, 'Thermodynamic characterization of human telomere quadruplex unfolding': 2, 'Energetic basis of human telomeric DNA folding into G quadruplex structures': 3, 'Folding and unfolding pathways of the human telomeric G quadruplex': 1, 'Kinetics and struc tures on the molecular path to the quadruplex form of the human telomere': 1, 'Direct measurement of sequential folding pathway and energy landscape of human telomeric G quadruplex structures': 1, 'Long loop G quadru plexes are misfolded population minorities with fast transi tion kinetics in human telomeric sequences': 3, 'Triplex intermediates in folding of human telomeric quadruplexes probed by microsecond scale molecular dynamics simulations': 1, 'Kinetics and mech anism of K + and Na + induced folding of models of human telomeric DNA into G quadruplex structures': 2, 'The kinet ics and folding pathways of intramolecular G quadruplex nucleic acids': 1, 'Stability and kinetics of c MYC promoter G quadruplexes studied by single molecule manipulation': 4, 'Hairpins participating in folding of human telomeric sequence quadruplexes studied by standard and T REMD simula tions': 1, 'Involvement of long lived intermediate states in the complex folding pathway of the human telomeric G quadruplex': 1, 'Kinetically governed polymorphism of d(G(4)T(4)G(3)) quadruplexes in K + solutions': 1, 'Tertiary DNA struc ture in the single stranded hTERT promoter fragment unfolds and refolds by parallel pathways via cooperative or sequential events': 1, 'Interaction of G quadruplexes in the full length 3′ human telomeric overhang': 2, 'G quadruplex and i motif are mutually exclusive in ILPR double stranded DNA': 2, 'Structural and mechanical properties of individual human telomeric G quadruplexes in molecularly crowded solu tions': 2, 'Role of the central cations in the mechanical unfolding of DNA and RNA G quadruplexes': 1, 'Single molecule study of G quadru plex disruption using dynamic force spectroscopy': 1, 'Direct quantification of loop interaction and pi pi stacking for G quadruplex stability at the submolecular level': 1, 'Kinetic partitioning modulates human telomere DNA G quadruplex structur al polymorphism': 1, 'Effect of flanking bases on quadruplex stability and Watson-Crick duplex competition': 1, 'Kinetics of quadruplex to duplex conversion': 1, 'Conformational transition of a hairpin structure to G quadruplex within the WNT1 gene promoter': 1, 'Strand invasion of DNA quadruplexes by PNA: comparison of homolo gous and complementary hybridization': 1, 'DNA gyrase driven generation of a G quadruplex from plasmid DNA': 1, 'Theoretical analysis of competing conformational transitions in super helical DNA': 1, 'Quantification of topological coupling between DNA superhelicity and G quadruplex formation': 1, '2012) I motif formation in gene promoters: unusually stable formation in sequences complementary to known G quadruplexes': 2, 'The dynamic character of the BCL2 promoter i motif provides a mechanism for modulation of gene expression by compounds that bind selectively to the alternative DNA hairpin structure': 2, 'Epigenetic modification, dehydration, and molecular crowding effects on the thermodynamics of i motif structure forma tion from C rich DNA': 1, 'Effect of interior loop length on the thermal stability and pK a of i motif DNA': 1, 'Distance dependent duplex DNA destabilization proximal to G quadruplex/i motif sequences': 1, 'Molecular crowding of the cosolutes induces an intramol ecular i motif structure of triplet repeat DNA oligomers at neutral pH': 1, 'The effect of molecular crowding on the stability of human c MYC promoter sequence i motif at neutral pH': 1, 'Mutually exclusive formation of G quadruplex and i motif is a general phenomenon governed by steric hin drance in duplex DNA': 1, 'The transcriptional complex between the BCL2 i motif and hnRNP LL is a molecular switch for control of gene expression that can be modulated by small molecules': 3, 'Structural basis of DNA quadruplex duplex junction formation': 1, 'Thermal stability of DNA quadruplex duplex hybrids': 1, 'Joining of multiple duplex stems at a single quadruplex loop': 1, 'Duplex stem loop containing quadruplex motifs in the human genome: a combined genomic and structural study': 1, 'A family of DNA aptamers with varied duplex region length that forms complexes with thrombin and prothrombin': 2, 'Coexistence of G quadruplex and duplex domains within the secondary structure of 31 mer DNA thrombin binding aptamer': 2, 'Beads on a string structure of long telomeric DNAs under molecular crowding conditions': 4, 'G quadruplex motifs arranged in tandem occurring in telomeric repeats and the insulin linked polymorphic region': 3, 'Stable domain assembly of a monomolecular DNA quadruplex: implications for DNA based nanoswitches': 2, 'Direct and single molecule visualization of the solution state structures of G hairpin and G triplex intermediates': 1, 'Stability and structure of long intramolecular G quadruplexes': 2, 'The major G quadruplex formed in the human platelet derived growth factor receptor beta promoter adopts a novel broken strand structure in K + solution': 1, 'Understanding the sta bility of DNA G quadruplex units in long human telomer ic strands': 1, 'G quadruplex binding ligands: from naturally occurring to rationally designed molecules': 1, 'Small molecule induced DNA damage identifies alternative DNA structures in human genes': 5, 'Methods of studying telomere damage induced by quadruplex-ligand complexes': 1, \"A hitchhiker's guide to G quadruplex ligands\": 1, 'DNA damage signaling induced by the G quadruplex lig and 12459 is modulated by PPM1D/WIP1 phosphatase': 1, 'Genetic instability triggered by G quadruplex interacting Phen DC compounds in Saccharomyces cerevisiae': 3, 'Solution structure of an intramole cular (3 + 1) human telomeric G quadruplex bound to a telomestatin derivative': 2, 'The crystal structure of human telomeric DNA complexed with berberine: an interesting case of stacked ligand to G tetrad ratio higher than 1 : 1': 2, 'The high resolution crystal structure of a parallel intermolecu lar DNA G 4 quadruplex/drug complex employing syn glycosyl linkages': 1, 'Synthesis, G quadruplex stabilization, docking studies, and effect on cancer cells of indolo[3,2 b]quinolines with one, two, or three basic side chains': 1, 'A single molecule platform for investiga tion of interactions between G quadruplexes and small molecule ligands': 1, 'Interaction of G quadruplexes with nonintercalating duplex DNA minor groove binding ligands': 1, 'Quadruplex binding enantiomers show chiral selective interactions with human telomere': 1, 'Chiral ruthenium(II) polypyridyl complex es: stabilization of G quadruplex DNA, inhibition of telomerase activity and cellular uptake': 1, 'Enantioselective targeting left handed Z G quadruplex': 1, 'G quadruplexes: targets in anti cancer drug design': 1, 'G quadruplex binding benzo[a]phenoxazines down regulate c KIT expression in human gastric carcinoma cells': 2, 'Hybrid ligand alkylating agents targeting telomeric G quadruplex structures': 2, 'The porphyrin TmPyP4 unfolds the extremely stable G quadruplex in MT3 MMP mRNA and alleviates its repressive effect to enhance translation in eukaryotic cells': 3, 'Molecular modeling and simulation of G quadruplexes and quadruplex-ligand complexes': 1, 'The polymorphisms of DNA G quadruplex investigated by docking experiments with telomestatin enantiomers': 1, 'G4LDB: a database for discovering and studying G quadruplex ligands': 1, 'G quadruplex ligands exhibit differential G tetrad selectivity': 1, 'The ther modynamics of binding of low molecular weight ligands at extreme tetrads of telomeric G quadruplexes': 1, 'A dual site simultaneous binding mode in the interaction between parallel stranded G quadruplex [d(TGGGGT)] 4 and cyanine dye 2,2′ diethyl 9 methyl selenacarbocya nine bromide': 1, 'Stabilizing parallel G quadruplex DNA by a new class of ligands: two non planar alkaloids through interaction in lateral grooves': 1, 'Energetics of ligand binding to G quadruplexes': 1, 'Disordering of human telomeric G quadruplex with novel antiproliferative anthrathiophenedione': 1, 'G quadruplex DNA as a molecular target for induced synthetic lethality in cancer cells': 1, 'Selectivity in lig and recognition of G quadruplex loops': 2, 'All atomic simulations on human telomeric G quadruplex DNA binding with thioflavin T': 2, 'Thermodynamic fingerprints of ligand binding to human telomeric G quadruplexes': 1, 'Binding properties of': 1, 'Higher order quadruplex structures': 1, 'Specific recognition and stabilization of monomeric and multimer ic G quadruplexes by cationic porphyrin TMPipEOPP under molecular crowding conditions': 1, 'Targeting human telomeric higher order DNA: dimeric G quadruplex units serve as preferred binding site': 1, 'Interaction of metal complexes with G quadruplex DNA': 1, 'Quadruplex DNA: a promising drug target for the medicinal inorganic chemist': 1, 'Dissecting the strand folding orien tation and formation of G quadruplexes in single and double stranded nucleic acids by ligand induced photo cleavage footprinting': 1, 'Experimental approaches to identify cellular G quadruplex structures and functions': 3, 'Quinone methides tethered to naphthalene diimides as selective G quadruplex alkylating agents': 1, 'Tetrasubstituted naphthalene diimide ligands with selectivity for telomeric G quadru plexes and cancer cells': 1, 'Small molecule mediated G quadruplex isolation from human cells': 2, 'In cell optical imaging of exogenous G quadruplex DNA by fluorogenic ligands': 2, 'A model of smart G quadruplex ligand': 1, 'Synthesis of a single G quartet platform in water': 1, 'A twice as smart synthetic G quartet: PyroTASQ is both a smart quadruplex ligand and a smart fluorescent probe': 2, 'Visualization of RNA quadruplexes in live cells': 2, 'An intramolecular G quadruplex structure is required for binding of telomeric repeat containing RNA to the telom eric protein TRF2': 5, 'Human DHX9 helicase preferentially unwinds RNA containing displace ment loops (R loops) and G quadruplexes': 1, 'Identification and characterization of nucleolin as a c myc G quadruplex binding protein': 3, 'Co self assembled nanoaggregates of BODIPY amphiphiles for dual colour imaging of live cells': 1, 'Identification and characteriza tion of RNA guanine quadruplex binding proteins': 1, 'Nucleophosmin mutations alter its nucleolar localization by impairing G quadruplex binding at ribosomal DNA': 1, 'DNA helicases involved in DNA repair and their roles in cancer': 1, 'Contributions of the specialised DNA polymerases to replication of structured DNA': 1, 'Evidence for the kinetic partitioning of polymerase activi ty on G quadruplex DNA': 2, 'Targeted detection of G quadruplexes in cellular RNAs': 3, 'Characterization of the intramolecular G quadruplex pro moting activity of Est1': 1, 'Cell cycle dependent regulation of telomere tether ing in the nucleus': 2, 'HRAS is silenced by two neighboring G quadruplexes and activated by MAZ, a zinc finger transcription factor with DNA unfolding property': 1, 'Pif1 family helicases suppress genome instability at G quadruplex motifs': 2, 'G quadruplexes are genomewide targets of transcriptional helicases XPB and XPD': 2, 'Nucleolin stabilizes G quadruplex structures folded by the LTR promoter and silences HIV 1 viral transcription': 2, 'Novel interaction of the Z DNA bind ing domain of human ADAR1 with the oncogenic c Myc promoter G quadruplex': 1, 'Structure function studies of FMRP RGG peptide recog nition of an RNA duplex quadruplex junction': 1, 'Structure of nucleophosmin DNA binding domain and analysis of its complex with a G quadruplex sequence from the c MYC promoter': 1, 'Binding of an RNA aptamer and a partial peptide of a prion protein: cru cial importance of water entropy in molecular recognition': 1, 'Insights into G quadruplex specific recognition by the DEAH box helicase RHAU: solution structure of a peptide-quadruplex complex': 1, 'Crystal structure reveals specific recognition of a G quadruplex RNA by a beta turn in the RGG motif of FMRP': 1, 'Specific binding of modified RGG domain in TLS/FUS to G quadruplex RNA: tyrosines in RGG domain recognize 2′ OH of the riboses of loops in G quadruplex': 1, 'The human specialized DNA polymerases and non B DNA: vital relationships to preserve genome integrity': 1, 'C9orf72 nucleotide repeat structures initiate molecular cascades of disease': 2, 'G quadruplex structures contribute to the neuroprotective effects of angiogenin induced tRNA fragments': 1, 'DNA replication through G quadruplex motifs is promoted by the Saccharomyces cerevisiae Pif1 DNA helicase': 1, 'FANCJ promotes DNA synthesis through G quadruplex structures': 1, 'DNA polymerase delta stalls on telomeric lag ging strand templates independently from G quadruplex formation': 2, 'Epigenetic instability due to defective replication of structured DNA': 1, 'The yeast Pif1 helicase prevents genomic instability caused by G quadruplex forming CEB1 sequences in vivo': 1, 'Red emissive AIE luminogens with high hole transporting properties for effi cient non doped OLEDs': 1, 'BLM unfolds G quadruplexes in different structur al environments through different mechanisms': 1, '2016 structures with varying degrees of efficiency': 1, 'RPA mediated unfold ing of systematically varying G quadruplex structures': 1, 'Telomeric overhang length determines structural dynamics and accessibility to telomerase and ALT associ ated proteins': 1, 'Mitochondrial dys function and nuclear mitochondrial shuttling of TERT are involved in cell proliferation arrest induced by G quadru plex ligands': 1, 'Quadruplex duplex motifs as new topoisomerase I inhibitors': 1, 'Yeast transcription co activator Sub1 and its human homolog PC4 preferentially bind to G quadruplex DNA': 1, 'G quadruplexes in viruses: function and potential therapeutic applications': 1, 'The SARS unique domain (SUD) of SARS coronavirus contains two macrodomains that bind G quadruplexes': 1, 'U3 region in the HIV 1 genome adopts a G quadruplex structure in its RNA and DNA sequence': 1, 'HIV 1 integrase inhibitor T30177 forms a stacked dimeric G quadruplex structure containing bulges': 1, 'Anticancer molecule AS1411 exhibits low nanomolar antiviral activity against HIV 1': 1, 'Selective recognition of a DNA G quadruplex by an engineered antibody': 2, 'Genome wide analysis of a G quadruplex specific single chain antibody that regulates gene expression': 1, 'G quadruplexes: from guanine gels to chemotherapeutics': 1, 'Structural insights into G quadruplexes: towards new anticancer drugs': 2, 'Telomere maintenance as a target for drug discovery': 1, 'The role of telom eres in stem cells and cancer': 1, 'Rudimentary G quadruplex based telomere capping in Saccharomyces cerevisiae': 3, 'G ruption: the third international meeting on G quadru plex and G assembly': 3, 'G quadruplex ligand induced DNA damage response coupled with telomere dysfunction and replication stress in glioma stem cells': 1, 'A novel transition pathway of ligand induced topological conversion from hybrid forms to par allel forms of human telomeric G quadruplexes': 1, 'Reduced or diminished stabilization of the telomere G quadruplex and inhibition of telomerase by small chemical ligands under molecular crowding condition': 1, 'Structure of human telomeric DNA in crowded solution': 2, 'Molecular engineer ing of G quadruplex ligands based on solvent effect of polyethylene glycol': 1, 'Polyethylene glycol binding alters human telomere G quadruplex structure by conformational selection': 1, 'High resolution insight into G overhang architecture': 5, 'Hydration is a major determinant of the G quadruplex stability and conformation of the human telomere 3′ sequence of d(AG3(TTAG3)3)': 1, 'G quadruplexes from human telomeric DNA: how many conformations in PEG containing solutions?': 1, 'Stability of human telomere quadruplexes at high DNA concentrations': 1, 'Human telomere sequence DNA in water free and high viscosity solvents: G quadruplex folding governed by Kramers rate theory': 1, 'Folding dynamics and conformational heterogeneity of human telomeric G quadruplex structures in Na + solutions by single molecule FRET microscopy': 1, 'An integrated molecular dynamics (MD) and experimental study of higher order human telomeric quadruplexes': 1, 'Single molecule studies of physiologically rele vant telomeric tails reveal POT1 mechanism for promot ing G quadruplex unfolding': 3, 'G quadruplex formation at the 3′ end of telomere DNA inhibits its extension by telomerase, polymerase and unwinding by helicase': 2, 'Repair of O6 methylguanine adducts in human telomeric G quadruplex DNA by O6 alkylguanine DNA alkyltransferase': 1, 'Loss of loop adenines alters human telomere d[AG3(TTAG3)3] quadruplex folding': 1, 'A G rich sequence within the c kit oncogene promoter forms a parallel G quadruplex having asymmetric G tetrad dynamics': 1, 'Extended molecular dynamics of a c kit promoter quadruplex': 1, 'Downregulation of the WT1 gene expression via TMPyP4 stabilization of promoter G quadru plexes in leukemia cells': 1, 'Solution structure of the major G quadruplex formed in the human VEGF promoter in K + : insights into loop interactions of the parallel G quadruplexes': 6, 'Evidence for G quadruplex in the promoter of vegfr 2 and its targeting to inhibit tumor angiogenesis': 1, 'Solution structure of all parallel G quadruplex formed by the oncogene RET promoter sequence': 1, 'Platination of telomeric sequences and nuclease hypersensitive elements of human c myc and PDGF A promoters and their ability to form G quadru plexes': 1, 'Molecular cloning of the human platelet derived growth factor receptor beta (PDGFR beta) promoter and drug targeting of the G quadruplex forming region to repress PDGFR beta expression': 1, 'Identification and charac terisation of a G quadruplex forming sequence in the pro moter region of nuclear factor (erythroid derived 2) like 2 (Nrf2)': 2, 'Topology of a DNA G quadruplex structure formed in the HIV 1 promoter: a potential target for anti HIV drug development': 1, 'HIV 1 nucleocapsid protein increases strand transfer recombination by promoting dimeric G quartet forma tion': 1, 'G quadruplex enabling sequence within the human tyrosine hydroxylase promoter differen tially regulates transcription': 2, 'Coexistence of two distinct G quadruplex conformations in the hTERT promoter': 1, 'An improved model for the hTERT promoter quadruplex': 3, 'Direct experimental evi dence for quadruplex-quadruplex interaction within the human ILPR': 2, 'Sequence, stability, and struc ture of G quadruplexes and their interactions with drugs': 1, 'Crystal structure of a c kit promoter quadruplex reveals the structural role of metal ions and water mole cules in maintaining loop conformation': 2, 'Relative stability of G quadruplex structures: inter actions between the human Bcl2 promoter region and derivatives of carbazole and diphenylamine': 1, 'A new G quadruplex with hairpin loop immediately upstream of the human BCL2 P1 promoter modulates transcription': 2, 'KRAS promoter oligonucleotide with decoy activity dimerizes into a unique topology consisting of two G quadruplex units': 1, 'MAZ binding G4 decoy with locked nucleic acid and twisted intercalating nucleic acid modifications suppresses KRAS in pancreatic cancer cells and delays tumor growth in mice': 1, 'In the sense of transcription regulation by G quadruplexes: asymmetric effects in sense and antisense strands': 3, 'A matter of location: influence of G quadruplexes on Escherichia coli gene expression': 1, 'Molecular population dynamics of DNA structures in a bcl 2 promoter sequence is regulated by small molecules and the transcription factor hnRNP LL': 1, 'Quadruplex single nucleotide polymorphisms (Quad SNP) influence gene expression difference among individ uals': 1, 'Research progress of RNA quadruplex': 2, 'Toward a digital gene response: RNA G quadru plexes with fewer quartets fold with higher cooperativity': 3, 'The folding of 5′ UTR human G quadruplexes possessing a long central loop': 1, 'An RNA G quadruplex in the 3′ UTR of the proto oncogene PIM1 represses trans lation': 2, 'Suppression of gene expression by G quadruplexes in open reading frames depends on G quadruplex stability': 2, 'Directly lighting up RNA G quadruplexes from test tubes to living human cells': 1, 'TERRA: telomeric repeat containing RNA': 1, 'Structural basis of telomeric RNA quadruplex-acridine ligand recognition': 5, 'Monomorphic RNA G quadruplex and polymorphic DNA G quadru plex structures responding to cellular environmental fac tors': 4, 'Structure of long human telomeric RNA (TERRA): G quadruplexes formed by four and eight UUAGGG repeats are stable building blocks': 4, 'A crystallographic and modelling study of a human telomeric RNA (TERRA) quadruplex': 6, 'Engineering the quadruplex fold: nucleoside conformation determines both folding topology and molecularity in guanine quadru plexes': 1, 'A com parison of DNA and RNA quadruplex structures and sta bilities': 1, 'A sequence independent analysis of the loop length dependence of intramolecular RNA G quadruplex stabili ty and topology': 1, 'The disease associated r(GGGGCC)n repeat from the C9orf72 gene forms tract length dependent uni and multimolecular RNA G quadruplex structures': 1, 'Functional complexity and regula tion through RNA dynamics': 1, 'An RNA hairpin to G quadruplex conformational transition': 2, 'Efficient suppression of gene expres sion by targeting 5′ UTR based RNA quadruplexes with bisquinolinium compounds': 1, 'Selective RNA versus DNA G quadruplex targeting by in situ click chemistry': 2, 'Formation of a stacked dimeric G quadruplex containing bulges by the 5′ terminal region of human telomerase RNA (hTERC)': 1, 'RNA G quadruplexes cause eIF4A dependent oncogene translation in cancer': 1, '5′ UTR RNA G quadruplexes: translation regulation and targeting': 3, 'G quadru plexes in RNA biology': 3, 'The BCL 2 5′ untranslated region contains an RNA G quadruplex forming motif that modulates protein expres sion': 1, 'Stimulation of ribosomal frameshifting by RNA G quadruplex structures': 1, 'Rationally induced RNA:DNA G quadruplex structures elicit an anticancer effect by inhibiting endogenous eIF 4E expression': 2, 'RNA G quadruplex invasion and translation inhi bition by antisense gamma peptide nucleic acid oligomers': 1, 'Targeting DNA G quadruplex structures with peptide nucleic acids': 1, 'Small antisense oligonucleotides against G quadruplexes: specific mRNA translational switches': 1, 'The G quadruplex augments translation in the 5′ untrans lated region of transforming growth factor beta2': 1, 'Role of G quadruplex located at 5′ end of mRNAs': 1, 'An RNA G quadruplex is essential for cap independent translation initiation in human VEGF IRES': 1, 'An independently folding RNA G quadruplex domain direct ly recruits the 40S ribosomal subunit': 1, 'Telomere length regulates TERRA levels through increased trimethylation of telomeric H3K9 and HP1alpha': 1, 'Telomeric repeat containing RNA/G quadruplex forming sequences cause genome wide alteration of gene expression in human can cer cells in vivo': 1, 'A three state model for the regulation of telomerase by TERRA and hnRNPA1': 1, 'Telomeric non coding RNA: telomeric repeat containing RNA in telom ere biology': 1, 'A G quadruplex containing RNA activates fluo rescence in a GFP like fluorophore': 1, 'Conformation sensitive nucleoside analogues as topology specific fluorescence turn on probes for DNA and RNA G quadruplexes': 1, 'Oligonucleotide models of telomeric DNA and RNA form a hybrid G quadruplex structure as a potential component of telom eres': 5, 'Co transcriptional formation of DNA:RNA hybrid G quadruplex and potential function as constitutional cis element for transcription control': 3, 'Bioinformatic analysis reveals an evolutional selection for DNA:RNA hybrid G quadruplex structures as putative transcription regulatory elements in warm blooded animals': 2, 'Mechanism and manipulation of DNA:RNA hybrid G quadruplex formation in transcription of G rich DNA': 2, 'A hybrid G quadruplex structure formed between RNA and DNA explains the extraordinary stability of the mitochondrial R loop': 1, 'Emerging role of RNA-DNA hybrids in C9orf72 linked neurodegeneration': 1, 'R loops associated with triplet repeat expansions promote gene silencing in Friedreich ataxia and fragile X syndrome': 1, 'G quadruplex structures are stable and detectable in human genomic DNA': 1, 'Human Rev1 polymerase dis rupts G quadruplex DNA': 1, 'Positive supercoiling affiliated with nucleosome formation repairs non B DNA structures': 1, 'Alternative DNA structures: G4 DNA in cells: itae missa est?': 1, 'Quantitative visualization of DNA G quadruplex structures in human cells': 1, 'Detection of G quadruplex DNA in mammalian cells': 1, 'evidence of mitochondrial G quadruplex DNA by using fluorescent anti cancer agents': 1, 'Visualization and selective chemical tar geting of RNA G quadruplex structures in the cytoplasm of human cells': 1, 'Elevated levels of G quadru plex formation in human stomach and liver cancer tissues': 1, 'Detection of cell carcinogenic transformation by a quadruplex DNA binding fluorescent probe': 1, 'Guanine quadruplex structures localize to heterochromatin': 1, 'G quadruplexes as novel cis elements controlling transcription during embry onic development': 1, 'Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection': 2, 'Coinfection with HIV-1 and HCV-a one-two punch': 3, 'HAART is associated with lower hepatic necroinflammatory activity in HIV-hepatitis C virus-coinfected patients with CD4 cell count of more than 350 cells/microl at the time of liver biopsy': 3, 'HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies': 3, 'Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis': 3, 'Hepatitis C virus in human immunodeficiency virus-infected individuals: an emerging comorbidity with significant implications': 3, 'Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis': 3, 'Liver cirrhosis': 3, 'Draft Guidance for Industry. Chronic Hepatitis C Virus Infection: Developing Direct-Acting Antiviral Drugs for Treatment': 2, 'Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C': 2, 'Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease': 2, 'Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver': 2, 'elastography) for the measurement of liver fibrosis': 2, 'Performance of transient elastography for the staging of liver fibrosis: a meta-analysis': 2, 'Proteomic patterns: their potential for disease diagnosis': 2, 'Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample bias': 2, 'The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification': 2, 'Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men': 1, 'Protein chip array profiling analysis in patients with severe acute respiratory syndrome identified serum amyloid a protein as a biomarker potentially useful in monitoring the extent of pneumonia': 2, \"Identification of novel diagnostic serum biomarkers for Chagas' disease in asymptomatic subjects by mass spectrometric profiling\": 2, 'A novel and accurate diagnostic test for human African trypanosomiasis': 2, 'Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum': 1, 'SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma': 3, 'Cohort profile: the Canadian HIVhepatitis C co-infection cohort study': 1, 'Biomarker Discovery in Serum/Plasma Using Surface Enhanced Laser Desorption Ionization Time of Flight (SELDI-TOF) Mass Spectrometry': 1, 'In-gel digestion for mass spectrometric characterization of proteins and proteomes': 1, 'ProteomeXchange provides globally coordinated proteomics data submission and dissemination': 1, 'Proteome analysis of human liver tumor tissue by two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization-mass spectrometry for identification of disease-related proteins': 1, 'Comparative proteomic analysis of de-N-glycosylated serum from hepatitis B carriers reveals polypeptides that correlate with disease status': 3, 'Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes': 1, 'Serum proteomics of hepatitis C virus infection reveals retinol-binding protein 4 as a novel regulator': 1, 'Comparative Proteomics of Sera From HCC Patients With Different Origins': 1, 'Differentially Expressed Proteins in Chronic Active Hepatitis, Cirrhosis, and HCC Related to HCV Infection in Comparison With HBV Infection: A proteomics study': 1, 'Evaluating liver fibrosis progression and the impact of antiretroviral therapy in HIV and hepatitis C coinfection using a noninvasive marker': 1, 'Systematic review: non-invasive methods of fibrosis analysis in chronic hepatitis C': 1, 'Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study': 1, 'Polyclonal free light chains: a biomarker of inflammatory disease or treatment target?': 1, 'Circulating serum free light chains as predictive markers of AIDS-related lymphoma': 1, 'Serum-free light chain assessment in hepatitis C virus-related lymphoproliferative disorders': 1, 'Investigation of plasma biomarkers in HIV-1/HCV mono-and coinfected individuals by multiplex iTRAQ quantitative proteomics': 1, 'Novel biomarker candidates to predict hepatic fibrosis in hepatitis C identified by serum proteomics': 1, 'Multiplex protein analysis to determine fibrosis stage and progression in patients with chronic hepatitis C': 1, 'Serum Biomarkers Indicate Long-term Reduction in Liver Fibrosis in Patients With Sustained Virological Response to Treatment for HCV Infection': 1, 'Is antiretroviral therapy causing long-term liver damage? A comparative analysis of HIV-mono-infected and HIV/hepatitis C co-infected cohorts': 1, 'Evaluating infants and children with interstitial lung disease': 1, 'Diffuse lung disease in young children: application of a novel classifi cation scheme': 5, 'Thoracoscopy in children: is a chest tube necessary?': 1, 'Thoracoscopic lung biopsy in infants and children with endoloops allows smaller trocar sites and discreet biopsies': 1, 'Idiopathic interstitial pneumonitis in children: a national survey in the United Kingdom and Ireland': 1, 'Clinical spectrum of chronic interstitial lung disease in children': 3, 'Pediatric interstitial lung disease: children are not small adults': 1, 'Infant lung biopsy: clarifying the pathologic spectrum': 1, 'Factors infl uencing survival in children with chronic interstitial lung disease': 1, 'Evaluation of a diagnostic approach to pediatric interstitial lung disease': 1, 'Imaging considerations: interstitial lung disease in children': 1, 'Imaging of childhood interstitial lung disease': 1, 'Diagnostic pathology of diffuse lung disease in children': 1, \"Airway cytokine profi les in children's interstitial lung diseases\": 1, \"Aptamer proteomic analysis of bronchoalveolar lavage fl uid yields different protein signatures from children with children's interstitial lund disease, cystic fi brosis and disease controls\": 1, 'What is interstitial lung disease in children?': 1, 'Expanding the phenotype of alveolar capillary dysplasia (ACD)': 1, 'Prolonged survival in alveolar capillary dysplasia syndrome': 1, 'Genomic and genic deletions of the FOX gene cluster on 16q24.1 and inactivating mutations of FOXF1 cause alveolar capillary dysplasia and other malformations': 1, 'Alveolar capillary dysplasia: a six-year single center experience': 1, 'Population and disease-based prevalence of the common mutations associated with surfactant defi ciency': 1, 'Population-based estimates of surfactant protein B defi ciency': 1, 'Clinical improvement in infants with ILD due to mutations in the surfactant protein C gene (SFTPC)': 1, 'Hydroxychloroquine and surfactant protein C defi ciency': 1, 'Haplotype analysis of ABCA3: association with respiratory distress in very premature infants': 1, 'Dramatic improvement by macrolides in surfactant deficiency with ABCA3 mutation': 1, 'Clinical, radiological and pathological features of ABCA3 mutations in children': 2, 'NKX2-1 mutations leading to surfactant protein promoter dysregulation cause interstitial lung disease in \"Brain-Lung-Thyroid Syndrome': 1, 'Deletion of NKX2.1 gene encoding thyroid transcription factor-1 in two siblings with hypothyroidism and respiratory failure': 1, \"Thyroid transcription factor 1 gene abnormalities: an under recognized cause of children's interstitial lung disease\": 1, 'Pulmonary pathology in thyroid transcription factor-1 defi ciency syndrome': 1, 'Brain-thyroidlung syndrome: a patient with a severe multi-system disorder due to a de novo mutation in the thyroid transcription factor 1 gene': 1, 'Infant pulmonary function testing in chilren neuroendocrine cell hyperplasia with and without lung biopsy': 1, 'Persistent tachypnea of infancy is associated with neuroendocrine cell hyperplasia': 1, 'Beyond infancy: persistence of chronic lung disease in neusroendocrine cell hyperplasia of infancy (NEHI)': 1, 'Neuroendocrine cell hyperplasia of infancy: diagnosis with high-resolution CT': 1, 'Familial neuroendocrine cell hyperplasia of infancy': 1, 'Radiographic appearance of follicular bronchitis in children': 1, 'Pulmonary interstitial glycogenosis: a new variant of neonatal interstitial lung disease': 1, 'Pulmonary interstitial glycogenosis in identical twins': 1, 'Pulmonary interstitial glycogenosis in the setting of lung growth abnormality: radiographic and pathologic correlation': 1, 'Diffuse lung disease in infancy: a proposed classifi cation applied to 259 diagnostic biopsies': 1, 'Diagnosis of bronchiolitis obliterans with computed tomography in children': 1, 'Bronchiolitis obliterans organizing pneumonia: pathogenesis, clinical features, imaging and therapy review': 1, 'Pulmonary capillaritis in children: a review of eight cases with comparison to other alveolar hemorrhage syndromes': 1, 'Cystic fi brosis: predictors of accelerated decline and distribution of disease in 230 patients': 1, 'Pulmonary complications of primary immunodefi ciencies': 1, 'Granulomatous-lymphocytic lung disease shortens survival in common variable immunodefi ciency': 1, 'Common variable immune deficiency: respiratory manifestations, pulmonary function and high-resolution CT scan findings': 1, 'Respiratory disorders in common variable immunodefi ciency': 1, 'Radionuclide imaging of acute lung transplant rejection with annexin V': 1, 'Posttransplantation lymphoproliferative disorder in children: clinical, histopathologic, and imaging features': 1, 'Primary pulmonary lymphangiectasia in infancy and childhood': 1, 'Pulmonary lymphangiectasia: diagnosis and clinical course': 1, 'Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston': 1, 'Impact of respiratory virus infections on persons with chronic underlying conditions': 1, 'Reduction in mortality associated with influenza vaccine during 1989-90 epidemic': 3, 'Influenza vaccine effectiveness in preventing hospitalization among the elderly during influenza type A and type B seasons': 3, 'Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease': 3, 'Is immunising all patients with chronic lung disease in the community against influenza cost-effective? Evidence from a general practice based clinical prospective cohort study in Utrecht, the Netherlands': 4, 'Influenza-associated morbidity and mortality in young and middle-aged women': 1, 'Excess pneumonia-and influenza-associated hospitalization during influenza epidemics in the United States, 1970-78': 1, 'Acute respiratory disease hospitalizations as a measure of impact of epidemic influenza': 1, 'Respiratory viruses and exacerbations of asthma in adults': 4, 'Viral respiratory infection and exacerbations of asthma in adult patients': 3, 'The safety of inactivated influenza vaccine in adults and children with asthma': 1, 'Vaccines for preventing influenza in people with asthma': 1, 'Sense and nonsense of influenza vaccination in asthma and chronic obstructive pulmonary disease': 2, 'Influenza season 1998/99; composition of vaccine for': 3, 'Influenza season': 3, 'Implementing Dutch College of General Practitioners (NHG) guidelines for influenza vaccination: an intervention study': 2, 'Prevention and control of influenza: recommendations of the Influenza Vaccination and Asthma or COPD 699': 2, 'The introduction of computer-based patient records in the Netherlands': 1, 'Improving influenza vaccination coverage among high-risk patients: a role for computer-supported prevention strategy?': 2, 'NHG Standaard COPD en Astma bij volwassenen: diagnostiek': 1, 'Simultaneous detection of influenza viruses A and B using real-time quantitative PCR': 2, 'Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications': 2, 'Benefits of influenza vaccination for low-, intermediate-and high-risk senior citizens': 1, 'Estimating causal effects from large data sets using propensity scores': 2, 'The effectiveness of right heart catherization in the initial care of critically ill patients': 2, 'Spirometrie in een gezondheidscentrum. (In Dutch)': 1, 'Underdiagnosis of asthma: is the doctor or the patient to blame? The DIMCA project': 1, 'The impact of influenza epidemics on hospitalizations': 2, 'The efficacy and cost-effectiveness of vaccination against influenza among elderly persons living in the community': 1, 'Rapid virological surveillance of community influenza infection in general practice': 1, 'Acute respiratory illness among immunized and nonimmunized patients with high-risk factors during a split season of influenza A and B': 1, 'Lack of clinical exacerbations in adults with chronic asthma after immunization with killed influenza virus': 1, 'Influenza and asthma': 1, 'Respiratory infection with influenza A virus interferes with the induction of tolerance to aeroallergens': 1, 'The incidence of respiratory tract infection in adults requiring hospitalization for asthma': 5, 'Cold Spring Harbor Symposium of Quantitative Biology LXV': 2, 'Translational control of gene expression, 371pp': 2, 'Programmed Alternative Reading of the Genetic Code': 4, 'Jamshed Iqbal': 1, 'Xuhong Qian and Lianpeng Tong': 2, 'Infrared and Raman Spectra of Inorganic and Coordination Compounds, 4 th Edn': 1, 'The pivotal regulatory landscape of RNA modifications': 1, 'N( 6 )-methyladenosine in mRNA disrupts tRNA selection and translation-elongation dynamics': 1, 'tRNA stabilization by modified nucleotides': 1, 'Tuning the ribosome: The influence of rRNA modification on eukaryotic ribosome biogenesis and function': 1, 'Detecting RNA modifications in the epitranscriptome: predict and validate': 1, 'Next-generation sequencing technologies for detection of modified nucleotides in RNAs': 1, 'Epitranscriptome sequencing technologies: decoding RNA modifications': 1, 'Methylated simian virus 40-specific RNA from nuclei and cytoplasm of infected BSC-1 cells': 1, 'Influenza viral mRNA contains internal N6-methyladenosine and 5 0 -terminal 7-methylguanosine in cap structures': 2, 'Precise localization of m6A in Rous sarcoma virus RNA reveals clustering of methylation sites: implications for RNA processing': 1, 'RNA modifications go viral': 1, 'Viral Epitranscriptomics': 2, 'Characterization and partial purification of mRNA N 6 -adenosine methyltransferase from HeLa cell nuclei. Internal mRNA methylation requires a multisubunit complex': 1, 'A METTL3-METTL14 complex mediates mammalian nuclear RNA N 6 -adenosine methylation': 3, 'Perturbation of m6A writers reveals two distinct classes of mRNA methylation at internal and 5 0 sites': 5, 'Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase': 3, 'Structural insights into the molecular mechanism of the m(6)A writer complex': 1, 'm( 6 )A RNA methylation promotes XIST-mediated transcriptional repression': 1, 'N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO': 1, 'ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility': 2, 'The m(6)A Methyltransferase METTL3 Promotes Translation in Human Cancer Cells': 1, 'N(6)-methyladenosine Modulates Messenger RNA Translation Efficiency': 1, '5 0 UTR m( 6 )A Promotes Cap-Independent Translation': 2, 'Topology of the human and mouse m6A RNA methylomes revealed by m 6 A-seq': 1, 'The dynamic epitranscriptome: N6-methyladenosine and gene expression control': 1, 'N(6)-methyladenosine-dependent RNA structural switches regulate RNA-protein interactions': 2, 'Dynamics of the human and viral m( 6 )A RNA methylomes during HIV-1 infection of T cells': 7, 'Posttranscriptional m( 6 )A Editing of HIV-1 mRNAs Enhances Viral Gene Expression': 4, 'N(6)-methyladenosine of HIV-1 RNA regulates viral infection and HIV-1 Gag protein expression': 5, 'Identification of a heterogeneous nuclear ribonucleoprotein-recognition region in the HIV Rev protein': 1, 'Dynamics of Human and Viral RNA Methylation during Zika Virus Infection': 6, 'Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA': 1, 'Functionally conserved architecture of hepatitis C virus RNA genomes': 1, 'The Coding Region of the HCV Genome Contains a Network of Regulatory RNA Structures': 1, 'Mechanisms of internal ribosome entry in translation initiation': 1, 'A prokaryotic-like mode of cytoplasmic eukaryotic ribosome binding to the initiation codon during internal translation initiation of hepatitis C and classical swine fever virus RNAs': 1, 'Interaction of hepatitis C virus core protein with viral sense RNA and suppression of its translation': 1, 'Type III Interferons Produced by Human Placental Trophoblasts Confer Protection against Zika Virus Infection': 1, 'Zika Virus Infects Human Cortical Neural Progenitors and Attenuates Their Growth': 1, 'Molecular signatures associated with ZIKV exposure in human cortical neural progenitors': 1, 'ATF6 signaling is required for efficient West Nile virus replication by promoting cell survival and inhibition of innate immune responses': 1, 'Dengue virus modulates the unfolded protein response in a time-dependent manner': 1, 'Induction of incomplete autophagic response by hepatitis C virus via the unfolded protein response': 2, 'Dengue virus RNA structure specialization facilitates host adaptation': 1, \"). hnRNP C and polypyrimidine tractbinding protein specifically interact with the pyrimidine-rich region within the 3'NTR of the HCV RNA genome\": 1, 'HeLa cell RNA (2 0 -O-methyladenosine-N6-)-methyltransferase specific for the capped 5 0 -end of messenger RNA': 1, 'N6, O2 0 -dimethyladenosine a novel methylated ribonucleoside next to the 5 0 terminal of animal cell and virus mRNAs': 1, 'Reversible methylation of m( 6 )A m in the 5 0 cap controls mRNA stability': 4, 'The absolute frequency of labeled N-6-methyladenosine in HeLa cell messenger RNA decreases with label time': 1, 'N6-methyladenosine-dependent regulation of messenger RNA stability': 1, '5 0 -Terminal and internal methylated nucleosides in herpes simplex virus type 1 mRNA': 1, '2 0 -O-methyl-modified RNAs act as TLR7 antagonists': 1, '2 0 -O methylation of the viral mRNA cap evades host restriction by IFIT family members': 2, 'West Nile virus 5 0 -cap structure is formed by sequential guanine N-7 and ribose 2 0 -O methylations by nonstructural protein': 1, 'Viral stressinducible protein p56 inhibits translation by blocking the interaction of eIF3 with the ternary complex eIF2.GTP.Met-tRNAi': 1, 'Distinct induction patterns and functions of two closely related interferon-inducible human genes, ISG54 and ISG56': 1, 'Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral': 1, 'Inosine-containing RNA is a novel innate immune recognition element and reduces RSV infection': 1, 'Editing of HIV-1 RNA by the double-stranded RNA deaminase ADAR1 stimulates viral infection': 4, 'Double-stranded RNA adenosine deaminases enhance expression of human immunodeficiency virus type 1 proteins': 2, 'RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself': 2, 'The RNA-editing enzyme ADAR1 controls innate immune responses to RNA': 1, 'Double-stranded RNA deaminase ADAR1 increases host susceptibility to virus infection': 1, 'Effects of viral respiratory infections on lung development and childhood asthma': 2, 'The childhood origins of asthma (COAST) study': 3, 'The Canadian Childhood Asthma Primary Prevention Study: outcomes at 7 years of age': 2, 'Asthma and wheezing in the first six years of life. The Group Health Medical Associates': 4, 'Primary prevention of asthma and allergy': 2, 'Maternal smoking in pregnancy, fetal development, and childhood asthma': 2, 'Surveillance for asthmadUnited States': 2, 'Otitis and respiratory distress episodes following a respiratory syncytial virus infection': 2, 'Bronchiolitis-associated hospitalizations among US children, 1980-1996': 3, 'Epidemiology of respiratory syncytial virus infection in Washington, D.C. I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection': 7, 'Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children': 13, 'Rhinovirus-associated hospitalizations in young children': 5, 'Human bocavirus infection in young children in the United States: molecular epidemiological profile and clinical characteristics of a newly emerging respiratory virus': 9, 'Respiratory syncytial virus activityd United States': 2, 'The relationship of meteorological conditions to the epidemic activity of respiratory syncytial virus': 1, 'Respiratory syncytial virus epidemics: the ups and downs of a seasonal virus': 1, 'Risk of primary infection and reinfection with respiratory syncytial virus': 2, 'The epidemiology of bronchiolitis': 3, 'Pathogenesis of bronchiolitisdepidemiologic considerations': 2, 'Superiority of reverse-transcription polymerase chain reaction to conventional viral culture in the diagnosis of acute respiratory tract infections in children': 3, 'Viral etiology of acute respiratory tract infections in children presenting to hospital: role of polymerase chain reaction and demonstration of multiple infections': 1, 'Frequency and natural history of rhinovirus infections in adults during autumn': 1, 'Viruses and bacteria in the etiology of the common cold': 2, 'Virological and serological analysis of rhinovirus infections during the first two years of life in a cohort of children': 1, 'Rhinovirus infections in an industrial population. I. The occurrence of illness': 1, 'Detection of rhinovirus RNA in lower airway cells during experimentally induced infection': 1, 'Rhinovirus and respiratory syncytial virus in wheezing children requiring emergency care. IgE and eosinophil analyses': 5, \"Viral infections of the respiratory tract in hospitalized children. A study from Oslo during a 90 months' period\": 3, 'Epidemiologic patterns of acute lower respiratory disease of children in a pediatric group practice': 1, 'The etiologic and epidemiologic spectrum of bronchiolitis in pediatric practice': 1, 'Respiratory picornaviruses and respiratory syncytial virus as causative agents of acute expiratory wheezing in children': 11, 'Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid': 1, \"The Tucson Children's Respiratory Study. II. Lower respiratory tract illness in the first year of life\": 3, 'Role of respiratory viruses in acute upper and lower respiratory tract illness in the first year of life: a birth cohort study': 2, 'Rhinovirus-associated wheezing in infancy: comparison with respiratory syncytial virus bronchiolitis': 1, 'Acute respiratory infection by human metapneumovirus in children in southern Brazil': 1, 'A 1-year experience with human metapneumovirus in children aged': 1, 'Human bocavirus and acute wheezing in children': 7, 'Cloning of a human parvovirus by molecular screening of respiratory tract samples': 11, 'Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing': 4, 'Respiratory syncytial virus infection and recurrent wheeze/ asthma in children under five years: an epidemiological survey': 1, 'The increasing burden and risk factors for bronchiolitis-related medical visits in infants enrolled in a state healthcare insurance plan': 1, 'Human metapneumovirus bronchiolitis in infancy is an important risk factor for asthma at age 5': 2, 'Rhinovirus-induced wheezing in infancydthe first sign of childhood asthma?': 2, 'Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years': 3, 'Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7': 4, 'Rhinovirus illnesses during infancy predict subsequent childhood wheezing': 5, 'Human metapneumovirus infection in children hospitalized for wheezing': 2, 'Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy': 1, 'Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: A longitudinal birth cohort study': 1, 'Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13': 3, 'Long-term prospective study in children after respiratory syncytial virus infection': 1, 'Infectious and allergic aspects of bronchiolitis': 1, 'Respiratory status and allergy after bronchiolitis': 2, 'Respiratory status and allergy nine to 10 years after acute bronchiolitis': 1, 'Acute bronchiolitis in infancy as risk factor for wheezing and reduced pulmonary function by seven years in Akershus County': 1, 'Asthma and lung function 20 years after wheezing in infancy: results from a prospective follow-up study': 1, 'Adult asthma after non-respiratory syncytial virus bronchiolitis in infancy: subgroup analysis of the 20-year prospective follow-up study': 1, 'Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma': 3, 'Respiratory virus infections and aeroallergens in acute bronchial asthma': 1, 'The association of viral and bacterial respiratory infections with exacerbations of wheezing in young asthmatic children': 3, 'Viruses as precipitants of asthmatic attacks in children': 1, 'Rhinovirus infections in hospitalized children. Provocative bacterial interrelationships': 1, 'Viruses as precipitants of asthma symptoms. I. Epidemiology': 1, 'Viral infection as a precipitant of wheeze in children. Combined home and hospital study': 2, 'Greater frequency of viral respiratory infections in asthmatic children as compared with their nonasthmatic siblings': 3, 'Respiratory infections and the autumn increase in asthma morbidity': 2, 'The contribution of respiratory viruses to severe exacerbations of asthma in adults': 2, 'A prospective study of respiratory infection in adult asthmatics and their normal spouses': 1, 'A case-control study of the role of cold symptoms and other historical triggering factors in asthma exacerbations': 1, 'Community study of role of viral infections in exacerbations of asthma in 9-11 year old children': 3, 'International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods': 1, 'The September epidemic of asthma exacerbations in children: a search for etiology': 3, 'The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis': 1, 'Prevalence of viral respiratory tract infections in children with asthma': 3, 'Role of viruses and atypical bacteria in exacerbations of asthma in hospitalized children: a prospective study in the Nord-Pas de Calais region (France)': 2, 'New Orleans asthma. II. Relationship of climatologic and seasonal factors to outbreaks': 1, 'Seasonal trends in US asthma hospitalizations and mortality': 1, 'Seasonal trends in childhood asthma in south east England': 1, 'The September epidemic of asthma hospitalization: school children as disease vectors': 1, 'Respiratory tract viral infections in inner-city asthmatic adults': 2, 'The effect of an interventional program on adherence to the American Academy of Pediatrics guidelines for palivizumab prophylaxis': 1, 'Epidemiology of respiratory viruses in patients hospitalized with near-fatal asthma, acute exacerbations of asthma, or chronic obstructive pulmonary disease': 2, 'Human metapneumovirus infection plays an etiologic role in acute asthma exacerbations requiring hospitalization in adults': 2, 'The relationship of rhinovirus-associated asthma hospitalizations with inhaled corticosteroids and smoking': 2, 'Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study': 2, 'Systemic lupus erythematosus: a review of the disease and treatment options': 1, 'Association study of genetic variants of pro-inflammatory chemokine and cytokine genes in systemic lupus erythematosus': 1, 'Current status of lupus genetics': 1, 'Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population': 1, 'Epidemiology and management of refractory lupus nephritis': 1, 'Delineating the genetic basis of systemic lupus erythematosus': 1, 'The immunogenetics of SLE': 1, 'Association of TNF-alpha gene polymorphisms with systemic lupus erythematosus in Taiwanese patients': 2, 'Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey': 1, 'Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus': 1, 'Increased bioactive TNF in human systemic lupus erythematosus: associations with cell death': 1, 'Tumor necrosis factor in the serum of patients with systemic lupus erythematosus': 1, 'The role of tumor necrosis factor-alpha (TNF-α) in the pathogenesis of systemic lupus erythematosus': 1, 'Non-HLA associations with autoimmune diseases': 1, 'Metaanalysis of TNF-α promoter − 308A/G polymorphism and SLE susceptibility in Asian populations': 1, 'TNF promoter −308 GNA and LTA 252 ANG polymorphisms in Portuguese patients with systemic lupus erythematosus': 2, 'Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection': 1, 'Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice': 1, 'Interferons as pathogenic effectors in autoimmunity': 1, 'Increased interferon-gamma (IFN-gamma), IL-10 and decreased IL-4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE)': 2, 'The interferon gamma gene polymorphism + 874 A/T is associated with severe acute respiratory syndrome': 1, 'A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production': 3, 'Interferon-gamma and interleukin-10 gene polymorphisms in pulmonary tuberculosis': 1, 'The 1982 revised criteria for the classification of systemic lupus erythematosus': 1, 'The classification of glomerulonephritis in systemic lupus erythematosus revisited': 1, 'ARMS-PCR methodologies to determine IL-10, TNF-alpha, TNF-beta and TGF-beta 1 gene polymorphisms': 1, 'Association between TNF promoter −308 GNA and LTA 252 ANG polymorphisms and systemic lupus erythematosus': 1, 'Association of TNF-α promoter-308 A/G polymorphism with susceptibility to systemic lupus erythematosus: a meta-analysis': 1, 'Tumor necrosis factor alpha promoter polymorphism −308 G/A in Brazilian patients with systemic lupus erythematosus': 1, 'Cytokine gene polymorphisms in Colombian patients with systemic lupus erythematosus': 1, 'Tumor necrosis factor-alpha is a common genetic risk factor for asthma, juvenile rheumatoid arthritis, and systemic lupus erythematosus in a Mexican pediatric population': 1, 'Genetic polymorphisms in tumor necrosis factor (TNF)-alpha and TNF-beta in a population-based study of systemic lupus erythematosus: associations and interaction with the interleukin-1alpha-889 C/T polymorphism': 2, 'Differential effect of IL10 and TNF{alpha} genotypes on determining susceptibility to discoid and systemic lupus erythematosus': 1, 'Meta-analysis of TNF-alpha promoter −308 A/G polymorphism and SLE susceptibility': 1, 'Interferon-gamma gene polymorphisms associated with susceptibility to systemic lupus erythematosus': 1, 'Interferon and granulopoiesis signatures in systemic lupus erythematosus blood': 1, 'Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus': 1, 'Association of the interferon-gamma receptor variant (Val14Met) with systemic lupus erythematosus': 1, '4G/5G plasminogen activator inhibitor-1 and −308 A/G tumor necrosis factor-α promoter gene polymorphisms in Argentinean lupus patients: focus on lupus nephritis': 1, 'Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with systemic lupus erythematosus (SLE)': 1, 'Genetic contribution of the tumour necrosis factor (TNF) B + 252*2/2 genotype, but not the TNFa,b microsatellite alleles, to systemic lupus erythematosus in Japanese patients': 1, \"Lack of association between TNF-308 polymorphism and the clinical and immunological characteristics of systemic lupus erythematosus and primary Sjögren's syndrome\": 1, 'Polymorphism of the regulatory region of tumour necrosis factor alpha gene in patients with systemic lupus erythematosus': 1, 'Association of interferon-gamma gene polymorphism (+ 874A) with arthritis manifestation in SLE': 1, 'Interferon gamma and Interleukin 10 polymorphisms in Brazilian patients with systemic lupus erythematosus': 1, 'Pertussis: a reemerging infection': 1, 'Modeling the impact of human mobility and travel restrictions on the potential spread of SARS-CoV-2 in Taiwan': 2, 'Calibrating the COVID-19 crisis response to the SDGs': 1, 'Over 24,000 coronavirus research papers are now available in one place': 1, 'Digital technology and COVID-19': 2, 'COVID-19: How Korea is using innovative technology and AI to flatten the curve': 1, 'Special emergency session of the broadband commission pushes for action to extend internet access and boost capacity to fight COVID-19': 1, 'The conspiracy linking 5G to coronavirus just will not die': 1, 'UK phone masts attacked amid 5G-coronavirus conspiracy theory': 2, 'Wireless communication and the pandemic: The story so far': 1, 'No scientific basis between 5G and COVID-19': 2, 'Pandemic drones: Useful for enforcing social distancing or for creating a police state': 1, 'Pandemic drones to monitor fever, crowds from above': 1, \"pandemic drones' could single people out in a crowd for coughing, sneezing, or running a temperature, developers say âȂŤ here's how they work\": 1, 'How satellite data can help with COVID-19 and beyond': 1, \"How Facebook and Google track public's movement in effort to fight COVID-19\": 1, 'Mobile applications to support contact tracing in the EUâȂŹs fight against COVID-19': 1, 'Can smart Thermometers track the spread of the coronavirus': 1, 'Johns Hopkins team launches temperature-tracking study and app to map and monitor potential COVID-19 cases': 1, 'A state-of-theart survey on multidimensional scaling-based localization techniques': 1, 'In the time of COVID-19 âȂŞ how will you maintain safe working distances': 1, 'Robust localisation algorithm for large scale 3D wireless sensor networks': 1, 'A survey on multidimensional scaling': 1, 'Telepresence robots are helping take pressure off hospital staff': 1, 'How next-generation information technologies tackled COVID-19 in china': 1, 'How technology can combat COVID-19': 1, 'How 5G and edge computing can enhance virtual reality': 1, 'AT&T feud with FreeConferenceCall.com heats up': 1, 'Forget video conferencingâȂŤhost your next meeting in VR': 1, 'KAUST launches vFabLab, its first virtual lab': 1, 'How mission critical connectivity has helped the world adapt to COVID-19 âȂŞ and prepare for the next crisis': 1, 'Policy and regulatory experiences and best practices that can improve COVID-19 responses': 1, 'What should 6G be?': 1, 'A 6G white paper on connectivity for remote areas': 1, 'Flying cellphone towers: Could drones bring internet coverage to remote areas': 1, 'Aerial base stations deployment in 6G cellular networks using tethered drones: The mobility and endurance trade-off': 1, 'On the 3-D placement of airborne base stations using tethered UAVs': 1, 'Connect people everywhere': 2, 'Zephyr pioneering the stratosphere': 2, 'Connecting the world': 1, 'Cubesat communications: Recent advances and future challenges': 1, \"Amazon's Kuiper Systems Joins SIA\": 1, 'SpaceX submits paperwork for 30,000 more starlink satellites': 1, 'Whereever you are, we will cover you': 1, 'Four billion people still have no internet access': 1, 'Terragraph solving the urban bandwidth challenge': 1, 'Coronavirus apps: the risk of slipping into a surveillance state': 1, 'Safety or surveillance: drones and the COVID-19 pandemic': 1, 'Can the internet keep up with the surge in demand': 1, 'Are We Ready for a Post-COVID-19 Cybersecurity Landscape': 2, 'Cybersecurity and COVID-19-the first 100 days': 2, '5G technology: Why not to worry and what to do if you are still afraid of it': 1, 'What will be the economic impact of COVID-19 in the US? rough estimates of disease scenarios': 1, 'The global macroeconomic impacts of COVID-19: Seven scenarios': 2, 'Coronavirus: OneWeb blames pandemic for collapse': 1, 'The new low touch economy: How to navigate the world after COVID-19': 2, 'COVID-19 will herald an automation boom': 1, 'Pandemic fuels demand for satellite imagery': 1, 'Industrial internet of things: Challenges, opportunities, and directions': 1, 'Industrial IoT in 5G environment towards smart manufacturing': 1, 'Amazon has hired 175,000 additional people': 1, '5G in E-commerce activities': 1, '5G will drive $12 billion in new mobile commerce revenue by 2021': 1, 'The front line: Visualizing the occupations with the highest COVID-19 risk': 1, '19-spreads-statement-un-security-council, online; accessed': 1, 'Statista dossier on the global m-health industry and market': 1, '9 future predictions for a post-Coronavirus world': 1, 'Towards the internet of X-things: New possibilities for underwater, underground, and outer space exploration': 1, 'Surveillance of dengue fever virus: a review of epidemiological models and early warning systems': 1, 'Is Dengvaxia a useful vaccine for dengue endemicareas?': 1, 'Assessing potential countermeasures against the dengue epidemic in non-tropical urban cities': 1, 'Sustained reduction of the dengue vector population resulting from an integrated control strategy applied in two Brazilian cities': 1, 'Proactive vector control strategies and improved monitoring and evaluation practices for dengue prevention': 1, 'Knowledge and attitude of the public towards dengue control in urban and rural areas of Punjab': 1, 'Epidemiological trends and risk factors associated with dengue disease in Pakistan (1980-2014): a systematic literature search and analysis': 1, 'Artificial intelligence based diagnostic screening for dengue fever': 1, 'Ud Din, I.: Dengue epidemic in postconflict Swat District': 2, 'Epidemiology: Beyond the Basics': 1, 'WHO: Who scales up response to worldwide surge in dengue': 1, 'Dengue and Dengue Hemorrhagic Fever': 1, 'Climate and dengue fever: early warning based on temperature and rainfall': 2, 'Monitoring the diversity of malaria and dengue vector in Karachi: studying variation of genera and subgenera of mosquitoes under different ecological conditions': 1, 'Mathematical models in infectious disease epidemiology': 1, 'Mathematical modeling of dengue -temperature effect on vectorial capacity': 4, 'An agent-based model for the spread of the dengue fever: a swarm platform simulation approach': 2, 'Agent-Based Modelling and Geographical Information Systems: A Practical Primer': 1, 'Multiagent modeling and simulation of an Aedes aegypti mosquito population': 1, 'Using multiple scale spatio-temporal patterns for validating spatially explicit agent-based models': 1, 'An open-data-driven agent-based model to simulate infectious disease outbreaks': 1, 'Dengueme: a tool for the modeling and simulation of dengue spatiotemporal dynamics': 1, 'Developing a dengue forecast model using machine learning: a case study in China': 1, 'World Health Organization: Dengue and severe dengue-fact sheet': 1, 'COVID-19 infection among asymptomatic and symptomatic pregnant women: Two weeks of confirmed presentations to an affiliated pair of New York City hospitals': 2, 'COVID-19 in pregnancy: early lessons': 1, 'Universal Screening for SARS-CoV-2 in Women Admitted for Delivery': 3, 'Rapid Development and Implementation of a Covid-19 Telehealth Clinic for Obstetric Patients. NEJM Catalyst': 1, 'Analysis of mRNA expression by real-time PCR': 2, 'Validation of housekeeping genes for normalizing RNA expression in real-time PCR': 2, 'Guideline to reference gene selection for quantitative realtime PCR': 2, 'Reference gene selection for quantitative real-time PCR analysis in virus infected cells: SARS corona virus, Yellow fever virus, Human Herpesvirus-6, Camelpox virus and Cytomegalovirus infections': 3, 'Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes': 6, 'Determination of stable housekeeping genes, differently regulated target genes and sample integrity: BestKeeper -Excel-based tool using pair-wise correlations': 3, 'Real-time RT-PCR normalisation; strategies and considerations': 3, 'Control selection for RNA quantitation': 1, 'Housekeeping gene variability in normal and cancerous colorectal, pancreatic, esophageal, gastric and hepatic tissues': 1, 'New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase': 1, 'Characterisation of salmon and trout CD8a and CD8b': 2, 'Tetraploidy and the evolution of salmonid fishes': 1, 'The impact of ancestral tetraploidy on antibody heterogeneity in salmonid fishes': 1, 'The basic': 2, 'Data analysis and interpretation': 3, 'Validation of internal control genes for gene expression analysis in diabetic glomerulosclerosis': 1, 'Reference genes identified in SH-SY5Y cells using custom-made gene arrays with validation by quantitative polymerase chain reaction': 1, 'Status and opportunities for genomics research with rainbow trout': 1, 'Selection of reference genes for gene expression studies in human neutrophils by real-time PCR': 1, 'Movement, migration, and smolting of Atlantic salmon': 1, 'Quantitative real-time RT-PCR -a perspective': 2, 'Not just for housekeeping: protein initiation and elongation factors in cell growth and tumorigenesis': 1, 'Identification and validation of endogenous reference genes for expression profiling of T helper cell differentiation by quantitative real-time RT-PCR': 1, 'Validation of reference genes for transcription profiling in the salmon louse, Lepeophtheirus salmonis, by quantitative real-time PCR': 1, 'Messenger RNA turnover in eukaryotes: pathways and enzymes': 1, 'Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction': 1, 'Berntssen MHG: mRNA expression of antioxidant enzymes (SOD, CAT and GSH-Px) and lipid peroxidative stress in liver of Atlantic salmon Salmo salar exposed to water hyperoxic conditions during smoltification': 2, 'Structure and transcription of the gene for translation elongation factor 1 subunit alpha of zebrafish (Danio rerio)': 1, 'Acute hepatitis associated with mouse leukemia. V. The neurotropic properties of the causal virus': 2, 'Identification of the filtrable, transmissible neurolytic agent isolated from toxoplasma-infected tissue as a new pleuropneumonia-like microbe': 1, 'The filtrable micro~rganisms of the pleuropneumonia group': 1, 'Rolling disease': 6, 'Low-power digital signal processing using approximate adders': 1, 'Bio-inspired imprecise computational blocks for efficient VLSI implementation of soft-computing applications': 1, 'Design of power-efficient approximate multipliers for approximate artificial neural networks': 1, 'Grater: an approximation workflow for exploiting datalevel parallelism in FPGA acceleration': 2, 'EvoApprox8b: library of approximate adders and multipliers for circuit design and benchmarking of approximation methods': 1, 'Automated high-level generation of low-power approximate computing circuits': 2, 'Approximate Circuits': 1, 'Evolutionary approach to approximate digital circuits design': 2, 'Efficient phenotype evaluation in cartesian genetic programming': 2, 'Precise error determination of approximated components in sequential circuits with model checking': 2, 'Approximate hardware generation using symbolic computer algebra employing grobner basis': 2, 'Towards low power approximate DCT architecture for HEVC standard': 2, 'MACACO: Modeling and analysis of circuits for approximate computing': 3, 'Approximating complex arithmetic circuits with formal error guarantees: 32-bit multipliers accomplished': 5, \"SAT based exact synthesis using DAG topology families. In: Design Automation Conference (DAC'2018)\": 3, 'Practical exact synthesis': 5, \"Busy man's synthesis: combinational delay optimization with sat\": 1, 'One method -all error-metrics: a threestage approach for error-metric evaluation in approximate computing': 1, 'On the glucose SAT solver': 2, 'Exact synthesis of majority-inverter graphs and its applications': 2, 'Cartesian genetic programming': 1, 'Z3: An efficient SMT solver': 1, 'The Math-SAT 4 SMT Solver': 1, 'An extensible SAT-solver': 1, 'Encoding redundancy for satisfaction-driven clause learning': 1, 'The design and implementation of vampire. AI Commun': 1, 'Cirkit (version 3': 1, 'ADAC: Automated design of approximate circuits': 1, 'IL-37: a new anti-inflammatory cytokine of the IL-1 family': 1, 'Interleukin-37: The Effect of Anti-Inflammatory Response in Human Coronary Artery Endothelial Cells': 1, 'Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by COVID-19 antiinflammatory strategies': 1, 'Spermatogenesis-associated 48 Is Essential for Spermatogenesis in Mice': 1, 'A statistical consideration in psychological research': 1, 'The Genotype-Tissue Expression (GTEx) project': 1, 'Microbiological diagnostic performance of metagenomic next-generation sequencing when applied to clinical practice': 1, 'The genome sequence of the SARS-associated coronavirus': 4, 'Characterization of a novel coronavirus associated with severe acute respiratory syndrome': 14, 'Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs': 10, 'A 3D model of SARS-CoV 3CL proteinse and its inhibitors design by virtual screening': 2, 'The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor': 6, 'Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS': 1, 'Docking studies on the complexed and uncomplexed FKBP12 structures with bound and unbound ligands: an implication of conformational selection mechanism for binding': 1, 'The picornaviral 3C proteinases: cysteine nucleophiles in serine proteinase folds': 2, 'The refined crystal structure of the 3C gene product from hepatitis A virus: specific proteinase activity and RNA recognition': 3, 'Protein structure computing in the genomic era': 2, 'Successful molecular dynamics simulation of two zinc complexes bridged by a hydroxide in phosphotriesterase using the cationic dummy atom method': 3, 'AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules': 2, 'A second generation force field for the simulation of proteins, nucleic acids, and organic molecules': 2, 'Molecular dynamics with coupling to an external bath': 2, 'Particle Mesh Ewald: An N log(N) method for Ewald sums in large systems': 1, 'Locally accessible conformations of proteins-multiple molecular dynamics simulations of crambin': 1, 'EUDOC: A computer program for identification of drug interaction sites in macromolecules and drug leads from chemical databases': 1, 'Dynamics of folded proteins': 2, 'Conservation of substrate specificities among coronavirus main proteases': 3, 'Crystal and molecular structures of the complex of alpha-chymotrypsin with its inhibitor turkey ovomucoid third domain at 1.8 Å resolution': 1, 'X-ray crystal structure of gamma-chymotrypsin in hexane': 1, 'Crystal structures of aged phosphonylated acetylcholinesterase: Nerve agent reaction products at the atomic level': 1, 'Successful virtual screening of a chemical database for farnesyltransferase inhibitor leads': 1, 'A Novel Coronavirus from Patients with Pneumonia in China': 5, 'Clinical Characteristics of Coronavirus Disease 2019 in China': 8, 'Faecal calprotectin indicates intestinal inflammation in COVID-19': 1, 'AGA Institute Rapid Review of the GI and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19': 2, 'SARS and MERS: recent insights into emerging coronaviruses': 2, 'SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor': 3, 'Early upregulation of acute respiratory distress syndrome-associated cytokines promotes lethal disease in an aged-mouse model of severe acute respiratory syndrome coronavirus infection': 3, 'Expression of elevated levels of proinflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS': 1, 'Cytokine release syndrome in severe COVID-19': 1, 'Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure': 1, 'COVID-19 and the liver: little cause for concern': 1, 'Clinical characteristics of non-ICU hospitalized patients with coronavirus disease 2019 and liver injury: A retrospective study': 3, 'Characteristics of and Important Lessons From the': 1, 'Clinical and virological data of the first cases of COVID-19 in Europe: a case series': 6, 'Liver impairment in COVID-19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city': 1, 'Characteristics of Liver Tests in COVID-19': 3, 'Multicenter analysis of clinical characteristics and outcome of COVID-19 patients with liver injury': 3, 'Autopsy in suspected COVID-19 cases': 2, 'Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies': 1, 'Metabolic Functions of Gut Microbes': 1, 'Liver injury in COVID-19: management and challenges': 4, 'IL-6 pathway in the liver: From physiopathology to therapy': 3, 'A guiding map for inflammation': 1, 'Gut Microbiome Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel Diseases': 1, 'A new definition for metabolic associated fatty liver disease: an international expert consensus statement': 1, 'Therapeutic and triage strategies for': 1, 'Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells': 2, 'Hepatic acute phase proteins--regulation by IL-6-and IL-1-type cytokines involving STAT3 and its crosstalk with NF-κB-dependent signaling': 1, 'Interleukin-6 signaling drives fibrosis in unresolved inflammation': 1, 'IL-6 as a keystone cytokine in health and disease': 1, 'Acute-phase proteins and other systemic responses to inflammation': 1, 'Subcutaneous administration of recombinant glycosylated interleukin 6 in patients with cancer: pharmacokinetics, pharmacodynamics and immunomodulatory effects': 1, 'A phase I trial of intravenous interleukin-6 in patients with advanced cancer': 1, 'Up-regulation of hepatic heme oxygenase-1 expression by locally induced interleukin-6 in rats administered carbon tetrachloride intraperitoneally': 1, 'The cytokine release syndrome (CRS) of severe': 1, 'Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?': 1, 'Inhibition of NF-κBmediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival': 1, 'Middle East Respiratory Syndrome: Emergence of a Pathogenic Human Coronavirus': 1, 'Liver injury during highly pathogenic human coronavirus infections': 4, 'SARS-CoV-2: a storm is raging': 1, 'In the eye of the COVID-19 cytokine storm': 3, 'Viral and host factors related to the clinical outcome of COVID-19': 1, 'Healthcare-associated infections: a public health problem': 1, 'Ministry of Health. Healthcare-associated infection': 1, 'The role of the intensive care unit environment and healthcare workers in the transmission of bacteria associated with hospital-acquired infections': 1, 'National e-Health strategy, VISION 2030': 1, 'Device-associated nosocomial infection in general hospitals, Kingdom of Saudi Arabia': 1, 'Epidemiological and microbiological profile of nosocomial infection in Taif hospitals, KSA (2010-2011)': 1, 'Prevalence of nosocomial infections in a Saudi Arabian teaching hospital': 1, 'Hospital-and communityacquired infections: a point prevalence and risk factors survey in a tertiary care center in Saudi Arabia': 1, 'Nosocomial infections and misuse of antibiotics in a provincial community hospital': 1, 'Knowledge of standard precautions among healthcare professionals in Saudi Arabia: need for filling the gaps': 1, \"Physicians' knowledge about hand hygiene at king Fahad Hospital of University\": 1, 'Predictors of hand hygiene practice among Saudi nursing students: a cross-sectional self-reported study': 1, 'Nosocomial infections in a neonatal intensive care unit in South-Western Saudi Arabia': 1, 'Department of Infection Prevention and Control': 2, 'Middle East respiratory syndrome coronavirus (MERS-CoV) -Saudi Arabia': 1, 'Interim infection prevention and control recommendations for hospitalized patients with Middle East respiratory syndrome coronavirus (MERS-CoV). National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases': 1, 'An ethics of mutual care in organizational surveillance': 1, 'Research design: qualitative, quantitative, and mixed methods approaches': 1, 'Knowledge, attitudes, and practices of healthcare workers regarding hand hygiene guidelines in Al-Qassim, Saudi Arabia: a multicenter study': 1, 'Biostatistical Basis of Inference in Heart Failure Study': 1, 'Research Methods': 1, 'Qualitative methods for Health Research sage': 1, 'Purposeful sampling for qualitative data collection and analysis in mixed method implementation research': 1, 'Content analysis and thematic analysis: implications for conducting a qualitative descriptive study': 1, 'video research in health': 1, 'Doing visual ethnography. Third edition: Sage': 1, 'Evaluating qualitative research for social work practitioners': 1, 'Awareness and practice of infection control amongst doctors and nurses in two ICUs of a tertiary care hospital in Delhi. Health and population perspective and issues': 1, 'Awareness and practice of infection control amongst doctors and nurses in two ICUs of a tertiary care hospital in Delhi': 1, 'Knowledge, awareness, and practice of infection control by health care workers in the intensive care units of a tertiary hospital in Nigeria': 1, 'Assessment of hospital staff knowledge, attitudes and practices (KAPS) on activities related to prevention and control of hospital acquired infections': 1, 'Types of healthcare-associated infections': 1, 'Do medical students receive training in correct use of personal protective equipment?': 1, 'Assessment of knowledge, attitude, and practice of hand hygiene among medical and health profession students at king Saud bin Abdulaziz University for health sciences in Saudi Arabia': 1, 'Knowledge and attitudes of infection prevention and control among health sciences students at University of Namibia': 1, 'Nosocomial infections: epidemiology, prevention, control and surveillance': 1, 'Update on hand hygiene': 1, 'Improving physician hand hygiene compliance using behavioural theories: a study protocol': 1, 'Hand hygiene practices among medical students. Inter discip Perspect Infect': 1, 'Infection control survey in the hospitals to examine the role of masks and respirators for the prevention of respiratory infections in healthcare workers (HCWs)': 1, 'Practices around the use of masks and respirators among hospital health care workers in 3 diverse populations': 1, 'Personal protective equipment knowledge and practices among nurses working at Al-Baha king Fahad hospital. Saudi Arabia Arch De Med': 1, 'The National Institute for Occupational Safety and Health (NIOSH)': 1, 'A system dynamics approach for hospital waste management in a city in a developing country: the case of Nablus': 1, 'ASSESSMENT OF KNOWLEDGE, Attitude and practices (KAP) towards hepatitis b, c and HIV among sanitary staff at a tertiary care hospital in MAKKAH city, Saudi Arabia': 1, 'Disinfection and sterilization in healthcare facilities: what clinicians need to know': 1, 'Risk and management of bloodborne infections in health care workers': 1, 'Middle East respiratory syndrome coronavirus; guidelines for healthcare professionals': 1, 'attitudes and behaviours of healthcare workers in the Kingdom of Saudi Arabia to MERS coronavirus and other emerging infectious diseases': 1, 'Knowledge and practices of primary health care physicians regarding updated guidelines of MERS-CoV infection in Abha city': 2, 'Beyond hand hygiene: a qualitative study of the everyday work of preventing cross-contamination on hospital wards': 1, \"To follow a rule? On frontline clinicians' understandings and embodiments of hospital-acquired infection prevention and control rules. Health (London)\": 1, 'The Saudi Ministry of Health': 1, 'Proc. Natl. Acad. Sci': 5, 'Membrane rearrangements mediated by coronavirus nonstructural proteins 3 and 4': 1, 'World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19)': 1, 'Health services provision of 48 public tertiary dental hospitals during the COVID-19 epidemic in China': 3, 'The impact of the COVID-19 epidemic on the utilization of emergency dental services': 3, 'Reasons for and barriers to attending continuing education activities and priorities for different dental specialties. Open Access Maced': 2, 'Internet continuing education for health care professionals: an integrative review': 1, 'Distance education: growth and diversity. Financ dev': 1, 'The effects of \"live online courses\" on students\\' achievement at distance education': 1, 'A review of continuing professional development for dentists in Europe': 2, 'The importance of continuing professional development to career satisfaction and patient care: meeting the needs of novice to mid-to late-career nurses throughout their career span': 1, 'Use of educational technology in promoting distance education': 1, 'Comparing face-to-face, synchronous, and asynchronous learning: postgraduate dental resident preferences': 1, 'Student and faculty perceptions of the quality of online learning experiences': 2, 'Online CME: an effective alternative to face-to-face delivery': 1, 'Evidence-based choices of physicians: a comparative analysis of physicians participating in internet CME and non-participants': 1, 'Direct assessment as a measure of institutional effectiveness in a dental hygiene distance education program': 1, 'Distance learning in dental radiology: immediate impact of the implementation': 1, 'WHO, Novel Coronavirus (2019-ncov) -Situation Report -1': 1, 'WHO, Novel Coronavirus (2019-ncov) -Situation Report -22': 1, 'Early transmission dynamics in wuhan, China, of novel coronavirus-infected pneumonia': 4, 'Clinical features of patients infected with 2019 novel coronavirus in wuhan': 1, 'Incubation period and other epidemiological characteristics of 2019 novel coronavirus infections with right truncation: a statistical analysis of publicly available case data': 3, 'Estimating the unreported number of novel coronavirus (2019-ncov) cases in China in the first half of january 2020: a data-driven modelling analysis of the early outbreak': 1, 'Consistent covariance matrix estimation with spatially dependent panel data': 1, 'Unequally spaced panel data regressions with ar (1) disturbances': 1, 'Estimation and inference in large heterogeneous panels with a multifactor error structure': 1, 'Cointegration testing and dynamic simulations of autoregressive distributed lag models': 2, 'Environmental sustainability assessment using dynamic autoregressive-distributed lag simulations-nexus between greenhouse gas emissions, biomass energy, food and economic growth': 2, 'Covid-19) -Situation Report -33': 3, 'Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment': 1, 'Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers': 1, 'Prevalence and burden of hepatitis D virus infection in the global population: A systematic review and meta-analysis': 1, \"A replication cycle for viroids and other small infectious RNA's\": 1, 'Hepatitis delta virus histone mimicry drives the recruitment of chromatin remodelers for viral RNA replication': 1, 'Structure, sequence and expression of the hepatitis delta (δ) viral genome': 1, 'Replicating hepatitis delta virus RNA is edited in the nucleus by the small form of ADAR1': 1, 'The hepatitis delta virus large antigen is farnesylated both in vitro and in animal cells': 2, 'Epidemiology and phylogenetic analysis of hepatitis D virus infection in Australia': 1, 'Eighth Major Clade for Hepatitis Delta Virus': 1, 'Origin of hepatitis δ virus': 1, 'Hepatitis delta virus (HDV) and woodchuck hepatitis virus (WHV) nucleic acids in tissues of HDV-infected chronic WHV carrier woodchucks': 1, 'Hepatitis delta virus infects the cells of hepadnavirus-induced hepatocellular carcinoma in woodchucks': 1, 'A divergent hepatitis D-like agent in birds': 5, 'Identification of a novel deltavirus in boa constrictors': 8, 'Novel hepatitis D-like agents in vertebrates and invertebrates': 3, 'A reference viral database (RVDB) to enhance bioinformatics analysis of high-throughput sequencing for novel virus detection': 1, 'A specific base transition occurs on replicating hepatitis delta virus RNA': 1, 'Bats carry pathogenic hepadnaviruses antigenically related to hepatitis B virus and capable of infecting human hepatocytes': 2, 'Enveloped viruses distinct from HBV induce dissemination of hepatitis D virus in vivo': 2, 'Ecological drivers of Hepacivirus infection in a neotropical rodent inhabiting landscapes with various degrees of human environmental change': 3, 'Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: A nationwide, cross-sectional, serological study': 1, 'The island syndrome in isolated populations of a tropical forest rodent': 1, 'Snake deltavirus utilizes envelope proteins of different viruses to generate infectious particles': 2, 'RAxML-NG: A fast, scalable and user-friendly tool for maximum likelihood phylogenetic inference': 1, 'Eighth major clade for hepatitis delta virus': 1, 'A novel hepatitis B virus species discovered in capuchin monkeys sheds new light on the evolution of primate hepadnaviruses': 1, 'Evolutionary biology of human hepatitis viruses': 1, 'RNA in extracellular vesicles': 1, 'Viroids and hepatitis delta virus': 1, 'HDV-like self-cleaving ribozymes': 1, 'A cellular homolog of hepatitis delta antigen: Implications for viral replication and evolution': 1, 'Delta-interacting protein A and the origin of hepatitis delta antigen': 1, 'The diversity, evolution and origins of vertebrate RNA viruses': 1, 'Swine influenza A (H1N1) infection in two children e Southern California, MarcheApril': 1, 'Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans': 2, 'World now at the start of 2009 influenza pandemic. Geneva: World Health Organization': 1, 'Pandemic (H1N1) 2009dupdate 112. Geneva: World Health Organization': 1, 'Centers for Disease Control and Prevention. CDC estimates of 2009 H1N1 influenza cases, hospitalizations and deaths in the United States': 1, 'Preliminary estimates of mortality and years of life lost associated with the 2009 A/H1N1 pandemic in the US and past influenza seasons': 1, 'Emergence and control of infectious diseases in China': 1, \"Clinical and epidemiologic characteristics of 3 early cases of influenza A pandemic (H1N1) 2009 virus infection, People's Republic of China\": 1, \"General Administration of Quality Supervision, Inspection and Quarantine of People's Republic of China. 757 confirmed cases with 2009 (H1N1) influenza infection were detected through border entry screening\": 1, 'The characteristics of imported cases and the effectiveness of outbreak control strategies of pandemic influenza A (H1N1) in China': 1, 'A primary school outbreak of pandemic 2009 influenza A (H1N1) in China': 1, 'Pattern on the spread of novel influenza A (H1N1) and quantitative assessment of containment in mainland China': 1, 'Chinese government earmarked 5 billion Yuan on H1N1 response': 1, 'Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China': 3, 'Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China': 1, 'Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in China': 1, 'Oseltamivir compared the Chinese traditional therapy MaxingshiganeYinqiaosan in the treatment of H1N1 influenza. A randomized trial': 1, 'The 5th WHO meeting on evaluation of pandemic influenza prototype vaccines in clinical trials': 1, 'Swine flu outbreak. China first to vaccinate against novel H1N1 virus': 2, 'Safety of influenza A (H1N1) vaccine in postmarketing surveillance in China': 3, 'Safety and effectiveness of a 2009 H1N1 vaccine in Beijing': 3, 'Briefing reports on pandemic (H1N1) 2009 influenza vaccination in China': 1, 'Seasonal influenza vaccine supply and target vaccinated population in China': 1, 'Knowledge, attitudes and practices (KAP) related to the pandemic (H1N1) 2009 among Chinese general population: a telephone survey': 1, 'The seroprevalence of pandemic influenza H1N1 (2009) virus in China': 1, 'Over 80% of Chinese were satisfied with pandemic H1N1 influenza response': 1, \"Statistical data by quarter. Beijing: National Bureau of Statistics of People's Republic of China\": 1, 'Application of deglycosylation and electrophoresis to the quantification of influenza viral hemagglutinins facilitating the production of 2009 pandemic influenza (H1N1) vaccines at multiple manufacturing sites in China': 1, 'Restriction enzyme analysis of faecal adenoviruses in Newcastle': 1, 'Turning financial markets inside out: Polanyi, performativity and disembeddedness': 1, \"It's the business model… Reframing the problems of UK retail banking\": 7, 'Disintermediation and the role of banks in Europe: An international comparison': 1, 'The theory of financial intermediation': 1, 'Foundational economy. The infrastructure of everyday life': 1, 'Banking with ethics: Strategic moves and structural changes of the banking industry in the aftermath of the subprime mortgage crisis': 1, 'Extracting rents through foreclosures: The rescue of Catalunya Banc as a new urban strategy following the burst of the Spanish bubble. Miscellanera Geographica': 1, 'Social movements, civil society and corporations: Taking stock and looking ahead': 2, 'Corporate social responsibility, public policy, and NGO activism in Europe and the United States: An institutional-stakeholder perspective': 1, 'Sustainability accounting for companies: Catchphrase or decision support for business leaders': 2, 'The role of governments in corporate social responsibility: Characterising public policies on CSR in Europe': 1, 'Corporate social performance and its relation with financial performance: International evidence in the banking industry': 1, 'The responsible corporation in a global economy': 4, 'Is integrated reporting really the superior mechanism for the integration of ethics into the core business model? An empirical analysis': 2, 'Instrumental and integrative logics in business sustainability': 1, 'Corporate social responsibility-A PR invention? Corporate Communications': 1, 'Corporate social responsibility/sustainability reporting among the Fortune Global 250: Greenwashing or green supply chain?': 1, 'Banks and financial discrimination: What can be learnt from the Spanish experience': 2, 'Responsible practices are culturally embedded: theoretical considerations on industry-specific corporate social responsibility': 5, 'The new institutionalism in organizational analysis': 2, 'Unternehmensethische Untersuchungen aus gesellschaftlicher Perspektive. Von der gesellschaftsorientierten Unternehmenslehre zur unternehmensorientierten Gesellschaftslehre': 2, 'Behind the mask: Revealing the true face of corporate citizenship': 1, 'Global Rules and Private Actors: Toward a New Role of the Transnational Corporation in Global Governance': 1, 'The fragile structure of free-market society: The radical implications of corporate social responsibility': 1, 'The new political role of business in a globalized world': 2, 'Corporate governance and democracy: The stakeholder debate revisited': 1, 'Against management: Organization in the age of managerialism': 1, 'CR in Europe: Government involvement in sector-specific initiatives': 3, 'Making globalization good: the moral challenges of global capitalism': 1, 'Making globalization good: The moral challenges of global capitalism': 1, 'Corporate responsibility coalitions: The past, present, and future of alliances for sustainable capitalism': 2, 'Striving for legitimacy through corporate social responsibility: Insights from oil companies': 1, 'Beyond corporate social responsibility: Minnows, mammoths and markets': 1, 'Civil Society in the Age of Crisis': 1, 'The role of governments in the business and society debate': 1, 'Social movements as catalysts for corporate social innovation: Environmental activism and the adoption of green information systems': 5, 'Corporate social responsibility, government, and civil society': 2, 'Who and what really matters to the firm: Moving stakeholder salience beyond managerial perceptions': 3, 'Toward a theory of stakeholder identification and salience: Defining the principle of who and what really counts': 3, 'Stakeholder salience revisited: Refining, redefining, and refueling an underdeveloped conceptual tool': 4, 'Stakeholder salience for stakeholder firms: An attempt to reframe a heuristic device': 2, 'Analyzing the essence of stakeholder relationships: What do we need in addition to power, legitimacy, and urgency': 3, 'Moral salience and the role of goodwill in firm-stakeholder trust repair': 1, 'A longitudinal study of significant change in stakeholder management': 1, 'Move your money? Sustainability transitions in regimes and practices in the UK Retail Banking Sector': 1, 'Swimming against the tide: Ethical banks as countermovement': 2, 'Turning stakeseekers into stakeholders: A political coalition perspective on the politics of stakeholder influence': 1, 'Power: A radical view': 1, 'A life cycle model of multi-stakeholder networks': 1, 'Why would corporations behave in socially responsible ways? An Institutional theory of corporate social responsibility': 1, 'The politics of the financialization of sustainability': 1, 'A review of corporate sustainability reporting tools (SRTs)': 1, 'Greenwash: Corporate Environmental Disclosure under Threat of Audit': 1, 'The role of civil society in holding financial powers accountable': 2, 'Civil society and financial markets: What is not happening and why': 1, 'The ecology of finance. London: New Economics Foundation': 1, 'An alternative report on banking': 1, 'The future of finance': 1, 'Understanding the loss of trust in large banks': 1, 'The relationship between corporate social performance and corporate financial performance in the banking sector': 1, 'Trust in banks. What went wrong and how to fix it': 1, 'Corporate social responsibility in Western Europe: An institutional mirror or substitute': 1, 'Consumer responses to dissatisfaction with financial service providers: An exploration of why some stay while others switch': 1, 'Un análisis de la situación del crédito en España. Boletín económico, Banco de España, octubre': 1, 'Competition in UK banking: A report to the Chancellor of the Exchequer': 1, 'Democracy lost: The financial crisis in Europe and the Role of Civil Society': 1, 'The politics of the financial services revolution': 1, 'For all their high hopes the challenger banks have finished up on the ropes': 1, 'From proletarians to proprietors': 1, 'International handbook of social innovation: Collective action, social learning and transdisciplinary research': 1, 'FCA publishes update on PPI work-firms have improved complaints handling and are reopening two and a half million old complaints to ensure fair redress is paid. Press Release': 2, 'Regulatory lessons from the payment protection insurance mis-selling scandal in the UK. European Business Organisation Law Review': 1, 'FSA wins PPI battle in High Court. Guardian': 1, 'Lloyds Banking Group fined record £28m in new mis-selling scandal': 1, 'After PPI, what could be the next banking mis-selling scandal? Financial Times': 1, 'Reclaim packaged bank account fees': 1, 'Fintech newbies pick up some bad old habits': 1, 'Cryptosporidiosis: epidemiology and impact': 1, 'Cryptosporidiosis: current trends and challenges': 1, 'Cryptosporidiosis: biology, pathogenesis and disease': 4, 'A hundred-year retrospective on cryptosporidiosis': 3, 'Overwhelming watery diarrhea associated with a cryptosporidium in an immunosuppressed patient': 1, 'Acute enterocolitis in a human being infected with the protozoan Cryptosporidium': 1, 'Cryptosporidium spp. and cryptosporidiosis': 1, 'Cryptosporidium species in humans and animals: current understanding and research needs': 4, 'Assessing the impact of environmental exposures and Cryptosporidium infection in cattle on human incidence of cryptosporidiosis in Southwestern Ontario': 1, 'Bovine cryptosporidiosis: impact, host-parasite interaction and control strategies': 3, 'Public health significance of zoonotic Cryptosporidium species in wildlife: Critical insights into better drinking water management': 1, 'Cryptosporidiosis-an overview': 2, 'Advances in the application of genetic manipulation methods to apicomplexan parasites': 1, 'The truth about in vitro culture of Cryptosporidium species': 1, 'Cryptosporidiosis: A zoonotic disease concern': 1, 'Epidemiology of anthroponotic and zoonotic human cryptosporidiosis in England and Wales': 1, 'Significance of wall structure, macromolecular composition, and surface polymers to the survival and transport of Cryptosporidium parvum oocysts': 1, 'Revisiting the global problem of cryptosporidiosis and recommendations': 4, 'Risk factors for Cryptosporidium infection in low and middle income countries: A systematic review and metaanalysis': 3, 'Addressing Cryptosporidium Infection among Young Children in Low-Income Settings: The Crucial Role of New and Existing Drugs for Reducing Morbidity and Mortality': 3, 'Potential Role of the Eastern Oyster, Crassostrea virginica, in the Epidemiology of Cryptosporidium parvum': 2, 'Epidemiology of Cryptosporidium: transmission, detection and identification': 2, 'Genotypic Characterization of Cryptosporidium Species in Humans and Peri-Domestic Animals in Ekiti and Oyo States': 1, 'Cryptosporidiosis and Cryptosporidium species in animals and humans: a thirty colour rainbow?': 1, 'The potential for zoonotic transmission of Giardia duodenalis and Cryptosporidium spp. from beef and dairy cattle in Ontario': 1, 'Assessment of zoonotic transmission of Giardia and Cryptosporidium between cattle and humans in rural villages in Bangladesh': 1, 'The zoonotic transmission of Giardia and Cryptosporidium': 3, 'Minireview: clinical cryptosporidiosis': 1, 'Symptoms and risk factors of Cryptosporidium hominis infection in children: data from a large waterborne outbreak in Sweden': 2, 'Prevalence of Cryptosporidium, microsporidia and Isospora infection in HIV-infected people: a global systematic review and meta-analysis. Parasites Vectors': 2, 'Parasitic infection among HIV/AIDS patients at Bela-Bela clinic, Limpopo province, South Africa with special reference to Cryptosporidium': 1, 'Cryptosporidium infection in solid organ transplantation': 1, 'Burden of disease from cryptosporidiosis': 1, 'Widespread occurrence of Cryptosporidium infections in patients with HIV/AIDS: Epidemiology, clinical feature, diagnosis, and therapy': 4, 'Cryptosporidium parvum disrupts intestinal epithelial barrier function via altering expression of key tight junction and adherens junction proteins': 1, 'Intestinal and Pulmonary Infection by Cryptosporidium Parvum in Two Patients with HIV': 1, 'Laboratory diagnosis of cryptosporidiosis': 5, 'Comparative diagnostic techniques for cryptosporidium infection': 3, 'Comparison of current methods used to detect Cryptosporidium oocysts in stools': 3, 'Detection of intestinal protozoa in the clinical laboratory': 1, 'Evaluation of four commercial rapid immunochromatographic assays for detection of Cryptosporidium antigens in stool samples: a blind multicenter trial': 1, 'Multisite performance evaluation of an enzyme-linked immunosorbent assay for detection of Giardia, Cryptosporidium, and Entamoeba histolytica antigens in human stool': 1, 'Evaluation of an immunoassay-based algorithm for screening and identification of giardia and cryptosporidium antigens in human faecal specimens from saudi arabia': 2, 'Evaluation of the Roche LightMix Gastro parasites multiplex PCR assay detecting Giardia duodenalis, Entamoeba histolytica, cryptosporidia, Dientamoeba fragilis, and Blastocystis hominis': 1, 'Is real-time PCR-based diagnosis similar in performance to routine parasitological examination for the identification of Giardia intestinalis, Cryptosporidium parvum/Cryptosporidium hominis and Entamoeba histolytica from stool samples? Evaluation of a new commercial multiplex PCR assay and literature review': 1, 'Comparison of three commercial multiplex PCR assays for the diagnosis of intestinal protozoa': 1, 'Ebola haemorrhagic fever': 3, 'Unexpected inheritance: multiple integrations of ancient bornavirus and ebolavirus/marburgvirus sequences in vertebrate genomes': 3, 'Filoviruses are ancient and integrated into mammalian genomes': 1, 'Long-term survival of an urban fruit bat seropositive for Ebola and Lagos bat viruses': 1, 'Human Ebola outbreak resulting from direct exposure to fruit bats in Luebo, Democratic Republic of Congo': 1, 'Fruit bats as reservoirs of Ebola virus': 3, 'How Ebola and Marburg viruses battle the immune system': 1, 'Progress in filovirus vaccine development: evaluating the potential for clinical use': 1, 'Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor': 2, 'Processing of the Ebola virus glycoprotein by the proprotein convertase furin': 2, 'The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing': 2, 'GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases': 3, 'Disulfide bond assignment of the Ebola virus secreted glycoprotein SGP': 1, 'Structure-function analysis of the soluble glycoprotein, sGP, of Ebola virus': 1, 'Ebola virus secretory glycoprotein (sGP) diminishes Fc gamma RIIIB-to-CR3 proximity on neutrophils': 1, 'The nonstructural small glycoprotein sGP of Ebola virus is secreted as an antiparallel-orientated homodimer': 1, 'Effects of Ebola virus glycoproteins on endothelial cell activation and barrier function': 1, 'Genomic RNA editing and its impact on Ebola virus adaptation during serial passages in cell culture and infection of guinea pigs': 1, 'Recombinant human monoclonal antibodies to Ebola virus': 2, 'Ebola virus can be effectively neutralized by antibody produced in natural human infection': 5, 'Ebola virus glycoprotein: proteolytic processing, acylation, cell tropism, and detection of neutralizing antibodies': 1, 'Infectivityenhancing antibodies to Ebola virus glycoprotein': 2, 'Production and characterization of monoclonal antibodies against different epitopes of Ebola virus antigens': 5, 'Influences of glycosylation on antigenicity, immunogenicity, and protective efficacy of ebola virus GP DNA vaccines': 4, 'Impact of Ebola mucin-like domain on antiglycoprotein antibody responses induced by Ebola virus-like particles': 2, 'Structure of an antibody in complex with Its mucin domain linear epitope that is protective against Ebola virus': 1, 'Characterization of Zaire ebolavirus glycoprotein-specific monoclonal antibodies': 1, 'Epitopes involved in antibody-mediated protection from Ebola virus': 4, 'Signals for ribosomal frameshifting in the Rous sarcoma virus gag-pol region': 1, 'Identification of Hepta-and Octo-Uridine stretches as sole signals for programmed +1 and 21 ribosomal frameshifting during translation of SARS-CoV ORF 3a variants': 1, 'Immunogenicity and efficacy of codon optimized DNA vaccines encoding the F-protein of respiratory syncytial virus': 1, 'Ectodomain shedding of the glycoprotein GP of Ebola virus': 1, 'Quantitative evaluation of indirect ELISA. Effect of calmodulin antagonists on antibody binding to calmodulin': 2, 'Rapid cloning of high-affinity human monoclonal antibodies against influenza virus': 1, 'The secreted form of respiratory syncytial virus G glycoprotein helps the virus evade antibodymediated restriction of replication by acting as an antigen decoy and through effects on Fc receptor-bearing leukocytes': 1, 'The glycoprotein G of rhabdoviruses': 1, 'Disquisitions of Original Antigenic Sin. I. Evidence in man': 1, 'Disquisitions on Original Antigenic Sin. II. Proof in lower creatures': 1, 'Designing immunogens to elicit broadly neutralizing antibodies to the HIV-1 envelope glycoprotein': 1, 'Ebola virus-like particle-induced activation of NF-kappaB and Erk signaling in human dendritic cells requires the glycoprotein mucin domain': 1, 'Steric shielding of surface epitopes and impaired immune recognition induced by the ebola virus glycoprotein': 1, 'Ebola virus glycoprotein 1: identification of residues important for binding and postbinding events': 1, 'Biochemical and structural characterization of cathepsin L-processed Ebola virus glycoprotein: implications for viral entry and immunogenicity': 2, 'Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity': 2, 'Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection': 10, 'Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein': 2, 'Induction of ebolavirus cross-species immunity using retrovirus-like particles bearing the Ebola virus glycoprotein lacking the mucin-like domain': 1, 'Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule': 1, 'Immune protection of nonhuman primates against Ebola virus with single lowdose adenovirus vectors encoding modified GPs': 1, 'A replicating cytomegalovirus-based vaccine encoding a single Ebola virus nucleoprotein CTL epitope confers protection against Ebola virus': 1, 'Functional CD8+ T cell responses in lethal Ebola virus infection': 1, 'The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis': 1, 'The P gene of human parainfluenza virus type 1 encodes P and C proteins but not a cysteinerich V protein': 1, 'Immunization by influenza virus-like particles protects aged mice against lethal influenza virus challenge': 1, 'Selection of recombinant vaccinia viruses on the basis of plaque formation': 1, 'Ebola virus-like particles produced in insect cells exhibit dendritic cell stimulating activity and induce neutralizing antibodies': 2, 'Solvent refined coal (SRC) processes': 1, 'Status of the development of EDS coal liquefaction. Science (Washington': 1, 'Transformation of Syrian hamster embryo cells by synfuel mixtures': 1, 'Mutagenic and carcinogenic activity of a hydrotreated coal liquid': 1, 'Initiation/promotion studies with coal-derived liquids': 1, 'Teratogenicity following inhalation exposure of rats to a high boiling coal liquid': 2, 'Chemical class separation and characterization of organic compounds in synthetic fuels': 1, 'Aerosol mixing in an animal exposure chamber having three levels of caging with excreta pans': 1, 'Generation and delivery of coal liquid aerosols for inhalation studies': 1, 'Statistical Theory': 1, 'Principles and Procedures of Statistics': 1, 'Non-Parametric Statistics for Behavioral Sciences': 1, 'Variation of composition with particle size in coal liquid aerosols generated for inhalation toxicology studies': 1, 'Petroleum hydrocarbon toxicity studies. XIV. Animal and human response to vapors of\"high aromatic solvent': 2, 'Benzo-[alpyrene-initiated leukemia in mice. Association with allelic differences at the Ah locus': 1, 'Measurement of the respiratory volumes of laboratory animals': 1, 'Comparative chemical composition and biological activity of single-and two-stage coal liquefaction process streams': 1, 'Nephrotoxicity of hydrocarbon propellants to male, Fischer-344 rats': 1, 'Effects of Stoddard solvent on kidney function and structure of Fischer-344 and Sprague-Dawley rats': 2, 'Comparison of the subchronic inhalation toxicity of petroleum and oil shale diesel fuel marine': 1, 'Renal toxicity of gasoline and related petroleum naphtha in male rats': 1, 'Histopathologic examination of the rat nasal cavity': 1, 'Lesions found in animals exposed to coal tar aerosols': 1, 'Hamster emeriti A review': 1, 'Psychoneuroendocrine influences on immunocompetence and neoplasia. Science (Washington': 1, 'Critical care lessons from severe acute respiratory syndrome': 1, 'Anaesthesia and SARS': 1, 'Outbreak of a new coronavirus: what anaesthetists should know': 1, 'Bovine respiratory disease': 4, 'Bovine respiratory syncytial virus-specific IgE is associated with interleukin-2 and -4, and interferon-gamma expression in pulmonary lymph of experimentally infected calves': 1, 'Bovine viral diarrhea viral infections in feeder calves with respiratory disease: interactions with Pasteurella spp., parainfluenza-3 virus, and bovine respiratory syncytial virus': 1, 'The contribution of infections with bovine viral diarrhea viruses to bovine respiratory disease': 1, 'Etiology of respiratory disease in non-vaccinated, non-medicated calves in rearing herds': 1, 'Serotyping of Mannheimia (Pasteurella) haemolytica isolates from the upper Midwest United States': 1, 'Pasteurella multocida and bovine respiratory disease': 1, 'Histophilus somni host-parasite relationships': 1, 'Leukotoxins of gram-negative bacteria': 1, 'Effect of bovine granulocyte colony-stimulating factor on the development of pneumonia caused by Mannheimia haemolytica': 1, 'Control methods for bovine respiratory disease for feedlot cattle': 1, 'Effects of vaccination against respiratory Article No~e00158 pathogens on feed intake, metabolic, and inflammatory responses in beef heifers': 1, 'Immunity of cattle following vaccination with a Mannheimia haemolytica chimeric PlpE-LKT (SAC89) protein': 2, 'Evidence for the Pasteurella haemolytica cytotoxin as a product of actively growing bacteria': 1, 'Identification and characterization of the Pasteurella haemolytica leukotoxin': 5, 'Nucleotide sequence of the leukotoxin genes of Pasteurella haemolytica A1': 1, 'Characterization of epitopes involved in the neutralization of Pasteurella haemolytica serotype A1 leukotoxin': 1, 'Efficacy of recombinant leukotoxin in protection against pneumonic challenge with live Pasteurella haemolytica A1': 1, 'How Mannheimia haemolytica defeats host defence through a kiss of death mechanism': 1, 'Mannheimia haemolytica: bacterial-host interactions in bovine pneumonia': 2, 'Pasteurella haemolytica antigens associated with resistance to pneumonic pasteurellosis': 2, 'Vaccination of calves with leukotoxic culture supernatant from Pasteurella haemolytica': 2, 'Protective capacity of the Pasteurella haemolytica transferrin-binding proteins TbpA and TbpB in cattle. Microb': 1, 'Improved method for predicting linear B-cell epitopes': 3, 'Protein production by auto-induction in high density shaking cultures': 1, 'Serine/threonine protein kinase PrkA of the human pathogen Listeria monocytogenes: biochemical characterization and identification of interacting partners through proteomic approaches': 1, 'Probability-based protein identification by searching sequence databases using mass spectrometry data': 1, 'Immunogenicity of Mannheimia haemolytica recombinant outer membrane proteins serotype 1-specific antigen, OmpA, OmpP2, and OmpD15': 3, 'TRAP transporters: an ancient family of extracytoplasmic solute-receptor-dependent secondary active transporters': 1, 'Immunogenicity of Pasteurella multocida and Mannheimia haemolytica outer membrane vesicles': 2, 'Identification of immunodominant proteins from Mannheimia haemolytica and Histophilus somni by an immunoproteomic approach': 4, 'Serum antibody responses of cattle to iron-regulated outer membrane proteins of Pasteurella haemolytica A1': 1, 'Cloning and expression of the leukotoxin gene of Pasteurella haemolytica A1 in Escherichia coli K-12': 1, 'Optimization of formaldehyde cross-linking for protein interaction analysis of non-tagged integrin beta1': 1, 'Proteome analysis of Streptococcus thermophilus grown in milk reveals pyruvate formate-lyase as the major upregulated protein': 1, 'ATP-binding cassette transporters are targets for the development of antibacterial vaccines and therapies': 2, 'Immunoproteomic analyses of outer membrane proteins of Mannheimia haemolytica and identification of potential vaccine candidates': 1, \"Decreased induction morbidity and mortality following modification to induction therapy in infants with acute lymphoblastic leukemia enrolled on AALL0631: a report from the children's oncology group\": 2, \"Modifications to induction therapy decrease risk of early death in infants with acute lymphoblastic leukemia treated on Children's Oncology Group P9407\": 1, 'Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience': 1, 'T-cell immunodeficiency following cytotoxic antineoplastic therapy: a review': 2, 'Reduced versus intensive chemotherapy for childhood acute lymphoblastic leukemia: impact on lymphocyte compartment composition': 3, 'Immune reconstitution after childhood acute lymphoblastic leukemia is most severely affected in the high risk group': 5, 'Clinical features that identify children with primary immunodeficiency diseases': 1, 'Immune reconstitution in children following chemotherapy for haematological malignancies: a long-term follow-up': 1, 'Recovery of natural killer cells after chemotherapy for childhood acute lymphoblastic leukemia and solid tumors': 1, 'Longitudinal assessment of immunological status and rate of immune recovery following treatment in children with ALL': 2, 'Early memory phenotypes drive T cell proliferation in patients with pediatric malignancies': 1, 'WHO. Report of the WHO-China Joint Mission on Coronavirus Disease': 1, 'Effect of non-pharmaceutical interventions to contain COVID-19 in China': 1, 'The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study': 2, 'Estimating the effects of nonpharmaceutical interventions on COVID-19 in Europe': 3, 'Covid-19: Global summary. epiforecasts': 3, 'Social distancing strategies for curbing the COVID-19 epidemic': 3, 'Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study': 3, 'Impact of nonpharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand': 2, \"Les hôpitaux d'Ile-de-France veulent évacuer des malades du coronavirus vers d'autres régions\": 2, 'The French connection: the first large population-based contact survey in France relevant for the spread of infectious diseases': 3, 'Estimates of the severity of coronavirus disease 2019: a model-based analysis': 8, 'Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19)': 4, 'Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study': 3, 'Modes of contact and risk of transmission in COVID-19 among close contacts': 4, 'Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children': 2, 'A case series of children with 2019 novel coronavirus infection: clinical and epidemiological features': 1, 'Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults': 1, \"Données hospitalières relatives à l'épidémie de COVID-19 -data\": 4, 'Data for Ilede-France': 2, 'The incubation period of 2019-nCoV from publicly reported confirmed cases: estimation and application': 2, 'Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing': 5, 'A note on generation times in epidemic models': 1, 'Chinese Center for Disease Control and Prevention': 1, 'The early phase of the COVID-19 outbreak in Lombardy, Italy. ArXiv200309320 Q-Bio': 1, 'Estimating the burden of SARS-CoV-2 in France': 6, 'The impact of illness on social networks: implications for transmission and control of influenza': 1, 'Devenez acteur de la surveillance du Covid19': 2, 'Population mobility reductions during COVID-19 epidemic in France under lockdown': 1, 'Durée et organisation du temps de travail. INSEE.fr': 1, 'Effectiveness of social distancing strategies for protecting a community from a pandemic with a data-driven contact network based on census and real-world mobility data': 1, 'French GPs Sentinelles network': 2, 'Expected impact of reopening schools after lockdown on COVID-19 epidemic in Îlede-France': 3, 'Quantifying the impact of physical distance measures on the transmission of COVID-19 in the UK': 4, 'Changes in contact patterns shape the dynamics of the COVID-19 outbreak in China': 3, 'On the definition and the computation of the basic reproduction ratio R0 in models for infectious diseases in heterogeneous populations': 1, 'COVID-19: One-month impact of the French lockdown on the epidemic burden. medRxiv': 4, 'Commission recommendations (EU) 2020/518 of 8': 2, 'Help speed up contact tracing with TraceTogether. Gov.sg': 1, \"fr seraient largement disposés à adopter une application permettant d'informer anonymement les personnes ayant été en contact avec un cas à la sortie du confinement\": 1, 'Global uncertainty related to coronavirus at record high. IMF Blog': 1, 'Respiratory virus shedding in exhaled breath and efficacy of face masks': 3, \"Is the coronavirus airborne? Experts can't agree\": 1, 'Expected impact of school closure and telework to mitigate COVID-19 epidemic in France': 1, 'Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study': 2, 'Hospital Respiratory Protection Program Toolkit': 1, 'Facemasks for the prevention of infection in healthcare and community settings': 2, 'Self-protection as a driver for hand hygiene among healthcare workers': 1, 'Preventing surgicalsite infections in nasal carriers of Staphylococcus aureus': 1, 'Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials': 1, 'Impact of non-pharmaceutical interventions (NPIs) to reduce Covid-19 mortality and healthcare demand': 1, 'Diagnostic and statistical manual of mental disorders (DSM-5®)': 1, 'Mental illness, mass shootings, and the politics of American firearms': 1, 'Survey of Depression Detection using Social Networking Sites via Data Mining': 1, 'World Health Organization': 6, 'Beyond Modelling: Understanding Mental Disorders in Online Social Media': 1, 'Depression and disclosure behavior via social media: A study of university students in China': 1, 'Depressed individuals express more distorted thinking on social media': 1, 'Depressive moods of users portrayed in Twitter': 1, 'A Depression Recognition Method for College Students Using Deep Integrated Support Vector Algorithm': 1, 'Using Social Media Content to Identify Mental Health Problems: The Case of# Depression in Sina Weibo': 1, 'Methods in predictive techniques for mental health status on social media: a critical review': 1, 'Take two aspirin and tweet me in the morning: how Twitter, Facebook, and other social media are reshaping health care': 1, 'Rethinking communication in the e-health era': 1, 'Identifying health-related topics on twitter': 1, 'Dissemination of health information through social networks: Twitter and antibiotics': 1, 'Depression detection using emotion artificial intelligence': 2, 'Predicting depression via social media': 4, 'Anxious Depression Prediction in Real-time Social Data': 4, 'Analysis of user-generated content from online social communities to characterise and predict depression degree': 1, 'Detecting and characterizing eatingdisorder communities on social media': 2, 'Detecting cognitive distortions through machine learning text analytics': 1, 'Depression Detection via Harvesting Social Media: A Multimodal Dictionary Learning Solution': 8, 'Deep learning for depression detection of twitter users': 1, 'Empirical evaluation of gated recurrent neural networks on sequence modeling': 1, 'Feature Fusion Text Classification Model Combining CNN and BiGRU with Multi-Attention Mechanism': 1, 'Combining convolution neural network and bidirectional gated recurrent unit for sentence semantic classification': 1, 'Salary Prediction using Bidirectional-GRU-CNN Model': 1, 'Rehabilitation of count-based models for word vector representations': 1, 'Predicting depression of social media user on different observation windows': 3, 'Recognizing depression from twitter activity': 2, 'Beyond LDA: Exploring Supervised Topic Modeling for Depression-Related Language in Twitter': 2, 'Cross-domain depression detection via harvesting social media': 2, 'Early risk detection of anorexia on social media': 2, 'Semi-supervised approach to monitoring clinical depressive symptoms in social media': 3, 'Modeling depression symptoms from social network data through multiple instance learning': 1, 'SenseMood: Depression Detection on Social Media': 2, 'BERT: Pre-training of deep bidirectional transformers for language understanding': 3, 'Multimodal depression detection on instagram considering time interval of posts': 1, 'Graph Attention Model Embedded With Multi-Modal Knowledge For Depression Detection': 1, 'Georgios Paraskevopoulos, Alexandros Potamianos, and Shrikanth Narayanan. 2020. Affective Conditioning on Hierarchical Networks applied to Depression Detection from Transcribed Clinical Interviews': 1, 'Estimating the effect of COVID-19 on mental health: Linguistic indicators of depression during a global pandemic': 1, 'Advances in pretraining distributed word representations': 1, 'Multi-modal social and psycho-linguistic embedding via recurrent neural networks to identify depressed users in online forums': 1, 'Utilizing neural networks and linguistic metadata for early detection of depression indications in text sequences': 1, 'Glove: Global vectors for word representation': 2, 'Relevance-based word embedding': 1, 'Towards Using Word Embedding Vector Space for Better Cohort Analysis': 1, 'Understanding Depression from Psycholinguistic Patterns in Social Media Texts': 1, 'Augmenting Semantic Representation of Depressive Language: From Forums to Microblogs': 1, 'Retrofitting word vectors to semantic lexicons': 1, 'Topic modeling based multi-modal depression detection': 1, 'Text-based detection and understanding of changes in mental health': 1, 'Natural Language Processing Methods Used for Automatic Prediction Mechanism of Related Phenomenon': 1, 'Borut Sluban, and Igor Mozetič': 1, 'Latent dirichlet allocation': 1, 'Sharing clusters among related groups: Hierarchical Dirichlet processes': 1, 'MedLDA: maximum margin supervised topic models. the': 1, 'Supervised deep feature extraction for hyperspectral image classification': 1, 'Topical n-grams: Phrase and topic discovery, with an application to information retrieval': 1, 'LIBSVM: A library for support vector machines': 1, 'On discriminative vs. generative classifiers: A comparison of logistic regression and naive bayes': 1, 'A comparison of supervised classification methods for the prediction of substrate type using multibeam acoustic and legacy grain-size data': 1, 'Timelines tag clouds and the case for vernacular visualization': 1, 'A biterm topic model for short texts': 1, 'Critically ill children during the 2009-2010 influenza pandemic in the United States': 1, 'Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America': 1, 'Vancomycin in combination with other antibiotics for the treatment of serious methicillin-resistant Staphylococcus aureus infections': 2, 'Efficacy of linezolid alone or in combination with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus': 1, 'In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods': 1, 'Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia': 1, 'Anti-alpha-hemolysin monoclonal antibodies mediate protection against Staphylococcus aureus pneumonia': 1, 'Comparative analysis of USA300 virulence determinants in a rabbit model of skin and soft tissue infection': 1, 'Staphylococcus aureus α-toxin: nearly a century of intrigue': 1, 'Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) PICFlu Study Group. Staphylococcus aureus α-toxin response distinguishes respiratory virus-methicillin-resistant S. aureus coinfection in children': 1, 'Pathogenesis of Staphylococcus aureus necrotizing pneumonia: the role of PVL and an influenza coinfection': 1, 'Community-acquired meticillin-resistant Staphylococcus aureus strain USA300 resists staphylococcal protein A modulation by antibiotics and antimicrobial peptides': 1, 'Effect of antibiotics, alone and in combination, on Panton-Valentine leukocidin production by a Staphylococcus aureus reference strain': 1, 'Effects of subinhibitory concentrations of antibiotics on virulence factor expression by community-acquired methicillin-resistant Staphylococcus aureus': 3, 'Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus': 1, 'Good practices for real-world data studies of treatment and/or comparative effectiveness: recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making': 2, 'Pediatric Acute Lung Injury and Sepsis Investigators Network PICFlu Study Investigators. Innate immune function and mortality in critically ill children with influenza: a multicenter study': 1, 'Cytokine profiles of severe influenza virus-related complications in children': 2, 'Evaluation of IFITM3 rs12252 association with severe pediatric influenza infection': 1, 'Advisory Committee on Immunization Practices Centers for Disease Control and Prevention': 1, 'Official CDC Health Advisory: Influenza-associated pediatric mortality and Staphylococcus aureus co-infection': 1, 'Effectiveness of influenza vaccine against life-threatening RT-PCR-confirmed influenza illness in US children': 2, 'Comparison of the GenMark Diagnostics eSensor respiratory viral panel to real-time PCR for detection of respiratory viruses in children': 1, 'PRISM III: an updated pediatric risk of mortality score': 1, 'Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support': 1, 'Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate': 1, 'An evaluation of vancomycin dosing for complicated infections in pediatric patients': 1, 'A randomized controlled trial of a vancomycin loading dose in children': 1, 'Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary': 2, 'Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices': 2, 'The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid': 1, 'Changing susceptibility of Staphylococcus aureus in a US pediatric population': 1, 'The role of antibiotics in modulating virulence in Staphylococcus aureus': 1, 'Ceftaroline for suspected of confirmed invasive methicillin-resistant Staphylococcus aureus: a pharmacokinetic case series': 1, 'Coronavirus covid-19 (sars-cov-2)': 3, 'Presymptomatic transmission of sars-cov-2 singapore': 2, 'Factors that make an infectious disease outbreak controllable': 3, 'Contact tracing and disease control': 3, 'Quantifying sars-cov-2 transmission suggests epidemic control with digital contact tracing': 11, 'Proximity: a recipe to break the outbreak (2020)': 2, 'Apple and google partner on covid-19 contact tracing technology': 2, 'Epimap: Towards quantifying contact networks for understanding epidemiology in developing countries': 1, 'Progress in Location-Based Services 2014 , Lecture Notes in Geoinformation and Cartography': 1, 'Feasibility of controlling covid-19 outbreaks by isolation of cases and contacts, The Lancet Global Health': 3, 'More is different': 1, 'On emergence from the perspective of physical science': 3, 'Contact tracing in stochastic and deterministic epidemic models': 1, 'Exact and approximate formulas for contact tracing on random trees': 1, 'The effectiveness of contact tracing in emerging epidemics': 1, 'Early dynamics of transmission and control of covid-19: a mathematical modelling study': 2, 'The novel coronavirus, 2019-ncov, is highly contagious and more infectious than initially estimated': 1, 'On the critical behavior of the general epidemic process and dynamical percolation': 2, 'Epidemic models and percolation': 2, 'Percolation, Die Grundlehren der mathematischen Wissenschaften in Einzeldarstellungen': 1, 'Telecom subscription data': 2, 'Using random testing to manage a safe exit from the covid-19 lockdown': 1, 'Covid-19 india, Ministry of Health and Family Welfare': 1, 'Accuracy characterization of cell tower localization': 1, 'Statistical mechanics of complex networks': 1, 'Epidemic processes in complex networks': 2, 'Contact tracing and epidemics control in social networks': 1, 'Disease contact tracing in random and clustered networks': 1, 'Infectious disease control using contact tracing in random and scale-free networks': 1, 'Self-organized critical forestfire model': 1, 'Forest-fire model with immune trees': 1, 'Longterm variations of air quality influenced by surface ozone in a coastal site in India: association with synoptic meteorological conditions with model simulations': 1, 'Influence of atmospheric particulate matter on ozone in Nanjing China: observational study and mechanistic analysis': 2, 'Diurnal and seasonal variation of volatile organic compounds in the atmosphere of Monterrey': 1, 'Atmospheric chemistry of VOCs and NOx': 1, 'Seasonal characteristics of SO 2, NO 2, and CO emissions in and around the Indo-Gangetic plain': 1, 'Spatial and temporal evaluation of long term trend (2005-2014) of OMI retrieved NO 2 and SO 2 concentrations in Henan Province China': 1, 'Does lockdown reduce air pollution? Evidence from 44 cities in northern China': 1, 'The response in air quality to the reduction of Chinese economic activities during the COVID-19 Outbreak': 1, 'Amplified ozone pollution in cities during the COVID-19 lockdown': 2, 'Effect of restricted emissions during COVID-19 on air quality in India': 1, 'Significance of PM 2.5 air quality at the Indian capital': 1, 'Tropospheric ozone and its precursors from the urban to the global scale from air quality to short-lived climate forcer': 1, 'Variation of urban atmospheric ammonia pollution and its relation with PM 25 chemical property in winter of Beijing China': 1, 'Association between short-term exposure to air pollution and COVID-19 infection: Evidence from China': 1, 'Detection of respiratory viruses by molecular methods': 2, 'Evidence of a novel human coronavirus that is associated with respiratory tract disease in infants and young children': 2, 'Clinical evaluation of NucliSENS magnetic extraction and NucliSENS analyte-specific reagents for real-time detection of human metapneumovirus in pediatric respiratory specimens': 1, 'Identification of a new human coronavirus': 4, 'Osterhaus AD: A newly discovered human pneumovirus isolated from young children with respiratory tract disease': 1, 'Microarray-based detection and genotyping of viral pathogens': 1, 'Diagnostic system for rapid and sensitive differential detection of pathogens': 1, 'Principles of the xTAG respiratory viral panel assay (RVP Assay)': 1, 'Comparison of the Seeplex reverse transcription PCR assay with the Rmix viral culture and immunofluorescence techniques for detection of eight respiratory viruses': 1, 'High-throughput, sensitive, and accurate multiplex PCR-microsphere flow cytometry system for large-scale comprehensive detection of respiratory viruses': 3, \"The Tennessee Children's Respiratory Initiative: Objectives, design and recruitment results of a prospective cohort study investigating infant viral respiratory illness and the development of asthma and allergic diseases\": 1, 'Osterhaus AD: A previously undescribed coronavirus associated with respiratory disease in humans': 1, 'The burden of hospitalized lower respiratory tract infection due to respiratory syncytial virus in rural Thailand': 3, 'Evaluation of quantitative and typespecific real-time RT-PCR assays for detection of respiratory syncytial virus in respiratory specimens from children': 2, 'Real-time reverse transcription-PCR assay for comprehensive detection of human rhinoviruses': 1, 'Real-time reverse transcriptase PCR assay for detection of human metapneumoviruses from all known genetic lineages': 2, 'Frequent detection of human coronaviruses in clinical specimens from patients with respiratory tract infection by use of a novel real-time reverse-transcriptase polymerase chain reaction': 1, 'Clinical characteristics and 30-day outcomes for influenza A 2009 (H1N1)': 1, 'Evaluation of a multiplexed PCR assay for detection of respiratory viral pathogens in a public health laboratory setting': 1, 'MultiCode-PLx system for multiplexed detection of seventeen respiratory viruses': 2, 'Comparison of reverse transcription-PCR with tissue culture and other rapid diagnostic assays for detection of type A influenza virus': 1, 'Nucleic acid amplification tests for detection of respiratory viruses': 1, 'Real-time PCR in the microbiology laboratory': 1, 'Comparison of the Eragen Multi-Code Respiratory Virus Panel with conventional viral testing and real-time multiplex PCR assays for detection of respiratory viruses': 2, 'The classification of viruses infecting the respiratory tract': 1, 'Simultaneous detection and high-throughput identification of a panel of RNA viruses causing respiratory tract infections': 1, 'Linkage between the journal and Quality Control Molecular Diagnostics (QCMD)': 1, 'Capability of air filters to retain airborne bacteria and molds in heating, ventilating and air-conditioning (HVAC) systems': 1, 'Indoor air pollution: new EU research reveals higher risks than previously thought': 1, 'Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial': 2, 'Antibody response to influenza vaccination in the elderly: a quantitative review': 2, 'Age-related changes in immunity: implications for vaccination in the elderly': 1, 'Age-related decline in immunity: implications for vaccine responsiveness': 1, 'The unmet need in the elderly: designing new influenza vaccines for older adults': 1, 'Advances in pneumococcal vaccines: what are the advantages for the elderly?': 1, 'Use of animal models in the development of human vaccines': 3, 'Reversal of age-related deficient influenza virus-specific CTL responses and IFN-gamma production by monophosphoryl lipid A': 2, 'Immune responses and protection in different strains of aged mice immunized intranasally with an adjuvant-combined influenza vaccine': 1, 'Agerelated impaired type 1 T cell responses to influenza: reduced activation ex vivo, decreased expansion in CTL culture in vitro, and blunted response to influenza vaccination in vivo in the elderly': 1, 'Enhanced immune responses and resistance against infection on aged mice conferred by Flu-IS-COMs vaccine correlate with up-regulation of costimulatory molecule CD86': 1, 'An aged mouse model for RSV infection and diminished CD8 + CTL responses': 1, 'Utility of the aged BALB/ c mouse model to demonstrate prevention and control strategies for Severe Acute Respiratory Syndrome coronavirus (SARS-CoV)': 1, 'Development of effective vaccines for old mice in a tumor model': 1, 'Comparison of the infectivity of isolates of Listeria monocytogenes following intragastric and intravenous inoculation in mice': 2, 'The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine': 1, 'A microbiological, histopathological and immunohistological study of the intragastric inoculation of Listeria monocytogenes in mice': 1, 'Porcine gamma delta T cells: possible roles on the innate and adaptive immune responses following virus infection': 2, 'Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse': 1, \"A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease\": 1, 'Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization': 1, 'A road less travelled: large animal models in immunological research': 1, 'Old rhesus macaques treated with interleukin-7 show increased TREC levels and respond well to influenza vaccination': 1, 'Toward modeling hemorrhagic and encephalitic complications of Alzheimer amyloid-beta vaccination in nonhuman primates': 1, 'Effect of different adjuvants in equines for the production of equine rabies immunoglobulins': 1, 'The effect of age in serum antibody titers after rabies and influenza vaccination in healthy horses': 1, 'Prominence of gamma delta T cells in the ruminant immune system': 1, 'Characterization of porcine T lymphocytes and their immune response against viral antigens': 1, 'Wild canids as sentinels of ecological health: a conservation medicine perspective': 1, 'The role of infectious diseases in biological conservation': 2, 'Infectious disease and the conservation of free-ranging large carnivores': 2, \"A serological survey of infectious disease in Yellowstone National Park's canid community\": 2, 'Diarrhea in puppies: parvovirus-like particles demonstrated in their feces, Southwest Vet': 2, 'Epizootiologic investigations of parvovirus infections in freeranging carnivores from Germany': 2, 'Canine parvovirus: the worldwide occurrence of antigenic variants': 3, 'Prevalence of antibodies against canine distemper virus and canine parvovirus among foxes and wolves from Spain': 4, 'Parvovirus infections in wild carnivores': 1, 'Snapshot of viral infections in wild carnivores reveals ubiquity of parvovirus and susceptibility of egyptian mongoose to feline Panleukopenia virus': 7, 'Comparative survey of canine parvovirus, canine distemper virus and canine enteric coronavirus infection in free-ranging wolves of central Italy and south-eastern France': 8, 'Detection of canine parvovirus in wolves from Italy': 2, 'The study molecular epidemiology of canine parvovirus': 1, 'A ten-year molecular survey on parvoviruses infecting carnivores in Bulgaria': 1, 'Canine distemper in terrestrial carnivores: a review': 1, 'Epizootiological investigations of canine distemper virus in free-ranging carnivores from Germany': 2, 'Pathogen evolution and disease emergence in carnivores': 1, 'Canine distemper in a genet (Gennetta gennetta), associated with endogenous lipid pneumonia': 1, 'Importance of canine distemper virus (CDV) infection in free-ranging Iberian lynxes (Lynx pardinus)': 1, 'Domestic dog origin of canine distemper virus in free-ranging wolves in Portugal as revealed by hemagglutinin gene characterization': 3, 'Arctic lineage-canine distemper virus as a cause of death in apennine wolves (Canis lupus) in Italy': 2, 'Canine coronavirus highly pathogenic for dogs': 1, 'Genetic evolution of canine coronavirus and recent advances in prophylaxis': 1, 'A serological survey of common feline pathogens in freeliving European wildcats (Felis silvestris) in central Spain': 1, 'Histopathological and immunohistochemical findings in lymphoid tissues of the endangered Iberian lynx (Lynx pardinus)': 1, 'The Status and Distribution of European Mammals': 1, 'Evidence of genetic distinction and long-term population decline in wolves (Canis lupus) in the Italian Apennines': 1, 'Canine parvovirus effect on wolf population change and pup survival': 2, \"Persistence of canine distemper virus in the Greater Yellowstone Ecosystem's carnivore community\": 2, 'Serologic survey for canine distemper virus and canine parvovirus in free-ranging wild carnivores from Portugal': 2, 'Lung-tissue extract as an alternative to serum for surveillance for brucellosis in chamois': 1, 'Molecular and serological surveillance of canine enteric viruses in stray dogs from Vila do Maio, Cape Verde': 1, 'Relevance of feline interferon omega for clinical improvement and reduction of concurrent viral excretion in retrovirus infected cats from a rescue shelter': 2, 'Binding of immunoglobulins to protein A and immunoglobulin levels in mammalian sera': 1, 'Wolf behaviour: reproductive, social and intelligent, Wolves: Behavior, Ecology, and Conservation': 1, 'Canine Viral Enteritis': 2, \"Parasite invasion following host reintroduction: a case study of Yellowstone's wolves\": 1, 'Canine parvovirus: environmental effects on infectivity': 1, 'Canine parvovirus-A review of epidemiological and diagnostic aspects, with emphasis on type 2c': 1, 'Canine distemper spillover in domestic dogs from urban wildlife, the veterinary clinics of North America': 1, 'Canine distemper epizootic among red foxes': 2, 'Emergence of canine distemper in Bavarian wildlife associated with a specific amino acid exchange in the haemagglutinin protein': 1, 'Infectious Diseases of the Dog and Cat': 1, 'Diagnosis of canine coronavirus infection using nested-PCR': 1, 'European surveillance for pantropic canine coronavirus': 1, 'Canine coronavirus: not only an enteric pathogen, the veterinary clinics of North America': 2, 'An update on canine coronaviruses: viral evolution and pathobiology': 2, 'Development of a nested PCR assay for the detection of canine coronavirus': 1, 'First detection of canine parvovirus type 2c in pups with G.M. Rosa, et al. Comparative Immunology, Microbiology and Infectious Diseases': 1, 'Canine distemper and related diseases: report of a severe outbreak in a kennel': 1, 'Parsing demographic effects of canine parvovirus on a Minnesota wolf population': 1, 'Fatal canine distemper infection in a pack of African wild dogs in the Serengeti ecosystem': 1, 'A canine distemper virus epidemic in Serengeti lions': 1, 'Livro Vermelho Dos Vertebrados de Portugal': 1, 'Age and long-term protective immunity in dogs and cats': 1, 'Serosurvey of pathogens in domestic dogs on the border of Noel Kempff Mercado National Park': 1, 'Analysis of the evolution of feline parvovirus (FPV)': 1, 'High rate of viral evolution associated with the emergence of carnivore parvovirus': 4, 'Pulmonary delivery of therapeutic siRNA': 2, 'Pulmonary vaccine delivery': 1, 'Inhibition of respiratory viruses by nasally administered siRNA': 17, 'Noninvasive delivery of small inhibitory RNA and other reagents to pulmonary alveoli in mice': 3, 'Immunological and toxicological implications of short-term studies in animals of pharmaceutical aerosol delivery to the lungs: relevance to humans': 2, 'A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus': 2, 'Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV)': 6, 'RNAi-mediated suppression of constitutive pulmonary gene expression by small interfering RNA in mice': 6, 'Clinical evaluation of inhaled insulin': 2, 'Inhalable lactose-based dry powder formulations of low molecular weight heparin': 2, 'Spray drying of siRNA-containing PLGA nanoparticles intended for inhalation': 5, 'Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA': 1, 'Extracellular barriers in respiratory gene therapy': 4, 'Nanodelivery in airway diseases: Challenges and therapeutic applications': 1, 'The lung as a route for systemic delivery of therapeutic proteins and peptides': 5, 'Expression of respiratory mucins in fatal status asthmaticus and mild asthma': 2, 'Remodeling in asthma and chronic obstructive lung disease': 1, 'Polymeric nanocarriers for drug delivery to the lung': 4, 'Nonviral delivery of synthetic siRNAs in vivo': 1, 'Rapid crossing of the pulmonary endothelial barrier by polyethylenimine/DNA complexes': 1, 'Delivery of siRNA therapeutics: Barriers and carriers': 1, 'Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape': 1, 'Delivering silence: advancements in developing siRNA therapeutics': 1, 'Gene silencing by adenovirus-delivered siRNA': 2, 'Effect of adenovirus-mediated RNA interference on endogenous microRNAs in a mouse model of multidrug resistance protein 2 gene silencing': 1, 'Lentivirus-mediated RNAi knockdown of NUPR1 inhibits human nonsmall cell lung cancer growth in vitro and in vivo': 2, 'Cancer gene therapy: Challenges and opportunities': 1, 'US gene therapy in crisis': 1, 'RNAi-dependent and -independent antiviral phenotypes of chromosomally integrated shRNA clones: role of VASP in respiratory syncytial virus growth': 1, 'Non-viral siRNA delivery to the lung': 3, 'Lipid-based systemic delivery of siRNA': 2, 'Attenuation of fibrosis in vitro and in vivo with SPARC siRNA': 4, 'Protection against lethal influenza virus challenge by RNA interference in vivo': 4, 'Fibronectin induces cell proliferation and inhibits apoptosis in human bronchial epithelial cells: pro-oncogenic effects mediated by PI3-kinase and NF-kappa B': 1, 'Inhibition of influenza virus production in virus-infected mice by RNA interference': 4, 'Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung': 1, 'Cationic liposome-mediated delivery of siRNAs in adult mice': 1, 'Lipidic systems for in vivo siRNA delivery': 2, 'Expression profiling reveals off-target gene regulation by RNAi': 1, 'Induction of an interferon response by RNAi vectors in mammalian cells': 1, 'Lack of interferon response in animals to naked siRNAs': 2, 'RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo': 2, 'Systemic delivery of RafsiRNA using cationic cardiolipin liposomes silences RAF-1 expression and inhibits tumor growth in xenograft model of human prostate cancer': 1, 'Intrapulmonary delivery of XCL1-targeting small interfering RNA in mice chronically infected with Mycobacterium tuberculosis': 6, 'Effective treatment of respiratory alphaherpesvirus infection using RNA interference': 8, 'Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis': 4, 'Pulmonary gene silencing in transgenic EGFP mice using aerosolised chitosan/siRNA nanoparticles': 3, 'A combinatorial library of lipid-like materials for delivery of RNAi therapeutics': 4, 'Immunologic aspects of chronic obstructive pulmonary disease': 1, 'Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics': 1, 'Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1': 2, 'The US National Institutes of Health': 1, 'Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque': 3, 'Respiratory syncytial virus infection in elderly and high-risk adults': 5, 'RNA interference therapy in lung transplant patients infected with respiratory syncytial virus': 1, 'Poly(ester amine)-mediated, aerosol-delivered Akt1 small interfering RNA suppresses lung tumorigenesis': 3, 'Rodriguez-Padilla, C. WT1 gene silencing by aerosol delivery of PEI-RNAi complexes inhibits B16-F10 lung metastases growth': 1, 'Down-regulation of IGF-IR using small, interfering, hairpin RNA (siRNA) inhibits growth of human lung cancer cell line A549 in vitro and in nude mice': 1, 'EZH2 silencing with RNAi enhances irradiation-induced inhibition of human lung cancer growth in vitro and in vivo': 1, 'Atu027, a liposomal small interfering RNA formulation targeting protein kinase N3, inhibits cancer progression': 2, 'PKN3 is required for malignant prostate cell growth downstream of activated PI 3-kinase': 1, 'Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer': 1, 'The stability of mRNA influences the temporal order of the induction of genes encoding inflammatory molecules': 1, 'Inhaled and systemic corticosteroids in chronic obstructive pulmonary disease': 1, 'Cigarette smoke induces senescence in alveolar epithelial cells': 1, 'Senescence in chronic obstructive pulmonary disease': 1, 'Identifying targets for COPD treatment through gene expression analyses': 2, 'Targeting the NF-kappaB pathway in asthma and chronic obstructive pulmonary disease': 1, 'Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice': 1, 'Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease': 1, 'Tumor necrosis factor-alpha gene polymorphism in chronic bronchitis': 1, 'Characterization of cigarette smoke-induced inflammatory and mucus hypersecretory changes in rat lung and the role of CXCR2 ligands in mediating this effect': 1, 'Comprehensive gene expression profiling of rat lung reveals distinct acute and chronic responses to cigarette smoke inhalation': 1, 'Alveolar wall apoptosis causes lung destruction and emphysematous changes': 1, 'Inhibition of VEGF receptors causes lung cell apoptosis and emphysema': 1, 'COPD: current therapeutic interventions and future approaches': 1, 'p38 MAPK inhibitors, IKK2 inhibitors, and TNFalpha inhibitors in COPD': 1, 'Chronic respiratory disease-Asthma': 1, 'Emerging oligonucleotide therapies for asthma and chronic obstructive pulmonary disease': 2, 'siRNA as a therapy for asthma': 1, 'Targeting allergic airway diseases by siRNA: An option for the future?': 1, 'Antisense-and RNA interference-based therapeutic strategies in allergy': 1, 'Aerosolized Syk antisense suppresses Syk expression, mediator release from macrophages, and pulmonary inflammation': 1, 'Syk tyrosine kinase participates in beta1-integrin signaling and inflammatory responses in airway epithelial cells': 1, 'Many roads to maturity: microRNA biogenesis pathways and their regulation': 1, 'MicroRNAs in lung diseases': 1, 'Downregulation of the serum response factor/miR-1 axis in the quadriceps of patients with COPD': 1, 'MicroRNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease': 3, 'miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis': 2, 'Inhibition and role of let-7d in idiopathic pulmonary fibrosis': 2, 'miR-29 is a major regulator of genes associated with pulmonary fibrosis': 1, 'Participation of miR-200 in pulmonary fibrosis': 1, 'Requirement of bic/microRNA-155 for normal immune function': 2, 'MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression': 2, 'Antagonism of microRNA-126 suppresses the effector function of TH2 cells and the development of allergic airways disease': 2, 'Down-regulation of miR-133a contributes to up-regulation of Rhoa in bronchial smooth muscle cells': 1, 'Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke': 2, 'COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention': 1, 'Transcriptomic studies of the airway field of injury associated with smoking-related lung disease': 1, 'MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium': 1, 'Reduced miR-146a increases prostaglandin E(2)in chronic obstructive pulmonary disease fibroblasts': 1, 'Gene expression networks in COPD: microRNA and mRNA regulation': 1, 'COPD, a multicomponent disease: implications for management': 1, 'Identification of keratinocyte growth factor as a target of microRNA-155 in lung fibroblasts: Implication in epithelial-mesenchymal interactions': 1, 'Asthma and allergic inflammation': 1, 'MicroRNA expression profiling in mild asthmatic human airways and effect of corticosteroid therapy': 1, 'MicroRNAs in inflammatory lung disease--master regulators or target practice?': 1, 'Artificial microRNAs as siRNA shuttles: improved safety as compared to shRNAs in vitro and in vivo': 1, 'The promise of microRNA replacement therapy': 2, 'RAS is regulated by the let-7 microRNA family': 1, 'Regression of murine lung tumors by the let-7 microRNA': 1, 'The let-7a microRNA protects from growth of lung carcinoma by suppression of k-Ras and c-Myc in nude mice': 1, 'The let-7 microRNA reduces tumor growth in mouse models of lung cancer': 2, 'Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34': 2, 'Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy': 1, 'Tumor suppressor miR-22 suppresses lung cancer cell progression through post-transcriptional regulation of ErbB3': 1, 'Silencing of microRNAs in vivo with \"antagomirs': 2, 'LNA-mediated microRNA silencing in non-human primates': 2, 'Regression of A549 lung cancer tumors by anti-miR-150 vector': 1, 'Role of microRNA in anticancer drug resistance': 1, 'The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44': 1, 'MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells': 1, 'A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster': 17, 'Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan': 1, 'Additional molecular testing of saliva specimens improves the detection of respiratory viruses': 5, 'Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: a diagnostic validity study': 2, 'Respiratory virus infection among hospitalized adult patients with or without clinically apparent respiratory infection: a prospective cohort study': 1, 'Detection of SARS-associated coronavirus in throat wash and saliva in early diagnosis': 9, 'Severe respiratory disease associated with a novel infectious agent-letters to doctors': 1, 'Wuhan reports first doctor death from coronavirus': 1, 'EMIT Consortium. Infectious virus in exhaled breath of symptomatic seasonal influenza cases from a college community': 1, 'Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tracts of rhesus macaques': 2, 'Neuronal ceroid-lipofuscinosis in a domestic cat: clinical, morphological and immunohistochemical findings': 3, 'Neuronal ceroid-lipofuscinosis in a Japanese domestic shorthair cat': 3, 'Mutational analysis of the feline CLN3 gene and an ultrastructural evaluation of lysosomal storage material in a cat with neuronal ceroid lipofuscinosis: an investigation into the molecular basis of the disease': 3, 'Characterization of neuronal ceroid-lipofuscinosis in 3 cats': 4, 'Towards understanding the neuronal ceroid lipofuscinoses': 1, 'A missensce mutation (c. 184C>T) in ovine CLN6 causes neuronal ceroid lipofuscinosis in Merino sheep whereas affected South Hampshire sheep have reduced levels of CLN6 mRNA': 1, 'Neuronal ceroid-lipofuscinosis in Nubian goats': 1, 'Neurovisceral ceroid lipofuscinosis in blind Devon cattle': 1, 'Neuronal ceroidlipofuscinosis in longhaired Chihuahuas: clinical, pathological, and MRI findings': 1, 'Neuronal ceroid lipofuscinosis in 3 Australian shepherd littermates': 2, 'Neuronal ceroidlipofuscinosis in a cat': 2, \"Motor neuron degeneration of mice is a model of neuronal ceroid lipofuscinosis (Battens's disease)\": 1, 'An unsual case of generalized ceroid-lipofuscinosis in a Cynomolgus monkey': 1, 'The neuronal ceroidliposfusinoses': 1, 'Canine neuronal ceroid lipofusicnosis: a promising model for preclinical testing of therapeutic interventions': 2, 'Clinical and magnetic resonance imaging findings in Batten disease: analysis of the major mutation (1.02-kb deletion)': 1, 'MRI in neuronal ceroid lipofuscinosis': 1, 'MRI of neuronal ceroid lipofuscinosis': 2, 'Magnetic resonance of neuronal ceroid lipofuscinosis in a Border collie': 1, 'Neuroimaging of lipid storage disorders': 1, 'Magnetic resonance findings of the corpus callosum in canine and feline lysosomal storage diseases': 1, 'Neuronal ceroid lipofuscinoses': 3, 'Correlations between genotype, ultrastructural morphology and clinical phenotype in neuronal ceroid lipofuscinoses': 1, 'A mutation in canine PPT1 causes early onset neuronal ceroid lipofuscinosis in a Dachshund': 1, 'A mutation in canine CLN5 causes neuronal ceroid lipofuscinosis in Border collie dogs': 1, 'A mutation in the CLN8 gene in English Setter dogs with neuronal ceroid lipofuscinosis': 1, 'A one base pair deletion in the canine ATP13A2 gene causes exon skipping and late-onset neuronal ceroid lipofuscinosis in the Tibetan terrier': 1, 'Analytical and Experimental Investigation of Rake Contact and Friction Behavior in Metal Cutting': 4, 'Study of Tribo-Chemical Lubricant Film Formation during Application of Nanolubricants in Minimum Quantity Lubrication (MQL) Grinding': 11, 'Study of Specific Energy and Friction Coefficient in Minimum Quantity Lubrication Grinding Using Oil-Based Nanolubricants': 4, 'Tribological Study of Nano Lubricant Integrated Soybean Oil for Minimum Quantity Lubrication (MQL) Grinding': 5, 'Performance of Novel MoS2 Nanoparticles Based Grinding Fluids in Minimum Quantity Lubrication Grinding': 4, 'Performance Evaluation of Ti-6Al-4V Grinding Using Chip Formation and Coefficient of Friction under the Influence of Nanofluids': 4, 'Mechanism of Nanoparticles Functioning and Effects in Machining Processes: A Review': 4, 'Advances in Engineered Surfaces for Functional Performance': 4, 'Bio-Inspired Textures for Functional Applications': 8, 'Surface Texture Manufacturing Techniques and Tribological Effect of Surface Texturing on Cutting Tool Performance: A Review': 4, 'Textured Grinding Wheels: A Review': 4, 'CIRP Encyclopedia of Production Engineering': 4, 'Understanding Evolution of Tribo-Chemical Interfaces during Boundary Lubrication in Manufacturing': 3, 'Fundamental Understanding of the Synthesis and Tribological Behavior of Organic-Inorganic Nanoparticles': 2, 'Tribological Behavior of Deagglomerated Active Inorganic Nanoparticles for Advanced Lubrication': 2, 'Molecular Basis of Lubrication': 1, 'Boundary and Extreme Pressure Lubrication': 1, 'Boundary Lubrication and Friction': 1, 'Boundary Lubrication and Lubricants': 2, 'Nanoparticle-Based Lubrication Systems': 1, 'Tribological Performance of Nanoparticles as Lubricating Oil Additives': 1, 'Roles of Nanoparticles in Oil Lubrication': 1, 'Understanding the Evolution of Surface Texture Under Boundary Lubrication': 1, 'The Break-in Stage of Cylinder-Ring Wear: A Correlation between Fired Engines and a Laboratory Simulator': 1, 'On the Nature of Running-In': 1, 'Mechanisms of Antiwear Tribofilm Growth Revealed in Situ by Single-Asperity Sliding Contacts': 1, 'The Synthesis of MoS2 Particles with Different Morphologies for Tribological Applications': 1, 'Microtribology and Friction-Induced Material Transfer in Layered MoS 2 Nanoparticles Sprayed on a Steel Surface': 1, 'Characterization of Tribofilm with the Remaining Lubricating Oil by Raman Spectroscopy': 1, 'New Insights on the Decomposition Mechanism of Molybdenum DialkyldiThioCarbamate (MoDTC): A Raman Spectroscopic Study': 1, 'Influence of Flash Temperatures on the Tribological Behaviour in Low-Speed Sliding: A Review': 1, 'The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature': 1, 'Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness': 1, 'Protective effect of bacillus Calmette Guerin (BCG) vaccine in the prevention of leprosy: a meta-analysis': 1, 'Preventing tuberculosis with bacillus Calmette-Guerin vaccine: a meta-analysis of the literature': 1, 'Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature': 1, 'BCG-different strains, different vaccines? Lancet Infect Dis': 6, 'Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis': 1, 'Field trials of tuberculosis vaccines: how could we have done them better? Control Clin Trials': 1, 'Differential effects of prior exposure to environmental mycobacteria on vaccination with Mycobacterium bovis BCG or a recombinant BCG strain expressing RD1 antigens': 1, \"The 'experimental stable' of the BCG vaccine: safety, efficacy, proof, and standards\": 1, 'The Swedish strain of BCG': 1, 'Changes in BCG strains': 2, 'Report on a WHO consultation on the characterisation of BCG strains': 1, 'Relationship between bacille Calmette-Guerin (BCG) strains and the efficacy of BCG vaccine in the prevention of tuberculosis': 1, 'Effect of freeze-drying on the colony morphology of various daughter strains of BCG': 1, 'Use of a Mycobacterium tuberculosis H37Rv bacterial artificial chromosome library for genome mapping, sequencing, and comparative genomics': 1, 'Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis': 5, 'Physical mapping of Mycobacterium bovis BCG pasteur reveals differences from the genome map of Mycobacterium tuberculosis H37Rv and from M. bovis. Microbiology': 1, 'Comparative genomics of BCG vaccines by wholegenome DNA microarray': 5, 'Comparative genomics uncovers large tandem chromosomal duplications in Mycobacterium bovis BCG Pasteur': 3, 'The in vitro evolution of BCG vaccines': 5, 'A historical and molecular phylogeny of BCG strains': 1, 'Genome plasticity of BCG and impact on vaccine efficacy': 15, 'Detection of deleted genomic DNA using a semiautomated computational analysis of GeneChip data': 3, 'Control of M. tuberculosis ESAT-6 secretion and specific T cell recognition by PhoP': 3, 'Identification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in Mycobacterium tuberculosis': 1, 'Tracking the evolution of the SARS coronavirus using high-throughput, high-density resequencing arrays': 2, 'Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence': 4, 'The complete genome sequence of Mycobacterium bovis': 4, 'The dimycocerosate ester polyketide virulence factors of mycobacteria': 1, 'Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice': 1, 'Transposon mutagenesis of Mb0100 at the ppe1-nrp locus in Mycobacterium bovis disrupts phthiocerol dimycocerosate (PDIM) and glycosylphenol-PDIM biosynthesis, producing an avirulent strain with vaccine properties at least equal to those of M. bovis BCG': 1, 'A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response': 1, 'Differential productions of lipid virulence factors among BCG vaccine strains and implications on BCG safety': 3, 'A novel polymorphic genetic locus in members of the Mycobacterium tuberculosis complex': 2, 'Type VII secretionmycobacteria show the way': 8, 'Differential gene expression in response to exposure to antimycobacterial agents and other stress conditions among seven Mycobacterium tuberculosis whiB-like genes': 1, 'Mycobacterium tuberculosis WhiB3 responds to O2 and nitric oxide via its [4Fe-4S] cluster and is essential for nutrient starvation survival': 1, 'Mycobacterium tuberculosis WhiB3 interacts with RpoV to affect host survival but is dispensable for in vivo growth': 2, 'Deletion of two-component regulatory systems increases the virulence of Mycobacterium tuberculosis': 2, 'Bitter W: A specific secretion system mediates PPE41 transport in pathogenic mycobacteria': 3, 'Evolution and expansion of the Mycobacterium tuberculosis PE and PPE multigene families and their association with the duplication of the ESAT-6 (esx) gene cluster regions': 1, 'Some biological, biochemical and morphological changes and their correlations in selected BCG vaccine strains': 1, 'Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree': 1, 'Mutation in the transcriptional regulator PhoP contributes to avirulence of Mycobacterium tuberculosis H37Ra strain': 2, 'The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs': 3, 'The Mycobacterium tuberculosis PhoPR two-component system regulates genes essential for virulence and complex lipid biosynthesis': 2, 'Use of gene probes based on the insertion sequence IS986 to differentiate between BCG vaccine strains': 1, 'IS6110 mediates increased transcription of the phoP virulence gene in a multidrug-resistant clinical isolate responsible for tuberculosis outbreaks': 5, 'High rate of tuberculosis reinfection during a nosocomial outbreak of multidrug-resistant tuberculosis caused by Mycobacterium bovis strain B': 1, 'Transcriptional autoregulation by Mycobacterium tuberculosis PhoP involves recognition of novel direct repeat sequences in the regulatory region of the promoter': 3, 'PhoP-PhoP interaction at adjacent PhoP binding sites is influenced by protein phosphorylation': 2, 'Structure of the DNA-binding domain of the response regulator PhoP from Mycobacterium tuberculosis': 2, 'Mycobacterial virulence and specialized secretion: same story, different ending': 1, 'Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis': 1, 'Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains': 2, 'Quality control of BCG vaccine by WHO: a review of factors that may influence vaccine effectiveness and safety': 3, 'Mapping of IS6110 insertion sites in Mycobacterium bovis isolates in relation to adaptation from the animal to human host': 1, 'BCG complications. Estimates of the risks among vaccinated subjects and statistical analysis of their main characteristics': 1, 'A point mutation in the two-component regulator PhoP-PhoR accounts for the absence of polyketide-derived acyltrehaloses but not that of phthiocerol dimycocerosates in Mycobacterium tuberculosis H37Ra': 1, 'The virulence-associated two-component PhoP-PhoR system controls the biosynthesis of polyketide-derived lipids in Mycobacterium tuberculosis': 2, 'Tuberculin sensitivity and skin lesions in children after vaccination with 11 different BCG strains': 1, 'Tuberculin sensitivity in guinea-pigs after vaccination with varying doses of BCG of 12 different strains': 1, 'Second IUATLD study on complications induced by intradermal BCG-vaccination': 1, 'Live tuberculosis vaccines based on phoP mutants: a step towards clinical trials': 1, 'Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis': 1, 'Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model': 1, 'A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis': 2, 'Enhancing the protective efficacy of Mycobacterium bovis BCG vaccination against tuberculosis by boosting with the Mycobacterium tuberculosis major secretory protein': 1, 'Maslesa-Galic S: A novel live recombinant mycobacterial vaccine against bovine tuberculosis more potent than BCG': 1, 'Advances in tuberculosis vaccine strategies': 1, 'A new attenuated Mycobacterium bovis vaccine protects brushtail possums (Trichosurus vulpecula) against experimental tuberculosis infection': 1, 'Gene expression analysis using oligonucleotide arrays produced by maskless photolithography': 1, \"Light-directed 5'-->3' synthesis of complex oligonucleotide microarrays\": 1, 'A self-tuning method for one-chip SNP identification': 1, \"World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 -11\": 1, 'UK coronavirus cases jump to 456 and eighth Briton dies': 1, 'Virus: Sombre day as UK deaths hit 10': 1, 'New Personal Protective Equipment (PPE) guidance for NHS Teams': 1, 'Personal protective equipment during the coronavirus disease (COVID) 2019 pandemic -a narrative review': 1, 'Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal': 1, 'Nitrogen fixing organisms': 1, 'Reconciling the incompatible: N, fixation and (': 2, 'Morphological development of the root and stem noduka of .4eschynomene indica I': 1, 'Nitrogen-fixing nodules induced by Rhizobium on the stem of the tropical legume .Sesbania rostrata': 5, '\\\\er\\\\a\\\\ stem nodules on Aeschynomene spp': 6, 'Stem and root nodulation in Aeschynomene spp': 3, \"I'ltrastructural characterization of nitrogen-fixing stem nodules on Aeschynomene indica\": 6, 'The structure of nitrogen fixing root nodules on tbe aquatic mimosoid legume Neptunia plena': 5, 'Die KnoUcben der adventiven Wasserwurzeln von Neptunia oleracea und ibre Bakteriensymbiose': 1, 'Nitrogen-fixing stem nodules of the legume, Discolobium pulchellum Bentb': 12, 'N^ fixation by Sesbania rostrata and Sesbania sesban estimated using': 2, 'Physiological comparisons of root and stem nodules of Aeschynomene scabra and Seshania rostrata': 6, 'Growtb of Sesbania rostrata (Brem) witb stem nodules under controlled conditions': 1, 'A simple open How system used to measure acetylene reduction activity of Sesbania rostrata stem and root nodules': 5, 'Nitrogen-fixing stem nodules on Aeschynomene afrnspern': 5, 'The unusual symbiosis between the diazotrophic stem-nodulating bacterium Azorhizobium caulinodans ()RS5721 and its host, the tropical legume Sesbania rostrata': 3, 'Humidity and ligbt affect tbe growtb, development and nitrogenase activity of stem nodules of .Sesbania rostrata (Brem)': 3, 'Bacteriochlorophyll and photosyntbetic reaction centers in Rhizobiuin strain BTAi 1': 3, 'Diversity of photosyntbetic Bradvrhizobium strains from stem nodules of Aeschynomene species': 2, 'Photosynthetic characteristics of strains of rhizobia isolated from stem nodules of Aeschynomene fiuminensis grown in tbe Pantanal region of Brazil': 2, 'Stem-nodulating \\\\ef!,\\\\ime-Rhizobium s\\\\ tnbiosis and its agronomic use in lowland rice': 3, 'Relative contributions to nitrogenase (acetylene reducing) acti\\\\ ity of stem and root nodules in Sesbania rostrata': 2, 'Tbe physiology and nitrogen-fixing capability of aquatically and terrestrially grown Neptunia plena: the importance of nodule oxygen supply': 3, 'Intercellular location of glycoprotein in soybean nodules: eflect of altered rhizosphere oxygen concentration': 5, 'Measurement of nitrogen fixation by the acetylene reduction assay: myths and mysteries': 2, 'Types of rhizobial nodules and their distribution among the Leguminosae': 4, 'Mechanism of soybean nodule adaptation to difTerent oxygen pressures': 4, 'Anatomy of the legume nodule cortex with respect to nodule permeability': 3, 'Time-course of changes invohed in tbe operation ofthe oxygen dilTusion barrier in white lupin noduWa': 3, 'Nitrogen Yatazawa M, Yoshida S, Maeda E. 1984. Fine structure of root fixation and oxygen in legume root nodules': 3, 'Common components of tbe infection thread matrix and tbe intercellular space identified by the immunocytochemical analysis of pea nodules and uninfected roots': 1, \"Correlation between nodule ultrastructure and ability to produce stem nodules in .'ieschynomene spp\": 4, 'Diversity of stem nodulation sites in Aeschynomene spp': 2, 'Initial stages in the morphogenesis of nitrogen-fixing stem nodules of Sesbania rostrata': 1, 'Structure and function of root nodules from woody legumes': 2, 'Development of stem nodules in a tropical forage legume, Aeschynomene afraspera': 2, 'Oleosomes (lipid bodies) in nitrogenfixing peanut nodules': 2, 'Ontogenese des nodules caulinaires du Sesbania rostrata (legumineuses)': 1, '\\\\ survey of Nj-fixing nodules in tbe Leguminosae with particular reference to intercellular glycoproteins and the control of oxygen diffusion': 1, \"Assessing countries' commitment to accelerate nutrition action demonstrated in PRSPs, UNDAFs and through nutrition governance. SCN news / United Nations\": 1, 'Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study': 1, 'Uneven dietary development: linking the policies and processes of globalization with the nutrition transition, obesity and diet-related chronic diseases': 1, \"Strong nutrition governance is a key to addressing nutrition transition in low and middle-income countries: review of countries' nutrition policies\": 2, 'Displacement in urban areas: new challenges, new partnerships': 1, 'Public opinion and the politics of obesity in America': 2, 'Globalization, Global Governance and the Social Determinants of Health: A review of the linkages and agenda for action. Ottowa: Globalization and Health Knowledge Network': 3, 'Food security and nutrition interventions in response to the AIDS epidemic: assessing global action and evidence': 1, 'Nutritional contribution of street foods to the diet of people in developing countries: a systematic review': 1, 'Health and welfare effects of integrating AIDS treatment with food assistance in resource constrained settings: A systematic review of theory and evidence': 1, 'Clinic-Based Food Assistance is Associated with Increased Medication Adherence among HIV-Infected Adults on Long-Term Antiretroviral Therapy in Zambia': 1, 'The right to food in the post-Cold War era': 2, 'Bilateral health aid: lessons from Europe': 1, 'Development and governance: an uneasy relationship': 1, 'Public-Private Partnerships for Combating Micronutrient Malnutrition': 1, 'Governing Health Systems': 1, 'Governance for global and national health: a role for framework conventions?': 1, 'Interactions with the recipient community in targeted food and nutrition programs': 2, 'Proceedings of the fourth international congress on tropical medicine and malaria': 1, 'Spaces for change?: the politics of citizen participation in new democratic arenas: Zed Books': 1, 'Bridging the divide: global governance of trade and health': 1, 'The new International Health Regulations: an historic development for international law and public health': 1, 'The race for Ebola drugs: pharmaceuticals, security and global health governance': 1, 'Ebola: a crisis in global health leadership': 1, 'Non-communicable diseases and global health governance: enhancing global processes to improve health development': 2, 'Governance matters VIII: aggregate and individual governance indicators': 1, 'Diet, health and globalization: five key questions': 1, 'A global response to a global problem: the epidemic of overnutrition': 1, 'Trade liberalization and the diet transition: a public health response': 2, 'Price Volatility in Food and Agricultural Markets: Policy Responses': 1, 'The 2008 food price crisis: rethinking food security policies: UN': 1, 'High food prices: the what, who, and how of proposed policy actions': 1, 'Maternal and Child Undernutrition Study Group. Effective international action against undernutrition: why has it proven so difficult and what can be done to accelerate progress?': 4, 'The history of the SUN Movement: Scaling Up Nutrition': 1, 'Nutrition Landscape Information System (NLIS) country profile indicators: interpretation guide. Geneva: WHO, 2012. 56. REACH. REACH Country Facilitator Manual': 1, 'Nutrition and sustainability: an emerging food policy discourse': 1, 'Nutrition: the new world disorder': 1, 'Feeding the world in the coming decades requires improvements in investment, technology and institutions': 1, 'Primary health care: making Alma-Ata a reality': 1, 'Population, development and food security: an unresolved challenge for the twenty-first century': 1, 'Ethical consequences for professionals from the globalization of food, nutrition and health': 1, 'Three decades of the WHO code and marketing of infant formulas': 1, 'Non-compliance with the International Code of Marketing of Breast Milk Substitutes is not confined to the infant formula industry': 1, 'We are forgotten on earth\": international development targets, poverty, and gender in Ethiopia': 1, \"Activists: Don't join SUN, a nutrition drive\": 1, 'Role of government in public health: Current scenario in India and future scope': 1, 'Flaws in Child Nutrition and Health Governance': 2, 'Why India needs a national nutrition strategy': 1, 'Health system challenges in organizing quality diabetes care for urban poor in South India': 1, \"Pakistan's maternal and child health policy: analysis, lessons and the way forward\": 2, 'Food security and marine capture fisheries: characteristics, trends, drivers and future perspectives': 1, 'Getting food policy on the Mayoral table: a comparison of two election cycles in New York and London': 1, 'The politics of success in the fight against malnutrition in Peru': 1, 'Perspectives for integration into the local health system of community-based management of acute malnutrition in children under 5 years: a qualitative study in Bangladesh': 1, 'Scaling up nutrition in fragile and conflict-affected states: The pivotal role of governance': 1, 'Tackling the drivers of child undernutrition in developing countries: what works and how should interventions be designed?': 2, 'Drinking water quality governance: A comparative case study of Brazil, Ecuador, and Malawi': 1, 'Utilisation of wartime nutrition survival experiences': 1, 'Lessons from collaborative governance and sociobiology theories for reinforcing sustained cooperation: a government food security case study': 1, 'Good governance for nutrition in the Philippines: elements, experiences, and lessons learned': 2, 'Précis of nutrition of children and women in Haiti: analyses of data from': 1, 'Governing childhood obesity: framing regulation of fast food advertising in the Australian print media': 1, 'Farmers are the most trusted part of the Australian food chain: results from a national survey of consumers': 1, 'The Danish tax on saturated fat: why it did not survive': 1, 'A systematic review of health system barriers and enablers for antiretroviral therapy (ART) for HIV-infected pregnant and postpartum women': 1, 'The role of health systems and policy in producing behavior and social change to enhance child survival and development in low-and middle-income countries: an examination of the evidence': 1, 'Agriculture for improved nutrition: the current research landscape': 1, 'Food Policy for Developing Countries: The Role of Government in Global, National, and Local Food Systems. 1 den': 1, 'Maternal and Child Nutrition Study Group. The politics of reducing malnutrition: building commitment and accelerating progress': 1, 'Global nutrition: What should change?': 1, 'Recent Shifts in Global Governance: Implications for the Response to Non-communicable Diseases': 1, 'Reducing Child Undernutrition: Past Drivers and Priorities for the Post-MDG Era': 2, 'Agriculture, health, and wealth convergence: bridging traditional food systems and modern agribusiness solutions': 1, 'Fighting maternal and child malnutrition: analysing the political and institutional determinants of delivering a national multisectoral response in six countries': 1, 'An accountability framework to promote healthy food environments': 1, 'A systematic policy approach to changing the food system and physical activity environments to prevent obesity': 1, 'Politics: Who Gets What, When, How': 1, 'Two Treatises of Government. London: Awnsham Churchill, 1690': 1, 'International Covenant on Economic, Social and Cultural Rights': 1, 'Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study': 1, 'Influenza and respiratory syncytial virus in the elderly. Expert review of vaccines': 1, 'Biological Challenges and Technological Opportunities for Respiratory Syncytial Virus Vaccine Development': 1, 'The three original publications on vaccination against smallpox': 1, 'Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine': 1, 'Field Evaluation Of a Respiratory Syncytial Virus Vaccine and a Trivalent Parainfluenza Virus Vaccine in a Pediatric Population1': 1, 'Immunization of cotton rats with the fusion (F) and large (G) glycoproteins of respiratory syncytial virus (RSV) protects against RSV challenge without potentiating RSV disease': 1, 'Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization': 1, 'Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus': 6, 'A Cysteine Zipper Stabilizes a Pre-Fusion F Glycoprotein Vaccine for Respiratory Syncytial Virus': 1, 'Structure-Based Design of Head-Only Fusion Glycoprotein Immunogens for Respiratory Syncytial Virus': 3, 'A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism': 1, 'Chimpanzee adenovirus-and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults': 1, 'Improved prefusion stability, optimized codon-usage, and augmented virion packaging enhance the immunogenicity of respiratory syncytial virus (RSV) fusion protein in a vectored vaccine candidate': 1, \"Mixed adjuvant formulations reveal a new combination that elicit antibody response comparable to Freund's adjuvants\": 2, 'A well-tolerated grass pollen-specific allergy vaccine containing a novel adjuvant, monophosphoryl lipid A, reduces allergic symptoms after only four preseasonal injections': 1, 'Vaccine priming is restricted to draining lymph nodes and controlled by adjuvant-mediated antigen uptake': 1, 'The Carbomer-Lecithin Adjuvant Adjuplex Has Potent Immunoactivating Properties and Elicits Protective Adaptive Immunity against Influenza Virus Challenge in Mice. Clinical and vaccine immunology: CVI': 3, 'The ability by different preparations of porcine parvovirus to enhance humoral immunity in swine and guinea pigs': 1, 'Effects of adjuvants on porcine circovirus type 2-associated lesions': 1, 'Antibody Responses in Sheep Vaccinated against Staphylococcus aureus Mastitis: A Comparison of Two Experimental Vaccines Containing Different Adjuvants': 1, 'Antigenicity and immunogenicity of equine influenza vaccines containing a Carbomer adjuvant': 1, 'Synthetic double-stranded RNAs are adjuvants for the induction of T helper 1 and humoral immune responses to human papillomavirus in rhesus macaques': 1, 'Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer': 1, 'Toll-like receptors: the swiss army knife of immunity and vaccine development': 1, 'Immunomodulators as adjuvants for vaccines and antimicrobial therapy': 1, 'New horizons in adjuvants for vaccine development': 1, 'Protection of calves by a prefusionstabilized bovine RSV F vaccine. npj Vaccines': 3, 'Primary respiratory syncytial virus infection in mice': 1, 'A stabilized respiratory syncytial virus reverse genetics system amenable to recombination-mediated mutagenesis': 1, 'Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera': 4, 'Evaluation of candidate vaccine approaches for MERS-CoV': 3, 'Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells': 2, 'Production of a novel antigen by conjugation of HIV-1 to Brucella abortus: studies of immunogenicity, isotype analysis, T-cell dependancy, and syncytia inhibition': 1, 'Key roles of adjuvants in modern vaccines': 1, 'Role of adjuvants in modeling the immune response': 1, 'AS04, an Aluminum Salt-and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity': 1, 'Alum Adjuvant Enhances Protection against Respiratory Syncytial Virus but Exacerbates Pulmonary Inflammation by Modulating Multiple Innate and Adaptive Immune Cells': 2, 'Lipopeptide-adjuvanted respiratory syncytial virus virosomes: A safe and immunogenic non-replicating vaccine formulation': 1, 'An adjuvanted respiratory syncytial virus fusion protein induces protection in aged BALB/c mice': 1, 'Atypical Measles and Enhanced Respiratory Syncytial Virus Disease (ERD) Made Simple': 1, 'Respiratory Syncytial Virus: Virology, Reverse Genetics, and Pathogenesis of Disease. Current topics in microbiology and immunology': 1, 'Immunization with Low Doses of Recombinant Postfusion or Prefusion Respiratory Syncytial Virus F Primes for Vaccine-Enhanced Disease in the Cotton Rat Model Independently of the Presence of a Th1-Biasing (GLA-SE) or Th2-Biasing (Alum) Adjuvant': 1, 'Mechanisms of coronavirus cell entry mediated by the viral spike protein': 1, 'SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines': 3, 'SARS-CoV-2 Vaccines: Status Report': 2, 'Developing Covid-19 Vaccines at Pandemic Speed': 2, 'Structure, Function, and Evolution of Coronavirus Spike Proteins': 1, 'Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion': 2, 'The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex': 2, 'The proximal origin of SARS-CoV-2': 5, 'A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells': 1, 'The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients': 1, 'Human coronaviruses OC43 and HKU1 bind to 9-O-acetylated sialic acids via a conserved receptor-binding site in spike protein domain A': 1, 'Identification of sialic acid-binding function for the Middle East respiratory syndrome coronavirus spike glycoprotein': 1, 'Structures of MERS-CoV spike glycoprotein in complex with sialoside attachment receptors': 1, 'Structural basis of receptor recognition by SARS-CoV-2': 2, 'Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein': 5, 'Characterization of the SARS-CoV-2 S Protein: Biophysical, Biochemical, Structural, and Antigenic Analysis. bioRxiv': 2, 'The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity. bioRxiv': 1, 'Structure and immune recognition of the porcine epidemic diarrhea virus spike protein. bioRxiv': 2, 'Differential processing of HIV envelope glycans on the virus and soluble recombinant trimer': 3, 'Distinct N-glycan fucosylation potentials of three lepidopteran cell lines': 1, 'Site-specific glycan analysis of the SARS-CoV-2 spike': 1, 'Unexpected free fatty acid binding pocket in the cryo-EM structure of SARSCoV-2 spike protein. bioRxiv': 1, 'SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 elicits immunogenicity in baboons and protection in mice': 1, 'Distinct conformational states of SARS-CoV-2 spike protein. bioRxiv': 1, 'Respiratory syncytial virus fusion glycoprotein expressed in insect cells form protein nanoparticles that induce protective immunity in cotton rats': 1, 'Improved Titers against Influenza Drift Variants with a Nanoparticle Vaccine': 1, 'Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen': 3, 'Leginon: a system for fully automated acquisition of 1000 electron micrographs a day': 1, 'Appion: an integrated, database-driven pipeline to facilitate EM image processing': 1, 'DoG Picker and TiltPicker: software tools to facilitate particle selection in single particle electron microscopy': 1, 'Topology representing network enables highly accurate classification of protein images taken by cryo electron-microscope without masking': 1, 'Automated molecular microscopy: the new Leginon system': 1, 'MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy': 1, 'cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination': 1, 'Gctf: Real-time CTF determination and correction': 1, 'New tools for automated high-resolution cryo-EM structure determination in RELION-3': 1, 'Structural analysis of glycoproteins: building N-linked glycans with Coot': 1, 'Automated structure refinement of macromolecular assemblies from cryo-EM maps using Rosetta': 2, 'EMRinger: side chain-directed model and map validation for 3D cryoelectron microscopy': 1, 'MolProbity: More and better reference data for improved all-atom structure validation': 1, 'Meeting modern challenges in visualization and analysis': 1, 'UCSF Chimera--a visualization system for exploratory research and analysis': 1, 'How will country-based mitigation measures influence the course of the COVID-19 epidemic?': 1, 'COVID-19 and Italy: what next?': 3, 'COVID-19 in Italy: momentous decisions and many uncertainties': 1, 'Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff': 4, 'Center for Disease Control and Prevention: Interim Infection Prevention and Control Recommendations for Patients with Suspected of Confirmed Coronavirus Disease 2019 (COVID-19) in Health Care Settings': 1, 'Assessment of N95 respirator decontamination and reuse for SARS-CoV-2': 1, 'Decontamination and Reuse of N95 Respirators with Hydrogen Peroxide Vapor to Address Worldwide Personal Protective Equipment Shortages During the SARS-CoV-2 (COVID-19) Pandemic': 1, 'Sourcing Personal Protective Equipment During the COVID-19': 1, 'Characteristics of Health Care Personnel with COVID-19 -United States': 1, 'Rapid implementation of mobile technology for real-time epidemiology of': 2, 'Loss of smell and taste in combination with other symptoms is a potential predictor of COVID-19 infection (in press) Nature Medicine 2020. 27. Health worker Ebola infections in Guinea': 1, 'SARS transmission among hospital workers in Hong Kong': 1, 'Pandemic (H1N1) 2009 risk for frontline health care workers': 2, 'Prevention of nosocomial transmission of swine-origin pandemic influenza virus A/H1N1 by infection control bundle': 1, 'Risk factors for pandemic (H1N1) 2009 virus seroconversion among hospital staff': 1, 'Digital disease detection--harnessing the Web for public health surveillance': 1, 'Pew Research Center for Internet & Technology: Mobile Fact Sheet. 2020': 1, 'Detection of SARS-CoV-2 in Different Types of Clinical Specimens': 2, 'Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China': 1, 'Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis': 1, 'Dysphagia affecting quality of life in cerebellar ataxia-a large survey': 1, 'Intensive care during the coronavirus epidemic': 1, 'The cerebellar cognitive affective syndrome -a meta-analysis': 1, 'Comparison of cognitive profiles in spinocerebellar ataxia subtypes: a case series': 1, 'The neuropsychiatry of the cerebellum -insights from the clinic': 1, 'The sequencing process generated by the cerebellum crucially contributes to social interactions': 1, 'Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists': 1, 'Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2': 6, 'Mental health and psychosocial problems of medical health workers during the COVID-19 epidemic in China': 1, 'Prevalence of influenza A virus in live-captured North Atlantic gray seals: a possible wild reservoir. Emerging microbes & infections 5': 1, 'Middle East respiratory syndrome coronavirus in bats, Saudi Arabia': 1, \"Bats as 'special' reservoirs for emerging zoonotic pathogens\": 2, 'Bats are a major natural reservoir for hepaciviruses and pegiviruses': 3, 'Bats and zoonotic viruses: can we confidently link bats with emerging deadly viruses? Memórias do Instituto Oswaldo Cruz': 3, 'New world bats harbor diverse influenza A viruses': 3, 'Differences in influenza virus receptors in chickens and ducks: Implications for interspecies transmission': 7, 'Endocytosis of influenza viruses. Microbes and infection': 1, 'Influenza A virus polymerase is a site for adaptive changes during experimental evolution in bat cells': 2, 'Comparative distribution of human and avian type sialic acid influenza receptors in the pig': 5, 'Mammalian innate resistance to highly pathogenic avian influenza H5N1 virus infection is mediated through reduced proinflammation and infectious virus release': 2, 'Sialic acid tissue distribution and influenza virus tropism. Influenza and other respiratory viruses 2': 1, 'Serological evidence of influenza A viruses in frugivorous bats from Africa': 1, 'Bat cells from Pteropus alecto are susceptible to influenza A virus infection and reassortment': 1, 'Host-range barrier of influenza A viruses': 1, 'Quail carry sialic acid receptors compatible with binding of avian and human influenza viruses': 1, 'Comparative Intestinal Histomorphology of Five Species of Phyllostomid Bats (Phyllostomidae, Microchiroptera): Ecomorphological Relations with Alimentary Habits': 1, 'Bat flight and zoonotic viruses': 5, \"Mass extinctions, biodiversity and mitochondrial function: are bats 'special' as reservoirs for emerging viruses? Current opinion in virology 1\": 1, 'Bat Flight and Zoonotic Viruses': 1, 'Global patterns of influenza a virus in wild birds': 1, 'Susceptibility of North American Ducks and Gulls to H5N1 Highly Pathogenic Avian Influenza Viruses': 1, 'A distinct lineage of influenza A virus from bats': 1, 'Synthetically derived bat influenza A-like viruses reveal a cell type-but not species-specific tropism': 1, 'Epidemic Modelling: An Introduction': 6, 'preprints.org (2020)': 4, 'medrxiv.org': 6, 'Ventilator-related causes of lung injury: the mechanical power': 1, 'Driving pressure and survival in the acute respiratory distress syndrome': 2, 'Mechanical power normalized to predicted body weight as a predictor of mortality in patients with acute respiratory distress syndrome': 2, 'Mechanical power of ventilation is associated with mortality in critically ill patients: an analysis of patients in two observational cohorts': 2, 'Epidemiology, mechanical power, and 3-year outcomes in ARDS patients using standardized screening: an observational cohort study': 2, 'Why is the dog an ideal model for aging research?': 1, 'From \"one medicine\" to \"one health\" and systemic approaches to health and well-being': 3, 'Healthy aging: the ultimate preventative medicine': 1, 'The dog aging project: translational geroscience in companion animals': 1, 'The biology of aging: citizen scientists and their pets as a bridge between research on model organisms and human subjects': 1, 'A randomized controlled trial to establish effects of shortterm rapamycin treatment in 24 middle-aged companion dogs': 1, 'Prevalence of inherited disorders among mixed-breed and purebred dogs: 27,254 cases (1995-2010)': 1, 'Aging and veterinary Care of Cats, dogs, and horses through the Records of Three University Veterinary Hospitals': 1, 'Mortality in north american dogs from 1984 to 2004: an investigation into age-, size-, and breed-related causes of death': 3, 'Reproductive capability is associated with lifespan and cause of death in companion dogs': 5, 'Do female dogs age differently than male dogs?': 2, 'The size-life span trade-off decomposed: why large dogs die young': 2, 'Multiple morbidities in companion dogs: a novel model for investigating age-related disease': 3, 'Health status and population characteristics of dogs and cats examined at private veterinary practices in the United States': 1, 'Factors associated with anesthetic-related death in dogs and cats in primary care veterinary hospitals': 1, 'Degenerative mitral valve disease: survival of dogs attending primary-care practice in England': 3, 'Longevity and mortality of owned dogs in England': 6, 'Risk factors associated with lifespan in pet dogs evaluated in primary care veterinary hospitals': 8, 'Mortality in over 350,000 insured Swedish dogs from 1995-2000: I. breed-, gender-, age-and causespecific rates': 1, 'Mortality in over 350,000 insured Swedish dogs from 1995-2000: II. Breed-specific age and survival patterns and relative risk for causes of death': 3, 'Disease surveillance and referral bias in the veterinary medical database': 2, 'Canine dystocia in 50 UK first-opinion emergency care veterinary practices: prevalence and risk factors': 1, 'Gastric dilation-volvulus in dogs attending UK emergencycare veterinary practices: prevalence, risk factors and survival': 1, 'Most Popular AKC Dog Breeds -Full Ranking List': 1, 'Top 20 KC Breeds in registration order for the years': 1, 'Anonymous (2017) The Pet Health Insurance Industry in North America': 1, \"Right censored data ('cohort bias') in veterinary life span studies\": 4, 'Bias in canine lifespan estimates through right censored data': 3, 'Nonparametric estimation from incomplete observations': 2, 'Regression models and life-tables': 2, 'Statistical analysis regarding the effects of height and weight on life span of the domestic dog': 4, 'Do large dogs die young?': 1, 'Age-related cataract in dogs: a biomarker for life span and its relation to body size': 2, 'Effect of purebred status, body size, gonadectomy, and dental cleaning of lifespan in pet dogs seen in private veterinary practice': 2, 'Desexing dogs: a review of the current literature': 3, 'Probing the perils of dichotomous binning: how categorizing female dogs as spayed or intact can misinform our assumptions about the lifelong health consequences of ovariohysterectomy': 4, 'Neutering dogs: effects on joint disorders and cancers in golden retrievers': 1, 'Half of 23 Belgian dog breeds has a compromised genetic diversity, as revealed by Urfer et al. Canine Medicine and Genetics': 1, 'Trends in genetic diversity for all kennel Club registered pedigree dog breeds': 1, 'Genetic diversity, inbreeding and breeding practices in dogs: results from pedigree analyses': 1, 'Recent breeding history of dog breeds in Sweden: modest rates of inbreeding, extensive loss of genetic diversity and lack of correlation between inbreeding and health': 1, 'Inbreeding impact on litter size and survival in selected canine breeds': 1, 'Inbreeding and fertility in Irish wolfhounds in Sweden: 1976 to': 1, 'Pedigree analysis for conservation of genetic diversity and purging': 1, 'Body size, inbreeding, and lifespan in domestic dogs': 3, 'Exceptional longevity in female Rottweiler dogs is not encumbered by investment in reproduction': 3, 'Genomic analyses of modern dog breeds': 3, 'Whole-genome sequence, SNP chips and pedigree structure: building demographic profiles in domestic dog breeds to optimize genetic-trait mapping': 2, 'Coefficients of inbreeding and relationship': 1, 'Population structure and inbreeding from pedigree analysis of purebred dogs': 2, 'One welfare -a platform for improving human and animal welfare': 1, 'Positioning animal welfare in the one health concept through evaluation of an animal welfare Center in Skopje': 1, 'Human relationships with domestic and other animals: one health, one welfare, one biology': 1, 'Epidemiology of surgical castration of dogs and cats in the United States': 1, 'Epidemiology, pathology, and genetics of histiocytic sarcoma in the Bernese mountain dog breed': 1, 'Systemic histiocytosis in the Bernese mountain dog': 1, 'Comparative longevity of pet dogs and humans: implications for gerontology research': 1, 'R: a language and environment for statistical computing. Vienna: R foundation for statistical Computing': 1, 'A new direction for kennel club regulations and breed standards': 1, 'Center for Diseases Control and Prevention (CDC) (2015) Yellow Book, general approach to the returned traveler': 4, 'Critically ill migrants with infection: diagnostic considerations for intensive care physicians in Europe': 4, 'A technical document on infectious diseases of special importance to newly arriving migrants to the EU/EEA': 2, 'Dengue and severe dengue: fact sheet': 1, 'Current Zika transmission': 2, 'Suspected female-to-male sexual transmission of Zika virus': 1, 'Center for Diseases Control and Prevention (CDC) (2016) Zika virus. CDC': 1, 'Yellow fever outbreak in Angola and DRC: the risk to the EU remains limited': 1, 'Year in review in Intensive Care Medicine 2014: III. Severe infections, septic shock, healthcare-associated infections, highly resistant bacteria, invasive fungal infections, severe viral infections, Ebola virus disease and paediatrics': 1, 'Working group of Ebola outbreak investigation team of Madrid (2015) First secondary case of Ebola outside Africa: epidemiological characteristics and contact monitoring': 2, 'Center for Diseases Control and Prevention (CDC) (2016) Middle East respiratory syndrome (MERS). CDC': 2, 'The role of international travel in the worldwide spread of multiresistant Enterobacteriaceae': 1, 'Transmission of multidrug-resistant tuberculosis in the UK: a cross-sectional molecular and epidemiological study of clustering and contact tracing': 1, 'The dependence of viral RNA replication on co-opted host factors': 1, 'Mechanisms of plant resistance to viruses': 1, 'Antiviral immunity directed by small RNAs': 1, 'RNA silencing suppression by plant pathogens: defence, counter-defence and counter-counter-defence': 3, 'Potato virus X amplicons in arabidopsis mediate genetic and epigenetic gene silencing': 3, 'SDE3 encodes an RNA helicase required for post-transcriptional gene silencing in Arabidopsis': 1, 'RNA polymerase IV directs silencing of endogenous DNA': 1, 'Ago hook and RNA helicase motifs underpin dual roles for SDE3 in antiviral defense and silencing of nonconserved intergenic regions': 2, 'Hierarchical action and inhibition of plant Dicer-like proteins in antiviral defense': 2, 'Methylation protects miRNAs and siRNAs from a 3 0 -end uridylation activity in Arabidopsis': 1, 'Arabidopsis HEN1: a genetic link between endogenous miRNA controlling development and siRNA controlling transgene silencing and virus resistance': 1, 'Aberrant growth and lethality of Arabidopsis deficient in nonsense-mediated RNA decay factors is caused by autoimmune-like response': 3, 'Upf1 phosphorylation triggers translational repression during nonsense-mediated mRNA decay': 1, \"Recognition of yeast mRNAs as ''nonsense containing'' leads to both inhibition of mRNA translation and mRNA degradation: implications for the control of mRNA decapping\": 1, 'Inter-kingdom conservation of mechanism of nonsense-mediated mRNA decay': 1, 'A role for nonsense-mediated mRNA decay in plants: pathogen responses are induced in Arabidopsis thaliana NMD mutants': 1, 'Both introns and long 3 0 -UTRs operate ascis-acting elements to trigger nonsense-mediated decay in plants': 4, 'Alternative splicing and nonsense-mediated decay modulate expression of important regulatory genes in Arabidopsis': 1, 'The exon-exon junction complex provides a binding platform for factors involved in mRNA export and nonsense-mediated mRNA decay': 1, \"Matthews' Plant Virology\": 3, 'Characterization of infectious transcripts from a potato virus X cDNA clone': 1, 'Argonaute quenching and global changes in Dicer homeostasis caused by a pathogenencoded GW repeat protein': 2, 'Isolation of mutants of Arabidopsis thaliana in which accumulation of tobacco mosaic virus coat protein is reduced to low levels': 1, 'Lossof-susceptibility mutants of Arabidopsis thaliana reveal an essential role for eIF(iso)4E during potyvirus infection': 2, 'Yeast genomewide screen reveals dissimilar sets of host genes affecting replication of RNA viruses': 1, 'Internal ribosome entry sequence-mediated translation initiation triggers nonsense-mediated decay': 1, 'Cytoplasmic and nuclear quality control and turnover of single-stranded RNA modulate post-transcriptional gene silencing in plants': 1, 'Regulation of Tomato golden mosaic virus AL2 and AL3 gene expression by a conserved upstream open reading frame': 1, 'Structural features in the Rous sarcoma virus RNA stability element are necessary for sensing the correct termination codon': 2, 'The human T-lymphotropic virus type 1 tax protein inhibits nonsense-mediated mRNA decay by interacting with INT6/EIF3E and UPF1': 1, 'Viral interference with host mRNA surveillance, the nonsense-mediated mRNA decay (NMD) pathway, through a new function of HTLV-1 Rex: implications for retroviral replication': 1, 'A microRNA superfamily regulates nucleotide binding site-leucine-rich repeats and other mRNAs': 1, 'An enhanced transient expression system in plants based on suppression of gene silencing by the p19 protein of tomato bushy stunt virus': 1, 'Novel Coronavirus (2019-nCoV)': 1, 'World Health Organization. 2019-nCoV Situation Report': 2, \"Koch's postulates fulfilled for SARS virus\": 2, 'Another decade, another coronavirus': 10, 'Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study': 3, 'First case of 2019 novel coronavirus in the United States': 7, 'Transmission of 2019-nCoV infection from an asymptomatic contact in Germany': 12, 'Importation and human-to-human transmission of a novel coronavirus in Vietnam': 3, 'Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan': 4, 'A novel coronavirus emerging in China -Key Questions for Impact Assessment': 1, 'A review of treatment modalities for middle east respiratory syndrome': 1, 'Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings': 2, 'Uncanny similarity of unique inserts in the 2019-nCoV spike protein to HIV-1 gp120 and Gag': 3, 'Interim Guidelines for Environmental Cleaning and Disinfection of Areas Exposed to Confirmed Case(s) of 2019 Novel Coronavirus (2019-nCoV) in Non-Healthcare Commercial Premises': 1, 'Hand Hygiene for Health Workers Caring for Ebola Patients': 1, 'Identification of a novel astrovirus in domestic sheep in Hungary': 1, 'Astrovirus infections in humans and animals -molecular biology, genetic diversity, and interspecies transmissions': 2, 'Rediscovery and genomic characterization of bovine astroviruses': 10, 'Detection of a novel astrovirus in brain tissue of mink suffering from shaking mink syndrome by use of viral metagenomics': 1, 'Complete genome sequence of an astrovirus identified in a domestic rabbit (Oryctolagus cuniculus) with gastroenteritis': 1, 'Isolation of small viruses resembling astroviruses and caliciviruses from acute enteritis of calves': 6, 'Detection of diverse astroviruses from bats in China': 1, 'Serotypes of bovine astrovirus': 2, 'Astrovirus and Breda virus infections of dome cell epithelium of bovine ileum': 3, 'Major foodborne illness causing viruses and current status of vaccines against the diseases': 1, 'Characterization of a calici-like virus (Newbury agent) found in association with astrovirus in bovine diarrhea': 4, 'Comparison of capsid sequences from human and animal astroviruses': 1, '3′ end cDNA amplification using classic RACE': 1, 'Detection of bovine torovirus in neonatal calf diarrhoea in Lower Austria and Styria (Austria)': 1, 'Detection of bovine Coronavirus by RT-PCR in a field study': 1, 'Detection of group A Bovine Rotavirus in diarrhoeic calves by Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) and electropherotyping': 1, 'Establishment and Application of a RT-PCR Assay for Detection of Bovine Viral Diarrhea Virus': 1, 'Identification and characterization of deer astroviruses': 1, 'Molecular characterisation of the 3′-end of the astrovirus genome': 2, 'Phylogenetic analysis of bovine astrovirus in Korean cattle': 2, 'Divergent astrovirus associated with neurologic disease in cattle': 1, 'Genomic analysis of closely related astroviruses': 1, 'Genomic analysis of two ORF2 segments of new porcine astrovirus isolates and their close relationship with human astroviruses': 1, 'Subgenomic RNA sequence of human astrovirus supports classification of Astroviridae as a new family of RNA viruses': 2, 'Identification and sequence determination of the capsid protein gene of human astrovirus serotype 1': 2, 'Complete sequence of a duck astrovirus associated with fatal hepatitis in ducklings': 1, 'Epidemiology of viral respiratory infections': 1, 'The common cold': 2, 'Otitis media in infants and children': 1, 'Textbook of pediatrics': 1, 'Incidence of acute otitis media and sinusitis complicating upper respiratory tract infection: the effect of age': 1, 'Smart health choices: making sense of health advice': 1, 'Statistics notes. Treatment allocation in controlled trials: why randomise?': 1, 'Grading quality of evidence and strength of recommendations': 1, 'GRADE: an emerging consensus on rating quality of evidence and strength of recommendations': 1, 'Systems for grading the quality of evidence and the strength of recommendations II: pilot study of a new system': 1, 'Report of a WHO/CIBA Foundation Workshop. Prevention of hearing impairment from chronic otitis media. Geneva: World Health Organisation': 1, 'Oxford: Wiley interScience': 1, 'Evidence-based otitis media. Hamilton: B.C': 9, 'Randomized, controlled trial efficacy of pneumococcal conjugate vaccine against otitis media among Navajo and White Mountain Apache infants': 3, 'Systematic review of existing evidence and primary care guidelines on the management of otitis media in Aboriginal and Torres Strait Islander populations. Canberra: Office of Aboriginal and Torres Strait Islander Health': 1, 'Recommendations for clinical care guidelines on the management of otitis media in Aboriginal and Torres Strait Islander populations. Canberra: Office of Aboriginal and Torres Strait Islander Health': 1, 'Otitis media in children (acute)': 7, 'Otitis media': 10, 'American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media. Diagnosis and management of acute otitis media': 2, 'Prophylaxis for otitis media in an Indian population': 1, 'Draining ears and deafness among Alaskan Eskimos': 1, 'Patterns of ear disease in the southwestern American Indian': 1, 'Eustachian tube function in an American Indian population': 2, 'Early otitis media among Minnesota American Indians: the little ears study': 1, 'An overview of twenty years of observation concerning etiology, prevalence, and evolution of otitis media and hearing loss among the Inuit in the eastern Canadian Arctic': 1, 'High rate of nasopharyngeal carriage of potential pathogens among children in Greenland: results of a clinical survey of middle-ear disease': 1, 'Prevalence of otitis media in a survey of 591 unselected Greenlandic children': 1, 'Outcome of mobile ear surgery for chronic otitis media in remote areas': 2, 'Otitis media in Australian Aboriginal children: an overview': 1, 'The prevalence of hearing impairment amongst Maori schoolchildren': 1, 'Prevalence and natural history of otitis media with perforation in Maori school children': 1, 'Epidemiology and pathogenesis of chronic suppurative otitis media: implications for prevention and treatment': 1, 'Middle-ear disease in Indians of the Mount Currie Reservation, British Columbia': 1, 'Childhood morbidity and mortality in Newcastle-Upon-Tyne. Further report on the thousand family study': 1, 'Bronchiectasis in Alaska Native children': 1, 'Otitis media in Inuit children in the Eastern Canadian Arctic-an overview 1968 to date': 1, 'Bronchiectasis in Alaska Native children: causes and clinical courses': 1, 'Lower respiratory tract infections among American Indian and Alaska Native children and the general population of U.S. children': 1, 'Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage': 1, 'Invasive pneumococcal disease in central Australia': 1, 'Bronchiectasis in indigenous children in remote Australian communities': 1, 'The burden and outcome of respiratory tract infection in Australian and aboriginal children': 2, 'Bacterial colonization of the nasopharynx predicts very early onset and persistence of otitis media in Australian aboriginal infants': 1, 'Carriage of multiple ribotypes of nonencapsulated Haemophilus influenzae in aboriginal infants with otitis media': 1, 'Measuring nasal bacterial load and its association with otitis media': 1, 'Report from a WHO working group: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae': 1, 'Evidence assessment of the accuracy of methods of diagnosing middle ear effusion in children with otitis media with effusion': 1, 'Does this child have acute otitis media?': 1, 'Otitis media and speech and language: a meta-analysis of prospective studies': 1, 'Antibiotics for acute otitis media: a meta-analysis with individual patient data': 3, 'Antibiotics for acute otitis media in children': 4, 'Chronic suppurative otitis media: a review': 3, 'Chronic suppurative otitis media': 3, 'Predictors of chronic suppurative otitis media in children': 1, 'Identification of children in the first four years of life for early treatment for otitis media with effusion': 1, 'Otitis media with effusion': 7, 'American Academy of Pediatrics Subcommittee on Otitis Media With Effusion. Otitis media with effusion': 4, 'Grommets (ventilation tubes) for hearing loss associated with otitis media with effusion in children': 3, 'Grommets in otitis media with effusion: an individual patient data meta-analysis': 1, 'Antihistamines and/or decongestants for otitis media with effusion (OME) in children': 2, 'Autoinflation for hearing loss associated with otitis media with effusion': 2, 'Oral or topical nasal steroids for hearing loss associated with otitis media with effusion in children': 2, 'Surgical prevention of otitis media': 2, 'Compared to placebo, long-term antibiotics resolve otitis media with effusion (OME) and prevent acute otitis media with perforation (AOMwiP) in a high-risk population: a randomized controlled trial': 2, 'Trends in otitis media and myringtomy with tube placement among American Indian/Alaska native children and the US general population of children': 2, 'Pneumococcal vaccines for preventing otitis media': 1, 'Vaccines for preventing influenza in healthy children': 1, 'The efficacy of influenza vaccine for healthy children: a meta-analysis evaluating potential sources of variation in efficacy estimates including study quality': 1, 'Impact of the pneumococcal conjugate vaccine on otitis media': 1, 'Decongestants and antihistamines for acute otitis media in children': 2, 'A randomized, double-blind, multicentre controlled trial of ibuprofen versus acetaminophen and placebo for symptoms of acute otitis media in children': 1, 'Short course antibiotics for acute otitis media': 1, 'Delayed antibiotics for respiratory infections': 1, 'Wait-and-see prescription for the treatment of acute otitis media: a randomized controlled trial': 1, 'Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media': 1, 'Antibiotics for the prevention of acute and chronic suppurative otitis media in children': 1, 'Prevention of otitis media by adenoidectomy in children younger than 2 years': 2, 'Adenoidectomy does not significantly reduce the incidence of otitis media in conjunction with the insertion of tympanostomy tubes in children who are younger than 4 years: a randomized trial': 2, 'Grommets (ventilation tubes) for recurrent acute otitis media in children': 1, 'Otitis media in Alaskan Eskimo children. Prospective evaluation of chemoprophylaxis': 1, 'Pneumococcal vaccination and otitis media in Australian Aboriginal infants: comparison of two birth cohorts before and after introduction of vaccination': 1, 'Topical antibiotics without steroids for chronically discharging ears with underlying eardrum perforations': 1, 'Systemic antibiotics versus topical treatments for chronically discharging ears with underlying eardrum perforations': 1, 'Interventions for chronic suppurative otitis media': 1, 'Effectiveness of trimethoprim/sulfamethoxazole for children with chronic active otitis media: a randomized, placebo-controlled trial': 1, 'Medical treatment of chronic suppurative otitis media without cholesteatoma in children-a two-year follow-up': 1, 'Outpatient management of chronic suppurative otitis media without cholesteatoma in children': 1, 'Effectiveness of ototopical antibiotics for chronic suppurative otitis media in Aboriginal children: a community-based, multicentre, double-blind randomised controlled trial': 1, 'Topical ciprofloxin versus topical framycetingramicidin-dexamethasone in Australian aboriginal children with recently treated chronic suppurative otitis media: a randomized controlled trial': 1, 'Outcomes of myringoplasty in Australian Aboriginal children and factors associated with success: a prospective case series': 1, 'Myringoplasty: a post-operative survey of 90 aborigine patients': 1, 'COVID-2019) situation reports. Geneva: World Health Organization': 1, 'Effects of long-duration wearing of N95 respirator and surgical facemask: a pilot study': 2, 'Revised National Pressure Ulcer Advisory Panel pressure injury staging system: revised pressure injury staging system': 1, 'How to properly put on and take off a disposable respirator. U.S. Department of Health and Human Services': 1, 'Evaluation of the benefits of the user seal check on N95 filtering facepiece respirator fit': 1, 'Device related pressure ulcers: SECURE prevention': 2, 'Geographical tracking and mapping of coronavirus disease COVID-19/severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic and associated events around the world: how 21st century GIS technologies are supporting the global fight against outbreaks and epidemics': 1, 'The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China, Zhonghua liu xing bing xue za zhi= Zhonghua liuxingbingxue zazhi': 2, 'Pathological findings of COVID-19 associated with acute respiratory distress syndrome, The Lancet respiratory medicine': 1, 'Novel isoprene sensor for a flu virus breath monitor': 2, 'Theoretical insights into the intermolecular and mechanisms of covalent interaction of Flutamide drug with COOH and COCl functionalized carbon nanotubes: A DFT approach': 1, 'Dopant species with Al-Si and N-Si bonding in the MOCVD of AlN implementing trimethylaluminum, ammonia and silane': 1, 'Applying the B12N12 nanoparticle as the CO, CO2, H2O and NH3 sensor': 1, 'DFT study on the functionalization of a BN nanotube with sulfamide': 1, 'Adsorption behavior of the': 1, 'The Possibility of Selective Sensing of the Straight-Chain Alcohols (Including Methanol to n-Pentanol) Using the C20 Fullerene and C18NB Nano Cage': 1, 'DFT study of the effect of platinum on the H2 gas sensing performance of ZnO nanotube: Explaining the experimental observations': 1, 'Switching behavior of an actuator containing germanium, silicon-decorated and normal C20 fullerene': 1, 'A selective nanosensor device for exhaled breath analysis': 1, 'Selective nanoprobes for \"signalling gases': 1, 'Gas sensors based on semiconducting metal oxide one-dimensional nanostructures': 3, 'One-dimensional nanostructures: fabrication, characterisation and applications': 1, 'Nanostructures Cluster Models in Solution: Extension to C, BC2N, and BN Fullerenes, Tubes, and Cones, in: Contemporary advancements in information technology development in dynamic environments': 1, 'TiO2 anatase thin films as gas sensors': 1, 'DNA sensing using nanocrystalline surface-enhanced Al2O3 nanopore sensors': 1, 'Laterally grown ZnO nanowire ethanol gas sensors': 2, 'Boron nitride nanotubes': 1, 'Humidity sensing properties of single Audecorated boron nitride nanotubes': 1, 'Assessment of the \"6-31+G** + LANL2DZ\" Mixed Basis Set Coupled with Density Functional Theory Methods and the Effective Core Potential: Prediction of Heats of Formation and Ionization Potentials for First': 1, 'The calculation of small molecular interactions by the differences of separate total energies. Some procedures with reduced errors': 1, 'Combining synchronous transit and quasi-newton methods to find transition states': 1, 'Theoretical study of O2 adsorption and reactivity on single-walled boron nitride nanotubes': 1, 'Adsorption of molecular oxygen on the walls of pristine and carbon-doped (5, 5) boron nitride nanotubes: Spin-polarized density functional study': 1, 'Comparative study on gas adsorption in defected carbon and boron nitride nanotube': 1, 'Analyzing genomes with cumulative skew diagrams': 3, 'Quantitative analysis of replication-related mutation and selection pressures in bacterial chromosomes and plasmids using generalised GC skew index': 1, 'Sequence analysis of origins of replication in the Saccharomyces cerevisiae genomes': 1, 'Identification of replication origins in prokaryotic genomes': 1, 'Impact of the biased nucleotide composition of viral RNA genomes on RNA structure and codon usage': 2, 'Nucleotide composition of the Zika virus RNA genome and its codon usage': 1, 'ViralZone: a knowledge resource to understand virus diversity': 1, 'ViralZone: recent updates to the virus knowledge resource': 1, 'Evolution of the sequence composition of Flaviviruses': 2, 'e GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae': 2, 'MAFFT: iterative refinement and additional methods': 1, 'MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets': 2, 'Anucleotide preference of HIV-1 in the context of its structured RNA genome': 2, 'On the biased nucleotide composition of the human coronavirus RNA genome': 3, 'e biased nucleotide composition of the HIV genome: a constant factor in a highly variable virus': 1, 'A cross-sectional study of perceived stress, mindfulness, emotional selfregulation, and self-care habits in registered nurses at a tertiary care medical center': 1, 'Psychological stress of ICU nurses in the time of COVID-19': 1, \"At the height of the storm: Healthcare staff's health conditions and job satisfaction and their associated predictors during the epidemic peak of COVID-19\": 1, \"Implications for COVID-19: a systematic review of nurses' experiences of working in acute care hospital settings during a respiratory pandemic\": 2, 'COVID-19) outbreak: what the department of endoscopy should know': 1, 'COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission': 1, 'European Centre for Disease Prevention and Control. Novel coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEAand the UK-sixth update: European Centre for Disease Prevention and Control': 1, 'Evolution of replicative DNA polymerases in archaea and their contributions to the eukaryotic replication machinery': 1, 'Primary structure of the catalytic subunit of human DNA polymerase delta and chromosomal location of the gene': 1, 'Human DNA polymerase delta gene maps to region 19q13.3-q13.4 by in situ hybridization': 1, 'Structure of the gene for the catalytic subunit of human DNA polymerase delta (POLD1)': 1, 'The human POLD1 gene. Identification of an upstream activator sequence, activation by Sp1 and Sp3, and cell cycle regulation': 2, 'Transcriptional regulation of the human DNA polymerase delta catalytic subunit gene POLD1 by p53 tumor suppressor and Sp1': 2, 'Cadmium treatment suppresses DNA polymerase delta catalytic subunit gene expression by acting on the p53 and Sp1 regulatory axis': 1, 'The CHR site: definition and genome-wide identification of a cell cycle transcriptional element': 1, 'Identification and functional analysis of a CDE/CHR element in the POLD1 promoter': 3, 'Structural and functional insight into proliferating cell nuclear antigen': 1, 'The p53-p21-DREAM-CDE/CHR pathway regulates G2/M cell cycle genes': 1, 'Cancer specificity of promoters of the genes controlling cell proliferation': 1, 'Genome-wide binding studies reveal DNA binding specificity mechanisms and functional interplay amongst Forkhead transcription factors': 1, 'miR-155 over-expression promotes genomic instability by reducing high-fidelity polymerase delta expression and activating error-prone DSB repair': 4, 'The eureka enzyme: the discovery of DNA polymerase': 1, 'A new mammalian DNA polymerase with 3′ to 5′ exonuclease activity: DNA polymerase delta': 1, 'Reconstitution and characterization of the human DNA polymerase delta four-subunit holoenzyme': 1, 'DNA polymerase delta, an essential enzyme for DNA transactions': 1, 'Structural insights into eukaryotic DNA replication': 1, 'Structural basis of high-fidelity DNA synthesis by yeast DNA polymerase delta': 1, 'The multiple biological roles of the 3′ → 5′ exonuclease of Saccharomyces cerevisiae DNA polymerase delta require switching between the polymerase and exonuclease domains': 1, 'Structural and biochemical investigation of the role in proofreading of a beta hairpin loop found in the exonuclease domain of a replicative DNA polymerase of the B family': 2, 'DNA polymerase 3′ → 5′ exonuclease activity: Different roles of the beta hairpin structure in family-B DNA polymerases': 1, 'DNA polymerase epsilon and its roles in genome stability': 1, 'RB69 DNA polymerase structure, kinetics, and fidelity': 1, 'Evolution of eukaryotic DNA polymerases via interaction between cells and large DNA viruses': 1, 'Exoribonuclease superfamilies: structural analysis and phylogenetic distribution': 1, 'A novel POLE mutation associated with cancers of colon, pancreas, ovaries and small intestine': 3, 'DNA polymerases divide the labor of genome replication': 2, 'Eukaryotic genome instability in light of asymmetric DNA replication': 3, 'ATP-independent loading of the proliferating cell nuclear antigen requires DNA ends': 1, 'Mechanism of ATPdriven PCNA clamp loading by S. cerevisiae RFC': 1, 'Replicative DNA polymerases': 1, 'Building a replisome from interacting pieces: sliding clamp complexed to a peptide from DNA polymerase and a polymerase editing complex': 1, 'Mechanism of asymmetric polymerase assembly at the eukaryotic replication fork': 1, 'Reconstitution of a eukaryotic replisome reveals suppression mechanisms that define leading/lagging strand operation': 1, 'The eukaryotic replication machine': 3, 'Unlocking the sugar \"steric gate\" of DNA polymerases': 1, 'The balancing act of ribonucleotides in DNA': 1, 'Structural mechanisms of DREAM complex assembly and regulation': 1, 'Interaction of the retinoblastoma protein (pRb) with the catalytic subunit of DNA polymerase delta (p125)': 2, 'Identification of a common subnuclear localization signal': 3, 'Immobilization of proteins in the nucleolus by ribosomal intergenic spacer noncoding RNA': 3, 'New Insights Into Nucleolar Structure and Function. F1000Prime Rep 7': 1, 'Biogenesis of cytosolic and nuclear iron-sulfur proteins and their role in genome stability': 1, 'MMS19 links cytoplasmic iron-sulfur cluster assembly to DNA metabolism': 1, 'MMS19 assembles iron-sulfur proteins required for DNA metabolism and genomic integrity': 1, 'Decreased gene expression responsible for post-ultraviolet DNA repair synthesis in aging: a possible mechanism of age-related reduction in DNA repair capacity': 1, 'Protein arginine methyltransferase 7 regulates cellular response to DNA damage by methylating promoter histones H2A and H4 of the polymerase delta catalytic subunit gene, POLD1': 1, 'Long non-coding RNA PVT1 and cancer': 1, 'Identification of crucial regulatory relationships between long non-coding RNAs and protein-coding genes in lung squamous cell carcinoma': 1, 'Characterization of the p125 subunit of human DNA polymerase delta and its deletion mutants. Interaction with cyclin-dependent kinase-cyclins': 1, 'Phosphorylation of the p68 subunit of Pol delta acts as a molecular switch to regulate its interaction with PCNA': 1, 'A novel DNA damage response: rapid degradation of the p12 subunit of dna polymerase delta': 2, 'Identification of RNF8 as a ubiquitin ligase involved in targeting the p12 subunit of DNA polymerase delta for degradation in response to DNA damage': 1, 'DNA damage alters DNA polymerase delta to a form that exhibits increased discrimination against modified template bases and mismatched primers': 3, 'The tail that wags the dog: p12, the smallest subunit of DNA polymerase delta, is degraded by ubiquitin ligases in response to DNA damage and during cell cycle progression': 4, 'A novel function of CRL4(Cdt2): regulation of the subunit structure of DNA polymerase delta in response to DNA damage and during the S phase': 2, 'Degradation of p12 subunit by CRL4Cdt2 E3 ligase inhibits fork progression after DNA damage': 1, 'Proteolysis of the human DNA polymerase delta smallest subunit p12 by mu-calpain in calcium-triggered apoptotic HeLa cells': 1, 'Werner protein recruits DNA polymerase delta to the nucleolus': 2, 'Cellular dynamics and modulation of WRN protein is DNA damage specific': 1, 'RAD18, WRNIP1 and ATMIN promote ATM signalling in response to replication stress': 1, 'Human Werner helicase interacting protein 1 (WRNIP1) functions as a novel modulator for DNA polymerase delta': 1, 'Coronavirus infection induces DNA replication stress partly through interaction of its nonstructural protein 13 with the p125 subunit of DNA polymerase delta': 1, 'PDIP46 (DNA polymerase delta interacting protein 46) is an activating factor for human DNA polymerase delta': 1, 'DNA replication and cancer: from dysfunctional replication origin activities to therapeutic opportunities': 2, 'The LMO2 oncogene regulates DNA replication in hematopoietic cells': 1, 'DNA replication-a matter of fidelity': 1, 'Saccharomyces cerevisiae DNA polymerase delta: high fidelity for base substitutions but lower fidelity for single-and multi-base deletions': 1, 'The high fidelity and unique error signature of human DNA polymerase epsilon': 2, 'Eukaryotic mismatch repair in relation to DNA replication': 2, 'Quantifying the contributions of base selectivity, proofreading and mismatch repair to nuclear DNA replication in Saccharomyces cerevisiae': 1, 'Genetic instability in budding and fission yeast-sources and mechanisms': 1, 'Division of labor at the eukaryotic replication fork': 1, 'DNA polymerases at the eukaryotic fork-20 years later': 1, 'A major role of DNA polymerase delta in replication of both the leading and lagging DNA strands': 2, 'Reconsidering DNA polymerases at the replication fork in eukaryotes': 2, 'Who is leading the replication fork, pol epsilon or pol delta?': 1, 'APOBEC3A and APOBEC3B preferentially deaminate the lagging strand template during DNA replication': 1, 'Laggingstrand replication shapes the mutational landscape of the genome': 1, 'Colon cancer-associated mutator DNA polymerase delta variant causes expansion of dNTP pools increasing its own infidelity': 1, 'Pools and Pols: mechanism of a mutator phenotype': 1, 'Telomerase-mediated telomere addition in vivo requires DNA primase and DNA polymerases alpha and delta': 1, 'Intramolecular telomeric Gquadruplexes dramatically inhibit DNA synthesis by replicative and translesion polymerases, revealing their potential to lead to genetic change': 1, 'The p12 subunit of human polymerase delta modulates the rate and fidelity of DNA synthesis': 1, 'Switching between polymerase and exonuclease sites in DNA polymerase epsilon': 1, 'Conformational coupling in DNA polymerase fidelity': 1, 'DNA replication fidelity': 1, 'DNA polymerase delta in DNA replication and genome maintenance': 1, 'DNA polymerases delta and lambda cooperate in repairing double-strand breaks by microhomology-mediated end-joining in Saccharomyces cerevisiae': 1, 'Proofreading exonuclease activity of human DNA polymerase delta and its effects on lesion-bypass DNA synthesis': 1, 'Tolerating DNA damage during eukaryotic chromosome replication': 1, 'DNA polymerase delta and zeta switch by sharing accessory subunits of DNA polymerase delta': 2, 'FF483-484 motif of human Poleta mediates its interaction with the POLD2 subunit of Poldelta and contributes to DNA damage tolerance': 1, 'Emerging critical roles of Fe-S clusters in DNA replication and repair': 1, 'Regulation of Rad6/Rad18 activity during DNA damage tolerance': 1, 'Dynamics of enzymatic interactions during short flap human Okazaki fragment processing by two forms of human DNA polymerase delta': 1, 'DNA replication error-induced extinction of diploid yeast': 1, 'Pathway correcting DNA replication errors in Saccharomyces cerevisiae': 1, 'Sensitivity to phosphonoacetic acid: a new phenotype to probe DNA polymerase delta in Saccharomyces cerevisiae': 1, 'Replication factor C recruits DNA polymerase delta to sites of nucleotide excision repair but is not required for PCNA recruitment': 1, 'DNA polymerase deltadependent repair of DNA single strand breaks containing 3′-end proximal lesions': 1, 'DNA polymerase delta is required for base excision repair of DNA methylation damage in Saccharomyces cerevisiae': 1, 'DNA polymerase delta is required for human mismatch repair in vitro': 1, 'Polymerase delta replicates both strands after homologous recombination-dependent fork restart': 1, 'Aberrant double-strand break repair resulting in half crossovers in mutants defective for Rad51 or the DNA polymerase delta complex': 1, 'Break-induced replication repair of damaged forks induces genomic duplications in human cells': 1, 'Stable interactions between DNA polymerase delta catalytic and structural subunits are essential for efficient DNA repair': 1, 'Human POLD1 modulates cell cycle progression and DNA damage repair': 1, 'A synthetic lethal screen identifies ATR-inhibition as a novel therapeutic approach for POLD1-deficient cancers': 1, 'An in-frame deletion at the polymerase active site of POLD1 causes a multisystem disorder with lipodystrophy': 2, 'Identification of a novel mutation in the polymerase delta 1 (POLD1) gene in a lipodystrophic patient affected by mandibular hypoplasia, deafness, progeroid features (MDPL) syndrome': 2, 'Mandibular hypoplasia, deafness, progeroid features and lipodystrophy (MDPL) syndrome in the context of inherited lipodystrophies': 2, 'Polymerase delta variants in RER colorectal tumours': 2, 'Chemotherapy of cellline-derived human colon carcinomas in mice immunosuppressed with antithymocyte serum': 1, 'Maturation-induction of tumor cells using a human colon carcinoma model': 1, 'Did the four human cancer cell lines DLD-1, HCT-15, HCT-8, and HRT-18 originate from one and the same patient?': 1, 'Mutations of GTBP in genetically unstable cells': 1, 'Speeding up the clock: the past, present and future of progeria': 1, 'Werner syndrome: clinical features, pathogenesis and potential therapeutic interventions': 3, 'POLD1 germline mutations in patients initially diagnosed with Werner syndrome': 4, 'The Werner syndrome exonuclease facilitates DNA degradation and high fidelity DNA polymerization by human DNA polymerase delta': 2, 'Nonenzymatic role for WRN in preserving nascent DNA strands after replication stress': 1, 'Nuclear envelope-related lipodystrophies': 1, 'Segregation of replicative DNA polymerases during S phase: DNA polymerase epsilon, but not DNA polymerases alpha/delta, are associated with lamins throughout S phase in human cells': 1, 'Identification of FAM96B as a novel prelamin A binding partner': 1, 'Maintaining epigenetic inheritance during DNA replication in plants': 1, 'The arabidopsis DNA polymerase delta has a role in the deposition of transcriptionally active epigenetic marks, development and flowering': 1, 'Detection of mutations in the DNA polymerase delta gene of human sporadic colorectal cancers and colon cancer cell lines': 1, 'DNA replication fidelity and cancer': 1, 'A panoply of errors: polymerase proofreading domain mutations in cancer': 2, 'Replicative DNA polymerase mutations in cancer': 1, 'Exonuclease mutations in DNA polymerase epsilon reveal replication strand specific mutation patterns and human origins of replication': 1, 'New insights into POLE and POLD1 germline mutations in familial colorectal cancer and polyposis': 5, 'POLE and POLD1 mutations in 529 kindred with familial colorectal cancer and/or polyposis: review of reported cases and recommendations for genetic testing and surveillance': 4, 'Genetic diagnosis of high-penetrance susceptibility for colorectal cancer (CRC) is achievable for a high proportion of familial CRC by exome sequencing': 2, 'Genetic variants that predispose to DNA double-strand breaks in lymphocytes from a subset of patients with familial colorectal carcinomas': 1, 'DNA polymerase epsilon and delta exonuclease domain mutations in endometrial cancer': 1, 'Polymerase epsilon exonuclease domain mutations in ovarian endometrioid carcinoma': 1, 'Mutation spectrum of POLE and POLD1 mutations in South East Asian women presenting with Grade 3 endometrioid endometrial carcinomas': 1, 'Combined mismatch repair and POLE/POLD1 defects explain unresolved suspected Lynch syndrome cancers': 2, 'Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations': 1, 'Comprehensive molecular characterization of human colon and rectal cancer': 1, 'High fidelity and lesion bypass capability of human DNA polymerase delta': 2, 'Biallelic Mismatch Repair Deficiency': 1, 'Avalanching mutations in biallelic mismatch repair deficiency syndrome': 1, 'Ribonucleotide incorporation, proofreading and bypass by human DNA polymerase delta': 1, 'Association of polymerase e-mutated and microsatellite-instable endometrial cancers with neoantigen load, number of tumor-infiltrating lymphocytes, and expression of PD-1 and PD-L1': 1, 'POLE proofreading mutations elicit an antitumor immune response in endometrial cancer': 1, 'Hypermutation in human cancer genomes: footprints and mechanisms': 1, 'DNA damage in cancer therapeutics: a boon or a curse?': 1, 'DNA damage and the balance between survival and death in cancer biology': 1, 'Immune checkpoint inhibition for hypermutant glioblastoma multiforme resulting from germline biallelic mismatch repair deficiency': 1, 'Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non': 1, 'DNA polymerase epsilon and delta proofreading suppress discrete mutator and cancer phenotypes in mice': 3, 'Defective DNA polymerase-delta proofreading causes cancer susceptibility in mice': 1, 'High incidence of epithelial cancers in mice deficient for DNA polymerase delta proofreading': 1, 'Mutation at the polymerase active site of mouse DNA polymerase delta increases genomic instability and accelerates tumorigenesis': 2, 'DNA polymerase delta is required for early mammalian embryogenesis': 1, 'Active site mutations in mammalian DNA polymerase delta alter accuracy and replication fork progression': 1, 'Germline mutation rates and the long-term phenotypic effects of mutation accumulation in wild-type laboratory mice and mutator mice': 1, 'Targeting the DNA damage response in cancer': 1, 'Development and applications of CRISPR-Cas9 for genome engineering': 1, 'Engineered CRISPR-Cas9 nucleases with altered PAM specificities': 1, 'What the genetics of lipodystrophy can teach us about insulin resistance and diabetes': 1, 'Network screening of Goto-Kakizaki rat liver microarray data during diabetic progression': 1, 'Modulation of DNA polymerases alpha, delta and epsilon by lactate dehydrogenase and 3-phosphoglycerate kinase': 2, 'Enzymes of the central carbon metabolism: are they linkers between transcription, DNA replication, and carcinogenesis?': 1, 'Effects of partial silencing of genes coding for enzymes involved in glycolysis and tricarboxylic acid cycle on the enterance of human fibroblasts to the S phase': 1, 'The role of DNA exonucleases in protecting genome stability and their impact on ageing': 1, 'Obesity-associated inflammation induces microRNA-155 expression in adipocytes and adipose tissue: outcome on adipocyte function': 1, 'DNA damage response (DDR) and senescence: shuttled inflamma-miRNAs on the stage of inflamm-aging': 1, 'Bridging barriers to advance global sustainability': 2, 'Co-producing urban sustainability transitions knowledge with community, policy and science': 1, 'Transdisciplinary research in sustainability science: practice, principles, and challenges. Sustain Sci': 1, 'A critical evaluation of interventions to progress transdisciplinary research': 1, 'Analyzing interdisciplinarity: typology and indicators': 1, 'Interdisciplinary trends in higher education': 1, 'Evaluating an interdisciplinary research project: lessons learned for organisations, researchers and funders': 1, 'Disciplinary capture and epistemological obstacles to interdisciplinary research: lessons from central African conservation disputes': 1, 'Systems integration for global sustainability': 1, 'Forging future organizational leaders for sustainability science': 2, 'Meeting the leadership challenges for interdisciplinary environmental research': 1, 'The future of sustainability science: a solutions-oriented research agenda': 1, 'Sustainable LA Grand Challenge Five-Year Work Plan (Full Report)': 1, 'Practices for facilitating interdisciplinary synthetic research: the National Socio-Environmental Synthesis Center (SESYNC)': 1, 'Culturing food deserts: recognizing the power of community-based solutions': 1, 'Hurricane Sandy and adaptation pathways in New York: lessons from a first-responder city': 1, 'The scholars we need: preparing transdisciplinary professionals by leveraging the scholarship of practice': 1, 'A simplified approach to stakeholder engagement in natural resource management: the five-feature framework': 1, 'Design features for social learning in transformative transdisciplinary research': 1, 'Toward a science of transdisciplinary action research': 1, 'Sustainable universities: a study of critical success factors for participatory approaches': 1, 'Ideals, practices, and future prospects of stakeholder involvement in sustainability science': 1, 'Interlinking open science and community-based participatory research for socio-environmental issues': 1, 'A Transdisciplinary approach is essential to community-based research with american indian populations': 1, 'Co-creating formalized models: participatory modelling as method and process in transdisciplinary research and its impact potentials': 1, 'Science as social knowledge: values and objectivity in scientific inquiry': 1, 'Building better bridges: toward a transdisciplinary science communication': 1, 'The Millennium Ecosystem Assessment: testing the limits of interdisciplinary and multi-scale science': 1, 'The turning point: science, society, and the rising culture. Bantam Books, New York Caves LSD (2020) On the emergence of interdisciplinary culture: the York Centre for Complex Systems Analysis (YCCSA) and the TRANSIT Project BT from astrophysics to unconventional computation: essays presented to susan stepney on the occasion of her 60th birthday': 1, 'Building a cross-disciplinary culture in academia through joint hires, degree programs, and scholarships. Strategies for team science success': 1, \"Oxford Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations\": 1, 'Learning for transdisciplinary leadership: why skilled scholars coming together is not enough': 1, 'A methodology for evaluating transdisciplinary research on coupled socio-ecological systems': 1, 'Ten tips for developing interdisciplinary socio-ecological researchers': 1, 'Expertise in research integration and implementation for tackling complex problems: when is it needed, where can it be found and how can it be strengthened?': 1, 'Participatory evaluation for adaptive co-management of social-ecological systems: a transdisciplinary research approach': 1, \"Interdisciplinary and transdisciplinary research and practice: balancing expectations of the 'old' academy with the future model of universities as 'problem solvers\": 1, 'Large-scale transdisciplinary collaboration for adaptation research: challenges and insights': 1, 'Being an interdisciplinary academic: how institutions shape university careers': 1, 'What kind of a science is sustainability science?': 1, 'A typology of stakeholders and guidelines for engagement in transdisciplinary': 1, 'Linking transdisciplinary research characteristics and quality to effectiveness: a comparative analysis of five research-for-development projects': 1, 'Differential seroprevalence of human bocavirus species 1-4 in Beijing, China': 1, 'Allander T: Human bocavirus': 2, 'Human bocavirus quantitative DNA detection in French children hospitalized for acute bronchiolitis': 3, 'Human bocavirus in children: mono-detection, high viral load and viraemia are associated with respiratory tract infection': 4, 'Human bocavirus in patients with respiratory tract infection': 2, 'Detection of spliced mRNA from human bocavirus 1 in clinical samples from children with respiratory tract infections': 3, 'Respiratory viruses from hospitalized children with severe pneumonia in the Philippines': 1, 'Detection of human bocavirus and human metapneumovirus by real-time PCR from patients with respiratory symptoms in Southern Brazil': 1, 'High frequency of human bocavirus 1 DNA in infants and adults with lower acute respiratory infection': 1, 'Detection and quantitative analysis of human bocavirus associated with respiratory tract infection in Osaka City': 1, 'Human bocavirus, a respiratory and enteric virus. Emerg Infect Dis': 1, 'High human bocavirus viral load is associated with disease severity in children under five years of age': 3, 'Detection of respiratory syncytial virus fusion protein variants between 2009 and 2012 in China': 1, 'Simultaneous detection of fourteen respiratory viruses in clinical specimens by two multiplex reverse transcription nested-PCR assays': 2, 'Simultaneous detection of influenza A, B, and C viruses, respiratory syncytial virus, and adenoviruses in clinical samples by multiplex reverse transcription nested-PCR assay': 1, 'Use of an improved quantitative polymerase chain reaction assay to determine differences in human rhinovirus viral loads in different populations': 1, 'Real-time quantitative PCR detection of four human bocaviruses': 5, 'Correlation between nucleotide mutation and viral loads of human bocavirus 1 in hospitalized children with respiratory tract infection': 1, 'Human bocavirus infection diagnosed serologically among children admitted to hospital with community-acquired pneumonia in a tropical region': 2, 'Detection of human bocaviruses 1 to 4 from nasopharyngeal swab samples collected from patients with respiratory tract infections': 1, 'High viral load of human bocavirus correlates with duration of wheezing in children with severe lower respiratory tract infection': 4, 'Severe human bocavirus infection': 3, 'Newly identified respiratory viruses associated with acute lower respiratory tract infections in children in Lanzou': 1, 'Human bocavirus infections in hospitalized children and adults': 3, 'Bocavirus episome in infected human tissue contains non-identical termini': 4, 'Detection of human bocaviruses 1, 2 and 3 in Irish children presenting with gastroenteritis': 1, 'The human bocavirus is associated with some lung and colorectal cancers and persists in solid tumors': 3, 'Clinical assessment and improved diagnosis of bocavirus-induced wheezing in children': 1, 'Modeling mouse and human development using organoid cultures': 3, 'Cystic organoid teratoma: (Report of a Case)': 1, 'Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche': 3, 'Organogenesis in a dish: modeling development and disease using organoid technologies': 1, 'Modeling development and disease with organoids': 2, \"A guide to using functional magnetic resonance imaging to study Alzheimer's disease in animal models\": 1, 'The haplotype-resolved genome and epigenome of the aneuploid HeLa cancer cell line': 1, 'The limited in vitro lifetime of human diploid cell strains': 1, 'Intestinal epithelial stem cells and progenitors': 1, 'From 3D cell culture to organson-chips': 1, 'Sustained in vitro intestinal epithelial culture within a Wnt-dependent stem cell niche': 2, 'Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro': 1, 'Engineered human pluripotent-stem-cell-derived intestinal tissues with a functional enteric nervous system': 1, 'Neural crest cell implantation restores enteric nervous system function and alters the gastrointestinal transcriptome in human tissue-engineered small intestine': 1, 'Differentiated Troy+ chief cells act as reserve stem cells to generate all lineages of the stomach epithelium': 1, 'In vitro expansion of human gastric epithelial stem cells and their responses to bacterial infection': 4, 'Oncogenic transformation of diverse gastrointestinal tissues in primary organoid culture': 1, 'Co-culture of gastric organoids and immortalized stomach mesenchymal cells': 1, 'Development of definitive endoderm from embryonic stem cells in culture': 1, 'Efficient differentiation of human embryonic stem cells to definitive endoderm': 1, 'Modelling human development and disease in pluripotent stem-cellderived gastric organoids': 3, 'Generation of stomach tissue from mouse embryonic stem cells': 1, 'Wnt/betacatenin promotes gastric fundus specification in mice and humans': 2, 'Histological organization in hepatocyte organoid cultures': 1, 'In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration': 3, 'From pluripotency to differentiation: laying foundations for the body pattern in the mouse embryo': 1, 'Vertebrate endoderm development and organ formation': 1, 'Understanding kidney morphogenesis to guide renal tissue regeneration': 1, 'FGF7 is a functional niche signal required for stimulation of adult liver progenitor cells that support liver regeneration': 1, 'Tissue-specific mutation accumulation in human adult stem cells during life': 1, 'Vascularized and functional human liver from an IPSC-derived organ bud transplant': 2, 'Massive and reproducible production of liver buds entirely from human pluripotent stem cells': 1, 'Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation': 2, 'Lgr5(+) stem and progenitor cells reside at the apex of a heterogeneous embryonic hepatoblast pool': 2, 'Disease modeling and gene therapy of copper storage disease in canine hepatic organoids': 1, 'Generation and characterization of rat liver stem cell lines and their engraftment in a rat model of liver failure': 1, 'Chromosomal abnormalities in hepatic cysts point to novel polycystic liver disease genes': 1, 'Human primary liver cancer-derived organoid cultures for disease modeling and drug screening': 2, 'Organoid models of human liver cancers derived from tumor needle biopsies': 1, 'Directed differentiation of human induced pluripotent stem cells into functional cholangiocyte-like cells': 1, 'Inflammatory cytokine TNFalpha promotes the long-term expansion of primary hepatocytes in 3D culture': 1, 'Artificial three-dimensional niches deconstruct pancreas development in vitro': 1, 'Unlimited in vitro expansion of adult bi-potent pancreas progenitors through the Lgr5/Rspondin axis': 1, 'Organoid models of human and mouse ductal pancreatic cancer': 1, 'Expansion of adult human pancreatic tissue yields organoids harboring progenitor cells with endocrine differentiation potential': 1, 'Directed differentiation of human pluripotent stem cells into mature airway epithelia expressing functional CFTR protein': 1, 'In vitro generation of human pluripotent stem cell derived lung organoids': 1, 'A bioengineered niche promotes in vivo engraftment and maturation of pluripotent stem cell derived human lung organoids': 1, 'A three-dimensional model of human lung development and disease from pluripotent stem cells': 1, 'Basal cells as stem cells of the mouse trachea and human airway epithelium': 1, 'Dual SMAD signaling inhibition enables long-term expansion of diverse epithelial basal cells': 1, 'Lung stem cell differentiation in mice directed by endothelial cells via a BMP4-NFATc1-thrombospondin-1 axis': 1, 'Type 2 alveolar cells are stem cells in adult lung': 1, 'Recruited monocytes and type 2 immunity promote lung regeneration following pneumonectomy': 1, 'Human embryonic lung epithelial tips are multipotent progenitors that can be expanded in vitro as longterm self-renewing organoids': 1, 'Long-term expanding human airway organoids for disease modeling': 2, 'Growth in culture of trypsin dissociated thyroid cells from adult rats': 1, 'Generation of functional thyroid from embryonic stem cells': 1, 'Regeneration of thyroid function by transplantation of differentiated pluripotent stem cells': 1, 'Development of a functional thyroid model based on an organoid culture system': 1, 'Redefining the in vivo origin of metanephric nephron progenitors enables generation of complex kidney structures from pluripotent stem cells': 1, 'Directing human embryonic stem cell differentiation towards a renal lineage generates a self-organizing kidney': 1, 'Directed differentiation of human pluripotent cells to ureteric bud kidney progenitor-like cells': 1, 'Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis': 1, 'Three-dimensional cellular development is essential for ex vivo formation of human bone': 1, 'The Notch and Wnt pathways regulate stemness and differentiation in human fallopian tube organoids': 1, 'Long-term, hormone-responsive organoid cultures of human endometrium in a chemically defined medium': 1, 'Development of organoids from mouse and human endometrium showing endometrial epithelium physiology and long-term expandability': 1, 'Lumen formation by epithelial cell lines in response to collagen overlay: a morphogenetic model in culture': 1, 'Influence of a reconstituted basement membrane and its components on casein gene expression and secretion in mouse mammary epithelial cells': 1, 'Isolation, immortalization, and characterization of a human breast epithelial cell line with stem cell properties': 1, 'In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells': 1, 'Quantification of regenerative potential in primary human mammary epithelial cells': 1, 'Salivary gland development: a template for regeneration': 2, 'Overview of human salivary glands: highlights of morphology and developing processes': 1, 'Lineage tracing of the endoderm during oral development': 1, 'Self-organizing optic-cup morphogenesis in three-dimensional culture': 1, 'Self-formation of optic cups and storable stratified neural retina from human ESCs': 1, 'photoreceptor outer segment-like structures in long-term 3D retinas from human pluripotent stem cells': 1, 'In vitro differentiation of transplantable neural precursors from human embryonic stem cells': 1, 'Self-organized formation of polarized cortical tissues from ESCs and its active manipulation by extrinsic signals': 4, 'Modeling human cortical development in vitro using induced pluripotent stem cells': 2, 'Directed differentiation of telencephalic precursors from embryonic stem cells': 1, 'Self-organization of axial polarity, inside-out layer pattern, and species-specific progenitor dynamics in human ES cell-derived neocortex': 1, 'Generation of functional hippocampal neurons from self-organizing human embryonic stem cell-derived dorsomedial telencephalic tissue': 1, 'Midbrain-like organoids from human pluripotent stem cells contain functional dopaminergic and neuromelaninproducing neurons': 1, 'Self-formation of functional adenohypophysis in three-dimensional culture': 1, 'Functional anterior pituitary generated in selforganizing culture of human embryonic stem cells': 1, 'Self-organization of polarized cerebellar tissue in 3D culture of human pluripotent stem cells': 1, 'Assembly of functionally integrated human forebrain spheroids': 1, 'Fused cerebral organoids model interactions between brain regions': 1, 'Fusion of regionally specified HPSC-derived organoids models human brain development and interneuron migration': 1, 'Cell diversity and network dynamics in photosensitive human brain organoids': 1, 'Generation of inner ear organoids containing functional hair cells from human pluripotent stem cells': 1, 'Rectal organoids enable personalized treatment of cystic fibrosis': 1, 'FOXG1-dependent dysregulation of GABA/glutamate neuron differentiation in autism spectrum disorders': 1, 'Human IPSC-derived cerebral organoids model cellular features of lissencephaly and reveal prolonged mitosis of outer radial Glia': 1, 'An organoid-based model of cortical development identifies non-cell-autonomous defects in Wnt signaling contributing to Miller-Dieker syndrome': 1, 'Identification and correction of mechanisms underlying inherited blindness in human IPSCderived optic cups': 1, 'Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay': 1, 'Systematic identification of genomic markers of drug sensitivity in cancer cells': 1, 'Genetic and transcriptional evolution alters cancer cell line drug response': 1, 'The secret lives of cancer cell lines': 1, 'Isolation and in vitro expansion of human colonic stem cells': 1, 'Tumor organoids as a pre-clinical cancer model for drug discovery': 1, 'Personalized in vitro and in vivo cancer models to guide precision medicine': 1, 'A comprehensive human gastric cancer organoid biobank captures tumor subtype heterogeneity and enables therapeutic screening': 1, 'Mouse and human urothelial cancer organoids: a tool for bladder cancer research': 1, 'Replication of human noroviruses in stem cell-derived human enteroids': 2, 'Modelling Cryptosporidium infection in human small intestinal and lung organoids': 1, 'Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus': 1, 'Differentiated human airway organoids to assess infectivity of emerging influenza virus': 1, 'Modeling infectious diseases and host-microbe interactions in gastrointestinal organoids': 1, 'Stem cellderived models of viral infections in the gastrointestinal tract': 1, 'Disease modeling in stem cell-derived 3D organoid systems': 2, 'Zika virus impairs growth in human neurospheres and brain organoids': 1, 'The Brazilian Zika virus strain causes birth defects in experimental models': 1, 'Brain-regionspecific organoids using mini-bioreactors for modeling ZIKV exposure': 1, 'The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication': 1, 'Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen': 1, '25-hydroxycholesterol protects host against Zika virus infection and its associated microcephaly in a mouse model': 1, 'The CRISPR tool kit for genome editing and beyond': 1, 'Crispr-Cas systems for editing, regulating and targeting genomes': 1, 'Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients': 1, 'CRISPR/Cas 9 genome editing and its applications in organoids': 1, 'Sequential cancer mutations in cultured human intestinal stem cells': 1, 'Modeling colorectal cancer using Crispr-Cas9-mediated engineering of human intestinal organoids': 1, 'Use of Crisprmodified human stem cell organoids to study the origin of mutational signatures in cancer': 1, 'Probing the tumor suppressor function of BAP1 in Crispr-engineered human liver organoids': 1, 'Genetically engineered cerebral organoids model brain tumor formation': 1, 'Vascularized and complex organ buds from diverse tissues via mesenchymal cell-driven condensation': 1, 'An in vivo model of functional and vascularized human brain organoids': 1, 'Flowenhanced vascularization and maturation of kidney organoids in vitro': 1, 'A method to recapitulate early embryonic spatial patterning in human embryonic stem cells': 1, 'Guided selforganization and cortical plate formation in human brain organoids': 1, 'Engineering induction of singular neural rosette emergence within HPSC-derived tissues': 1, 'Human brain organoids on a chip reveal the physics of folding': 1, 'Organ/body-on-a-chip based on microfluidic technology for drug discovery': 1, 'Wuhan Novel Coronavirus': 2, 'Flights Carrying Roughly 300 Coronavirus Evacuees Scheduled to Arrive in US, 31,400 Infected Globally | Fox News': 1, 'Joining Hands to Fight the 2019-nCov Epidemic. The Jakarta Post': 1, 'Not a virus, but an upgrade\": The ethics of epidemic evolution in Greg Bear\\'s Darwin\\'s Radio': 1, 'Novel Coronavirus (2019-nCoV) Situation Reports. Available from': 5, 'The Effect of Travel Restrictions on the Domestic Spread of the Wuhan Coronavirus 2019-nCov': 1, 'Economic impacts of Wuhan 2019-nCoV on China and the world': 5, 'Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: A modelling study': 1, \"Inside Wuhan's lockdown\": 1, 'Daily Briefing on Novel Coronavirus Cases in China': 1, 'Coronavirus Carrier Faces Jail in Singapore for Lying Over Movements. The Jakarta Post': 1, 'who-director-general-s-opening-remarks-at-the-mission-briefingon-covid': 1, 'Nigeria Confirms First Coronavirus Case': 1, 'First Death from Coronavirus in the United States Confirmed in Washington State -CNN': 1, 'Novel coronavirus, poor quarantine, and the risk of pandemic': 1, 'Outbreak of coronavirus disease 2019': 1, 'Estimated effectiveness of traveller screening to prevent international spread of 2019 novel coronavirus (2019-nCoV)': 1, 'Early containment strategies and core measures for prevention and control of novel coronavirus pneumonia in China': 1, \"14% of Recovered Coronavirus Patients in China's Guangdong Tested Positive Again. The Straits Times\": 1, 'Ethics of outbreaks position statement. Part 2: family-centered care': 1, 'Reflections on the Ebola public health emergency of international concern, Part 2: The unseen epidemic of posttraumatic stress among health-care personnel and survivors of the 2014-2016 Ebola outbreak': 1, 'SARS control and psychological effects of quarantine': 1, 'Telemedicine: A new health care delivery system': 1, 'Telemedicine improved diabetic management': 1, 'A randomized trial of telemedicine-based collaborative care for depression': 1, 'Telemedicine can lower costs and improve access': 1, 'Telemedicine: A cost-reducing means of delivering psychotherapy to rural combat veterans with PTSD': 1, 'Use of telemedicine in evading cholera outbreak in Mahakumbh Mela, Prayag, UP, India: An encouraging experience': 1, 'Telemedicine: Potential applications in epidemic situations': 1, 'Cost-effectiveness analysis of hospital infection control response to an epidemic respiratory virus threat': 1, 'Stockpile of personal protective equipment in hospital settings: Preparedness for influenza pandemics': 1, 'Telemedicine Use Decreases Rural Emergency Department Length of Stay for Transferred North Dakota Trauma Patients': 1, 'Does Telemedicine Reduce ED Congestion? Evidence from New York State: HICSS': 2, 'Reducing Emergency Department Utilization Through Engagement in Telemedicine by Senior Living Communities': 1, 'Does a mandatory telemedicine call prior to visiting a physician reduce costs or simply attract good risks?': 1, 'Appropriateness of disposition following telemedicine consultations in rural emergency departments': 1, 'Potential of telemedicine to provide acute medical care for adults in senior living communities': 1, \"Academic College of Emergency Experts in India's INDO-US Joint Working Group and OPUS12 Foundation Consensus Statement on Creating A Coordinated, Multi-Disciplinary, Patient-Centered, Global Point-of-Care Biomarker Discovery Network\": 1, 'The Emergence of Zika Virus as a Global Health Security Threat: A Review and a Consensus Statement of the INDUSEM Joint working Group (JWG)': 1, 'Tracking the spatial diffusion of influenza and norovirus using telehealth data: A spatiotemporal analysis of syndromic data': 1, 'Telemedicine Emerging as a First Line of Defense during Flu Season. Physicians Practice': 1, 'Application of Telemedicine in Acute-Onset Disaster Situations': 1, 'Smart-TV Based Integrated E-Health Monitoring System with Agent Technology': 1, 'Using TV white space spectrum to practise telemedicine: A promising technology to enhance broadband internet connectivity within healthcare facilities in rural regions of developing countries': 1, \"Israel's Sheba Hospital Turns to Telehealth to Treat Incoming Coronavirus-Exposed Patients. MobiHealthNews; 2020\": 2, 'Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese center for disease control and prevention': 1, 'Potential Maternal and Infant Outcomes from (Wuhan) Coronavirus 2019-nCoV Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections': 1, 'Covid-19 -Navigating the Uncharted': 1, 'First Case of 2019 Novel Coronavirus in the United States': 3, \"Italy's Elderly Suffer Heavy Toll as Coronavirus Spreads-The New York Times\": 1, 'Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study': 5, \"Experts Envision Two Scenarios if New Coronavirus isn't Contained. STAT; 2020\": 1, 'Clinical signs and symptoms of mucucutaneous lymph node syndrome': 2, 'Outbreak of Kawasaki syndrome in Finland': 1, 'The TTRSs: 13 constraints for dimensioning and tolerancing': 2, 'An integrated view of geometrical product specification and verification': 1, 'A novel coronavirus emerging in China-key questions for impact assessment': 1, 'Coronavirus infections-more than just the common cold': 1, 'World Health Organization. Novel Coronavirus (2019-nCoV) situation reports': 1, 'Coronaviruses: an overview of their replication and pathogenesis': 3, 'A major outbreak of severe acute respiratory syndrome in Hong Kong': 3, 'Middle East respiratory syndrome': 4, 'Superspreading sars events': 2, 'MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study': 2, 'Clinical and epidemiologic characteristics of spreaders of Middle East respiratory syndrome coronavirus during the 2015 outbreak in Korea': 2, 'Open source clinical science for emerging infections': 1, 'Pan American Health Organization/WHO (2014) Operational guidelines for sentinel severe acute respiratory infection (SARI) surveillance': 2, 'Microbial aetiology of community-acquired pneumonia and its relation to severity': 1, 'Climate change and infectious diseases: from evidence to a predictive framework': 1, 'Macrolidebased regimens in absence of bacterial co-infection in critically ill H1N1 patients with primary viral pneumonia': 1, 'Impact of Candida spp. isolation in the respiratory tract in patients with intensive care unitacquired pneumonia': 1, 'Towards a sensible comprehension of severe community-acquired pneumonia': 1, 'Communityacquired respiratory coinfection in critically ill patients with pandemic 2009 influenza A(H1N1) virus': 1, 'Procalcitonin (PCT) levels for ruling-out bacterial coinfection in ICU patients with influenza: a CHAID decision-tree analysis': 1, 'Evaluation of two influenza surveillance systems in South Africa': 1, 'Pandemic and postpandemic influenza A (H1N1) infection in critically ill patients': 1, 'Surveillance for severe acute respiratory infections (SARI) in hospitals in the WHO European region-an exploratory analysis of risk factors for a severe outcome in influenza-positive SARI cases': 1, 'Ventilatorassociated events: prevalence, outcome, and relationship with ventilatorassociated pneumonia': 1, \"Complications of mechanical ventilation-the CDC's new surveillance paradigm\": 1, 'Identification of a third human polyomavirus': 1, 'Identification of a novel polyomavirus from patients with acute respiratory tract infections': 1, 'Seroepidemiology of human polyomaviruses': 2, 'Serological evidence of frequent human infection by the WU and KI polyomaviruses': 2, 'Reactivation and mutation of newly discovered WU, KI, and Merkel cell carcinoma polyomaviruses in immunosuppressed individuals': 1, 'Polyomaviruses KI and WU in immunocompromised patients with respiratory disease': 2, 'Prevalence and clinical impact of polyomaviruses KI and WU in lung transplant recipients': 1, 'Incidence of occupational exposures in a tertiary health care center': 1, 'Updated US Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis': 1, 'Occupational exposure to blood and body fluids among health care workers in a general hospital, China': 1, 'Occupational exposure to HIV among health care providers: a qualitative study in Yunnan': 1, 'Sociocognitive determinants of observed and self-reported compliance to hand hygiene guidelines in child day care centers': 1, \"Healthcare workers' compliance with universal precautions in Turkey\": 1, 'China Ministry of Health. Rules to be in charge of hospitals by grade (RCG). Beijing, China: Ministry of Health': 1, 'Covid-19: four fifths of cases are asymptomatic, China figures indicate': 3, 'Characteristics of Hospitalized Adults With COVID-19 in an Integrated Health Care System in California': 3, 'Covid-19 in Critically Ill Patients in the Seattle Region -Case Series': 2, 'Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the': 2, 'Is low dose radiation therapy a potential treatment for COVID-19 pneumonia?': 2, 'Roentgen therapy of \"virus\" pneumonia': 1, 'Primary atypical pneumonia; analysis of therapeutic results in 155 cases': 1, 'The effect of roentgen therapy on experimental virus pneumonia; on feline virus pneumonia': 2, 'The effect of roentgen therapy on experimental virus pneumonia; on pneumonia produced in white mice by swine influenza virus': 2, 'National Academy of Sciences Committee on the Biological Effects of Radiation. Health risks from exposure to low levels of ionizing radiation': 2, 'United Nations Scientific Committee on the Effects of Atomic Radiation. Sources and effects of ionizing radiation UNSCEAR 2006 Report to the general assembly, with scientific annexes': 2, 'Space radiation risks for astronauts on multiple International Space Station missions': 2, 'Space radiation cancer risk projections and uncertainties-2012. NASA TP 2013-217375': 2, 'Risk of ischemic heart disease in women after radiotherapy for breast cancer': 1, 'Systematic review and meta-analysis of circulatory disease from exposure to low-level ionizing radiation and estimates of potential population mortality risks. Environ Health Perspect': 2, 'Do Patients with Cancer Have a Poorer Prognosis of COVID-19? An Experience': 1, 'Inhibition of Japanese encephalitis virus infection by nitric oxide: antiviral effect of nitric oxide on RNA virus replication': 1, 'Interferon, ribavirin, 6-azauridine, and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses': 2, 'Induction of inducible nitric oxide synthase expression by 18␤-glycyrrhetinic acid in macrophages': 1, 'Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study': 1, 'Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records': 2, 'H1N1 2009 influenza virus infection during pregnancy in the USA': 1, 'Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome': 1, \"COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis\": 1, 'Clinical Management of Severe Acute Respiratory Infection When COVID-19 Is': 1, 'Implications for the pregnant patient': 1, \"The mystery of the pandemic's 'happy hypoxia\": 1, 'A Review of Coronavirus Disease-2019 (COVID-19)': 2, 'COVID-19 cytokine storm: the interplay between inflammation and coagulation': 1, 'Disseminated Intravascular Coagulation': 1, 'Clinical features and outcomes of pregnant women suspected of coronavirus disease 2019': 1, 'Pregnancy and thrombotic risk': 1, 'Hemodynamic changes in pregnancy': 1, 'Pregnancy: a stress test for life': 1, 'Cardiovascular complications in COVID': 2, 'Two cases of coronavirus 2019-related cardiomyopathy in pregnancy': 1, 'Cardiovascular disease and COVID-19': 1, 'Hepatic and gastrointestinal involvement in coronavirus disease 2019 (COVID-19): What do we know till now?': 1, 'The Novel Coronavirus 2019 epidemic and kidneys': 1, 'Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations': 2, 'Covid-19 in critically ill patients in the Seattle region -case series': 1, 'Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region': 4, \"Intubation and ventilation amid the COVID-19 outbreak: Wuhan's experience\": 6, \"Covid-19: doctors' leaders warn that staff could quit and may die over lack of protective equipment\": 1, 'Emergency tracheal intubation in 202 patients with COVID-19 in Wuhan, China: lessons learnt and international expert recommendations': 3, 'The Italian coronavirus disease 2019 outbreak: recommendations from clinical practice': 3, 'Consensus guidelines for managing the airway in patients with COVID-19: guidelines from the Difficult Airway Society, the Association of Anaesthetists the Intensive Care Society, the Faculty of Intensive Care Medicine and the Royal College of Anaesthetists': 1, 'Consensus statement: safe Airway Society principles of airway management and tracheal intubation specific to the COVID-19 adult patient group': 1, 'Mental health care for medical staff in China during the COVID-19 outbreak': 1, 'False negative tests for SARS-CoV-2 infection-challenges and implications': 1, 'Preventing infection of patients and healthcare workers should be the new normal in the era of novel coronavirus epidemics': 1, 'Case for continuing community NIV and CPAP during the COVID-19 epidemic': 1, 'The severe acute respiratory syndrome coronavirus in tears': 1, 'Conjunctiva-upper respiratory tract irrigation for early diagnosis of severe acute respiratory syndrome': 1, 'World Health Organization. Global Age-friendly Cities: A Guide; World Health Organization': 4, 'What makes a community age-friendly: A review of international literature': 2, 'Exploring the age-friendliness of purpose-built retirement communities: Evidence from England': 2, \"Evolving images of place in aging and 'aging-in-place\": 1, 'How Should We Tackle the Loneliness Epidemic': 1, 'Is Loneliness a Health Epidemic': 1, 'Lonely older people as a problem in society-Construction in Finnish media': 1, \"Prime Minister's Office; Office for Civil Society; The Rt Hon Theresa May MP. PM Commits to Government-Wide Drive to Tackle Loneliness\": 1, 'The firekeepers: Aging considered as a resource': 1, 'Never too old': 1, 'Older voices: Supporting community radio production for civic participation in later life': 1, 'Researching Age-Friendly Communities: Stories from Older People as Co-Investigators': 1, 'An age-old problem: Examining the discourses of ageing in HCI and strategies for future research': 2, 'Friends or Frenemies? The Role of Social Technology in the Lives of Older People': 2, 'An investigation into the patterns of loneliness and loss in the oldest old-Newcastle 85+ Study': 1, 'Being alone in later life: Loneliness, social isolation and living alone': 1, 'The high cost of isolation': 1, 'The Social Connectedness of Older Adults: A National Profile': 1, 'The Importance of Social Connectedness in Building Age-Friendly Communities': 1, 'Assistive technology, computers and Internet may decrease sense of isolation for homebound elderly and disabled persons': 1, 'Ethnographic Research on the Experience of Japanese Elderly People Online': 1, 'Tales of the map of my mobile life: Intergenerational computer-mediated communication between older people and fieldworkers in their early adulthood': 3, 'Multimodal Computer-Mediated Communication and Social Support among Older Chinese Internet Users': 1, 'Desiring to be in touch in a changing communications landscape': 3, 'Tsunagari-kan\" Communication: Design of a New Telecommunication Environment and a Field Test with Family Members Living Apart': 1, 'Keeping in Touch: Talking to Older People about Computers and Communication': 2, \"Older people's use of social network sites while participating in local online communities from an ethnographical perspective\": 2, 'Age-friendly cities and communities: A manifesto for change': 1, \"Ageing in urban environments: Developing 'age-friendly' cities\": 1, 'The WHO Global Network of Age-Friendly Cities and Communities: Origins, Developments and Challenges. In Age-Friendly Cities and Communities in International Comparison': 1, 'Interviewing for Social Scientists': 1, 'Office for National Statistics': 1, 'Research Interviewing: Context and Narrative': 1, 'Using thematic analysis in psychology': 5, 'Les villes amies des aînés au Québec: Un mouvement de changement à large échelle en faveur des aînés': 1, 'Experiences of Place and Neighbourhood in Later Life: Developing Age-Friendly Communities': 2, 'Not for me: Older adults choosing not to participate in a social isolation intervention': 1, \"Who Doesn't Think about Technology When Designing Urban Environments for Older People?\": 1, \"Managing loneliness: A qualitative study of older people's views\": 2, 'An Alternative Age-Friendly Handbook': 1, 'Later Life Audio and Radio Network': 1, 'Proceedings of the 2016 CHI Conference on Human Factors in Computing Systems': 1, 'Good Practice Guide: Transport and Social Inclusion': 1, 'The PARP superfamily': 1, 'Poly(ADP-ribose): novel functions for an old molecule': 3, 'The histone variant macroH2A interferes with transcription factor binding and SWI/SNF nucleosome remodeling': 1, 'The histone variant mH2A1.1 interferes with transcription by down-regulating PARP-1 enzymatic activity': 1, 'Poly(ADP-ribose) Polymerase 1 is inhibited by a histone H2A variant, Macroh2a, and contributes to silencing of the inactive X chromosome': 1, 'The macro domain is an ADP-ribose binding module': 2, 'Structural and functional basis for ADP-ribose and poly-(ADP-ribose) binding by viral macro domains': 1, 'BAL is a novel risk-related gene in diffuse large B-cell lymphomas that enhances cellular migration': 2, 'BAL1 and BBAP are regulated by a gamma interferon-responsive bidirectional promoter and are overexpressed in diffuse large B-cell lymphomas with a prominent inflammatory infiltrate': 11, 'Selective potentiation of Stat-dependent gene expression by collaborator of Stat6 (CoaSt6), a transcriptional cofactor': 2, 'Collaborator of Stat6 (CoaSt6)-associated Poly(ADP-ribose) Polymerase Activity Modulates Stat6-dependent Gene Transcription': 1, 'The BAL-binding protein BBAP and related Deltex family members exhibit ubiquitin-protein isopeptide ligase activity': 1, 'Notch signaling: cell fate control and signal integration in development': 1, 'B-aggressive lymphoma (BAL) family proteins have unique domains that modulate transcription and exhibit Poly(ADP-ribose) polymerase activity': 2, 'Poly(ADP-ribose) polymerase-2 (PARP-2) is required for efficient base excision DNA repair in association with PARP-1 and XRCC1': 3, 'Organizing cell renewal in the intestine: stem cells, signals and combinatorial control': 1, 'Distinct gene expression profiles characterize cellular phenotypes of follicle-associated epithelium and m cells': 2, 'IL-4-induced STAT6 suppresses IFN-gammastimulated STAT1-dependent transcription in mouse macrophages': 1, 'Reproductive failure of unknown etiology': 1, 'Assessment of the economic impact of porcine reproductive and respiratory syndrome on swine production in the United States': 1, 'Isolation of swine infertility and respiratory syndrome virus (isolate ATCC VR-2332) in North America and experimental reproduction of the disease in gnotobiotic pigs': 6, 'North American and European porcine reproductive and respiratory syndrome viruses differ in non-structural protein coding regions': 4, 'Porcine reproductive and respiratory syndrome virus comparison: divergent evolution on two continents': 4, 'Pathogenic viruses: smart manipulators of the interferon system': 1, 'Interferons and viruses: an interplay between induction, signaling, antiviral responses and virus countermeasures': 2, 'Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome': 1, 'Inverse interference: how viruses fight the interferon system': 2, 'vivo and in vitro interferon (IFN) studies with the porcine reproductive and respiratory syndrome virus (PRRSV)': 1, 'Recombinant swine beta interferon protects swine alveolar macrophages and MARC-145 cells from infection with porcine reproductive and respiratory syndrome virus': 1, 'Deciphering the involvement of innate immune factors in the development of the host responses to PRRSV vaccination': 2, 'Gradual development of the interferon-gamma response of swine to porcine reproductive and respiratory syndrome virus infection or vaccination': 1, 'Interferon type I response in porcine reproductive and respiratory syndrome virus-infected MARC-145 cells': 2, 'Porcine reproductive and respiratory syndrome virus (PRRSV) suppresses interferon-β production by interfering with the RIG-I signaling pathway': 3, 'The molecular biology of arteriviruses': 4, 'Cross-reactive antibody responses to nsp1 and nsp2 of porcine reproductive and respiratory syndrome virus': 5, 'Full-length sequence of a Canadian porcine reproductive and respiratory syndrome virus (PRRSV) isolate': 1, 'Virus-encoded proteinases and proteolytic processing in the Nidovirales': 5, 'Crystal structure of porcine reproductive and respiratory syndrome virus (PRRSV) leader protease Nsp1{alpha}': 2, 'Nuclear localization of non-structural protein 1 and nucleocapsid protein of equine arteritis virus': 2, 'Mutations in the NS1 protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs': 2, 'Mda-5, but not RIG-1, is a common target for paramixovirus V proteins': 1, 'The hepatitis C virus NS3/4A protease complex interferes with pathways of the innate immune response': 1, 'Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF': 1, 'The NPro product of bovine viral diarrhea virus inhibits DNA binding by interferon regulatory factor 3 and targets it for proteasomal degradation': 1, 'Classical swine fever virus Npro interacts with interferon regulatory factor 3 and induces its proteasomal degradation': 1, 'Ubiquitination and proteasomal degradation of interferon regulatory factor-3 induced by Npro from a cytopathic bovine viral diarrhea virus': 1, 'The Npro product of classical swine fever virus and bovine viral diarrhea virus uses a conserved mechanism to target interferon regulatory factor-3': 1, 'Thogoto virus ML protein suppresses IRF3 function': 1, 'Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain': 4, 'Ovarian tumor domain-containing viral proteases evade ubiquitin-and ISG15-dependent innate immune responses': 1, 'Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists': 4, 'Hemagglutinating virus of Japanliposome mediated gene delivery to vascular cells': 1, 'Antibody response of nonstructural proteins: implication for diagnostic detection and differentiation of Type I and Type II porcine reproductive and respiratory syndrome virus': 1, 'Production and characterization of monoclonal antibodies against the nucleocapsid protein of severe acute respiratory syndrome coronavirus (SARS-CoV)': 1, 'A 10-kDa structural protein of porcine reproductive and respiratory syndrome virus encoded by ORF 2b': 2, 'Inhibition of interferon signaling by dengue virus': 1, 'Autocrine amplification of type I interferon gene expression mediated by interferon stimulated gene factor 3 (ISGF3)': 1, 'Bovine parainfluenza virus type 3 accessory proteins that suppress beta interferon production': 1, 'Triggering the interferon response: the role of IRF-3 transcription factor': 1, 'Strategies and challenges for the next generation of therapeutic antibodies': 1, 'High level production of a kringle domain variant by high-cell-density cultivation of Escherichia coli': 1, 'Advances in the production of human monoclonal antibodies': 1, 'Selecting and screening recombinant antibody libraries': 1, 'Synthetic therapeutic antibodies': 1, 'Yeast surface display for screening combinatorial polypeptide libraries': 4, 'Applications of display technology in protein analysis': 1, 'Targeting recombinant antibodies to the surface of E. coli: Fusion to a peptidoglycan associated lipoprotein': 2, 'Isolation of high-affinity ligand-binding proteins by periplasmic expression with cytometric screening (PECS)': 4, 'Separation of E. coli expressing functional cell-wall bound antibody fragments by FACS': 2, 'Anchored periplasmic expression, a versatile technology for the isolation of highaffinity antibodies from Escherichia coli-expressed libraries': 4, 'Development of an optimized expression system for the screening of antibody libraries displayed on the E. coli surface': 2, 'Nanogap field-effect transistor biosensors for electrical detection of avian influenza': 2, 'Label-free optical diagnosis of hepatitis B virus with genetically engineered fusion proteins': 2, 'High-yield production of the VP1 structural protein epitope from serotype O foot-andmouth disease virus in Escherichia coli': 2, 'Directed evolution of a G protein-coupled receptor for expression, stability, and binding selectivity': 1, 'Universal Genetic Assay for Engineering Extracellular Protein Expression': 2, 'Kabat database and its applications: 30 years after the first variability plot': 1, 'Simultaneous mutagenesis of antibody CDR regions by overlap extension and PCR': 1, 'A vector for the removal of deletion mutants from antibody libraries': 1, 'Secretory production of recombinant protein by a high cell density culture of a protease negative mutant Escherichia coli strain': 1, 'Development of human anti-murine antibody (HAMA) response in patients': 1, 'The immunogenicity of humanized and fully human antibodies: residual immunogenicity resides in the CDR regions': 1, 'Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides': 2, 'Construction of a large synthetic human scFv library with six diversified CDRs and high functional diversity': 1, 'Biophysical properties of human antibody variable domains': 1, 'Rapid construction and characterization of synthetic antibody libraries without DNA amplification': 1, 'Recombining germline-derived CDR sequences for creating diverse singleframework antibody libraries': 1, 'A novel synthetic naïve human antibody library allows the isolation of antibodies against a new epitope of oncofetal fibronectin': 1, 'Flow cytometric screening of cellbased libraries': 1, 'APEx 2-hybrid, a quantitative protein-protein interaction assay for antibody discovery and engineering': 1, 'Circular polymerase extension cloning for highthroughput cloning of complex and combinatorial DNA libraries': 1, 'Isolation and expression of recombinant antibody fragments to the biological warfare pathogen Brucella melitensis': 1, 'Tocilizumab treatment in COVID-19: a single center experience': 1, 'The Sequence Alignment/Map format and SAMtools': 2, 'IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies': 1, 'The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity': 2, 'Genomic diversity and hotspot mutations in 30,983 SARS-CoV-2 genomes: moving toward a universal vaccine for the \"confined virus': 1, 'Large scale genomic analysis of 3067 SARS-CoV-2 genomes reveals a clonal geo-distribution and a rich genetic variations of hotspots mutations': 1, 'Smallpox: the death of a disease': 1, 'House on fire: the fight to eradicate smallpox': 1, 'The origin of AIDS': 1, 'The Great Influenza: the story of the deadliest pandemic in history. Viking, Penguin Books': 1, 'From emergence to eradication: the epidemiology of poliomyelitis deconstructed': 1, 'A unifying role for prions in neurodegenerative diseases': 1, 'Deadly Choices: How the Anti-Vaccine Movement Threatens Us All': 1, 'Observations made during the epidemic of measles on the Faroe Islands in the year 1846': 1, 'Airborne transmission of influenza A/H5N1 virus between ferrets': 1, 'Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets': 1, 'Impact of rumors or misinformation on coronavirus disease (COVID-19) in social media': 2, 'Evaluation of symptom checkers for self diagnosis and triage: audit study': 2, 'Digital and online symptom checkers and assessment services for urgent care to inform a new digital platform: a systematic review': 2, \"I asked eight chatbots whether I had Covid-19. The answers ranged from 'low' risk to 'start home isolation\": 1, 'Report of the WHO-china joint mission on coronavirus disease 2019 (covid-19). 2020': 2, 'From symptom to diagnosis-symptom checkers re-evaluated : Are symptom checkers finally sufficient and accurate to use?': 1, 'Accuracy of a Computer-Based Diagnostic Program for Ambulatory Patients With Knee Pain': 1, 'A study of automated self-assessment in a primary care student health centre setting': 1, 'Older adult experience of online diagnosis: results from a scenario-based think-aloud protocol': 1, 'Artificial intelligence versus clinicians: systematic review of design, reporting standards, and claims of deep learning studies': 1, 'A survey of virus infections of the respiratory tract of cattle and their association with disease': 1, 'Severe respiratory disease in dairy cows caused by infection with bovine respiratory syncytial virus': 1, 'Bovine respiratory syncytial virus': 1, 'Evolution of bovine respiratory syncytial virus': 2, 'Comparison of targeting F and G protein genes to detect bovine and ovine respiratory syncytial viruses': 1, 'Evaluation of a nested reverse transcription-PCR assay based on the nucleoprotein gene for diagnosis of spontaneous and experimental bovine respiratory syncytial virus infections': 2, 'A comparison of diagnostic methods for the detection of bovine respiratory syncytial virus in experimental clinical specimens': 4, 'Local and systemic antibody response to bovine respiratory syncytial virus infection and reinfection in calves with and without maternal antibodies': 1, 'Diagnosis of enzootic pneumonia in Danish cattle: reverse transcription-polymerase chain reaction assay for detection of bovine respiratory syncytial virus in naturally and experimentally infected cattle': 2, 'Identifying bovine respiratory syncytial virus by reverse transcription-polymerase chain reaction and oligonucleotide hybridizations': 1, 'Development of nested PCR assays for detection of bovine respiratory syncytial virus in clinical samples': 2, 'Molecular diagnosis of animal diseases: some experiences over the past decade': 2, 'An experimental infection model for reproduction of calf pneumonia with bovine respiratory syncytial virus (BRSV) based on one combined exposure of calves': 1, 'Detection of all seven serotypes of foot-andmouth disease virus by real-time, fluorogenic reverse transcription polymerase chain reaction assay': 1, 'Sites of replication of bovine respiratory syncytial virus in naturally infected calves as determined by in situ hybridization': 1, 'Cytokine responses of bovine dendritic cells and T cells following exposure to live or inactivated bovine respiratory syncytial virus': 1, 'Quantitation of respiratory syncytial virus RNA in nasal aspirates of children by real-time RT-PCR assay': 1, 'Evidence based health promotion: recollections, reflections, and reconsiderations': 1, 'The unbearable lightness of healthcare policy making: a description of a process aimed at giving it some weight': 1, 'Dictionary On-Line': 1, 'Barriers and bridges to evidence based clinical practice': 1, 'Oxfordshire (UK): CAB International': 3, 'Centre for Global eHealth Innovation. The Global eHealth Innovation Network. Ontario, Canada: Centre for Global eHealth Innovation': 3, 'Knowledge acquisition, dissemination and application': 3, 'The Knowledge Management Forum': 4, 'Enhancing the uptake of research knowledge in health policy. Presentation slides': 3, 'Canada: Canadian Health Services Research Foundation': 2, 'Knowledge transfer and exchange. Toronto, Canada: Institute for Work and Health': 2, \"NIDRR's long range plan -knowledge dissemination and utilization\": 2, 'Getting the right knowledge to the right people at the right time: an invitational roundtable on knowledge transfer. Ottawa, Canada: Health Canada': 1, 'Epidemiologic design options for health risk studies on dental amalgam': 1, 'Concepts of modern risk assessment and management': 1, 'Levels of evidence and grades of recommendation': 1, 'Health insight -take charge of health information': 1, 'Perspectives on epidemiologic surveillance in the 21 st century': 5, 'Mobile phone -brain tumor risk in the limelight again: focus on Swedish and U.S. epi studies. New York: Microwave News': 1, 'Bias, overview': 2, 'Hypothesis Testing, Type I and Type II Errors': 1, 'A dictionary of epidemiology': 2, 'Reducing variability in treatment decision making: effectiveness of educating clinicians about uncertainty': 1, 'Cell type identification in leukemia: the level of agreement among four independent diagnostic methods': 1, 'A catalog of biases in questionnaires': 1, 'Look before you leap: stratify before you standardize': 1, 'Modern epidemiology': 1, 'Mass screening for rectal neoplasm in Jiashan County': 2, 'Problems of spectrum and bias in evaluating the efficacy of diagnostic tests': 1, 'Sensitivity and specificity of a single diagnostic test in the presence of work-up bias': 1, 'Guides for reading and interpreting systematic reviews': 4, 'Evidencebased medicine': 1, 'Bridging the gap between scientists and decision makers': 1, 'Meta-analysis. Potentials and promise': 2, 'Systematic review of near patient test evaluations in primary care': 1, 'What are the most effective ways of improving population health through transport interventions? Evidence from systematic reviews': 1, 'Meta-analysis: principles and procedures': 1, 'World Wide Web electronic publication. Glossary Searched Term: Metadatabase': 1, 'Committee of Officials for the Ministers Responsible for Seniors. An inventory of Canadian programs for the prevention of falls among seniors living in the community. Ottawa, Canada: Health Canada': 1, 'What is a public health observatory?': 1, 'Lessons for surveillance in the 21 st century: a historical perspective from the past 5 millennia': 1, 'Two information dissemination approaches for public health decision-makers: encyclopaedia and fire alarm': 1, 'Understanding the basic concepts of public health surveillance': 1, 'Future challenges for diagnostic research: striking a balance between simplicity and complexity': 1, 'A simple approximate mathematical model to predict the number of severe acute respiratory syndrome cases and deaths': 2, 'Health proverbs': 1, 'Innovative ideas needed for timely and effective information dissemination': 3, 'Centre for Chronic Disease Prevention and Control, Public Health Agency of Canada. Chronic disease clock': 1, 'World Health Organization. The World Health Report': 2, 'Modulated release of health risk informa': 1, 'Prioritization of occupational sentinel health events for workplace health and hazard surveillance: the Pan American Health Organization experience': 1, 'Understanding the basic principles of knowledge translation': 2, 'Smoking makes you uglyan innovative approach to smoking cessation': 1, 'Cigarette smoking associated with premature facial wrinkling: image analysis of facial skin replicas': 1, 'Tobacco isolated as a cause of skin aging still another reason to quit smoking': 1, 'Association between smoking and hair loss: another opportunity for health education against smoking?': 1, 'Life Expectancy Calculator': 1, 'Scholarship reconsidered: priorities of the professorate': 2, 'Riech-und Schmeckstörungen. 1. Auflage Thieme Verlag': 2, 'Olfactory mucosal findings and clinical course in patients with olfactory disorders following upper respiratory viral infection': 1, 'Does SARS-Cov-2 invade the brain? Translational lessons from animal models': 1, 'Clinical and Epidemiological Characteristics of 1420 European Patients with mild-to-moderate Coronavirus Disease': 2, 'Self-reported olfactory loss associates with outpatient clinical course in Covid-19': 1, 'Association of chemosensory dysfunction and Covid-19 in patients presenting with influenza-like symptoms': 4, 'COVID-19 Anosmia Reporting Tool: Initial Findings. Otolaryngol Head Neck Surg': 1, 'Olfactory and Gustatory Dysfunction in Coronavirus Disease 19 (COVID-19)': 1, 'Acute-onset smell and taste disorders in the context of Covid-19: a pilot multicenter PCR-based case-control study': 1, 'The role of self-reported olfactory and gustatory dysfunction as a screening criterion for suspected COVID-19': 2, 'Prevalence of olfactory impairment in older adults': 1, 'Ratings of Overall Olfactory Function': 1, 'Presentation of new onset anosmia during the COVID-19 pandemic': 2, 'Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): Early report from the United States': 1, 'Neurologische Manifestationen: Wie COVID-19 die Nerven tangiert': 1, 'Organ Procurement and Transplantation Network': 1, 'Organ Procurement and Transplantation Network. Transplants by donor type': 1, 'Complications in patients with ventricular assist devices': 5, 'Nonvalvular cardiovascular device-related infections': 3, 'Ventricular assist devices in the adult': 3, 'Ventricular assist device-related infections': 11, 'Device-related infections: a review': 2, 'Immunobiologic consequences of assist devices': 2, 'Mechanical circulatory support device database of the International Society for Heart and Lung Transplantation: Third Annual Report -2005': 1, \"Late-onset driveline infections: the Achilles' heel of prolonged left ventricular assist device support\": 1, 'Infections during left ventricular assist device support do not affect posttransplant outcomes': 1, 'LVAD bloodstream infections: therapeutic rationale for transplantation after LVAD infection': 1, 'Donor-derived disease transmission events in the United States: Data reviewed by the OPTN/UNOS Disease Transmission Advisory Committee': 2, 'The epidemiology and prevention of donor-derived infections': 1, 'Donor infection and transmission to recipient of a solid allograft': 2, 'Bacterial infection during adult donor care': 3, 'Available at: http:// optn.transplant.hrsa.gov/PoliciesandBylaws2': 1, 'Infection in solid organ transplant recipients': 1, 'Bacterial infections in the early period after liver transplantation: etiological agents and their susceptibility': 2, 'Transplant complications: infectious diseases': 5, 'Approach to the immunocompromised host with infection in the intensive care unit': 1, 'Clinical aspects of invasive candidiasis in solid organ transplant recipients': 1, 'New therapies for fungal pneumonia': 1, 'Risk factors and approaches to infections in transplant recipients': 5, 'Intestine transplantation': 1, \"Mandell, Douglas and Bennett's principles and practice of infectious diseases\": 2, 'Neurologic manifestations of transplant complications': 4, 'Infections of the central nervous system in transplant recipients': 2, 'HIV-1 reverse transcriptase and antiviral drug resistance. Part 1': 2, 'Nucleoside/nucleotide analog inhibitors of hepatitis B virus polymerase: mechanism of action and resistance': 1, 'Perspectives on the development of acyclic nucleotide analogs as antiviral drugs': 1, 'Novel inhibitors of human CMV': 1, 'Hepatitis C virus: Virology, diagnosis and treatment': 1, \"Kaposi's sarcoma herpesvirus microRNAs induce metabolic transformation of infected cells\": 3, 'Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy': 4, 'Adenovirus E4ORF1-induced MYC activation promotes host cell anabolic glucose metabolism and virus replication': 1, 'Targeting Epstein-Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy': 1, 'Dengue virus induces and requires glycolysis for optimal replication': 1, 'Temporal proteome and lipidome profiles reveal hepatitis C virus-associated reprogramming of hepatocellular metabolism and bioenergetics': 3, 'Metabolic effects of influenza virus infection in cultured animal cells: Intra-and extracellular metabolite profiling': 1, 'Vaccinia virus requires glutamine but not glucose for efficient replication': 3, 'Human Cytomegalovirus Regulates Bioactive Sphingolipids': 2, 'Self-enhancement of hepatitis C virus replication by promotion of specific sphingolipid biosynthesis': 2, 'The composition of West Nile Virus lipid envelope unveils a role of sphingolipid metabolism in flavivirus biogenesis': 1, 'Sphingolipid metabolites in inflammatory disease': 1, 'Antiviral activity of cyclopentenone prostanoids': 1, 'Prostaglandin E2 reduces the release and infectivity of new cell-free virions and cell-to-cell HIV-1 transfer': 1, 'Aspirin attenuates cytomegalovirus infectivity and gene expression mediated by cyclooxygenase-2 in coronary artery smooth muscle cells': 1, 'Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication': 1, 'A cyclooxygenase-2 homologue encoded by rhesus cytomegalovirus is a determinant for endothelial cell tropism': 1, 'Targeted prostaglandin E2 inhibition enhances antiviral immunity through induction of type I interferon and apoptosis in macrophages': 1, 'Macrophage tropism of HIV-1 depends on efficient cellular dNTP utilization by reverse transcriptase': 3, 'Intracellular nucleotide levels and the control of retroviral infections': 1, 'Characterization of simian immunodeficiency virus SIVSM/human immunodeficiency virus type 2 Vpx function in human myeloid cells': 1, 'SIVSM/HIV-2 Vpx proteins promote retroviral escape from a proteasome-dependent restriction pathway present in human dendritic cells': 1, 'SAMHD1 is the dendritic-and myeloidcell-specific HIV-1 restriction factor counteracted by Vpx': 2, 'SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates': 1, 'Sirtuins are evolutionarily conserved viral restriction factors': 1, 'Sirtuin functions in health and disease': 1, 'Regulation of glycolytic enzyme phosphoglycerate mutase-1 by Sirt1 protein-mediated deacetylation': 1, 'Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation': 1, 'Oxysterols regulate encephalitogenic CD4 (+) T cell trafficking during central nervous system autoimmunity': 1, '25-Hydroxycholesterol acts as an amplifier of inflammatory signaling': 1, 'Identification of cholesterol 25-hydroxylase as a Novel Host restriction factor and a part of the primary innate immune responses against hepatitis C virus infection': 1, 'Interferon-inducible cholesterol-25-hydroxylase inhibits hepatitis C virus replication via distinct mechanisms': 1, 'Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance': 1, 'On the origin of cancer cells': 2, 'The molecular determinants of de novo nucleotide biosynthesis in cancer cells': 1, 'Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology': 1, 'Activation of ATP citrate lyase by mTOR signal induces disturbed lipid metabolism in hepatitis B virus pre-S2 mutant tumorigenesis': 1, 'Localization of HPV-18 E2 at mitochondrial membranes induces ROS release and modulates host cell metabolism': 1, 'Effects of the human papilloma virus HPV-16 E7 oncoprotein on glycolysis and glutaminolysis: role of pyruvate kinase type M2 and the glycolytic-enzyme complex': 1, 'Metabolic cooperation between different oncogenes during cell transformation: interaction between activated ras and HPV-16 E7': 1, 'Hepatitis C virus-linked mitochondrial dysfunction promotes hypoxia-inducible factor 1 alpha-mediated glycolytic adaptation': 1, \"Induction of the Warburg effect by Kaposi's sarcoma herpesvirus is required for the maintenance of latently infected endothelial cells\": 1, 'Global metabolic profiling of infection by an oncogenic virus: KSHV induces and requires lipogenesis for survival of latent infection': 1, 'Metabolic pathways promoting cancer cell survival and growth': 1, 'Incidental CT findings suspicious for COVID-19 associated pneumonia on nuclear medicine exams: recognition and management plan': 1, 'CT imaging features of 2019 novel coronavirus (2019-nCoV)': 1, 'CDC site for COVID 19': 1, 'Incidental findings suggestive of COVID-19 in asymptomatic patients undergoing nuclear medicine procedures in a high prevalence region': 1, '18 F-FDG PET/CT and serial chest CT findings in a COVID-19 patient with dynamic clinical characteristics in different period': 1, 'Nuclear medicine in responding to global pandemic COVID-19-American College of Nuclear Medicine member experience': 1, 'Coronavirus disease 2019 (COVID-19) outbreak at the Department of Ophthalmology': 1, 'Innate sensing of DNA virus genomes': 1, 'Innate immune response to cytoplasmic DNA: Mechanisms and diseases': 1, 'The cytoplasmic DNA sensor cGAS promotes mitotic cell death': 3, 'cGAS in action: Expanding roles in immunity and inflammation': 2, 'DNA-stimulated cell death: implications for host defence, inflammatory diseases and cancer': 6, 'Nucleic acid sensors and programmed cell death': 4, 'An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome': 1, 'AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA': 1, 'AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC': 1, 'HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA': 1, \"cGAS produces a 2'-5'-linked cyclic dinucleotide second messenger that activates STING\": 1, \"Structure-function analysis of STING activation by c[G(2',5')pA(3',5')p] and targeting by antiviral DMXAA\": 1, 'Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway': 1, 'Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity': 1, 'Cyclic GMP-AMP signalling protects bacteria against viral infection': 1, 'Molecular evolutionary and structural analysis of the cytosolic DNA sensor cGAS and STING': 1, \"Ancient origin of cGAS-STING reveals mechanism of universal 2',3' cGAMP signaling\": 1, 'The mammalian PYHIN gene family: phylogeny, evolution and expression': 4, 'Extensive evolutionary and functional diversity among mammalian AIM2-like receptors': 3, 'Unique loss of the PYHIN gene family in bats amongst mammals: implications for inflammasome sensing': 3, 'Identifying SARS-CoV-2 related coronaviruses in Malayan pangolins': 2, 'Probable pangolin origin of SARS-CoV-2 associated with the COVID-19 outbreak': 1, 'Pangolins lack IFIH1/ MDA5, a cytoplasmic RNA sensor that initiates innate immune defense upon coronavirus infection': 3, 'Convergent losses of TLR5 suggest altered extracellular flagellin detection in four mammalian lineages': 1, 'Pangolin genomes and the evolution of mammalian scales and immunity': 3, 'Basic local alignment search tool': 2, 'Multiple sequence alignment with hierarchical clustering': 1, 'Tree of life reveals clock-like speciation and diversification': 1, 'IFI16 is an innate immune sensor for intracellular DNA': 1, 'Unterholzner L (2017) IFI16 and cGAS cooperate in the activation of STING during DNA sensing in human keratinocytes': 1, 'IFI16 is required for DNA sensing in human macrophages by promoting production and function of cGAMP': 1, 'Viral metagenomics revealed Sendai virus and coronavirus infection of Malayan pangolins (Manis javanica)': 1, 'Interferon-ε protects the female reproductive tract from viral and bacterial infection': 1, 'Sensing of endogenous nucleic acids by ZBP1 induces keratinocyte necroptosis and skin inflammation': 1, 'Pasparakis M (2020) Z-nucleic-acid sensing triggers ZBP1-dependent necroptosis and inflammation': 1, 'Control of cell death-associated danger signals during cornification prevents autoinflammation of the skin': 1, 'Identification of novel mammalian caspases reveals an important role of gene loss in shaping the human caspase repertoire': 1, 'Duplication of the caspase-12 prodomain and inactivation of NLRC4/IPAF in the dog': 1, 'Modes of transmission of virus causing Covid-19: Implications for IPC precaution recommendations: Scientific brief': 2, 'Airborne Contagion and Air Hygiene. An Ecological Study of Droplet Infections': 1, 'Natural Ventilation for Infection Control in Health-Care Settings (World Health Organization': 2, 'How far droplets can move in indoor environments-Revisiting the wells evaporation-falling curve': 4, 'Dynamics of infectious disease transmission by inhalable respiratory droplets': 1, 'Spatial dynamics of airborne infectious diseases': 1, 'Toward understanding the risk of secondary airborne infection: Emission of respirable pathogens': 3, 'Capillary flow as the cause of ring stains from dried liquid drops': 1, 'On the lifetimes of evaporating droplets with related initial and receding contact angles': 2, 'Retention and infiltration of bacteria on a plant leaf driven by surface water evaporation': 1, 'Precision stacking of nanoparticle laden sessile droplets to control solute deposit morphology': 1, 'Insights into vapor-mediated interactions in a nanocolloidal droplet system: Evaporation dynamics and affects on self-assembly topologies on macro-to microscales': 1, 'Fluid Dynamics and Transport of Droplet and Sprays': 4, 'Evaporating droplets in turbulence studied with statistically stationary homogeneous direct numerical simulation': 1, 'Violent expiratory events: On coughing and sneezing': 3, 'Combustion Physics': 3, 'A directed relation graph method for mechanism reduction': 2, 'Turbulent Combustion': 3, 'Modeling and Simulation of Turbulent Combustion': 1, 'Effects of acoustic-streaming-induced flow in evaporating nanofluid droplets': 1, 'Experimental analysis of thermo-physical processes in acoustically levitated heated droplets': 1, 'Unsteady turbulent round jets and vortex motion': 3, 'Environmental Fluid Mechanics': 2, 'On coughing and airborne droplet transmission to humans': 1, 'The numbers and the sites of origin of the droplets expelled during expiratory activities': 1, 'Exhaled droplets due to talking and coughing': 1, 'Validation of the exhaled breath temperature measure: Reference values in healthy subjects': 1, 'Drying kinetics of salt solution droplets: Water evaporation rates and crystallization': 1, 'Salt transport and crystallization in porous limestone: Neutron-xray imaging and poromechanical modeling': 2, 'The size and the duration of air-carriage of respiratory droplets and droplet-nuclei': 2, 'On air-borne infection: Study II. Droplets and droplet nuclei': 1, 'Coughing frequency in patients with persistent cough: Assessment using a 24 hour ambulatory recorder': 1, 'Continuity of Care and Outpatient Management for Patients with and at High Risk for Cardiovascular Disease during the COVID-19 Pandemic: A Scientific Statement from the American Society for Preventive Cardiology': 1, 'Policy Recommendations to Guide the Use of Telemedicine in Primary Care Settings: An American College of Physicians Position Paper': 1, 'Tackling covid-19: are the costs worth the benefits?': 1, 'COVID-19-exploring the Implications of long-term condition type and extent of multimorbidity on years of life lost: a modelling study': 2, 'The fiscal value of human lives lost from coronavirus disease (COVID-19) in China': 1, 'A standardized rate for mortality defined in units of lost years of life': 1, 'Scaling COVID-19 against inequalities: should the policy response consistently match the mortality challenge? medRxiv': 1, 'Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis': 1, 'Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study': 1, 'Asymptomatic SARS coronavirus infection among healthcare workers, Singapore. Emerg Infect Dis': 1, 'Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital': 4, 'The important role of serology for COVID-19 control': 1, 'What policy makers need to know about COVID-19 protective immunity': 1, 'Immune surveillance for vaccine-preventable diseases': 1, 'Chemiluminescent immunoassay technology: what does it change in autoantibody detection? Auto-Immun highlights. 2017/06/24': 1, 'Luminex corporation. Overcoming the cost and performance limitations of ELISA with xMAP(r) Technology. Tech Note': 2, 'Characterization and development of a Luminex(®)-based assay for the detection of human IL-23': 1, 'Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay': 2, 'Analysis of factors affecting the variability of a quantitative suspension bead array assay measuring IgG to multiple Plasmodium antigens': 1, 'The time course of the immune response to experimental coronavirus infection of man': 1, 'Reinfection could not occur in SARS-CoV-2 infected rhesus macaques': 1, 'Two Year Prospective Study of the Humoral Immune Response of Patients with Severe Acute Respiratory Syndrome': 1, 'Development of quantitative suspension array assays for six immunoglobulin isotypes and subclasses to multiple Plasmodium falciparum antigens': 1, 'Immunoassay for serodiagnosis of Zika virus infection based on time-resolved Förster resonance energy transfer': 1, 'Classification and Regression by randomForest. R News': 1, 'Optimization of incubation conditions of Plasmodium falciparum antibody multiplex assays to measure IgG, IgG(1-4), IgM and IgE using standard and customized reference pools for sero-epidemiological and vaccine studies': 1, 'Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)': 2, 'Profile of specific antibodies to SARS-CoV-2: The first report': 1, 'Antibody Testing For Covid-19': 1, 'Development of an enzyme-linked immunosorbent assay-based test with a cocktail of nucleocapsid and spike proteins for detection of severe acute respiratory syndrome-associated coronavirus-specific antibody': 1, 'Detection of Nucleocapsid Antibody to SARS-CoV-2 is More Sensitive than Antibody to Spike Protein in COVID-19 Patients. medRxiv': 1, 'Antigenic crossreactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43': 1, 'Beyond the Spike: identification of viral targets of the antibody response to SARS-CoV-2 in COVID-19 patients. medRxiv': 1, 'Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals': 2, 'Presence of SARS-CoV-2 reactive T cells in COVID-19 patients and healthy donors. medRxiv': 1, 'Toward a theory of situation awareness in dynamic systems': 1, 'Possible model semantics for disjunctive databases': 9, 'A novel architecture for situation awareness systems': 5, 'The stable model semantics for logic programming': 1, 'The Logic Programming Paradigm: A 25-Year Perspective': 1, 'Disjunctive datalog': 1, 'Classical negation in logic programs and disjunctive databases': 1, 'An alternative approach to the semantics of disjunctive logic programs and deductive databases': 5, 'Complexity results for disjunctive logic programming and application to nonmonotonic logics': 1, 'A tableau calculus for minimal model reasoning': 1, 'Chapter 5 -on the declarative semantics of deductive databases and logic programs': 1, 'Expressing and supporting efficiently greedy algorithms as locally stratified logic programs. Technical Communications of ICLP': 1, 'On the logic of theory change: partial meet contraction and revision functions': 1, 'Chapter 8 belief revision': 1, 'Characterization of logic program revision as an extension of propositional revision': 1, 'Revision specifications by means of programs': 1, 'Revision programming': 1, 'Hyper tableaux with equality': 1, 'System description: E-KRHyper': 1, 'Checking compliance of execution traces to business rules': 2, 'Computing trace alignment against declarative process models through planning': 1, 'Event-based diagnosis for evolutive systems': 1, 'Toward a theory of diagnosis, testing and repair': 1, 'nfer -a notation and system for inferring event stream abstractions': 1, 'The Calculus of Computation': 1, 'Answer sets': 1, 'Blocking and other enhancements for bottom-up model generation methods': 1, 'Hyper tableaux': 2, 'Modeling rover communication using hierarchical state machines with scala': 1, 'Paracrine and autocrine growth mechanisms in tumor metastasis to specific sites with particular emphasis on brain and lung metastasis': 1, 'Metastatic potential correlates with enzymatic degradation of basement membrane collagen': 1, 'Effect of plasminogen activator (Urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane': 1, 'Cathepsin B activity in B16 melanoma cells: A possible marker for metastatic potential': 1, 'Inhibition of tumor cell invasion by ubenimex (bestatin) in vitro': 1, 'Human aminopeptidases: A review of the literature': 1, 'Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N': 1, 'Major localization of aminopeptidase M in rat brain': 1, 'Metabolism of neutropeptides': 1, 'Metabolism of vasoactive peptides by plasma and purified renal aminopeptidase M': 1, 'Pool sequencing of natural HLA-DR, -DQ, and -DP ligands reveals detailed peptide motifs, constraints of processing, and general rules': 1, 'Monoclonal antibodies detect monocyte/macrophage activation and differentiation antigens and identify functionally distinct subpopulations of human rheumatoid synovial tissue macropharges': 1, 'Surface aminopeptidase activity of human lymphocytes. I. Biochemical and biologic properties of intact cells': 1, 'Human aminopeptidase N is a receptor for human coronavirus 229E': 5, 'Inhibition of alanyl aminopeptidase induces MAP-kinase p43/ERK2 in the human T cell line KARPAS-299': 2, 'Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation': 4, 'Biochemical and functional characterization of aminopeptidase N expressed by human melanoma cells': 4, 'Human melanoma invasion and metastasis enhancement by high expression of aminopeptidase N/CD13': 4, 'Possible contribution of aminopeptidase N (APN/CD13) to invasive potential enhanced by interleukin-6 and soluble interleukin-6 receptor in human osteosarcoma cell lines': 3, 'Expression of aminopeptidase N (CD13) in mesenchymal tumors': 1, 'Regulation of the expression of aminopeptidase A, aminopeptidase N/CD13 and dipeptidylpeptidase IV/CD26 in renal carcinoma cells and renal tubular epitherial cells by cytokines and cAMP-increaing mediators': 1, 'CD13 (human aminopeptidase N) mediates human cytomegalovirus infection': 1, 'Membrane alanyl aminopeptidase': 2, 'Specific regulation by antisense, sense and antigene nucleic acids': 1, 'Expression of aminopeptidase N on human choriocarcinoma cells and cell growth suppression by inhibition of aminopeptidase N activity': 1, 'Effect of ubenimex on the proliferation and differentiation of U937 human histiocytic lymphoma cells': 2, 'Aminopeptidase N-mediated signal transduction and inhibition of human myeloid cells': 2, 'Immunotherapy with bestatin for acute nonlymphocytic leukemia in adults': 1, 'Induction of apoptosis by bestatin (ubenimex) in human leukemic cell lines': 1, 'Antitumor activity of actinonin in vitro and in vivo': 1, 'Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis': 1, 'Clinical features of patients infected with 2019 novel coronavirus in': 4, 'Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in': 1, \"National Health and Health Commission of the People's Republic of China. Diagnosis and Treatment of Pneumonia of New Coronavirus Infection\": 2, 'IL-6 and related cytokines as the critical lynchpins between inflammation and cancer': 2, 'Epidemiological and clinical features of COVID-19 patients with and without pneumonia in': 2, 'Reducing mortality from 2019-nCoV: host-directed therapies should be an option': 1, 'Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP), medRxiv': 1, \"National Health and Health Commission of the People's Republic of China. Diagnosis and Treatment of Pneumonia of New Coronavirus Infection (Trial Version 5)\": 1, 'Interleukin-6 mediates angiotensinogen gene expression during liver regeneration': 1, 'C-reactive protein: a critical update': 1, 'C-Reactive protein levels but not CRP dynamics predict mortality in patients with pneumococcal pneumonia': 1, 'Is procalcitonin to C-reactive protein ratio useful for the detection of late onset neonatal sepsis?': 1, 'Procalcitonin levels predict infectious complications and response to treatment in patients undergoing cytoreductive surgery for peritoneal malignancy': 1, 'Novel applications for serum procalcitonin testing in clinical practice': 1, 'Serum sTREM-1, PCT, CRP, Lac as biomarkers for death risk within 28 days in patients with severe sepsis': 1, 'Relationship between acute kidney injury and serum procalcitonin (PCT) concentration in critically ill patients with influenza infection': 1, 'Passive antibody therapy for infectious diseases': 1, 'Virus entry: molecular mechanisms and biomedical applications': 1, 'Preventing infectious disease with passive immunization': 1, 'Development of Motavizumab, an Ultra-potent Antibody for the Prevention of Respiratory Syncytial Virus Infection in the Upper and Lower Respiratory Tract': 1, 'Antibodies, viruses and vaccines': 3, 'Passive antibody therapies: progress and continuing challenges': 1, 'Phage display of combinatorial antibody libraries': 2, 'Antibody engineering': 1, 'Recombinant antibodies for cancer diagnosis and therapy': 1, 'Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodies': 1, 'Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody': 1, 'Identification of a novel CD4i human monoclonal antibody Fab that neutralizes HIV-1 primary isolates from different clades': 1, 'Broadly cross-reactive HIV neutralizing human monoclonal antibody Fab selected by sequential antigen panning of a phage display library': 2, 'Selection of a novel gp41-specific HIV-1 neutralizing human antibody by competitive antigen panning': 2, 'Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes': 1, 'Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies': 1, 'Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies': 1, 'Immunization against viral diseases': 1, 'Folding and assembly of viral membrane proteins': 1, 'The structure and function of the hemagglutinin membrane glycoprotein of influenza virus': 1, 'Antigenic implications of human immunodeficiency virus type 1 envelope quaternary structure: oligomer-specific and -sensitive monoclonal antibodies': 2, 'Prospects for an AIDS vaccine: three big questions, no easy answers': 1, 'Receptor binding, fusion inhibition, and induction of cross-reactive neutralizing antibodies by a soluble g glycoprotein of hendra virus': 2, 'Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities': 1, 'Structure of the uncleaved ectodomain of the paramyxovirus (hPIV3) fusion protein': 1, 'Characterization of stable, soluble trimers containing complete ectodomains of human immunodeficiency virus type 1 envelope glycoproteins': 1, 'Generation and structural analysis of soluble oligomeric gp140 envelope proteins derived from neutralization-resistant and neutralization-susceptible primary HIV type 1 isolates': 1, 'Oligomeric and conformational properties of a proteolytically mature, disulfide-stabilized human immunodeficiency virus type 1 gp140 envelope glycoprotein': 2, 'Characterization of a secreted form of measles virus haemagglutinin expressed from a vaccinia virus recombinant': 1, 'The flavivirus envelope protein E: isolation of a soluble form from tick-borne encephalitis virus and its crystallization': 1, 'Structure and function of a membrane anchor-less form of the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus': 1, 'Expression and characterization of a soluble rubella virus E1 envelope protein': 1, 'Expression and characterization of soluble human parainfluenza virus type 1 hemagglutinin-neuraminidase glycoprotein': 1, 'Soluble ectodomain of rabies virus glycoprotein expressed in eukaryotic cells folds in a monomeric conformation that is antigenically distinct from the native state of the complete, membrane-anchored glycoprotein': 1, 'Immunization Against Viral Diseases': 1, 'Recombinant vaccinia viruses. Design, generation, and isolation': 1, 'A switch between two-, three-, and four-stranded coiled coils in GCN4 leucine zipper mutants': 1, 'Crystal structure of an isoleucine-zipper trimer': 1, 'Highly Stable Trimers Formed by Human Immunodeficiency Virus Type 1 Envelope Glycoproteins Fused with the Trimeric Motif of T4 Bacteriophage Fibritin': 1, 'Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form': 1, 'Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1': 1, 'Quality function deployment (QFD)-a means for developing usable products': 2, 'Customer-driven product development through quality function deployment in the US and Japan': 1, 'Introducing quality function deployment in the marketing classroom': 1, 'Evaluating the strategic design parameters of airports in Thailand to meet service expectations of low-cost airlines using the fuzzy-based QFD method': 1, 'A fuzzy three-stage multi-attribute decisionmaking approach based on customer needs for sustainable supplier selection': 1, 'An extended approach for manufacturing strategy process base on organization performance through fuzzy QFD': 1, 'Fuzzy cognitive map based quality function deployment approach for dishwasher machine selection': 1, 'Pythagorean hesitant fuzzy Hamacher aggregation operators and their application to multiple attribute decision making': 1, 'Intuitionistic fuzzy Hamacher aggregation operators with entropy weight and their applications to multi-criteria decision-making problems': 1, 'Designing software as a service in cloud computing using quality function deployment': 1, 'A QFD-based decision making model for computer-aided design software selection': 1, 'Bipolar fuzzy sets and relations: a computational frame work for cognitive modelling and multiagent decision analysis': 2, 'Bipolar fuzzy sets': 2, 'Uber logische Vernüpfungen unscharfer Aussagen und deren Zugehörige Bewertungsfunctionen': 1, 'Bipolar fuzzy Hamacher aggregation operators in multiple attribute decision making': 1, 'Quality Function Deployment: How to Make QFD Work for You': 1, 'Ribosomal frameshifting on viral RNAs': 1, \"NS1' of flaviviruses in the Japanese encephalitis virus serogroup is a product of ribosomal frameshifting and plays a role in viral neuroinvasiveness\": 3, 'Evidence for ribosomal frameshifting and a novel overlapping gene in the genomes of insect-specific flaviviruses': 2, 'Achieving a golden mean: mechanisms by which coronaviruses ensure synthesis of the correct stoichiometric ratios of viral proteins': 2, 'Translating old drugs into new treatments: Identifying compounds that modulate programmed -1 ribosomal frameshifting and function as potential antiviral agents': 3, 'Ribosomal frameshifting efficiency and Gag/Gag-pol ratio are critical for yeast M 1 double-stranded RNA virus propagation': 2, 'Translational maintenance of frame: mutants of Saccharomyces cerevisiae with altered -1 ribosomal frameshifting efficiencies': 1, '5S rRNA is involved in fidelity of translational reading frame': 2, 'is an allele of the UPF1/IFS2 gene which affects both mRNA turnover and -1 ribosomal frameshifting efficiency': 1, 'Peptidyl transferase inhibitors have antiviral properties by altering programmed -1 ribosomal frameshifting efficiencies: development of model systems': 3, 'The Upf3p is a component of the surveillance complex that monitors both translation and mRNA turnover and affects viral maintenance': 1, 'The Mof2/Sui1 protein is a general monitor of translational accuracy': 1, 'Ribosomal protein L3 mutants alter translational fidelity and promote rapid loss of the yeast killer virus': 1, 'Ribosomal protein L5 helps anchor peptidyl-tRNA to the P-site in Saccharomyces cerevisiae': 2, 'New targets for antivirals: the ribosomal A-site and the factors that interact with it': 1, 'Decreased peptidyltransferase activity correlates with increased programmed -1 ribosomal frameshifting and viral maintenance defects in the yeast Saccharomyces cerevisiae': 1, 'Delayed rRNA processing results in significant ribosome biogenesis and functional defects': 1, 'Virus-like particle of yeast': 1, 'Three different M 1 RNA-containing viruslike particle types in Saccharomyces cerevisiae: in vitro M 1 double-stranded RNA synthesis': 1, 'Fungal virus capsids, cytoplasmic compartments for the replication of double-stranded RNA, formed as icosahedral shells of asymmetric Gag dimers': 1, 'Structure of L-A virus: a specialized compartment for the transcription and replication of double-stranded RNA': 1, 'A rare tRNA-Arg(CCU) that regulates Ty1 element ribosomal frameshifting is essential for Ty1 retrotransposition in Saccharomyces cerevisiae': 3, 'Spermidine deficiency increases +1 ribosomal frameshifting efficiency and inhibits Ty1 retrotransposition in Saccharomyces cerevisiae': 1, 'Translational misreading: Mutations in translation elongation factor 1a differentially affect programmed ribosomal frameshifting and drug sensitivity': 1, 'Pokeweed antiviral protein specifically inhibits Ty1 directed +1 ribosomal frameshifting and Ty1 retrotransposition in Saccharomyces cerevisiae': 1, 'Ty1 retrotransposition and programmed +1 ribosomal frameshifting require the integrity of the protein synthetic translocation step': 1, 'A C-terminal deletion mutant of pokeweed antiviral protein inhibits programmed +1 ribosomal frameshifting and Ty1 retrotransposition without depurinating the sarcin/ricin loop of rRNA': 1, 'Overexpression of the gag-pol precursor from human immunodeficiency virus type-I proviral genomes results in efficient proteolytic processing in the absence of virion production': 1, 'Expression of the gag-pol fusion protein of moloney murine leukemia virus without gag protein does not induce viron formation or proteolytic processing': 1, 'Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles': 1, 'Importance of ribosomal frameshifting for human immumodeficiency virus type 1 assembly and replication': 1, 'Analysis of natural variants of the human immunodeficiency virus type 1 gag-pol frameshift stem-loop structure': 1, 'The human immunodeficiency virus type 1 ribosomal frameshifting site is an invariant sequence determinant and an important target for antiviral therapy': 1, 'Nonsense-mediated decay mutants do not affect programmed -1 frameshifting': 1, 'An in vivo dual-luciferase assay system for studying translational recoding in the yeast Saccharomyces cerevisiae': 5, 'A homogeneous cell-based bicistronic fluorescence assay for high-throughput identification of drugs that perturb viral gene recoding and read-through of nonsense stop codons': 1, 'Systematic analysis of bicistronic reporter assay data': 2, 'Ribosomal frameshifting in yeast viruses': 1, 'Comparative study of the effects of heptameric slippry site composition on -1 frameshifting among different translational assay systems': 1, 'COVID-19: Gastrointestinal Manifestations and Potential Fecal-Oral Transmission': 1, 'Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission': 1, 'Evidence for Gastrointestinal Infection of SARS-CoV-2': 1, 'Virus shedding patterns in nasopharyngeal and fecal specimens of COVID-19 patients': 2, 'SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients': 1, 'Persistent viral shedding of SARS-CoV-2 in faeces -a rapid review': 1, 'Faecal-oral transmission of SARS-COV-2: practical implications': 1, 'First confirmed detection of SARS-CoV-2 in untreated wastewater in Australia: A proof of concept for the wastewater surveillance of COVID-19 in the community': 4, 'Prolonged presence of SARS-CoV-2 viral RNA in faecal samples': 2, 'Evaluation of lockdown impact on SARS-CoV-2 dynamics through viral genome quantification in Paris wastewaters': 6, 'SARS-CoV-2 RNA in wastewater anticipated COVID-19 occurrence in a low prevalence area': 6, 'Metropolitan Wastewater Analysis for COVID-19 Epidemiological Surveillance': 1, 'First detection of SARS-CoV-2 in untreated wastewaters in Italy': 3, 'Presence and vitality of SARS-CoV-2 virus in wastewaters and rivers': 1, 'Survival of surrogate coronaviruses in water': 1, 'Emerging investigators series: the source and fate of pandemic viruses in the urban water cycle': 1, 'Identification of Viral Pathogen Diversity in Sewage Sludge by Metagenome Analysis': 1, 'Interim indications on the management of sewage sludge for the prevention of the spread of the SARS-CoV-2 virus': 1, 'Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV': 3, 'Stability of SARS-CoV-2 in different environmental conditions': 7, 'Stability and inactivation of SARS coronavirus': 1, 'Feasibility of thermophilic anaerobic processes for treating waste activated sludge under low HRT and intermittent mixing': 1, 'Minimization of municipal sewage sludge by means of a thermophilic membrane bioreactor with intermittent aeration': 1, 'Mechanism of virus inactivation in wastewater sludges': 1, 'Survival of Coronaviruses in Water and Wastewater': 1, 'Survival of Viruses in Water': 1, 'Survival of human enteric viruses in the environment and food': 1, 'SARS-CoV-2 in wastewater: State of the knowledge and research needs. Sci. Total Environ. 139076': 2, 'Coronavirus in water environments: Occurrence, persistence and concentration methods -A scoping review': 1, 'Future perspectives of wastewater-based epidemiology: Monitoring infectious disease spread and resistance to the community level': 2, 'Environmental and Health Perspective for COVID-19 OAn environmental and health perspective for COVID-19 outbreak: Meteorology and air quality influence, sewage epidemiology indicator, hospitals disinfection, drug therapies and recommendations': 1, 'SARS-CoV-2 in wastewater: potential health risk, but also data source': 1, 'Rapid flu diagnosis using silicon nanowire sensor': 3, 'Reducing transmission of SARS-CoV-2': 2, 'Rapid expert consultation on the possibility of bioaerosol Spread of SARS-CoV-2 for the COVID-19 pandemic': 4, 'Fluorescent bioaerosol particles resulting from human occupancy with and without respirators': 1, 'Asymptomatic cases in a family cluster with SARS-CoV-2 infection': 1, 'Industries Reopening by Phase': 1, \"Mayor of London statement on Prime Minister's announcement\": 1, 'Connecting the world to combat coronavirus': 1, 'Covid-19: how Japan squandered its early jump on the pandemic': 1, 'Inequality & COVID-19: The Forgotten Vulnerable. Public Health': 1, 'Immunity passports\" in the context of COVID-19': 1, 'A new bat-HKU2-like coronavirus in swine': 3, 'Isolation and characterization of a highly pathogenic strain of porcine enteric alphacoronavirus causing watery diarrhea and high mortality in newborn piglets': 1, 'Complete genome sequence of bat coronavirus HKU2 from Chinese horseshoe bats revealed a much smaller spike gene with a different evolutionary lineage from the rest of the genome': 1, 'Discovery of a novel swine enteric alphacoronavirus (SeACoV) in southern China': 4, 'Development of a novel real-time polymerase chain reaction assay for the quantitative detection of Nipah virus replicative viral RNA': 1, 'Development of a TaqMan MGB RT-PCR assay for the detection of type A and subtype H10 avian influenza viruses': 1, \"Development of a duplex real-time RT-PCR for the simultaneous detection and differentiation of Theiler's murine encephalomyelitis virus and rat theilovirus\": 2, 'Development of a TaqMan-based real-time RT-PCR assay for the detection of SADS-CoV associated with severe diarrhea disease in pigs': 7, 'Newly emerged porcine enteric alphacoronavirus in southern China: identification, origin and evolutionary history analysis': 1, 'Anti-HCV, nucleotide inhibitors, repurposing against COVID-19': 6, 'Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2': 4, 'Teicoplanin: an alternative drug for the treatment of coronavirus COVID-19?': 1, 'Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus (2019-nCoV) related coronavirus model': 1, 'Therapeutic options for the 2019 novel coronavirus (2019-nCoV)': 4, 'Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL (pro)) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates': 1, 'Drug repurposing for the treatment of glioblastoma multiforme': 1, 'mTOR signaling and drug development in cancer': 2, 'Rapamycin and mTOR: a serendipitous discovery and implications for breast cancer': 1, 'Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial': 1, 'TORC-specific phosphorylation of mammalian target of rapamycin (mTOR): phospho-Ser2481 is a marker for intact mTOR signaling complex 2': 1, 'mTORC1 directly inhibits AMPK to promote cell proliferation under nutrient stress': 1, 'AMPK: guardian of metabolism and mitochondrial homeostasis': 2, 'Molecular logic of mTORC1 signalling as a metabolic rheostat': 1, 'Host mTORC1 signaling regulates Andes virus replication': 2, 'Host cell mTORC1 is required for HCV RNA replication': 2, 'Antiviral potential of ERK/MAPK and PI3K/AKT/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysis': 2, 'Adjuvant treatment with a mammalian target of rapamycin inhibitor, sirolimus, and steroids improves outcomes in patients with severe H1N1 pneumonia and acute respiratory failure': 3, 'Randomized phase II trial of Ridaforolimus in advanced endometrial carcinoma': 1, 'Guidelines for the use and interpretation of assays for monitoring autophagy': 5, 'Targeting AMPK signaling pathway to overcome drug resistance for Cancer therapy': 1, 'Metabolic reprogramming: the emerging concept and associated therapeutic strategies': 1, 'Role of autophagy in the maintenance and function of cancer stem cells': 1, 'Chloroquine in cancer therapy: a double-edged sword of autophagy': 2, 'Targeting autophagy in cancer': 2, 'Time to use a dose of Chloroquine as an adjuvant to anti-cancer chemotherapies': 1, 'Institutional experience with chloroquine as an adjuvant to the therapy for glioblastoma multiforme': 1, 'Adding chloroquine to conventional treatment for glioblastoma multiforme: a randomized, doubleblind, placebo-controlled trial': 1, 'Therapy of glioblastoma multiforme improved by the antimutagenic chloroquine': 1, 'Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century': 2, \"Effects of chloroquine on viral infections: an old drug against today's diseases?\": 2, 'Glycoconjugate glycans as viral receptors': 1, 'New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?': 1, 'Different host cell proteases activate the SARS-coronavirus spike-protein for cell-cell and virus-cell fusion': 1, 'Inhibition of human coronavirus 229E infection in human epithelial lung cells (L132) by chloroquine: involvement of p38 MAPK and ERK': 1, 'Enhancement of T cell-mediated immune responses to whole inactivated influenza virus by chloroquine treatment in vivo': 1, 'Chloroquine and hydroxychloroquine equally affect tumor necrosis factoralpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells': 1, 'Effect of high vs low doses of Chloroquine Diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial': 1, 'Hydroxychloroquine in patients with COVID-19: an open-label, randomized, controlled trial': 3, 'Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19': 1, 'mTOR signaling in growth, metabolism, and disease': 1, 'Aminoquinolines against coronavirus disease 2019 (COVID-19): Chloroquine or Hydroxychloroquine': 1, 'Audio interview: new research on possible treatments for Covid-19': 1, 'Sgk1 activates MDM2-dependent p53 degradation and affects cell proliferation, survival, and differentiation': 2, 'Sgk1 enhances RANBP1 transcript levels and decreases taxol sensitivity in RKO colon carcinoma cells': 1, 'SI113, a specific inhibitor of the Sgk1 kinase activity that counteracts cancer cell proliferation': 1, 'Preclinical model in HCC: the SGK1 kinase inhibitor SI113 blocks tumor progression in vitro and in vivo and synergizes with radiotherapy': 2, 'The small molecule SI113 synergizes with mitotic spindle poisons in arresting the growth of human glioblastoma multiforme': 2, 'The kinase inhibitor SI113 induces autophagy and synergizes with quinacrine in hindering the growth of human glioblastoma multiforme cells': 1, 'MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile': 1, 'Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1': 1, 'Deregulation of SGK1 in ulcerative colitis: a paradoxical relationship between immune cells and colonic epithelial cells': 1, 'Tocilizumab: the first interleukin-6-receptor inhibitor': 2, 'Interleukin-6 induces drug resistance in renal cell carcinoma': 1, \"Nivolumab-induced cytokine-release syndrome in relapsed/refractory Hodgkin's lymphoma: a case report and literature review\": 1, 'Cellular therapy: immune-related complications': 1, 'Cytokine release syndrome': 1, 'Effective treatment of severe COVID-19 patients with tocilizumab': 1, 'Sperimentazioni cliniche -COVID-19': 3, 'COVID-19 Pneumonia (TOCIVID-19': 1, 'Sarilumab, a fully human monoclonal antibody against IL-6Ralpha in patients with rheumatoid arthritis and an inadequate response to methotrexate: efficacy and safety results from the randomised SARIL-RA-MOBILITY part a trial': 1, 'Immunotherapeutic Interleukin-6 or Interleukin-6 receptor blockade in Cancer: challenges and opportunities': 1, 'Treatment of refractory hemophagocytic lymphohistiocytosis with emapalumab despite severe concurrent infections': 1, 'Anakinra for rheumatoid arthritis': 1, 'Anti-NKG2A mAb is a checkpoint inhibitor that promotes anti-tumor immunity by unleashing both T and NK cells': 1, 'Doseranging and cohort-expansion study of Monalizumab (IPH2201) in patients with advanced gynecologic malignancies: a trial of the Canadian Cancer trials group (CCTG): IND221': 1, 'NKG2A, a new kid on the immune checkpoint block': 1, 'Functional exhaustion of antiviral lymphocytes in COVID-19 patients': 1, 'Non-small-cell lung cancer vaccine therapy: a concise review': 1, 'Association of BCG vaccination in childhood with subsequent Cancer diagnoses: a 60-year follow-up of a clinical trial': 1, 'Optimizing pharmacokinetics of intravesical chemotherapy for bladder cancer': 1, 'BCG-associated heterologous immunity, a historical perspective: experimental models and immunological mechanisms': 1, 'BCG vaccination and reduced risk of asthma': 1, 'Bacillus Calmette-Guerin alleviates airway inflammation and remodeling by preventing TGF-beta1 induced epithelial-mesenchymal transition': 1, 'Use of an anti-viral drug, ribavirin, as an anti-glioblastoma therapeutic': 2, 'Cidofovir: a novel antitumor agent for glioblastoma': 1, 'Lopinavir-Ritonavir Combination Induces Endoplasmic Reticulum Stress and Kills Urological Cancer Cells': 1, 'A single-arm, proof-of-concept trial of Lopimune (Lopinavir/ritonavir) as a treatment for HPV-related pre-invasive cervical disease': 1, 'A trial of Lopinavirritonavir in adults hospitalized with severe Covid-19': 1, 'Ribavirin for the treatment of chronic hepatitis C virus infection: a review of the proposed mechanisms of action': 2, 'The mechanism of inhibition of randependent nuclear transport by cellular ATP depletion': 1, 'The use of ribavirin as an anticancer therapeutic: will it go viral?': 1, 'Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection': 1, 'Adaptive COVID-19 Treatment Trial (ACTT)': 2, 'Compassionate use of Remdesivir for patients with severe Covid-19': 1, 'Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial': 2, 'NIH Clinical Trial Shows Remdesivir Accelerates Recovery from Advanced COVID-19': 1, 'The 1918 influenza pandemic: 100 years of questions answered and unanswered': 1, 'Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved alpha-ketoamide inhibitors': 1, 'Survivors of Ebola virus disease develop Polyfunctional antibody responses': 1, 'Comprehending a killer: the Akt/ mTOR signaling pathways are temporally high-jacked by the highly pathogenic 1918 influenza virus. EBioMedicine': 1, 'Metabolic regulation of natural killer cells': 1, 'We need to talk about the Warburg effect': 1, 'The Warburg effect as an adaptation of cancer cells to rapid fluctuations in energy demand': 1, 'mTOR Cross-Talk in Cancer and Potential for Combination Therapy': 1, 'Caring for patients with cancer in the COVID-19 era': 1, 'Why Sub-Saharan Africa needs a unique response to COVID-19': 1, 'Covid-19: identifying and isolating asymptomatic people helped eliminate virus in Italian village': 2, 'The burden of COVID-19 in people living with HIV: a syndemic perspective': 1, 'Symptoms, stress, and HIV-related care among older people living with HIV during the COVID-19 pandemic': 1, 'Collective call to action for HIV/AIDS community-based collaborative science in the era of COVID-19': 1, 'Group for lessons from pandemic HIV prevention for the COVID-19 response. Three lessons for the COVID-19 response from pandemic HIV': 1, 'A Survey for COVID-19 Among HIV/AIDS Patients in Two Districts of Wuhan': 3, 'Computed tomography imaging of an HIV-infected patient with coronavirus disease 2019 (COVID-19)': 2, 'One case of Coronavirus disease 2019 (COVID-19) in a patient co-infected by HIV with a low CD4+ T cell count': 1, 'Early virus clearance and delayed antibody response in a case of COVID-19 with a history of co-infection with HIV-1 and HCV': 2, 'SARS-CoV-2 pandemic expanding in sub-Saharan Africa: Considerations for COVID-19 in people living with HIV': 1, 'COVID-19 in patients with HIV: clinical case series': 2, 'Darunavir does not prevent SARS-CoV-2 infection in HIV patients': 3, 'Protease inhibitors targeting coronavirus and filovirus entry': 1, 'A trial of Lopinavir-Ritonavir in adults hospitalized with severe Covid-19': 1, 'Lack of severe acute respiratory syndrome in 19 AIDS patients hospitalized together': 1, 'Post-exposure prophylaxis for Middle East respiratory syndrome in healthcare workers': 1, 'Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID-19: initial assessment': 1, 'Burden of respiratory viral infection in persons with human immunodeficiency virus. Influenza Other Respir Viruses': 1, 'Mortality amongst patients with influenza-associated severe acute respiratory illness, South Africa': 1, 'Clinical and immunologic features in severe and moderate Coronavirus Disease': 1, 'Dysregulation of immune response in patients with COVID-19 in Wuhan, China': 4, 'New signatures of poor CD4 cell recovery after suppressive antiretroviral therapy in HIV-1-infected individuals: involvement of miR-192, IL-6, sCD14 and miR-144': 1, 'The impact of influenza and tuberculosis interaction on mortality among individuals aged ≥15 years hospitalized with severe respiratory illness in South Africa': 1, 'The influence of influenza on tuberculosis': 1, 'Regulation of immunity to tuberculosis': 1, 'CD4+ regulatory T cells and CD4+ activated T cells in new active and relapse tuberculosis': 1, 'Pulmonary tuberculosis and SARS': 1, 'Lowered tuberculosis notifications and deterred health care seeking during the SARS epidemic in Hong Kong': 1, 'Global Burden of Disease Study. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study': 1, 'Mixed viral infections: detection and management': 4, 'Single, dual and multiple respiratory virus infections and risk of hospitalization and mortality': 7, 'Influenza A viruses dual and multiple infections with other respiratory viruses and risk of hospitalisation and mortality. Influenza Other Respir Viruses': 4, 'Multiple versus single virus respiratory infections: viral load and clinical disease severity in hospitalized children. Influenza and other respir viruses': 6, 'Epidemiology of Multiple Respiratory Viruses in Childcare Attendees': 5, 'Infection With Multiple Viruses is not Associated With Increased Disease Severity in Children With Bronchiolitis': 6, 'High Incidence of Multiple Viral Infections Identified in Upper Respiratory Tract Infected Children under Three Years of Age in Shanghai': 5, 'Children with multiple viral respiratory infections are older than those with single viruses. Acta paediatr': 4, 'Three-Year Study of Viral Etiology and Features of Febrile Respiratory Tract Infections in Japanese Pediatric Outpatients': 1, 'Pandemic clinical case definitions are non-specific: multiple respiratory viruses circulating in the early phases of the 2009 influenza pandemic in New South Wales': 1, 'Interference Phenomena Between Animal Viruses: A Review': 1, 'An interference phenomenon in relation to yellow fever and other viruses': 1, 'Interference by one virus with the growth of another in tissue-culture': 1, 'Interference between the influenza viruses: 1. The effect of active viruses upon the multiplication of influenza viruses in the chick embryo': 1, 'Single Versus Dual Respiratory Virus Infections in Hospitalized Infants Impact on Clinical Course of Disease and Interferon γ Response': 1, 'Pathology of Guinea Pigs Experimentally Infected with a Novel Reovirus and Coronavirus Isolated from SARS Patients': 1, 'In vitro and ex vivo analyses of co-infections with swine influenza and porcine reproductive and respiratory syndrome viruses. Vet mircobiol': 3, 'In vitro growth profiles of respiratory syncytial virus in the presence of influenza virus': 7, 'Kinetics of influenza A virus infection in humans': 4, 'On Identifiability of Nonlinear ODE Models and Applications in Viral Dynamics': 2, 'An accurate two-phase approximate solution to an acute viral infection model': 3, 'Modeling amantadine treatment of influenza A virus in vitro': 2, 'Improvements in methods for calculating virus titer estimates from TCID 50 and plaque assays': 1, 'Impact of the H275Y and I223V Mutations in the Neuraminidase of the 2009 Pandemic Influenza Virus In Vitro and Evaluating Experimental Reproducibility': 2, 'Assessing the In Vitro Fitness of an Oseltamivir-Resistant Seasonal A/H1N1 Influenza Strain Using a Mathematical Model': 2, 'The H275Y Neuraminidase Mutation of the Pandemic A/H1N1 Influenza Virus Lengthens the Eclipse Phase and Reduces Viral Output of Infected Cells, Potentially Compromising Fitness in Ferrets': 2, 'Assessing uncertainty in A2 respiratory syncytial virus (RSV) viral dynamics': 2, 'Modeling inoculum dose dependent patterns of acute virus infections': 1, 'Dominance of hepatitis C virus (HCV) is associated with lower quantitative hepatitis B surface antigen and higher serum interferon-gamma-induced protein 10 levels in HBV/HCV-coinfected patients': 2, 'Viral interaction and clinical implications of coinfection of hepatitis C virus with other hepatitis viruses': 3, 'Hepatitis B and C virus coinfection: a novel model system reveals the absence of direct viral interference': 3, 'Rates and effectiveness of antiviral use among hospitalized influenza patients': 1, 'Chemotherapy of respiratory syncytial virus infections: the final breakthrough': 1, 'A novel broad-spectrum treatment for respiratory virus infections: Influenza-based defective interfering virus provides protection against pneumovirus infection in vivo. Vaccine': 1, 'Cloned Defective Interfering Influenza RNA and a Possible Pan-Specific Treatment of Respiratory Virus Diseases': 1, 'Defective interfering influenza A virus protects in vivo against disease caused by a heterologous influenza B virus': 1, 'Coinfection in acute gastroenteritis predicts a more severe clinical course in children': 1, 'Coinfection of Viral Agents in Korean Children with Acute Watery Diarrhea': 1, 'Hepatitis B virus/hepatitis C virus coinfection: Epidemiology, clinical features, viral interactions and treatment': 1, 'The influence of hepatitis B and C virus coinfection on liver histopathology in children': 1, 'Genital prevalence of HPV types and co-infection in men': 1, 'A systematic approach to virus-virus interactions': 1, 'Assessing mathematical models of influenza infections using features of the immune response': 2, 'The Lung: Scientific Foundations': 2, 'Superinfection exclusionby Citrus tristeza virus does not correlate with the production of viral small RNAs': 1, 'Sialic Acid Receptors of Viruses': 2, 'Viral Tropism and the Pathogenesis of Influenza in the Mammalian Host': 1, 'Respiratory syncytial virus receptor expression in the mouse and viral tropism': 2, 'Experimental Human Metapneumovirus Infection of Cynomolgus Macaques (Macaca fascicularis) Results in Virus Replication in Ciliated Epithelial Cells and Pneumocytes with Associated Lesions throughout the Respiratory Tract': 2, 'Sialic acid-specific lectins: occurrence, specificity and function': 1, 'A conservation law for virus infection kinetics in vitro': 1, 'Quantifying relative within-host replication fitness in influenza virus competition experiments': 1, 'GNU Octave version 3.6.4; 2010. A free open-source software for solving linear and nonlinear problems numerically, and for performing other numerical experiments using a language that is mostly compatible with Matlab': 1, 'Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy': 1, 'Stuck on sugars-how carbohydrates regulate cell adhesion, recognition, and signaling': 1, 'Protein-glycan interactions in the control of innate and adaptive immune responses': 1, 'Galectins: Their network and roles in immunity/tumor growth control': 1, 'Siglec-mediated regulation of immune cell function in disease': 1, 'C-type lectins: Their network and roles in pathogen recognition and immunity': 4, 'The functional relevance of shrimp C-type lectins in host-pathogen interactions': 1, 'Insect C-type lectins in innate immunity': 1, 'Cell Antifungal Immunity and the Role of C-Type Lectin Receptors': 1, 'Early Stop Polymorphism in Human DECTIN-1 is Associated with Increased Candida Colonization in Hematopoietic Stem Cell Transplant Recipients': 1, 'Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient-and donor-dependent mechanisms of antifungal immunity': 1, 'DNGR-1 in dendritic cells limits tissue damage by dampening neutrophil recruitment': 1, 'Lectin Receptor Dectin-1 Suppresses the Development of Experimental Autoimmune Encephalomyelitis': 1, 'Signaling by myeloid C-type lectin receptors in immunity and homeostasis': 1, 'Endogenous ligands for C-type lectin receptors: The true regulators of immune homeostasis': 1, 'Bacterial glycans and their interactions with lectins in the innate immune system': 1, 'Myeloid C-Type Lectin Receptors in Viral Recognition and Antiviral Immunity': 1, 'Parasitic Infections: A Role for C-Type Lectins Receptors': 1, 'The innate immune receptor Dectin-2 mediates the phagocytosis of cancer cells by Kupffer cells for the suppression of liver metastasis': 1, 'C-type lectins in immunity: Recent developments': 1, 'C-type lectins in immunity and homeostasis': 2, 'Contact, Collaboration, and Conflict: Signal Integration of Syk-Coupled C-Type Lectin Receptors': 2, 'Flexible Signaling of Myeloid C-Type Lectin Receptors in Immunity and Inflammation': 2, 'MICL controls inflammation in rheumatoid arthritis': 1, 'The C-type Lectin Receptor-Driven, Th17 Cell-Mediated Severe Pathology in Schistosomiasis: Not All Immune Responses to Helminth Parasites Are Th2 Dominated': 1, 'The C-type Lectin Receptor CLEC12A Recognizes Plasmodial Hemozoin and Contributes to Cerebral Malaria Development': 2, 'The C-Type Lectin Receptor DCIR Is Crucial for the Development of Experimental Cerebral Malaria': 1, 'Inhibition of TREM-1 and Dectin-1 Alleviates the Severity of Fungal Keratitis by Modulating Innate Immune Responses': 2, 'Lectin-Like Receptors as Emerging Orchestrators of Sterile Inflammation Represent Potential Therapeutic Targets': 2, 'C-type lectins facilitate tumor metastasis': 1, 'A platform to screen for C-type lectin receptor-binding carbohydrates and their potential for cell-specific targeting and immune modulation': 3, 'Characterization of murine MGL1 and MGL2 C-type lectins: Distinct glycan specificities and tumor binding properties': 1, 'Direct Binding Analysis Between C-Type Lectins and Glycans Using Immunoglobulin Receptor Fusion Proteins': 1, 'Comparison of innate and Th1-type host immune responses in Oesophagostomum dentatum and Trichuris suis infections in pigs': 2, 'Van Die, I. Trichuris suis-induced modulation of human dendritic cell function is glycan-mediated': 1, 'C-Type Lectin Receptor (CLR)-Fc Fusion Proteins As Tools to Screen for Novel CLR/Bacteria Interactions: An Exemplary Study on Preselected Campylobacter jejuni Isolates': 1, 'Lectin Receptor MCL Facilitates Mincle Expression and Signaling through Complex Formation': 1, 'Identification of Distinct Ligands for the C-type Lectin Receptors Mincle and Dectin-2 in the Pathogenic Fungus Malassezia': 1, 'Van Die, I. Schistosoma mansoni soluble egg antigens are internalized by human dendritic cells through multiple C-type lectins and suppress TLR-induced dendritic cell activation': 1, 'The Syk-Coupled C-Type Lectin Receptors Dectin-2 and Dectin-3 Are Involved in Paracoccidioides brasiliensis Recognition by Human Plasmacytoid Dendritic Cells': 1, 'Toll-Like Receptor 2 and Mincle Cooperatively Sense Corynebacterial Cell Wall Glycolipids': 1, 'Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle': 1, 'Clec12a Is an Inhibitory Receptor for Uric Acid Crystals that Regulates Inflammation in Response to Cell Death': 1, 'Human Mincle Binds to Cholesterol Crystals and Triggers Innate Immune Responses': 2, 'C-Type Lectin Receptor DCAR Recognizes Mycobacterial Phosphatidyl-Inositol Mannosides to Promote a Th1 Response during Infection': 1, 'Mechanistic Insights into the Role of C-Type Lectin Receptor/CARD9 Signaling in Human Antifungal Immunity': 1, 'The C-type lectin receptor CLECSF8/CLEC4D is a key component of anti-mycobacterial immunity': 1, 'Porcine CLEC12B is expressed on alveolar macrophages and blood dendritic cells': 1, 'Cell type-specific differences in β-glucan recognition and signalling in porcine innate immune cells': 1, 'Immune transcriptome reveals the mincle C-type lectin receptor acts as a partial replacement for TLR4 in lipopolysaccharide-mediated inflammatory response in barramundi (Lates calcarifer)': 1, 'The selective Dectin-1 agonist, curdlan, induces an oxidative burst response in chicken heterophils and peripheral blood mononuclear cells': 1, 'Mincle and STING-Stimulating Adjuvants Elicit Robust Cellular Immunity and Drive Long-Lasting Memory Responses in a Foot-and-Mouth Disease Vaccine': 2, 'CD23 is a glycan-binding receptor in some mammalian species': 1, 'Bacterial Polysaccharide Specificity of the Pattern Recognition Receptor Langerin Is Highly Species-dependent': 1, 'Mycobacterium tuberculosis β-gentiobiosyl diacylglycerides signal through the pattern recognition receptor Mincle: Total synthesis and structure activity relationships': 1, 'Recent insights into structures and functions of C-type lectins in the immune system': 1, 'Glycerol Monomycolate Is a Novel Ligand for the Human, but Not Mouse Macrophage Inducible C-type Lectin, Mincle': 1, 'The signaling relations between three adaptors of porcine C-type lectin receptor pathway': 1, 'Ovine C-type lectin receptor hFc-fusion protein library-A novel platform to screen for host-pathogen interactions': 4, 'Mammalian lectin arrays for screening host-microbe interactions': 4, 'fr: New generation phylogenetic services for non-specialists': 1, 'Single-nucleotide polymorphisms in CLEC7A, CD209 and TLR4 gene and their association with susceptibility to paratuberculosis in Indian cattle': 2, 'Genome-wide association analysis in dogs implicates 99 loci as risk variants for anterior cruciate ligament rupture': 2, \"Bovine CLEC7A genetic variants and their association with seropositivity in Johne's disease ELISA\": 2, 'Association of Bovine CLEC7A gene polymorphism with host susceptibility to paratuberculosis disease in Indian cattle': 2, 'Polymorphisms of the immune-modulating receptor dectin-1 in pigs: Their functional influence and distribution in pig populations': 6, 'Single nucleotide variants in innate immune genes associated with Salmonella shedding and colonization in swine on commercial farms': 2, 'Broilers with low serum Mannose-binding Lectin show increased fecal shedding of Salmonella enterica serovar Montevideo': 2, 'Polymorphisms in mannose-binding lectin (MBL) gene and their association with MBL protein levels in serum in the Hu sheep': 2, 'Identification and expression modulation of a C-type lectin domain family 4 homologue that is highly expressed in monocytes/macrophages in rainbow trout (Oncorhynchus mykiss)': 3, 'Characterization and Functional Analysis of Two Transmembrane C-Type Lectins in Obscure Puffer (Takifugu obscurus). Front': 2, 'Studies Into β-Glucan Recognition in Fish. Suggests a Key Role for the C-Type Lectin Pathway': 4, 'Beta-glucan recognition by the innate immune system': 2, 'Recognition of purified beta 1,3/1,6 glucan and molecular signalling in the intestine of Atlantic salmon': 1, 'Dectin-1 Positive Dendritic Cells Expand after Infection with Leishmania major Parasites and Represent Promising Targets for Vaccine Development': 3, 'Dectin-1 Activation during Leishmania amazonensis Phagocytosis Prompts Syk-Dependent Reactive Oxygen Species Production to Trigger Inflammasome Assembly and Restriction of Parasite Replication': 1, 'Recombinant Forms of Leishmania amazonensis Excreted/Secreted Promastigote Surface Antigen (PSA) Induce Protective Immune Responses in Dogs': 1, 'Early antibody response and clinical outcome in experimental canine leishmaniasis': 1, 'Assessment of Vaccine-Induced Immunity Against Canine Visceral Leishmaniasis': 1, 'The genetic architecture of helminth-specific immune responses in a wild population of Soay sheep (Ovis aries)': 2, 'Association of CLEC16A with human common variable immunodeficiency disorder and role in murine B cells': 1, 'Gene Expression Response to Sea Lice in Atlantic Salmon Skin: RNA Sequencing Comparison Between Resistant and Susceptible Animals': 1, 'Comparative transcriptomics of Atlantic Salmo salar, chum Oncorhynchus keta and pink salmon O. gorbuscha during infections with salmon lice Lepeophtheirus salmonis': 1, 'Impact of uterine macrophage phenotype on placental retention in dairy cows': 1, 'Investigating the epithelial barrier and immune signatures in the pathogenesis of equine insect bite hypersensitivity': 1, 'An Essential Role for Dectin 1 in the Pathogenesis of Aspergillus fumigatus Keratitis': 1, 'The uric acid crystal receptor Clec12A potentiates type I interferon responses': 1, 'DC-SIGN as a Receptor for Phleboviruses': 1, 'Chapter Six-Feline Coronaviruses: Pathogenesis of Feline Infectious Peritonitis': 1, 'Feline Lectin Activity Is Critical for the Cellular Entry of Feline Infectious Peritonitis Virus': 1, 'Expression of the C-type lectins DC-SIGN or L-SIGN alters host cell susceptibility for the avian coronavirus, infectious bronchitis virus': 3, 'Yersinia pestis Interacts With SIGNR1 (CD209b) for Promoting Host Dissemination and Infection': 1, 'Lectins Promote Host Invasion, Dissemination, and Infection of Toxoplasma gondii': 2, 'Fasciola hepatica glycoconjugates immuneregulate dendritic cells through the Dendritic Cell-Specific Intercellular adhesion molecule-3-Grabbing Non-integrin inducing T cell anergy': 1, 'Neospora abortions in dairy cattle: Diagnosis, mode of transmission and control': 1, 'Dectin-1 Compromises Innate Responses and Host Resistance against': 1, 'Identification of a new C-type lectin, TES-70, secreted by infective larvae of Toxocara canis, which binds to host ligands': 1, 'A novel C-type lectin secreted by a tissue-dwelling parasitic nematode': 1, 'Glycan gimmickry by parasitic helminths: A strategy for modulating the host immune response? Glycobiology': 2, 'Helminth glycomics-glycan repertoires and host-parasite interactions': 1, 'Analysis of Swine Conventional Dendritic Cells, DEC205+CD172a+/-CADM1+, from Blood and Spleen in Response to PRRSV and PEDV': 1, 'Glycointeractions in bacterial pathogenesis': 1, 'Lectin microarrays for glycoproteomics: An overview of their use and potential. Expert Rev': 1, 'Cutting edge: Mincle is essential for recognition and adjuvanticity of the mycobacterial cord factor and its synthetic analog trehalose-dibehenate': 1, 'Rational design of adjuvants targeting the C-type lectin Mincle': 1, 'Targeting Syk-Card9-activating C-type lectin receptors by vaccine adjuvants: Findings, implications and open questions': 1, 'Targeting the Mincle and TLR3 receptor using the dual agonist cationic adjuvant formulation 9 (CAF09) induces humoral and polyfunctional memory T cell responses in calves': 1, 'A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human': 1, 'Aasted, B. CAF01 Potentiates Immune Responses and Efficacy of an Inactivated Influenza Vaccine in Ferrets': 1, 'Injection Vaccines Formulated with Nucleotide, Liposomal or Mineral Oil Adjuvants Induce Distinct Differences in Immunogenicity in Rainbow Trout': 1, 'Aryl Trehalose Derivatives as Vaccine Adjuvants for Mycobacterium tuberculosis': 1, 'Characterization of the Porcine CLEC12A and Analysis of Its Expression on': 1, 'Pustulan Activates Chicken Bone Marrow-Derived Dendritic Cells In Vitro and Promotes Ex Vivo CD4+ T Cell Recall Response to Infectious Bronchitis Virus': 1, 'Targeting antigens to Dec-205 on dendritic cells induces a higher immune response in chickens: Hemagglutinin of avian influenza virus example': 1, 'Construction and expression of a single-chain variable fragment antibody against chicken DEC 205 for targeting the bacterial expressed hemagglutinin-neuraminidase of Newcastle disease virus': 1, 'Identification and tissue-expression profiling of novel chicken c-type lectin-like domain containing proteins as potential targets for carbohydrate-based vaccine strategies': 1, 'Administration of β-glucan following Leishmania major infection suppresses disease progression in mice': 1, 'Non-specific and specific stimulation of resistance against Leishmania donovani in C57BL/6 mice': 1, 'Molecular Detection of Leishmania spp. in Skin and Blood of Stray Dogs from Endemic Areas of Cutaneous Leishmaniasis in Saudi Arabia': 1, 'Phylogenetic insights on Leishmania detected in cats as revealed by nucleotide sequence analysis of multiple genetic markers': 1, 'Molecular investigation of vector-borne pathogens in red foxes (Vulpes vulpes) from southern France': 1, 'Molecular identification of Toxoplasma gondii in domesticated and broiler chickens (Gallus domesticus) that possibly augment the pool of human toxoplasmosis': 1, 'Helminth-derived immunomodulators: Can understanding the worm produce the pill?': 1, 'The carbohydrate-recognition domain of Dectin-2 is a C-type lectin with specificity for high mannose': 1, 'Mechanism of pathogen recognition by human dectin-2': 1, 'Mite allergoids coupled to nonoxidized mannan from Saccharomyces cerevisae efficiently target canine dendritic cells for novel allergy immunotherapy in veterinary medicine': 1, 'Mincle, an Innate Immune Receptor, Is Expressed in Urothelial Cancer Cells of Papillomavirus-Associated Urothelial Tumors of Cattle': 1, 'Symbiotic Bacteria Direct Expression of an Intestinal Bactericidal Lectin': 1, 'Microbiota Inhibit Epithelial Pathogen Adherence by Epigenetically Regulating C-Type Lectin Expression': 1, 'C-type lectin receptor-mediated immune recognition and response of the microbiota in the gut': 1, 'The Effects of Lentinan on the Expression Patterns of β-Catenin, Bcl-2, and Bax in Murine Bone Marrow Cells Are Associated with Enhancing Dectin-1': 1, 'The Prefrontal Dectin-1/AMPA Receptor Signaling Pathway Mediates the Robust and Prolonged Antidepressant Effect of Proteo-β-Glucan from Maitake': 2, 'Lentinan produces a robust antidepressant-like effect via enhancing the prefrontal Dectin-1/AMPA receptor signaling pathway': 1, 'Tryptophan Metabolites Along the Microbiota-Gut-Brain Axis: An Interkingdom Communication System Influencing the Gut in Health and Disease': 1, 'Nutraceuticals: An. Alternative Strategy for the Use of Antimicrobials': 1, 'Dietary Bacillus amyloliquefaciens enhance survival of white spot syndrome virus infected crayfish': 1, 'Supplementation Alters Gut Microbiome and Corrects Dyslipidemia in Rats': 1, 'Innate Immune Responses of Skin Mucosa in Common Carp (Cyprinus Carpio) Fed a Diet Supplemented with Galactooligosaccharides': 1, 'Active fractions of mannoproteins derived from yeast cell wall stimulate innate and acquired immunity of adult and elderly dogs': 1, 'Expression of C-type lectin receptors and Toll-like receptors in decidua of patients with unexplained recurrent spontaneous abortion': 1, 'Expression and function of macrophage-inducible C-type lectin (Mincle) in inflammation driven parturition in fetal membranes and myometrium': 1, 'Discovery of candidate genes and pathways in the endometrium regulating ovine blastocyst growth and conceptus elongation': 1, 'Neurologic features in severe SARS-CoV-2 infection': 1, 'Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic?': 3, 'Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and metaanalysis with comparison to the COVID-19 pandemic': 1, 'Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study': 2, 'Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms': 2, 'Magnetic resonance imaging alteration of the brain in a patient with coronavirus disease 2019 (COVID-19) and anosmia': 1, 'Is the collapse of the respiratory center in the brain responsible for respiratory breakdown in COVID-19 patients?': 2, 'The anatomical connections of the macaque monkey orbitofrontal cortex': 1, 'PET imaging of COVID-19: the target and the number': 1, 'Infection and inflammation imaging: beyond FDG': 1, 'Coronavirus: Organization, replication and expression of genome': 1, 'Evolving the largest RNA virus genome': 1, 'An evolutionary perspective on synonymous codon usage in unicellular organisms': 2, 'An information-intensive approach to the molecular pharmacology of cancer': 2, 'DAMBE5: A comprehensive software package for data analysis in molecular biology and evolution': 2, 'The codon adaptation index-A measure of directional synonymous codon usage bias, and its potential applications': 1, 'Coronavirus genomics and bioinformatics analysis': 2, 'Insights into the genetic and host adaptability of emerging porcine circovirus': 2, \"The 'effective number of codons' used in a gene\": 3, 'Directional mutation pressure and neutral molecular evolution': 3, 'Mutations in disordered proteins as early indicators of nucleic acid changes triggering speciation': 5, 'Clustal Omega, accurate alignment of very large numbers of sequences': 1, 'Molecular Evolutionary Genetics Analysis across Computing Platforms': 1, 'ModelTest-NG: A New and Scalable Tool for the Selection of DNA and Protein Evolutionary Models': 1, 'Analysis of preferred codon usage in the coronavirus N genes and their implications for genome evolution and vaccine design': 2, 'Cytosine deamination and selection of CpG suppressed clones are the two major independent biological forces that shape codon usage bias in coronaviruses': 1, 'Analysis of the codon usage pattern in Middle East Respiratory Syndrome Coronavirus': 1, 'Cross-species transmission of the newly identified coronavirus 2019-nCoV': 1, \"Why snakes probably aren't spreading the new China virus\": 4, 'Protein Structure and Sequence Reanalysis of 2019-nCoV Genome Refutes Snakes as Its Intermediate Host and the Unique Similarity between Its Spike Protein Insertions and HIV-1': 2, 'Genomic variance of the 2019-nCoV coronavirus': 1, 'Coronavirus Diversity, Phylogeny and Interspecies Jumping': 1, 'The Coronavirus Surface Glycoprotein': 1, 'The coronavirus E protein: assembly and beyond': 1, 'A structural analysis of M protein in coronavirus assembly and morphology': 1, 'Cloning, sequencing, expression, and purification of SARS-associated coronavirus nucleocapsid protein for serodiagnosis of SARS': 3, 'COVID-19 Tragic Pandemic: Concerns over Unintentional \"Directed Accelerated Evolution\" of Novel Coronavirus (SARS-CoV-2) and Introducing a Modified Treatment Method for ARDS': 1, 'The acute respiratory distress syndrome: from mechanism to translation': 2, 'The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The experience of clinical immunologists from China': 1, 'How radiotherapy was historically used to treat pneumonia: Could it be useful today?': 1, 'Is low dose radiation herapy a potential treatment for COVID-19 pneumonia? Radiother. Oncol. 2020. [CrossRef] c 2020 by the authors': 1, 'Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus': 2, 'Systematic assembly of a full-length infectious cDNA of mouse hepatitis virus strain A59': 1, 'Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus': 5, 'Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry': 3, 'Four proteins processed from the replicase gene polyprotein of mouse hepatitis virus colocalize in the cell periphery and adjacent to sites of virion assembly': 4, 'Mouse hepatitis virus replicase protein complexes are translocated to sites of M protein accumulation in the ERGIC at late times of infection': 1, 'Coronavirus M protein accumulates in the Golgi complex beyond the site of virion budding': 1, 'Characterization of the budding compartment of mouse hepatitis virus: evidence that transport from the RER to the Golgi complex requires only one vesicular transport step': 1, 'The putative helicase of the coronavirus mouse hepatitis virus is processed from the replicase gene polyprotein and localizes in complexes that are active in viral RNA synthesis': 2, 'Mouse hepatitis virus replicase proteins associate with two distinct populations of intracellular membranes': 3, 'Localization of mouse hepatitis virus nonstructural proteins and RNA synthesis indicates a role for late endosomes in viral replication': 2, 'Characterization of the coronavirus mouse hepatitis strain A59 small membrane protein E': 1, 'Characterization of the coronavirus M protein and nucleocapsid interaction in infected cells': 1, 'Complex formation between the spike protein and the membrane protein during mouse hepatitis virus assembly': 1, 'Envelope glycoprotein interactions in coronavirus assembly': 1, 'Analysis of constructed E gene mutants of mouse hepatitis virus confirms a pivotal role for E protein in coronavirus assembly': 1, 'Programmed ribosomal frameshifting in decoding the SARS-CoV genome': 1, 'Programmed-1 ribosomal frameshifting in the SARS coronavirus': 2, 'Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity': 5, 'pH-dependent conformational flexibility of the SARS-CoV main proteinase (M(pro)) dimer: molecular dynamics simulations and multiple X-ray structure analyses': 4, 'Processing of the MHV-A59 gene 1 polyprotein by the 3C-like proteinase': 1, 'Mouse hepatitis virus 3C-like protease cleaves a 22-kilodalton protein from the open reading frame 1a polyprotein in virus-infected cells and in vitro': 1, 'Characterization of the leader papain-like proteinase of MHV-A59: identification of a new in vitro cleavage site': 1, 'Characterization of a second cleavage site and demonstration of activity in trans by the papain-like proteinase of the murine coronavirus mouse hepatitis virus strain A59': 1, 'Determinants of the p28 cleavage site recognized by the first papain-like cysteine proteinase of murine coronavirus': 1, 'Processing of the replicase of murine coronavirus: papain-like proteinase 2 (PLP2) acts to generate p150 and p44': 1, 'Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage': 4, 'Expression of murine coronavirus recombinant papain-like proteinase: efficient cleavage is dependent on the lengths of both the substrate and the proteinase polypeptides': 1, 'Episodic evolution mediates interspecies transfer of a murine coronavirus': 1, 'Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China': 5, 'Severe acute respiratory syndrome coronavirus group-specific open reading frames encode nonessential functions for replication in cell cultures and mice': 7, 'A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice': 8, 'Identification and characterization of severe acute respiratory syndrome coronavirus replicase proteins': 4, 'The nsp2 replicase proteins of murine hepatitis virus and severe acute respiratory syndrome coronavirus are dispensable for viral replication': 5, 'Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation': 2, 'A role for the non-structural protein-1 of SARS-coronavirus in chemokine dysregulation': 1, 'ADP-ribose-1 -monophosphatase: a conserved coronavirus enzyme that is dispensable for viral replication in tissue culture': 2, 'Intracellular processing of the N-terminal ORF 1a proteins of the coronavirus MHV-A59 requires multiple proteolytic events': 1, 'Processing of the coronavirus mhv-jhm polymerase polyprotein: identification of precursors and proteolytic products spanning 400 kilodaltons of ORF1a': 2, 'The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity': 1, 'The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme': 1, 'Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme': 2, 'Papain-like protease 2 (PLP2) from severe acute respiratory syndrome coronavirus (SARS-CoV): expression, purification, characterization, and inhibition': 1, 'Identification of the polymerase polyprotein products p72 and p65 of the murine coronavirus MHV-JHM': 1, 'Intracellular localization and protein interactions of the gene 1 protein p28 during mouse hepatitis virus replication': 1, 'Mouse hepatitis virus strain A59 RNA polymerase gene ORF 1a: heterogeneity among MHV strains': 2, 'RNA replication of mouse hepatitis virus takes place at double-membrane vesicles': 1, 'Coronavirus replication complex formation utilizes components of cellular autophagy': 4, 'Identification of the murine coronavirus MP1 cleavage site recognized by papain-like proteinase 2': 3, 'Intracellular and in vitro translated 27-kDa proteins contain the 3C-like proteinase activity of the coronavirus MHV-A59': 1, 'The severe acute respiratory syndrome coronavirus Nsp15 protein is an endoribonuclease that prefers manganese as a cofactor': 1, 'Mechanisms and enzymes involved in SARS coronavirus genome expression': 2, 'Identification of polypeptides encoded in open reading frame 1b of the putative polymerase gene of the murine coronavirus mouse hepatitis virus A59': 1, 'Discovery of an RNA virus 3 →5 exoribonuclease that is critically involved in coronavirus RNA synthesis': 2, 'Single-amino-acid substitutions in open reading frame (ORF) 1b-nsp14 and ORF 2a proteins of the coronavirus mouse hepatitis virus are attenuating in mice': 2, 'Effects of mutagenesis of murine hepatitis virus nsp1 and nsp14 on replication in culture': 1, 'RNA recognition and cleavage by the SARS coronavirus endoribonuclease': 1, 'Quaternary structure of the severe acute respiratory syndrome (SARS) coronavirus main protease': 1, 'The severe acute respiratory syndrome-coronavirus replicative protein nsp9 is a single-stranded RNA-binding subunit unique in the RNA virus world': 1, 'Crystal structure of nonstructural protein 10 from the severe acute respiratory syndrome coronavirus reveals a novel fold with two zinc-binding motifs': 2, 'Crystal structures of the main peptidase from the SARS coronavirus inhibited by a substrate-like aza-peptide epoxide': 1, 'Crystal structure and mechanistic determinants of SARS coronavirus nonstructural protein 15 define an endoribonuclease family': 1, 'Structural basis of severe acute respiratory syndrome coronavirus ADP-ribose-1 -phosphate dephosphorylation by a conserved domain of nsP3': 1, 'Dodecamer structure of severe acute respiratory syndrome coronavirus nonstructural protein nsp10': 2, 'The nsp9 replicase protein of SARS-coronavirus, structure and functional insights': 1, 'Insights into SARS-CoV transcription and replication from the structure of the nsp7-nsp8 hexadecamer': 1, 'New antiviral target revealed by the hexameric structure of mouse hepatitis virus nonstructural protein nsp15': 1, 'The inclusive cost of pandemic influenza risk (working paper 22137)': 1, 'An R&D blueprint for action to prevent epidemics. Accelerating R&D and saving lives. Geneva: World Health Organization': 1, \"Report from the World Health Organization's Product Development for Vaccines Advisory Committee (PDVAC) meeting\": 1, 'Antibiotic resistance threats in the United States': 1, 'The Coalition for Epidemic Preparedness Innovations (CEPI)': 1, 'Establishing a global vaccine-development fund (perspective)': 1, 'The compelling need for game-changing influenza vaccines': 1, 'Advances in the development of influenza virus vaccines': 1, 'Induction of unnatural immunity: prospects for a broadly protective universal influenza vaccine (commentary)': 1, 'Global Vaccine Action Plan 2011-2020. Geneva: World Health Organization': 1, 'SAGE Working Group on Vaccine Hesitancy. How to deal with vaccine hesitancy?': 1, 'Global Action Plan for Influenza Vaccines. Geneva: World Health Organization': 1, 'Pandemic Influenza Preparedness (PIP) Framework. Geneva: World Health Organization': 1, 'Melbourne: Peter Doherty Institute for Infection and Immunity': 1, 'Global Action Plan for Influenza Vaccines': 1, 'A literature review to identify factors that determine policies for influenza vaccination': 1, 'Rift Valley fever': 4, 'Rift Valley fever: an emerging mosquitoborne disease': 2, 'The risk of Rift Valley fever virus introduction and establishment in the United States and European Union': 2, 'Rainfall and epizootic Rift Valley fever': 1, 'Risk factors for severe Rift Valley fever infection in Kenya': 1, 'Enzootic hepatitis or rift valley fever. An undescribed virus disease of sheep cattle and man from east africa': 1, 'The pathogenesis of Rift Valley fever': 1, 'Hemorrhagic fever viruses as biological weapons: medical and public health management': 1, 'Rift Valley fever virus: a real bioterror threat': 1, 'Molecular biology of Rift Valley fever virus': 1, 'Rift Valley fever virus nonstructural protein NSs promotes viral RNA replication and transcription in a Minigenome system': 1, 'NSm and 78-kilodalton proteins of Rift Valley fever virus are nonessential for viral replication in cell culture': 1, 'NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis': 1, 'NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription': 1, 'Genetic evidence for an interferon-antagonistic function of Rift Valley fever virus nonstructural protein NSs': 1, 'Rift Valley Fever Virus NSs Protein Promotes Post-Transcriptional Downregulation of Protein Kinase PKR and Inhibits eIF2α Phosphorylation': 1, 'Rift Valley fever: an uninvited zoonosis in the Arabian peninsula': 2, 'Prediction, assessment of the Rift Valley fever activity in east and southern Africa 2006-2008 and possible vector control strategies': 1, 'An investigation of a major outbreak of Rift Valley fever in Kenya': 2, 'Exploratory space-time analyses of Rift Valley fever in South Africa in': 2, 'Rift Valley fever in Namibia': 2, 'Rift Valley fever outbreak, southern Mauritania': 2, 'Widespread Rift Valley fever emergence in Senegal in 2013-2014': 2, 'Rift Valley fever and a new paradigm of research and development for zoonotic disease control': 1, 'The Nucleocapsid protein of Rift Valley fever virus is a potent human CD8(+) T cell antigen and elicits memory responses': 2, 'A glycoprotein subunit vaccine elicits a strong Rift Valley fever virus neutralizing antibody response in sheep': 2, 'A recombinant Rift Valley fever virus glycoprotein subunit vaccine confers full protection against Rift Valley fever challenge in sheep': 1, 'A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection': 1, 'Virus-like particles expressing the nucleocapsid gene as an efficient vaccine against Rift Valley fever virus. Vector Borne Zoonotic Dis': 1, 'Preparation and evaluation of a recombinant Rift Valley fever virus N protein for the detection of IgG and IgM antibodies in humans and animals by indirect ELISA': 2, 'Immunization against rift valley fever virus. Studies on the immunogenicity of lyophilized formalin-inactivated vaccine': 1, 'Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study': 1, 'Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep': 1, 'Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment': 1, 'Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus': 1, 'Baculovirus expression of the M genome segment of Rift Valley fever virus and examination of antigenic and immunogenic properties of the expressed proteins': 1, 'Vaccination with virus-like particles protects mice from lethal infection of Rift Valley fever virus': 1, 'Efficacy of three candidate Rift Valley fever vaccines in sheep': 2, 'Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever': 1, 'Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate': 1, 'Rift Valley fever virus clearance and protection from neurologic disease are dependent on CD4(+) T cell and virus-specific antibody responses': 3, 'Epitope-based vaccine target screening against highly pathogenic MERS-CoV: an in silico approach applied to emerging infectious diseases': 1, 'Recombinant and epitope-based vaccines on the road to the market and implications for vaccine design and production': 2, 'Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine development': 2, 'Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: a randomized, placebo controlled trial for dose optimization in 128 healthy subjects': 1, 'Approaching rational epitope vaccine design for hepatitis C virus with meta-server and multivalent scaffolding': 2, 'Construction and immunological evaluation of multivalent hepatitis B virus (HBV) core virus-like particles carrying HBV and HCV epitopes': 1, 'A novel HIV T helper epitope-based vaccine elicits cytokine-secreting HIV-specific CD4+ T cells in a Phase I clinical trial in HIV-uninfected adults': 2, 'Time for T? Immunoinformatics addresses vaccine design for neglected tropical and emerging infectious diseases': 2, 'ViPR: an open bioinformatics database and analysis resource for virology research': 1, 'Multiple sequence alignment using ClustalW and ClustalX': 1, 'VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines': 1, 'Predicting transmembrane protein topology with a hidden markov model: application to complete gen-omes11 Edited by F': 2, 'Evaluation of methods for the prediction of membrane spanning regions': 1, 'Largescale validation of methods for cytotoxic T-lymphocyte epitope prediction': 2, 'Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method': 1, 'Vaccine development': 1, 'Properties of MHC class I presented peptides that enhance immunogenicity': 1, 'Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccines': 1, 'AllerHunter: a SVM-pairwise system for assessment of allergenicity and allergic cross-reactivity in proteins': 1, 'Prediction of IL4 inducing peptides': 2, 'Predicting population coverage of T-cell epitope-based diagnostics and vaccines': 2, 'Prediction of continuous B-cell epitopes in an antigen using recurrent neural network': 2, 'Improved PEP-FOLD approach for peptide and miniprotein structure prediction': 1, 'PEP-FOLD: an updated de novo structure prediction server for both linear and disulfide bonded cyclic peptides': 1, 'AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility': 1, 'AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading': 1, 'Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand': 7, 'Open babel: an open chemical toolbox': 1, 'Crystallographic structure of a rheumatoid arthritis MHC susceptibility allele, HLA-DR1 (DRB1*0101), complexed with the immunodominant determinant of human type II collagen': 1, 'After 2015: infectious diseases in a new era of health and development': 1, 'Emerging and neglected infectious diseases: insights, advances, and challenges': 1, 'A highly conserved GEQYQQLR epitope has been identified in the nucleoprotein of Ebola virus by using an in silico approach': 1, 'In silicobased vaccine design against Ebola virus glycoprotein': 1, 'Computational elucidation of potential antigenic CTL epitopes in Ebola virus': 3, 'From ZikV genome to vaccine: in silico approach for the epitope-based peptide vaccine against Zika virus envelope glycoprotein': 1, 'Computational prediction and analysis of potential antigenic CTL epitopes in Zika virus: a first step towards vaccine development': 1, 'A computational assay to design an epitopebased peptide vaccine against chikungunya virus': 1, 'In silico prediction of epitopes for Chikungunya viral strains': 1, 'Prediction of epitopebased peptides for the utility of vaccine development from fusion and glycoprotein of Nipah virus using in silico approach': 1, 'Structural basis of T cell recognition': 1, 'Rift Valley fever virus: unanswered questions': 1, 'Peptide based vaccine approaches for cancer-a novel approach using a WT-1 synthetic long peptide and the IRX-2 immunomodulatory regimen': 2, 'Conserved peptides containing overlapping CD4+ and CD8 + T-cell epitopes in the H1N1 influenza virus: an immunoinformatics approach': 1, 'Metadherin peptides containing CD4(+) and CD8(+) T cell epitopes as a therapeutic vaccine candidate against cancer': 1, 'Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge': 1, 'Prediction and analysis of promiscuous T cellepitopes derived from the vaccine candidate antigens of Leishmania donovani binding to MHC class-II alleles using in silico approach': 1, 'Activated mouse T cells downregulate, process and present their surface TCR to cognate anti-idiotypic CD4 + T cells': 1, 'Rift Valley fever virus: a review of diagnosis and vaccination, and implications for emergence in Europe': 1, 'Anti-Cancer Agent': 1, 'Molegro Virtual Docker, DK-8000': 1, \"The European Prevention of Alzheimer's Dementia (EPAD) Longitudinal Cohort Study: Baseline Data Release V500.0. J Prev Alzheimers Dis\": 1, 'Integrated Care for Older People and the Implementation in the INSPIRE Study': 1, 'Revisiting the Hallmarks of Aging to Identify Markers of Biological Age': 1, \"Shift in Hospitalizations for Alzheimer's Disease to Related Dementias in France between\": 1, 'Virtually Perfect? Telemedicine for Covid-19': 1, 'Letter to the Editor: Preventing Dementia through Community Involvement and Altruistic Behaviors': 1, \"Geographic Clusters of Alzheimer's Disease Mortality Rates in the USA\": 1, 'COVID-19 and the consequences of isolating the elderly Lancet Public Health': 1, 'Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review': 1, 'Prevalence and severity of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis': 1, 'As COVID-19 cases, deaths and fatality rates surge in Italy, underlying causes require investigation': 3, 'Cross-country comparison of case fatality rates of COVID-19 / SARS-CoV-2': 3, 'Prevalence and fatality rates of COVID-19: what are the reasons for the wide variations worldwide': 5, 'Regulation and trust: 3-month follow-up study on COVID-19 mortality in 25 European countries': 2, 'The rise and impact of COVID-19 in India': 1, 'Spatial disparities in coronavirus incidence and mortality in the United States: an ecological analysis as of': 2, 'Distinct viral clades of SARS-CoV-2: implications for modeling of viral spread': 2, 'Gut-lung axis and dysbiosis in COVID-19': 5, 'Direct evidence of active SARS-CoV-2 replication in the intestine': 2, 'Transmission of SARS-CoV-2: an update of current literature': 2, 'SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor': 5, 'COVID-19, coronavirus, SARS-CoV-2 and the small bowel': 1, 'TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes': 3, 'Relative abundance of SARS-CoV-2 entry genes in the enterocytes of the lower gastrointestinal tract': 1, 'Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention, and management': 1, 'Viruses causing gastroenteritis': 1, 'Human coronaviruses are uncommon in patients with gastrointestinal illness': 1, 'Viral diarrhoea in a rural coastal region of Karnataka. India': 2, 'Rotavirus and coronavirus outbreak: etiology of annual diarrhea in Costa Rican children': 2, 'Infection by enteric adenoviruses, rotaviruses, and other agents in a rural African environment': 2, 'Viruses in acute gastroenteritis in children in Pune': 1, 'Antibody prevalence to human enteric coronaviruslike particles and indications of antigenic differences between particles from different areas': 1, 'Global challenges in acute diarrhea': 1, 'Income security during periods of ill health: a scoping review of policies, practice and coverage in low-income and middle-income countries': 1, 'Diarrhea and altered inflammatory cytokine pattern in severe COVID-19: impact on disease course and in-hospital mortality': 1, 'Diarrhea is associated with prolonged symptoms and viral carriage in coronavirus disease 2019': 2, 'Gastrointestinal symptoms associated with severity of coronavirus disease 2019 (COVID-19): a pooled analysis': 1, 'Detection of SARS-CoV-2 RNA in fecal samples of patients with confirmed COVID-19: a meta-analysis': 1, 'Understanding the age divide in COVID-19: why are children overwhelmingly spared?': 1, 'Novel coronavirus infection in children outside of Wuhan, China': 1, 'Prevalence of antibody to human coronaviruses 229E, OC43 and neonatal calf diarrhea coronavirus (NCDCV) in patients of Northern Italy': 1, 'Disease burden and mortality estimates: disease burden': 1, 'Ministry of Health and Family Welfare, Government of India. COVID-19 statewise status': 1, \"Public Health Foundation of India, and Institute for Health Metrics and Evaluation. India: health of the nation's states -the India state-level disease burden initiative\": 1, 'Characteristics of Australian human enteric coronavirus-like particles: comparison with human respiratory coronavirus 229E and duodenal brush border vesicles': 1, 'Shedding of coronavirus-like particles by children in Lesotho': 1, 'Features of enteric disease from human coronaviruses: implications for COVID-19': 2, 'Detection of human coronaviruses in children with acute gastroenteritis': 3, 'Gut microbiota and COVID-19 -possible link and implications': 1, 'The psychological impact of quarantine and how to reduce it: Rapid review of the evidence': 2, 'Disasters and youth: A meta-analytic examination of posttraumatic stress': 1, 'The mental health consequences of COVID-19 and physical distancing: The need for prevention and early intervention': 1, 'Twins Early Development Study: A Genetically Sensitive Investigation into Behavioral and Cognitive Development from Infancy to Emerging Adulthood': 4, 'Behavioral genetics': 3, 'Meta-analysis of the heritability of human traits based on fty years of twin studies': 1, 'Why are children in the same family so different from each other? (With Open Peer Commentary and Response)': 1, 'The nurture assumption: Why children turn out the way they do': 1, 'Statistical power analyses for the behavioral sciences': 3, 'Top 10 replicated ndings from behavioral genetics': 1, 'Emerging Adulthood: The winding road from the late teens through the twenties': 1, 'Lost in transition: The dark side of emerging adulthood': 1, 'Adjustment of twin data for the effects of age and sex': 1, 'Analytic approaches to twin data using structural equation models': 3, 'OpenMx: an open source extended structural equation modeling framework': 1, 'The effect of treatment time in locally advanced cervical cancer in the era of concurrent chemoradiotherapy': 2, 'Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer': 1, 'Postoperative radiationtherapy for surgically staged endometrial cancer -impact of time factors (overall treatment time and surgery-to-radiation interval) on outcome': 1, 'Relationship between interval from surgery to radiotherapy and local recurrence rate in patients with endometrioid-type endometrial cancer: A retrospective mono-institutional Italian study': 1, 'Interval between hysterectomy and start of radiation treatment is predictive of recurrence in patients with endometrial carcinoma': 1, 'Does interval between hysterectomy and start of radiation treatment influence survival in early stage endometrial carcinoma? A national cancer database analysis': 1, 'American Brachytherapy Society recurrent carcinoma of the endometrium task force patterns of care and review of the literature': 1, 'Consensus statement for brachytherapy for the treatment of medically inoperable endometrial cancer': 1, 'American Brachytherapy Society consensus guidelines for interstitial brachytherapy for vaginal cancer': 1, 'Definitive radiation therapy for squamous cell carcinoma of the vagina': 1, 'Definitive radiotherapy for primary squamous cell carcinoma of the vagina: Are high-dose external beam radiotherapy and high-dose-rate brachytherapy boost the best treatment? Experience of two Italian institutes': 1, 'Society of surgical oncology-American society for radiation oncology-American society of clinical oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in ductal carcinoma in situ': 1, 'Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: Long-term follow-up of CALGB 9343': 1, 'Accelerated partial breast irradiation: Executive summary for the update of an ASTRO evidence-based consensus statement': 1, 'The American Brachytherapy Society consensus statement for accelerated partial breast irradiation': 1, 'The American Society of breast surgeons consensus guideline on accelerated partial breast irradiation': 1, 'Delay in radiotherapy is associated with an increased risk of disease recurrence in women with ductal carcinoma in situ': 1, 'Optimal timing for adjuvant radiation therapy in breast cancer: A comprehensive review and perspectives': 1, 'Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review': 1, 'Timing of curative treatment for prostate cancer: A systematic review': 1, 'Does a delay in external beam radiation therapy after tissue diagnosis affect outcome for men with prostate carcinoma?': 2, 'The impact of a delay in initiating radiation therapy on prostate-specific antigen outcome for patients with clinically localized prostate carcinoma': 1, 'Does the time from biopsy to surgery affect biochemical recurrence after radical prostatectomy?': 1, 'Delay of radical prostatectomy and risk of biochemical progression in men with low risk prostate cancer': 1, 'Sequencing of androgendeprivation therapy with external-beam radiotherapy in localized prostate cancer: A phase III randomized controlled trial': 1, 'Androgen suppression combined with elective nodal and dose escalated radiation therapy (the ASCENDE-RT trial): An analysis of survival endpoints for a randomized trial comparing a low-dose-rate brachytherapy boost to a dose-escalated external beam boost for high-and intermediate-risk prostate cancer': 1, 'Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group': 1, 'Prospective phase 2 trial of permanent seed implantation prostate brachytherapy for intermediate-risk localized prostate cancer: Efficacy, toxicity, and quality of life outcomes': 1, 'Is supplemental external beam radiation therapy essential to maximize brachytherapy outcomes in patients with unfavorable intermediate-risk disease?': 1, 'Is supplemental external beam radiation therapy necessary for patients with higher risk prostate cancer treated with 103Pd? Results of two prospective randomized trials': 1, 'Compendium of fractionation choices for gynecologic HDR brachytherapy-an American brachytherapy society task group report': 3, 'Radiobiological analysis of outcomes using external beam radiotherapy plus high dose-rate brachytherapy (4x7 Gy or 2x9 Gy) for cervical cancer in a multi-institution trial': 1, 'Dose-effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study': 1, 'American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy': 1, 'American Brachytherapy Task Group Report: Adjuvant vaginal brachytherapy for early-stage endometrial cancer: A comprehensive review': 2, '5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breastconserving surgery for low-risk invasive and in-situ carcinoma of the female breast: A randomised, phase 3, non-inferiority trial': 1, 'Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13': 1, 'Clinical Practive Guidelines in Oncology, Prostate Cancer Version 1': 1, 'Anesthesia and procedural care for brachytherapy': 3, 'Cortisol resistance in man': 1, 'Progesterone resistance': 1, 'Clinical Characteristics of coronavirus disease 2019 in China': 1, 'ISTH interim guidance on recognition and management of coagulopathy in COVID-19': 1, 'Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: Results of a prospective trial and preliminary guidelines for standardized contours': 1, 'The impact of sectional imaging on dose escalation in endocavitary HDRbrachytherapy of cervical cancer: Results of a prospective comparative trial': 1, 'Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer': 1, 'Early outcomes and impact of a hybrid IC/IS applicator for a new MRI-based cervical brachytherapy program': 1, 'Value of magnetic resonance imaging without or with applicator in place for target definition in cervix cancer brachytherapy': 1, 'The use of MRI deformable image registration for CT-based brachytherapy in locally advanced cervical cancer': 1, 'Factors associated with deformation accuracy and modes of failure for MRI-optimized cervical brachytherapy using deformable image registration': 1, 'Implementing MRI-based target delineation for cervical cancer treatment within a rapid workflow environment for image-guided brachytherapy: A practical approach for centers without in-room MRI': 1, 'Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: Results of the French STIC prospective study': 1, 'Conservative treatment with medroxyprogesterone acetate plus levonorgestrel intrauterine system for early-stage endometrial cancer in young women pilot study': 1, 'Oncologic and Reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 Adenocarcinoma: A systematic review': 1, 'Levonorgestrel-releasing intrauterine systems versus oral cyclic medroxyprogesterone acetate in endometrial hyperplasia therapy: A meta-analysis': 1, 'Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women': 1, 'Copper and Copper Alloys': 2, 'Andrographolide: an X-ray crystallographic analysis': 1, 'Study on stability in vitro of Andrographolide': 1, 'Chinese herbal medicine effective component': 1, 'Andrographolide: progression in its modifications and applications-a patent review': 1, 'Development in synthesis of andrographolide derivatives': 1, 'Andrographolide and its pharmacological action and clinical research progress of preparation. China Pharm': 1, 'The research progress of Andrographolide': 1, 'A comprehensive review of the epidemiology and disease burden of influenza B in 9 European countries. Hum Vaccines Immunother': 2, 'Continental synchronicity of human influenza virus epidemics despite climactic variation': 1, 'Application of an autoregressive integrated moving average model for predicting injury mortality in Xiamen, China': 1, 'Influenza (Seasonal)': 1, 'Epidemiology and ARIMA model of positive-rate of influenza viruses among children in Wuhan, China: A nine-year retrospective study': 1, 'Comparison of the incidence of influenza in relation to climate factors during 2000-2007 in five countries': 1, 'Influenza virus transmission is dependent on relative humidity and temperature': 1, 'Environmental predictors of seasonal influenza epidemics across temperate and tropical climates': 5, 'Impact of ambient fine particulate matter (PM 2.5) exposure on the risk of influenza-like-illness: a time-series analysis in Beijing': 4, 'Impact of atmospheric dispersion and transport of viral aerosols on the epidemiology of influenza': 2, 'Analysis on relationship between influenza a (H1N1) and meteorological conditions and its prediction model': 2, 'Analysis of atmospheric environment change during flu rage and flu occurrence forecast': 1, 'The biology of influenza viruses': 3, 'Different responses of influenza epidemic to weather factors among Shanghai, Hong Kong, and British Columbia': 8, 'Influenza and the winter increase in mortality in the United States, 1959-1999': 1, 'Low influenza vaccination rates among child care workers in the United States: assessing knowledge, attitudes, and behaviors': 2, 'Impact of weather factors on influenza hospitalization across different age groups in subtropical Hong Kong': 9, 'Influenza seasonality: lifting the fog': 2, 'Influenza seasonality: underlying causes and modeling theories': 3, 'The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children': 2, 'Air pollution, temperature and pediatric influenza in': 5, \"Epidemiological analysis of influenza in Nanjing children's hospital from 2013 to 2017\": 1, 'Effect of weather variability on seasonal influenza among different age groups in Queensland, Australia: a Bayesian spatiotemporal analysis': 1, 'Weather conditions and spatio-temporal spreading risk of the Beijing 2009 influenza a (H1N1) epidemic': 2, 'The spatio-temporal response of influenza A (H1N1) to meteorological factors in Beijing': 1, 'Survival of the respiratory syncytial virus during storage under various conditions': 1, 'Inactivation of respiratory syncytial virus in aerosol': 1, 'The effect of ambient temperature on the activity of influenza and influenza like illness in Jiangsu Province': 5, 'The effects of meteorological factors on influenza among children in Guangzhou, China. Influenza Other Respir Viruses': 3, 'High temperature (30 C) blocks aerosol but not contact transmission of influenza virus': 3, 'Effects of temperature, humidity, and diurnal temperature range on influenza incidence in a temperate region. Influenza Other Respir Viruses': 3, 'A four year seasonal survey of the relationship between outdoor climate and epidemiology of viral respiratory tract infections in a temperate climate': 2, 'Change of influenza pandemics because of climate change: complex network simulations': 2, 'El Niño effects on influenza mortality risks in the state of California': 2, 'Climate change and influenza: the likelihood of early and severe influenza seasons following warmer than average winters': 2, 'Update Related to the Current Outbreak of COVID-19': 1, 'Saliva in Health and Disease. The Present and Future of A Unique Sample for Diagnosis': 1, 'Influence of the way of reporting alpha-amylase values in saliva in different naturalistic situations: A pilot study': 2, 'Coronavirus COVID-19 impacts to dentistry and potential salivary diagnosis': 1, 'Human Saliva: Non-Invasive Fluid for Detecting Novel Coronavirus (2019-nCoV)': 1, 'First Saliva Test for COVID-19 Approved for Emergency Use by FDA|The Scientist Magazine ®': 1, 'Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: A diagnostic validity study': 1, 'Saliva as a non-invasive tool for assessment of metabolic and inflammatory biomarkers in children': 3, 'Consistent Detection of 2019 Novel Coronavirus in Saliva | Clinical Infectious Diseases|Oxford Academic': 3, 'Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: An observational cohort study': 3, 'Saliva is a reliable tool to detect SARS-CoV-2': 3, 'Salivary Glands: Potential Reservoirs for COVID-19 Asymptomatic Infection': 1, 'Sequential Analysis of Viral Load in a Neonate and Her Mother Infected With SARS-CoV-2-PubMed': 1, 'Evaluation of Advanced Reverse Transcription-PCR Assays and an Alternative PCR Target Region for Detection of Severe Acute Respiratory Syndrome-Associated Coronavirus': 1, 'Epithelial Cells Lining Salivary Gland Ducts Are Early Target Cells of Severe Acute Respiratory Syndrome Coronavirus Infection in the Upper Respiratory Tracts of Rhesus Macaques': 1, 'Porcine epidemic diarrhea virus (PEDV) detection and antibody response in commercial growing pigs': 2, 'Tissue localization, shedding, virus carriage, antibody response, and aerosol transmission of Porcine epidemic diarrhea virus following inoculation of 4-week-old feeder pigs': 1, 'Human saliva can be a diagnostic tool for Zika virus detection': 1, 'Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns': 1, 'Sensitive assays for viral antibodies in saliva: An alternative to tests on serum': 3, 'Novel methods for the detection of microbial antibodies in oral fluid': 3, 'High similarity of IgG antibody profiles in blood and saliva opens opportunities for saliva based serology': 1, 'Detection of antibody to HIV in saliva: A brief review': 1, 'Detection of hepatitis C virus antibodies in oral fluid specimens for prevalence studies': 1, 'Immunity after SARS-CoV-2 Infection': 1, 'Clinical features and treatment of COVID-19 patients in northeast Chongqing': 1, 'Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV': 2, 'A seven-point plan for acute phase protein interpretation in companion animals': 1, 'Relationships among Lymphocyte Subsets, Cytokines, and the Pulmonary Inflammation Index in Coronavirus (COVID-19) Infected Patients': 1, 'C-Reactive Protein Measurement in Canine Saliva': 1, \"Salivary adiponectin, but not adenosine deaminase, correlates with clinical signs in women with Sjögren's syndrome: A pilot study\": 1, 'Acute phase proteins, saliva and education in laboratory science: An update and some reflections': 1, \"Methodology Assays for the Salivary Biomarkers' Identification and Measurement\": 1, 'Saliva proteomics updates in biomedicine': 1, 'A New Symptom of COVID-19: Loss of Taste and Smell': 1, 'Saliva in Ingestive Behavior Research: Association with Oral Sensory Perception and Food Intake': 1, 'Changes of salivary biomarkers under different storage conditions: Effects of temperature and length of storage': 1, 'One-year follow-up of anti-Leishmania antibody concentrations in serum and saliva from experimentally infected dogs': 1, 'Depressive symptoms among survivors of Ebola virus disease in Conakry (Guinea): preliminary results of the PostEboGui cohort': 1, 'Mental health status of people isolated due to Middle East Respiratory Syndrome': 1, 'Mental health of nurses working at a government-designated hospital during a MERS-CoV outbreak: a cross-sectional study': 1, 'The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus': 4, 'Clinical usefulness of fatigue severity scale for patients with fatigue, and anxiety or depression': 2, 'Psychological trauma of Middle East Respiratory Syndrome victims and bereaved families': 1, 'The PHQ-9: validity of a brief depression severity measure': 1, 'The PHQ-9: a new depression diagnostic and severity measure': 2, 'A study on reliability and validity of the Korean version of impact of event scale-revised': 1, 'PROCESS: a versatile computational tool for observed variable mediation, moderation, and conditional process modeling (White paper)': 2, 'Introduction to Mediation, Moderation, and Conditional Process Analysis: a Regression-Based Approach': 2, 'Longitudinal assessment of anxiety, depression, and fatigue in people with multiple sclerosis': 2, 'Predictors of posttraumatic outcomes following the 1999 Taiwan earthquake': 4, 'Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up': 2, 'Long-term psychiatric morbidities among SARS survivors': 2, 'Post-disaster mental health problems and the utilization of mental health services: a four-year longitudinal comparative study': 1, 'Post-traumatic stress disorder following disasters: a systematic review': 1, 'Factors associated with depression among individuals with chronic fatigue syndrome: findings from a nationally representative survey': 2, 'Chronic fatigue syndrome: diagnosis and treatment': 2, 'Stress and psychological distress among SARS survivors 1 year after the outbreak': 1, 'An Event-B Model of an Automotive Adaptive Exterior Light System': 1, 'The B-Book -Assigning Programs to Meanings': 1, 'Modeling in Event-B': 1, 'From animation to data validation: the prob constraint solver 10 years on': 1, 'Functional documents for computer systems': 1, 'Modeling of a Speed Control System using Event-B': 2, 'Adaptive exterior light and speed control system': 4, 'Formalizing hybrid systems with Event-B and the Rodin platform': 1, 'An Event-B model of the hybrid ERTMS/ETCS level 3 standard': 1, 'Modeling a landing gear system in Event-B': 1, 'New DNA viruses identified in patients with acute viral infection syndrome': 3, 'Evidence of human coronavirus HKU1 and human bocavirus in Australian children': 5, 'Detection of human bocavirus in Japanese children with lower respiratory tract infections': 5, 'Bocavirus infection in hospitalized children': 1, 'The association of newly identified respiratory viruses with lower respiratory tract infections in Korean children': 5, 'Human bocavirus infection': 3, 'Frequent detection of bocavirus DNA in German children with respiratory tract infections': 2, 'Human bocavirus in French children': 1, 'Simmonds P. Epidemiological profile and clinical associations of human bocavirus and other human parvoviruses': 5, 'Novel parvovirus and related variant in human plasma': 2, 'Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy': 3, 'A study of the role of parvovirus B19 in rheumatoid arthritis': 3, 'Integrity and full coding sequence of B19 virus DNA persisting in human synovial tissue': 2, 'Evidence for persistence of parvovirus B19 DNA in livers of adults': 2, 'High prevalence of viral genomes and multiple viral infections in the myocardium of adults with \"idiopathic\" left ventricular dysfunction': 2, 'Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue': 7, 'Persistent B19 infection in immunocompetent individuals: implications for transfusion safety': 1, 'Persistent parvovirus B19 infection without the development of chronic anemia in HIV-infected and -uninfected children: the Women and Infants Transmission Study': 1, 'Parvovirus B19 infection-persistence and genetic variation': 2, 'An immune control model for viral replication in the CNS during presymptomatic HIV infection': 2, 'Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers': 2, 'Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis': 2, 'Identification of shared populations of human immunodeficiency virus type 1 infecting microglia and tissue macrophages outside the central nervous system': 1, 'Hedman K. Persistence of human parvovirus B19 in human tissues': 1, 'Prolonged activation of virusspecific CD8 + T cells after acute B19 infection': 1, 'Parvovirus B19-specific DNA in bone marrow from B19 arthropathy patients: evidence for B19 virus persistence': 1, 'Clinical and laboratory findings in immunocompetent patients with persistent parvovirus B19 DNA in bone marrow': 1, 'Presence and significance of human parvovirus B19 DNA in synovial membranes and bone marrow from patients with arthritis of unknown origin': 1, 'Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis': 1, 'Chronic human parvovirus B19 infection in rheumatic disease of childhood and adolescence': 1, 'Persistence of parvovirus B19 DNA in synovium of patients with haemophilic arthritis': 1, 'Parvovirus B19 and chronic arthritis-causal or casual association?': 1, 'Detection of adeno-associated virus 2 and parvovirus B19 in the human dorsolateral prefrontal cortex': 1, 'TTV viral load as a marker for immune reconstitution after initiation of HAART in HIV-infected patients': 1, 'Effect of immune modulation on TT virus (TTV) and TTV-like-mini-virus (TLMV) viremia': 1, 'TT virus infection: prevalence of elevated viraemia and arguments for the immune control of viral load': 1, 'Phylogenetic evidence for the rapid evolution of human B19 erythrovirus': 3, 'Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: A report of nosocomial transmission': 1, 'Cluster of SARS among medical students exposed to single patient': 1, 'SARS-A perspective from a school of nursing in Hong Kong': 1, 'Why did outbreaks of severe acute respiratory syndrome occur insome hospital wards but not in others?': 1, 'Swine flu infection among medical students: An issue of concern': 1, 'Handwashing practice and the use of personal protective equipment among medical students after the SARS epidemic in Hong Kong': 1, 'Assessment of the awareness level of dental students toward middle east respiratory syndrome-coronavirus': 3, 'China upgrades surveillance and control measures of middle east respiratory syndrome (MERS)': 1, 'Centers for Disease Control and Prevention. Interim Infection Prevention and Control Recommendations for Hospitalized Patients with Middle East Respiratory Syndrome Coronavirus (Mers-Cov)': 1, 'Pre-clinical year medical students: At-Risk of contracting swine flu': 1, 'Teaching anthropology to medical students': 1, 'Some important disorders of cats': 3, 'A review of feline infectious peritonitis virus infection: 1963-2008': 2, 'A Tale of Two Viruses: The Distinct Spike Glycoproteins of Feline Coronaviruses': 2, 'An update on feline infectious peritonitis: Virology and immunopathogenesis. The Vet': 5, 'Feline coronaviruses: pathogenesis of feline infectious peritonitis': 1, 'Spike Protein Fusion Peptide and Feline Coronavirus Virulence': 4, 'Amino acid changes in the spike protein of feline coronavirus correlate with systemic spread of virus from the intestine and not with feline infectious peritonitis': 2, 'Comparison of the performance of laboratory tests in the diagnosis of feline infectious peritonitis': 1, 'Diagnosis of Feline Infectious Peritonitis: A Review of the Current Literature': 2, 'Feline Infectious Peritonitis: still an enigma?': 2, 'Bayesian phylogeography finds its roots': 1, 'Bayesian phylogenetics with BEAUti and the BEAST 1.7': 3, 'Feline coronavirus isolates from a part of Brazil: insights into molecular epidemiology and phylogeny inferred from the 7b gene': 4, 'Comparison of serologic techniques for the detection of antibodies against feline coronaviruses': 1, 'Prevalence of Leishmania infantum and co-infections in stray cats in northern Italy': 1, 'Sequence analysis of the nucleocapsid gene of feline coronaviruses circulating in Italy': 1, 'Identification of a feline coronavirus type I strain from a cat with feline infectious peritonitis by RT-pCR and phylogenetic analysis': 1, 'Samples with high virus load cause a trend toward lower signal in feline coronavirus antibody tests': 1, 'Discrepancies between feline coronavirus antibody and nucleic acid detection in effusions of cats with suspected feline infectious peritonitis': 1, 'Detection of feline coronavirus RNA in feces, tissues, and body fluids of naturally infected cats by reverse transcriptase PCR': 1, 'TREE-PUZZLE: maximum likelihood phylogenetic analysis using quartets and parallel computing': 1, 'Likelihood-mapping: a simple method to visualize phylogenetic content of a sequence alignment': 1, 'MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets': 1, 'jModelTest: phylogenetic model averaging': 1, 'Bayesian selection of continuous-time Markov chain evolutionary models': 1, 'Bayes factors': 1, 'Feline infectious peritonitis': 1, 'Feline infectious peritonitis and pleurisy': 1, 'Peritonitis infecciosa felina (informe de un caso)': 1, 'The occurrence of feline infectious peritonitis in Denmark': 1, 'Feline infectious peritonitis: present knowledge': 1, 'Causes of death and disease in cats based on 1969-1982 autopsy statistics': 3, 'Evolutionary insights into the ecology of coronaviruses': 1, 'Modeling the geographic spread of rabies in China': 1, 'That Yankee cat: the Maine Coon': 1, 'Veterinary medical guide to dog and cat breeds': 1, 'Unofficial Ambassadors: American Military Families Overseas and the Cold War': 1, \"Coronaviridae. In: Fenner's Veterinary Virology, Fifth Edition\": 1, 'Herpesvirus systematics': 1, 'Distribution of bovine herpesvirus type 5 DNA in the central nervous systems of latently, experimentally infected calves': 3, 'Olfactory transmission of neurotropic viruses': 7, 'Comparison of inflammatory infiltrates in trigeminal ganglia of cattle infected with wild-type Bovine herpesvirus 1 versus a virus strain containing a mutation in the LR (latency-related) gene': 2, 'Herpes simplex virus 1 targets the murine olfactory neuroepithelium for host entry': 4, 'The olfactory nerve: a shortcut for influenza and other viral diseases into the central nervous system': 3, 'Neuropathology of bovine herpesvirus type 5 (BHV-5) meningoencephalitis in a rabbit seizure model': 1, 'Latency of bovine herpesvirus type 5 (BoHV-5) in tonsils and peripheral blood leukocytes': 1, 'Toll-like receptors and viruses: induction of innate antiviral immune responses': 2, 'Role of microRNAs in the regulation of innate immune cells under neuroinflammatory conditions': 2, 'Tolllike receptor expression in the nervous system of bovine alphaherpesvirus-infected calves': 5, 'Cellular response markers and cytokine gene expression in the central nervous system of cattle naturally infected with bovine herpesvirus 5': 8, 'Role of microRNAs in herpesvirus latency and persistence': 2, 'MicroRNAs in large herpesvirus DNA genomes: recent advances': 2, 'Repertoire of bovine miRNA and miRNA-like small regulatory of bovine miRNA and miRNA-like small regulatory RNAs expressed upon viral infection': 1, 'The role of microRNAs in the pathogenesis of herpesvirus infection': 1, 'The role of microRNAs in metabolic interactions between viruses and their hosts': 1, 'MicroRNA 155 and viral-induced neuroinflammation': 3, 'Critical role of microRNA-155 in herpes simplex encephalitis': 5, 'MicroRNA-155 enhances T cell trafficking and antiviral effector function in a model of coronavirus-induced neurological disease': 4, 'miR-155 induction in microglial cells suppress Japanese encephalitis virus replication and negatively modulates innate immune responses': 2, 'Role of miR-155 in the pathogenesis of herpetic stromal keratitis': 1, 'Induction of multiple miR-200/182 members in the brains of mice are associated with acute herpes simplex virus 1 encephalitis': 3, 'Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method': 1, 'Capillaries in the olfactory bulb but not the cortex are highly susceptible to virusinduced vascular leak and promote viral neuroinvasion': 3, 'Neurotropic virus infections as the cause of immediate and delayed neuropathology': 1, 'Toll like receptor 3 and viral infections of nervous system': 2, 'Bovine herpesvirus 5 encodes a unique pattern of microRNAs compared with bovine herpesvirus 1': 1, 'Enhanced immunogenicity following miR-155 incorporation into influenza A virus genome': 1, 'Treatment of eosinophilic annular erythema with chloroquine': 6, 'Eosinophilic annular erythema limited on the palms and the soles and possibly associated with thymoma': 4, 'Annular erythema of infancy': 3, 'Eosinophilic annular erythema is a peculiar subtype in the spectrum of Wells syndrome: a multicentre long-term follow-up study': 7, 'Eosinophilic annular erythema: an expression of the clinical and pathological polymorphism of wells syndrome': 6, 'Eosinophilic annular erythema in a patient with autoimmune pancreatitis: nicotinamide therapy may be beneficial for achieving remission': 4, 'A case of eosinophilic annular erythema as a presenting sign for autoimmune hepatitis': 4, 'Eosinophilic annular erythema in a patient with metastatic prostate adenocarcinoma': 3, 'Eosinophilic annular erythema is clinically characterized by central pigmentation reflecting basal melanosis: a clinicopathological study of 10 cases': 3, 'Prolonged treatment of eosinophilic erythema annulare with chloroquine': 3, 'Eosinophilic annular erythema: complete clinical response with dapsone': 3, 'Dapsone for recalcitrant eosinophilic annular erythema: a case report and literature review': 3, 'Dapsone treatment for eosinophilic annular erythema': 3, \"Eosinophilic annular erythema: a subset of Wells' syndrome or a distinct entity?\": 3, 'Eosinophilic annular erythema: successful response to ultraviolet B therapy': 2, 'Efficacy of suplatast tosilate in a case of recurrent eosinophilic annular erythema': 2, 'Eosinophilic annular erythema treated with dupilumab': 2, 'Eosinophilic cellulitis (Wells syndrome) successfully treated with mepolizumab': 2, 'Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review': 6, 'Transplantation of ACE2 -mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia': 2, 'Expanding on exosomes and ectosomes in cancer': 1, 'Extracellular vesicles: a new frontier for rese Q5 arch in acute respiratory distress syndrome': 1, 'Therapeutic use of extracellular vesicles for acute and chronic lung disease': 1, 'Mesenchymal stem cell derived extracellular vesicles for tissue engineering and regenerative medicine applications': 1, 'Inhibiting extracellular vesicles formation and release: a review of EV inhibitors': 1, 'The new mathematics and an old culture. A study of learning among the Kpelle of Liberia': 1, 'Are humans good intuitive statisticians after all? Rethinking some conclusions from the literature on judgment under uncertainty': 1, 'Judgment under uncertainty: heuristics and biases': 1, 'Gigerenzer G Gut feelings: the intelligence of the unconscious': 1, 'Re-analysing Ebola spread in Sierra Leone: the importance of local social dynamics': 3, 'Shaw R Memories of the slave trade: ritual and the historical imagination in Sierra Leone': 1, \"how a people's science helped end an epidemic\": 1, 'Transmission Dynamics and control of Severe Acute Respiratory Syndrome': 1, 'Lyapunov Functions and Global Stability for SIR and SIRS Epidemiological Models with Non-linear Transmission': 1, 'Adomain decomposition approach to a SIR epidemic model model with constant vaccination strategy': 1, 'The effect of constant and pulse vaccination of SIR epidemic model with horizontal and vertical transmission': 1, 'Review of SIR Epidemic Model with Application To Transmission Dynamics of HIV/ AIDS in a proportional mixing population': 2, 'The influence of education in reducing the HIV epidemic': 1, 'Stability and Biurcation for multiple group model fro the dynamics of HIV/AIDS Transmission': 1, 'Mathematical model for HIV/AIDS with complacency in a population with declining prevalence': 3, 'An HIV/AIDS model with Vertical transmission and time delay': 1, 'Mathematical modelling of Infectious diseases': 1, 'The impact of Migration on HIV-1 Transmission in South Africa: A study of Migrant and non migrant and their partners. Sexually transmitted diseases': 4, 'Modelling the impact of migration on the HIV epidemic in South Africa': 4, 'Mobility ans HIV in Tanzania Couples: both mobile persons and their partners show increase risk': 4, 'Mobility and the spread of human immunodeficiency virus into rural areas of West Africa': 3, 'The role of in-migrants in the increasing rural HIV-1 epidemic: results from a village population survey in the Kilimanjaro region of Tanzania': 2, 'Migration, ethnicity and environment: HIV risk factors for women on the sugar cane plantations of the Dominican Republic': 2, 'The epidemiology of HIV-1 infection in urban areas, roadside settlements and rural villages in Mwanza Region Tanzania': 2, 'Risk factors of sexually transmitted infections among migrant and non-migrant sexual partnerships from rural South Africa. Epidemiology and Infection': 3, 'Migration, mines and mores: the HIV epidemic in Southern Africa': 2, 'Corridors of Hope in Southern Africa: HIV prevention needs and opportunities in Four Border Towns. Family Health International': 2, 'Patterns of Movement and Risk of HIV Infection in Rural Zimbabwe': 1, 'HIV: Rural-urban migrants in Tanzania. Social science and medicine': 1, 'Linking migration, mobility and HIV. Tropical Medicine and International Health': 2, 'Quarantine in a multi-species epidemic model with spatial dynamics': 1, 'Epidemical models for Heterogeneous Populations:Proportionate Mixing, Parameters Estimation, and Immunization programs': 1, 'Dynamics and control of infectious diseases in stochastic metapopulation models': 1, 'Impact of the Infection Period Distribution on the Epidemic Spread in a Metapopulation Model': 1, 'Disease spread in metapopulations. Nonlinear dynamics and evolution equations': 2, 'A Fractional SEIR Epidemic Model for Spatial and Temporal Spread of Measles in Metapopulations': 1, 'A structured Epidemic Model Incorporating Geographic Mobility Among Regions': 1, 'A multi-species epidemic model with spatial dynamics': 1, 'Can we spend our way of the AIDS epidemic? A world halting AIDS model': 1, 'Predicting the HIV/AIDS epidemic and measuring the effect of mobility in mainland China': 1, 'Modeling Infectious Dieseases in Human and Animals': 2, 'Country-counties in Kenya': 2, 'DataBank Home, and Corporate Procurement': 2, 'Supplementary Material on the Quantifying the impact of human mobility on Malaria': 5, 'The transmission dynamics of human immunodeficiency virus': 1, 'HIV-1 Transmission, by stage of Infection': 1, 'Rates of HIV-1 Transmission per coital act, by stage of HIV-1 Infection': 1, 'The Epidemiology of HIV Infections: Variable incubation plus Infectious periods and Heterogeneity in sexual Activity': 1, 'The construction of next-generation matrices for compartmental epidemic models': 1, 'Positive linear systems': 1, 'Nonnegative matrices in the mathematical sciences': 1, 'A model-based approach for estimating the mean incubation period of transfusion associated acquired immunodeficiency syndrome': 1, 'Definition and estimation of an actual reproduction number describing past infectious disease transmission: application to HIV epidemics among homosexual men in Denmark': 1, 'Correcting the actual reproduction number: a simple method to estimate R 0 from early epidemic growth data. International journal of environmental research and public health': 1, 'R 0 and the elimination of HIV in Africa: will 90-90-90 be sufficient?': 1, 'Stream gradient as a function of order, Magnitude and Discharge': 1, 'High-speed Scanning in Human Memory': 1, 'Circular migration and sexual networking in Rural Kwazulu/Natal: Implication or the spread of HIV and other sexually transmitted diseases': 1, 'Travel and the emergence of Infectious Diseases': 1, 'Short communications prevalence of HIV-1 in east African lorry drivers': 1, 'Prevalence of HIV Among Truck Drivers Visiting Sex Workers in KwaZulu Natal, South Africa. Sexually transmitted diseases': 1, 'Human immunodeficiency virus infection in long-distance truck drivers in east Africa': 1, 'The role of the airline transportation network in the prediction and predictability of global epidemics': 4, 'The role of population heterogeneity and human mobility in the spread of pandemic influenza': 2, 'AIDS:Sex, abstinence and behaviour change. The Lancet infectious diseases': 3, 'The role of Abstinence Monogamy and Condom Use in HIV Decline': 2, 'Trends in Loss to Follow-Up among Migrant workers on Antiretraviral Therapy in a community Cohort in Lesotho': 1, 'Migration adversely affects antiretroviral adherence in a population-based cohort of HIV/AIDS patients. Social science and medicine': 1, 'The use of mobile phone data for the estimation of the travel patterns and imported Plasmodium falciparum rates among Zanzibar residents': 1, 'On the use of Human Mobility Proxies for Modelling Epidemics': 2, 'Elastic and inelastic multi-storey buildings under earthquake excitation with the effect of pounding': 2, 'Seismic pounding behavior of multi-story buildings in series considering the effect of infill panels': 2, 'Non-linear strain rate analysis of earthquake-induced pounding between steel buildings': 2, 'Seismic pounding between adjacent buildings: identification of parameters, soil interaction issues and mitigation measures': 2, 'Experimental study on effectiveness of a prototype seismic isolation system made of polymeric bearings': 1, 'Traffic vibrations in buildings': 2, 'Modeling of two-dimensional random fields': 1, 'What turing did after he invented the universal turing machine': 1, 'Machine Learning: An Artificial Intelligence Approach': 1, 'Machine Learning. McGraw-Hill Science': 1, 'Application of SVM and ANN for intrusion detection': 1, 'Monitoring system to detect potential dangerous situations': 1, 'Wybrane metody eksploracji danych i uczenia maszynowego w analizie stanu uszkodzeń oraz zużycia technicznego zabudowy terenów górniczych': 1, 'Power wind mill fault detection via one-class ν-SVM vibration signal analysis': 1, 'Ocena szkodliwości drgań przekazywanych przez podłoże na budynki: Evaluation of the harmfulness of building vibrations due to ground motion, Polish Committee for Standardization of Measurement and Quality': 7, 'Oddziaływania parasejsmiczne przekazywane na obiekty budowlane': 3, 'ISO 10137:2007: Bases for design of structures -serviceability of buildings and walkways against vibrations': 1, 'Directive 2002/49/EC of the European parliament and the Council of 25': 1, 'DIN 4150-2: Structural vibration': 1, 'Guide to evaluation of human exposure to vibration in buildings': 1, 'The idea of using Bayesian networks in forecasting impact of traffic-induced vibrations transmitted through the ground on residential buildings': 3, 'Support-vector networks': 1, 'Neural Networks and Machine Learning': 1, 'Kernel functions for machine learning applications': 5, 'An Introduction to Support Vector Machines and Other Kernel-based Learning Methods': 2, 'Machine Learning for Hackers': 2, 'Generalized portrait method for pattern recognition': 1, 'A training algorithm for optimal margin classifiers': 1, 'Support vector machines: hype or hallelujah?': 1, 'Wpływ poprawy stanu drogi na redukcję drgań w zabytkowym kompleksie budynków': 1, 'Fields Virology. Philadelphia: Lippincott, Wilkinson and Wilkins': 1, 'Molecular epizootiology, pathogenesis, and prophylaxis of equine herpesvirus-1 infections': 1, 'Pathogenesis of equine herpesvirus-1 in specific pathogen-free foals: primary and secondary infections and reactivation': 1, 'Equine herpesvirus myeloencephalopathy: A potential emerging disease': 1, 'The equine immune response to equine herpesvirus-1: the virus and its vaccines': 2, 'Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1)': 2, 'Outbreak of neurologic disease caused by equine herpesvirus-1 at a university equestrian center': 2, 'Pharmacokinetics of acyclovir after intravenous infusion of acyclovir and after oral administration of acyclovir and its prodrug valacyclovir in healthy adult horses': 1, 'In vitro susceptibility of six isolates of equine herpesvirus 1 to acyclovir, ganciclovir, cidofovir, adefovir, PMEDAP and foscarnet': 1, 'Evaluation of orally adminstered valacyclovir in experimentally EHV1-infected ponies': 1, 'Knocking down disease with siRNAs': 1, 'Silencing viral infection': 1, 'Therapeutic potential of RNA interference against cellular targets of HIV infection': 1, 'Progress and prospects: RNA-based therapies for treatment of HIV infection': 1, 'An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection': 2, 'Analysis of the contributions of the equine herpesvirus 1 glycoprotein gB homolog to virus entry and direct cell-to-cell spread': 2, 'Cloning and expression of an equine herpesvirus 1 origin-binding protein': 2, 'Analysis of the DNA-binding domain of the HSV-1 origin-binding protein': 1, 'Sequence-specific inhibition of small RNA function': 1, 'A mouse model for testing the pathogenicity of equine herpes virus-1 strains': 1, 'Equine herpesvirus-1 strain KyA, a candidate vaccine strain, reduces viral titers in mice challenged with a pathogenic strain': 1, 'Potential of DNA-mediated vaccination for equine herpesvirus 1': 1, 'DNAmediated immunization with glycoprotein D of equine herpesvirus 1 (EHV-1) in a murine model of EHV-1 respiratory infection': 1, 'Contribution of gene products encoded within the unique short segment of equine herpesvirus 1 to virulence in a murine model': 1, 'Argentine strain of equine herpesvirus 1 isolated from an aborted foetus shows low virulence in mouse respiratory and abortion models': 1, 'Pathogenicity and immunogenicity of equine herpesvirus type 1 mutants defective in either gI or gE gene in murine and hamster models': 1, 'In vitro and in vivo characterization of equine herpesvirus type 1 (EHV-1) mutants devoid of the viral chemokine-binding glycoprotein G (gG)': 4, 'CCL3 and viral chemokine-binding protein gG modulate pulmonary inflammation and virus replication during equine herpesvirus type 1 (EHV-1) infection': 1, 'Herpesvirus chemokine-binding glycoprotein G (gG) efficiently inhibits neutrophil chemotaxis in vitro and in vivo': 1, 'Prospects of RNA interference therapy in respiratory viral diseases: update': 2, 'Intranasal antisense therapy: preclinical models with a clinical future?': 2, 'Phenotypic silencing of cytoplasmic genes using sequence-specific double-stranded short interfering RNA and its application in the reverse genetics of wild type negative-strand RNA viruses': 1, 'Prophylactic and therapeutic effects of small interfering RNA targeting SARS-coronavirus': 1, 'Human immunodeficiency virus type 1 escape from RNA interference': 1, 'Hepatitis C virus replicons escape RNA interference induced by a short interfering RNA directed against the NS5b coding region': 1, 'Activation of the interferon system by short-interfering RNAs': 1, 'Sequencedependent stimulation of the mammalian innate immune response by synthetic siRNA': 2, 'RNAi: a novel antisense technology and its therapeutic potential': 1, 'A point mutation in a herpesvirus polymerase determines neuropathogenicity': 3, 'Use of lambda gt11 and monoclonal antibodies to map the genes for the six major glycoproteins of equine herpesvirus 1': 1, \"Multiple alternative splicing to exons II and III of viral interleukin-8 (vIL-8) in the Marek's disease virus genome: the importance of vIL-8 exon I\": 1, 'Clinical Characteristics of 138 Hospitalized Patients With': 2, 'Epidemiology Working Group for NCIP Epidemic Response. An update on the epidemiological characteristics of novel coronavirus pneumonia (COVID-19)': 2, \"National Health Commission of the People's Republic of China. What is fecal-oral transmission?\": 1, \"The State Council Information Office of the People's Republic of China. Press Conference of the Joint Prevention and Control of the State Council\": 2, 'A 30-hour old infant in Wuhan diagnosed and mother-to-child infection suspected': 1, 'Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia': 2, 'Epidemiology Working Group for NCIP Epidemic Response. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China': 1, \"The Investigation and Research on Fuyang's off farm workers\": 1, 'Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. The New England journal of medicine 2020': 1, 'A Systematic Review of therapeutic agents for the treatment of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV)': 1, 'Covid-19: Demand for dexamethasone surges as RECOVERY trial publishes preprint': 1, 'Coronavirus breakthrough: dexamethasone is first drug shown to save lives': 1, 'Anti-inflammatory action of glucocorticoids--new mechanisms for old drugs': 2, 'Effects of glucocorticoids in ventilated piglets with severe pneumonia': 2, \"Statins in coronavirus outbreak: it's time for experimental and clinical studies\": 1, 'Clinical features of patients': 2, 'New concepts of IL-10-induced lung fibrosis: fibrocyte recruitment and M 2 activation in a CCL2/CCR2 axis': 1, 'The cholesterol biosynthesis pathway regulates IL-10 expression in human Th1 cells': 2, 'Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia': 2, 'Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis': 1, 'Rosuvastatin use improves measures of coagulation in patients with venous thrombosis': 1, 'The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and mice': 1, 'The Black Death, 1346-1353. The Complete History': 1, 'Impacts of Social and Economic Factors on the Transmission of Coronavirus Disease 2019 (COVID-19) in China': 1, 'To be Paranoid is the Standard? Panic Responses to the SARS Outbreak in the Hong Kong Special Administrative Region': 1, 'Introduction: Globalization and Anti-globalization of SARS in Chinese societies': 1, 'The Coronavirus is Killing Globalization as we Know it': 1, 'Coronavirus and the Future of Globalization. The Diplomat': 1, 'Sicken thy neighbour: The initial trade policy response to COVID-19': 2, 'The End of Globalization: Lessons from the Great Depression': 1, 'Information and Communications Technology (ICT) and International Trade: Evidence from Turkey': 1, 'France and Germany Exceed Italy, South Korea and Japan in Temperature-adjusted Corona Proliferation: A Quick and Dirty Sunday Morning Analysis': 1, 'Temperature Significant Change': 1, 'The Epidemiology and Pathogenesis of Coronavirus Disease (COVID-19) Outbreak': 1, 'Does Globalization Affect Growth? Evidence from a New Index of Globalization': 1, 'The Evidence on Globalization': 1, 'Gen Y customer loyalty in online shopping: an integrated model of trust, user experience and branding': 2, 'The role of satisfaction and website usability in developing customer loyalty and positive word-of-mouth in the e-banking services': 1, 'Mobile application usability: conceptualization and instrument development': 1, 'Explaining post-implementation employee system use and job performance: impacts of the content and source of social network ties': 1, 'Business intelligence systems use in performance measurement capabilities: implications for enhanced competitive advantage': 2, 'Designing the User Interface: Strategies for Effective Human-Computer Interaction': 3, 'Lessons learned in usability consulting': 2, 'Usability 101: introduction to usability': 2, 'Return on investment (ROI) for usability': 1, 'Modelling Techniques for Business Process Re-engineering and Benchmarking': 1, 'Entrepreneurship: starting and operating a small business': 1, 'Benchmarking information technology practices in small firms': 2, 'Strategic management of information systems': 3, 'Entrepreneurship as the basic element for the successful employment of benchmarking and business innovations': 2, 'From infrastructure to culture: A/B testing challenges in large scale social networks': 1, 'Methodologies for developing information systems: a historical perspective': 1, 'Design Science Research Methods and Patterns: Innovating Information and Communication Technology': 1, 'Extending quality in use to provide a framework for usability measurement': 1, 'Principles of Information Systems': 1, 'Management information systems 13e': 1, 'User-centered design': 2, 'Designing for digital transformation: lessons for information systems research from the study of ICT and societal challenges': 1, 'Living lab research landscape: from user centred design and user experience towards user cocreation. Presented at the First European Summer School \"Living Labs': 2, 'The user experience landscape of South Africa': 2, 'Applying user centred and participatory design approaches to commercial product development': 2, 'People, organizations, and processes: an inquiry into the adoption of user-centered design in industry': 1, 'Design principles for cognitive artifacts': 2, 'Usability testing: a review of some methodological and technical aspects of the method': 1, 'Research Methods in Human-Computer Interaction': 1, 'Usability Testing Essentials: Ready, Set… Test!': 1, 'Benchmarking deep reinforcement learning for continuous control': 1, 'On theory development in design science research: anatomy of a research project': 1, 'The value of comparative usability and UX evaluation for e-commerce organisations': 1, 'User centered system design': 2, 'Business Research Methods': 2, 'To measure or not to measure UX: an interview study. Presented at the I-UxSED': 1, 'Quantitative Models for Performance Evaluation and Benchmarking: Data Envelopment Analysis with Spreadsheets': 1, 'How many participants are really enough for usability studies?': 1, 'Crosstalk between T lymphocytes and dendritic cells': 1, 'TLR signalling regulated antigen presentation in dendritic cells': 3, 'Lymph node homing of T cells and dendritic cells via afferent lymphatics': 3, \"Ono'e, Activation of extracellular signalrelated kinase by TNF-a controls the maturation and function of murine dendritic cells\": 3, 'The cross-talk between dendritic and regulatory T cells: good or evil?': 1, 'Dendritic cells and the maintenance of self-tolerance': 1, 'Modulation of dendritic cell properties by laquinimod as a mechanism for modulating multiple sclerosis': 1, 'Impact of valproic acid on dendritic cells function': 1, 'Impact of HDAC inhibitors on dendritic cell functions': 1, 'The active metabolite of leflunomide, A77 1726, interferes with dendritic cell function': 1, 'Gold sodium thiomalate suppresses the differentiation and function of human dendritic cells from peripheral blood monocytes': 1, 'Corticosterone impairs dendritic cell maturation and function': 1, 'Innovating by developing new uses of already-approved drugs: trends in the marketing approval of supplemental indications': 1, 'Evaluation of oncology drugs at the European Medicines Agency and US Food and Drug Administration: when differences have an impact on clinical practice': 1, 'Worm cure without tears. The effect of niclosamide on taeniasis saginata in man': 1, 'Energy metabolism in Cotugnia digonopora and the effect of anthelmintics': 1, 'Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt/b-catenin pathway': 2, 'Antihelminth compound niclosamide downregulates Wnt signaling and elicits antitumor responses in tumors with activating APC mutations': 2, 'Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-kappaB pathway and generation of reactive oxygen species': 4, 'Identification of niclosamide as a new small molecule inhibitor of the STAT3 signaling pathway': 3, 'Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling': 2, 'Structure-activity analysis of niclosamide reveals potential role for cytoplasmic pH in control of mammalian target of rapamycin complex 1 (mTORC1) signaling': 3, 'The autonomous notch signal pathway is activated by baicalin and baicalein but is suppressed by niclosamide in K562 cells': 2, 'Dextromethorphan inhibits activations and functions in dendritic cells': 2, 'RNA interference-mediated silencing of Foxo3 in antigen-presenting cells as a strategy for the enhancement of DNA vaccine potency': 2, 'Immunosuppressive effect of quercetin on dendritic cell activation and function': 2, 'Proteoglycan isolated from Phellinus linteus induces toll-like receptors 2-and 4-mediated maturation of murine dendritic cells via activation of ERK, p38, and NFjB': 2, 'Dendritic cell survival and maturation are regulated by different signaling pathways': 2, 'Adjuvant effect of lipopolysaccharide on the induction of contact hypersensitivity to haptens in mice': 1, 'Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide': 2, 'New life for an old drug: the anthelmintic drug niclosamide inhibits Pseudomonas aeruginosa quorum sensing': 2, 'Dendritic cells and cytokines in human inflammatory and autoimmune diseases': 1, 'Cytokine secretion by pathogen recognition receptor-stimulated dendritic cells in rheumatoid arthritis and ankylosing spondylitis': 1, 'Role of increased production of monocytes TNF-alpha, IL-1beta and IL-6 in psoriasis: relation to focal infection, disease activity and responses to treatments': 1, 'Cytokines and allergic diseases: clinical aspects': 1, 'Anti-TNF-a agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls': 1, 'The therapy of autoimmune diseases by anti-interleukin-6 receptor antibody': 1, 'The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses': 1, 'Signaling by Toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages': 1, 'The innate immune response in house dust mite-induced allergic inflammation': 1, 'NF-jB as a target for modulating inflammatory responses': 1, 'Distinct roles of different NF-kappa B subunits in regulating inflammatory and T cell stimulatory gene expression in dendritic cells': 1, 'The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors': 1, 'In vitro trypanocidal activity of the antihelminthic drug niclosamide': 1, 'WHO specifications and evaluations for public health pesticides: niclosamide. World Health Organisation': 1, 'Pharmacokinetics of anti-SARS-CoV agent niclosamide and its analogs in rats': 2, 'Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation': 1, 'Niclosamide therapy for tapeworm infections': 1, 'Niclosamide is a proton carrier and targets acidic endosomes with broad antiviral effects': 1, 'Dendritic cells-at the front-line of pathogen attack': 1, 'Type I interferon is selectively required by dendritic cells for immune rejection of tumors': 1, 'Prevention (cdc): coronavirus disease 2019 (coVid-19)': 1, 'risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, china': 2, 'clinical course and risk factors for mortality of adult inpatients with coVid-19 in Wuhan, china: a retrospective cohort study': 1, 'coVid-19 pandemic, coronaviruses, and diabetes mellitus': 1, 'ruiz-Palacios gM 55. grimes ca, Bolhuis dP, he FJ and nowson ca: dietary sodium intake and overweight and obesity in children and adults: a protocol for a systematic review and meta-analysis': 1, 'hypertonic stress regulates T cell function via pannexin-1 hemichannels and P2X receptors': 1, 'Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease': 1, 'Systemic inflammation in chronic obstructive pulmonary disease: May adipose tissue play a role? review of the literature and future perspectives': 1, 'Clinical findings of patients with coronavirus disease 2019 in Jiangsu Province, china: a retrospective': 1, 'Factors associated with hospitalization and critical illness among 4,103 patients with coVid-19 disease in new york city': 1, 'age-related increases in circulating inflammatory markers in men are independent of BMi, blood pressure and blood lipid concentrations': 1, 'inflammation-related gene expression by lipid oxidation-derived products in the progression of atherosclerosis': 1, 'Thymic regeneration: Teaching an old immune system new tricks': 1, 'inflammatory biomarkers as predictors of hospitalization and death in community-dwelling older adults': 1, '76. alam i, ng TP and larbi a: does inflammation determine whether obesity is metabolically healthy or unhealthy? The aging perspective': 1, 'immunologic profile of excessive body weight': 1, 'Saper cB and elmquist Jk: leptin differentially regulates nPy and PoMc neurons projecting to the lateral hypothalamic area': 1, \"The role of leptin and adiponectin in obesity-associated cognitive decline and alzheimer's disease\": 1, 'Honce r and schultz-Cherry s: impact of obesity on influenza a virus pathogenesis, immune response, and evolution': 1, 'Tsatsakis aM and rizos ak: a global assessment of phthalates burden and related links to health effects': 1, 'Burgio e, lopomo a and Migliore l: obesity and diabetes: From genetics to epigenetics': 1, 'Beta 1, Beta 2 and Beta 3 adrenergic receptor gene polymorphisms in a Southeastern european population': 1, 'impact of food immunoglobulin g-based elimination diet on subsequent food immunoglobulin g and quality of life in overweight/obese adults': 1, 'Winer d and dosch hM: obesity predisposes to Th17 bias': 1, 'Zinc and respiratory tract infections: Perspectives for coVid-19 (review). int': 1, 'increased activity of interleukin-23/interleukin-17 proinflammatory axis in obese women': 1, 'Wittekindt oh: Tight junctions in pulmonary epithelia during lung inflammation': 1, 'al: Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza': 1, 'Bennett g, greenberg aS and obin MS: T-cell recruitment and Th1 polarization in adipose tissue during diet-induced obesity in c57Bl/6 mice': 1, 'Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COViD-19 patients. natl sci rev': 1, 'are patients with hypertension and diabetes mellitus at increased risk for coVid-19 infection?': 1, 'coVid-19 infection and rheumatoid arthritis: Faraway, so close! autoimmun rev 19: 102523': 1, 'angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system': 1, 'Prolonging healthy aging: longevity vitamins and proteins': 1, 'lipid accumulation in non-adipose tissue and lipotoxicity': 1, 're-evaluating lipotoxic triggers in skeletal muscle: relating intramyocellular lipid metabolism to insulin sensitivity': 1, 'oxidative Stress': 1, 'Jones DP: redefining oxidative stress': 1, 'identification of 4-hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids': 2, 'Bernlohr da: oxidative stress and lipotoxicity': 1, 'Ferretti c, dianzani c, lepore a and gentile F: role of 4-hydroxynonenal-protein adducts in human diseases': 1, 'carbonylation of adipose proteins in obesity and insulin resistance: identification of adipocyte fatty acid-binding protein as a cellular target of 4-hydroxynonenal': 1, 'reactive lipid species from cyclooxygenase-2 inactivate tumor suppressor lkB1/STk11: cyclopentenone prostaglandins and 4-hydroxy-2-nonenal covalently modify and inhibit the aMP-kinase kinase that modulates cellular energy homeostasis and protein translation': 1, 'gonzález-Mangado n and Peces-Barba g: cigarette smoke-induced oxidative stress in skeletal muscles of mice': 1, \"Proteomic identification of oxidatively modified proteins in alzheimer's disease brain. Part i: Creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase l-1. Free radic\": 1, 'Malondialdehyde (Mda) and protein carbonyl (Pco) levels as biomarkers of oxidative stress in subjects with familial hypercholesterolemia': 1, '4-hydroxynonenal and cholesterol oxidation products in atherosclerosis': 1, 'Zarkovic k: 4-hydroxynonenal and neurodegenerative diseases': 1, 'kassir r: risk of coVid-19 for patients with obesity. obes rev: apr': 1, 'Perilipin 5 reduces oxidative damage associated with lipotoxicity by activating the Pi3k/erk-mediated nrf2-are signaling pathway in inS-1 pancreatic β-cells': 1, 'obesity expands a distinct population of T cells in adipose tissue and increases vulnerability to infection': 1, 'specific biological features of adipose tissue, and their impact on hiV persistence': 1, 'is adipose tissue a reservoir for viral spread, immune activation and cytokine amplification in coVid-19. obesity (Silver Spring)': 1, 'H1n1 influenza infection: The Mayo Clinic experience': 1, 'al; california Pandemic (h1n1) Working group: Factors associated with death or hospitalization due to pandemic 2009 influenza a(h1n1) infection in california': 1, 'risk factors for 2009 pandemic influenza a (H1n1)-related hospitalization and death among racial/ethnic groups in new Mexico': 1, 'Burgoa c: obesity and its implications for coVid-19 mortality. obesity (Silver Spring)': 1, 'Weight and prognosis for influenza a(H1n1)pdm09 infection during the pandemic period between 2009 and 2011: a systematic review of observational studies with meta-analysis': 1, 'clinical characteristics of 30 medical workers infected with new coronavirus pneumonia': 1, 'he Ma, cheng lX, huang k and Zeng QT: clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-ncoV': 1, 'The pivotal link between ace2 deficiency and SarS-coV-2 infection': 1, 'SarS-coV-2 cell entry depends on ace2 and TMPrSS2 and is blocked by a clinically proven protease inhibitor': 1, 'Baig aa, amanullah a and aziz B: structural variations in human aCe2 may influence its binding with SarS-coV-2 spike protein': 1, ') and the renin-angiotensin system': 1, 'Mehra a and ardhanari S: impact of obesity and weight loss on cardiac performance and morphology in adults': 1, 'Deciuceis C, Montezano a and schiffrin eL: increased inflammatory biomarkers in hypertensive type 2 diabetic patients: improvement after angiotensin ii type 1 receptor blockade': 1, 'Lumeng Cn and saltiel ar: inflammatory links between obesity and metabolic disease': 1, 'World health organization (Who): advice on the use of masks in the context of coVid-19: interim guidance': 1, 'World health organization (Who): rational use of personal protective equipment for coronavirus disease (coVid-19) and considerations during severe shortages: interim guidance': 1, 'adipose tissue renin-angiotensin-aldosterone system (raaS) and progression of insulin resistance': 1, 'Body mass index is independently associated with hospital mortality in mechanically ventilated adults with acute lung injury': 1, 'adipose-lung cell crosstalk in the obesity-ardS paradox': 1, 'obesity survival paradox in pneumonia: a meta-analysis': 1, 'Schulze MB and ludwig dS: obesity and impaired metabolic health in patients with coVid-19': 1, 'exploring the crosstalk between adipose tissue and the cardiovascular system': 1, 'Francois F and Stachel a: obesity in patients younger than 60 years is a risk factor for covid-19 hospital admission. clin infect dis ciaa415': 1, 'SarS during pregnancy, united States. emerg infect dis': 1, 'impact of influenza on acute cardiopulmonary hospitalizations in pregnant women': 1, 'Boon ac and Zambon MC: influenza virus infection in the second and third trimesters of pregnancy: a clinical and seroepidemiological study': 1, 'inhibitory effect of leptin on human uterine contractility in vitro': 1, 'characterizing the pregnancy immune phenotype: results of the viral immunity and pregnancy (ViP) study': 1, 'Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon': 1, 'Inform: Emergency Department Evaluation and Management for Patients Under Investigation (PUIs) for Ebola Virus Disease (EVD)': 1, 'Identify-Isolate-Inform: A Tool for Initial Detection and Management of Measles Patients in the Emergency Department': 1, 'Identify-Isolate-Inform: A modified tool for initial detection and management of Middle East Respiratory Syndrome patients in the emergency department': 1, 'Can You Catch It? Lessons Learned and Modification of ED Triage Symptom and Travel Screening Strategy': 2, 'Signs and Symptoms': 1, 'Health Topics: Measles. NYC Department of Health and Hygiene': 1, 'Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys': 3, 'Discovery and synthesis of a phosphoramidate prodrug of a pyrrolo[2,1-f ][triazin-4-amino] adenine C-nucleoside (GS-5734) for the treatment of Ebola and emerging viruses': 4, 'A randomized, controlled trial of ZMapp for Ebola virus infection': 1, 'Characterization of Ebola virus disease (EVD) in rhesus monkeys for development of EVD therapeutics': 1, 'Systematic analysis of monoclonal antibodies against Ebola virus GP defines features that contribute to protection': 1, 'Antibody-mediated therapy against HIV/AIDS: where are we standing now?': 1, 'Novel mutations in Marburg virus glycoprotein associated with viral evasion from antibody mediated immune pressure': 1, 'Emergence of Ebola virus escape variants in infected nonhuman primates treated with the MB-003 antibody cocktail': 1, 'A perspective on the structural and functional constraints for immune evasion: insights from influenza virus': 1, 'First newborn baby to receive experimental therapies survives Ebola virus disease': 1, 'Post-Ebola syndrome': 3, 'Study of Ebola virus disease survivors in Guinea': 2, 'Multidisciplinary assessment of post-Ebola sequelae in Guinea (Postebogui): an observational cohort study': 2, 'A longitudinal study of Ebola sequelae in Liberia': 1, 'Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients': 1, 'Late ophthalmologic manifestations in survivors of the 1995 Ebola virus epidemic in Kikwit, Democratic Republic of the Congo': 1, 'Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts': 1, 'Identification and pathological characterization of persistent asymptomatic Ebola virus infection in rhesus monkeys': 1, 'Severe Ebola virus infection with encephalopathy: evidence for direct virus involvement': 1, 'Ebola virus-related encephalitis': 1, 'Ebola virus disease complicated by late-onset encephalitis and polyarthritis': 1, 'Late Ebola virus relapse causing meningoencephalitis: a case report': 3, 'Persistence of Ebola virus in ocular fluid during convalescence': 2, 'Ebola RNA persistence in semen of Ebola virus disease survivors-final report': 2, 'Resurgence of Ebola virus disease in Guinea linked to a survivor with virus persistence in seminal fluid for more than 500 days': 2, 'Persistence and sexual transmission of filoviruses': 1, 'Molecular evidence of sexual transmission of Ebola virus': 2, 'Reduced evolutionary rate in reemerged Ebola virus transmission chains': 1, 'Unusual Ebola virus chain of transmission': 1, 'Ebola virus infection associated with transmission from survivors': 1, 'Persistence of Ebola virus after the end of widespread transmission in Liberia: an outbreak report': 1, 'A 40-month follow-up of Ebola virus disease survivors in Guinea (PostEbogui) reveals long-term detection of Ebola viral ribonucleic acid in semen and breast milk': 1, 'Efficacy of immune plasma in treatment of Argentine haemorrhagic fever and association between treatment and a late neurological syndrome': 1, 'Current status of the treatment of Argentine hemorrhagic fever': 1, 'Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)': 2, 'GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses': 1, 'Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase': 1, 'GS-5734) protects African green monkeys from Nipah virus challenge': 1, 'Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever': 1, 'Sofosbuvir as treatment against dengue?': 1, 'New nucleoside analogues for the treatment of hemorrhagic fever virus infections': 1, 'Systematic approaches towards the development of host-directed antiviral therapeutics': 1, 'Host-directed antivirals: a realistic alternative to fight Zika virus': 1, 'Nucleoside analog GS-5734 protects nonhuman primates against aerosolized Ebola virus': 1, 'Model-based estimates of COVID-19 burden in King and Snohomish counties through': 1, 'Allocating scarce resources in disasters: emergency department principles': 1, 'The importance of addressing advanced care planning and decisions about do not resuscitate orders during COVID-19': 1, 'Available from www.vitaltalk.org': 1, 'Chlamydia psittaci (psittacosis) as a cause of community-acquired pneumonia: a systematic review and meta-analysis': 3, 'Compendium of measures to control chlamydia psittaci infection among humans (Psittacosis) and pet birds': 5, 'The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy': 1, 'Two fatal cases of psittacosis caused by Chlamydophila psittaci': 1, 'Compendium of measures to control Chlamydophila psittaci (formerly Chlamydia psittaci) infection among humans (psittacosis) and pet birds': 2, 'A psittacosis outbreak among english office workers with little or no contact with birds': 2, 'Three cases of atypical pneumonia caused by Chlamydophila psittaci': 2, 'Development of a real-time PCR for the detection of Chlamydia psittaci': 3, 'Disease burden of psittacosis in the Netherlands': 2, 'Validation of metagenomic next-generation sequencing tests for universal pathogen detection': 1, 'Integrating host response and unbiased microbe detection for lower respiratory tract infection diagnosis in critically ill adults': 2, 'Incremental value of metagenomic next generation sequencing for the diagnosis of suspected focal infection in adults': 1, 'The feasibility of metagenomic next-generation sequencing to identify pathogens causing tuberculous meningitis in cerebrospinal fluid': 1, 'Infectious diseases society of America/American thoracic society consensus guidelines on the management of community-acquired pneumonia in adults': 2, 'Chlamydia psittaci: update on an underestimated zoonotic agent': 1, 'Emendation of the family Chlamydiaceae: proposal of a single genus, Chlamydia, to include all currently recognized species': 1, 'Treatment of Chlamydial infections: 2014 update': 1, 'Zoonotic Chlamydophila psittaci infections from a clinical perspective': 1, 'Comparative in-vitro activity of moxifloxacin, minocycline and azithromycin against Chlamydia Spp': 1, 'Laboratory methods for case finding in human psittacosis outbreaks: a systematic review': 1, 'New real-time PCR tests for species-specific detection of Chlamydophila psittaci and Chlamydophila abortus from tissue samples': 1, 'Clinical metagenomic sequencing for diagnosis of meningitis and encephalitis': 1, 'Current practices in sedation and analgesia for mechanically ventilated critically ill patients: a prospective multicenter patient-based study': 2, 'Analgesic, sedative, antipsychotic, and neuromuscular blocker use in Canadian intensive care units: a prospective, multicentre, observational study': 3, 'Daily sedation interruption in mechanically ventilated critically ill patients cared for with a sedation protocol: a randomized controlled trial': 1, 'Impact of oversedation prevention in ventilated critically ill patients: a randomized trial-the AWARE study': 1, 'Early sedation with dexmedetomidine in critically ill patients': 1, 'Protocolized sedation vs usual care in paediatric patients mechanically ventilated for acute respiratory failure: a randomized clinical trial': 3, 'Sedation and analgesia practices in neonatal intensive care units (EUROPAIN): results from a prospective cohort study': 1, 'Randomized evaluation of sedation titration for respiratory failure study I. Patient, process, and system predictors of iatrogenic withdrawal syndrome in critically ill children': 1, 'Frequency, risk factors and symptomatology of iatrogenic withdrawal from opioids and benzodiazepines in critically ill neonates, children and adults: a systematic review of clinical studies': 1, 'Risk factors associated with iatrogenic opioid and benzodiazepine withdrawal in critically ill paediatric patients: a systematic review and conceptual model': 1, 'Opioid and benzodiazepine withdrawal syndrome in PICU patients: which risk factors matter?': 2, 'Acute withdrawal syndrome related to the administration of analgesic and sedative medications in adult intensive care unit patients': 3, 'Adverse sedation events in paediatrics: a critical incident analysis of contributing factors': 1, 'Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit': 4, 'Clinical recommendations for pain, sedation, withdrawal and delirium assessment in critically ill infants and children: an ESPNIC position statement for healthcare professionals. Intensive Care Med': 6, 'Consensus guidelines on sedation and analgesia in critically ill children': 2, 'Task Force of the American College of Critical Care Medicine of the Society of Preventing and Managing Opioid/Benzodiazepine Iatrogenic Withdrawal in the Critically Ill: A Systematic Review Critical Care M, the American Society of Health-System Pharmacists ACoCP. Sedation, analgesia, and neuromuscular blockade of the critically ill adult: revised clinical practice guidelines for 2002': 1, 'Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU': 6, 'Clinical pathways: effects on professional practice, patient outcomes, length of stay and hospital costs. Cochrane Database Syst Rev': 1, 'Successful implementation of a paediatric sedation protocol for mechanically ventilated patients': 1, 'A paediatric sedation protocol for mechanically ventilated patients requires sustenance beyond implementation': 1, 'Ten tips for ICU sedation. Intensive Care Med': 1, 'Chronic pain disorders after critical illness and ICU-acquired opioid dependence: two clinical conundra': 1, 'Discharge prescribing of enteral opioids after initiation as a weaning strategy from continuous opioid infusions in the Intensive Care Unit': 2, 'QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system': 2, 'Preferred reporting items for systematic reviews and meta-analyses: the prisma statement': 1, 'ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions': 1, 'Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated': 1, 'Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range': 1, 'Quality of evidence. In: Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach': 1, 'Implementation of a risk-stratified opioid and benzodiazepine weaning protocol in a paediatric cardiac ICU': 50, 'Iatrogenic withdrawal in enteral versus parenteral conversions of sedative infusions in a paediatric ICU': 17, 'Methadone/Lorazepam weaning protocol reduces sedative/analgesia withdrawal symptoms in paediatric ICU patients': 36, 'Development and implementation of a pharmacistmanaged, neonatal and paediatric, opioid-weaning protocol': 39, 'Respiratory, metabolic and hemodynamic effects of clonidine in ventilated patients presenting with withdrawal syndrome': 22, 'Analgesia and sedation protocol for mechanically ventilated postsurgical children reduces benzodiazepines and withdrawal symptoms-but not in all patients': 37, 'Evaluation of an opiate-weaning protocol using methadone in paediatric intensive care unit patients': 40, 'Implementation of a risk-stratified opioid weaning protocol in a paediatric intensive care unit': 41, 'Evaluation of a pharmacist-managed methadone taper': 45, 'Iatrogenic opiate withdrawal in paediatric patients: implementation of a standardized methadone weaning protocol and withdrawal assessment tool': 31, 'A prospective evaluation of opioid weaning in opioid-dependent paediatric critical care patients': 36, 'A trial of methadone tapering schedules in paediatric intensive care unit patients exposed to prolonged sedative infusions': 29, 'Replacement of fentanyl infusion by enteral methadone decreases the weaning time from mechanical ventilation: a randomized controlled trial': 33, 'Effective Practice and Organisation of Care taxonomy of health systems interventions. EPOC Resources for review authors. Norwegian Knowledge Centre for the Health Services': 1, 'Nurse-driven paediatric analgesia and sedation protocol reduces withdrawal symptoms in critically ill medical paediatric patients': 1, 'Outcome reporting in neonates experiencing withdrawal following opioid exposure in pregnancy: a systematic review': 1, 'The use of methadone to facilitate opioid weaning in paediatric critical care patients: a systematic review of the literature and meta-analysis': 3, 'High prevalence of corrected QT interval prolongation in acutely ill patients is associated with mortality: results of the QT in Practice (QTIP) Study': 1, 'Prolonged corrected QT interval is associated with shortterm and long-term mortality in critically ill patients: results from the FROG-ICU study': 1, 'Inappropriate medication prescriptions in elderly adults surviving an intensive care unit hospitalization': 1, 'Opioid tapering and weaning protocols in paediatric critical care units: a systematic review': 2, 'Randomized evaluation of sedation titration for respiratory failure baseline study I. Patterns of sedation weaning in critically ill children recovering from acute respiratory failure': 2, 'The Withdrawal Assessment Tool-1 (WAT-1): an assessment instrument for monitoring opioid and benzodiazepine withdrawal symptoms in paediatric patients': 2, 'Screening paediatric delirium with an adapted version of the Sophia Observation withdrawal Symptoms scale (SOS)': 4, 'Construction of the Sophia Observation withdrawal Symptomsscale (SOS) for critically ill children': 2, 'Assessment of Paediatric Delirium: a valid, rapid, observational tool for screening delirium in the PICU': 2, 'Diagnosing delirium in critically ill children: Validity and reliability of the Paediatric Confusion Assessment Method for the Intensive Care Unit': 2, 'Iatrogenic withdrawal syndrome or undiagnosed delirium?': 2, 'The stepped wedge cluster randomised trial: rationale, design, analysis, and reporting': 1, 'Opioid-associated iatrogenic withdrawal in critically ill adult patients: a multicenter prospective observational study': 1, 'Validation of the withdrawal assessment tool-1 in adult intensive care patients': 1, 'Organizational contextual features that influence the implementation of evidence-based practices across healthcare settings: a systematic integrative review': 1, 'Clinical review: International comparisons in critical care-lessons learned': 1, 'International analgesia, sedation, and delirium practices: a prospective cohort study': 1, 'Changing mechanisms of opiate tolerance and withdrawal during early development: animal models of the human experience': 1, 'Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult': 1, 'Contamination of hospital wastewater with hazardous compounds as defined by 7a WHG': 1, 'Occurrence and behaviour of X-ray contrast media in sewage facilities and the aquatic environment': 2, 'Degradation of the endocrine disrupting chemicals (EDCs) carbamazepine, clofibric acid, and iopromide by corona discharge over water': 1, 'Biodegradation of the iodinated X-ray contrast media diatrizoate and iopromide': 3, 'Phototransformation of selected pharmaceuticals during UV treatment of drinking water': 1, 'Ozone degradation of iodinated pharmaceutical compounds': 3, 'Degradation of X-ray contrast media compounds by combined ozone and ultrasound': 1, 'The aqueous degradation of butylated hydroxyanisole by UV/S2O8 2− : Study of reaction mechanisms via dimerization and mineralization': 2, 'Analytical studies on the oxidative degradation of the reactive textile dye uniblue A': 2, 'Fighting SARS-common disinfectants may slow SARS': 1, 'Solar photocatalytic degradation of water and air pollutants: challenges and perspectives': 1, 'Kinetics and mechanism of oxidations by peroxydisulfate': 1, 'Light-assisted 1,4-dioxane degradation': 1, 'Dictionary of inorganic water quality parameters and pollutants, in: Applications of Environmental Chemistry, A Practical Guide for Environmental Professionals': 2, 'Effect of trace additives on the efficiency of peroxydisulfate regeneration': 1, 'Oxidation efficiencies of potassium persulfate and hydrogen peroxide in pressurized hot water with and without preheating': 1, 'Transformation of the X-ray contrast medium iopromide in soil and biological wastewater treatment': 1, 'Ozonation and reductive deiodination of iopromide to reduce the environmental burden of iodinated X-ray contrast media': 1, 'Photodechlorination of polychlorobenzene congeners in surfactant micelle solutions': 1, 'Karpel Vel Leitner, Degradation of acetic acid with sulphate radical generated by persulfate ions photolysis': 6, 'Kinetics and mechanism of protection of thymine from sulphate radical anion under anoxic conditions': 1, 'Formation of oxidation by-products of the iodinated X-ray contrast medium iomeprol during ozonation': 1, 'Structural characterization of metabolites of the X-ray contrast agent iopromide in activated sludge using ion trap mass spectrometry': 1, 'Infectious agents associated with diarrhoea in neonatal foals in central Kentucky: A comprehensive molecular study': 1, 'Emerging outbreaks associated with equine coronavirus in adult horses': 13, 'Epidemic of equine coronavirus at Obihiro Racecourse, Hokkaido, Japan in 2012': 7, 'Isolation of an equine coronavirus from adult horses with pyrogenic and enteric disease and its antigenic and genomic characterization in comparison with the NC99 strain': 8, 'Putative intestinal hyperammonaemia in horses: 36 cases': 1, 'Coronavirus Disease (COVID-19) in Children -What We Know So Far and What We Do Not?': 2, 'Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol': 2, 'Do chronic respiratory diseases or their treatment affect the REFERENCES 1. Choudhary B, Goyal JP. Management concern for noncovid children during the covid pandemic. Indian Pediatr': 4, 'The human genome project and its impact on psychiatry': 1, 'In utero infection and adult schizophrenia': 1, 'Glial expression of borna disease virus phosphoprotein induces behavioral and neurological abnormalities in transgenic mice': 4, 'Pathogenesis of viral infections': 1, 'Cytokine-induced sickness behaviour: mechanisms and implications': 3, 'Cytokine-induced sickness behavior': 2, 'Borna disease viral infection of adult and neonatal rats: models for neuropsychiatric disease': 1, 'Cytokines and the acute phase response to influenza virus in mice': 1, 'Distribution of Borna disease virus in the brain of rats infected with an obesity-inducing virus strain': 1, 'Strain differences in sleep and other pathophysiological sequelae of influenze virus infection in naïve and immunized, ice': 1, 'Sleep patterns are disturbed in cats infected with feline immunodeficiency virus': 1, 'Paradigms for behavioral assessment of viral pathogenesis': 2, 'Viruses and behavioural changes: a review of clinical and experimental findings': 1, 'Persistent neonatal Borna disease virus (BDV) infection of the brain causes chronic emotional abnormalities in adult rats': 2, 'Developmental brain injury associated with abnormal play behavior in neonatally Borna disease virusinfected Lewis rats: a model of autism': 1, 'Molecular basis of aggression': 4, 'Aggressive behavioral phenotypes in mice': 1, 'Experimental rabies in skunks: effects of immunosuppression induced by cyclophosphamide': 1, 'Pathogenesis of Borna disease in rats: immune-mediated viral ophthalmoencephalopathy causing blindness and behavioral abnormalities': 1, 'A novel permissive role for glucocorticoids in induction of febrile and behavioral signs of experimental herpes simplex virus encephalitis': 1, 'Behavior, chemosignals and endocrine functions in male mice infected with tick-borne encephalitis virus': 1, 'Perspective: viral infections and the death of neurons': 1, 'Molecular and cellular biology of Borna disease viral infection. Microbes Infect': 2, 'To kill or be killed: viral evasion of apoptosis': 1, 'Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase': 1, 'Regulation of T cell responses during central nervous system viral infection': 1, 'Immune-mediated brain atrophy. CD8 þ T cells contribute to tissue destruction during Borna disease': 1, 'Virus demyelination': 2, 'Pathways to neuronal injury and apoptosis in HIV-associated dementia': 1, 'Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function': 1, 'The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection': 1, 'Cytokines and chronic fatigue syndrome': 1, 'Central administration of IL-1 reduces anxiety and induces sickness behaviour in rats': 1, 'Mechanisms of sickness-induced decreases in food-motivated behavior': 1, 'Mechanisms of the behavioral effects of interleukin 1. Role of prostaglandins and CRF': 1, 'Interleukin-1b-converting enzyme-deficient mice resist central but not systemic endotoxin-induced anorexia': 1, 'Cytokine-induced sickness behavior: where do we stand?': 1, 'Cytokine activation of the HPA axis': 2, 'Neurobiology of depression': 3, 'The cellular neurobiology of depression': 2, 'Cytokines and acute neurodegeneration': 2, 'Brain glia release factors with opposing actions upon neuronal survival': 1, 'Innate immunity: the missing link in neuroprotection and neurodegeneration': 1, 'Expression of fas antigen in the normal mouse brain': 1, 'Correlations between in vitro affinity of antipsychotics to various central neurotransmitter receptors and clinical incidence of their adverse drug reactions': 1, 'Serotonin neurons, neuroplasticity, and homeostasis of neural tissue': 1, 'Cerebrospinal fluid 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in HIV-1 infection': 1, 'Neurotrophins and depression': 1, 'Involvement of 5-HT1A receptors in animal tests of anxiety and depression: evidence from genetic models': 1, 'Regional changes in 5-HT1A but not in 5-HT2A receptors in mouse brain after Semliki Forest viral infection: radioligand binding and autoradiographic studies': 1, 'Rabies virus selectively alters 5-HT1 receptor subtypes in rat brain': 1, 'Effects of genetic background on neonatal Borna disease viral infection-induced neurodevelopmental damage. II. Neurochemical alterations and responses to pharmacological treatments': 1, 'Schizophrenia: diverse approaches to a complex disease': 1, 'Glial cell abnormalities in major psychiatric disorders: the evidence and implications': 2, 'The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia': 2, 'Oligodendrocyte dysfunction in schizophrenia and bipolar disorder': 1, 'Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia': 1, 'Synaptic efficacy enhanced by glial cells in vitro': 1, 'New insights into neuronglia communication': 1, 'Control of synapse number by glia': 1, 'Inflammation in neurodegenerative disease -a double-edged sword': 1, 'Borna disease virus phosphoprotein binds a neurite outgrowth factor, amphoterin/HMG-1': 1, 'Heparin-binding proteins HB-GAM (pleiotrophin) and amphoterin in the regulation of cell motility': 1, 'Amphoterin (P30, HMG-1) and RIP are early markers of oligodendrocytes in the developing rat spinal cord': 1, 'World health organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19)': 3, 'Coronavirus disease 2019 (COVID-19): what we know': 1, 'A review of the 2019 novel coronavirus (COVID-19) based on current evidence': 1, 'A model society: maths, models and expertise in viral outbreaks': 1, 'Effective containment explains sub-exponential growth in confirmed cases of recent COVID-19 outbreak in mainland china': 2, 'Transmission dynamics of the COVID-19 outbreak and effectiveness of government interventions: a data-driven analysis': 2, 'A conceptual model for the coronavirus disease 2019 (COVID-19) outbreak in Wuhan, China with individual reaction and governmental action': 2, 'Analysis and forecast of COVID-19 spreading in China, Italy and France': 1, 'Assessing the global tendency of COVID-19 outbreak': 1, 'A modified sir model for the covid-19 contagion in Italy': 1, 'Why is it difficult to accurately predict the COVID-19 epidemic?': 2, 'Forecasting the worldwide spread of COVID-19 based on logistic model and SEIR model': 1, 'A note on the evolution of covid-19 in italy': 1, 'COVID-19 epidemic outcome predictions based on logistic fitting and estimation of its reliability': 2, 'Mathematical biology: i. an introduction': 1, 'Dynamical prediction of flu seasonality driven by ambient temperature: influenza vs. common cold': 1, 'Bi-logistic model for disease dynamics caused by mycobacterium tuberculosis in russia': 1, 'A simple substitution model of technological change': 1, 'Fitting models to biological data using linear and nonlinear regression: a practical guide to curve fitting': 1, \"Coronavirus cases have dropped sharply in South Korea. what's the secret to its success\": 1, 'The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) -China': 1, 'ACE and ACE2: a tale of two enzymes': 1, 'Number of confirmed cases of coronavirus (COVID-19) in Spain as of April 6, 2020 by autonomous community': 1, 'Discarded coronavirus face masks and gloves rising threat to ocean life, conservationists warn': 1, 'Disaster waste management after flood events': 1, 'Disaster Waste Management Using Systems Dynamics: A Case Study in Southern Brazil': 1, 'Canterbury earthquake construction and demolition waste management: issues and improvement suggestions': 1, 'Post-disaster Waste Management: Lessons Learnt from 2015 Nepal Earthquake Sustainable Waste Management: Policies and Case Studies': 1, 'Disaster waste management in Italy: Analysis of recent case studies': 1, 'Capacity building for post disaster construction and demolition waste management. Disaster Prevention and Management': 1, 'Post disaster waste management strategies in developing countries: Case of Sri Lanka': 1, 'Recycling disaster waste: Feasibility, method and effectiveness. Resources, Conservation and Recycling': 1, 'Innovative Solutions for Reusing Packaging Waste Materials in Humanitarian Logistics': 1, 'Earthquake disaster waste management reviews: Prediction, treatment, recycling, and prevention': 1, 'Reliability analysis for disaster waste management systems': 1, 'Analysis of key factors for waste management in humanitarian response: An interpretive structural modelling approach': 1, 'Restoring waste management following disasters': 1, 'Restoration of services in disrupted infrastructure systems: A network science approach': 1, 'What 11 Billion People Mean for Disease Outbreaks': 1, 'Plastics Had Been Falling Out of Favor. Then Came the Virus': 1, 'Disinfecting wipes are being flushed down toilets and causing major pipe problems': 1, \"We can't go back to normal': how will coronavirus change the world?\": 1, 'Therapeutically targeting RNA viruses via lethal mutagenesis': 1, 'Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population': 4, 'Engineering attenuated virus vaccines by controlling replication fidelity': 2, 'Structural basis for proteolysis-dependent activation of the poliovirus RNA-dependent RNA polymerase': 3, 'Structural basis for active site closure by the poliovirus RNA-dependent RNA polymerase': 4, 'Poliovirus RNA-dependent RNA polymerase (3Dpol): pre-steady-state kinetic analysis of ribonucleotide incorporation in the presence of Mg2+ Biochemistry': 1, 'Remote site control of an active site fidelity checkpoint in a viral RNA-dependent RNA polymerase': 2, 'Crystal structure of poliovirus 3CD protein: virally encoded protease and precursor to the RNAdependent RNA polymerase': 2, 'Dynamics: the missing link between structure and function of the viral RNA-dependent RNA polymerase?': 3, 'Long-range interaction networks in the function and fidelity of poliovirus RNA-dependent RNA polymerase studied by nuclear magnetic resonance': 2, 'Relating protein motion to catalysis': 1, 'A hierarchy of timescales in protein dynamics is linked to enzyme catalysis': 2, 'Analysis of RNA-dependent RNA polymerase structure and function as guided by known polymerase structures and computer predictions of secondary structure': 1, 'Clustered charged-to-alanine mutagenesis of poliovirus RNAdependent RNA polymerase yields multiple temperature-sensitive mutants defective in RNA synthesis': 2, 'Picornavirus genome replication. Identification of the surface of the poliovirus (PV) 3C dimer that interacts with PV 3Dpol during VPg uridylylation and construction of a structural model for the PV 3C2-3Dpol complex': 2, 'Collective motions in proteins: a covariance analysis of atomic fluctuations in molecular dynamics and normal mode simulations': 1, 'Structure of footand-mouth disease virus RNA-dependent RNA polymerase and its complex with a templateprimer RNA': 2, 'Poliovirus RNA-dependent RNA polymerase (3Dpol): kinetic, thermodynamic, and structural analysis of ribonucleotide selection': 1, 'Determinants of RNAdependent RNA polymerase (in)fidelity revealed by kinetic analysis of the polymerase encoded by a foot-and-mouth disease virus mutant with reduced sensitivity to ribavirin': 2, 'Dynamics on multiple timescales in the RNA-directed RNA polymerase from the cystovirus phi6': 1, 'Relationships among the positive strand and double-strand RNA viruses as viewed through their RNA-dependent RNA polymerases': 1, 'Poliovirus RNA-dependent RNA polymerase (3D(pol)). Assembly of stable, elongation-competent complexes by using a symmetrical primer-template substrate (sym/ sub)': 2, 'Recombinant viral RdRps can initiate RNA synthesis from circular templates': 2, 'A ratchet mechanism of transcription elongation and its control': 1, 'Crystal structures of active and inactive conformations of a caliciviral RNA-dependent RNA polymerase': 1, 'The Amber biomolecular simulation programs': 1, 'Comparison of simple potential functions for simulating liquid water': 1, 'Ewald--an Nlog(N) method for Ewald sums in large systems': 1, 'Clustering Molecular Dynamics Trajectories: 1. Characterizing the Performance of Different Clustering Algorithms': 2, 'Essential dynamics of proteins': 1, 'A single mutation in poliovirus RNA-dependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity': 1, 'Ribavirin and lethal mutagenesis of poliovirus: molecular mechanisms, resistance and biological implications': 1, 'An antiviral mechanism investigated with ribavirin as an RNA virus mutagen for foot-and-mouth disease virus': 1, 'Foot-and-mouth disease virus mutant with decreased sensitivity to ribavirin: implications for error catastrophe': 1, 'Incorporation fidelity of the viral RNA-dependent RNA polymerase: a kinetic, thermodynamic and structural perspective': 1, 'Coronavirus Disease-19: Summary of 2,370 contact investigations of the first 30 cases in the Republic of Korea': 1, 'Environmental Contamination and Viral Shedding in MERS Patients during MERS-CoV Outbreak in South Korea': 1, 'Airflow as a possible transmission route of Middle East respiratory syndrome at an initial outbreak hospital in Korea': 1, \"Airflow analysis of Pyeongtaek St. Mary's hospital during hospitalization of the first Middle East respiratory syndrome patient in Korea\": 1, 'Type II transmembrane serine proteases. Insights into an emerging class of cell surface proteolytic enzymes': 5, 'Type II transmembrane serine proteases in development and disease': 6, 'Type II transmembrane serine proteases': 6, 'The adrenal secretory serine protease AsP is a short secretory isoform of the transmembrane airway trypsin-like protease': 1, 'Structure and activity of human pancreasin, a novel tryptic serine peptidase expressed primarily by the pancreas': 1, 'The Drosophila Stubble-stubbloid gene encodes an apparent transmembrane serine protease required for epithelial morphogenesis': 1, 'A genome-wide analysis of immune responses in Drosophila': 1, 'Characterization of human gamma-tryptases, novel members of the chromosome 16p mast cell tryptase and prostasin gene families': 4, 'Identification of a new member of the tryptase family of mouse and human mast cell proteases which possesses a novel COOH-terminal hydrophobic extension': 2, 'Prostasin is a novel human serine proteinase from seminal fluid. Purification, tissue distribution, and localization in prostate gland': 5, 'Prostasin is a glycosylphosphatidylinositol-anchored active serine protease': 3, 'Prostasin regulates epithelial monolayer function, cell-specific Gpld1-mediated secretion and functional role for GPI anchor': 5, 'A mouse serine protease TESP5 is selectively included into lipid rafts of sperm membrane presumably as a glycosylphosphatidylinositol-anchored protein': 8, 'Testisin, a new human serine proteinase expressed by premeiotic testicular germ cells and lost in testicular germ cell tumors': 5, 'Netzel-Arnett S. The cutting edge, membraneanchored serine protease activities in the pericellular microenvironment': 3, 'Membrane anchored serine proteases, a rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer': 3, 'Human and mouse proteases, a comparative genomic approach': 1, 'Demonstration of the acyl-enzyme mechanism for the hydrolysis of peptides and anilides by chymotrypsin': 1, 'Catalytic domain structures of MT-SP1/matriptase, a matrixdegrading transmembrane serine proteinase': 1, 'The structure of the extracellular region of human hepsin reveals a serine protease domain and a novel scavenger receptor cysteine-rich (SRCR) domain': 2, 'Crystal structure of enteropeptidase light chain complexed with an analog of the trypsinogen activation peptide': 3, 'Crystal structure of the catalytic domain of DESC1, a new member of the type II transmembrane serine proteinase family': 2, 'Active site conformational changes of prostasin provide a new mechanism of protease regulation by divalent cations': 3, 'Discovery of inhibitors of the channel-activating protease prostasin (CAP1/PRSS8) utilizing structure-based design': 2, 'Structure of human prostasin, a target for the regulation of hypertension': 2, 'Introduction, serine peptidases and their clans': 1, 'On the size of the active site in proteases. I. Papain': 1, 'Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and singlechain urokinase-type plasminogen activator as substrates': 5, 'Protease specificity determination by using cellular libraries of peptide substrates (CLiPS)': 1, 'Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers': 5, 'Biochemical characterization of prostasin, a channel activating protease': 4, 'Expression and characterization of recombinant gamma-tryptase': 2, 'Serase-1B, a new splice variant of polyserase-1/TMPRSS9, activates urokinase-type plasminogen activator and the proteolytic activation is negatively regulated by glycosaminoglycans': 3, 'The activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitor': 3, 'Roles and regulation of membrane-associated serine proteases': 1, 'Catalytic cleavage of the androgen-regulated TMPRSS2 protease results in its secretion by prostate and prostate cancer epithelia': 6, 'Activation of epithelial sodium channels by mouse channel activating proteases (mCAP) expressed in Xenopus oocytes requires catalytic activity of mCAP3 and mCAP2 but not mCAP1': 1, 'Neurobin/TMPRSS11c, a novel type II transmembrane serine protease that cleaves fibroblast growth factor-2 in vitro': 2, 'Identification and cloning of the membrane-associated serine protease, hepsin, from mouse preimplantation embryos': 2, 'Bovine proenteropeptidase is activated by trypsin, and the specificity of enteropeptidase depends on the heavy chain': 1, 'Identification of domain structures in the propeptide of corin essential for the processing of proatrial natriuretic peptide': 2, 'Mutation G827R in matriptase causing autosomal recessive ichthyosis with hypotrichosis yields an inactive protease': 1, 'Zymogen activation, inhibition, and ectodomain shedding of matriptase': 3, 'Production of soluble matriptase by human cancer cell lines and cell surface activation of its zymogen by trypsin': 1, 'Deregulated activation of matriptase in breast cancer cells': 2, 'The androgenregulated type II serine protease TMPRSS2 is differentially expressed and mislocalized in prostate adenocarcinoma': 1, 'Protein inhibitors of proteinases': 1, 'Molecular cloning of cDNA for matriptase, a matrix-degrading serine protease with trypsin-like activity': 2, 'HAI-1 regulates activation and expression of matriptase, a membrane-bound serine protease': 2, 'Roles of functional and structural domains of hepatocyte growth factor activator inhibitor type 1 in the inhibition of matriptase': 1, 'Potent inhibition and global colocalization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity': 3, 'Hepsin activates pro-hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor-1B (HAI-1B) and HAI-2': 3, 'Identification of hepatocyte growth factor activator inhibitor-1B as a potential physiological inhibitor of prostasin': 2, 'The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature': 1, 'Serpin structure, mechanism, and function': 1, 'Cloning of the human homolog of mouse transmembrane tryptase': 1, 'Biochemical and functional characterization of human transmembrane tryptase (TMT)/tryptase gamma. TMT is an exocytosed mast cell protease that induces airway hyperresponsiveness in vivo via an interleukin-13/interleukin-4 receptor alpha/signal transducer and activator of transcription (STAT) 6-dependent pathway': 3, 'High degree of conservation of the multigene tryptase locus over the past 150-200 million years of mammalian evolution': 1, 'Mast cells': 1, 'Mast cell tryptases and chymases in inflammation and host defense': 1, 'Enteropeptidase, a type II transmembrane serine protease': 4, 'The chemical nature of enzymes': 1, 'Formation of trypsin from crystalline trypsinogen by means of enterokinase': 1, 'Purification and concentration of enterokinase': 1, 'Enterokinase (enteropeptidase), comparative aspects': 1, 'The amino-terminal sequence of the catalytic subunit of bovine enterokinase': 1, 'cDNA sequence and chromosomal localization of human enterokinase, the proteolytic activator of trypsinogen': 2, 'Enterokinase, the initiator of intestinal digestion, is a mosaic protease composed of a distinctive assortment of domains': 2, 'Cloning and functional expression of a cDNA encoding the catalytic subunit of bovine enterokinase': 1, 'Structural characterization of porcine enteropeptidase': 1, 'Structure of murine enterokinase (enteropeptidase) and expression in small intestine during development': 1, 'Immunofluorescent localisation of enterokinase in human small intestine': 1, 'New method with a synthetic substrate and its comparison with the trypsinogen procedure': 1, 'Apical sorting of bovine enteropeptidase does not involve detergentresistant association with sphingolipid-cholesterol rafts': 2, 'Mucin-like domain of enteropeptidase directs apical targeting in Madin-Darby canine kidney cells': 1, 'Intestinal enterokinase. Mechanisms of tts \"secretion\" into the lumen of the small intestine': 1, 'Duodenase, a new serine protease of unusual specificity from bovine duodenal mucosa. Purification and properties': 1, 'Subcellular localization, substrate specificity and crystallization of duodenase, a potential activator of enteropeptidase': 1, 'Activation of recombinant proenteropeptidase by duodenase': 1, 'BACE1 is a newly discovered protein secreted by the pancreas which cleaves enteropeptidase in vitro': 1, 'Substrate specificities of porcine and bovine enteropeptidases toward the peptide Val-(Asp)4-Lys-Ile-Val-Gly and its analogs': 1, 'Intestinal enterokinase deficiency': 1, 'Intestinal enterokinase deficiency. Occurrence in two sibs and age dependency of clinical expression': 1, 'A novel trypsin-like serine protease (hepsin) with a putative transmembrane domain expressed by human liver and hepatoma cells': 1, 'Cloning and sequence analysis of rat hepsin, a cell surface serine proteinase': 1, 'Complete nucleotide sequence, origin of isoform and functional characterization of the mouse hepsin gene': 2, 'Gene targeting in hemostasis': 1, 'Pegylated kunitz domain inhibitor suppresses hepsin-mediated invasive tumor growth and metastasis': 1, 'Hepsin activates prostasin and cleaves the extracellular domain of the epidermal growth factor receptor': 2, 'Activation of rat liver microsomal glutathione transferase by hepsin': 1, 'Laminin-332 is a substrate for hepsin, a protease associated with prostate cancer progression': 1, 'The serine protease corin in cardiovascular biology and disease': 3, 'Hepsin, a putative membrane-associated serine protease, activates human factor VII and initiates a pathway of blood coagulation on the cell surface leading to thrombin formation': 1, 'Hepsin, a putative cell-surface serine protease, is required for mammalian cell growth': 1, 'CVS-3983, a selective matriptase inhibitor, suppresses the growth of androgen independent prostate tumor xenografts': 1, 'Mice deficient in hepsin, a serine protease, exhibit normal embryogenesis and unchanged hepatocyte regeneration ability': 1, 'Mice deficient for the type II transmembrane serine protease, TMPRSS1/hepsin, exhibit profound hearing loss': 2, 'Delineation of prognostic biomarkers in prostate cancer': 1, 'Expression profiling reveals hepsin overexpression in prostate cancer': 1, 'Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia': 1, 'Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer': 1, 'Hepsin and prostate cancer': 2, 'Antibodies neutralizing hepsin protease activity do not impact cell growth but inhibit invasion of prostate and ovarian tumor cells in culture': 1, 'Hepsin promotes prostate cancer progression and metastasis': 1, 'Cloning of the TMPRSS2 gene, which encodes a novel serine protease with transmembrane, LDLRA, and SRCR domains and maps to 21q22.3': 2, 'Cloning and characterization of the cDNA and gene for human epitheliasin': 1, 'Cloning, genomic organization, chromosomal assignment and expression of a novel mosaic serine proteinase, epitheliasin': 2, 'Prostatelocalized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2': 2, 'TMPRSS2, a serine protease expressed in the prostate on the apical surface of luminal epithelial cells and released into semen in prostasomes, is misregulated in prostate cancer cells': 2, 'Regulation of the epithelial sodium channel by serine proteases in human airways': 1, 'Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors': 2, 'Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium': 1, 'The membraneanchored serine protease, TMPRSS2, activates PAR-2 in prostate cancer cells': 1, 'Phenotypic analysis of mice lacking the Tmprss2-encoded protease': 1, 'Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer': 1, 'An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression': 1, 'Role of the TMPRSS2-ERG gene fusion in prostate cancer': 1, 'Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer': 1, 'Androgeninduced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements': 1, 'Ovarian tumor cells express a novel multi-domain cell surface serine protease': 1, 'Insertion of beta-satellite repeats identifies a transmembrane protease causing both congenital and childhood onset autosomal recessive deafness': 2, 'Linkage of congenital recessive deafness (gene DFNB10) to chromosome 21q22.3': 1, 'TMPRSS3, a type II transmembrane serine protease mutated in non-syndromic autosomal recessive deafness': 3, 'An integrated genetic and functional analysis of the role of type II transmembrane serine proteases (TMPRSSs) in hearing loss': 3, 'The transmembrane serine protease (TMPRSS3) mutated in deafness DFNB8/10 activates the epithelial sodium channel (ENaC) in vitro': 2, 'No evidence of hearing loss in pseudohypoaldosteronism type 1 patients': 1, 'A novel transmembrane serine protease (TMPRSS3) overexpressed in pancreatic cancer': 3, 'Synergistic Activation of ENaC by Three Membrane-bound Channel-activating Serine Proteases (mCAP1, mCAP2, and mCAP3) and S': 2, 'ENaC proteolytic regulation by channel-activating protease 2': 1, 'Proteolytic activation of the 1918 influenza virus hemagglutinin': 1, 'ECM1 and TMPRSS4 are diagnostic markers of malignant thyroid neoplasms and improve the accuracy of fine needle aspiration biopsy': 1, 'Hepatocyte growth factor activator inhibitor type 1 regulates epithelial to mesenchymal transition through membrane-bound serine proteinases': 1, 'TMPRSS4 promotes invasion, migration and metastasis of human tumor cells by facilitating an epithelialmesenchymal transition': 1, 'TMPRSS4 induces invasion and epithelial-mesenchymal transition through upregulation of integrin alpha5 and its signaling pathways': 1, 'Spinesin/TMPRSS5, a Novel Transmembrane Serine Protease, Cloned from Human Spinal Cord': 2, 'Mosaic serine proteases in the mammalian central nervous system': 2, 'Cloning and expression of novel mosaic serine proteases with and without a transmembrane domain from human lung': 1, 'Novel type II transmembrane serine proteases, MSPL and TMPRSS13, Proteolytically activate membrane fusion activity of the hemagglutinin of highly pathogenic avian influenza viruses and induce their multicycle replication': 1, 'Identification and characterization of a novel matrix-degrading protease from hormone-dependent human breast cancer cells': 2, 'Transmembrane serine protease TADG-15 (ST14/Matriptase/MT-SP1), expression and prognostic value in ovarian cancer': 1, 'Cloning and chromosomal mapping of a gene isolated from thymic stromal cells encoding a new mouse type II membrane serine protease, epithin, containing four LDL receptor modules and two CUB domains': 1, 'Delineation of matriptase protein expression by enzymatic gene trapping suggests diverging roles in barrier function, hair formation, and squamous cell carcinogenesis': 4, 'Matriptase inhibition by hepatocyte growth factor activator inhibitor-1 is essential for placental development': 6, 'Evidence for a matriptase-prostasin proteolytic cascade regulating terminal epidermal differentiation': 3, 'Hepatocyte growth factor activator inhibitor-1 (HAI-1) is essential for the integrity of basement membranes in the developing placental labyrinth': 4, 'Characterization of matriptase expression in normal human tissues': 4, 'Reverse biochemistry, use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue': 2, 'Sphingosine 1-phosphate, present in serum-derived lipoproteins, activates matriptase': 1, 'Regulation of cell surface protease matriptase by HAI2 is essential for placental development, neural tube closure and embryonic survival in mice': 6, 'Initiation of plasminogen activation on the surface of monocytes expressing the type II transmembrane serine protease matriptase': 1, 'Matriptase expression in the normal and neoplastic mast cells': 1, 'Loss of proteolytically processed filaggrin caused by epidermal deletion of Matriptase/MT-SP1': 3, 'Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis': 1, 'Neutral cysteine protease bleomycin hydrolase is essential for the breakdown of deiminated filaggrin into amino acids': 1, 'Epithelial integrity is maintained by a matriptase-dependent proteolytic pathway': 2, 'The epidermal barrier function is dependent on the serine protease CAP1/Prss8': 2, 'Co-localization of the channel activating protease prostasin/(CAP1/PRSS8) with its candidate activator, matriptase': 1, 'Ichthyosis, Follicular Atrophoderma, and Hypotrichosis Caused by Mutations in ST14 Is Associated with Impaired Profilaggrin Processing': 2, 'Autosomal recessive ichthyosis with hypotrichosis syndrome, further delineation of the phenotype': 1, 'Autosomal ichthyosis with hypotrichosis syndrome displays low matriptase proteolytic activity and is phenocopied in ST14 hypomorphic mice': 2, 'Matriptase initiates activation of epidermal pro-kallikrein and disease onset in a mouse model of Netherton syndrome': 1, 'Membrane-anchored serine protease matriptase regulates epithelial barrier formation and permeability in the intestine': 2, 'Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk': 2, 'Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo': 1, 'Expression of serine protease SNC19/matriptase and its inhibitor hepatocyte growth factor activator inhibitor type 1 in normal and malignant tissues of gastrointestinal tract': 2, 'Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation': 2, 'Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1': 1, 'Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is required for branching morphogenesis in the chorioallantoic placenta': 1, 'Defect of hepatocyte growth factor activator inhibitor type 1/serine protease inhibitor, Kunitz type 1 (Hai-1/Spint1) leads to ichthyosis-like condition and abnormal hair development in mice': 1, 'Inactivation of serine protease Matriptase1a by its inhibitor Hai1 is required for epithelial integrity of the zebrafish epidermis': 1, 'Characterization of a novel, membrane-bound, 80-kDa matrix-degrading protease from human breast cancer cells. Monoclonal antibody production, isolation, and localization': 1, 'Expression of the serine protease, matriptase, in breast ductal carcinoma of Chinese women, correlation with clinicopathological parameters': 1, 'Tissue microarray analysis of hepatocyte growth factor/Met pathway components reveals a role for Met, matriptase, and hepatocyte growth factor activator inhibitor 1 in the progression of node-negative breast cancer': 1, 'Increasing expression of serine protease matriptase in ovarian tumors, tissue microarray analysis of immunostaining score with clinicopathological parameters': 1, 'The novel serine protease tumor-associated differentially expressed gene-15 (matriptase/MT-SP1) is highly overexpressed in cervical carcinoma': 1, 'Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer, correlation with clinical outcome and tumor clinicopathological parameters': 1, 'A novel biomarker for staging human prostate adenocarcinoma, overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activator inhibitor-1': 1, 'Increased expression of matriptase is associated with histopathologic grades of cervical neoplasia': 1, 'The ratio of Matriptase/HAI-1 mRNA is higher in colorectal cancer adenomas and carcinomas than corresponding tissue from control individuals': 1, 'Characterization of a membrane-bound arginine-specific serine protease from rat intestinal mucosa': 1, 'A role for membrane-type serine protease (MT-SP1) in intestinal epithelial turnover': 1, 'Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease': 2, 'Coordinate expression and functional profiling identify an extracellular proteolytic signaling pathway': 1, 'Local protease signaling contributes to neural tube closure in the mouse embryo': 3, 'Adhesion signaling by a novel mitotic substrate of src kinases': 1, 'Proteolysis induced amino terminal ectodomain shedding of the integral membrane glycoprotein CUB domain containing protein 1 (CDCP1) is accompanied by tyrosine phosphorylation of its carboxy terminal domain and recruitment of Src and PKC{delta}': 1, 'Matriptase-2, a membrane-bound mosaic serine proteinase predominantly expressed in human liver and showing degrading activity against extracellular matrix proteins': 2, 'Mouse matriptase-2, identification, characterization and comparative mRNA expression analysis with mouse hepsin in adult and embryonic tissues': 2, 'Proteolytic processing of the serine protease matriptase-2, identification of the cleavage sites required for its autocatalytic release from the cell surface': 1, 'Membrane-bound serine protease matriptase-2 (Tmprss6) is an essential regulator of iron homeostasis': 2, 'The serine protease TMPRSS6 is required to sense iron deficiency': 2, 'Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA)': 2, 'The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin': 1, 'Molecular mechanisms of the defective hepcidin inhibition in TMPRSS6 mutations associated with iron-refractory iron deficiency anemia': 1, 'Matriptase-3 is a novel phylogenetically preserved membrane-anchored serine protease with broad serpin reactivity': 3, 'Polyserase-I, a human polyprotease with the ability to generate independent serine protease domains from a single translation product': 2, 'Identification and analysis of the promoter region of the type II transmembrane serine protease polyserase-1 and its transcript variants': 1, 'Corin, a mosaic transmembrane serine protease encoded by a novel cDNA from human heart': 1, 'Localization of the mosaic transmembrane serine protease corin to heart myocytes': 1, 'A novel low-density lipoprotein receptor-related protein with type II membrane protein-like structure is abundant in heart': 1, 'Genomic structures of the human and murine corin genes and functional GATA elements in their promoters': 2, 'Corin is co-expressed with pro-ANP and localized on the cardiomyocyte surface in both zymogen and catalytically active forms': 2, 'Role of glycosylation in corin zymogen activation': 3, 'Functional analysis of the transmembrane domain and activation cleavage of human corin, design and characterization of a soluble corin': 2, 'Molecular insights into cancer invasion, strategies for prevention and intervention': 1, 'new insights into the natriuretic peptide system': 2, 'Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation': 1, 'Corin, a transmembrane cardiac serine protease, acts as a proatrial natriuretic peptide-converting enzyme': 2, 'Hypertension in mice lacking the proatrial natriuretic peptide convertase corin': 1, 'Genetic inversion in mast cell-deficient (W(sh)) mice interrupts corin and manifests as hematopoietic and cardiac aberrancy': 1, 'The serine protease Corin is a novel modifier of the Agouti pathway': 1, 'Furin-mediated processing of Pro-C-type natriuretic peptide': 1, 'Corin gene minor allele defined by 2 missense mutations is common in blacks and associated with high blood pressure and hypertension': 1, 'Corin I555(P568) allele is associated with enhanced cardiac hypertrophic response to increased systemic afterload': 1, 'Dysfunctional Corin I555(P568) Allele Is Associated With Impaired Brain Natriuretic Peptide Processing and Adverse Outcomes in Blacks With Systolic Heart Failure, Results From the Genetic Risk Assessment in Heart Failure Substudy': 1, 'Corin variant associated with hypertension and cardiac hypertrophy exhibits impaired zymogen activation and natriuretic peptide processing activity': 2, 'Enzyme-linked immunoabsorbent assay for detection of human serine protease corin in blood': 1, 'Plasma soluble corin in patients with heart failure': 1, 'Mouse DESC1 is located within a cluster of seven DESC1-like genes and encodes a type II transmembrane serine protease that forms serpin inhibitory complexes': 5, 'Autoproteolysis coupled to protein folding in the SEA domain of the membrane-bound MUC1 mucin': 1, 'Purification, characterization, and localization of a novel trypsin-like protease found in the human airway': 2, 'Cloning and characterization of the cDNA for human airway trypsin-like protease': 2, 'Human airway trypsin-like protease stimulates human bronchial fibroblast proliferation in a protease-activated receptor-2-dependent pathway': 2, 'Fibrinogenolytic activity of a novel trypsin-like enzyme found in human airway': 3, 'Human airway trypsin-like protease induces PAR-2-mediated IL-8 release in psoriasis vulgaris': 2, 'Localization of human airway trypsin-like protease in the airway, an immunohistochemical study': 2, 'Effect of human airway trypsin-like protease on intracellular free Ca2+ concentration in human bronchial epithelial cells': 4, 'Human airway trypsin-like protease induces amphiregulin release through a mechanism involving protease-activated receptor-2-mediated ERK activation and TNF alpha-converting enzyme activity in airway epithelial cells': 2, 'The human airway trypsin-like protease modulates the urokinase receptor (uPAR, CD87) structure and functions': 1, 'Novel insights into proteolytic cleavage of influenza virus hemagglutinin': 1, 'Differential expression of a novel serine protease homologue in squamous cell carcinoma of the head and neck': 2, 'Expression of the serine protease DESC1 correlates directly with normal keratinocyte differentiation and inversely with head and neck squamous cell carcinoma progression': 1, 'Human DESC1 serine protease confers tumorigenic properties to MDCK cells and it is upregulated in tumours of different origin': 1, 'Probing the substrate specificities of matriptase, matriptase-2, hepsin and DESC1 with internally quenched fluorescent peptides': 1, 'Cleavage of the SARS coronavirus spike glycoprotein by airway proteases enhances virus entry into human bronchial epithelial cells in vitro': 1, 'Activation of epithelial sodium channels by prostasin in Xenopus oocytes': 1, 'Activation of the amiloride-sensitive epithelial sodium channel by the serine protease mCAP1 expressed in a mouse cortical collecting duct cell line': 1, 'Prostasin, a membrane-anchored serine peptidase, regulates sodium currents in JME/CF15 cells, a cystic fibrosis airway epithelial cell line': 1, 'Organization and chromosomal localization of the murine Testisin gene encoding a serine protease temporally expressed during spermatogenesis': 7, 'Tryptase 4, a new member of the chromosome 17 family of mouse serine proteases': 4, 'Localization, expression and genomic structure of the gene encoding the human serine protease testisin': 5, 'An epithelial serine protease activates the amiloride-sensitive sodium channel': 1, 'Expression of prostasin and its inhibitors during colorectal cancer carcinogenesis': 1, 'Urinary prostasin in humans, relationships among prostasin, aldosterone and epithelial sodium channel activity': 2, 'Urinary prostasin, a possible biomarker for renal pressure natriuresis in black adolescents': 1, 'Urinary prostasin, a candidate marker of epithelial sodium channel activation in humans': 1, 'Inhibition of prostasin secretion by serine protease inhibitors in the kidney': 1, 'Prostasin-dependent activation of epithelial Na+ channels by low plasmin concentrations': 1, 'Inhibition of prostasin-induced ENaC activities by PN-1 and regulation of PN-1 expression by TGF-beta1 and aldosterone': 2, 'Camostat attenuates airway epithelial sodium channel function in vivo through the inhibition of a channel-activating protease': 1, 'Regulation of the epithelial Na+ channel by peptidases': 1, 'Epithelial Na+ channels are fully activated by furin-and prostasin-dependent release of an inhibitory peptide from the gamma-subunit': 1, 'Proteolytic processing of the epithelial sodium channel gamma subunit has a dominant role in channel activation': 1, 'Defining an inhibitory domain in the gamma subunit of the epithelial sodium channel': 1, 'ENaC-mediated alveolar fluid clearance and lung fluid balance depend on the channel-activating protease 1': 1, 'Sodium channels and cystic fibrosis': 1, 'Prostasin expression is regulated by airway surface liquid volume and is increased in cystic fibrosis': 1, 'Prostasin, a possible candidate gene for human hypertension': 1, 'Implication of ENaC in salt-sensitive hypertension': 1, 'Camostat mesilate inhibits prostasin activity and reduces blood pressure and renal injury in salt-sensitive hypertension': 1, 'Prostasin regulates iNOS and cyclin D1 expression by modulating protease-activated receptor-2 signaling in prostate epithelial cells': 3, 'Prostasin induces protease-dependent and independent molecular changes in the human prostate carcinoma cell line PC-3': 1, 'Prostasin regulates human placental trophoblast cell proliferation via the epidermal growth factor receptor signaling pathway': 1, 'Clinical significance of low expression of Prostasin mRNA in human gastric cancer': 2, 'Prostasin inhibits cell invasion in human choriocarcinomal JEG-3 cells': 1, 'Cloning and tissue distribution of a novel serine protease esp-1 from human eosinophils': 3, 'Structural analysis of esp-1 gene (PRSS 21)': 2, 'The glycosylphosphatidylinositol-anchored serine protease PRSS21 (testisin) imparts murine epididymal sperm cell maturation and fertilizing ability': 6, 'Endothelial cell serine proteases expressed during vascular morphogenesis and angiogenesis': 1, \"Hypermethylation of the 5' CpG island of the gene encoding the serine protease Testisin promotes its loss in testicular tumorigenesis\": 2, 'Cloning, expression analysis, and tissue distribution of esp-1/testisin, a membrane-type serine protease from the rat': 1, 'Reduced fertility of mouse epididymal sperm lacking Prss21/Tesp5 is rescued by sperm exposure to uterine microenvironment': 1, 'Mice Lacking Two Sperm Serine Proteases, ACR and PRSS21, Are Subfertile, but the Mutant Sperm Are Infertile In Vitro': 1, 'Overexpression of testisin, a serine protease expressed by testicular germ cells, in epithelial ovarian tumor cells': 2, 'Testisin, a glycosylphosphatidylinositol-linked serine protease, promotes malignant transformation in vitro and in vivo': 1, 'Epigenetic silencing of the putative tumor suppressor gene testisin in testicular germ cell tumors': 1, 'Animal migration and infectious disease risk': 1, 'Deciphering arboviral emergence within insular ecosystems': 1, 'An annotated checklist of pathogenic microorganisms associated with migratory birds': 1, 'Evolution and ecology of influenza A viruses': 2, 'Host range of avian influenza virus in free-living birds': 1, 'Global patterns of influenza A virus in wild birds': 4, 'Evolutionary dynamics and emergence of panzootic H5N1 influenza viruses': 1, 'The genesis and source of the H7N9 influenza viruses causing human infections in China': 2, 'Laridae: A neglected reservoir that could play a major role in avian influenza virus epidemiological dynamics': 2, 'Biomass consumption by breeding seabirds in the western Indian Ocean: direct interactions with fisheries and implications for management': 1, 'Birds of the Indian Ocean islands. Chamberlain. Struik Nature': 3, 'An inventory of Sooty Terns (Sterna fuscata) in the western Indian Ocean with special reference to threats and trends': 2, 'Mechanisms of population differentiation in seabirds': 1, 'Comparison of two commercial enzymelinked immunosorbent assays for detection of influenza A virus antibodies': 1, 'Hemagglutination-inhibition test for avian influenza virus subtype identification and the detection and quantification of serum antibodies to avian influenza viruses': 1, 'R: A language and environment for statistical computing. R Foundation for Statistical Computing': 1, 'Absence of coronaviruses, paramyxoviruses, and influenza A viruses in seabirds in the Southwestern Indian Ocean': 1, 'Development of a Real-Time Reverse Transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes': 2, 'Subtyping of avian influenza viruses H1 to H15 on the basis of hemagglutinin genes by PCR assay and molecular determination of pathogenic potential': 1, 'Increased detection of influenza A H16 in the United States': 1, 'Identification and subtyping of avian influenza viruses by reverse transcription-PCR': 1, 'A reverse transcription-PCR for subtyping of the neuraminidase of avian influenza viruses': 1, 'The influenza virus resource at the National Center for Biotechnology Information': 1, 'New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0': 1, 'BEAST: Bayesian evolutionary analysis by sampling trees': 1, 'Gene flow and competitive exclusion of avian influenza A virus in natural reservoir hosts': 1, 'Host shifts and molecular evolution of H7 avian influenza virus hemagglutinin': 1, 'Choosing appropriate substitution models for the phylogenetic analysis of protein-coding sequences': 1, 'Bayesian coalescent inference of past population dynamics from molecular sequences': 1, 'The isolation and classification of Tern virus: Influenza virus A/Tern/South Africa/1961': 2, 'Isolation of ortho-and paramyxoviruses from wild birds in Western Australia, and the characterization of novel influenza A viruses': 1, 'Characterization of a novel influenza hemagglutinin, H15: criteria for determination of influenza A subtypes': 1, 'Prevalence of antibodies to type A influenza virus in wild avian species using two serologic assays': 2, 'Habitat use by Seychelles sooty terns Sterna fuscata and implications for colony management': 1, 'Hoatzin to Auks. Barcelona: Lynx Edicions': 1, 'Epidemiology of influenza A virus among black-headed gulls': 2, 'Extensive geographic mosaicism in avian influenza viruses from gulls in the northern hemisphere': 2, 'Coinfection of wild ducks by influenza A viruses: distribution patterns and biological significance': 1, 'Influenza A viruses in feral Canadian ducks: extensive reassortment in nature': 1, 'The evolutionary genetics and emergence of avian influenza viruses in wild birds': 1, 'Reassortant influenza A viruses in wild duck populations: effects on viral shedding and persistence in water': 1, 'Bird migration routes and risk for pathogen dispersion into western Mediterranean wetlands': 1, 'Coincident ruddy turnstone migration and horseshoe crab spawning creates an ecological \"hot spot\" for influenza viruses': 2, 'Diverse inter-continental and host lineage reassortant avian influenza A viruses in pelagic seabirds': 1, 'Perpetuation and reassortment of gull influenza A viruses in Atlantic North America': 1, 'The ecology of influenza A viruses in wild birds in Southern Africa': 1, 'Understanding the ecological drivers of avian influenza virus infection in wildfowl: a continental-scale study across Africa': 1, 'Avian influenza circulation in the Camargue (South of France) during the 2006-07 season': 1, 'Duck migration and past influenza A (H5N1) outbreak areas': 1, 'Maladies infectieuses et écosystèmes: écologie des virus influenza aviaires en Camargue': 1, 'Investigating avian influenza infection hotspots in old-world shorebirds': 1, 'Spatial, temporal, and species variation in prevalence of influenza A viruses in wild migratory birds': 1, 'Influenza-A viruses in ducks in Northwestern Minnesota: fine scale spatial and temporal variation in prevalence and subtype diversity': 1, 'H9N2 avian influenza virus in a Mediterranean gull': 1, 'Molecular epidemiologic studies on North American H9 avian influenza virus isolates from waterfowl and shorebirds': 1, 'Characterization of H9 subtype influenza viruses from the ducks of Southern China: a candidate for the next influenza pandemic in humans?': 1, 'Molecular characterization of H9N2 influenza viruses: Were they the donors of the \"internal\" genes of H5N1 viruses in Hong Kong?': 3, 'Human infection with influenza H9N2': 1, 'Antigenic and molecular characterization of avian influenza A(H9N2) viruses': 1, 'Live bird markets of Bangladesh: H9N2 viruses and the near absence of highly pathogenic H5N1 influenza': 1, 'Genetic analysis of H9N2 avian influenza viruses isolated from India': 1, 'Geolocation reveals migration patterns of a superabundant tropical seabird species, the sooty tern Onychoprion fuscatus': 1, 'Coronavirus impact on GCC economies could be much bigger. Gulf News': 5, 'Mapping the coronavirus outbreak': 3, 'Economic paralysis: Coronavirus slams brakes on China economy': 1, \"Is COVID-19 eroding China's influence in Southeast Asia? The Diplomat\": 1, \"Coronavirus infects Africa's economy. Deutsche Welle\": 1, \"China's massive belt and road initiative. Council On Foreign Relations\": 1, 'Europe widens virus lockdown, moves to limit economic damage': 1, \"Here's what older at risk people should know about Corona virus\": 2, 'The impact of coronavirus on Gulf economies': 2, 'Will Coronavirus outbreak derail the global economy? The Guardian': 1, \"China's belt and road initiative and its impact in Central Asia. Voices on Central Asia\": 1, 'Why Central Asia chooses Chinese investment': 2, 'What is coronavirus, how did it start, and could the outbreak grow bigger? Telegraph': 1, 'The economic fallout of the coronavirus in Southeast Asia. Carnegie Endowment For International Peace': 1, 'Economic vulnerabilities to the coronavirus: Top countries at risk. Overseas Development Institute': 2, \"The coronavirus outbreak may have a twoquarter hit on China's economy. CNBC\": 2, 'Coronavirus outbreak puts belt and road projects on hold': 2, 'Europe ponders economic stimulus to counter coronavirus impact': 1, \"Coronavirus slows China's major belt and road projects in Asia. The Japan Times\": 1, 'Chinese economy suffers record blow from coronavirus. The Banker': 1, 'Could Corona virus make China stronger than ever. ExpatGuides': 1, \"The impact of China's belt and road initiative on Central Asia and the South Caucasus. E -INTERNATIONAL RELATIONS\": 1, 'Which African countries are most vulnerable to the coronavirus? The New Humanitarian': 1, \"Cooperation, co-existence or clash? China and Russia's ambitions in Central Asia. The Diplomat\": 1, 'Infection spread and high-resolution detection of close contact behaviors': 2, 'Dynamic population flow based risk analysis of infectious disease propagation in a metropolis': 1, 'Quantifying social distancing arising from pandemic influenza': 1, 'Community mitigation during SARS-CoV-2 pandemic: Mission impossible in developing countries. Population Health Management': 1, 'The concept of R0 in epidemic theory': 1, 'Pandemic potential of a strain of influenza A (H1N1): early findings': 1, 'Perspectives on the basic reproductive ratio': 2, 'High contagiousness and rapid spread of severe acute respiratory syndrome coronavirus 2': 1, 'Modeling influenza epidemics and pandemics: insights into the future of swine flu (H1N1)': 2, 'Estimating the number of infections and the impact of non-pharmaceutical interventions on COVID-19 in 11 European countries. London: Imperial College': 1, 'Severe acute respiratory syndrome coronavirus 2-specific antibody responses in coronavirus disease 2019 patients': 1, 'SYFPEITHI: database for MHC ligands and peptide motifs': 1, 'ProPred: Prediction of HLA-DR binding sites': 1, 'SVMHC: a server for prediction of MHC-binding peptides': 1, 'Hidden Markov model-based prediction of antigenic peptides that interact with MHC class II molecules': 1, \"Sensitive quantitative predictions of peptide-MHC binding by a 'Query by Committee' artificial neural network approach\": 1, 'Benchmarking B cell epitope prediction: Underperformance of existing methods': 1, 'Harnessing bioinformatics to discover new vaccines': 1, 'The antigenic index: a novel algorithm for predicting antigenic determinants': 2, 'Prediction of Continuous B-cell Epitopes in an Antigen Using Recurrent Neural Network': 1, 'Prediction of residues in discontinuous B-cell epitopes using protein 3D structures': 1, 'CEP: a conformational epitope prediction server': 1, 'Cytotoxic T-lymphocyte epitope vaccination protects against human metapneumovirus infection and disease in mice': 1, 'In silico prediction and ex vivo evaluation of potential T-cell epitopes in glycoproteins 4 and 5 and nucleocapsid protein of genotype-I (European) of porcine reproductive and respiratory syndrome virus': 1, 'MHCPred: bringing a quantitative dimension to the online prediction of MHC binding': 1, 'Computational Prediction and Identification of Epstein-Barr Virus Latent Membrane Protein 2A Antigen-Specific CD8 + T-Cell': 1, 'Identification of a novel conserved HLA-A*0201-restricted epitope from the spike protein of SARS-CoV': 1, 'A novel HIV T helper epitope-based vaccine elicits cytokinesecreting HIV-specific CD4 + T cells in a Phase I clinical trial in HIV-uninfected adults': 1, 'Dendritic cell mediated delivery of plasmid DNA encoding LAMP/ HIV-1 Gag fusion immunogen enhances T cell epitope responses in HLA DR4 transgenic mice': 1, 'Ab and T cell epitopes of influenza A virus, knowledge and opportunities': 1, 'Screening and identification of B cell epitopes of structural proteins of foot-and-mouth disease virus serotype Asia1': 1, 'Circulating interferon-like viral i n h i b i t i o n in p a t i e n t s w i t h meningitis due to Haemophilus inJluenzae': 1, 'T h e use of volunteers': 1, 'Application of immunofluorescent antibody technique in rapid diagnosis of respiratory syncytial virus infection': 1, 'Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection': 5, 'Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell-cell fusion': 1, 'Cooperation between transmissible gastroenteritis coronavirus (TGEV) structural proteins in the in vitro induction of virusspecific antibodies': 1, 'Production and immunogenicity of multiple antigenic peptide (MAP) constructs derived from the S1 glycoprotein of infectious bronchitis virus (IBV': 1, 'Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus': 4, 'Immune responses against SARS-coronavirus nucleocapsid protein induced by DNA vaccine': 3, 'Induction of SARS-nucleoprotein-specific immune response by use of DNA vaccine': 3, 'Cytotoxic T lymphocytes are critical in the control of infectious bronchitis virus in poultry': 1, 'The carboxyl-terminal 120-residue polypeptide of infectious bronchitis virus nucleocapsid induces cytotoxic T lymphocytes and protects chickens from acute infection': 1, 'A new mutant of dermovaccinia virus': 2, 'Structural analysis of vaccinia virus DIs strain: application as a new replication-deficient viral vector': 4, 'Immunological detection of severe acute respiratory syndrome coronavirus by monoclonal antibodies': 4, 'The SARS-CoV S glycoprotein: expression and functional characterization': 1, 'Phosphorylation of p38 MAPK and its downstream targets in SARS coronavirus-infected cells': 3, 'Oligomerization of a membrane protein correlates with its retention in the Golgi complex': 1, 'Differential maturation and subcellular localization of severe acute respiratory syndrome coronavirus surface proteins': 2, 'Subcellular localization of the severe acute respiratory syndrome coronavirus nucleocapsid protein': 4, 'Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice': 5, 'Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity': 7, 'A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice': 5, 'Advances in mucosal vaccination': 1, 'Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein': 1, 'Immunogenicity of an attenuated strain of vaccinia virus on rabbits and monkeys': 1, 'Nonreplicating vaccinia vector efficiently expresses recombinant genes': 1, 'A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus': 1, 'Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing human immunodeficiency virus 89.6 envelope protein': 1, 'Protection against lethal Japanese encephalitis virus infection of mice by immunization with the highly attenuated MVA strain of vaccinia virus expressing JEV prM and E genes': 1, 'Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies': 1, 'A consecutive priming-boosting vaccination of mice with simian immunodeficiency virus (SIV) gag/pol DNA and recombinant vaccinia virus strain DIs elicits effective anti-SIV immunity': 1, 'Treatment and vaccines for severe acute respiratory syndrome': 1, 'Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets': 6, 'Severe acute respiratory syndrome coronavirus nucleocapsid protein expressed by an adenovirus vector is phosphorylated and immunogenic in mice': 2, 'A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies': 1, 'Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine': 6, 'Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice': 7, 'Effects of a SARSassociated coronavirus vaccine in monkeys': 2, 'Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets': 2, 'Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses': 2, 'Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model': 1, 'Enhancement of mucosal immune response against HIV-1 Gag by DNA immunization': 1, 'Escherichia coli gpt gene provides dominant selection for vaccinia virus open reading frame expression vectors': 1, 'A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice': 1, 'Synthetic double-stranded RNA poly (I:C) combined with mucosal vaccine protects against influenza virus infection': 1, 'Diagnostic virology': 1, 'An Introduction to Mathematical Biology': 1, 'Infectious Diseases of Humans: Dynamics and Control': 2, 'An Introduction to Dynamical Systems': 1, 'A review of mathematical models for leukemia and lymphoma': 1, 'Theoretical Neuroscience: Computational and Mathematical Modeling of Neural Systems. Computational Neuroscience': 1, 'Mathematical Models in Biology': 1, 'Dynamic Models in Biology': 1, 'Differential Equations, Dynamical Systems, and an Introduction to Chaos. 3rd': 1, 'Dynamical Systems in Neuroscience: The Geometry of Excitability and Bursting. Computational Neuroscience': 1, 'Differential Dynamical Systems, Revised Edition': 1, 'Nonlinear Dynamics and Chaos: With Applications to Physics': 1, 'Introduction to Applied Nonlinear Dynamical Systems and Chaos. 2nd': 1, 'A Multi-stage Representation of Cell Proliferation as a Markov Process': 1, 'Making ecological models adequate': 1, 'Effects of the infectious period distribution on predicted transitions in childhood disease dynamics': 1, 'Exact finite dimensional representations of models for physiologically structured populations. I: The abstract formulation of linear chain trickery': 1, 'Stage Structure Models Applied in Evolutionary Ecology': 1, 'A matter of maturity: To delay or not to delay? Continuoustime compartmental models of structured populations in the literature': 2, 'Appropriate Models for the Management of Infectious Diseases': 3, \"Generalizations of the 'Linear Chain Trick': incorporating more flexible dwell time distributions into mean field ODE models\": 10, 'An introduction to delay differential equations with applications to the life sciences': 2, \"Phase Type and Matrix Exponential Distributions in Stochastic Modeling''. In: Principles of Performance and Reliability Modeling and Evaluation: Essays in Honor of Kishor Trivedi on his 70th Birthday\": 3, 'BuTools 2: A rich toolbox for Markovian performance evaluation': 1, \"Phase-Type Distributions''. In: Resilience Assessment and Evaluation of Computing Systems\": 2, 'Efficient Generation of PH-Distributed Random Variates': 4, 'On the Phase-Type Approximations of General Distributions': 1, 'Cluster-based fitting of phase-type distributions to empirical data': 1, 'Consumer--Resource Dynamics': 2, 'Graphical Representation and Stability Conditions of Predator-Prey Interactions': 1, \"A derivation of Holling's type I, II and III functional responses in predator-prey systems\": 1, 'The Effects of Harvesting and Time Delay on Predator-prey Systems with Holling Type II Functional Response': 1, 'Mathematical epidemiology of infectious diseases: Model building, analysis and interpretation': 1, 'Disease Extinction and Community Size: Modeling the Persistence of Measles': 1, 'Containing Papers of a Mathematical and Physical Character 115': 1, 'Contributions to the Mathematical Theory of Epidemics. II. The Problem of Endemicity': 1, 'Contributions to the Mathematical Theory of Epidemics. III. Further Studies of the Problem of Endemicity': 1, 'Contributions to the mathematical theory of epidemics-I': 1, 'Sensitivity of Model-Based Epidemiological Parameter Estimation to Model Assumptions': 1, 'Epidemiological Models with Non-Exponentially Distributed Disease Stages and Applications to Disease Control': 1, 'Evaluations of Interventions Using Mathematical Models with Exponential and Non-exponential Distributions for Disease Stages: The Case of Ebola': 1, 'Mathematical models of Ebola-Consequences of underlying assumptions': 2, 'Solving Differential Equations in R: Package deSolve': 2, 'Understanding Coronanomics: The economic implications of the coronavirus (COVID-19) pandemic': 1, 'The coronavirus and the great influenza pandemic: Lessons from the \"spanish flu\" for the coronavirus\\'s potential effects on mortality and economic activity (No. w26866)': 1, 'Economic effects of Coronavirus outbreak (COVID-19) on the world economy': 1, 'Covid-induced economic uncertainty (No. w26983)': 2, 'Using Disasters to Estimate the Impact of Uncertainty (No. w27167)': 1, 'News and uncertainty about COVID-19: Survey evidence and short-run economic impact. FRB of Cleveland Working Paper No': 1, 'Covid19 and the macroeconomic effects of costly disasters (No. w26987)': 1, 'The uncertainty channel of the coronavirus, Economic Letters': 1, 'Uncertainty shocks in a model of effective demand': 1, 'Bounds testing approaches to the analysis of level relationships': 1, 'Likelihood ratio statistics for autoregressive time series with a unit root': 1, 'Testing for a unit root in time series regression': 1, 'Do COVID-19 and crude oil prices drive the US economic policy uncertainty': 2, \"Public sector information in the digital age: Between markets, public management and citizens' rights\": 10, 'Freedom of Information and privacy in Australia': 1, 'Understanding ripple effects: The cross-national adoption of policy instruments for bureaucratic accountability': 1, 'Blacked out: Government secrecy in the information age': 1, 'Individualism and Freedom of Information Legislation. Freedom of Information Review': 1, 'The new public management: A perspective from mainland Europe': 1, 'Structural pluralism and the right to information': 1, 'Opening up the mindset is key to change. The Canberra Times': 1, 'How the electronic Freedom of Information Act amendments of 1996 update public access for the information age': 3, 'Hold high the great banner of Deng Xiaoping theory for an all-round advancement of the cause of building socialism with Chinese characteristics to the 21st Century. Presented at the 15th National Congress of the Communist Party of China': 1, 'Subsidiary report on learning FOI Regulations': 3, \"FOI Regulations will bring about six changes. People's Daily (Beijing)\": 1, \"The background, main contents and inventory compilation concerning China's FOI Regulations\": 1, \"Assessing China's efforts in constructing an E-Government\": 1, 'The breakthrough of legislating on FOI after a decade': 1, 'Speech delivered at Seminar on the FOI Regulations': 1, 'Rapid development, broad coverage and various methods: Discussion of the use of current documents': 1, 'The legislative affairs of the State Council introduces FOI Regulations': 2, 'Analysis of FOI law-making activities in China': 1, 'Academic draft of FOI Regulations': 2, 'Freedom of Information: Principles for legislation': 3, 'China adopts first nationwide open government information regulations': 3, 'China vows government transparency, within limits': 1, 'China moves to boost transparency, but much is kept hidden': 1, 'Enacting and implementing open government information regulations in China: Motivations and barriers': 1, 'Freedom of Information: Some International Characteristics': 1, 'Freedom of Information/access to government information checklist: Minimum requirements for a Freedom of Information Act (FOIA) and its implementation': 1, 'Freedom of Information in Ireland': 2, 'The nature and structure of exempting provisions and the use of the concept of a public interest override': 1, 'Effective open government: Improving public access to government information': 1, 'Seriously adhere to the spirits of the 17th National Congress of the Communist Party of China to promote vigorously the work of incorruptibility construction and anti-corruption': 1, 'Selected works of Xiaoping Deng': 1, 'Several issues in relation to FOI Regulations (Pt 2)': 1, 'Neonatal necrotising enterocolitis: bridging the basic science with the clinical disease': 2, 'Doppler studies in the growth-retarded fetus and prediction of neonatal necrotising enterocolitis, haemorrhage, and neonatal morbidity': 1, 'Ibuprofen for the treatment of a patent ductus arteriosus in preterm and/or low birth weight infants': 1, 'Anaesthetic considerations for the management of very low and extremely low birth weight infants': 1, 'Necrotising enterocolitis': 3, 'Newborn intestinal circulation. Physiology and pathophysiology': 1, 'Short and long term outcomes of necrotising enterocolitis in infants with congenital heart disease': 1, 'The development of necrotising enterocolitis following repair of gastroschisis: a surprising high incidence': 1, 'Treatment and prevention of necrotising enterocolitis': 1, 'Randomised trial of fentanyl anaesthesia in preterm babies undergoing surgery: effect on the stress response': 1, 'Tandem mass spectrometry of small-molecule antiviral drugs: 1. HIVrelated antivirals': 3, 'Tandem mass spectrometry of small-molecule antiviral drugs: 2. Hepatitis-related antivirals': 3, 'Antiviral therapies for herpesviruses: current agents and new directions': 1, 'Simultaneous determination of 14 antiviral drugs and relevant metabolites in chicken muscle by UPLC-MS/MS after QuEChERS preparation': 1, 'Simultaneous determination of antiviral drugs in chicken tissues by ultra-high performance liquid chromatography with tandem mass spectrometry': 1, 'Chromatography column comparison and rapid pretreatment for the simultaneous analysis of amantadine, rimantadine, acyclovir, ribavirin, and moroxydine in chicken muscle by ultra-high performance liquid chromatography and tandem mass spectrometry': 1, 'Agilent forensic toxicology LC/MS personal compound database and library': 2, 'Interpretation of MS-MS mass spectra of drugs and pesticides': 4, 'Solvation of acylium fragment ions in electrospray ionization quadrupole ion trap and Fourier transform ion cyclotron resonance mass spectrometry': 1, 'Simultaneous determination of amantadine, rimantadine and memantine in chicken muscle using multi-walled carbon nanotubes as a reversed-dispersive solid phase extraction sorbent': 1, 'Simultaneous determination of antibiotics and amantadines in animal-derived feedstuffs by ultraperformance liquid chromatographic-tandem mass spectrometry': 1, 'Analysis of amantadine in Laminaria Japonica and seawater of Daqin Island by ultra-high performance liquid chromatography with positive electrospray ionization tandem mass spectrometry': 1, 'Liquid chromatographic-tandem mass spectrometric method for the determination of the neuraminidase inhibitor zanamivir (GG167) in human serum': 1, 'Evaluation of the phototransformation of the antiviral zanamivir in surface waters through identification of transformation products': 3, 'Metabolite identification of arbidol in human urine by the study of CID fragmentation pathways using HPLC coupled with ion trap mass spectrometry': 1, 'Antiviral strategies against human coronaviruses': 1, 'Development and validation of a LC-MS/MS method for the determination of letermovir in sprague dawley rat plasma and its application to pharmacokinetic study': 1, 'Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases': 3, 'New antiviral drugs, vaccines and classic public health interventions against SARS coronavirus': 1, 'Therapies for coronaviruses. Part I of II --viral entry inhibitors': 1, 'Therapies for coronaviruses. Part 2: Inhibitors of intracellular life cycle': 1, 'Coronaviruses -drug discovery and therapeutic options': 3, 'A review of candidate therapies for Middle East respiratory syndrome from a molecular perspective': 2, 'Compounds with therapeutic potential against novel respiratory 2019 coronavirus': 1, 'Review of emerging pharmacotherapy for the treatment of coronavirus disease 2019': 1, 'Discovery and development of safein-man broad-spectrum antiviral agents': 5, 'Chloroquine and hydroxychloroquine in covid-19': 1, 'Clinical regimens of favipiravir inhibit zika virus replication in the hollow-fiber infection model': 1, 'Electrospray ionization tandem mass fragmentation pattern of camostat and its degradation product, 4-(4-guanidinobenzoyloxy)phenylacetic acid': 1, 'Chemical Ionization Mass Spectrometry': 1, 'Unimolecular decompositions of even-electron ions': 1, \"The 'even-electron' rule\": 1, 'Even-electron ions: a systematic study of the neutral species lost in the dissociation of quasimolecular ions': 1, 'Host species barriers to influenza virus infections': 2, 'Natural selection on the influenza virus genome': 1, 'Broadening of neutralization activity to directly block a dominant antibody-driven SARS-coronavirus evolution pathway': 2, 'Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors': 4, 'Avian flu: influenza virus receptors in the human airway': 2, 'Antiviral antibody responses: the two extremes of a wild spectrum': 2, 'The growth and potential of human antiviral monoclonal antibody therapeutics': 1, 'Neutralizing antiinfluenza virus monoclonal antibodies: therapeutics and tool for discovery': 1, 'Kinetics of protective antibodies are determined by the viral surface antigen': 1, 'Serologic cross-reactivity among humans and birds infected with highly pathogenic avian influenza A subtype H5N1 viruses in China': 1, 'A single amino acid substitution (R441A) in the receptor-binding domain of SARS coronavirus spike protein disrupts the antigenic structure and binding activity': 1, 'Comparison of epitope structures of H3HAs through protein modeling of influenza A virus hemagglutinin: mechanism for selection of antigenic variants in the presence of a monoclonal antibody': 1, 'The evolution of epidemic influenza': 1, 'Immunization by avian H5 influenza hemagglutinin mutants with altered receptor binding specificity': 1, 'Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus': 3, 'Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets': 1, 'Peptide mimics of a conserved H5N1 avian influenza virus neutralization site': 1, 'Chemoenzymatic synthesis and application of glycopolymers containing multivalent sialyloligosaccharides with a poly (L-glutamic acid) backbone for inhibition of infection by influenza viruses': 1, 'Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract': 1, 'Receptor binding and membrane fusion in virus entry: the Influenza hemagglutinin': 2, 'The quail and chicken intestine have sialyl-galactose sugar chains responsible for the binding of influenza A viruses to human type receptors': 1, 'Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin': 1, 'Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift': 1, 'Identification of amino acids in HA and PB2 critical for the transmission of H5N1 avian influenza viruses in a mammalian host': 1, 'Simultaneous amino acid substitutions at antigenic sites drive influenza A hemagglutinin evolution': 1, 'Possibility of mutation prediction of influenza hemagglutinin by combination of hemadsorption experiment and quantum chemical calculation for antibody binding': 1, 'Differential neutralization efficiency of hemagglutinin epitopes, antibody interference, and the design of influenza vaccines': 1, ') Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses': 1, 'Routine childhood immunization may protect against COVID-19': 1, 'Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China': 1, 'Insight into 2019 novel coronavirus -an updated intrim review and lessons from SARS-CoV and MERS-CoV': 2, 'Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in': 3, 'Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia': 2, '3D medical animation corona virus.jpg -Wikimedia Commons': 1, 'Coronavirus Disease 2019 (COVID-19): Role of Chest CT in Diagnosis and Management': 2, 'Identifying Medical Diagnoses and Treatable Diseases by Image-Based Deep Learning': 2, 'COVID-Net: A Tailored Deep Convolutional Neural Network Design for Detection of COVID-19 Cases from Chest Radiography Images': 11, 'COVID-19 Image Data Collection': 3, 'Rapid AI Development Cycle for the Coronavirus (COVID-19) Pandemic: Initial Results for Automated Detection & Patient Monitoring using Deep Learning CT Image Analysis Authors': 2, 'Deep Learning System to Screen Coronavirus Disease': 2, 'A deep learning algorithm using CT images to screen for corona virus disease (COVID-19)': 2, 'An AI Powered Population Screening of COVID-19 Cases Using Chest Radiography Images': 1, 'Covid-Caps: A Capsule Network-Based Framework for Identification of Covid-19 Cases From X-Ray Images': 1, 'A Deep Learning Framework for Screening of COVID19 from Radiographs': 2, 'Can AI help in screening Viral and COVID-19 pneumonia? ArXiv': 3, 'Deep learning at chest radiography: Automated classification of pulmonary tuberculosis by using convolutional neural networks': 1, 'Pneumonia Detection Using CNN based Feature Extraction': 1, 'DCCMED-Net: Densely connected and concatenated multi Encoder-Decoder CNNs for retinal vessel extraction from fundus images': 2, 'An expert system for brain tumor detection: Fuzzy C-means with super resolution and convolutional neural network with extreme learning machine': 3, 'SqueezeNet: AlexNetlevel accuracy with 50x fewer parameters and <0.5MB model size': 3, 'Recognizing Multiple Types of Rocks Quickly and Accurately Based on Lightweight CNNs Model': 1, 'Squeeze-and-Excitation SqueezeNext: An Efficient DNN for Hardware Deployment': 1, 'Hyperparameter optimization for machine learning models based on Bayesian optimization': 6, 'Recent advances in convolutional neural networks': 1, 'EEG based multi-class seizure type classification using convolutional neural network and transfer learning': 1, 'Automatic sleep stage classification using time-frequency images of CWT and transfer learning using convolution neural network': 2, 'RobNet: real-time road-object 3D point cloud segmentation based on SqueezeNet and cyclic CRF': 1, 'Fault Diagnosis of High-Speed Train Bogie by Residual-Squeeze Net': 1, 'Application of convolutional neural networks featuring Bayesian optimization for landslide susceptibility assessment': 1, 'Scalable Bayesian Optimization Using Deep Neural Networks. 32nd Int. Conf. Mach. Learn. ICML 2015': 1, 'On the Bayes Methods for Seeking the Extremal Point': 2, 'Taking the human out of the loop: A review of Bayesian optimization': 2, 'Shallow Understanding on Bayesian Optimization -Towards Data Science 2020': 1, 'Labeled Optical Coherence Tomography (OCT) and Chest X-Ray Images for Classification. Mendeley Data': 1, 'A systematic study of the class imbalance problem in convolutional neural networks': 1, 'WHO -Coronavirus disease 2019 info web site n.d': 1, 'Differential expression of transforming growth factor-/31, /32, and /33 by glioblastoma cell, astrocytes, and microglia': 1, 'Monokinc production by microglial cell clones': 1, 'Production of tumor necrosis factor-alpha by microglia and astrocytc in culture': 3, 'TNF alpha induces IL-6 production by astrocytes but not by microglia': 6, 'Production of interleukin-5 by mouse astrocytes and microglia in culture': 2, 'Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to lL-lbeta and tumor necrosis factor-alpha': 2, 'On the cellular source and function of interleukin-6 produced in the central nervous system in viral diseases': 2, 'Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus': 1, 'Production of hemopoietic colony-stimulating factors by astrocytes': 2, 'Production of granuloeyte/macrophagc colony-stimulating factor by cultured astrocytes': 5, 'Monokine modulation of human astroglial cell production of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor': 2, 'Macrophage-and astrocyte-derived transforming growth factor b as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome': 1, 'In situ hybridization histochemistry localization of interleukin-3 mRNA in mouse brain': 1, 'Rat microglial interleukin-3': 1, 'Production of interleukin-10 by mouse glial cells in culture': 1, 'Expression of cytokine receptors in cultured neuronal and glial cells': 4, 'Activation and proliferation of the isolated microglia by colonystimulating factor-I and possible involvement of protein kinase C': 1, 'Effects of colony-stimulating factors on isolated microglia in vitro': 3, 'Morphological transformation of microglia in vitro': 3, 'lnterleukin -3 induce class II MHC antigen expression in microglia': 2, 'Regulation of BSF-2/IL-6 production by human mononuclear cells. Macrophage-dependent synthesis of BSF-2/1L-6 by T cells': 1, 'Bacterial lipopolysaccharide (endotoxin) enhances expression and secretion of beta 2 interferon by human fibroblasts': 1, 'Induction of IL-6 (B cell stimulatory factor-2/IFN-beta 2) production by HIV': 1, 'Regulation of the expression of IL-6 in human monocytes': 2, 'The isolation and long-term culturc of oligodendrocytes from newborn mouse brain': 1, 'MHC antigen expression on bulk isolated macrophage-microglia in vitro:induction of class !I MHC antigen expression by interferon': 1, 'Induction of glial cell MHC antigen expression in neurotropic corona virus infection: characterization of the H-2 inducing soluble factor elaborated by infected brain cells': 2, 'Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction': 1, 'Simple, sensitive and specific bioassay of interleukin-1': 1, 'Establishment of interleukin 6(IL-6)/B cell stimulatory factor 2(BSF-2)-dependent cell line and preparation of anti-IL-6/BSF-2 monoclonal antibodies': 1, 'Transforming growth factor-beta suppresses activation and proliferation of microglia in vitro': 1, 'Biological and clinical aspects of interleukin-6, lmmunol. Today': 1, 'Interleukin-6 as a neurotrophic factor for promoting the survival of cultured basal forebrain cholinergic neurons form postnatal rat': 1, 'Expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat brain during postnatal development': 2, 'Expression of cytokines during glial differentiation': 2, 'Localization of intcrleukin-6 mRNA and interleukin-6 receptor mRNA in rat brain': 2, 'Cerebrospinal fluid interleukin-6 activity in HIV infection and inflammatory and noninflammatory diseases of the nervous system': 1, 'Elevated levels of interleukin-6 in serum and cerebrospinal fluid of HTLV-Iassociated myelopathy/tropical spastic paraparesis': 1, 'Elevated levels of inteleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement': 1, \"lnterleukin-6 and a-2-macroglobulin indicate an acute phase state in Alzheimer's disease cortices\": 1, \"Detection of interleukin-6 and a2-macroglobulin immunoreaetibity in cortex and hippocampus of Alzheimer's disease patients\": 1, 'Induction and regulation of interleukin-6 gene expression in rat astrocytes': 1, 'Expression of interleukin(IL)-l/3, IL-6 and their respective receptors in the normal rat brain and after injury': 1, 'Interleukin-6 secretion from human astrocytoma cell induced by substance P': 1, 'Trophic effect of granulocyte-macrophage colony-stimulating factor on central cholinergic neurons in vitro': 1, 'Increase of macrophage colony-stimulating factor and granuloeyte-macrophagc colony-stimulating factor receptors in the regenerating rat facial nucleus': 1, 'A stochastic epidemic model incorporating media coverage': 1, 'Dynamics of an SEQIHRS epidemic model with media coverage quarantine and isolation in a community with pre-existing immunity': 1, 'The impact of media coverage on the transmission dynamics of human influenza': 1, 'Asymptotic behavior of global positive solution to a stochastic SIR model incorporating media coverage': 1, 'A stochastic sis epidemic model incorporating media coverage in a two patch setting': 2, 'Ergodic stationary distribution of a stochastic SIRS epidemic model incorporating media coverage and saturated incidence rate': 2, 'Dynamic behavior of a stochastic SIRS epidemic model with media coverage': 1, 'The spread of awareness and its impact on epidemic outbreaks': 1, 'Impact of media coverage on epidemic spreading in complex networks': 1, 'Media impact switching surface during an infectious disease outbreak': 1, 'Optimal control of a social epidemic model with media coverage': 1, 'A class of stochastic delayed SIR epidemic models with generalized nonlinear incidence rate and temporary immunity': 1, 'Global properties of a delayed SIR model with temporary immunity and nonlinear incidence rate': 5, 'Analysis of an SVEIS epidemic model with partial temporary immunity and saturation incidence rate': 1, 'Travelling waves and global attractivity of an SIRS disease model with spatial diffusion and temporary immunity': 1, 'Stability and bifurcations in an epidemic model with varying immunity period': 1, 'Global stability of a delayed SIRS epidemic model with saturation incidence and temporary immunity': 1, 'An SIR epidemic model with partial temporary immunity modeled with delay': 1, 'Analysis of a delayed vaccinated SIR epidemic model with temporary immunity and Lévy jumps': 2, 'Stochastic population dynamics driven by Lévy noise': 1, 'Dynamics of a stochastic SIS model with double epidemic diseases driven by Lévy jumps': 1, 'Stochastic versions of the LaSalle theorem': 1, 'Dynamics analysis and numerical simulations of a stochastic non-autonomous predator-prey system with impulsive effects': 1, 'Survival analysis of stochastic competitive models in a polluted environment and stochastic competitive exclusion principle': 1, 'Dynamical analysis of a stochastic SIS epidemic model with nonlinear incidence rate and double epidemic hypothesis': 1, 'Threshold behavior in a class of stochastic SIRS epidemic models with nonlinear incidence': 1, 'An algorithmic introduction to numerical simulation of stochastic differential equations': 1, 'The Euler scheme for Lévy driven stochastic differential equations': 1, 'Analysis of a stochastic tumor-immune model with regime switching and impulsive perturbations': 1, 'Analysis of a stochastic hybrid population model with Allee effect': 1, 'Stationary distribution of a stochastic hybrid phytoplankton-zooplankton model with toxin-producing phytoplankton': 1, 'Massive cutback in orthopaedic healthcare services due to the COVID-19 pandemic an online survey of almost 1400 orthopaedic surgeons in Austria, Germany and Switzerland': 1, 'Disruption of joint arthroplasty services in Europe during the COVID-19 pandemic: an online survey within the European Hip Society (EHS) and the European Knee Associates (EKA)': 1, 'Returning to orthopaedic business as usual after COVID-19: strategies and options': 1, 'Protecting healthcare staff from severe acute respiratory syndrome: filtration capacity of multiple surgical masks': 2, \"Elenco dei Medici caduti nel corso dell'epidemia di Covid-19\": 4, 'Offline: COVID-19 and the NHS-\"a national scandal': 1, 'Italian doctors call for protecting healthcare workers and boosting community surveillance during COVID-19 outbreak': 3, 'Aerosols produced by high-speed cutters in cervical spine surgery: extent of environmental contamination': 4, 'Contamination during removal of cement in revision hip arthroplasty. A cadaver study using ultrasound and highspeed cutters': 4, 'Exposure to blood-containing aerosols in the operating room: a preliminary study': 1, 'Blood-containing aerosols generated by surgical techniques: a possible infectious hazard': 1, 'Transmission and prevention of occupational infections in orthopaedic surgeons': 3, 'Surgical smoke and infection control': 2, 'Particle size-selective assessment of protection of European Standard FFP respirators and surgical masks against particles-tested with human subjects': 3, 'Extensor mechanism allograft reconstruction after total knee arthroplasty. A comparison of two techniques': 1, 'Medical masks vs N95 respirators for preventing COVID-19 in health care workers a systematic review and meta-analysis of randomized trials. Influenza Other Respir Viruses': 2, 'The risks of splash injury when using power tools during orthopaedic surgery: a prospective study': 1, 'Eye protection for the surgeon': 1, 'Eye protection for the vascular surgeon': 1, \"National Health Commission of the People's Republic of China, State Administration of Traditional Chinese Medicine. Prevention and Control Protocols of Novel Coronavirus Pneumonia\": 1, 'Glove perforation in orthopaedic and trauma surgery. A comparison between single, double indicator gloving and double gloving with two regular gloves': 2, 'Incidence of glove failure during orthopedic operations and the protective effect of double gloves': 3, 'Surgical glove bacterial contamination and perforation during total hip arthroplasty implantation: when gloves should be changed': 1, 'Electronic personal protective equipment: a strategy to protect emergency department providers in the age of COVID-19': 1, 'Results of a new telemedicine strategy in traumatology and orthopedics. Telemed J E Health': 5, 'Face to face appointment vs. telemedicine in first time appointment orthopedic oncology patients: a cost analysis': 1, 'Expert reaction to questions about COVID-19 and viral load': 1, 'Guidance (2020) COVID-19 personal protective equipment (PPE)': 2, 'WHO Rational use of personal protective equipment (PPE) for coronavirus disease (COVID-19) Interim guidance': 1, 'Sterile field contamination from powered air-purifying respirators (PAPRs) versus contamination from surgical masks': 1, 'The shapley taylor interaction index': 8, 'Avazu click-through-rate prediction': 2, 'Handbook of design and analysis of experiments': 2, 'Matching and prediction on the principle of biological classification': 3, 'Bert: Pre-training of deep bidirectional transformers for language understanding': 1, 'ImageNet: A Large-Scale Hierarchical Image Database': 2, 'Can ai help in screening viral and covid-19 pneumonia?': 2, 'Covid-19 image data collection': 2, 'Layer-wise relevance propagation for neural networks with local renormalization layers': 1, 'Learning to explain: An information-theoretic perspective on model interpretation': 2, 'Towards better understanding of gradient-based attribution methods for deep neural networks': 1, 'Interaction terms in logit and probit models': 7, 'A lasso for hierarchical interactions': 1, 'Statistical methods for research workers': 4, '048: The arrangement of field experiments': 3, \"On the'probable error'of a coefficient of correlation deduced from a small sample\": 1, 'Multiple regression: Testing and interpreting interactions': 1, 'Human bocavirus infection in children with respiratory tract disease': 3, 'Serodiagnosis of human bocavirus infection': 2, 'Clinical and epidemiologic characteristics of human bocavirus in danish infants: results from a prospective birth cohort study': 1, 'Human bocavirus infection in children with acute gastroenteritis in Japan and Thailand': 1, 'Human bocavirus, a respiratory and enteric virus': 3, 'Human bocavirus infection in children hospitalized with acute gastroenteritis in China': 3, 'Detection of human bocavirus in children hospitalized because of acute gastroenteritis': 3, 'Human bocavirus in children hospitalized for acute gastroenteritis: a case-control study': 4, 'A novel bocavirus associated with acute gastroenteritis in Australian children': 9, 'A newly identified bocavirus species in human stool': 2, 'Human bocaviruses are highly diverse, dispersed, recombination prone, and prevalent in enteric infections': 2, 'Development of a real-time PCR assay for detecting and quantifying human bocavirus 2': 4, 'Detection of human bocavirus-2 in children with acute gastroenteritis in South Korea': 3, 'High prevalence of human bocavirus 2 and its role in childhood acute gastroenteritis in China': 10, 'Detection of human bocavirus 3 in China': 4, 'The first detection of human bocavirus 2 infections in China': 1, 'Simmonds P. Absence of detectable replication of human bocavirus species 2 in respiratory tract': 1, 'Human bocavirus 2 in children': 1, 'Rotavirus gastroenteritis in Finnish children in 2006-2008, at the introduction of rotavirus vaccination': 4, 'Noroviruses in children seen in a hospital for acute gastroenteritis in Finland': 2, 'Aichi virus infection in children with acute gastroenteritis in Finland': 2, 'Mixed viral infections causing acute gastroenteritis in children in a waterborne outbreak': 4, 'Protein interaction data curation: the International Molecular Exchange (IMEx) consortium': 1, 'MatrixDB: integration of new data with a focus on glycosaminoglycan interactions': 1, 'Capturing variation impact on molecular interactions in the IMEx Consortium mutations data set': 1, 'A SARS-CoV-2 protein interaction map reveals targets for drug repurposing': 2, 'Protein-protein interaction networks: the puzzling riches': 1, 'An empirical framework for binary interactome mapping': 1, 'Maximizing binary interactome mapping with a minimal number of assays': 1, '2019) data.table: Extension of `data.frame`. data.table: Extension of `data': 1, 'ggVennDiagram: A \"ggplot2\" Implement of Venn Diagram. ggVennDiagram: A \"ggplot2\" Implement of Venn Diagram': 1, 'COVID-19) Situation Reports. Who': 1, 'COVID-19 and African Americans': 5, 'COVID-19 and Racial/Ethnic Disparities': 2, 'Communication About Health Disparities in the Mass Media': 1, 'Socioeconomic Disparities in Health Behaviors': 2, 'COVID-19 and Health Equity-A New Kind of': 5, 'the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted': 1, 'Census Bureau QuickFacts: United States. Census Bureau QuickFacts': 2, 'COVID-19 Hospitalizations': 1, 'Medicare COVID-19 Data Release Blog | CMS. Cms': 1, 'Vital Signs: Leading Causes of Death, Prevalence of Diseases and Risk Factors, and Use of Health Services Among Hispanics in the United States -2009-2013': 1, 'Health Insurance Coverage: Early Release of Estimates From the National Health Interview Survey': 1, 'Function, and Evolution of Coronavirus Spike Proteins': 1, 'A programming language for software integration and development': 1, 'AndrejŠali A; Blundell TL Comparative Protein Modelling by Satisfaction of Spatial Restraints': 1, 'Coronavirus genomics and bioinformatics analysis. Viruses': 1, 'Molecular and phylogenetic analysis of bovine coronavirus based on the spike glycoprotein gene': 3, 'Molecular characterization of a Korean porcine epidemic diarrhea virus strain NB1': 3, 'Game consumption and the 2019 novel coronavirus': 1, 'Genomic Characterisation and Phylogenetic Analysis of Sars-Cov-2 in Italy': 1, 'Deduced sequence of the bovine coronavirus spike protein and identification of the internal proteolytic cleavage site': 1, 'A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence': 2, 'Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cells': 3, 'Genetic evolution and tropism of transmissible gastroenteritis coronaviruses': 3, 'Pre-fusion structure of a human coronavirus spike protein': 2, 'Immunogenicity and antigenic relationships among spike proteins of porcine epidemic diarrhea virus subtypes G1 and G2': 3, 'Canine coronavirus, Greece. Molecular analysis and genetic diversity characterization': 2, 'IQ-TREE: A fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies': 2, 'Improving the ultrafast bootstrap approximation': 1, 'Selective regimen shift and demographic growth increase associated with the emergence of high-fitness variants of canine parvovirus': 1, 'Localization of neutralizing epitopes and the receptor-binding site within the amino-terminal 330 amino acids of the murine coronavirus spike protein': 2, 'Roles in cell-to-cell fusion of two conserved hydrophobic regions in the murine coronavirus spike protein': 1, 'Structure, function, and evolution of coronavirus spike proteins': 1, 'Two amino acid changes at the N-terminus of transmissible gastroenteritis coronavirus spike protein result in the loss of enteric tropism': 2, 'BepiPred-2.0: Improving sequence-based B-cell epitope prediction using conformational epitopes': 1, 'Prediction of protein conformation': 3, 'A semi-empirical method for prediction of antigenic determinants on protein antigens': 3, 'New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: Correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites': 3, 'Naturally occurring hepatitis B virus B-cell and T-cell epitope mutants in hepatitis B vaccinated children': 2, 'Removal of B cell epitopes as a practical approach for reducing the immunogenicity of foreign protein-based therapeutics': 2, 'The antigenic index: A novel algorithm for predicting antigenic determinants': 3, 'Vaccination of dogs with canine parvovirus type 2b (CPV-2b) induces neutralising antibody responses to CPV-2a and CPV-2c': 1, 'Anterior Endoscopic Discectomy and Fusion for Adolescent Idiopathic Scoliosis. Spine (Phila. Pa. 1976)': 1, 'Combined anterior and posterior instrumentation in severe and rigid idiopathic scoliosis': 1, 'Classification of Operative Adolescent Idiopathic Scoliosis: Treatment Guidelines': 1, 'Is anterior release necessary in severe scoliosis treated by posterior segmental pedicle screw fixation? Eur': 1, 'Comparative Analysis of Combined (First Anterior, Then Posterior) Versus Only Posterior Approach for Treating Severe Scoliosis: A Mean Follow Up of 8.5 Years. Spine (Phila': 1, 'Anterior release may not be necessary for idiopathic scoliosis with a large curve of more than 75° and a flexibility of less than 25%': 1, 'Advances in Uniportal Video-Assisted Thoracoscopic Surgery. Pushing the Envelope': 1, 'Systematic review and meta-analysis of uniportal versus multiportal video-assisted thoracoscopic lobectomy for lung cancer': 2, 'Computed tomography-guided patent blue vital dye localization of pulmonary nodules in uniportal thoracoscopy': 3, 'Uniportal vs standard three-port VATS technique for spontaneous pneumothorax: comparison of post-operative pain and residual paraesthesia': 1, 'One-port (uniportal) video-assisted thoracic surgical resections-A clear advance': 1, 'Anterior thoracoscopic spine release in deformity surgery: a meta-analysis and review': 1, 'Early experiences with video-assisted thoracoscopic surgery: Our first 70 cases. Spine (Phila': 1, 'Does video-assisted thoracic surgery provide a safe alternative to conventional techniques in patients with limited pulmonary function who are otherwise suitable for lung resection?': 1, 'From full thoracotomy to uniportal video-assisted thoracic surgery: lessons learned': 2, 'Precise anesthesia in thoracoscopic operations': 1, 'Tubeless Uniportal Thoracoscopic Wedge Resection for Peripheral Lung Nodules': 1, 'Devising the guidelines: the concept of uniportal video-assisted thoracoscopic surgeryincisions and anesthetic management': 1, 'Viral and host factors in human respiratory Syncytial virus pathogenesis': 1, 'Respiratory syncytial virus-a comprehensive review': 3, 'Circulation of HRSV in Belgium: from multiple genotype circulation to prolonged circulation of predominant genotypes': 1, 'Respiratory Syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious Cytopathology': 1, 'Epidemiology and risk factors for severe respiratory syncytial virus infections requiring pediatric intensive care admission in Hong Kong children': 1, 'Vaccine development for respiratory syncytial virus': 1, 'Selected populations at increased risk from respiratory syncytial virus infection': 1, 'Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis': 3, 'Novel antigens for RSV vaccines': 1, 'Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus': 2, 'Identification of linear heparin-binding peptides derived from human respiratory syncytial virus fusion glycoprotein that inhibit infectivity': 1, 'Ability of low-molecular-weight heparin to alleviate proteinuria by inhibiting respiratory syncytial virus infection': 1, 'RSV fusion: time for a new model': 3, 'Host cell entry of respiratory syncytial virus involves macropinocytosis followed by proteolytic activation of the F protein': 2, 'Caveolin-1 is incorporated into mature respiratory syncytial virus particles during virus assembly on the surface of virus-infected cells': 1, 'Hsp90 inhibitors exhibit resistance-free antiviral activity against respiratory Syncytial virus': 3, 'Direct inhibition of cellular fatty acid Synthase impairs replication of respiratory Syncytial virus and other respiratory viruses': 2, 'A synthetic serine protease inhibitor, Nafamostat Mesilate, is a drug potentially applicable to the treatment of Ebola virus disease': 1, 'The novel cyclophilin inhibitor CPI-431-32 concurrently blocks HCV and HIV-1 infections via a similar mechanism of action': 1, 'The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells': 1, 'Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2': 2, 'Cleavage of the respiratory syncytial virus fusion protein is required for its surface expression: role of furin': 1, 'Kinetics of synthesis of respiratory syncytial virus glycoproteins': 1, 'Respiratory syncytial virus polypeptides. V. The kinetics of glycoprotein synthesis': 1, 'Post-translational processing and oligomerization of the fusion glycoprotein of human respiratory syncytial virus': 1, 'effect of Proteolytic processing at two distinct sites on shape and aggregation of an anchorless fusion protein of human respiratory Syncytial virus and fate of the intervening segment': 1, 'Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion': 1, 'Prevention of respiratory Syncytial virus attachment protein cleavage in Vero cells rescues infectivity of progeny Virions for primary human airway cultures': 1, 'Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein': 1, 'Effects of protease inhibitors on replication of various myxoviruses': 1, 'Pharmacological inhibition of neuronal NADPH oxidase protects against 1-methyl-4-phenylpyridinium (MPP+)-induced oxidative stress and apoptosis in mesencephalic dopaminergic neuronal cells': 1, '4-(2-Aminoethyl)benzenesulfonyl fluoride attenuates tumor-necrosis-factor-??-induced blood-brain barrier opening': 2, 'Protease inhibitor reduces airway response and underlying inflammation in cockroach allergen-induced Murine model': 3, 'Serine protease inhibitor attenuates ovalbumin induced inflammation in mouse model of allergic airway disease': 2, 'The histopathology of fatal untreated human respiratory syncytial virus infection': 1, 'Respiratory syncytial virus and influenza virus infections: observations from tissues of fatal infant cases': 1, 'The immune response to respiratory syncytial virus infection: friend or foe?': 1, 'Persistent airway inflammation after resolution of respiratory Syncytial virus infection in rats': 1, 'The endtimes of human rights': 1, 'Social Policy Section, Department of Parliamentary Services, Parliament of Australia Posner EA (2014a) The twilight of human rights law: inalienable rights series': 1, \"Moving beyond false binarisms: on Samuel Moyn's the last utopia\": 2, 'That S word: sovereignty, and globalization, and human rights, et cetera': 2, 'at 2 ¶ 6. Many thanks to Laura I. Schaefer, Esq., from the American Bar Association for clarifying some procedural aspects of this case for me': 1, 'Since 2016 and continuing to this day, CBP has engaged in an unlawful, widespread pattern and practice of denying asylum seekers access to the asylum process at POEs on the U.S.-Mexico border through a variety of illegal tactics. These tactics include lying; using threats, intimidation and coercion; employing verbal abuse and applying physical force; physically obstructing access to the POE building; imposing unreasonable delays before granting access to the asylum process; denying outright access to the asylum process; and denying access to the asylum process in a racially discriminatory manner': 1, 'at 2, ¶ 3. References Articles, Chapters, and Books Abizadeh A (2008) Democratic theory and border coercion: no right to unilaterally control your own borders': 1, 'Political theology: four chapters on the concept of sovereignty': 1, 'Status non-citizens': 1, 'Prologue: democratic theory and the boundary problem': 1, 'The model international mobility convention': 1, 'Planning a public health surveillance system': 1, 'Establishing an ICD-10 code based SARI-surveillance in Germany -description of the system and first results from five recent influenza seasons': 2, 'Sentinel Network of Hospitals': 1, 'Improving regional influenza surveillance through a combination of automated outbreak detection methods: the 2015/16 season in France. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin': 2, 'Annual report Surveillance of influenza and other respiratory infections in the Netherlands: winter': 1, 'Updated Guidelines for Evaluating Public Health Surveillance Systems': 1, 'Data quality monitoring and surveillance system evaluation -A handbook of methods and application. Stockholm2014. 32. EuroMOMO. Mortality monitoring in Europe': 1, 'Influenza-associated mortality determined from allcause mortality': 1, 'Syndromic surveillance: two decades experience of sustainable systems -its people not just data! Epidemiology and infection': 1, 'Challenges and opportunities: builiding sustainable surveillance systems': 1, 'Quality of information: a European challenge. The Journal of hospital infection': 1, 'MERS outbreak in Korea: hospital-to-hospital transmission': 2, 'Middle East respiratory syndrome and severe acute respiratory syndrome': 1, 'Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies': 1, 'Protective efficacy of recombinant modified vaccinia virus Ankara delivering Middle East respiratory syndrome coronavirus spike glycoprotein': 1, 'Immunogenicity of an adenoviral-based Middle East respiratory syndrome coronavirus vaccine in BALB/c mice': 4, 'Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus': 1, 'A highly immunogenic and protective Middle East respiratory syndrome coronavirus vaccine based on a recombinant measles virus vaccine platform': 2, 'An orthopoxvirusbased vaccine reduces virus excretion after MERS-CoV infection in dromedary camels': 1, 'Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments--the importance of immunofocusing in subunit vaccine design': 2, 'Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: implication for designing novel mucosal MERS vaccines': 2, 'Tailoring subunit vaccine immunity with adjuvant combinations and delivery routes using the Middle East respiratory coronavirus (MERS-CoV) receptor-binding domain as an antigen': 2, 'Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus': 2, 'Recombinant receptor binding domain protein induces partial protective immunity in rhesus macaques against Middle East respiratory syndrome coronavirus challenge': 2, 'Optimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus': 2, 'MERS-CoV virus-like particles produced in insect cells induce specific humoural and cellular imminity in rhesus macaques': 2, 'A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates': 2, 'DNA vaccines: a review': 1, 'A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial': 1, 'Humoral and cellular immune responses induced by 3a DNA vaccines against severe acute respiratory syndrome (SARS) or SARS-like coronavirus in mice': 1, 'Middle East respiratory syndrome coronavirus \"MERS-CoV\": current knowledge gaps': 1, 'Vaccines for the prevention against the threat of MERS-CoV': 3, 'Current advancements and potential strategies in the development of MERS-CoV vaccines': 6, 'Structure of the fusion core and inhibition of fusion by a heptad-repeat peptide derived from the S protein of MERS-CoV': 1, 'The spike protein of SARS-CoV --a target for vaccine and therapeutic development': 1, 'Middle East respiratory syndrome: current status and future prospects for vaccine development': 1, 'Rapid generation of a mouse model for Middle East respiratory syndrome': 1, 'The humoral immune response is initiated in lymph nodes by B Cells that acquire soluble antigen directly in the follicles': 1, 'B-cell follicle development remodels the conduit system and allows soluble antigen delivery to follicular dendritic cells': 1, 'Regulation of T helper cell differentiation in vivo by soluble and membrane proteins provided by antigen-presenting cells': 1, 'Differing effects of monoclonal anti-hapten antibodies on humoral responses to soluble or particulate antigens': 1, 'Extensive positive selection drives the evolution of nonstructural proteins in lineage C Betacoronaviruses': 1, 'DNA vaccine encoding MERS-CoV S1 gene induced humoral and cellular immune responses': 1, 'Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID--19) cases on board the Diamond Princess cruise ship': 1, 'Insight into COVID--2019 for pediatricians': 1, 'Coronavirus Disease 2019 in Children-United States': 1, 'SARS--CoV--2 (COVID--19): What do we know about children? A systematic review': 1, 'Children with Coronavirus Disease 2019 (COVID--19): A Review of Demographic, Clinical, Laboratory and Imaging Features in 2,597 Pediatric Patients': 1, 'Evidence of SARS--CoV--2 infection in returning travelers from Wuhan, China': 1, 'Evidence Supporting Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 While Presymptomatic or Asymptomatic': 1, 'Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS--CoV--2)': 1, 'COVID--19 in children: the link in the transmission chain. The Lancet Infectious Diseases': 1, 'A Case Series of children with 2019 novel coronavirus infection: clinical and epidemiological features': 1, 'A well infant with coronavirus disease 2019 with high viral load': 1, 'The SARS--CoV--2 seroprevalence is the key factor for deconfinement in France': 1, 'Fatal Eosinophilic Myocarditis in a Healthy 17--Year--Old Male with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS--CoV--2c)': 1, 'Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits': 2, 'Point prevalence of SARS--CoV--2 and infection fatality rate in Orleans and Jefferson Parish': 1, 'Seroprevalence of immunoglobulin M and G antibodies against SARS--CoV--2 in China': 1, 'Seroprevalence of SARS--CoV--2-Specific Antibodies Among Adults': 1, 'Seroprevalence of anti--SARS--CoV--2 IgG antibodies in Geneva, Switzerland (SEROCoV--POP): a population--based study': 1, 'Seroprevalence of SARS--CoV--2 among children visiting a hospital during the initial Seattle outbreak': 1, 'Multiple Risk Factor Intervention Trial Research G. ZIP--code--based versus tract--based income measures as long--term risk--adjusted mortality predictors': 1, 'Socioeconomic disparities in the seroprevalence of cytomegalovirus infection in the US population: NHANES III': 1, 'Importance of collecting data on socioeconomic determinants from the early stage of the COVID--19 outbreak onwards': 1, 'Coronavirus: la emergencia geriá trica de 2020. Documento conjunto de la Secció n de Cardiología Geriá trica de la Sociedad Españ ola de Cardiología y la Sociedad Españ ola de Geriatría y Gerontología': 1, 'Enfermedad por el coronavirus (COVID-19)': 1, 'Melatonin in Mitochondria: Mitigating Clear and Present Dangers': 4, 'Melatonin has multiorgan effects': 1, 'Melatonin Inhibits COVID-19-induced Cytokine Storm by Reversing Aerobic Glycolysis in Immune Cells': 1, 'Therapeutic algorithm for the use of melatonin in patients with COVID-19': 3, 'Vaccination in the elderly: an immunological perspective': 1, 'Human gut microbiome viewed across age and geography': 1, 'GenABEL: an R library for genome-wide 1514 association analysis': 1, 'Blood groups in infection and host susceptibility': 2, 'Selfish operons: the evolutionary impact of gene clustering in prokrayotes and 1640 eukaryotes': 1, 'BlastKOALA and GhostKOALA: KEGG tools for functional 1626 characterization of genome and metagenome sequences': 1, 'The investigation of linkage between a quantitative trait and a 1608 marker locus': 2, 'Vulnerabilities in the North American Power Grid: Global Security Studies': 3, 'Autonomous Vehicles: Uncertainties and Energy implications': 1, 'Evaluating the effectiveness of a machine learning approach based on response time and reliability for islanding detection of distributed generation': 3, 'Big data analytics in smart grids: a review': 3, 'Mining energy consumption behavior patterns for households in smart grid': 1, 'A combined wavelet and data-mining based intelligent protection scheme for microgrid': 1, 'Energy disaggregation via discriminative sparse coding': 1, 'A learning intelligent system for classification and characterization of localized faults in smart grids': 1, 'A data analytic approach fault diagnosis and prognosis for distribution automation': 1, 'Early warning method for transmission line galloping based on SVM and AdaBoost bi-level classifiers': 1, 'Intelligent early warning of power system dynamic insecurity risk toward optimal accuracy-earliness tradeoff': 1, 'Using social sensors for detecting emergency events: a case of power outages in the electrical utility industry': 1, 'Data-driven power outage detection by social sensors': 1, 'System self-awareness and related methods for improving the use and understanding of data within DoD': 1, 'Big data and deep learning for understanding DoD data': 1, 'US patent 8,903,756: System and method for knowledge pattern search from networked agents': 1, 'The Book of Why: The New Science of Cause and Effect': 2, 'The Seven Pillars of Causal Reasoning with Reflections on': 1, 'Causal learning using pair-wise associations to discover supply chain vulnerability': 1, \"Saudi health minister outlines Kingdom's preventive measures against coronavirus\": 2, 'COVID-19 in the Shadows of MERS-CoV in the Kingdom of Saudi Arabia': 2, 'Preparedness and Response to COVID-19 in Saudi Arabia: Lessons Learned from MERS-CoV Preprints 2020': 1, 'Novel Corona Virus (2019-nCoV) Infection Guidelines V1.0. Kingdom of Saudi Arabia: Saudi Center for Disease Prevention and Control Ministry of Health': 3, 'COVID-19 Trends and Forecast in the Eastern Mediterranean Region With a Particular Focus on Pakistan': 1, 'Impact of Non-pharmaceutical Interventions (NPIs) to Reduce COVID-19 Mortality and Healthcare Demand': 2, 'Early estimates of epidemic final sizes': 1, 'A logistic growth model for COVID-19 proliferation: experiences from China and international implications in infectious diseases': 1, 'The Math of Epidemic Outbreaks and Spread (Part 2) Least Squares Parameter Estimation for Logistic Models': 1, 'Generalized logistic growth modeling of the COVID-19 outbreak in 29 provinces in China and in the rest of the world': 3, 'Estimating and forecasting COVID-19 attack rates and mortality': 1, 'A mathematical model to investigate the transmission of COVID-19 in the Kingdom of Saudi Arabia': 1, 'Reducing demand uncertainty in the platelet supply chain through artificial neural networks and ARIMA models': 1, 'A comparative time series analysis and modeling of aerosols in the contiguous United States and China': 2, 'Estimation of COVID-19 prevalence in Italy': 2, 'The early origins of the logit model': 1, 'Analysis of logistic growth models': 1, 'Estimation of the final size of the COVID-19 epidemic': 1, \"Corona's mortality rate, readiness of hospital after an increase in cases\": 1, 'Information about coronavirus disease COVID-19 Saudi Arabia: The Saudi Center for Disease Prevention and Control': 1, 'Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in china: summary of a report of 72,314 cases from the Chinese Center for Disease Control and Prevention': 1, 'High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation': 1, 'Obesity survival paradox in pneumonia: a meta-analysis': 2, 'Causes, characteristics, and consequences of metabolically unhealthy normal weight in humans': 2, 'Monsters in the uterus: teratoma-like tumors in senescent C. Elegans result from a parthenogenetic quasi-program': 1, 'The TORC1 inhibitor Nprl2 protects age-related digestive function in Drosophila': 1, 'Answering the ultimate question \"what is the proximal cause of aging': 1, 'Dementia incidence continues to increase with age in the oldest old: the 90+ study': 1, 'Disease or not, aging is easily treatable': 1, 'The changing profile of infant mortality from bacterial, viral and fungal infection over two decades': 1, 'Coronavirus disease (COVID-19) and neonate: what neonatologist need to know': 1, 'SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes': 2, \"The pathogenesis and treatment of the 'Cytokine storm' in COVID-19\": 3, 'On the alert for cytokine storm: immunopathology in COVID-19': 2, 'Obesity and COVID-19: immune and metabolic derangement as a possible link to adverse clinical outcomes': 2, 'Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2': 1, 'Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19': 2, 'The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease': 2, 'The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak': 4, 'Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19': 1, 'COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal': 1, 'Lymphopenia in COVID-19: therapeutic opportunities': 1, 'Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study': 1, 'Elevated plasmin(ogen) as a common risk factor for COVID-19 susceptibility': 1, 'Aging and immortality: quasiprogrammed senescence and its pharmacologic inhibition': 5, 'Aging is not programmed: genetic pseudo-program is a shadow of developmental growth': 1, 'The GH/IGF-1 axis in ageing and longevity': 1, 'The somatotropic axis and aging: benefits of endocrine defects': 1, 'Disruption of the GH receptor gene in adult mice increases maximal lifespan in females': 1, 'mTORC1 overactivation as a key aging factor in the progression to type 2 diabetes mellitus. Front Endocrinol (Lausanne)': 1, 'Reciprocal regulation of mTOR complexes in pancreatic islets from humans with type 2 diabetes': 1, 'Why men age faster but reproduce longer than women: mTOR and evolutionary perspectives': 1, 'Changes in primary lymphoid organs with aging': 3, 'Obesity accelerates thymic aging': 1, 'Inhibition of thymic adipogenesis by caloric restriction is coupled with reduction in age-related thymic involution': 1, 'The role of sex steroids and gonadectomy in the control of thymic involution': 1, 'Prospective treatment of agerelated diseases by slowing down aging': 3, 'An observational study of the association between androgenetic alopecia and size of the prostate': 1, 'Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD': 1, 'Aging boosts antiviral CD8+T cell memory through improved engagement of diversified recall response determinants': 2, 'Trained immunity: a program of innate immune memory in health and disease': 1, 'Convergence of innate and adaptive immunity during human aging': 2, 'The twilight of immunity: emerging concepts in aging of the immune system': 1, 'Exacerbated innate host response to SARS-CoV in aged non-human primates': 2, 'From inflamm-aging to immune-paralysis: a slippery slope during aging for immune-adaptation': 4, 'Paradoxical changes in innate immunity in aging: recent progress and new directions': 1, 'mTOR signaling pathway as a master regulator of memory CD8 + t-cells, Th17, and NK cells development and their functional properties': 1, 'Inflamm-aging. An evolutionary perspective on immunosenescence': 3, 'Immunosenescence and inflamm-aging as two sides of the same coin: friends or foes? Front Immunol': 3, 'Chronic inflammation (inflammaging) and its potential contribution to ageassociated diseases': 3, 'Growth stimulation leads to cellular senescence when the cell cycle is blocked': 3, 'Rapamycin, proliferation and geroconversion to senescence': 6, 'Cell senescence and hypermitogenic arrest': 1, 'Pharmacologic inhibition of MEK and PI-3K converges on the mTOR/S6 pathway to decelerate cellular senescence': 1, 'MEK drives cyclin D1 hyperelevation during geroconversion': 2, 'Dual mTORC1/C2 inhibitors: gerosuppressors with potential anti-aging effect': 1, 'Gerosuppression by pan-mTOR inhibitors': 1, 'Reversal of phenotypes of cellular senescence by pan-mTOR inhibition': 1, 'Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism': 2, 'Rapamycin reverses the senescent phenotype and improves immunoregulation of mesenchymal stem cells from MRL/lpr mice and systemic lupus erythematosus patients through inhibition of the mTOR signaling pathway': 1, 'Targeted elimination of senescent ras-transformed cells by suppression of MEK/ERK pathway': 1, 'Attenuation of TORC1 signaling delays replicative and oncogenic RAS-induced senescence': 1, 'Paradoxical suppression of cellular senescence by p53': 1, 'Contact inhibition and high cell density deactivate the mammalian target of rapamycin pathway, thus suppressing the senescence program': 1, 'Rapamycin retards epigenetic ageing of keratinocytes independently of its effects on replicative senescence, proliferation and differentiation': 1, 'Status of mTOR activity may phenotypically differentiate senescence and quiescence': 1, 'Does rapamycin slow down time?': 2, 'Validation of anti-aging drugs by treating age-related diseases': 1, 'A geroscience perspective on COVID-19 mortality': 1, 'Geroscience: linking aging to chronic disease': 1, 'mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells': 6, 'Rapamycin-induced enhancement of vaccine efficacy in mice': 1, 'Immunostimulatory activity of lifespan-extending agents': 1, 'mTOR regulates memory CD8 t-cell differentiation': 2, 'Paradoxical aspects of rapamycin immunobiology in transplantation': 2, 'Sirolimus enhances the magnitude and quality of viralspecific CD8+ t-cell responses to vaccinia virus vaccination in rhesus macaques': 1, 'Chronic mTOR inhibition in mice with rapamycin alters T, B, myeloid, and innate lymphoid cells and gut flora and prolongs life of immune-deficient mice': 5, 'mTOR inhibition improves immune function in the elderly': 1, 'Cutting edge: rapamycin augments pathogen-specific but not graft-reactive CD8+ T cell responses': 1, 'Aging, obesity, and inflammatory age-related diseases': 1, 'Immunosenescence in aging: between immune cells depletion and cytokines up-regulation': 1, 'mTORC1 signaling governs hematopoietic stem cell quiescence': 1, 'Aging, stem cells, and mammalian target of rapamycin: a prospect of pharmacologic rejuvenation of aging stem cells': 1, 'Geroconversion of aged muscle stem cells under regenerative pressure': 1, 'Microenvironmental contributions to hematopoietic stem cell aging': 1, 'Long-term adaptation to hypoxia preserves hematopoietic stem cell function': 1, 'Regulation of the HIF-1alpha level is essential for hematopoietic stem cells': 1, 'Hypoxia suppresses conversion from proliferative arrest to cellular senescence': 1, 'Rapamycin enhances long-term hematopoietic reconstitution of ex vivo expanded mouse hematopoietic stem cells by inhibiting senescence': 1, 'Rapamycin is highly effective in murine models of immune-mediated bone marrow failure': 2, 'Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells': 1, 'Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis': 1, 'TOR signaling in growth and metabolism': 6, 'The mammalian target of rapamycin pathway regulates nutrient-sensitive glucose uptake in man': 1, 'Rapamycin reverses insulin resistance (IR) in highglucose medium without causing IR in normoglycemic www.aging-us.com medium': 1, 'Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance': 1, 'Rapamycin for longevity: opinion article': 3, 'Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the bronx, new york': 1, 'Obesity and its implications for COVID-19 mortality': 1, 'Obesity predisposes to the risk of higher mortality in young COVID-19 patients': 1, 'Clinical course and risk factors for mortality of adult inpatients with COVID-19 in wuhan, China: a retrospective cohort study': 1, 'Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in wuhan, China': 1, 'COVID-19 and diabetes: knowledge in progress': 1, 'Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia -a systematic review, meta-analysis, and meta-regression': 1, 'Clinical characteristics and outcomes of patients with severe covid-19 with diabetes': 1, 'Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis': 1, 'Remission of human type 2 diabetes requires decrease in liver and pancreas fat content but is dependent upon capacity for β cell recovery': 1, 'Restoring normoglycaemia by use of a very low calorie diet in long-and short-duration type 2 diabetes': 1, 'Population response to information on reversibility of type 2 diabetes': 1, 'Caloric restriction and its effect on blood pressure, heart rate variability and arterial stiffness and dilatation: a review of the evidence': 1, 'Rapamycin and quasi-programmed aging: four years later': 1, 'mTOR inhibition alleviates mitochondrial disease in a mouse model of leigh syndrome': 1, 'mTOR pathway activation drives lung cell senescence and emphysema': 1, 'Restoration of corticosteroid sensitivity in chronic obstructive pulmonary disease by inhibition of mammalian target of rapamycin': 1, 'National Institutes of Health Rare Lung Diseases Consortium, and MILES Trial Group. Efficacy and safety of sirolimus in lymphangioleiomyomatosis': 2, 'Fasting and rapamycin: diabetes versus benevolent glucose intolerance': 3, \"Diabetes after transplantation and sirolimus: what's the connection?\": 1, 'Conversion to sirolimus therapy in kidney transplant recipients with new onset diabetes mellitus after transplantation': 1, 'The clinical course and potential underlying mechanisms of everolimus-induced hyperglycemia': 2, 'Geroprotective and senoremediative strategies to reduce the comorbidity, infection rates, severity, and lethality in gerophilic and gerolavic infections': 1, 'COVID-19 and chronological aging: senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection? Aging (Albany NY)': 1, 'Targeting t-cell senescence and cytokine storm with rapamycin to prevent severe progression in COVID-19': 1, 'Immunoregulation with mTOR inhibitors to prevent COVID-19 severity: a novel intervention strategy beyond vaccines and specific antiviral medicines': 1, 'The mechanistic target of rapamycin (mTOR): novel considerations as an antiviral treatment': 1, 'Inhaled biguanides and mTOR inhibition for influenza and coronavirus (review)': 1, 'Rejuvenating immunity: \"anti-aging drug today\" eight years later': 1, 'Comprehending a killer: the Akt/mTOR signaling pathways are temporally high-jacked by the highly pathogenic 1918 influenza virus. EBioMedicine': 1, 'Antiviral potential of ERK/MAPK and PI3K/AKT/mTOR signaling modulation for middle east respiratory syndrome coronavirus infection as identified by temporal kinome analysis': 1, 'Optimisation of a screening platform for determining IL-6 inflammatory signalling in the senescence-associated secretory phenotype (SASP)': 1, 'Mechanistic insights into impaired dendritic cell function by rapamycin: inhibition of Jak2/Stat4 signaling pathway': 1, 'Deoxynivalenol: toxicology and potential effects on humans': 1, 'Report from SCOOP task 3.2.10 \"collection of occurrence data of Fusarium toxins in food and assessment of dietary intake by the population of EU member states': 1, 'Toxicological features of T-2 toxin and related trichothecenes': 3, 'Fusarium poae and F. sporotichiodes as principal causal agents of alimentary toxic aleukia': 1, 'The role of T-2 toxin in experimental alimentary toxic aleukia: a toxicity study in cats': 1, 'Apoptotic cellular damage in mice after T-2 toxin-induced acute toxicosis': 1, 'Process of the development of T-2 toxin-induced apoptosis in the lymphoid organs of mice': 2, 'T-2 toxin-induced apoptosis in lymphoid organs of mice': 2, 'T-2 toxin induces thymic apoptosis in vivo in mice': 2, \"Development of apoptosis and changes in lymphocyte subsets in thymus, mesenteric lymph nodes and Peyer's patches of mice orally inoculated with T-2 toxin\": 3, 'T-2 toxin impairment of murine response to Salmonella Typhimurium: a histopathologic assessment': 1, 'Effect of T-2 toxin on resistance to systemic Salmonella Typhimurium infection of newly hatched chickens': 1, 'Cecal volatile fatty acids and broiler chick susceptibility to Salmonella Typhimurium colonization as affected by aflatoxins and T-2 toxin': 1, 'Differential effect of T-2 toxin on murine host resistance to three facultative intracellular bacterial pathogens: Listeria monocytogenes, Salmonella Typhimurium, and Mycobacterium bovis': 2, 'T-2 toxin effects on the serum amyloid P-component (SAP) response of Listeria monocytogenes-and Salmonella Typhimurium-infected mice': 1, 'Comparison of the effect of T-2 toxin with that of dexamethasone or cyclophosphamide on resistance to Babesia microti infection in mice': 1, 'Decreased resistance to mycobacterial infection in mice fed a trichothecene compound (T-2 toxin)': 1, 'The effects of dietary T-2 toxin on acute herpes simplex virus type 1 infection in mice': 1, 'Immunotoxicology of regional lymphoid tissue: the respiratory and gastrointestinal tracts and skin': 1, 'Gut mucosal immunotoxicology in rodents': 1, 'Enteric reovirus infection as a probe to study immunotoxicity of the gastrointestinal tract': 2, 'Reoviruses and their replication': 2, 'Prevalence of reovirus-specific antibodies in young children in': 1, 'Reoviruses and the host cell': 3, \"Gut mucosal immunization with reovirus serotype 1/L stimulates virus-specific cytotoxic T cell precursors as well as IgA memory cells in Peyer's patches\": 4, 'Effects of the route of infection on immunoglobulin G subclasses and specificity of the reovirus-specific humoral immune response': 2, \"Role of immunoglobulin A in protection against reovirus entry into murine Peyer's patches\": 3, 'Antibody protects against lethal infection with the neurally spreading reovirus type 3 (Dearing)': 2, \"Developmental relationship between cytotoxic alpha/beta T cell receptor-positive intraepithelial lymphocytes and Peyer's patch lymphocytes\": 1, 'T-Helper 1 and T-helper 2 cytokine responses in gut-associated lymphoid tissue following enteric reovirus infection': 1, 'Role of interleukin-4 (IL-4) and IL-10 in serum immunoglobulin G antibody responses following mucosal or systemic reovirus infection': 2, 'Effects of trichothecene structure on cytokine secretion and gene expression in murine CD4+ T-cells': 1, 'Sigma 1 protein of mammalian reoviruses extends from the surfaces of viral particles': 1, 'Passive immunity to fatal reovirus serotype 3-induced meningoencephalitis mediated by both secretory and transplacental factors in neonatal mice': 1, \"Use of Peyer's patch and lymph node fragment cultures to compare local immune responses to Morganella morganii\": 1, 'Enhanced mucosal and systemic immune responses to intestinal reovirus infection in beta2-microglobulin-deficient mice': 2, 'Gene expression profiling in spleens of deoxynivalenol-exposed mice: immediate early genes as primary targets': 1, 'Mechanism of interferon action: human leukocyte and immune interferons regulate the expression of different genes and induce different antiviral states in human amnion U cells': 1, 'The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression': 1, 'Sensitivity and predictivity in immunotoxicity testing: immune endpoints and disease resistance': 1, 'An outbreak of infection with a type 1 reovirus among children in an institution': 1, 'T-2 and HT-2 toxins. Safety Evaluation of Certain Mycotoxins in Food': 3, 'Role of mucosal antibodies in viral infections': 1, 'The immune response to viruses': 2, 'Intestinal M cells: a pathway for entry of reovirus into the host': 1, 'The viral sigma1 protein and glycoconjugates containing alpha2-3-linked sialic acid are involved in type 1 reovirus adherence to M cell apical surfaces': 1, 'Secretory component: a new role in secretory IgAmediated immune exclusion in vivo': 1, 'Occupancy and mechanism in antibodymediated neutralization of animal viruses': 1, 'The role of gamma interferon in antimicrobial immunity': 1, 'The role of Th1 and Th2 cells for mucosal IgA responses': 1, 'The two faces of IL-6 on Th1/Th2 differentiation': 1, 'IL-10, an inflammatory/inhibitory cytokine, but not always': 1, 'Respiratory reovirus 1/L induction of intraluminal fibrosis, a model of bronchiolitis obliterans organizing pneumonia, is dependent on T lymphocytes': 1, 'Differential role for T cells in the development of fibrotic lesions associated with reovirus 1/L-induced bronchiolitis obliterans organizing pneumonia versus Acute Respiratory Distress Syndrome': 1, 'Respiratory reovirus 1/L induction of diffuse alveolar damage: a model of acute respiratory distress syndrome': 1, 'Pathology of guinea pigs experimentally infected with a novel reovirus and coronavirus isolated from SARS patients': 2, 'Degeneration and Regeneration of the Central Nervous System': 1, \"Die sogenannte 'akute multiple Sklerose' (Encephalomyelitis periaxialis scleroticans)\": 2, 'Zur Frage der akuten multiplen Sklerose und der encephalomyelitis disseminata im Kindesalter': 1, 'Ultrastructural study of remyelination in an experimental lesion in adult cat spinal cord': 1, 'Regenerative phenomena in the feline spinal cord in late stages of lesions inflicted by cerebrospinal fluid manipulation': 1, 'Neurological lesions in cats following cerebrospinal fluid manipulation': 1, 'Electron microscopic features of multiple sclerosis lesions': 1, 'Central remyelination restores secure conduction': 2, 'The restoration of conduction by central remyelination': 1, 'A Colour Atlas of Multiple Sclerosis and Other Myelin Disorders': 1, 'Multicontrast MRI of remyelination in the central nervous system': 1, 'Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination': 1, 'A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases': 1, 'Remyelination in the human central nervous system': 1, 'Comparative Neuropathology of Chronic Experimental Allergic Encephalomyelitis and Multiple Sclerosis': 1, 'Continual breakdown and regeneration of myelin in progressive multiple sclerosis plaques': 1, 'Multiple sclerosis. Pathology of recurrent lesions': 3, 'Remyelination in multiple sclerosis': 3, 'Multiple sclerosis: Remyelination in acute lesions': 2, 'Schwann cell remyelination of demyelinated axons in spinal cord multiple sclerosis lesions': 1, 'Spinal cord multiple sclerosis lesions in Japanese patients: Schwann cell remyelination occurs in areas that lack glial fibrillary acidic protein (GFAP)': 1, 'The case for a central nervous system (CNS) origin for the Schwann cells that remyelinate CNS axons following concurrent loss of oligodendrocytes and astrocytes': 1, 'Visual evoked potentials after optic neuritis. EVect of time interval, age and disease dissemination': 1, 'Axonal damage in multiple sclerosis lesions': 1, 'Axonal changes if chronically demyelinated cervical spinal cord plaques': 1, 'Axonal transection in the lesions of multiple sclerosis': 1, 'A function of myelin is to protect axons from subsequent injury: Implications for deficits in multiple sclerosis': 2, 'Ions, energy and axonal injury: Towards a molecular neurology of multiple sclerosis': 1, 'Multiple sclerosis and chronic autoimmune encephalomyelitis: A comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions': 2, 'Patients lacking the major CNS myelin protein, proteolipid protein 1, develop lengthdependent axonal degeneration in the absence of demyelination and inflammation': 1, 'Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination': 1, 'Murine oligodendroglial cells express nerve growth factor': 1, 'A role for oligodendrocyte-derived IGF-1 in trophic support of cortical neurons': 1, 'Mechanisms of axon ensheathment and myelin growth': 1, 'Clustering of Naþ channels and node of Ranvier formation in remyelinating axons': 1, 'Molecular reconstruction of nodes of Ranvier after remyelination by transplanted olfactory ensheathing cells in the demyelinated spinal cord': 1, 'Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology': 1, 'Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat': 1, 'Mechanisms of immunopathology in murine models of central nervous system demyelinating disease': 2, 'Targeting experimental autoimmune encephalomyelitis lesions to a predetermined axonal tract system allows for refined behavioral testing in an animal model of multiple sclerosis': 1, 'Response of the oligodendrocyte progenitor cell population (defined by NG2 labelling) to demyelination of the adult spinal cord': 1, \"Theiler's virus infection: A model for multiple sclerosis\": 1, 'Quantifying the early stages of remyelination following cuprizone-induced demyelination': 1, 'Human endogenous retrovirus glycoproteinmediated induction of redox reactants causes oligodendrocyte death and demyelination': 1, 'Cell depletion due to diphtheria toxin fragment A after Cre-mediated recombination': 1, 'A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration': 1, 'Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes viruses': 1, 'Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion': 1, 'Suppression of remyelination in the CNS by X-irradiation': 1, 'Oligodendrocyte progenitor cell (OPC) transplantation is unlikely to oVer a means of preventing X-irradiation induced damage in the CNS': 2, 'NG2-expressing cells as oligodendrocyte progenitors in the normal and demyelinated adult central nervous system': 2, 'The remyelinating potential and in vitro diVerentiation of MOG-expressing oligodendrocyte precursors isolated from the adult rat CNS': 1, 'Identification of post-mitotic oligodendrocytes incapable of remyelination within the demyelinated adult spinal cord': 1, 'Why does remyelination fail in multiple sclerosis?': 6, 'In vivo proliferation of oligodendrocyte progenitors expressing PDGFalphaR during early remyelination': 2, 'Fibroblast growth factor 2 (FGF2) and FGF receptor expression in an experimental demyelinating disease with extensive remyelination': 1, 'Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination': 2, 'Defective oligodendrocyte development and severe hypomyelination in PDGF-A knockout mice': 1, 'PDGF and FGF2 pathways regulate distinct oligodendrocyte lineage responses in experimental demyelination with spontaneous remyelination': 1, 'Neuregulin in neuron/glial interactions in the central nervous system. GGF2 diminishes autoimmune demyelination, promotes oligodendrocyte progenitor expansion, and enhances remyelination': 1, 'Impaired remyelination and depletion of oligodendrocyte progenitors does not occur following repeated episodes of focal demyelination in the rat central nervous system': 1, 'bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS': 1, 'Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice': 1, 'Insulin-like growth factors and binding proteins in multiple sclerosis plaques': 1, 'Generation of transgenic mice expressing insulin-like growth factor-1 under the control of the myelin basic protein promoter: Increased myelination and potential for studies on the eVects of increased IGF-1 on experimentally and genetically induced demyelination': 1, 'In vivo actions of insulin-like growth factor-I (IGF-I) on brain myelination: Studies of IGF-I and IGF binding protein-1 (IGFBP-1) transgenic mice': 1, 'A role for TGF-beta in oligodendrocyte diVerentiation': 1, 'The age-related decrease in CNS remyelination eYciency is attributable to an impairment of both oligodendrocyte progenitor recruitment and diVerentiation': 2, 'Increasing local levels of IGF-I mRNA expression using adenoviral vectors does not alter oligodendrocyte remyelination in the CNS of aged rats': 1, 'Axonal signals in central nervous system myelination, demyelination and remyelination': 3, 'Induction of myelination in the central nervous system by electrical activity': 1, 'The role of ion channels and neurotransmitter receptors in glial cell development': 1, 'Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus': 1, 'Cells expressing the NG2 antigen contact nodes of Ranvier in adult CNS white matter': 1, 'A cell-intrinsic timer that operates during oligodendrocyte development': 1, 'Number of oligodendrocyte progenitors recruited to the lesioned spinal cord is modulated by the levels of the cell cycle regulatory protein': 1, 'LINGO-1 negatively regulates myelination by oligodendrocytes': 1, 'Delayed remyelination in the rat spinal cord following ethidium bromide injection': 1, 'Chronic demyelination inhibits remyelination in the central nervous system': 1, 'Functional genomic analysis of remyelination reveals importance of inflammation in oligodendrocyte regeneration': 2, 'TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination': 1, 'EYcient central nervous system remyelination requires T cells': 2, 'Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination': 1, 'Interleukin-1beta promotes repair of the CNS': 1, 'Corticosteroids delay remyelination of experimental demyelination in the rodent central nervous system': 3, 'Minocycline-mediated inhibition of microglia activation impairs oligodendrocyte progenitor cell responses and remyelination in a non-immune model of demyelination': 1, 'The eVect of dexamethasone on L-alphalysophosphatidyl choline (lysolecithin)-induced demyelination of the rat spinal cord': 1, 'Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells': 3, 'Myelin specific genes and their mutations in the mouse': 1, 'Inflammation stimulates myelination by transplanted oligodendrocyte precursor cells': 1, 'Decline in rate of colonization of oligodendrocyte progenitor cell (OPC)-depleted tissue by adult OPCs with age': 1, 'New insights into remyelination failure in multiple sclerosis: Implications for glial cell transplantation': 1, 'NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions': 1, 'Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis': 1, 'Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord': 3, 'Oligodendrocyte progenitor cells in the adult rat CNS express myelin oligodendrocyte glycoprotein (MOG)': 1, 'Purification and characterization of adult oligodendrocyte precursor cells from the rat optic nerve': 1, 'Patients with active relapsing-remitting multiple sclerosis synthesize antibodies recognizing oligodendrocyte progenitor cell surface protein: Implications for remyelination': 1, 'EYcient recolonisation of progenitor-depleted areas of the CNS by adult oligodendrocyte progenitor cells': 1, 'Increasing local levels of neuregulin (glial growth factor-2) by direct infusion into areas of demyelination does not alter remyelination in the rat CNS': 1, 'Dysfunctional oligodendrocyte progenitor cell (OPC) populations may inhibit repopulation of OPC depleted tissue': 3, 'Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis': 1, 'Early glial responses in murine models of multiple sclerosis': 1, 'New concepts in the immunopathogenesis of multiple sclerosis': 1, 'Repair of demyelinated lesions by transplantation of purified O-2A progenitor cells': 1, 'Type 1 astrocytes inhibit myelination by adult rat oligodendrocytes in vitro': 1, 'The presence of astrocytes in areas of demyelination influences remyelination following transplantation of oligodendrocyte progenitors': 1, 'Inflammation stimulates remyelination in areas of chronic demyelination': 2, 'Transplanted type-1 astrocytes facilitate repair of demyelinating lesions by host oligodendrocytes in adult rat spinal cord': 1, 'PDGF and FGF2 regulate oligodendrocyte progenitor responses to demyelination': 1, 'Distinctive patterns of PDGF-A, FGF-2, IGF-I, and TGF-beta1 gene expression during remyelination of experimentally-induced spinal cord demyelination': 1, 'Multiple sclerosis: Re-expression of a developmental pathway that restricts oligodendrocyte maturation': 1, 'Inhibition of Notch signaling enhances tissue repair in an animal model of multiple sclerosis': 1, 'Neuregulin: An oligodendrocyte growth factor absent in active multiple sclerosis lesions': 1, 'Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation': 1, 'Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis': 1, 'Promotion of remyelination by immunoglobulins: Implications for the treatment of multiple sclerosis': 1, 'Enhancing central nervous system remyelination in multiple sclerosis': 1, 'Remyelination and restoration of axonal function by glial cell transplantation': 1, 'Olfactory ensheathing cells: Ripples of an incoming tide?': 1, 'Stem cells for the treatment of myelin loss': 2, 'Glial grafting for demyelinating disease': 1, 'Human embryonic stem cells diVerentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation': 1, 'Transplanted CG4 cells (an oligodendrocyte progenitor cell line) survive, migrate, and contribute to repair of areas of demyelination in X-irradiated and damaged spinal cord but not in normal spinal cord': 1, 'Oligodendrocyte precursors survive poorly and do not migrate following transplantation into the normal adult central nervous system': 1, 'Olfactory ensheathing cells (OECs) and the treatment of CNS injury: Advantages and possible caveats': 1, 'Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain': 1, 'Reproductive importance of dominant male greater-prairie chickens': 1, 'Behavioral, endocrine, and immunological correlates of immigration by an aggressive-male into a natural primate group': 1, 'Queeneworker conflict over sex-ratio: a comparison of primary and secondary sex-ratios in the argentine ant, Iridomyrmex humilis': 1, 'Network theory and SARS: predicting outbreak diversity': 3, 'Food web complexity and species diversity': 1, 'A conversation on refining the concept of keystone species': 1, 'Ecological implications of behavioral syndromes': 1, 'The mix matters: behavioural types and group dynamics in water striders': 2, 'The keystone individual concept: an ecological and evolutionary overview': 2, 'Policing stabilizes construction of social niches in primates': 1, 'Robustness mechanisms in primate societies: a perturbation study': 2, 'Predation on a white shark (Carcharodon carcharias) by a killer whale (Orcinus orca) and a possible case of competitive displacement': 1, 'A pacific culture among wild baboons: its emergence and transmission': 1, 'Superspreading SARS events': 1, 'Leadership in elephants: the adaptive value of age': 2, 'Causes and consequences of cooperation and permanent sociality in spiders': 1, 'Predation on social and solitary individuals of the spider Stegodyphus dumicola (Araneae, Eresidae)': 1, 'Amplified fragment length polymorphism fingerprints support limited gene flow among social spider populations': 1, 'Octopamine and serotonin have opposite effects on antipredator behavior in the orb-weaving spider, Larinioides cornutus': 1, 'A test for correlations among fitness-linked behavioural traits in the spider Agelenopsis aperta (Araneae, Agelenidae)': 1, 'Individual personalities drive task differentiation in a social spider': 2, \"Linking levels of personality: personalities of the 'average' and 'most extreme' group members predict colonylevel personality\": 4, 'Levels of predation and genetically based antipredator behavior in the spider, Agelenopsis aperta': 1, 'Predator-induced changes in the boldness of naïve field crickets, Gryllus integer, depends on behavioural type': 1, 'Integrating behaviour with life history: boldness of the field cricket, Gryllus integer, during ontogeny': 1, 'Task specialization in two social spiders, Stegodyphus sarasinorum (Eresidae) and Anelosimus eximius (Theridiidae)': 2, 'Shoal composition determines foraging success in the guppy': 1, 'Population structure mediates sexual conflict in water striders': 1, 'The role of multilevel selection in the evolution of sexual conflict in the water strider Aquarius remigis': 1, 'Productivity increases with variation in aggression among group members in Temnothorax ants': 1, 'Diverse societies are more productive: a lesson from ants': 1, 'Infanticide-driven intersexual conflict over matings in primates and its effects on social organization': 1, 'Iterative evolution of increased behavioral variation characterizes the transition to sociality in spiders and proves advantageous': 1, 'How within-group behavioral variation and task efficiency enhance fitness in a social group': 2, 'Frequency-dependent success of cheaters during foraging bouts might limit their spread within colonies of a socially polymorphic spider': 1, 'Personalitydependent dispersal in the invasive mosquitofish: group composition matters': 1, 'Social feedback and the emergence of leaders and followers': 2, 'The effect of personality on social foraging: shy barnacle geese scrounge more': 1, 'Individual variation in helping in a cooperative breeder: relatedness versus behavioural type': 1, 'The effect of repeated vibration signals on worker behavior in established and newly founded colonies of the honey bee, Apis mellifera': 1, 'Personality and social context': 1, 'Selforganization in social insects': 1, 'Individual and collective decisionmaking during nest site selection by the ant Leptothorax albipennis': 1, 'The principles of collective animal behaviour': 1, 'A modelling framework for understanding social insect foraging': 1, 'Behavioral syndromes and social insects: multiple levels of personality': 1, 'Interindividual variability in social insects: proximate causes and ultimate consequences': 1, 'Polistes paper wasps: a model genus for the study of social dominance hierarchies': 1, 'Queen regulation of worker foraging in paper wasps: a social feedback-control system (Polistes fuscatus, Hymenoptera, Vespidae)': 1, 'Testing the importance of the distribution of worker sizes to colony performance in the ant species formica obscuripes forel': 1, 'Fire ant polymorphism: the ergonomics of brood production': 1, 'Within-group behavioral variation promotes biased task performance and the emergence of a defensive caste in a social spider': 1, 'Models of division of labor in social insects': 1, 'Assessing disease burden of respiratory disorders in Hong Kong children with hospital discharge data and linked laboratory data': 1, 'Rapid multiplex nested PCR for detection of respiratory viruses': 5, 'Infection control for SARS in a tertiary paediatric centre in Hong Kong': 1, 'Rapid identification of nine microorganisms causing acute respiratory tract infections by single-tube multiplex reverse transcription-PCR: Feasibility study': 1, 'Impact of rapid detection of viral and atypical bacterial pathogens by real-time polymerase chain reaction for patients with lower respiratory tract infection': 3, 'Comparison of multiplex PCR assays and conventional techniques for the diagnostic of respiratory virus infections in children admitted to hospital with an acute respiratory illness': 2, 'Development of a respiratory virus panel test for detection of twenty human respiratory viruses by use of multiplex PCR and a fluid microbead-based assay': 1, 'Nasal swab versus nasopharyngeal aspirate for isolation of respiratory viruses': 1, 'Laboratory diagnosis and surveillance of human respiratory viruses by PCR in': 1, \"Ten years' experience with year-round active surveillance of up to 19 respiratory pathogens in children\": 1, 'Etiology of communityacquired pneumonia in 254 hospitalized children': 1, 'Respiratory viral infections among pediatric inpatients and outpatients in Taiwan from 1997 to 1999': 1, 'Rhinovirus infection in hospitalized children in Hong Kong': 1, 'Direct diagnosis of human respiratory coronaviruses 229E and OC43 by the polymerase chain reaction': 1, 'Rhinovirus-induced airway inflammation in asthma: Effect of treatment with inhaled corticosteroids before and during experimental infection': 1, 'Relationship between five common viruses and febrile seizure in children': 1, 'A cluster of adenovirus serotype 3 infections in children in northern Taiwan: Clinical features and laboratory findings': 1, 'Cost-effectiveness of rapid diagnosis of viral respiratory tract infections in pediatric patients': 1, 'Clinical features and rapid viral diagnosis of human disease associated with avian influenza H5N1 virus': 1, 'Outbreak of avian influenza A (H5N1) virus infection in Hong Kong in 1997': 1, 'Genome-wide analysis of integral membrane proteins from eubacterial, archaean, and eukaryotic organisms': 1, 'Membrane protein folding and stability: physical principles': 5, 'Solving the membrane protein folding problem': 1, 'Membrane protein structure: prediction versus reality': 1, 'A limited universe of membrane protein families and folds': 1, 'Biophysical dissection of membrane proteins': 1, 'Computer simulations of membrane proteins': 1, 'Systematic multiscale simulation of membrane protein systems': 1, 'Reduced models of proteins and their applications': 2, 'Coarse-grained models for proteins': 1, 'Folding simulations of small proteins': 1, 'How native proteins aggregate in solution: a dynamic Monte Carlo simulation': 1, 'The helix-coil transition re-visited': 4, 'The MARTINI force field: coarse grained model for biomolecular simulations': 1, 'Coarse-grained molecular dynamics simulations of membrane proteins and peptides': 2, 'Implicit membrane models for membrane protein simulation': 1, 'An implicit membrane generalized Born theory for the study of structure, stability, and interactions of membrane proteins': 1, 'A generalized Born implicit-membrane representation compared to experimental insertion free energies': 2, 'Computer simulations of membrane protein folding: structure and dynamics': 2, 'Modelling of proteins in membranes': 2, 'The transmembrane oligomers of coronavirus protein E': 2, 'Full length Vpu from HIV-1: combining molecular dynamics simulations with NMR spectroscopy': 1, 'Role of CD4 receptor down-regulation during HIV-1 infection': 1, 'Total chemical synthesis of the integral membrane protein influenza A virus M2: role of its C-terminal domain in tetramer assembly': 1, 'Effect of cytoplasmic tail truncations on the activity of the M-2 ion channel of influenza A virus': 1, 'Coronavirus envelope protein: a small membrane protein with multiple functions': 1, 'Model of a putative pore: the pentameric alpha-helical bundle of SARS coronavirus E protein in lipid bilayers': 2, 'The M2 proton channels of influenza A and B viruses': 1, 'Structural basis for the function and inhibition of an influenza virus proton channel': 1, 'Structure and mechanism of the M2 proton channel of influenza A virus': 5, 'Hydrogen bonds in membrane proteins': 1, 'Lipophobicity and the residue environments of the transmembrane alpha-helical bundle': 2, 'A simple method for displaying the hydropathic character of a protein': 2, 'The bond fluctuation method: a new effective algorithm for the dynamics of polymers in all spatial dimensions': 2, 'Inter-diffusion and self-diffusion in polymer mixtures: a Monte Carlo study': 2, 'Monte Carlo calculations on the dynamics of polymers in dilute solution': 1, 'Analysis of Monte Carlo results on the kinetics of lattice polymer chains with excluded volume': 1, 'Correlation between rate of folding, energy landscape, and topology in the folding of a model protein HP-36': 1, 'Continuous anisotropic representation of coarse-grained potentials for proteins by spherical harmonics synthesis': 1, 'Equation of state calculations by fast computing machines': 1, 'The Symmetric Eigenvalue Problem': 1, 'Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features': 1, 'Helix packing in membrane proteins': 1, 'Evaluating tilt angles of membraneassociated helices: comparison of computational and NMR techniques': 1, 'Current perspective on exercise immunology': 5, 'Epidemiology, pathogenesis, and treatment of the common cold': 1, 'Transmission of experimental rhinovirus colds in volunteer married couples': 7, 'Virus isolations from common colds occurring in a residential school': 2, 'Transmission of experimental rhinovirus infection by contaminated surfaces': 5, 'Sinusitis in the common cold': 1, 'Infection, immunity and exercise': 1, 'Antibiotics for the common cold and acute purulent rhinitis': 2, 'The effectiveness of antihistamines in reducing the severity of runny nose and sneezing: a meta-analysis': 1, 'Vitamin C for preventing and treating the common cold': 2, 'Zinc for the common cold': 1, 'Treatment of the common cold with Echinacea: a structured review': 2, 'Physical activity, training and the immune response': 1, 'Centers for disease control and prevention. Nonspecific upper respiratory tract infection': 2, 'Acute community-acquired sinusitis': 1, 'Clinical practice. Acute bacterial sinusitis': 2, 'Clinical evaluation for sinusitis: making the diagnosis by history and physical examination': 1, 'The clinical diagnosis of acute purulent sinusitis in general practicea review': 1, 'Comparison between transillumination and x-ray in diagnosing paranasal sinus disease': 1, 'Comparison of sinus x-rays with computed tomography scans in acute sinusitis': 2, 'Computed tomographic study of the common cold': 1, 'for the Sinus and Allergy Health Partnership. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis': 3, 'Subcommittee on the Management of Sinusitis and Committee on Quality Improvement': 2, 'Acute sinusitis: current status of etiologies, diagnosis, and treatment': 1, 'The Cochrane Collaboration. Nasal decongestants for the common cold. Cochrane database of systematic reviews': 2, 'Principles of appropriate antibiotic use for acute pharyngitis in adults: background': 2, 'for the Infectious Diseases Society of America. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis': 1, 'The diagnosis of strep throat in adults in the emergency room': 1, 'Health matters: the common cold': 1, 'Streptococcal pharyngitis: optimal site for throat culture': 1, 'Heated, humidified air for the common cold': 1, 'Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care: a placebo-controlled randomized trial': 1, 'Diagnosis of streptococcal pahryngitis: differentiation of active infection from the carrier state in the symptomatic child': 1, 'How effective are treatments other than antibiotics for acute sore throat?': 1, 'Effectiveness of oral dexamethasone in the treatment of moderate to severe pharyngitis in children': 1, 'Duration of positive throat cultures for group A streptococci after initiation of antibiotic therapy': 3, 'Prospective study of the natural history of infectious mononucleosis caused by Epstein-Barr virus': 4, 'Viral infections of human epidemiology and control': 1, 'Spontaneous rupture of the spleen in patients with infectious mononucleosis': 1, 'Ultrasound assessment of spleen size in collegiate athletes': 1, 'Laboratory findings in infectious mononucleosis': 2, 'A prospective evaluation of heterophile and Epstein-Barr virus-specific IgM antibody tests in clinical and subclinical infectious mononucleosis: specificity and sensitivity of the tests and persistence of antibody': 1, 'Ayclovir and prednisolone treatment of acute infectious mononucleosis: a multicenter, double-blind, placebo-controlled study': 1, 'Acyclovir for treatment of infectious mononucleosis: a meta-analysis': 1, 'Spontaneous splenic rupture in infectious mononucleosis: sonographic diagnosis and follow-up': 2, 'Sécurité des patients et analyse des causes racines': 1, 'Saint-Maurice : Institut national de veille sanitaire (INVS)': 1, 'Emerging infectious diseases that threaten the blood supply': 5, 'From mad cows to sensible blood transfusion: the risk of prion transmission by labile blood components in the United Kingdom and in France': 5, 'An update of the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products': 1, 'Transmission of BSE by blood transfusion in sheep': 1, 'Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion': 2, 'Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient': 2, 'Clinical presentation and pre-mortem diagnosis of blood transfusion-associated variant CJD': 1, 'Fourth case of transfusion-associated vCJD infection in the United Kingdom': 1, 'Transmission of West Nile virus through blood transfusion in the United States in 2002': 1, 'Transmission of West Nile virus from an organ transplant recipients': 1, 'Emerging infectious disease agents and their potential threat to transfusion': 2, 'Cost-effectiveness of alternative bloodscreening strategies for West Nile virus in the United States': 2, \"Virus West Nile : à nouveau en France chez l'homme et les chevaux\": 1, 'Dengue virus in blood donations': 1, 'Dengue viremia in blood donors from Honduras, Brazil, and Australia': 1, 'Review of dengue fever cases in Hong Kong during': 1, 'Transfusion-Transmitted Dengue Infection study group. Dengue hemorrhagic fever transmitted by blood transfusion': 1, 'Manille: The World Health Organization Regional Office for the Western Pacific (WPRO); ©': 1, 'Surveillance de la dengue aux Antilles. Le point épidémiologique n o 2, 28 juillet': 1, 'First cases of autochthonous dengue fever and chikungunya fever in France: from bad dream to reality': 2, \"Estimation quantitative du risque de contamination d'un don de sang par le chikungunya lors de l'épidémie survenue à La Réunion\": 1, 'Centers for Disease Control and Prevention and National Institute of Health. Biosafety in microbiological and biomedical laboratories (BMBL) 5th Edition. Washington; US Government': 1, 'Novel Chikiungunya virus variant in travellers returning from Indian Ocean islands': 1, 'Infection with Chikungunya virus in Italy: an outbreak in a temperate region': 1, 'Tick-borne viral encephalitis in Finland. The clinical features of Kimlinge disease during 1959-1987': 1, 'Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors': 1, \"Seroprevalence of human herpesvirus-8 in healthy human subjects and patients with AIDSassociated and classical Kaposi's sarcoma in France\": 1, 'Possible transmission of human herpesvirus-8 by blood transfusion in a historical United States cohort': 1, 'Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients': 1, 'Transmission of human herpesvirus 8 by blood transfusion': 1, 'Parvovirus B19 transmission by a high-purity factor VIII concentrate': 1, 'Clinical illness due to parvovirus B19 infection after infusion of solvent/detergent-treated pooled plasma': 1, 'Parvovirus B19 transmission by heat-treated clotting factor concentrates': 1, 'Transmission of hepatitis A via WBC-reduced RBCs and FFP from a single donation': 1, 'Silent transfusion-transmitted hepatitis A virus infection in an infant': 1, 'Molecular and serologic tracing of a transfusion-transmitted hepatitis A virus': 1, 'Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido': 1, 'Transfusion-transmitted hepatitis E in a \"nonhyperendemic country': 1, 'Hépatite E : maladie émergente ?': 1, \"Une hépatite émergente : l'hépatite E\": 1, 'Hepatitis E: virus and chronic hepatitis in organ-transplant recipients': 1, 'Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France': 1, 'Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients': 1, 'Emerging infectious diseases agents and their potential threat to transfusion safety': 2, 'Transfusiontransmitted infections': 2, 'Genève : Organisation mondiale de la santé (OMS) ; ©': 1, 'Potential impact of pandemic influenza on blood safety and availability': 1, 'Emerging and re-emerging infections at the turn of the millennium': 1, 'Preserving blood safety against emerging retroviruses': 1, 'Characterizing the threat to the blood supply associated with nonoccupational exposure to emerging simian retroviruses': 1, 'Nucleic acid testing to detect HBV infection in blood donors': 1, 'Detection of prion infection in variant Creutzfeldt-Jakob disease: a bloodbased assay': 1, 'The spectrum of safety: a review of the safety of current hemophilia products': 1, 'Protecting the blood supply from emerging pathogens: the role of pathogen inactivation': 1, 'Alternative strategies in assuring blood safety: an overview': 1, 'DGS/RI1/2010/163 du 17 mai 2010 relative aux modalités de mise en oeuvre du plan anti-dissémination du chikungunya et de la dengue en métropole. Disponible sur': 1, 'Hot crises and media reassurance: A comparison of emerging diseases and 522': 1, 'Variable evolutionary routes to host establishment across repeated rabies virus host shifts among bats': 1, 'Replication strategies of rabies virus': 1, 'Human rabies: Neuropathogenesis, diagnosis, and management': 2, 'Still Neglected after 125 Years of Vaccination': 1, 'Selected highlights from other journals: Estimating the global burden of canine rabies': 2, 'Public Health Responses to Reemergence of Animal Rabies': 1, 'Molecular Epidemiology and Evolution of European Bat Lyssavirus 2': 2, 'Evidence of two Lyssavirus phylogroups with distinct pathogenicity and immunogenicity': 1, 'Taxonomy of the order Mononegavirales: Update': 1, 'Lyssavirus in Japanese Pipistrelle': 1, 'Tentative novel lyssavirus in a bat in Finland': 1, 'Ecology and evolution of rabies virus in Europe': 1, 'The role of viral evolution in rabies host shifts and emergence': 1, 'A perspective on lyssavirus emergence and perpetuation': 2, 'Codon usage in twelve species of Drosophila': 1, 'Analysis of codon usage bias of envelope glycoprotein genes in nuclear polyhedrosis virus (NPV) and its relation to evolution': 1, 'Evolutionary and genetic analysis of the VP2 gene of canine parvovirus': 1, 'Factors affecting the codon usage bias of SRY gene across mammals': 1, 'Analysis of phylogeny and codon usage bias and relationship of GC content, amino acid composition with expression of the structural nif genes': 1, 'Codon Usage Bias and Determining Forces in Taenia solium Genome': 1, 'Analysis of codon usage bias of mitochondrial genome in Bombyx mori and its relation to evolution': 1, 'The impact of host genetic diversity on virus evolution and emergence': 1, 'Recombination in the rabies virus and other lyssaviruses': 1, 'The Lyssavirus glycoprotein: A key to cross-immunity': 1, 'Production and neurotropism of lentivirus vectors pseudotyped with lyssavirus envelope glycoproteins': 1, 'Role of the glycoprotein G in lyssavirus pathogenicity': 1, 'Emergence of Lyssaviruses in the old world: The case of Africa': 1, 'The Global Phylogeography of Lyssaviruses-Challenging the \"Out of Africa\" Hypothesis': 1, 'Science & SciLifeLab Prize. From persistence to cross-species emergence of a viral zoonosis': 1, 'Codon usage bias in the N gene of rabies virus': 2, 'Synonymous codon usage pattern in glycoprotein gene of rabies virus': 1, 'Analysis of synonymous codon usage in H5N1 virus and other influenza A viruses': 1, 'Revelation of Influencing Factors in Overall Codon Usage Bias of Equine Influenza Viruses': 2, 'Genome-wide analysis of codon usage bias in Ebolavirus': 1, 'The characteristic of codon usage pattern and its evolution of hepatitis C virus': 1, 'Characterization of the porcine epidemic diarrhea virus codon usage bias': 1, 'Evolution of codon usage in Zika virus genomes is host and vector specific': 2, 'Evolutionary characterization of Tembusu virus infection through identification of codon usage patterns': 1, 'CpG oligonucleotide activates Toll-like receptor 9 and causes lung inflammation in vivo': 1, 'Clinical application of CpG-, non-CpG-, and antisense oligodeoxynucleotides as immunomodulators': 1, 'Genetic Recombination, and Pathogenesis of Coronaviruses': 1, 'Epidemiology, Evolution, and Pathogenesis of H7N9 Influenza Viruses in Five Epidemic Waves since 2013 in China': 1, 'Novel Influenza D virus: Epidemiology, pathology, evolution and biological characteristics': 1, 'Phylogenetic analysis reveals a low rate of homologous recombination in negative-sense RNA viruses': 1, 'Codon usage bias and the evolution of influenza A viruses. Codon Usage Biases of Influenza Virus': 1, 'Theory and Applications of Correspondence-Analysis-Greenacre': 1, 'Genetic and codon usage bias analyses of polymerase genes of equine influenza virus and its relation to evolution': 2, 'The Effective Number of Codons Used In a Gene': 1, 'Comprehensive analysis of the overall codon usage patterns in equine infectious anemia virus': 1, 'Translation-coupled violation of Parity Rule 2 in human genes is not the cause of heterogeneity of the DNA G+C content of third codon position': 1, 'Intrastrand Parity Rules of DNA-Base Composition and Usage Biases of Synonymous Codons': 1, 'Dinucleotide relative abundance extremes: A genomic signature': 1, 'Genomic analysis of codon usage shows influence of mutation pressure, natural selection, and host features on Marburg virus evolution': 1, 'The role of dendritic cells in innate and adaptive immunity to respiratory syncytial virus, and implications for vaccine development': 1, 'Challenges and opportunities for respiratory syncytial virus vaccines': 4, 'The path to an RSV vaccine': 2, 'Respiratory syncytial virus vaccine development': 1, 'The pneumonia virus of mice infection model for severe respiratory syncytial virus infection: identifying novel targets for therapeutic intervention': 2, 'Innate and adaptive immune response to pneumonia virus of mice in a resistant and a susceptible mouse strain': 5, 'Animal pneumoviruses: molecular genetics and pathogenesis': 1, 'Animal models of human respiratory syncytial virus disease': 1, 'The respiratory syncytial virus fusion protein formulated with a novel combination adjuvant induces balanced immune responses in lambs with maternal antibodies': 1, 'Intranasal treatment with poly(I*C) protects aged mice from lethal respiratory virus infections': 1, 'Poly(I: C) is an effective adjuvant for antibody and multi-functional CD4þ T cell responses to Plasmodium falciparum circumsporozoite protein (CSP) and alphaDEC-CSP in non human primates': 1, 'Synthetic cationic peptide IDR-1002 provides protection against bacterial infections through chemokine induction and enhanced leukocyte recruitment': 1, 'Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide': 1, 'Immune modulation by multifaceted cationic host defense (antimicrobial) peptides': 1, 'Poly[di(sodium carboxylatoethylphenoxy) phosphazene] (PCEP) is a potent enhancer of mixed Th1/Th2 immune responses in mice immunized with influenza virus antigens': 1, 'Activation of adjuvant core response genes by the novel adjuvant PCEP': 1, 'Blunted inflammatory and mucosal IgA responses to pneumonia virus of mice in C57BL/6 neonates are correlated to reduced protective immunity upon re-infection as elderly mice': 3, 'The novel adjuvant combination of CpG ODN, indolicidin and polyphosphazene induces potent antibody-and cellmediated immune responses in mice': 1, 'Guidelines on the recognition of pain, distress and discomfort in experimental animals and an hypothesis for assessment': 1, 'Altered pathogenesis of severe pneumovirus infection in response to combined antiviral and specific immunomodulatory agents': 3, 'Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice': 3, 'Alveolar macrophages contribute to the pathogenesis of human metapneumovirus infection while protecting against respiratory syncytial virus infection': 2, 'Alveolar macrophages are a major determinant of early responses to viral lung infection but do not influence subsequent disease development': 1, 'Mechanisms regulating neutrophil survival and cell death': 1, 'Neutrophil in viral infections, friend or foe?': 2, 'Interferon-gamma coordinates CCL3-mediated neutrophil recruitment in vivo': 1, 'Functions of natural killer cells': 2, 'Interferon-gamma: an overview of signals, mechanisms and functions': 1, 'MircroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells': 18, 'Micro-masters of glioblastoma biology and therapy: increasingly recognized roles for microRNAs': 2, 'Matrix metalloproteinases and their biological function in human gliomas': 1, 'Current Concepts in the Surgical Management of Glioma Patients': 2, 'Current review of in vivo GBM rodent models: emphasis on the CNS-1 tumour model': 1, 'Photodynamic therapy of high grade glioma -long term survival': 1, 'Molecular mechanisms of glioma cell migration and invasion': 1, 'Current status of local therapy in malignant gliomas-a clinical review of three selected approaches': 1, 'Diffuse glioma growth: a guerilla war': 3, 'Current epidemiological trends and surveillance issues in brain tumors': 1, \"Cancer's molecular sweet tooth and the Warburg effect\": 3, 'Understanding the Warburg effect: the metabolic requirements of cell proliferation': 1, 'Why do cancers have high aerobic glycolysis?': 2, 'AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy': 2, 'MicroRNAs: target recognition and regulatory functions': 1, 'Non-coding RNAs as epigenetic regulator of glioma stem-like cell differentiation': 1, 'OncomiRs-microRNAs with a role in cancer': 1, 'MicroRNA Regulation of a Cancer Network: Consequences of the Feedback Loops Involving miR-17-92, E2F, and Myc': 2, 'Targeting of the BMI-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal': 1, 'Emerging functions of microRNAs in glioblastoma': 1, 'microRNA-451: A conditional switch controlling glioma cell proliferation and migration': 6, 'Reactive Astrocytes in Glioblastoma Multiforme': 1, 'The role of astrocytes in the progression of brain cancer: complicating the picture of the tumor microenvironment': 1, 'Glioma-astrocyte interaction modifies the astrocyte phenotype in a co-culture experimental model': 1, 'Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion': 2, 'Effect of brain-and tumor-derived connective tissue growth factor on glioma invasion': 2, 'miR451 and AMPK/MARK mutual antagonism in glioma cells migration and proliferation': 4, 'Regulation of cell proliferation and migration in glioblastoma: New therapeutic approach. Frontiers in Molecular and Cellular Oncology': 2, 'Strategies of eradicating glioma cells: A multi-scale mathematical model with miR-451-AMPK-mTOR control': 4, 'A mathematical model of Brain tumor: pattern formation of glioma cells outside the tumor spheroid core': 2, 'A hybrid model for cell proliferation and migration in glioblastoma': 4, 'Collective behavior of brain tumor cells: the role of hypoxia': 1, 'A model for short-and long-range interactions of migrating tumour cell': 1, 'Invasion from a cell aggregate-the roles of active cell motion and mechanical equilibrium': 1, 'Identification of intrinsic in vitro cellular mechanisms for glioma invasion': 1, \"Go or grow': the key to the emergence of invasion in tumour progression\": 1, 'The biology and mathematical modelling of glioma invasion: a review': 1, 'Modelling the effects of cell-cycle heterogeneity on the response of a solid tumour to chemotherapy: Biological insights from a hybrid multiscale cellular automaton model': 2, 'Regulation of the eukaryotic cell cycle: molecular antagonism, hysteresis, and irreversible transitions': 2, 'Modelling the controls of the eukaryotic cell cycle': 2, 'The role of myosin II in glioma invasion: A mathematical model': 2, 'Effect of low glutamine/glucose on hypoxia-induced elevation of hypoxia-inducible factor-1alpha in human pancreatic cancer MiaPaCa-2 and human prostatic cancer DU-145 cells': 2, 'Regulation of hypoxia-inducible factor 1 by glucose availability under hypoxic conditions': 2, 'Tumour-promoting tissue mechanics': 1, 'Biphasic modeling of brain tumor biomechanics and response to radiation treatment': 1, 'How cellular movement determines the collective force generated by the Dictyostelium discoideum slug': 8, 'A hybrid model for tumor spheroid growth in vitro I: Theoretical development and early results': 8, 'The role of the microenvironment in tumor growth and invasion': 6, 'A hybrid model of tumor-stromal interactions in breast cancer': 2, 'Targeting cellular pathways in glioblastoma multiforme': 1, 'Mer receptor tyrosine kinase promotes invasion and survival in glioblastoma multiforme': 1, 'Cell mechanics and feedback regulation of actomyosin networks': 1, 'Cancer invasion and the microenvironment: Plasticity and reciprocity': 2, 'The role of myosin II in glioma invasion of the brain': 1, 'Regeneration beyond the glial scar': 1, 'How does chondroitinase promote functional recovery in the damaged CNS?': 1, 'Optimal control strategies of eradicating invisible glioblastoma cells after conventional surgery': 1, 'On the control of cell migration and proliferation in glioblastoma': 1, 'Glioblastoma: Overview of Disease and Treatment': 1, 'Psychiatric symptoms in glioma patients: from diagnosis to managemen': 1, 'Leukocyte common antigen-related phosphatase is a functional receptor for chondroitin sulfate proteoglycan axon growth inhibitors': 1, 'Microglia-derived TGF-beta as an important regulator of glioblastoma invasion-an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor': 2, 'The role of microglia and macrophages in glioma maintenance and progression': 1, 'Macrophage plasticity and polarization in tissue repair and remodelling': 1, \"Diverse Brain Myeloid Expression Profiles Reveal Distinct Microglial Activation States and Aspects of Alzheimer's Disease Not Evident in Mouse Models\": 1, \"Microglia in Alzheimer's disease\": 1, \"Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson's Disease\": 1, 'Chondroitinase ABC has a long-lasting effect on chondroitin sulphate glycosaminoglycan content in the injured rat brain': 1, 'Chondroitinase ABC promotes functional recovery after spinal cord injury': 1, 'Alterations in chondroitin sulfate proteoglycan expression occur both at and far from the site of spinal contusion injury': 2, 'novel matrix structure composed of chondroitin sulfate proteoglycan in the brain': 1, 'Cell Cycle Regulation of Stem Cells by MicroRNAs': 1, 'Treating cancer with microRNA replacement therapy: A literature review': 1, 'MicroRNA therapeutics: towards a new era for the management of cancer and other diseases': 1, 'Contribution of microRNAs to radio-and chemoresistance of brain tumors and their therapeutic potential': 1, 'Metabolic Reprogramming in Glioma': 2, 'The Microenvironmental Landscape of Brain Tumors': 1, 'Oxidation of Akt2 kinase promotes cell migration and regulates G1-S transition in the cell cycle': 1, 'G1 cell-cycle control and cancer': 1, 'Mechanisms of glioma formation: iterative perivascular glioma growth and invasion leads to tumor progression, VEGFindependent vascularization, and resistance to antiangiogenic therapy': 1, 'Multiscale Models of Cell and Tissue Dynamics': 1, 'Hybrid models of cell and tissue dynamics in tumor growth': 1, 'Glioblastoma cells inhibit astrocytic p53-expression favoring cancer malignancy': 1, 'Expression of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1 in human brain tumors and their involvement in glial proliferation in vitro': 1, 'Exploitation of astrocytes by glioma cells to facilitate invasiveness: a mechanism involving matrix metalloproteinase-2 and the urokinase-type plasminogen activator-plasmin cascade': 1, 'Regeneration in the spinal cord of the cat and dog': 1, 'Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice': 1, 'Essential protective roles of reactive astrocytes in traumatic brain injury': 1, 'Reactive astrocytes potentiate tumor aggressiveness in a murine glioma resection and recurrence model': 1, 'Review: molecular mechanism of microglia stimulated glioblastoma invasion': 1, 'The brain tumor microenvironment': 1, 'Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo': 1, 'Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain': 1, 'Two faces of chondroitin sulfate proteoglycan in spinal cord repair: a role in microglia/macrophage activation': 1, 'Microglia processes block the spread of damage in the brain and require functional chloride channels': 1, 'Microglia-glioblastoma interactions: New role for Wnt signaling': 1, 'The LAR family of prosynaptic proteins help mediate glial scar induced axonal regeneration failure following spinal cord injury': 1, 'Why one-sizefits-all vaso-modulatory interventions fail to control glioma invasion: in silico insights': 1, 'A neurocentric perspective on glioma invasion': 1, 'Lost in disruption: role of proteases in glioma invasion and progression': 1, 'Expression of a cleaved brain-specific extracellular matrix protein mediates glioma cell invasion in vivo': 1, 'A role for receptor tyrosine phosphataseζ in glioma cell migration': 1, 'Novel tumor-specific isoforms of BEHAB/brevican identified in human malignant gliomas': 1, 'Complex role of NK cells in regulation of oncolytic virus-bortezomib therapy': 1, 'A Glial Signature and Wnt7 Signaling Regulate Glioma-Vascular Interactions and Tumor Microenvironment': 3, 'Glioma progression through the prism of heat shock protein mediated extracellular matrix remodeling and epithelial to mesenchymal transition': 2, 'Chondroitin sulfate proteoglycans from salmon nasal cartilage inhibit angiogenesis': 1, 'The mode and dynamics of glioblastoma cell invasion into a decellularized tissue-derived extracellular matrix-based three-dimensional tumor model': 1, 'Extracellular matrix remodeling in vivo for enhancing tumor-targeting efficiency of nanoparticle drug carriers using the pulsed high intensity focused ultrasound': 1, 'Engineering strategies to mimic the glioblastoma microenvironment': 1, 'Regulation of growth factor signaling by FRS2 family docking/scaffold adaptor proteins': 1, 'Enhancing the therapeutic efficacy of adenovirus in combination with biomaterials': 1, 'Retargeting polymer-coated adenovirus to the FGF receptor allows productive infection and mediates efficacy in a peritoneal model of human ovarian cancer': 1, 'Targeted therapies in bladder cancer-an update': 1, 'Virotherapy of ovarian cancer with polymer-cloaked adenovirus retargeted to the epidermal growth factor receptor': 1, 'TGF-beta signaling and its targeting for glioma treatment': 1, 'CSF-1R inhibition alters macrophage polarization and blocks glioma progression': 1, 'Coronavirus genetically redirected to the epidermal growth factor receptor exhibits effective antitumor activity against a malignant glioblastoma': 1, 'Severe sepsis and septic shock': 2, 'Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy': 1, 'Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach': 7, 'The new normal: immunomodulatory agents against sepsis immune suppression': 2, 'Advances in the management of sepsis and the understanding of key immunologic defects': 1, 'The immunopathogenesis of sepsis': 2, 'Immunomodulatory therapies in sepsis': 2, 'Immunotherapy of Sepsis: Blind Alley or Call for Personalized Assessment?': 3, 'Bacterial Autophagy: Offense and Defense at the Host-Pathogen Interface': 2, 'Autophagy in sepsis: Degradation into exhaustion?': 1, 'Autophagy: A Potential Therapeutic Target for Reversing Sepsis-Induced Immunosuppression': 2, 'The state of the art in anti-malarial drug discovery and development': 1, 'Developmental toxicity of artesunate and an artesunate combination in the rat and rabbit': 1, 'The anti-malarial artesunate is also active against cancer': 1, 'Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-kappa B activation': 6, 'Further evidence for an anti-inflammatory role of artesunate in experimental cerebral malaria': 1, 'Mechanistic Investigation of the Specific Anticancer Property of Artemisinin and Its Combination with Aminolevulinic Acid for Enhanced Anticolorectal Cancer Activity': 1, 'Animal research: reporting in vivo experiments: the ARRIVE guidelines': 1, 'Immunodesign of experimental sepsis by cecal ligation and puncture': 1, 'Systematic investigation on the turning point . CC-BY-NC-ND 4.0 International license author/funder. It is made available under a The copyright holder for this preprint (which was not peer-reviewed) is the': 1, 'Immune responsive gene 1 (IRG1) promotes endotoxin tolerance by increasing A20 expression in macrophages through reactive oxygen species': 1, 'Lentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection': 1, 'TCMSP: a database of systems pharmacology for drug discovery from herbal medicines': 1, 'The Chemistry Development Kit (CDK): an open-source Java library for Chemo-and Bioinformatics': 1, 'Intestinal epithelial vitamin D receptor . CC-BY-NC-ND 4.0 International license author/funder. It is made available under a The copyright holder for this preprint (which was not peer-reviewed) is the': 1, 'Activation of the EIF2AK4-EIF2A/eIF2alpha-ATF4 pathway triggers autophagy response to Crohn disease-associated adherent-invasive Escherichia coli infection': 1, 'Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers': 1, 'Vitamin D receptor (VDR)-mediated actions of 1alpha,25(OH)(2)vitamin D(3): genomic and non-genomic mechanisms': 1, 'VDR/vitamin D receptor regulates autophagic activity through ATG16L1': 2, 'Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages': 2, 'Autophagy in immunity and inflammation': 1, 'Vitamin D, vitamin D receptor, and macroautophagy in inflammation and infection': 1, 'LC3/GABARAP family proteins: autophagy-(un)related functions': 1, 'The two NF-kappaB activation pathways and their role in innate and adaptive immunity': 1, 'Increased NF-kappaB activity in fibroblasts lacking the vitamin D receptor': 2, 'Vitamin D receptor negatively regulates bacterial-stimulated NF-kappaB activity in intestine': 2, 'Artesunate Attenuates Pro-Inflammatory Cytokine Release from Macrophages by Inhibiting TLR4-Mediated Autophagic Activation via the TRAF6-Beclin1-PI3KC3 Pathway': 4, 'The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)': 3, 'Vitamin D deficiency in critically ill patients with traumatic injuries': 2, 'Impact of vitamin D on infectious disease': 2, 'Vitamin D and outcomes in adult . CC-BY-NC-ND 4.0 International license author/funder. It is made available under a The copyright holder for this preprint (which was not peer-reviewed) is the': 2, 'Artesunate protects sepsis model mice challenged with Staphylococcus aureus by decreasing TNF-alpha release via inhibition TLR2 and Nod2 mRNA expressions and transcription factor NF-kappaB activation': 1, 'The nuclear vitamin D receptor: biological and molecular regulatory properties revealed': 2, 'Structure of the full human RXR/VDR nuclear receptor heterodimer complex with its DR3 target DNA': 1, 'Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor': 1, '1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A': 1, '1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro': 1, 'Vitamin D: modulator of the immune system': 1, 'Vitamin D and Infectious Diseases: Simple Bystander or Contributing Factor? Nutrients 9': 1, 'Evidence for the involvement of TNF and NF-kappaB in hippocampal synaptic plasticity': 1, 'NF-kappaB in the nervous system': 1, 'Single versus combined immunoregulatory approach using PD-1 and CTLA-4 modulators in controlling sepsis': 1, 'Avian influenza: A review': 1, 'Highly pathogenic) avian influenza as a zoonotic agent': 2, 'Transmission of influenza a/h5n1 viruses in mammals': 1, 'Diseases of Poultry': 2, 'Is low pathogenic avian influenza virus virulent for wild waterbirds?': 1, 'Control of low pathogenicity avian influenza': 1, 'Avian influenza virus (H5N1): A threat to human health': 1, 'Molecular epidemiology of H5N1 avian influenza': 1, 'Highly pathogenic avian influenza viruses and generation of novel reassortants': 2, 'Multiple reassortment events among highly pathogenic avian influenza A(H5N1) viruses detected in Bangladesh': 2, 'Effect of cocirculation of highly pathogenic avian influenza H5N1 subtype with low pathogenic H9N2 subtype on the spread of infections': 1, 'Cross-reactive, cell-mediated immunity and protection of chickens from lethal H5N1 influenza virus infection in Hong Kong poultry markets': 2, 'Modulation of the severity of highly pathogenic H5N1 influenza in chickens previously inoculated with Israeli H9N2 influenza viruses': 1, 'Heterologous post-infection immunity against Egyptian avian influenza virus (AIV) H9N2 modulates the course of subsequent infection by highly pathogenic AIV H5N1, but vaccination immunity does not': 2, 'Review of infectious bronchitis virus around the world': 1, 'Coronavirus avian infectious bronchitis virus': 3, 'Monne, I. S1 gene-based phylogeny of infectious bronchitis virus: An attempt to harmonize virus classification': 1, 'The long view: 40 Years of infectious bronchitis research': 1, 'Molecular survey of avian respiratory pathogens in commercial broiler chicken flocks with respiratory diseases in Jordan': 1, 'Prevalence of avian respiratory viruses in broiler flocks in Egypt': 2, 'Identification of a trypsin-like serine proteinase domain encoded by ORF 1a of the coronavirus IBV': 1, 'New real time and conventional RT-PCRs for updated molecular diagnosis of infectious bronchitis virus infection (IBV) in chickens in Egypt associated with frequent co-infections with avian influenza and Newcastle disease viruses': 1, 'Coinfection of avian influenza virus (H9N2 subtype) with infectious bronchitis live vaccine': 1, 'An experimental study on broiler chicken co-infected with the specimens containing avian influenza (H9 subtype) and infectious bronchitis (4/91 strain) viruses. Iran': 2, 'Newcastle disease, other avian paramyxoviruses and avian metapneumovirus infections': 2, 'Römer-Oberdörfer, A. Different regions of the Newcastle disease virus fusion protein modulate pathogenicity': 1, 'The epidemiology and control of avian influenza and Newcastle disease': 1, 'Cocultivation of avian orthomyxoviruses and paramyxoviruses in embryonated eggs: Implications for surveillance studies': 1, 'Receptor and molecular mechanism of the host range variation of influenza viruses': 1, 'Virulence of Newcastle disease virus: What is known so far?': 1, 'Effect of lentogenic Newcastle disease virus (Lasota) on low pathogenic avian influenza virus (H9N2) infection in fayoumi chicken': 1, 'Virus interference between H7N2 low pathogenic avian influenza virus and lentogenic Newcastle disease virus in experimental co-infections in chickens and turkeys': 1, 'Molecular mechanism of complex infection by bacteria and virus analyzed by a model using serratial protease and influenza virus in mice': 1, 'Previous infection with virulent strains of Newcastle disease virus reduces highly pathogenic avian influenza virus replication, disease, and mortality in chickens': 2, 'Experimental co-infections of domestic ducks with a virulent Newcastle disease virus and low or highly pathogenic avian influenza viruses': 2, 'Co-infection of mallards with low-virulence Newcastle disease virus and low-pathogenic avian influenza virus': 2, 'Interactions between bacteria and influenza A virus in the development of influenza pneumonia': 1, 'Role of staphylococcus protease in the development of influenza pneumonia': 1, 'Modification of the hemagglutinin cleavage site allows indirect activation of avian influenza virus H9N2 by bacterial staphylokinase': 1, 'Co-infection of staphylococcus aureus or haemophilus paragallinarum exacerbates H9N2 influenza A virus infection in chickens': 2, 'Isolation and serotyping of ornithobacterium rhinotracheale from poultry': 1, 'Pathological study on the upper respiratory tract infection of chickens and isolation, identification of causal bacteria': 1, 'Ornithobacterium rhinotracheale: A review': 2, 'Molecular epidemiology of Ornithobacterium rhinotracheale': 1, 'Preliminary characterization of a pleomorphic gram-negative rod associated with avian respiratory disease': 1, 'In vitro antibiotic sensitivity of Ornithobacterium rhinotracheale strains from poultry and wild birds': 1, 'Ornithobacterium rhinotracheale in nestling falcons': 1, 'Nervous signs associated with otitis and cranial osteomyelitis and with Ornithobacterium rhinotracheale infection in red-legged partridges (Alectoris rufa)': 1, 'Phenotypic and molecular characterization of isolates of Ornithobacterium rhinotracheale from chickens and pigeons in Taiwan': 1, 'Ornithobacterium rhinotracheale infection': 1, 'Co-infection of broilers with Ornithobacterium rhinotracheale and H9N2 avian influenza virus': 3, 'Experimental study on tissue tropism and dissemination of H9N2 avian influenza virus and Ornithobacterium rhinotracheale co-infection in SPF chickens': 1, 'Introduction: Mycoplasmosis': 1, 'Manual of Diagnostic Tests and Vaccines for Terrestrial Animals': 1, 'Avian mycoplasma infections: Prototype of mixed infections with mycoplasmas, bacteria and viruses': 1, 'Pathologic lesions caused by coinfection of Mycoplasma gallisepticum and H3N8 low pathogenic avian influenza virus in chickens': 2, 'Effect of low-pathogenicity influenza virus H3N8 infection on Mycoplasma gallisepticum infection of chickens': 2, 'Mycoplasma gallisepticum modifies the pathogenesis of influenza a virus in the avian tracheal epithelium': 1, 'A survey of Mycoplasma gallisepticum and Mycoplasma synovaie with avian influenza H9 subtype in meat-type chicken in Jordan between 2011-2015': 1, 'Co-infection with multiple respiratory pathogens contributes to increased mortality rates in Algerian poultry flocks': 1, 'Natural cases and an experimental study of H9N2 avian influenza in commercial broiler chickens of Iran': 1, 'Evaluation of pathogenic potential of avian influenza virus serotype H9N2 in chickens': 1, 'Standardisation of a new model of H9N2/Escherichia coli challenge in broilers in the Lebanon': 2, 'Experiences in autotuning matrix multiplication for energy minimization on GPUs': 1, 'Search space generation and pruning system for autotuners': 2, 'Bonsai. In: ISC 2018': 1, 'Search space pruning constraints visualization': 1, 'Power and performance characterization and modeling of GPU-accelerated systems': 1, 'Break down GPU execution time with an analytical method': 1, 'Performance analysis and tuning for general purpose graphics processing units (GPGPU)': 2, 'Better performance at lower occupancy': 2, 'TensorFlow Machine Learning Cookbook': 1, \"Hands-On Machine Learning with Scikit-Learn and TensorFlow: Concepts, Tools, and Techniques to Build Intelligent Systems. O'Reilly Media Inc\": 1, 'Neural Networks for Pattern Recognition': 1, 'Machine Learning: A Probabilistic Perspective': 2, 'Machine Learning in Python: Essential Techniques for Predictive Analysis': 1, 'The COVID-19 outbreak: Potential fallout for sexual and reproductive health and rights': 1, \"Adolescents' and young adults' reports of barriers to confidential health care and receipt of contraceptive services\": 1, 'World Health Organization. Guidelines for the management of sexually transmitted infections': 1, 'The favorable IFNL3 genotype escapes mRNA decay mediated by AU-rich elements and hepatitis C virus-induced microRNAs': 1, 'Interferon-l cures persistent murine norovirus infection in the absence of adaptive immunity': 1, 'Interferon-lambda Mediates Non-redundant': 1, 'Differential Activation of the Transcription Factor IRF1 Underlies the Distinct Immune Responses Elicited by Type I and Type III Interferons': 2, 'Type III interferons disrupt the lung epithelial barrier upon viral recognition': 5, 'Type I and III interferons disrupt lung epithelial repair during recovery from viral infection': 4, 'Interferon-l restricts West Nile virus neuroinvasion by tightening the blood-brain barrier': 2, 'Type III Interferons in Antiviral Defenses at Barrier Surfaces': 2, 'IFN-l suppresses intestinal inflammation by non-translational regulation of neutrophil function': 1, 'Current challenges in lower respiratory infections in children': 1, 'Office pediatrics: current issues in lower respiratory infections in children': 1, 'Emerging viral infections in a rapidly changing world': 2, 'Prevention or control of influenza in the pediatric population': 1, 'Newer respiratory virus infections: human metapneumovirus, avian influenza virus, and human coronaviruses': 1, 'Human metapneumovirus: a not so new virus': 13, 'Clinical impact and diagnosis of human metapneumovirus infection': 12, 'Human metapneumovirus: a new player among respiratory viruses': 12, 'Human metapneumovirus as a major cause of human respiratory tract disease': 16, 'Use of the P gene to genotype human metapneumovirus identifies 4 viral subtypes': 5, 'Human metapneumovirus in otherwise healthy infants and children': 7, 'Impact of human metapneumovirus in childhood: comparison with respiratory syncytial virus and influenza viruses': 12, 'Human metapneumovirus among children hospitalized for acute respiratory illness': 5, 'A 1-year experience with human metapneumovirus in children aged <5 years': 4, 'Changing circulation rate of human metapneumovirus strains and types among hospitalized pediatric patients during three consecutive winter-spring seasons': 5, 'Frequency of human metapneumovirus in the upper respiratory tract of children with symptoms of an acute otitis media': 2, 'Seasonality and clinical features of human metapneumovirus infection in children in Northern Alberta': 1, 'Antigenic and genetic variability of human metapneumovirus': 1, 'Global genetic diversity of human metapneumovirus fusion gene': 3, 'Recombinant human metapneumovirus lacking the small hydrophobic SH and ⁄ or attachment G glycoprotein: deletion of G yields a promising vaccine candidate': 3, 'Dual infection of infants by human metapneumovirus and human respiratory syncytial virus is strongly associated with severe bronchiolitis': 2, 'Prospective study of human metapneumovirus infection in children less than 3 years of age': 1, 'Human metapneumovirus and severity of respiratory syncytial virus disease': 2, 'Do children presenting with lower respiratory infection (LRI) caused by human metapneumovirus (hMPV) differ from those with respiratory syncytial virus (RSV) and influenza A virus (FluA) LRI?': 1, 'Human metapneumovirus detection in patients with severe acute respiratory syndrome': 1, 'Human metapneumovirus associated with atypical pneumonia and SARS': 1, 'Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients': 3, 'Life-threatening human metapneumovirus pneumonia requiring extracorporeal membrane oxygenation in a preterm infant': 2, 'Human metapneumovirus persists in BALB ⁄ c mice despite the presence of neutralizing antibodies': 3, 'The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness': 1, 'Experimental human metapneumovirus infection of cynomolgus macaques (Macaca fascicularis) results in virus replication in ciliated epithelial cells and pneumocytes with associated lesions throughout the respiratory tract': 1, 'Development of a cotton rat-human metapneumovirus (hMPV) model for identifying and evaluating potential hMPV antivirals and vaccines': 1, 'Pathology of human metapneumovirus infection: insights into the pathogenesis of a newly identified respiratory virus': 3, 'Early reinfection with human metapneumovirus in an infant': 1, 'Metapneumovirus and acute wheezing in children': 4, 'Differential production of inflammatory cytokines in primary infection with human metapneumovirus and with other common respiratory virus in infancy': 1, 'Respiratory tract reinfection by the new human metapneumovirus in an immunocompromised child': 2, 'Virological features and clinical manifestation associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory infections in all age groups': 2, 'Molecular assays for the detection of human metapneumovirus': 2, 'Development and validation of an enzyme-linked immunosorbent assay for human metapneumovirus serology based on a recombinant viral protein': 3, 'Seroepidemiology of human metapneumovirus (hMPV) on the basis of a novel enzyme-linked immunosorbent assay utilizing hMPV fusion protein expressed in recombinant vesicular stomatitis virus': 3, 'Detection of human metapneumovirus antigens in nasopharyngeal secretions by an immunofluorescent-antibody test': 1, 'Detection of human metapneumovirus in clinical samples by immunofluorescence staining of shell vial centrifugation cultures prepared from three different cell lines': 1, 'Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro': 1, 'World Health Organization WHO. Pandemic Influenza Preparedness and Response: A WHO Guidance Document': 1, 'COVID-19 pandemic: perspectives on an unfolding crisis': 2, 'Italian society of colorectal surgery recommendations for good clinical practice in colorectal surgery during the novel coronavirus pandemic': 3, 'Inflammatory Bowel Disease (IBD) management by the Association of': 1, 'Consideration for Multidisciplinary Management of Patients with Colorectal Cancer during the COVID-19': 1, 'World Health Organization WHO. Coronavirus disease 2019 (COVID-19) Situation Report -73': 1, 'Unraveling R0: Considerations for Public Health Applications': 1, 'Recomendaciones de gestión para la vuelta a normalidad y \"desescalada\" en los servicios de cirugía general en el contexto de la pandemia COVID-19': 11, 'National Healthcare Safety Network. COVID-19 Module -Patient Impact and Hospital Capacity Pathway': 1, 'Advice on maintaining cancer treatment during the COVID-19 response': 2, 'Prioritising Surgical Treatment in Coronavirus Pandemic \"Salford Score': 1, 'Coronavirus pandemic and Colorectal surgery: practical advice based on the Italian experience': 2, 'American College of Surgeons ACS. COVID-19 and Surgical Procedures: A Guide for Patients': 1, 'Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility': 1, 'Developing screening services for colorectal cancer on Android smartphones': 1, 'Randomized clinical trial of accelerated enhanced recovery after minimally invasive colorectal cancer surgery (RecoverMI trial)': 1, 'Efficacy of physician associate delivered virtual outpatient clinic': 1, 'The Ostom-i™ Alert Sensor: a new device to measure stoma output': 1, 'Telemedicine in postoperative follow-up of STOMa PAtients: a randomized clinical trial (the STOMPA trial)': 1, 'Italy working on coronavirus tracing app to help lockdown exit. Reuters': 1, 'Overview of guidance for endoscopy during the coronavirus disease 2019 (COVID-19) pandemic': 1, 'Guideline for Disinfection and Sterilization in Healthcare Facilities': 1, 'COVID-19: JCST Statement update': 1, 'COVID-19: your wellbeing -Looking after yourself': 2, 'salut-mental-al-personal-de-l-Hospital-Universitari-Vall-d-Hebronenfront-la-COVID-19.pdf (date accessed': 1, 'The effects of COVID-19 on surgeons and patients BJS Cutting Edge Blog': 1, 'supporting-the-mental-wellbeing-of-doctors-and-medical-students (date accessed': 1, 'Advice on the use of masks in the context of COVID-19': 1, 'Microbes Infect': 1, 'ACE inhibtors appear to be safe and beneficial for COVID-19, say researchers': 1, 'COVID-19 CORONAVIRUS OUTBREAK. World Meters': 2, 'Ministry of Health and Medical Education': 2, 'Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China': 1, 'Incidence and case-fatality rates resulting from the 1998 enterovirus 71 outbreak in Taiwan': 1, '2019-novel Coronavirus (2019-nCoV): estimating the case fatality rate-a word of caution': 1, 'Why You Must Act Now. Politicians, community leaders and business leaders: what should you do and when': 1, 'Epidemiological features and trends of Ebola virus disease in West Africa': 1, 'Severe acute respiratory syndrome coronavirus phylogeny: toward consensus': 1, 'Close relationship between SARScoronavirus and group 2 coronavirus': 2, 'Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol': 2, 'Growth and intracellular development of a new respiratory virus': 1, 'Growth in suckling-mouse brain of \"IBV-like\" viruses from patients with upper respiratory tract disease': 1, 'Isolation of rhinoviruses and coronaviruses from 38 colds in adults': 1, 'Human coronaviruses: a brief review': 1, 'Severe acute respiratory syndrome: an update': 1, 'A previously undescribed coronavirus associated with respiratory disease in humans': 1, 'The widening scope of coronaviruses': 1, 'Association between a novel human coronavirus and Kawasaki disease': 1, 'Human coronavirus NL63 is not detected in the respiratory tracts of children with acute Kawasaki disease': 1, 'New human coronavirus, HCoV-NL63, associated with severe lower respiratory tract disease in Australia': 1, 'Human coronavirus NL63 infection in Canada': 1, 'Human coronavirus NL63 infection and other coronavirus infections in children hospitalized with acute respiratory disease in Hong Kong China': 1, 'A prospective hospital-based study of the clinical impact of non-severe acute respiratory syndrome (Non-SARS)-related human coronavirus infection': 2, 'Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia': 2, 'Coronavirus HKU1 infection in the United States': 1, 'Coronavirus HKU1 and other coronavirus infections in Hong Kong': 1, 'Detection of the new human coronavirus HKU1: a report of 6 cases': 1, 'Recombinant protein-based enzyme-linked immunosorbent assay and immunochromatographic tests for detection of immunoglobulin G antibodies to severe acute respiratory syndrome (SARS) coronavirus in SARS patients': 1, 'Comprehensive antibody epitope mapping of the nucleocapsid protein of severe acute respiratory syndrome (SARS) coronavirus: insight into the humoral immunity of SARS': 1, 'Profiles of antibody responses against severe acute respiratory syndrome coronavirus recombinant proteins and their potential use as diagnostic markers': 1, 'Clinical and molecular epidemiological features of coronavirus HKU1-associated communityacquired pneumonia': 1, 'Comparative analysis of 22 coronavirus HKU1 genomes reveals a novel genotype and evidence of natural recombination in coronavirus HKU1': 2, 'Severe acute respiratory syndrome diagnostics using a coronavirus protein microarray': 1, 'Antigenic cross-reactivity between the nucleocapsid protein of severe acute respiratory syndrome (SARS) coronavirus and polyclonal antisera of antigenic group I animal coronaviruses: implication for SARS diagnosis': 2, 'False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid enzyme-linked immunosorbent assay due to HCoV-OC43 and HCoV-229E rectified by Western blotting with recombinant SARS-CoV spike polypeptide': 1, 'Naturally occurring anti-Escherichia coli protein in the sera of healthy humans cause analytical interference in a recombinant nucleocapsid protein-based enzyme-linked immunosorbent essay for serodiagnosis of severe acute respiratory syndrome': 1, 'Retrospective serological investigation of severe acute respiratory syndrome coronavirus antibodies in recruits from mainland China': 1, 'A patient with asymptomatic severe acute respiratory syndrome (SARS) and antigenemia from the 2003-2004 community outbreak of SARS in Guangzhou, China': 1, 'Asymptomatic SARS coronavirus infection among healthcare workers Singapore': 1, 'Vicarious traumatization in the general public, members, and non-members of medical teams aiding in COVID-19 control': 4, 'How doctors gain social and economic returns in online health-care communities: A professional capital perspective': 1, 'Social media and online health services: A health empowerment perspective to online health information': 2, 'The use of social networking sites (SNSs) in health communication campaigns: Review and recommendations': 2, 'Adoption and use of social media among public health departments': 1, 'What motivates physicians to share free health information on online health platforms? Information Processing & Management': 1, \"Exploring factors influencing Chinese user's perceived credibility of health and safety information on Weibo\": 1, \"What sources to rely on? Laypeople's source selection in online health information seeking\": 3, \"The role of perceived e-health literacy in users' continuance intention to use mobile healthcare applications: An exploratory empirical study in China\": 3, 'eHealth literacy: Essential skills for consumer health in a networked world': 3, 'Does the eHealth Literacy Scale (eHEALS) measure what it intends to measure? Validation of a Dutch version of the eHEALS in two adult populations': 4, 'Relationship between parental and adolescent eHealth literacy and online health information seeking in Taiwan': 2, 'Quantifying health literacy and eHealth literacy using existing instruments and browser-based software for tracking online health information seeking behavior': 3, \"The influence of individual differences on consumer's selection of online sources for health information\": 4, 'Diffusion size and structural virality: The effects of message and network features on spreading health information on twitter': 2, 'Attracting views and going viral: How message features and news-sharing channels affect health news diffusion': 2, 'Intentions to trust and share online health rumors: An experiment with medical professionals': 3, 'Reposting negative information on microblogs: Do personality traits matter? Information Processing & Management': 2, 'What makes online content viral': 3, 'The role of emotions and social cognitive variables in online health information seeking processes and effects': 1, \"The influence of prior beliefs, frequency cues, and magnitude cues on consumers' perceptions of comparative price data\": 1, 'Confirmation bias in sequential information search after preliminary decisions: An expansion of dissonance theoretical research on selective exposure to information': 2, 'When do consumers value positive vs. negative reviews? An empirical investigation of confirmation bias in online word of mouth': 6, 'Overcoming bias to learn about controversial topics': 4, 'Confirmation bias in online searches: Impacts of selective exposure before an election on political attitude strength and shifts': 3, 'Preelection selective exposure: Confirmation bias versus informational utility': 3, 'Sharing health information and influencing behavioral intentions: The role of health literacy, information overload, and the Internet in the diffusion of healthy heart information': 2, 'Distance students and online research: Promoting information literacy through media literacy. The Internet and Higher Education': 2, 'Exploring an adverse impact of smartphone overuse on academic performance via health issues: A stimulus-organism-response perspective': 2, 'Health literacy as a public health goal: A challenge for contemporary health education and communication strategies into the 21st century': 1, 'Consumer health information needs: A systematic review of measures': 2, 'Online health information seeking and eHealth Literacy among patients attending a primary care clinic in Hong Kong: A crosssectional survey': 2, 'Cognitive factors of using health apps: Systematic analysis of relationships among health consciousness, health information orientation, eHealth literacy, and health app use efficacy': 1, 'Information tailoring and framing in wearable health communication': 1, 'Exploring the online doctor-patient interaction on patient satisfaction based on text mining and empirical analysis': 1, 'The influence of affective cues on positive emotion in predicting instant information sharing on microblogs: Gender as a moderator': 1, 'How attitude strength biases information processing and evaluation on the web?': 1, 'Feeling torn and fearing rue: Attitude ambivalence and anticipated regret as antecedents of biased information seeking': 1, 'How young is too young to use social media?': 1, 'Harnessing social media for health promotion and behavior change': 1, 'Urbanisation and health in China': 1, 'Mental health of young people: A global public-health challenge': 1, 'It would be weird to have that on Facebook\": Young people\\'s use of social media and the risk of sharing sexual health information': 2, 'Belief updating and the demand for information': 1, 'Trust in online hotel reviews across review polarity and hotel category': 1, 'The research design maze: Understanding paradigms, cases, methods and methodologies': 1, 'How low should you go? Low response rates and the validity of inference in IS questionnaire research': 1, \"Comparing the web and mobile platforms of a social Q&A service from the user's perspective\": 1, 'Effects of conflicting aggregated rating on eWOM review credibility and diagnosticity: The moderating role of review valence': 2, \"Influence of firm's recovery endeavors upon privacy breach on online customer behavior\": 1, 'Designing experiments and analyzing data: A model comparison perspective': 2, 'To share or not to share: The role of epistemic belief in online health rumors': 1, 'Health risks among travellers e need for regular updates': 1, 'Pre-travel health adviceseeking behavior among US international travelers departing from Boston Logan international airport': 1, 'Travel clinic consultation and risk assessment': 1, \"Guidelines for the prevention and treatment of travelers' diarrhea: a graded expert panel report\": 1, '104e10. FURTHER READING Lalloo DG, Hill DR. Preventing malaria in travellers': 1, 'The non-specific and sex-differential effects of vaccines': 1, 'Relation between BCG coverage rate and COVID-19 infection worldwide': 1, 'Is BCG vaccination affecting the spread and severity of COVID-19?': 1, 'Empirical Tests of the Validity of the Regression Discontinuity Design': 1, 'When does regression discontinuity design work? Evidence from random election outcomes': 1, 'The impact of changing BCG coverage on tuberculosis incidence in Swedish-born children between 1969 and 1989': 2, 'Regression discontinuity designs: A guide to practice': 1, 'Robust Nonparametric Confidence Intervals for Regression-Discontinuity Designs': 1, 'Robust Data-Driven Inference in the Regression-Discontinuity Design': 1, 'What is meant by intention to treat analysis? Survey of published randomised controlled trials': 1, 'Identification and Estimation of Local Average Treatment Effects': 1, 'Global shortages of BCG vaccine and tuberculous meningitis in children': 1, 'Costs of disorders of the brain in Europe. Executive summary': 1, 'A conceptual introduction to geriatric neuroscience': 5, \"The clinical and costeffectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease\": 2, 'Pharmacological treatment of Alzheimer disease: from phychotropic drugs and cholinesterase inhibitors to pharmacogenomics': 4, \"Pharmacogenomics in Alzheimer's disease\": 57, 'Pharmacogenomics for the treatment of dementia': 4, 'Pharmacogenetics and drug development: the path to safer and more effective drugs': 2, \"Molecular genetics of Alzheimer's disease and aging\": 27, 'Molecular genetics of bipolar disorder and depression': 2, 'Confounding in genetic association studies and its solutions': 2, 'Molecular genetics of schizophrenia: a critical review': 2, 'Lifespan and mitochondrial control of neurodegeneration': 1, \"High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain\": 1, \"The application of functional genomics to Alzheimer's disease\": 20, \"Pharmacogenomics and therapeutic prospects in Alzheimer's disease\": 21, \"Pharmacogenomics, nutrigenomics and therapeutic optimization in Alzheimer's disease\": 37, \"Pharmacogenomics, nutrigenomics and future therapeutics in Alzheimer's disease\": 45, \"Cerebrovascular risk factors in Alzheimer's disease: brain hemodynamics and pharmacogenomic implications\": 15, 'Phenotypic profi les and functional genomics in dementia with a vascular component': 15, 'High throughput protein expression screening in the nervous system -needs and limitations': 1, 'Gene expression atlas of the mouse central nervous system: impact and interactions of age, energy intake and gender': 1, 'Subtelomeric study of 132 patients with mental retardation reveals 9 chromosomal anomalies and contributes to the delineation of submicroscopic deletions of 1pter, 2qter, 4pter, 5qter and 9qter': 1, 'The functional genome of CA1 and CA3 neurons under native conditions and in response to ischemia': 1, 'Fibroblast and lymphoblast gene expression profi les in schizophrenia : are non-neural cells informative ?': 1, 'Runs of homozygosity reveal highly penetrant recessive loci in schizophrenia': 1, 'The use of microarrays to characterize neuropsychiatric disorders: post-mortem studies of substance abuse and schizophrenia': 1, 'High-throughput analysis of promoter occupancy reveals direct neuronal targets of FOXP2, a gene mutated in speech and language disorders': 1, \"Microarray analysis of oxidative stress regulated genes in mesencephalic dopaminergic neuronal cells: relevance to oxidative damage in Parkinson's disease\": 1, \"Towards a pathway defi nition of Parkinson's disease: a complex disorder with links to cancer, diabetes and infl ammation\": 1, \"Analysis of potential transcriptomic biomarkers for Huntington's disease in peripheral blood\": 1, 'Comprehensive transcriptional profi ling of prion infection in mouse models reveals networks of responsive genes': 1, 'Transcriptional profi ling in human epilepsy: expression array and single cell real-time qRT-PCR analysis reveal distinct cellular gene regulation': 1, 'Molecular profi ling of temporal lobe epilepsy: comparison of data from human tissue and animal models': 1, 'The antiepileptic drug levetiracetam selectively modifi es kindling-induced alterations in gene expression in the temporal lobe of rats': 2, 'Increased apoptosis, p53 up-regulation, and cerebellar neuronal degeneration in repair-defi cient Cockayne syndrome mice': 1, 'Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett síndrome': 1, 'HDAC inhibitors correct frataxin defi ciency in a Friedreich ataxia mouse model': 1, 'Gene expression profi ling in a Mouse model of infantile neuronal lipofuscinosis reveals upregulation of immediate early genes and mediators of the infl ammatory response': 1, 'Multiple sclerosis as a generalized CNS disease -comparative microarray analysis of normal appearing white matter and lesions in secondary progressive MS': 1, 'Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis': 1, 'Gene expression in cortex and hippocampus during acute pneumococcal meningitis': 1, 'Role of lipids in brain injury and diseases': 1, 'Expression profi le analysis of neurodegenerative disease: advances in specifi city and resolution': 1, 'Methodological considerations regarding single-cell gene expression profi ling for brain injury': 1, 'Genotoxicants target distinct molecular networks in neonatal neurons': 1, 'Functional gene expression differences between inbred alcohol-preferring and -non-prerats in fi ve brain regions': 1, 'Neuroadaptations in human chronic alcoholics: tion of the NF-κB system': 1, 'Gene expression profi le of the nucleus accumbens of human cocaine abusers : evidence for dysregulation of myelin': 1, 'Transcriptional changes common to human cocaine, cannabis and phencyclidine abuse': 1, 'MicroRNA expression in the adult mouse central nervous system': 1, \"A pharmacogenomic approach to Alzheimer's disease\": 2, 'Clinical Psychiatry. Jobe TH': 2, 'Genomics and phenotypic profi les in dementia: implications for pharmacological treatment': 5, 'A functional genomics approach to the analysis of biological markers in Alzheimer disease': 8, \"Genomic characterization of Alzheimer's disease and genotype-related phenotypic analysis of biological markers in dementia\": 6, 'The histamine-cytokine network in Alzheimer disease: etiopathogenic and pharmacogenomic implications': 1, 'Histamine function in brain disorders': 1, \"Histamine in Alzheimer's disease pathogenesis: biochemistry and functional genomics\": 1, \"Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer's disease individuals\": 1, 'International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome': 1, \"Pharmacogenetics and pharmacogenomics. In: Emery and Rimoin's Principles and Practice of Medical Genetics. 4th Edn\": 2, 'Pharmacogenomics: the inherited basis for interindividual differences in drug response': 2, 'Pharmacogenetics and pharmacogenomics: development, science, and translation': 3, 'Pharmacogenomics and therapeutic prospect in dementia': 28, \"Pharmacogenetic basis for therapeutic optimization in Alzheimer's disease\": 28, \"Infl uence of pharmacogenetic factors on Alzheimer's disease therapeutics\": 21, \"Pharmacogenetic aspects of therapy with cholinesterase inhibitors: the role of CYP2D6 in Alzheimer's disease pharmacogenetics\": 26, 'From pharmacogenetics and ecogenetics to pharmacogenomics': 2, 'Inheritance and drug response': 3, 'Pharmacogenomics-Drug disposition, drug targets, and side effects': 3, 'National estimates of medication use in nursing homes': 1, 'Antidepressant drugs prescribing among elderly subjects: a population-based study': 1, 'Potentially inappropriate medication use among elderly home care patients in Europe': 1, 'Potentially inappropriate medication use by elderly persons in U.S. Health Maintenance Organizations': 1, 'The Metabolic & Molecular Bases of Inherited Disease': 2, 'DNA sequence variations in a 3.7-kb noncoding sequence 5-prime of the CYP1A2 gene: implications for human population history and natural selection': 1, 'PM frequencies of major CYPs in Asians and Caucasians': 2, 'Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population': 1, 'CYP2C9 allelic variants: ethnic distribution and functional signifi cance': 2, 'Identifi cation and functional characterization of a new CYP2C9 variant (CYP2C9 * 5 1 ) expressed among African Americans': 2, 'Molecular basis of ethnic differences in drug disposition and response': 3, 'Isolation, sequence and genotyping of the drug metabolizer CYP2D6 gene in the Colombian population': 4, 'Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes': 2, 'Cytochrome P450 in the brain: a review': 4, 'The expression of CYP2B6, CYP2C9 and CYP2A4 genes: a tangle of networks of nuclear and steroid receptors': 1, 'Catalog of 680 variants among eight cytochrome P450 (CYP) genes: nine esterase genes, and two other genes in the Japanese population': 1, 'The CYP2C19 enzyme polymorphism': 1, 'Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences': 3, 'Clinically signifi cant drug interactions with cholinesterase inhibitors: a guide for neurologists': 2, 'Assessment of the predictive power of genotypes for the in-vivo catalytic function of CYP2D6 in a German population': 1, 'Ten percent of North Spanish individuals carry duplicated or triplicated CYP2D6 genes associated with ultrarapid metabolism of debrisoquine': 1, 'Clinical pharmacokinetics of galantamine': 1, \"Impact of the CYP2D6 polymorphism on steady-state plasma concentrations and clinical outcome of donepezil in Alzheimer's disease patients\": 1, \"Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety, and depression\": 20, \"Pharmacogenomic studies with a combination therapy in Alzheimer's disease\": 5, 'Interethnic differences in genetic polymorphisms of CYP2D6 in the U.S. population: clinical implications': 1, 'Effects of cholinergic markers in rat brain and blood after short and prolonged administration of donepezil': 1, 'The O-demethylation of the antidementia drug galantamine is catalyzed by cytochrome P450 2D6': 1, \"Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacology\": 1, 'Galantamine pharmacokinetics, safety, and tolerability profi les are similar in healthy Caucasian and Japanese subjects': 1, \"Pharmacokinetics and drug interactions of cholinesterase inhibitors administered in Alzheimer's disease\": 1, 'The metabolism and excretion of galantamine in rats, dogs, and humans': 1, 'Prevalence of potentially inappropriate medication use in elderly patients. Comparison between general medicine and geriatric wards': 2, 'PharGKB update: II. CYP3A5, cytochrome P450, family 3, subfamily A, polypeptide 5': 1, 'Genomics and the future of pharmacotherapy in psychiatry': 3, 'CYP2D6 polymorphism: implications for antipsychotic drug response, schizophrenia and personality traits': 1, 'Cytochrome P450 polymorphisms and response to antipsychotic therapy': 1, 'Infl uence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects': 1, 'Pharmacogenomics in schizophrenia: the quest for individualized therapy': 1, 'The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment': 1, 'Dopamine D4 receptor gene exon III polymorphism and interindividual variation in response to clozapine': 1, 'Association between multidrug resistance 1 (MDR1) gene polymorphism and therapeutic response to bromperidol in schizophrenic patients: a preliminary study': 1, 'Genetic susceptibility to tardive dyskinesia among schizophrenia subjects: IV. Role of dopaminergic pathway gene polymorphisms': 1, 'DRD2 promoter region variation as a predictor of sustained response to antipsychotic medication in fi rst-episode schizophrenic patients': 1, 'The relationship between P-glycoprotein (PGP) polymorphisms and response to olanzapine treatment in schizophrenia': 1, 'Polymorphisms of the ABCB1 gene are associated with the therapeutic response to risperidone in Chinese schizophrenia patients': 1, 'Systematic investigation of genetic variability in 111 human genes -implications for studying variable drug response': 1, 'Pharmacogenetics of psychotropic drug response': 2, 'Pharmaco-Genomics Handbook. 2nd Edn. Lexi-Comp': 1, 'Drug Information Handbook with International Trade Names Index. 17th Edn. Lexi-Comp': 1, 'Drug Information Handbook for Psychiatry. 6th Edn. Lexi-Comp': 1, 'Individualizing antipsychotic drug therapy in schizophrenia: the promise of pharmacogenetics': 1, 'Pharmacogenetics and schizophrenia': 1, 'Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research': 1, 'Phosphodiesterase genes are associated with susceptibility to major depression and antidepressant treatment response': 1, 'Variation in the purinergic P2RX(7) receptor gene and schizophrenia': 1, 'The CNR1 gene as a pharmacogenetic factor for antipsychotics rather than a susceptibility gene for schizophrenia': 1, 'Druginduced activation of SREP-controlled lipogenic gene expression in CNS-related cell lines: marked differences between various antipsychotic drugs': 1, 'Further evidence for association of the RGS2 gene with antipsychoticinduced parkinsonism: protective role of a functional polymorphism in the 3′-untranslated region': 1, 'Ethnic stratifi cation of the association of RGS4 variants with antipsychotic treatment response in schizophrenia': 1, 'Pharmacogenetic assessment of antipsychotic-induced movement disorders: contribution of the dopamine D3 receptor and cytochrome P450 1A2 genes': 1, 'Association between CYP2D6 genotype and tardive dyskinesia in Korean schizophrenics': 1, 'Haplotype analysis of endothelial nitric oxide synthase (NOS3) genetic variants and tardive dyskinesia in patients with schizophrenia': 1, 'Could HTR2A T102C and DRD3 Ser9Gly predict clinical improvement in patients with acutely exacerbated schizophrenia? Results from treatment responses to risperidone in a naturalistic setting': 1, 'The -1019 C/G polymorphism of the 5-HT1A receptor gene is associated with negative symptom response to risperidone treatment in schizophrenia patients': 1, 'Interaction between NOTCH4 and catechol-O-methyltransferase genotypes in schizophrenia patients with poor response to typical neuroleptics': 1, 'Effect of a ciliary neurotrophic factor polymorphism on schizophrenia symptom improvement in an iloperidone clinical trial': 1, 'Association of the dopamine receptor interacting protein gene, NEF3, with early response to antipsychotic medication': 1, 'Pharmacogenetic study of atypical antipsychotic drug response : involvement of the norepinephrine transporter gene': 1, 'Association of clozapineinduced weight gain with a polymorphism in the leptin promoter region in patients with chronic schizophrenia in a Chinese population': 1, 'Leptin and leptin receptor gene polymorphisms and increases in body mass index (BMI) from olanzapine treatment in persons with schizophrenia': 1, 'Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a fi rst-episode psicosis': 1, 'Transcriptional profi ling of the rat frontal cortex following administration of the mGlu5 antagonists MPEP and MTEP': 1, 'Association of GRIK4 with outcome of antidepressant treatment in the STAR * D cohort': 1, 'Glycogen synthase kinase-3beta gene is associated with antidepressant treatment response in Chinese major depressive disorder': 1, 'Lithium response and genetic variation in the CREB family of genes': 1, \"The medial and lateral substantia nigra in Parkinson's disease: mRNA profi les associated with higher brain tissue vulnerability\": 1, 'Phosphoproteome and transcriptome analysis of the neuronal response to a CDK5 inhibitor': 1, 'Allelic mRNA expression of X-linked monoamine oxidase A (MAOA) in human brain : dissection of epigenetic and genetic factors': 1, 'Epigenetics and its implications for behavioural neuroendocrinology': 2, 'Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines': 1, 'Epigenetic alterations of the dopaminergic system in major psychiatric disorders': 1, 'Central Nervous system drug development: an integrative biomarker approach toward individualized medicine': 1, \"Pleiotropic effects of APOE in dementia: infl uence on functional genomics and pharmacogenetics. In: Advances in Alzheimer's and Parkinson's disease. Insights, Progress, and Perspectives\": 2, 'APOE-Related dementia symptoms: frequency and progression': 1, 'APOE-Related frequency of cognitive and noncognitive symptoms in dementia': 1, 'Behavioral changes associated with different apolipoprotein E genotypes in dementia': 1, 'Polymorphisms in the angiotensin-converting enzyme gene are associated with unipolar depression, ACE activity and hypercortisolism': 1, 'Apolipoprotein E gene polymorphism in early and late onset bipolar patients': 1, 'Angiotensinrelated genes in patients with panic disorder': 1, 'Risk factors for neuropsychiatric symptoms in dementia : the Cache County Study': 1, 'Apolipoprotein E genotype infl uences presence and severity of delusions and aggressive behavior in Alzheimer disease': 1, \"Depression in Alzheimer's disease might be associated with apolipoprotein E epsilon 4 allele frequency in women but not in men\": 1, \"Four components describe behavioral symptoms in 1,120 individuals with late-onset Alzheimer's disease\": 1, \"Association analysis of apolipoprotein E genotype and risk of depressive symptoms in Alzheimer's disease\": 1, \"Behavioural pathology in Alzheimer's disease with special reference to apolipoprotein E genotype\": 1, 'Apolipoprotein E genotype and major depression in a community of older adults. The Cache County Study': 1, 'Protective effect of the Apoε2 allele in major depressive disorder in Taiwanese': 1, 'APOE is associated with age-of-onset, but not cognitive functioning, in late-life depression': 1, 'ApoE isoforms and measures of anxiety in probable AD patients and Apoe-/-mice': 1, 'Differences in anxietyrelated behaviour between apolipoprotein E-defi cient C57BL/6 and wild type C57BL/6 mice': 1, 'Role of H3-receptor-mediated signaling in anxiety and cognition in wild-type and Apoe-/-mice': 1, 'Relationship of deep white matter hyperintensities and apolipoprotein E genotype to depressive symptoms in older adults without clinical depression': 1, 'Caudate nucleus volumes and genetic determinants of homocysteine metabolism in the prediction of psychomotor speed in older persons with depression': 1, 'A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects': 1, 'Reduced hippocapal volumes and memory loss in patients with early-and late-onset depression': 1, 'Vascular/risk and late-life depression in a Korean community population': 1, 'Measuring the value of pharmacogenomics': 1, 'Pharmacological treatment of neuropsychiatric symptoms of dementia. A review of the evidence': 1, \"Memantine in moderate-to-severe Alzheimer's disease\": 1, \"Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study\": 1, \"Donepezil for severe Alzheimer's disease\": 1, 'Priorities and standards in pharmacogenetic research': 1, 'Genomic screening and replication using the same data set in familybased association testing': 1, 'Pharm acogenomics and individualized drug therapy': 1, 'Ethical considerations in the use of DNA for the diagnosis of disease': 1, 'Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clinical infectious diseases: an official publication of the': 1, 'Odds FC (1988) Candida and candidosis: a review and bibliography': 1, 'Aetiology and management: a review. Part 2. Oral diseases caused by Candida species': 1, 'Oral candidiasis': 4, 'Candida biofilms and their role in infection': 3, 'Epidemiology and etiology of denture stomatitis': 4, 'Virulence factors of Candida albicans': 1, 'Growth of Candida albicans hyphae': 1, 'Denture stomatitis: a role for Candida biofilms. Oral surgery, oral medicine, oral pathology': 2, 'Biofilm lifestyle of Candida: a mini review': 1, 'Epidemiology of Candida species infections in critically ill non-immunosuppressed patients': 1, 'Candida species bloodstream infection: epidemiology and outcome in a single institution from 1991 to': 1, 'Epidemiology of invasive candidiasis: a persistent public health problem': 1, 'Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options': 1, 'Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program': 1, 'Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance': 1, 'An insight into the antifungal pipeline: selected new molecules and beyond': 1, 'Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment': 1, 'Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation': 1, 'Management of invasive fungal infections: a role for polyenes': 1, 'Persistent Candida albicans colonization and molecular mechanisms of azole resistance in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients': 1, 'Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact': 1, 'Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistance': 1, 'At what cost echinocandin resistance': 1, 'Antifungal susceptibility and virulence attributes of bloodstream isolates of Candida from Hong Kong and Finland': 2, 'Emergence of a Candida krusei isolate with reduced susceptibility to caspofungin during therapy': 1, 'Antibacterial and antifungal drug discovery': 1, 'Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics': 1, 'Small-molecule inhibitors of the budded-to-hyphal-form transition in the pathogenic yeast Candida albicans': 3, 'An amino acid liquid synthetic medium for the development of mycelial and yeast forms of Candida albicans': 1, 'Reference method for broth dilution antifungal susceptibility testing of yeasts': 1, 'Biofilmforming ability of Candida albicans is unlikely to contribute to high levels of oral yeast carriage in cases of human immunodeficiency virus infection': 1, 'Improvement of XTT assay performance for studies involving Candida albicans biofilms': 1, 'Adhesion of oral Candida albicans isolates to denture acrylic following limited exposure to antifungal agents': 1, 'Antifungal resistance of candidal biofilms formed on denture acrylic in vitro': 1, 'Biofilm formation of Candida albicans is variably affected by saliva and dietary sugars': 2, 'Rapid screening method for compounds that affect the growth and germination of Candida albicans, using a real-time PCR thermocycler': 1, 'In vitro activity of E1210, a novel antifungal, against clinically important yeasts and molds': 1, 'Organ-specific innate immune responses in a mouse model of invasive candidiasis': 2, 'A novel murine model of oral candidiasis with local symptoms characteristic of oral thrush': 2, 'Protective effects of human saliva on experimental murine oral candidiasis': 1, 'Rapid flow cytometric susceptibility testing of Candida albicans': 1, 'Inhibitors of cellular signalling are cytotoxic or block the budded-to-hyphal transition in the pathogenic yeast Candida albicans': 1, 'Novel highthroughput screen against Candida albicans identifies antifungal potentiators and agents effective against biofilms': 2, 'Small molecule inhibitors of the Candida albicans budded-to-hyphal transition act through multiple signaling pathways': 2, 'Small-molecule inhibitors of biofilm formation in laboratory and clinical isolates of Candida albicans': 1, 'Nonfilamentous C. albicans mutants are avirulent': 1, 'Effects of imidazole-and triazole-derivative antifungal compounds on the growth and morphological development of Candida albicans hyphae': 1, 'Comparisons of the effects of fungicidal and fungistatic antifungal agents on the morphogenetic transformation of Candida albicans': 2, 'Antifungal susceptibility testing': 1, \"Amphotericin B: time for a new ''gold standard''. Clinical infectious diseases: an official publication of the\": 1, 'Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance': 1, 'Antifungal drug discovery, six new molecules patented after 10 years of feast: why do we need new patented drugs apart from new strategies?': 1, 'Pharmacodynamics of fluconazole in a murine model of systemic candidiasis': 1, 'Comparison of the efficacies of amphotericin B, fluconazole, and itraconazole against a systemic Candida albicans infection in normal and neutropenic mice': 2, 'Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis': 1, 'Animal model pharmacokinetics and pharmacodynamics: a critical review': 1, 'Challenges for NHS hospitals during covid-19 epidemic': 1, 'Microbiology of tracheal secretions: what to expect with children and adolescents with tracheostomies': 1, 'Vocal cord dysfunction in bronchial asthma. A review article': 1, 'Speech and Language Therapy Led Endoscopic Procedures in the COVID-19 Pandemic': 2, 'Randomized controlled trial of a multisite speech pathology telepractice service providing swallowing and communication intervention to patients with head and neck cancer: evaluation of service outcomes': 1, 'Clinical practice guideline: hoarseness (dysphonia) (update). Otolaryngology-Head and Neck Surgery': 1, 'Laryngeal injury and upper airway symptoms after oral endotracheal intubation with mechanical ventilation during critical care: a systematic review': 3, 'Speech and language therapy for management of chronic cough': 1, 'Rapid implementation of an evidencebased remote triaging system for assessment of suspected referrals and patients with head and neck cancer on follow-up after treatment during the COVID-19 pandemic: Model for international collaboration': 2, 'Head and neck oncology during the COVID-19 pandemic: reconsidering traditional treatment paradigms in light of new surgical and other multilevel risks': 2, 'Long-term outcomes after surgical or nonsurgical initial therapy for patients with T4 squamous cell carcinoma of the larynx: a 3-decade survey': 1, 'Swallowing outcomes following surgical and non-surgical treatment for advanced laryngeal cancer': 1, 'Speech and swallowing following tongue cancer surgery and free flap reconstruction-a systematic review': 2, \"Dysphagia after nonsurgical head and neck cancer treatment: patients' perspectives\": 1, 'Management of benign vocal fold lesions: current perspectives on the role for voice therapy. Current Opinion in Otolaryngology Head and Neck Surgery': 1, 'Laryngeal oedema associated with COVID-19 complicating airway management': 1, 'Cover-body theory of vocal fold vibration': 1, 'Features of mild-to-moderate COVID-19 patients with dysphonia': 1, 'Psychological stress and vocal symptoms among university professors in Israel: implications of the shift to online synchronous teaching during the COVID-19 pandemic': 1, 'Impact of dysphagia severity on clinical decision making via telerehabilitation': 1, 'Predicting the difficult airway': 1, 'Nebulizer use in adults with subglottic stenosis: a survey study': 1, 'Voice and swallowing outcomes for adults undergoing reconstructive surgery for laryngotracheal stenosis. Current Opinion in Otolaryngology and Head and Neck Surgery': 1, 'Self-care for doctors during the COVID-19 crisis': 1, 'Influenza A in immunocompromised patients': 5, 'Respiratory virus infections in adults with hematologic malignancies: a prospective study': 2, 'Risk factors for pneumonia in immunocompromised patients with influenza': 4, 'Outbreak of swine-origin influenza A (H1N1) virus infection-Mexico': 1, 'Hospitalized patients with novel influenza A (H1N1) virus infection-California': 3, 'H1N1 influenza in the United States': 3, 'Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy': 5, 'Influenza virus infection in adult solid organ transplant recipients': 4, 'A prediction rule to identify low-risk patients with community-acquired pneumonia': 1, 'Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study': 1, 'Emergence of a novel swine-origin influenza A (H1N1) virus in humans': 2, 'Clinical characteristics of paediatric H1N1 admissions in Birmingham': 1, 'Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection': 1, 'H1n1 influenza infection in cancer patients and hematopoietic stem cell transplant recipients': 1, 'The clinical impact of infection with Swine flu (H1N1 09) strain of influenza virus in hematopoietic stem cell transplant recipients': 1, 'Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study': 2, 'Respiratory syncytial virus infection in immunocompromised adults': 2, 'The challenge of respiratory virus infections in hematopoietic cell transplant recipients': 1, 'Association between severe pandemic 2009 influenza A (H1N1) virus infection and immunoglobulin G(2) subclass deficiency': 1, 'Impact of corticosteroid treatment and antiviral therapy on clinical outcomes in hematopoietic cell transplant patients infected with influenza virus': 2, 'Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1)-United States': 1, 'Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections': 2, 'Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenza': 1, 'Antiviral treatment for patients hospitalized with severe influenza infection may affect clinical outcomes': 1, 'Olfactory and gustatory dysfunctions as a clinical presentation of mild-tomoderate forms of the coronavirus disease (COVID-19): a multicenter European study': 2, 'Clinical and epidemiological characteristics of 1,420 european patients with mildto-moderate coronavirus disease 2019': 5, 'Acute-onset smell and taste disorders in the context of COVID-19: a pilot multicenter PCR-based case-control study': 1, 'New onset of loss of smell or taste in household contacts of home-isolated SARS-CoV-2-positive subjects': 1, 'Neurologic manifestations of hospitalized patients with coronavirus disease': 8, 'Bilateral transient olfactory bulbs edema during COVID-19-related anosmia': 1, 'Sars-cov-2: olfaction, brain infection, and the urgent need for clinical samples allowing earlier virus detection': 1, 'Novel coronavirus infection (COVID-19) in humans: a scoping review and meta-analysis': 1, 'Headaches during COVID-19: my clinical case and review of the literature': 1, 'Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study': 3, 'Neurologic features in severe sars-cov-2 infection': 3, 'Nervous system involvement after infection with COVID-19 and other coronaviruses': 2, 'COVID-19: ICU delirium management during sars-cov-2 pandemic': 1, 'Characteristics, symptom management and outcomes of 101 patients with COVID-19 referred for hospital palliative care': 1, 'Hyperactive delirium requires more aggressive management in patients with COVID-19: temporarily rethinking \"low and slow': 1, 'Delirium in critically ill patients': 1, 'Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in': 4, 'COVID-19 related neuroimaging findings: a signal of thromboembolic complications and a strong prognostic marker of poor patient outcome': 1, 'Emergency room neurology in times of COVID-19: malignant ischemic stroke and sars-cov2 infection': 1, 'Characteristics of ischaemic stroke associated with COVID-19': 1, 'Large-vessel stroke as a presenting feature of COVID-19 in the young': 1, 'Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in': 2, 'The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome': 2, 'Analysis of coagulation parameters in patients with COVID-19 in': 1, 'The baffling case of ischemic stroke disappearance from the casualty department in the COVID-19 era': 1, 'Triage of acute ischemic stroke in confirmed COVID-19: large vessel occlusion associated with coronavirus infection': 1, 'Acute cerebral stroke with multiple infarctions and COVID-19': 1, 'Ischaemic stroke and SARS-CoV-2 infection: a causal or incidental association?': 1, 'Stroke in a young COVID -19 patient': 1, 'Stroke in patients with SARS-CoV-2 infection: case series': 1, 'Coexistence of COVID-19 and acute ischemic stroke report of four cases': 1, 'Cerebrovascular disease in COVID-19': 1, 'Acute ischemic stroke complicating common carotid artery thrombosis during a severe COVID-19 infection': 1, 'Protected code stroke: hyperacute stroke management during the coronavirus disease': 1, 'Steroid-responsive encephalitis in COVID-19 disease': 1, 'Neuroleptic Malignant Syndrome in a COVID-19 patient': 1, 'Acute transverse myelitis after COVID-19 pneumonia': 1, 'Neurologic manifestations in an infant with COVID-19': 1, 'Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology': 2, 'A first case of meningitis/encephalitis associated with sars-coronavirus-2': 1, 'SARS-CoV-2 detected in cerebrospinal fluid by PCR in a case of COVID-19 encephalitis': 1, 'Central nervous system manifestations of COVID-19: a systematic review': 1, 'Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study': 1, 'COVID-19 and neuromuscular disorders': 4, 'Guillain-Barre syndrome related to COVID-19 infection': 1, 'Guillain-Barre syndrome associated with sars-cov-2 infection: causality or coincidence?': 1, 'Early Guillain-Barré syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital': 1, 'SARS-CoV-2 associated Guillain-Barre Syndrome with dysautonomia. Muscle Nerve': 1, 'Guillain-Barré syndrome in the COVID-19 era: just an occasional cluster?': 1, 'Acute polyradiculoneuritis with locked-in syndrome in a patient with COVID-19': 1, 'Guillain-Barre syndrome associated with COVID-19 infection: a case report': 1, 'Miller fisher syndrome and polyneuritis cranialis in COVID-19': 1, 'COVID-19 presenting with ophthalmoparesis from cranial nerve palsy': 1, 'Guillain-Barré syndrome associated with SARS-CoV-2': 3, 'Guillain-Barre syndrome': 1, 'Acute neurology during the COVID-19 pandemic: supporting the front line': 1, 'Myasthenic crisis in COVID-19': 1, 'Amyotrophic lateral sclerosis care and research in the USA during the COVID-19 pandemic: challenges and opportunities. Muscle Nerve': 1, 'Feasibility of real-time internet-based teleconsultation in patients with multiple sclerosis: interventional pilot study': 1, 'Practical guidance for managing EMG requests and testing during the COVID-19 pandemic': 1, 'Scoping review of prevalence of neurologic comorbidities in patients hospitalized for COVID-19': 1, 'Cerebrovascular disease is associated with an increased disease severity in patients with coronavirus disease 2019 (COVID-19): a pooled analysis of published literature': 1, 'Neurologic complications of coronavirus infections': 1, 'Neurological implications of COVID-19 infections': 1, 'The spectrum of neurologic disease in the severe acute respiratory syndrome coronavirus 2 pandemic infection: neurologists move to the frontlines': 1, 'The neuroinvasive potential of sars-cov2 may play a role in the respiratory failure of COVID-19 patients': 1, 'Respiratory failure alone does not suggest central nervous system invasion by sars-cov-2': 1, 'Status of sars-cov-2 in cerebrospinal fluid of patients with COVID-19 and stroke': 1, 'Neurological manifestations of the coronavirus (sars-cov-2) pandemic 2019-2020': 1, 'Temperature-sensitive mutants of fowl plaque virus defective in the intracellutar transport of hemagglutinin': 1, 'Partial characterization of temperature-sensitive mutants of pseudorabies virus': 1, 'Isolation and characterization of a temperature-sensitive uncoating mutant of pseudorabies virus': 1, 'A temperature-sensitive mutant ofpoliovirus type 1 altered in capsid assembly': 1, 'Preliminary characterization of Coxsackie virus B 3 temperature-sensitive mutants': 2, 'Nuclear accumulation of measles virus nucleoprotein associated with a temperature-sensitive mutant': 1, 'Induction of demyelination by a temperature-sensitive mutant of the coronavirus MHV-A59 is associated with restriction of viral replication in the brain': 1, 'Replication process of the parvovirus H-1. V. Isolation and characterization of temperature-sensitive H-1 mutants defective in progeny DNA synthesis': 1, 'Isolation and characterization of thermosensitive mutants from Kilham rat virus, a rodent parvovirus': 1, 'Establishment of an attenuated strain of porcine parvovirus by serial passage at low temperature': 2, 'Establishment of the attenuated strain of porcine parvovirus for the live vaccine and its biological-immunological characteristics': 2, 'Porcine parvovirus DNA: characterization of the genomic and replicative form DNA of two virus isolates': 1, 'Parvovirus infection in pigs with necrotic and vesicle-like lesions': 1, 'Porcine parvovirus: virus purification and structural and antigenic properties of virus polypeptides': 4, 'b) Rapid diagnostic techniques for detection of parvovirus infection in mummified fetuses': 1, 'Covalent association of protein with replicative form DNA of parvovirus H-1': 1, 'Porcine parvovirus: replication in and inhibition of selected cellular functions of swine alveolar macrophages and peripheral blood lymphocytes': 2, 'Inhibition of porcine parvovirus replication by empty particles': 1, 'Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients. Can': 1, 'Telemedicine in the Era of COVID-19': 2, 'Factors associated with mental health outcomes among health care workers exposed to coronavirus disease 2019': 1, \"Use of rapid online surveys to assess people's perceptions during infections disease outbreaks: A cross sectional survey of COIVD-19\": 1, 'A mnrine virus (JHM) causing disseminated encephalomyelitis with extensive destruction of myelin': 1, 'Adoptive transfer of EAE-like lesions from rats with coronavirus-induced demyelinating encephalomyelitis': 1, 'Viral particles induce Ia antigen expression on astrocytes': 5, 'Inducibility of Ia antigen on astrocytes by murine coronavirus JHM is rat strain dependent': 4, 'Astrocytes present myelin basic protein to encephalitogenic T-cell lines': 1, 'Coronavirus infection induces H-2 antigen expression on oligodendrocytes and astrocytes': 2, 'Establishment of T-cell clones specific for cells infected with mouse hepatitis virus': 2, 'Adenoviruses of subgenera B, C, D and E modulate cell surface expression of major histocompatibility complex class I antigens': 4, \"E3/19K' protein of adenovirus type 2 inhibits lysis of cytolytic T lymphocytes by blocking cell surface expression of histocompatibility class I antigen\": 5, 'Pathophysiology and epidemiology of acute viral infections of the nervous system': 2, 'Viral Infections of the Nervous System': 2, 'Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients': 2, 'Presentation of myelin basic protein by murine cerebral vascular endothelial cells': 4, 'Interaction between myelin basic protein-sensitized T lymphocytes and murine cerebral vascular endothelial cells': 4, 'Resistance to fatal central nervous system disease by mouse hepatitis virus strain JHM. I. Genetic analysis': 3, 'Mouse hepatitis virus type 4 (JHM strain) induced fatal central nervous system disease. I. Genetic control and the murine neuron as the susceptible site of disease': 4, 'The isolation and culture of capillary endothelium from epididymal fat. Microvasc': 1, 'Specific labelling of endothelial cells using fluorescent acetylated low density lipoprotein': 2, 'Identification of endothelial cells by specific lectin binding': 1, 'Host genetic control of mouse hepatitis virus type-4 (JHM strain) replication. II. The gene locus for susceptibility is linked to the Svp-2 locus on mouse chromosome 7': 2, 'Rapid one step staining procedures for analysis of cellular DNA and protein by single and dual laser flow cytometry': 1, 'Mouse hepatitis virus receptor maps to the chromosome 7 site regulating resistance to virus replication': 1, 'Genetic control of resistance to lethal coronavirus strain JHM encephalomyelitis': 1, 'Fc and C3 receptors induced by herpes simplex virus on cultured human endothelial cells': 1, 'Induction of glial cell MHC antigen expression in neurotropic coronavirus infections. Characterization of the H-2-inducing soluble factor elaborated by infected brain cells': 1, 'Tumor necrosis factor induces expression of MHC class I antigens on mouse astrocytes': 1, 'Differential induction of H-2K vs H-2D class I major histocompatibility complex antigen expression by murine recombinant interferon gamma': 1, 'Reversal of oncogenesis by the expression of a major histocompatibility complex class I gene': 1, 'Human (HLA-A and HLA-B) and murine (H-2K and H-2D) histocompatibility antigens are cell surface receptors for Semliki forest virus': 1, 'Receptor-like role of HLA-class I antigens: regulation of T cell activation': 1, 'Interactions between cytomegalovirus and class I HLA molecules: role in viral infectivity': 1, 'Acute experimental allergic encephalomyelitis in the mouse. Immunopathology of the developing lesion': 1, 'Immune response products (Ia antigens) on glial and endothelial cells in virus-induced demyelination': 1, 'Tumor necrosis factor amplifies measles virusmediated Ia induction on astrocytes': 1, 'Chinese Center for Disease Control and Prevention. The epidemiologic characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China': 1, 'COVID-19 Autopsies': 1, 'Pulmonary Manifestations of Acute Lung Injury: More Than Just Diffuse Alveolar Damage': 1, 'Surgical lung biopsy in adult respiratory distress syndrome: a meta-analysis': 1, 'orticosteroids in sepsis: from bench to bedside?': 1, 'Corticosteroids in Severe Sepsis and Septic Shock: A Concise Review': 1, 'Synthesizing Software Verifiers from Proof Rules': 1, 'Horn Clause Solvers for Program Verification': 2, 'StarExec: A Cross-Community Infrastructure for Logic Solving': 1, 'The ELDARICA Horn Solver': 3, 'Facilitating CHC Solving with Improving Interpolation Abstraction Exploration': 1, 'Counterexample Guided Abstraction Refinement Via Program Execution': 1, 'Open-source IC3 Modulo Theories with Implicit Predicate Abstraction': 1, 'Infinite-state invariant checking with IC3 and predicate abstraction': 1, 'SAT-Based Model Checking without Unrolling. In: VMCAI': 1, 'The MathSAT5 SMT Solver': 1, 'Tools and Algorithms for the Construction and Analysis of Systems': 3, 'Property-directed k-induction': 2, 'A Cooperative Parallelization Approach for Property-Directed k-Induction': 1, 'Yices 2.2': 1, 'OpenSMT2: An SMT Solver for Multi-core and Cloud Computing': 1, 'SMTS: Distributed, Visualized Constraint Solving': 1, 'SMT-based model checking for recursive programs': 1, 'Global Guidance for Local Generalization in Model Checking': 1, 'A Constraint Sequent Calculus for First-Order Logic with Linear Integer Arithmetic': 1, 'Infection control measures for operative procedures in severe acute respiratory syndrome-related patients': 1, 'Prolonged viral shedding in feces of pediatric patients with coronavirus disease 2019': 1, 'SARS-CoV-2 is not detectable in the vaginal fluid of women with severe COVID-19 infection': 1, 'Clinical characteristics and risk assessment of newborns born to mothers with COVID-19': 1, 'Updated intercollegiate general surgery guidance on COVID-19': 2, 'SAGES and EAES Recommendations Regarding Surgical Response to COVID-19 Crisis': 2, 'Coronavirus Disease 2019 (COVID-19) Situation Summary': 1, 'Preparing for a COVID-10 pandemic: a review of operating room outbreak response measures in a large tertiary hospital in Singapore': 2, 'Detecting hepatitis B virus in surgical smoke emitted during laparoscopic surgery': 1, 'Pathogens and parasites, introduction to wastewater treatment': 12, 'Gerardi M (ed) Wastewater pathogens wastewater microbiology': 5, 'Microbial agents associated with waterborne diseases': 3, 'Microbiological quality of sewage treatment plant effluents. AWT Science and Environment report number 94/123, Sydney Water Corporation': 4, 'Microorganisms and disease': 3, 'Anthropogenic environmental change and the emergence of infectious diseases in wildlife': 6, 'Impact of ecological changes on tropical animal health and disease control': 2, 'Observations on an accidental case of raw sewage pollution in Antarctica': 2, 'Clean water ecology in the polar regions': 2, 'Bacteriological examination of the water supply on an Antarctic base': 1, 'Disribution of enteric bacteria in Antarctic seawater surrounding a sewage outfall': 3, 'The role of the rock cod Notothenia coriiceps Richardson, 1844 in the life-cycle of Antarctic parasites': 2, 'Population structure and transmission of Escherichia coli in an isolated human community; studies on an Antarctic base': 2, 'QMRA (quantitative microbial risk assessment) and HACCP (hazard analysis and critical control points) for management of pathogens in wastewater and sewage sludge treatment and reuse': 2, 'Standard Methods for the Examination of Water and Wastewater': 2, 'Terrestrial microbiology, invertebrates and ecosystems': 5, 'Viability of coliform bacteria in Antarctic soil': 2, 'Waste disposal at Australian Antarctic stations': 5, 'Sanitation and waste disposal in Antarctica': 2, 'Subsurface radar investigations at the Pegasus glacial-ice runway and Williams field, McMurdo Station': 6, 'Inauguration of King Sejong, Antarctic research station': 2, 'Concentrations of bacteria in the treated sewage from each step of the septic tank of the King Sejong Base, and in the nearby water of Marion Cove': 3, 'Study of a new waste water treatment plant for the Italian Antarctic station': 4, 'Dispersion and fate of sewage and wastewater components from Scott Base, Antarctica. Dissertation': 6, 'Water contamination indices at Terra Nova Bay Station': 2, 'Reducing sewage pollution in the Antarctic marine environment using a sewage treatment plant': 4, 'Waste disposal and waste management in Antarctica and the Southern Ocean': 3, 'Human impact on an oligotrophic lake in the Larsemann Hills': 2, 'Viable organisms from faeces and foostuffs from early Antarctic expeditions': 2, 'Controlled Ecological Life Support System Antarctic Analog Project: waste treatment technology development for use at Amundsen Scott South Pole Station': 2, \"Borehole drilling for sewage disposal and rise of the hole's bottom at Asuka Station, East Antarctica\": 1, 'Rise of snow temperatures caused by the sewage disposal': 1, 'A simple method to reduce discharge of sewage microorganisms from an Antarctic research station': 2, 'Recycling and optimized utilization of materials at antarctic research stations': 1, 'Effluent on ice': 1, \"Statement of Greenpeace before the subcommittee on human rights and international organizations of the committee on foreign affairs of the US house of representatives in preserving Antarctica's ecosystem. Greenpeace USA\": 1, 'Coming to grips with a slippery issue: human waste disposal in cold climates': 1, 'Benthic changes during 10 years of organic enrichment by McMurdo Station': 4, 'Protocol on Environmental Protection to the Antarctic Treaty': 1, 'Ross Sea region 2001: a state of the environment report for the Ross Sea region of Antarctica': 4, 'Food and foraging behavior of lesser sheathbills (Chionis minor) at Marion Island': 2, \"Man's impact on Antarctic birds\": 2, 'Pathogen reduction capabilities of freeze/thaw sludge conditioning': 2, 'Faecal indicator organisms': 3, 'Water chlorination: essential process or cancer hazard?': 1, 'Nature and chlorine reactivity of organic constituents from reclaimed water in groundwater': 1, 'Chlorine dynamics and ambient toxicity in receiving streams': 1, 'The toxicity of chlorinated wastewater: instream and laboratory case studies': 1, 'Bacterial survival in snow made from wastewater': 1, 'Aerial dispersal and survival of sewage-derived faecal coliforms in Antarctica': 2, 'Aerosolized enteric bacteria and viruses generated by spray irrigation of wastewater': 2, 'Intense and localized benthic marine pollution around McMurdo Station': 2, 'Patterns of survival and behavior in Antarctic benthic invertebrates exposed to contaminated sediments: field and laboratory bioassay experiments': 3, 'The effects of sewage organic matter in biogeochemical processes within midshelf sediments offshore Sydney': 3, 'Estrogenic effects of effluents from sewage treatment works': 2, 'Benthic foraminifera and trace metals in sediments off the Scott Base sewer outfall': 2, 'Water and wastewater quality monitoring, McMurdo Station': 1, 'Relationships between indicators, pathogens and water quality in an estuarine system': 1, 'Hydrocarbons and sterols in marine sediments and soils at Davis Station, Antarctica: a survey for human-derived contaminants': 2, 'Hydrocarbon and coprostanol levels in seawater, sea-ice algae and sediments near Davis Station in eastern Antarctica: a regional survey and preliminary results for a field fuel spill experiment': 3, 'Effect of low temperatures on BOD in antarctic seawater': 1, 'Bacterial attack of corals in polluted water': 1, 'Assessment of the coastal marine environment at Admiralty Bay': 3, 'Ecological significance of endocrine disruption in marine invertibrates': 1, 'Endocrine disruption in marine fish': 1, 'Biological invasions in the Antarctic: extent, impacts and implications': 1, 'Endangered Antarctic environments': 2, 'Dissemination and survival of non-indigenous bacterial genomes in pristine Antarctic environments': 2, 'Genomics for environmental microbiology': 1, 'Microbial ecology in the age of genomics and metagenomics: concepts, tools, and recent advances': 1, 'Ecotoxicogenomics: the challenge of integrating genomics into aquatic and terrestrial ecotoxicology': 1, 'Transferable drug resistance associated with coliforms isolated from hospital and domestic sewage': 1, 'Transfer of multiple drug resistance plasmids between bacteria of diverse origins in natural microenvironments': 2, 'Antibiotic resistance patterns of fecal coliforms isolated from domestic sewage before and after treatment in an aerobic lagoon': 1, 'Bacterial gene transfer by natural genetic transformation in the environment': 3, 'Antimicrobial spread in aquatic environments': 1, 'Environmental pollution with resistant microbes': 1, 'Gene transfer in marine water column and sediment microcosms by natural plasmid transformation': 2, 'Distribution of tetracycline resistance determinants among gram-negative bacteria isolated from polluted and unpolluted marine sediments': 1, 'Conjugative plasmid transfer between bacteria under simulated marine oligotrophic conditions': 2, 'Bacterial plasmids in Antarctic natural microbial assemblages': 2, 'Plasmids from the soil bacteria of Schirmacher Oasis': 1, 'Plasmid maintenance and expression in Escherichia coli exposed to the Antarctic marine environment': 1, 'Salmonella in sub-Antarctica: low heterogeneity in Salmonella serotypes in South Georgian seals and birds': 1, 'Source tracking fecal bacteria in water: a critical review of current methods': 1, 'Adenovirus 21 infection in an isolated Antarctic station: transmission of the virus and susceptibility of the population': 2, 'Estimates of the severity of illnesses associatedwith bathing in marine recreational waters contaminated with domestic sewage': 2, 'A review of epidemiological studies from exposure to recreational water': 2, 'Swimming-associated gastroenteritis and water quality': 2, 'Comparison of total coliform, fecal coliform, and enterococcus bacterial indicator response for ocean recreational water quality testing': 1, 'Monitoring costal marine waters for spore-forming bacteria of faecal and soil origin to determine point from non-point source pollution': 1, 'Benthic distribution of sewage sludge indicated by Clostridium perfringens at a deep-ocean dump site': 2, 'Elimination of viruses and indicator bacteria at each step of treatment during preparation of drinking water at seven water treatment plants': 1, 'Clostridium perfringens and somatic coliphages as indicators of the efficiency of drinking water treatment for viruses and protozoan cysts': 2, 'Relative value of surrogate indicators for detecting pathogens in lakes and reservoirs': 2, 'Occurrence and levels of phages proposed as surrogate indicators of enteric viruses in different types of sludges': 1, 'A review. Bacteriophages as indicators of enteric viruses and public health risk in groundwaters': 1, 'Distribution of genotypes of F-specific RNA bacteriophages in human and non-human sources of faecal pollution in South Africa and Spain': 1, 'An improved role for faecal coliform to faecal streptococci ratios in the differentiation between human and non-human pollution sources': 1, 'Association of multiple antibiotic resistance profiles with point and nonpoint sources of E. coli in Appalachicola Bay': 1, 'Classification of antibiotic resistance patterns of indicator bacteria by drscriminant analysis: use in predicting the source of fecal contamination in subtropical waters': 1, 'Faecal coliform and faecal streptococci density relationships in waste discharges and receiving waters': 1, 'Distribution of Clostridium perfringens and fecal sterols in a benthic coastal marine environment influenced by the sewage outfall from McMurdo Station': 7, 'Distribution of sewage pollution around a maritime Antarctic research station indicated by faecal coliforms, Clostridium perfringens and faecal sterol markers': 6, 'Coprostanols in Antarctic marine sediments: a biomarker for marine mammals and not human pollution': 2, 'Coprostanol as a sewage tracer in McMurdo Sound': 1, 'Sterols in ocean sediments: novel tracers to examine habitats of cetaceans, pinnipeds, penguins and humans': 1, 'Concentrations of coprostanol that correspond to existing bacterial indicator guidelines': 1, 'Principles and applications of methods for DNA-based typing of microbial organisms': 1, 'A review of current and future molecular diagnostic tests for use in the microbiology laboratory': 1, 'A survey of the methods for the characterization of microbial consortia and communities': 1, 'Outbreaks of avian cholera in Hope Bay': 2, 'Some antarctic acanthocephalans of the genus Corynosoma parasitizing Pinnipedia, with descriptions of 3 new species': 1, 'Adjustment of anisakid nematode life cycles to the high Antarctic food web as shown by Contracaecum radiatum and Contracoecum osulatum in the Weddell sea': 1, 'Oocysts in addition to sarcocysts in the musculature of an Antarctic seal': 1, 'A synonymic catalogue of the Acari from Antarctica, the sub-Antarctic islands and the southern ocean': 1, 'The impact of parasites on marine mammals: a review': 1, 'On some aspects of the biology of the Ross seal Ommatophoca rossii from King Haakon VII Sea': 1, 'Cestodes of Antarctic seals': 1, 'On taxonomic status of cestodes with uncommon locality in organs of Antarctic seals': 1, 'Redescription of Corynosoma hamanni and description of Corynosoma pseudohamanni, new species (Acanthocephala) from the environs of the South Shetlands (Antarctica)': 1, 'Acanthocephala in fish in the Weddell Sea (Antarctic)': 1, 'Acanthocephalan infection of inshore fish in two fjords at South Georgia': 1, 'Faecal pollution indicators in the Terra Nova Bay': 6, 'Influence of seasonal environmental variables on the distribution of presumptive fecal coliforms around an Antarctic research station': 8, 'Occurrence of microbial indicators and Clostridium perfringens in wastewater, water column samples, sediments, drinking water, and Weddell seal feces collected at McMurdo station': 8, 'Distribution of the McMurdo Station sewage plume': 2, \"Distribution of enteric bacteria in Antarctic seawater surrounding the Dumont d'Urville permanent station\": 3, 'Distribution of enteric bacteria in Antarctic seawater surrounding the Port-aux-Francais permanent station (Kerguelen Island)': 3, 'Microbial ecosystems of Antarctica': 1, 'Ecological aspects of Antarctic microbiology': 1, 'Microbiological investigation of the human pollution at Syowa Station in Antarctica. Special reference to the specimen collected by the 23rd Japanese Antarctic Research Expedition': 1, 'Detecting human bacterial contamination in Antarctic soils': 1, 'Detection of human commensals in the area around an Antarctic research station': 1, 'Effect of an activated sludge wastewater treatment plant on ambient air densities of aerosols containing bacteria and viruses': 1, 'Seasonality in Antarctic airborne fungal spores': 1, 'The effects of a small sewage outfall on an algal epifaunal community at Macquarie Island (sub-Antarctic): a drop in the Southern Ocean': 1, 'Survival, physiological response, and recovery of enteric bacteria exposed to a polar marine environment': 2, 'Long-term survival of microorganisms in frozen material from early Antarctic base camps at McMurdo Sound': 1, 'Long-term survival of human faecal microorganisms on the Antarctic Peninsula': 2, 'Long-term survival of enteric microoganisms in frozen wastewater': 1, 'Soil microorganisms at Paradise Harbor': 1, 'Survival of Escherichia coli in zero-degree centigrade sea water': 1, 'Survival of human enteric and other sewage microorganisms under simulated deep-sea conditions': 1, 'Survival of faecal bacteria in antarctic coastal waters': 2, 'Effect of solar radiation on sewage bacteria viability': 2, 'Common colds in Antarctica': 1, 'Infectious disease in Antarctica and its relation to aerospace medicine:a review': 1, 'Trends in mucosal immunity in Antarctica during six Australian winter expeditions': 1, 'Epstein-Barr vurus reactivation associated with diminished cell-mediated immunity in Antarctic expeditioners': 2, 'Giardiasis in pinnipeds from eastern Canada': 1, 'Giardiasis in ringed seals from the western Arctic': 1, 'Salmonella in Adélie penguins (Pygoscelis adeliae) and south polar skuas (Catharacta maccormicki) on Ross Island Antarctica': 1, 'Salmonella enteriditis in Antarctica: zoonosis in man or humanosis in penguins': 1, 'Isolation of Campylobacter lari from seabirds in Hope Bay': 2, 'Clostridium perfringens as a potential indicator for the presence of sewage solids in marine sediments': 1, 'Salmonellae in the environment': 2, 'Bacteria associated with crabs from cold waters with emphasis on the occurrence of potential human pathogens': 1, 'Uptake of Escherichia coli, Vibrio cholerae non-O1 and Enterococcus durans by, and depuration of mussels (Mytilus galloprovincialis)': 1, 'Clams (Corbicula fluminea) as bioindicators of fecal contamination with Cryptosporidium and Giardia spp. in freshwater ecosystems in California': 1, 'Sewage impact on shellfish microbial contamination': 1, 'The etiology of white pox, a lethal disease of the Caribbean elkhorn coral, Acropora palmata': 1, 'The role of wildlife in emerging and re-emerging zoonoses': 1, 'Emerging infectious diseases in wildlife': 1, 'Host adaptation and host-parasite co-evolution in Cryptosporidium: implications for taxonomy and public health': 1, 'Practical biological indicators of human impacts in Antarctica': 2, 'Fluorogenic and chromogenic substrates in culture media and identification tests': 1, 'Rapid confirmation of Clostridium perfringens by using chromogenic and fluorogenic substrates': 1, 'Enterococci as indicators of Lake Michigan recreational water quality: comparison of two methodologies and their impacts on public health regulatory events': 1, 'Social rhythm therapy -a potentially translatable psychosocial intervention for bipolar disorder': 1, 'Bipolar disorder and comorbid alcoholism: prevalence rate and treatment considerations': 1, \"L: Still's diseasein the adutt\": 1, \"Adult 8611's d~sease: a muIticenter survey ofjapanese patients\": 2, \"Evaluation ofsemm ferritin as a marker for adult Stll's desease activity\": 1, \"Semm Fer¡ and lsoferritins aro tools for diabmosis of active adult Still's disease\": 3, 'Hyperferririnemia in malignant histiocytosis and virus-associared hemophagocytic syndrome': 2, 'Hematophagic hisfiocytosis': 2, 'Infektassoziiertes h~i-mophagozytisches Syndrom mit letalem Verlauf': 2, 'IKeactive hemophagocytic syndrome -a clinicopatholoh~cal study of 40 patients in an oriental population. Amor': 2, 'Kienzler: Manifestations cutanees de la maladie de Still de 1\" aduhe. A propos de quatre observations': 1, 'esnick: Carpal altera¡ in adult-onset Stil1\"s desease, juvenile chronic arthritis and adult omet rheumatoid arth¡ comparanve study': 1, 'Esdai~[e: R_eliability oŸ ffench version ~ad validity in adult s¡ desease': 1, 'Interleukin 1 and the pathogenesis of the acute-phase reponse': 1, 'Tranlational control during the acute phase reponse. Fertitin synthesis in reponse to lnterleukin 1': 1, \"Akizuki: Preliminary criteria for classification ofadult Still's desease\": 1, \"Adultonset Still's disease. Expe¡ in 23 patient~ and literature review with emphasis on organ failure\": 1, 'tntrarticuhr fer¡ bound iron in rheumatoid arthtitis': 1, 'Macrophage ferntin and iron deposition in the rat air pouch model ofinflammatory synovitis': 1, 'Brurming: Virusassociated hemophagocytic syndrome': 1, 'Bactefia-associated hemophagocy• syndrome': 1, \"Decaux: Hyperferrifinemia in aduh onset Stdl's d• and the hemophagocytic syndrome\": 3, \"Still's desease associated with coxaackie infection and haemophagocytic syndrome\": 2, \"Davson: Still's disease and the virus-associated haemophagocytic synd~ome\": 2, 'AccumuIation aod release ofisoferritins duting incubatmn in vitro of hmnan pe¡ blood mononuclear cells': 1, 'Reorganization of a large academic hospital to face COVID-19 outbreak: The model of Parma': 1, 'COVID-19 pandemic planning, response, and lessons learned at a community hospital': 1, 'The biology and pathogenesis of coronavirus': 1, 'Discovery of seven novel mammalian and avian coronaviruses in the genus Deltacoronavirus supports bat coronaviruses as the gene source of Alphacoronavirus and Betacoronavirus and avian coronaviruses as the gene source of Gammacoronavirus and Deltacoronavirus': 1, 'Genomic characterization of equine coronavirus': 1, 'Coronavirus pathogenesis': 2, 'Disease associated with equine coronavirus infection and high case fatality rate': 9, 'Experimental inoculation of equine coronavirus into Japanese draft horses': 5, 'Experimentally induced coronavirus infections in calves: viral replication in the respiratory and intestinal tracts': 1, 'Experimental inoculation of adult dairy cows with bovine coronavirus and detection of coronavirus in feces by RT-PCR': 1, 'Experimental reproduction of winter dysentery in lactating cows using BCV -comparison with BCV infection in milk-fed calves': 1, 'Patterns of detection of respiratory viruses in nasal swabs from calves in Ireland: a retrospective study': 1, 'First detection of equine coronavirus (ECoV) in Europe': 1, 'Necrotizing enteritis and hyperammonemic encephalopathy associated with equine coronavirus infection in equids': 1, 'Study on the resistance of severe acute respiratory syndrome-associated coronavirus': 1, 'Characterization of a coronavirus isolated from a diarrheic foal': 2, 'Neonatal enterocolitis associated with coronavirus infection in a foal: a case report': 2, 'Viral loads in clinical specimens and SARS manifestations': 3, 'Nasopharyngeal shedding of severe acute respiratory syndrome-associated coronavirus is associated with genetic polymorphisms': 1, 'Spike protein fusion peptide and feline coronavirus virulence': 3, 'Infectious agents associated with diarrhoea in neonatal foals in central Kentucky: a comprehensive molecular study': 2, 'Enhancement of enteropathogenic Escherichia coli pathogenicity in young turkeys by concurrent turkey coronavirus infection': 1, 'Immune evasion by pathogens of bovine respiratory disease complex': 2, 'Coinfection of pigs with porcine respiratory coronavirus and Bordetella bronchiseptica': 1, 'Suppression of NK cells and regulatory T lymphocytes in cats naturally infected with feline infectious peritonitis virus': 1, 'Adaptation and serial passage of bovine coronavirus in an established diploid swine testicular cell line and subsequent development of a modified live vaccine': 1, 'Effects of angiotensin on the central nervous system': 1, 'Angiotensin in the brain': 1, 'Brain angiotensin: pathways and pharmacology': 2, 'Brain and pituitary angiotensin': 7, 'Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities': 1, 'Brain angiotensin receptor subtypes in the control of physiological and behavioral responses': 1, 'Angiotensin, thirst, and sodium appetite': 1, 'Angiotensin II in central nervous system physiology': 1, 'Brain angiotensinergic activity: the state of our current knowledge': 2, 'Proteases: a primer': 1, 'Membrane bound members of the M1 family: more than aminopeptidases': 7, 'The zinc metallopeptidase family: new faces, new functions': 4, 'The enzymatic degradation of various angiotensin II derivatives by serum, plasma or kidney homogenate': 2, 'Location and secretion of brain angiotensinogen': 1, 'The preparation, purification, and amino acid sequence of a polypeptide renin substrate': 1, 'Renin-angiotensin system: biochemistry and mechanisms of action': 1, 'Evidence for renin in rat brain: differentiation from other reninlike enzymes': 1, 'Molecular biology of renin. I: Gene and protein structure, synthesis and processing': 1, 'Distinct renin isoforms generated by tissue-specific transcription initiation and alternative splicing': 1, 'Identification of three human renin mRNA isoforms from alternative tissue-specific transcriptional initiation': 1, 'Adjacent expression of renin and angiotensinogen in the rostral ventrolateral medulla using a dual-reporter transgenic model': 1, 'Evidence supporting a functional role for intracellular renin in the brain': 1, 'Renin activity in dog brain: enzymological similarity to cathepsin D': 1, 'Isorenin, pseudorenin, cathepsin D and renin. A comparative enzymatic study of angiotensinforming enzymes': 1, 'Processing of the precursors to neurotensin and other bioactive peptides by cathepsin E': 2, 'Cathepsin E in the central nervous system': 1, 'Serine proteases in rodent hippocampus': 2, 'Release and degradation of angiotensin I and angiotensin II from angiotensinogen by neutrophil serine proteinases': 3, 'Expression of cathepsin G-like and alpha 1-antichymotrypsin-like proteins in reactive astrocytes': 1, 'Cathepsin G: localization in human cerebral cortex and generation of amyloidogenic fragments from the beta-amyloid precursor protein': 1, 'Distribution of tonin-and kallikrein-like activities in rat brain': 2, 'des-Asp-angiotensin I: its identification in rat blood and confirmation as a substrate for converting enzyme': 2, 'Metabolism of angiotensin-(1-7) by angiotensin-converting enzyme': 1, 'Angiotensin converting enzyme (ACE) and neprilysin hydrolyze neuropeptides: a brief history, the beginning and follow-ups to early studies': 1, 'Membraneassociated zinc peptidase families: comparing ACE and ACE2': 3, 'Rethinking the renin-angiotensin system and its role in cardiovascular regulation': 1, 'Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism': 5, 'Recent advances in knowledge of the structure and function of the angiotensin I converting enzyme': 1, 'Renal metabolism of angiotensin I and II': 7, 'Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase': 4, 'Rat brain contains high levels of mannose-6-phosphorylated glycoproteins including lysosomal enzymes and palmitoyl-protein thioesterase, an enzyme implicated in infantile neuronal lipofuscinosis': 1, 'Cathepsin A/protective protein: an unusual lysosomal multifunctional protein': 1, 'Expression of protective protein in human tissue': 1, 'Human lysosomal protective protein has cathepsin A-like activity distinct from its protective function': 1, 'A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase': 1, 'Action of brain cathepsin B, cathepsin D, and high-molecular-weight aspartic proteinase on angiotensins I and II': 3, 'Lysosomal cysteine proteases: structural features and their role in apoptosis': 1, 'Chymase: a new pharmacologic target in cardiovascular disease': 1, 'High levels of human chymase expression in the pineal and pituitary glands': 1, 'Proteolytic conversion of angiotensins in rat brain tissue': 3, 'Angiotensin metabolism by cerebral microvascular aminopeptidase A': 3, 'Metabolism of angiotensin peptides by neuronal and glial cultures from rat brain': 5, 'Discovery of a distinct binding site for angiotensin II (3-8), a putative angiotensin IV receptor': 1, 'The brain angiotensin system and extracellular matrix molecules in neural plasticity, learning, and memory': 2, 'Aminopeptidase A, which generates one of the main effector peptides of the brain renin-angiotensin system, angiotensin III, has a key role in central control of arterial blood pressure': 1, 'Roles of brain angiotensins II and III in thirst and sodium appetite': 1, 'Pressor Actions of Aminopeptidase-Resistant Analogs of Angiotensin II in the Rat Brain: Challenging the Angiotensin III Hypothesis. Hypertension': 1, 'Degradation of angiotensin I to [des-Asp1] angiotensin I by a novel aminopeptidase in the rat hypothalamus': 2, 'Purification, characterization, and cloning of a cytosolic aspartyl aminopeptidase': 5, 'The C-terminal domain, but not the interchain disulphide, is required for the activity and intracellular trafficking of aminopeptidase A': 2, 'Localization of immunoreactive glutamyl aminopeptidase in rat brain. II. Distribution and correlation with angiotensin II': 1, 'The in vivo metabolism of cholecystokinin (CCK-8) is essentially ensured by aminopeptidase A': 1, 'Molecular characterization of a puromycin-insensitive leucyl-specific aminopeptidase, PILS-AP': 3, 'The oxytocinase subfamily of M1 aminopeptidases': 7, 'Characterization of recombinant human adipocyte-derived leucine aminopeptidase expressed in Chinese hamster ovary cells': 2, 'Evidence that the angiotensin IV (AT(4)) receptor is the enzyme insulin-regulated aminopeptidase': 2, 'Determination of aminopeptidase X activity in tissues of normo-and hypertensive rats by capillary electrophoresis': 1, 'An aminopeptidase from mouse brain cytosol that cleaves N-terminal acidic amino acid residues': 1, 'Cerebroventricular and intravascular metabolism of [125I]angiotensins in rat': 1, 'Angiotensin III and IV activation of the brain AT1 receptor subtype in cardiovascular function': 1, 'Enzymatic properties of human aminopeptidase A. Regulation of its enzymatic activity by calcium and angiotensin IV': 2, 'Des-aspartate-angiotensin I and angiotensin AT1 receptors in rat cardiac ventricles': 2, 'Identification of human placental leucine aminopeptidase as oxytocinase': 1, 'Human leukocyte-derived arginine aminopeptidase. The third member of the oxytocinase subfamily of aminopeptidases': 2, 'PC18, a specific aminopeptidase N inhibitor, induces vasopressin release by increasing the half-life of brain angiotensin III': 1, 'Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects': 4, 'Characterization of angiotensin IV-degrading enzymes and receptors on rat mesangial cells': 3, 'Soluble and membrane-bound leucyl-and arginyl-aminopeptidase activities in subcellular fractions of young and adult rat brains': 2, 'Aminopeptidase B (EC 3.4.11.6)': 1, 'Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release': 1, 'Aminopeptidase A inhibitors as potential central antihypertensive agents': 1, 'Dipeptidyl-aminopeptidase III of rat brain. Selective affinity for enkephalin and angiotensin': 7, 'Properties of rat brain dipeptidyl aminopeptidases in the presence of detergents': 3, 'Dipeptidyl aminopeptidase III of guinea-pig brain: specificity for short oligopeptide sequences': 1, 'Human kidney \"enkephalinase\", a neutral metalloendopeptidase that cleaves active peptides': 1, 'Purification of the main somatostatin-degrading proteases from rat and pig brains, their action on other neuropeptides, and their identification as endopeptidases 24.15 and 24.16': 2, 'EP24.15 interacts with the angiotensin II type I receptor and bradykinin B2 receptor': 3, 'Evidence that prolyl endopeptidase participates in the processing of brain angiotensin': 2, 'Purification and characterization of a novel membrane-bound form of prolyl endopeptidase from bovine brain': 2, 'Involvement of endopeptidase 24.15 in the inactivation of bradykinin by rat brain slices': 1, 'A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11': 1, 'Neuropeptide specificity and inhibition of recombinant isoforms of': 1, 'Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin-(1-7) heptapeptide': 1, 'Novel angiotensin peptides': 2, 'Angiotensin-(1-7) enhances LTP in the hippocampus through the G-protein-coupled receptor Mas': 1, 'Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology': 2, 'Mammalian membrane metallopeptidases': 2, 'Metabolism of angiotensins II and III by membrane-bound peptidases from rat brain': 1, 'Pathways for angiotensin-(1-7) metabolism in pulmonary and renal tissues': 1, 'Molecular cloning and expression of rat brain endopeptidase 3.4.24.16': 1, 'The intracellular distribution and secretion of endopeptidases 24': 1, 'Soluble metalloendopeptidase from rat brain: action on enkephalin-containing peptides and other bioactive peptides': 1, 'Synaptosomal membrane-bound form of endopeptidase-24.15 generates Leu-enkephalin from dynor-phin1-8, alpha-and beta-neoendorphin, and Met-enkephalin from Metenkephalin-Arg6-Gly7-Leu8': 1, 'Immunocytochemical localization of endopeptidase 24.15 in rat brain': 1, 'Comparative fine structural distribution of endopeptidase 24': 1, 'Distinct properties of neuronal and astrocytic endopeptidase 3.4.24.16: a study on differentiation, subcellular distribution, and secretion processes': 1, 'The prolyl oligopeptidase family': 3, 'Prolyl peptidases: a serine protease subfamily with high potential for drug discovery': 3, 'Characterization of proline endopeptidase from rat brain': 1, 'In vitro metabolism of LVV-Hemorphin-7 by renal cytosol and purified prolyl endopeptidase': 1, 'Proline specific endo-and exopeptidases': 2, 'Prolyl endopeptidase': 1, 'Purification and properties of prolylcarboxypeptidase (angiotensinase C) from human kidney': 2, 'Degradation of bradykinin and its metabolites by rat brain synaptic membranes': 1, 'Similarity to both serine carboxypeptidase and prolylendopeptidase families': 2, 'Shariat-Madar Z. Identification of prolylcarboxypeptidase as the cell matrixassociated prekallikrein activator': 1, 'Cellular carboxypeptidases': 1, 'Properties of angiotensin II receptors in the bovine and rat adrenal cortex': 2, 'Angiotensin II binding to mammalian brain membranes': 3, 'Distribution of angiotensin II receptors in rat brain': 1, 'Brain angiotensin II receptor affinity and capacity in SHR and WKY rats: effects of acute dietary changes in NaCl': 1, 'The distribution of angiotensin II binding sites in rodent brain': 1, 'Evidence for a functional, independent brain-angiotensin system: correlation between regional distribution of brain angiotensin receptors, brain angiotensin and drinking during the estrous cycle of rats': 2, 'Characterization of angiotensin binding to gerbil brain membranes using [125I]angiotensin III as the radioligand': 2, 'Characterization of angiotensin binding in the African green monkey': 2, 'Angiotensin II receptor localization in the canine CNS': 1, 'Brain Peptides and Catecholamines in Cardiovascular Regulation': 5, 'Autoradiographic localization of angiotensin II receptors in the rat brainstem': 1, 'Autoradiographic localization of angiotensin II receptors in the rat brain and kidney': 1, 'Autoradiographic localization of angiotensin II receptors in rat brain': 1, 'Quantitative autoradiography of 125I-[Sar1, Ile8]-angiotensin II binding in the brain of spontaneously hypertensive rats': 2, 'Novel angiotensin II binding sites in the mesopontine area of the rat brain': 1, \"Highperformance liquid chromatographic analysis of 'specifically bound' label after [125I]angiotensin II binding to rat brain membranes\": 2, 'Binding, degradation and pressor activity of angiotensins II and III after aminopeptidase inhibition with amastatin and bestatin': 5, 'Receptor binding interactions of the angiotensin II antagonist, 125I-[sarcosine1,leucine8]angiotensin II, with mammalian brain and peripheral tissues': 2, 'Dipeptidyl arylamidase III of the pituitary. Purification and characterization': 2, 'Human thimet oligopeptidase': 2, 'Thiol activation of endopeptidase EC 3.4.24.15. A novel mechanism for the regulation of catalytic activity': 2, 'Binding and degradation of angiotensin II by mesenteric artery subcellular membranes': 3, 'Conversion of angiotensin II into active fragments by an endosomal pathway in bovine adrenal medullary cells in primary culture': 1, 'Identification of a novel non-AT1, non-AT2 angiotensin binding site in the rat brain': 3, 'Characteristics and regulation of angiotensin II receptors in pituitary, circumventricular organs and kidney': 1, 'Quantitative autoradiographic characterization of receptors for angiotensin II and other neuropeptides in individual brain nuclei and peripheral tissues from single rats': 1, 'Identification of angiotensin II receptors in the rat ovary': 1, 'A specific competitive inhibitor of angiotensin II': 1, 'Analogs of angiotensin II. II. Mechanism of receptor interaction': 1, 'Interaction of Phe(8) of angiotensin II with Lys(199) and His(256) of AT(1) receptor in agonist activation': 1, 'The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. IV. Effects of guanylnucleotides on binding of 125I-glucagon': 1, 'The hepatic angiotensin II receptor II. Effect of guanine nucleotides and interaction with cyclic AMP production': 1, 'Discrimination of two angiotensin II receptor subtypes with a selective agonist analogue of angiotensin II, p-aminophenylalanine6 angiotensin II': 1, 'Characterization of a rat type 2 angiotensin II receptor stably expressed in 293 cells': 2, 'Identification and characterization of angiotensin-II receptor subtypes in cultured bovine and human adrenal fasciculata cells and PC12W cells': 1, 'Role of the N-terminal amino acid for the biological activities of angiotensin and inhibitory analogues': 1, 'Identification and characterization of the high affinity vascular angiotensin II receptor in rat mesenteric artery': 1, 'Characterization of angiotensin II receptor subtypes in rat liver': 1, 'Preliminary biochemical characterization of two angiotensin II receptor subtypes': 1, 'Discrimination of angiotensin II receptor subtypes by dithiothreitol': 1, 'Sulfhydryl reducing agents distinguish two subtypes of angiotensin II receptors in the rat brain': 2, 'Angiotensin II receptor subtypes in rat brain: dithiothreitol inhibits ligand binding to AII-1 and enhances binding to AII-2': 1, 'Preservation of 125-I-Angiotensin II in brain AT-1 receptor binding assays': 1, 'Full spectrum of COVID-19 severity still being depicted': 1, 'Clinical Features and Short-term Outcomes of 102 Patients with Corona Virus Disease': 2, 'Invasive aspergillosis complicating pandemic influenza A (H1N1) infection in severely immunocompromised patients': 1, 'High rates of influenza-associated invasive pulmonary aspergillosis may not be universal: a retrospective cohort study from Alberta': 2, 'Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study': 1, 'Higher mortality of severe influenza patients with probable aspergillosis than those with and without other coinfections': 1, 'Invasive pulmonary aspergillosis in patients with influenza infection: A retrospective study and review of the literature': 1, 'Outcomes in Invasive Pulmonary Aspergillosis Infections Complicated by Respiratory Viral Infections in Patients With Hematologic Malignancies: A Case-Control Study': 2, 'Influenza virus infection decreases tracheal mucociliary velocity and clearance of Streptococcus pneumoniae': 1, 'The lymphocyte response to influenza in humans': 1, 'Diagnostic importance of relative lymphopenia as a marker of swine influenza (H1N1) in adults': 1, 'Influenza virus infection induces functional alterations in peripheral blood lymphocytes': 1, 'Inhibition of Host Neuraminidase Increases Susceptibility to Invasive Pulmonary Aspergillosis': 1, 'Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients': 1, 'Clinical and immunological features of severe and moderate coronavirus disease 2019': 4, 'High prevalence of putative invasive pulmonary aspergillosis in critically ill COVID-19 patients': 1, 'Coagulopathy of COVID-19 and antiphospholipid antibodies': 1, 'Immunothrombosis in Acute Respiratory Distress Syndrome: Cross Talks between Inflammation and Coagulation': 1, 'Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study': 1, 'Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results From a Prospective, Single-Center': 1, 'Advances in Understanding Human Genetic Variations That Influence Innate Immunity to Fungi': 1, 'Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period': 3, 'Computed tomographic pulmonary angiography for diagnosis of invasive mold diseases in patients with hematological malignancies': 1, 'A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients': 1, 'mRNA capping: biological functions and applications': 1, 'When your cap matters: structural insights into self vs non-self recognition of 5 0 RNA by immunomodulatory host proteins': 1, 'A conserved histidine in the RNA sensor RIG-I controls immune tolerance to N1-2 0 O-methylated self RNA': 1, 'Ribose 2 0 -O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5': 1, '0 -O methylation of the viral mRNA cap evades host restriction by IFIT family members': 1, 'Conventional and unconventional mechanisms for capping viral mRNA': 1, 'Mechanism of mRNA capping by vaccinia virus guanylyltransferase: characterization of an enzymeguanylate intermediate': 2, 'X-ray crystallography reveals a large conformational change during guanyl transfer by mRNA capping enzymes': 2, 'Mutational analysis of mRNA capping enzyme identifies amino acids involved in GTP binding, enzyme-guanylate formation, and GMP transfer to RNA': 2, 'Identification of the vaccinia virus mRNA guanyltransferase active site lysine': 3, 'Crystal structure of vaccinia virus mRNA capping enzyme provides insights into the mechanism and evolution of the capping apparatus': 5, 'West Nile virus 5 0 -cap structure is formed by sequential guanine N-7 and ribose 2 0 -O methylations by nonstructural protein 5': 1, 'Separate molecules of West Nile virus methyltransferase can independently catalyze the N7 and 2 0 -O methylations of viral RNA cap': 1, 'In vitro reconstitution of SARS-coronavirus mRNA cap methylation': 1, 'Unconventional mechanism of mRNA capping by the RNA-dependent RNA polymerase of vesicular stomatitis virus': 1, 'Reaction in alphavirus mRNA capping: formation of a covalent complex of nonstructural protein nsP1 with 7-methyl-GMP': 2, 'Characterization of the AdoMet-dependent guanylyltransferase activity that is associated with the N terminus of bamboo mosaic virus replicase': 2, 'mRNA capping by Venezuelan equine encephalitis virus nsP1: functional characterization and implications for antiviral research': 2, 'The Nterminal domain of the arenavirus L protein is an RNA endonuclease essential in mRNA transcription': 1, 'Mondragó n A: Crystal structure of baculovirus RNA triphosphatase complexed with phosphate': 1, 'Characterization of a trifunctional mimivirus mRNA capping enzyme and crystal structure of the RNA triphosphatase domain': 1, 'Nanomolar inhibitors of Trypanosoma brucei RNA triphosphatase': 1, 'Bluetongue virus VP4 is an RNA-capping assembly line': 1, 'Structure of the reovirus core at 3.6 Å resolution': 1, 'Insights into RNA unwinding and ATP hydrolysis by the flavivirus NS3 protein': 1, 'The flavivirus NS2B-NS3 protease-helicase as a target for antiviral drug development': 1, 'RNA capping enzyme and DNA ligase: a superfamily of covalent nucleotidyl transferases': 2, 'RNA methyltransferases involved in 5 0 cap biosynthesis': 1, 'The 1.85 Å structure of vaccinia protein VP39: a bifunctional enzyme that participates in the modification of both mRNA ends': 1, 'Metabolism and antiviral activity of ribavirin': 2, 'A structural basis for the inhibition of the NS5 dengue virus mRNA 2 0 -O-methyltransferase domain by ribavirin 5 0 -triphosphate': 1, 'Small molecule inhibitors that selectively block dengue virus methyltransferase': 2, 'Zika virus methyltransferase: structure and functions for drug design perspectives': 3, 'Discovery of novel dengue virus NS5 methyltransferase non-nucleoside inhibitors by fragmentbased drug design': 1, 'Identification and characterization of novel broad-spectrum inhibitors of the flavivirus methyltransferase': 1, 'Structural insight into NS5 of Zika virus leading to the discovery of MTase inhibitors': 2, 'The influenza virus polymerase complex: an update on its structure, functions, and significance for antiviral drug design': 2, 'Quantitative analysis of influenza virus RNP interaction with RNA cap structures and comparison to human cap binding protein eIF4E': 2, 'Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2': 2, 'Structural basis for m7G recognition and 2 0 -O-methyl discrimination in capped RNAs by the innate immune receptor RIG-I': 1, 'Coronavirus nsp10/nsp16 methyltransferase can be targeted by nsp10-derived peptide in vitro and in vivo to reduce replication and pathogenesis': 1, 'Broad-spectrum antiviral activities of neplanocin A, 3-deazaneplanocin A, and their 5 0 -nor derivatives': 2, '3-Deazaneplanocin A induces massively increased interferon-alpha production in Ebola virus-infected mice': 1, 'Ebola virus (EBOV) infection: therapeutic strategies': 1, 'The viral capping enzyme nsP1: a novel target for the inhibition of chikungunya virus infection': 1, 'Histidine-mediated RNA transfer to GDP for unique mRNA capping by vesicular stomatitis virus RNA polymerase': 1, 'Structure of the L protein of vesicular stomatitis virus from electron cryomicroscopy': 1, 'Comparative structural and functional analysis of bunyavirus and arenavirus cap-snatching endonucleases': 1, 'HIV integrase inhibitors: 20-year landmark and challenges': 1, 'The structural basis for cap binding by influenza virus polymerase subunit PB2': 1, 'Molecular basis of mRNA cap recognition by influenza B polymerase PB2 subunit': 1, 'Binding of the methyl donor S-adenosyl-L-methionine to middle east respiratory syndrome coronavirus 2 0 -Omethyltransferase nsp16 promotes recruitment of the allosteric activator nsp10': 1, 'Asymptomatic novel coronavirus pneumonia patient outside Wuhan: The value of CT images in the course of the disease': 1, 'Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing': 3, 'COVID-19 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals': 1, 'Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): facts and myths': 1, 'Covert coronavirus infections could be seeding new outbreaks': 3, 'The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China': 1, 'Evolving epidemiology and impact of non-pharmaceutical interventions on the outbreak of coronavirus disease 2019 in Wuhan, China. medRxiv': 1, 'Singapore claims first use of antibody test to track coronavirus infections': 1, 'High transmissibility of COVID-19 near symptom onset. medRxiv': 1, 'SARS-CoV-2 viral load in upper respiratory specimens of infected patients': 4, 'EV71: an emerging infectious disease vaccine target in the Far East': 1, 'Morphological characteristics of fatal pediatric hand, foot and mouth disease: a clinicopathological study with related receptors of EV71': 1, 'The preferential infection of astrocytes by enterovirus 71 plays a key role in the viral neurogenic pathogenesis': 1, 'Encephalitis due to emerging viruses: CNS innate immunity and potential therapeutic targets': 1, 'Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice': 2, 'ZO-1 controls endothelial adherens junctions, cell-cell tension, angiogenesis, and barrier formation': 1, 'Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis': 1, 'Structure of human enterovirus 71 in complex with a capsid-binding inhibitor': 1, 'Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene': 1, 'Scavenger receptor B2 is a cellular receptor for enterovirus 71': 1, 'Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71': 1, 'Annexin II binds to capsid protein VP1 of enterovirus 71 and enhances viral infectivity': 1, 'Heat shock protein 70 as a supplementary receptor facilitates enterovirus 71 infections in vitro': 1, 'Cell surface vimentin is an attachment receptor for enterovirus 71': 2, 'Formation of cytoskeletal elements during mouse embryogenesis': 1, 'Vimentin as an integral regulator of cell adhesion and endothelial sprouting': 1, 'Vimentin function in lymphocyte adhesion and transcellular migration': 2, 'Measles virus-induced block of transendothelial migration of T lymphocytes and infection-mediated virus spread across endothelial cell barriers': 1, 'Tissue damage and senescence provide critical signals for cellular reprogramming in vivo': 1, 'Plasminogen activator inhibitor 1 promotes immunosuppression in human non-small cell lung cancers by enhancing TGF-beta1 expression in macrophage': 1, 'Expression of EV71-VP1, PSGL-1 and SCARB2 in tissues of infants with brain stem encephalitis': 1, 'Permeability of the blood-brain barrier to albumin and insulin in the young and aged SAMP8 mouse': 1, 'Markers for blood-brain barrier integrity: how appropriate is Evans blue in the twenty-first century and what are the alternatives?': 2, 'TGFbeta1 regulation of vimentin gene expression during differentiation of the C2C12 skeletal myogenic cell line requires Smads, AP-1 and Sp1 family members': 1, 'Regulation of the expression of the human vimentin gene: application to cellular immortalization': 1, 'Stat3 enhances vimentin gene expression by binding to the antisilencer element and interacting with the repressor protein, ZBP-89': 1, 'An update on enterovirus 71 infection and interferon type I response': 1, 'An inactivated enterovirus 71 vaccine in healthy children': 1, 'Blood-brain barrier integrity, intrathecal immunoactivation, and neuronal injury in HIV': 1, 'Viral infection of the central nervous system and neuroinflammation precede blood-brain barrier disruption during Japanese encephalitis virus infection': 1, 'Viral disruption of the blood-brain barrier': 1, 'HIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: implication for viral neuropathogenesis': 1, 'Mast cells contribute to enterovirus 71 infection-induced pulmonary edema in neonatal mice': 1, 'VEGFmediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown': 1, 'Enterovirus 71 VP1 activates calmodulin-dependent protein kinase II and results in the rearrangement of vimentin in human astrocyte cells': 1, 'Endothelial targeting of cowpea mosaic virus (CPMV) via surface vimentin': 1, 'Superficial vimentin mediates DENV-2 infection of': 1, 'Surface vimentin is critical for the cell entry of SARS-CoV': 1, 'Foot-and-mouth disease virus modulates cellular vimentin for virus survival': 1, 'Effect of vimentin on activation of NLRP3 inflammasome in the brain of mice with EV71 infection': 1, 'Disruption of the blood brain barrier is vital property of neurotropic viral infection of the central nervous system': 1, 'Vimentin diversity in health and disease': 1, 'William Osler as an infectious disease specialist': 1, 'The pathophysiological basis and consequences of fever': 4, 'Factors associated with the recurrence of dengue fever in villages in Chian Rai, Thailand: A community-based case-control study': 1, 'The epidemiology of malaria in a Karen population on the western border of Thailand': 1, 'Thermoregulation as a disease tolerance defense strategy': 1, 'Pathogenesis of Fever': 1, 'Ethnobotany of Karens at Ban Mai Sawan and Ban Huay Pu Ling, Ban Luang Sub-District': 1, 'Diversity of medicinal plants for fever healing from Khao Phanom Benja National Park': 3, 'A Survey of medicinal plants used by Karen people at Ban Chan and Chaem Luang Subdidtricts': 1, \"Potential impact of climatic change on medicinal plants used in the Karen women's health care in northern Thailand\": 1, 'Traditional uses of Leguminosae among the Karen in Thailand. Plants (Basel) 2019, 8, 600': 1, 'Ethnomedicinal plant diversity in Thailand': 2, 'Important Medicinal Plant Families in Thailand': 1, 'An analysis of the food plants and drug plants of native North America': 1, 'Patterns of medicinal plant use: An examination of the Ecuadorian Shuar medicinal flora using contingency table and binomial analyses': 1, 'Quantitative methods in ethnobotany and ethnopharmacology: Considering the overall flora-hypothesis testing for over-and underused plant families with the Bayesian approach': 1, 'Cross-cultural comparison of three medicinal floras and implications for bioprospecting strategies': 1, 'Comparative ethnobotany in Nan Province': 1, 'Use of Medicinal Plants among Thai Ethnic Groups: A Comparison': 1, 'Chloroquine: Mechanism of drug action and resistance in Plasmodium falciparum': 1, 'In vitro inhibition of severe acut respiratory syndrome coronavirus by chloroquine': 1, 'Artemisinin: Mechanisms of action, resistance and toxicity': 2, 'Antipyretics: Mechanisms of action and clinical use in fever suppression': 3, 'From Petri Dish to Patient: Bioavailability Estimation and Mechanism of Action for Antimicrobial and Immunomodulatory Natural Products': 1, 'Natural remedies used by Bunong people in Mondulkiri province (Northeast Cambodia) with special reference to the treatment of 11 most common ailments': 1, 'Phytochemical screening and antimicrobial activity of the plant extracts of Mimosa pudica L. against selected microbes': 1, 'Laajvanti): An overview': 1, 'An overview of Mimosa pudica Linn. Chemistry and pharmacological profile': 1, 'Chemistry and biology. Res': 2, 'Chemical constituetns from the roots of Elephantopus scaber L': 1, 'Bioactivities of compounds from Elephantopus scaber, an ethnomedicinal plant from southwest china. Evid.-Based Compl': 1, 'Melicodenine I, a new quinolinone alkaloid from Melicope denhamii leaves': 1, 'Quinoline alkaloids and other constituents of Melicope semecarpifolia with antiplatelet aggregation activity': 1, 'Quinine, an old anti-malarial drug in a modern world: Role in the treatment of malaria': 1, 'Harnessing the medicinal properties of Andrographics paniculata for diseases and beyond: A review of its phytochemistry and pharmacology. Asian Pac': 1, 'Medicinal plants with potential antipyretic activity: A review. Asian Pac': 1, 'In vitro production of echioidinin, 7-O-methywogonin from callus cultures of Andrographis lineata and their cytotoxicity on cancer cells': 1, 'Dimethyl 3, 3 , 4, 4 -tetrahydroxy-δ-truxinate isolated from the leaves of Andrographis lineata. Wall. ex. Nees suppress adipogenesis in 3T3-L1 preadipocytes for type 2 diabetes': 1, 'Anti-inflammatory properties of extracts, fractions and lignans isolated from Phyllanthus amarus': 1, 'Effect of Phyllanthus amarus on chronic carriers of hepatitis B virus': 1, 'Chemical and biological evaluation on scopadulane-type diterpenoids from Scoparia dulcis of vietnamese origins': 1, 'Antiviral agents of plant origin. 2. Antiviral activity of scopadulcic acid B derivatives': 1, 'Antipyretic activity of plantain (Plantago major L.) leaves extract in yeast-induced mice': 1, 'Chemical constituents and medical benefits of Plantago major': 2, 'Cultural Importance Indices: A Comparative Analysis Based on the Useful Wild Plants of Southern Cantabria (Northern Spain)': 2, 'Infectious diseases in a new era of health and development': 1, 'Emerging infectious diseases: Public health issues for the 21st century': 3, 'Hospital based infectious disease related proportional mortality study': 1, 'Coronavirus Cases:. (n.d.). Available online': 1, 'From SARS to MERS, Thrusting Coronaviruses into the Spotlight': 1, 'A manifesto for the future of laboratory medicine professionals': 1, 'Complexity of the Basic Reproduction Number (R0)': 1, 'Covid-19 in South Korea-Challenges of Subclinical Manifestations': 2, 'Interrupting transmission of COVID-19: Lessons from containment efforts in Singapore': 1, 'Outcome and Distal Access Patency in Subintimal Arterial Flossing with Antegrade-Retrograde Intervention for Chronic Total Occlusions in Lower Extremity Critical Limb Ischemia': 1, 'Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis': 3, 'Critical role of nosocomial transmission in the toronto sars outbreak': 1, 'Late recognition of SARS in nosocomial outbreak': 1, 'Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review': 2, 'A Six-Sigma approach for comparing diagnostic errors in healthcare-where does laboratory medicine stand?': 1, 'Coronavirus and the race to distribute reliable diagnostics': 1, 'Building a bridge to safe diagnosis in health care. The role of the clinical laboratory': 1, 'The EFLM strategy for harmonization of the preanalytical phase': 1, 'PREDICT: A checklist for preventing preanalytical diagnostic errors in clinical trials': 1, 'Errors in clinical laboratories or errors in laboratory medicine?': 1, 'Mistakes in a stat laboratory: Types and frequency': 1, 'Real-time PCR in clinical microbiology: Applications for routine laboratory testing': 2, 'Research Techniques Made Simple: High-Throughput Sequencing of the T-Cell Receptor': 2, 'Lessons in diagnostic virology: Expected and unexpected sources of error': 2, 'Estimating the intra-and inter-individual imprecision of manual pipetting': 1, 'Chest CT for Typical 2019-nCoV Pneumonia: Relationship to Negative RT-PCR Testing': 1, 'A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster': 2, 'A case report of COVID-19 with false negative RT-PCR test: Necessity of chest CT': 5, 'Development of Reverse Transcription Loop-mediated Isothermal Amplification (RT-LAMP) Assays Targeting SARS-CoV-2': 1, 'Point-of-Care RNA-Based Diagnostic Device for COVID-19. Diagnostics (Basel) 2020, 10, 165': 1, 'Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany': 2, 'Presumed Asymptomatic Carrier Transmission of COVID-19': 5, 'Computed Tomographic Imaging of 3 Patients With Coronavirus Disease 2019 Pneumonia With Negative Virus Real-time Reverse-Transcription Polymerase Chain Reaction Test': 1, 'Estimating false-negative detection rate of SARS-CoV-2 by RT-PCR': 1, 'False-Negative Results of Real-Time Reverse-Transcriptase Polymerase Chain Reaction for Severe Acute Respiratory Syndrome Coronavirus 2: Role of Deep-Learning-Based CT Diagnosis and Insights from Two Cases': 1, 'Novel Coronavirus Disease (COVID-19): Paving the Road for Rapid Detection and Point-of-Care Diagnostics': 2, 'New York SARS-CoV-2 Real-time RT-PCR Diagnostic Panel; Food and Drug Administration': 1, 'COVID-19) Technical Guidance: Laboratory Testing for 2019-nCoV in Humans': 1, 'Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 (COVID-19)': 1, 'Molecular and Antibody Point-of-Care Tests to Support the Screening, Diagnosis and Monitoring of COVID-19; The Centre for Evidence-Based Medicine develops, promotes and disseminates better evidence for healthcare': 4, 'Loop-mediated isothermal amplification of DNA': 3, 'Rapid colorimetric detection of COVID-19 coronavirus using a reverse tran-scriptional loop-mediated isothermal amplification (RT-LAMP) diagnostic plat-form: iLACO': 1, 'Alert to Potential Contagiousness: A Case of Lung Cancer with Asymptomatic SARS-CoV-2 Infection': 1, 'Rapid Detection of SARS-CoV-2 Using Reverse transcription RT-LAMP method': 3, 'Rapid Molecular Detection of SARS-CoV-2 (COVID-19) Virus RNA Using Colorimetric LAMP': 1, 'Cellex Emergency Use Authorization': 2, 'Testing for COVID-19': 2, 'Study Finds Nearly Everyone Who Recovers From COVID-19 Makes Coronavirus Antibodies': 2, 'In Vitro Diagnostic Assays for COVID-19: Recent Advances and Emerging Trends': 1, 'Covid-19: Testing times': 1, 'Molecular and serological investigation of 2019-nCoV infected patients: Implication of multiple shedding routes': 1, 'The Laboratory Diagnosis of COVID-19 Infection: Current Issues and Challenges': 2, 'Antigenic cross-reactivity between the nucleocapsid protein of severe acute respiratory syndrome (SARS) coronavirus and polyclonal antisera of antigenic group I animal coronaviruses: Implication for SARS diagnosis': 1, 'Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures': 3, 'Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2': 1, 'DiaSorin Announces the Launch of a Fully Automated Serology Test': 1, 'Automated ELISA Systems for COVID-19 Assays': 1, 'Scientific Launches MagLumi COVID-19 Automated Test from Its Partner SNIBE for COVID-19 Serology': 1, 'Understanding the Role of Antibody Testing in Battling the Spread of COVID-19': 1, 'Chapter 4-Methods to Study Viruses': 2, 'Serum virus neutralization assay for detection and quantitation of serum-neutralizing antibodies to influenza A virus in swine': 1, 'Chapter 4-Diagnosis of Aquatic Animal Viral Diseases': 1, 'Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2': 3, '58-Rhabdoviruses': 1, \"A Human DPP4-Knockin Mouse's Susceptibility to Infection by Authentic and Pseudotyped MERS-CoV\": 1, 'Antibody-dependent-cellular-cytotoxicity-inducing antibodies significantly affect the post-exposure treatment of Ebola virus infection': 1, 'Development of in vitro and in vivo rabies virus neutralization assays based on a high-titer pseudovirus system': 1, 'Comparative Serological Study for the Prevalence of Anti-MERS Coronavirus Antibodies in High-and Low-Risk Groups in Qatar': 3, 'Laboratory Testing for Middle East Respiratory Syndrome Coronavirus': 1, 'Real-Time Estimation of the Risk of Death from Novel Coronavirus (COVID-19) Infection: Inference Using Exported Cases': 1, 'Nucleic acid detection with CRISPR-Cas13a/C2c2': 1, 'Rapid and Sensitive Detection of COVID-19 Using CRISPR/Cas12a-based Detection with Naked Eye Readout, CRISPR/Cas12a-NER': 3, 'Applications of gold nanoparticles in virus detection': 1, 'A Review on Functionalized Gold Nanoparticles for Biosensing Applications': 1, 'MRI appearance of COVID-19 infection': 2, 'Simultaneous detection and quantification of three bacterial meningitis pathogens by SERS': 2, 'SERS as a bioassay platform: Fundamentals, design, and applications': 2, 'Duplex microfluidic SERS detection of pathogen antigens with nanoyeast single-chain variable fragments': 1, 'Toward Flexible Surface-Enhanced Raman Scattering (SERS) Sensors for Point-of-Care Diagnostics': 1, 'Prospects for point-of-care pathogen diagnostics using surface-enhanced Raman scattering (SERS)': 1, 'Consistent Detection of 2019 Novel Coronavirus in Saliva': 1, 'Crisis management for infectious disease-learn from SARS experience and prepare for the influenza pandemic (summary)': 1, 'The genome sequence of the SARSassociated coronavirus': 1, 'Subcellular location and topology of severe acute respiratory syndrome coronavirus envelope protein': 1, 'The cytoplasmic tail of infectious bronchitis virus E protein directs Golgi targeting': 2, 'The hydrophobic domain of infectious bronchitis virus E protein alters the host secretory pathway and is important for release of infectious virus': 1, 'Structure and inhibition of the SARS coronavirus envelope protein ion channel': 2, 'Self-assembly of a nine-residue amyloid-forming peptide fragment of SARS corona virus E-protein: mechanism of self aggregation and amyloid-inhibition of hIAPP': 3, 'Protein misfolding, functional amyloid, and human disease': 1, 'Interaction of Alzheimer β-amyloid peptide (1-40) with lipid membranes': 1, 'Amyloid aggregation: role of biological membranes and the aggregate-membrane system': 1, 'Fmoc Solid Phase Peptide Synthesis': 1, 'Sequence context induced antimicrobial activity: insight into lipopolysaccharide permeabilization': 1, 'NMR structure and binding of esculentin-1a (1-21) NH 2 and its diastereomer to lipopolysaccharide: correlation with biological functions': 1, 'Biophysical characterization of essential phosphorylation at the flexible C-terminal region of C-Raf with 14-3-3ζ protein': 1, '1-[4-(Trimethylamino) phenyl]-6-phenylhexa-1, 3, 5-triene: synthesis, fluorescence properties, and use as a fluorescence probe of lipid bilayers': 1, 'Role of aromatic amino acids in lipopolysaccharide and membrane interactions of antimicrobial peptides for use in plant disease control': 1, 'Micelle-bound structures and dynamics of the hinge deleted analog of melittin and its diastereomer: implications in cell selective lysis by D-amino acid containing antimicrobial peptides': 1, 'Structural determinants of the specificity of a membrane binding domain of the scaffold protein Ste5 of budding yeast: implications in signaling by the scaffold protein in MAPK pathway': 1, 'NMR structure, localization, and vesicle fusion of Chikungunya virus fusion peptide': 1, '1H, 13C and 15N chemical shift referencing in biomolecular NMR': 1, 'Double GC: GC mismatch in dsDNA enhances local dynamics retaining the DNA footprint: a highresolution NMR study': 1, 'Indolicidin targets duplex DNA: structural and mechanistic insight through a combination of spectroscopy and microscopy': 1, 'Helical hairpin structure of a potent antimicrobial peptide MSI-594 in lipopolysaccharide micelles by NMR spectroscopy': 1, 'Membrane protein-lipid interactions in mixed micelles studied by NMR spectroscopy with the use of paramagnetic reagents': 1, 'Automated NMR structure calculation with CYANA, Protein NMR Techniques': 1, 'PREDITOR: a web server for predicting protein torsion angle restraints': 1, 'AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR': 1, 'Determination of micelle structure and charge by neutron small-angle scattering': 1, 'Micellar Systems as Solvents in Peptide and Protein Structure Determination': 1, '1H, 13C and 15N random coil NMR chemical shifts of the common amino acids. I. Investigations of nearest-neighbor effects': 1, 'The chemical shift index: a fast and simple method for the assignment of protein secondary structure through NMR': 1, 'The predictive accuracy of secondary chemical shifts is more affected by protein secondary structure than solvent environment': 1, 'Macromolecular NMR spectroscopy for the non-spectroscopist': 1, 'Structure of a conserved Golgi complextargeting signal in coronavirus envelope proteins': 1, 'Mapping polypeptide self-recognition through 1H off-resonance relaxation': 1, 'Structural and thermodynamic analyses of the interaction between melittin and lipopolysaccharide': 1, 'Mechanism of fluorescence concentration quenching of carboxyfluorescein in liposomes: energy transfer to nonfluorescent dimers': 1, 'Direct visualization of membrane leakage induced by the antibiotic peptides: maculatin, citropin, and aurein': 1, 'Direct measurement of protein binding energetics by isothermal titration calorimetry': 1, 'Isothermal titration calorimetry': 1, 'Thermodynamics of protein association reactions: forces contributing to stability': 1, 'Epidemiology, Pathogenesis, and Control of COVID-19. viruses': 1, 'TH17 Responses in Cytokine Storm of COVID-19: An Emerging Target of JAK2 Inhibitor Fedratinib': 3, 'Coronavirus infection, ER stress and Apoptosis': 1, 'COVID-19 infection: the perspectives on immune responses': 1, 'Hypothesis for potential pathogenesis of SARS-CoV-2 infection--a review of immune changes in patients with viral pneumonia': 2, 'Classification and diagnosis of diabetes. Diabetes Care': 1, 'Clinical presentation and diagnosis of diabetes. Diabetes and Primary Care': 1, 'Critical nodes in signalling pathways: insights into insulin action': 2, 'Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome. Experimental & molecular medicine': 3, 'Inflammation and insulin resistance': 9, 'Diabetes mellitus and inflammation. Current diabetes reports': 7, 'Insulin sensitivity: modulation by nutrients and inflammation': 1, 'NF-κB, inflammation, and metabolic disease': 6, 'Ser/Thr phosphorylation of IRS proteins: a molecular basis for insulin resistance': 1, 'SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2': 1, 'Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26': 2, 'DPP-4 (CD26) inhibitor sitagliptin exerts anti-inflammatory effects on rat insulinoma (RINm) cells via suppressing NF-κB activation': 7, 'Analgesic and anti-inflammatory effectiveness of sitagliptin and vildagliptin in mice': 3, 'Dipeptidyl peptidase-4 (CD26): knowing the function before inhibiting the enzyme': 6, 'DPP4 regulates the inflammatory response in a rat model of febrile seizures': 1, 'Sitagliptin exerts an antinflammatory action': 2, 'Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?': 1, 'Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet': 2, 'Inflammation as a Modulator of Host Susceptibility to Pulmonary Influenza, Pneumococcal, and Co-Infections. Front Immunol': 1, 'The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease': 2, 'The nuclear factor NF-kappaB pathway in inflammation': 1, 'The complexity of NF-kappaB signaling in inflammation and cancer': 2, 'NF-kappaB Signaling in Macrophages: Dynamics, Crosstalk, and Signal Integration': 1, 'Nanomodulation of Macrophages in Multiple Sclerosis. Cells': 1, 'NF-kappaB: roles and regulation in different CD4(+) T-cell subsets': 2, 'Pattern recognition receptors and inflammation': 1, 'Immune phenotyping based on neutrophil-to-lymphocyte ratio and IgG predicts disease severity and outcome for patients with COVID-19': 1, 'Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID-19 patients': 1, 'Markers of inflammation and hemodynamic measurements in obesity: Copenhagen City Heart Study. American journal of hypertension': 2, 'Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development': 1, 'T-ing up inflammation in fat': 1, 'Molecular mechanisms of inflammation in obesity-linked insulin resistance': 1, 'Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections': 2, 'Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB. Nature medicine': 1, 'IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α-and obesity-induced insulin resistance': 1, 'Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy': 1, 'Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?': 3, 'COVID-19 Pandemic, Corona Viruses, and Diabetes Mellitus': 2, 'Reduced Mycobacterium tuberculosis association with monocytes from diabetes patients that have poor glucose control': 3, 'The alteration of Th1/Th2/Th17/Treg paradigm in patients with type 2 diabetes mellitus: relationship with diabetic nephropathy': 1, 'An effective treatment approach of DPP-IV inhibitor encapsulated polymeric nanoparticles conjugated with anti-CD-4 mAb for type 1 diabetes': 1, 'An effective delivery system of sitagliptin using optimized mucoadhesive nanoparticles': 1, 'DPP-4 (CD26) inhibitor alogliptin inhibits TLR4-mediated ERK activation and ERKdependent MMP-1 expression by U937 histiocytes': 1, \"Neuroprotective activity of sitagliptin via reduction of neuroinflammation beyond the incretin effect: Focus on Alzheimer's disease\": 1, 'The toughest triage -allocating ventilators in a pandemic': 2, 'Effect of noninvasive ventilation delivered by helmet vs face mask on the rate of endotracheal intubation in patients with acute respiratory distress syndrome: a randomized clinical trial': 1, 'Critical care management of patients with COVID-19: early experience in Thailand': 1, 'Rising to the challenge of COVID-19: advice for pulmonary and critical care and an agenda for research': 1, 'Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area': 1, 'Is sleep medicine \"essential': 1, 'Association between physician burnout and patient safety, professionalism, and patient satisfaction': 1, 'Sleep, fatigue and burnout among physicians: an American Academy of Sleep Medicine position statement': 1, 'Epidemiology of respiratory syncytial virus infection in Washington, DC: importance of the virus in different respiratory tract syndrome and temporal distribution of infection': 1, 'Epidemiology of respiratory syncytial virus infection among infants and children in Chicago': 1, 'Respiratory syncytial virus and other infections in persons with chronic cardiopulmonary disease': 1, 'Viral respiratory infections in the institutionalized elderly: clinical and epidemiologic ®ndings': 3, 'Evaluation of four methods for the diagnosis of respiratory syncytial virus infection in older adults': 3, 'Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults': 1, 'Respiratory syncytial virus infections within families': 2, 'Respiratory syncytial virus infection in adults: clinical, virologic, and serial pulmonary function studies': 2, 'Rapid diagnosis of respiratory syncytial virus infections in immunocompromised adults': 2, 'Detection of respiratory syncytial virus by RNA-polymerase chain reaction and differentiation of subgroups with oligonucleotide probes': 1, 'Detection of respiratory syncytial virus by reverse transcription-PCR and hybridization with a DNA enzyme immunoassay': 1, 'Diagnosis of viral respiratory tract infections in children by using a reverse transcription-PCR panel': 1, 'Improved detection of respiratory syncytial virus in nasal aspirates by seminested RT-PCR': 1, 'Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community': 1, 'Evaluation of the live attenuated cpts 248/404 RSV vaccine in combination with a subunit RSV vaccine (PFP-2) in healthy young and older adults': 3, 'Simpli®ed sample processing combined with a sensitive one-tube nested PCR assay for detection of Pneumocystis carinii in respiratory specimens': 1, 'Nucleotide sequence of the gene encoding the fusion (F) glycoprotein of human respiratory syncytial virus': 1, 'Respiratory syncytial virus': 1, 'A method for nested PCR with single closed reaction tubes': 1, 'Direct genotype detection of Mycobacterium tuberculosis rifampin resistance in clinical specimens by using single-tube heminested PCR': 1, 'Severe Salje, H': 1, 'bbmle: Tools for general maximum likelihood estimation': 11, 'Ecological models and data in R': 1, 'Centers for Disease Control and Prevention. National, Regional, and State Level Outpatient Illness and Viral Surveillance 2020': 5, 'Early Detection of Covid-19 through a Citywide Pandemic Surveillance Platform': 8, 'Cryptic transmission of SARS-CoV-2 in Washington State': 1, 'SARS-CoV-2 detection in patients with influenza-like illness': 4, 'Influenza Surveillance System: Purpose and Methods | CDC 2020': 1, 'Risk for Transportation of 2019 Novel Coronavirus Disease from Wuhan to Other Cities in China': 1, 'Learning deep features for one-class classification': 2, 'Ocmst: One-class novelty detection using convolutional neural network and minimum spanning trees': 1, 'Using two-class classifiers for multiclass classification 2': 1, 'Dynamic ensemble selection for multi-class classification with one-class classifiers': 1, 'Estimating the support of a high-dimensional distribution': 2, 'Minimum spanning tree based one-class classifier': 4, 'A classification methodology based on subspace graphs learning': 5, 'Binary classification using pairs of minimum spanning trees or n-ary trees': 7, 'Fast structural ensemble for one-class classification': 3, 'Deep one-class classification': 1, 'One-class kernel subspace ensemble for medical image classification': 1, 'Detecting anomalous data using auto-encoders': 1, 'A hybrid semi-supervised anomaly detection model for high-dimensional data': 1, 'Deep learning with support vector data description': 1, 'Anomaly detection using oneclass neural networks': 1, 'Multi-modality in one-class classification': 1, 'Modular ensembles for one-class classification based on density analysis': 1, 'Support vector data description': 1, 'Hierarchical community detection in social networks based on micro-community and minimum spanning tree': 1, 'Biological signaling pathways and potential mathematical network representations: biological discovery through optimization': 1, 'General election effect on the network topology of pakistans stock market: network-based study of a political event': 1, 'Sur leséquations algébriques ayant toutes leurs racines réelles': 1, 'Dynamic hypersphere svdd without describing boundary for one-class classification': 1, 'Preparedness and education in airway management': 2, 'Major complications of airway management in the UK: results of the 4th National Audit Project of the Royal College of Anaesthetists and the Difficult Airway Society. Part 1 Anaesthesia': 2, 'Royal College of Anaesthetists': 1, \"Preparing for, and more importantly preventing, 'cannot intubate, cannot oxygenate' events\": 1, 'A national survey of practical airway training in UK anaesthetic departments. Time for a national strategy': 1, 'Covert skill learning in a cortical-basal ganglia circuit': 1, 'Difficult Airway Society 2015 guidelines for management of unanticipated difficult intubation in adults. Difficult Airway Society intubation guidelines working group': 6, 'Training time and consultant practice': 1, 'Defining and developing expertise in tracheal intubation using a GlideScope® for anaesthetists with expertise in Macintosh laryngoscopy: an in-vivo longitudinal study': 1, 'Universal videolaryngoscopy: a structured approach to conversion to videolaryngoscopy for all intubations in an anaesthetic and intensive care department': 1, 'The Availability of Advanced Airway Equipment and Experience with Videolaryngoscopy in the UK: Two UK Surveys': 1, 'Videoassisted instruction improves the success rate for tracheal intubation by novices': 1, 'Videolaryngoscopy as a new standard of care': 1, 'Heuristic decision making in medicine': 3, 'Can There Ever Be Too Many Options? A Meta-Analytic Review of Choice Overload': 1, 'Hurry up and decide: Empirical tests of the choice overload effect using cognitive process models': 1, \"Time to abandon the 'vintage' laryngeal mask airway and adopt second-generation supraglottic airway devices as first choice\": 1, 'Guidelines for the management of tracheal intubation in critically ill adults': 1, 'The Airway Lead -opportunities to improve institutional and personal preparedness for airway management': 1, \"Surgical intervention during a Can't intubate Can't\": 1, 'Front of neck access: A survey among anesthetists and surgeons': 1, \"Institutional preparedness to prevent and manage anaesthesiarelated 'can't intubate, can't oxygenate' events in Australian and New Zealand teaching hospitals\": 1, 'Videolaryngoscope assisted fibreoptic intubation for tracheal tube exchange in a difficult airway': 1, 'Consensus guidelines for managing the airway in patients with COVID-19. Guidelines from the Difficult Airway Society, the Association of Anaesthetists the Intensive Care Society, the Faculty of Intensive Care Medicine and the Royal College of Anaesthetists': 3, 'Consensus statement: Safe Airway Society principles of airway management and tracheal intubation specific to the COVID-19 adult patient group': 2, \"Florida's ESSENCE system: from syndromic surveillance to routine epidemiologic analysis across syndromic and nonsyndromic data sources (Abstract)\": 1, 'History of public health surveillance': 1, 'Blueprint for a National Public Health Surveillance System for the 21st Century': 1, 'Status of state electronic disease surveillance systems -United States': 1, 'Prioritizing investigations of reported cases of selected enteric infections. Paper presented at Council of State and Territorial Epidemiologists': 1, 'Nationally notifi able disease surveillance system case defi nitions': 1, 'Association of State and Territorial Health Offi cers. Biosense 2.0 governance': 1, 'Updated guidelines for evaluating public health surveillance systems, recommendations from the Guidelines Working Group': 1, 'Design and operation of local and state infectious disease surveillance systems': 1, 'Oxford handbook of public health practice': 1, 'Behavioral risk factor surveillance system': 1, 'Overview of infl uenza surveillance in the United States': 1, 'International Society for Disease Surveillance Meaningful Use Workgroup. Final recommendation: core processes and EHR requirements for public health syndromic surveillance': 1, 'Electronic syndromic surveillance using hospital in patient and ambulatory clinical care electronic health record data': 1, 'National Program of Cancer Registries': 1, 'Coverdell National Acute Stroke Registry Surveillance -four states': 1, 'Atlanta Congenital Defects Program (MACDP)': 1, 'North American Association of Central Cancer Registries, Inc. (NAACCR). Implementation guidelines and recommendations': 1, 'Report on birth defects in Florida': 1, 'A comparison of two surveillance strategies for selected birth defects in Florida': 1, 'Online food and waterborne illness complaint form': 1, 'Biosurveillance plan for human health, version 2.0. Atlanta': 1, 'National Notifi able Diseases Surveillance System (NNDSS), CDC. Accessed at http:// wwwn.cdc.gov/nndss/ on': 1, 'Available from www.coast2coastin-formatics.com': 1, 'National Electronic Laboratory Reporting (ELR) Snapshot Survey. Available from www.coast2coastinformatics.com . Cited': 1, 'Statewide system of electronic notifi able disease reporting from clinical laboratories: comparing automated reporting with conventional methods': 1, 'A comparison of the completeness and timeliness of automated electronic laboratory reporting and spontaneous reporting of notifi able conditions': 1, 'Potential effects of electronic laboratory reporting on improving timeliness of infectious disease notifi cation -Florida': 1, 'Health Level Seven (HL7 ® ) homepage. Available at': 1, 'Logical Observation Identifi ers Names and Codes (LOINC ® )': 1, 'Systematized Nomenclature of Medicine-Clinical Terms (SNOMED CT ® )': 1, 'See for example section 64D-3.031(5) of the Florida Administrative Code: notifi cation by laboratories': 1, 'Public health emergency preparedness cooperative agreement, budget period 1, performance measures specifi cation and implementation guidance, at-a-glance summary': 1, 'Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses': 2, 'Epidemiological, molecular, and clinical features of enterovirus respiratory infections in French children between 1999 and': 2, 'Enteroviruses in Spain over the decade 1998-2007: virological and epidemiological studies': 2, 'Enterovirus 68 in children with acute respiratory tract infections': 2, 'Prevalence of human respiratory viruses in adults with acute respiratory tract infections in Beijing': 2, 'Sensitive, seminested PCR amplifi cation of VP1 sequences for direct identifi cation of all enterovirus serotypes from original clinical specimens': 1, 'Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classifi cation': 1, 'The Coe virus: an apparently new virus recovered from patients with mild respiratory disease': 1, 'A probable new human picornavirus associated with respiratory diseases': 1, 'Upsurge of human enterovirus 68 infections in patients with severe respiratory tract infections': 2, 'Enterovirus surveillance-United States': 2, 'Enyzme-immunoassay': 1, 'Heterogeneous enzyme immunoassay': 1, 'Enzymelinked immunosorbent assay using staphylococcal protein A for detecting virus antibodies': 1, 'Application of the indirect enzyme labelled antibody microtest to the detection and surveillance of animal disease': 1, 'A solid phase enzyme-linked immunosorbent assay for detection of African swine fever antigen and antibodies': 3, 'Enzyme-linked immunosorbent assay for Aleutian disease virus antibody': 1, 'Detection of chicken antibodies against avian encephalomyelitis virus by an enzyme-linked immunosorbent assay': 1, 'Comparative studies with an enzyme-linked immunosorbent assay (ELISA) for antibodies to avian infectious bronchitis virus': 1, 'Antigen requirements and specificity of a microplate enzyme-linked immunosorbent assay (ELISA) for detecting infectious bronchitis viral antibodies in chicken serum': 1, 'Enzyme-linked immunosorbent assay for the detection of antibodies to infectious bronchitis virus': 1, 'An enzyme-linked immunosorbent assay for detecting avian leukosis sarcoma virus': 1, 'Application of enzyme labelled test in pseudorabies': 1, \"Application of enzymelinked immunosorbent assay for diagnosis of Aujeszky's disease in swine\": 1, \"Enzyme-linked immunosorbent assay for detection of antibodies to Aujeszky's disease virus in pig\": 1, 'Studies on bovine leukosis. VI. Enzyme linked immunosorbent assay for the detection of antibodies to bovine leukosis virus': 1, 'An enzyme linked immunosorbent assay for enzootic bovine leukosis virus antibodies': 1, 'An enzyme linked immunosorbent assay for the des of antibodies to canine adenoviruses': 1, 'Enzyme linked immunosorbent assay for evaluation of antibodies to canine distemper virus': 1, 'Enzyme-linked immunosorbent assay (ELISA) for detection of equine infectious anaemia viral antigen': 1, 'Enzyme-linked immunosorbent assay for diagnosis of equine infectious anaemia': 1, 'ELISA for the serology of FIP virus (feline infectious peritonitis)': 1, 'A test for detection of feline leukemia virus': 1, 'Comparison of ELISA and FA test for the detection of feline leukemia virus': 1, 'Detection of antibodies to bovine infectious rhinotracheitis virus by the ELISA technique': 1, 'An indirect enzyme-linked immunosorbent assay (ELI-SA) for measuring antibodies in chicken infected with infectious bursal disease virus': 1, \"Enzyme-linked immunosorbent assay of serum antibodies to Marek's disease virus in vaccinated chickens\": 1, 'A plaque assay for murine leukemia virus using enzyme coupled antibodies': 1, 'An enzyme immunosorbent assay (ELISA) for detecting chicken anti-reovirus antibody at high sensitivity': 1, 'Micro ELISA test for detecting antibodies to rinderpest virus antigens': 1, 'Evaluation of three immunodiagnostic procedures for porcine strongyloidiosis': 2, 'Application of enzyme linked immunosorbent assay (ELISA) to the detection of calf rotavirus antibodies': 1, 'Enzyme-linked immunosorbent assay for identification of rotaviruses from different animal species': 1, 'Use of electronmicroscopy and enzyme-linked immunosorbent assay for the detection of rotavirus in neonatal calf diarrhoea': 1, 'Rotavirus antibody assay on monkey sera: a comparison of enzyme immunoassay with neutralization and complement fixation test': 1, 'Sensitivity of enzyme-linked immunosorbent assay, complement fixation and haemagglutination inhibition serological tests for detection of Sendal virus antibodies in laboratory mice': 1, 'Development of an enzyme-linked immunosorbent assay for the identification of arthropod-borne togavirus antibodies': 1, 'Enzyme immunoassay with special reference to ELISA techniques': 1, 'Evaluation of dried blood samples as a source of antibody in the micro ELISA test for Babasia divergens': 1, 'Dictyocaulus viviparus in calves: quatitation of antibody activities in sera and respiratory secretions by immunoenzymatic analysis': 1, 'The detection of circulating antibodies against sarcocystis in human and bovine sera by the enzyme linked immunosorbent assay (ELISA) technique': 1, 'Toxocariasis, serological diagnosis by enzyme immunoassay': 1, 'Evaluation of enzyme-linked immunosorbent assay (ELISA) in the serological diagnosis of toxoplasmosis in swine': 1, 'Repeatability of ELISA as a control method for detection of Trichinella spiralis infection in conventionally raised pigs': 1, 'Trichinella spiralis infection in pigs. Comparison of homologous passive cutaneous anaphylactic reactions with the enzyme-linked immunosorbent assay (ELISA)': 1, 'Preventing zoonotic diseases in immunocompromised persons: the role of physicians and veterinarians': 1, 'Pneumonia due to Cryptococcus neoformans in a patient receiving infliximab: possible zoonotic transmission from a pet cockatiel': 1, 'Update: interim guidance for minimizing risk for human lymphocytic choriomeningitis virus infection associated with pet rodents': 1, 'Centers for Disease Control and Prevention. Salmonellosis associated with pet turtles-Wisconsin and Wyoming': 1, 'Outbreak of multidrugresistant Salmonella typhimurium associated with rodents purchased at retail pet stores-United States': 2, 'Update: multistate outbreak of monkeypox-Illinois': 3, 'Streptococcus suis meningitis in an Italian blood donor': 1, 'Streptococcus suis as threat to pigfarmers and abattoir workers': 1, 'Airborne Campylobacter infection in a poultry worker: case report and review of the literature': 1, 'Centers for Disease Control and Prevention. Fatal rat-bite fever⎯Florida and Washington': 1, 'Medical-legal aspects of veterinary public health in private practice': 2, 'US General Accounting Office. West Nile virus outbreak. Lessons for public health preparedness. Washington: The Office': 5, 'Animal health at the crossroads: preventing, detecting, and diagnosing animal diseases': 3, 'The West Nile outbreak of 1999 in New York: the Flushing Hospital experience': 1, 'New emerging zoonoses: a challenge and an opportunity for the veterinary profession': 1, 'The ABCs of bioterrorism for veterinarians, focusing on category A agents': 1, 'The ABCs of bioterrorism for veterinarians, focusing on category B and C agents': 1, 'Risk factors for human disease emergence': 1, 'Diseases of humans and their domestic mammals: pathogen characteristics, host range and the risk of emergence': 1, 'The next influenza pandemic: lessons from Hong Kong': 1, 'Widespread West Nile virus activity, eastern United States': 1, 'The epidemic of West Nile virus in the United States': 1, 'Chronic wasting disease and potential transmission to humans': 1, 'West Nile virus infection of horses': 1, 'Animals and disease. An introduction to the history of comparative medicine': 3, 'Immunological surveillance against altered self components by sensitized T lymphocytes in lymphocytic choriomeningitis': 1, 'Physician-scientists-endangered and essential': 2, 'Emerging opportunities and career paths for the young physician-scientist': 1, 'National need and priorities for veterinarians in biomedical research': 4, 'The role of medical school admissions committees in the decline of physician-scientists': 1, \"Biomedical research and veterinarians: where's Waldo?\": 1, \"Musings of a Connecticut Yankee in King Arthur's court: antemortem analysis of the veterinary profession\": 2, 'The NIH roadmap': 1, 'Critical needs for research in veterinary science': 1, 'Training and Careers': 1, 'Centers for Disease Control and Prevention. FoodNet website': 1, 'SARS and other coronaviruses as causes of pneumonia': 3, 'Middle East respiratory syndrome coronavirus: Another zoonotic betacoronavirus causing SARS-like disease': 2, 'WHO Scientific and Technical Advisory Group for Infectious Hazards. COVID-19: What is next for public health?': 3, 'The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China': 1, 'Pathogenicity and transmissibility of 2019-nCoV: A quick overview and comparison with other emerging viruses': 1, 'Super-spreaders in infectious diseases': 2, 'SARS-CoV-2 induced diarrhoea as onset symptom in patient with COVID-19. Gut. Epub ahead of print 5': 1, 'Evidence of SARS-CoV-2 infection in returning travelers from Wuhan, China': 2, 'Sex difference and smoking predisposition in patients with COVID-19': 3, 'Bulk and single-cell transcriptomics identify tobacco-use disparity in lung gene expression of ACE2, the receptor of 2019-nCov. medRxiv. Epub ahead of print 28': 1, 'COVID-19) outbreak: What the department of endoscopy should know. Gastrointest Endosc. Epub ahead of print 13': 2, 'ASGE guideline for infection control during GI endoscopy': 2, 'Human coronaviruses: insights into environmental resistance and its influence on the development of new antiseptic strategies': 1, 'Implications of COVID-19 for patients with pre-existing digestive diseases. Lancet Gastroenterol. Epub ahead of print 11': 1, \"Switch to adalimumab in patients with Crohn's disease controlled by maintenance infliximab: Prospective randomised SWITCH trial\": 1, 'Coronaviruses and immunosuppressed patients. The facts during the third epidemic. Liver Transpl. Epub ahead of print': 2, 'The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus': 1, 'In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)': 6, 'A trial of lopinavir-ritonavir in adults hospitalized with severe COVID-19': 1, 'Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: A study protocol': 1, 'Differential expression of interferon (IFN) regulatory factors and IFN-stimulated genes at early times after West Nile virus infection of mouse embryo fibroblasts': 1, 'Early production of type I interferon during West Nile virus infection: role for lymphoid tissues in IRF3-independent interferon production': 1, 'Gamma interferon plays a crucial early antiviral role in protection against West Nile virus infection': 1, 'Problem solved? West Nile virus and transfusion safety': 1, 'Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing': 2, 'Emerging vector-borne infections': 1, 'Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera': 1, 'Preparation and immunogenic properties of a recombinant West Nile subunit vaccine': 1, 'CD4 ϩ T cell migration into the cornea is reduced in CXCL9 deficient but not CXCL10 deficient mice following herpes simplex virus type 1 infection': 1, 'Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice': 3, 'Neuronal CXCL10 directs CD8 ϩ T-cell recruitment and control of West Nile virus encephalitis': 1, 'West Nile virus encephalitis: sequential histopathological and immunological events in a murine model of infection': 1, 'High-resolution CRISPR screens reveal fitness genes and genotype-specific cancer liabilities': 3, 'Identification and characterization of essential genes in the human genome': 1, 'Functional genomic landscape of human breast cancer drivers, vulnerabilities, and resistance': 7, 'Defining a cancer dependency map': 2, 'Project DRIVE: a compendium of cancer dependencies and synthetic lethal relationships uncovered by large-scale, deep RNAi screening': 1, 'Gene essentiality profiling reveals gene networks and synthetic lethal interactions with oncogenic Ras': 1, 'Identification of essential genes for cancer immunotherapy': 1, 'Improved estimation of cancer dependencies from large-scale RNAi screens using model-based normalization and data integration': 1, 'Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells': 6, 'Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens': 4, 'Global transcription network incorporating distal regulator binding reveals selective cooperation of cancer drivers and risk genes': 3, 'Reverse engineering of regulatory networks in human B cells': 3, 'The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours': 2, 'Network perturbation by recurrent regulatory variants in cancer': 2, 'BAGEL: a computational framework for identifying essential genes from pooled library screens': 2, 'Essential gene profiles in breast, pancreatic, and ovarian cancer cells': 2, 'Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool': 1, 'Human housekeeping genes, revisited': 1, 'Measuring error rates in genomic perturbation screens: gold standards for human functional genomics': 1, 'Tumor cell dependence on Ran-GTP-directed mitosis': 1, 'Cancer vulnerabilities unveiled by genomic loss': 1, 'Oncogene addiction': 1, 'Synthetic lethality and cancer': 2, 'Activation of the ran GTPase is subject to growth factor regulation and can give rise to cellular transformation': 1, 'Three-dimensional structure of the human DNA-PKcs/Ku70/Ku80 complex assembled on DNA and its implications for DNA DSB repair': 1, 'ASF1a promotes non-homologous end joining repair by facilitating phosphorylation of MDC1 by ATM at double-strand breaks': 1, 'Cancer-specific defects in DNA repair pathways as targets for personalized therapeutic approaches': 3, 'A functional cancer genomics screen identifies a druggable synthetic lethal interaction between MSH3 and PRKDC': 4, 'Novel cancer gene variants and gene fusions of triple-negative breast cancers (TNBCs) reveal their molecular diversity conserved in the patient-derived xenograft (PDX) model': 1, 'Landscape of EGFR signaling network in human cancers: biology and therapeutic response in relation to receptor subcellular locations': 1, 'Nuclear EGFR shuttling induced by ionizing radiation is regulated by phosphorylation at residue Thr654': 1, 'XRCC3 promotes homology-directed repair of DNA damage in mammalian cells': 1, 'Specific killing of BRCA2-deficient tumours with inhibitors of poly (ADP-ribose) polymerase': 1, 'Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy': 1, 'Inhibition of poly (ADP-ribose) polymerase in tumors from BRCA mutation carriers': 1, 'Synthetic lethality between mutation in Atm and DNA-PK (cs) during murine embryogenesis': 1, 'Therapeutic targeting of a robust nononcogene addiction to PRKDC in ATM-defective tumors': 1, 'ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context': 1, 'Rational siRNA design for RNA interference': 1, 'Theano: a CPU and GPU math compiler in Python': 1, 'Why does unsupervised pre-training help deep learning?': 1, 'Regularization and variable selection via the elastic net': 1, 'On the importance of initialization and momentum in deep learning': 1, 'Classification and regression by randomForest. R News': 1, 'Misc functions of the Department of Statistics, Probability Theory Group, TU Wien. R Packag. version 1.6-2': 2, 'Modern applied statistics with S Fourth edition by. World': 1, 'GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers': 1, 'A census of human cancer genes': 1, 'Cancer genome landscapes': 1, \"Cost of preterm birth during initial hospitalization: a care provider's perspective\": 2, 'Inflammation induced preterm labor and birth': 2, 'Preterm labor: one syndrome, many causes': 1, 'Inflammation and preterm birth': 1, 'The epidemiology, etiology, and costs of preterm birth': 2, 'Cost effects of preterm birth: a comparison of health care costs associated with early preterm, late preterm, and full-term birth in the first 3 years after birth': 1, 'A case control study of risk factors and neonatal outcomes of preterm birth': 1, 'Prevalence and clinical significance of sterile intra-amniotic inflammation in patients with preterm labor and intact membranes': 2, 'A review of antibiotic use in pregnancy': 1, 'Antibiotics in pregnancy: are they safe?': 1, 'Disseminated intravascular coagulation, hemoperitoneum, and reversible ischemic neurological deficit complicating anaphylaxis to prophylactic antibiotics during cesarean delivery: a case report and review of literature': 1, 'Antibiotic prophylaxis in cesarean section causing anaphylaxis and intrauterine fetal death': 1, 'Case report: anaphylaxis in pregnancy: a rare cause of neonatal mortality': 1, 'Anaphylaxis during pregnancy': 1, 'Changing patterns in neonatal escherichia coli sepsis and ampicillin resistance in the era of intrapartum antibiotic prophylaxis': 1, 'Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome': 1, 'Could peripartum antibiotics have delayed health consequences for the infant?': 1, 'Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial': 1, 'Antibiotics for preterm rupture of membranes': 1, 'Prophylactic antibiotics for inhibiting preterm labour with intact membrane': 1, 'Antibiotics and preterm labor': 1, 'Antibiotics, pregnancy, and fetal mental illnesses: where is the link?': 1, 'Antibiotic therapy increases the risk of preterm birth in preterm labor without intra-amniotic microbes, but may prolong the gestation period in preterm labor with microbes, evaluated by rapid and high-sensitive PCR system': 2, 'The preterm parturition syndrome': 4, 'Overview of the interleukin-1 family of ligands and receptors': 1, 'The interleukin-1 family: back to the future': 2, 'Leukocyte density and pro-inflammatory cytokine expression in human fetal membranes, decidua, cervix and myometrium before and during labour at term': 1, 'IL-1β and IL-8 in human fetal membranes: changes with gestational age, labor, and culture conditions': 1, 'Novel noncompetitive IL-1 receptor-biased ligand prevents infection-and inflammation-induced preterm birth': 1, 'The natural interleukin-1 receptor antagonist prevents interleukin-l-induced preterm delivery in mice': 1, 'Systemic administration of interleukin-1 induces preterm parturition in mice': 1, 'Integrated review of cytokines in maternal, cord, and newborn blood: part I-associations with preterm birth': 2, 'Infection and labor: III. interleukin-1: a signal for the onset of parturition': 1, 'Positive association of serum interleukin-1β and CRH levels in women with pre-term labor': 1, 'Dexamethasone or interleukin-10 blocks interleukin-1β-induced uterine contractions in pregnant rhesus monkeys': 1, 'The promise of prostaglandins: have they fulfilled their potential as therapeutic targets for the delay of preterm birth?': 1, 'Interleukin-1 stimulates prostaglandin biosynthesis by human amnion': 1, 'A spontaneous induction of fetal membrane prostaglandin production precedes clinical labour': 1, 'Induction of cyclooxygenase-2 expression in human myometrial smooth muscle cells by interleukin-1β: involvement of p38 mitogen-activated protein kinase': 1, 'Role of matrix metalloproteinases in preterm labour': 3, 'Tumor necrosis factor and regulatory T cells': 1, 'The role of tumor necrosis factor α in the biology of uterine fibroids and the related symptoms': 1, 'Signaling via the type I IL-1 and TNF receptors is necessary for bacterially induced preterm labor in a murine model': 1, 'Inhibition of cyclooxygenase-2 prevents inflammation-mediated preterm labor in the mouse': 1, 'An experimental model for intraamniotic infection and preterm labor in rhesus monkeys': 1, 'Pro-inflammatory cytokines induce expression of matrix-metabolizing enzymes in human cervical smooth muscle cells': 1, 'Targeting interleukin-6 signaling in clinic': 1, 'Fetal and early neonatal interleukin-6 response': 1, 'Inflammatory cytokines and spontaneous preterm birth in asymptomatic women: a systematic review': 1, 'Interleukin-6 is an essential determinant of on-time parturition in the mouse': 1, 'Interleukin-6 stimulates prostaglandin production by human amnion and decidual cells': 1, 'Effect of IL-1β and IL-6 on oxytocin secretion in human uterine smooth muscle cells': 1, 'Review on prostaglandin and oxytocin activity in preterm labor': 1, 'Mechanism of interleukin-1β stimulation of human amnion prostaglandin biosynthesis: mediation via a novel inducible cyclooxygenase': 1, 'Toll-like receptor stimulation in cancer: a pro-and anti-tumor double-edged sword': 2, 'Toll-like receptors at the maternal-fetal interface in normal pregnancy and pregnancy complications': 1, 'NF-κB signaling in inflammation': 1, 'Toll-like receptor signaling pathways': 1, 'The role of inflammation and infection in preterm birth': 1, 'Prostaglandins and mechanisms of preterm birth': 1, 'MyD88: a central player in innate immune signaling': 1, 'Toll-like receptors in the uterus, cervix, and placenta: is pregnancy an immunosuppressed state?': 1, 'Toll-like receptor 4 mediates the response of epithelial and stromal cells to lipopolysaccharide in the endometrium': 1, 'Bacterially-induced preterm labor and regulation of prostaglandin-metabolizing enzyme expression in mice: the role of toll-like receptor 4': 1, 'A new model for inflammation-induced preterm birth: the role of platelet-activating factor and toll-like receptor-4': 1, 'Toll-like receptor 4 contributes to uterine activation by upregulating pro-inflammatory cytokine and CAP expression via the NF-κB/P38MAPK signaling pathway during pregnancy': 1, 'Novel toll-like receptor-4 antagonist (+)-naloxone protects mice from inflammation-induced preterm birth': 1, 'Antimicrobial agents induce monocytes to release IL-1α, IL-6, and Tnf and induce lymphocytes to release IL-4 and TNFτ': 1, 'Risk of endotoxemia during the initial phase of gut decontamination with antimicrobial agents': 1, 'Antibiotics promote inflammation through the translocation of native commensal colonic bacteria': 1, 'Correlation of antibiotic-induced endotoxin release and cytokine production in Escherichia coli-inoculated mouse whole blood ex vivo': 1, 'Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways': 1, 'Antibiotics regulate the immune response in both presence and absence of lipopolysaccharide through modulation of Toll-like receptors, cytokine production and phagocytosis in vitro': 1, 'Expression of toll-like receptor 4 and endotoxin responsiveness in mice during perinatal period': 1, 'Maternal endotoxin-induced preterm birth in mice: fetal responses in toll-like receptors, collectins, and cytokines': 1, 'Effect of ceftazidime on systemic cytokine concentrations in rats': 1, 'The American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 169: interim update multifetal gestations: twin, triplet and higher-order multifetal pregnancies': 1, 'World Health Organization. WHO recommendations on interventions to improve preterm birth outcomes': 1, 'National Institute for Health and Care Excellence': 1, 'Clinical guidelines for prevention and management of preterm birth: a systematic review': 1, 'Piezoelectric materials for high temperature sensors': 1, 'High-temperature piezoelectric sensing': 1, 'dielectric and piezoelectric properties of (Pb 1−x Sr x )Nb 1.96 Ti 0.05 O 6 ceramics': 2, 'Properties of substituted PbNb 2 O 6 ceramics and measurement of their low electromechanical coefficients': 1, 'Synthesis and properties of Pb 0.92 Sr 0.08 (Nb 1-y Ta y ) 2 O 6 high Curie temperature piezoelectric ceramics': 1, 'Effects of microstructure and composition on the Curie temperature of lead barium niobate solid solutions': 1, 'Piezoelectric and dielectric properties of PbNb 2 O 6 -based piezoelectric ceramics with high Curie temperature': 1, 'Dielectric and piezoelectric properties of Sm 3+ doped lead barium niobate (PBN) ceramics': 1, 'Effects of CeO 2 doping on electrical properties of lead metaniobate based ceramics': 1, 'Sintering behavior and microwave dielectric properties of Li 4 Mg 3': 1, 'Structure and microwave dielectric properties of BaAl 2 Si 2 O 8 ceramic with Li 2 O-B 2 O 3 sintering additive': 2, 'Effect of LMZBS glass on the microstructure and microwave dielectric properties of monocelsian ceramics': 1, 'Low-temperature sintering and electrical properties of Sr 2 Nb 2 O 7 piezoceramics by CuO addition': 2, 'Excellent piezoelectric properties of PNN-PHT ceramics sintered at low temperature with CuO addition': 2, 'Influence of CuO on the structure and piezoelectric properties of the alkaline niobate-based lead-free ceramics': 1, 'An investigation of chevron notch 3-point bend fracture-toughness speccimen': 1, 'Effects of poling state and pores on fracture toughness of Pb(Zr 0·95 Ti 0·05 )O 3 ferroelectric ceramics': 1, 'Investigation on resonant vibration performances of Fe-doped BiScO 3 -PbTiO 3 ceramics in high-temperature environment': 1, 'Phase ratio, dielectric, ferroelectric, and magnetic properties of BCTZ ceramics with CuO doping synthesized by the solid state combustion technique': 1, 'Effect of microstructure on the dielectric property of ceramics': 1, 'Effects of La on dielectric and piezoelectric properties of Pb 1−x La 2x/3 (Nb 0.95 Ti 0.0625 ) 2 O 6 ceramics': 1, 'Effects of KCl/LiF additives on the structure, phase transitions and dielectric properties of BSPT ceramics': 1, 'Piezoelectric properties of lithium modified silver niobate perovskite single crystals': 1, 'From bench to bountiful harvests: a road map for the next decade of Arabidopsis research': 1, '50 years of Arabidopsis research: highlights and future directions': 1, 'Arabidopsis FLL2 promotes liquid-liquid phase separation of polyadenylation complexes': 1, 'Nucleocytoplasmic partitioning of ARF proteins controls auxin responses in arabidopsis thaliana': 1, 'Mobile PEAR transcription factors integrate positional cues to prime cambial growth': 1, 'Optogenetic manipulation of stomatal kinetics improves carbon assimilation, water use, and growth': 1, 'Mass-spectrometry-based draft of the Arabidopsis proteome': 2, 'Genome Context Viewer: visual exploration of multiple annotated genomes using microsynteny': 1, 'A host-pathogen interactome uncovers phytopathogenic strategies to manipulate plant ABA responses': 1, 'The pan-genome effector-triggered immunity landscape of a host-pathogen interaction': 1, \"An 'eFP-Seq Browser' for visualizing and exploring RNA sequencing data\": 1, 'Directions for research and training in plant omics: Big Questions and Big Data': 1, 'Accelerating structure-function mapping using the ViVa webtool to mine natural variation': 1, 'AraPheno and the AraGWAS Catalog 2020: a major database update including RNA-Seq and knockout mutation data for Arabidopsis thaliana': 1, 'Sustainable funding for biocuration: The Arabidopsis Information Resource (TAIR) as a case study of a subscription-based funding model': 1, 'Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays': 2, 'A cell-based luminescence assay is effective for high-throughput screening of potential influenza antivirals': 1, 'High-throughput screening of a 100,000-compound library for inhibitors of influenza A virus (H3N2)': 1, 'Development and validation of a high-throughput screen for inhibitors of SARS CoV and its application in screening of a 100,000-compound library': 1, 'Fluoxetine is a potent inhibitor of coxsackievirus replication': 1, 'Growth characteristics of human parechovirus 1 to 6 on different cell lines and cross-neutralization of human parechovirus antibodies: a comparison of the cytopathic effect and real time PCR': 1, 'Anti-poliovirus activity of protease inhibitor AG-7404, and assessment of in vitro activity in combination with antiviral capsid inhibitor compounds': 1, 'Molecular mechanisms of endothelial hyperpermeability: Implications in inflammation': 3, 'Mechanisms of disease -atherosclerosis -an inflammatory disease': 1, 'Key differences in TLR3/poly I : C signaling and cytokine induction by human primary cells: A phenomenon absent from murine cell systems': 1, 'A second binding site for double-stranded RNA in TLR3 and consequences for interferon activation': 2, 'Structural basis of toll-like receptor 3 signaling with double-stranded RNA': 1, 'When two strands are better than one: The mediators and modulators of the cellular responses to double-stranded RNA': 1, 'A key role for toll-like receptor-3 in disrupting the hemostasis balance on endothelial cells': 1, 'Extracellular RNA mediates endothelial-cell permeability via vascular endothelial growth factor': 4, 'Activation of endothelial toll-like receptor 3 impairs endothelial function': 1, 'Modulation of doublestranded RNA-mediated gene induction by interferon in human umbilical vein endothelial cells': 1, 'Toll-like receptor signaling': 1, 'TLR3 in antiviral immunity: Key player or bystander?': 1, 'IFN-alpha enhances TLR3-mediated antiviral cytokine expression in human endothelial and epithelial cells by up-regulating TLR3 expression': 1, 'CXCR2/CXCR2 ligand biological axis impairs alveologenesis during dsRNAinduced lung inflammation in mice': 1, 'TLR3 activation stimulates cytokine secretion without altering agonist-induced human small airway contraction or relaxation': 1, 'Long-term activation of TLR3 by poly(I:C) induces inflammation and impairs lung function in mice': 1, 'Doublestranded RNA exacerbates pulmonary allergic reaction through TLR3: Implication of airway epithelium and dendritic cells': 1, 'Double-stranded RNA induces similar pulmonary dysfunction to respiratory syncytial virus in BALB/c mice': 1, 'Signaling mechanism of extracellular RNA in endothelial cells': 1, 'Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation': 1, 'Peripheral blood mononuclear cells increase the permeability of dengue virus-infected endothelial cells in association with downregulation of vascular endothelial cadherin': 3, 'Ca2+ signaling, TRP channels, and endothelial permeability': 1, 'Sustained Ca2+ transfer across mitochondria is essential for mitochondrial Ca2+ buffering, store-operated Ca2+ entry, and Ca2+ store refilling': 1, 'Ion channels and their functional role in vascular endothelium': 2, 'Store-operated calcium entry promotes shape change in pulmonary endothelial cells expressing Trp1': 2, 'Functional role of TRPC channels in the regulation of endothelial permeability': 1, 'Requirement of the inositol trisphosphate receptor for activation of storeoperated Ca2+ channels': 1, 'Ca2+ refilling of the endoplasmic reticulum is largely preserved albeit reduced Ca2+ entry in endothelial cells': 2, 'The sarco/endoplasmic reticulum calcium-ATPase 2b is an endoplasmic reticulum stress-inducible protein': 1, 'Ca2+-pumps and na+-Ca2+-exchangers in coronary artery endothelium versus smooth muscle': 2, 'SERCA pump isoform expression in endothelium of veins and arteries: Every endothelium is not the same': 1, 'Modulation of B-cell endoplasmic reticulum calcium homeostasis by epstein-barr virus latent membrane protein-1 RID E-8501-2011 RID B-2880-2009': 1, 'The exit from G(0) into the cell cycle requires and is controlled by sarco(endo)plasmic reticulum Ca2+ pump': 4, 'Endothelium-derived prostaglandin I-2 controls the migration of eosinophils': 1, 'Alterations in the ankyrin domain of TRPV4 cause congenital distal SMA, scapuloperoneal SMA and HMSN2C': 1, 'A new generation of ca-2+ indicators with greatly improved fluorescence properties': 1, 'Changes induced by hyperosmotic mannitol in cerebral endothelial cells: An atomic force microscopic study': 1, 'Regulation of cerebral endothelial cell morphology by extracellular calcium': 1, 'Protein kinase C modulates pulmonary endothelial permeability: A paradigm for acute lung injury': 1, 'Bluetongue virus and double-stranded RNA increase human vascular permeability: Role of p38 MAPK': 2, 'Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling': 2, 'Phosphatidylinositol 3-kinase regulates Ca2+ signaling in pancreatic acinar cells through inhibition of sarco(endo)plasmic reticulum Ca2+-ATPase': 1, 'Endothelial permeability is controlled by spatially defined cytoskeletal mechanics: Atomic force microscopy force mapping of pulmonary endothelial monolayer': 2, 'Stiffness and heterogeneity of the pulmonary endothelial glycocalyx measured by atomic force microscopy': 1, 'Phospholamban is present in endothelial cells and modulates endothelium-dependent relaxationevidence from phospholamban gene-ablated mice': 1, 'Ca2+-related signaling and protein phosphorylation abnormalities play central roles in a new experimental model of electrical storm': 1, 'Cytokines downregulate the sarcoendoplasmic reticulum pump Ca2+ ATPase 2b and deplete endoplasmic reticulum Ca2+, leading to induction of endoplasmic reticulum stress in pancreatic beta-cells': 1, 'COVID-19 pandemic: impact on psychiatric care in the United States': 1, 'Psychiatrist experience of remote consultations by telephone in an outpatient psychiatric department during the COVID-19 pandemic': 1, 'The global circulation of seasonal infl uenza A (H3N2) viruses': 1, 'United Nations Systems Infl uenza Coordination. Responses to avian infl uenza and state of pandemic readiness: third global progress report. New York: The Coordination and World Bank': 2, 'H5N1 infl uenza-continuing evolution and spread': 1, 'European Centre for Disease Prevention and Control. Report for policymakers. Pandemic preparedness in the European Union, Autumn': 1, 'European Centre for Disease Prevention and Control. Technical report: pandemic infl uenza preparedness in the EU. Status report as of Autumn': 2, 'Pandemic infl uenza preparedness in the Asia-Pacifi c region': 3, 'Pandemic infl uenza preparedness in Africa is a profound challenge for an already distressed region: analysis of national preparedness plans': 1, 'How prepared is Europe for pandemic infl uenza? Analysis of national plans': 1, 'Exercise development guide for validating infl uenza pandemic preparedness plans. Manila: WHO Regional Offi ce for the Western Pacifi c': 1, 'Pandemic infl uenza and hospital resources': 2, 'Strategies for containing an emerging infl uenza pandemic in Southeast Asia': 2, 'Clinical practice guideline for human avian infl uenza (H5N1). Nonthaburi (Thailand): Ministry of Public Health': 1, 'Table top exercises for pandemic infl uenza preparedness at provincial level (guideline for managers and facilitators)': 1, 'Surge capacity associated with restrictions on nonurgent hospital utilization and expected admissions during an infl uenza pandemic: lessons from the Toronto severe acute respiratory syndrome outbreak': 1, 'Hospital emergency surge capacity: an empiric New York statewide survey': 1, 'Containing pandemic infl uenza at the source': 1, 'Avian infl uenza fact sheet': 1, 'Wibulpolprasert S, Pengpaibon P. Integrated strategies to tackle the inequitable distribution of doctors in Thailand: four decades of experience': 1, 'Federal health policy response to Hurricane Katrina: what it was and what it could have been': 1, 'Infl uenza pandemics in Singapore, a tropical, globally connected city': 1, 'Novel human adenovirus strain': 1, 'Analysis of human adenovirus type 19 associated with epidemic keratoconjunctivitis and its reclassification as adenovirus type 64': 2, 'Genetic analysis of a novel human adenovirus with a serologically unique hexon and a recombinant fiber gene': 1, 'Isolation and typing of adenoviruses recovered from military recruits with acute respiratory disease in The Netherlands': 1, 'Molecular epidemiology and brief history of emerging adenovirus 14-associated respiratory disease in the United States': 2, 'Deaths associated with human adenovirus-14p1 infections': 1, 'First reported cases of human adenovirus serotype 14p1 infection': 1, 'Genome sequence of the first human adenovirus type 14 isolated in China': 2, 'Severe community-acquired pneumonia caused by adenovirus type 11 in immunocompetent adults in Beijing': 1, 'Complete genome sequence of human adenovirus prototype 17': 1, 'Genome sequences of human adenovirus 14 isolates from mild respiratory cases and a fatal pneumonia, isolated during 2006-2007 epidemics in North America': 1, 'Genome typing of adenovirus strains isolated from conjunctivitis in Japan, Australia, and the Philippines': 1, 'Outbreak of acute respiratory disease in China caused by B2 species of adenovirus type 11': 2, 'Genomic analyses of recombinant adenovirus type 11a in China': 1, 'Evidence of molecular evolution driven by recombination events influencing tropism in a novel human adenovirus that causes epidemic keratoconjunctivitis': 1, 'Spread of epidemic keratoconjunctivitis due to a novel serotype of human adenovirus in Japan': 1, 'Computational analysis and identification of an emergent human adenovirus pathogen implicated in a respiratory fatality': 1, 'Overreliance on the hexon gene, leading to misclassification of human adenoviruses': 1, 'Computational analysis of human adenovirus type 22 provides evidence for recombination among species D human adenoviruses in the penton base gene': 1, 'Epitopes and hemagglutination binding domain on subgenus B:2 adenovirus fibers': 1, 'Computational analysis identifies human adenovirus type 55 as a re-emergent acute respiratory disease pathogen': 3, 'Retrospective study of adenovirus in autopsied pulmonary tissue of pediatric fatal pneumonia in South China': 1, 'Detection of three human adenovirus species in adults with acute respiratory infection in China': 1, 'Adenovirus serotype 7 associated with a severe lower respiratory tract disease outbreak in infants in Shaanxi Province': 1, 'Molecular evolution of human species D adenoviruses': 1, 'Genomic and bioinformatics analysis of HAdV-4, a human adenovirus causing acute respiratory disease: implications for gene therapy and vaccine vector development': 1, 'Genomic and bioinformatics analyses of HAdV-14p, reference strain of a reemerging respiratory pathogen and analysis of B1/B2': 1, 'Using the whole-genome sequence to characterize and name human adenoviruses': 1, 'Sequential reassortments underlie diverse influenza H7N9 genotypes in China': 1, 'The pathology of influenza virus infections': 2, 'Pathogenesis of influenza-induced acute respiratory distress syndrome': 3, 'Intravascular coagulation complicating influenza A virus infection': 1, 'Efficient influenza A virus replication in the respiratory tract requires signals from TLR7 and RIG-I': 1, 'Activation of the NLRP3 inflammasome by IAV virulence protein PB1-F2 contributes to severe pathophysiology and disease': 1, 'Influenza virus activates inflammasomes via its intracellular M2 ion channel': 1, 'Receptor interacting protein kinase 2-mediated mitophagy regulates inflammasome activation during virus infection': 1, 'Multiple roles of the coagulation protease cascade during virus infection': 2, 'Platelet activation and aggregation promote lung inflammation and influenza virus pathogenesis': 3, 'Hemostatic disorders in bird flu infection': 1, 'Autopsy findings in eight patients with fatal H1N1 influenza': 1, 'Pathological changes associated with the 2009 H1N1 virus': 1, 'Novel H1N1 influenza A viral infection complicated by alveolar hemorrhage': 1, 'Lung pathology in fatal novel human influenza A (H1N1) infection': 1, 'Acute myocardial infarction and influenza: a metaanalysis of case-control studies': 1, 'Influenza vaccines for preventing cardiovascular disease': 1, 'Effects on coagulation and fibrinolysis induced by influenza in mice with a reduced capacity to generate activated protein C and a deficiency in plasminogen activator inhibitor type 1': 1, 'Inflammation and coagulation in the cardiovascular system: the contribution of influenza': 3, 'Influenza virus-induced lung injury: pathogenesis and implications for treatment': 2, 'H1N1 influenza (swine flu)-associated thrombotic microangiopathy with a markedly high plasma ratio of von Willebrand factor to ADAMTS13': 1, 'Influenza virus H1N1 activates platelets through FcgammaRIIA signaling and thrombin generation': 1, 'Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury': 3, 'pandemic influenza virus and Streptococcus pneumoniae co-infection results in activation of coagulation and widespread pulmonary thrombosis in mice and humans': 1, 'Procoagulant activity of endothelial cells after infection with respiratory viruses': 1, 'Review: viral infections and mechanisms of thrombosis and bleeding': 1, 'Important roles of platelets as immune cells in the skin': 1, 'Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum': 1, 'Innate immunity and coagulation': 1, 'Emerging evidence for platelets as immune and inflammatory effector cells': 1, 'Plateletneutrophil-interactions: linking hemostasis and inflammation': 2, 'Platelet-neutrophil interactions under thromboinflammatory conditions': 1, 'Platelets and endothelial cells': 1, 'CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells': 1, 'CD40L-positive platelets induce CD40L expression de novo in endothelial cells: adding a loop to microvascular inflammation': 1, 'Clinical findings in 111 cases of influenza A (H7N9) virus infection': 1, 'Thrombocytopenia as a mortality risk factor in acute respiratory failure in H1N1 influenza': 1, 'In vivo platelet activation in critically ill patients with primary 2009 influenza A(H1N1)': 1, 'Measuring inconsistency in meta-analyses': 1, 'A key role for Toll-like receptor-3 in disrupting the hemostasis balance on endothelial cells': 1, 'Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4': 1, 'PAR1 contributes to influenza A virus pathogenicity in mice': 1, 'Protective role for protease-activated receptor-2 against influenza virus pathogenesis via an IFN-gamma-dependent pathway': 1, 'Regulation of inflammatory responses by natural anticoagulants': 1, 'Efficacy and safety of recombinant human activated protein C for severe sepsis': 1, 'Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis': 1, 'Protective effects of activated protein C in sepsis': 1, 'Nebulized activated protein C in a paediatric patient with severe acute respiratory distress syndrome secondary to H1N1 influenza': 1, 'Impact of endogenous protein C on pulmonary coagulation and injury during lethal H1N1 influenza in mice': 1, 'Antithrombin III prevents and rapidly reverses leukocyte recruitment in ischemia/ reperfusion': 1, 'The C-terminal 26-residue peptide of serpin A1 is an inhibitor of HIV-1': 1, 'Influenza A infection triggers thrombotic thrombocytopenic purpura by producing the anti-ADAMTS13 IgG inhibitor': 1, 'Plasminogen receptors and their role in the pathogenesis of inflammatory, autoimmune and malignant disease': 1, 'A novel mechanism for the acquisition of virulence by a human influenza A virus': 2, 'Pathologic mechanisms of influenza encephalitis with an abnormal expression of inflammatory cytokines and accumulation of mini-plasmin': 1, 'Annexin II incorporated into influenza virus particles supports virus replication by converting plasminogen into plasmin': 1, 'Plasminogen promotes influenza A virus replication through an annexin 2-dependent pathway in the absence of neuraminidase': 1, 'A serpin shapes the extracellular environment to prevent influenza A virus maturation': 1, 'Influenza and bacterial superinfection: illuminating the immunologic mechanisms of disease': 1, 'The co-pathogenesis of influenza viruses with bacteria in the lung': 2, 'Insights into the interaction between influenza virus and pneumococcus': 1, 'Immunobiotic lactobacilli reduce viral-associated pulmonary damage through the modulation of inflammation-coagulation interactions': 1, 'Food safety risk analysis: a guide for national food safety authorities. World Health Organization, Food and Agricultural Association of the United Nations': 22, 'Risk profi le: hepatitis A virus infection associated with consumption of fresh and fresh-cut produce': 11, 'Food and agriculture: food policy in the United States: an introduction, Earthscan food and agriculture series': 2, 'Risk communication: a handbook for communicating environmental, safety, and health risks': 1, 'Microbial risk assessment guidelines: pathogenic microorganisms with focus on food and water, EPA/100/J-12/001; USDA/FSIS/2012-001. Prepared by the Interagency Microbiological Risk Assessment Guideline Workgroup Escudero BI': 1, 'Risk assessment. In: Frumkin H (ed) Environmental health -from global to local': 1, 'The WTO agreement on the application of sanitary and phytosanitary measures (SPS agreement)': 1, 'Human rotavirus studies in volunteers: determination of infectious dose and serological responses to infection': 4, 'Quantitative approach of risk management strategies for hepatitis A virus-contaminated oyster production areas': 6, 'Studies of echovirus-12 in volunteers: determination of minimal infectious dose and the effect of previous infection on infectious dose': 3, 'Quantitative exposure model for the transmission of norovirus in retail food preparation': 5, 'A decision support tool to compare waterborne and foodborne infection and/or illness risks associated with climate change': 1, 'Health risks in wastewater irrigation: comparing estimates from quantitative microbial risk analyses and epidemiological studies': 3, 'Estimation of norovirus infection risks to consumers of wastewater-irrigated food crops eaten raw': 4, 'Microbial risks from wastewater irrigation of salad crops: a screening-level assessment': 3, 'Quantitative farm-to-fork risk assessment model for norovirus and hepatitis A virus in European leafy green vegetable and berry fruit supply chains': 7, 'The Monte Carlo simulation method for system reliability and risk analysis, Springer series in reliability engineering': 5, 'The Monte Carlo method in science and engineering': 3, 'virus: how infectious is it': 1, 'Risk of norovirus gastroenteritis from consumption of vegetables irrigated with highly treated municipal wastewater -evaluation of methods to estimate sewage quality': 5, 'Norwalk virus shedding after experimental human infection': 3, 'Virus inactivation on hard surfaces or in suspension by chemical disinfectants: systematic review and meta-analysis of norovirus surrogates': 2, 'CAC/GL-30 -1999, Codex Alimentarius Commission CAC (2012) Guidelines on the application of general principles of food hygiene to the control of viruses in food': 1, 'Temperature-dependent survival of hepatitis A virus during storage of contaminated onions': 1, 'Institute of Environmental Science & Research Limited report prepared as part of a New Zealand Food Safety Authority contract for scientifi c services': 1, 'Bacterial and viral pathogens in live oysters: 2007 United States market survey': 1, 'Enteric viruses in ready-to-eat packaged leafy greens': 1, 'A survey of Australian oysters for the presence of human noroviruses': 1, 'Prevalence of human noroviruses in frozen marketed shellfi sh, red fruits and fresh vegetables': 2, 'Adenovirus and norovirus contaminants in commercially distributed shellfi sh': 1, 'Qualitative and quantitative assessment of viral contamination in bivalve molluscs harvested in Italy': 1, 'Norovirus contamination on French marketed oysters': 1, 'Impact of the prevalence of different pathogens on the performance of sampling plans in lettuce products': 2, 'Tracing enteric viruses in the European berry fruit supply chain': 1, 'Batch testing for noroviruses in frozen raspberries': 1, 'Survey of Canadian retail pork chops and pork livers for detection of hepatitis E virus, norovirus, and rotavirus using real time RT-PCR': 1, 'Norovirus cross-contamination during preparation of fresh produce': 1, 'Transfer of noroviruses between fi ngers and fomites and food products': 1, 'Tenacity of human norovirus and the surrogates feline calicivirus and murine norovirus during long-term storage on common nonporous food contact surfaces': 1, 'Persistence of caliciviruses on enviromnental surfaces and their transfer to food': 1, 'Evaluation of murine norovirus persistence in environments relevant to food production and processing': 1, 'Persistence of human noroviruses on food preparation surfaces and human hands': 1, 'Comprehensive comparison of cultivable norovirus surrogates in response to different inactivation and disinfection treatments': 1, 'Effi cacy of commonly used disinfectants for inactivation of human noroviruses and their surrogates': 1, 'Simultaneous comparison of murine norovirus, feline calicivirus, coliphage MS2, and GII.4 norovirus to evaluate the effi cacy of sodium hypochlorite against human norovirus on a fecally soiled stainless steel surface': 1, 'Inactivation of hepatitis A virus and norovirus surrogate in suspension and on food-contact surfaces using pulsed UV light (pulsed light inactivation of food-borne viruses)': 1, 'UV light inactivation of hepatitis A virus, Aichi virus, and feline calicivirus on strawberries, green onions, and lettuce': 1, 'Human norovirus inactivation in oysters by high hydrostatic pressure processing: a randomized, double-blinded clinical trial': 1, 'Predictive model for inactivation of feline calicivirus, a norovirus surrogate, by heat and high hydrostatic pressure': 1, 'Inactivation of hepatitis A virus by high-pressure processing: the role of temperature and pressure oscillation': 1, 'Mathematical model for viral depuration kinetics in shellfi sh: an useful tool to estimate the risk for the consumers': 1, 'Thermal inactivation kinetics of human norovirus surrogates and hepatitis A virus in Turkey deli meat': 1, 'Quantifying the reduction in potential health risks by determining the sensitivity of poliovirus type 1 chat strain and rotavirus SA-11 to electron beam irradiation of iceberg lettuce and spinach': 2, 'Susceptibility of murine norovirus and hepatitis A virus to electron beam irradiation in oysters and quantifying the reduction in potential infection risks': 2, 'Minimal infective dose of attenuated polio virus for man': 1, 'Infection by viruses': 1, 'Human infective dose determinations for oral poliovirus type 1 vaccine in infants': 1, 'Sabin type 1 (LSc2ab) oral poliomyelitis vaccine: effect of dose upon response of newborn infants': 1, 'Project summary: determination of minimal infectious dose of an enterovirus in drinking water. United States Environmental Protection Agency': 2, 'Relative infectivity of hepatitis A virus by the oral and intravenous routes in 2 species of nonhuman primates': 1, 'Estimation of risk due to low doses of microorganisms: a comparison of alternative methodologies': 2, 'Determination of the 50% human infectious dose for Norwalk virus': 2, 'Infectivity of GI and GII noroviruses established from oyster related outbreaks': 4, 'Quantitative microbial risk assessment': 2, 'Risk assessment in shellfi sh-borne outbreaks of hepatitis A': 4, 'Quantitative risk assessment for viral contamination of shellfi sh and coastal waters': 1, 'Quantitative microbial risk assessment models for consumption of raw vegetables irrigated with reclaimed water': 3, 'Of: microbial risks from wastewater irrigation of salad crops: a screening-level risk assessment': 2, 'Epidemiology of foodborne norovirus outbreaks': 1, 'Vital signs: foodborne norovirus outbreaks -United States': 1, 'An outbreak of norovirus gastroenteritis associated with wedding cakes': 1, 'Outbreak of norovirus infection among river rafters associated with packaged delicatessen meat': 1, 'Transmission of Norwalk virus during a football game': 1, 'Large outbreak of norovirus: the baker who should have known better': 1, 'Outbreak of small round structured virus gastro-enteritis arose after kitchen assistant vomited': 1, 'A quantitative exposure model simulating human norovirus transmission during preparation of deli sandwiches': 2, 'Are liver pericytes just precursors of myofibroblasts in hepatic diseases? Insights from the crosstalk between perivascular and inflammatory cells in liver injury and repair': 1, 'Interpretation of observational studies': 1, 'Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics': 3, 'Benefits and risks of continuing angiotensin-converting enzyme inhibitors, angiotensin II receptor antagonists, and mineralocorticoid receptor antagonists during hospitalizations for acute heart failure': 1, '2019-nCoV epidemic: Address mental health care to empower society': 1, 'The mental health of medical workers in Wuhan, China dealing with the 2019novel coronavirus': 2, 'Public responses to the novel 2019 coronavirus (2019-nCoV) in Japan: Mental health consequences and target populations': 4, 'The consequences of the COVID-19 pandemic on mental health and implications for clinical practice': 2, 'A preliminary assessment of novel coronavirus (COVID-19) knowledge and perceptions in Nigeria': 1, 'Development of a comprehensive, sustained community mental health system in A': 1, 'The 1995 Kikwit Ebola outbreak: Lessons hospitals and physicians can apply to future viral epidemics. General Hospital Psychiatry': 1, 'Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China': 2, 'Psychosocial and coping responses within the community health care setting towards a national outbreak of an infectious disease': 1, 'The impact of community psychological responses on outbreak control for severe acute respiratory syndrome in Hong Kong': 1, 'Coronavirus: The psychological effects of quarantining a city': 1, 'Is there a case for quarantine? Perspectives from SARS to Ebola. Disaster Medicine and Public Health Preparedness': 1, 'Ebola fight in Africa is hurt by limits on ways to get out': 1, 'Children are dying of preventable diseases all the time in Africa': 1, 'The impact of event scale: Revised': 1, 'A brief measure for assessing generalized anxiety disorder': 1, 'Validity of a brief depression severity measure': 1, 'Validation of the Insomnia Severity Index as an outcome measure for insomnia research': 1, '10 of the deadliest natural disasters': 1, 'Mental health problems and social media exposure during COVID-19 outbreak': 2, 'Posttraumatic stress symptoms and attitude toward crisis mental health services among clinically stable patients with COVID-19 in China': 1, 'Prevalence and predictors of PTSS during COVID-19 outbreak in China hardest-hit areas: Gender difference matter': 2, \"How COVID-19 affects women's sexual and reproductive health\": 1, 'Women are suffering domestic violence because of COVID-19': 1, 'Sleep problems: An emerging global epidemic? Findings from the indepth WHO-sage study among more than 40,000 older adults from 8 countries across Africa and Asia': 1, 'Sex differences in insomnia: A meta-analysis': 1, 'Gender differences influence over insomnia in Korean population: A cross-sectional study': 1, 'Cultural beliefs fuel domestic violence. Archived from the original on september': 1, 'Opportunities to expand telehealth use amid the coronavirus pandemic': 1, 'Epidemiology, practice of ventilation and outcome for patients at increased risk of postoperative pulmonary complications: LAS VEGAS -an observational study in 29 countries': 4, 'Incidence of mortality and morbidity related to postoperative lung injury in patients who have undergone abdominal or thoracic surgery: a systematic review and meta-analysis': 2, 'Prediction of postoperative pulmonary complications in a population-based surgical cohort': 2, 'Prospective external validation of a predictive score for postoperative pulmonary complications': 2, 'Mortality after surgery in Europe: a 7 day cohort study': 1, 'Prediction of postoperative pulmonary complications': 1, 'Postoperative pulmonary complications': 2, 'Pulmonary atelectasis: a pathogenic perioperative entity': 2, 'A trial of intraoperative low-tidal-volume ventilation in abdominal surgery': 3, 'Effect of lung protection mechanical ventilation on respiratory function in the elderly undergoing spinal fusion': 2, 'Protective mechanical ventilation during general anesthesia for open abdominal surgery improves postoperative pulmonary function': 4, 'High versus low positive end-expiratory pressure during general anaesthesia for open abdominal surgery (PROVHILO trial): a multicentre randomised controlled trial': 9, 'Effect of intraoperative high positive end-expiratory pressure (PEEP) with recruitment maneuvers vs low PEEP on postoperative pulmonary complications in obese patients: a randomized clinical trial': 6, 'Association between driving pressure and development of postoperative pulmonary complications in patients undergoing mechanical ventilation for general anaesthesia: a meta-analysis of individual patient data': 2, 'Individualised perioperative open-lung approach versus standard protective ventilation in abdominal surgery (iPROVE): a randomised controlled trial': 8, 'Driving pressure during thoracic surgery: a randomized clinical trial': 3, 'The fragility of statistically significant findings in randomised controlled anaesthesiology trials: systematic review of the medical literature': 1, 'The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome': 1, 'American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care': 2, 'Standards for definitions and use of outcome measures for clinical effectiveness research in perioperative medicine: European Perioperative Clinical Outcome (EPCO) definitions: a statement from the ESA-ESICM joint taskforce on perioperative outcome measures': 2, 'Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury': 1, 'Rationale and study design for an individualised perioperative open-lung ventilatory strategy with a high versus conventional inspiratory oxygen fraction (iPROVE-O2) and its effects on surgical site infection: study protocol for a randomised controlled trial': 1, 'Protective versus conventional ventilation for surgery: a systematic review and individual patient data meta-analysis': 2, 'Lung protective ventilation in patients undergoing major surgery: a systematic review incorporating a Bayesian approach': 1, 'A meta-analysis of intraoperative ventilation strategies to prevent pulmonary complications: is low tidal volume alone sufficient to protect healthy lungs?': 1, 'Intraoperative protective mechanical ventilation for prevention of postoperative pulmonary complications: a comprehensive review of the role of tidal volume, positive end-expiratory pressure, and lung recruitment maneuvers': 2, 'Inspiratory vs. expiratory pressure-volume curves to set end-expiratory pressure in acute lung injury': 1, 'Individual positive end-expiratory pressure settings optimize intraoperative mechanical ventilation and reduce postoperative atelectasis': 2, \"Alveolar recruitment strategy' improves arterial oxygenation during general anaesthesia\": 1, 'Treatment of anesthesia-induced lung collapse with lung recruitment maneuvers': 1, 'Pulmonary densities during anesthesia with muscular relaxation--a proposal of atelectasis': 1, 'Analysis of lung density by computed tomography before and during general anaesthesia': 1, 'Positive end-expiratory pressure prevents atelectasis during general anaesthesia even in the presence of a high inspired oxygen concentration': 1, 'Intraoperative protective mechanical ventilation and risk of postoperative respiratory complications: hospital based registry study': 1, 'Prevention of atelectasis in morbidly obese patients during general anesthesia and paralysis: a computerized tomography study': 1, 'Total respiratory system, lung, and chest wall mechanics in sedated-paralyzed postoperative morbidly obese patients': 1, 'The effects of body mass on lung volumes, respiratory mechanics, and gas exchange during general anesthesia': 2, 'Perioperative management of obese patients': 1, 'Value and limitations of transpulmonary pressure calculations during intra-abdominal hypertension': 1, 'Intraoperative recruitment maneuver reverses detrimental pneumoperitoneum-induced respiratory effects in healthy weight and obese patients undergoing laparoscopy': 1, 'Abdominal distension alters regional pleural pressures and chest wall mechanics in pigs in vivo': 1, 'Recoding: reprogrammed genetic decoding': 2, 'Expression of peptide chain release factor 2 requires high-efficiency frameshift': 1, 'Slippery runs, shifty stops, backward steps, and forward hops: -2, -1, +1, +2, +5 and +6 ribosomal frameshifting': 2, 'Use of tRNA suppressors to probe regulation of Escherichia coil release fac!or 2': 2, 'Ornithine decarboxylase antizymes': 1, 'Recent advances in the biochemistry of polyamines in eukaryotes': 1, 'Amine synthesis in regenerating rat liver: extremely rapid turnover of ornithine decarboxylase': 1, 'Multiple mechanisms for the regulation of mammalian ornithine decarboxylase': 1, 'Destabilization of ornithine decarboxylase by transfected antizyme gene expression in hepatoma tissue culture cells': 4, 'Antizyme, a protein induced by polyamines, accelerates the degradation of ornithine decarboxylase in Chinese-hamster ovarycell extracts': 1, 'Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination': 1, 'ATP-and antizyme-dependent endoproteolysis of ornithine decarboxylase to oligopeptides by the 26S proteasome': 1, 'Degradation of ornithine decarboxylase: exposure of the C-terminal target by a polyamine-inducible inhibitory protein': 1, 'Distinct domains of antizyme required for binding and proteolysis of ornithine decarboxylase': 1, 'Functional regions of ornithine decarboxylase antizyme': 1, 'Intracellular protein degradation in mammalian and bacterial cells: part 2': 1, 'The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53': 1, 'Feedback repression of polyamine transport is mediated by antizyme in mammalian tissue-culture cells': 2, 'Antizyme protects against abnormal accumulation and toxicity of polyamines in ornithine decarboxylase-overproducing cells': 2, 'The appearance of an ornithine decarboxylase inhibitory protein upon the addition of putrescine to cell cultures': 1, 'Monoclonal antibody studies on the properties and regulation of murine ornithine decarboxylase antizymes': 2, 'Analyses of ornithine decarboxylase antizyme mRNA with a cDNA cloned from rat liver': 6, 'Enhanced differential synthesis of proteins in a mammalian cell-free system by addition of polyamines': 2, 'RNA pseudoknots: translational frameshifting and readthrough on viral': 2, 'Cloning and characterization of a rat gene encoding omithine decarboxylase antizyme': 2, 'Polyamines regulate the expression of omithine decarboxylase antizyme in vitro by inducing ribosomal frame-shifting': 1, 'Purification and some properties of a protein inhibitor (antizyme) of ornithine decarboxylase from rat liver': 1, 'Transitional frameshifting mediated by a viral sequence in plant cells': 1, 'Characterization of an efficient coronavirus ribosomal frameshiftJng signal: requirement for an RNA pseudoknot': 1, 'An RNA pseudoknot and an optimal heptameric shift site are required for highly efficient ribosomal frameshifting on a retroviral messenger RNA': 1, 'A new principle of RNA folding based on pseudoknotting': 1, 'Discontinuous triplet decoding with, or without, re-pairing by peptidy! tRNA': 1, 'A novel programed frameshift expresses the POL3 gene of retrotransposon Ty3 of yeast: frameshifting without tRNA slippage': 1, 'Coding from a distance: dissection of the mRNA determinants required for the incorporation of selenocysteine into protein': 1, 'Spermidine deficiency increases +1 ribosomal frameshifting efficiency and inhibits Tyl retrotransposition in Saccharomyces cerevisiae': 1, 'A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions': 1, \"High efficiency T7 polymerase synthesis of infectious RNA from cloned brome mosaic virus cDNA and effects of 5' extensions on transcript infectivity\": 1, 'Vectors for constitutive and inducible gene expression in yeast': 1, 'Inhibition of translation of mRNAs for ornithine decarboxylase and S-adenosylmethionine decarboxylase by polyamines': 2, 'Apremilast (Otezla): a new oral treatment for adults with psoriasis and psoriatic arthritis': 2, 'Apremilast for a psoriasis patient with HIV and hepatitis C': 1, 'Apremilast ameliorates carfilzomib-induced pulmonary inflammation and vascular injuries': 1, 'The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality': 5, 'SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor': 1, 'A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score': 1, 'Practical diagnosis and treatment of suspected venous thromboembolism during COVID-19 pandemic': 1, 'Acute pulmonary embolism in COVID-19 patients on CT angiography and relationship to D-dimer levels': 1, 'Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients': 1, 'Importance of the nef gene for maintenance of high virus loads and for development of AIDS': 1, 'Absence of Intact nef Sequences in a Long-Term Survivor with Nonprogressive HIV-1 Infection': 1, 'Nef from primary isolates of human immunodeficiency virus type 1 suppresses surface CD4 expression in human and mouse T cells': 1, 'CD4 down-regulation by nef alleles isolated from human immunodeficiency virus type 1-infected individuals': 1, 'Serine phosphorylation-independent downregulation of cellsurface CD4 by nef': 1, 'Human immunodeficiency virus Nef induces rapid internalization of the T-cell coreceptor CD8alphabeta': 1, 'Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein': 1, 'Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene': 1, 'Human immunodeficiency virus type 1 Nef functions at the level of virus entry by enhancing cytoplasmic delivery of virions': 1, 'Nef Does Not Affect the Efficiency of Human Immunodeficiency Virus Type 1 Fusion with Target Cells': 1, 'Disruption of the actin cytoskeleton can complement the ability of Nef to enhance human immunodeficiency virus type 1 infectivity': 1, 'HIV-1 virion fusion assay: uncoating not required and no effect of Nef on fusion': 1, 'The membrane-proximal tyrosine-based sorting signal of human immunodeficiency virus type 1 gp41 is required for optimal viral infectivity': 1, 'Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell': 1, 'Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis': 1, 'HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation': 13, 'SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef': 8, 'SERINC5 protein inhibits HIV-1 fusion pore formation by promoting functional inactivation of envelope glycoproteins': 4, 'The Antagonism of HIV-1 Nef to SERINC5 Particle Infectivity Restriction Involves the Counteraction of Virion-Associated Pools of the Restriction Factor': 1, 'The Potency of Nef-Mediated SERINC5 Antagonism Correlates with the Prevalence of Primate Lentiviruses in the Wild': 1, 'S2 from equine infectious anemia virus is an infectivity factor which counteracts the retroviral inhibitors SERINC5 and SERINC3': 2, 'MLV glycosylated-Gag is an infectivity factor that rescues Nef-deficient HIV-1': 1, 'Functional Interplay Between Murine Leukemia Virus Glycogag, Serinc5, and Surface Glycoprotein Governs Virus Entry, with Opposite Effects on Gammaretroviral and Ebolavirus Glycoproteins': 8, 'Nef decreases HIV-1 sensitivity to neutralizing antibodies that target the membrane-proximal external region of TMgp41': 4, 'HIV-1 Nef responsiveness is determined by Env variable regions involved in trimer association and correlates with neutralization sensitivity': 2, 'Variant influenza virus hemagglutinin that induces fusion at elevated pH': 1, 'Ebola virus entry requires the cholesterol transporter Niemann-Pick C1': 2, 'Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection': 2, 'Ebola Virus Glycoprotein with Increased Infectivity Dominated the 2013-2016 Epidemic': 1, 'Human Adaptation of Ebola Virus during the West African Outbreak': 1, 'Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein': 1, 'Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions': 1, 'Mutation of the dominant endocytosis motif in human immunodeficiency virus type 1 gp41 can complement matrix mutations without increasing Env incorporation': 1, 'Retained in vitro infectivity and cytopathogenicity of HIV-1 despite truncation of the C-terminal tail of the env gene product': 1, 'Disputes mire BWC review conference. Arms control today': 1, 'Biotechnology and the american media: The policy process and the elite press': 1, 'The public and nanotechnology: How citizens make sense of emerging technologies': 1, 'The Oxford handbook of the science of science communication': 1, 'Biotechnology E-commerce: A disruptive challenge to biological arms control': 1, 'Deadly cultures: Biological weapons since 1945': 1, 'Preventing biological threats: What you can doBradford, UK: Bradford Disarmament Research Centre': 1, \"Flu researcher ron fouchier: 'It's a pity that it has to come to this' science\": 1, 'United States Government policy for institutional oversight of life sciences DURC': 1, 'Flu researcher ron fouchier loses legal fight over H5N1 studies. Science': 1, 'United States government policy for oversight of life sciences dual use research of concern': 1, 'Risk and benefit analysis of gain of function research draft final reportTakoma Park': 1, 'White paper: Gain-of-function research: Ethical analysis': 1, 'Recommendations for the evaluation and oversight of proposed gain-of-function research: A report of the national science advisory board for biosecurityWashington, DC: National Institutes of Health': 1, 'NIH lifts 3-year ban on funding risky virus studies. Science': 1, 'NIH lifts ban on research that could make deadly viruses even worse. National Public Radio': 1, \"Global partnership against weapons and materials of mass destruction: President's report for 2013London: Foreign and Commonwealth Office\": 1, 'The Great Influenza: The Story of the Deadliest Pandemic in History': 1, 'influenza: the mother of all pandemics': 1, 'The 1918-1919 influenza pandemic in England and Wales: spatial patterns in transmissibility and mortality impact': 3, 'Excess mortality associated with influenza epidemics in Portugal': 1, 'Spatial dynamics of the 1918 influenza pandemic in England, Wales and the United States': 3, 'Mortality from the influenza pandemic of 1918-19 in Indonesia': 1, 'Deaths associated with influenza pandemic of 1918-19': 1, 'The influenza pandemic of 1918-1919 in Sri Lanka: its demographic cost, timing, and propagation. Influenza Other Respir Viruses': 1, 'Influenza pandemics in Singapore, a tropical, globally connected city': 1, 'Mortality from the influenza pandemic of 1918-1919: the case of India': 2, 'Excess deaths and immunoprotection during 1918-1920 influenza pandemic': 1, 'A comparative study of the 1918-1920 influenza pandemic in Japan, USA and UK: mortality impact and implications for pandemic planning': 1, 'The evolution of pandemic influenza: evidence from India': 6, 'The pandemic of influenza in India in the year 1918': 3, 'Influenza in India 1918: excess mortality reassessed': 2, 'The shifting demographic landscape of pandemic influenza': 1, 'Epidemiologic characterization of the 1918 influenza pandemic summer wave in copenhagen: implications for pandemic control strategies': 2, 'The El Niño-Southern Oscillation (ENSO)-pandemic Influenza connection: coincident or causal?': 2, 'Inferring the causes of the three waves of the 1918 influenza pandemic in England and Wales': 2, 'Global environmental drivers of influenza': 1, 'Influenza sentinel surveillance in Rwanda': 1, 'Epidemiology of seasonal influenza in Bangkok between 2009 and 2012': 1, 'The role of temperature and humidity on seasonal influenza in tropical areas: Guatemala, El Salvador and Panama': 1, 'Seasonality of influenza in the tropics: a distinct pattern in northeastern Brazil': 1, 'Global influenza seasonality: reconciling patterns across temperate and tropical regions': 2, 'Trade routes and plague transmission in pre-industrial Europe': 1, 'Spatial spread of the West Africa Ebola epidemic': 1, 'Spread of Zika virus in the Americas': 1, 'Boats, trains, and immunity: The spread of the spanish flu on the island of Newfoundland': 1, 'Transmissibility and geographic spread of the 1889 influenza pandemic': 1, \"Statistical Abstract Relating to British India from 1910-11 to 1919-20. London, United Kingdom: His Majesty's Stationary Office\": 2, 'Annual Report of the Sanitary Commissioner With the Government of India for 1916. Calcutta, India: Superintendent Government Printing': 2, 'Annual Report of the Sanitary Commissioner With the Government of India for 1917. Calcutta, India: Superintendent Government Printing': 2, 'Annual Report of the Sanitary Commissioner With the Government of India for 1918. Calcutta, India: Superintendent Government Printing': 2, 'Annual Report of the Sanitary Commissioner With the Government of India for 1919. Calcutta, India: Superintendent Government Printing': 2, 'Annual Report of the Sanitary Commissioner With the Government of India for 1920. Calcutta, India: Superintendent Government Printing': 2, 'Characterizing exposure-disease association in human populations using the Lorenz curve and Gini index': 1, 'Improved peak detection in mass spectrum by incorporating continuous wavelet transformbased pattern matching': 1, 'SciPy: open source scientific tools for Python': 1, 'Revealing mechanisms of infectious disease transmission through empirical contact networks': 2, 'Impact of school cycles and environmental forcing on the timing of pandemic influenza activity in Mexican states': 1, 'Seasonality in risk of pandemic influenza emergence': 1, 'Malaria in India': 1, 'Seasonality, timing, and climate drivers of influenza activity worldwide': 1, 'Influenza in tropical regions': 3, 'Updated world map of the Köppen-Geiger climate classification': 1, 'Differences in influenza seasonality by latitude, northern India': 1, 'Multisite virological influenza surveillance in India: 2004-2008. Influenza Other Respir Viruses': 1, 'Dynamics of influenza seasonality at sub-regional levels in India and implications for vaccination timing': 1, 'The 1918 influenza pandemic in Florianopolis: a subtropical city in Brazil': 1, 'Spatial transmission of 2009 pandemic influenza in the US': 1, 'Rainfall distribution over Indian subdivisions during the wettest and the driest monsoons of the period 1901-1960': 1, 'All-India monthly and seasonal rainfall series': 1, 'The interaction between nutrition and infection': 1, 'Health effects of drought: a systematic review of the evidence': 1, 'Synchrony, waves, and spatial hierarchies in the spread of influenza': 3, 'Multiscale mobility networks and the spatial spreading of infectious diseases': 5, 'Contagion and control: managing disease, epidemics, and mobility': 1, 'Will travel restrictions control the international spread of pandemic influenza': 4, 'Modeling human mobility responses to the large-scale spreading of infectious diseases': 2, 'Prisons and custodial settings are part of a 248 comprehensive response to COVID-19': 1, 'Aminopeptidase N is a major receptor for the enteropathogenic coronavirus TGEV': 6, 'Feline aminopeptidase N serves as a receptor for feline, canine, porcine, and human coronaviruses in serogroup I': 1, 'Feline aminopeptidase N is a receptor for all group I coronaviruses': 1, 'Molecular analysis of the coronavirus-receptor function of aminopeptidase N': 1, 'Major receptor-binding and neutralization determinants are located within the same domain of the transmissible gastroenteritis virus (coronavirus) spike protein': 1, 'Propagation of the virus of porcine epidemic diarrhea in cell culture': 3, 'Differentiation of a Vero cell adapted porcine epidemic diarrhea virus from Korean field strains by restriction fragment length polymorphism analysis of ORF 3': 1, 'Further characterization of aminopeptidase-N as a receptor for coronaviruses': 1, 'The coronavirus transmissible gastroenteritis virus causes infection after receptor-mediated endocytosis and acid-dependent fusion with an intracellular compartment': 1, 'Analysis of the sialic acid-binding activity of the transmissible gastroenteritis virus': 1, 'Analysis and simulation of a neutralizing epitope of transmissible gastroenteritis virus': 1, 'Soluble CD4 enhances simian immunodeficiency virus SIVagm infection': 1, 'Effects of soluble CD4 on simian immunodeficiency virus infection of CD4-positive and CD4-negative cells': 1, 'High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus': 1, 'Soluble receptor potentiates receptorindependent infection by murine coronavirus': 2, 'Cloning and sequence analysis of the M gene of porcine epidemic diarrhea virus LJB/03': 1, 'Cloning and sequence analysis of the N gene of porcine epidemic diarrhea virus LJB/03': 1, 'Direct and rapid detection of porcine epidemic diarrhea virus by RT-PCR': 1, 'Detection and differentiation of porcine epidemic diarrhoea virus and transmissible gastroenteritis virus in clinical samples by multiplex RT-PCR': 1, 'Completion of the porcine epidemic diarrhoea coronavirus (PEDV) genome sequence': 1, 'Cloning of the pig aminopeptidase N gene. Identification of possible regulatory elements and the exon distribution in relation to the membrane-spanning region': 1, 'Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications': 1, 'The spike protein of SARS-CoV-a target for vaccine and therapeutic development': 1, 'Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcgammaRIIdependent entry into B cells in vitro': 1, 'Plug-and-play inference for disease dynamics: measles in large and small populations as a case study': 1, 'Time series analysis via mechanistic models': 1, 'Medical Student Education in the Time of COVID-19': 1, \"Interim guidance on medical students' participation in direct patient contact activities: principles and guidelines. Association of American Medical Colleges\": 1, 'Digital natives, digital immigrants. On the Horizon': 1, 'Teaching and learning resilience: a new agenda in medical education': 1, 'Incidence of New-Onset and Worsening Heart Failure Before and After the COVID-19 Epidemic Lockdown in Denmark: A Nationwide Cohort Study': 1, 'Deceases in Acute Heart Failure Hospitalizations during COVID-19': 1, 'The impact of COVID-19 on heart failure hospitalization and management: report from a Heart Failure Unit in London during the peak of the pandemic': 1, 'Reductions in Heart Failure Hospitalizations During the COVID-19 Pandemic': 1, \"Who isn't using patient portals and why? Evidence and implications from a national sample of US adults\": 1, 'The limitations of poor broadband internet access for telemedicine use in rural America: an observational study': 1, 'Optimizing and validating the technical infrastructure of a novel tele-cystoscopy system': 1, 'Transcontinental robot-assisted remote telesurgery: feasibility and potential applications': 1, 'SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor': 6, 'Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China': 3, 'WHO Declares COVID-19 a Pandemic': 2, 'Coronaviruses as the cause of respiratory infections': 1, 'Persistence of coronaviruses on inanimate surfaces and its inactivation with biocidal agents': 1, 'Two mutations were critical for bat-to-human transmission of middle east respiratory syndrome coronavirus': 2, 'Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2': 5, 'Ezrin interacts with the SARS coronavirus spike protein and restrains infection at the entry stage': 1, 'Emerging COVID-19 coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26': 1, 'Angiotensin-Converting Enzyme 2 (ACE2) is a keymodulator of the renin angiotensin systemin health and disease': 1, 'Age-and genderrelated difference of ACE2 expression in rat lung': 1, 'Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods': 1, 'Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus': 1, 'Pulmonary Angiotensin-Converting Enzyme 2 (ACE2) and inflammatory lung disease': 1, 'SARS-CoV-2 and the pathophysiology of coronavirus disease 2019': 1, 'Angiotensin Converting Enzyme 2 May Mediate Disease Severity In COVID-19': 1, 'Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues': 1, 'Coronavirus and obesity: could insulin resistance mediate the severity of Covid-19 infection? Front': 1, 'TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection': 1, 'Tmprss2 is essential for influenza H1N1 virus pathogenesis in mice': 2, 'Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites': 1, 'SARS coronavirus entry into host cells through a novel clathrin-and caveolaeindependent endocytic pathway': 1, 'Coronaviruses post-SARS: update on replication and Pathogenesis': 1, 'Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients': 2, 'Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2': 1, 'Molecular docking as a popular tool in drug design, an in silico travel': 1, 'Molecular docking study of novel COVID-19 protease with low risk terpenoides compounds of plants': 1, 'On the Inhibition of COVID-19 protease by indian herbal plants: an in silico investigation': 1, 'The origin, transmission and clinical therapies on coronavirus disease (COVID-19) outbreak -an update on the status': 3, 'Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein': 1, 'Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody': 1, 'Updated Approaches against SARS-CoV-2': 1, 'Inhibition of SARS-CoV replication by siRNA': 1, 'A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusion': 1, 'Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses': 1, 'Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta analysis': 1, 'Structure-based discovery of a novel angiotensin-converting enzyme-2 inhibitor': 1, 'Baricitinib as potential treatment for 2019-nCoV acute respiratory disease': 1, 'Mannose-binding lectin and mannosebinding lectin-associated serine protease 2 in susceptibility, severity, and outcome of pneumonia in adults': 1, 'Mannose-binding lectin deficiency and respiratory tract infection': 1, 'Human mannose-binding protein functions as an opsonin for Influenza A viruses': 1, 'Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection': 1, 'Multifacility outbreak of Middle East respiratory syndrome in Taif, Saudi Arabia': 3, 'Notes from the field: nosocomial outbreak of Middle East respiratory syndrome in a large tertiary care hospital-Riyadh, Saudi Arabia': 2, 'MERS-CoV outbreak in Jeddah-a link to health care facilities': 2, 'Transmission of MERS-coronavirus in household contacts': 2, 'Infection prevention and control guidelines for Middle East Emerging Infectious Diseases • www': 1, 'World Health Organization. Laboratory testing for Middle East respiratory syndrome coronavirus-interim guidance': 1, 'Epidemiology of a novel recombinant MERS-CoV in humans in Saudi Arabia': 2, 'Risk factors for primary Middle East respiratory syndrome coronavirus illness in humans, Saudi Arabia': 1, \"The People's Republic of China DPAC\": 1, 'Patients with mental health disorders in the COVID-19 epidemic': 1, 'Multivariate data analysis with readings': 2, 'Self-focused attention and negative affect: a meta-analysis': 1, 'A meta-analysis of emotional reactivity in major depressive disorder': 1, 'A meta-analysis of the relationship between anxiety/depression and negative cognitive emotion strategies': 1, 'Cognitive therapy of anxiety disorders: science and practice': 1, 'Which type of social activities decrease depression in the elderly? An analysis of a population-based study in South Korea': 1, 'Attentional bias of high trait anxious individuals': 1, 'Psychiatry: life events and social support in late life depression': 1, 'Hospital volume and surgical mortality in the United States': 1, 'Comparison of hospitals affiliated with PPS-Exempt Cancer Centers, other hospitals affiliated with NCI-designated Cancer Centers, and other hospitals that provide cancer care': 1, 'Computational design of proteins targeting the conserved stem region of influenza hemagglutinin': 1, 'Development of High Affinity and High Specificity Inhibitors of Matrix Metalloproteinase 14 through Computational Design and Directed Evolution': 1, 'Engineering a protein-protein interface using a computationally designed library': 1, 'Effects of oncogenic mutations and DNA response elements on the binding of p53 to p53-binding protein 2 (53BP2)': 1, 'Structural interface between LRRK2 and 14-3-3 protein': 1, 'Hot spot-based design of smallmolecule inhibitors for protein-protein interactions': 1, 'Low-stringency selection of TEM1 for BLIP shows interface plasticity and selection for faster binders': 1, 'Improved antibody-based ricin neutralization by affinity maturation is correlated with slower offrate values': 1, 'Structural model for the interaction of a designed Ankyrin Repeat Protein with the human epidermal growth factor receptor 2': 1, 'Two-step binding mechanism for T-cell receptor recognition of peptide MHC': 1, 'Complete proteinprotein association kinetics in atomic detail revealed by molecular dynamics simulations and Markov modelling': 1, 'Mapping of the binding landscape for a picomolar protein-protein complex through computation and experiment': 2, 'SKEMPI: a Structural Kinetic and Energetic database of Mutant Protein Interactions and its use in empirical models': 3, 'Intermolecular Contact Potentials for Protein-Protein Interactions Extracted from Binding Free Energy Changes upon Mutation': 1, 'Inferring the microscopic surface energy of protein-protein interfaces from mutation data': 1, 'CCharPPI web server: computational characterization of protein-protein interactions from structure': 1, 'IRaPPA: information retrieval based integration of biophysical models for protein assembly selection': 1, 'A machine learning approach for ranking clusters of docked protein-protein complexes by pairwise cluster comparison': 1, 'A systematic analysis of scoring functions in rigid-body protein docking: The delicate balance between the predictive rate improvement and the risk of overtraining': 1, 'The scoring of poses in protein-protein docking: current capabilities and future directions': 1, 'On human diseasecausing amino acid variants: statistical study of sequence and structural patterns': 1, 'Elucidating common structural features of human pathogenic variations using large-scale atomic-resolution protein networks': 1, 'Investigating the linkage between diseasecausing amino acid variants and their effect on protein stability and binding': 1, 'Allosteric Dynamic Control of Binding': 1, 'Conservation of hot regions in protein-protein interaction in evolution': 1, 'Exploring the interplay between experimental methods and the performance of predictors of binding affinity change upon mutations in protein complexes': 5, 'Characterizing changes in the rate of protein-protein dissociation upon interface mutation using hotspot energy and organization': 1, 'An integrated computational approach can classify VHL missense mutations according to risk of clear cell renal carcinoma': 1, 'Binding interface prediction by combining protein-protein docking results': 1, 'A Machine Learning Approach for Hot-Spot Detection at Protein-Protein Interfaces': 1, 'Co-Occurring Atomic Contacts for the Characterization of Protein Binding Hot Spots': 1, 'New Parameters for Higher Accuracy in the Computation of Binding Free Energy Differences upon Alanine Scanning Mutagenesis on Protein-Protein Interfaces': 1, 'mCSM: predicting the effects of mutations in proteins using graph-based signatures': 1, 'BeAt-MuSiC: Prediction of changes in protein-protein binding affinity on mutations': 1, 'Determining effects of non-synonymous SNPs on protein-protein interactions using supervised and semi-supervised learning': 1, 'Combining structural modeling with ensemble machine learning to accurately predict protein fold stability and binding affinity effects upon mutation': 1, 'Expanding the frontiers of protein-protein modeling: from docking and scoring to binding affinity predictions and other challenges': 1, 'Predicting Binding Free Energy Change Caused by Point Mutations with Knowledge-Modified MM/PBSA Method': 1, 'A multiscale approach to predicting affinity changes in protein-protein interfaces': 1, 'MutaBind estimates and interprets the effects of sequence variants on protein-protein interactions': 1, 'BindProfX: Assessing Mutation-Induced Binding Affinity Change by Protein Interface Profiles with Pseudo-Counts': 1, 'The Iterative Protein Redesign and Optimization (IPRO) suite of programs': 1, 'Interaction Entropy for Computational Alanine Scanning': 1, 'Enhancing Structure Prediction and Design of Soluble and Membrane Proteins with Explicit Solvent-Protein Interactions': 1, 'Flex ddG: Rosetta Ensemble-Based Estimation of Changes in Protein-Protein Binding Affinity upon Mutation': 1, 'A structure-based benchmark for protein-protein binding affinity': 1, 'ASEdb: a database of alanine mutations and their effects on the free energy of binding in protein interactions': 1, 'PINT: Protein-protein Interactions Thermodynamic Database': 1, 'Updates to the Integrated Protein-Protein Interaction Benchmarks: Docking Benchmark Version 5 and Affinity Benchmark Version 2': 1, 'AB-Bind: Antibody binding mutational database for computational affinity predictions': 1, 'PROXiMATE: a database of mutant protein-protein complex thermodynamics and kinetics': 1, 'dbMPIKT: A web resource for the kinetic and thermodynamic database of mutant protein interactions': 1, 'A simple definition of structural regions in proteins and its use in analyzing interface evolution': 1, 'The Protein Data Bank': 1, 'Dynamic use of multiple parameter sets in sequence alignment': 1, 'A frustrated binding interface for intrinsically disordered proteins': 1, 'Molecular architecture of the human sperm IZUMO1 and egg JUNO fertilization complex': 1, 'Structural and mutational analysis of human Ad37 and canine adenovirus 2 fiber heads in complex with the D1 domain of coxsackie and adenovirus receptor': 1, 'Structural basis for variation in adenovirus affinity for the cellular coxsackievirus and adenovirus receptor': 1, 'Predicting the reactivity of proteins from their sequence alone: Kazal family of protein inhibitors of serine proteinases': 1, 'Binding hot spots in the TEM1-BLIP interface in light of its modular architecture': 1, 'Identification of the β-lactamase inhibitor protein-II (BLIP-II) interface residues essential for binding affinity and specificity for class A β-lactamases': 1, 'Structure of the interferon-receptor complex determined by distance constraints from double-mutant cycles and flexible docking': 1, 'Structural linkage between ligand discrimination and receptor activation by type I interferons': 1, 'Conformational Changes in the GM-CSF Receptor Suggest a Molecular Mechanism for Affinity Conversion and Receptor Signaling': 1, 'Rational design of receptor-specific variants of human growth hormone': 1, 'Two independent histidines, one in human prolactin and one in its receptor, are critical for pH-dependent receptor recognition and activation': 1, 'Affinity enhancement of an in vivo matured therapeutic antibody using structurebased computational design': 1, 'Free Energy Perturbation Calculation of Relative Binding Free Energy between Broadly Neutralizing Antibodies and the gp120 Glycoprotein of HIV-1': 1, 'A mutational analysis of binding interactions in an antigen-antibody protein-protein complex': 1, 'Characterization of the functional epitope on the urokinase receptor. Complete alanine scanning mutagenesis supplemented by chemical cross-linking': 1, 'A detailed thermodynamic analysis of ras/effector complex interfaces': 1, 'The basis for limited specificity and MHC restriction in a T cell receptor interface': 1, 'Protein-protein interaction specificity of Im9 for the endonuclease toxin colicin E9 defined by homologue-scanning mutagenesis': 2, 'Strategy for analysing the co-operativity of intramolecular interactions in peptides and proteins': 2, 'Analyses of Mlc-IIBGlc interaction and a plausible molecular mechanism of Mlc inactivation by membrane sequestration': 1, 'A thiophene-modified screen printed electrode for detection of dengue virus NS1 21 protein': 1, 'Coronavirus disease 2019. World Heal': 2, 'Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand': 3, 'Report An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China': 3, \"News: Goldman Sees China's Economy Slumping 9% in First Quarter\": 4, 'Social contacts and mixing patterns relevant to the spread of infectious diseases': 3, 'Report/ Annual number of hospital beds in the UK from': 3, 'Modified SEIR and AI prediction of the epidemics trend of COVID-19 in China under public health interventions': 5, 'The Global Impact of COVID-19 and Strategies for Mitigation and Suppression': 1, 'The transmissibility of novel Coronavirus in the early stages of the 2019-20 outbreak in Wuhan: Exploring initial point-source exposure sizes and durations using scenario analysis': 2, 'Transmissibility of 2019-nCoV': 2, 'Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures': 1, 'Living longer -how our population is changing and why it matters': 1, 'Identification of Plasmodium PI4 kinase as target of MMV390048 by chemoproteomics': 1, 'Targeting Plasmodium PI(4)K to eliminate malaria': 3, 'A proposed target product profile and developmental cascade for new cryptosporidiosis treatments': 1, 'Cryptosporidiosis drug discovery: opportunities and challenges': 1, '5-Diaryl-2-aminopyridines as a novel class of orally active antimalarials demonstrating single dose cure in mice and clinical candidate potential': 1, 'Preparation of pyrazolopyridine compounds for the treatment of parasitic diseases': 1, 'Genetic modification of the diarrhoeal pathogen Cryptosporidium parvum': 2, 'Direct inhibitors of InhA are active against Mycobacterium tuberculosis': 1, 'High-throughput in vitro profiling assays: lessons learnt from experiences at Novartis': 7, 'Artificial membrane assays to assess permeability': 1, 'PI4 kinase is a prophylactic but not radical curative target in Plasmodium vivax-type malaria parasites': 1, 'Detection and differentiation of Cryptosporidium hominis and Cryptosporidium parvum by dual TaqMan assays': 1, 'White-to-brite conversion in human adipocytes promotes metabolic reprogramming towards fatty acid anabolic and catabolic pathways': 3, 'High-intensity interval training and calorie restriction promote remodeling of glucose and lipid metabolism in diet-induced obesity': 3, 'Biomarkers of browning of white adipose tissue and their regulation during exercise-and diet-induced weight loss': 3, 'Mild calorie restriction induces fat accumulation in female C57BL/6J mice': 2, 'Whitening and impaired glucose utilization of brown adipose tissue in a rat model of type 2 diabetes mellitus': 1, 'Brown and beige fat: molecular parts of a thermogenic machine': 1, 'Brown fat and browning for the treatment of obesity and related metabolic disorders': 2, 'Pharmacological and nutritional agents promoting browning of white adipose tissue': 3, 'Reduced UCP-1 content in in vitro differentiated beige/ brite adipocytes derived from preadipocytes of human subcutaneous white adipose tissues in obesity': 1, 'Curcumin promotes browning of white adipose tissue in a norepinephrine-dependent way': 1, 'PPARgamma agonists induce a white-to-brown fat conversion through stabilization of PRDM16 protein': 1, 'BMP8B increases brown adipose tissue thermogenesis through both central and peripheral actions': 2, 'BMP7 activates brown adipose tissue and reduces dietinduced obesity only at subthermoneutrality': 2, 'Transcriptional and epigenetic control of brown and beige adipose cell fate and function': 3, 'Bioassay-guided isolation of active anti-adipogenic compound from royal jelly and the study of possible mechanisms': 1, 'Specific hydroxy fatty acids in royal jelly activate TRPA1': 3, 'New findings on biological actions and clinical applications of Royal Jelly: a review': 1, 'Royal jelly supplementation reduces skeletal muscle lipotoxicity and insulin resistance in aged obese rats': 1, 'Vitamin E as a potential interventional treatment for metabolic syndrome: evidence from animal and human studies': 3, 'Tocotrienols reverse cardiovascular, metabolic and liver changes in high carbohydrate, high fat diet-fed rats': 2, 'Regulation of obesity and metabolic complications by gamma and delta tocotrienols': 1, 'Gamma-tocotrienol attenuates TNF-alpha-induced changes in secretion and gene expression of MCP-1, IL-6 and adiponectin in 3T3-L1 adipocytes': 1, 'Guide for the care and use of laboratory animals: National Academies': 1, 'Royal jelly ameliorates insulin resistance in fructose-drinking rats': 1, 'Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method': 2, 'Transplantation of interscapular brown adipose tissue in rats': 1, 'Weight loss, weight maintenance, and adaptive thermogenesis': 1, 'Royal jelly ameliorates diet-induced obesity and glucose intolerance by promoting brown adipose tissue thermogenesis in mice': 2, 'Promoting effect of alpha-tocopherol on beige adipocyte differentiation in 3T3-L1 cells and rat white adipose tissue': 1, 'Delta-tocopherol promotes thermogenic gene expression via PGC-1alpha upregulation in 3T3-L1 cells': 1, 'Gammatocotrienol attenuates high-fat diet-induced obesity and insulin resistance by inhibiting adipose inflammation and M1 macrophage recruitment': 1, 'Influencing factors of thermogenic adipose tissue activity': 1, 'A functional link between AMPK and orexin mediates the effect of BMP8B on energy balance': 1, 'BCX4430-A broad-spectrum antiviral adenosine 631 nucleoside analog under development for the treatment of Ebola virus disease': 1, 'An all-atom, active site exploration of 637 antiviral drugs that target flaviviridae polymerases': 1, 'Prediction and prevention of the next pandemic zoonosis': 1, 'Emerging human infectious diseases and the link to global food production': 1, 'Bats, Coronaviruses, and Deforestation: Toward the Emergence of Infectious Diseases?': 1, 'Anthropocene: Human interactions with earth systems': 1, 'An evolving Anthropocene for science and society': 1, 'COVID-19: The conjunction of events leading to the pandemic and lessons to learn for future threats': 1, '258, and P-path antibodies define three classes of sagittally organized 12465-12471. bands of Purkinje cells': 5, 'A cell surface molecule distributed in a dorsoventral GD3. Kidney Int. 42, 624-631. gradient in the perinatal rat retina': 1, 'Influenza Expression cloning of the Golgi CMP-sialic acid transporter': 2, 'Influence of sialic acid O-acetylation of mouse erythrocyte R., 1986. The action of sialidases on substrates containing O-acetyl glycoconjugates on malaria infection': 1, 'Developmental regulation of gancharacterization of a cDNA encoding a novel membrane protein glioside antigens recognized by the JONES antibody': 9, 'DNA sequencing with Bacterial cell wall recycling provides cytosolic muropeptides as chain-termination inhibitors': 2, 'A cell-type specific': 1, \"Professor C.R. Rao's Contributions to Econometrics, SSRN eLibrary\": 2, 'ET Interview: Professor C R Rao': 1, 'Comments: Econometrics and software': 1, 'An Autobiographical Account of Research Work': 2, 'Estimation of Median: Quasi-Likelihood and Optimum Estimating Functions, Working paper, Statistics Department': 1, 'An Extension of the Cramer-Rao Inequality for Statistical Estimation Functions': 1, 'Semiparametric efficiency bounds': 1, 'Hands-on Intermediate Econometrics Using R: Templates for Extending Dozens of Practical Examples': 1, 'On Large-Sample Estimation and Testing in Parametric Models': 1, 'Maximum-likelihood Estimation of Parameters Subject to Restraints': 1, 'The Lagrange multiplier test and its application to model specification in econometrics': 3, 'Maximum Entropy Bootstrap for Time Series: The meboot R Package': 1, 'Forecasting the CoViD-19 diffusion in Italy and the related occupancy of Intensive Care Units': 1, 'Tests of Significance in Multivariate Analysis': 1, 'Econometrics of joint production': 1, 'Canonical ridge and econometrics of joint production': 1, 'Edgeworth Expansion of a Function of Sample Means': 1, 'Large sample tests of statistical hypotheses concerning several parameters with applications to problems of estimation': 1, \"Rao's Weighted Distribution in Econometrics: An Application to Unemployment Statistics and Okun's Law\": 1, 'Characterization Problems in Mathematical Statistics': 1, 'Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries': 1, 'Annual report to the nation on the status of cancer, featuring cancer in men and women Age 20-49 years': 1, 'Potential scenarios for the progression of a COVID-19 epidemic in the European Union and the European Economic Area': 1, 'Cancer Guidelines During the COVID-19 Pandemic': 1, 'Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China': 6, 'Covid-19 navigating the uncharted': 1, 'Anosmia and ageusia: common findings in COVID-19 patients': 1, 'Correlation of Chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases': 2, 'Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan. China': 2, 'SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China': 1, 'A segregated-team model to maintain cancer care during the COVID-19 outbreak at anacademic center in Singapore': 1, 'Cancer care delivery challenges amidst coronavirus disease-19 (COVID-19) outbreak: Specific precautions for cancer patients and cancer care providers to prevent spread': 1, \"Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists' perspective\": 2, 'Active and effective measures for the care of patients with cancer during the COVID-19 spread in China': 1, 'Home care for cancer patients during COVID-19 pandemic: the \"double triage\" protocol': 1, 'COVID-19 infection in cancer patients: early observations and unanswered questions': 1, 'Managing drug-drug interactions with new direct-acting antiviral agents in chronic hepatitis C': 1, 'Fair allocation of scarce medical resources in the time of Covid-19': 3, 'Time intervals from first symptom to treatment of cancer: a cohort study of 2,212 newly diagnosed cancer patients': 1, 'Managing cancer care during the COVID-19 pandemic: agility and collaboration toward a common goal': 1, 'Covid-19 outbreak in northern Italy: first practical indications for radiotherapy departments': 1, 'COVID-19: protecting health-care workers': 4, \"Protecting health care workers during the COVID-19 coronavirus outbreak-lessons from Taiwan's SARS response\": 1, 'Undocumented US immigrants and Covid-19': 1, 'Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic': 1, 'COVID-19: briefing note': 1, 'Can you put a price on COVID-19 options? Experts weigh lives versus economics': 1, 'Recent declines in cancer incidence: related to the Great Recession? Cancer Causes Control': 1, 'Economic downturns, universal health coverage, and cancer mortality in high-income and middle-income countries, 1990-2010: a longitudinal analysis': 1, 'Psychological interventions for people affected by the COVID-19 epidemic': 1, 'A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: implications and policy recommendations': 1, 'Cancer research ethics and COVID-19': 1, 'Response to COVID-19 in Taiwan: big data analytics, new technology, and proactive testing': 1, 'With COVID-19, modeling takes on life and death importance': 1, 'Adult umbilical cord blood transplantation: a comprehensive review': 3, 'Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia': 2, 'A meta-analysis of unrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in adult and pediatric patients': 3, 'The kinetics of immune reconstitution after cord blood transplantation and selected CD34+ stem cell transplantation in children: comparison with bone marrow transplantation': 1, 'Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation': 3, 'Infectious complications following unrelated cord blood transplantation': 7, 'Long-term immune reconstitution and infection burden after mismatched hematopoietic stem cell transplantation': 1, 'Immune reconstitution and outcome after unrelated cord blood transplantation: a single paediatric institution experience': 1, 'Invasive fungal infection following reduced-intensity cord blood transplantation for adult patients with hematologic diseases': 1, 'Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time': 1, 'Reduction of infection-related mortality after allogeneic PBSCT from HLA-identical siblings: longitudinal analysis from 1994 to 2008 at a single institution': 1, 'Analysis of non-relapse mortality and causes of death over 15 years following allogeneic hematopoietic stem cell transplantation': 1, 'Serious infection risk and immune recovery after double-unit cord blood transplantation without antithymocyte globulin': 6, 'Prevention and treatment of cancer-related infections, version 2.2016, NCCN clinical practice guidelines in oncology': 1, 'Defining the intensity of conditioning regimens: working definitions': 1, 'Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/ Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) consensus group': 1, 'Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials': 1, 'Infectious complications after unrelated umbilical cord blood transplantation in adult patients with hematologic malignancies': 2, 'Severe infections after single umbilical cord blood transplantation in adults with or without the co-infusion of CD34+ cells from a third-party donor: results of a multicenter study from the Grupo Español de Trasplante Hematopoyético (GETH)': 2, 'Eurocord transplant group and the European blood and marrow transplantation group': 1, 'Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival': 1, 'Cytomegalovirus infection after allogeneic transplantation: comparison of cord blood with peripheral blood and marrow graft sources': 2, 'CMV infection after transplant from cord blood compared to other alternative donors: the importance of donor-negative CMV serostatus': 1, 'Impact of cytomegalovirus (CMV) reactivation after umbilical cord blood transplantation': 1, 'Human herpesvirus 6 reactivation before engraftment is strongly predictive of graft failure after double umbilical cord blood allogeneic stem cell transplantation in adults': 1, 'Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis': 1, 'Association of the emergence of acyclovir-resistant herpes simplex virus type 1 with prognosis in hematopoietic stem cell transplantation patients': 1, 'Acyclovir-resistant herpes simplex virus 1 infection early after allogeneic hematopoietic stem cell transplantation with T-cell depletion': 1, 'Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients': 1, 'The emergence of vancomycin-resistant enterococcal bacteremia in hematopoietic stem cell transplant recipients': 2, 'The changing epidemiology of vancomycin-resistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients': 1, 'Evaluation of risk factors for vancomycin-resistant Enterococcus bacteremia among previously colonized hematopoietic stem cell transplant patients': 1, 'Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation': 1, 'Risk factors for vancomycin-resistant Enterococcus bacteremia and its influence on survival after allogeneic hematopoietic cell transplantation': 1, 'Clinical significance of nontuberculous mycobacteria from respiratory specimens in stem cell transplantation recipients': 2, 'Mycobacterial infections following bone marrow transplantation: a 20 year retrospective review': 1, 'Mycobacterial infection: a difficult and late diagnosis in stem cell transplant recipients': 1, 'Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients': 2, 'Risk factors for acute and chronic graftversus-host disease after allogeneic hematopoietic cell transplantation with umbilical cord blood and matched sibling donors': 2, 'Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors': 1, 'Building an industry 4.0 analytics platform': 1, 'Predictive, prescriptive and detective analytics for smart manufacturing in the information age': 3, 'Big Data Challenges in Smart Manufacturing: A discussion paper for BDVA and EFFRA Research & Innovation roadmap alignment BDVA': 2, 'The age of analytics: competing in a data-driven world': 1, \"Predictive maintenance in a digital factory shopfloor: data mining on historical and operational data coming from manufacturers' information systems\": 1, 'The internet of things for smart manufacturing: a review': 1, 'Recent advances and trends in predictive manufacturing systems in big data environment': 1, 'A full history proportional hazards model for preventive maintenance scheduling': 1, 'A neural network application for reliability modelling and conditionbased predictive maintenance': 1, 'Data mining in manufacturing: a review based on the kind of knowledge': 1, 'Data mining in manufacturing: a review': 1, 'A practical approach to combine data mining and prognostics for improved predictive maintenance': 1, 'Application of data mining in a maintenance system for failure prediction': 1, 'Analyzing maintenance data using data mining methods': 1, 'Machine learning for predictive maintenance: a multiple classifier approach': 1, 'Prescriptive analytics': 1, 'Smart manufacturing with prescriptive analytics': 2, 'Prescriptive analytics: literature review and research challenges': 1, 'Reinforcement Learning: An Introduction': 1, 'Model-free adaptive optimal control of episodic fixedhorizon manufacturing processes using reinforcement learning': 1, 'A reinforcement learning framework for optimal operation and maintenance of power grids': 1, 'Human-centered reinforcement learning: a survey': 1, 'Multiobjective reinforcement learning: a comprehensive overview': 2, 'Many-objective stochastic path finding using reinforcement learning': 1, 'Policy shaping: integrating human feedback with reinforcement learning': 1, 'COVID-19 control in low-income settings and displaced populations: what can realistically be done? London: London School of Hygiene & Tropical Medicine': 1, 'Round-the-clock curfew in Jordan to battle coronavirus outbreak': 1, 'Challenges associated with providing diabetes care in humanitarian settings': 1, 'Risk Communication and Community Engagement Working Group on COVID-19 Preparedness and Response, WHO, IFRC, OCHA: COVID-19: How to include marginalized and vulnerable people in risk communication and community engagement': 1, 'Provision and continuation of antiretroviral therapy during acute conflict: the experience of MSF in Central African Republic and Yemen': 1, 'Protecting public health in Yemen': 1, 'From one \"dragon sleigh\" to another: Advocating for immigrant women facing violence in Kansas': 4, \"Needs and preferences for the prevention of intimate partner violence among Hispanics: A community's perspective\": 3, 'Battered immigrant women in the U.S. and protection orders: An exploratory research': 1, 'Barriers preventing Latina immigrants from seeking advocacy services for domestic violence victims: A qualitative analysis': 7, 'He said they\\'d deport me\": Factors influencing domestic violence helpseeking practices among Latina immigrants': 3, 'Help-seeking in a national sample of victimized Latino women: The influence of victimization types': 3, 'Yes, I can (Sí, Yo Puedo): An empowerment program for immigrant Latina women in group settings': 1, 'Elements of effective interventions for addressing intimate partner violence in Latina women: A systematic review': 6, 'From isolation to connection: Understanding a support group for Hispanic women living with gender-based violence in': 6, 'The \"Comadre\" group approach: A wellness-based group model for monolingual Mexican women. The Journal for Specialists in G r o u p W o r k , 3 1 , 5-2 4': 11, 'Allow me to speak\": Stories of courage among immigrant Latina survivors of intimate partner violence': 2, 'Violence against Latinas: The effects of undocumented status on rates of victimization and help-seeking': 7, \"Reducing intimate partner violence among Latinas through the moms' empowerment program: An efficacy trial\": 2, 'Empowerment in Latina immigrant women recovering from interpersonal violence: A concept analysis': 4, \"Integrating women's voices and theory: A comprehensive domestic violence intervention for Latinas\": 9, 'Expanding evidence-based practice models for domestic violence initiatives: A communitycentered approach': 3, 'Pocket guides to social work research methods: Systematic reviews and meta-analysis': 1, 'Applied social research: Tool for the human services': 2, 'The relevance of the structural approach to group work with immigrant and refugee women': 6, \"Divorcing abused Latina immigrant women's experiences with domestic violence support groups\": 5, 'Sí,Yo Puedo: Latinas examining domestic violence, relationships, and self': 6, 'Reaching Latinas with our bodies, ourselves and the guía de capacitación para promotoras de salud: Health education for social change': 4, 'Selfempowerment of immigrant Latina survivors of domestic violence: A promotora model of community leadership. Hispanic Health Care International': 7, 'A mental health intervention strategy for low-income, trauma-exposed Latina immigrants in primary care: A preliminary study': 7, 'Proyecto Interconexiones: A pilot test of a community-based depression care program for Latina violence survivors': 9, 'Psychological empowerment: Issues and illustrations': 1, 'Sexual politics': 1, 'Toward an experimental ecology of human development': 1, 'Causes and maintenance of domestic violence: An ecological analysis': 1, 'Cognitive therapy and the emotional disorders': 1, 'Cognitive behavior therapy: Basics and beyond': 1, 'Demarginalizing the intersection of race and sex: A black feminist critique of antidiscrimination doctrine, feminist theory and antiracist politics': 1, 'The discovery of being: Writings in existential psychology': 1, 'The mutual-aid approach to working with groups: Helping people help each other': 1, 'Self-reported olfactory and taste disorders in SARS-CoV-2 patients: A cross-sectional study': 1, 'Cutaneous manifestations in COVID-19: A first perspective': 2, 'Giant cell arteritis with arteritic anterior ischemic optic neuropathy': 1, 'Features of anosmia in COVID-19': 1, 'Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases': 1, 'Anosmia and ageusia: common findings in COVID-19 Patients': 1, 'Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): A multicenter European study': 4, 'Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2': 4, 'Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations': 1, 'A single-cell atlas of the airway epithelium reveals the CFTR-rich pulmonary ionocyte': 1, 'Morphologic changes in the nasal cavity associated with sialodacryoadenitis virus infection in the Wistar rat': 1, 'Inflammatory obstruction of the olfactory clefts and olfactory loss in humans: A new syndrome?': 1, 'High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa': 4, 'Reduced salivary mucin binding and glycosylation in older adults influences taste in an in vitro cell model': 1, 'MRI detection of olfactory bulb and tract': 2, 'Coincidence of COVID-19 epidemic and olfactory dysfunction outbreak': 1, 'COVID-19 and treatment with NSAIDs and corticosteroids: Should we be limiting their use in the clinical setting': 1, 'Topical therapy in anosmia: Relevance of steroid-responsiveness': 1, 'Effects of olfactory training in patients with olfactory loss': 1, 'Olfactory training is helpful in postinfectious olfactory loss: A randomized, controlled, multicenter study': 1, 'Olfactory training changes electrophysiological responses at the level of the olfactory epithelium': 1, \"WHO director-general's opening remarks at the media briefing on COVID-19\": 1, 'Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou': 1, 'Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China': 1, 'Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome': 1, 'Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury': 3, 'Caecal motility in the rabbit. III Duality of faecal excretion (Article in French, English Abstract)': 1, 'Saunders Comprehensive Veterinary Dictionary': 1, 'Bacteria of the rabbit gut and their role in the health of the rabbit': 2, 'Microbial dysbiosis in rabbit mucoid enteropathy': 3, 'The nutrition of the commercial rabbit. Part 1. Physiology, digestibility and nutrient requirements': 5, 'An hypothesis of the pathogenesis of diarrhoea in the rabbit based on intestinal contents (Article in French, English Abstract)': 1, 'Fiber digestion and utilisation in rabbits': 1, 'The effect of different fibre components on growth rate, nutrient digestibility, rate of digesta passage and hindgut fermentation in domestic rabbits': 1, 'Susceptibility of the rabbit to an enteropathogenic strain of Escherichia coli 0103; effect of animals age (Abstract)': 1, 'Relationships between microflora and caecal fermentation in rabbits before and after weaning (Abstract)': 1, 'Electrolytes, blood gases, and acid base balance': 1, 'Changes in hydromineral metabolism in diarrhoeic rabbits 2. Study of the modifications of electrolyte metabolism': 1, 'Acute respiratory alkalosis and acidosis and rabbit intestinal ion transport in vivo (Abstract)': 1, 'Influence of acid-base changes on carbechol and potassium induced contractions of taenia coli of the rabbit (Abstract)': 1, 'Treatment for hairballs': 3, 'Medical and surgical management of gastric obstruction from a hairball in the rabbit': 2, 'Hairballs and pregnancy toxaemia': 2, 'Parasites of laboratory animals': 5, 'Intestinal stasis and rupture in rabbits': 1, 'Intestinal motor and transit disturbances associated with experimental coccidiosis (Eimeria magna) in the rabbit': 1, 'The response of the caecotrophy rhythm of the rabbit to single light signals': 1, 'The Domestic Rabbit': 1, 'Comparative Vertebrate Endocrinology': 1, 'Absorption and metabolism of the volatile fatty acids in the hind-gut of the rabbit': 1, 'Origin and utilisation of volatile fatty acids and lactate in the rabbit: influence of the faecal excretion pattern': 1, 'Lipid composition of plasma obtained from various parts of the vascular system of the rabbit': 1, 'An extra-adrenal action of adrenocorticotrophin: physiological induction of lipolysis by secretion of adrenocorticotrophin in obese rabbits (Abstract)': 1, 'Alpha-adrenergic responses in rabbit white fat cells: the influence of obesity and food restriction (Abstract)': 1, 'Effects of dietary lipid level on ketonaemia and other plasma parameters related to glucose and fatty acid metabolism in the rabbit during fasting': 1, 'Clinical biochemistry and haematology': 1, 'Hepatic metabolism during fasting-refeeding transition in conscious pregnant rabbits (Abstract)': 1, 'Radiological examination of the rabbit. II The abdomen': 1, 'Plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits during laboratory handling procedures': 1, 'Gastric ulceration in the rabbit': 1, 'Catecholamines and experimental stress ulcer: morphological and biochemical changes in the gastric mucosa (Abstract)': 1, 'Gastric acid and pepsin secretion in conscious rabbits': 1, 'Clostridial enteropathies of rabbits': 1, 'Effect of stress on the cortisone and ascorbic acid content of the blood plasma of rabbits': 1, 'Intestinal obstruction in rabbits by locust bean seeds': 1, 'Unusual cause of intestinal blockage in the female rabbit': 1, 'Surgical soft tissue suture techniques: current recommendations for the dog and cat': 1, 'Recent findings and future perspectives of digestive physiology in rabbits: a review': 1, 'Effect of caecotrophy on protein and amino acid metabolism of Angora rabbits': 1, 'Effect of type of fiber on the rate of passage and on the contribution of soft feces to nutrient intake of finishing rabbits (Abstract)': 1, 'Effect of type of lucerne hay on caecal fermentation and nitrogen contribution through caecotrophy in rabbits': 1, 'The digestive system of the rabbit': 1, 'Effect of diet on composition of cecal contents and on excretion and composition of soft and hard feces of rabbits': 1, 'Colonic formation of soft feces in rabbits: a role for endogenous prostaglandins (Abstract)': 2, 'Rabbit Feeding and Nutrition': 1, 'Caecal impaction in the rabbit: relationships with dysautonomia': 2, 'Leporine dysautonomia: further evidence that hares suffer from grass sickness': 1, 'Do hares suffer from grass sickness?': 1, 'Mucoid enteropathy in UK rabbits: dysautonomia confirmed': 1, 'Mucoid enteropathy syndrome (English Translation': 1, 'Grass sickness: an update': 1, 'Opportunistic bacteria isolated from the caecum of rabbits with mucoid enteritis': 1, 'Metabolic, traumatic, mycotic and miscellaneous diseases': 1, 'Mucus secretagogue activity in cecal contents of rabbits with mucoid enteropathy': 1, 'Experimental production of rabbit mucoid enteritis': 1, 'Cecal short-chain fatty acids in experimental rabbit mucoid enteropathy (Abstract)': 1, 'Mucoid enteropathy in rabbits': 1, 'Comparison of toltrazuril and sulphadimethoxine in the treatment of intestinal coccidiosis in pet rabbits': 2, 'The Biology and Medicine of Rabbits and Rodents': 1, 'Gastroenteric conditions in rabbits': 1, 'Protozoal diseases of rabbits and rodents': 1, 'Biology and Medicine of Rabbits and Rodents': 3, 'Eimeria stiedae in rabbits: the demonstration of different responses to chemotherapy (Abstract)': 1, 'Efficacy of toltrazuril against intestinal and heptic coccidiosis in rabbits (Abstract)': 1, 'Detection of Clostridium difficile toxins from the small intestine and cecum of rabbits with naturally acquired enterotoxaemia': 2, 'Antibiotic associated diarrhea of rabbits': 1, 'Digestion of starch and sugars': 1, 'Experimental and spontaneous clostridial enteropathies of laboratory and free living lagomorphs': 1, 'Bacterial diseases': 2, 'Evaluation of a toxoid for protection of rabbits against enterotoxaemia experimentally induced by trypsin-activated supernatant of Clostridium spriroforme (Abstract)': 1, \"Tyzzer's disease in rabbits\": 1, 'The effect of combined rotavirus and Escherichia coli infections in rabbits': 2, 'Rotavirus and rabbits': 1, 'Viral diseases': 2, 'Prevalence of coronavirus antibodies in rabbits': 1, 'Lead-induced toxicosis in two domestic rabbits': 1, 'Protozoal diseases': 1, 'Th17 cytokines and the gut mucosal barrier': 1, 'Regulation of airway MUC5AC expression by IL-1beta and IL-17A; the NF-kappaB paradigm': 1, 'Cxcr2 and Cxcl5 regulate the IL-17/G-CSF axis and neutrophil homeostasis in mice': 1, 'Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies': 1, 'Resistance to intestinal Entamoeba histolytica infection is conferred by innate immunity and Gr-1ϩ cells': 2, 'Amebiasis and mucosal IgA antibody against the Entamoeba histolytica adherence lectin in Bangladeshi children': 1, 'Singlecell sequencing provides clues about the host interactions of segmented filamentous bacteria (SFB)': 1, 'Comparative analysis of the distribution of segmented filamentous bacteria in humans, mice and chickens': 1, 'Habitat, succession, attachment, and morphology of segmented, filamentous microbes indigenous to the murine gastrointestinal tract': 1, 'Segmented filamentous bacteria antigens presented by intestinal dendritic cells drive mucosal Th17 cell differentiation': 2, 'Induction of intestinal Th17 cells by segmented filamentous bacteria': 4, 'Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice': 1, 'Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells': 1, 'Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis': 1, 'Gut microbiota promote hematopoiesis to control bacterial infection': 1, 'Commensal bacteria-derived signals regulate basophil hematopoiesis and allergic inflammation': 2, 'Dysregulated hematopoietic stem and progenitor cell activity promotes interleukin-23-driven chronic intestinal inflammation': 2, 'The intestinal metabolome: an intersection between microbiota and host': 1, 'Modulation of dendritic cell differentiation in the bone marrow mediates sustained immunosuppression after polymicrobial sepsis': 3, 'Distinct roles for IL-6 and IL-12p40 in mediating protection against Leishmania donovani and the expansion of IL-10 ϩ CD4 ϩ T cells': 2, 'Evasion by stealth: inefficient immune activation underlies poor T cell response and severe disease in SARS-CoV-infected mice': 1, 'Variation in the gut microbiota of laboratory mice is related to both genetic and environmental factors': 1, 'Temporal stability of the mouse gut microbiota in relation to innate and adaptive immunity': 1, 'Jmjd3-mediated epigenetic regulation of inflammatory cytokine gene expression in serum amyloid A-stimulated macrophages': 4, 'Serum amyloid A activates the NLRP3 inflammasome and promotes Th17 allergic asthma in mice': 1, 'Dendritic cell immunization route determines integrin expression and lymphoid and nonlymphoid tissue distribution of CD8 T cells': 1, 'Human nutrition, the gut microbiome and the immune system': 1, 'Gut microbiota promote hematopoiesis to control bacterial Infection': 1, 'Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis': 1, 'The genome of Th17 cell-inducing segmented filamentous bacteria reveals extensive auxotrophy and adaptations to the intestinal environment': 1, 'The lifestyle of the segmented filamentous bacterium: a non-culturable gut-associated immunostimulating microbe inferred by whole-genome sequencing': 2, 'The mouse model of amebic colitis reveals mouse strain susceptibility to infection and exacerbation of disease by CD4 ϩ T cells': 1, 'Segmented filamentous bacteria are indigenous intestinal bacteria that activate intraepithelial lymphocytes and induce MHC class II molecules and fucosyl asialo GM1 glycolipids on the small intestinal epithelial cells in the ex-germ-free mouse': 1, 'Realtime-PCR assay for diagnosis of Entamoeba histolytica infection': 1, 'Emerging infectious diseases: threats to human health and global stability': 1, \"Plague's Progress: A Social History of Man and Disease\": 2, 'Modeling Infectious Diseases in Humans and Animals': 3, 'Effectiveness of travel restrictions in the rapid containment of human influenza: a systematic review': 2, 'An Introduction to Mathematical Modelling': 1, 'Model verification and validation': 1, 'Verification and validation of simulation models': 1, 'Formal aspects of model validity and validation in system dynamics': 2, 'Model validation in operations research': 1, 'The Use and Reporting of Airline Passenger Data for Infectious Disease Modelling: A Systematic Review': 1, 'Scoping studies: towards a methodological framework': 2, 'Scoping studies: advancing the methodology': 2, 'Combination strategies for pandemic influenza response-a systematic review of mathematical modeling studies': 1, 'Effect of air travel on the spread of an avian influenza pandemic to the United States': 1, 'The effect of global travel on the spread of SARS': 1, 'A mathematical model for predicting the geographic spread of new infectious agents': 5, 'Epidemiological implications of mobility between a large urban centre and smaller satellite cities': 4, 'Global spatio-temporal patterns of influenza in the post-pandemic era': 3, 'Human mobility networks, travel restrictions, and the global spread of 2009 H1N1 pandemic': 4, 'Seasonal transmission potential and activity peaks of the new influenza A(H1N1): A Monte Carlo likelihood analysis based on human mobility': 3, 'Human mobility and the worldwide impact of intentional localized highly pathogenic virus release': 4, 'Realtime numerical forecast of global epidemic spreading: case study of 2009 A/ H1N1pdm': 3, 'The GLEaMviz computational tool, a publicly available software to explore realistic epidemic spreading scenarios at the global scale': 2, 'Modeling the spatial spread of infectious diseases: The GLobal Epidemic and Mobility computational model': 1, 'FluTE, a Publicly Available Stochastic Influenza Epidemic Simulation Model': 3, 'Simulation of the spread of infectious diseases in a geographical environment': 2, 'The hidden geometry of complex, network-driven contagion phenomena': 3, 'Validation of the gravity model in predicting the global spread of influenza': 2, 'The role of different transportation in the spreading of new pandemic influenza in mainland China': 1, 'The Cost of Simplifying Air Travel When Modeling Disease Spread': 3, 'Epidemic spread and variation of peak times in connected regions due to travel-related infections-dynamics of an antigravity-type delay differential model': 2, 'Age-specific contacts and travel patterns in the spatial spread of 2009 H1N1 influenza pandemic': 2, 'Metapopulation epidemic models with heterogeneous mixing and travel behaviour': 3, 'Sampling for global epidemic models and the topology of an International airport network': 2, 'An epidemiological model of spatial coupling for trips longer than the infectious period': 3, 'Dynamics of modern epidemics. SARS: A Case Study in Emerging Infections': 4, 'The effect of travel restrictions on the spread of a moderately contagious disease': 2, 'Modeling the worldwide spread of pandemic influenza: Baseline case and containment interventions': 3, 'The modeling of global epidemics: Stochastic dynamics and predictability': 2, 'Predictability and epidemic pathways in global outbreaks of infectious diseases: The SARS case study': 4, 'Epidemic predictions and predictability in complex environments': 2, 'Small islands and pandemic influenza: Potential benefits and limitations of travel volume reduction as a border control measure': 3, 'Controlling pandemic flu: The value of international air travel restrictions': 2, 'A mathematical model for the European spread of influenza': 3, 'Modelling the 1985 influenza epidemic in France': 2, 'A method for assessing the global spread of HIV-1 infection based on air travel': 3, 'Potential for a global dynamic of Influenza A (H1N1)': 3, 'Strategies for containing a global influenza pandemic': 3, 'Arrival time statistics in global disease spread': 2, 'Global disease spread: Statistics and estimation of arrival times': 1, 'A stochastic equation-based model of the value of international air-travel restrictions for controlling pandemic flu': 2, 'Assessing the impact of airline travel on the geographic spread of pandemic influenza': 2, 'Epidemic spreading on hierarchical geographical networks with mobile agents': 2, 'Frequent travelers and rate of spread of epidemics': 3, 'Transmission and control of an emerging influenza pandemic in a small-world airline network': 3, 'A multilayer epidemic simulation framework integrating geographic information system with traveling networks': 2, 'Forecast and control of epidemics in a globalized world': 1, 'A model-based tool to predict the propagation of infectious disease via airports': 2, 'Modeling the Spread of influenza Among Cities': 2, 'On the treatment of Airline travelers in mathematical models': 3, 'The global transmission and control of influenza': 2, 'Does the effectiveness of control measures depend on the influenza pandemic profile?': 3, 'Global stability of a transport-related infection model with general incidence rate in two heterogeneous cities': 2, 'Reducing influenza spreading over the airline network': 2, 'A mathematical model for the global spread of influenza': 2, 'Empirical Evidence for the Effect of Airline Travel on Inter-Regional Influenza Spread in the United States': 3, 'The role of subway travel in an influenza epidemic: A New York city simulation': 1, 'Strategies for mitigating an influenza pandemic': 1, 'Unifying viral genetics and human transportation data to predict the global transmission dynamics of human influenza H3N2': 2, 'Critical paths in a metapopulation model of H1N1: Efficiently delaying influenza spreading through flight cancellation': 2, 'Determinants of the spatiotemporal dynamics of the 2009 H1N1 pandemic in Europe: Implications for real-time modelling': 1, 'Assessment of the potential for international dissemination of Ebola virus via commercial air travel during the 2014 west African outbreak': 1, 'The geographical spread of influenza': 1, 'Spread of a Novel Influenza A (H1N1) Virus via Global Airline Transportation': 1, 'History and epidemiological features of pandemic influenza': 1, \"COVID-19: 20 Countries' Higher Education Intra-Period Digital Pedagogy Responses\": 1, \"Influence of COVID-19 confinement in students ' performance in higher education\": 1, 'How can the COVID-19 pandemic help higher education ?': 1, 'Lockdown in India: Lockdown till May 31 can stall coronavirus pandemic, says study | India News -Times of India': 1, 'COVID 2019 outbreak: The disappointment in Indian teachers': 1, 'UGC Guidelines: UGC issues new calendar for universities; 2020-21 session to begin from': 1, 'Coronavirus: India\\'s education minister aims to \"save\" academic year | Times Higher Education (THE)': 1, 'COVID-19 and medical education': 1, 'Pandemics and Their Impact on Medical Training: Lessons from Singapore': 1, 'Ophthalmic clinical skills teaching in the time of COVID-19: A crisis and opportunity': 1, 'A non-randomised trial of video and written educational adjuncts in undergraduate ophthalmology': 1, 'Education and the COVID-19 pandemic': 1, 'Our Education, Our Concerns: Medical Student Education Impact due to COVID-19': 2, \"Twelve tips for facilitating Millennials' learning\": 1, \"Teacher training, social distancing: Here's how Indian universities will function post-lockdown\": 1, 'Using Technology , Bioinformatics and Health Informatics Approaches to Improve Learning Experiences in Optometry Education': 1, 'The Effectiveness of Blended Learning in Health Professions: Systematic Review and Meta-Analysis': 2, 'Why India may do much better off with COVID-19': 1, 'Sentiment Analysis of Nationwide Lockdown due to COVID 19 Outbreak: Evidence from India': 1, 'Optometry-facilitated teleophthalmology: an audit of the first year in Western Australia': 1, 'Innovative Approaches in the Delivery of Primary and Secondary Eye Care. Switzerland: Springer Nature': 1, 'Demystifying the Millennial student: A reassessment in measures of character and engagement in professional education': 1, 'Ready for action Listos para la acción': 1, 'Pattern of Optometry Practice and Range of Services in India': 1, 'Practical byzantine fault tolerance': 5, 'Bitcoin: a peer-to-peer electronic cash system': 2, 'Ethereum: a next-generation smart contract and decentralized application platform': 1, 'Hyperledger fabric: a distributed operating system for permissioned blockchains': 1, 'The next 700 BFT protocols': 4, 'State machine replication in the libra blockchain': 2, 'Algorand: Scaling byzantine agreements for cryptocurrencies': 1, 'SBFT: a scalable and decentralized trust infrastructure': 3, 'Scalable BFT consensus mechanism through aggregated signature gossip': 3, 'Hotstuff: BFT consensus with linearity and responsiveness': 3, 'Paxos made simple': 1, 'Ring Paxos: a high-throughput atomic broadcast protocol': 1, 'The mutable consensus protocol': 1, 'Enhancing bitcoin security and performance with strong consistency via collective signing': 1, 'Compact multi-signatures for smaller blockchains': 1, 'Making BFT protocols really adaptive': 1, 'Dispel: byzantine SMR with distributed pipelining': 1, 'Integral Transforms and Their Applications': 2, 'Analog and Digital Signal Analysis: From Basics to Applications': 1, 'An Introduction to the Theory of Stationary Random Functions': 1, 'Fuzzy Relational Systems: Foundations and Principles': 3, 'Residuated Lattices: An Algebraic Glimpse at Substructural Logics': 1, 'Mathematical Principles of Fuzzy Logic': 2, 'Fuzzy transforms: theory and applications': 3, 'Spaces with fuzzy partitions and fuzzy transform': 1, 'Axiomatic of lattice-valued f-transform. Fuzzy Sets Syst': 1, 'F-transforms and semimodule homomorphisms': 1, 'Fuzzy objects in spaces with fuzzy partitions': 1, 'Lattice-valued f-transforms and similarity relations': 1, 'Lattice-valued F-transforms as interior operators of L-fuzzy pretopological spaces': 1, 'Generalized residuate lattice based F-transform': 1, 'Integral transforms on spaces of complete residuated lattice valued functions': 7, 'Residuated variants of sugeno integrals: towards new weighting schemes for qualitative aggregation methods': 5, 'L-fuzzy quantifiers of type 1 determined by fuzzy measures': 6, 'Triangular Norms': 1, 'Fuzzy Measures and Integrals. Theory and Applications. Studies in Fuzziness and Soft Computing': 1, 'A universal integral as common frame for Choquet and Sugeno integral': 1, 'A note on the links between different qualitative integrals': 1, 'Set Functions, Games and Capacities in Decision Making': 1, 'New topology in residuated lattices': 1, 'Assessment of water quality on the Yamuna river using principle component analysis: a case study': 1, 'DO-BOD modeling of River Yamuna for national capital territory, India using STREAM II, a 2D water quality model': 1, 'Impact of Climate Change on River Water Quality: A Case Study on the Yamuna River': 1, 'The status and effects of the Yamuna Action Plan (YAP)': 1, 'Social vulnerability indices: A comparative assessment using uncertainty and sensitivity analysis': 1, 'Add or multiply? A tutorial on ranking and choosing with multiple criteria': 1, 'COVID-19 and surface water quality: Improved lake water quality during the lockdown': 1, 'Business Process Management. Concepts, Languages, Architectures': 3, 'Multi-perspective process mining': 1, \"What's my process model composed of? A systematic literature review of meta-models in BPM\": 1, 'Object Management Group: Business Process Model and Notation (BPMN)': 2, 'Towards a framework for comparing process modelling languages': 3, 'Guidelines for performing systematic literature reviews in software engineering': 1, 'Lessons from applying the systematic literature review process within the software engineering domain': 2, 'On the notion of goal in business process models': 3, 'Event-driven Process Chains (EPC). Metrics for Process Models. LNBIP': 1, 'On the notion of soft-goals in business process modeling': 2, 'An ontological analysis of value propositions': 1, 'Modeling resources and capabilities in enterprise architecture: a wellfounded ontology-based proposal for archimate': 4, 'The ontology of states, processes, and events': 3, 'States, processes and events, and the ontology of causal relations': 2, 'Business process activity relationships: is there anything beyond arrows? In: Weske': 2, 'A generic enterprise resource ontology': 2, 'Modeling manufacturing resources: an ontological approach': 3, 'Relational roles and qua-individuals': 2, 'Social roles and their descriptions': 3, 'WonderWeb deliverable D18 ontology library (final)': 1, 'Business processes and their participants: an ontological perspective': 2, 'An evaluation of conceptual business process modelling languages': 1, 'A meta-meta-model for seven business process modeling languages': 1, 'Events and activities: is there an ontology behind BPMN?': 1, 'An ontology-based semantic foundation for ARIS EPCs': 1, 'Using the unified foundational ontology (UFO) as a foundation for general conceptual modeling languages': 1, 'Towards ontological foundations for the conceptual modeling of events': 1, 'Business process modelinga comparative analysis': 1, 'Toward a theory of the deep structure of information systems': 1, 'Animal noroviruses': 1, 'Epidemiology of Norwalk-like virus infections in cattle in The Netherlands': 1, 'SYBR Green based real-time RT-PCR assay for detection and genotype prediction of bovine noroviruses and assessment of clinical significance in Norway': 2, 'Genetic heterogeneity of bovine noroviruses in Italy': 1, 'Infection of calves with bovine norovirus GIII. 1 strain Jena virus: an experimental model to study the pathogenesis of norovirus infection': 1, 'Pathogenesis of GIII. 2 bovine norovirus, CV186-OH/00/US strain in gnotobiotic calves': 1, 'Complete genomic characterization and antigenic relatedness of genogroup III, genotype 2 bovine noroviruses': 1, 'Caliciviridae: the noroviruses': 1, 'Zackenvirus\" (Jena agent 117/ 80)-a new diarrhea pathogen in calves': 1, 'Molecular detection of norovirus in sheep and pigs in New Zealand farms': 1, 'Norovirus recombination': 1, 'Molecular detection of bovine Noroviruses in Argentinean dairy calves: Circulation of a tentative new genotype': 1, 'Norwalk virus minor capsid protein VP2 associates within the VP1 shell domain': 1, 'Variation in ORF3 of genogroup 2 Norwalk-like viruses': 2, 'Evolutionary dynamics of GII. 4 noroviruses over a 34-year period': 1, 'Molecular detection of enteric viruses from diarrheic calves in Egypt': 4, 'Reverse transcription-PCR assays for detection of bovine enteric caliciviruses (BEC) and analysis of the genetic relationships among BEC and human caliciviruses': 1, \"DNASTAR's Lasergene sequence analysis software\": 1, 'Bovine noroviruses: a missing component of calf diarrhoea diagnosis': 1, 'Molecular prevalence of bovine noroviruses and neboviruses detected in centraleastern Tunisia': 1, 'Genetic and evolutionary perspectives on genogroup III, genotype 2 bovine noroviruses': 1, 'Predominance and circulation of enteric viruses in the region of Greater Cairo': 1, 'Covariation of major and minor viral capsid proteins in norovirus genogroup II genotype 4 strains': 1, 'Section 3: Current Antibiotic Resistance Threats in the United States, by Microorganism': 1, 'Self-assembled arginine-rich peptides as effective antimicrobial agents': 1, 'Treatment of infections associated with surgical implants': 1, 'The diagnosis and management of prosthetic joint infections': 1, 'Reducing bacterial infections and biofilm formation using nanoparticles and nanostructured antibacterial surfaces': 2, 'Health care-associated infections: AMetaanalysis of costs and financial impact on the US health care system': 1, 'The role of bacterial biofilms in chronic infections': 1, 'Microbial biofilm formation: a need to act': 1, 'From bench to patient: model systems in drug discovery': 1, 'Three-dimensional in vitro cell culture models in drug discovery and drug repositioning': 1, 'The application of in vitro models of drug metabolism and toxicity in drug discovery and drug development': 1, 'Vivo Models for Drug Discovery': 1, 'Animals devoid of pulmonary system as infection models in the study of lung bacterial pathogens': 1, 'MINIREVIEW animal models in the evaluation of antimicrobial agents': 1, 'Differences in innate immune response between man and mouse': 1, 'Animal testing and marketing bans of the EU cosmetics legislation': 1, 'Incorporation of multicellular spheroids into 3-D polymeric scaffolds provides an improved tumor model for screening anticancer drugs': 1, 'Towards automated production and drug sensitivity testing using scaffold-free spherical tumor microtissues': 1, 'Robert Koch and the \"golden age\" of bacteriology': 1, 'Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study': 1, 'Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis': 2, 'Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis': 1, 'Strategies for combating bacterial biofilm infections': 1, 'Antimicrobial susceptibility testing in biofilm-growing bacteria': 2, 'Mechanisms of biofilm resistance to antimicrobial agents': 2, 'The in vivo biofilm': 4, 'The limitations of in vitro experimentation in understanding biofilms and chronic infection': 3, 'Forging a link between biofilms and disease': 1, 'Biofilm infections, their resilience to therapy and innovative treatment strategies': 1, 'consulting external expert Werner Zimmerli, ESCMID* guideline for the diagnosis and treatment of biofilm infections': 1, 'Multistate point-prevalence survey of health care-associated infections': 1, 'The EPS matrix: the \"house of biofilm cells': 1, 'Diffusion in biofilms': 1, 'Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin': 1, 'Pseudomonas aeruginosa tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum-sensing dependent': 2, 'Pseudomonas aeruginosa recognizes and responds aggressively to the presence of polymorphonuclear leukocytes': 2, 'Compromised host defense on Pseudomonas aeruginosa biofilms: characterization of neutrophil and biofilm interactions': 2, 'Indirect pathogenicity of Haemophilus influenzae and Moraxella catarrhalis in Polymicrobial Otitis media occurs via interspecies quorum signaling': 1, 'Mutualism versus independence: strategies of mixed-species oral biofilms in vitro using saliva as the sole nutrient source': 1, 'Bacterial persistence as a phenotypic switch': 1, 'Persister cells': 2, 'Persistent bacterial infections and persister cells': 1, 'Antibiofilm approaches: prevention of catheter colonization': 1, 'Increased transfer of a multidrug resistance plasmid in Escherichia coli biofilms at the airliquid interface': 1, 'Handbook of Animal Models of Infection : Experimental Models in Antimicrobial Chemotherapy': 1, 'New mouse model for chronic infections by gram-negative bacteria enabling the study of antiinfective efficacy and host-microbe interactions': 1, 'Animal models of chronic lung infection with Pseudomonas aeruginosa : useful tools for cystic fibrosis studies': 1, 'Catheter-associated urinary tract infection by Pseudomonas aeruginosa is mediated by exopolysaccharide-independent biofilms': 1, 'An In Vivo Polymicrobial Biofilm Wound Infection Model to Study Interspecies Interactions': 1, 'Community surveillance enhances Pseudomonas aeruginosa virulence during polymicrobial infection': 1, 'From in vitro to in vivo models of bacterial biofilm-related infections': 3, 'In vitro and in vivo model systems to study microbial biofilm formation': 2, 'The effects of culture concentration and age, time, and temperature on bacterial attachment to polstyrene': 1, 'Rapid colorimetric assay for antimicrobial susceptibility testing of Pseudomonas aeruginosa': 1, 'Influence of Calcium in Extracellular DNA Mediated Bacterial Aggregation and Biofilm Formation': 1, 'Analysis by confocal laser scanning microscopy of the MDPB bactericidal effect on S. mutans biofilm CLSM analysis of MDPB bactericidal effect on biofilm': 1, 'Superparamagnetic iron oxide-encapsulating polymersome nanocarriers for biofilm eradication': 1, 'Planktonic replication is essential for biofilm formation by Legionella pneumophila in a complex medium under static and dynamic flow conditions': 1, 'The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms': 1, 'Biofilm bacteria: formation and comparative susceptibility to antibiotics': 1, 'Metabolite-enabled eradication of bacterial persisters by aminoglycosides': 1, 'The use of microscopy and three-dimensional visualization to evaluate the structure of microbial biofilms cultivated in the Calgary biofilm device': 5, 'A new device for rapid evaluation of biofilm formation potential by bacteria': 1, 'Preliminary results of a new antibiotic susceptibility test against biofilm installation in device-associated infections: the Antibiofilmogram ®': 1, 'Comparison between the biofilm initiation of Campylobacter jejuni and Campylobacter coli strains to an inert surface using BioFilm Ring Test ®': 1, 'The BioFilm ring test: a rapid method for routine analysis of Pseudomonas aeruginosa biofilm formation kinetics': 1, 'New method showing the influence of matrix components in leuconostoc mesenteroides biofilm': 1, 'Inactivation of the SecA2 protein export pathway in Listeria monocytogenes promotes cell aggregation, impacts biofilm architecture and induces biofilm formation in environmental condition': 1, 'Insight into the microbial multicellular lifestyle via flow-cell technology and confocal microscopy': 1, 'Observations of fouling biofilm formation': 1, 'Candida albicans biofilm formation on peptide functionalized polydimethylsiloxane': 1, 'Cyclodextrin-functionalized biomaterials loaded with miconazole prevent Candida albicans biofilm formation in vitro': 1, 'Optimal antimicrobial catheter lock solution, using different combinations of minocycline, EDTA, and 25-percent ethanol, rapidly eradicates organisms embedded in biofilm': 2, 'Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections': 1, 'Multicellular organization in a degradative biofilm community': 2, 'Comparison of velocity profiles for different flow chamber designs used in studies of microbial adhesion to surfaces': 2, 'Growing and analyzing biofilms in flow chambers': 2, 'Biofilm formation by Pseudomonas aeruginosa wild type, flagella and type IV pili mutants': 1, 'Involvement of bacterial migration in the development of complex multicellular structures in Pseudomonas aeruginosa biofilms': 1, 'Development and characterization of an oral multispecies biofilm implant flow chamber model': 1, 'Chapter 4 in vitro biofilm models. An overview': 2, 'Observing the biofilm matrix of staphylococcus epidermidis ATCC 35984 grown using the CDC biofilm reactor': 1, 'A method for growing a biofilm under low shear at the air-liquid interface using the drip flow biofilm reactor': 1, 'A constant depth film fermenter to grow microbial biofilms': 2, 'Bursting the bubble on bacterial biofilms: a flow cell methodology': 1, 'Model system for growing and quantifying Streptococcus pneumoniae biofilms in situ and in real time': 1, 'Real time monitoring of the impedance characteristics of Staphylococcal bacterial biofilm cultures with a modified CDC reactor system': 1, 'Label-free interdigitated microelectrode based biosensors for bacterial biofilm growth monitoring using Petri dishes': 1, 'Interdigitated microelectrode biosensor for bacterial biofilm growth monitoring by impedance spectroscopy technique in 96-well microtiter plates': 1, 'Microelectrode measurements of local mass transport rates in heterogeneous biofilms': 1, 'In Vitro biofilm models for device-related infections': 1, 'Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum': 1, 'Gene repression by the ferric uptake regulator in Pseudomonas aeruginosa: cycle selection of iron-regulated genes': 1, 'Bacterial biofilms: a common cause of persistent infections, Science (80-. )': 1, 'Essential genome of Pseudomonas aeruginosa in cystic fibrosis sputum': 1, 'Dynamic interactions of neutrophils and biofilms': 1, 'Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection response': 1, 'Bacterial biofilms: a common cause of persistent infections': 1, 'Host defence against Staphylococcus aureus biofilms infection: phagocytosis of biofilms by polymorphonuclear neutrophils (PMN)': 1, 'Inactivation of the rhlA gene in Pseudomonas aeruginosa prevents rhamnolipid production, disabling the protection against polymorphonuclear leukocytes': 1, 'Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis': 1, 'Polymorphonuclear leukocytes restrict growth of Pseudomonas aeruginosa in the lungs of cystic fibrosis patients': 1, 'Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents': 1, 'Microbial diversity in the early in vivo-formed dental biofilm': 1, 'Polymicrobial interactions: impact on pathogenesis and human disease': 1, 'Distribution, organization, and ecology of bacteria in chronic wounds': 1, 'A new method by which sponges may be artificially reared': 1, 'Organogenesisin a dish: modeling development and disease using organoid technologies, Science (80': 1, 'Engineering stem cell organoids': 1, 'Humans in a dish: the potential of organoids in modeling immunity and infectious diseases': 1, 'Synergistic engineering: organoids meet organson-a-chip': 2, 'Salmonella-infected crypt-derived intestinal organoid culture system for host-bacterial interactions': 1, 'Early cellular responses to Salmonella infection: dendritic cells, monocytes, and more': 1, 'Chronic effects of a salmonella type III secretion effector protein AvrA in vivo': 1, 'Expansion of paneth cell population in response to enteric Salmonella enterica Serovar Typhimurium infection': 1, 'A novel human gastric primary cell culture system for modelling Helicobacter pylori infection in vitro': 1, 'Isolation and culturing of highly polarized primary epithelial cells from normal human stomach (antrum) as spheroid-like vesicles': 1, 'Cerebral organoids model human brain development and microcephaly': 2, 'Human cerebral organoids recapitulate gene expression programs of fetal neocortex development': 1, 'Zika virus: Zika virus impairs growth in human neurospheres and brain organoids': 2, 'Beltrao-Braga, The Brazilian Zika virus strain causes birth defects in experimental models': 2, 'The third dimension bridges the gap between cell culture and live tissue': 1, 'From 3D cell culture to organs-on-chips': 2, 'Microfabrication of human organs-on-chips': 1, 'Organs-on-chips at the frontiers of drug discovery': 3, 'Biodegradable microfluids': 1, 'Chaotic mixing in three-dimensional microvascular networks fabricated by direct-write assembly': 1, 'Microcontact printing of proteins': 1, 'Cells and organs on chip -a revolutionary platform for biomedicine': 1, 'Effects of oxygenation and flow on the viability and function of rat hepatocytes cocultured in a microchannel flat-plate bioreactor': 1, 'Reconstituting organ-level lung functions on a chip': 3, 'An artificial liver sinusoid with a microfluidic endothelial-like barrier for primary hepatocyte culture': 2, 'Skin-on-a-chip model simulating inflammation, edema and drug-based treatment': 3, 'Characterization of a microfluidic in vitro model of the bloodbrain barrier (μBBB)': 2, 'Metabolic consequences of inflammatory disruption of the blood-brain barrier in an organ-on-chip model of the human neurovascular unit': 3, 'Mimicking the kidney: a key role in organ-on-chip development': 2, 'Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip': 3, 'Topographical micropatterning of poly (dimethylsiloxane) using laminar flows of liquids in capillaries': 1, 'Reverse engineering human pathophysiology with organs-on-chips': 3, 'A microfluidic 3D invitro model for specificity of breast cancer metastasis to bone': 1, 'High-throughput screening (HTS) of anticancer drug efficacy on a micropillar/ microwell chip platform': 1, 'Multifunctional inverse opal particles for drug delivery and monitoring': 1, 'The Complete Spleen: Structure, Function and Clinical Disorders': 1, 'Development of a three-dimensional, all-human in vitro model of the blood-brain barrier using mono-, co-, and tri-cultivation Transwell models': 1, 'Infection and immunity on a chip: a compartmentalised microfluidic platform to monitor immune cell behaviour in real time': 1, 'Chemotaxis of cell populations through confined spaces at Single-Cell resolution': 1, 'Directional decisions during neutrophil chemotaxis inside bifurcating channels': 1, 'Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow': 2, 'The host-microbe interface within the gut': 1, 'Inhibitory effects of Lactobacillus casei subsp. rhamnosus on Salmonella lipopolysaccharide-induced inflammation and epithelial barrier dysfunction in a co-culture model using Caco-2/peripheral blood mononuclear cells': 1, 'VSL#3 probiotics regulate the intestinal epithelial barrier in vivo and in vitro via the p38 and ERK signaling pathways': 1, 'Co-culture of epithelial cells and bacteria for investigating host-pathogen interactions': 3, 'A comparative study between human skin substitutes and normal human skin using Raman microspectroscopy': 1, 'In vitro 3D full-thickness skinequivalent tissue model using silk and collagen biomaterials': 2, 'Production of human tissue-engineered skin trilayer on a plasma-based hypodermis': 2, 'Organs-on-a-Chip: a fast track for engineered human tissues in drug development': 1, 'Pumpless microfluidic platform for drug testing on human skin equivalents': 1, 'In vitro micro-physiological immune-competent model': 2, 'Skin integrated with perfusable vascular channels on a chip': 1, 'Bacteria and wound healing': 1, 'Microfluidic wound model for studying the behaviors of Pseudomonas aeruginosa in polymicrobial biofilms': 2, 'A novel microfluidic wound model for testing antimicrobial agents against Staphylococcus pseudintermedius biofilms': 2, 'A microfluidic device for a pharmacokineticpharmacodynamic (PK-PD) model on a chip': 2, 'Multi-tissue interactions in an integrated threetissue organ-on-a-chip platform': 2, 'A four-organ-chip for interconnected long-term co-culture of human intestine, liver, skin and kidney equivalents': 4, 'A microfluidic wound-healing assay for quantifying endothelial cell migration': 1, 'Full-thickness human skin-on-chip with enhanced epidermal morphogenesis and barrier function': 1, 'Comparison of biocompatibility and adsorption properties of different plastics for advanced microfluidic cell and tissue culture models': 1, 'Advantages and challenges of microfluidic cell culture in polydimethylsiloxane devices': 1, 'Poly(Dimethylsiloxane) (PDMS) Affects Gene Expression in PC12 Cells Differentiating into Neuronal-Like Cells': 1, 'Skin diseases modeling using combined tissue engineering and microfluidic technologies': 1, 'Noninvasive nanoparticle strategies for brain tumor targeting': 1, 'Controlling ferrofluid permeability across the blood-brain barrier model': 1, 'New experimental models of the blood-brain barrier for CNS drug discovery': 1, 'Three-dimensional blood-brain barrier model for in vitro studies of neurovascular pathology': 1, 'Blood-brain barrier modeling: challenges and perspectives': 1, 'Permeability across a novel microfluidic blood-tumor barrier model': 1, 'Human immunodeficiency virus infection of human astrocytes disrupts blood-brain barrier integrity by a gap junction-dependent mechanism': 1, 'The role of autophagy during group B streptococcus infection of blood-brain barrier endothelium': 3, 'A modular approach to create a neurovascular unit-on-a-chip': 1, 'Biofilm streamers cause catastrophic disruption of flow with consequences for environmental and medical systems': 1, 'Microbial sciences: the superficial life of microbes': 1, 'Towards diagnostic guidelines for biofilm-associated infections': 1, 'Biofilms: survival mechanisms of clinically relevant microorganisms': 1, 'Laminar flow around corners triggers the formation of biofilm streamers': 1, 'Tumour-on-a-chip: microfluidic models of tumour morphology, growth and microenvironment': 1, 'Tumour-on-achip provides an optical window into nanoparticle tissue transport': 1, 'Tumourvessel-on-a-chip models for drug delivery': 1, 'Human organ chip models recapitulate orthotopic lung cancer growth, therapeutic responses, and tumor dormancy in vitro': 1, 'Body-on-a-chip simulation with gastrointestinal tract and liver tissues suggests that ingested nanoparticles have the potential to cause liver injury, Lab a Chip -Miniaturisation': 1, 'The design and fabrication of three-chamber microscale cell culture analog devices with integrated dissolved oxygen sensors': 2, 'A dynamic multi-organ-chip for long-term cultivation and substance testing proven by 3D human liver and skin tissue co-culture': 1, 'Low-cost microbioreactor for high-throughput bioprocessing': 1, 'Organs-on-chips: progress, challenges, and future directions': 2, 'Cells, tissues, and organs on chips: challenges and opportunities for the cancer tumor microenvironment': 1, 'Organ-on-a-chip and the kidney': 1, 'The Multi-organ Chip -a Microfluidic Platform for Long-term Multi-tissue Coculture': 1, 'Exploring the applications of invertebrate host-pathogen models for in vivo biofilm infections': 1, 'Biofilm models of polymicrobial infection': 1, 'elegans: an all in one model for antimicrobial drug discovery': 1, 'Development and validation of an automated high-throughput system for zebrafish in vivo screenings': 1, 'Mechanisms of synergy in polymicrobial infections': 1, 'Discerning the complexity of community interactions using a Drosophila model of polymicrobial infections': 1, 'Porcine models of biofilm infections with focus on pathomorphology': 2, 'Bacterialinduced epithelial damage promotes fungal biofilm formation in a sheep model of sinusitis': 1, 'In vivo detection of staphylococcus aureus in biofilm on vascular prostheses using non-invasive biophotonic imaging': 1, 'The ethics of animal research. Talking Point on the use of animals in scientific research': 1, 'Genomic responses in mouse models poorly mimic human inflammatory diseases': 1, 'Increasing the presence of biofilm and healing delay in a porcine model of MRSAinfected wounds': 2, 'Induction of experimental chronic Pseudomonas aeruginosa lung infection with P. aeruginosa entrapped in alginate microspheres': 1, 'Improved outcome of chronic Pseudomonas aeruginosa lung infection is associated with induction of a Th1-dominated cytokine response': 1, 'Effect of microand nanoscale topography on the adhesion of bacterial cells to solid surfaces': 1, 'Effects of growth surface topography on bacterial signaling in coculture biofilms': 1, 'Defined spatial structure': 1, 'Imaging in vivo secondary caries and ex vivo dental biofilms using cross-polarization optical coherence tomography': 1, 'Biofilm maturity studies indicate sharp debridement opens a time-dependent therapeutic window': 1, 'Modeling tuberculosis pathogenesis through ex vivo lung tissue infection': 2, 'Development of an ex vivo porcine lung model for studying growth Virulence, and signaling of pseudomonas aeruginosa': 6, 'Human lung tissue explants reveal novel interactions during Legionella pneumophila infections': 1, 'Mycobacteria infect different cell types in the human lung and cause species dependent cellular changes in infected cells': 4, 'Infection of murine precision cut lung slices (PCLS) with respiratory syncytial virus (RSV) and chlamydophila pneumoniae using the Krumdieck technique': 1, 'Ex vivo lung function measurements in precision-cut lung slices (PCLS) from chemical allergen-sensitized mice represent a suitable alternative to in vivo studies': 1, 'Effects of rhinovirus 39 infection on airway hyperresponsiveness to carbachol in human airways precision cut lung slices': 1, 'Human wound-healing research: issues and perspectives for studies using wide-scale Analytic platforms': 1, 'Increased proliferation in keloid fibroblasts wounded in vitro': 1, 'Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors': 1, 'Strategies for improving the physiological relevance of human engineered tissues': 1, 'Living in three dimensions: 3D nanostructured environments for cell culture and regenerative medicine': 1, 'Laser microdissection of the alveolar duct enables single-cell genomic analysis': 1, 'A novel 3D skin explant model to study anaerobic bacterial infection': 2, 'A novel human skin chamber model to study wound infection ex vivo': 3, 'The pig as a model for human wound healing': 1, 'Ex vivo skin infection model': 1, 'Development of a novel ex vivo porcine skin explant model for the assessment of mature bacterial biofilms': 1, 'A surfactant-based wound dressing can reduce bacterial biofilms in a porcine skin explant model': 1, 'Antimicrobial dressing efficacy against mature Pseudomonas aeruginosa biofilm on porcine skin explants': 1, 'Wound microbiology and associated approaches to wound management': 1, 'Methods for cultivation of keratinocytes with an air-liquid interface': 1, 'Phenotypes of non-attached pseudomonas aeruginosa aggregates resemble surface attached biofilm': 1, 'Three-dimensional cell cultures in drug discovery and development': 1, 'Organoids as an in vitro model of human development and disease': 1, 'Growing self-organizing mini-guts from a single intestinal stem cell: mechanism and applications': 1, 'A brain slice culture model of viral encephalitis reveals an innate CNS cytokine response profile and the therapeutic potential of caspase inhibition': 1, 'Metabolic network modeling and simulation for drug targeting and discovery': 1, 'Mathematical modelling of tooth demineralisation and pH profiles in dental plaque': 1, 'Recent Advances in Organ-on-achip Technologies and Future Challenges: a Review': 1, 'Zooming in to see the bigger picture: microfluidic and nanofabrication tools to study bacteria': 1, 'Modeling viral infectious diseases and development of antiviral therapies using human induced pluripotent stem cell-derived systems': 1, 'The Global Impact of COVID-19 and Strategies for Mitigation and Suppression. On behalf of the imperial college covid-19 response team': 2, 'Covid Act Now': 1, 'Clinical progression of patients with COVID-19 in Shanghai': 1, 'Santiago: Biblioteca del Congreso Nacional de Chile; 2020b. Ministry of Health. Dispone régimen especial de cumplimiento de jornada laboral y flexibilidad horaria por brote de coronavirus (COVID-19)': 1, 'Estimates of the demand for mechanical ventilation in the United States during an influenza pandemic': 1, 'El mapa actualizado de las camas de hospitales en Chile. La Tercera': 3, 'Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand. 2020. 2. Ministry of Health. Dispone medidas sanitarias que indica por brote de COVID-19. Norms 1143498, 1143591, 1746958': 1, 'Evaluation of Allplex respiratory panel 1/2/3 multiplex real-time PCR assays for the detection of respiratory viruses with influenza A virus subtyping': 2, \"Feigin and Cherry's Textbook of Pediatric Infectious Diseases\": 3, 'Epidemiology and clinical presentation of parainfluenza type 4 in children: a 3-year comparative study to parainfluenza types 1-3': 4, 'Estimates of parainfluenza virus-associated hospitalizations and cost among children aged less than 5 years in the United States': 3, 'Epidemiology and clinical presentation of the four human parainfluenza virus types': 3, 'Epidemiological investigation and seroprevalence of human parainfluenza virus in Mie Prefecture in Japan during 2009-2013': 2, 'Global prevalence of the human parainfluenza virus. Public Health Weekly Rep': 1, 'Characterization of acute respiratory infections among 340 infants in Wuxi': 1, 'Ten year retrospective evaluation of the seasonal distribution of agent viruses in childhood respiratory tract infections': 1, 'Detection and identification of human parainfluenza viruses 1, 2, 3, and 4 in clinical samples of pediatric patients by multiplex reverse transcription-PCR': 1, 'A prospective study of parainfluenza virus type 4 infections in children attending daycare': 2, 'Picornavirus infections in children diagnosed by RT-PCR during longitudinal surveillance with weekly sampling: association with symptomatic illness and effect of season': 2, 'Prospective study of human bocavirus (HBoV) infection in a pediatric university hospital in Germany': 1, 'Analytical and Numerical Simulation of Tsunami Mitigation by Mangroves in Penang': 1, 'Dynamics life table model for Aedes Aegypti: Analysis of the literature and model development': 1, 'Non-linear regression of biological temperature-dependent rate models based on an absolute reaction-rate theory': 1, 'Temperature-dependent development and survival rates of culex quinquefasciatus and aedes aegypti (diptera: Culicidae)': 1, 'Dengue Fever Epidemic Potential as Projected by General Circulation Models of Global Climate Change. Environmental Health Perspective': 1, 'Climate Change and Mosquito-Borne Disease': 1, 'Worldwide fluctuations in dengue fever cases related to climate variability': 1, 'Emergency control of Aedes aegypti as a disease vector in urban areas': 1, 'A hydrologically driven model of swamp water mosquito population dynamics': 1, 'Modeling Biological Invasion: The Case of Dengue and Mangrove': 1, 'Selective Degradation of Host RNA Polymerase II Transcripts by Influenza A Virus PA-X Host Shutoff Protein': 9, 'The contribution of PA-X to the virulence of pandemic 2009 H1N1 and highly pathogenic H5N1 avian influenza viruses': 2, 'PA-X protein decreases replication and pathogenicity of swine influenza virus in cultured cells and mouse models': 2, 'Influenza A Virus Protein PA-X Contributes to Viral Growth and Suppression of the Host Antiviral and Immune Responses': 3, 'PA-X decreases the pathogenicity of highly pathogenic H5N1 influenza A virus in avian species by inhibiting virus replication and host response': 2, 'PA-X-associated early alleviation of the acute lung injury contributes to the attenuation of a highly pathogenic H5N1 avian influenza virus in mice': 2, 'An overlapping protein-coding region in influenza A virus segment 3 modulates the host response': 5, 'PA-X protein contributes to virulence of triple-reassortant H1N2 influenza virus by suppressing early immune responses in swine': 1, 'Critical Role of the PA-X C-Terminal Domain of Influenza A Virus in Its Subcellular Localization and Shutoff Activity': 8, 'Mapping of a Region of the PA-X Protein of Influenza A Virus That Is Important for Its Shutoff Activity': 6, 'Evolutionary conservation of the PA-X open reading frame in segment 3 of influenza A virus': 3, 'respectively, using Phusion site-directed PCR mutagenesis to introduce the TAG stop codon in +1 ORF (synonymous ATT to ATA substitution at PA Ile-201 codon, TTG to TAG substitution at PA-X Leu-201). pCR3.1-PA-X_9aa-myc and pCR3.1-PA-X_15aa-myc were generated from the pCR3.1-PA-Xmyc constructs by amplifying the truncated coding region and inserting it into the SalI-MluI sites of a pCR3.1-C-terminal-myc backbone. pCR3.1-PA-X_Udorn-myc was generated by PCR amplifying the 5 0 portion of the segment 3 RNA from a PolI-Udorn construct (kind gift from A. Mehle), adding a single nucleotide deletion to shift the frame of the X-ORF, and inserting into the SalI-MluI sites of a pCR3.1-C-terminal-myc backbone. pTRIPZ-PA-X-Nterm-myc and pTRIPZ_PA-X_Udorn-myc were generated by PCR amplifying PA-N191 from pCR3.1-PA-N191-myc and PA-X-Udorn-myc from pCR3.1-PA-X_Udorn-myc, respectively, and inserting these sequences into the backbone of pTRIPZ-RFP_SV40_3 0 UTR (Khaperskyy et al., 2016) after RFP excision with AgeI and ClaI. pCMV-IFN-l2 cDNA, genomic and single intron constructs were generated by PCR amplifying the full human IFN-l2 cDNA, the genomic locus, or combinations of fragments of the two, and inserting into the pd2eGFP-N1 construct (Clontech) after the GFP was excised using NheI and NotI. The 5 0 splice site of intron 2 or 4 was then mutated from TTAjGT and TGTjGT, respectively, to CAGjGT within the single-intron constructs to generate the intron 2 and 4 mutant constructs. Gibson cloning using HiFi assembly mix (New England Biolabs) was used to make all of these constructs, unless otherwise stated. The expression vector for the biotin ligase from E. coli with the R118G mutation BirA* (pcDNA3.1-myc-BioID2-MCS) (Roux et al., 2012) was obtained from Addgene (#74223) and the BirA* ORF was amplified by PCR and inserted into the pCR3.1-myc vector (Khaperskyy et al., 2012) between KpnI and EcoRI sites to generate pCR3.1-BirA*-myc. The PCR-amplified X-ORF sequences from pCR3.1-PA-X-myc and pCR3.1-PA-X(4A)-myc (Khaperskyy et al., 2016) were inserted in frame with BirA* ORF using EcoRI and MluI to generate pCR3.1-BirA*-X61-myc': 4, 'Lytic KSHV infection inhibits host gene expression by accelerating global mRNA turnover': 1, 'Host shutoff during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasion': 1, 'A two-pronged strategy to suppress host protein synthesis by SARS coronavirus Nsp1 protein': 3, 'Highly selective escape from KSHVmediated host mRNA shutoff and its implications for viral pathogenesis': 1, 'Effects of influenza A virus NS1 protein on protein expression: the NS1 protein enhances translation and is not required for shutoff of host protein synthesis': 2, 'Attenuated strains of influenza A viruses do not induce degradation of RNA polymerase II': 2, 'Influenza a virus host shutoff disables antiviral stress-induced translation arrest': 5, 'Nuclear import of cytoplasmic poly(A) binding protein restricts gene expression via hyperadenylation and nuclear retention of mRNA': 1, 'Importin a-mediated nuclear import of cytoplasmic poly(A) binding protein occurs as a direct consequence of cytoplasmic mRNA depletion': 1, 'Aberrant herpesvirus-induced polyadenylation correlates with cellular messenger RNA destruction': 1, 'Crystal structure of an avian influenza polymerase PA( N ) reveals an endonuclease active site': 2, 'CTD serine-2 plays a critical role in splicing and termination factor recruitment to RNA polymerase II in vivo': 2, 'Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo': 1, 'Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals': 2, 'A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells': 1, 'Stable-isotope dimethyl labeling for quantitative proteomics': 2, 'Evidence that cleavage factor Im is a heterotetrameric protein complex controlling alternative polyadenylation': 1, 'Molecular Mechanisms for CFIm-Mediated Regulation of mRNA Alternative Polyadenylation': 1, 'Large-scale proteomic analysis of the human spliceosome': 2, 'Comprehensive proteomic analysis of the human spliceosome': 2, 'Transcription Elongation Can Affect Genome 3D Structure': 2, 'Influenza virus infection causes global RNAPII termination defects': 3, 'The Splicing History of an mRNA Affects Its Level of Translation and Sensitivity to Cleavage by the Virion Host Shutoff Endonuclease during Herpes Simplex Virus Infections': 1, 'Interactomic landscape of PA-X-chicken protein complexes of H5N1 influenza A virus': 1, 'Nuclease escape elements protect messenger RNA against cleavage by multiple viral endonucleases': 1, 'A ribonucleoprotein complex protects the interleukin-6 mRNA from degradation by distinct herpesviral endonucleases': 1, 'Cleavage factor Im (CFIm) as a regulator of alternative polyadenylation': 1, 'An active role for splicing in 3 0 -end formation': 1, 'Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3 0 end formation of cellular pre-mRNAs': 2, 'Inefficient control of host gene expression by the 2009 pandemic H1N1 influenza A virus NS1 protein': 1, 'Functional Evolution of the 2009 Pandemic H1N1 Influenza Virus NS1 and PA in Humans': 2, 'Synthesis of influenza virus polypeptides in cells resistant to alpha-amanitin: evidence for the involvement of cellular RNA polymerase II in virus replication': 1, 'The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible': 1, 'Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists': 1, 'Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources': 2, \"Michel Foucault et l'éthique des techniques: Le cas de la RFID (mémoire de DEA)\": 1, \"Introduction to Kant's Anthropology\": 1, 'Evolutionary struggles between NK cells and viruses': 1, 'The innate immune response to tumors and its role in the induction of T-cell immunity': 1, 'Effector and regulatory events during natural killer-dendritic cell interactions': 1, 'Natural killer cells and pregnancy': 1, 'Up on the tightrope: natural killer cell activation and inhibition': 1, 'Conservation and variation in human and common chimpanzee CD94 and NKG2 genes': 1, 'KIR: Diverse, Rapidly Evolving Receptors of Innate and Adaptive Immunity': 4, 'MHC class I molecules and KIRs in human history, health and survival': 3, 'Understanding how combinations of HLA and KIR genes influence disease': 1, 'The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense': 1, 'A novel system of polymorphic and diverse NK cell receptors in primates': 2, 'Identification of the mouse killer immunoglobulin-like receptor-like (Kirl) gene family mapping to chromosome X': 1, 'Divergent and convergent evolution of NK-cell receptors': 1, 'The expanded cattle KIR genes are orthologous to the conserved single-copy KIR3DX1 gene of primates': 1, 'Co-evolution of KIR2DL3 with HLA-C in a human population retaining minimal essential diversity of KIR and HLA class I ligands': 2, 'Chimpanzees in hepatitis C virus research: 1998-2007': 1, 'Sequencing the chimpanzee genome: insights into human evolution and disease': 1, 'Human leucocyte antigen (HLA) expression of primary trophoblast cells and placental cell lines, determined using single antigen beads to characterize allotype specificities of anti-HLA antibodies': 1, 'NK receptor interactions with MHC class I molecules in pregnancy': 1, 'Common chimpanzees have greater diversity than humans at two of the three highly polymorphic MHC class I genes': 1, 'Rapid evolution of NK cell receptor systems demonstrated by comparison of chimpanzees and humans': 4, 'Single haplotype analysis demonstrates rapid evolution of the killer immunoglobulinlike receptor (KIR) loci in primates': 2, 'Plasticity in the organization and sequences of human KIR/ILT gene families': 1, 'Variation within the human killer cell immunoglobulin-like receptor (KIR) gene family': 2, 'Chimpanzees use more varied receptors and ligands than humans for inhibitory killer cell Ig-like receptor recognition of the MHC-C1 and MHC-C2 epitopes': 3, 'Humans differ from other hominids in lacking an activating NK cell receptor that recognizes the C1 epitope of MHC class I': 3, 'Human natural killer receptors, co-receptors, and their ligands': 3, 'Evolution of killer cell Ig-like receptor (KIR) genes: definition of an orangutan KIR haplotype reveals expansion of lineage III KIR associated with the emergence of MHC-C': 2, 'Protein kinase C regulates expression and function of inhibitory killer cell Ig-like receptors in NK cells': 2, 'IPD-the Immuno Polymorphism Database': 4, 'Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues': 1, 'Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex': 4, 'The human natural killer cell immune synapse': 1, 'Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2) can play a direct role in the inhibitory function of killer cell Ig-like receptors in human NK cells': 1, 'Decoding protein-protein interactions through combinatorial chemistry: sequence specificity of SHP-1, SHP-2, and SHIP SH2 domains': 1, 'Kinase peptide specificity: improved determination and relevance to protein phosphorylation': 1, 'Determination of the specific substrate sequence motifs of protein kinase C isozymes': 1, 'The HLA-B73 antigen has a most unusual structure that defines a second lineage of HLA-B alleles': 1, 'NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80': 1, 'The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor': 1, 'The interlocus recombinant HLA-B*4601 has high selectivity in peptide binding and functions characteristic of HLA-C': 3, 'Going east: new genetic and archaeological perspectives on the modern human colonization of Eurasia': 2, 'Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3': 4, \"Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by ''group 2'' or ''group 1'' NK clones\": 1, 'MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response': 1, 'Distinctive polymorphism at the HLA-C locus: implications for the expression of HLA-C': 1, 'Diversity and diversification of HLA-A,B,C alleles': 1, 'A single bottleneck in HLA-C assembly': 1, 'Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype': 1, 'Brain size at birth throughout human evolution: a new method for estimating neonatal brain size in hominins': 1, 'Genomic evolution of MHC class I region in primates': 1, 'HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection': 1, 'A roadmap for HLA-A, HLA-B, and HLA-C peptide binding specificities': 1, 'Evolutionarily conserved amino acids that control TCR-MHC interaction': 1, 'Killer-cell immunoglobulin-like receptor (KIR) nomenclature report': 1, 'Haplotype inference for presentabsent genotype data using previously identified haplotypes and haplotype patterns': 1, 'Natural killer cell immunoglobulin-like receptor (KIR) locus profiles in African and South Asian populations': 1, 'Definition of gene content for nine common group B haplotypes of the Caucasoid population: KIR haplotypes contain between seven and eleven KIR genes': 1, 'Predominance of group A KIR haplotypes in Japanese associated with diverse NK cell repertoires of KIR expression': 1, 'MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment': 1, 'High KIR diversity in Amerindians is maintained using few gene-content haplotypes': 1, 'DnaSP v5: a software for comprehensive analysis of DNA polymorphism data': 1, 'KIR2DL5 alleles mark certain combination of activating KIR genes': 1, 'Duplication, mutation and recombination of the human orphan gene KIR2DS3 contribute to the diversity of KIR haplotypes': 1, 'SNP haplotypes and allele frequencies show evidence for disruptive and balancing selection in the human leukocyte receptor complex': 1, 'PAML: a program package for phylogenetic analysis by maximum likelihood': 2, 'IMGT/ HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex': 2, 'Komerofsky R New allele frequency database': 1, 'New, improved version of generic mapping tools released': 1, 'Balancing selection and heterogeneity across the classical human leukocyte antigen loci: a meta-analytic review of 497 population studies': 1, 'DIVERGE: phylogeny-based analysis for functional-structural divergence of a protein family': 1, 'Stable isotope labeling and resonance assignment in larger proteins': 2, 'Nuclear Magnetic Resonance Spectroscopy': 1, 'Kidney impairment is associated with in-hospital death of COVID-19 patients': 1, 'Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in wuhan, china': 1, 'Caution on kidney dysfunctions of 2019-nCoV patients': 2, 'Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection': 1, 'Kidney involvement in COVID-19 and rationale for extracorporeal therapies': 1, 'Conservative fluid management or deresuscitation for patients with sepsis or acute respiratory distress syndrome following the resuscitation phase of critical illness: A systematic review and meta-analysis': 1, 'Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19': 1, 'Coagulopathy and antiphospholipid antibodies in patients with covid-19': 1, 'Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in china': 1, 'Multiorgan and renal tropism of SARS-CoV-2 [epub ahead of print': 1, '2019-nCoV transmission through the ocular surface must not be ignored': 1, '伴发 或首发病毒性结膜炎的新型冠状病毒感染 下眼科医师的防': 1, 'Ophthalmologic evidence against the interpersonal transmission of 2019 novel coronavirus through conjunctiva. unpublished. Received on': 1, 'Therapeutic targets of renin-angiotensin system in ocular disorders': 1, 'The SARS epidemic in mainland China: bringing together all epidemiological data': 3, 'Severe acute respiratory syndrome: review and lessons of the 2003 outbreak': 1, 'Fighting the Ebola virus': 1, 'Improving imperfect data from health management information systems in Africa using space-time geostatistics': 2, 'SARS in Singapore: surveillance strategies in a globalising city': 1, 'Understanding the spatial clustering of severe acute respiratory syndrome (SARS) in': 1, 'Spatial dynamics of an epidemic of severe acute respiratory syndrome in an urban area': 1, 'Descriptive review of geographic mapping of severe acute respiratory syndrome (SARS) on the Internet': 1, 'Need for improved methods to collect and present spatial epidemiologic data for vectorborne diseases': 1, 'Large-scale spatial-transmission models of infectious disease': 1, 'Experience of severe acute respiratory syndrome in Singapore: importation of cases, and defense strategies at the airport': 1, 'The severe acute respiratory syndrome: impact on travel and tourism': 1, 'Transmission of the severe acute respiratory syndrome on aircraft': 1, 'Isolation of Nipah virus from Malaysian island flying-foxes': 1, 'Isolation of Hendra virus from pteropid bats: a natural reservoir of Hendra virus': 1, 'Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats': 8, 'Haematophagous bats in Brazil, their role in rabies transmission, impact on public health, livestock industry and alternatives to an indiscriminate reduction of bat population': 1, 'Bat lyssavirus infections': 1, 'Virology. Researchers tie deadly SARS virus to bats': 1, 'Characterisation of a recently isolated lyssavirus in frugivorous zoo bats': 1, 'Presence of European bat lyssavirus RNAs in apparently healthy Rousettus aegyptiacus bats': 1, 'Bats as a continuing source of emerging infections in humans': 1, 'Experimental inoculation of plants and animals with Ebola virus': 1, 'Viruses and interferons': 1, 'Manipulation of the nuclear factor-kappaB pathway and the innate immune response by viruses': 1, 'Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus': 1, 'The interferon in TLR signaling: more than just antiviral': 1, 'Monophyletic origin of the order Chiroptera and its phylogenetic position among mammalia, as inferred from the complete sequence of the mitochondrial DNA of a Japanese megabat, the Ryukyu flying fox (Pteropus dasymallus)': 1, 'Pegasoferae, an unexpected mammalian clade revealed by tracking ancient retroposon insertions': 1, 'Molecular cloning and sequencing of the cDNA encoding the bat CD4': 1, 'Nipah encephalitis outbreak in Malaysia': 1, 'Mutational analysis of cis-acting RNA signals in segment 7 of influenza A virus': 2, 'Efficient generation and growth of influenza virus A/PR/8/34 from eight cDNA fragments': 1, 'Identification of the domains of the influenza A virus M1 matrix protein required for NP binding, oligomerization and incorporation into virions': 2, 'Retroviral transduction of DT40': 1, 'Nuclear export of influenza A virus mRNAs requires ongoing RNA polymerase II activity': 1, 'The Jpred 3 secondary structure prediction server': 1, 'Sequence logos: a new way to display consensus sequences': 1, 'Highthroughput mapping of a dynamic signaling network in mammalian cells': 1, 'A Rab11-and microtubule-dependent mechanism for cytoplasmic transport of influenza A virus viral RNA': 1, 'Unfolding grammars in adhesive categories': 4, 'Coreflective concurrent semantics for single-pushout graph grammars': 3, 'Unfolding semantics of graph transformation': 6, 'Fundamentals of Algebraic Graph Transformation': 4, 'Lazy graph transformation': 2, 'Symbolic attributed graphs for attributed graph transformation': 2, 'Unfolding graph transformation systems: theory and applications to verification': 5, 'Unfoldings: A Partial-Order Approach to Model Checking': 1, 'Towards the verification of attributed graph transformation systems': 1, '2011 IEEE 26th Annual Symposium on Logic in Computer Science': 1, 'Moleculenet: a benchmark for molecular machine learning': 3, 'Evaluating protein transfer learning with tape': 9, 'The properties of known drugs. 1. molecular frameworks': 2, 'The Pfam protein families database in 2019': 1, 'Understanding deep learning requires rethinking generalization': 2, 'Learning protein sequence embeddings using information from structure': 1, 'Generalizing across domains via cross-gradient training': 2, 'Learning to generalize: Meta-learning for domain generalization': 3, 'Learning from multiple sources': 1, 'A theory of learning from different domains': 1, 'Domain generalization for object recognition with multi-task autoencoders': 1, 'Unified deep supervised domain adaptation and generalization': 1, 'Deeper, broader and artier domain generalization': 2, 'Domain generalization with adversarial feature learning': 1, 'Deep domain generalization via conditional invariant adversarial networks': 1, 'Undoing the damage of dataset bias': 1, 'Unbiased metric learning: On the utilization of multiple datasets and web images for softening bias': 1, 'Scope: Structural classification of proteins-extended, integrating scop and astral data and classification of new structures': 1, 'Metareg: Towards domain generalization using meta-regularization': 1, 'Episodic training for domain generalization': 1, 'Feature-critic networks for heterogeneous domain generalization': 1, 'Domain generalization via model-agnostic learning of semantic features': 1, 'Domain generalization via invariant feature representation': 1, 'Domain-adversarial training of neural networks': 6, 'On learning invariant representation for domain adaptation': 1, 'Conditional adversarial domain adaptation': 2, 'Domain adaptation with conditional distribution matching and generalized label shift': 1, 'Step change improvement in admet prediction with potentialnet deep featurization': 1, 'National center for biotechnology information. pubchem database. source=the scripps research institute molecular screening center': 1, 'Sars-cov-2 main protease structure and xchem fragment screen. Diamond Light Source': 2, 'Identification of antiviral drug candidates against sars-cov-2 from fda-approved drugs. bioRxiv': 2, 'Analyzing learned molecular representations for property prediction': 2, 'From SARS-CoV to Wuhan 2019-nCoV outbreak: similarity of early epidemic and prediction of future trends': 1, 'Emerging understandings of 2019-nCoV': 1, 'Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan': 1, 'Thrombocytopenia in patients with severe acute respiratory syndrome (review)': 1, 'Genomic characterization of the 2019 novel humanpathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan': 1, 'Aberrant pathogenic GM-CSF+ T cells and inflammatory CD14+ CD16+ monocytes in severe pulmonary syndrome patients of a new coronavirus': 1, 'The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors': 1, 'Complement-independent, peroxide-induced antibody lysis of platelets in HIV-1-related immune thrombocytopenia': 2, 'HIV-related thrombocytopenia': 1, 'Usher proteins in inner ear structure and function': 1, 'HOMER2, a stereociliary scaffolding protein, is essential for normal hearing in humans and mice': 1, 'Novel myosin mutations for hereditary hearing loss revealed by targeted genomic capture and massively parallel sequencing': 1, 'Usher protein functions in hair cells and photoreceptors': 2, 'Usher I syndrome: unravelling the mechanisms that underlie the cohesion of the growing hair bundle in inner ear sensory cells': 1, 'Association of cadherin23 single nucleotide polymorphism with age-related hearing impairment in Han Chinese': 1, 'Review series: the cell biology of hearing': 1, 'Stereocilin connects outer hair cell stereocilia to one another and to the tectorial membrane': 1, 'Genetics and pathological mechanisms of Usher syndrome': 2, 'Gipc3 mutations associated with audiogenic seizures and sensorineural hearing loss in mouse and human': 1, 'GRM7 variants confer susceptibility to age-related hearing impairment': 1, 'Harmonin enhances voltage-dependent facilitation of Cav1.3 channels and synchronous exocytosis in mouse inner hair cells': 2, 'Otoferlin interacts with myosin VI: implications for maintenance of the basolateral synaptic structure of the inner hair cell': 1, 'Role for a novel Usher protein complex in hair cell synaptic maturation': 1, 'The role of an inwardly rectifying K(+) channel (Kir4.1) in the inner ear and hearing loss': 1, 'Molecular and physiological bases of the K+ circulation in the mammalian inner ear': 1, 'Disease-causing dysfunctions of barttin in Bartter syndrome type IV': 1, 'Contribution of genetic factors to noiseinduced hearing loss: a human studies review': 1, 'Preparation, functional characterization, and NMR studies of human KCNE1, a voltage-gated potassium channel accessory subunit associated with deafness and long QT syndrome': 1, 'KCNQ4: a gene for age-related hearing impairment?': 1, 'Mucin gene expression in human middle ear epithelium': 2, 'Targeted high-throughput sequencing identifies pathogenic mutations in KCNQ4 in two large Chinese families with autosomal dominant hearing loss': 1, 'Genetic variations in protocadherin 15 and their interactions with noise exposure associated with noise-induced hearing loss in Chinese population': 1, 'Otitis, media, acute': 1, \"Ferri's Clinical Advisor 2018. 5 Books in 1\": 1, 'Nontypeable Haemophilus influenzae lipoprotein P6 induces MUC5AC mucin transcription via TLR2-TAK1-dependent p38 MAPK-AP1 and IKKbeta-IkappaBalpha-NF-kappaB signaling pathways': 1, 'Altered Toll-and Nod-like receptor expression in human middle ear mucosa from patients with chronic middle ear disease': 1, 'Role of Toll-like receptor 4 in innate immune responses in a mouse model of acute otitis media': 1, 'TLR-9, NOD-1, NOD-2, RIG-I and immunoglobulins in recurrent otitis media with effusion': 1, 'Decreased pattern-recognition receptor-mediated cytokine mRNA expression in obese children with otitis media with effusion': 1, 'Induction of beta defensin 2 by NTHi requires TLR2 mediated MyD88 and IRAK-TRAF6-p38MAPK signaling pathway in human middle ear epithelial cells': 1, 'Decreased expression of TLR-9 and cytokines in the presence of bacteria in patients with otitis media with effusion': 1, 'Role of innate immunity in the pathogenesis of otitis media': 1, 'Synergistic effect of interleukin 1 alpha on nontypeable Haemophilus influenzae-induced up-regulation of human beta-defensin 2 in middle ear epithelial cells': 1, 'NOD proteins: regulators of inflammation in health and disease': 1, 'Lysozyme M deficiency leads to an increased susceptibility to Streptococcus pneumoniae-induced otitis media': 1, 'Attenuated TLRs in middle ear mucosa contributes to susceptibility of chronic suppurative otitis media': 1, 'Understanding the aetiology and resolution of chronic otitis media from animal and human studies': 1, 'Both canonical and noncanonical NF-κB activation contribute to the proliferative response of the middle ear mucosa during bacterial infection': 1, 'Up-regulation of MUC5AC and MUC5B mucin genes in nasopharyngeal respiratory mucosa and selective up-regulation of MUC5B in middle ear in pediatric otitis media with effusion': 1, 'Genetic polymorphisms in immunoresponse genes TNFA, IL6, IL10, and TLR4 are associated with recurrent acute otitis media': 1, 'MKP1 regulates the induction of MUC5AC mucin by Streptococcus pneumoniae pneumolysin by inhibiting the PAK4-JNK signaling pathway': 1, 'The transcriptome of a complete episode of acute otitis media': 1, 'Identification of MUC5B mucin gene in human middle ear with chronic otitis media': 1, 'MUC5AC expression in human middle ear epithelium of patients with otitis media': 1, 'TLR4-mediated induction of TLR2 signaling is critical in the pathogenesis and resolution of otitis media': 1, 'Altered expression of middle and inner ear cytokines in mouse otitis media': 1, 'MUC5B is the predominant mucin glycoprotein in chronic otitis media fluid': 1, 'Synergistic induction of MUC5AC mucin by nontypeable Haemophilus influenzae and Streptococcus pneumoniae': 1, 'MUC2 expression in human middle ear epithelium of patients with otitis media': 1, 'Directive 2008/98/EC of the European Parliament': 2, 'Council Directive 1999/31/EC on the landfill of waste': 2, 'Biodiesel production from residual oils recovered from spent bleaching earth': 2, 'Recycling of spent oil bleaching earth as source of glycerol for the anaerobic production of acetone, butanol, and ethanol with Clostridium diolis and lipolytic Clostridium lundense': 1, \"From Fuller ' s earth to bleaching earth: a historical note\": 1, 'Lipase-catalysed production of biodiesel fuel from vegetable oils contained in waste activated bleaching earth': 2, 'Application of waste activated bleaching earth containing rapeseed oil on riboflavin production in the culture Ashbya gossypii': 1, 'Efficient production of fatty acid metyl ester from waste activated bleaching earth using diesel oil as organic solvent': 2, 'Oxidation of rapeseed oil in waste activated bleaching earth and its effect on riboflavin production in culture of Ashbya gossypii': 3, 'Spent bleaching earth-obtaining and directions of utilization': 1, 'Waste management in the oil industry in the Mediterranean region by composting': 1, 'Composting of oiled bleaching earth: fatty acids degradation, phytotoxicity and mutagenicity changes': 1, 'Aquaculture engineering technologies for future': 1, 'A study of residual oils recovered from spent bleaching earth: their characteristics and applications': 1, \"ed) Bailey's industrial oil and fat products\": 1, 'Evaluation of spent bleaching clay as a feed supplement in broiler diets': 1, 'Studies on evaluation of spent bleaching clay as a feed ingredient in broiler chicks Korean': 1, 'on undesirable substances in animal feed -Council statement': 1, 'Potential application of industrial oily wastes on biodiesel fuel production using Candida cylindracea lipase in organic solvent system': 1, 'Lipase-catalyzed biodiesel production from waste activated bleaching earth as raw material in a pilot plant': 1, 'Two-step biodiesel production from Calophyllum inophyllum oil: optimization of modified b-zeolite catalyzed pretreatment': 1, 'An optimized process for biodiesel production from high FFA spent bleaching earth': 1, 'Adsorption of chromium(VI) and nickel(II) ions on acid-and heat-activated deoiled spent bleaching clay': 1, 'Kinetics of copper desorption from regenerated spent bleaching Earth': 1, 'Stabilization and solidification of spent bleaching earth using cement kiln dust': 1, 'Synthesis and antiviral activity of hydrazides and substituted benzal benzalhyrazides of betulinic acid and its derivatives': 2, 'Methods of analysis and evaluation of properties of soils and plants. Catalogue. Institute of Environmental Protection': 2, 'Fundamentals of analytical chemistry. International Edition, 7th edn': 1, 'Improvement of the BCR three step sequential extraction of new sediment and soil reference materials': 1, 'Gas chromatography and mass spectrometry. A practical guide': 1, 'Infrared spectroscopy: fundamentals and applications': 1, 'Commission Decision of 3 May 2000 (with amendments) establishing a list of wastes pursuant to Article 1(a) of Council Directive 75/442/EEC on waste and Council Decision 94/904/EC establishing a list of hazardous waste': 1, 'D 1 3 0 9 9 & e i = d T 1 M U 5 _ J A -f y 7 A a S p o G YA Q & u s g = AFQjCNFghNCnQhqhglzHfFjm0eauvftVdA&bvm=bv. 64542518,d.ZGU. Accessed': 1, 'Basic microbiology techniques': 1, 'Atlas of clinical fungi': 1, 'A laboratory guide to common Penicillium species. CSIRO Division of Food Processing': 1, 'Yeast characteristics and identification': 1, 'Inhibition of microbial lipases by fatty acids': 1, 'Bio enhancement of microbial biomass: an appropriate technology': 1, 'Bio-sorption of mercury by the inactivated cells of Pseudomonas aeruginosa PU 21 (Rip 64)': 1, 'Bacterial sorption of heavy metals': 1, 'Microbial solubilization and immobilization of toxic metals: biogeochemical processes for treatment of contamination': 1, 'Heavy metal: bio-sorption by dried powdered mycelium of Fusarium flocciferum': 1, 'Biosorption removal of cadmium from aqueous solution by using pretreated fungal Biomass culture d from starch wastewater': 1, 'Cadmium uptake capacity of two strains of Saccharomyces cerevisiae cells': 1, 'Effect of lead and copper on the growth of heavy metal resistance fungi isolated from second industrial city in Riyadh, Saudi Arabia': 1, 'An introduction to the chemistry and biochemistry of fatty acids and their glycerides': 2, 'Enzymes as biocatalysts in the modification of natural lipids': 1, 'An investigation into microbial removal of fats, oil and greases': 1, 'Microbial ecology, fundamentals and applications': 1, 'Life at the oxic-anoxic interface: microbial activities and adaptations': 1, 'Influence of soil moisture on the sequestration of organic compounds in soil': 1, 'Microbial population dynamics, especially stress tolerant Bacillus thuringiensis, in partially anaerobic rice field soils during post-harvest period of the Himalayan, island, brackish water and coastal habitats of India': 1, 'Drying and rewetting effects on C and N mineralization and microbial activity in surface and subsurface California grassland soils': 1, 'Dynamics of microbiological changes and fat transformation in oily bleaching earth according to its modification. Studies and Monographs': 1, 'Yeast Yarrowia lipolytica in the biodegradation of fatty substances of the oily bleaching earth': 1, 'The viable but non-culturable state of wine microorganisms during storage': 1, 'The viable but non-culturable state in bacteria': 1, 'Triterpenoid extractives in the outer bark of Betula lenta (black birch)': 1, 'Glycyrrhizin, an active component of liquorice roots and replication of SARS-associated coronavirus': 2, 'A bioactive triterpenoid and vulpinic acid derivatives from the mushroom Scleroderma citrinum': 2, 'Plant-based vaccines': 3, 'Expression of a synthetic E. coli heat-labile enterotoxin B sub-unit (LT-B) in maize': 1, 'Corn as a production system for human and animal vaccines': 2, 'A plant-based multicomponent vaccine protects mice from enteric diseases': 3, 'Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato': 3, 'Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes': 3, 'A plant-derived edible vaccine against hepatitis B virus': 2, 'Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine': 1, 'Plant-based vaccines: unique advantages': 5, 'Delivery of subunit vaccines in maize seed': 5, 'Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants': 1, 'Congress Symposium on Molecular Farming: development of an edible subunit vaccine in corn against enterotoxigenic strains of Escherichia coli': 1, 'Molecular biology of transmissible gastroenteritis virus': 2, 'Immunity to transmissible gastroenteritis virus and porcine respiratory coronavirus infections in swine': 1, 'Vaccine effectiveness in older individuals: what has been learned from the influenzavaccine experience': 2, 'Influenza illness and hospitalizations averted by influenza vaccination in the United States': 1, 'Predicting clinical severity based on substitutions near epitope A of influenza A/H3N2': 1, \"Public Health Agency of Catalonia. Department of Health. Pla d'informació de les infeccions respiratòries agudes a Catalunya (PIDIRAC)\": 1, 'Estratègia de vigilància dels casos greus de grip hospitalitzats': 2, 'Vigilancia de casos graves hospitalizados confirmados de virus de la gripe': 1, 'The Global Influenza Hospital Surveillance Network (GIHSN): a new platform to describe the epidemiology of severe influenza': 3, 'Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis': 1, 'Virological surveillance of influenza and other respiratory viruses during six consecutive seasons from': 1, 'Severe influenza in 33 US hospitals, 2013-2014: complications and risk factors for death in 507 patients': 1, 'Early administration of oral oseltamivir increases the benefits of influenza treatment': 3, 'Effectiveness of antiviral treatment in preventing death in hospitalized cases of severe influenza over six influenza seasons': 2, 'Increased antiviral treatment among hospitalized children and adults with laboratory-confirmed influenza': 2, 'Estimating the burden of seasonal influenza in Spain from surveillance of mild and severe influenza disease': 1, 'Estimated influenza illnesses, medical visits, hospitalizations, and deaths averted by vaccination in the united states seasonal influenza (Flu) CDC. Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (NCIRD)': 1, 'Zika virus and birth defects-reviewing the evidence for causality': 1, 'Microcephaly in Brazil: how to interpret reported numbers?': 1, 'Is the call for Zika virus abortions the new eugenics?': 1, 'Surge of Zika virus has Brazilians re-examining strict abortion laws': 1, 'Group prepares action in the Supreme Court for abortion in cases of microcephaly (in Portugese)': 2, \"The Zika virus and Brazilian women's right to choose\": 4, 'The WHO must include access to birth control and abortion in its temporary recommendations for Zika-associated public health emergency of international concern': 2, 'Health, human rights and the Zika virus': 2, 'With abortion banned in Zika countries, women beg on web for abortion pills': 1, 'Planned parenthood international using Zika to fundraise for abortion advocacy': 1, 'Zika virus: fear is pushing women into backstreet abortions': 1, 'Will Zika become the 2016 NTD of the year?': 1, \"We've neglected diseases like the Zika virus for too long\": 1, 'Neglected diseases-a human rights analysis': 1, 'Health impact fund-making new medicines accessible for all. Incentives for Global Health': 2, \"Ebola outbreaks were different from the current Zika outbreak: their modes of transmission as well as the ethical considerations they raised were all different. Yet, what SARS, H1N1, Ebola and Zika have in common is that they were all declared 'Public Health Emergencies of International Concern\": 1, 'Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target': 3, 'Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19': 4, 'Nicotine and the renin-angiotensin system': 3, 'Nicotine downregulates the compensatory angiotensin-converting enzyme 2/angiotensin type 2 receptor of the renin-angiotensin system': 3, 'Bulk and single-cell transcriptomics identify tobacco-use disparity in lung gene expression of ACE2, the receptor of 2019-nCov': 3, 'Sin DD (2020) ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for': 3, 'Smoking upregulates angiotensin-converting enzyme-2 receptor: a potential adhesion site for novel coronavirus SARS-CoV-2 (Covid-19)': 3, 'A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury': 2, 'Replication-dependent downregulation of cellular angiotensin-converting enzyme 2 protein expression by human coronavirus NL63': 1, 'Global Adult Tobacco Survey (GATS)': 2, 'Comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis': 5, 'Analysis of epidemiological and clinical features in older patients with Corona Virus Disease 2019 (COVID-19) out of Wuhan': 3, 'Epidemiological clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms': 2, 'Clinical characteristics of refractory COVID-19 pneumonia in': 1, 'Clinical features and treatment of COVID-19 patients in Northeast Chongqing': 1, 'Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease': 3, 'Cardiovascular implications of fatal outcomes of patients': 3, 'Prevalence and patterns of tobacco smoking among Chinese adult men and women: findings of the 2010 national smoking survey': 3, 'Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19)': 1, 'COVID-19 and smoking: a systematic review of the evidence': 1, 'Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019-United States': 1, 'Charakteristik von 50 hospitalisierten COVID-19-Patienten mit und ohne ARDS': 1, 'Nicotine exerts an antiinflammatory effect in a murine model of acute lung injury': 1, 'Nicotine reduces TNF-α expression through a α7 nAChR/MyD88/NF-ĸB pathway in HBE16 airway epithelial cells': 1, 'Nicotine exposure alters in vivo human responses to endotoxin': 1, 'Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation': 2, 'Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis': 1, 'The cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis': 1, 'Physiology and immunology of the cholinergic antiinflammatory pathway': 1, 'The vagus nerve and the nicotinic anti-inflammatory pathway': 1, 'The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation': 1, 'The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation': 1, 'Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies': 2, 'Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs': 1, 'Manson JJ (2020) HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression': 1, 'FDA Approves Phase III Clinical Trial of Tocilizumab for COVID-19 Pneumonia. CancerNetwork': 1, 'Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed': 1, 'The discovery of angiotensin-converting enzyme 2 and its role in acute lung injury in mice': 1, 'Alternative roles of STAT3 and MAPK signaling pathways in the MMPs activation and progression of lung injury induced by cigarette smoke exposure in ACE2 knockout mice': 1, 'Will children reveal their secret? The coronavirus dilemma': 1, 'COVID-19 infection and the predictive ACE2 soluble levels: the favourable protection of children and women. Front Pediatr': 1, 'Transdermal nicotine for active ulcerative colitis': 1, \"Chronic high dose transdermal nicotine in Parkinson's disease: an open trial\": 1, 'Nicotine treatment of mild cognitive impairment: a 6-month double-blind pilot clinical trial': 1, 'Nicotine aerosol generation from thermally reversible zinc halide complexes using the Staccato system': 1, \"Un livret d'aide à la pratique pour les professionnels\": 1, 'A convenient approach to the generation of multiple internal control DNA for a panel of real-time PCR assays': 2, 'Stable and noncompetitive RNA internal control for routine clinical diagnostic reverse transcription-PCR': 1, 'Use of lyophilized standards for the calibration of a newly developed real time PCR assay for human herpes type six (HHV6) variants A and B': 1, 'Development of a multiple internal control for clinical diagnostic real-time amplification assays': 1, 'Use of bovine viral diarrhea virus as an internal control for amplification of hepatitis C virus': 2, 'Real-time PCR quantitation of hepatitis B virus DNA using automated sample preparation and murine cytomegalovirus internal control': 2, 'The development of a qualitative real-time RT-PCR assay for the detection of hepatitis C virus': 2, 'Use of bacteriophage MS2 as an internal control in viral reverse transcription-PCR assays': 4, 'Implementation of a T4 extraction control for molecular assays of cerebrospinal fluid and stool specimens': 2, 'RNA and DNA bacteriophages as molecular diagnosis controls in clinical virology: a comprehensive study of more than 45,000 routine PCR tests': 2, 'An internal control for routine diagnostic PCR: design, properties, and effect on clinical performance': 1, 'Practical considerations in design of internal amplification controls for diagnostic PCR assays': 1, 'Internal controls for the quality assessment of polymerase chain reaction methods for the diagnosis of infectious & autoimmune disease': 2, 'An internally controlled, one-step, real-time RT-PCR assay for norovirus detection and genogrouping': 2, 'Internal control DNA for PCR assays introduced into lambda phage particles exhibits nuclease resistance': 1, 'Strategic approach to produce low-cost, efficient, and stable competitive internal controls for detection of RNA viruses by use of reverse transcription-PCR': 3, 'Nuclease-resistant double-stranded DNA controls or standards for hepatitis B virus nucleic acid amplification assays': 2, 'Armored RNA technology for production of ribonucleaseresistant viral RNA controls and standards': 2, 'Ribonuclease-resistant RNA controls (Armored RNA) for reverse transcription-PCR, branched DNA, and genotyping assays for hepatitis C virus': 1, \"TaqMan 5'-nuclease human immunodeficiency virus type 1 PCR assay with phage-packaged competitive internal control for high-throughput blood donor screening\": 1, 'Highly sensitive assay for detection of enterovirus in clinical specimens by reverse transcription-PCR with an armored RNA internal control': 1, 'Preparation of His-tagged armored RNA phage particles as a control for real-time reverse transcription-PCR detection of severe acute respiratory syndrome coronavirus': 1, 'Armored RNA as positive control and standard for quantitative reverse transcription-polymerase chain reaction assay for rubella virus': 1, 'RNaseresistant virus-like particles containing long chimeric RNA sequences produced by two-plasmid coexpression system': 1, 'Development of a versatile and stable internal control system for RT-qPCR assays': 1, 'A novel hepatitis C virus genotyping method based on liquid microarray': 2, 'Complete nucleotide sequence of bacteriophage MS2 RNA: primary and secondary structure of the replicase gene': 2, 'Signal to cut-off (S/CO) ratio and detection of HCV genotype 1 by real-time PCR one-step method: is there any direct relationship?': 1, 'Primary screening of blood donors by nat testing for HCV-RNA: development of an \"in-house\" method and results': 1, 'Acute respiratory distress in adults': 2, 'Incidence and recognition of acute respiratory distress syndrome in a UK intensive care unit': 1, 'Incidence and outcomes of acute lung injury': 2, 'Acute respiratory distress syndrome in the trauma intensive care unit: morbid but not mortal': 1, 'Acute respiratory distress syndrome: advances in diagnosis and treatment': 3, 'Mechanical ventilation strategies for intensive care unit patients without acute lung injury or acute respiratory distress syndrome: a systematic review and network meta-analysis': 1, 'Neuromuscular blocking agents for acute respiratory distress syndrome': 2, 'Neuromuscular blockers in early acute respiratory distress syndrome': 21, 'Executive summary: clinical practice guidelines for the prevention and Management of Pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU': 2, 'Surviving Sepsis campaign: international guidelines for management of sepsis and septic shock': 2, 'Neuromuscular blocking agents for adult patients with acute respiratory distress syndrome: a meta-analysis of randomized controlled trials': 2, 'Clinical practice guideline of acute respiratory distress syndrome': 1, 'Scandinavian clinical practice guideline on fluid and drug therapy in adults with acute respiratory distress syndrome': 1, 'Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient': 4, 'Early neuromuscular blockade in the acute respiratory distress syndrome': 26, 'Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome': 18, 'Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome': 18, 'Effects of neuromuscular blockers on transpulmonary pressures in moderate to severe acute respiratory distress syndrome': 14, 'Clinical study of early use of neuromuscular blocking agents in patients with severe sepsis and acute respiratory distress syndrome': 7, 'Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials': 2, 'The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed': 1, 'Neuromuscular blocking agents in ARDS': 1, 'A fresh look at paralytics in the critically ill: real promise and real concern': 1, 'Colorado pulmonary outcomes research G: an observational study of the efficacy of Cisatracurium compared with Vecuronium in patients with or at risk for acute respiratory distress syndrome': 1, 'Refractory hypoxemia and use of rescue strategies. A U.S. National Survey of adult Intensivists': 1, 'Formal guidelines: management of acute respiratory distress syndrome': 1, 'Neuromuscular blocking agents in patients with acute respiratory distress syndrome: a summary of the current evidence from three randomized controlled trials': 1, 'Sedation intensity in the first 48 hours of mechanical ventilation and 180-day mortality: a multinational prospective longitudinal cohort study': 1, 'Early intensive care sedation predicts long-term mortality in ventilated critically ill patients': 1, 'Practice patterns and outcomes associated with early sedation depth in mechanically ventilated patients: a systematic review and metaanalysis': 1, 'Mechanical ventilation-induced reversetriggered breaths: a frequently unrecognized form of neuromechanical coupling': 1, 'Early paralytic agents for ARDS? Yes, no, and sometimes': 1, 'Critical illness myopathy and neuropathy': 1, 'The use of paralytics in patients with acute respiratory distress syndrome': 1, 'Laudanosine, an atracurium and cisatracurium metabolite': 1, 'Phenotypes in acute respiratory distress syndrome: moving towards precision medicine': 1, 'Apelin-36-[L28A] and Apelin-36-[L28C(30kDa-PEG)] peptides that improve diet induced obesity are G protein biased ligands at the apelin receptor': 1, 'International Union of Basic and Clinical Pharmacology. CVII. Structure and Pharmacology of the Apelin Receptor with a Recommendation that Elabela/Toddler Is a Second Endogenous Peptide Ligand': 1, 'Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase': 2, 'Discovery and Structure-Activity Relationship of a Bioactive Fragment of ELABELA that Modulates Vascular and Cardiac Functions': 1, 'Stability and degradation patterns of chemically modified analogs of apelin-13 in plasma and cerebrospinal fluid': 4, 'Angiotensin-Converting Enzyme 2 Metabolizes and Partially Inactivates Pyr-Apelin-13 and Apelin-17: Physiological Effects in the Cardiovascular System': 4, '-12) Is a Biologically Active ACE2 Metabolite of the Endogenous Cardiovascular Peptide [Pyr1] Apelin-13': 3, 'Plasma kallikrein cleaves and inactivates apelin-17: Palmitoyl-and PEG-extended apelin-17 analogs as metabolically stable blood pressure-lowering agents': 1, 'Pyroglutamyl apelin-13 identified as the major apelin isoform in human plasma': 1, 'Linking (Pyr)1apelin-13 pharmacokinetics to efficacy: Stabilization and measurement of a high clearance peptide in rodents': 1, 'Degradation and transport of AVP by proximal tubule': 1, 'Osmoregulation of thirst and vasopressin release in severe chronic renal failure': 1, 'Metabolism and synthesis of arginine vasopressin in conscious newborn sheep': 1, 'Angiotensin-converting enzyme 2 is an essential regulator of heart function': 1, 'Loss of Angiotensin-Converting Enzyme-2 Leads to the Late Development of Angiotensin II-Dependent Glomerulosclerosis': 1, 'Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure': 1, 'Plasma concentrations of the novel peptide apelin are decreased in patients with chronic heart failure': 1, 'Cardiac resynchronization therapy increases plasma levels of the endogenous inotrope apelin': 1, 'Finding covid-19 500 from chest x-rays using deep learning on a small dataset': 1, 'Deep learning system to screen 505 coronavirus disease 2019 pneumonia': 1, 'Global epidemiological surveillance standards for influenza': 1, 'Detecting 2009 pandemic influenza A (H1N1) virus infection: availability of diagnostic testing led to rapid pandemic response': 1, 'Initial identification and characterization of an emerging zoonotic influenza virus prior to pandemic spread': 1, 'WHO information for laboratory diagnosis of pandemic (H1N1) 2009 virus in humans -revised': 1, 'Epidemiology of pathogen-specific respiratory infections among three US populations': 1, 'Influenza viruses in Thailand: 7 years of sentinel surveillance data': 2, 'Results from the first six years of national sentinel surveillance for influenza in Kenya': 1, 'Surveillance for severe acute respiratory infections (SARI) in hospitals in the WHO European region -an exploratory analysis of risk factors for a severe outcome in influenza-positive SARI cases': 1, 'Severe acute respiratory infection in children in a densely populated urban slum in Kenya': 3, 'Population-based incidence of severe acute respiratory virus infections among children aged <5 years in rural Bangladesh': 2, 'Viral etiology and clinical profiles of children with severe acute respiratory infections in China': 3, 'Influenza surveillance in 15 countries in Africa': 1, 'Antiviral agents for the treatment and chemoprophylaxis of influenza -recommendations of the Advisory Committee on Immunization Practices (ACIP)': 1, 'Viral shedding and clinical illness in naturally acquired influenza virus infections': 1, 'Ageand sex-related risk factors for influenza-associated mortality in the United States between 1997-2007': 1, '-11 through 2013-14 State, Regional, and National Vaccination Trend Report': 1, 'Available at Border Crossing/Entry Data': 1, 'Notes from the field: hospitalizations for respiratory disease among unaccompanied children from Central America -multiple States': 1, 'Overlay and solid-phase analysis of glycolipid receptors for bacteria and viruses': 1, 'Ss Recognition of a leukemia-related antigen by an anti-idiotypic antiserum to an anti-gp70 monoclonal antibody': 1, 'Cell receptors for the mammalian reovirus. I1. Monoclonal anti-idiotypic antibody blocks viral binding to cells': 1, 'Cell receptors for the mammalian reovirus. 1. Syngeneic monoclonal anti-idiotypic antibody identifies a cell surface receptor for reovirus': 1, 'Leukocytes roll on a selection at physiologic flow rates: distinction from and prerequisite for adhesion through integrins': 1, 'Virus receptors: binding, adhesion strengthening, and changes in viral structure': 2, 'Identification of the integrin VLA-2 as a receptor for echovirus 1': 3, 'Integrins czV[33 and aVl]5 promote adenovirus internalization but not virus attachment': 1, 'Class [ major histocompatibility proteins are an essential component of the simian virus 40 receptor': 1, 'Virus-induced cell fusion': 1, 'La Crosse bunyavirus can mediate pH-dependent fusion from without. Virology 1': 1, 'On the entry of Semliki forest virus into BHK-21 cells': 1, 'Adsorptive endocytosis of Semliki forest virus': 1, 'Are lysosomes a site of enveloped-virus penetration? Cold Spring Harbor Symp': 1, 'Penetration of Semliki forest virus from acidic prelysosomal vacuoles': 1, 'Rapid acidification ofendocytic vesicles containing cz-2-macroglobulin': 1, 'The T4 gene encodes for the AIDS virus receptor and is expressed in the immune system and in the brain': 1, 'Identification of heat shock protein 70 in the rabies virion': 1, 'Identification of cellular actin within the rabies virus': 1, \"Cellular Receptors for Animal l'iruses\": 1, 'Virus receptors: implication for pathogenesis and the design of antiviral agents': 1, 'Retrovirus receptors': 1, 'Studies of propagation of Col SK group of viruses in various tissue culture media': 1, 'Receptors for encephalomyocarditis virus on murine and human cells': 1, 'Persistent infection of K562 cells by encephalomyocarditis virus': 1, 'The major human rhinovirus receptor is ICAM-I': 1, 'eDNA cloning reveals that the major group rbinovirus receptor on HeLa cells is intercellular adhesion molecule I': 1, 'Infection by echoviruses l and 8 depends on the a 2 subunit of human VLA-2. ,I. Virol': 2, 'Entry of coxsackievirus A9 into host cells: specific interactions with ctvlB 3 integrin, the vitronectin receptor': 2, 'Efficient RGD-independent entry process of coxsaekievirus A9': 1, 'Antibodies to the vitronectin receptor (integtin ~v133) inhibit binding and infection of thor-and-mouth disease virus to cultured cells': 2, 'Specific interactions between human integrin otVl33 and chimeric hepatitis B virus core panicles bearing the receptor-binding epitope of foot-and-mouth disease virus': 1, 'Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate': 1, 'Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein; is a receptor for several echoviruses': 1, 'Isolation of a human erythrocyte membrane gtycoprotein with decay accelerating activity for C3 convertases of the complement system': 1, 'Cellular Receptors for Animal Viruses': 1, 'The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses': 1, \"Analysis of virus-cell binding characteristics on the determination of Japanese encephalitis virus susceptibility. Arch. l,'irol\": 1, 'The envelope glycoprotein from tick-borne encephalitis virus at 2 tit resolution': 1, 'The immunoglobulin fold. Structural classification, sequence patterns and common core': 1, 'A putative host-cell receptor for tick-borne encephalitis virus identified by anti-idiotypic antibodies and virus affinoblotting': 1, 'Isolation of a cellular receptor for tick-borne encephalitis virus using antiidiotypic antibodies': 1, 'A 65-kDa trypsin-sensible membrane cell protein as a possible receptor lbr dengue virus in cultured neuroblastoma cells': 1, 'Binding of hepatitis C virus to CDSI': 1, 'Cloning of the mouse hepatitis virus (MHV) receptor: expression in human and hamster cell lines confers susceptibility to MHV': 1, 'Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. ,1. Virot': 1, 'Aminopeptidase N is a major receptor for the euteropathogenic coronavirus TGEV': 1, 'Human amino peptidase N is a receptor lbr human coronavirus 229E': 1, 'Transmissible gastroenteritis virus, but not the related porcine respiratory coronavirus, has a sialic acid (N-glycolylneuraminic acid) binding activity': 1, 'Cellular receptors and viral glycoproteins involved in retroviral entry': 1, 'The E3 protein of bovine coronavirus is a receptor-destroying enzyme with acetylesterase activity': 1, 'Initial events in bovine coronavirus infection: analysis through immunogold probes and lysosomotropic inhibitors': 1, 'Rabies virus binding to the nicotinic acetylcholine receptor a subunit demonstrated by virus overlay protein binding assay, d': 1, 'Measles virus-substance P receptor interactions. 3': 1, 'Structural homology between hemagglutinin (HA) of measles virus and the active site of long neurotoxins': 1, 'Moesin: a cell membrane protein linked with susceptibility to measles virus infection': 1, 'A heparin-binding protein involved in inhibition of smooth muscle cell proliferation': 1, 'Activation of the Sendal virus fusion protein by receptor binding': 1, 'Crystallographic detection of a second ligand binding site in influenza virus hemagglutinin': 1, 'Structure of the influenza virus b~emagglutinin complexed with its receptor, sialic acid': 1, 'M: Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding': 1, 'Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution': 1, 'The structure of the complex influenza virus neuraminidase and sialic acid, the viral receptor': 1, 'The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid': 1, 'Structure of influenza hemagglutinin at the pH of membrane fusion': 1, 'A sialic acid analogue acting as a receptor determinant for binding but not for infection by influenza C virus': 1, 'Photolabeling identifies a putative fusion domain in the envelope glycoprotein of rabies and vesicular stomatitis viruses, d': 1, 'Characterization of binding of simian rotavirus SAIl to cultured epithelial cells': 1, 'Binding to sialic acids is not an essential step lbr the entry of animal rotaviruses to epithelial cells in culture': 1, 'Identification and partial characterization of a rhesus rotavirus binding glycoprotein on murine enterocytes': 1, 'Rotaviruses specifically bind to the neutral glycosphingolipid': 1, 'Interaction of rotavirus particles with liposomes': 1, 'Cell surface ligands for rotavirus mouse intestinal glycolipids and synthetic carbohydrate analogs': 1, 'Bovine immunodeficiency virus: molecular biology and virus-host interactions': 1, 'T-lymphocyte T4 molecule behaves as the receptor tbr human retrovirus LAV': 1, 'The human and simian immunodeficiency viruses HIV-1, HIV-2, and SIV interact with similar epitopes on their cellular receptor, the CD4 molecule': 1, 'Isolation and characterization ofa 2.3-kilobase-pair cDNA fragment encoding the binding domain of the bovine leukemia virus cell receptor': 1, 'A human amphotropic retrovirus receptor is a second member of the gibbon ape leukemia virus receptor family': 1, 'Feline leukemia virus subgroup B uses the same cell surface receptor as gibbon ape leukemia virus': 1, 'Transport of cationic amino acids by the mouse ecotropic retrovirus receptor': 1, 'Cell-surface receptor for ecotropic routine retroviruses is a basic amino-acid transporter': 1, 'D: Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters': 1, 'Isolation of a chicken gene that conl~rs susceptibility to infection by subgroup A avian leukosis and sarcoma viruses': 1, 'CD4-independent infection of human neural cells by human immunodeficiency virus type 1.3. Virol': 1, 'Identification of a putative cellular receptor for the lentivirus visna virus, d': 1, 'Activation of caprine arthritis-encephalitis virus expression during maturation of monocytes to macrophages. Infee/.lmmun. 4 I': 1, 'Carbohydrate structures of the human immunodeficiency virus (HIV) recombinant envelope glycoprotein gpl20 produced in Chinese-hamster ovary cells': 1, 'Carbohydrates of human immunodeficiency virus': 1, 'Glycosylation of the envelope glycoprotein gpl30 of simian immunodeficiency virus from sooty mangabey (Cercocebus atys)': 1, 'Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type I recombinant human immunodeficiency virus envelope glycoprotein (gpl20) expressed in Chinese hamster ovary cells, d': 1, 'Biological roles of HIV~ glycoprotein glycans. Paper presented m Glyr XII: 12th lnternat. Syrup. on Glycoconjugates, Krak6w (Poland)': 1, 'Functions of HIV envelope glycans': 1, 'Lectin-carbohydrate interactions and infectivity of human imrnunodeficiency virus type 1 (HIV-I)': 1, 'Cellular proteins bound to immunodeficiency viruses: implications tbr pathogenesis and vaccines': 1, 'HIV-I entry co-factor: functional eDNA cloning of a seven-transmembrane, G protein-coupled receptor': 1, 'Leucocyte Typing V: White Cell Differentiation Antigens': 1, 'An antibody that binds the immunoglobulin CDR3-1ike region of the CD4 molecule inhibits provirus transcription in HIV-infected T cells': 1, 'Identification of a putative cellular receptor for feline immunodeficiency virus as the feline homologue of CD9': 1, 'Origin of mink eytopathir focus-forming (MCF) viruses: comparison with ecotropic and xenotropic murine leukemia virus genomes': 1, 'A novel murine oncornavirus with dual eco-and xenotropie properties': 1, 'A new class of routine leukemia virus associated with development of spontaneous lymphomas': 1, 'Properties of a unique form of the murine amphotropic leukemia virus receptor expressed on hamster cells': 1, 'The dual-function hamster receptor for amphotropic murine leukemia virus (MuLV), 10AI MuLV, and Gibbon ape leukemia virus is a phosphate symporter': 1, 'Galactosylceramide or a derivative is an essential component of the neural receptor for HIV-I envelope glycoprotein gpl20': 1, 'Infection of colonic epithelial cell lines by type I human immunodeficiency virus is associated with cell surface expression of galactosyleeramide, a potential gp120 receptor': 1, 'Infection of vaginal and colonic epithelial cells by the human immunodeficiency virus type 1 is neutralized by antibodies raised against conserved epitopes on the envelope glycoprotein gpl20': 1, 'Microbial interaction with animal cell surface carbohydrates': 1, 'Conformational changes in cell surface HIV-I envelope glycoproteins are triggered by cooperation between cell surface CD4 and co-receptors': 1, 'The CC chemokine 1-309 inhibits CCRg-dependent infection by diverse HIV-I strains': 1, 'Co-receptors for HIV-I entry': 1, 'Endonexin II, present on human liver plasma membranes, is a specific binding protein of small hepatitis B virus (HBV) envelope protein': 1, 'Structure of routine polyomavirus complexed with an oligosaccharide receptor fragment': 1, 'Identification of the ~t 6 integrin as a candidate receptor lbr papillomaviruses': 1, 'Molecular epidemiology of Epstein-Barr virus infection': 1, 'Epstein-Barr virus uses HLA class 11 as a cofactor tbr infection ofB lymphocytes': 1, \"Anti-idiotypic antibodies mimicking glycoprotein D of herpes simplex virus identi~' a cellular protein required tbr virus spread from cell to cell and virus-induced polykaryocytosis\": 1, 'Molecular biology of African swine fever virus': 1, 'Virus-host interactions in African swine t~ver: the attachment to cellular receptors': 1, 'WHO characterizes COVID-19 as a pandemic': 1, 'Coronavirus Disease (COVID-19) Situation Reports': 1, 'Special Feature: Severe Acute Respiratory Syndrome (SARS)': 2, 'Preventing intra-hospital infection and transmission of COVID-19 in healthcare workers': 2, 'Strong National Push to Stem Spread of COVID-19': 1, 'Apr 25) Important coronavirus updates for ophthalmologists': 1, 'COVID-19 and the risk to health care workers: a case report': 1, 'Preparing for a COVID-19 pandemic: a review of operating room outbreak response measures in a large tertiary hospital in Singapore': 1, 'Continuation of Essential Healthcare Services during Period of Heightened Safe Distancing Measures': 1, 'Perspectives on Coronavirus disease 2019 control measures for ophthalmology clinics based on a Singapore center experience': 1, 'Sustainable practice of ophthalmology during COVID-19: challenges and solutions': 1, 'Next generation telemedicine platforms to screen and triage': 1, 'Severe acute respiratory syndrome-related coronavirus: The species and its viruses-a statement of the Coronavirus Study Group': 1, 'Situation report-36, Novel Coronavirus (COVID-19)': 1, 'Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov': 1, 'Clinical Features and Treatment of 2019-nCov Pneumonia Patients in Wuhan: Report of A Couple Cases': 1, 'COVID-19 airway management principles': 1, 'infection-prevention-and-control/reducing-the-risk-of-transmissionof-covid-19-in-the-hospital-setting': 1, 'Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations. WHO Scientific Brief': 1, 'Virus taxonomy': 1, 'Bat coronaviruses in china': 1, 'Viral metagenomics revealed sendai virus and coronavirus infection of malayan pangolins (manis javanica)': 2, 'Mental health and coping with stress during covid-19 pandemic': 1, 'Olivia health analytics platform': 1, 'Private kits: Safepaths; privacy-by-design covid19 solutions using gps+bluetooth for citizens and public health officials': 1, 'Apps gone rogue: Maintaining personal privacy in an epidemic': 1, 'Covid-19/coronavirus real time updates with credible sources in us and canada': 2, 'Covidnet: To bring the data transparency in era of covid-19': 2, 'Novel coronavirus 2019 dataset': 1, 'Covid-19 open research dataset challenge (cord-19)': 1, \"A county-level dataset for informing the united states' response to covid-19\": 2, 'Comparing and integrating us covid-19 daily data from multiple sources: A county-level dataset with local characteristics': 2, 'Using reports of symptoms and diagnoses on social media to predict covid-19 case counts in mainland china: Observational infoveillance study': 1, 'Predicting mortality risk in patients with covid-19 using artificial intelligence to help medical decision-making': 1, 'Spatiotemporal dynamics, nowcasting and forecasting of covid-19 in the united states': 5, 'Covid-19 simulator': 1, 'Learning to forecast and forecasting to learn from the covid-19 pandemic': 1, 'Fast and accurate forecasting of covid-19 deaths using the sikja model': 1, 'Arima-based forecasting of the dynamics of confirmed covid-19 cases for selected european countries': 2, 'Initial simulation of sars-cov2 spread and intervention effects in the continental us': 4, 'Us census demographical data': 1, 'Us mortality rates by county': 1, 'Us county-level mortality': 1, 'Us county-level trends in mortality rates for major causes of death': 1, 'Diversity index of us counties': 1, 'Us drought monitor': 1, 'United states droughts by county': 1, 'County presidential election': 1, 'Icu beds by county in the us': 1, 'Us household income statistics': 1, 'A weekly summary of us covid-19 hospitalization data': 1, 'Laboraty-confirmed covid-19 associated hospitalizations': 1, 'State statistics': 1, 'Us data for download': 3, 'Principal component analysis': 1, 'Deep learning and the information bottleneck principle': 1, '4 reasons coronavirus is hitting black communities so hard': 1, 'Selecting effective antisense reagents on combinatorial oligonucleotide arrays': 1, 'Comparison of oligonucleotide-microarray and serial analysis of gene expression (SAGE) in transcript profiling analysis of megakaryocytes derived from CD34+ cells': 1, 'Comparative genome-scale analysis of gene expression profiles in T cell lymphoma cells during malignant progression using a complementary DNA microarray': 2, 'Impact of surface chemistry and blocking strategies in DNA microarrays': 1, 'Quantitative monitoring of gene expression patterns with a complementary DNA microarray': 1, 'Preparation of SARS 60mer oligonucleotide probes for microarray printing': 1, 'Design and application of 60mer oligonucleotide microarray in SARS coronavirus detection': 1, 'Robust and efficient synthetic method for forming DNA microarrays': 1, 'Understanding of COVID-19 based on current evidence': 1, 'Covid-19 UK outbreak, measures and impact': 1, 'Coronavirus disease 2019 (COVID-19) Situation Report e 43. 2020': 1, 'Newer Vaccine Technologies Deployed to Develop COVID-19 Shot': 1, 'Situation Report e 37': 1, 'Soluble receptor-induced retroviral infection of receptor-deficient cells': 1, 'The soluble ectodomain of herpes simplex virus gD contains a membrane-proximal pro-fusion domain and suffices to mediate virus entry': 4, 'Activation of a cell entry pathway common to type C mammalian retroviruses by soluble envelope fragments': 2, 'Glycoproteins gB, gD, and gHgL of herpes simplex virus type 1 are necessary and sufficient to mediate membrane fusion in a Cos cell transfection system': 1, 'Virus membrane-fusion proteins: more than one way to make a hairpin': 1, 'The herpesvirus glycoproteins B and HL are sequentially recruited to the receptor-bound gD to effect membrane fusion at virus entry': 1, 'An alpha-helical domain within the carboxyl terminus of herpes simplex virus type 1 (HSV-1) glycoprotein B (gB) is associated with cell fusion and resistance to heparin inhibition of cell fusion': 1, 'Crystal structure of glycoprotein B from herpes simplex virus 1': 1, 'Crystal structure of the low-pH form of the vesicular stomatitis virus glycoprotein G': 1, 'Characterization of human cytomegalovirus glycoprotein-induced cell-cell fusion': 1, 'Membrane fusion mediated by herpesvirus glycoproteins: the paradigm of varicella-zoster virus': 1, 'Coiled-coil domains in glycoproteins B and H are involved in human cytomegalovirus membrane fusion': 1, 'Analysis of synthetic peptides from heptadrepeat domains of herpes simplex virus type 1 glycoproteins H and B': 1, 'Hydrophobic α-helices 1 and 2 of herpes simplex virus gH interact with lipids, and their mimetic peptides enhance virus infection and fusion': 1, 'Herpes simplex virus: receptors and ligands for cell entry': 1, 'Soluble V domain of Nectin-1/HveC enables entry of herpes simplex virus type 1 (HSV-1) into HSV-resistant cells by binding to viral glycoprotein D': 1, 'Glycoprotein D of herpes simplex virus (HSV) binds directly to HVEM, a member of the tumor necrosis factor receptor superfamily and a mediator of HSV entry': 1, 'Examination of the kinetics of herpes simplex virus glycoprotein D binding to the herpesvirus entry mediator, using surface plasmon resonance': 1, 'Herpes simplex virus glycoprotein D bound to the human receptor HveA': 1, 'The pro-fusion domain of herpes simplex virus glycoprotein D (gD) interacts with the gD N terminus and is displaced by soluble forms of viral receptors': 2, 'Use of herpes simplex virus and pseudorabies virus chimeric glycoprotein D molecules to identify regions critical for membrane fusion': 2, 'Structure of unliganded HSV gD reveals a mechanism for receptor-mediated activation of virus entry': 2, 'Cross-linking of glycoprotein oligomers during herpes simplex virus type 1 entry': 1, 'Identification of functional regions of herpes simplex virus glycoprotein gD by using linker-insertion mutagenesis': 1, 'An analysis of the biological properties of monoclonal antibodies against glycoprotein D of herpes simplex virus and identification of amino acid substitutions that confer resistance to neutralization': 1, 'Retrovirus envelope domain at 1.7 angstrom resolution': 1, 'A proline-rich motif downstream of the receptor binding domain modulates conformation and fusogenicity of murine retroviral envelopes': 2, 'Structure of a murine leukemia virus receptor-binding glycoprotein at 2.0 angstrom resolution': 1, 'Activation of membrane fusion by murine leukemia viruses is controlled in cis or in trans by interactions between the receptor-binding domain and a conserved disulfide loop of the carboxy terminus of the surface glycoprotein': 2, 'Glycoprotein gL-independent infectivity of pseudorabies virus is mediated by a gD-gH fusion protein': 1, 'From essential to beneficial: glycoprotein D loses importance for replication of bovine herpesvirus 1 in cell culture': 1, 'At the end of the war Abel withdrew to his estate at Mondsee 692 and dropped out of sight. Heinrich Schade was still a prisoner of war in Yugoslavia. Lenz initially remained in eastern Westphalia, and -as the first of the \"Dahlem circle\" -was appointed associate professor for human genetic theory at the University of Göttingen in October 1946. 693 With this it appeared that the institute\\'s \"political baggage\" had been swept under the carpet. Verschuer indulged himself in the hope that he would be able to reestablish the Kaiser Wilhelm Institute for Anthropology, Human Heredity and Eugenics, whereby of the former department chiefs he wanted to reappoint only his friend': 1, 'There is no evidence of collaboration between Mengele and Kranz, however': 1, 'Bericht über die im Jahre 1938 durchgeführten und für das Jahr 1939 geplanten Forschungen': 1, 'Cf. Koslowski, Einfügung. The genetic psychology part of the project was to be carried out by a \"Miss Dorer': 1, 'Erbbiologische Bestandsaufnahme': 1, 'Rep. 86 A (Münster), Nr. 7': 1, 'Tuberculosis (Bericht für den Zeitraum vom 1. April bis zum 30': 1, 'R 96 I/2': 1, 'Formulation proposal by Lenz, in square brackets: formulation proposal by Kurt Pohlisch': 1, '668. Formulation proposal by Lenz': 1, 'Eickstedt himself was not present in Leipzig, his lecture must have been read by a deputy. Cf. Verschuer to Fischer, 9/2/1943, MPG Archive': 1, \"On Hitler's orders, a large portion of the African prisoners of war -around 80,000 men -had been deported to Southern France (Bordeaux)\": 1, 'Pictures for the Work on Pygmy Soles of the Foot': 1, \"The same formulation is included in Verschuer's Tätigkeitsbericht for 1943/44 (MPG Archive\": 1, 'On this in detail: Schmuhl, Ärzte in der Anstalt Bethel': 1, 'Von der Rassenhygiene zur Humangenetik': 6, 'general Heiber': 1, '* 1912) worked at the RuSHA in 1941 and served as an aptitude tester for the Germanization of Poles, especially in Łódž': 1, 'Sievers to Brandt, 3/5/1943, quoted in Lösch, Rasse': 1, 'Falkenburg am Krössinsee\" addressed the KWI-A in June 1942, requesting that it make available \"for preparatory works for deployment in the future Reich Commissariat in the Caucausus […] data and material about population density, races, nations and religions in the Caucasian and central Russian areas, respectively': 1, 'Sievers had expressed himself quite similarly in a letter to Richard Korherr (* 1903), the Inspector for Statistics at the Reichsführer-SS Office': 1, '22/5/1943, quoted in Lösch, Rasse': 1, 'On the following': 1, 'BDC, Wi A-0494. Cf. Sievers to Hirt, 3/1/1942, BArch': 1, 'Review: Lothar Stengel von Rutkowski, Grundzüge der Erbkunde und Rassenpflege; idem., Review: Gerhard Venzmer, Erbmasse und Krankheit; idem., Review: Gottfried Pressler, Untersuchungen über den Einfluß der Großstadt; idem., Review: Georg von Knorre': 1, 'On the discussions about the naming of this disease in the Third Reich, cf. Schmuhl, Ärzte in der Westfälischen Diakonissenanstalt Sarepta': 1, 'Verschuer and his staff had produced 448 paternity opinions. Verschuer, Vaterschaftsgutachten, pp. 25 f. Cf. also idem': 1, \"After the re-integration of the Auschwitz II camp into the main camp in November 1944 he became Executive Camp Physician in the men's hospital area B II f. Kubica\": 1, 'On this, the letter by Wilhelm R. Mann, the director of I.G. Farben, to Verschuer': 1, 'From the European standpoint the Jewish question is not solved by the circumstance that Jews emigrate from the racially thinking states to the other states': 1, 'Only 5-8% of the new members of the NSDAP before 1933 were women. Cf. Falter, Hitlers Wähler': 1, 'So Georg Melchers (1906-1997) in an interview with Müller-Hill, Tödliche Wissenschaft': 1, 'esp. pp. 63 ff': 1, 'Also Walter Groß and the later \"Gypsy researcher': 1, 'Extensive case histories and dissection protocols were sent to Dahlem with the eye specimens for inspection. After processing they had to be returned, as case histories are the property of the hospital or the treating physician as a matter of principle': 1, ') gave the \"Race Biology and Anthropological Institute in Berlin-Dahlem\" as the address for dispatch, this could -if it is not simply a mistaken memory -have been because one of the possible addressees, Wolfgang Abel, was both Director of the Department for Race Science at the KWI-A and, since 1943, Director of the Institute for Race Biology at the University of Berlin. Abel used letterhead with the address': 1, 'Kumpania': 1, 'According to Ernst Klee, the mother of the Hungarian composer György Ligeti also performed such autopsies': 1, 'in that Magnussen, in view of possible fluctuations in manifestation': 1, 'Verschuer reports to Fischer that he now had the technical assistent Irmgard Eisenlohr and that \"with her the research with Abderhalden\\'s reaction, now finally picking up steam': 1, 'Müller-Hill, Tödliche Wissenschaft': 1, 'Spezifische Eiweißkörper': 1, '10/8/1942, ibid. At this point in time Diehl had around 450 live rabbits at his disposal, although around 100 young animals had died in the previous weeks': 1, \"From Mollison's work: Mollison, Serodiagnostik; idem., Verwandtschaftsforschung; idem\": 1, 'On this celebration in detail: Lösch, Rasse': 1, 'Rep. 86 A (Münster)': 1, 'Von der Rassenhygiene zur Humangenetik, p. 63, is presumably correct in viewing Lenz\\'s \" \\'vacation\\' \" as a \"move to withdraw from Berlin': 1, 'Rep. 86 B': 1, 'Rep. 86 A (Münster': 2, '12/3/1945, MPG Archive, Dept. I, Rep. 1 A, Ni. 2400': 1, \"one of the institute's secretaries] I learned that many files remained here, which should, or must, be destroyed before falling into enemy hands. While I have not yet taken a look to see what and how much is concerned, I presume that Miss Jarofki knows this exactly. You did not speak about this with me, otherwise I would have advised that the things be taken to Solz. In any case we may not choose too late a point in time for their destruction\": 1, 'v. On Verschuer\\'s news that a trailer truck had been \"made available\" to the institute, a marginal comment reads': 1, 'v. Here Verschuer also claimed that he had been in contact': 1, 'No. 12. 680 Nachtsheim to Verschuer, 12/3/1945, quoted in Kröner, Von der Rassenhygiene zur Humangenetik': 1, 'The global epidemic of the metabolic syndrome': 1, 'Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies': 1, 'Prevalence and trends of metabolic syndrome among adults in the Asia-Pacific region: a systematic review': 2, 'JIS definition identified more Malaysian adults with metabolic syndrome compared to the NCEP-ATP III and IDF criteria': 1, 'A review of metabolic syndrome research in Malaysia': 1, 'Cardiovascular disease and risk factors in Asia: a selected review': 1, 'Risk Factors & Other Health Problems. Ministry of Health Malaysia': 1, 'Prevalence and clinical characteristics of metabolic syndrome among Malaysian hypertensive subjects using the International Diabetes Federation definition': 2, 'Developing and evaluating complex interventions: updating Medical Research Council guidance to take account of new methodological and theoretical approaches': 3, 'National Cardiovascular Disease Database (NCVD): annual report of the Acute Coronary Syndrome (ACS) Registry 2014-2015. Kuala Lumpur: National Heart Association of Malaysia (NHAM) and Ministry of Health Malaysia': 3, 'Improving chronic illness care: translating evidence into action': 9, 'Patient self-management of chronic disease in primary care': 6, 'Effectiveness of Chronic Care Model-oriented interventions to improve quality of diabetes care: a systematic review': 1, 'Effectiveness of chronic care models: opportunities for improving healthcare practice and health outcomes: a systematic review': 1, 'Effectiveness of chronic care models for the management of type 2 diabetes mellitus in Europe: a systematic review and meta-analysis': 1, 'A systematic review of chronic disease management interventions in primary care': 1, 'Feasibility of implementing Chronic Care Model in the Malaysian public primary care setting': 1, 'Effectiveness of the EMPOWER-PAR Intervention in improving clinical outcomes of type 2 diabetes mellitus in primary care: a pragmatic cluster randomised controlled trial': 1, 'The effectiveness and cost effectiveness of a national lay-led self care support programme for patients with long-term conditions: a pragmatic randomised controlled trial': 1, 'Effectiveness of empowerment-based selfmanagement interventions on patients with chronic metabolic diseases: a systematic review and meta-analysis': 1, 'Effects of lifestyle modification on metabolic syndrome: a systematic review and meta-analysis': 1, 'Conceptualising patient empowerment: a mixed methods study': 1, 'Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers': 2, 'Development and testing of a short form of the Patient Activation Measure': 5, 'Do increases in patient activation result in improved self-management behaviors?': 3, 'How engaged are consumers in their health and health care, and why does it matter? Res Brief': 1, \"Improving the outcomes of disease management by tailoring care to the patient's level of activation\": 1, 'Measuring patient activation in Italy: translation, adaptation and validation of the Italian version of the Patient Activation Measure 13 (PAM13-I)': 1, 'When patient activation levels change, health outcomes and costs change, too': 1, 'The association between patient activation and accessing online health information: results from a national survey of US adults': 2, 'Why does patient activation matter? An examination of the relationships between patient activation and health-related outcomes': 2, 'Patient activation and 30-day post-discharge hospital utilization': 2, 'Patient activation for selfmanagement is associated with health status in patients with atrial fibrillation': 1, 'Designing and evaluating a web-based self-management site for patients with type 2 diabetes -systematic website development and study protocol': 2, 'Interactive web-based lifestyle intervention and metabolic syndrome: findings from the Red Ruby (a randomized controlled trial)': 2, 'The effectiveness of self-management mobile phone and tablet apps in long-term condition management: a systematic review': 2, 'Mobile phone-based selfmanagement tools for type 2 diabetes: the Few Touch application': 2, 'Development and evaluation of a mobile decision support system for hypertension management in the primary care setting in Brazil: mixed-methods field study on usability, feasibility, and utility': 1, 'Persuasive technology for health and wellness: state-of-theart and emerging trends': 6, 'SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials': 2, 'statement: extension to randomised pilot and feasibility trials': 2, 'Designing a research project: randomised controlled trials and their principles': 1, 'Role of feasibility and pilot studies in randomised controlled trials: a cross-sectional study': 1, 'Optimisation of complex health interventions prior to a randomised controlled trial: a scoping review of strategies used': 2, 'Pilot and feasibility studies: is there a difference from each other and from a randomised controlled trial?': 2, 'A study of Software Development Life Cycle process models': 2, 'Using natural experiments to evaluate population health interventions: new Medical Research Council guidance': 2, 'A detailed study of Software Development Life Cycle (SDLC) models': 2, 'Healthy living with persuasive technologies: framework, issues, and challenges': 2, 'The impact of community-based eHealth self-management intervention among elderly living alone with hypertension': 1, 'Smartphone-based home care model improved use of cardiac rehabilitation in postmyocardial infarction patients: results from a randomised controlled trial': 1, 'Twelve-month outcomes of an Internet-based diabetes self-management support program': 1, 'Cluster-randomized trial of a mobile phone personalized behavioral intervention for blood glucose control': 1, 'Patientcentred home-based management of heart failure: findings from a randomised clinical trial evaluating a tablet computer for self-care, quality of life and effects on knowledge': 1, 'DialBetics: a novel smartphone-based self-management support system for type 2 diabetes patients': 1, 'A mobile telephonebased interactive self-care system improves asthma control': 1, 'Development, testing and reporting of mobile apps for psycho-social interventions: lessons from the pharmaceuticals': 1, 'Development and pilot evaluation of a tablet-based application to improve quality of care in child mental health treatment': 1, 'ISO 9241-11 revised: what have we learnt about usability since': 1, 'Clinical practice guidelines on the primary & secondary prevention of cardiovascular disease 2017. Putrajaya: Ministry of Health Malaysia': 2, 'Complementary tools to empower and sustain behavior change: motivational interviewing and mindfulness': 6, 'A systematic review of the literature on health and wellness coaching: defining a key behavioral intervention in healthcare': 3, 'Health coaching interventions for persons with chronic conditions: a systematic review and meta-analysis protocol': 3, 'Integrative health coaching and motivational interviewing: synergistic approaches to behavior change in healthcare': 3, 'Lost in knowledge translation: time for a map?': 4, 'Validity and reliability of the Patient Assessment on Chronic Illness Care (PACIC) questionnaire: the Malay version': 3, \"Psychometric properties of the 'Skala Kepuasan Interaksi Perubatan-11' to measure patient satisfaction with physician-patient interaction in Malaysia\": 3, 'Perceptions of cardiovascular risk among patients with hypertension or diabetes': 3, 'General cardiovascular risk profile for use in primary care: the Framingham Heart Study': 2, 'Perception of health and understanding of cardiovascular risk among patients with recently diagnosed diabetes and/or metabolic syndrome': 2, 'National Pharmaceutical Regulatory Agency (NPRA), Ministry of Health Malaysia': 1, 'International Physical Activity Questionnaire: 12-country reliability and validity': 1, 'Reliability and validity of Malay language version of International Physical Activity Questionnaire (IPAQ-M) among the Malaysian cohort participants': 3, 'The International Physical Activity Questionnaire: guidelines for data processing and analysis of the International Physical Activity Questionnaire (IPAQ)': 2, 'The Dutch Eating Behavior Questionnaire (DEBQ) for assessment of restrained, emotional, and external eating behavior': 1, 'Psychometric properties of the Malay version of the Dutch Eating Behaviour Questionnaire (DEBQ) in a sample of Malaysian adults attending a health care facility': 2, 'Development and validation of the Patient Assessment of Chronic Illness Care (PACIC)': 2, \"The 'Medical Interview Satisfaction Scale' (MISS-21) adapted for British general practice\": 1, 'Validation of the Framingham general cardiovascular risk score in a multiethnic Asian population: a retrospective cohort study': 1, 'Power and sample size calculations': 1, 'Effects of a Web-based intervention for adults with chronic conditions on patient activation: online randomized controlled trial': 3, 'Measuring agreement in method comparison studies': 1, 'Improving primary care for patients with chronic illness': 1, 'The effectiveness of motivational interviewing for health behaviour change in primary care settings: a systematic review': 1, 'Study protocol of EMPOWER Participatory Action Research (EMPOWER-PAR): a pragmatic cluster randomised controlled trial of multifaceted chronic disease management strategies to improve diabetes and hypertension outcomes in primary care': 1, 'Nipah virus: a recently emergent deadly paramyxovirus': 4, 'Hendra and Nipah viruses: different and dangerous': 2, 'Henipaviruses': 1, 'Hendra and Nipah viruses: lethal zoonotic paramyxoviruses': 2, 'A morbillivirus that caused fatal disease in horses and humans': 1, 'Nipah virus-associated encephalitis outbreak': 1, 'Genetic characterization of Nipah virus': 2, 'Nipah virus encephalitis reemergence': 2, 'Foodborne transmission of Nipah virus': 1, 'Bat Nipah virus': 2, 'Antibodies to Nipah-like virus in bats': 1, \"Nipah virus in Lyle's flying foxes\": 2, 'Henipavirus in Pteropus vampyrus bats': 1, 'Henipavirus and Tioman virus antibodies in pteropodid bats': 1, 'Evidence of henipavirus infection in West African fruit bats': 1, 'Antibodies to Nipah or Nipah-like viruses in bats': 1, 'Recombinant vesicular stomatitis viruses from DNA': 1, 'A system for functional analysis of Ebola virus glycoprotein': 2, 'Efficient selection for high-expression transfectants with a novel eukaryotic vector': 1, 'Quantitative analysis of Nipah virus proteins released as virus-like particles reveals central role for the matrix protein': 1, 'Pseudotyped vesicular stomatitis virus for analysis of virus entry mediated by SARS coronavirus spike proteins': 1, 'Experimental infections of pigs with Japanese encephalitis virus and closely related Australian flaviviruses': 1, 'Evaluation of a novel vesicular stomatitis virus pseudotype-based assay for detection of neutralizing antibody responses to SARS-CoV': 3, 'Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein': 2, 'Virus entry is a major determinant of cell tropism of Edmonston and wild-type strains of measles virus as revealed by vesicular stomatitis virus pseudotypes bearing their envelope proteins': 1, 'Use of vesicular stomatitis virus pseudotypes bearing hantaan or seoul virus envelope proteins in a rapid and safe neutralization test': 1, 'Characterization of pseudotype VSV possessing HCV envelope proteins': 1, 'EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus': 1, 'Multifaceted activities of the HIV-1 transactivator of transcription, Tat': 2, 'Tat trans-activates the human immunodeficiency virus through a nascent RNA target': 2, 'The human immunodeficiency virus type 1 Rev protein: a pivotal protein in the viral life cycle': 4, 'The HIV-1 Rev protein': 5, 'Nuclear mRNA export: insights from virology': 4, 'A human cell factor is essential for HIV-1 Rev action': 1, 'DEAD-box proteins: the driving forces behind RNA metabolism': 1, 'DEAD-box helicases: posttranslational regulation and function': 1, 'DDX3 DEAD-box RNA helicase is required for hepatitis C virus RNA replication': 1, 'Hepatitis C virus hijacks P-body and stress granule components around lipid droplets': 1, 'Cellular RNA helicase p68 relocalization and interaction with the hepatitis C virus (HCV) NS5B protein and the potential role of p68 in HCV RNA replication': 1, 'PML tumor suppressor protein is required for HCV production': 1, 'Autogenous translational regulation of the Borna disease virus nagative control factor X from polycistronic mRNA using host RNA helicases': 1, 'The capsid-binding nucleolar helicase DDX56 is important for infectivity of West Nile virus': 1, 'Viral and cellular RNA helicases as antiviral targets': 3, 'Role of the DExH motif of the Japanese encephalitis virus and hepatitis C virus NS3 proteins in the ATPase and RNA helicase activities': 1, 'From promoting to inhibiting: diverse roles of helicases in HIV-1 replication': 3, 'Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function': 5, 'A DEAD box protein facilitates HIV-1 replication as a cellular co-factor of Rev': 6, 'The RNA helicase DDX1 is involved in restricted HIV-1 Rev function in human astrocytes': 6, 'Single-molecule studies reveal that DEAD box protein DDX1 promotes oligomerization of HIV-1 Rev on the Rev response element': 5, 'DDX1 is an RNA-denpendent ATPase involved in HIV-1 Rev function and virus replication': 5, 'Functional cross-talk of HIV-1 Tat with p53 through its C-terminal domain': 1, 'Ataxia-telangiectasia-mutated (ATM) protein can enhance human immunodeficiency virus type 1 replication by stimulating Rev function': 1, 'Host cell interactome of HIV-1 Rev includes RNA helicases involved in multiple facets of virus production': 2, 'A role for RNA helicase A in posttranscriptional regulation of HIV type 1': 1, 'The DEAD-box RNA helicase DDX6 is required for efficient encapsidation of a retroviral genome': 1, 'HIV-1 Gag co-opts a cellular complex containing DDX6, a helicase that facilitates capsid assembly': 1, 'Cellular microRNA and P bodies modulate host-HIV-1 interactions': 1, 'Suppression of HIV-1 replication by microRNA effectors': 1, 'Cellular gene expression upon human immunodeficiency virus type 1 infection of CD4 + -T-cell lines': 1, 'Alterations in the expression of DEAD-box and other RNA binding proteins during HIV-1 replication': 1, 'Host cell gene expression during human immunodeficiency virus type 1 latency and reactivation and effects of targeting genes that are differentially expressed in viral latency': 2, 'The detection of defective members of large populations': 1, 'The use of a square array scheme in blood testing': 1, 'DNA Sudoku -Harnessing high throughput sequencing for multiplexed specimen analysis': 1, 'In one Italian town, we showed mass testing could eradicate the coronavirus': 1, 'Evaluation of COVID-19 RT-qPCR test in multi-sample pools': 1, 'Pool testing for COVID-19 works! Can detect a single positive sample within a pool of 64 samples. Collaboration of: @RambamHCC @TechnionLive @BiologyTechnion @RoyKishony @yuval geffen': 1, \"@GovRicketts says state is 'pooling' tests now, so combining five tests into one test tube. If it comes back 'negative,' then you know all were negative; if one was 'positive,' then those five will have to be retested\": 2, 'A framework for identifying regional outbreak and spread of COVID-19 from one-minute population-wide surveys': 1, 'Identification of COVID-19 Can be Quicker through Artificial Intelligence framework using a Mobile Phone-Based Survey in the Populations when Cities/Towns Are Under Quarantine': 1, 'Division of Viral Diseases. CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel': 2, 'Government of Kyrgyzstan announces number of coronavirus test systems. https : / / 24 . kg / english / 146493 _ Government _ of _ Kyrgyzstan _ announces _ number _ of _ coronavirus _ test_systems': 2, 'Coronavirus Disease (COVID-19)-Research and Statistics': 5, 'Mechanistic-statistical SIR modelling for early estimation of the actual number of cases and mortality rate from COVID-19': 1, 'Spatio-temporal assessment of illicit drug use at large scale: evidence from 7 years of international wastewater monitoring': 1, 'Characterizing occupations that cannot work from home: a means to identify susceptible worker groups during the COVID-19 pandemic': 1, 'Development and validation of a rapid single-step reverse transcriptase loopmediated isothermal amplification (RT-LAMP) system potentially to be used for reliable and highthroughput screening of COVID-19': 1, 'A Single and Two-Stage, Closed-Tube, Molecular Test for the 2019 Novel Coronavirus (COVID-19) at Home, Clinic, and Points of Entry': 1, 'Rapid Detection of Novel Coronavirus (COVID-19) by Reverse Transcription-Loop-Mediated Isothermal Amplification': 1, \"Mexico's Low Coronavirus Count Spurs Doubts On Testing Rate\": 1, 'COVID-19: what has been learned and to be learned about the novel coronavirus disease': 1, 'Novel Coronavirus (2019-nCoV) Global Epidemic -31': 1, 'Diagnostic insufficiency in Africa': 2, 'South Africa is leading the continent´s coronavirus testing challenge boosted by private labs': 1, \"Boozers' go thirsty as Zimbabwe bans alcohol under Covid-19 lockdown\": 1, 'Statement by Ministry of health minister and social services on the occassion of a press briefing on covid-19 in Namibia': 1, 'Rwanda´s successes and challenges in response to COVID-19': 1, 'Nairobi´s fight against Coronavirus gets violent': 1, 'World Health Organisation. Laboratory testing strategy recommendations for COVID-19: interim guidance': 1, 'COVID-19 Coronovirus Pandemic': 1, 'Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan': 2, 'A practical approach to the management of cancer patients during the novel coronavirus disease 2019 (COVID-19) pandemic: An International Collaborative Group Oncologist': 1, 'Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA': 1, 'Radiotherapy in low-and middle-income countries. what can we do differently?': 1, 'Global access to radiotherapy services: have we made progress during the past decade?': 1, 'COVID-19) Testing': 1, 'Association of age, race, and public health insurance with stage of cervical cancer at diagnosis in Brazil: results of the EVITA cohort study (LACOG0215)': 1, 'World Health Organization Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases': 1, 'Radiological Society of North America expert consensus statement on reporting chest CT findings related to COVID-19. Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA': 1, 'Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases Radiology': 1, '19-resources-for-health-care-practitioners/anti-cancer-therapy-and-clinical-trial-considerations-forgyn-onc-patients': 1, 'SEER Cancer Stat Facts: Cervix Uteri Cancer': 1, 'COVID-19 global pandemic: options for management of gynecologic cancers': 2, 'Surgical considerations for gynecologic oncologists during the COVID-19 pandemic': 1, 'Effect of time interval from diagnosis to treatment for cervical cancer on survival: a nationwide cohort study': 1, 'Data-derived treatment duration goal for cervical cancer: should 8 weeks remain the target in the era of concurrent chemoradiation?': 1, 'Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study': 1, 'Improved survival with bevacizumab in advanced cervical cancer': 1, 'ASCCP Interim Guidance for Timing and Treatment Procedures for Patients with Abnormal Cervical Screening Tests': 1, 'UTERUS-11 STUDY: A randomized clinical trial on surgical staging versus ctstaging prior to primary chemoradiation in patients with FIGO2009 stages IIB-IVA cervical cancer': 1, 'The impact of systemic therapy beyond first-line treatment for advanced cervical cancer': 1, 'Society of Surgical Oncology Resource for Management Options of Breast Cancer During COVID-19': 1, 'Neoadjuvant chemotherapy with cisplatin and gemcitabine followed by chemoradiation versus chemoradiation for locally advanced cervical cancer: a randomized phase ii trial': 1, 'The EIRENE and B2-EIRENE codes': 2, 'Neutral gas transport modeling with DEGAS 2': 2, 'Numerical methods for kinetic equations': 2, 'A model for collision processes in gases. I. Small amplitude processes in charged and neutral one-component systems': 2, 'Introduction to Monte Carlo Methods for Transport and Diffusion Equations': 4, 'Uniformly accurate diffusive relaxation schemes for multiscale transport equations': 1, 'A particle micro-macro decomposition based numerical scheme for collisional kinetic equations in the diffusion scaling': 3, 'The moment-guided Monte Carlo method': 2, 'Hybrid multiscale methods II. Kinetic equations': 1, 'Fluid solver independent hybrid methods for multiscale kinetic equations': 1, 'An implicit Monte Carlo method for rarefied gas dynamics': 1, 'An introduction to Monte Carlo method for the Boltzmann equation': 1, 'Numerical solution of the Boltzmann equation by time relaxed Monte Carlo (TRMC) methods': 1, 'Asymptotic-preserving Monte Carlo methods for transport equations in the diffusive limit': 6, 'Kinetic-diffusion asymptotic-preserving Monte Carlo algorithms for plasma edge neutral simulation. Contrib. Plasma Phys. e201900134': 1, 'A Multilevel Monte Carlo asymptoticpreserving particle method for kinetic equations in the diffusion limit': 4, 'Multilevel Monte Carlo path simulation': 2, 'Hybrid multiscale methods for hyperbolic and kinetic problems': 2, 'A multilevel Monte Carlo method for asymptotic-preserving particle schemes': 3, 'Weak taylor approximations': 2, 'First case of psittacine proventricular dilatation syndrome (macaw wasting disease) in Australia': 2, 'Pathology of Pet and Aviary Birds Iowa State Press': 2, 'Peripheral Neuritis in psittacine birds with proventricular dilatation disease': 3, 'Isolation of a coronavirus from a green-cheeked Amazon parrot': 1, 'Management of common avian infectious diseases': 1, 'Diagnosing and preventing common viral infections in companion birds': 1, 'Progress in understanding proventricular dilatation disease': 1, 'Resolution of clinical proventricular dilation disease by Cyclooxygenase 2 inhibition': 1, 'Characteristics of workers in low work-from-home and high personal-proximity occupations': 3, 'Unequal we stand: An empirical analysis of economic inequality in the united states': 1, 'How many jobs can be done at': 3, 'Neighborhood income and physical distancing during the COVID-19 pandemic in the u': 1, 'Effectiveness and compliance to social distancing during COVID-19': 1, 'Achieving house staff competence in emergency airway management: results of a teaching program using a computerized patient simulator': 2, 'Teaching lifesaving procedures: the impact of model fidelity on acquisition and transfer of cricothyrotomy skills to performance on cadavers': 1, 'The standardized live patient and mechanical patient models--their roles in trauma teaching': 1, 'Retention of neonatal resuscitation skills and knowledge: a randomized controlled trial': 1, 'Initial airway management skills of senior residents: simulation training compared with traditional training': 2, 'Training with video imaging improves the initial intubation success rates of paramedic trainees in an operating room setting': 1, 'Teaching recognition of agonal breathing improves accuracy of diagnosing cardiac arrest': 1, 'Delays and errors in cardiopulmonary resuscitation and defibrillation by pediatric residents during simulated cardiopulmonary arrests. Resuscitation': 1, 'Teaching antiarrhythmic therapy and ECG in simulator-based interdisciplinary undergraduate medical education': 1, 'RNA of mouse hepatitis virus': 1, 'Molecular cloning of the gene encoding the putative polymerase of mouse hepatitis virus, strain A59': 1, 'The complete sequence (22 kilobases) of murine coronavirus gene 1 encoding the putative proteases and RNA polymerase': 1, 'Mouse hepatitis virus A59: mRNA structure and genetic localization of the sequence divergence from hepatotropic strain MHV-3': 1, 'The virus-specific intracellular RNA species of two murine coronaviruses: MHV-A59 and MHV-JHM': 1, 'Characterization of leader RNA sequences on the virion and mRNAs of mouse hepatitis virus, a cytoplasmic RNA virus': 2, 'Coronavirus mRNA synthesis involves fusion of non-contiguous sequences': 3, 'Coronavirus subgenomic minus-strand RNAs and the potential for mRNA replicons': 2, 'Minusstrand copies of replicating coronavirus mRNAs contain antileaders': 1, 'Coronavirus transcription: subgenomic mouse hepatitis virus replicative intermediates function in RNA synthesis': 2, 'Genetics of mouse hepatitis virus transcription: evidence that subgenomic negative strands are functional templates': 1, 'Mechanism of coronavirus transcription: duration of primary transcription initiation activity and effect of subgenomic RNA transcription on RNA replication': 2, 'A system for study of coronavirus mRNA synthesis: a regulated, expressed subgenomic defective interfering RNA results from intergenic site insertion': 3, 'Identification of the cis-acting signal for minus-strand RNA synthesis of a murine coronavirus: implication for the role of minusstrand RNA in RNA replication and transcription': 3, 'The 3% untranslated region of coronavirus RNA is required for subgenomic mRNA transcription from a defective interfering RNA': 2, 'Analysis of cis-acting sequences essential for coronavirus defective interfering RNA replication': 2, 'Characterization of a murine coronavirus defective interfering RNA internal cis-acting replication signal': 2, 'Deletion mapping of a mouse hepatitis virus defective interfering RNA reveals the requirement of an internal and discontiguous sequence for replication': 2, 'Analysis of efficiently packaged defective interfering RNAs of murine coronavirus: localization of a possible RNA-packaging signal': 1, 'Identification and characterization of a coronavirus packaging signal': 1, 'Murine coronavirus packaging signal confers packaging to nonviral RNA': 1, 'High-frequency leader sequence switching during coronavirus defective interfering RNA replication': 1, 'Replication and plaque formation of mouse hepatitis virus (MHV-2) in mouse cell line DBT culture': 1, 'Coronavirus transcription early in infection': 1, 'The synthesis of the subgenomic mRNAs of mouse hepatitis virus is initiated independently: evidence from UV transcription mapping': 2, 'A domain at the 3%-end of the polymerase gene is essential for encapsidation of coronavirus defective interfering RNAs': 2, 'Coronavirus mRNA transcription: UV light transcription mapping studies suggest an early requirement for a genomic-length template': 3, 'Equine arteritis virus subgenomic RNA transcription: UV inactivation and translation inhibition studies': 2, 'A cis-acting viral protein is not required for the replication of a coronavirus defectiveinterfering RNA': 1, 'BHK cells expressing sindbis virus-induced homologous interference allow the translation of nonstructural genes of the superinfecting virus': 1, 'Facemasks and hand hygiene to prevent influenza transmission in households: a cluster randomized trial': 1, 'Estimating the impact of school closure on influenza transmission from Sentinel data': 1, 'Comparison of facemask characteristics with user assessment of comfort': 2, 'Analysis of hygienic face mask patterns for young people': 1, 'Face mask use and control of respiratory virus transmission in households': 1, 'The role of facemasks and hand hygiene in the prevention of influenza transmission in households: results from a cluster randomised trial': 1, 'Different electrostatic methods for making electret filters': 1, 'M514333 Folding three-piece three-dimensional mask, Taiwan Patent Application 104216695': 2, 'Fitted face mask': 1, 'Face mask. U.S. Patent Application 29/591,044': 1, 'Face mask. U.S. Patent Application 15/583': 1, 'M563890 Full cover narrow mask. Taiwan Patent Application 107204072': 1, 'M464196 Folding stereo mask. Taiwan Patent Application 102212318': 1, 'Linking design thinking with innovation outcomes through cognitive bias reduction': 1, 'Become more creative': 1, 'The medical device regulation of the European Union intensifies focus on clinical benefits of devices': 1, 'Ultraviolet-C and other methods of decontamination of filtering facepiece N-95 respirators during the COVID-19 pandemic': 1, 'Modified full-face snorkel mask as COVID-19 personal protective equipment: Quantitative results': 1, 'DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells': 1, 'Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DCSIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals': 1, 'The mannose receptor mediates dengue virus infection of macrophages': 1, 'Differing infection patterns of dengue and yellow fever viruses in a human hepatoma cell line': 1, 'Lysosomes revisited': 1, 'SYBR green and TaqMan real-time PCR assays are equivalent for the diagnosis of dengue virus type 3 infections': 1, \"Effects of chloroquine on viral infections: An old drug against today's diseases?\": 2, 'Chemotherapy of Malaria': 1, 'Chloroquine-resistant malaria': 1, 'Chloroquine inhibits dengue virus type 2 replication in Vero cells but not in C6/36 cells': 1, 'Antiviral strategies in chronic hepatitis B virus infection: II. Inhibition of duck hepatitis B virus in vitro using conventional antiviral agents and supercoiled-DNA active compounds': 1, 'Inhibition of duck hepatitis B virus infection by lysosomotropic agents': 1, 'Inhibition of multiplication of herpes simplex virus type 1 by ammonium chloride and chloroquine': 1, 'In vitro inhibition of human influenza A virus replication by chloroquine': 1, 'Inhibition of human immunodeficiency virus type 1 replication by hydroxychloroquine in T cells and monocytes': 1, 'Chloroquine inhibits HIV-1 replication in human peripheral blood lymphocytes': 1, 'Anti-HIV effects of chloroquine: Inhibition of viral particle glycosylation and synergism with protease inhibitors': 1, 'In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine': 2, 'Potential antivirals and antiviral strategies against SARS coronavirus infections': 1, 'Epstein-Barr virus enters B cells and epithelial cells by different routes': 1, 'Dengue virus activates membrane TRAIL relocalization and IFN-a production by human plasmacytoid dendritic cells in vitro and in vivo': 2, 'A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults': 2, 'Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells': 1, 'Chloroquine interferes with lipopolysaccharide-induced TNF-alpha gene expression by a nonlysosomotropic mechanism': 1, 'Inhibition of mitogen-activated protein kinase signaling by chloroquine': 1, 'Chloroquine inhibits production of TNF-alpha, IL-1beta and IL-6 from lipopolysaccharide-stimulated human monocytes/ macrophages by different modes': 1, 'Chloroquine decreases cell-surface expression of tumour necrosis factor receptors in human histiocytic U-937 cells': 1, 'Differential activation of human monocyte-derived and plasmacytoid dendritic cells by West Nile virus generated in different host cells': 1, 'Chloroquine inhibits processing of tumor necrosis factor in lipopolysaccharide-stimulated RAW 264. 7 macrophages': 1, 'Low inflation, pass-through, and the pricing power of firms': 1, 'Has exchange rate pass-through really declined? Evidence from Canada': 3, 'Exchange rate pass-through to domestic prices: does the inflationary environment matter': 3, 'Monetary policy and exchange rate pass-through': 3, 'Exchange rate pass-through in new member states and candidate countries of the EU': 1, 'Deflation: determinants, risks, and policy options-findings of an interdepartmental task force': 4, 'Testing and modeling multivariate threshold models': 5, 'Declining exchange rate pass-through to U.S. import prices: the potential role of global factors': 2, 'Time-varying exchange rate pass-through: experiences of some industrial countries. Bank for International Settlements': 2, 'Exchange rate pass-through into import prices': 3, 'Exchange rate pass-through in the 1980s: the case of U.S. imports of manufactures': 4, 'Threshold autoregressive model of exchange rate pass-through effect: the case of Croatia': 1, 'Exchange rate pass-through: the case of Korean exports of manufactures': 1, 'Exchange rates and imports prices in the U.S.: a varying-parameter estimation of exchange rate pass-through': 1, 'Price discrimination by U.S. and German exporters': 1, 'International comparisons of pricing-to-market behavior': 1, 'Pricing to market in response to unobservable and observable shocks': 1, 'Trade integration, competition, and the decline in exchange rate pass-through': 1, 'Testing for a Unit Root in Time Series Regressions': 1, 'Family Reoviridae': 1, 'Orthoreoviruses and their replication': 1, 'Genus Orthoreovirus': 2, 'Extensive sequence divergence and phylogenetic relationships between the fusogenic and nonfusogenic orthoreoviruses: a species proposal': 1, 'A previously unknown reovirus of bat origin is associated with an acute respiratory disease in humans': 6, 'Structure and cytopathic effects of Nelson Bay virus': 4, 'Pulau virus; a new member of the Nelson Bay orthoreovirus species isolated from fruit bats in Malaysia': 4, 'Bats: important reservoir hosts of emerging viruses': 4, 'A novel morbillivirus pneumonia of horses and its transmission to humans': 1, 'An apparently new virus (family Paramyxoviridae) infectious for pigs, humans, and fruit bats': 1, 'Bats are natural reservoirs of SARS-like coronaviruses': 2, 'Nelson Bay virus. A novel reovirus': 1, 'A novel approach for collecting samples from fruit bats for isolation of infectious agents': 1, 'Severe acute respiratory syndrome': 1, 'Anthropogenic deforestation, El Nino and the emergence of Nipah virus in Malaysia': 1, 'Zoonotic viruses of wildlife: hither from yon': 1, 'Host range and emerging and reemerging pathogens': 1, 'Molecular biology of Hendra and Nipah viruses': 1, 'Prevalence and genetic diversity of coronaviruses in bats from China': 2, 'Molecular diversity of coronaviruses in bats': 2, 'Antibodies to Nipah-like virus in bats (Pteropus lylei)': 1, 'The natural history of Hendra and Nipah viruses': 1, 'Nipah virus infection in bats (order Chiroptera) in peninsular Malaysia': 1, 'CoVDB: a comprehensive database for comparative analysis of coronavirus genes and genomes': 1, 'Evolutionary relationships between bat coronaviruses and their hosts': 1, 'Detection and prevalence patterns of group I coronaviruses in bats': 1, 'Coronavirus antibodies in African bat species': 1, 'Detection of group 1 coronaviruses in bats in North America': 2, 'Strategies for the sequence determination of viral dsRNA genomes': 2, 'MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0': 1, 'Association between quality of end-of-life care and possible complicated grief among bereaved family members': 1, 'Methods for the thematic synthesis of qualitative research in systematic reviews': 3, 'Community beliefs and fears during a cholera outbreak in Haiti': 4, 'Psychological distress among Ebola survivors discharged from an Ebola treatment unit in Monrovia, Liberia -a qualitative study': 5, 'Experience of Ebola Survivors: causes of distress and sources of resilience': 4, 'Post-Ebola psychosocial experiences and coping mechanisms among Ebola survivors: a systematic review': 3, 'Mental health care during the Ebola virus outbreak in Sierra Leone': 1, 'Psychological responses to war and atrocity: the limitations of current concepts': 1, 'Is there an ideal animal model for SARS?': 2, 'Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans': 4, 'Antiviral antibody responses: the two extremes of a wide spectrum': 2, 'High-level primary CD8(+) Tcell response to human immunodeficiency virus type 1 gag and env generated by vaccination with recombinant vesicular stomatitis viruses': 2, 'Robust recall and long-term memory T-cell responses induced by prime-boost regimens with heterologous live viral vectors expressing human immunodeficiency virus type 1 Gag and Env proteins': 2, 'Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice': 1, 'Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters': 1, 'Prevalence of overweight and obesity in the United States': 2, 'Respiratory complications of obesity': 1, 'De geruisloze, maar succesvolle revolutie van chronische beademing bij patiënten met neuromusculaire aandoeningen, in het bijzonder de ziekte van Duchenne': 1, 'Changing patterns in longterm noninvasive ventilation': 1, 'Long-term outcome of non-invasive positive pressure ventilation for obesity hypoventilation syndrome': 2, 'Clinical heterogeneity among patients with obesity hypoventilation syndrome: therapeutic complications': 1, 'Long-term effects of gastric surgery for treating respiratory insufficiency of obesity': 2, 'Bariatric surgery and long-term control of morbid obesity': 1, \"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China\": 1, 'Identification of severe acute respiratory syndrome in Canada': 5, 'Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong': 1, 'Do men have a higher case fatality rate of severe acute respiratory syndrome than women do?': 1, 'Infectious diseases. Early indications point to lab infection in new SARS case': 1, 'Infectious diseases. Second lab accident fuels fears about SARS': 1, 'Laboratory diagnosis of four recent sporadic cases of community-acquired SARS, Guangdong Province': 2, 'Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor': 1, 'Middle East respiratory syndrome coronavirus: epidemiology and disease control measures': 1, 'Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study': 5, 'Middle East respiratory syndrome coronavirus (MERS-CoV) serology in major livestock species in an affected region in Jordan': 3, 'Human infection with MERS coronavirus after exposure to infected camels': 1, 'Coronaviruses': 2, 'CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus': 3, 'Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus': 7, 'Mice transgenic for human angiotensin-converting enzyme 2 provide a model for SARS coronavirus infection': 3, 'From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses': 2, 'A decade after SARS: strategies for controlling emerging coronaviruses': 1, 'Resolution of primary severe acute respiratory syndrome-associated coronavirus infection requires Stat1': 1, 'Mice susceptible to SARS coronavirus': 1, 'The clinical pathology of severe acute respiratory syndrome (SARS): a report from': 1, 'Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore': 1, 'Aged BALB/ c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans': 3, 'Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human angiotensin-converting enzyme 2 virus receptor': 3, 'Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters': 7, 'A live attenuated severe acute respiratory syndrome coronavirus is immunogenic and efficacious in golden Syrian hamsters': 2, 'Evaluation of cotton rats as a model for severe acute respiratory syndrome': 1, 'The SARS-CoV ferret model in an infection-challenge study': 3, 'Virology: SARS virus infection of cats and ferrets': 3, 'Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets': 2, 'Adenovirus-based vaccine prevents pneumonia in ferrets challenged with the SARS coronavirus and stimulates robust immune responses in macaques': 1, 'Severe acute respiratory syndrome coronavirus infection in vaccinated ferrets': 2, 'Cynomolgus macaque as an animal model for severe acute respiratory syndrome': 3, \"Aetiology: Koch's postulates fulfilled for SARS virus\": 1, 'Animal models for SARS': 2, 'Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys': 3, 'Macaque model for severe acute respiratory syndrome': 2, 'An animal model of SARS produced by infection of Macaca mulatta with SARS coronavirus': 2, 'Comparative pathogenesis of three human and zoonotic SARS-CoV strains in cynomolgus macaques': 2, 'Pneumonitis and multi-organ system disease in common marmosets (Callithrix jacchus) infected with the severe acute respiratory syndrome-associated coronavirus': 3, 'Structure of SARS coronavirus spike receptor-binding domain complexed with receptor': 5, 'Structural analysis of major species barriers between humans and palm civets for severe acute respiratory syndrome coronavirus infections': 4, 'Mechanisms of host receptor adaptation by severe acute respiratory syndrome coronavirus': 2, 'A virusbinding hot spot on human angiotensin-converting enzyme 2 is critical for binding of two different coronaviruses': 2, 'Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2': 1, 'Civets are equally susceptible to experimental infection by two different severe acute respiratory syndrome coronavirus isolates': 1, 'Molecular determinants of severe acute respiratory syndrome coronavirus pathogenesis and virulence in young and aged mouse models of human disease': 7, 'Transcriptomic analysis reveals a mechanism for a prefibrotic phenotype in STAT1 knockout mice during severe acute respiratory syndrome coronavirus infection': 1, 'A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo': 2, 'The Middle East respiratory syndrome coronavirus (MERS-CoV) does not replicate in Syrian hamsters': 3, 'Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques': 4, 'Infection with MERS-CoV causes lethal pneumonia in the common marmoset': 3, 'Pneumonia from human coronavirus in a macaque model': 4, 'Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques': 1, 'Receptor variation and susceptibility to Middle East respiratory syndrome coronavirus infection': 3, 'Host species restriction of Middle East respiratory syndrome coronavirus through its receptor, dipeptidyl peptidase 4': 1, 'Mouse dipeptidyl peptidase 4 is not a functional receptor for Middle East respiratory syndrome coronavirus infection': 5, 'Genome editing. the new frontier of genome engineering with CRISPR-Cas9': 1, 'Receptor-binding domain-based subunit vaccines against MERS-CoV': 1, 'Broadspectrum antivirals for the emerging Middle East respiratory syndrome coronavirus': 1, 'Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays': 1, 'Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection': 1, 'The S protein of severe acute respiratory syndrome (SARS) associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients': 8, 'Report of the WHO-China Joint Mission on Coronavirus Disease': 3, 'Italians struggle with \"surreal\" lockdown as coronavirus cases rise': 1, 'Improved inference of time-varying reproduction numbers during infectious disease outbreaks': 1, 'EpiEstim\": estimate time varying reproduction numbers from epidemic curves': 1, 'FIGURE 1 (Upper Panel) Incidence rates (per 10,000 inhabitants) of COVID-19 cases in the red zone from': 1, 'Life is complicated': 1, 'Ligand assays: from electrophoresis to miniaturized microarrays': 2, 'Statistical issues with microarrays: Processing and analysis': 1, 'Microarray reality checks in the context of a complex disease': 1, 'Evaluation of DNA microarray results with quantitative gene expression platforms': 1, 'Multiplexed bead-based mesofluidic system for gene diagnosis and genotyping': 1, 'Multicomponent mesofluidic system for the detection of veterinary drug residues based on competitive immunoassay': 1, 'Multiplexed bead-based mesofluidic system for detection of food-borne pathogenic bacteria': 1, 'Bead-based mesofluidic system for residue analysis of chloramphenicol': 1, 'Overview and application of suspension array technology': 2, 'Multiplex genotyping of human minor histocompatibility antigens': 1, 'Antibody Arrays in cancer research': 1, 'Reverse-phase versus sandwich antibody microarray, technical comparison from a clinical perspective': 1, 'Bioconjugated silica nanoparticles: Development and applications': 1, 'Excitonplasmon interactions inmolecular spring assemblies of nanowires and wavelength-based protein detection': 1, 'Single-mismatch detection using gold-quenched fluorescent oligonucleotides': 1, 'Nano-flares: Probes for transfection and mRNA detection in living cells': 1, 'Self-assembled nanoparticle probes for recognition and detection of biomolecules': 1, 'Carbon nanotube-quenched fluorescent oligonucleotides: Probes that fluoresce upon hybridization': 1, 'Goldnanoparticle-based multicolor nanobeacons for sequence-specific DNA analysis': 1, 'A graphene nanoprobe for rapid, sensitive, and multicolor fluorescent DNA analysis': 1, 'Controlled assembly of dendrimer-like DNA': 1, 'Multiplexed detection of pathogen DNA with DNA-based fluorescence nanobarcodes': 3, 'Direct multiplexed measurement of gene expression with color-coded probe pairs': 2, 'A perturbation model of the gene regulatory network for oral and aboral ectoderm specification in the sea urchin embryo': 1, 'Submicrometer metallic barcodes': 1, 'In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags': 1, 'SERS as a foundation for nanoscale, optically detected biological labels': 1, 'Electromagnetic contributions to single-molecule sensitivity in surface-enhanced Raman scattering': 1, 'Single molecule Raman spectroscopy at the junctions of large Ag nanocrystals': 1, 'Nanoparticles with Raman spectroscopic fingerprints for DNA and RNA detection': 1, 'Protein microarrays with carbon nanotubes as multicolor Raman labels': 1, 'Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins': 1, 'Bio-barcodes based on oligonucleotide-modified nanoparticles': 1, 'Bio-bar-code-based DNA detection with PCR-like sensitivity': 1, 'A microfluidic detection system based upon a surface immobilized biobarcode assay': 1, 'A bio-barcode assay for onchip attomolar-sensitivity protein detection': 1, 'Electrochemical coding technology for simultaneous detection of multiple DNA targets': 1, 'DNA-based amplified bioelectronic detection and coding of proteins': 1, 'Encoding microcarriers: Present and future technologies': 1, 'Encoded microcarriers for high-throughput multiplexed detection': 1, 'Quantum-dot-tagged microbeads for multiplexed optical coding of biomolecules': 1, 'Self-assembled combinatorial encoding nanoarrays for multiplexed biosensing': 1, 'Physics -Photonic crystal made to work at an optical wavelength': 1, 'Biomolecular screening with encoded porous-silicon photonic crystals': 1, 'Porous silicon photonic crystals as encoded microcarriers': 1, 'Multiplexed DNA detection using spectrally encoded porous sio2 photonic crystal particles': 1, 'Uniformly colorized beads for multiplex immunoassay': 1, 'Colloidal crystal beads as supports for biomolecular screening': 1, 'Encoded silica colloidal crystal beads as supports for potential multiplex immunoassay': 1, 'Fabrication of colloidal crystal beads by a drop-breaking technique and their application as bioassays': 1, 'Sintering photonic beads for multiplex biosensing': 1, 'Encoded porous beads for label-free multiplex detection of tumor markers': 1, 'Quantum-dot-coated encoded silica colloidal crystals beads for multiplex coding': 1, 'Colloidal crystal beads coated with multicolor CdTe quantum dots: microcarriers for optical encoding and fluorescence enhancement': 2, 'Multiplex detection of tumor markers with photonic suspension array': 1, 'Enhanced fluorescence emission from quantum dots on a photonic crystal surface': 1, 'Three-dimensionally ordered macroporous polymer materials: An approach for biosensor applications': 1, 'Label-free cell-based assays using photonic crystal optical biosensors': 1, 'Self-assembled watersoluble nucleic acid probe tiles for label-free RNA hybridization assays': 1, 'Nanodisk codes': 1, 'Silver-based nanodisk codes': 1, 'Multifunctional encoded particles for high-throughput biomolecule analysis': 2, 'Multiplexed Protein Quantification with Barcoded Hydrogel Microparticles': 1, 'Optimization of encoded hydrogel particles for nucleic acid quantification': 1, 'Colour-barcoded magnetic microparticles for multiplexed bioassays': 1, 'Structural colour printing using a magnetically tunable and lithographically fixable photonic crystal': 1, 'A multicomponent recognition and separation system established via fluorescent, magnetic, dualencoded multifunctional bioprobes': 1, 'Theoretical detection limits of magnetic biobarcode sensors and the phase space of nanobiosensing': 1, 'Aptamer-barcode based immunoassay for the instantaneous derivatization chemiluminescence detection of IgE coupled to magnetic beads': 1, 'Update on the neutralization of animal viruses': 1, 'The immunological reactions of the filterable viruses': 8, 'Mechanisms of viral neutralization': 1, 'A multi-hit model for the neutralization of animal viruses': 4, 'Neutralization of animal viruses': 6, 'The neutralization of viruses': 1, 'The neutralizing antibody response to HIV-1: Viral evasion and escape from humoral immunity': 4, 'A study of the basic aspects of neutralization of two animal viruses, Western equine encephalitis virus and poliomyelitis virus': 8, 'Neutralization of poliovirus: A hypothesis to explain the mechanism and the one-hit character of the neutralization reaction': 6, 'Single-and multi-hit kinetics of immunoglobulin G neutralization of human immunodeficiency virus type 1 by monoclonal antibodies': 2, 'Neutralization of poliovirus by a monoclonal antibody: Kinetics and stoichiometry': 9, 'Quantitative relationships between an influenza virus and neutralizing antibody': 7, 'Neutralization of HIV-1 by antibody to gp120 is determined primarily by occupancy of sites on the virion irrespective of epitope specificity': 8, 'Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1': 2, 'Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer': 2, 'Analysis of the cleavage site of the human immunodeficiency virus type 1 glycoprotein: Requirement of precursor cleavage for glycoprotein incorporation': 1, 'Increased envelope spike density and stability are not required for the neutralization resistance of primary human immunodeficiency viruses': 2, 'HIV-1 antibody-Debris or virion?': 1, 'Virus aggregation as the cause of the non-neutralizable persistent fraction': 1, 'Incomplete neutralization of hepatitis A virus in vitro due to lipid-associated virions': 1, 'Challenges for development of hepatitis C virus vaccines': 1, 'Immune enhancement of viral infection': 3, 'Profiles of antibody-dependent enhancement of dengue virus type 2 infection': 3, 'Mechanisms of rabies virus neutralization': 9, 'Over een Contagium vivum fluidum als oorzaak van de vlekziekte der tabaksbladen': 1, \"Beijerinck's contribution to the virus concept-An introduction\": 1, 'The development of the phage-inactivating properties of serum during the course of specific immunization of an animal: Reversible and irreversible inactivation': 2, 'A mathematical and experimental study of the kinetics of neutralization of bacteriophage X 174 by antibodies': 4, 'Antibody interactions with rhinovirus; lessons for mechanisms of neutralization and the role of immunity in viral evolution': 5, 'Reversibility of the reaction between poliovirus and neutralizing antibody of rabbit origin': 2, 'Functional basis of poliovirus neutralization determined with monospecific neutralizing antibodies': 2, 'Lack of quantitative correlation between the neutralization of poliovirus and the antibody-mediated pI shift of the virions': 1, 'Structural studies on antibody interacting with viruses': 1, 'Structure of a neutralizing antibody bound bivalently to human rhinovirus 2': 1, 'Structure of human rhinovirus complexed with Fab fragments from a neutralizing antibody': 4, 'Neutralising antibody to human rhinovirus 14 penetrates the receptor-binding canyon': 1, 'Antibody-mediated neutralization of human rhinovirus 14 explored by means of cryoelectron microscopy and X-ray crystallography of virus-Fab complexes': 1, 'Interaction betwen poliovirus and immunoglobulins. II. Basic aspects of virusantibody interaction': 2, 'Interaction between poliovirus and immunoglobulins I. Detection of virus antibodies by partition in aqueous polymer phase systems': 1, 'Interaction of the poliovirus receptor with poliovirus': 2, 'Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site': 2, 'Natural variation of poliovirus neutralization epitopes': 1, 'Antigenic variation and resistance to neutralization in poliovirus Type': 1, 'Rapidity of specific antibody-antigen interactions': 1, 'The interaction between virus and antibody': 2, 'Quantitative model of antibody-and soluble CD4-mediated neutralization of primary isolates and T-cell line-adapted strains of human immunodeficiency virus type 1': 4, 'The interaction between virus and antibody II. Mechanism of the reaction': 1, 'Extracellular enveloped vaccinia virus escapes neutralization': 2, 'Antibodies against vaccinia virus do not neutralize extracellular enveloped virus but prevent virus release from infected cells and comet formation': 2, 'Viral epitopes and monoclonal antibodies: Isolation of blocking antibodies that inhibit virus neutralization': 2, 'The neutralization of arboviruses. I. Neutralization in homologous virusserum mixtures with two group B arboviruses': 1, 'The enhancement of virus infectivity by antibody': 2, 'The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells': 1, 'Increased adhesion as a mechanism of antibody-dependent and antibody-independent complementmediated enhancement of human immunodeficiency virus infection': 2, 'Summary report: Workshop on the potential risks of antibody-dependent enhancement in human HIV vaccine trials': 1, 'Antibody-dependent enhancement of human immunodeficiency virus type 1 infection': 1, 'Enhancement of infectivity of a non-syncytium inducing HIV-1 by sCD4 and by human antibodies that neutralize syncytium inducing HIV-1': 1, 'Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry': 1, 'Fc receptors for IgG (Fc␥ Rs) on human monocytes and macrophages are not infectivity receptors for human immunodeficiency virus type 1 (HIV-1): Studies using bispecific antibodies to target HIV-1 to various myeloid cell surface molecules, including the Fc␥ R': 1, 'Complement receptor type 2 mediates infection of the human CD4-negative Raji B-cell line with opsonized HIV': 1, 'Two parallel routes of the complement-mediated antibody-dependent enhancement of HIV-1 infection': 1, 'Determinants of human immunodeficiency virus type 1 envelope glycoprotein activation by soluble CD4 and monoclonal antibodies': 1, 'Antibody-mediated activation of Sindbis virus': 1, 'Phenotypic mixing of vesicular stomatitis virus with fowl plague virus': 2, 'Phenotypic mixing of vesicular stomatitis virus with HVJ (Sendai Virus)': 2, 'Monoclonal antibodies to newcastle disease virus: Delineation of four epitopes on the HN Glycoprotein': 1, 'Neutralization of Newcastle disease virus by monoclonal antibodies to the Hemagglutinin-Neuraminidase Glycoprotein: Requirement for antibodies to four sites for complete neutralization': 2, 'Enhanced neutralization of La Crosse Virus by the binding of specific pairs of monoclonal antibodies to the G1 glycoprotein': 1, 'Virus neutralization and virus-induced immune complex disease': 1, 'Complement can neutralize HIV-1 plasma virus by a C5-independent mechanism': 2, 'Monoclonal antibodies which recognize the acidic configuration of the rabies glycoprotein at the surface of the virion can be neutralizing': 4, 'Assembly and morphology of HIV: Potential effect of structure on viral function': 1, 'Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates': 1, 'An analysis of the inactivation of MS2 bacteriophage with antiserum': 1, 'Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins': 1, 'Two antibodies that neutralize papillomavirus by different mechanisms show distinct binding patterns at 13 • A resolution': 2, 'Studies on the mechanism of neutralization of influenza virus by antibody: Evidence that neutralizing antibody (anti-haemagglutinin) inactivates influenza virus in vivo by inhibiting virions transcriptase activity': 1, 'Neutralization of Chlamydia trachomatis: Kinetics and stoichiometry': 2, 'Antibodies against HIV-1 from phage display libraries: Mapping of an immune response and progress towards anti-viral immunotherapy': 1, 'Bivalent attachment of antibody onto poliovirus leads to conformational alteration and neutralization': 1, 'Immunological studies of the functions of paramyxovirus glycoproteins': 1, 'Monoclonal antibodies to GP5 of porcine reproductive and respiratory syndrome virus are more effective in virus neutralization than monoclonal antibodies to GP4': 2, 'Kinetics of sensitization of herpes simplex virus and its relationship to the reduction in the neutralization rate constant': 1, 'Kinetics of neutralization of sensitized herpes simplex virus with antibody fragments': 1, 'The protein data bank': 1, 'Refined structure of an intact IgG2a monoclonal antibody': 1, 'Reduced surface: An efficient way to compute molecular surfaces': 2, 'Python: A programming language for software integration and development': 1, 'Orthomyxoviruses. In Fields Virology': 2, 'Antiviral activity of antiserum specific for an influeza virus neuraminidase': 1, 'Preparation and properties of antibody directed specifically against the neuraminidase of influenza virus': 2, 'Influenza A virus M2 protein: Monoclonal antibody restriction of virus growth and detection of M2 in virions': 2, 'Association of serum anti-neuraminidase antibody with resistance to influenza in man': 1, 'Orthomyxoviridiae: The viruses and their replication': 1, 'Cellular proteins bound to immunodeficiency viruses: Implications for pathogenesis and vaccines': 2, 'Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus': 2, 'A simple and reliable method to detect cell membrane proteins on infectious human immunodeficiency virus type 1 particles': 1, 'MHC-antigens: Constituents of the envelopes of human and simian immunodeficiency viruses': 1, 'Nonrandom association of cellular antigens with HTLV-III virions': 1, 'Association of host cell surface adhesion receptors and other membrane proteins with HIV and SIV': 1, 'Detection of HLA-DR associated with monocytotropic, primary, and plasma isolates of human immunodeficiency virus type 1': 1, 'Neutralization of feline leukemia virus with feline antisera to leukocyte alloantigens': 1, 'Towards a vaccine against AIDS: Lessons from simian immunodeficiency virus vaccines': 1, 'Contribution of virion ICAM-1 to human immunodeficiency virus infectivity and sensitivity to neutralization': 2, 'Effect of the cytoplasmic domain of the simian immunodeficiency virus envelope protein on incorporation of heterologous envelope proteins and sensitivity to neutralization': 2, 'Dimeric association and segmental variability in the structure of human CD4': 1, 'Identification of the residues in human CD4 critical for the binding of HIV': 1, 'Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding': 6, 'Epitopes of the CD4 antigen and HIV infection': 1, 'Internalization of the human immunodeficiency virus does not require the cytoplasmic domain of CD4': 1, 'A region in domain 1 of CD4 distinct from the primary gp120 binding site is involved in HIV infection and virus-mediated fusion': 4, 'Inhibition of virus attachment to CD4 + target cells is a major mechanism of T cell line-adapted HIV-1 neutralization': 2, 'Functional epitope analysis of the human CD4 molecule. The MHC class II-dependent activation of resting T cells is inhibited by monoclonal antibodies to CD4 regardless of whether or not they recognize epitopes involved in the binding of MHC class II or HIV gp120': 2, 'HIV entry and tropism: The chemokine receptor connection': 1, 'Vaccinia virus immune evasion': 1, 'Neutralization of cytomegalovirus virions: The role of complement': 1, 'Host cell components affect the sensitivity of HIV type 1 to complement-mediated virolysis': 1, 'Role of virion-associated glycosylphosphatidylinositollinked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1': 2, 'Role of complement in HIV infection': 1, 'Susceptibility of HIV-1 plasma virus to complement-mediated lysis': 5, 'Neutralization of human immunodeficiency virus type 1 by complement occurs by viral lysis': 1, 'Mechanisms of resistance of HIV-1 primary isolates to complement-mediated lysis': 3, 'Heightened complement sensitivity of acquired immunodeficiency syndrome lymphocytes related to diminished expression of decay-accelerating factor': 1, 'Decreased expression of the membrane inhibitor of complement-mediated cytolysis CD59 on T-lymphocytes of HIV-infected patients': 1, 'The complement control protein homolog of herpesvirus saimiri regulates serum complement by inhibiting C3 convertase activity': 1, 'Inhibition of the complement cascade by the major secretory protein of vaccinia virus': 2, 'Inhibition of complement-mediated cytolysis by the terminal complement-inhibitor of herpesvirus saimiri': 1, 'Viral subversion of the immune system': 3, 'Role of cell-associated enveloped vaccinia virus in cell-to-cell spread': 1, 'A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope': 1, 'Characterization of a vaccinia virusencoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope': 1, 'Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope': 1, 'Functional characterization of soluble and membrane-bound forms of vaccinia complement control protein': 1, 'Opsonization-enhanced phagocytosis of foot-and-mouth disease virus': 3, 'Human antibody effector function': 1, 'Preparation of genetically engineered monoclonal antibodies for human immunotherapy': 1, 'Viral interference with antibody and complement': 2, 'Immunocytochemical colocalization of specific immunoglobulin A with sendai virus protein in infected polarized epithelium': 1, 'Comparison of IgA versus IgG monoclonal antibodies for passive immunization of the murine respiratory tract': 2, 'Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies': 1, 'Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dlgA or IgM': 3, 'Human monoclonal antibody Fab fragments cloned from combinatorial libraries: Potential usefulness in prevention and/or treatment of major human viral diseases': 3, 'Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1': 1, 'Protection against HIV-1 infection in hu-PBL-SCID mice by passive immunization with a neutralizing human monoclonal antibody against the gp120 CD4-binding site': 1, 'Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design': 1, 'Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection': 1, 'Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies': 1, 'Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys': 1, 'Protection of macaques against pathogenic SHIV-89.6PD by passive transfer of neutralizing antibodies': 1, 'A neutralizing human monoclonal antibody protects macaques against challenge with a pathogenic R5 SHIV': 1, 'A study of passive immunization against a transplanted G+ leukemia with specific antiserum': 2, 'Identification of the Gross cell surface antigen associated with murine leukemia virus-infected cells': 1, 'Monoclonal IgM antibodies that inhibit primary Moloney murine sarcoma growth': 1, 'Protective efficacy of nonneutralizing monoclonal antibodies in acute infection with murine leukemia virus': 2, 'A nonstructural gag-encoded glycoprotein precursor is necessary for efficient spreading and pathogenesis of murine leukemia viruses': 1, 'Identification of a sequence in the unique 5 open reading frame of the gene encoding glycosylated Gag which influences the incubation period of neurodegenerative disease induced by a murine retrovirus': 1, 'Use of monoclonal anti-gp70 antibodies to mimic the effects of the Rfv-3 gene in mice with Friend virus-induced leukemia': 1, 'Immunotherapy of murine leukemia. IX. The requirement for the Fc portion of antibody for successful passive serum therapy of Friend leukemia virus-induced disease': 1, 'Characterization of a live-attenuated retroviral vaccine demonstrates protection via immune mechanisms': 1, 'Requirement for multiple lymphocyte subsets in protection by a live-attenuated vaccine against retroviral infection': 4, 'Kinetics of the development of protective immunity in mice vaccinated with a live-attenuated retrovirus': 1, 'Protection against lethal viral infection by neutralizing and nonneutralizing monoclonal antibodies: Distinct mechanisms of action in vivo': 1, 'The role of antibody concentration and avidity in antiviral protection': 1, 'Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis': 1, 'Protective monoclonal antibodies define maturational and pH-dependent antigenic changes in Sindbis virus E1 glycoprotein': 1, 'Mechanisms of monoclonal antibody-mediated protection against virulent Semliki Forest virus': 1, 'Role of complement and the Fc portion of immunoglobulin G in immunity to Venezuelan equine encephalomyelitis virus infection with glycoprotein-specific monoclonal antibodies': 1, 'Mechanisms of antibody-mediated protection against lymphocytic choriomeningitis virus infection: Mother-to-baby transfer of humoral protection': 1, 'Antiviral antibodies attenuate T-cell-mediated immunopathology following acute lymphocytic choriomeningitis virus infection': 1, 'Murine hepatitis virus-4 (strain JHM)-induced neurologic disease is modulated in vivo by monoclonal antibody': 1, 'Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence': 1, 'Hybridoma antibodies to the murine coronavirus JHM: Characterization of epitopes on the peplomer protein': 1, 'Protective effect of monoclonal antibodies on lethal mouse hepatitis virus infection in mice': 1, 'Protection from mouse hepatitis virus type 3-induced acute disease by an antinucleoprotein monoclonal antibody': 1, 'Protection from lethal coronavirus infection by immunoglobulin fragments': 1, 'A recombinant single chain antibody neutralizes coronavirus infectivity but only slightly delays lethal infection of mice': 1, 'Epitopes involved in antibody-mediated protection from Ebola Virus': 1, 'A human neutralizing antibody protects against challenge with Ebola Zaire in an animal model': 2, 'Neutralizing (54K) and nonneutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice': 1, 'Neutralizing F(ab ) 2 fragments of protective monoclonal antibodies to yellow fever virus (YF) envelope protein fails to protect mice against lethal YF encephalitis': 2, 'Comparison of measles virus-specific antibodies with antibody-dependent cellular cytotoxicity and neutralizing functions': 1, 'Pre-and postexposure protection by passive immunoglobulin but no enhancement of infection with a flavivirus in a mouse model': 1, 'In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody': 1, 'Role of Fc fragments in antibody-mediated recovery from ocular and subcutaneous herpes simplex virus infections': 1, 'IgG-mediated viral clearance in experimental infection with herpes simplex virus type 1: Role for neutralization and Fc-dependent functions but not C cytolysis and C5 chemotaxis': 1, 'Mechanism of antibody-mediated protection against herpes simplex virus infection in athymic nude mice: Requirement of Fc portion of antibody': 1, 'Protection against lethal challenge of balb/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex type 2': 1, 'Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease': 1, 'Protection against zosteriform spread of herpes simplex virus by monoclonal antibodies': 1, 'IgG subtype is correlated with efficiency of passive protection and effector function of anti-herpes simplex virus glycoprotein D monoclonal antibodies': 1, 'Topically applied human recombinant monoclonal IgG antibody and its Fab and F(ab ) fragments protect mice form vaginal transmission of HSV-2': 1, 'A pulmonary influenza virus infection in SCID mice can be cured by treatment with hemagglutininspecific antibodies that display very low virus-neutralizing activity in vitro': 2, 'Immune protection against foot-and-mouth disease virus studied using virus neutralizing and non neutralizing concentrations of monoclonal antibodies': 1, 'Protective immune response against foot-and-mouth disease': 1, 'Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats': 1, 'Protection from respiratory syncytial virus infection in cotton rats by passive transfer of monoclonal antibodies': 1, 'The characterization and uses of monoclonal antibodies to respiratory syncytial virus': 1, 'Involvement of the complement system in the protection of mice from challenge with respiratory syncytial virus Long strain following passive immunization with monoclonal antibody 18A2B2': 1, 'Passive protection of gnotobiotic calves using monoclonal antibodies directed at different epitopes on the fusion protein of bovine respiratory syncytial virus': 1, 'Intranasal monoclonal immunoglobulin A against respiratory syncytial virus protects against upper and lower respiratory tract infections in mice': 1, 'A direct comparison of the activities of two humanized respiratory syncytial virus monoclonal antibodies: MEDI-493 and RSHZ19': 1, 'Protection of mice against Sendai virus pneumonia by non-neutralizing anti-F monoclonal antibodies': 1, 'Passive protection of mice and sheep against bluetongue virus by a neutralizing monoclonal antibody': 1, 'Selective antibody neutralization prevents neuropathogenic lactate dehydrogenase-elevating virus from causing paralytic disease in immunocompetent mice': 1, 'Treatment of influenza virusinfected SCID mice with nonneutralizing antibodies specific for the transmembrane proteins matrix 2 and neuraminidase reduces the pulmonary virus titer but fails to clear the infection': 1, 'Viral spread in the presence of neutralization antibody: Mechanisms of persistence in foamy virus infection': 1, 'Effect of anti-V3 antibodies on cell-free and cell-to-cell human immunodeficiency virus transmission': 1, 'Passive infusion of immune serum into simian immunodeficiency virus-infected rhesus macaques undergoing a rapid disease course has minimal effect on plasma viremia': 1, 'Passive immunotherapy for retroviral disease: Influence of major histocompatibility complex type and T-cell responsiveness': 1, 'Respiratory syncytial viruses': 1, 'Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat': 1, 'Human RSV monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice': 2, 'Studies of passive immunotherapy for infections of respiratory syncytial virus in the respiratory tract of a primate model': 1, 'Effectiveness of topically administered neutralizing antibodies in experimental immunotherapy of respiratory syncytial virus infection in cotton rats': 1, 'Mechanism of antibody-mediated viral clearance in immunotherapy of respiratory syncytial virus infection of cotton rats': 2, 'Intranasal monoclonal IgA antibody to respiratory syncytial virus protects rhesus monkeys against upper and lower respiratory tract infection': 1, \"Survival of athymic (nu/nu) mice after Theiler's murine encephalomyelitis virus infection by passive administration of neutralizing monoclonal antibody\": 1, 'Antibody-induced restriction of viral gene expression in measles encephalitis in rats': 1, 'Antibody mediated clearance of Sindbis encephalomyelitis in SCID mice: A novel mechanism for recovery from viral infection': 1, 'Roles of immunoglobulin valency and the heavy-chain constant domain in antibody-medicated downregulation of sindbis virus replication in persistently infected neurons': 1, 'Delineation of putative mechanisms involved in antibody-mediated clearance of rabies virus from the central nervous system': 1, 'Antibody-induced modulation of Friend virus cell surface antigens decreases virus production by persistent erythroleukemia cells: Influnce of the Rfv-3 gene': 1, 'Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity': 1, 'Complement enhancement of neutralizing antibody to the structural proteins of Chlamydia trachomatis': 1, 'An OspC-specific monoclonal antibody passively protects mice from tick-transmitted infection by Borrelia burgdorferi B31': 1, 'Monoclonal antibodies mediating viable immunofluorescence and protection against Trypanosoma cruzi infection': 1, 'Human antibody responses to mature and immature forms of viral envelope in respiratory syncytial virus infection: Significance for subunit vaccines': 1, 'Antigen-specific human antibodies from mice comprising four distinct genetic modifications': 1, 'Making antibodies by phage display technology': 1, 'Antibody engineering: Comparison of bacterial, yeast, insect and mammalian expression systems': 1, 'Transgenic milk as a method for the production of recombinant antibodies': 1, 'Molecular farming of recombinant antibodies in plants': 1, 'Emerging human coronaviruses -disease potential and preparedness': 1, 'Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic?': 1, 'In-vitro renal epithelial cell infection reveals a viral kidney tropism as a potential mechanism for acute renal failure during Middle East respiratory syndrome (MERS) coronavirus infection': 1, 'Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group': 2, 'Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS': 1, 'Close relative of human Middle East respiratory syndrome coronavirus in bat': 2, 'Hospital outbreak of Middle East respiratory syndrome coronavirus': 1, 'Fifteen years of HIV protease inhibitors: raising the barrier to resistance': 1, 'Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers': 1, 'Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised': 1, 'Synthesis and biological evaluation of alpha-ketoamides as inhibitors of the Dengue virus protease with antiviral activity in cell-culture': 1, 'Aprotinin and similar protease inhibitors as drugs against influenza': 1, 'Development of broad-spectrum halomethyl ketone inhibitors against coronavirus main protease 3CL(pro)': 1, 'Stable benzotriazole esters as mechanism-based inactivators of the severe acute respiratory syndrome 3CL protease': 1, 'Peptide aldehyde inhibitors challenge the substrate specificity of the SARScoronavirus main protease': 1, 'Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease': 2, 'Proteolytic processing and deubiquitinating activity of papain-like proteases of human coronavirus NL63': 1, 'Deubiquitinating and interferon antagonism activities of coronavirus papainlike proteases': 1, 'PLP2, a potent deubiquitinase from murine hepatitis virus, strongly inhibits cellular type I interferon production': 1, 'Crystal structure of the MERS coronavirus papain-like protease bound to ubiquitin facilitates targeted disruption of deubiquitinating activity to demonstrate its role in innate immune suppression': 2, 'Crystal structure of the papain-like protease of MERS coronavirus reveals unusual, potentially druggable active-site features': 3, 'Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus': 8, 'Differential domain structure stability of the severe acute respiratory syndrome coronavirus papain-like protease': 1, 'Studies on liver alcohol hydrogenase complexes. 3. Multiple inhibition kinetics in the presence of two competitive inhibitors': 2, 'Thiopurine analogue inhibitors of severe acute respiratory syndrome-coronavirus papain-like protease, a deubiquitinating and deISGylating enzyme': 1, 'Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus': 5, 'DNA inhibits catalysis by the carboxyltransferase subunit of acetyl-CoA carboxylase: implications for active site communication': 1, 'Enzymes: A Practical Introduction to Structure, Mechanism, and Data Analysis, second ed': 1, 'Thiopurines in current medical practice: molecular mechanisms and contributions to therapy-related cancer': 2, '6-Thioguanine: a drug with unrealized potential for cancer therapy': 1, 'Cellular IMPDH enzyme activity is a potential target for the inhibition of Chikungunya virus replication and virus induced apoptosis in cultured mammalian cells': 1, 'Mycophenolic acid inhibits dengue virus infection by preventing replication of viral RNA': 1, 'Mycophenolic acid inhibits replication of Japanese encephalitis virus': 1, 'Identification of active antiviral compounds against a New York isolate of West Nile virus': 1, 'The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase': 1, 'Antiviral or proviral action of mycophenolic acid in hepatitis B infection': 1, 'Synergistic inhibitor binding to the papain-like protease of human SARS coronavirus: mechanistic and inhibitor design implications': 1, 'Structural basis for catalysis and ubiquitin recognition by the severe acute respiratory syndrome coronavirus papain-like protease': 1, 'Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin': 1, 'System effects of widespread use of fully automated vehiclesthree scenarios': 1, 'Autonomes fahren und stadtstruktur': 2, 'Research to examine behavioral responses to automated vehicles': 2, 'Integration of shared mobility approaches in Sustainable Urban Mobility Planning': 1, 'Einführungsszenarien für höhergradig automatisierte Straßenfahrzeuge': 1, \"Autonomous Driving. Disruptive innovation that promises to change the automotive industry as we know it -it's time for every player to think:act!\": 1, 'Autonome Fahrzeuge und autonomes Fahren aus Sicht der Nachfragemodellierung': 1, 'Automated vehicles and the rethinking of mobility and cities': 1, 'Autonomous vehicle technology: a guide for policymakers': 2, 'Mobilität in Deutschland -MiD Ergebnisbericht': 1, 'An analysis of possible energy impacts of automated vehicle': 3, 'Urbane Mobilität und autonomes Fahren im Jahr 2035. Welche Veränderungen durch Robotaxis auf Automobilhersteller': 1, 'Mobility-as-a-service: Why self-driving cars could change everything': 1, 'BMVI: Ethik-Kommission. Automatisiertes und vernetztes Fahren': 2, 'Datengetriebene Geschäftsmodelle rund um das vernetzte Auto. Grundrechtsschutz im Smart Car. D': 1, 'Elektrifiziert, automatisiert, vernetzt -herausforderungen und chancen für die antriebsentwicklung von morgen. VPC -Simulation und Test': 1, 'Der Beitrag des automatisierten Fahrens zur Erhöhung der Verkehrssicherheit. Grundrechtsschutz im Smart Car. D': 1, 'Verkehrliche Wirkung autonomer Fahrzeuge': 1, 'Unfallentwicklung auf deutschen Straßen': 1, 'Systems biology of cellular rhythms': 1, 'Circannual rhythms in birds': 1, 'Plant dormancy in the perennial context': 1, 'Scaling of embryonic patterning based on phase-gradient encoding': 1, 'Dissociation of per1 and bmal1 circadian rhythms in the suprachiasmatic nucleus in parallel with behavioral outputs': 1, 'A doppler eect in embryonic pattern formation': 1, 'Least-squares frequency analysis of unequally spaced data': 2, 'The lomb-scargle periodogram in biological rhythm research: Analysis of incomplete and unequally spaced time-series': 2, 'Quantication of circadian rhythms in single cells': 1, 'Quantitative analysis of circadian single cell oscillations in response to temperature': 1, 'Quantitative analysis of regulatory exibility under changing environmental conditions': 2, 'Circadian System Phase An Aspect of Temporal Morphology; Procedures and Illustrative Examples': 1, 'Circadian rhythms determined by cosine curve tting: analysis of continuous work and sleep-loss data': 1, 'Least squares analysis of uorescence data': 1, 'Calls out of chaos: the adaptive signicance of nonlinear phenomena in mammalian vocal production': 1, 'Self-organization of embryonic genetic oscillators into spatiotemporal wave patterns': 1, 'Circadian oscillations in rodents: A systematic increase of their frequency with age': 1, 'Plasticity of the intrinsic period of the human circadian timing system': 1, 'Jtk_cycle: An ecient nonparametric algorithm for detecting rhythmic components in genomescale data sets': 2, 'Detecting rhythms in time series with rain': 2, 'Wavelet analysis of circadian and ultradian behavioral rhythms': 2, 'WAVECLOCK: wavelet analysis of circadian oscillation': 2, 'Performance of dierent synchronization measures in real data: a case study on electroencephalographic signals': 1, 'Theory of communication. part 1: The analysis of information': 1, 'Foundations of time-frequency analysis': 1, 'A practical guide to wavelet analysis': 2, 'On estimation of the wavelet variance': 1, \"Problem solving: a statistician's guide\": 1, 'Smoothing and dierentiation of data by simplied least squares procedures': 1, 'Photobleaching kinetics of uorescein in quantitative uorescence microscopy': 1, \"The scientist and engineer's guide to digital signal processing\": 1, 'On adjusting the hodrick-prescott lter for the frequency of observations': 1, 'Identication of chirps with continuous wavelet transform': 1, 'A sevenday cycle in covid-19 infection and mortality rates: Are inter-generational social interactions on the weekends killing susceptible people? medRxiv': 1, 'Fundamentals of ecology': 1, 'The eects of proliferation status and cell cycle phase on the responses of single cells to chemotherapy': 1, 'Excitability in the p53 network mediates robust signaling with tunable activation thresholds in single cells': 1, 'Chemical turbulence': 1, 'A threshold selection method from gray-level histograms': 1, 'Functional network inference of the suprachiasmatic nucleus': 1, 'Subharmonics, biphonation, and deterministic chaos in mammal vocalization': 1, 'The summation of random causes as the source of cyclic processes': 1, 'Methods for serial analysis of long time series in the study of biological rhythms': 1, 'Period Coding of Bmal1 Oscillators in the Suprachiasmatic Nucleus': 1, 'Measuring relative coupling strength in circadian systems': 1, 'Quantifying Stochastic Noise in Cultured Circadian Reporter Cells': 1, 'Extension of a genetic network model by iterative experimentation and mathematical analysis': 1, 'Reciprocal regulation of carbon monoxide metabolism and the circadian clock': 1, 'Circada: Shiny apps for exploration of experimental and synthetic circadian time series with an educational emphasis': 1, 'Strengths and limitations of period estimation methods for circadian data': 1, 'Persistent cellautonomous circadian oscillations in broblasts revealed by six-week singlecell imaging of per2::luc bioluminescence': 1, 'Beyond spikes: Multiscale computational analysis of in vivo long-term recordings in the cockroach circadian clock': 1, 'Wavos: a matlab toolkit for wavelet analysis and visualization of oscillatory systems': 1, 'Analyzing circadian expression data by harmonic regression based on autoregressive spectral estimation': 1, 'MetaCycle: an integrated R package to evaluate periodicity in large scale data': 1, 'Dierential rhythmicity: detecting altered rhythmicity in biological data': 1, 'Time-Scale and Time-Frequency Analyses of Irregularly Sampled Astronomical Time Series': 1, 'Matplotlib: A 2d graphics environment': 1, 'Mckinney, wes. \"data structures for statistical computing in python': 1, 'On generating power law noise': 1, 'Avis provisoire Recommandations relatives à la prévention et à la prise en charge du COVID-19 chez les patients à risque de formes sévères': 1, \"au nom d'un groupe de travail de l'Académie nationale de médecine\": 1, 'Gene-environment interactions in asthma and other respiratory diseases': 1, 'Genome-wide association studies in lung disease': 1, 'Allelic frequencies and patterns of single-nucleotide polymorphisms in candidate genes for asthma and atopy in Iceland': 1, 'Transforming growth factor-beta1 promoter polymorphism C-509T is associated with asthma': 1, 'Transforming growth factor-␤1 C-509T polymorphism, oxidant stress, and early-onset childhood asthma': 1, 'Variants in TGFB1, dust mite exposure, and disease severity in children with asthma': 1, 'Genetic modifiers of lung disease in cystic fibrosis': 1, 'The transforming growth factor-beta1 (TGFB1) gene is associated with chronic obstructive pulmonary disease (COPD)': 2, 'TGF-beta 1 modulates human airway smooth-muscle cell proliferation induced by mitogens': 1, 'Genetic control of the circulating concentration of transforming growth factor type beta1': 1, 'TGF-beta1 causes airway fibrosis and increased collagen I and III mRNA in mice': 1, 'The contribution of transforming growth factor-beta and epidermal growth factor signalling to airway remodelling in chronic asthma': 1, 'Transforming growth factor-␤: master regulator of the respiratory system in health and disease': 1, 'The stumpy gene is required for mammalian ciliogenesis': 1, 'A comprehensive cis-eQTL analysis revealed target genes in breast cancer susceptibility loci identified in genome-wide association studies': 1, 'Characterization of the promoter region of the human transforming growth factor-beta 1 gene': 1, 'A functional polymorphism C-509T in TGF␤-1 promoter contributes to susceptibility and prognosis of lone atrial fibrillation in Chinese population': 1, 'CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes': 3, 'Systematic mapping of functional enhancer-promoter connections with CRISPR interference': 1, 'Enhancer connectome in primary human cells identifies target genes of disease-associated DNA elements': 1, 'Systematic identification of regulatory variants associated with cancer risk': 1, 'Dissecting super-enhancer hierarchy based on chromatin interactions': 1, 'High-throughput screening of prostate cancer risk loci by single nucleotide polymorphisms sequencing': 1, 'Evaluation of off-target and on-target scoring algorithms and integration into the guide RNA selection tool CRISPOR': 1, 'Kras(G12D) and Nkx2-1 haploinsufficiency induce mucinous adenocarcinoma of the lung': 2, 'The 3D Genome Browser: a web-based browser for visualizing 3D genome organization and long-range chromatin interactions': 1, 'The human genome browser at UCSC': 1, 'An integrated encyclopedia of DNA elements in the human genome': 2, \"The Hitchhiker's guide to Hi-C analysis: practical guidelines\": 1, 'Gene signature driving invasive mucinous adenocarcinoma of the lung': 3, 'Systematic perturbation of retroviral LTRs reveals widespread long-range effects on human gene regulation': 1, 'High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells': 1, 'Expression quantitative trait loci: present and future': 1, 'Transforming growth factor-beta-and tumor necrosis factor-alpha-mediated induction and proteolytic activation of MMP-9 in human skin': 1, 'TGF-beta1 induced MMP-9 expression in HNSCC cell lines via Smad/MLCK pathway': 1, 'Transforming growth factor-␤1 induces matrix metalloproteinase-9 and cell migration in astrocytes: roles of ROS-dependent ERK-and JNK-NF-B pathways': 1, 'A common MUC5B promoter polymorphism and pulmonary fibrosis': 1, 'A large-scale, consortium-based genomewide association study of asthma': 1, 'Genome-wide association study to identify genetic determinants of severe asthma': 1, 'Chromosome 17q21 genes ORMDL3 and GSDMB in asthma and immune diseases': 1, 'A decade of research on the 17q12-21 asthma locus: piecing together the puzzle': 1, 'Why is ORMDL3 on chromosome 17q21 highly linked to asthma?': 1, 'SNPedia: a wiki supporting personal genome annotation, interpretation and analysis': 1, 'ORMDL3 is an inducible lung epithelial gene regulating metalloproteases, chemokines, OAS, and ATF6': 1, 'GSDMB induces an asthma phenotype characterized by increased airway responsiveness and remodeling without lung inflammation': 1, 'A decade of 3C technologies: insights into nuclear organization': 1, 'The role of enhancers in cancer': 1, 'Lineage-specific genome architecture links enhancers and non-coding disease variants to target gene promoters': 1, 'Functional dissection of the Sox9-Kcnj2 locus identifies nonessential and instructive roles of TAD architecture': 1, 'Mitigation of off-target toxicity in CRISPR-Cas9 screens for essential non-coding elements': 1, 'siRNA vs. shRNA: similarities and differences': 1, 'Versatility of chemically synthesized guide RNAs for CRISPR-Cas9 genome editing': 1, 'Use of antiviral drugs to reduce COVID-19 transmission': 4, 'Supramolecular architecture of severe acute respiratory syndrome coronavirus revealed by electron cryomicroscopy': 1, 'Clinical features of 69 cases with coronavirus disease': 1, 'Chloroquine and hydroxychloroquine as available weapons to fight COVID-19': 1, 'Virological and clinical cure in covid-19 patients treated with hydroxychloroquine: a systematic review and meta-analysis': 1, 'Favipiravir versus Arbidol for COVID-19: a randomized clinical trial. medRxiv. Preprint posted': 2, 'Extinction of hepatitis C virus by ribavirin in hepatoma cells involves lethal mutagenesis': 1, 'Coronavirus susceptibility to the antiviral Remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease. mBio': 1, 'Nifedipine and phosphodiesterase inhibitors: rationale for their utilization as adjunctive countermeasures in the treatment of coronavirus disease 2019 (COVID-19)': 4, 'Mechanisms of action of acetazolamide in the prophylaxis andtreatment of acute mountain sickness': 1, 'The kidney and acid-base regulation': 3, 'Hypoxaemia related to COVID-19: vascular and perfusion abnormalities on dual-energy CT': 1, 'Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of antiinterferon serum. -II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses': 1, 'Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. -I. Rapid evolution of encephalomyocarditis virus infection': 1, 'Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. -V. Protective role in MHVa infection of susceptible and resistant strains of mice': 1, 'Transmissible gastro-enteritis, in <<Diseases of swine~': 1, 'Transmissible gastroenteritis of swine as a model for the study of enteric disease': 1, 'High interferon titer in newborn pig intestine during experimentally induced viral enteritis': 5, 'Cytocidal effect of interferons on porcine renal cells': 1, 'Large-scale production of human leucocyte interferon containing 108 units per ml': 1, 'Differences between human-~ (leucocyte) and [~ (fibroblast) interferons (brief review)': 2, 'Weak susceptibility of rotavirus to bovine interferon in calf kidney cells': 1, 'Neutralisation of interferon by antibody: appraisals of methods of determining and expressing the neutralization titer': 1, 'The complete purification of human leucocyte interferon': 1, 'Replication of enteropathogenic coronavirus TGEV in swine alveolar macrophages': 1, 'Porcine leukocyte inferferon and antiviral activity in human cells': 1, 'Sensitivity of ovine plexus cells to human and other animal interferons': 1, 'Identification, production, and characterization of murine monoclonal antibody (LO-22) recognizing 12 native species of human alpha interferon': 1, 'Characterization of monoclonal antibody specific for human alpha interferon': 1, 'A monoclonal antibody for large-scale purification of human leucocyte interferon': 1, 'Isolation of a subspecies of murine interferon antigenically related to human leukocyte interferon': 1, 'Antigenic cross-reaction between the a types of human and mouse interferon': 2, 'Characterization of a subspecies of mouse interferon cross-reactive on human cells and antigenically related to human leukocyte interferon': 2, 'Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Patients in Wuhan': 1, 'ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection': 6, 'ESPEN Guideline ESPEN guidelines on definitions and terminology of clinical nutrition': 1, 'The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material': 1, 'Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support': 1, 'Prevalence of malnutrition and analysis of related factors in elderly patients with COVID-19 in Wuhan, China': 1, 'GLIM criteria for the diagnosis of malnutrition -A consensus report from the global clinical nutrition community': 3, 'The mini nutritional assessment (MNA) and its use in grading the nutritional state of elderly patients': 1, 'Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials': 2, 'Decreased food intake is a risk factor for mortality in hospitalised patients: the NutritionDay survey': 1, 'ESPEN guideline on clinical nutrition in the intensive care unit': 1, 'Early nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (COVID-19): Rationale and feasibility of a shared pragmatic protocol': 1, 'Architecture of the SARS coronavirus prefusion spike': 1, 'Host cell entry of Middle East Figure 3. Forest plots of unadjusted odds ratio of outcomes across NLR and LCR groups. NLR: neutrophil-to-lymphocyte ratio': 1, 'Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19': 3, 'Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer': 1, 'Lymphocyte-to-C-reactive protein ratio and score are clinically feasible nutrition-inflammation markers of outcome in patients with gastric cancer': 2, 'Systemic analysis of predictive biomarkers for recurrence in colorectal cancer patients treated with curative surgery': 1, 'Combined C-reactive protein and Neutrophil to Lymphocyte ratio use predict survival innon-small-cell lung cancer': 1, 'The combined use of the neutrophillymphocyte ratio and C-reactive protein level as prognostic predictors in adult patients with soft tissue sarcoma': 1, 'Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A metaanalysis': 2, 'LeishVet update and recommendations on feline leishmaniosis': 2, 'What do we know about feline leishmaniosis?': 1, 'Prevalence study and risk factor analysis of selected bacterial, protozoal and viral, including vector-borne, pathogens in cats from Cyprus': 3, 'Cross-sectional serosurvey of feline leishmaniasis in ecoregions around the Northwestern Mediterranean': 1, 'Canine leishmaniosis in the United Kingdom: a zoonotic disease waiting for a vector?': 1, \"Infection simultanée d'un enfant, d'un chien et d'un chat dans la même habitation\": 1, 'Primeiro caso de leishmaniose em gato doméstico (Felis catus domesticus) detectado em Portugal (Concelho de Sesimbra). Nota preliminar': 1, 'Two cases of feline visceral and cutaneous leishmaniosis in Spain': 1, 'Successful treatment of feline leishmaniosis using a combination of allopurinol and N-methyl-glucamine antimoniate': 3, 'Infection of sandflies by a cat naturally infected with Leishmania infantum': 1, 'Case report of leishmaniasis in four cats': 1, 'Ocular signs, diagnosis and long-term treatment with allopurinol in a cat with leishmaniasis': 1, 'Diagnostic performance of ELISA, IFAT and Western blot for the detection of anti-Leishmania infantum antibodies in cats using a Bayesian analysis without a gold standard': 1, 'Canine tick-borne pathogens in Cyprus and a unique canine case of multiple co-infections': 1, 'Hydroxychloroquine and azithromycin as a treatment of COVID-19: Results of an open-label non-randomized clinical trial': 1, 'Novel RNA viruses associated with Plasmodium vivax in human malaria and Leucocytozoon parasites in avian disease': 2, 'Public health responses to COVID-19 outbreaks on cruise ships worldwide': 1, 'Relationship between the ABO blood group and the COVID-19 susceptibility': 1, 'Comparative analyses of SAR-CoV2 genomes from different geographical locations and other coronavirus family genomes reveals unique features potentially consequential to host-virus interaction and pathogenesis': 1, 'Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro': 1, 'Pharmacokinetics of hydroxychloroquine and its clinical implications in chemoprophylaxis against malaria caused by plasmodium vivax': 2, 'Steadystate pharmacokinetics of hydroxychloroquine in patients with cutaneous lupus erythematosus': 2, 'Plasma protein binding of the enantiomers of hydroxychloroquine and metabolites': 1, 'Simultaneous quantitation of hydroxychloroquine and its metabolites in mouse blood and tissues using LC-ESI-MS/MS: an application for pharmacokinetic studies': 1, 'Hydroxychloroquine is much less active than chloroquine against chloroquine-resistant Plasmodium falciparum, in agreement with its physicochemical properties': 1, 'A pilot study of hydroxychloroquine in treatment of patients with common coronavirus disease-19 (COVID-19)': 1, 'Viruses associated with acute respiratory infections and influenza-like illness among outpatients from the influenza incidence surveillance project': 1, 'Antibiotic prescribing for acute respiratory tract infections in primary care: a systematic review and meta-ethnography': 1, 'Viral infections in outpatients with medically attended acute respiratory illness during the 2012-2013 influenza season': 1, 'Interventions to improve antibiotic prescribing practices in ambulatory care': 1, 'Predictors of broad-spectrum antibiotic prescribing for acute respiratory tract infections in adult primary care': 1, 'Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians': 1, 'Effectiveness of physician-targeted interventions to improve antibiotic use for respiratory tract infections': 1, 'Evaluation of a webbased intervention to reduce antibiotic prescribing for LRTI in six European countries: quantitative process analysis of the GRACE/INTRO randomised controlled trial': 1, 'Educational interventions to improve prescription and dispensing of antibiotics: a systematic review': 1, 'Behavior change strategies to influence antimicrobial prescribing in acute care: a systematic review': 1, 'Diagnostic tests for agents of community-acquired pneumonia': 2, 'Molecular diagnostics for detection of bacterial and viral pathogens in community-acquired pneumonia': 1, 'Limited value of routine microbiological diagnostics in patients hospitalized for community-acquired pneumonia': 1, 'Bacterial complications of respiratory tract viral illness: a comprehensive evaluation': 1, 'Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults': 1, 'A multicenter analysis of the ED diagnosis of pneumonia': 1, 'Misdiagnosis of community-acquired pneumonia and inappropriate utilization of antibiotics: side effects of the 4-h antibiotic administration rule': 1, 'Antibiotic timing and errors in diagnosing pneumonia': 1, 'A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use': 1, 'Collateral damage\" from cephalosporin or quinolone antibiotic therapy': 1, 'Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes': 1, 'Can serum procalcitonin levels help interpret indeterminate chest radiographs in patients hospitalized with acute respiratory illness?': 1, 'Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial': 2, 'Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis': 1, 'Diagnostic efficacy and prognostic value of serum procalcitonin concentration in patients with suspected sepsis': 1, 'Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis': 2, 'High serum procalcitonin concentrations in patients with sepsis and infection': 1, 'Procalcitonin as a predictor of vesicoureteral reflux in children with a first febrile urinary tract infection': 1, 'Serum procalcitonin level and other biological markers to distinguish between bacterial and aseptic meningitis in children: a European multicenter case cohort study': 3, 'Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms': 1, 'Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in \"real life\": an international, multicenter poststudy survey (ProREAL)': 1, 'Procalcitonin as a biomarker in respiratory tract infection': 3, 'ProCalcitonin for triage of patients with respiratory tract symptoms: A case study in the trial design process for approval of a new diagnostic test for lower respiratory tract infections': 2, 'Influence of procalcitonin on decision to start antibiotic treatment in patients with a lower respiratory tract infection: insight from the observational multicentric ProREAL surveillance': 1, 'Serum procalcitonin measurement and viral testing to guide antibiotic use for respiratory infections in hospitalized adults: A randomized controlled trial': 3, 'Manual of Clinical Microbiology': 1, 'Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults': 1, 'Improved diagnosis of the etiology of community-acquired pneumonia with real-time polymerase chain reaction': 2, 'Impact of rapid diagnosis on management of adults hospitalized with influenza': 1, 'The use of antimicrobial agents after diagnosis of viral respiratory tract infections in hospitalized adults: antibiotics or anxiolytics?': 1, 'Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia': 1, 'Reliability of radiographic findings and the relation to etiologic agents in community-acquired pneumonia': 1, 'Patients admitted to hospital with suspected pneumonia and normal chest radiographs: epidemiology, microbiology, and outcomes': 1, 'Diagnostic value of microscopic examination of Gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia': 1, 'Quantitative PCR assay using sputum samples for rapid diagnosis of pneumococcal pneumonia in adult emergency department patients': 1, 'HAI transmission in the health care environment. Health Facil Manage': 1, 'A review of the CDC recommendations for prevention of HAIs in outpatient settings': 1, 'Severe Acute Respiratory Syndrome)': 1, 'Dynamic basic reproduction number based evaluation for current prevention and control of COVID-19 outbreak in China': 1, 'Epidemic trend of corona virus disease 2019 (COVID-19) in mainland China': 1, 'COVID-19) Situation Report -43': 2, 'Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2': 2, 'Single-cell RNA sequencing reveals distinct gene expression patterns in glucose metabolism of human preimplantation embryos': 1, 'Systems Biology-Based Investigation of Cellular Antiviral Drug Targets Identified by Gene-Trap Insertional Mutagenesis': 1, 'Drug Repurposing: New Treatments for Zika Virus Infection?': 1, 'Peptide-Protein Interaction Studies of Antimicrobial Peptides Targeting Middle East Respiratory Syndrome Coronavirus Spike Protein: An In Silico Approach': 1, 'TCGAbiolinks: An R/Bioconductor package for integrative analysis of TCGA data': 1, 'Portrait of Tissue-Specific Coexpression Networks of Noncoding RNAs (miRNA and lncRNA) and mRNAs in Normal Tissues': 1, 'The Gene Ontology Resource: 20 years and still GOing strong': 2, 'How interacting pathways are regulated by miRNAs in breast cancer subtypes': 1, 'Radiation-Induced Gene Expression Changes in High and Low Grade Breast Cancer Cell Types': 1, 'Controlling the false discovery rate: A practical and powerful approach to multiple testing': 3, 'SpidermiR: An R/Bioconductor Package for Integrative Analysis with miRNA Data': 1, 'In silico identification of drug target pathways in breast cancer subtypes using pathway cross-talk inhibition': 2, 'SuperTarget and Matador: resources for exploring drug-target relationships': 2, 'DGIdb 3.0: A redesign and expansion of the drug-gene interaction database': 2, 'Transcriptional responses to loss or gain of function of the leucine-rich repeat kinase 2 (LRRK2) gene uncover biological processes modulated by LRRK2 activity': 2, 'Microsomal epoxide hydrolase 1 (EPHX1): Gene, structure, function, and role in human disease': 2, 'Plasticity and virus specificity of the airway epithelial cell immune response during respiratory virus infection': 2, 'The major cellular sterol regulatory pathway is required for Andes virus infection': 1, 'Molecular requirement for sterols in herpes simplex virus entry and infectivity': 1, 'Aspartate is a limiting metabolite for cancer cell proliferation under hypoxia and in tumours': 1, 'The unfolded protein response in virus infections': 1, 'Role of cytoplasmic vacuoles in varicella-zoster virus glycoprotein trafficking and virion envelopment': 2, 'Serum paraoxonase and arylesterase activities in various forms of hepatitis B virus infection': 1, 'Adenosine dialdehyde: A potent inhibitor of vaccinia virus multiplication in mouse L929 cells': 1, 'ACSS2-mediated acetyl-CoA synthesis from acetate is necessary for human cytomegalovirus infection': 2, 'Protein and Amino Acid Metabolism': 1, 'Membrane Cholesterol Modulates Oligomeric Status and Peptide-Membrane Interaction of Severe Acute Respiratory Syndrome Coronavirus Fusion Peptide': 1, 'Effectiveness of Periodic Treatment of Quercetin against Influenza A Virus H1N1 through Modulation of Protein Expression': 1, 'Heat shock protein 70 modulates influenza A virus polymerase activity': 1, 'Upregulation of heat shock proteins (HSPA12A, HSP90B1, HSPA4, HSPA5 and HSPA6) in tumour tissues is associated with poor outcomes from HBV-related early-stage hepatocellular carcinoma': 1, 'The chaperone dynein LL1 mediates cytoplasmic transport of empty and mature hepatitis B virus capsids': 1, 'Novel role for integrin-linked kinase in modulation of coxsackievirus B3 replication and virus-induced cardiomyocyte injury': 1, 'Lymphomas driven by Epstein-Barr virus nuclear antigen-1 (EBNA1) are dependant upon Mdm2': 1, 'Dual inhibition of MDM2 and MDM4 in virus-positive Merkel cell carcinoma enhances the p53 response': 1, 'Seasonal allergic rhinitis: Fluticasone propionate and fluticasone furoate therapy evaluated': 1, 'Fluticasone propionate: A potent inhaled corticosteroid for the treatment of asthma': 1, 'Anti-inflammatory activity of thiabendazole and its relation to parasitic disease': 1, 'Trends and targets in antiviral phototherapy': 1, 'An update on its antiviral activity, pharmacokinetic properties and therapeutic efficacy in the management of HIV disease': 1, 'The interaction between geminivirus pathogenicity proteins and adenosine kinase leads to increased expression of primary cytokinin-responsive genes': 1, 'Chronic Blockade of the Androgen Receptor Abolishes Age-Dependent Increases in Blood Pressure in Female Growth-Restricted Rats': 1, \"Contribution of Nepal's free delivery care policies in improving utilisation of maternal health services\": 1, 'Assessment of facility and health worker readiness to provide quality antenatal, intrapartum and postpartum care in rural Southern Nepal': 1, 'Ministry of Health and Population. Nepal demographic and health survey 2016. Kathmandu, and Calverton, MA: Ministry of Health, Government of Nepal': 1, 'Effect of the COVID-19 pandemic response on intrapartum care, stillbirth, and neonatal mortality outcomes in Nepal: a prospective observational studyy': 2, 'Lockdown is officially eased, with private vehicles allowed on odd-even basis and shops to open': 1, 'A 200 percent increase in maternal mortality since the lockdown began': 1, 'Frequency and management of maternal infection in health facilities in 52 countries (GLOSS): a 1-week inception cohort study': 1, 'Chronic obstructive pulmonary disease: current burden and future projections': 1, 'Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease': 1, 'Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUP-PORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments)': 1, 'Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease': 1, 'Risk factors for hospital readmission in patients with chronic obstructive pulmonary disease. Respir': 1, 'Risk factors of readmission to hospital for a COPD exacerbation: a prospective study': 1, 'Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary': 3, 'Exacerbation phenotyping in chronic obstructive pulmonary disease': 1, 'Factors associated with a prolonged length of stay after acute exacerbation of chronic obstructive pulmonary disease (AECOPD)': 1, 'Evaluation of the COPD Assessment Test in patients with stable COPD': 1, 'Health status assessment in routine clinical practice: the chronic obstructive pulmonary disease assessment test score in outpatients. Respir: Int Rev Thoracic Dis': 1, 'Tests of the responsiveness of the COPD assessment test following acute exacerbation and pulmonary rehabilitation': 1, 'Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test to evaluate severity of COPD exacerbations': 1, 'Upper-respiratory viral infection, biomarkers, and COPD exacerbations': 1, 'Infection in the pathogenesis and course of chronic obstructive pulmonary disease': 1, 'Prevalence of viral infection detected by PCR and RT-PCR in patients with acute exacerbation of COPD: a systematic review': 2, 'Role of infection in chronic bronchitis': 1, 'Viral etiology of acute exacerbations of COPD in Hong Kong': 1, 'Viral pathogens in acute exacerbations of chronic obstructive pulmonary disease': 1, 'A communitybased, time-matched, case-control study of respiratory viruses and exacerbations of COPD': 1, 'Studying bacteria in respiratory specimens by using conventional and molecular microbiological approaches': 1, 'Spectrum and antimicrobial resistance of common pathogenic bacteria isolated from patients with acute exacerbation of chronic obstructive pulmonary disease in mainland of China': 1, 'Predictors of outcome after exacerbation of chronic obstructive pulmonary disease': 1, 'Acute exacerbation of chronic obstructive pulmonary disease: influence of social factors in determining length of hospital stay and readmission rates': 1, 'Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease': 1, 'Relationship between the GOLD combined COPD assessment staging system and bacterial isolation': 2, 'Detection of multiple viral and bacterial infections in acute exacerbation of chronic obstructive pulmonary disease: a pilot prospective study': 1, 'Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients': 2, 'Clinical course and mortality risk of severe COVID-19': 1, 'Correction to: Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China': 2, \"The pathogenesis and treatment of the `Cytokine Storm' in COVID-19\": 1, 'COVID-19 Illness in Native and Immunosuppressed States: A Clinical-Therapeutic Staging Proposal': 1, 'Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia': 2, 'Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients': 3, 'Tocilizumab treatment in COVID-19: A single center experience': 1, 'Tocilizumab, an anti-IL6 receptor antibody, to treat Covid-19-related respiratory failure: a case report': 1, 'First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab': 1, 'COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD': 1, 'Experiences of Leadership in Health Care in Sub-Saharan Africa': 1, 'Exploring the Structural Dynamics of Crohnic Poverty: A Sociological Approach': 1, 'Corruption, Growth, and Public Finance': 1, 'Corruption and Provision of Health Care and Education Services': 1, 'Corruption and Free-Election Chances of Incumbent Parties in Developing Countries': 1, 'An Equilibrium Queuing Model of Bribery': 1, 'Africa Transforms its Medical Education with Medical Education Partnership Initiative (MEPI)': 1, \"WHO's and the World Bank's African Region is headquartered in Brazzaville, Congo, and is divided into two: North Africa and Sub-Saharan Africa. UNICEF divides the continent into three regions: Eastern and Southern Africa\": 1, 'Bomb: The Inside Story of Mulago Hospital\\'s Troubles.\" www.co.ug/News/National/Time-bomb-the-insidestory-of-Mulago-hospital-s-troubles': 1, 'An Analysis of the Risk for Risk Factors for Coronary Heart Diseases in Patients Aged 55 and Younger with Proven Heart Disease': 1, 'The Global Burden of Disease Assessments-WHO is Responsible?': 1, 'World Medical Times: Poverty and Poor Health Care in Africa: To What Extent Are governments to Blame': 1, 'Updated research nosology for HIV-associated neurocognitive disorders': 1, 'Early brain changes in HIV infection: neuropathological study of 11 HIV seropositive, non-AIDS cases': 2, 'Central nervous system in pediatric AIDS. Results from Neuropathologic Pediatric AIDS Registry': 1, 'HIV-1-related central nervous system diseases': 1, 'The neuropathology of the acquired immune deficiency syndrome (AIDS). A review': 1, 'The changing pattern of HIV neuropathology in the HAART era': 1, 'Neuropathology and general autopsy findings in AIDS during the last 15 years': 1, 'Changing patterns in the neuropathogenesis of HIV during the HAART era': 1, 'Immune reconstitution inflammatory syndrome (IRIS): what pathologists should know': 1, 'IRIS: the unfortunate rainbow of HIV': 1, 'Neurologic consequences of the immune reconstitution inflammatory syndrome (IRIS)': 1, 'Mononuclear phagocyte immunity and the neuropathogenesis of HIV-1 infection': 1, 'Morphometry, histopathology, and tomography of cerebral atrophy in the acquired immunodeficiency syndrome': 2, 'Cerebral atrophy in AIDS: a stereological study': 1, 'Stereological analysis of cerebral atrophy in human immunodeficiency virus-associated dementia': 1, 'Macroscopic morphometry of human brains in neurodegeneration': 1, 'Loss of neurons in the frontal cortex in AIDS brains': 1, 'Neuronal damage in the cerebral cortex of AIDS brains: a morphometric study': 2, 'A review of neuronal damage in human immunodeficiency virus infection: its assessment, possible mechanism and relationship to dementia': 1, 'Degeneration of the cerebellar dentate nucleus and the inferior olivary nuclei in HIV-1-infected brains: a morphometric analysis': 1, 'Nigral degeneration in acquired immune deficiency syndrome (AIDS)': 1, 'Neuronal damage of the substantia nigra in HIV-1 infected brains': 1, 'Neocortical damage during HIV infection': 1, 'White matter changes in HIV-1 infected brains: a combined gross anatomical and ultrastructural morphometric investigation of the corpus callosum': 1, 'Morphometric comparisons of optic nerve axon loss in acquired immunodeficiency syndrome': 1, 'Astroglial changes in the cerebral cortex of AIDS brains: a morphometric and immunohistochemical investigation': 1, 'The involvement of the cerebral cortex in human immunodeficiency virus encephalopathy: a morphological and immunohistochemical study': 1, 'Fate of oligodendrocytes in HIV-1 infection': 1, 'Activation of microglia in HIV-1 infected brains is not dependent on the presence of HIV-1 antigens': 1, 'Vascular changes in the cerebral cortex in HIV-1 infection. II An immunohistochemical and lectinhistochemical investigation': 2, 'Vascular changes in the cerebral cortex in HIV-1 infection: I. A morphometric investigation by light and electron microscopy': 2, 'Capillaries in the human cerebral cortex: a quantitative electronmicroscopical study': 1, 'Mechanisms of HIV neuropathogenesis: role of cellular communication systems': 2, 'Neuropathogenesis of HIV: from initial neuroinvasion to HIV-associated neurocognitive disorder (HAND)': 1, 'Overview on the tricks of HIV tat to hit the blood brain barrier': 1, 'HIV-associated synaptic degeneration': 1, 'Viral and cellular factors underlying neuropathogenesis in HIV associated neurocognitive disorders (HAND)': 1, 'The meningeal lymphatic system: a route for HIV brain migration?': 1, 'HIV-1 induced CNS dysfunction: current overview and research priorities': 1, 'Neuropathogenesis of HIV-associated neurocognitive disorders: roles for immune activation, HIV blipping and viral tropism': 1, 'HIV-associated neurocognitive disorders: recent advances in pathogenesis, biomarkers, and treatment': 1, 'Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications': 1, 'Progressive multifocal leukoencephalopathy: why gray and white matter': 1, 'Family Flaviviridae': 4, 'The effect of bovine viral diarrhea virus infections on health and performance of feedlot cattle': 1, 'Quantification of economic losses consecutive to infection of a dairy herd with bovine viral diarrhea virus': 1, 'Economic impact of BVDV infection in dairies': 1, 'Pathogenicity of an Indian isolate of bovine viral diarrhea virus 1b in experimentally infected calves': 1, 'Thrombocytopenia in weaned beef calves': 1, 'Investigation of bovine viral diarrhea virus infections in a range beef cattle herd': 3, 'Isolation of cytopathic and noncytopathic bovine viral diarrhea virus from the spleen of cattle acutely and chronically affected with bovine viral diarrhea': 1, 'Prevalence of bovine viral diarrhea virus infection in US alpacas': 4, 'Segregation of bovine viral diarrhea virus into genotypes': 1, 'Comparative virulence of isolates of bovine viral diarrhea virus type II in experimentally inoculated six-to nine-month-old calves': 2, 'Virulence markers in the 5′ untranslated region of genotype 2 bovine viral diarrhea virus isolates': 2, 'Antiviral response by natural killer cells through TRAIL gene induction by IFN-alpha/beta': 1, 'Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6': 1, 'DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL': 1, 'IFN-α subtypes differentially affect human T cell motility': 1, 'Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon': 1, 'The role of Stat4 in species-specific regulation of Th cell development by type I IFNs': 1, 'Self\" and \"nonself\" manipulation of interferon defense during persistent infection: bovine diarrhea virus resists alpha/beta interferon without blocking antiviral activity against unrelated viruses replicating in its host cells': 2, 'Noncytopathic bovine viral diarrhea virus inhibits double-stranded RNA-induced apoptosis and interferon synthesis': 1, 'Evaluation of bovine viral diarrhea virus in New World camelids': 4, 'Bovine diarrhea virus in alpaca: abortion and persistent infection': 2, 'Bovine viral diarrhea virus infection of alpacas (Vicugna pacos) in the UK': 2, 'Isolation of bovine diarrhea virus from an alpaca': 2, 'Persistent infection with bovine viral diarrhea virus in an alpaca': 2, 'Modulation of PKR activity in cells infected by bovine viral diarrhea virus': 1, 'Characterization of the camel skin cell line Dubca': 2, 'Limited BVDV transmission and full protection against CSFV transmission in pigs experimentally infected with BVDV type 1b': 1, 'Comparison of type I and type II bovine viral diarrhea virus infection in swine': 2, 'Genotyping and phylogenetic analysis of bovine viral diarrhea virus isolates from BVDV infected alpacas in North America': 1, 'Recent avian H5N1 viruses exhibit increased propensity for acquiring human receptor specificity': 1, 'Mechanisms of zoonotic severe acute respiratory syndrome coronavirus host range expansion in human airway epithelium': 1, 'The amino-terminal domain of bovine viral diarrhea virus Npro protein is necessary for alpha/beta interferon antagonism': 7, 'Cloning and expression of interferon alpha/gamma from a domestic porcine breed and its effect on classical swine fever virus': 1, 'Identification of a cell population that produces alpha/beta interferon in vitro and in vivo in response to noncytopathic bovine viral diarrhea virus': 1, 'RNasedependent inhibition of extracellular, but not intracellular, dsRNA-induced interferon synthesis by E rns of pestiviruses': 1, 'Foot and mouth disease in camelids: a review': 1, 'Alteration of leukocyte populations in calves concurrently infected with bovine respiratory syncytial virus and bovine viral diarrhea virus': 2, 'Inhibition of beta interferon transcription by noncytopathic bovine viral diarrhea virus is through an interferon regulatory factor 3 dependent mechanism': 1, 'Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hos': 1, 'Large-vessel stroke as a presenting feature of covid-19 in the young': 1, 'Disorders of Organic acids': 2, 'Neurological diseases in disorders of organic acids': 2, 'Malonic aciduria': 3, 'Quantitative analysis for organic acids in biological samples : Batch isolation followed by gas chromatographic-mass spectrometric analysis': 1, 'Automatic recording apparatus for use in the chromatography of amino acids': 1, 'Measurement of carnitine and 0-acylcarnitines': 1, 'Inherited selective intestinal cobalamin malabsorption and cobalamin deficiency in dogs': 1, 'Organic acidurias : A review . Part 1': 2, 'Organic acidurias : A review . Part 2': 2, 'Malonyl coenzyme A decarboxylase deficiency': 3, 'Incomplete development of the brain in a newborn with methylmalonic aciduria': 1, 'Diminished concentration of ganglioside N-acetylneuraminic acid (G-NeuAc) in cerebellum of young rats receiving chronic administration of methylmalonic acid': 1, 'Principles and practice of infectious disease': 1, 'Pharyngitis, sinusitis, otitis, and other upper respiratory tract infectiions': 1, 'Prevention and control of influenza with: recommendations of the Advisory Committee on Immunization Practices (ACIP)': 1, 'Dietary supplement users: demographics, product use, and medical system interaction': 2, 'Echinacea purpurea therapy for the treatment of the common cold: a randomized, double-blind, placebo-controlled clinical trial': 3, 'Protective effect of fermented red ginseng on a transient focal ischemic rats': 2, 'Efficacy and safety of the standardised Ginseng extract G115 for potentiating vaccination against the influenza syndrome and protection against the common cold': 2, 'Anticarcinogenic effect of Panax ginseng C.A. Meyer and identification of active compounds': 1, 'Ginseng treatment reduces bacterial load and lung pathology in chronic Pseudomonas aeruginosa pneumonia in rats': 1, 'A placebo-controlled trial of a proprietary extract of North American ginseng (CVT-E002) to prevent acute respiratory illness in institutionalized older adults': 2, 'Efficacy of an extract of North American ginseng containing poly-furanosyl-pyranosylsaccharides for preventing upper respiratory tract infections: a randomized controlled trial': 3, 'Efficacy of COLD-fX in the prevention of respiratory symptoms in community-dwelling adults: a randomized, double-blinded, placebo controlled trial': 1, 'Effects of oral administration of Korean red ginseng on influenza A (H1N1) virus infection': 2, 'Ginseng and Salviae herbs play a role as immune activators and modulate immune responses during influenza virus infection': 2, 'Immunomodulating activity of CVT-E002, a proprietary extract from North American ginseng (Panax quinquefolium)': 2, 'Double-blind study of a multivitamin complex supplemented with ginseng extract': 1, 'Ginseng total saponin improves podocyte hyperpermeability induced by high glucose and advanced glycosylation endproducts': 1, 'Panax ginseng as a potential immunomodulator: studies in mice': 1, 'Effect of subcutaneous injection of ginseng on cows with subclinical Staphylococcus aureus mastitis': 1, 'Effects of ginseng root saponins and ginsenoside Rb1 on immunity in cold water swim stress mice and rats. Zhongguo Yao Li Xue Bao': 1, 'Effects of Red Ginseng extract on allergic reactions to food in Balb/c mice': 1, 'Immune system effects of echinacea, ginseng, and astragalus: a review': 1, 'Antioxidant and anti-tumor promoting activities of the methanol extract of heat-processed ginseng': 1, 'Epub 2020/03/18': 10, 'Conformational states of the severe acute respiratory syndrome coronavirus spike protein ectodomain': 1, 'Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins': 2, 'Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate Fc␥RII-dependent entry into B cells in vitro': 2, 'Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH-and cysteine protease-independent Fc␥R pathway': 3, 'Monoclonal antibody analysis of neutralization and antibody-dependent enhancement of feline infectious peritonitis virus': 3, 'Antibody-dependent enhancement of feline infectious peritonitis virus infection in feline alveolar macrophages and human monocyte cell line U937 by serum of cats experimentally or naturally infected with feline coronavirus': 2, 'A conformation-dependent neutralizing monoclonal antibody specifically targeting receptor-binding domain in Middle East respiratory syndrome coronavirus spike protein': 4, 'Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies': 1, 'Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein': 1, 'Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains': 1, 'Lysosomal proteases are a determinant of coronavirus tropism': 2, 'Extensive complement-dependent enhancement of HIV-1 by autologous non-neutralising antibodies at early stages of infection': 1, 'Traitors of the immune systemenhancing antibodies in HIV infection: their possible implication in HIV vaccine development': 1, 'Antibodydependent enhancement of Ebola virus infection': 1, 'Neutralizing antibodies after infection with dengue 1 virus': 1, 'Crossreacting antibodies enhance dengue virus infection in humans': 1, 'Antibody-dependent enhancement of severe dengue disease in humans': 2, 'Prospects for a dengue virus vaccine': 1, 'A human protein atlas for normal and cancer tissues based on antibody proteomics': 1, 'Single-dose treatment with a humanized neutralizing antibody affords full protection of a human transgenic mouse model from lethal Middle East respiratory syndrome (MERS)-coronavirus infection': 1, 'Identification of an ADAM17 cleavage region in human CD16 (FcgammaRIII) and the engineering of a non-cleavable version of the receptor in NK cells': 1, 'Expression of a recombinant high affinity IgG Fc receptor by engineered NK cells as a docking platform for therapeutic mAbs to target cancer cells': 1, 'A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motifbearing FcgammaRIIb alters receptor expression and associates with autoimmunity. II. Differential binding of GATA4 and Yin-Yang1 transcription factors and correlated receptor expression and function': 1, 'Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines': 1, 'Cryo-electron microscopy structure of porcine deltacoronavirus spike protein in the prefusion state': 1, 'Receptor usage and cell entry of porcine epidemic diarrhea coronavirus': 1, 'Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus': 1, 'Cell entry of porcine epidemic diarrhea coronavirus is activated by lysosomal proteases': 1, 'Bench-to-bedside review: Rhabdomyolysis-an overview for clinicians': 1, 'A risk prediction score for kidney failure or mortality in rhabdomyolysis': 1, 'Human coronavirus NL-63 infection in a Brazilian patient suspected of H1N1 2009 influenza infection: description of a fatal case': 1, 'Rhabdomyolysis associated with acute renal failure in patients with severe acute respiratory syndrome': 1, 'Highsensitivity assays for troponin in patients with cardiac disease': 1, 'Prevention of acute renal failure in traumatic rhabdomyolysis': 1, 'Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: Interim guidance V 1': 1, 'Case 17-2020: A 68-Year-Old Man with Covid-19 and Acute Kidney Injury': 1, 'Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis': 1, 'Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges': 3, 'Kidney disease is associated with in-hospital death of patients with COVID-19': 1, 'ACE2 expression in kidney and testis may cause kidney and testis damage after 2019-nCoV infection. medRxiv': 1, 'Multiorgan and Renal Tropism of SARS-CoV-2': 1, 'Novel Coronavirus can be detected in urine, blood, anal swabs and oropharyngeal swabs samples. medRxiv': 1, 'Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study': 2, 'Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin': 1, 'Cardiac Involvement in a Patient With Coronavirus Disease': 1, 'Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants': 4, 'Animal models and vaccines for SARS-CoV infection': 2, 'Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus': 2, 'Severe acute respiratory syndrome vaccine efficacy in ferrets: whole killed virus and adenovirus-vectored vaccines': 3, 'Immunogenicity, safety, and protective efficacy of an inactivated SARS-associated coronavirus vaccine in rhesus monkeys': 1, 'Safety and immunogenicity from a phase I trial of inactivated severe acute respiratory syndrome coronavirus vaccine': 1, 'Development of subunit vaccines against severe acute respiratory syndrome': 1, 'Vaccine design for severe acute respiratory syndrome coronavirus': 1, 'A chimeric multi-epitope DNA vaccine elicited specific antibody response against severe acute respiratory syndrome-associated coronavirus which attenuated the virulence of SARS-CoV in vitro': 1, 'Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS': 1, 'Induction of neutralising antibodies and cellular immune responses against SARS coronavirus by recombinant measles viruses': 1, 'Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogens': 1, 'SARS vaccine based on a replication-defective recombinant vesicular stomatitis virus is more potent than one based on a replicationcompetent vector': 1, 'Characterization of an efficient coronavirus ribosomal frameshifting signal: requirement for an RNA pseudoknot': 1, 'The coronavirus replicase': 1, 'The intracellular sites of early replication and budding of SARS-coronavirus': 2, 'Severe acute respiratory syndrome coronavirus 3a protein is a viral structural protein': 1, 'Severe acute respiratory syndrome coronavirus 7a accessory protein is a viral structural protein': 2, 'Severe acute respiratory syndrome coronavirus accessory protein 6 is a virion-associated protein and is released from 6 protein-expressing cells': 1, 'The severe acute respiratory syndrome coronavirus 3a is a novel structural protein': 1, 'The ORF7b protein of SARS-CoV is expressed in virus-infected cells and incorporated into SARS-CoV particles': 2, ') 7a protein of severe acute respiratory syndrome coronavirus inhibits cellular protein synthesis and activates p38 mitogen-activated protein kinase': 1, 'Severe acute respiratory syndrome coronavirus protein 6 accelerates murine hepatitis virus infections by more than one mechanism': 1, 'Angiotensin-converting enzyme 2 is a functional receptor for de SARS coronavirus': 1, 'Animal coronavirus vaccines: lessons for SARS': 2, 'Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus': 2, 'Development of protection against coronavirus induced diseases. A Review': 1, 'Identification of essential genes as a strategy to select a SARS candidate vaccine using a SARS-CoV infectious cDNA': 1, 'Engineering infectious cDNA of coronavirus as bacterial artificial chromosomes': 1, 'Engineering the largest RNA virus genome as an infectious bacterial artificial chromosome': 8, 'A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo': 8, 'Stabilization of a fulllength infectious cDNA clone of transmissible gastroenteritis coronavirus by insertion of an intron': 1, 'Strategy for systematic assembly of large RNA and DNA genomes: the transmissible gastroenteritis virus model': 1, 'Infectious RNA transcribed in vitro from a cDNA copy of the human coronavirus genome cloned in vaccinia virus': 2, 'Reverse genetics system for the avian coronavirus infectious bronchitis virus': 1, 'Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic mice': 7, 'A live attenuated SARS coronavirus is immunogenic and efficacious in golden Syrian hamsters': 6, 'Immunization with an attenuated severe acute respiratory syndrome coronavirus deleted in E protein protects against lethal respiratory disease': 7, 'SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium': 1, 'Antibody responses to individual proteins of SARS coronavirus and their neutralization activities': 1, 'Severe acute respiratory syndrome-associated coronavirus 3a protein forms an ion channel and modulates virus release': 7, 'The small envelope protein E is not essential for murine coronavirus replication': 1, 'Heterologous gene expression from transmissible gastroenteritis virus replicon particles': 1, 'Generation of a replication-competent, propagation-deficient virus vector based on the transmissible gastroenteritis coronavirus genome': 1, 'Therapy with a severe acute respiratory syndromeassociated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters': 2, 'Initial viral load and the outcomes of SARS': 1, 'Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human Angiotensin-converting enzyme 2 virus receptor': 1, 'Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice': 1, 'Participation of both host and virus factors in induction of severe acute respiratory syndrome (SARS) in F344 rats infected with SARS coronavirus': 1, 'Modulation of host stress and immune responses by severe acute respiratory syndrome coronavirus envelope E protein': 1, 'Initiation of the Immune Response by Extracellular Hsp72: Chaperokine Activity of Hsp72': 1, 'Heat-shock protein 90 associates with N-terminal extended peptides and is required for direct and indirect antigen presentation': 1, 'Stress proteins and the immune response': 1, 'Role of heat shock proteins in protection from and pathogenesis of infectious diseases': 2, 'High fidelity of murine hepatitis virus replication is decreased in nsp14 exoribonuclease mutants': 1, 'Construction of a SARS-CoV infectious cDNA clone and a replicon to study coronavirus RNA synthesis': 1, 'Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane': 1, 'The envelope protein of severe acute respiratory syndrome coronavirus interacts with the nonstructural protein 3 and is ubiquitinated': 1, 'Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication': 1, 'Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines': 2, 'Mutagenesis of the murine hepatitis virus nsp1-coding region identifies residues important for protein processing, viral RNA synthesis, and viral replication': 2, 'Rapid identification of coronavirus replicase inhibitors using a selectable replicon RNA': 1, 'Murine coronaviruses encoding nsp2 at different genomic loci have altered replication, protein expression, and localization': 2, 'Pathology and pathogenesis of severe acute respiratory syndrome': 1, 'Augmentation of chemokine production by severe acute respiratory syndrome coronavirus 3a/X1 and 7a/X4 proteins through NF-kappaB activation': 1, 'Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells': 1, 'SARS coronavirus accessory proteins': 1, 'Rewiring the severe acute respiratory syndrome coronavirus (SARS-CoV) transcription circuit: engineering a recombinationresistant genome': 2, 'The relationship between the occurrence of undifferentiated bovine respiratory disease and titer changes to bovine coronavirus and bovine viral diarrhea virus in 3 Ontario feedlots': 1, 'Disseminated intravascular coagulation in experimentally induced feline infectious peritonitis': 1, 'Antibody-dependent enhancement of viral infectivity': 1, 'Antibody-mediated enhancement of disease in feline infectious peritonitis: comparisons with dengue hemorrhagic fever': 1, 'Localization of antigenic sites of the S glycoprotein of feline infectious peritonitis virus involved in neutralization and antibody-dependent enhancement': 1, 'Identification of antigenic sites mediating antibody-dependent enhancement of feline infectious peritonitis virus infectivity': 1, 'B-cell responses in patients who have recovered from severe acute respiratory syndrome target a dominant site in the S2 domain of the surface spike glycoprotein': 1, 'Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease': 2, 'SARS virus infection of cats and ferrets': 1, 'Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein': 1, 'Immunogenicity and protective efficacy in monkeys of purified inactivated Vero-cell SARS vaccine': 1, 'Generation of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein of respiratory syncytial virus': 1, 'Immunization of macaques with formalin-inactivated respiratory syncytial virus (RSV) induces interleukin-13-associated hypersensitivity to subsequent RSV infection': 1, 'Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine': 1, 'Coronavirus maintain viability despite dramatic rearrangements of the strictly conserved genome organization': 1, 'Reduction of the rate of poliovirus protein synthesis through large-scale codon deoptimization causes attenuation of viral virulence by lowering specific infectivity': 2, 'Codon bias and heterologous protein expression': 2, 'Tissue-specific codon usage and the expression of human genes': 1, 'Vaccines for severe acute respiratory syndrome virus and other coronaviruses': 1, 'Coronavirus reverse genetics and development of vectors for gene expression': 1, 'Temporal upregulation of host surface receptors provides a window of opportunity for bacterial adhesion and disease': 1, 'Cardiovascular disease and COVID-19: Australian/New Zealand consensus statement': 1, 'Coronavirus disease 2019 (COVID-19) infection and renin angiotensin system blockers': 1, 'World Health Organization. Coronavirus disease (COVID-2019) situation report-119': 2, 'Clinical characteristics and results of semen tests among men with coronavirus disease 2019': 1, 'SARS-CoV-2 isolation from ocular secretions of a patient with COVID-19 in Italy with prolonged viral RNA detection': 1, 'Potential impact of contaminated bronchoscopes on novel coronavirus disease (COVID-19) patients': 2, 'Aerosolgenerating procedures and risk of transmission of acute respiratory infections: a systematic review. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health': 2, 'The Republic of Turkey Ministry of Health Covid-19 Science Committee Guideline': 1, 'Bronchoscope-associated clusters of multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Klebsiella pneumoniae': 1, 'Interim infection prevention and control recommendations for patients with suspected or confirmed coronavirus disease (COVID-19) in healthcare settings': 1, 'Bronchoscopy in the age of COVID-19': 1, 'Variation in false-negative rate of reverse transcriptase polymerase chain reaction-based SARS-CoV-2 tests by time since exposure': 1, 'American Association for Bronchology and Interventional Pulmonology (AABIP) statement on the use of bronchoscopy and respiratory specimen collection in patients with suspected or confirmed COVID-19 infection': 1, 'Performing bronchoscopy in times of the COVID-19 pandemic: practice statement from an international expert panel': 1, 'The use of bronchoscopy during the COVID-19 pandemic: CHEST/AABIP guideline and expert panel report': 1, 'Summarizing societal guidelines regarding bronchoscopy during the COVID-19 pandemic': 1, 'Safe performance of diagnostic bronchoscopy/EBUS during the SARS-CoV-2 pandemic': 1, 'Clinical and organizational factors in the initial evaluation of patients with lung cancer: Diagnosis and management of lung cancer': 1, 'Quality gaps and comparative effectiveness in lung cancer staging and diagnosis': 1, 'The evolution and expansion of regional disease surveillance networks and their role in mitigating the threat of infectious disease outbreaks': 2, 'Doenças transmissíveis na Faixa de Fronteira Amazônica: o caso da malária': 2, 'Border Infectious Disease Surveillance project: establishing bi-national border surveillance': 2, 'Quantifying cross-border movements and migrations for guiding the strategic planning of malaria control and elimination': 1, 'A population-based study of first and second-line drug-resistant tuberculosis in a high-burden area of the Mexico/United States border': 1, 'Delays in the diagnosis of tuberculosis in a town at the triple border of Brazil, Paraguay, and Argentina': 1, 'Emergências em saúde pública de importância nacional e internacional no brasil': 1, 'Local cross-border disease surveillance and control: experiences from the Mekong Basin': 1, 'Condiciones de vida, situación de la salud y disponibilidad de servicios de salud en La frontera de Brasil: un enfoque geográfico': 1, 'The La Paz Agreement 30 years on': 1, 'United States-Mexico Border Health Commission. Border region': 1, 'Surveillance and control of Aedes albopictus in the Swiss-Italian border region: differences in egg densities between intervention and non-intervention areas': 1, 'Avaliação da vigilância epidemiológica ampliada do rotavírus. Rev Bras Promoç Saúde': 3, 'Multinational disease surveillance programs: promoting global information exchange for infectious diseases': 1, 'Technique for the measurement of attitudes': 1, 'Likert-type scale response anchors': 1, 'Likert scales and data analyses. Qual Prog': 1, 'Technical guidelines for United States-Mexico coordination on public health events of mutual interest': 2, \"Health at the borders: Bayesian multilevel analysis of women's malnutrition determinants in Ethiopia\": 1, 'Epidemiological aspects of pulmonar tuberculosis in Mato Grosso do Sul': 1, 'Acute viral hepatitis in the United States-Mexico border region: data from the Border Infectious Disease Surveillance (BIDS) Project': 1, 'Gabinete do Ministro. Portaria nº 2.761, de 18 de novembro de 2008. Aprova a Resolução GMC nº 22': 1, 'Laboratory support during and after the Ebola virus endgame: towards a sustained laboratory infrastructure': 1, 'Active monitoring of travelers arriving from Ebola-affected countries': 1, 'Magnitude das doenças de notificação compulsória e avaliação dos indicadores de vigilância epidemiológica em municípios da linha de fronteira do Brasil': 1, 'Montevidéo: MERCOSUR': 1, 'A new paradigm for quarantine and public health activities at land borders: opportunities and challenges': 1, 'Airport sentinel surveillance and entry quarantine for dengue infections following a fever screening program in Taiwan': 5, 'Border Screening for SARS. Emerg Infect Dis': 3, 'Entry screening for severe acute respiratory syndrome (SARS) or influenza: policy evaluation': 3, 'Entry screening to delay local transmission of 2009 pandemic influenza A (H1N1)': 3, 'Epidemiological trends and the effect of airport fever screening on prevention of domestic dengue fever outbreaks in Taiwan': 3, 'International travels and fever screening during epidemics: a literature review on the effectiveness and potential use of non-contact infrared thermometers': 3, 'Investigation of febrile passengers detected by infrared thermal scanning at an international airport': 3, 'Travel medicine and mHealth technology: a study using smartphones to collect health data during travel': 3, 'The quantified self during travel: mapping health in a prospective cohort of travellers': 3, 'Early detection of Zika virus infection among travellers from areas of ongoing transmission in China: Table 1': 1, 'The pathways for Bovine Virus Diarrhoea virus biotypes in the pathogenesis of disease': 1, 'Proteins encoded by bovine viral diarrhea virus: the genomic organization of a pestivirus': 1, 'The clinical manifestations of bovine viral diarrhoea infection': 1, 'Foetal cross-protection experiments between type 1 and type 2 Bovine Viral Diarrhoea virus in pregnant ewes': 1, 'Selection and use of laboratory diagnostic assays in BVD control programmes': 1, 'Real-time PCR for simultaneous detection and genotyping of Bovine Viral Diarrhoea virus': 2, 'Housekeeping genes as internal standards: use and limits': 2, 'A method for the absolute quantification of cDNA using real-time PCR': 1, 'Experimental inoculation of calves with laboratory strains of Bovine Viral Diarrhea Virus': 1, 'DNA vaccination against Bovine Viral Diarrhoea virus induces humoral and cellular responses in cattle with evidence for protection against viral challenge': 1, 'A new mathematical model for relative quantification in real-time RT-PCR': 1, 'Quantitation of viral load using real-time amplification techniques': 2, 'Detection of yellow fever virus: a comparison of quantitative real-time PCR and plaque assay': 4, 'Control of inflammation, cytokine expression and germinal center formation by BCL-6': 1, 'Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assay': 1, 'Accurate normalisation of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes': 1, 'Quantitative analysis of tyrosinase transcripts in blood': 1, 'Pocket Companion to Veterinary Medicine': 1, 'Use of Bovine Viral Diarrhoea virus as an internal control for amplification of Hepatitis C Virus': 1, 'TaqMan amplification system with an internal positive control for HCV RNA quantitation': 1, 'From containment to mitigation of COVID-19 in the US': 1, 'High SARS-CoV-2 antibody prevalence among healthcare workers exposed to COVID-19 patients': 2, 'Retracted: Clinical and epidemiological characteristics of 34 children with 2019 novel coronavirus infection in Shenzhen': 1, 'Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus': 1, 'The novel coronavirus (2019-nCoV) outbreak: think the unthinkable and be prepared to face the challenge. Diagnosis (Berl)': 1, 'Epidemiology of human infections with avian influenza A(H7N9) virus in China': 3, 'Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: a population-based study of laboratory-confirmed cases': 3, \"Detection of mild to moderate influenza A/H7N9 infection by China's national sentinel surveillance system for influenza-like illness: case series\": 2, 'LIve poultry markets permanently closed in 11 cities of Zhejiang province (Chinese)': 2, 'Permanent LPM closure in Jingan district and LPMs in other districts in Shanghai will reopen next month (Chinese': 2, 'Rural villagers and urban residents exposure to poultry in China': 2, 'Human exposure to live poultry and psychological and behavioral responses to influenza A(H7N9), China. Emerg Infect Dis': 4, 'Community psychological and behavioral responses through the first wave of the 2009 influenza A(H1N1) pandemic in Hong Kong': 1, 'Longitudinal assessment of community psychobehavioral responses during and after the 2003 outbreak of severe acute respiratory syndrome in Hong Kong': 1, 'Live-animal markets and influenza A (H7N9) virus infection': 1, 'Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome': 1, 'Effect of closure of live poultry markets on poultry-to-person transmission of avian influenza A H7N9 virus: an ecological study': 1, 'The patient activity scale-II is a generic indicator of active disease in patients with rheumatic disorders': 1, 'Potential shortages of hydroxychloroquine for patients with lupus during the coronavirus disease': 1, 'Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: A scoping review': 2, 'COVID-19 outbreak and its monetary implications for dental practices, hospitals and healthcare workers': 2, 'COVID-19 transmission in dental practice: Brief review of preventive measures in Italy': 3, 'Response to the Letter to the Editor: How to deal with suspended oral treatment during the COVID-19 epidemic': 3, 'Transmission routes of 2019-nCoV and controls in dental practice': 2, 'COVID-19 Outbreak: An overview on dentistry': 1, 'Cross-transmission in the dental office: Does this make you ill? Current Oral Health Reports': 2, 'Guidelines for infection control in dental health-care settings-2003': 3, 'A scoping review on bio-aerosols in healthcare and the dental environment': 2, '2007 guideline for isolation precautions: Preventing transmission of infectious agents in health care settings': 1, 'The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: Estimation and application': 1, 'A family cluster of SARS-CoV-2 infection involving 11 patients in Nanjing, China. The Lancet Infectious Diseases': 1, 'A familial cluster of infection associated with the 2019 novel coronavirus indicating possible person-to-person transmission during the incubation period': 1, 'A confirmed asymptomatic carrier of 2019 novel coronavirus (SARS-CoV-2)': 2, 'Asymptomatic cases in a family cluster with SARS-CoV-2 infection. The Lancet Infectious Diseases': 1, 'Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths': 1, 'Estimates of the severity of coronavirus disease 2019: A model-based analysis. The Lancet Infectious Diseases': 3, 'The many estimates of the COVID-19 case fatality rate. The Lancet Infectious Diseases': 1, 'SARS-CoV-2 infection in 86 healthcare workers in two Dutch hospitals in': 1, 'Duration of viral detection in throat and rectum of a patient with COVID-19': 1, 'Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) From a symptomatic patient': 2, 'Airborne spread of expiratory droplet nuclei between the occupants of indoor environments: A review': 1, 'Exposure to influenza virus aerosols during routine patient care': 3, 'Aerosol transmission of infectious disease': 1, 'Towards aerodynamically equivalent COVID19 1.5 m social distancing for walking and running': 1, 'Dental aerosols: Microbial composition and spatial distribution': 1, 'Microbial aerosols in general dental practice': 2, 'Influenza virus aerosols in the air and their infectiousness': 2, 'Emerging infections -implications for dental care': 1, 'Maintaining dental education and specialist dental care during an outbreak of a new coronavirus infection. Part 2: Control of the disease, then elimination': 1, 'Coronavirus Disease 2019 (COVID-19): Emerging and future challenges for dental and oral medicine': 3, 'Letter to the Editor: How to deal with suspended oral treatment during the COVID-19 epidemic': 1, 'Coronavirus disease 19 (COVID-19): Implications for clinical dental care': 2, 'COVID-19 considerations in dental care': 1, 'Coronavirus disease (COVID-19): Characteristics in children and considerations for dentists providing their care': 1, 'Guidelines for dental care provision during the COVID-19 pandemic': 1, 'Adoption of COVID-19 triage strategies for low-income settings': 1, 'COVID-19: Its impact on dental schools in Italy, clinical problems in endodontic therapy and general considerations': 1, 'Human saliva: Non-invasive fluid for detecting novel coronavirus (2019-nCoV)': 1, 'Hand hygiene and the novel coronavirus pandemic: The role of healthcare workers': 1, 'Hand-hygiene mitigation strategies against global disease spreading through the air transportation network': 1, 'Risk factors of healthcare workers with corona virus disease 2019: A retrospective cohort study in a designated hospital of Wuhan in China': 1, 'Hand hygiene and face touching in family medicine offices: A Cincinnati Area Research and Improvement Group (CARInG) network study': 1, 'Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents': 2, 'Inactivation of severe acute respiratory syndrome coronavirus 2 by WHO-recommended hand rub formulations and alcohols': 1, 'COVID-19-associated shortage of alcohol-based hand rubs, face masks, medical gloves and gowns; proposal for a risk-adapted approach to ensure patient and healthcare worker safety': 3, 'Development of ventilation design strategy for effective removal of pollutant in the isolation room of a hospital': 1, 'COVID-19 outbreak associated with air conditioning in Restaurant': 1, 'Behavioral interventions to improve infection control practices': 1, 'The efficacy of the rubber dam as a barrier to the spread of microorganisms during dental treatment': 1, 'Maintenance of the aseptic working field during endodontic treatment': 2, 'The efficacy of rubber dam isolation in reducing atmospheric bacterial contamination': 1, 'Evaluation of the spatter-reduction effectiveness of two dry-field isolation techniques': 1, 'Aerosol and splatter contamination from the operative site during ultrasonic scaling': 2, 'A study to evaluate and compare the efficacy of preprocedural mouthrinsing and high volume evacuator attachment alone and in combination in reducing the amount of viable aerosols produced during ultrasonic scaling procedure': 1, 'Role of preprocedural rinse and high volume evacuator in reducing bacterial contamination in bioaerosols': 1, 'Importance of oral and nasal decontamination for patients undergoing anesthetics during the COVID-19 era': 1, 'Efficacy of preprocedural mouthrinses in the reduction of microorganisms in aerosol: A systematic review': 1, 'The effectiveness of respiratory protection worn by communities to protect from volcanic ash inhalation. Part II: Total inward leakage tests': 1, 'Effectiveness of N95 respirators versus surgical masks against influenza: A systematic review and meta-analysis': 1, 'Detection of infectious influenza virus in cough aerosols generated in a simulated patient examination room': 1, 'Efficacy of face shields against cough aerosol droplets from a cough simulator': 1, 'International Long Term Care Policy Network. Mortality associated with COVID-19 outbreaks in care homes: Early international evidence': 1, 'Stability of preferences regarding life-sustaining treatment: A two-year prospective study of nursing home residents': 1, 'Advance care planning in dementia: Recommendations for healthcare professionals': 1, 'A review of the implementation and research strategies of advance care planning in nursing homes': 1, 'Overall mortality and causes of death in newly admitted nursing home residents': 1, 'Laboratory and clinical aspects of human herpesvirus 6 infections': 2, 'Update on human herpesvirus 6 biology, clinical features, and therapy': 3, 'Human herpesviruses 6 and 7 and central nervous system infection in children': 6, 'Clinical impact of primary infection with roseoloviruses': 1, 'Review part 3: human herpesvirus-6 in multiple non-neurological diseases': 2, 'Congenital infections with human herpesvirus 6 (HHV6) and human herpesvirus 7 (HHV7)': 2, 'Transplacental human herpesvirus 6 (HHV-6) congenital infection caused by maternal chromosomally integrated virus': 2, 'Sequence analysis of transplacentally acquired human herpesvirus 6 DNA is consistent with transmission of a chromosomally integrated reactivated virus': 5, 'Human herpesvirus-6 infection in children: a prospective study of complications and reactivation': 2, 'HHV-6 infection during pregnancy and spontaneous abortion': 1, 'Viral infection in hydrops fetalis, spontaneous abortion and unexplained fetal death in utero': 1, 'Detection of HHV-6 in over a thousand samples: new types of infection revealed by an analysis of positive results': 2, 'Chromosomal integration of human herpesvirus 6 is the major mode of congenital human herpesvirus 6 infection': 5, 'Serological evidence for congenital transmission of human herpesvirus 6': 3, 'Examination of human breast milk for evidence of human herpesvirus 6 by polymerase chain reaction': 1, 'Human herpesvirus 6 and neuroinflammation': 1, 'Association of human herpesvirus 6 infection of the central nervous system with recurrence of febrile convulsions': 1, 'Human herpesvirus 6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients: does it have clinical significance?': 1, 'Potential clinical impact of the film array meningitis encephalitis panel in children with suspected central nervous system infections': 1, 'Early developmental outcomes of children with congenital HHV-6 infection': 2, 'Evidence of human herpesvirus-6 and -7 reactivation in miscarrying women with pityriasis rosea': 1, 'Waning immunity against mumps in vaccinated young adults': 1, 'Effectiveness of a Third Dose of MMR Vaccine for Mumps Outbreak Control': 1, 'Zika Virus (I). Isolations and serological specificity': 1, 'Zika virus outbreak on Yap Island, Federated States of Micronesia': 1, 'Zika virus, French polynesia, South pacific': 1, 'Zika virus and birth defects-Reviewing the evidence for causality': 1, 'Quantitative real-time PCR detection of Zika virus and evaluation with field-caught Mosquitoes': 1, 'Association between Zika virus and microcephaly in French Polynesia': 1, 'Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: A case-control study': 1, 'Virus Vaccine Development: Progress in the Face of New Challenges': 1, 'Vaccinia virus vaccines: Past, present and future': 1, 'A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS,S/AS02A and MVA-CS': 1, 'Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1': 1, 'Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02)': 1, 'Phase I safety and immunogenicity evaluation of MVA-CMDR, a multigenic, recombinant modified vaccinia Ankara-HIV-1 vaccine candidate': 1, 'Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors': 7, 'Differences in Virus-Induced Cell Morphology and in Virus Maturation between MVA and Other Strains (WR, Ankara, and NYCBH) of Vaccinia Virus in Infected Human Cells': 1, 'Available online: www': 2, 'A Vaccine Based on a Modified Vaccinia Virus Ankara Vector Expressing Zika Virus Structural Proteins Controls Zika Virus Replication in Mice': 2, 'A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a': 1, 'Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses': 1, 'A Single Immunization with MVA Expressing GnGc Glycoproteins Promotes Epitope-specific CD8+-T Cell Activation and Protects Immune-competent Mice against a Lethal RVFV Infection': 3, 'ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice': 1, 'Optimization of Zika virus envelope protein production for ELISA and correlation of antibody titers with virus neutralization in Mexican patients from an arbovirus endemic region': 2, 'Vaccine protection against Zika virus from Brazil': 2, 'Formation of parallel four-stranded complexes by guanine-rich motifs in DNA and its implications for meiosis': 1, 'Human telomere, oncogenic promoter and 5 0 -UTR G-quadruplexes: diverse higher order DNA and RNA targets for cancer therapeutics': 1, 'Human telomeric G-quadruplex: structures of DNA and RNA sequences': 1, 'DNA architecture: from G to Z': 1, 'G-quadruplex DNA structures-variations on a theme': 1, 'Four-stranded nucleic acids: structure, function and targeting of G-quadruplexes': 1, 'Human telomeric G-quadruplex: the current status of telomeric Gquadruplexes as therapeutic targets in human cancer': 1, 'Targeting G-quadruplexes in gene promoters: a novel anticancer strategy?': 1, 'Intracellular transcription of G-rich DNAs induces formation of G-loops, novel structures containing G4 DNA': 1, 'Telomere maintenance as a target for anticancer drug discovery': 1, 'G-quadruplex structures and their interaction diversity with ligands': 1, 'Structure-based design of selective and potent G quadruplex-mediated telomerase inhibitors': 1, 'Trisubstituted acridine derivatives as potent and selective telomerase inhibitors': 1, 'The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function': 1, 'A G-quadruplex-interactive potent small-molecule inhibitor of telomerase exhibiting in vitro and in vivo antitumor activity': 1, 'Genome-wide computational and expression analyses reveal G-quadruplex DNA motifs as conserved cis-regulatory elements in human and related species': 1, 'Genomic distribution and functional analyses of potential G-quadruplexforming sequences in Saccharomyces cerevisiae': 1, 'Genome-wide study predicts promoter-G4 DNA motifs regulate selective functions in bacteria: radioresistance of D. radiodurans involves G4 DNAmediated regulation': 1, 'Genome-wide prediction of G4 DNA as regulatory motifs: role in Escherichia coli global regulation': 1, 'Investigation of mRNA quadruplex formation in Escherichia coli': 1, 'G-quadruplexes regulate Epstein-Barr virus-encoded nuclear antigen 1 mRNA translation': 1, 'Role for G-quadruplex RNA binding by Epstein-Barr virus nuclear antigen 1 in DNA replication and metaphase chromosome attachment': 1, 'A dynamic G-quadruplex region regulates the HIV-1 long terminal repeat promoter': 1, 'Formation of a unique cluster of G-quadruplex structures in the HIV-1 Nef coding region: implications for antiviral activity': 1, 'Anti-HIV-1 activity of the G-quadruplex ligand BRACO-19': 1, 'The SARS-unique domain (SUD) of SARS coronavirus contains two macrodomains that bind G-quadruplexes': 1, 'High GC content of simple sequence repeats in Herpes simplex virus type 1 genome': 1, 'Anatomy of herpes simplex virus DNA: evidence for four populations of molecules that differ in the relative orientations of their long and short components': 1, 'Herpes Simplex Viruses': 1, 'Acyclovir-resistant herpes simplex virus pneumonia post-unrelated stem cell transplantation: a word of caution': 1, 'Herpes simplex esophagitis in patients with AIDS: report of 34 cases. The Cooperative Study Group on Herpetic Esophagitis in HIV Infection': 1, 'Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies': 1, 'Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy': 2, 'Characterization of a herpes simplex virus sequence which binds a cellular protein as either a single-stranded or double-stranded DNA or RNA': 1, 'Cellular proteins specifically bind single-and double-stranded DNA and RNA from the initiation site of a transcript that crosses the origin of DNA replication of herpes simplex virus 1': 1, 'Analysis of the UL36 open reading frame encoding the large tegument protein (ICP1/2) of herpes simplex virus type 1': 1, 'Selective interactions of cationic porphyrins with G-quadruplex structures': 2, 'Bcl-2 promoter sequence G-quadruplex interactions with three planar and non-planar cationic porphyrins: TMPyP4, TMPyP3, and TMPyP2': 1, 'The multipartite system that mediates entry of herpes simplex virus into the cell': 1, 'Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity': 1, 'Microtubule-mediated transport of incoming herpes simplex virus 1 capsids to the nucleus': 1, 'A time-of-drug addition approach to target identification of antiviral compounds': 1, 'Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives': 1, 'Current and future therapies for herpes simplex virus infections: mechanism of action and drug resistance': 1, 'Sequence variant (CTAGGG)n in the human telomere favors a G-quadruplex structure containing a G.C.G.C tetrad': 1, 'The yeast Pif1 helicase prevents genomic instability caused by G-quadruplex-forming CEB1 sequences in vivo': 1, 'Quantitative visualization of DNA G-quadruplex structures in human cells': 1, 'Overcoming natural replication barriers: differential helicase requirements': 1, 'Unraveling cell type-specific and reprogrammable human replication origin signatures associated with G-quadruplex consensus motifs': 1, 'Antiviral agents for herpes simplex virus': 1, 'The prevalence of hepatitis C among healthcare workers: A systematic review and meta-analysis': 1, 'Incidence of influenza in healthy adults and healthcare workers: A systematic review and meta-analysis': 1, 'Emerging occupational lung infections': 1, 'The aetiology, origins and diagnosis of severe acute respiratory syndrome': 1, 'Major outbreak of severe acute respiratory syndrome in Hong Kong': 1, 'Clinical features and short term outcomes of 144 patients with SARS in the Greater Toronto Area': 1, 'Working Adult Influenza Cohort Study Group. Risk factors for influenza among health care workers during 2009 pandemic': 1, 'The Occupational Risk of Influenza A (H1N1) Infection among Healthcare Personnel during the 2009 Pandemic: A Systematic Review and Meta-Analysis of Observational Studies': 1, 'MRSA carriage among healthcare workers in non-outbreak settings in Europe and the United States: A systematic review': 2, 'Occupational deaths among healthcare workers': 1, 'Needle stick injuries in health care: Frequency, causes and preventive strategies': 2, 'Characterisation of occupational blood and body fluid exposures beyond the Needlestick Safety and Prevention Act': 1, 'Council Directive 2010/32/EU of May 2010 implementing the Framework Agreement on prevention from sharp injuries in the hospital and healthcare sector concluded by HOSPEEM and EPSU': 1, 'Biological Agents in Health Care and Welfare Facilities (Technische Regel Biologische Arbeitsstoffe 250) Last Amendment': 1, 'Ordinanz for Preventive Occupational Medical Care (Verordnung zur Arbeitsmedizinischen Vorsorge-ArbMedVV)': 2, 'Infectious diseases in healthcare workers-An analysis of the standardised data set of a German compensation board': 1, 'Hepatitis C among healthcare personnel: Secondary data analyses of costs and trends for hepatitis C infections with occupational causes': 2, 'Criteria for successful hepatitis B vaccination in adults: Results of a case study': 1, 'Vaccination status among nurses in hospitals. Results of a cross sectional study at Harzklinikum Dorothea Christiane Erxleben Quedlinburg': 1, 'Work-related infections in dentistry: Risk perception and preventive measures': 1, 'Zur Situation bei wichtigen Infektionskrankheiten in Deutschland Hepatitis C im Jahr': 1, 'Study of blood contact in simulated surgical needlestick injuries with single or double latex gloving': 1, \"Compensation Claims for Needlestick Injuries Among Healthcare Personnel in Hospitals, Doctors' Surgeries and Nursing Institutions\": 1, 'Causes of needlestick injuries in three healthcare settings: Analysis of accident notifications registered six months after the implementation of EU Directive 2010/32/EU in Germany': 1, 'Seroconversion after needlestick injuries-Analyses of statutory accident insurance claims in Germany': 1, 'The management of needlestick injuries': 1, 'Tuberculosis in healthcare workers-A narrative review from a German perspective': 1, 'Consequences of tuberculosis among asylum seekers for health care workers in Germany': 1, 'Prolonged in-hospital exposure to an infant with active pulmonary tuberculosis': 1, 'Serial IGRA testing of trainees in the healthcare sector in a country with low incidence for tuberculosis-A prospective cohort study': 1, 'IFN-γ release assay versus tuberculin skin test for monitoring TB infection in healthcare workers': 1, 'Interferon-gamma release assays for the tuberculosis serial testing of health care workers: A systematic review': 1, 'Results of five-year systematic screening for latent tuberculosis infection in healthcare workers in Portugal': 1, 'Evaluation of the interferon-gamma release assay in healthcare workers': 2, 'Seasonal Influenza Vaccination in Health Care Workers. A Pre-Post Intervention Study in an Italian Paediatric Hospital': 1, 'A systematic review and meta-analysis of the direct epidemiological and economic effects of seasonal influenza vaccination on healthcare workers': 1, 'Influenza vaccination for healthcare workers who care for people aged 60 or older living in long-term care institutions': 1, \"Prevalence of CMV infection among staff in a metropolitan children's hospital-Occupational health screening findings\": 1, 'Are female daycare workers at greater risk of cytomegalovirus infection? A secondary data analysis of CMV seroprevalence between': 1, 'Epidemic keratoconjunctivitis: The current situation and recommendations for prevention and treatment': 2, 'Adenoviral keratoconjunctivitis': 1, 'MRSA Prevalence and Risk Factors among Health Personnel and Residents in Nursing Homes in Hamburg, Germany-A Cross-Sectional Study': 1, 'Prevalence and risk factors of MRSA colonisations: A cross-sectional study among personnel in outpatient care settings in': 1, 'MRSA prevalence among patient transport staff in Hamburg. GMS Hyg': 1, \"Infection Control Professionals' Views on the Handling of MRSA-Colonised Healthcare Workers\": 1, 'Involvement of occupational physicians in the management of MRSA-colonised healthcare workers in Germany-A survey': 1, 'MRSA as an occupational disease: A case series': 1, 'Infections as occupational diseases-Analysis of the data of the Accident Insurance Institution for the Health and Welfare Services for': 1, 'COVID-19 infection also occurs in patients taking hydroxychloroquine': 1, 'A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19': 2, 'Remdesivir for the treatment of Covid-19 -preliminary report': 2, 'Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation': 1, 'In vitro activity of lopinavir/ritonavir and hydroxychloroquine against SARS-CoV-2 at concentrations achievable by usual doses': 1, 'Package Insert. ALLTEST 2019-nCoV IgG/IgM rapid test cassette': 2, 'the clinic. Delirium': 1, 'Delirium in elderly people': 6, 'American Psychiatric Association (1999) Practice guideline for the treatment of patients with delirium': 1, 'High risk of cognitive and functional decline after postoperative delirium. A three-year prospective study': 3, 'Delirium: an independent predictor of functional decline after cardiac surgery': 4, 'Prognostic significance of delirium in frail older people': 2, 'Incidence and short-term consequences of delirium in critically ill patients: a prospective observational cohort study': 1, 'Postoperative delirium in intensive care patients: risk factors and outcome': 1, 'One-year health care costs associated with delirium in the elderly population': 1, 'Delirium in older emergency department patients: recognition, risk factors, and psychomotor subtypes': 1, 'Modified hospital elder life program: effects on abdominal surgery patients': 1, 'Daily physical activity and ageing': 1, 'Strength training in the elderly: effects on risk factors for age-related diseases': 1, 'Preventing falls among communitydwelling older persons: results from a randomized trial': 1, 'Ageing and activity: their effects on the functional reserve capacities of the heart and vascular smooth': 1, 'Comprehensive geriatric assessment for older adults admitted to hospital: meta-analysis of randomised controlled trials': 1, 'Influence of prehospital function and strength on outcomes of critically ill older adults': 1, 'Precipitating factors for delirium in hospitalized elderly persons. Predictive model and interrelationship with baseline vulnerability': 1, 'Risk factors and outcomes of delirium in older patients admitted to postacute care with and without dementia': 1, 'Preoperative physical activity in relation to postoperative delirium in elective cardiac surgery patients': 1, 'Effectiveness of multicomponent nonpharmacological delirium interventions: a meta-analysis': 2, 'Twenty-four-hour mobility during acute hospitalization in older medical patients': 1, 'Association of posture and ambulation with function 30 days after hospital discharge in older adults with heart failure': 1, 'Impact of a nursedriven mobility protocol on functional decline in hospitalized older adults': 2, 'The underrecognized epidemic of low mobility during hospitalization of older adults': 2, 'Prevalence and outcomes of low mobility in hospitalized older patients': 2, 'A multicomponent intervention to prevent delirium in hospitalized older patients': 4, 'Predisposing and precipitating factors for delirium in community-dwelling older adults admitted to hospital with this condition: a prospective case series': 1, 'Precipitating factors associated with delirium among long-term care residents with dementia': 1, 'Patient injury and physical restraint devices: a systematic review': 1, 'Physical restraint use with elderly patients: perceptions of nurses and nursing assistants in Spanish acute care hospitals': 1, 'Morbidity and mortality associated with the utilization of restraints: a review of literature': 2, 'Restraint and seclusion: a review of the literature': 1, 'Use of physical restraints in nursing homes and hospitals and related factors: a cross-sectional study': 1, 'Predictors of physical restraint use in Canadian intensive care units': 1, 'A longitudinal study of motor subtypes in delirium: frequency and stability during episodes': 1, 'Impairments in balance and mobility identify delirium in patients with comorbid dementia': 2, 'Delirium subtypes and 1-year mortality among elderly patients discharged from a post-acute rehabilitation facility': 1, 'A longitudinal study of motor subtypes in delirium: relationship with other phenomenology, etiology, medication exposure and prognosis': 1, 'Delirium subtypes and associated characteristics in older patients with exacerbation of chronic conditions': 2, 'The overlap between falls and delirium in hospitalized older adults: a systematic review': 1, 'The role of executive function and attention in gait': 1, 'Hospital elder life program: systematic review and meta-analysis of effectiveness': 1, 'Delirium in the emergency department and its extension into hospitalization (DELINEATE) study: effect on 6-month function and cognition': 1, 'Delirium in the ICU and subsequent long-term disability among survivors of mechanical ventilation': 1, 'Incidence and impact of delirium on clinical and functional outcomes in older patients hospitalized for acute cardiac diseases': 2, 'Delirium is independently associated with poor functional recovery after hip fracture': 1, 'Predictors of functional decline in hospitalized elderly patients: a systematic review': 1, 'Clinical and prognostic implications of delirium in elderly patients with non-ST-segment elevation acute coronary syndromes': 1, 'Trajectory of functional recovery after postoperative delirium in elective surgery': 1, 'Intracerebral hemorrhage and delirium symptoms. Length of stay, function, and quality of life in a 114-patient cohort': 1, 'Quality improvement and cost savings with multicomponent delirium interventions: replication of the Hospital Elder Life Program in a community hospital': 1, 'Patient-centred physical therapy is (cost-) effective in increasing physical activity and reducing frailty in older adults with mobility problems: a randomized controlled trial with 6 months follow-up': 1, 'Frailty and the prediction of negative health outcomes: a meta-analysis': 1, 'Frailty: an emerging public health priority': 1, 'Using the Short Physical Performance Battery to screen for frailty in young-old adults with distinct socioeconomic conditions': 1, 'Frailty status can be accurately assessed using inertial sensors and the TUG test': 1, 'Transitions between frailty states among community-living older persons': 1, 'Integrated primary and geriatric care for frail older adults in the community: implementation of a complex intervention into real life': 1, 'Hospital use, institutionalisation and mortality associated with delirium': 1, 'The impact of frailty and delirium on mortality in older inpatients': 1, 'Impact of frailty and residual subsyndromal delirium on 1-year functional recovery: a prospective cohort study': 1, 'Frailty and delirium in older adults: a systematic review and meta-analysis of the literature': 1, 'Effectiveness of an intervention to prevent frailty in pre-frail community-dwelling older people consulting in primary care: a randomised controlled trial': 1, 'A multicomponent exercise intervention that reverses frailty and improves cognition, emotion, and social networking in the community-dwelling frail elderly: a randomized clinical trial': 1, 'Effects of physical exercise interventions in frail older adults: a systematic review of randomized controlled trials': 1, 'Effects of a physical activity intervention on measures of physical performance: results of the lifestyle interventions and independence for Elders Pilot': 1, 'A physical activity intervention to treat the frailty syndrome in older persons-results from the LIFE-P study': 1, 'Effects of nutritional prehabilitation, with and without exercise, on outcomes of patients who undergo colorectal surgery: a systematic review and meta-analysis': 1, 'Prehabilitation before major intra-abdominal cancer surgery: a systematic review of randomised controlled trials': 1, 'The role of prehabilitation in frail surgical patients: a systematic review': 1, 'Multimodal prehabilitation to reduce the incidence of delirium and other adverse events in elderly patients undergoing elective major abdominal surgery: an uncontrolled before-and-after study': 1, 'A limited clinical, pathologic, and epidemiologic study of patients with pulmonary lesions associated with atypical acid-fast bacilli in the sputum': 1, 'A clinical study of the chronic lung disease due to nonphotochromogenic acid-fast bacilli': 1, \"The relationship of 'atypical' acid-fast bacteria to human disease: a preliminary report\": 1, 'Mycobacterium avium complex pulmonary disease presenting as an isolated lingular or middle lobe pattern. The Lady Windermere syndrome': 1, 'Multiple drug resistance in Mycobacterium avium: is the wall architecture responsible for exclusion of antimicrobial agents?': 1, 'Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors': 1, 'Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients': 1, 'MOOC completion rates: the data': 1, 'YouEDU: addressing confusion in MOOC discussion forums by recommending instructional video clips': 2, 'Exploring the effect of confusion in discussion forums of Massive Open Online Courses': 1, 'Deep learning for a smart e-learning system': 1, 'Forecasting student achievement in MOOCs with natural language processing': 1, 'DocBERT: BERT for document classification': 1, 'BERT: pre-training of deep bidirectional transformers for language understanding': 1, 'Web ontology language: OWL': 1, 'Stemming and lemmatization: a comparison of retrieval performances': 1, 'Adam: a method for stochastic optimization': 1, 'The SARS working group': 1, 'Coronavirus confirmed as cause of SARS': 1, 'Transmission dynamics and control of severe acute respiratory syndrome': 1, 'Control measures for severe acute respiratory syndrome (SARS) in Taiwan': 2, 'Dengue virus structural differences that correlate with pathogenesis': 1, 'Molecular and in vitro analysis of eight dengue type 2 viruses isolated from patients exhibiting different disease severities': 1, 'A single nucleotide change in the E protein gene of dengue virus 2 Mexican strain affects neurovirulence in mice': 1, 'The Genome Sequence of the SARS-associated Coronavirus': 3, 'Epidemic spread of adenovirus type 4-associated acute respiratory disease between US Army installations': 2, 'Theoretical uncertainty of measurements using quantitative polymerase chain reaction': 2, 'Detection of specific polymerase chain reaction product by utilizing the 5 -3 exonuclease activity of Thermus aquaticus DNA polymerase': 1, 'A plaque technique for the titration of yellow fever virus and antisera': 1, 'A simple micro-culture method for the study of group B arboviruses': 1, 'Quantitative RT-PCR: pitfalls and potential': 2, 'Real-time PCR in virology': 1, 'Detection of SARS coronavirus in patients with severe acute respiratory syndrome by conventional and real-time quantitative reverse transcription-PCR assays': 1, 'Coronavirus-positive nasopharyngeal aspirate as predicator for severe acute respiratory syndrome mortality': 1, 'Rapid diagnosis of dengue viremis by reverse transcriptase-polymerase chain reaction using 3 -noncoding region universal primers': 1, 'Quantitative detection of dengue 2 virus using fluorogenic RT-PCR based on 3 -noncoding sequence': 1, 'Development of a fluorogenic RT-PCR system for quantitative identification of dengue virus serotypes 1-4 using conserved and serotype-specific 3 -noncoding sequences': 1, 'Emergenza COVID 2019: percorso per la presa in carico dei pazienti con malattia renale cronica': 2, 'Practical indications for the prevention and management of SARS-CoV-2 in ambulatory dialysis patients: lessons from the first phase of the epidemics in Lombardy': 1, 'Wuhan novel coronavirus 2019ncov-update': 1, 'Nelfinavir was predicted to be a potential inhibitor of 2019 ncov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation': 1, 'A standard database for drug repositioning. Scientific data': 1, 'Drugsurv: a resource for repositioning of approved and experimental drugs in oncology based on patient survival information': 1, 'Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines. Drug discovery today': 1, 'Innovative Approaches in Drug Discovery: Ethnopharmacology': 1, 'A survey of current trends in computational drug repositioning': 2, 'Representability of algebraic topology for biomolecules in machine learning based scoring and virtual screening': 4, 'DG-GL: Differential geometry-based geometric learning of molecular datasets': 4, 'Return of the coronavirus: 2019-nCoV': 2, 'Evolution of the novel coronavirus from the ongoing wuhan outbreak and modeling of its spike protein for risk of human transmission': 1, 'Crystal structures of the main peptidase from the sars coronavirus inhibited by a substrate-like aza-peptide epoxide': 3, 'ChEMBL: a large-scale bioactivity database for drug discovery': 2, 'Comparative assessment of scoring functions: The casf-2016 update': 3, 'Drugbank 5.0: a major update to the drugbank database': 2, 'Size theory as a topological tool for computer vision': 2, 'Topological persistence and simplification': 3, 'Persistence barcodes for shapes': 2, 'Persistent homology analysis of protein structure, flexibility, and folding. International journal for numerical methods in biomedical engineering': 2, 'Spectral graph theory. Number 92': 1, 'Mathematical deep learning for pose and binding affinity prediction and ranking in D3R Grand Challenges': 2, 'MathDL: mathematical deep learning for D3R Grand Challenge 4': 6, 'Predicting commercially available antiviral drugs that may act on the novel coronavirus (2019-nCoV), wuhan, china through a drug-target interaction deep learning model. bioRxiv': 1, 'Agl-score: Algebraic graph learning score for protein-ligand binding scoring, ranking, docking, and screening': 1, 'Computational homology': 1, 'Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy': 1, 'Astroglial cell contributions to neuronal survival and neuritic growth': 1, 'Models of neuronal injury in AIDS: another role for the NMDA receptor?': 1, 'Neurotrans~itter t&porters (plus): a promising new gene family': 1, 'Manual of stem cell and bone marrow transplantation': 4, 'An update on pulmonary complications of hematopoietic stem cell transplantation': 11, 'The spectrum of noninfectious pulmonary complications following hematopoietic stem cell transplantation': 2, 'Non-infectious pulmonary complications after bone marrow transplantation': 1, 'Hematopoietic stem cell transplantation': 1, 'Engraftment syndrome after allogeneic hematopoietic cell transplantation predicts poor outcomes': 4, 'Diffuse alveolar hemorrhage after unrelated cord blood transplantation': 2, 'Peri-engraftment respiratory distress syndrome during autologous hematopoietic stem cell transplantation': 2, 'Association between acute graft versus host disease and lung injury after allogenic hematopoietic stem cell transplantation': 2, 'Diffuse alveolar hemorrhage and infection-associated alveolar hemorrhage following hematopoietic stem cell transplantation: related and high-risk clinical syndromes': 3, 'Pneumonia in allogeneic stem cell transplantation recipients: a multicenter prospective study': 3, 'Pulmonary complications following hematopoietic stem cell transplantation: diagnostic approaches': 4, 'Invasive fungal infection in allogeneic hematopoietic stem cell transplant recipients: single center experiences of 12 years': 4, 'β-D-Glucan screening for detection of invasive fungal disease in children undergoing allogeneic hematopoietic stem cell transplantation': 1, 'Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients': 3, 'Surgical resection of persistent pulmonary fungus nodules and secondary prophylaxis are effective in preventing fungal relapse in patients receiving chemotherapy or bone marrow transplantation for leukemia': 2, 'How I treat mucormycosis': 1, 'High-resolution CT findings of idiopathic pneumonia syndrome after haematopoietic stem cell transplantation: based on the updated concept of idiopathic pneumonia syndrome by the': 6, 'An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin': 1, 'Risk factor analysis of idiopathic pneumonia syndrome after allogeneic hematopoietic SCT in children': 7, 'Idiopathic pneumonia syndrome: changing spectrum of lung injury after marrow transplantation': 2, 'Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation': 2, 'Randomized, double-blind, placebo-controlled trial of soluble tumor necrosis factor receptor: enbrel (etanercept) for the treatment of idiopathic pneumonia syndrome after allogeneic stem cell transplantation: blood and marrow transplant clinical trials network protocol': 2, 'Biopsy-verified bronchiolitis obliterans and other noninfectious lung pathologies after allogeneic hematopoietic stem cell transplantation': 1, 'Pre-transplant risk factors for cryptogenic organizing pneumonia/bronchiolitis obliterans organizing pneumonia after hematopoietic cell transplantation': 1, 'Bronchiolitis obliterans following haematopoietic stem cell transplantation': 1, 'How I treat bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation': 11, 'Bronchiolitis obliterans after allogeneic hematopoietic SCT: further insight-new perspectives?': 6, 'Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation-an increasingly recognized manifestation of chronic graftversus-host disease': 3, 'Diagnostic value of bronchoalveolar lavage in leukemic and bone marrow transplant patients: the impact of antimicrobial therapy': 1, 'azithromycin and montelukast therapy in reducing corticosteroid exposure in bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: a case series of eight patients': 1, 'Management of respiratory viral infections in hematopoietic cell transplant recipients': 6, 'Review of epidemiology, diagnosis, and treatment of invasive mould infections in allogeneic hematopoietic stem cell transplant recipients': 1, 'Infections caused by mycobacterium tuberculosis in recipients of hematopoietic stem cell transplantation': 5, 'Mycobacterial infections in adult recipients of allogeneic hematopoietic stem cell transplantation: a cohort study in high endemic area': 1, 'Infections caused by mycobacterium tuberculosis in patients with hematological disorders and in recipients of hematopoietic stem cell transplant, a twelve year retrospective study': 2, 'Cytomegalovirus in hematopoietic stem cell transplant recipients': 6, 'How we treat cytomegalovirus in hematopoietic cell transplant recipients': 4, 'CMV in hematopoietic stem cell transplantation': 4, 'Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies': 4, 'Respiratory viral infections after hematopoietic stem cell transplantation in children': 7, 'Invasive adenoviral infections in T-cell-depleted allogeneic hematopoietic stem cell transplantation: high mortality in the era of cidofovir': 4, 'How I treat adenovirus in hematopoietic stem cell transplant recipients': 3, 'Toxoplasmosis after allogeneic stem cell transplantation-a single centre experience': 1, 'China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China': 1, 'China Medical Treatment Expert Group for Covid-19': 1, 'Viral load of SARS-CoV-2 in clinical samples': 1, 'Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China': 1, 'Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient': 1, 'Evidence for gastrointestinal infection of SARS-CoV-2': 2, 'Evidence of airborne transmission of the severe acute respiratory syndrome virus': 1, 'Filoviridae: Marburg and Ebola viruses Fields Virology': 3, 'Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda': 3, 'Filovirus tropism: cellular molecules for viral entry': 1, 'Niemann-Pick C1 functions independently of Niemann-Pick C2 in the initial stage of retrograde transport of membraneimpermeable lysosomal cargo': 1, 'Deficiency of niemann-pick type C-1 protein impairs release of human immunodeficiency virus type 1 and results in Gag accumulation in late endosomal/lysosomal compartments': 1, 'Cellular entry of ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes': 2, 'Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoproteindependent manner': 2, 'Ebola virus enters host cells by macropinocytosis and clathrin-mediated endocytosis': 2, 'Analysis of filovirus entry into vero e6 cells, using inhibitors of endocytosis, endosomal acidification, structural integrity, and cathepsin (B and L) activity': 4, 'Comprehensive search for cysteine cathepsins in the human genome': 1, 'Cellular proteolysis. An overview': 1, 'Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c': 1, 'Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis': 2, 'Cathepsin L deficiency as molecular defect of furless: hyperproliferation of keratinocytes and pertubation of hair follicle cycling. The FASEB journal : official publication of the Federation of': 1, 'Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus': 1, 'Human cathepsin L rescues the neurodegeneration and lethality in cathepsin B/L double-deficient mice': 1, 'Neuronal loss and brain atrophy in mice lacking cathepsins B and L': 1, 'Cathepsin L and cathepsin B mediate reovirus disassembly in murine fibroblast cells': 1, 'Animal cell invasion by a large nonenveloped virus: reovirus delivers the goods': 1, 'Cathepsin L is involved in proteolytic processing of the Hendra virus fusion protein': 1, 'Activation of the Nipah virus fusion protein in MDCK cells is mediated by cathepsin B within the endosomal-recycling compartment': 2, 'Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture': 3, 'Proteolytic processing of the Ebola virus glycoprotein is not critical for Ebola virus replication in nonhuman primates': 3, 'A simple method of estimating fifty percent endpoints': 6, 'Enzyme-linked immunosorbent assay for the detection of filovirus speciesspecific antibodies': 1, 'Vesicular stomatitis virus-based Ebola vaccines with improved cross-protective efficacy': 2, 'A forward genetic strategy reveals destabilizing mutations in the Ebolavirus glycoprotein that alter its protease dependence during cell entry': 2, 'A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever': 1, 'Specialized roles for cysteine cathepsins in health and disease': 1, 'Filoviruses require endosomal cysteine proteases for entry but exhibit distinct protease preferences': 5, 'Cathepsins B and L activate Ebola but not Marburg virus glycoproteins for efficient entry into cell lines and macrophages independent of TMPRSS2 expression': 1, 'Molecular Mechanisms of HIV entry': 1, 'Molecular and cellular aspects of rhabdovirus entry': 1, 'Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease': 1, 'Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response': 1, 'A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry': 1, 'Cathepsin K-dependent toll-like receptor 9 signaling revealed in experimental arthritis': 1, 'Cathepsins are required for Toll-like receptor 9 responses': 1, 'The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor': 1, 'Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9': 1, 'Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase': 1, 'Immunization with potato plants expressing VP60 protein protects against rabbit hemorrhagic disease virus': 1, 'Expression of immunogenic glycoprotein S polypeptides from transmissible gastroenteritis coronavirus in transgenic plants': 1, 'Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity': 2, 'Induction of a protective antibody response to foot and mouth disease virus in mice following oral or parenteral immunization with alfalfa transgenic plants expressing the viral structural protein VP1': 1, 'Rotavirus VP6 expressed by PVX vectors in Nicotiana benthamiana coats PVX rods and also assembles into viruslike particles': 1, 'Characterization virus-like particles produced by the expression of rotavirus capsid proteins in insect cells': 2, 'Efficient promoter cassettes for enhanced expression of T. Matsumura et al.: Rotavirus VP6 produced in transgenic potatoes foreign genes in dicotyledonous and monocotyledonous plants': 2, 'Restricted virus multiplication in potato plants transformed with the putative replicase component gene of potato leafroll virus': 1, 'Synthesis and immunogenicity of the rotavirus major capsid antigen using a baculovirus expression system': 1, 'Plant expression systems for the production of vaccines': 2, 'Production of recombinant proteins in transgenic plants: practical considerations': 1, 'Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein': 1, 'Functional mapping of protective domains and epitopes in the rotavirus VP6 protein': 1, 'Perspective: edible vaccines -a concept coming of age': 1, 'Production of hepatitis B surface antigen in transgenic plants for oral immunization': 1, 'Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage': 1, 'Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic': 1, 'Impact of Coronavirus Disease 2019 (COVID-19) outbreak on ST-segment-elevation myocardial infarction care in Hong Kong': 1, 'Improving health and wellness through access to nature': 3, 'The impact of walking in different urban environments on brain activity in older people': 1, 'Governmental public health powers during the COVID-19 pandemic: stay-at-home orders, business closures, and travel restrictions': 1, 'Centers for Disease Control and Prevention. Visiting parks and recreational facilities': 1, 'The missing mandate: promoting physical activity to reduce disparities during COVID-19 and beyond': 1, 'Active monitoring of persons exposed to patients with confirmed COVID-19 -United States': 3, 'COVID-19 Systematic Urgent Review Group Effort (SURGE) study authors. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and metaanalysis': 1, 'The psychological impact of quarantine and how to reduce it: rapid review of the evidence': 4, 'Urban as a determinant of health': 2, 'Chapter 1: Children in an increasingly urban world': 1, 'Are food deserts also play deserts?': 1, 'COVID-19 and outdoor safety: considerations for use of outdoor recreational spaces. National Collaborating Centre for Environmental Health': 1, 'Coronavirus disease (COVID-19): The need to maintain regular physical activity while taking precautions': 1, 'The relationship between buildings and health: a systematic review': 1, \"Stop using the term 'social distancing' -Start talking about 'physical distancing, social connection\": 1, 'Making healthy places: designing and building for health, well-being, and sustainability': 2, \"Step It Up! The Surgeon General's Call to Action to promote walking and walkable communities\": 1, 'Prescription for a healthy nation: a new approach to improving our lives by fixing our everyday world': 1, 'Physical activity: built environment approaches combining transportation system interventions with land use and environmental design': 1, \"Urban green space, public health, and environmental justice: the challenge of making cities 'just green enough'\": 2, 'A complex landscape of inequity in access to urban parks: a literature review': 1, '2020 bike investments to accelerate, including 20 miles of Stay Healthy Streets to become permanent in Seattle': 1, 'Public green spaces and positive mental health -investigating the relationship between access, quantity and types of parks and mental wellbeing': 1, 'The relationship between greenspace and the mental wellbeing of adults: a systematic review': 1, 'Effects of changing exposure to neighbourhood greenness on general and mental health: a longitudinal study': 1, 'Simulated sunlight rapidly inactivates SARS-CoV-2 on surfaces': 1, 'People who need to take extra precautions': 1, 'cryoSPARC: Algorithms for rapid unsupervised cryo-EM structure determination': 1, 'High-resolution noise substitution to measure overfitting and validate resolution in 3D structure determination by single particle electron cryomicroscopy': 1, 'The promise and challenge of therapeutic genome editing': 4, 'Principles of and strategies for germline gene therapy': 3, 'Refining strategies to translate genome editing to the clinic': 4, 'Brave new genome': 1, 'Toward responsible human genome editing': 1, 'After the storm-a responsible path for genome editing': 1, 'Ten ways He Jiankui violated ethics': 1, \"CRISPR's unwanted anniversary\": 1, 'Realigning gene editing with clinical research ethics: what the \"CRISPR twins\" debacle means for Chinese and international research ethics governance': 1, 'Editing policy to fit the genome?': 1, 'The landscape for human genome editing': 1, 'Convention for the protection of human rights and dignity of the human being with regard to the application of biology and medicine': 1, 'Statement on NIH funding of research using gene-editing technologies in human embryos': 1, 'Genome editing and human reproduction: social and ethical Issues': 1, \"Don't edit the human germ line\": 1, 'The case for banning heritable genome editing': 3, 'Global health ethics: human genome editing': 1, 'Project: international commission on the clinical use of human germline genome editing': 1, 'Getting serious about the challenge of regulating germline gene therapy': 2, 'Heritable genome editing: who speaks for \"future\" children?': 1, 'A global observatory for gene editing': 2, 'Focusing on human rights: a framework for CRISPR germline genome editing ethics and regulation': 1, 'Human germline CRISPR-Cas modification: toward a regulatory framework': 1, 'What to expect when expecting CRISPR baby number four': 2, 'Shaping the CRISPR gene editing debate: questions about enhancement and germline modification': 2, 'Altered inheritance: CRISPR and the ethics of human germline genome editing': 2, 'Who goes first? Deaf people and CRISPR germline editing': 1, \"Moving beyond 'therapy' and 'enhancement' in the ethics of gene editing\": 1, 'Correction of a genetic disease by CRISPR-Cas9-mediated gene editing in mouse spermatogonial stem cells': 1, 'Revising, correcting, and transferring genes': 2, 'Carry on editing': 1, 'Estimating demand for germline genome editing: an in vitro fertilization clinic perspective': 2, 'Could failure in preimplantation genetic diagnosis justify editing the human embryo genome?': 1, 'Germline genome editing versus preimplantation genetic diagnosis: is there a case in favour of germline interventions?': 2, 'From clinical trials to clinical practice: practical considerations for gene replacement therapy in SMA type 1': 1, 'Gene therapy as a curative option for beta-thalassemia': 1, 'Mosaicism in CRISPR/Cas9-mediated genome editing': 1, 'The technical risks of human gene editing': 1, 'Clinical germline genome editing: when will good be good enough?': 1, 'The impact of mosaic embryos on procreative liberty and procreative responsibility: time to put innovative technology on \"pause': 1, 'Correction of a pathogenic gene mutation in human embryos': 1, 'Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements': 1, 'Inter-homologue repair in fertilized human eggs?': 1, 'Disease resistance and the definition of genetic enhancement': 1, \"Yesterday's child: how gene editing for enhancement will produce obsolescence-and why it matters\": 1, 'Is enhancement the price of prevention in human gene editing?': 1, 'Human genome editing: science, ethics, and governance. Washington: National Academies Press; 2017. A major review of the science and ethics of gene editing': 1, 'Time to re-evaluate ART protocols in the light of advances in knowledge about methylation and epigenetics: an opinion paper': 1, 'Epigenetics and assisted reproductive technology: a call for investigation': 1, 'Intergenerational monitoring in clinical trials of germline gene editing': 2, 'Designing ethical trials of germline gene editing': 1, 'Germline modification and policymaking: the relationship between mitochondrial replacement and gene editing': 1, 'Should long-term follow-up post-mitochondrial replacement be left up to physicians, parents, or offspring?': 1, 'CRISPR-Cas9 and germline modification: new difficulties in obtaining informed consent': 1, 'Precaution and governance of emerging technologies': 1, 'Genome editing: bioethics shows the way': 1, 'Transmissible gastroenteritis virus infection: a vanishing specter': 1, 'Coronaviruses: structure and genome expression': 1, 'Antigenic structure of transmissible gastroenteritis virus. II. Domains in the peplomer glycoprotein': 1, 'Bacterial expression of antigenic sites A and D in the spike protein of transmissible gastroenteritis virus and evaluation of their inhibitory effects on viral infection': 1, 'Evaluation on the efficacy and immunogenicity of recombinant DNA plasmids expressing spike genes from porcine transmissible gastroenteritis virus and porcine epidemic diarrhea virus': 1, 'Construction, safety and immunogenicity analysis of attenuated Salmonella typhimurium harbouring TGEV DNA vaccine': 1, 'Localization of antigenic sites of the E2 glycoprotein of transmissible gastroenteritis coronavirus': 1, 'Expression of swine transmissible gastroenteritis virus envelope antigens on the surface of infected cells: epitopes externally exposed': 1, 'Clinical evaluation of transmissible gastroenteritis virus vaccines and vaccination procedures for inducing lactogenic immunity in sows': 1, 'A monoclonal antibody against transmissible gastroenteritis virus generated via immunization of a DNA plasmid bearing TGEV S1 gene': 1, '25 years and counting: Centers for Disease Control and Prevention identifies opportunities and challenges for diabetes prevention and control': 1, 'Development of a recombinant vaccinia-rabies vaccine for oral vaccination of foxes against rabies': 1, 'Recombinant fowlpox virus inducing protective immunity in non-avian species': 1, 'Recombinant swinepox virus expressing betagalactosidase: investigation of viral host range and gene expression levels in cell culture': 1, 'Construction of recombinant swinepox viruses and expression of the classical swine fever virus E2 protein': 1, 'Replication and expression of a swinepox virus vector delivering feline leukemia virus Gag and Env to cell lines of swine and feline origin': 1, 'Feline B7.1 and B7.2 proteins produced from swinepox virus vectors are natively processed and biologically active: potential for use as nonchemical adjuvants': 1, 'First insights into the protective effects of a recombinant swinepox virus expressing truncated MRP of Streptococcus suis type 2 in mice': 2, 'Immune responses and protection efficacy of a recombinant swinepox virus expressing HA1 against swine H3N2 influenza virus in mice and pigs': 2, 'A novel vaccine against Streptococcus equi ssp. zooepidemicus infections: the recombinant swinepox virus expressing M-like protein': 2, 'Joint production of prime/boost pairs of Fowlpox Virus and modified Vaccinia Ankara recombinants carrying the same transgene': 2, 'Recombinant adenovirus encoding the HA gene from swine H3N2 influenza virus partially protects mice from challenge with heterologous virus: A/HK/1/68 (H3N2)': 1, 'Co-expressing GP5 and M proteins under different promoters in recombinant modified vaccinia virus ankara (rMVA)-based vaccine vector enhanced the humoral and cellular immune responses of porcine reproductive and respiratory syndrome virus (PRRSV)': 1, 'Parvovirus evades interferondependent viral control in primary mouse embryonic fibroblasts': 1, 'Induction of antibodies protecting against transmissible gastroenteritis coronavirus (TGEV) by recombinant adenovirus expressing TGEV spike protein': 2, 'Oral immunization of mice with recombinant Lactococcus lactis expressing porcine transmissible gastroenteritis virus spike glycoprotein': 1, 'Regulatory T cells: the suppressor arm of the immune system': 2, 'Natural regulatory T cells in autoimmunity': 1, 'Regulatory T cells in virus infections': 4, 'Foxp3+ regulatory T cells, immune stimulation and host defence against infection': 7, 'Regulatory T cells and infection: a dangerous necessity': 4, 'Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor?': 1, 'The regulatory T-cell response during acute retroviral infection is locally defined and controls the magnitude and duration of the virus-specific cytotoxic T-cell response': 1, 'Functional impairment of CD8+ T cells by regulatory T cells during persistent retroviral infection': 1, 'Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B': 1, 'Coordination of early protective immunity to viral infection by regulatory T cells': 2, 'The novel CD4+CD25+ regulatory T cell effector molecule fibrinogen-like protein 2 contributes to the outcome of murine fulminant viral hepatitis': 1, 'CD25+ natural regulatory T cells are critical in limiting innate and adaptive immunity and resolving disease following respiratory syncytial virus infection': 2, 'CD4+CD25+ regulatory T cells control the severity of viral immunoinflammatory lesions': 3, \"Virus expanded regulatory T cells control disease severity in the Theiler's virus mouse model of MS\": 4, 'Regulatory T cells selectively preserve immune privilege of self-antigens during viral central nervous system infection': 2, 'Role of regulatory T cells in coronavirus-induced acute encephalitis': 2, 'Regulatory T cells inhibit T cell proliferation and decrease demyelination in mice chronically infected with a coronavirus': 5, 'Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo': 1, 'Interleukin-12 (IL-12), but not IL-23, deficiency ameliorates viral encephalitis without affecting viral control': 4, 'Enhanced antiviral T cell function in the absence of B7-H1 is insufficient to prevent persistence but exacerbates axonal bystander damage during viral encephalomyelitis': 4, 'Type I interferons are essential in controlling neurotropic coronavirus infection irrespective of functional CD8 T cells': 1, 'Transient depletion of regulatory T cells in transgenic mice reactivates virus-specific CD8+ T cells and reduces chronic retroviral set points': 2, 'Regulatory T cells suppress CD8+ T cell responses induced by direct priming and cross-priming and moderate immunodominance disparities': 2, 'CD4+ T cell help and innate-derived IL-27 induce Blimp-1-dependent IL-10 production by antiviral CTLs': 1, 'Shifting hierarchies of interleukin-10-producing T cell populations in the central nervous system during acute and persistent viral encephalomyelitis': 7, 'Highly activated cytotoxic CD8 T cells express protective IL-10 at the peak of coronavirus-induced encephalitis': 3, 'Inverted immunodominance and impaired cytolytic function of CD8+ T cells during viral persistence in the central nervous system': 4, 'Target-dependent B7-H1 regulation contributes to clearance of central nervous system infection and dampens morbidity': 2, 'Role of viral persistence in retaining CD8+ T cells within the central nervous system': 1, 'IFN-gamma-and IL-10-expressing virus epitopespecific Foxp3+ T reg cells in the central nervous system during encephalomyelitis': 2, 'Foxp3+ CD4 regulatory T cells limit pulmonary immunopathology by modulating the CD8 T cell response during respiratory syncytial virus infection': 2, 'Regulatory T cells promote early influx of CD8+ T cells in the lungs of respiratory syncytial virus-infected mice and diminish immunodominance disparities': 2, 'Partial depletion of natural CD4+ CD25+ regulatory T cells with anti-CD25 antibody does not alter the course of acute influenza A virus infection': 2, 'Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation': 2, 'Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction': 1, 'Interleukin-6 is crucial for recall of influenza-specific memory CD4 T cells': 1, 'Differential effects of IL-12 on Tregs and non-Treg T cells: roles of IFNgamma, IL-2 and IL-2R': 2, 'Virally expressed interleukin-10 ameliorates acute encephalomyelitis and chronic demyelination in coronavirus-infected mice': 1, 'New directions in the basic and translational biology of interleukin-27': 1, 'Epstein-Barr virus-induced gene 3 negatively regulates neuroinflammation and T cell activation following coronavirusinduced encephalomyelitis': 1, 'Cutting edge: CD8 T cell-mediated demyelination is IFN-gamma dependent in mice infected with a neurotropic coronavirus': 1, 'Memory CD4+ T-cell-mediated protection from lethal coronavirus encephalomyelitis': 1, 'Nonredundant roles for B cellderived IL-10 in immune counter-regulation': 1, 'Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies': 3, 'CD4 T cells promote CD8 T cell immunity at the priming and effector site during viral encephalitis': 2, 'Life with 6000 genes': 1, 'Yeast as a model for medical and medicinal research': 1, 'Systematic screen for human disease genes in yeast': 1, 'Systematic, genomewide identification of host genes affecting replication of a positive-strand RNA virus': 1, 'Yeast genome-wide screen reveals dissimilar sets of host genes affecting replication of RNA viruses': 1, 'Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis': 1, 'Molecular determinants and genetic modifiers of aggregation and toxicity for the als disease protein fus/tls': 1, 'Polyglutamine misfolding in yeast: toxic and protective aggregation': 1, 'Synthesis and assembly of hepatitis B virus surface antigen particles in yeast': 1, 'Discovering modes of action for therapeutic compounds using a genomewide screen of yeast heterozygotes': 1, 'EBP2 plays a key role in Epstein-Barr virus mitotic segregation and is regulated by Aurora family kinases': 1, 'Saccharomyces cerevisiae: a versatile eukaryotic system in virology': 1, 'The yeast dsRNA Virus L-A resembles mammalian dsRNA virus cores': 1, 'RNA-dependent replication, transcription, and persistence of brome mosaic virus RNA replicons in S. cerevisiae': 1, 'Yeast as a model host to explore plant virus-host interactions': 1, 'Stable replication of papillomavirus genomes in Saccharomyces cerevisiae': 1, 'Yeast as a model host to study replication and recombination of defective interfering RNA of Tomato bushy stunt virus': 1, 'Replication of Carnation Italian ringspot virus defective interfering RNA in Saccharomyces cerevisiae': 1, 'The DNA-A component of a plant Geminivirus (Indian Mung Bean Yellow Mosaic Virus) replicates in budding yeast cells': 1, 'Saccharomyces cerevisiae is permissive for replication of bovine papillomavirus type 1': 1, 'Nodamura virus RNA replication in Saccharomyces cerevisiae: Heterologous gene expression allows replication-dependent colony formation': 1, 'A novel genetic system to detect protein-protein interactions': 1, 'The yeast two-hybrid system for studying protein-protein interactions': 1, 'Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5': 2, 'Yeast two-hybrid detection of integrase-host factor interactions': 1, 'A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase': 1, 'Visualization of the intracellular behavior of HIV in living cells': 2, 'Hybrid Ty1/HIV-1 elements used to detect inhibitors and monitor the activity of HIV-1 reverse transcriptase': 1, 'Expression of active human immunodeficiency virus reverse transcriptase in Saccharomyces cerevisiae': 1, 'HIV-1 integrase: structural organization, conformational changes, and catalysis': 1, 'Retroviral DNA integration': 1, 'Integrase and integration: biochemical activities of HIV-1 integrase': 1, 'The mechanism of retroviral integration from X-ray structures of its key intermediates': 1, 'Structural insights into the retroviral DNA integration apparatus': 1, 'Functional and structural characterization of the integrase from the prototype foamy virus': 1, 'Regulated expression of endonuclease EcoRI in Saccharomyces cerevisiae: nuclear entry and biological consequences': 1, 'Expression of functional HIV-1 integrase in the yeast Saccharomyces cerevisiae leads to the emergence of a lethal phenotype: potential use for inhibitor screening': 1, 'Contribution of the C-terminal region within the catalytic core domain of HIV-1 integrase to yeast lethality, chromatin binding and viral replication': 1, 'The lethal phenotype observed after HIV-1 integrase expression in yeast cells is related to DNA repair and recombination events': 1, 'Inactivation of the SNF5 transcription factor gene abolishes the lethal phenotype induced by the expression of HIV-1 integrase in yeast': 2, 'HIV-1 integrase interacts with yeast microtubule-associated proteins': 1, 'Nuclear import defect of human immunodeficiency virus type 1 DNA flap mutants is not dependent on the viral strain or target cell type': 1, 'Chromosomal integration of LTR-flanked DNA in yeast expressing HIV-1 integrase: down regulation by RAD51': 3, 'Suppression of retroviral infection by the RAD52 DNA repair protein': 1, 'Stimulation of the human RAD51 nucleofilament restricts HIV-1 integration in vitro and in infected cells': 1, 'Cell killing by HIV-1 protease': 1, 'Mutational analysis of the human immunodeficiency virus vpr open reading frame': 1, 'Identification of HIV-1 vpr product and function': 1, 'HIV-1 Accessory Protein Vpr: relevance in the pathogenesis of HIV and potential for therapeutic intervention': 1, 'HIV-1 Vpr induces defects in mitosis, cytokinesis, nuclear structure, and centrosomes': 1, 'HIV-1 Vpr-induced cell death in Schizosaccharomyces pombe is reminiscent of apoptosis': 1, 'A second posttranscriptional trans-activator gene required for HTLV-III replication': 1, 'HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA': 1, 'A cis-acting peptide signal in human immunodeficiency virus type I Rev which inhibits nuclear entry of small proteins': 1, 'The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA': 1, 'Identification of a novel nuclear pore-associated protein as a functional target of the HIV-1 Rev protein in yeast': 1, 'A role for nucleoporin FG repeat domains in export of human Journal of Biomedicine and Biotechnology immunodeficiency virus type 1 Rev protein and RNA from the nucleus': 1, 'Functional analysis of the interaction of the human immunodeficiency virus type 1 Rev nuclear export signal with its cofactors': 1, 'A new nucleoporinlike protein interacts with both HIV-1 Rev nuclear export signal and CRM-1': 1, 'Candidacidal effects of Rev (11-20) derived from HIV-1 Rev protein': 1, 'Antifungal properties of a peptide derived from the signal peptide of the HIV-1 regulatory protein, Rev': 1, 'HIV expression strategies: ribosomal frameshifting is directed by a short sequence in both mammalian and yeast systems': 1, 'In vivo HIV-1 frameshifting efficiency is directly related to the stability of the stem-loop stimulatory signal': 1, 'Solution structure of the HIV-1 frameshift inducing stem-loop RNA': 1, 'Translational errors: from yeast to new therapeutic targets': 1, 'Torsional restraint: a new twist on frameshifting pseudoknots': 4, 'Programmed ribosomal frameshifting in HIV-1 and the SARS-CoV': 1, 'Pokeweed antiviral protein accesses ribosomes by binding to L3': 1, 'Phylogeny and nomenclature of the genus Talaromyces and Taxa accommodated in Penicillium subgenus Biverticillium': 1, 'Penicilliosis in children without HIV infectionare they immunodeficient?': 2, 'Insights into the pathogenicity of Penicillium marneffei': 2, 'Function and molecular evolution of multicopper blue proteins': 3, 'AreA controls nitrogen source utilisation during both growth programs of the dimorphic fungus Penicillium marneffei': 3, 'An STE12 homolog from the asexual, dimorphic fungus Penicillium marneffei complements the defect in sexual development of an Aspergillus nidulans steA mutant': 5, 'New tools for the genetic manipulation of filamentous fungi': 1, 'Phagocytosis and killing of human pathogenic, Penicillium marneffei and non-pathogenic, Penicillium citrinum by mouse macrophage J774.1 cells': 1, 'Rapid identification of Penicillium marneffei by PCR-based detection of specific sequences on the rRNA gene': 1, 'Membrane topology of murine coronavirus replicase nonstructural protein 3': 1, 'A basic helix-loop-helix protein with similarity to the fungal morphological regulators, Phd1p, Efg1p and StuA, controls conidiation but not dimorphic growth in Penicillium marneffei': 1, 'Melanization of Penicillium marneffei in vitro and in vivo. Microbiology': 3, 'The fungal type II myosin in Penicillium marneffei, MyoB, is essential for chitin deposition at nascent septation sites but not actin localization': 1, 'Melanins and their importance in pathogenic fungi': 4, 'Melanin biosynthesis inhibitors (MBIs) for control of rice blast': 2, 'The second naphthol reductase of fungal melanin biosynthesis in Magnaporthe grisea: tetrahydroxynaphthalene reductase': 3, 'Combined sequence and structure analysis of the fungal laccase family': 2, 'Basic and applied features of multicopper oxidases, CueO, bilirubin oxidase, and laccase': 2, 'Laccases: a never-ending story': 2, 'Phylogenetic comparison and classification of laccase and related multicopper oxidase protein sequences': 2, 'Multiple multi-copper oxidase gene families in basidiomycetes-what for? Curr Genomics': 1, 'MEGA6: Molecular Evolutionary Genetics Analysis version 6.0': 1, 'Molecular Characterization of the Aspergillus nidulans yA locus': 2, 'A developmentally regulated gene cluster involved in conidial pigment biosynthesis in Aspergillus fumigatus': 2, 'Characterisation of the laccase-encoding gene abr2 of the dihydroxynaphthalene-like melanin gene cluster of Aspergillus fumigatus': 3, 'Induction and transcriptional regulation of laccases in fungi': 1, 'Fungal laccases-occurrence and properties': 2, 'Laccase: Microbial sources, production, purification, and potential biotechnological applications': 2, 'Synthesis and assembly of fungal melanin': 2, 'Melanin synthesis in microorganisms-biotechnological and medical aspects': 4, 'Biosynthesis of fungal melanins and their importance for human pathogenic fungi': 4, 'Melanin is an essential component for the integrity of the cell wall of Aspergillus fumigatus conidia': 2, 'DOPA and DHN pathway orchestrate melanin synthesis in Aspergillus species': 1, 'The effects of tricyclazole, pyroquilon, phthalide, and related fungicides on the production of conidial wall pigments by Penicillium and Aspergillus species': 3, 'The melanin biosynthesis gene of Alternaria alternate can restore pathogenicity of the melanin-deficient mutants of Magnaporthe grisea': 1, '1,8-Dihydroxynaphthalene (DHN)-melanin biosynthesis inhibitors increase erythritol production in Torula corallina, and DHN-melanin inhibits erythrose reductase': 1, 'Isolation and molecular characterization of the Aspergillus nidulans wA gene': 2, 'Identification of a polyketide synthase gene (pksP) of Aspergillus fumigatus involved in conidial pigment biosynthesis and virulence': 1, 'Strategies for the molecular genetic manipulation and visualization of the human fungal pathogen Penicillium marneffei': 2, 'Site of inhibition by tricyclazole in the melanin biosynthetic pathway of Verticillium dahliae': 1, 'Characterization of melanin pigment produced by Aspergillus nidulans': 1, 'The developmentally regulated alb1 gene of Aspergillus fumigatus: its role in modulation of conidial morphology and virulence': 1, 'Pentaketide melanin biosynthesis in Aspergillus fumigatus requires chain-length shortening of a heptaketide precursor': 1, 'Hydrolytic polyketide shortening by Ayg1p, a novel enzyme involved in fungal melanin biosynthesis': 1, 'Assortment planning: review of literature and industry practice': 2, 'Optimal retail assortments for substitutable items purchased in sets': 1, 'Optimizing product assortment under customer-driven demand substitution': 1, 'Mass customization vs. mass production: variety and price competition': 1, 'Reducing assortment: an attribute-based approach': 1, 'Centralized and competitive inventory model with demand substitution': 2, 'Variety for sale: mass customization or mass confusion?': 3, 'Ontology-based web service architecture for retail supply chain management': 1, 'Using information content to evaluate semantic similarity in a taxonomy': 3, 'Semantic similarity estimation in the biomedical domain: an ontology-based information-theoretic perspective': 1, 'Robust selection of domainspecific semantic similarity measures from uncertain expertise': 1, 'A new measure for functional similarity of gene products based on gene ontology': 3, 'Evaluating go-based semantic similarity measures': 2, \"Semantic customers' segmentation\": 1, \"Impact des mesures de similarité sémantique dans un algorithme de partitionnement : d'un cas biomédicalà la détection de comportements de consommation. SFC\": 1, 'Resilience and stability of ecological system': 1, 'Searching for safety': 2, 'Leader cognition in real-world settings: How do leaders think about crises? The Leadership Quarterly': 3, 'Leadership in times of crisis: A framework for assessment': 3, 'SARS plague: Duty of care or medical heroism? Annals of the Academy of Medicine': 1, \"Singapore made 'right' decisions. The Straits Times\": 1, 'The evolutionary role of interorganizational communication: Modelling social capital in disaster contexts': 3, 'Resilience thinking: Sustaining ecosystems and people in a changing world': 1, 'Resilience: Revisiting the concept and its utility for social research': 1, 'Safe operation as a social construct': 1, 'Foundations of social theory': 1, 'Social capital, intellectual capital, and the organizational advantage': 1, 'Reclaiming resilience and safety: Resilience activation in the critical period of crisis': 3, 'Integrating crisis into the organizational lifecycle through transitional networks': 2, 'A macrosociological theory of social structure': 1, 'Reframing crisis management. Academy of Management Review': 3, 'Managing crises responses to largescale emergencies': 3, 'Does leadership matter? CEO leadership attributes and profitability under conditions of perceived environmental uncertainty': 1, 'Self-sacrificial behaviour in crisis situations: The competing roles of behavioural and situational factors': 1, 'Organizational discourse analysis (ODA): Examining leadership as a relational process': 2, 'Multilevel theorizing about creativity in organizations: A sensemaking perspective': 2, 'Leadership: A communicative perspective': 1, 'Sensemaking in organizations': 2, 'The power of framing: Creating the language of leadership': 1, 'Leading under pressure: From surviving to thriving before, during and after a crisis': 1, 'Crisis management: Informing a new leadership research agenda. The Academy of Management': 1, \"Leaders' sensemaking under crises: Emerging cognitive consensus over time within management teams\": 1, 'The social processes of organizational sensemaking': 3, 'Sensegiving and the role of cognitive shifts in the work of leadership': 1, 'Sensemaking and sensegiving in strategic change initiation': 2, 'Learning through rare events: Significant interruptions at the Baltimore & Ohio Railroad Museum': 1, 'Narratives of organizational identity and identification: A case study of hegemony and resistance': 1, \"Strategy through dialogue and doing: A game of 'Mornington Crescent'? Management Learning\": 1, 'Public health response: A view from Singapore': 1, 'A defining moment: How Singapore beat SARS. Singapore: Ministry of Information': 1, 'SARS in Singapore-Key lessons from an epidemic': 2, 'Leadership in the plural': 1, 'Designing resilience: Preparing for extreme events': 1, 'Neither market nor hierarchy-network forms of organization': 1, 'Threshold models of collective behavior': 1, 'Communication management and trust: Their role in building resilience to \"surprises\" such as natural disasters, pandemic flu and terrorism': 1, 'Back to the future: Ecosystem dynamics and local knowledge': 1, 'Swift trust and temporary groups': 1, 'The collapse of sensemaking in organizations: The Mann Gulch Disaster': 1, 'Sensemaking in organizations: Taking stock and moving forward': 1, 'Cross understanding: Implications for group cognition and performance': 1, 'Organizing for resilience': 1, 'The role of positive affectivity in team effectiveness during crises': 1, 'Empathy: A social psychological approach': 1, 'Relational practice: A feminist reconstruction of work': 1, 'Basics of qualitative research: Techniques and procedures for developing grounded theory': 1, 'Exploring the relationships among liminal transitions. Symbolic consumption and the extended self': 1, 'Guidelines for good manufacturing practices for medicinal products for human and veterinary use': 2, 'The European Parliament and the Council of the European Union': 2, 'European Medicines Agency Guideline on human cellbased medicinal products': 1, 'Validation of analytical procedures: text and methodology Q2 (R1)': 2, 'Quality control assays for clinical-grade human mesenchymal stromal cells: validation strategy': 2, 'A practical approach for the validation of sterility, endotoxin and potency testing of bone marrow mononucleated cells used in cardiac regeneration in compliance with good manufacturing practice': 2, 'Validation of analytical methods in compliance with good manufacturing practice: a practical approach': 2, 'Identification and validation of multiple cell surface markers of clinical-grade adipose-derived mesenchymal stromal cells as novel release criteria for good manufacturing practicecompliant production': 1, 'Guidelines on Good Manufacturing Practice specific to Advanced Therapy Medicinal Products': 2, 'Challenges of running a GMP facility for regenerative medicine in a public hospital': 1, 'How we make cell therapy in Italy': 2, 'EU guidelines to good manufacturing practice: medicinal products for human and veterinary use': 2, 'Microbiological Control of Cellular Products': 2, 'Microbiological Examination of Cell-Based Preparations 9': 2, 'Standard requirement of a microbiological quality control program for the manufacture of human mesenchymal stem cells for clinical use': 1, 'Validation of the BacT/ALERT(R) 3D system for rapid sterility testing of biopharmaceutical samples': 1, 'Use of the BacT/alert system for rapid detection of microbial contamination in a pilot study using pancreatic islet cell products': 1, 'Food and Drug Administration and US Department of Health and Human Services, Guidance for Industry-Pyrogen and Endotoxins Testing: Questions and Answers': 1, 'Cell-based detection of microbial biomaterial contaminations': 1, 'Human endothelial cell-based assay for endotoxin as sensitive as the conventional limulus amebocyte lysate assay': 1, 'Viral safety evaluation of biotechnology products derived from cell lines of human or animal origin Q5A (R1': 1, 'Systematic evaluation of in vitro and in vivo adventitious virus assays for the detection of viral contamination of cell banks and biological products': 1, 'Nucleated cell count and viability': 1, 'Validation of analytical methods in GMP: the disposable Fast Read 102® device, an alternative practical approach for cell counting': 1, 'Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement': 1, 'Reference materials for cellular therapeutics': 1, 'Validation of cellbased fluorescence assays: practice guidelines from the ICSH and ICCS, part V: assay performance criteria': 1, 'The mesenchymal stromal cells dilemma-does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?': 1, 'Regulatory perspective on in vitro potency assays for human mesenchymal stromal cells used in immunotherapy': 1, 'Potency analysis of mesenchymal stromal cells using a combinatorial assay matrix approach': 1, 'New challenges and opportunities for echocardiographic education during the COVID-19 pandemic: a call to focus on competency and pathology': 2, 'The assessment of technical and interpretative proficiency in echocardiography': 1, 'The role of simulation-based education in cardiology': 1, 'Moving into a new era for echocardiography education with simulation and workshop-based training': 1, 'EACVI communication paper: first international young dedicated multimodal cardiovascular imaging simulation education event organized by the ESC': 1, 'WHO. Rolling updates on coronavirus disease': 1, 'COVID-19 and the cardiovascular system': 2, 'Global burden of cancer': 1, 'Association of public health interventions with the epidemiology of the COVID-19 outbreak in Wuhan, China': 1, 'Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance': 1, \"National Health Commission of the People's Republic of China. Chinese management guideline for COVID-19\": 1, 'Two-tailed significance tests for 2 × 2 contingency tables: what is the alternative': 2, 'Role of TNF-alpha in virus-induced airway hyperresponsiveness and neuronal M(2) muscarinic receptor dysfunction': 3, 'Unleashing endogenous TNF-alpha as a cancer immunotherapeutic': 2, 'Differentiation of effector CD4 T cell populations': 2, 'T-cell exhaustion in HIV infection': 2, 'Implications of COVID-19 for patients with pre-existing digestive diseases': 2, 'Compassionate use of remdesivir for patients with severe Covid-19': 2, 'Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong': 4, 'Predictors of mortality in Middle East respiratory syndrome (MERS)': 4, 'The acute respiratory distress syndrome': 3, 'IFN and cytokine responses in ducks to genetically similar H5N1 influenza A viruses of varying pathogenicity': 2, 'The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome': 2, 'Notes on the pathogenesis of subacute sclerosis panencephalitis': 1, 'The peripheral nervous system in multiple sclerosis, a review and pathogenic hypothesis': 1, 'Lecons sur les maladies du systeme nerveux faites a la Salpetriere Paris': 1, 'Clinical data and identification of special forms of multiple sclerosis in 1271 cases studied with a standardized documentation system': 1, \"McAlpine's Multiple Sclerosis. Churchill Livingstone\": 2, 'Studies on disseminated sclerosis with special reference to symptomatology. course, and prognosis': 1, 'Clinical aspects of multiple sclerosis. ~129 in Multiple Sclerosis': 1, 'Multiple sclerosis and related conditions': 1, 'Pain syndromes in multiple sclerosis': 2, 'Principles of Neurology, Fourth Edition': 1, 'Acute and chronic pain syndromes in multiple sclerosis': 2, 'Acute radicular pain as a presenting symptom in multiple sclerosis': 2, 'Comparative Anatcmy of the Vettebrates. limes Mirror/Mosby': 1, 'Eduard Pemkcpf Atlas of Topographical and Applied Human Anatomy': 1, 'Year Book Medical Publishers': 1, 'Repott of two clinically silent cases discovered at autopsy': 1, 'Chronic relapsing experimental allergic encephalomyelitis: an experimental model of multiple sclerosis': 1, 'Viral infections of the nervous system': 4, 'Human slow infections-priori diseases ~545 in: Principles and Practice of Clinical Virology': 1, 'Measles encephalomyelitis+linical and immunologic studies': 2, 'Measles encephalomyelitis: lack of evidence of viral invasion of the central nervous system and quantitative study of the nature of demyelination': 1, 'Detection of corcnavirus RNA and antigen in multiple sclerosis brain': 1, 'Viral infections and demyelinating diseases': 1, 'Ihe possible role of viral infections in multiple sclerosis and other related demyelinating diseases. ~241 in Multiple Sclerosis': 2, 'Hoges H L Isolation of virus from a patient with fatal encephalitis complicating measles': 1, 'Inclusion bodies in measles encephalitis': 1, 'Viral infections of Toronto children during 1965,. II. Measles encephalitis and other complications': 1, 'Isolation of infectious measles virus in measles encephalitis': 1, 'A case of acute measles meningoencephalitis with virus isolation': 1, 'Measles antibodies in multiple sclerosis': 1, 'Measles and other vimsspecific immunoglobulins in multiple sclerosis': 1, 'Infectious Disease and Medical Microbiology': 2, 'Pathology of the peripheral nervous system in human rabies. A study of nine autopsy uLses': 2, 'xxalytic accidents of antirabies vaccination with suckling mouse brain vaccine': 2, 'Fatal rabies and the postvaccinal reaction. ANA poster presentation': 2, 'ucoend phalite scl6rosante subaigue avec 16sions &s ganglions rachidiens et des nerfs': 1, 'Retinal lesions is subacute sclerosing panencephalitis. Arch Gphthal84: 6lti21': 1, 'Visual and motor changes in patients with multiple sclerosis': 1, 'Effects of induced hyperthemtia on some neurological diseases': 1, 'The effect-s of induced hyperthermia on patients with multiple sclemsis': 1, 'Persistent neurological deficit precipitated by hot bath test in multiple sclerosis': 1, 'Latent herpes simplex virus in human trigeminal ganglia': 1, 'Latent varicellaroster viral DNA in human trigeminal and thoracic ganglia': 1, 'World Health Organization: Avian influenza in humans': 1, 'Global concerns regarding novel influenza A (H7N9) virus infections': 1, 'World Health Organization: Coronavirus infections': 1, 'Team KM-CI: Hospital outbreak of Middle East respiratory syndrome coronavirus': 1, 'World Health Organization: Avian influenza A (H7N9) virus': 1, 'Threat of an influenza pandemic: family physicians in the front line': 1, 'Kobe City Medical Association: Final report of response to pandemic influenza 2009 A/H1N1. Kobe': 1, 'Facing the threat of influenza pandemic -roles of and implications to general practitioners': 1, 'Working Adult Influenza Cohort Study G: Risk factors for influenza among health care workers during 2009 pandemic': 1, \"The GP's response to pandemic influenza: a qualitative study\": 5, 'World Health Organization: WHO global influenza preparedness plan. The role of WHO and recommendations for national measures before and during pandemics': 2, 'Assessing public health emergency preparedness: concepts, tools, and challenges': 1, 'Inter-ministerial Avian Influenza Committee: Pandemic influenza preparedness action plan of the Japanese government': 1, 'General practice and pandemic influenza: a framework for planning and comparison of plans in five countries': 4, 'General practice: professional preparation for a pandemic': 1, 'World Health Organization: WHO checklist for influenza pandemic preparedness planning': 2, 'World Health Organization: Epidemic-prone & pandemic-prone acute respiratory diseases: infection prevention & control in health-care facilities': 2, 'Inter-ministerial Avian Influenza Committee: Guidelines for the prevention and control of pandemic influenza -Phase 4 onwards': 1, 'Physical interventions to interrupt or reduce the spread of respiratory viruses': 1, 'The 2003 SARS outbreak and its impact on infection control practices': 1, 'How will Australian general practitioners respond to an influenza pandemic? A qualitative study of ethical values': 1, 'Primary care physicians in Hong Kong and Canada-how did their practices differ during the SARS epidemic?': 1, 'Transmission of influenza A in human beings': 2, 'Protecting healthcare workers from pandemic influenza: N95 or surgical masks?': 1, 'Surgical mask vs n95 respirator for preventing influenza among health care workers: a randomized trial': 2, 'Availability, consistency and evidence-base of policies and guidelines on the use of mask and respirator to protect hospital health care workers: a global analysis': 1, 'Personal protective equipment in an influenza pandemic: a UK simulation exercise': 2, 'United States Department of Health and Social Services: Medical Offices and Clinics Pandemic Influenza Planning Checklist': 1, 'American Academy of Family Physician: Business planning checklist to prepare family medicine offices for pandemic influenza': 1, 'Canadian Medical Association: Pandemic Influenza Planning Checklist for the Physician Office': 1, 'United States Department of Health and Social Services: Hospital Pandemic Influenza Planning Checklist': 1, 'Will the NHS continue to function in an influenza pandemic? A survey of healthcare workers in the West Midlands': 2, 'Flu pandemic': 1, 'The ecology of medical care': 1, 'The ecology of medical care in Japan': 1, 'A survey of the preparedness for an influenza pandemic of general practitioners in the West Midlands, UK': 2, 'Ensuring a broad and inclusive approach: a provincial perspective on pandemic preparedness': 1, 'Unprepared for a pandemic': 1, 'Did pandemic preparedness aid the response to pandemic (H1N1) 2009? A qualitative analysis in seven countries within the WHO European Region': 1, 'The global dimensions of public health preparedness and implications for US action': 1, \"Contamination of doctors ' and nurses ' pens with nosocomial pathogens\": 1, 'Computer keyboards as reservoirs for Acinetobacter baumannii in a burn hospital': 1, 'Guidelines for environmental infection control in healthcare facilities: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC)': 3, 'Hygiene procedures in the home and their effectiveness: a review of the scientifi c evidence base': 1, 'Foodborne pathogenic microorganisms and natural toxins handbook': 2, 'Handwashing among female college students': 2, 'Who washes hands after using the bathroom?': 2, 'Federale Overheidsdienst Buitenlandse Zaken -De Federale Politie . Handleiding BIODEV-systeem ( Operating Manual BIODEV-system )': 1, 'Microbial fl ora of hands of homemakers': 1, \"A comparison of the bacteria found on the hands of ' homemakers ' and neonatal intensive care unit nurses\": 1, 'Hand carriage of aerobic gram-negative rods may not be transient': 1, \"Faecal contamination on children ' s hands and environmental surfaces in primary schools in Leeds\": 1, 'Epidemiologic background of hand hygiene and evaluation of the most important agents for scrubs and rubs': 3, 'Hygiene in the home: relating bugs and behaviour': 2, 'How long do nosocomial pathogens persist on inanimate surfaces? A systematic review': 6, 'Survival of enteric viruses on environmental fomites': 2, 'Survival of enterococci and staphylococci on hospital fabrics and plastic': 1, 'A survey of gram-negative bacteria survival on hospital fabrics and plastics': 1, 'Effect of relative humidity and air temperature on survival of hepatitis A virus on environmental surfaces': 1, 'Potential role of fomites in the vehicular transmission of human astroviruses': 2, 'Comparative surfaceto-hand and fi ngertip-to-mouth transfer effi ciency of gram-positive bacteria, gram-negative bacteria, and phage': 2, 'Transmission of rhinovirus colds by self-inoculation': 7, 'Pertinacious habit on a rehabilitation unit: repetitive fi nger licking while paging through the clinical chart': 1, 'Rhinotillexomania: psychiatric disorder or habit?': 1, 'Human enterobiasis in evolution: origin, specifi city and transmission': 1, 'SARS in hospital emergency room': 1, 'Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee': 1, 'An experimental model for study of Candida survival and transmission in human volunteers': 1, 'Recovery of vancomycin-resistant enterococci on fi ngertips and environmental surfaces': 1, 'Contamination, disinfection, and crosscolonization: are hospital surfaces reservoirs for nosocomial infection?': 1, 'Methicillinresistant Staphylococcus aureus (MRSA) in nursing homes in a major UK city: an anonymized point prevalence survey': 1, 'The emergence of severe, communityacquired methicillin-resistant Staphylococcus aureus infections': 1, 'Foodborne viruses: an emerging problem': 2, 'Survival of Shigella dysenteriae type 1 on fomites': 1, 'Public attitudes toward the uses of biometric identifi cation technologies by government and the private sector: summary of survey fi ndings': 1, 'establishing the Visa Information System (VIS) (2004/512/EC)': 1, 'Survival and disinfection of parainfl uenza viruses on environmental surfaces': 1, 'Enterically infecting viruses: pathogenicity, transmission and signifi cance for food and waterborne infection': 1, 'Environmental monitoring for gastroenteric viruses in a pediatric primary immunodefi ciency unit': 1, 'Sensitive populations: who is at the greatest risk?': 1, 'From 2009 children could be obliged to give fi ngerprints': 1, 'Potential role of hands in the spread of respiratory viral infections: studies with human parainfl uenza virus 3 and rhinovirus 14': 1, 'Survival of hepatitis A virus on human hands and its transfer on contact with animate and inanimate surfaces': 2, 'Transmission of viruses via contact in a household setting: experiments using bacteriophage straight phiX174 as a model virus': 1, 'Refractory methicillin-resistant Staphylococcus aureus carriage associated with contamination of the home environment': 1, 'Dealing with the dangers of fear: the role of risk communication': 1, 'Quantitative risk assessment: an emerging tool for emerging foodborne pathogens': 1, 'Monte Carlo simulation of the risk of contamination of apples with Escherichia coli O157:H7': 1, 'CSYD, China Statistical Yearbook': 1, 'The fear of CoVId-19 and its role in preventive behaviors': 1, 'The effect of medical cannabis on alcohol and tobacco use in veterans with post-traumatic stress disorder (PTSD)': 1, 'The fear of COVID-19 scale: development and initial validation': 1, 'COVID-19 fear in Eastern Europe: validation of the fear of COVID-19 scale': 1, 'Structure of anxiety associated with the COVID-19 pandemic in the Russian-speaking sample: results from on-line survey': 2, 'Intolerance of uncertainty moderates the relations among religiosity and motives for religion, depression, and social evaluation fears': 1, 'Religion, spirituality, and health: a review and update': 1, 'Features of religiousness of Moscow students': 1, 'Neither public nor private religion: the Russian Orthodox Church in the public sphere of contemporary Russia': 1, \"Europe's Outlier: Belarus and COVID-19\": 1, 'Bat biology, genomes, and the Bat1K Project: to generate chromosome-level genomes for all living bat species': 7, 'Mammal species of the world. A taxonomic and geographic reference': 1, 'Phylogeny, genes, and hearing: implications for the evolution of echolocation in bats': 1, 'A molecular phylogeny for bats illuminates biogeography and the fossil record': 1, 'Crowd vocal learning induces vocal dialects in bats: Playback of conspecifics shapes fundamental frequency usage by pups': 1, 'An Eocene big bang for bats': 1, \"Mass extinctions, biodiversity and mitochondrial function: are bats 'special' as reservoirs for emerging viruses?\": 1, 'Global patterns in coronavirus diversity': 3, 'Differential transcriptional responses to Ebola and Marburg virus infection in bat and human cells': 2, 'The immune gene repertoire of an important viral reservoir, the Australian black flying fox': 4, 'Non-coding RNAs: the architects of eukaryotic complexity': 1, 'Novel insight into the non-coding repertoire through deep sequencing analysis': 1, 'Genome annotation: from sequence to biology': 1, 'Applications of next generation sequencing in molecular ecology of non-model organisms': 1, 'Next-generation genome annotation: we still struggle to get it right': 1, 'Transcriptomic and epigenomic characterization of the developing bat wing': 5, 'Virus-and interferon alpha-induced transcriptomes of cells from the microbat Myotis daubentonii. iScience': 6, 'The white-nose syndrome transcriptome: activation of anti-fungal host responses in wing tissue of hibernating little brown myotis': 2, 'Effect of torpor on host transcriptomic responses to a fungal pathogen in hibernating bats': 3, 'QUAST: quality assessment tool for genome assemblies': 1, 'RNA-Seq gene expression estimation with read mapping uncertainty': 1, 'RALEE--RNA Alignment editor in Emacs': 1, 'Characterisation of novel microRNAs in the Black flying fox (Pteropus alecto) by deep sequencing': 3, 'Blood miRNomes and transcriptomes reveal novel longevity mechanisms in the long-lived bat': 2, 'A comprehensive study of de novo genome assemblers: current challenges and future prospective': 1, 'A high-resolution map of human evolutionary constraint using 29 mammals': 1, 'Comparative analysis of bat genomes provides insight into the evolution of flight and immunity': 5, 'The genomes of two bat species with long constant frequency echolocation calls': 1, 'Hologenomic adaptations underlying the evolution of sanguivory in the common vampire bat': 1, \"Genome analysis reveals insights into physiology and longevity of the Brandt's bat Myotis brandtii\": 1, 'Down but not out: the role of microRNAs in hibernating bats': 1, 'Animal mitochondrial genomes': 1, 'A computational screen for mammalian pseudouridylation guide H/ACA RNAs': 1, 'Small RNAs with big implications: new insights into H/ACA snoRNA function and their role in human disease': 1, 'LNCipedia 5: towards a reference set of human long non-coding RNAs': 1, 'Long noncoding RNAs: past, present, and future': 1, 'Incredible RNA: dual functions of coding and noncoding': 1, 'cncRNAs: Bi-functional RNAs with protein coding and non-coding functions': 1, 'Evolution of spliceosomal snRNA genes in metazoan animals': 1, 'Social Choice and Individual Values': 1, 'The Logic of Collective Action: Public Goods and the Theory of Groups': 1, 'The Netherlands life sciences report 2005. New challenges ahead': 2, 'New European rules on orphan drugs': 3, 'Adopting an orphan': 4, 'Priority medicines for Europe and the world -A public health approach to innovation. World Health Organization': 3, 'Pharming Group N': 1, 'Orphan drugs': 2, 'Managing drugs for rare genetic diseases: trends and insights': 1, 'Two decades of orphan product development': 2, 'Rare essentials? Drugs for rare diseases on the Essential Medicines List. Discussion paper WHO Expert Committee on the selection and use of essential medicines': 3, 'The Orphan Drug Backlash': 4, 'Equity, access and economic evaluation in rare diseases. The impact of orphan drug legislation on health policy and patient care': 1, 'Controversy under the Orphan Drug Act: is resolution on the way': 1, \"Quest of Tomorrow's Medicines\": 1, 'Het Geneesmiddel': 1, 'Development of orphan vaccines: an industry perspective': 1, 'Advies Orphan Drugs. Advies nr': 2, 'Concept Beleidsregel CI-892: Weesgeneesmiddelen in academische ziekenhuizen. College Tarieven Gezondheidszorg/Zorgauthoriteit i': 1, 'Study on Orphan Drugs. Phase I. Overview of the Conditions for Marketing Orphan Drugs in Europe': 1, 'Managing Innovation. Integrating Technological Market and Organizational Change': 3, 'Innovation characteristics and innovation adoption-implementation: a meta-analysis of findings': 2, 'Development of an instrument to measure the perceptions of adopting an information technology innovation': 6, 'De adoptie van weesgeneesmiddelen': 11, 'Research and development of orphan drugs. The willingness of pharmaceutical companies to perform orphan drug R&D': 1, 'Orphan drug development. A user perspective': 1, 'Sociological Research-I: A Case Approach': 1, 'US Center for Disease Control and Prevention. Preliminary estimates of the prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 -United States': 1, 'Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19)': 1, 'Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention (Pocket Guide, 2020 update)': 1, 'COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic': 1, 'The inhaled corticosteroid ciclesonide blocks coronavirus RNA replication by targeting viral NSP15': 1, 'Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells': 1, 'Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2': 1, 'Molecular and cellular mechanisms underlying the therapeutic effects of budesonide in asthma': 1, 'Critically Ill Patients in the Seattle Region -Case Series': 1, 'Clinical 30 Characteristics of Covid-19 in New York City': 1, 'Presenting Characteristics, Comorbidities, and Outcomes Among': 1, 'Quarantine alone or in combination with other public health measures to control COVID-19: A rapid review': 1, 'KFF coronavirus poll': 1, 'Awareness, attitudes, and actions related to COVID-19 among adults with chronic conditions at the onset of the U.S. outbreak: A cross-sectional survey': 1, 'Knowledge, perceptions, and preferred information sources related to COVID-19 among central Pennsylvania adults early in the pandemic: Results of a mixed methods cross sectional survey': 2, 'Coronaphobia: Fear and the 2019-nCoV outbreak': 1, 'A social-cognitive model of pandemic influenza H1N1 risk perception and recommended behaviors in Italy': 1, 'Relationship of subjective and objective social status with psychological and physiological functioning: Preliminary data in healthy white women. Health Psychology: Official Journal of the Division of Health Psychology': 1, 'The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies': 1, 'As Georgia lifts restrictions, its hospitals may be unready for a COVID-19 surge. National Public Radio': 1, 'Philadelphia pausing full green phase reopening, announces travel advisory. 6ABCAction-News': 1, 'Coronavirus in DC, Maryland, Virginia: What to know on July 9': 1, 'Socioeconomic status, health inequalities and non-communicable diseases: A systematic review': 1, 'African American adherence to COVID-19 public health recommendations': 1, 'Cyclosporin A inhibits the replication of diverse coronaviruses': 1, 'Effect of interferon alpha and cyclosporine treatment separately and in combination on Middle East respiratory syndrome coronavirus (MERS-CoV) replication in a human in-vitro and ex-vivo culture model': 1, 'A single ventilator for multiple simulated patients to meet disaster surge': 1, 'How One Las Vegas ED Saved Hundreds of Lives after the Worst Mass Shooting in U.S. History. Emergency Physicians Monthly': 1, 'Letter from Chief Scientist of the Food and Drug Administration': 1, 'A nationwide survey of psychological distress among Italian people during the COVID-19 pandemic: Immediate psychological responses and associated factors': 1, 'Incremental validity of coronaphobia: Coronavirus anxiety explains depression, generalized anxiety, and death anxiety': 1, 'Fear of the coronavirus (COVID-19): Predictors in an online study': 1, 'Media use and acute psychological outcomes during COVID-19 outbreak in China': 1, 'Alcohol use and misuse during the COVID-19 pandemic: A potential public health crisis? The Lancet: Public Health': 1, 'Anxiety among university students during the SARS epidemic in Hong Kong': 1, 'Tracing \"fearbola\": Psychological predictors of anxious response to the threat of Ebola': 1, 'The behavioral immune system (and why it matters)': 1, 'Do pre-existing anxiety-related and mood disorders differentially impact COVID-19 stress responses and coping': 1, 'Multiple pathways to functional impairment in obsessive-compulsive disorder': 1, 'Obsessive-compulsive disorder symptom dimensions show specific relationships to psychiatric comorbidity': 1, 'Substance use disorders in patients with posttraumatic stress disorder: A review of the literature': 1, 'Anxiety sensitivity, self-reported motives for alcohol and nicotine use, and level of consumption': 1, 'Anxiety sensitivity as a prospective predictor of alcohol use disorders': 1, 'Marijuana use motives: Concurrent relations to frequency of past 30-day use and anxiety sensitivity among young adult marijuana smokers': 1, 'COVID Stress Syndrome: Concept, structure, and correlates. Depression and Anxiety': 1, 'The long view: 40 years of infectious bronchitis research': 1, 'RDP4: detection and analysis of recombination patterns in virus genomes': 1, 'Vaccination against infectious bronchitis virus: a continuous challenge': 1, 'RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak': 1, 'Serology assays to manage COVID-19': 1, 'Cluster of COVID-19 in northern France: A retrospective closed cohort study': 1, 'Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in': 2, 'Detection of SARS-CoV-2': 2, 'Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)': 2, 'Profile of IgG and IgM antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)': 2, 'Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States': 1, 'Development of a Sensitive and Specific Serological Assay Based on Luminex Technology for Detection of Antibodies to Zaire Ebola Virus': 5, 'Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients': 1, 'Evaluation of serologic and antigenic relationships between middle eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronaviruses': 1, 'Bat coronavirus phylogeography in the': 1, 'Immunology of COVID-19: current state of the science': 2, 'Haute Autorité de Santé HAS': 1, 'A systematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of disease': 1, 'Disappearance of antibodies to SARS-associated coronavirus after recovery': 1, 'Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome': 1, 'Potent human neutralizing antibodies elicited by SARS-CoV-2 infection': 2, 'Survey of Ebola Viruses in Frugivorous and Insectivorous Bats in Guinea, Cameroon, and the Democratic Republic of the Congo': 1, 'Prevalence of infection among asymptomatic and paucisymptomatic contact persons exposed to Ebola virus in Guinea: a retrospective, cross-sectional observational study': 1, 'Serological Evidence of Ebola Virus Infection in Rural Guinea before the 2014 West African Epidemic Outbreak': 1, 'Critical care for patients with severe COVID-2019 in Sichuan Province': 1, 'Acute respiratory distress syndrome: the Berlin definition': 4, 'COVID-19 Does Not Lead to a \"typical\" acute respiratory distress syndrome': 2, 'Antigenic relationship between human eoronavirus strain OC 43 and hemagglutinating encephalomyelitis virus strain 67N of swine: Antibody responses in human and animal sera': 1, 'Neonatal calf diarrhea: Purification and electron microscopy of a coronavirus-Iike agent': 1, 'Properties of a coronavirus isolated from a cow with epizootic diarrhea': 2, 'Epizootic diarrhoea of adult cattle associated with a coronavirus-like agent': 1, 'Calf diarrhoea coronavirus': 1, 'Physicochemical and biological properties of neonatal calf diarrhea eoronaviruses isolated in Quebec and comparison with the Nebraska calf eoronavirus': 1, 'New pathogenetic characters of reticuloendotheliosis virus isolated from Chinese partridge in specific-pathogen-free chickens. Microbial pathogenesis': 2, 'Molecular characterization and phylogenetic analysis of the reticuloendotheliosis virus isolated from wild birds in Northeast China. Veterinary microbiology': 1, 'Simultaneous endemic infections with subgroup J avian leukosis virus and reticuloendotheliosis virus in commercial and local breeds of chickens': 1, \"Isolation of recombinant field strains of Marek's disease virus integrated with reticuloendotheliosis virus genome fragments\": 1, 'Existence of variant strains Fowlpox virus integrated with Reticuloendotheliosis virus in its genome in field isolates in Tanzania. Tropical animal health and production': 1, 'Characterization of reticuloendotheliosis virus isolates obtained from broiler breeders, turkeys, and prairie chickens located in various geographical regions in the United States': 1, 'Complete genomic sequence of a Muscovy duck-origin reticuloendotheliosis virus from China': 1, 'Synergetic effects of subgroup J avian leukosis virus and reticuloendotheliosis virus co-infection on growth retardation and immunosuppression in SPF chickens': 1, \"Effects of reticuloendotheliosis virus and Marek's disease virus infection and co-infection on IFN-gamma production in SPF chickens. The Journal of veterinary medical science / the Japanese Society of Veterinary Science\": 1, 'Pathogenicity of Bordetella avium under immunosuppression induced by Reticuloendotheliosis virus in specific-pathogen-free chickens. Microbial pathogenesis': 1, 'Development of a DNA microarray-based multiplex assay of avian influenza virus subtypes H5, H7, H9, N1, and N2': 1, \"Integrated analyses of genome-wide DNA occupancy and expression profiling identify key genes and pathways involved in cellular transformation by Marek's disease oncoprotein\": 1, \"Transcriptional profile of Marek's disease virus genes in chicken thymus during different phases of MDV infection. Archives of virology\": 2, 'Chicken anemia virus: an understanding of the in-vitro host response over time': 1, 'Transcription analysis of the response of chicken bursa of Fabricius to avian leukosis virus subgroup J strain JS09GY3': 4, 'Monoclonal antibodies against avian reticuloendotheliosis virus: identification of strain-specific and strain-common epitopes': 1, 'Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method': 1, '18S rRNA is a reliable normalisation gene for real time PCR based on influenza virus infected cells': 1, 'Comparative evaluation of in vitro and in vivo assays for the detection of reticuloendotheliosis virus as a contaminant in a live virus vaccine of poultry': 1, 'Microarray resources for genetic and genomic studies in chicken: a review': 1, 'Transcriptional profiling of host gene expression in chicken embryo lung cells infected with laryngotracheitis virus': 1, 'Gene expression profiling of host response in models of acute HIV infection': 1, 'Chicken interferons, their receptors and interferonstimulated genes': 1, 'Interferon-stimulated genes: roles in viral pathogenesis. Current opinion in virology': 1, 'Interferon-stimulated genes and their antiviral effector functions. Current opinion in virology': 1, 'Interferon-stimulated genes: a complex web of host defenses': 2, 'Innate immune recognition of viral infection': 3, 'A virological view of innate immune recognition': 1, 'Activation of the TLR3 pathway regulates IFNbeta production in chickens': 1, 'Toll-like receptors and their crosstalk with other innate receptors in infection and immunity': 1, 'Innate sensing of viruses by pattern recognition receptors in birds. Veterinary research': 1, 'Cytokine production through PKC/p38 signaling pathways, not through JAK/STAT1 pathway, in mast cells stimulated with IFNgamma': 1, 'Essential impact of NF-kappaB signaling on the H5N1 influenza A virus-induced transcriptome': 3, 'Host gene expression profiling in influenza A virus-infected lung epithelial (A549) cells: a comparative analysis between highly pathogenic and modified H5N1 viruses': 1, 'Discovering the role of the major histocompatibility complex in the immune response. Annual review of immunology': 1, 'Primordial linkage of beta2-microglobulin to the MHC': 1, \"Expression kinetics of chicken beta2-microglobulin and Class I MHC in vitro and in vivo during Marek's disease viral infections. Veterinary research communications\": 1, 'Transcriptome analysis of chicken kidney tissues following coronavirus avian infectious bronchitis virus infection': 1, 'Effects of Reticuloendotheliosis Virus Infection on Cytokine Production in SPF Chickens': 2, 'Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins': 1, 'Pathogenicity and transmission of reticuloendotheliosis virus isolated from endangered prairie chickens. Avian diseases': 1, \"Full genome sequence and some biological properties of reticuloendotheliosis virus strain APC-566 isolated from endangered Attwater's prairie chickens. Virus research\": 1, 'Sites of integration of reticuloendotheliosis virus DNA in chicken DNA. Proceedings of the National Academy of Sciences of the United States of America': 1, 'Molecular pathways in virus-induced cytokine production': 1, 'IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells': 1, 'Tumor-derived interleukin (IL)-6 induced anti-tumor effect in immune-compromised hosts': 1, 'Cancer cachexia is mediated in part by the induction of IL-6-like cytokines from the spleen': 1, 'The role of IL-6 in the radiation response of prostate cancer': 1, 'Human soluble IL-6 receptor: its detection and enhanced release by HIV infection': 1, 'Avian leukosis virus p27 inhibits tumor necrosis factor alpha expression in RAW264.7 macrophages after stimulation with lipopolysaccharide. Acta virologica': 1, \"Differential cytokine responses following Marek's disease virus infection of chickens differing in resistance to Marek's disease\": 1, \"Host responses are induced in feathers of chickens infected with Marek's disease virus\": 1, 'Negative regulation of cytokine signaling pathways': 1, 'Cloning and functional analysis of new members of STAT induced STAT inhibitor (SSI) family: SSI-2 and SSI-3. Biochemical and biophysical research communications': 1, 'IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages': 1, 'Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation': 1, 'Glucocorticoids target suppressor of cytokine signaling 1 (SOCS1) and type 1 interferons to regulate Toll-like receptor-induced STAT1 activation': 1, 'Cutting edge: innate immune response triggered by influenza A virus is negatively regulated by SOCS1 and SOCS3 through a RIG-I/IFNAR1-dependent pathway': 1, 'Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis': 1, 'Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis': 1, 'Replication of reticuloendotheliosis viruses in cell culture: chronic infection. The Journal of general virology': 1, 'Differential expression of microRNAs in avian leukosis virus subgroup J-induced tumors. Veterinary microbiology': 1, 'Mammary stem cells and cancer: roles of Wnt signaling in plain view': 1, 'Targeting MAPK (Ras/ERK) and PI3K/Akt pathways in pituitary tumorigenesis': 1, 'The Resilience of the Spanish Health System Against the COVID-19 Pandemic': 2, \"Effets psychosociaux d'une flambée de maladie à virus ebola aux échelles individuelle\": 1, 'Survey of stress reactions among health care workers involved with the SARS outbreak': 1, 'Mental health of medical workers in Pakistan during the pandemic COVID-19 outbreak': 1, 'Mental Health and Psychosocial Aspects of Coronavirus Outbreak in Pakistan: Psychological Intervention for Public Mental Health Crisis': 1, 'Taking control amidst the chaos: Emotion regulation during the COVID-19 pandemic': 1, 'Social capital and sleep quality in individuals who self-isolated for 14 days during the coronavirus disease 2019 (COVID-19) outbreak in January 2020 in China': 1, 'Sleep behaviors in traditional-age college students: A state of the science review with implications for practice': 1, 'Class start times, Sleep, and academic performance in college: A path analysis': 1, 'Deveci, I. Morningness-eveningness preferences and academic achievement of university students': 1, 'Idoiaga-Mondragon, N. Stress, anxiety, and depression levels in the initial stage of the COVID-19 outbreak in a population sample in the northern Spain': 1, 'Sleep, Health, and Society': 1, 'Sleep Patterns and Predictors of Disturbed Sleep in a Large Population of College Students': 2, 'Sleep patterns and fatigue of nursing students who work': 1, 'Coping, stress, and personality in Spanish nursing students: A longitudinal study': 1, 'Stress and quality of sleep in undergraduate nursing students': 3, 'Changes in sleep pattern, sense of time and digital media use during COVID-19 lockdown in Italy': 1, 'The Spanish version of EuroQol: A description and its applications. European Quality of Life scale': 1, 'A 14-item mediterranean diet assessment tool and obesity indexes among high-risk subjects: The PREDIMED trial': 1, 'The Pittsburgh sleep quality index: Validity and factor structure in young people': 2, 'Psychological health during the coronavirus disease 2019 pandemic outbreak': 1, \"University Students' Mental Health Amidst the COVID-19 Quarantine in Greece\": 1, 'Suicidal ideation during the COVID-19 pandemic: The role of insomnia': 1, 'The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research': 1, 'The impact of a randomized sleep education intervention for college students': 1, 'Sleep quality is inversely related to body mass index among university students': 1, 'The epidemiology of sleep and obesity': 1, 'Sleep-obesity relation: Underlying mechanisms and consequences for treatment': 1, 'Current Alcohol Use is Associated with Sleep Patterns in First-Year College Students': 1, 'Haimov, I. The Interplay Between Tobacco Dependence and Sleep Quality Among Young Adults': 1, 'The Relationship Between Tobacco Smoking, Cortisol Secretion, and Sleep Continuity': 1, 'Sleep patterns in college students: Gender and grade differences': 1, 'Sleep in a large, multi-university sample of college students: Sleep problem prevalence, sex differences, and mental health correlates': 1, 'Sleep in University Students Prior to and During COVID-19 Stay-at-Home Orders': 1, 'The relationship between sleep quality and internet addiction among female college students': 1, 'Measuring sleep efficiency: What should the denominator be?': 1, 'A longitudinal analysis of the relationships among daytime dysfunction, fatigue, and depression in college students': 1, 'Impact of sleep health on self-perceived health status': 1, 'The effects of physical activity on sleep: A meta-analytic review': 1, 'Quality of sleep and depression in college students: A systematic review': 1, 'Sleep quantity, quality, and insomnia symptoms of medical students during clinical years: Relationship with stress and academic performance': 1, 'College residential sleep environment': 1, 'Will Ebola change the game? Ten essential reforms before the next pandemic. The report of the Harvard-LSHTM Independent Panel on the Global Response to Ebola': 2, 'Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China': 1, 'Three Emerging Coronaviruses in Two Decades': 1, 'Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in': 1, 'Coronavirus Disease (COVID-19) Situation Report-105. Available online': 1, 'Strategies for containing an emerging influenza pandemic in Southeast Asia': 1, 'Validating Human Behavior Representation Model of General Personnel During Offshore Emergency Situations': 1, 'COVID-19 pandemic: What consequences for cardiac rehabilitation? Monaldi Arch': 1, 'Anxiety Regarding Contracting COVID-19 Related to Interoceptive Anxiety Sensations: The Moderating Role of Disgust Propensity and Sensitivity': 1, 'Are people with chronic diseases interested in using telehealth? A cross-sectional postal survey': 1, 'Patient Attitudes Toward Telemedicine for Diabetic Retinopathy': 2, 'Potential of Mobile Health Technology to Reduce Health Disparities in Underserved Communities': 2, \"Patients' Satisfaction with and Preference for Telehealth Visits\": 1, 'Patterns of Use and Correlates of Patient Satisfaction with a Large Nationwide Direct to Consumer Telemedicine Service': 1, \"Systematic review of patient and caregivers' satisfaction with telehealth videoconferencing as a mode of service delivery in managing patients' health\": 1, 'Measuring patient trust in telemedicine services: Development of a survey instrument and its validation for an anticoagulation web-service': 2, 'Trust in telemedicine portals for rehabilitation care: An exploratory focus group study with patients and healthcare professionals': 1, \"Privacy and data security in E-Health: Requirements from the user's perspective. Health Inform\": 2, 'Predictors of eHealth usage: Insights on the digital divide from the Health Information National Trends Survey 2012': 1, 'Patient ability and willingness to participate in a web-based intervention to improve hypertension control': 1, 'Factors associated with change in Internet usage of Swedish older adults': 1, \"Health in old age, and patients' approaches to telemedicine in Poland\": 1, 'Awareness, Attitudes, and Actions Related to COVID-19 Among Adults With Chronic Conditions at the Onset of the U.S. Outbreak: A Cross-Sectional Survey': 1, 'Respiratory disease of the bovine neonate': 1, 'Bacterial pathogens of the bovine respiratory disease complex': 4, 'Investigation of polymerase chain reaction assays to improve detection of bacterial involvement in bovine respiratory disease': 3, 'The bronchopneumonias (respiratory disease complex of cattle, sheep and goats)': 1, 'Mycoplasma bovis: disease, diagnosis, and control': 1, 'Bovine mycoplasmosis: silent and deadly': 4, 'Mycoplasma bovis pneumonia in cattle': 2, 'Pathogenesis and pathology of bovine pneumonia': 1, 'Respiratory disease in calves: microbiological investigations on trans-tracheally aspirated bronchoalveolar fluid and acute phase protein response': 1, 'Isolation of Mycoplasmas from nasal swabs of calves affected with respiratory diseases and antimicrobial susceptibility of their isolates': 1, 'Laboratory diagnosis of Mycoplasma infection in young cattle': 1, 'Use of a polymerase chain reaction for detection of Mycoplasma dispar in the nasal mucus of calves': 1, 'Rapid detection of Mycoplasma dispar and M. Bovirhinis using allele specific polymerase chain reaction protocols': 1, 'Use of a novel real-time PCR technique to monitor and quantitate Mycoplasma bovis infection in cattle herds with mastitis and respiratory disease': 2, 'In vitro amplification of the 16S rRNA genes from Mycoplasma bovirhinis, Mycoplasma alkalescens and Mycoplasma bovigenitalium by PCR': 1, 'Nicholas RA 16S rDNA PCR and denaturing gradient gel electrophoresis; a single generic test for detecting and differentiating Mycoplasma species': 4, 'A novel rapid DNA microarray assay enables identification of 37 Mycoplasma species and highlights multiple Mycoplasma infections': 1, 'Standardized bacteriologic techniques for the characterization of mycoplasma species': 1, 'Bronchopulmonary lavage in the calf: a new technique': 1, 'Comprehensive DNA signature discovery and validation': 1, 'A quantitative map of nucleotide substitution rates in bacterial RNA': 1, 'Sensitivity\" and \"specificity\" reconsidered: the meaning of these terms in analytical and diagnostic settings': 2, 'Phylogeny of some mycoplasmas from ruminants based on 16S rRNA sequences and definition of a new cluster within the hominis group': 2, 'Estimating disease prevalence and the interpretation of screening test results': 1, 'A spreadsheet for the calculation of comprehensive statistics for the assessment of diagnostic tests and inter-rater agreement': 1, 'In vitro amplification of the 16S rRNA genes from Mycoplasma bovis and Mycoplasma agalactiae by PCR': 1, 'Genus and species-specific identification of mycoplasmas by 16S rRNA amplification': 1, 'Mycoplasma bovis as an agent of mastitis, pneumonia, arthritis and genital disorders in cattle': 1, 'Contagious agalactia of sheep and goats': 1, 'Severe otitis and pneumonia in adult cattle with mixed infection of Mycoplasma bovis and Mycoplasma agalactiae': 1, 'Evaluation of PCR systems for the identification and differentiation of Mycoplasma agalactiae and Mycoplasma bovis: a collaborative trial': 1, 'Origin and evolution of the adaptive immune system: genetic events and selective pressures': 2, 'Highly diversified innate receptor systems and new forms of animal immunity': 5, 'Evolution of innate and adaptive immune recognition structures': 1, 'The role of body size in host specificity: reciprocal transfer experiments with feather lice': 1, 'Insectdefense behavior by desert bighorn sheep': 1, 'Foraging efficiency and parasite risk in eastern grey kangaroos (Macropus giganteus)': 1, 'Macroevolution: Pattern and Process': 1, 'Genetics, Paleontology and Macroevolution': 1, 'The relationship between blood groups and disease': 1, 'From evolutionary genetics to human immunology: how selection shapes host defence genes': 2, 'Association of trypanolytic ApoL1 variants with kidney disease in African Americans': 1, 'The trypanolytic factor-mechanism, impacts and applications': 2, 'Are innate immune signaling pathways in plants and animals conserved?': 1, 'The Amphimedon queenslandica genome and the evolution of animal complexity': 1, 'The 2 -5 -oligoadenylate synthetase in the lowest metazoa: isolation, cloning, expression and functional activity in the sponge Lubomirskia baicalensis': 1, 'The diversity of C-type lectins in the genome of a basal metazoan, Nematostella vectensis': 1, 'How Hydra senses and destrys microbes': 1, 'A hypervariable invertebrate allodeterminant': 1, 'A conserved Toll-like receptor for Caenorhabditis elegans innate immunity': 1, 'Evolution of host innate defence: insights from Caenorhabditis elegans and primitive invertebrates': 1, 'Caenopores are antimicrobial peptides in the nematode Caenorhabditis elegans instrumental in nutrition and immunity': 2, 'The host defense of Drosophila melanogaster': 1, 'Pathogenomics of Culex quinquefasciatus and meta-analysis of infection responses to diverse pathogens': 2, 'Innate immune responses of a lepidopteran insect, Manduca sexta': 1, 'Anopheles fibrinogen-related proteins provide expanded pattern recognition capacity against bacteria and malaria parasites': 2, 'Dscam and DSCAM: complex genes in simple animals, complex animals yet simple genes': 1, 'AgDscam, a hypervariable immunoglobulin domaincontaining receptor of the Anopheles gambiae innate immune system': 1, 'Dynamic evolution of the innate immune system in Drosophila': 2, 'Comparative analysis of five immunityrelated genes reveals different levels of adaptive evolution in the virilis and melanogaster groups of Drosophila': 1, 'Immune pathways and defence mechanisms in honey bees Apis mellifera': 1, 'Draft genome of the red harvester ant Pogonomyrmex barbatus': 1, 'The bug and the bacterium: interdependent genomes': 1, 'Toll-like receptor genes (TLRs) from Capitella capitata and Helobdella robusta (Annelida)': 1, 'Diversification of Ig superfamily genes in an invertebrate': 1, 'Evidence of high individual diversity on myticin C in mussel (Mytilus galloprovincialis)': 1, 'The immune gene repertoire encoded in the purple sea urchin genome': 2, 'Genomic analysis of the immune gene repertoire of amphioxus reveals extraordinary innate complexity and diversity': 3, 'Genomic complexity of the variable regioncontaining chitin-binding proteins in amphioxus': 1, 'Plasticity of the immunoglobulin domain in the evolution of immunity': 1, 'The basis for haplotype complexity in VCBPs, an immune-type receptor in amphioxus': 1, 'Identification and characterisation of a homolog of an activation gene for the recombination activating gene 1 (RAG 1) in amphioxus': 1, 'Individual protochordates have unique immune-type receptor repertoires': 1, 'Genomic analysis of immunity in a urochordate and the emergence of the vertebrate immune system: \"waiting for Godot': 1, 'Somatic diversification of variable lymphocyte receptors in the agnathan sea lamprey': 1, 'The origins of the Rag genes -from transposition to V(D)J recombination': 1, 'that mediates type-2 immunity': 1, 'IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses': 1, 'A unique T cell receptor discovered in marsupials': 1, 'Protein phylogenies provide evidence of a radical discontinuity between arthropod and vertebrate immune systems': 1, 'Functional diversification of the toll-like receptor gene family': 1, 'Domain architecture evolution of pattern-recognition receptors': 2, 'The Cambrian conundrum: early divergence and later ecological success in the early history of animals': 1, 'Linking immune defenses and life history at the levels of the individual and the species': 1, 'The evolutionary ecology of a sepiolid squid-vibrio association: from cell to environment': 1, 'The obligate mutualist Wigglesworthia glossinidia influences reproduction, digestion, and immunity processes of its host, the tsetse fly': 1, 'The human microbiome project': 1, 'On being a parasite in an invertebrate host -a short survival course': 1, 'Insect immunity: from pattern recognition to symbiont-mediated host defense': 1, 'Immunity and symbiosis': 1, 'A new vision of immunity: homeostasis of the superorganism': 1, 'What brought the adaptive immune system to vertebrates? The jaw hypothesis and the seahorse': 1, 'Adaptive immunity in invertebrates: a straw house without a mechanistic foundation': 1, 'Some scaling principles for the immune system': 1, 'Advantage of rare HLA supertype in HIV disease progression': 1, 'The cost of being common: evidence from natural Daphnia populations': 1, 'Parasitic castration: the evolution and ecology of body snatchers': 1, 'The natural genetic engineering of polydnaviruses': 1, 'Time series analysis of the transcriptional responses of Biomphalaria glabrata throughout the course of intramolluscan development of Schistosoma mansoni and Echinostoma paraensei': 2, 'Is MHC enough for understanding wildlife immunogenetics?': 4, 'Metazoan parasites and resource heterogeneity: constraints and benefits': 2, 'Evolutionary Biology of Parasites': 1, 'Animal Species and Evolution': 1, 'Host specificity under molecular and experimental scrutiny': 4, 'How specialists can be generalists: resolving the \"parasite paradox\" and implications for emerging infectious disease': 2, 'Parasitism: The Ecology and Evolution of Intimate Interactions': 1, 'Ancient isolation and independent evolution of the three clonal lineages of the exotic sudden oak death pathogen Phytophthora ramorum': 1, 'Ecology and pathology of amphibian ranaviruses': 1, 'Emergence of zoonotic arboviruses by animal trade and migration': 1, 'Wildlife ecology -emerging infectious diseases of wildlife -threats to biodiversity and human health': 1, 'Crossspecies virus transmission and the emergence of new epidemic diseases. Microbiol': 3, 'Zoonotic mosquito-borne flaviviruses: worldwide presence of agents with proven pathogenicity and potential candidates of future emerging diseases': 1, 'Host resources govern the specificity of swiftlet lice: size matters': 1, 'Schistosoma mansoni, NIH-SM-PR-2 strain, in susceptible and nonsusceptible stocks of Biomphalaria glabrata: comparative histology': 1, 'Review of human': 1, 'Toll-like receptors and their role in experimental models of microbial infection': 1, 'Experimental infection of North American mammals with epidemic Venezuelan Encephalitis Virus': 1, 'Experimental infection of ectoparasitic arthropods with Rickettsia prowazekii (GVF-16 Strain) and transmission to flying squirrels': 1, 'Experimental infection of Contracaecum multipapillatum (Nematoda, Anisakinae) from Mexico in the domestic cat': 1, 'Experimental infection of pregnant ewes with Chlamydia pecorum': 1, 'Mechanisms underlying digeneansnail specificity: role of miracidial attachment and host plasma factors': 1, 'Failed attempts at experimental transplantation and transmission of nocturnallyperiodic simian Loa from monkey to man': 1, 'Phylogenetic determinants of potential host shifts in fungal pathogens': 3, 'Linking the emergence of fungal plant diseases with ecological speciation': 5, 'Experimental infection of North American birds with the New York 1999 strain of West Nile virus': 1, 'Rapid evolution of immune proteins in social insects': 1, 'Multiple reciprocal adaptations and rapid genetic change upon experimental coevolution of an animal host and its microbial parasite': 1, 'Parasite immune evasion: a momentous molecular war': 1, 'Fitness consequences of immune responses: strengthening the empirical framework for ecoimmunology': 1, 'An experimental evaluation of host specificity: the role of encounter and compatibility filters for a rhizocephalan parasite of crabs': 3, 'Hosts as ecological traps for the vector of Lyme disease': 1, 'Serum factors in Raja radiata toxic to Acanthobothrium quadripartitum (Cesoda-Tetraphyllidea), a parasite specific to R. naevus. Parasitology 61': 1, 'Innate immunity and its evasion and suppression by hymenopteran endoparasitoids': 1, 'Disruption of Erk-dependent type I interferon induction breaks the myxoma virus species barrier': 1, 'A single amino acid determinant governs the species-specific sensitivity of APOBEC3G to vif action': 1, 'Restrictions to crossspecies transmission of lentiviral infection gleaned from studies of FIV': 1, 'Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases': 1, 'Staphylococcus aureus host specificity: comparative genomics of human versus animal isolates by multi-strain microarray': 1, 'Chlamydial IFN-gamma immune evasion is linked to host infection tropism': 1, 'Poxviruses and immune evasion': 2, 'Interactions between monogenean parasites and their fish hosts': 1, 'Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement': 1, 'A comparative study of Bacillus cereus, Bacillus thuringiensis and Bacillus anthracis extracellular proteomes': 1, 'Codivergence in heteromyid rodents (Rodentia: Heteromyidae) and their sucking lice of the genus Fahrenholzia (Phthiraptera: Anoplura)': 1, 'Withinpopulation variation in prevalence and lineage distribution of avian malaria in blue tits': 1, 'Controls of spatial variation in the prevalence of trematode parasites infecting a marine snail': 1, 'Geographic patterns in the evolution of resistance and virulence in Drosophila and its parasitoids': 2, 'Differential parasite (Trematoda) encapsulation in Gammarus aequicauda (Amphipoda)': 2, \"Immunological investments reflect parasite abundance in island populations of Darwin's finches\": 2, 'Local differences in immunocompetence reflect resistance of sticklebacks against the eye fluke Diplostomum pseudospathaceum': 2, 'MHC adaptive divergence between closely related and sympatric African cichlids': 3, 'Local adaptation of immunity against a trematode parasite in marine amphipod populations': 2, 'Who is in control of the stickleback immune system: interactions between Schistocephalus solidus and its specific vertebrate host': 2, 'Sympatric and allopatric divergence of MHC Genes in Threespine Stickleback': 4, 'Genetic variation in a host-parasite association: potential for coevolution and frequencydependent selection': 1, 'Diversity and specificity in the interaction between Caenorhabditis elegans and the pathogen Serratia marcescens': 1, 'Phenotypic variation in infectivity of Diplostomum spathaceum cercariae within a population': 1, 'Genotypic variation and the role of defensive endosymbionts in an all parthenogenetic hostparasitoid interaction': 2, 'Surface carbohydrate composition of a tapeworm in its consecutive intermediate hosts: individual variation and fitness consequences': 1, 'Variation and covariation in infectivity, virulence and immunodepression in the host-parasite association Gammarus pulex-Pomphorhynchus laevis': 1, 'Immunology and Evolution of Infectious Disease': 2, 'Parasitic exploitation as an engine of diversity': 1, 'Immunity in a variable world': 3, 'Bovine immunity -a driver for diversity in Theileria parasites?': 1, 'A parasite-driven wedge: infectious diseases may explain language and other biodiversity': 4, 'The Geographic Mosaic of Coevolution': 2, 'Host phylogeny constrains crossspecies emergence and establishment of rabies virus in bats': 3, 'Can specialized pathogens colonize distantly related hosts? Schistosome evolution as a case study': 2, 'Emerging pathogens: the epidemiology and evolution of species jumps': 2, 'On ecological fitting, plant-insect associations, herbivore host shifts, and host plant selection': 1, 'Diversity begets diversity: host expansions and the diversification of plant-feeding insects': 1, 'A macroevolutionary mosaic: episodic host-switching, geographical colonization and diversification in complex host-parasite systems': 1, 'A three-genome phylogeny of malaria parasites (Plasmodium and closely related genera): evolution of life-history traits and host switches': 2, 'Cophylogeny of the anther smut fungi and their caryophyllaceous hosts: prevalence of host shifts and importance of delimiting parasite species for inferring cospeciation': 1, 'Repeated climate-linked host shifts have promoted diversification in a temperate clade of leafmining flies': 1, 'To speciate, or not to speciate? Resource heterogeneity, the subjectivity of similarity, and the macroevolutionary consequences of niche-width shifts in plant-feeding insects': 1, 'A newly-identified lineage of Schistosoma': 1, 'Speciation by host switch and adaptive radiation in a fish parasite genus Gyrodactylus (Monogenea, Gyrodactylidae)': 1, 'Evolution of the trypanorhynch tapeworms: parasite phylogeny supports independent lineages of sharks and rays': 1, 'SARS associated coronavirus has a recombinant polymerase and coronaviruses have a history of hostshifting': 1, 'Euphorine phylogeny -the evolution of diversity in host utilization by parasitoid wasps (Hymenoptera, Braconidae)': 1, 'The origins of plant pathogens in agro-ecosystems': 1, 'An immunological axis of biocontrol: infections in field-trapped insects': 2, 'Bats, in black and white': 1, 'Covariance in species diversity and facilitation among noninteractive parasite taxa: all against the host': 2, 'Trematode-gastropod associations in 9 non-lacustrine habitats in the Mwanza region of Tanzania': 1, 'Parasites reduce food web robustness because they are sensitive to secondary extinction as illustrated by an invasive estuarine snail. Philos': 1, 'Thermal stress and coral cover as drivers of coral disease outbreaks': 1, 'Factors affecting susceptibility of the coral Montastraea faveolata to blackband disease': 1, 'Copulation corrupts immunity: a mechanism for a cost of mating in insects': 1, 'Phenotypic and molecular characterisation of fish-borne Flavobacterium johnsoniae-like isolates from aquaculture systems in South Africa': 1, 'Agrochemicals increase trematode infections in a declining amphibian species': 1, 'Effect of road deicing salt on the susceptibility of amphibian embryos to infection by water molds': 1, 'Effect of dietary Curcuma longa on enzymatic and immunological profiles of rohu, Labeo rohita (Ham.), infected with Aeromonas hydrophila': 1, 'Parasitic and infectious disease responses to changing global nutrient cycles': 1, 'Elevated resource availability sufficient to turn opportunistic into virulent fish pathogens': 2, 'Impact of an ectoparasite on the immunity and pathology of an invertebrate: evidence for host immunosuppression and viral amplification': 1, 'Direct and indirect immunosuppression by a malaria parasite in its mosquito vector': 1, 'Differential phenoloxidase activity between native and invasive gammarids infected by local acanthocephalans: differential immunosuppression?': 1, 'Endoparasitoid wasp bracovirus-mediated inhibition of hemolin function and lepidopteran host immunosuppression': 1, 'Response of immunocompetent and immunosuppressed Spodoptera littoralis larvae to baculovirus infection': 1, 'Polydnavirus-mediated inhibition of lysozyme gene expression and the antibacterial response': 1, 'Obligatory multiparasitism in the tussock moth': 1, 'Survival of Schistosoma mansoni and other trematode larvae in the snail Biomphalaria glabrata -a discussion of the interference theory': 1, 'Austrobilharzia terrigalensis -schistosome dominant in interspecific interactions in the molluscan host': 1, 'The influence of Calicophoron microbothrium on the susceptibility of Bulinus tropicus to Schistosoma bovis': 1, 'HIV related opportunistic infections: still relevant after 25 years of AIDS progress': 1, 'Disease and evolution': 1, 'Historical and contemporary selection of teleost MHC genes: did we leave the past behind?': 1, 'Immunogenetics and genomics': 2, 'Defense strategies and immunityrelated genes': 1, 'Parasite selection for immunogenetic optimality': 1, 'Clinal variation in MHC diversity with temperature: evidence for the role of host-pathogen interaction on local adaptation in Atlantic salmon': 1, 'Pathogen-driven selection and worldwide HLA class I diversity': 1, 'Coevolutionary relationship between helminth diversity and MHC class II polymorphism in rodents': 1, 'Preferences for human odors are associated with paternally inherited HLA alleles': 1, 'Major histocompatibility complex and mate choice in a monogamous rodent': 1, \"Good genes as heterozygosity': the major histocompatibility complex and mate choice in Atlantic salmon (Salmo salar)\": 1, 'Mate choice decisions of stickleback females predictably modified by MHC peptide ligands': 2, 'Malaria as a possible selective factor in the speciation of macaques': 1, 'Parasite diversity, patterns of MHC II variation and olfactory based mate choice in diverging three-spined stickleback ecotypes': 2, 'The coevolving web of life': 1, 'On the origin of species by natural and sexual selection': 1, 'Heritable true fitness and bright birds -a role for parasites': 1, 'Phenotypic variability induced by parasites: extent and evolutionary implications': 1, \"Parasites may contribute to 'magic trait' evolution in the adaptive radiation of three-spined sticklebacks, Gasterosteus aculeatus (Gasterosteiformes: Gasterosteidae)\": 1, 'The major histocompatibility complex, sexual selection, and mate choice': 1, 'Mechanisms of species divergence through visual adaptation and sexual selection: perspectives from a cichlid model system': 1, 'Resistance of hybrid plants to herbivores: genes, environment, or both?': 1, 'Parasites in hybridizing communities: the Red Queen again?': 1, 'An infectious topic in reticulate evolution: introgression and hybridization in animal parasites': 1, 'Parasite infectivity to hybridising host species: a link between hybrid resistance and allopolyploid speciation?': 1, 'Biodiversity extinction by numbers': 1, 'Species coextinctions and the biodiversity crisis': 3, 'Comparative losses of British butterflies, birds and plants and the global extinction crisis': 1, 'The sixth mass coextinction: are most endangered species parasites and mutualists': 1, 'Competition promotes the evolution of host generalists in obligate parasites': 1, 'Parasites and marine invasions': 1, 'Historical mammal extinction on Christmas Island (Indian Ocean) correlates with introduced infectious disease': 1, 'A role for immunology in invasion biology': 1, 'Hosts and parasites as aliens': 2, \"Avian malaria Plasmodium relictum in native Hawaiian forest birds: epizootiology and demographic impacts on 'apapane Himatione sanguinea\": 1, 'Does reduced MHC diversity decrease viability of vertebrate populations?': 2, 'Chasing the genes that control resistance to gastrointestinal nematodes': 1, 'Control of human host immunity to mycobacteria': 1, 'The major histocompatibility complex (MHC) in declining populations: an example of adaptive variation': 1, 'Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV)': 1, 'Decreto do Presidente da República nº 14-A/2020': 1, 'Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia': 1, 'Neurobiology of fear and specific phobias': 1, 'The neurocircuitry of fear, stress, and anxiety disorders': 1, \"Ebola's mental-health wounds linger in Africa\": 1, 'A scale for the estimation of sleep problems in clinical research': 2, 'Translation, cross-cultural adaptation and psychometric properties of the Jenkins Sleep Scale in a sample of Portuguese shift workers. Laboratório de Psicologia': 1, 'Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease': 1, 'Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention': 1, 'WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment 2020': 1, 'Gender and socio-economic patterning of self-reported sleep problems in Britain. Social science & medicine (1982)': 1, 'Sleep complaints in middle-aged women and men: the contribution of working conditions and work-family conflicts': 1, 'Prevalence of insomnia symptoms in patients with sleep-disordered breathing': 2, 'Sleep disorders as core symptoms of depression': 2, 'Comparison of a Sleep Item From the General Health Questionnaire-12 With the Jenkins Sleep Questionnaire as Measures of Sleep Disturbance': 2, 'American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders': 1, 'Associations of accelerometer-based sleep duration and self-reported sleep difficulties with cognitive function in late mid-life: the Finnish Retirement and Aging Study': 1, 'Association between unemployment and insomnia-related symptoms based on the Comprehensive Survey of Living Conditions: a large cross-sectional Japanese population survey': 2, 'Sociodemographic and socioeconomic differences in sleep duration and insomnia-related symptoms in Finnish adults': 1, 'Who gets the best sleep? Ethnic and socioeconomic factors related to sleep complaints': 1, 'Trends in prevalence and incidence of chronic respiratory diseases from 1990 to 2017': 1, 'Sex differences in obstructive sleep apnoea': 1, \"Exploring sex and gender differences in sleep health: a Society for Women's Health Research Report\": 1, 'Gender and Regional Differences in Sleep Quality and Insomnia: A General Population-based Study in Hunan Province of China': 1, 'Gender differences in depression in representative national samples: Meta-analyses of diagnoses and symptoms': 1, 'Gender differences in anxiety disorders: prevalence, course of illness, comorbidity and burden of illness': 1, 'Emerging new coronavirus infection in Wuhan, China: situation in early 2020. Case Study Case Rep': 1, 'Chronic alcohol consumption increases the severity of murine influenza virus infections': 1, 'Cooperation between transmissible gastroenteritis coronavirus (TGEV) structural proteins in the invitro induction of virusspecific antibodies': 1, 'Antibody-mediated enhancement of disease in feline infectious peritonitis: comparison with dengue hemorrhagic fever': 1, 'Toll-like receptor-9 induced by physical trauma mediates release of cytokines following exposure to CpG motif in mouse skin': 1, 'SARS vaccine race': 1, 'Effects of a SARS-associated coronavirus vaccine in monkeys': 1, 'Proteosomes, emulsomes and cholera Toxin B improve nasal immunogenicity of human immunodeficiency virus gp160 in mice: induction of serum, intestinal, vaginal and lung IgA and IgG': 1, 'Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions': 1, 'Antibody-dependent and-independent protection following intranasal immunization of mice with rotavirus particles': 1, 'Safety and immunogenicity of a proteosome-shigella flexneri 2a lipopolysaccharide vaccine administered intranasally to healthy adults': 1, 'Enhancement of mucosal immunization with virus-like particles of simian immunodeficiency virus': 1, 'Intranasal immunization with killed unencapsulated whole cell prevents colonization and invasive disease by capsulated pneumococci': 1, 'A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity': 1, 'CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice': 1, 'Induction of CD8 T-cell-specific systemic and mucosal immunity against herpes simplex virus with CpG-peptide complexes': 1, 'Immunization against hepatitis B virus by mucosal administration of antigen-antibody complexes': 1, 'Optimization of poly(ethylene glycol) precipitation of hepatitis A virus used to prepare VAQTA, a highly purified inactivated vaccine': 1, 'Improved pharmacokinetic properties of a polyethylene glycol-modified form of interferon-beta-1a with preserved in vitro bioactivity': 1, 'Angiostensin-convering enzyme 2 is a functional receptor for the SARS coronavirus': 1, 'Further notes on the basic reproduction number': 1, 'Estimating COVID-19 cases and reproduction number in Brazil': 2, 'Mathematical Epidemiology': 2, 'Early dynamics of transmission and control of COVID-19 : a mathematical modelling study': 3, 'The incubation period of coronavirus disease 2019 (Covid-19) from publicly reported confirmed cases: estimation and application': 1, 'Using machine learning to estimate unobserved COVID-19 infections in North America': 2, 'An introduction to stochastic epidemic models': 2, 'Hydroxychloroquine or chloroquine for treatment or prophylaxis of COVID-19: a living systematic review': 1, 'Observational study of hydroxychloroquine in hospitalized patients with covid-19': 1, 'Hydroxychloroquine is associated with slower viral clearance in clinical COVID-19 patients with mild to moderate disease: a retrospective study. medRxiv. Preprint posted online 2': 1, 'Early hydroxychloroquine is associated with an increase of survival in COVID-19 patients: an observational study': 1, 'Hydroxychloroquine application is associated with a decreased mortality in critically ill patients with COVID-19. medRxiv. Preprint posted online 1': 1, 'Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19. medRxiv. Preprint posted online 23': 1, 'Preliminary evidence from a multicenter prospective observational study of the safety and efficacy of chloroquine for the treatment of COVID-19. medRxiv': 1, 'Past, present, and future of Japanese encephalitis': 1, 'Proinflammatory mediators released by activated microglia induces neuronal death in Japanese encephalitis': 3, 'Upregulation of RANTES gene expression in neuroglia by Japanese encephalitis virus infection': 1, 'Regulation of microglia effector functions by tumor necrosis factor signaling': 1, 'Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases': 1, 'Highly permissive infection of microglial cells by Japanese encephalitis virus: a possible role as a viral reservoir': 1, 'MicroRNA-15b modulates Japanese encephalitis virus-mediated inflammation via targeting RNF125': 3, 'MicroRNA-33a-5p modulates Japanese encephalitis virus replication by targeting eukaryotic translation elongation factor 1A1': 2, 'MicroRNA-19b-3p modulates Japanese encephalitis virus-mediated inflammation via targeting RNF11': 1, 'Quantitative phosphoproteomic analysis identifies the critical role of JNK1 in neuroinflammation induced by Japanese encephalitis virus': 2, 'lincRNAs: genomics, evolution, and mechanisms': 1, 'Long non-coding RNA UCA1 regulated cell cycle distribution via CREB through PI3-K dependent pathway in bladder carcinoma cells': 1, 'Regulation of chromatin structure by long noncoding RNAs: focus on natural antisense transcripts': 1, 'Evidence for natural antisense transcript-mediated inhibition of microRNA function': 1, 'lncRNA expression signatures in response to enterovirus 71 infection': 1, 'Unique signatures of long noncoding RNA expression in response to virus infection and altered innate immune signaling': 1, 'NRAV, a long noncoding RNA, modulates antiviral responses through suppression of interferonstimulated gene transcription': 3, 'The human long noncoding RNA lnc-IL7R regulates the inflammatory response': 2, 'Expression and regulation of long noncoding RNAs in TLR4 signaling in mouse macrophages': 1, 'A long noncoding RNA mediates both activation and repression of immune response genes': 1, 'A mammalian pseudogene lncRNA at the interface of inflammation and antiinflammatory therapeutics': 2, 'MicroRNAs: genomics, biogenesis, mechanism, and function': 1, 'Neuroinflammation and depression: microglia activation, extracellular microvesicles and microRNA dysregulation': 1, 'Enhanced detection and study of murine norovirus-1 using a more efficient microglial cell line': 1, 'The gene ontology (GO) project in 2006': 1, 'Gene ontology: tool for the unification of biology. The Gene Ontology Consortium': 2, 'The KEGG resource for deciphering the genome': 1, 'WholePathwayScope: a comprehensive pathway-based analysis tool for high-throughput data': 1, 'A systems biology approach for pathway level analysis': 1, 'Human gene coexpression landscape: confident network derived from tissue transcriptomic profiles': 1, \"Collective dynamics of 'small-world' networks\": 1, 'Gene connectivity, function, and sequence conservation: predictions from modular yeast co-expression networks': 1, 'Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses': 1, 'Synergistic activation of stress-activated protein kinase 1/c-Jun N-terminal kinase (SAPK1/JNK) isoforms by mitogen-activated protein kinase kinase 4 (MKK4) and MKK7': 1, 'Diverse functions of JNK signaling and c-Jun in stress response and apoptosis': 1, 'GENCODE: the reference human genome annotation for The ENCODE Project': 1, 'Differentially expressed miRNA in inflammatory mucosa of chronic rhinosinusitis': 1, 'Transcriptomic landscape of lncRNAs in inflammatory bowel disease': 1, 'lncRNAs regulate the innate immune response to viral infection': 1, 'Negative regulation of the interferon response by an interferon-induced long non-coding RNA': 1, 'Regulation of type I interferon responses': 1, 'Blocking of interferon-induced Jak-Stat signaling by Japanese encephalitis virus NS5 through a protein tyrosine phosphatase-mediated mechanism': 1, 'NOD1 and NOD2 signaling in infection and inflammation': 1, 'Dynamic changes in global microRNAome and transcriptome reveal complex miRNA-mRNA regulated host response to Japanese encephalitis virus in microglial cells': 1, 'Vibrio parahaemolyticus infections in the United States, 1973-1998': 1, 'Pandemic spread of an O3: K6 clone of Vibrio parahaemolyticus and emergence of related strains evidenced by arbitrarily primed PCR and toxRS sequence analyses': 1, 'Antibiotic susceptibility profiles of some Vibrio strains isolated from wastewater final effluents in a rural community of the Eastern Cape Province of South Africa': 1, 'Isolation, molecular characterization, and antibiotic susceptibility of Vibrio parahaemolyticus in Korean seafood': 5, 'Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium': 3, 'Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy': 1, 'Therapeutic potential of bacteriophage in treating Klebsiella pneumoniae B5055-mediated lobar pneumonia in mice': 1, 'Efficacy of bacteriophage treatment in murine burn wound infection induced by Klebsiella pneumoniae': 1, 'Bacteriophage therapy in humans': 2, 'Bacteriophage in the treatment of experimental septicemic mice from a clinical isolate of multidrug resistant Klebsiella pneumoniae': 1, 'Isolation and characterization of bacteriophages infecting Staphylococcus epidermidis': 2, 'Complete genome sequence of a novel marine siphovirus, pVp-1, infecting Vibrio parahaemolyticus': 2, 'Characterization of a T7-like lytic bacteriophage of Klebsiella pneumoniae B5055: a potential therapeutic agent': 3, 'Bacteriophage therapy': 2, 'Preparation of endotoxin-free bacteriophages': 2, 'Bacteriophage therapy for Staphylococcus aureus bacteremia in streptozotocin-induced diabetic mice': 1, 'Using antibodies, a laboratory manual': 1, 'Bacteriophage diversity in the North Sea': 1, 'Drug companies snub antibiotics as pipeline threatens to run dry': 1, 'Lack of development of new antimicrobial drugs: a potential serious threat to public health': 1, 'The antibiotic pipeline-challenges, costs, and values': 1, 'Phage therapy of local and systemic disease caused by Vibrio vulnificus in iron-dextrantreated mice': 3, 'Long-circulating bacteriophage as antibacterial agents': 1, 'Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics': 1, 'Phage therapy': 2, 'Quality-controlled smallscale production of a well-defined bacteriophage cocktail for use in human clinical trials': 1, 'Phage therapy: facts and fiction': 1, 'Biotechnological challenges of phage therapy': 1, 'Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle': 1, 'Impact of Ambient Temperature and Relative Humidity on the Incidence of Hand-Foot-Mouth Disease in Wuhan, China': 1, 'Physical and Socioeconomic Driving Forces of Land-Use and Land-Cover Changes: A Case Study of Wuhan City': 1, 'Effects of PM2.5 and PM10 on congenital hypothyroidism in Qingdao, China': 1, 'Epidemiological characteristics of children respiratory tract viral infection in Hubei area': 2, 'Neotropical Anopheles (Kerteszia) mosquitoes associated with bromeliad-malaria transmission in a changing world': 1, \"WHO Director-General's opening remarks at the media briefing on COVID-19 -11\": 1, 'Coronavirus map: tracking the spread of the outbreak': 1, 'Guidelines International Network': 1, 'Clinic terminology of traditional Chinese medical diagnosis and treatment-Syndromes': 1, 'Dictionary of traditional Chinese medicine formula': 1, 'Regional Office for the Western Pacific. WHO international standard terminologies on traditional medicine in the Western Pacific Region': 1, 'Notice on the issuance of the new 7th version of the COVID-19 diagnosis and treatment guideline': 1, 'Can Chinese medicine be used for prevention of corona virus disease 2019 (COVID-19)? A review of historical classics, research evidence and current prevention programs': 2, 'Announcement of the first version of Oriental Medicice Clinical Practice Guideline by the National University Network of Traditional Medicine Department of Internal Medicine': 1, 'Essentials of Chinese materia medica and medical formulas: new century traditional Chinese medicine': 3, 'Protective effects of platycodin D on lipopolysaccharide-induced acute lung injury by activating LXR␣-ABCA1 signaling pathway': 1, 'Magnoflorine ameliorates lipopolysaccharide-induced acute lung injury via suppressing NF-B and MAPK activation': 1, 'Pharmacological effects of Chinese herb aconite (Fuzi) on cardiovascular system': 1, 'Pharmacokinetics of aconitine-type alkaloids after oral administration of Fuzi (Aconiti Lateralis Radix Praeparata) in rats with chronic heart failure by microdialysis and ultra-high performance liquid chromatography-tandem mass spectrometry': 1, 'Study on compatibility source of Radix Aconiti Lateralis Praeparata and Radix et Rhizoma Rhei': 1, 'Traditional Chinese herbal medicine as a source of molecules with antiviral activity': 1, 'In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds': 1, 'Study on in vitro anti-inflammatory activity of total flavonoids from Glycyrrhizae Radix et Rhizoma and its ingredients': 1, 'Investigating the mechanism of Qing-Fei-Pai-Du-Tang for the treatment of Novel Coronavirus Pneumonia by network pharmacology': 1, 'Data collection of the Herbal Medicine Quality Standardization Research Group': 1, 'The American-European consensus conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination': 1, 'Epidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE study': 1, 'Acute respiratory distress syndrome: frequency, clinical course, and costs of care': 1, 'APACHE II: a severity of disease classification system': 1, 'A new simplified acute physiology score (SAPS II) based on a European/north American multicenter study': 1, 'Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on \"sepsis-related problems\" of the European Society of Intensive Care Medicine': 1, 'Age, PaO2/FIO2, and plateau pressure score: a proposal for a simple outcome score in patients with the acute respiratory distress syndrome': 4, 'National survey of outcomes and practices in acute respiratory distress syndrome in Singapore': 1, 'Assessing the performance of prediction models: a framework for traditional and novel measures': 1, 'External validation of the APPS, a new and simple outcome prediction score in patients with the acute respiratory distress syndrome': 2, 'Racial and ethnic disparities in mortality from acute lung injury': 1, 'Sex, race, and the development of acute lung injury': 1, 'Adiponectin gene polymorphisms and acute respiratory distress syndrome susceptibility and mortality': 1, 'Inflammation and immune-related candidate gene associations with acute lung injury susceptibility and severity: a validation study': 1, 'The association between a Darc gene polymorphism and clinical outcomes in African American patients with acute lung injury': 1, 'Angiotensin-converting enzyme polymorphism affects outcome of local Chinese with acute lung injury': 1, 'Genotypes and haplotypes of the VEGF gene are associated with higher mortality and lower VEGF plasma levels in patients with ARDS': 1, 'Polymorphism of the angiotensin-converting enzyme gene affects the outcome of acute respiratory distress syndrome': 1, 'Outcome value of Clara cell protein in serum of patients with acute respiratory distress syndrome': 1, 'An expanded definition of the adult respiratory distress syndrome': 1, 'Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial': 1, 'The APPS: an outcome score for the acute respiratory distress syndrome': 1, 'Assessment of PaO (2)/FiO (2) for stratification of patients with moderate and severe acute respiratory distress syndrome': 1, 'Advances in Neural Information Processing Systems': 2, 'Addressing two problems in deep knowledge tracing via prediction-consistent regularization': 3, 'Learning with interpretable structure from RNN': 2, 'Why self-attention? a targeted evaluation of neural machine translation architectures': 1, 'Long short-term memory': 1, 'Attention is all you need pp': 3, 'Performance factors analysis -a new alternative to knowledge tracing': 1, 'Knowledge tracing: modeling the acquisition of procedural knowledge. User Modeling and User-Adapted Interaction pp': 1, 'Evolution in contemporary human populations: Medical': 1, 'Recent acceleration of human adaptive evolution': 2, 'Convergent adaptation of human lactase persistence in Africa and Europe': 1, 'Genetics of lactase persistence and lactose intolerance': 1, 'Testosterone-mediated immune functions and male life histories': 1, 'Menstrual cycling and breast cancer: an evolutionary perspective': 1, 'Evolutionary medicine': 1, 'Evolutionary, historical, and political economic perspectives on health and disease': 3, 'Lifestyle, diet and disease: comparative perspectives on the determinants of chronic health risks': 2, 'Diabete mellitus: a \"thrifty\" genotype rendered detrimental by \"progress': 1, 'Insulin resistance in an energy-centered perspective': 1, 'The nutrition and health transition in the North West Province of South Africa: a review of the THUSA (Transition and Health during Urbanization of South Africans) Study': 1, 'Worms, asthma, and the hygiene hypothesis': 1, 'Hay fever, hygiene, and household size': 1, 'Can worms tame the immune system': 1, 'Evolution and the origins of disease': 1, 'Treatment options for nausea and vomiting during pregnancy': 1, 'Nausea and vomiting of early pregnancy and pregnancy outcome. A meta-analytical review': 1, 'Morning sickness: a mechanism for protecting mother and embryo': 1, 'Human factors in emerging infectious diseases': 1, 'Members of the Working Group on Land Use Change Disease Emergence. Unhealthy landscapes: policy recommendations on land use change and infectious disease emergence': 1, 'exotic pets, and emerging zoonoses': 1, 'AIDS as a zoonosis: scientific and public health implications': 1, 'Journal Watch Infectious Diseases': 1, 'Human genetic variation of medical significance': 1, 'Race, ancestry, and genes: implications for defining disease risk': 1, 'Cytokine removal in extracorporeal blood purification: an in vitro study': 1, 'Continuous hemodiafiltration with PMMA hemofilter in the treatment of patients with septic shock': 1, 'Successful delivery of RRT in Ebola virus disease': 1, 'National Institution of Infectious Disease in Japan. Manual for the detection of pathogen 2019-nCoV Ver.2.6': 1, 'Covid-19: navigating the uncharted': 1, 'Rational use of personal protective equipment for coronavirus disease 2019 (COVID-19), Interim guidance': 1, 'Continuous hemodialfiltration using PMMA membrane: clinical efficacy and its mechanisms': 1, 'Enhanced isolation of the novel 2019 coronavirus by TMPRSS2-expressing cells': 1, 'Percussive jets-State-of-the-art': 3, 'Effects of pulsating water jet impact on aluminium surface': 4, 'Utilization of ultrasound to enhance high-speed water jet effects': 3, 'The brittle fracture of solids by liquid impact, by solid impact, and by shock': 3, 'High-speed impact between a liquid drop and a solid surface': 3, 'Computational study of high-speed liquid droplet impact': 3, 'Method and apparatus for forming high-speed liquid': 3, 'Experimental and numerical framework for study of low velocity water droplet impact dynamics': 3, 'Elastic anisotropy of dual-phase steels with varying martensite content': 2, 'Normal impact force of Rayleigh jets': 1, 'Microscopic highspeed liquid-metal jets in vacuum': 1, 'Measurements of breakup length in high speed jet': 1, 'Mechanism of atomization of a liquid jet': 1, 'The terminal velocity of fall for water droplets in stagnant air': 1, 'Analytic solution of liquid-drop impact problems': 1, 'Shock wave formation in droplet impact on a rigid surface: lateral liquid motion and multiple wave structure in the contact line region': 1, 'Determination of the shear modulus of orthotropic thin sheets with the anticlastic-plate-bending experiment': 1, 'Erosion mechanisms during abrasive waterjet machining: model microstructures and single particle experiments': 2, 'A modeling study of metal cutting with abrasive waterjets': 1, 'State of the art of research and development in abrasive waterjet machining': 1, 'A finite element-based model for pure waterjet process simulation': 1, 'Energy based modeling of ultra high-pressure waterjet surface preparation processes': 1, 'Analysis of particulate erosion': 1, 'An erosion model of polycrystalline ceramics in abrasive waterjet cutting': 1, 'Experimental determination of forces applied by liquid water drops at high drop velocities impacting a glass plate with and without a shallow water layer using wavelet deconvolution': 1, 'Evidence for Cardiomyocyte Renewal in Humans': 1, 'First experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarction': 1, 'Cardiopoietic stem cell therapy in heart failure: The C-CURE (cardiopoietic stem cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics': 1, 'Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial': 1, 'Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): Initial results of a randomised phase 1 trial': 1, 'Increasing transplanted cell survival with cell-based angiogenic gene therapy': 1, 'Assessment and optimization of cell engraftment after transplantation into the heart': 1, 'Myocardial substrate and route of administration determine acute cardiac retention and lung biodistribution of cardiosphere-derived cells': 1, 'Investigating the secretome lessons about the cells that comprise the heart': 1, 'Biogenesis and secretion of exosomes Introduction: the discovery of exosomes': 1, 'Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells': 2, 'Exosomes -vesicular carriers for intercellular communication': 2, 'Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells': 2, 'Immune Surveillance Properties of Human NK Cell-Derived Exosomes': 2, 'Exosomes: nanoparticles involved in cardioprotection?': 2, 'Exosomes: mobile platforms for targeted and synergistic signaling across cell boundaries': 2, 'Identification of therapeutic covariant microRNA clusters in hypoxia-treated cardiac progenitor cell exosomes using systems biology': 1, 'Exosomes as critical agents of cardiac regeneration triggered by cell therapy': 7, 'Cardiac progenitor-derived exosomes protect ischemic myocardium from acute ischemia/reperfusion injury': 1, 'Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction': 3, 'Catheter-based delivery of cells to the heart': 1, 'Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection': 2, 'Biodistribution and function of extracellular miRNA-155 in mice': 2, 'Exosomes from cardiac stem cells amplify their own bioactivity by converting fibroblasts to therapeutic cells': 2, 'Intravenous Cardiac Stem Cell-Derived Exosomes Ameliorate Cardiac Dysfunction in Doxorubicin Induced Dilated Cardiomyopathy': 2, 'Identification of targeting peptides for ischemic myocardium by in vivo phage display': 3, 'Targeted gene delivery to ischemic myocardium by homing peptide-guided polymeric carrier': 2, 'A Centrifugal Ultrafiltration-Based Method for Enrichment of Microvesicles': 1, 'Exosomes are natural carriers of exogenous siRNA to human cells in vitro': 1, 'Isolation and Characterization of Exosomes from Cell Culture Supernatants': 1, 'Ongoing activation of sphingosine 1-phosphate receptors mediates maturation of exosomal multivesicular endosomes': 1, 'Globally optimal stitching of tiled 3D microscopic image acquisitions': 1, 'Exploring the genetic signature of body size in Yucatan miniature pig': 1, 'Isolation and Cryopreservation of Neonatal Rat Cardiomyocytes': 1, 'Cryopreservation of Neonatal Cardiomyocytes': 1, 'Exosomes for drug delivery -a novel application for the mesenchymal stem cell': 1, 'Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: Selective externalization of the receptor': 1, 'Transferrin recycling in reticulocytes: pH and iron are important determinants of ligand binding and processing': 1, 'Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes': 1, 'Revisiting the road to the discovery of exosomes': 1, 'Exosomes: Looking back three decades and into the future': 1, 'Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction': 1, 'Extracellular/circulating microRNAs and their potential role in cardiovascular disease': 1, 'Functional screening identifies miRNAs inducing cardiac regeneration': 1, 'Increased expression of microRNA-146a decreases myocardial ischaemia/reperfusion injury': 2, 'Vázquez-Carrera M. miR-146a targets Fos expression in human cardiac cells': 1, 'Overview of microRNAs in cardiac hypertrophy, fibrosis, and apoptosis': 1, 'MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of fas ligand': 1, 'Ischemic Postconditioning-Mediated miRNA-21 Protects against Cardiac ischemia/reperfusion Injury via PTEN/Akt Pathway': 1, 'Combination of microRNA-21 and microRNA-146a Attenuates Cardiac Dysfunction and Apoptosis During Acute Myocardial Infarction in Mice': 3, 'A combinatorial microRNA therapeutics approach to suppressing non-small cell lung cancer': 2, 'MicroRNAs: Target Recognition and Regulatory Functions': 1, 'Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets': 1, 'Prediction of Mammalian MicroRNA Targets': 1, 'The Widespread Impact of Mammalian MicroRNAs on mRNA Repression and Evolution': 1, 'MicroRNA Targeting Specificity in Mammals: Determinants beyond Seed Pairing': 1, 'Prediction of microRNA targets': 1, 'Co-inhibition of microRNA-10b and microRNA-21 exerts synergistic inhibition on the proliferation and invasion of human glioma cells': 1, 'Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways': 1, 'Combination of miRNA499 and miRNA133 exerts a synergic effect on cardiac differentiation': 1, 'Biodistribution and delivery efficiency of unmodified tumor-derived exosomes': 2, 'Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome': 1, \"Preparation and in vitro evaluation of anti-VCAM-1-Fab'-conjugated liposomes for the targeted delivery of the poorly water-soluble drug celecoxib\": 1, 'Dendronized heparin-doxorubicin conjugate based nanoparticle as pH-responsive drug delivery system for cancer therapy': 1, 'Targeting of macromolecular carriers and liposomes by antibodies to myosin heavy chain': 1, 'Plug and seal: Prevention of hypoxic cardiocyte death by sealing membrane lesions with antimyosin-liposomes': 1, 'Dose-response to cytoskeletal-antigen specific immunoliposome therapy for preservation of myocardial viability and function in langendorff instrumented rat hearts': 1, 'Cytoskeletal-antigen specific immunoliposome-targeted in vivo preservation of myocardial viability': 1, 'Gene delivery into ischemic myocardium by double-targeted lipoplexes with anti-myosin antibody and TAT peptide': 1, 'Aiming for the heart: targeted delivery of drugs to diseased cardiac tissue': 1, 'Nanoparticles for targeting the infarcted heart': 1, 'Label-free enrichment of functional cardiomyocytes using microfluidic deterministic lateral flow displacement': 1, 'Enzyme-Responsive Nanoparticles for Targeted Accumulation and Prolonged Retention in Heart Tissue after Myocardial Infarction': 1, 'Micromanaging cardiac regeneration: Targeted delivery of microRNAs for cardiac repair and regeneration': 1, 'Vascular permeability in cardiovascular disease and cancer': 1, 'The use of antibody modified liposomes loaded with AMO-1 to deliver oligonucleotides to ischemic myocardium for arrhythmia therapy': 1, 'Targeted repair of heart injury by stem cells fused with platelet nanovesicles': 1, 'Therapeutic microparticles functionalized with biomimetic cardiac stem cell membranes and secretome': 1, 'Fabrication of synthetic mesenchymal stem cells for hear repair': 1, 'Antibody-based proteomics and biomarker research -Current status and limitations': 1, 'Advances in Nucleic Acid-Based Detection Method': 1, 'LabDisk with complete reagent prestorage for sample-to-answer nucleic acid based detection of respiratory pathogens verified with influenza A H3N2 virus': 1, 'Rapid and Sensitive Detection of Severe Acute Respiratory Syndrome Coronavirus by Rolling Circle Amplification': 1, 'Identification and Characterization of Immunoglobulin G in Blood as a Major Inhibitor of Diagnostic PCR': 1, 'PCR inhibitors -Occurrence, properties and removal': 1, 'Direct DNA Amplification from Crude Clinical Samples Using a PCR Enhancer Cocktail and Novel Mutants of Taq': 1, 'Purification and Characterization of PCR-Inhibitory Components in Blood Cells': 1, 'The microfluidic chip module for the detection of murine norovirus in oysters using charge switchable micro-bead beating': 2, 'Evaluation of Inhibitor-Resistant Real-Time PCR Methods for Diagnostics in Clinical and Environmental Samples': 1, 'Extraction: The Past and The Present': 1, 'Solidphase reversible immobilization for the isolation of PCR products': 1, 'Rapid and Simple Method for Purification of Nucleic Acids': 1, 'Automated bead-trapping apparatus and control system for single-molecule DNA sequencing': 1, 'One-step pathogen specific DNA extraction from whole blood on a centrifugal microfluidic device': 1, 'A microfluidic system for the separation and detection of E.coli O157: H7 in soil sample using ternary interactions between humic acid, bacteria, and a hydrophilic surface': 1, 'Amplification of DNA from Whole Blood': 1, 'Effect of Amplification Facilitators on diagnostic PCR in the Presence of Blood, Feces, and Meat': 1, 'The influence of PEG molecular weight on morphologies and properties of PVDF asymmetric membranes': 1, 'Spotlight for healthy adolescents and adolescents with preexisting chronic diseases during the COVID-19 pandemic': 1, 'Respiratory muscle training in stroke patients with respiratory muscle weakness, dysphagia and dysarthria -a prospective randomized trial': 1, 'Interventions for oropharyngeal dysphagia in acute and critical care: a protocol for a systematic review and meta-analysis': 1, 'COVID-19 information center': 1, 'books?id¼2V4UAAAAQBAJ&pg¼PT53&lpg¼PT53&dq¼% 220fþtheþprofession,þforþtheþpublic%22þABIM&source ¼bl&ots¼MmK9fihthp&sig¼ACfU3U30H1RcZLhck190S-C4LckgR40Ggng&hl¼en&sa¼X&ved¼2ahUKEwiL3qSf8Z_-pAhXZlXIEHcurA5MQ6AEwAHoECAoQAQ&authuser¼1#-v¼onepage&q¼%220f%20the%20profession%2C%20for %20the%20public%22%20ABIM&f¼false': 1, 'Proteome Research: New Frontiers in Functional Genomics': 1, 'Two-dimensional database of a Burkitt lymphoma cell line (DG 75) proteins: protein pattern changes following treatment with 5Ј-azycytidine': 1, 'Fields Virology': 3, 'Neonatal herpes: what have we learned': 1, 'Cellular elongation factor 1delta is modified in cells infected with representative alpha-, beta-, or gammaherpesviruses': 1, 'Conserved protein kinases encoded by herpesviruses and cellular protein kinase cdc2 target the same phosphorylation site in eukaryotic elongation factor 1delta': 1, 'Phosphorylation of eIF4E by Mnk-1 enhances HSV-1 translation and replication in quiescent cells': 2, 'Identification of ribosome-associated viral and cellular basic proteins during the course of infection with herpes simplex virus type 1': 5, 'Proteomics of herpes simplex virus infected cell protein 27: association with translation initiation factors': 5, 'Proteomics of herpes simplex virus replication compartments: association of cellular DNA replication, repair, recombination, and chromatin remodeling proteins with ICP8': 3, 'Prevalence of IgG antibody to SARS-associated coronavirus in animal traders': 2, 'Severe acute respiratory syndrome (SARS)-paradigm of an emerging viral infection': 1, 'Proteomic fingerprints for potential application to early diagnosis of severe acute respiratory syndrome': 3, 'Plasma proteome of severe acute respiratory syndrome analyzed by two-dimensional gel electrophoresis and mass spectrometry': 2, 'Clinical manifestations of hepatitis C': 1, 'Proteomic approach identifies HSP27 as an interacting partner of the hepatitis C virus NS5A protein': 3, 'Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans': 1, 'Comparison of proteome between hepatitis B virus-and hepatitis C virusassociated hepatocellular carcinoma': 1, 'Management of chronic hepatitis C in HIV-co-infected patients-results from the First International Workshop on HIV and Hepatitis Co-infection': 2, 'HIV and hepatitis C virus co-infection': 1, 'Proteomic fingerprinting of HIV-1-infected human monocytederived macrophages: a preliminary report': 6, 'Proteomic fingerprinting of human immunodeficiency virus type 1-associated dementia from patient monocyte-derived macrophages: a case study': 2, 'Macrophage proteomic fingerprinting predicts HIV-1-associated cognitive impairment': 1, 'Acid-labile formylation of amino terminal proline of human immunodeficiency virus type 1 p24(gag) was found by proteomics using two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry': 2, 'Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome': 8, 'Analysis of the adenovirus type 5 proteome by liquid chromatography and tandem mass spectrometry methods': 1, 'Proteolytic 18O labeling for comparative proteomics: model studies with two serotypes of adenovirus': 1, 'A dataset of human liver proteins identified by protein profiling via isotopecoded affinity tag (ICAT) and tandem mass spectrometry': 1, 'National center for biotechnology information viral genomes project': 2, \"Host and viral proteins in the virion of Kaposi's sarcoma-associated herpesvirus\": 3, \"Lytic replication of Kaposi's sarcoma-associated herpesvirus results in the formation of multiple capsid species: isolation and molecular characterization of A, B, and C capsids from a gammaherpesvirus\": 2, 'Functional dissection of VP16, the trans-activator of herpes simplex virus immediate early gene expression': 1, 'Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)': 1, \"Virion proteins of Kaposi's sarcoma-associated herpesvirus\": 2, 'Epstein-Barr virus: 40 years on': 1, 'Proteomic analysis of Epstein-Barr virus-transformed human B-lymphoblastoid cell lines before and after immortalization': 2, 'Proteome analysis of Epstein-Barr virus-transformed B-lymphoblasts and the proteome database': 2, 'A transformationincompetent, nuclear antigen 2-deleted Epstein-Barr virus associated with replicative infection': 1, 'B-cell proliferation and induction of early G1-regulating proteins by Epstein-Barr virus mutants conditional for EBNA2': 1, 'The protooncogene c-myc is a direct target gene of Epstein-Barr virus nuclear antigen 2': 1, 'c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1': 1, 'Identification of Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) target proteins by proteome analysis: activation of EBNA2 in conditionally immortalized B cells reflects early events after infection of primary B cells by EBV': 3, 'Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells': 1, 'Herpes simplex viruses and their replication': 1, 'Nuclear sites of herpes simplex virus type 1 DNA replication and transcription colocalize at early times postinfection and are largely distinct from RNA processing factors': 1, 'Functional order of assembly of herpes simplex virus DNA replication proteins into prereplicative site structures': 1, 'P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro': 2, 'Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro': 1, 'Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation': 1, 'Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation': 1, 'Chromatin remodeling and modification during HIV-1 Tatactivated transcription': 4, 'Acetylation of HIV-1 Tat by CBP/P300 increases transcription of integrated HIV-1 genome and enhances binding to core histones': 1, 'Epidemiology of human immunodeficiency virus encephalopathy in the United States': 1, 'Pathogenesis of HIV-1 associated neurodegeneration': 1, 'Intracellular human immunodeficiency virus Tat expression in astrocytes promotes astrocyte survival but induces potent neurotoxicity at distant sites via axonal transport': 1, 'Proteomics analysis of human astrocytes expressing the HIV protein Tat': 5, 'Rate and severity of HIV-associated dementia (HAD): correlations with Gp41 and iNOS': 1, 'Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41': 1, 'HTLV-1 and associated adult T-cell leukemia/lymphoma': 3, 'Mechanisms of HTLV-1 transformation': 3, 'The trans-activator tax of human T-cell leukemia virus type 1 (HTLV-1) interacts with cAMP-responsive element (CRE) binding and CRE modulator proteins that bind to the 21-base-pair enhancer of HTLV-1': 1, 'Mechanism of transcriptional activation of viral and cellular genes by oncogenic protein of HTLV-1': 2, 'Protein profile of tax-associated complexes': 3, 'Immunoelectron microscopic localization of the pX gene products in human T-cell leukemia virus type 1-producing cells': 1, 'Epidemiology of primary liver cancer': 1, 'Hepatitis B virus. The major etiology of hepatocellular carcinoma': 1, 'HCVassociated hepatocellular carcinoma without cirrhosis': 1, 'Hepatitis C virus and hepatocellular carcinoma': 1, 'Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures': 1, 'Rising incidence of hepatocellular carcinoma in the United States': 2, 'A proteomic approach for the discovery of early detection markers of hepatocellular carcinoma': 1, 'Micropreparative immobilized pH gradient twodimensional electrophoresis in combination with protein microsequencing for the analysis of human liver proteins': 2, 'Twodimensional electrophoresis map of the human hepatocellular carcinoma cell line, HCC-M, and identification of the separated proteins by mass spectrometry': 2, 'Identification of differentially expressed proteins between human hepatoma and normal liver cell lines by twodimensional electrophoresis and liquid chromatography-ion trap mass spectrometry': 2, 'Biomedical applications of two-dimensional electrophoresis using immobilized pH gradients: current status': 3, 'An in vitro model of hepatitis C virion production': 2, 'Complete replication of hepatitis C virus in cell culture': 2, 'Efficient initiation of HCV RNA replication in cell culture': 1, 'Cleavage of hepatitis C virus nonstructural protein 5A by a caspase-like protease(s) in mammalian cells': 1, 'HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis': 1, 'On the role of Hsp27 in regulating apoptosis': 1, 'Disease proteomics': 1, 'Biomedical informatics for proteomics': 1, 'The current state of two-dimensional electrophoresis with immobilized pH gradients': 1, 'Current two-dimensional electrophoresis technology for proteomics': 3, \"Activation of latent Kaposi's sarcoma-associated herpesvirus by demethylation of the promoter of the lytic transactivator\": 1, 'Use of serum PIVKA-II (DCP) determination for differentiation between benign and malignant liver diseases': 1, 'A strategy for the comparative analysis of serum proteomes for the discovery of biomarkers for hepatocellular carcinoma': 2, 'Proteomic profiling of proteins decreased in hepatocellular carcinoma from patients infected with hepatitis C virus': 1, 'Early induction of apoptosis in hematopoietic cell lines after exposure to flavopiridol': 1, 'Laser capture microdissection: molecular analysis of tissue': 1, 'Protein sequencing by tandem mass spectrometry': 1, 'Evaluation of twodimensional gel electrophoresis-based proteome analysis technology': 1, 'Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol': 1, 'Isoelectric focusing nonporous RP HPLC: a two-dimensional liquid-phase separation method for mapping of cellular proteins with identification using MALDI-TOF mass spectrometry': 1, 'Multi-analyte procedures for screening for and quantification of drugs in blood, plasma, or serum by liquid chromatography-single stage or tandem mass spectrometry (LC-MS or LC-MS/MS) relevant to clinical and forensic toxicology': 1, 'Targeted proteomics of low-level proteins in human plasma by LC/MSn: using human growth hormone as a model system': 1, 'Liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of estradiol and estrone in human plasma': 1, 'Quantitative analysis of thymosin alpha1 in human serum by LC-MS/MS': 1, 'Serial analysis of plasma proteomic signatures in pediatric patients with severe acute respiratory syndrome and correlation with viral load': 1, 'Profiling the humoral immune response to infection by using proteome microarrays: highthroughput vaccine and diagnostic antigen discovery': 2, 'Cleavage of structural proteins during the assembly of the head of bacteriophage T4': 2, 'High resolution two-dimensional electrophoresis of proteins': 1, 'Potential use of pharmacological cyclin dependent kinase inhibitors as anti HIV therapeutics': 2, 'Pharmacological cyclin-dependent kinase inhibitors as HIV-1 antiviral therapeutics': 1, 'Flavopiridol inhibits P-TEFb and blocks HIV-1 replication': 1, 'Proteomic analysis of human plasma: failure of centrifugal ultrafiltration to remove albumin and other high molecular weight proteins': 1, 'Multi-component immunoaffinity subtraction chromatography: an innovative step towards a comprehensive survey of the human plasma proteome': 2, 'An approach to remove albumin for the proteomic analysis of low abundance biomarkers in human serum': 1, 'Effective depletion of albumin using a new peptide-based affinity medium': 2, 'SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer': 1, 'Small animal clinical otology. Surgery 1-Myringotomy': 2, 'Veterinary Neuroanatomy and Clinical Neurology': 2, 'White fur, blue eyes, and deafness in the domestic cat': 1, 'Results of surgery in cats with ceruminous gland adenocarcinoma': 1, 'Evaluation of dogs and cats with tumours of the ear canal: 145 cases (1978-1992)': 1, 'Adenocarcinoma of the middle ear with osteolysis of the tympanic bulla in a cat': 2, \"Extracranial neoplasia with facial nerve paralysis in 'two cats\": 1, 'Feline neurology': 4, 'Tympanic bulla osteotomy for treatment of middle-ear disease in cats: 19 cases (1984-1991)': 1, 'Computed tomographic appearance of inflammatory polyps in three cats': 1, 'Review of idiopathic feline vestibular syndrome in 75 cats': 1, 'Cerebrospinal cuterebriasis in cats and its association with feline ischemic encephalopathy': 1, 'Clinical and clmicopathologic features in 11 cats with Cuterebra larvae myiasis of the central nervous system': 1, 'Ototoxicity in dogs and cats': 1, 'Toxic effects of dihydrostreptomycin upon the central vestibular mechanism of the cat': 1, 'Blue tailed lizard': 1, 'What is your diagnosis?': 1, 'Thiamine deficiency encephalopathy in cats': 1, 'Naturally-occurring and experimental thiamine deficiency in cats receiving commercial cat food': 1, 'A condition resembling Chastek paralysis in cats': 1, 'Feline coronavirus infection': 1, 'Diagnostic features of clinical neurologic feline infectious peritonitis': 4, 'Toxoplasmosis and neosporosis. Chapter 80': 1, 'Greene CE (ed) Infectious Diseases of the Dog and Cat. 2nd edn. Philadelphia: WB Saunders': 1, 'Reversible central nervous system toxicosis associated with metronidazole therapy in three cats': 1, 'Central nervous system toxicosis associated with metronidazole treatment of dogs: Five cases (1984-87)': 1, 'Identifi cation of a novel polyomavirus from patients with acute respiratory tract infections': 4, 'Identifi cation of a third human polyomavirus': 3, 'Clinical and epidemiologic characterization of WU polyomavirus infection': 4, 'WU polyomavirus in children': 2, 'WU polyomavirus in children with acute lower respiratory tract infections': 3, 'No evidence for an association between infections with WU and KI polyomaviruses and respiratory disease': 3, 'Viral specimen collection by parents increases response rate in population-based virus studies': 1, 'Feline infectious peritonitis: role of the feline coronavirus 3c gene in intestinal tropism and pathogenicity based upon isolates from resident and adopted shelter cats': 1, 'A review of feline infectious peritonitis infection: 1963-2008': 7, 'Pathogenesis of feline enteric coronavirus infection': 1, 'Basic and Clinical Immunology': 1, 'Prevalence of feline infectious peritonitis in specific cat breeds': 2, 'Epidemiology of feline infectious peritonitis among cats examined at veterinary medical teaching hospitals': 1, 'Risk factors for feline infectious peritonitis in Australian cats': 1, 'Both ends of the leash -the human links to good dogs with bad genes': 1, 'Cytidine monophospho-N-acetylneuraminic acid hydroxylase (CAMH) mutations associated with the domestic cats AB blood group': 1, 'Selkirk Rex: morphological and genetic characterization of a new cat breed': 1, 'The naked truth: Sphynx and Devon Rex cat breed mutations in KRT71': 1, 'A novel CYP27B1 mutation causes a feline vitamin D-dependent rickets type IA': 1, 'Extent of linkage disequilibrium in the domestic cat, Felis silvestris catus, and its breeds': 1, 'PLINK: a toolset for wholegenome association and population-based linkage analysis': 2, 'CED-12/ELMO, a novel member of the CrkII/Dock180/Rac pathway, is required for phagocytosis and cell migration': 1, 'Signal transduction induced by apoptotic cells inhibits HIV transcription in monocytes/macrophages': 1, \"Following TRAIL's path in the immune system\": 1, 'Type I interferons and interferon regulatory factors regulate TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected macrophages': 1, 'Functional tumor necrosis factor-related apoptosis-inducing ligand production by avian influenza virus-infected macrophages': 1, 'Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily': 1, 'Interaction of an adenovirus 14.7-kilodalton protein inhibitor of tumor necrosis factor alpha cytolysis with a new member of the GTPase superfamily of signal transducers': 1, 'The final cut: how ERAP1 trims MHC ligans to size': 1, 'Genetic diversity at endoplasmic reticulum aminopeptidases is maintained by balancing selection and is associated with natural resistance to HIV-1 infection': 1, 'Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results': 2, 'Genetics, statistics and human disease: analytical retooling for complexity': 1, 'Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof': 1, 'Suspected anaphylactic reaction to Cremophor EL': 1, 'Anaphylactoid reactions to IV substances': 1, 'Complement-mediated reactions to diazepam with Cremophor as solvent (Stesolid MR)': 1, 'Cyclodextrin nephrosis in the rat': 2, 'Sulfoalkyl ether-alkyl ether cyclodextrin derivatives, their synthesis, NMR characterization, and binding of 6α-methylprednisolone': 1, 'Amorphous water soluble derivatives of cyclodextrins: From test tube to patient': 1, 'Development and Evaluation of the Usefulness and Parenteral Safety of Modified Cyclodextrins': 10, 'Change of phase-solubility behavior by gamma-cyclodextrin derivatization': 1, 'Solubilization of drugs by modified β-cyclodextrins': 1, 'Preliminary safety evaluation of parenterally administered sulfoalkyl ether β-cyclodextrin derivatives': 4, 'Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof': 2, 'RNA interference: listening to the sound of silence': 1, 'RNA interference': 1, 'RNA interference is mediated by 21-and 22-nucleotide RNAs': 1, 'RNA interference by expression of shortinterfering RNAs and hairpin RNAs in mammalian cells': 1, 'RNA interference: biology, mechanism, and applications, Microbiology and': 1, 'Gene silencing in mammals by small interfering RNAs': 1, 'Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): mechanism of action': 1, 'Antisense RNA: function and fate of duplex RNA in cells of higher eukaryotes': 1, 'Potency of siRNA versus shRNA mediated knockdown in vivo': 1, 'shRNAs targeting hepatitis C: effects of sequence and structural features, and comparison with siRNA': 1, 'Nguyen, I. siRNA-027 study, RNAi-based treatment for neovascular age-related macular degeneration by siRNA-027': 1, 'RNA interference advances to early-stage clinical trials': 2, 'Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles': 1, 'A randomized, double-blind, placebocontrolled study of an RNAi-based therapy directed against respiratory syncytial virus': 5, 'Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells': 1, 'Poly(beta-amino ester) as a carrier for si/shRNA delivery in lung cancer cells': 1, 'Small RNAs and non-small cell lung cancer': 1, 'Inhibition of non-small cell lung cancer cell proliferation and tumor growth by vector-based small interfering RNAs targeting HER2/neu': 1, 'WT1 gene silencing by aerosol delivery of PEI-RNAi complexes inhibits B16-F10 lung metastases growth': 1, 'RNA interference-mediated silencing of the respiratory syncytial virus nucleocapsid defines a potent antiviral strategy': 1, 'RNA interference of avian influenza virus H5N1 by inhibiting viral mRNA with siRNA expression plasmids': 1, 'Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in rhesus macaque': 4, 'RNA interference: new therapeutics in allergic diseases': 1, 'Involvement of Syk kinase in TNF-induced nitric oxide production by airway epithelial cells': 1, 'Selective inhibition of endoplasmic reticulumassociated degradation rescues Delta F508-cystic fibrosis transmembrane regulator and suppresses interleukin-8 levels': 1, 'Intratracheal instillation as an exposure technique for the evaluation of respiratory tract toxicity: uses and limitations': 3, 'Adenovirus vector-mediated doxycycline-inducible RNA interference': 1, 'Adenovirus-mediated transfer of siRNA against survivin enhances the radiosensitivity of human nonsmall cell lung cancer cells': 1, 'Down-regulation of expression of rat pyruvate dehydrogenase E1 alpha gene by self-complementary adeno-associated virus-mediated small interfering RNA delivery': 1, 'Gene therapy for human small-cell lung carcinoma by inactivation of Skp-2 with virally mediated RNA interference': 1, 'Small interfering RNA against interleukin-5 decreases airway eosinophilia and hyper-responsiveness': 1, 'Gene transfer to the lung: lessons learned from more than 2 decades of CF gene therapy': 1, 'Immune responses to gene therapy vectors: influence on vector function and effector mechanisms': 1, 'Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer': 2, 'Gene therapy insertional mutagenesis insights': 1, 'A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency': 1, 'Occurrence of leukaemia following gene therapy of X-linked SCID': 1, 'Gene therapy: second child in French trial is found to have leukemia': 1, 'Lung delivery studies using siRNA conjugated to TAT(48-60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity': 8, 'Drug Delivery to the Lung': 1, 'Aerosols in Medicine: Principles, Diagnosis, and Therapy': 1, 'In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery': 4, 'Inhaled nanoparticles -a current review': 1, 'Formation, characterization, and fate of inhaled drug nanoparticles': 1, 'Nanodelivery in airway diseases: challenges and therapeutic applications': 1, 'Mucus clearance as a primary innate defense mechanism for mammalian airways': 1, 'Nonviral siRNA delivery to the lung: investigation of PEG-PEI polyplexes and their in vivo performance': 4, 'Interaction of bronchoalveolar lavage fluid with polyplexes and lipoplexes: analysing the role of proteins and glycoproteins': 1, 'Pulmonary surfactant inhibits cationic liposome-mediated gene delivery to respiratory epithelial cells in vitro': 1, 'Mechanisms of macromolecule absorption by the lungs': 2, 'Large porous particles for pulmonary drug delivery': 1, 'Inhalation system for pulmonary aerosol drug delivery in rodents using large porous particles': 1, 'NanoCipro encapsulation in monodisperse large porous PLGA microparticles': 1, 'Mucus altering agents as adjuncts for nonviral gene transfer to airway epithelium': 2, 'Inhalation of dry-powder mannitol increases mucociliary clearance': 1, 'Effect of increasing doses of mannitol on mucus clearance in patients with bronchiectasis': 1, 'Inhaled mannitol improves the hydration and surface properties of sputum in patients with cystic fibrosis': 1, 'Using magnetic forces to enhance non-viral gene transfer to airway epithelium in vivo': 1, 'Targeted delivery of magnetic aerosol droplets to the lung': 1, 'Use of ultrasound to enhance nonviral lung gene transfer in vivo': 1, 'Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery': 4, 'A versatile vector for gene and oligonucleotide transfer into cells in culture and in-vivo polyethylenimine': 3, 'A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo': 1, 'Multifunctional siRNA delivery system: polyelectrolyte complex micelles of six-arm PEG conjugate of siRNA and cell penetrating peptide with crosslinked fusogenic peptide': 1, 'Intracellular siRNA delivery system using polyelectrolyte complex micelles prepared from VEGF siRNA-PEG conjugate and cationic fusogenic peptide': 1, 'Fusogenic peptides enhance endosomal escape improving siRNA-induced silencing of oncogenes': 1, 'Mechanisms of alveolar epithelial translocation of a defined population of nanoparticles': 1, 'Lipid rafts and caveolae as portals for endocytosis: new insights and common mechanisms': 1, 'Innate sensing of self and non-self RNAs by Toll-like receptors': 1, 'RNA interference and innate immunity': 1, 'Evaluation of aerosol delivery of nanosuspension for pre-clinical pulmonary drug delivery': 1, 'Systemic delivery of parathyroid hormone (1-34) using inhalation dry powders in rats': 1, 'Inhalable large porous microspheres of low molecular weight heparin: in vitro and in vivo evaluation': 1, 'Modified-Release Drug Delivery Technology, Informa Healthcare': 2, 'Inhaled insulin is approved in Europe and United States': 1, \"Inhaled insulin's last gasp?\": 1, 'Exubera Phase, Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes -results of a 6-month, randomized, comparative trial': 1, 'Exubera Phase, Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes -results of a 6-month, randomized, comparative trial': 1, 'Safety and efficacy of inhaled human insulin (Exubera) during discontinuation and readministration of therapy in adults with type 2 diabetes: a 3-year randomized controlled trial': 1, 'Exubera inhaled insulin in patients with type 1 and type 2 diabetes: the first 12 months': 1, 'Exubera Phase, Efficacy of inhaled insulin in patients with type 2 diabetes not controlled with diet and exercise -a 12-week, randomized, comparative trial': 1, 'Prospects of formulating proteins/peptides as aerosols for pulmonary drug delivery': 2, 'Spray drying of biopharmaceuticals: stability and process considerations': 1, 'Pulmonary delivery of therapeutic peptides via dry powder inhalation: effects of micronisation and manufacturing': 3, 'Non-invasive pulmonary aerosol delivery in mice by the endotracheal route': 1, 'Intratracheal versus intravenous liposomal delivery of siRNA, antisense oligonucleotides and anticancer drug': 1, 'Silencing of Fas, but not caspase-8, in lung epithelial cells ameliorates pulmonary apoptosis, inflammation, and neutrophil influx after hemorrhagic shock and sepsis': 2, 'Efficient gene silencing in lungs and liver using imidazole-modified chitosan as a nanocarrier for small interfering RNA': 1, 'RNA interference in vitro and in vivo using a chitosan/siRNA nanoparticle system': 3, 'Small interfering RNA targeting heme oxygenase-1 enhances ischemia-reperfusion-induced lung apoptosis': 3, 'Intranasal insulin delivery and therapy': 2, 'Deposition of particles in the human respiratory tract in the size range 0.005-15 μm': 1, 'Intranasal drug delivery': 1, 'Chemically modified siRNA: tools and applications': 1, 'Systemic delivery of RafsiRNA using cationic cardiolipin liposomes silences Raf-1 expression and inhibits tumor growth in xenograft model of human prostate cancer': 1, 'Progress towards in vivo use of siRNAs': 1, 'Inhaled liposomes -current strategies and future challenges': 1, 'Delivery vehicles for small interfering RNA in vivo': 1, 'Oxygen radicalmediated pulmonary toxicity induced by some cationic liposomes': 1, 'Surface modifications of nanoparticles to oppose uptake by the mononuclear phagocyte system': 1, 'Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial': 1, 'A clinical inflammatory syndrome attributable to aerosolized lipid-DNA administration in cystic fibrosis': 1, 'Inefficient cationic lipid-mediated siRNA and antisense oligonucleotide transfer to airway epithelial cells in vivo': 1, 'Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs': 1, 'Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures': 1, 'RNAi-mediated gene silencing in non-human primates': 1, 'Lipid-like materials for low-dose, in vivo gene silencing': 1, 'Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers': 1, 'Nucleic acid delivery with chitosan and its derivatives': 2, 'Polymeric nanocarriers for siRNA delivery: challenges and future prospects': 1, 'Development and characterisation of chitosan nanoparticles for siRNA delivery': 2, 'Degradable polyethylenimine-alt-poly(ethylene glycol) copolymers as novel gene carriers': 2, 'Identification of novel superior polycationic vectors for gene delivery by high-throughput synthesis and screening of a combinatorial library': 1, 'Chitosan-based formulations for delivery of DNA and siRNA': 1, 'The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing': 1, 'Biodegradable nanoparticles for drug and gene delivery to cells and tissue': 1, 'Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactideco-glycolide) and its derivatives': 2, 'Spray-drying preparation of microparticles containing cationic PLGA nanospheres as gene carriers for avoiding aggregation of nanospheres': 1, 'Cellular uptake of the TAT protein from human immunodeficiency virus': 1, 'siRNA delivery using peptide transduction domains': 1, 'Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides': 3, 'Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells': 1, 'RNA targeting with peptide conjugates of oligonucleotides, siRNA and PNA': 3, 'Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells': 1, 'Highly efficient small interfering RNA delivery to primary mammalian neurons induces MicroRNA-like effects before mRNA degradation': 1, 'Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells': 1, 'Cellular delivery of small interfering RNA by a non-covalently attached cell-penetrating peptide: quantitative analysis of uptake and biological effect': 2, 'A new potent secondary amphipathic cellpenetrating peptide for siRNA delivery into mammalian cells': 1, 'Insight into the cellular uptake mechanism of a secondary amphipathic cell-penetrating peptide for siRNA delivery': 1, 'Design and evaluation of histidine-rich amphipathic peptides for siRNA delivery': 1, 'Cell-penetrating peptides': 1, 'Tat peptide-mediated cellular delivery: back to basics': 1, 'Membrane-permeable arginine-rich peptides and the translocation mechanisms': 1, 'Cell-penetrating peptides: tools for intracellular delivery of therapeutics': 1, 'Cell-penetrating-peptide-mediated siRNA lung delivery': 1, \"WHO Director-General's opening remarks at the media briefing on COVID-19-11\": 1, 'Novel Coronavirus Infection (COVID-19) in Humans: A Scoping Review and Meta-Analysis': 1, 'Risikobewertung zu Covid-19': 1, 'Risk perception and effectiveness of uncoordinated behavioral responses in an emerging epidemic': 2, 'CDC AA refVal = https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus% 2F2019-ncov%2Fsymptoms-testing%2Fshare-facts.html': 2, 'WHO: Coronavirus disease 2019 (COVID-19) Situation Report -45': 2, 'Bundeszentrale für gesundheitliche Aufklärung (BZgA): Informationen zum neuartigen Coronavirus /Covid-19': 2, 'Ebola risk perception in Germany': 2, 'Knowledge Risk Perceptions, and Xenophobic Attitudes: Evidence from Italy During the Ebola Outbreak': 1, 'Risk perception and information-seeking behaviour during the 2009/10 influenza A(H1N1)pdm09 pandemic in Germany': 4, 'Preventive Behaviors Conveyed on YouTube to Mitigate Transmission of COVID-19: Cross-Sectional Study': 1, 'How to fight an infodemic': 1, 'Using rapid online surveys to assess perceptions during infectious disease outbreaks: a cross-sectional survey on Covid-19 among the general public in the United States and United Kingdom': 1, 'Stellungnahme der Deutschen Gesellschaft für Epidemiologie (DGEpi) zur Verbreitung des neuen Coronavirus (SARS-CoV': 1, 'SARS Risk Perception, Knowledge Precautions, and Information Sources, the Netherlands': 2, 'Perceptions of Zika virus risk in Germany in 2016': 1, 'Der infizierte Rechtsstaat': 1, 'Die Mannheimer Corona-Studie: Gesellschaftliche Akzeptanz politischer Maßnahmen und befürchtete Konsequenzen für die Wirtschaft': 1, 'Factors associated with attrition in a longitudinal online study: results from the HaBIDS panel': 1, 'Comparative assessment of three Southeast Asian tourism recovery campaigns: Singapore roars: post SARS': 6, \"Rethinking the Prime Minister's Dilemma\": 1, 'Perceived risk and risk reductions in holiday purchase: A cross-cultural and gender analysis': 1, 'Risk perceptions and pleasure tourist: An exploratory analysis': 1, 'The impact of the severe acute respiratory syndrome on hotels: A case study of Hong Kong': 1, 'Managing a health-related crisis: SARS in Singapore': 1, 'The over-reaction to SARS and the collapse of Asian tourism': 1, 'Perceived travel risks regarding terrorism and disease: The case of Thailand': 2, 'Crisis management and recovery: How restaurants in Hong Kong responded to SARS': 1, \"A case study of best practice-visit Scotland's prepared response to an influenza pandemic\": 1, 'The effect of risk perceptions on intentions to tourist in the aftermath of': 1, 'Perceived risk and the noninstitutionalized tourist role: The case of Israeli student ex-backpackers': 1, 'Tourism, terrorism, and political instability': 3, 'Determining future tourist behavior from past tourist experience and perceptions of risk and safety': 2, \"Tsunami recovery: A case study of Thailand's Tourism\": 9, 'Tour operators and destination safety': 2, 'The role of security information in tourism crisis management: The missing link': 5, 'Editorial: Tourism and terrorism': 4, \"Responding to disaster: Thai and Scandinavian tourists' motivation to visit Phuket\": 3, 'Marketing your community: Correcting a negative image': 2, 'Crisis management: Preparing for an managing disasters': 1, 'Towards a framework for tourism disaster management': 3, 'Recovery marketing: What to do after a natural disaster': 6, 'Managing the Asian financial crisis: Tourist attractions in Singapore': 4, 'Communicating in a crisis: Flight SQ 006': 1, 'No-escape natural disaster: Mitigating impacts on tourism': 1, 'Earthquake devastation and recovery in tourism: The Taiwan case': 5, 'Corporate social responsibility and tourism: Hotel companies in Phuket Thailand, after the Indian Ocean Tsunami': 2, 'Recovery from natural disaster: Travel writers and tourist destinations': 6, 'Responding to natural disasters: Managing a hotel in the aftermath of the Indian Ocean Tsunami': 5, \"The malevolent ''Undead'': Cross-cultural perspectives. Handbook of Death & Dying\": 3, 'Ghostly topographies: Landscape and biopower in modern Singapore': 5, 'The ritual refining of restless ghost among the Chinese of Thailand': 6, 'Ghost illness in a North Indian village': 7, 'Belief in ghost month can help prevent drowning deaths: A natural experiment on the effects of cultural beliefs on risky behaviors': 6, \"The missionary as stranger: A phenomenological analysis of Christian missionaries' encounter with the folk religions of Thailand\": 7, \"Christianity and Buddhism in Thailand: The ''battle of the axes'' and the ''contest of power\": 8, 'Psychology of the Thai people: Values and behavioral patterns': 5, 'Buddhism and the spirit cults in': 7, 'The Buddhist saints of the forest and the cult of amulets: A study in charisma, hagiography, sectarianism, and millennial Buddhism': 4, 'Monks and magic: An analysis of religious ceremonies in central Thailand': 7, 'The Taoist (Chinese) way of death. Handbook of death and dying': 2, 'Cross-cultural behavior in tourism: Concepts and analysis': 5, 'Transcending death. Encyclopedia of death and the human experience': 1, 'Animism. Encyclopedia of death and the human experience': 1, 'Cultural tourism, the state, and day of the dead': 1, 'Dimensions of religiosity among believers in Japanese folk religion': 1, 'Chinese death taboos. Encyclopedia of death and the human experience': 1, 'Views of mental illness and metal health care in Thailand: A report of an ethnographic study': 7, 'Superstitious, marginal, and paranormal beliefs: An integrative model': 3, 'Inside Thai society: Religion everyday life change': 1, 'Accident risk and driver behaviors': 2, 'Folk religion and tourist intention': 2, '2000 Science and technology: Public attitudes and public understanding, belief in the paranormal or pseudoscience': 1, 'An investigation into the alleged haunting of Hampton court palace: Psychological variables and magnetic fields': 1, 'Burial at Sea: Separating and placing the dead during the age of sail': 3, 'Paranormal beliefs among Swedish Youth. Young': 4, 'Highland and other haunter ghosts in Scottish Tourism': 2, 'Socio-Cultural variations': 1, 'The selectivity of nonmaterial beliefs in interpreting life events': 1, 'Welcoming a monster to the world: Myths, oral tradition, and modern societal response to volcanic disasters': 1, \"Culture's consequences: International differences in work-related values\": 1, \"Culture's consequences: Campaign values, behavior, institutions, and organizations across nations\": 1, 'Cross-cultural perspectives on motivation': 1, 'Travel anxiety and intentions to travel internationally: Implications of travel risk perception': 1, 'Consumer behavior in Asia': 1, 'Cultural differences between Asian tourist markets and Australian hosts, Part 1': 2, 'Providing safety for tourists: A study of a selected sample of tourist destinations in the United States and Brazil': 1, 'Effects of news shock on inbound tourist demand volatility in Korea': 1, 'Cycles of war, terror, and peace: Determinants and management of crisis and recovery of the Israeli tourism industry': 1, 'Reputational disaster in Phuket: The secondary impact of the Tsunami on inbound tourism. Disaster Prevention and Management': 1, 'Current status of tourist health and safety': 1, \"What recovery? A commentary in response to Bongkosh Ngamsom Rittichainuwat's ''Tsunami recovery: A case study of Thailand's tourism\": 1, 'A commentary on effective responses to tourism disasters': 1, 'Non-contingent positive and negative reinforcement schedules of superstitious behaviors': 1, 'Superstition, risk-taking and risk perception of accidents among South African taxi drivers': 1, \"Applying Hofstede's national culture measures in tourism research: Illuminating issues of divergence and convergence\": 1, 'Interim guidance for life support for COVID-19': 1, 'Development and testing of a low cost videolaryngoscope in a resource limited setting': 2, 'A do-it-yourself videolaryngoscope for under 25$: a solution for lower income countries?': 1, 'The complexities of tracheal intubation with direct laryngoscopy and alternative intubation devices': 1, 'Defining and developing expertise in tracheal intubation using a GlideScope® for anaesthetists with expertise in Macintosh direct laryngoscopy: an in-vivo longitudinal study': 1, 'Burnout in physicians who are exposed to workplace violence': 1, 'Appeal from Chinese doctors to end violence': 1, 'Chinese doctors are under threat': 1, 'Human bocavirus: passenger or pathogen in acute respiratory tract infections?': 1, 'Human parvovirus B19-induced cell cycle arrest and apoptosis': 1, 'Human parvovirus B19 induces cell cycle arrest at G(2) phase with accumulation of mitotic cyclins': 1, 'In vivo accumulation of cyclin A and cellular replication factors in autonomous parvovirus minute virus of mice-associated replication bodies': 1, 'Cyclin A activates the DNA polymerase delta -dependent elongation machinery in vitro: a parvovirus DNA replication model': 1, 'The NS1 protein of the autonomous parvovirus minute virus of mice blocks cellular DNA replication: a consequence of lesions to the chromatin?': 1, 'S-phase-dependent cell cycle disturbances caused by Aleutian mink disease parvovirus': 1, 'The nonstructural proteins of the autonomous parvovirus minute virus of mice interfere with the cell cycle, inducing accumulation in G2': 1, 'Influence of adeno-associated virus on adherence and growth properties of normal cells': 1, 'Interaction of virally coded protein and a cell cycle-regulated cellular protein with the bovine parvovirus left terminus ori': 1, 'Molecular biology and pathogenicity of human and animal parvoviruses': 1, 'Human bocavirus can be cultured in differentiated human airway epithelial cells': 1, 'Characterization of the gene expression profile of human bocavirus': 1, 'Rolling hairpin model for replication of parvovirus and linear chromosomal DNA': 1, 'Replication initiator protein NS1 of the parvovirus minute virus of mice binds to modular divergent sites distributed throughout duplex viral DNA': 1, 'Encapsidation of minute virus of mice DNA: aspects of the translocation mechanism revealed by the structure of partially packaged genomes': 1, 'Genome packaging sense is controlled by the efficiency of the nick site in the right-end replication origin of parvoviruses minute virus of mice and LuIII': 1, 'The left-end and right-end origins of minute virus of mice DNA differ in their capacity to direct episomal amplification and integration in vivo': 1, \"An asymmetric nucleotide in the parvoviral 3' hairpin directs segregation of a single active origin of DNA replication\": 1, 'Asymmetric resolution of a parvovirus palindrome in vitro': 1, 'In vitro excision and replication of 59 telomeres of minute virus of mice DNA from cloned palindromic concatemer junctions': 1, 'Novel application for isothermal nucleic acid sequence-based amplification (NASBA)': 1, 'Detection of head-to-tail DNA sequences of human bocavirus in clinical samples': 2, 'Genomic features of the human bocaviruses': 3, 'A novel bocavirus in canine liver': 1, 'Detection of a bocavirus circular genome in fecal specimens from children with acute diarrhea in beijing, china': 1, 'Identification and characterization of porcine bocavirus episomes': 1, 'Genetic fate of recombinant adenoassociated virus vector genomes in muscle': 1, 'Establishment of a reverse genetics system for studying human bocavirus in human airway epithelia': 2, 'Herpes simplex virus-induced \"rolling circle\" amplification of SV40 DNA sequences in a transformed hamster cell line correlates with tandem integration of the SV40 genome': 2, 'Herpes simplex virus-directed overreplication of chromosomal DNA physically linked to the simian virus 40 integration site of a transformed hamster cell line': 1, 'Genome replication and progeny virion production of herpes simplex virus type 1 mutants with temperature-sensitive lesions in the origin-binding protein': 1, 'Definition of herpes simplex virus type 1 helper activities for adeno-associated virus early replication events': 2, 'Infection with Parvovirus B19 and Herpes viruses in early pregnancy and risk of second trimester miscarriage or very preterm birth': 2, 'Human parvovirus B19, varicella zoster virus, and human herpesvirus-6 in mesenchymal stem cells of patients with osteoarthritis: analysis with quantitative real-time polymerase chain reaction': 2, 'Fatal myocarditis associated with acute parvovirus B19 and human herpesvirus 6 coinfection': 2, 'Human herpesvirus 6 (HHV-6) is a helper virus for adeno-associated virus type 2 (AAV-2) and the AAV-2 rep gene homologue in HHV-6 can mediate AAV-2 DNA replication and regulate gene expression': 3, 'Does human bocavirus infection depend on helper viruses? A challenging case report': 1, 'Human herpesvirus-6 and parvovirus B19 infections in children': 1, 'Herpesviruses provide helper functions for avian adeno-associated parvovirus': 1, 'Detection of HBoV DNA in idiopathic lung fibrosis': 1, 'Identification and functional analysis of novel non-structural proteins of human bocavirus 1': 1, 'Seroprevalence of antibody against human bocavirus in Beijing, China': 1, 'Prevalence and clinical aspects of human bocavirus infection in children': 1, 'Seroepidemiology of human bocaviruses 1-4': 2, 'The genomic and seroprevalence of human bocavirus in healthy Chinese plasma donors and plasma derivatives': 1, 'Community surveillance of respiratory viruses among families in the Utah Better identification of germs-longitudinal viral epidemiology (BIG-LoVE) study': 7, 'Low copy number detection of HBoV DNA in BAL of asymptomatic adult patients': 6, 'Viral etiology of acute lower respiratory tract infections in hospitalized young children in Northern Taiwan': 2, 'Clinical features of human metapneumovirus genotypes in children with acute lower respiratory tract infection in Changsha': 2, 'Detection of human bocavirus in nasopharyngeal aspirates versus in bronchoalveolar lavage fluids in children with lower respiratory tract infections': 2, 'High prevalence of human bocavirus 1 in infants with lower acute respiratory tract disease in Argentina': 2, 'Human bocavirus amongst an all-ages population hospitalised with acute lower respiratory infections in Cambodia': 3, 'Viral infections of the lower respiratory tract: old viruses, new viruses, and the role of diagnosis': 2, \"Human bocavirus in children suffering from acute lower respiratory tract infection in Beijing Children's Hospital\": 2, 'Human bocavirus DNA detected by quantitative real-time PCR in two children hospitalized for lower respiratory tract infection': 2, 'High prevalence of human bocavirus detected in young children with severe acute lower respiratory tract disease by use of a standard PCR protocol and a novel real-time PCR protocol': 2, 'Techniques used for the diagnostic of upper and lower respiratory tract viral infections': 2, 'Evidence of human bocavirus circulating in children and adults': 1, 'Detection of human bocavirus from children and adults with acute respiratory tract illness in Guangzhou, southern China': 1, 'Detection of human bocavirus DNA by polymerase chain reaction in children and adults with acute respiratory tract infections': 1, 'Severe pneumonia and human bocavirus in adult': 1, 'Seroepidemiology of human bocavirus in Hokkaido prefecture': 1, 'Seroepidemiology of human bocavirus in': 1, 'Original antigenic sin with human bocaviruses 1-4': 3, 'Detection of human bocavirus in the cerebrospinal fluid of children with encephalitis': 1, 'Human bocavirus in patients with encephalitis': 1, 'Human bocavirus infection induces cytokine expression associated with lung fibrosis': 2, 'Lung infection by human bocavirus induces the release of profibrotic mediator cytokines in vivo and in vitro': 1, 'Comparison of Th-cell immunity against human bocavirus and parvovirus B19: proliferation and cytokine responses are similar in magnitude but more closely interrelated with human bocavirus': 1, 'Viral infections and colorectal cancer: a systematic review of epidemiological studies': 1, 'Human Bocavirus: from common cold to cancer? Speculations on the importance of an episomal genomic form of human bocavirus': 2, 'Cellular interactions in the pathogenesis of interstitial lung diseases': 1, 'The role of chemokines and cytokines in lung fibrosis': 2, 'Cytokines and pulmonary fibrosis': 1, 'The role of the Th2 CC chemokine ligand CCL17 in pulmonary fibrosis': 1, 'Pathogenesis of cBFL in common with IPF? Correlation of IP-10/TARC ratio with histological patterns': 1, 'Human bocavirus NP1 inhibits IFN-beta production by blocking association of IFN regulatory factor 3 with IFNB promoter': 1, 'Human bocavirus 1 primary infection and shedding in infants': 4, 'Evaluation of commercial ResPlex II v2.0, MultiCode-PLx, and xTAG respiratory viral panels for the diagnosis of respiratory viral infections in adults': 2, 'A novel RT-multiplex PCR for detection of Aichi virus, human parechovirus, enteroviruses, and human bocavirus among infants and children with acute gastroenteritis': 2, 'Comparison of four nasal sampling methods for the detection of viral pathogens by RT-PCR-A GA(2)LEN project': 2, 'Comparison of the film array respiratory panel and prodesse realtime PCR assays for detection of respiratory pathogens': 2, 'Human bocaviruses are not significantly associated with gastroenteritis: results of retesting archive DNA from a case control study in the UK': 1, 'Detection of bocavirus in saliva of children with and without respiratory illness': 2, 'Clinical and epidemiologic characteristics of human bocavirus in Danish infants: results from a prospective birth cohort study': 1, 'Human bocavirus detection in nasopharyngeal aspirates of children without clinical symptoms of respiratory infection': 1, 'Human bocavirus infection in children with acute respiratory tract infection in India': 1, 'Fatal human bocavirus infection in an 18-month-old child with chronic lung disease of prematurity': 1, 'Comorbidity and high viral load linked to clinical presentation of respiratory human bocavirus infection': 1, 'Clinical outcomes associated with respiratory virus detection before allogeneic hematopoietic stem cell transplant': 1, 'Atypical presentation of human bocavirus: severe respiratory tract infection complicated with encephalopathy': 1, 'Human bocavirus infections in hospitalized Greek children': 1, 'Clinical and microbiological impact of human bocavirus on children with acute otitis media': 1, 'Association of human bocavirus 1 infection with respiratory disease in childhood follow-up study': 1, 'Human bocavirus 1 infects commercially available primary human airway epithelium cultures productively': 1, 'Human bocavirus in the nasopharynx of otitis-prone children': 1, 'Persistence of human bocavirus DNA in immunocompromised children': 1, 'Plethora of respiratory viruses and respiratory virus data': 1, 'Comparison of the Luminex xTAG RVP fast assay and the Idaho Technology FilmArray RP assay for detection of respiratory viruses in pediatric patients at a cancer hospital': 2, 'Clinical assessment and improved diagnosis of bocavirusinduced wheezing in children': 1, \"Don't forget serum in the diagnosis of human bocavirus infection\": 1, 'Dating of human bocavirus infection with protein-denaturing IgG-avidity assays-Secondary immune activations are ubiquitous in immunocompetent adults': 1, 'Serologically verified human bocavirus pneumonia in children': 1, 'Do youth employment programs improve labor market outcomes? A quantitative review': 5, 'Young People in the Labor Market: Past, Present, Future. Routledge': 3, 'Positive Youth Development: Theory, Research, and Applications': 3, 'The evidence is In: How Should youth Employment in Low Income Countries be Designed? Policy Research Working Paper 8500': 1, 'Earning, learning, and access to support: The role of early engagement in work, employment skills development and supportive relationships in employment outcomes for vulnerable youth in New Zealand': 1, 'Youth Labor Market Dynamics in South Africa: Evidence from NIDS 1-2-3. SALDRU Working Paper Series Working Paper No. 39': 3, \"From Assets to School Outcomes How Finances Shape Children's Perceived Possibilities and Intentions\": 1, 'Assets and Educational Achievement: Theory and Evidence': 1, 'The Global Findex Database 2014 : measuring financial inclusion around the world (English)': 1, 'International Labor Organisation (ILO), 2019. World Employment and Social Outlook: Trends 2019. International Labor Organisation': 1, 'A Review of Interventions to Support Young Workers: Findings of the Youth Employment Inventory (Discussion Paper No. 715)': 1, 'What Works? A Meta Analysis of Recent Active Labor Market Program Evaluations': 2, 'Positive Youth Development in the United States: Research Findings on Evaluations of Positive Youth Development Programs': 1, \"Whose Skill Is It Anyway? 'Soft' Skills and Polarization\": 1, 'Experimental and Quasi-Experimental Designs for Generalized Causal Inference': 1, 'Society and the adolescent self-image': 1, 'Simultaneous Administration of the Rosenberg Self-Esteem Scale in 53 Nations: Exploring the Universal and Culture-Specific Features of Global Self-Esteem': 1, 'Household Food Insecurity Access Scale (HFIAS) for Measurement of Food Access: Indicator Guide. Version 3. Food and Nutrition Technical Assistance Project, Academy for Education Development': 1, 'Smooth, staggered or stopped? Educational transitions in the South African Youth Panel Study': 1, 'Facing the Future: The Perceptions of Black Adolescents on their Prospects in South Africa': 1, 'Persistence of delays in presentation and treatment for patients with acute myocardial infarction: The GUSTO-I and GUSTO-III experience': 2, 'Fourth Universal Definition of': 1, 'National efforts to improve door-toballoon time results from the Door-to-Balloon Alliance': 1, 'When is door-to-balloon time critical? Analysis from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) and CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trials': 1, 'Health-care access during the Ebola virus epidemic in Liberia': 1, 'Patient delay in seeking care for heart attack symptoms: findings from focus groups conducted in five U.S. regions': 1, 'Delay in calling for help during Journal Pre-proof infarction: Reasons for the delay and subsequent pattern of accessing care': 1, 'Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment-Elevation Myocardial Infarction Care in Hong Kong, China. Circ Cardiovasc Qual Outcomes': 1, 'Herpesvirus lytic replication and the cell cycle: arresting new developments': 1, 'Cell cycle arrest during measles virus infection: a G0-like block leads to suppression of retinoblastoma protein expression': 1, 'Cell cycle arrest in G2/M promotes early steps of infection by human immunodeficiency virus': 1, 'Murine coronavirus replication induces cell cycle arrest in G0/G1 phase': 3, 'The coronavirus infectious bronchitis virus nucleoprotein localizes to the nucleolus': 1, 'Localization to the nucleolus is a common feature of coronavirus nucleoproteins, and the protein may disrupt host cell division': 1, 'Interaction of the coronavirus nucleoprotein with nucleolar antigens and the host cell': 1, 'Nucleolar localization of non-structural protein 3b, a protein specifically encoded by the severe acute respiratory syndrome coronavirus': 1, 'Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine': 1, 'DNA measurement and cell cycle analysis by flow cytometry': 1, 'Creation of a ribonuclease abzyme through site-directed mutagenesis': 1, 'Exploiting antibody-based technologies to manage environmental pollution': 1, 'Respiratory syncytial virus infection': 1, 'Antibodies for defense against biological attack': 2, 'Recombinant immunoglobulin A: powerful tools for fundamental and applied research': 1, 'Antibody-mediated protection against intracellular pathogens': 1, 'Neutralizing antibodies against HIVback in the major leagues?': 1, 'Assessment of radiolabeled stabilized F(ab′)2 fragments of monoclonal antiferritin in nude mouse model': 1, 'Lymphoma Mabs rivalry continues': 1, 'The effect of a monoclonal antibody coupled to ricin A chain-derived peptides on endothelial cells in vitro: insights into toxin-mediated vascular damage': 1, 'Antifection: an antibody-mediated method to introduce genes into lymphoid cells in vitro and in vivo': 1, 'Recombinant antibody fragments': 2, 'The rabbit antibody repertoire as a novel source for the generation of therapeutic human antibodies': 1, 'A recombinant, fully human monoclonal antibody with antitumor activity constructed from phage-displayed antibody fragments': 1, 'Expression of mouse IgA by transgenic mice, pigs and sheep': 1, 'Genes encoding a mouse monoclonal antibody are expressed in transgenic mice, rabbits and pigs': 1, 'Immunoprophylaxis in fish by injection of mouse antibody genes': 1, 'Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies': 1, 'Production of fully human antibodies by transgenic mice': 1, 'Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice': 1, 'Functional expression and germline transmission of a human chromosome fragment in chimaeric mice': 1, 'Production of secretory IgA antibodies in plants': 3, 'In vitro comparison of the antigen-binding and stability properties of the various molecular forms of IgA antibodies assembled and produced in CHO cells': 1, 'Effect of glycosylation on antibody function: implications for genetic engineering': 1, 'Perfect mammalian glycoproteins in plants come of age': 2, 'A murine monoclonal antibody produced in transgenic plants with plant-specific glycans is not immunogenic in mice': 2, 'Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans': 1, 'Human anti-rhesus D IgG1 antibody produced in transgenic plants': 1, 'Transgenic animal bioreactors in biotechnology and production of blood proteins': 1, 'Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics': 1, 'Transgenic mice secreting coronavirus neutralizing antibodies into the milk': 1, 'Engineering passive immunity in transgenic mice secreting virusneutralizing antibodies in milk': 1, 'Production of active anti-CD6 mouse/human chimeric antibodies in the milk of transgenic mice': 1, 'Expression of a functional mouse-human chimeric anti-CD19 antibody in the milk of transgenic mice': 1, 'Antitransferrin receptor antibody-RNase fusion protein expressed in the mammary gland of transgenic mice': 1, 'Vector design for transgene expression': 1, 'Position-effect protection and enhancer blocking by the chicken β β-globin insulator are separable activities': 1, 'Association of the 5′ ′HS4 sequence of the chicken β β-globin locus control region with human EF1 α α gene promoter induces ubiquitous and high expression of human CD55 and CD59 cDNAs in transgenic rabbits': 1, 'Position-independent and high-level expression of human α α-lactalbumin in the milk of transgenic rats carrying a 210-kb YAC DNA': 1, 'Position-independent and copy-number-related expression of a goat bacterial artificial chromosome α α-lactalbumin gene in transgenic mice': 1, 'Position-independent and tissue-specific expression of porcine whey acidic protein gene from a bacterial artificial chromosome in transgenic mice': 1, 'Therapeutic antibody expression technology': 1, 'Plantibodies: applications, advantages and bottlenecks': 1, 'Transgenic animal bioreactors': 1, 'Expression of exogenous protein in the egg white of transgenic chickens': 2, 'Cloned transchromosomic calves producing human immunoglobulin': 1, 'Toward a new cash cow': 1, 'Uncorking the biomanufacturing bottleneck': 1, 'The reproductive number of COVID-19 is higher compared to SARS coronavirus': 1, 'Transmissibility of 1918 pandemic influenza': 1, 'WHO. Coronavirus disease 2019 -Situation Report -174': 1, 'European Centre for Disease Prevention and Control. Safe use of personal protective equipment in the treatment of infectious diseases of high consequence: a tutorial for trainers in healthcare settings': 2, 'Staff safety during emergency airway management for COVID-19 in Hong Kong': 3, 'At the epicenter of the Covid-19 pandemic and humanitarian crises in Italy: changing perspectives on preparation and mitigation. NEJM Catal Innov Care Deliv': 1, 'Will Colombian intensive care units collapse due to the COVID-19 pandemic': 1, 'The Italian COVID-19 outbreak: experiences and recommendations from clinical practice': 2, '2019 novel coronavirus: where we are and what we know': 1, 'Airborne spread of infectious agents in the indoor environment': 2, 'Turbulent gas clouds and respiratory pathogen emissions: potential implications for reducing transmission of COVID-19': 1, 'Coronavirus disease 2019 (COVID-19) in Italy': 1, 'COVID-19 Colombia | Reporte 17-06-2020': 1, \"Barriers and facilitators to healtcare workers' adherence with prevention and control (IPC) guidelines for respiratory infectious diseases : a rapid qualitative evidence synthesis ( review )\": 1, \"Healthcare workers' and students' knowledge regarding the transmission, epidemiology and symptoms of COVID-19 in 41 cities of Bolivia and Colombia\": 1, 'COVID-19: a crisis that requires urgent training measures': 1, 'Airborne transmission of severe acute respiratory syndrome coronavirus-2 to healthcare workers: a narrative review': 1, 'WHO. Transmission of SARS-CoV-2: implications for infection prevention precautions. Scientific Briefing': 4, 'Personal protective equipment (PPE) needs in healthcare settings for the care of patients with suspected or confirmed novel coronavirus (2019-nCoV)': 3, 'Medical masks vs N95 respirators for preventing COVID-19 in healthcare workers: a systematic review and meta-analysis of randomized trials. Influenza Other Respir Viruses': 1, 'Storage and availability of elastomeric respirators in health care': 1, 'Training and fit testing of health care personnel for reusable elastomeric half-mask respirators compared with disposable N95 respirators': 1, 'Non-technical skills in the intensive care unit': 1, 'ICU admission, discharge, and triage guidelines: a framework to enhance clinical operations, development of institutional policies, and further research': 1, 'Preparing your intensive care unit for the COVID-19 pandemic: practical considerations and strategies': 1, 'Surviving sepsis campaign: guidelines on the management of critically ill adults': 2, 'Consensus guidelines for managing the airway in patients with COVID-19: guidelines from the Difficult Airway Society, the Association of Anaesthetists the Intensive Care Society, the Faculty of Intensive Care Medicine and the Royal College of Anaesthetist': 2, 'Clear plastic drapes may be effective at limiting aerosolization and droplet spray during extubation: implications for COVID-19': 1, 'Recommendation of a practical guideline for safe tracheostomy during the COVID-19 pandemic': 2, 'Personal protective equipment (PPE) for surgeons during COVID-19 pandemic: a systematic review of availability, usage, and rationing': 1, 'COVID-19: infection prevention and control guidance': 1, 'COVID-19 in cardiac arrest and infection risk to rescuers: a systematic review': 1, 'Covid-19 practical guidance for implementation': 1, 'Risk factors for SARS infection among hospital healthcare workers in Beijing: a case control study': 1, 'Safe management of bodies of deceased persons with suspected or confirmed COVID-19 : a rapid systematic review': 1, 'Protection and disinfection policies': 1, 'Cleaning and disinfection of environmental surfaces in the context of COVID-19: interim guidance': 2, 'Human factors risk analyses of a doffing protocol for Ebola-level personal protective equipment: mapping errors to contamination': 1, 'Difficult airway in the critically ill patient: much more than technical skills': 1, 'Evaluation of cognitive load and emotional states during multidisciplinary critical care simulation sessions': 1, 'Relationship among mental models , theories of change , and metacognition : structured clinical simulation': 1, 'Cognitive load and performance of health care professionals in donning and doffing PPE before and after a simulation': 1, 'COVID-19: how prepared are front-line healthcare workers in England?': 1, 'WHO Coronavirus disease (COVID-19) situation report -84': 1, 'Aminopeptidase N is a major receptor for the entero-pathogenic coronavirus TGEV': 1, 'The sialic acid binding activity of the S protein facilitates infection by porcine transmissible gastroenteritis coronavirus': 1, 'Binding of transmissible gastroenteritis coronavirus to brush border membrane sialoglycoproteins': 1, 'Porcine respiratory coronavirus: molecular features and virus-host interactions': 1, 'Differentiation between transmissible gastroenteritis virus and porcine respiratory coronavirus using a cDNA probe': 1, 'Jejunal epithelium in transmissible gastroenteritis of swine. An electron microscopic and histochemical study': 1, 'Tubulins interact with porcine and human S proteins of the genus Alphacoronavirus and support successful assembly and release of infectious viral particles': 1, 'Immunogenicity of porcine transmissible gastroenteritis virus spike protein expressed in plants': 1, 'High-dose dietary zinc oxide mitigates infection with transmissible gastroenteritis virus in piglets': 1, 'Retinoic acid facilitates inactivated transmissible gastroenteritis virus induction of CD8(+) T-cell migration to the porcine gut': 1, 'Immune response in sows given transmissible gastroenteritis virus or canine coronavirus': 1, 'Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies': 10, 'In situ hybridization technique for the detection of swine enteric and respiratory coronaviruses, transmissible gastroenteritis virus (TGEV) and porcine respiratory coronavirus (PRCV), in formalinfixed paraffin-embedded tissues': 1, 'Precision cut intestinal slices are an appropriate ex vivo model to study NSAID-induced intestinal toxicity in rats': 1, 'Precision-cut rat, mouse, and human intestinal slices as novel models for the earlyonset of intestinal fibrosis': 1, 'Targeted recombination demonstrates that the spike gene of transmissible gastroenteritis coronavirus is a determinant of its enteric tropism and virulence': 4, 'Antibody responses in serum, colostrum, and milk of swine after infection or vaccination with transmissible gastroenteritis virus': 5, 'Antigenic homology among coronaviruses related to transmissible gastroenteritis virus': 3, 'Differential contributions of the complement anaphylotoxin receptors C5aR1 and C5aR2 to the early innate immune response against Staphylococcus aureus infection': 1, \"Human bocavirus: prevalence and clinical spectrum at a children's hospital\": 1, 'Realtime PCR in clinical microbiology: applications for routine laboratory testing': 2, 'Real-time PCR assays for detection of bocavirus in human specimens': 3, 'Detection and typing of respiratory adenoviruses in a single-tube multiplex polymerase chain reaction': 1, 'Practical implementation of a multiplex PCR for acute respiratory tract infections in children': 1, 'Hospital preparedness for COVID-19: a practical guide from a critical care perspective': 1, \"The birth of intensive care medicine: Björn Ibsen's records\": 1, 'Novel coronavirus and old lessons -preparing the health system for the pandemic': 1, 'Convertible Top Replacement Co': 1, 'Jazz Photo, 264 F.3d': 1, 'News reports claim that the ventilator valves fabricated in Italy for a cost of about 1 Euro each were previously sold by the manufacturer for 10,000 Euro each. Peters, supra note 25': 1, 'The Challenges Of 3D Printing to the Repair-Reconstruction Doctrine In Patent Law': 1, 'Regulation laying down ecodesign requirements': 1, \"EU brings in 'right to repair' rules for appliances\": 1, \"Maryland Suddenly Looks Like it Might Break John Deere's Repair Monopoly, Vice.com\": 1, 'Functional assessment of cell entry and receptor usage for lineage B β-coronaviruses': 1, 'Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human': 3, 'Gapped BLAST and PSI-BLAST: a new generation of protein database search programs': 1, 'Bats Are Natural Reservoirs of SARS-Like Coronaviruses': 1, 'Bat Origins of MERS-CoV Supported by Bat Coronavirus HKU4 Usage of Human Receptor CD26': 1, 'Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus': 2, 'Evolution of relative synonymous codon usage in Human Immunodeficiency Virus type-1': 1, 'The I-TASSER Suite: protein structure and function prediction': 1, 'Trends in global clinical trial registration: an analysis of numbers of registered clinical trials in different parts of the world from': 1, 'Conducting clinical trials in emerging markets of sub-Saharan Africa: a review of guidelines and resources for foreign sponsors': 1, 'Review: impact, challenges, and future projections of vaccine trials in Africa': 1, 'Search of: vaccines | Phase 1 -Results on Map -ClinicalTrials.gov [Internet]': 2, 'Improving site selection in clinical studies: a standardized, objective, multistep method and first experience results': 2, 'Clinical trials have gone global: is this a good thing': 3, 'Factors influencing clinical trial site selection in Europe: the survey of attitudes towards trial sites in Europe (the SAT-EU study) conclusions: investigator-dependent factors and ease': 2, 'The challenges and opportunities of conducting a clinical trial in a low resource setting: the case of the Cameroon mobile phone SMS (CAMPS) trial, an investigator initiated trial': 1, 'Barriers for conducting clinical trials in developing countries-a systematic review': 1, 'The case for conducting first-in-human (phase 0 and phase 1) clinical trials in low and middle-income countries': 1, 'Ethical Issues in International Biomedical Research: a casebook': 1, 'Using the TDR global competency framework for clinical research [Internet]. WHO. World Health Organization': 1, 'Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings': 1, 'Centre for Disease Control': 1, 'Current research for a vaccine against Lassa hemorrhagic fever virus': 2, 'Coalition for Epidemic Preparedness Innovations. Priority diseases -CEPI': 1, 'Safety, tolerability and immunogenicity of INO-4500 in healthy volunteers -full text view -ClinicalTrials.gov [Internet': 1, 'Themis begins phase 1 trial of MV-LASV Lassa fever vaccine candidate': 1, 'Lassa virus diversity and feasibility for universal prophylactic vaccine': 1, 'Selecting study-appropriate clinical sites in 3 steps': 1, 'Clinical studies: Europe or the United States? | MDDI Online': 1, 'Diagnostic applications for Lassa fever in limited-resource settings': 1, 'WHO j Pneumonia of unknown cause -China. WHO': 1, 'Crystal structure ofSARS-CoV-2 (2019-nCoV) main protease provides a basis for design of improved a-ketoamide inhibitors': 3, 'Wuhan Municipal Health Committee': 1, 'Key coronavirus question: how are children affected? -Harvard Gazette': 1, 'Epidemiology of COVID-19 Among Children in China': 1, 'CT imaging of the 2019 novel coronavirus (2019-nCoV) pneumonia': 1, 'Transmission of Coronavirus Disease 2019 (COVID-19) j CDC': 2, 'Chatbot provides assistance during current coronavirus pandemic j newswire': 1, \"WHO Director-General's opening remarks at the media briefing on COVID-19 -11 March 2020, www.who.int/dg/speeches/detail/whodirector-general-s-opening-remarks-at-the-media-briefing-on-covid\": 1, 'Coronavirusesdrug discovery and therapeutic options': 1, 'Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin': 2, 'New drug target found for COVID-19': 1, 'The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade': 1, 'The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) -China': 1, 'Middle east respiratory syndrome: emergence of a pathogenic human coronavirus': 1, 'Asymptomatic Middle east respiratory syndrome coronavirus (MERS-CoV) infection: extent and implications for infection control: a systematic review': 2, 'Analysis of intrapatient heterogeneity uncovers the microevolution of Middle East respiratory syndrome coronavirus': 1, 'PAHO/WHO j Similarities and differences -COVID-19 and influenza, www.paho.org/hq/index.php?option=com_content&view=article &id=15760:similarities-and-differences-covid-19-and-influen za&catid=740&lang=en&Itemid=1926': 1, 'Coronavirus is most contagious before, during first week of symptoms j Science News': 1, 'Primerdesign launches new molecular test for novel coronavirus': 1, 'Co-Diagnostics launches RUO test for novel coronavirus': 1, \"These nine companies are working on coronavirus treatments or vaccines -here's where things stand -MarketWatch, www.marketwatch. com/story/these-nine-companies-are-working-on-coronavirus-treat ments-or-vaccines-heres-where-things\": 2, 'CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor': 1, 'Mount Sinai to Begin the Transfer of COVID-19 Antibodies into Critically Ill Patients j Inside Mount Sinai': 1, 'COVID-19) advice for the public: myth busters': 2, 'Shortage of personal protective equipment endangering health workers worldwide, www.who.int/news-room/detail/03-03-2020-sh ortage-of-personal-protective-equipment-endangering-health-work ers-worldwide': 2, 'On the origin and continuing evolution of SARS-CoV-2': 2, 'Announcing the COVID-19 Therapeutics Accelerator -Bill & Melinda Gates Foundation': 1, 'Responding to covid-19 -a once-in-a-Century pandemic?': 1, 'Taiwan Used Big Data, Transparency and a Central Command to Protect Its People from Coronavirus': 1, 'Hospital Emergency Management Plan During the COVID-19 Epidemic': 1, \"Special attention to nurses' protection during the COVID-19 epidemic\": 1, 'Suggestions for safety and protection control in Department of Nuclear Medicine during the outbreak of COVID-19': 1, 'Sourcing personal protective equipment during the COVID-19 pandemic': 1, 'Globalization and Its Impact to the Ukrainian Regions': 1, 'Post-socialist cities': 1, 'A socially resilient urban transition? The contested landscapes of apartment building extensions in two post-communist cities': 1, 'Resilience of the territory under big city influence: risks, vulnerability, new management approaches': 1, \"Uneven urban resilience: the economic adjustment and polarization of Russia's cities. Understanding Geographies of Polarization and Peripheralization\": 1, 'Resilience Thinking: Sustaining Ecosystems and People in a Changing World': 1, 'Understanding uncertainty and reducing vulnerability: lessons from resilience thinking': 1, \"Institutional ecology 'translations' and boundary objects: amateurs and professionals in Berkeley's museum of vertebrate zoology\": 1, 'Resilience and (in) security: practices, subjects, temporalities. Security Dialogue': 1, 'Emergent self-organisation in emergencies: resilience rationales in interconnected societies': 1, 'On the program for creation of additional workplaces for Chornobyl NPP employees released after the closure of the station, and the slavutych municipalities': 1, 'Risk analysis-a field within security studies?': 1, \"The concept of ''resilience'' in modern security research\": 1, 'National risk registers: security scientism and the propagation of permanent insecurity': 1, 'Producing and governing community (through) resilience': 1, 'Integrating humans into ecology: opportunities and challenges for studying urban ecosystems': 1, 'Complexity of coupled human and natural systems': 1, 'Urban transitions: on urban resilience and human-dominated ecosystems': 1, 'Climate change and urban resilience': 1, 'Climate change and urban resilience: the Singapore story. Globalization, Development, and Security in Asia': 1, 'Morphology dependent assessment of resilience for urban areas': 1, 'Cities in a Time of Terror: Space, Territory, and Local Resilience': 1, \"Abingdon: Routledge. Decision of the slavutych city council No. 1326-55-VII of March 6, 2019 ''on the results of the socio-economic and cultural development of the city of slavutych in 2018 within the framework of the strategic plan for the social and economic development of the city of slavutych by 2020\": 1, 'Social cohesion and resilience across communities that have experienced a disaster': 1, 'The role of spatial planning in strengthening urban resilience. Resilience of Cities to Terrorist and Other Threats': 1, 'Code of ethics, honesty, decency, good faith and effective management of slavutych territorial community, approved by the decision of slavutych city council dated': 1, 'The Resilient City: How Modern Cities Recover from Disaster': 1, 'From fail-safe to safe-to-fail: sustainability and resilience in the new urban world': 2, 'Resilient cities: meaning, models, and metaphor for integrating the ecological, socio-economic, and planning realms': 1, 'Inventing the atomograd. Nuclear urbanism as a way of life in Eastern Europe': 1, 'Observations on the chernobyl disaster and LNT': 1, 'Slavutych: Architectural Guide': 2, 'The Utopia of a small town: how the festival of 86 changes slavutych': 1, 'Understanding the complexity of economic, ecological, and social systems': 1, 'Multiple transformations: conceptualising the post-communist urban transition. Urban Studies': 1, 'The hybrid spatialities of transition: Capitalism, legacy and uneven urban economic restructuring': 1, 'The Resilient City: On the Determinants of Successful Urban Economies. Centre-Urbanisation, culture, société': 1, 'Tissue Plasminogen Activator (tPA) Treatment for COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS): A Case Series': 1, 'Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia': 1, 'Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines': 1, 'Three unsuspected CT diagnoses of COVID-19': 1, 'Management of upper GI bleeding in patients with COVID-19 pneumonia': 1, 'Hemorrhagic Problem Among the Patients With COVID-19: Clinical Summary of 41 Thai Infected Patients': 1, 'Plasma D-Dimer Concentrations and Risk of Intracerebral Hemorrhage: A Systematic Review and Meta-Analysis. Front Neurol [Internet]': 1, 'Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial': 3, 'Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study. Travel medicine and infectious disease': 2, 'No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection': 2, 'Clinical efficacy of lopinavir/ritonavir in the treatment of Coronavirus disease 2019. European review for medical and pharmacological sciences': 2, 'Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19. The Journal of infection': 2, 'An exploratory randomized controlled study on the efficacy and safety of lopinavir/ritonavir or arbidol treating adult patients hospitalized with mild/moderate COVID-19 (ELACOI)': 3, 'Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study. The Journal of infection': 4, 'Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study. Engineering': 2, 'Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial': 3, 'Compassionate Use of Remdesivir for Patients with Severe Covid-19': 5, 'Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2020. 23. World Health Organisation, 202. WHO COVID-19 Dashboard': 1, 'Regulators split on antimalarials for COVID-19. The Lancet': 1, 'In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)': 1, 'Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial': 2, 'First case of Coronavirus Disease 2019 (COVID-19) pneumonia in Taiwan': 1, 'Case Report: Hepatotoxicity Associated with the Use of Hydroxychloroquine in a Patient with Novel Coronavirus Disease (COVID-19). The American journal of tropical medicine and hygiene': 1, 'Inpatient use of mobile continuous telemetry for COVID-19 patients treated with hydroxychloroquine and azithromycin. HeartRhythm Case Reports': 1, 'Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia. Annals of the rheumatic diseases': 1, 'The course of clinical diagnosis and treatment of a case infected with coronavirus disease 2019': 1, 'Delayed Initiation of Remdesivir in a COVID-19 Positive Patient': 1, 'The First Case of 2019 Novel Coronavirus Pneumonia Imported into Korea from Wuhan, China: Implication for Infection Prevention and Control Measures': 1, 'Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Infected Pneumonia Monitored by Quantitative RT-PCR': 1, 'A locally transmitted case of SARS-CoV-2 infection in Taiwan': 1, 'A Case of SARS-CoV-2-pneumonia with successful antiviral therapy in a 77-year-old male with heart transplant. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons': 1, 'COVID-19) complicated with pneumonia in a patient with rheumatoid arthritis receiving conventional disease-modifying antirheumatic drugs': 1, 'Benign COVID-19 in an immunocompromised cancer patient -the case of a married couple': 1, 'Coronavirus Disease 2019 (COVID-19) Pneumonia in a Hemodialysis Patient. Kidney medicine': 1, 'Assessing the Burden of Nondeferrable Major Uro-oncologic Surgery to Guide Prioritisation Strategies During the COVID-19 Pandemic: Insights from Three Italian High-volume Referral Centres. European Urology. 48. A randomised trial of treatments to prevent': 1, 'Vesicular stomatitis virusbased vaccines for prophylaxis and treatment of filovirus infections': 1, 'Framework for the design and operation of high-level isolation units: consensus of the European Network of Infectious Diseases': 1, 'Biochemical analysis of the secreted and virion glycoproteins of Ebola virus': 1, 'Covalent modifications of the Ebola virus glycoprotein': 1, 'Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients': 1, 'Molecular Biology and Evolution of Filoviruses. Unconventional Agents and Unclassified Viruses': 1, 'Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines': 1, 'Role of antibodies in protection against Ebola virus in nonhuman primates immunized with three vaccine platforms': 1, 'Novel cross-reactive monoclonal antibodies against Ebolavirus glycoproteins show protection in a murine challenge model': 3, 'More than one reason to rethink the use of peptides in vaccine design': 2, 'Reverse vaccinology': 1, 'De novo structural modeling and conserved epitopes prediction of zika virus envelop protein for vaccine development': 3, 'Epitope-based peptide vaccine design and target site depiction against Ebola viruses: an immunoinformatics study': 1, 'In silico-based vaccine design against Ebola virus glycoprotein': 2, 'In silico identification of potential epitopes present in human adenovirus proteins for vaccine design and of putative drugs for treatment against viral infection': 1, 'Peptide vaccine against chikungunya virus: immuno-informatics combined with molecular docking approach': 1, 'Exploring dengue genome to construct a multi-epitope based subunit vaccine by utilizing immunoinformatics approach to battle against dengue infection': 1, 'A highly conserved WDYPKCDRA epitope in the RNA directed RNA polymerase of human coronaviruses can be used as epitopebased universal vaccine design': 2, 'In silico vaccine design based on molecular simulations of rhinovirus chimeras presenting HIV-1 gp41 epitopes': 2, 'Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses': 2, 'Reliable B cell epitope predictions: impacts of method development and improved benchmarking': 3, 'Protective efficacy of neutralizing monoclonal antibodies in a nonhuman primate model of Ebola hemorrhagic fever': 1, 'A computational approach for identification of epitopes in dengue virus envelope protein: a step towards designing a universal dengue vaccine targeting endemic regions': 1, 'Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes': 1, 'Sopma Secondary Structure Prediction Method': 1, 'Scalable web services for the PSIPRED protein analysis workbench': 1, 'The Phyre2 web portal for protein modeling, prediction and analysis': 1, 'JPred4: a protein secondary structure prediction server': 1, 'Predicting linear B-cell epitopes using string kernels': 1, 'Influence of protein flexibility and peptide conformation on reactivity of monoclonal anti-peptide antibodies with a protein alpha-helix': 1, 'Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide': 1, 'Structure-based conformational preferences of amino acids': 1, 'ProPred1: prediction of promiscuous MHC Class-I binding sites': 1, 'ProPred: prediction of HLA-DR binding sites': 1, 'Mechanism of binding to Ebola virus glycoprotein by the ZMapp, ZMAb, and MB-003 cocktail antibodies': 1, 'Cross-Reactive and potent neutralizing antibody responses in human survivors of natural ebolavirus infection': 1, 'Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial': 1, 'Safety and immunogenicity of novel adenovirus type 26-and modified vaccinia ankara-vectored Ebola vaccines: a randomized clinical trial': 1, 'An adenovirus vaccine expressing Ebola virus variant makona glycoprotein is efficacious in Guinea pigs and nonhuman primates': 1, 'Potent neutralizing monoclonal antibodies against Ebola virus infection': 1, 'T-cell epitope vaccine design by immunoinformatics': 1, 'Determinants of antigenicity and specificity in immune response for protein sequences': 1, 'Continuous and discontinuous protein antigenic determinants': 1, 'Role of CD8+ T cells in control of West Nile virus infection': 1, 'ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)': 2, 'The coronary circulation as a target of cardioprotection': 1, 'The \"no-reflow\" phenomenon after temporary coronary occlusion in the dog': 1, 'Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention': 1, 'No-reflow phenomenon and lesion morphology in patients with acute myocardial infarction': 1, 'Relation of atherothrombosis burden and volume detected by intravascular ultrasound to angiographic no-reflow phenomenon during stent implantation in patients with acute myocardial infarction': 1, 'Randomized trial of primary PCI with or without routine manual thrombectomy': 1, 'Turco reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial)': 1, 'Is Aspiration Thrombectomy Beneficial in Patients Undergoing Primary Percutaneous Coronary Intervention?': 1, 'Thrombus Aspiration for ST-Segment-Elevation Myocardial Infarction in Modern Era: Still an Issue of Debate?': 1, 'Adenosine as an Adjunct Therapy in ST Elevation Myocardial Infarction Patients: Myth or Truth? Cardiovasc Drugs Ther': 1, 'The effect on myocardial perfusion and clinical outcome of intracoronary nicorandil injection prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction': 1, 'Effect of intracoronary nitroprusside in preventing no reflow phenomenon during primary percutaneous coronary intervention: a meta-analysis': 1, 'Cyclosporine before PCI in Patients with Acute Myocardial Infarction': 1, 'Other pathophysiological conditions with expected survival time <1 year 23. Unsuitability to participate in this study due to other diseases Abbreviations: ECG, electrocardiogram; CPR, cardio-pulmonary resuscitation': 1, 'ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines': 1, '10-year follow-up of intensive glucose conrol in type 2 diabetes': 1, 'Metabolic surgery for the treatment of type 2 diabetes in obese individuals': 3, 'Success (but unfinished) story of metabolic surgery': 2, 'Bariatric surgery is associated with a lower rate of death after myocardial infarction and stroke: a nationwide study': 1, 'Obesity management for the treatment of type 2 diabetes: standards of medical care in diabetes-2020': 1, 'Metabolic surgery to treat type 2 diabetes in patients with a BMI <35 kg/m²': 1, 'Information about Middle East respiratory syndrome (MERS)': 1, 'Relative contributions of four exposure pathways to influenza infection risk': 4, 'Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination': 1, 'Summary and risk assessment of current situation in Republic of Korea and China': 1, 'Environmental contamination and viral shedding in MERS patients during MERS-CoV outbreak in South Korea': 1, 'MERS-CoV outbreak in Jeddah: a link to health care facilities': 1, 'World Health Organization. WHO statement on the tenth meeting of the IHR Emergency Committee regarding MERS': 1, 'Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study': 1, \"Epidemiologic features of the first MERS outbreak in Korea: focus on Pyeongtaek St. Mary's Hospital\": 3, 'The first case of the 2015 Korean Middle East respiratory syndrome outbreak': 1, \"30 cases linked to Pyeongtaek St. Mary's Hospital\": 1, 'An integrated model of infection risk in a healthcare environment': 2, 'Quantifying the routes of transmission for pandemic influenza': 3, 'Relative Effectiveness of Ventilation in Community Indoor Environments for Controlling Infection. Hong Kong: HKU Theses Online (HKUTO)': 2, 'Role of fomites in SARS transmission during the largest hospital outbreak in Hong Kong': 2, 'A multi-agent based framework for the simulation of human and social behaviors during emergency evacuations': 1, 'Agent-Based Models. London: Sage': 2, 'The scaling laws of human travel': 1, 'Understanding individual human mobility patterns': 1, 'Applied Regression Analysis': 1, 'Assessing infection control measures for pandemic influenza': 1, 'Prediction of intrinsic disorder in MERS-CoV/HCoV-EMC supports a high oral-fecal transmission': 1, 'Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection': 1, 'Role of ventilation in airborne transmission of infectious agents in the built environment-A multidisciplinary systematic review': 1, 'Passenger thermal comfort and behavior: a field investigation in commercial aircraft cabins': 1, 'Flow and contaminant transport in an airliner cabin induced by a moving body: Model experiments and CFD predictions': 1, 'Computational fluid dynamics modeling of transport and deposition of pesticides in an aircraft cabin': 1, 'Study on the carbon dioxide lockup phenomenon in aircraft cabin by computational fluid dynamics': 1, 'Alternative ventilation concepts for aircraft cabins': 1, 'Determination of the optimal control parameter range of air supply in an aircraft cabin': 1, 'A computational and experimental investigation of the human thermal plume': 1, 'Experimental parametric study of forced and mixed convection in a passenger aircraft cabin mock-up': 1, 'Effects of passenger thermal plume on the transport and distribution characteristics of airborne particles in an airliner cabin section': 1, 'Statistical analysis of turbulent thermal convection in a cabin mockup': 1, 'PIV methods for quantifying human thermal plumes in a cabin environment without ventilation': 1, 'Chaotic behavior of human thermal plumes in an aircraft cabin mockup': 2, 'Experimental characterization of airflows in aircraft cabins: part II -Results and research recommendations': 1, 'Computational modeling of effects of thermal plume adjacent to the body on the indoor airflow and particle transport': 1, 'Experimental investigation of the human convective boundary layer in a quiescent indoor environment': 1, 'Statistical Theory and Modeling for Turbulent Flows': 1, 'Turbulence characterization of instantaneous airflow in an aisle of an aircraft cabin mockup': 1, 'Numerical simulations of the instantaneous flow fields in a generic aircraft cabin with various categories turbulence models': 1, 'A preliminary parametric study on performance of SARS virus cleaner using CFD simulation': 1, 'Novel personalized and humidified air supply for airliner passengers': 1, 'Experimental measurements and numerical simulations of particle transport and distribution in ventilated rooms': 1, '2D-PIV measurement of aircraft cabin air distribution with a high spatial resolution': 5, 'The numerical computation of turbulent flows': 1, 'Evaluation of various categories of turbulence models for predicting air distribution in an airliner cabin': 3, 'Modeling dynamic responses of aircraft environmental control systems by coupling with cabin thermal environment simulations': 2, 'Numerical investigation of airborne contaminant transport under different vortex structures in the aircraft cabin': 2, 'Optimization design of inner-structure of the slot-jet in aircraft cabin and investigation of multi-scale characteristic in slot turbulent jet flow': 1, 'Analyzing grid independency and numerical viscosity of computational fluid dynamics for indoor environment applications': 1, 'The Structure of Turbulent Shear Flow': 1, 'Lectures in Mathematical Models of Turbulence': 1, 'Numerical investigation of the unsteady flow characteristics of human body thermal plume': 4, 'From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017': 5, 'Chronic obstructive pulmonary disease (COPD), data and statistics': 1, 'Expert panel report 3: guidelines for the diagnosis and management of asthma full report': 7, 'Bronchodilator responsiveness in patients with COPD': 1, 'Differentiating COPD from asthma in clinical practice': 1, 'Differential assessment and management of asthma vs chronic obstructive pulmonary disease': 1, 'Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta-2 agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma': 1, 'UC Davis Division of Pulmonary and Critical Care Medicine ROAD Center Program': 1, 'Diagnosis of Diseases of Chronic Airflow Limitations: Asthma COPD and Asthma -COPD Overlap Syndrome (ACOS)': 2, 'Clinical characteristics of the asthma-COPD overlap syndrome-a systematic review': 2, 'Asthma and chronic obstructive pulmonary disease overlap syndrome (ACOS): structured literature review and physician insights': 1, 'The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations': 2, 'Asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): current literature review': 2, 'Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma': 1, 'Prevalence and localization of pulmonary embolism in unexplained acute exacerbations of COPD': 2, 'Prevalence of pulmonary embolism in acute exacerbations of COPD': 1, 'Risk of pulmonary embolism and deep venous thrombosis in patients with asthma: a nationwide caseÀcontrol study from Sweden': 1, 'Asthma increases pulmonary thromboembolism risk: a nationwide population cohort study': 1, 'Asthma-chronic obstructive pulmonary disease overlap syndrome associated with risk of pulmonary embolism': 1, 'Umeclidinium/vilanterol as step-up therapy from tiotropium in patients with moderate COPD: a randomized, parallel-group, 12-week study': 2, 'Tiotropium bromide step-up therapy for adults with uncontrolled asthma': 1, 'Tiotropium in asthma poorly controlled with standard combination therapy': 1, 'Patient perspectives on fluticasone-vilanterol versus other corticosteroid combination products for the treatment of asthma': 1, 'Effectiveness of fluticasone furoate-vilanterol for COPD in clinical practice': 1, 'Evaluation of a therapeutic interchange from fluticasone/ salmeterol to mometasone/formoterol in patients with chronic obstructive pulmonary disease': 1, 'Mometasone furoate/formoterol in the treatment of persistent asthma': 1, 'Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD)': 1, 'Efficacy of aclidinium bromide 400 mg twice daily compared with placebo and tiotropium in patients with moderate to severe COPD': 1, 'Aclidinium bromide for stable chronic obstructive pulmonary disease': 1, 'Control of asthma for reducing the risk of bronchospasm in asthmatics undergoing general anesthesia and/or intravascular administration of radiographic contrast media': 1, 'Acute adrenal crisis in asthmatics treated with high-dose fluticasone propionate': 1, 'Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom': 1, 'The use of inhaled corticosteroids and the risk of adrenal insufficiency': 1, 'Chronic Obstructive pulmonary disease in over 16s: diagnosis and management': 1, 'Summary of probable SARS cases with onset of illness from 1': 1, 'WHO. Middle East respiratory syndrome coronavirus': 2, 'A novel coronavirus emerging in China -key questions for impact assessment': 1, 'Eepidemiologic and clinical characteristics of novel coronavirus infection involving 13 patients outside wuhan': 2, 'Potential of large \"first generation\" human-to-human transmission of 2019-nCoV': 1, 'Accessed date': 1, 'COVID-19 coronavirus -update': 1, 'The global spread of 2019-nCoV: a molecular evolutionary analysis. Pathog Glob Health': 1, 'The first two cases of 2019-nCoV in Italy: where they come from': 1, 'First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures': 1, 'Viral load kinetics of SARS-CoV-2 infection in first two patients in korea': 1, 'Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series': 1, 'Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infectionis suspected: interim guidance': 1, 'Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in wuhan': 1, 'Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea, 2015: epidemiology, characteristics and public health implications': 1, 'Spread of MERS to South Korea and China': 1, 'Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies': 2, 'FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0': 1, 'Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2': 1, '18 F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases': 1, 'Management of patients with HIV in the intensive care unit': 5, 'AIDS epidemic update': 1, 'Intensive care of human immunodeficiency virus-infected patients during the era of highly active antiretroviral therapy': 1, 'Impact of HAART advent on admission patterns and survival in HIV-infected patients admitted to an intensive care unit': 1, 'Outcomes of intensive care for patients with human immunodeficiency virus infection': 1, 'Survival for patients with HIV ADMITTED to the ICU continues to improve in the current era of combination antiretroviral therapy': 1, 'AIDS-defining opportunistic illnesses in US patients': 1, 'Intensive care of patients with HIV infection': 5, \"Lung disease among HIV infected patients admitted to the ''Instituto Nacional del Tórax\": 2, 'Improvements in outcomes of acute respiratory failure for patients with human immunodeficiency virus related Pneumocystis carinii pneumonia': 2, 'Low tidal volume ventilation is associated with reduced mortality in HIV-infected patients with acute lung injury': 2, 'Pneumocystis pneumonia': 7, 'Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the multicenter AIDS cohort study: 1985-1991': 1, 'Discontinuation of secondary prophylaxis against pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy': 1, 'Speich R (2006) HIV, AIDS, and the lung': 11, 'Roentgenographic patterns of Pneumocystis carinii pneumonia in 104 patients with': 1, 'Respiratory infections in persons infected with human immunodeficiency virus': 5, 'Reappraisal of the aetiology and prognostic factors of severe acute respiratory failure in HIV patients': 1, 'Critical care management and outcome of severe Pneumocystis pneumonia in patients with and without HIV infection': 2, 'Noninvasive ventilation for treating acute respiratory failure in AIDS patients with Pneumocystis jiroveci pneumonia': 1, 'Acute Respiratory Distress Syndrome Network (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome': 1, 'Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV medicine association of the infectious diseases society of America': 17, 'Nosocomial bacterial pneumonia in human immunodeficiency virus infected subjects: incidence, risk factors and outcome': 3, 'A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome': 2, 'Improved survival with highly active antiretroviral therapy in HIV-infected patients with severe Pneumocystis carinii pneumonia': 2, 'Bacterial community-acquired pneumonia in HIVinfected patients': 6, 'Pulmonary manifestations of HIV infection in the era of highly active antiretroviral therapy': 4, 'Community-acquired bacterial pneumonia in human immunodeficiency virus-infected patients validation of severity criteria': 8, 'Infectious diseases society of American/American thoracic society consensus guidelines on the management of community-acquired pneumonia in adults': 1, 'Nosocomial pulmonary infections in HIV-positive patients': 1, 'Bacteremia in hospitalized patients with human immunodeficiency virus: a prospective, cohort study': 1, 'Cytomegalovirus in the lungs of patients with AIDS. Respiratory pathogen or passenger': 1, 'Laboratory diagnosis of cytomegalovirus infection and disease in immunocompromised patients': 2, 'Epstein-Barr virus infection': 1, 'Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1)': 1, 'An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases': 4, 'Management of tuberculosis in the United States': 4, 'TB/HIV: a clinical manual': 3, 'Timing of initiation of antiretroviral drugs during tuberculosis therapy': 3, 'Mycobacterium avium complex infection in patients with the acquired immunodeficiency syndrome. A clinicopathologic study': 2, 'Recent trends in the epidemiology of invasive mycoses': 1, 'A controlled trial of itraconazole as primary prophylaxis for systemic fungal infections in patients with advanced human immunodeficiency virus infection in Thailand': 1, 'Acute respiratory failure associated with cryptococcosis in patients with AIDS: analysis of predictive factors': 1, 'Cryptococcal pneumonia': 1, 'Current approaches to diagnosis and treatment of invasive aspergillosis': 3, 'Aspergillosis among people infected with human immunodeficiency virus: incidence and survival. Adult and adolescent spectrum of HIV disease project': 3, 'Pulmonary aspergillosis: a clinical update': 2, \"Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men-New York City and California\": 1, \"Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection\": 1, \"Kaposi's sarcoma\": 2, \"The epidemiologic, pathologic, and clinical features of AIDSassociated pulmonary Kaposi's sarcoma\": 3, \"Pegylated liposomal doxorubicin plus highly active antiretroviral therapy versus highly active antiretroviral therapy alone in HIV patients with Kaposi's sarcoma\": 1, 'Immune reconstitution in HIV infected patients': 1, 'Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals': 1, 'Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients': 1, 'The role of vitamin D in suppressing cytokine storm in COVID-19 patients and associated mortality': 1, 'Effectiveness of surgical and cotton masks in blocking SARS-CoV-2: a controlled comparison in 4 patients': 1, 'Analysis of Ten Microsecond simulation data of SARS-CoV-2 dimeric main protease': 1, 'Computational analysis suggests putative intermediate animal hosts of the SARS-CoV-2': 1, 'Mortality of a pregnant patient diagnosed with COVID-19: A case report with clinical, radiological, and histopathological findings': 1, 'Hydroxychloroquine plus azithromycin: a potential interest in reducing in-hospital morbidity due to COVID-19 pneumonia': 1, 'First viral replication of Covid-19 identified in the peritoneal dialysis fluid of a symptomatic patient': 1, \"WITHDRAWN: COVID-19 emergency responders in FDA's center for drug evaluation and research\": 1, \"WITHDRAWN: Potential false-positive rate among the'asymptomatic infected individuals' in close contacts of COVID-19 patients\": 1, 'Mental health status and coping strategy of medical workers in China during The COVID-19 outbreak': 1, 'RETRACTED: Chinese medical staff request international medical assistance in fighting against COVID-19. The Lancet Global health': 1, 'An epidemiological investigation of 2019 novel coronavirus diseases through aerosol-borne transmission by public transport': 1, 'WITHDRAWN: Managing college operations during the coronavirus outbreak': 1, 'The big-data mystery behind retracted Covid-19 studies of hydroxychloroquine, other drugs': 1, 'Covid-19 studies based on flawed Surgisphere data force medical journals to review processes. The Guardian': 1, 'Cellular entry of the SARS coronavirus': 1, 'Reuse of N95 masks. Engineering': 1, 'Fluence (UV dose) required to achieve incremental log inactivation of bacteria, protozoa, viruses and algae (IUVA)': 1, 'Guideline for disinfection and sterilization in healthcare facilities': 2, 'Current and emergent strategies for disinfection of hospital environments': 2, 'Mixture of sodium hypochlorite and hydrogen peroxide on adhered Aeromonas hydrophila to solid substrate in water: impact of concentration and assessment of the synergistic effect': 2, 'Inactivation of viruses on surfaces by ultraviolet germicidal irradiation': 1, 'Aerosol susceptibility of influenza virus to UV-C light': 1, 'A device for disinfecting PPEs and the method there of': 1, 'Spectrum of sodium hypochlorite toxicity in man-also a concern for nephrologists': 1, 'Electrolyzed water as a novel sanitizer in the food industry: current trends and future perspectives': 1, 'Evaluation of liquid-and fog-based application of sterilox hypochlorous acid solution for surface inactivation of human norovirus': 1, 'Guideline for hand hygiene in health-care settings: Recommendations of the healthcare infection control practices advisory committee and the HICPAC/SHEA/APIC/IDSA hand hygiene task force': 1, 'Testing a new alcohol-free hand sanitizer to combat infection': 1, 'No time for handwashing, can we achieve 100% compliance?': 2, 'Replace hand washing with use of a waterless alcohol hand rub?': 1, 'The effect of hand hygiene on illness rate among students in university residence halls': 1, \"University students' hand hygiene practice during a gastrointestinal outbreak in residence: What they say they DO and what they actually do\": 1, 'Interventions to improve sanitation during food preparation': 1, 'Moderating effects of social assistance on verbal interventions to promote safety belt use: An analysis of weak plys': 2, 'Promoting safety-belt use with the traffic signs and prompters': 3, 'Skin care: Principles of hand-washing': 1, 'Prompting consumer behaviors for pollution control': 2, 'Explaining hand hygiene practice: An extended application of the theory of planned behavior': 1, 'A strategy for applied research: Learning based but outcome oriented': 1, 'Rule-governed behavior and behavioral anthropology': 2, 'The achievement of evasive goals: Control by rules describing contingencies that are not direct acting': 2, 'Rotavirus survival on human hands and transfer of infectious virus to animate and nonporous inanimate surfaces': 1, 'An individual-subject approach to the study of community-based interventions': 1, 'What caused the Black Death?': 3, 'Detection of the signature of natural selection in humans: evidence from the Duffy blood group locus': 2, 'Reduced Vitamin K Status as A Potentially Modifiable Prognostic Risk Factor in COVID-19': 4, 'Researchers ponder why covid-19 appears deadlier in the U.S. and Europe than in Asia. The Washington Post': 1, 'Vitamin K, an example of triage theory: is micronutrient inadequacy linked to diseases of aging?': 5, 'Human endothelial cells synthesize protein S': 4, 'Dietary phylloquinone depletion and repletion in older women': 1, 'Effect of vitamin K intake on the stability of oral anticoagulant treatment: dose-response relationships in healthy subjects': 1, 'Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization': 1, 'Japanese fermented soybean food as the major determinant of the large geographic difference in circulating levels of vitamin K2: possible implications for hip-fracture risk': 2, 'This Japanese Region Has No Coronavirus. The Wall Street Journal': 1, 'VKORC1 and the vitamin K cycle': 3, 'Positive selection in the chromosome 16 VKORC1 genomic region has contributed to the variability of anticoagulant response in humans': 2, 'Worldwide allele frequency distribution of four polymorphisms associated with warfarin dose requirements': 2, 'Institute of Medicine (US) Panel on Micronutrients': 1, 'Classic selective sweeps were rare in recent human evolution': 1, 'Malaria continues to select for sickle cell trait in Central Africa': 1, 'Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19': 1, 'The SARS-CoV-2 outbreak: what we know': 1, 'Institute for Health Metrics and Evaluation. Forecasting COVID-19 impact on hospital bed-days, ICU-days, ventilator days and deaths by US state in the next 4 months': 1, 'COVID-19 educational disruption and response': 1, 'Community-based measures to mitigate the spread of coronavirus disease (COVID-19) in Canada': 1, 'Can telehealth help flatten the curve of COVID-19': 1, 'COVID-19: Pandemic contingency planning for the allergy and immunology clinic': 1, 'Canadian Pediatric Society Practice Point: paediatric asthma and COVID-19': 2, 'Responding to global infectious disease outbreaks: lessons from SARS on the role of risk perception, communication and management': 5, \"Chernobyl's legacy: health, environmental and socio-economic impacts\": 1, 'Chernobyl: the true scale of the accident': 1, 'Poor risk communication in Japan is making the risk much worse': 1, 'American College of Allergy, Asthma & Immunology. A message to asthma sufferers about a shortage of albuterol metered dose inhalers': 1, 'Paracetamol and Ventolin limited to one per customer as Australia combats coronavirus hoarding': 2, 'Transmission of corona virus by nebulizer-a serious, underappreciated risk': 1, 'Coronavirus sees pharmacies run out of critical medication, endangering the lives of people with chronic illnesses': 2, 'Shortage of personal protective equipment endangering health workers worldwide': 2, \"There aren't enough medical masks to fight coronavirus: here's why it's not going to get better anytime soon\": 1, 'COVID-19) infection control': 1, 'More than 50 doctors in Italy have now died from coronavirus': 1, 'Clinical review: SARS-lessons in disaster management': 3, 'The Fukushima nuclear crisis reemphasizes the need for improved risk communication and better use of social media': 1, 'Social media engagement and public health communication: implications for public health organizations being truly \"social': 1, 'Social media and disasters: a functional framework for social media use in disaster planning, response, and research': 1, 'Challenges to transforming unconventional social media data into actionable knowledge for public health systems during disasters': 1, '19 and asthma: what you need to know moving forward': 1, 'But now that I have an immunocompromised partner, the coronavirus makes me truly scared. Time Magazine': 1, 'Messages from the COVID-19 Response Task Force': 1, 'International Encyclopedia of Public Health: Risk Communication': 1, 'Responding to Community Outrage: Strategies for Effective Risk Communication': 1, 'Dynamical Processes on Complex Networks': 3, 'Networks: An Introduction': 1, 'Multiplex Networks: Basic Formalism and Structural Properties': 1, 'Proc. Natl. Acad. Sci. USA': 1, 'Proceedings of the 10th ACM Conference on Web Science': 1, 'for a complete derivation of our model and additional experiments': 9, 'A novel coronavirus from patients with Pneumonia in China': 1, 'Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding': 1, 'Genetic diversity of coronaviruses in bats in Lao PDR and Cambodia': 3, 'Rodent reservoirs of future zoonotic diseases': 1, 'Host and viral traits predict zoonotic spillover from mammals': 1, 'Newton P (2019) Toward a quantification of risks at the nexus of conservation and health: the case of bushmeat markets in Lao PDR': 2, 'Identification of a severe acute respiratory syndrome coronavirus-like virus in a leaf-nosed bat in Nigeria': 1, 'Bat coronaviruses and experimental infection of bats, the Philippines': 2, 'Identification of mosquito bloodmeals using mitochondrial cytochrome oxidase subunit I and cytochrome b gene sequences': 1, 'MRBAYES 3.2: efficient Bayesian phylogenetic inference and model selection across a large model space': 1, 'Wild animal surveillance for coronavirus HKU1 and potential variants of other coronaviruses': 2, 'Discovery, diversity and evolution of novel coronaviruses sampled from rodents in China': 1, 'Detection of potentially novel paramyxovirus and coronavirus viral RNA in bats and rats in the Mekong Delta region of southern Viet Nam': 2, 'Detection of alpha-and betacoronaviruses in rodents from Yunnan': 1, 'Identification of alpha and beta coronavirus in wildlife species in France: bats, rodents, rabbits, and hedgehogs': 1, 'Epidemiology and causes of preterm birth': 1, 'Tumor necrosis factor-alpha promoter variant 2 (TNF2) is associated with preterm delivery, infant mortality, and malaria morbidity in western Kenya: Asembo Bay Cohort Project IX': 1, 'Tumor necrosis factoralpha gene G308A polymorphism is associated with the risk of preterm delivery': 1, 'Adverse outcomes after preterm labor are associated with tumor necrosis factoralpha polymorphism 2863, but not 2308, in mother-infant pairs': 1, 'Tumor necrosis factor-alpha promoter gene polymorphism 2308 and chorioamnionitis': 1, 'Interleukins-1, -4, -6, -10, tumor necrosis factor, transforming growth factorbeta, FAS, and mannose-binding protein C gene polymorphisms in Australian women: Risk of preterm birth': 1, 'Polymorphisms of genes involved in innate immunity: association with preterm delivery': 1, 'Interleukin-4 and -10 gene polymorphisms and spontaneous preterm birth in multifetal gestations': 1, 'A polymorphism in the promoter region of TNF and bacterial vaginosis: preliminary evidence of gene-environment interaction in the etiology of spontaneous preterm birth': 1, 'An investigation into the association among preterm birth, cytokine gene polymorphisms and periodontal disease': 1, 'Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs': 1, 'Genetic contributions to preterm birth: implications from epidemiological and genetic association studies': 1, 'Mapping a new spontaneous preterm birth susceptibility gene, IGF1R, using linkage, haplotype sharing, and association analysis': 2, 'Insights into the multifactorial nature of preterm birth: proteomic profiling of the maternal serum glycoproteome and maternal serum peptidome among women in preterm labor': 2, 'Proteomic identification of serum peptides predicting subsequent spontaneous preterm birth': 1, 'Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel biomarkers': 2, 'Noninvasive diagnosis of intraamniotic infection: proteomic biomarkers in vaginal fluid': 1, 'Expression profile of microRNAs and mRNAs in human placentas from pregnancies complicated by preeclampsia and preterm labor': 3, 'Molecular markers of preterm labor in the choriodecidua': 2, 'mRNA of placental origin is readily detectable in maternal plasma': 1, 'Detection of the placental epigenetic signature of the maspin gene in maternal plasma': 1, 'Systematic micro-array based identification of placental mRNA in maternal plasma: towards non-invasive prenatal gene expression profiling': 4, 'Detection and characterization of placental microRNAs in maternal plasma': 1, 'Stability of endogenous and added RNA in blood specimens, serum, and plasma': 1, 'Effects of blood-processing protocols on fetal and total DNA quantification in maternal plasma': 1, 'Development of extraction protocols to improve the yield for fetal RNA in maternal plasma': 1, 'The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments': 2, 'Exploration, normalization, and summaries of high density oligonucleotide array probe level data': 1, 'Controlling the false discovery rate: a practical and powerful approach to multiple testing': 1, 'AmiGO: online access to ontology and annotation data': 1, 'Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection': 1, 'Small molecule inhibitors of Staphylococcus aureus RnpA alter cellular mRNA turnover, exhibit antimicrobial activity, and attenuate pathogenesis': 1, 'Intraamniotic infection upregulates decidual cell vascular endothelial growth factor (VEGF) and neuropilin-1 and -2 expression: implications for infection-related preterm birth': 1, 'Identification and quantification of preterm birth biomarkers in human cervicovaginal fluid by liquid chromatography/tandem mass spectrometry': 1, 'Suppression subtractive hybridization identified a marked increase in thrombospondin-1 associated with parturition in pregnant sheep myometrium': 1, 'Angiogenesis gene expression in mouse uterus during the common pathway of parturition': 1, 'Stretch activates human myometrium via ERK, caldesmon and focal adhesion signaling': 1, 'Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery': 1, 'The length of the cervix and the risk of spontaneous premature delivery. National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network': 1, 'The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice': 2, 'Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2': 1, 'Olmesartan Is an Angiotensin II Receptor Blocker with an Inhibitory Effect on Angiotensin-Converting Enzyme': 2, 'Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors': 1, 'Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker': 1, 'Urinary mRNA expression of ACE and ACE2 in human type 2 diabetic nephropathy': 1, 'SARS-CoV-2 receptor ACE2 gene expression and RAAS inhibitors': 1, 'Angiotensin-converting enzyme 2 protects from severe acute lung failure': 5, 'Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study': 1, 'Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19': 1, 'Variation in COVID-19 Hospitalizations and Deaths Across New York City Boroughs': 1, 'COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: What Is the Evidence?': 1, 'Clinical Relevance and Role of Neuronal AT1 Receptors in ADAM17-Mediated ACE2 Shedding in Neurogenic Hypertension': 1, 'The shedding protease ADAM17: Physiology and pathophysiology': 1, 'Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome': 1, 'Circulating plasma concentrations of angiotensinconverting enzyme 2 in men and women with heart failure and effects of renin-angiotensinaldosterone inhibitors': 1, 'On optimal neighbor discovery': 4, 'Slotless protocols for fast and energy-efficient neighbor discovery': 5, 'Griassdi: Mutually assisted slotless neighbor discovery': 1, 'Static and dynamic crowd densities at major public events. Vereinigung zur Förderung des Deutschen Brandschutzes e. V. (vfdb), German Fire Protection Association, Technical-scientific advisory board (TWB)': 1, 'Specification of the Bluetooth system 5': 1, 'Samsung galaxy s10+ teardown': 1, 'Silicon Laboratories Inc. AN1128: Bluetooth coexistence with wifi': 1, 'Connection-less ble performance evaluation on smartphones': 2, 'Accessory design guidelines for Apple devices': 1, 'Neighbor discovery latency in BLE-like protocols': 1, 'Energy modeling for the bluetooth low energy protocol': 3, 'Online power profiler': 2, 'Nordic Semiconductor. nRF52832 product specification v1': 1, 'Contact tracing bluetooth specification': 2, 'Statistical analysis and performance evaluation for on-body radio propagation with microstrip patch antennas': 1, 'Analysis of path loss characteristics in body area network for different physical structures': 1, 'ITO demonstration app': 1, 'Smartphone-markt: Konjunktur und trends': 1, 'Development and performance analysis of an intra-body communication device': 2, 'Experioexploiting periodicity for opportunistic energy-efficient data transmission': 1, 'Radio frequency time-of-flight distance measurement for low-cost wireless sensor localization': 1, 'Airborne transmission of SARS-CoV-2: The world should face the reality': 2, 'Evidence for probable aerosol transmission of SARS-CoV-2 in a poorly ventilated restaurant. medRxiv': 1, 'Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals': 1, 'SARS-Cov-2 RNA found on particulate matter of': 2, 'Dynamics and dispersion modelling of nanoparticles from road traffic in the urban atmospheric environment -a review': 1, 'Challenges for African swine fever vaccine development-\"… perhaps the end of the beginning': 1, 'Related strains of African swine fever virus with different virulence: genome comparison and analysis': 1, 'Cellular immunity in ASFV responses': 4, 'Antibody-mediated neutralization of African swine fever virus: myths and facts': 4, 'Unraveling the armor of a killer: evasion of host defenses by African swine fever virus': 2, 'Macrophage transcriptional responses following in vitro infection with a highly virulent African swine fever virus isolate': 2, 'Modulation of immune cell population and activation markers in the pathogenesis of African swine fever virus infection': 3, 'The low-virulent African swine fever virus (ASFV/NH/P68) induces enhanced expression and production of relevant regulatory cytokines (IFNalpha, TNFalpha and IL12p40) on porcine macrophages in comparison to the highly virulent ASFV/L60': 2, 'African swine fever virus-cell interactions: from virus entry to cell survival': 3, 'Identification of cellular proteins modified in response to African swine fever virus infection by proteomics': 5, 'Sensitivity of African swine fever virus to type I interferon is linked to genes within multigene families 360 and 505': 2, 'African swine fever virus: a review': 1, 'African swine fever virus controls the host transcription and cellular machinery of protein synthesis': 1, 'Expression library immunization can confer protection against lethal challenge with African swine fever virus': 2, 'Localization of African swine fever viral antigen, swine IgM, IgG and C1q in lung and liver tissues of experimentally infected pigs': 3, 'Live attenuated African swine fever viruses as ideal tools to dissect the mechanisms involved in viral pathogenesis and immune protection': 13, 'African swine fever virus induced polypeptides in porcine alveolar macrophages and in Vero cells: twodimensional gel analysis': 3, 'Virus-host interactome: putting the accent on how it changes': 1, 'iTRAQbased comparative proteomic analysis of Vero cells infected with virulent and CV777 vaccine strain-like strains of porcine epidemic diarrhea virus': 1, 'Proteomic alteration of PK-15 cells after infection by classical swine fever virus': 1, 'Quantitative proteomics by 2-DE, 16O/18O labelling and linear ion trap mass spectrometry analysis of lymph nodes from piglets inoculated by porcine circovirus type 2': 2, 'An in vivo proteomic study of the interaction between Salmonella Typhimurium and porcine ileum mucosa': 2, 'Technical variability of 2D gel electrophoresis-application to soybean allergens': 1, 'Small heat shock proteins and the cytoskeleton: an essential interplay for cell integrity?': 1, 'Expression of hemopexin in acute rejection of rat liver allograft identified by serum proteomic analysis': 1, \"Inflammation, antichymotrypsin, and lipid metabolism: autogenic etiology of Alzheimer's disease\": 1, 'Effects of vitamin D-binding protein-derived macrophage-activating factor on human breast cancer cells': 1, 'Regulation of Rho GTPase activity at the leading edge of migrating cells by p190RhoGAP': 1, 'Apoptosis: a mechanism of cell killing and lymphoid organ impairment during acute African swine fever virus infection': 1, 'Small Rho GTPases and cholesterol biosynthetic pathway intermediates in African swine fever virus infection': 2, 'Regulation of innate immunity by Rho GTPases': 2, 'Vimentin rearrangement during African swine fever virus infection involves retrograde transport along microtubules and phosphorylation of vimentin by calcium calmodulin kinase II': 1, 'Autoimmune hepatitis: a classic autoimmune liver disease': 1, 'Identification of immunodominant autoantigens in rat autoimmune orchitis': 1, 'Identification of alpha-enolase as an autoantigen associated with severe asthma': 1, 'The role of alternative splicing in the control of immune homeostasis and cellular differentiation': 1, 'Identification of hnRNPH1, NF45, and C14orf166 as novel host interacting partners of the mature hepatitis C virus core protein': 1, 'Role of cellular RNA processing factors in human immunodeficiency virus type 1 mRNA metabolism, replication, and infectivity': 1, 'Dengue virus infection induces up-regulation of hn RNP-H and PDIA3 for its multiplication in the host cell': 1, 'Identification of HNRNPK as regulator of hepatitis C virus particle production': 1, 'African swine fever virus protein p30 interaction with heterogeneous nuclear ribonucleoprotein K (hnRNP-K) during infection': 1, 'African swine fever virus organelle rearrangements': 2, 'African swine fever virus gets undressed: new insights on the entry pathway': 2, 'Involvement of clathrin-mediated endocytosis in human immunodeficiency virus type 1 entry': 1, 'Kaposis sarcoma associated herpesvirus modulated microtubule dynamics via RhoA-GTPdiaphanous 2 signaling and utilizes the dynein motors to deliver its DNA to the nucleus': 1, 'Visualization and biochemical analyses of the emerging mammalian 14-3-3-phosphoproteome': 1, 'Phosphoproteomics combined with quantitative 14-3-3-affinity capture identifies SIRT1 and RAI as novel regulators of cytosolic double-stranded RNA recognition pathway': 1, 'Cytosolic RNA recognition pathway activates 14-3-3 protein mediated signaling and caspase dependent disruption of cytokeratin network in human keratinocytes': 1, 'Parainfluenza virus 5 m protein interaction with host protein 14-3-3 negatively affects virus particle formation': 1, 'African swine fever virus morphogenesis': 1, '14-3-3 proteins block apoptosis and differentially regulate MAPK cascades': 2, 'The G2/M regulator 14-3-3sigma prevents apoptosis through sequestration of Bax': 1, 'Cell-cycle responses to DNA damage in G2': 1, 'Proteomic changes in HEK-293 cells induced by hepatitis delta virus replication': 1, 'African swine fever virus': 1, 'Modulation of p53 cellular function and cell death by African swine fever virus': 1, 'A phosphomimetic-based mechanism of dengue virus to antagonize innate immunity': 1, 'DNA vaccination partially protects against African swine fever virus lethal challenge in the absence of antibodies': 2, '26S proteasome exhibits endoribonuclease activity controlled by extra-cellular stimuli': 1, 'Vitamin A and immune function: retinoic acid modulates population dynamics in antigen receptor and CD38-stimulated splenic B cells': 1, 'Galacto mutarotase and other galactose-related genes are rapidly induced by retinoic acid in human myeloid cells': 1, 'The ATF6 branch of unfolded protein response and apoptosis are activated to promote African swine fever virus infection': 1, 'Coronavirus-induced ER stress response and its involvement in regulation of coronavirus-host interactions': 1, 'Vaccination with an adenoviral vector expressing calreticulin-human papillomavirus 16 E7 fusion protein eradicates E7 expressing established tumors in mice': 1, 'The role of serpin and cystatin antiproteases in mucosal innate immunity and their defense against HIV': 1, 'Modulation of the granzyme B inhibitor proteinase inhibitor 9 (PI-9) by activation of lymphocytes and monocytes in vitro and by Epstein-Barr virus and bacterial infection': 3, 'Antiviral cytokines induce hepatic expression of the granzyme B inhibitors, proteinase inhibitor 9 and serine proteinase inhibitor 6': 1, 'A role for the granzyme B inhibitor serine protease inhibitor 6 in CD8 + memory cell homeostasis': 1, 'Guideline for isolation precautions: preventing transmission of infectious agents in health care settings': 9, 'Comparison of two broadly multiplexed PCR systems for viral detection in clinical respiratory tract specimens from immunocompromised children': 1, 'Comparison of the Idaho Technology FilmArray system to real-time PCR for detection of respiratory pathogens in children': 1, 'Fil-mArray, an automated nested multiplex PCR system for multi-pathogen detection: development and application to respiratory tract infection': 1, 'Summaries of Infectious Diseases': 4, 'Multiple versus single virus respiratory infections: viral load and clinical disease severity in hospitalized children': 6, 'FilmArray respiratory panel instruction booklet. Salt Lake City': 1, 'Frequent detection of viral coinfection in children hospitalized with acute respiratory tract infection using a real-time polymerase chain reaction': 1, 'Multiple viral respiratory pathogens in children with bronchiolitis': 4, 'Prospective Multicenter Study of Viral Etiology and Hospital Length of Stay in Children With Severe Bronchiolitis': 4, 'Role of real-time reverse transcription polymerase chain reaction for detection of respiratory viruses in critically ill children with respiratory disease: is it time for a change in algorithm?': 2, 'Frequency and clinical outcome of respiratory viral infections and mixed viralbacterial infections in children with cancer, fever and neutropenia': 1, 'Diagnosis and management of bronchiolitis': 1, 'Two-year prospective study of single infections and co-infections by respiratory syncytial virus and viruses identified recently in infants with acute respiratory disease': 1, 'Bordetella pertussis and concomitant viral respiratory tract infections are rare in children with cough illness': 2, 'Clinical disease and viral load in children infected with respiratory syncytial virus or human metapneumovirus': 2, 'Multipathogen infections in hospitalized children with acute respiratory infections': 2, 'Respiratory syncytial virus infections in hospitalized infants: association between viral load, virus subgroup, and disease severity': 1, 'Bronchiolitis: too-familiar yet too-mysterious disease of childhood': 1, 'Nosocomial respiratory syncytial virus infections: the cost-effectiveness and cost-benefit of infection control': 1, 'COVID-19: preparing for superspreader potential among Umrah pilgrims to Saudi Arabia': 1, 'Paniz-Mondolfi Alberto. The holy week 2020 and the beginning of COVID-19 epidemics in Latin America': 1, 'The cancellation of mass gatherings (MGs)? Decision making in the time of COVID-19': 1, 'Severe Acute Respiratory Syndrome: Historical, Epidemiologic, and Clinical Features': 1, 'CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade': 1, 'Pathological findings of COVID-19 associated with acute respiratory distress syndrome. The Lancet Respiratory Medicine': 1, 'Pulmonary pathology of early phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer': 1, 'Expression of lymphocytes and lymphocyte subsets in patients with severe acute respiratory syndrome': 1, 'Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome': 1, 'A cluster of patients with severe acute respiratory syndrome in a chest ward in southern Taiwan': 1, '4-1BB co-stimulation enhances human CD8(+) T cell priming by augmenting the proliferation and survival of effector CD8(+) T cells': 1, 'Revisiting immune exhaustion during HIV infection. Curr HIV/AIDS Rep 30': 1, 'High levels of circulating GM-CSF(+)CD4(+) T cells are predictive of poor outcomes in sepsis patients: a prospective cohort study': 1, 'The Cytokine GM-CSF Drives the Inflammatory Signature of CCR2+ Monocytes and Licenses Autoimmunity': 1, 'Reducing mortality from 2019-nCoV: host-directed therapies should be an option. The Lancet': 1, 'Clinical experience of IL-6 blockade in rheumatic diseases -implications on IL-6 biology and disease pathogenesis': 1, 'The novel coronavirus originating in Wuhan, China: Challenges for global health governance': 1, 'The first two cases of 2019-nCoV in Italy: Where they come from': 1, 'COVID-19 can present with a rash and be mistaken for dengue': 1, 'Classification of the cutaneous manifestations of COVID-19: A rapid prospective nationwide consensus study in Spain with 375 cases': 1, 'COVID-19: learning from experience': 1, 'Case definition and European surveillance for COVID-19, as of 2': 1, 'Acute undifferentiated fever in Asia: a review of the literature': 4, 'Clinical and epidemiologic characteristics of dengue and other aetiologic agents among patients with acute febrile illness': 1, 'Febrile illness in Asia: gaps in epidemiology, diagnosis, management for informing health policy': 3, 'Acute undifferentiated fever in Binh Thuan province, Vietnam: imprecise clinical diagnosis and irrational pharmaco-therapy': 3, 'Dengue as a cause of acute undifferentiated fever in Vietnam': 3, 'Viral respiratory tract infections among patients with acute undifferentiated fever in Vietnam': 4, 'Acute undifferentiated febrile illness in rural Cambodia: a 3-year prospective observational study': 6, 'Epidemiologic studies need asymptomatic controls': 2, 'Causes of acute undifferentiated fever and the utility of biomarkers in Chiangrai, northern Thailand': 3, 'Tickborne rickettsioses in the Americas: clinical and epidemiological advances': 2, 'Rickettsial infections and fever': 3, 'Rickettsioses and Q fever in travelers (2004-2013)': 1, 'Scrub typhus and military operations in Indochina': 1, 'Scrub typhus after a trip to Vietnam': 1, 'Clinical and epidemiological characteristics of scrub typhus and murine typhus among hospitalized patients with acute undifferentiated fever in Northern Vietnam': 2, 'Rickettsial Diseases and Leptospirosis. US Army Medical Department': 1, 'Seroprevalence of scrub typhus, typhus, and spotted fever Among rural and Urban populations of Northern Vietnam': 1, 'Rickettsia felis: from a rare disease in the USA to a common cause of fever in sub-Saharan Africa': 3, 'Transmission potential of Rickettsia felis infection by Anopheles gambiae mosquitoes': 2, 'Common epidemiology of Rickettsia felis infection and malaria': 1, 'Evidence of rickettsial and leptospira infections in Andean northern Peru': 1, 'Etiology of acute undifferentiated febrile illness in the Amazon basin of Ecuador': 1, 'Acute Q fever in febrile patients in northwestern of Iran': 1, 'Dual genotype Orientia tsutsugamushi infection in patient with rash and eschar': 2, 'Use of eschar swabbing for the molecular diagnosis and genotyping of Orientia tsutsugamushi causing scrub typhus in Quang Nam province': 5, 'Syndromic classification of rickettsioses: an approach for clinical practice': 1, 'Rickettsia felis infection in man': 1, 'Rickettsia felis-associated uneruptive fever': 1, 'Human infection with Rickettsia felis': 1, 'Differential diagnosis of illness in travelers arriving from Sierra Leone, Liberia, or Guinea: a cross-sectional study from the GeoSentinel surveillance Network': 1, 'Sero-prevalence of specific Leptospira serovars in fattening pigs from 5 provinces in Vietnam': 1, 'Three decades of dengue surveillance in five highly endemic South East Asian countries': 1, 'The comparative accuracy of 8 commercial rapid immunochromatographic assays for the diagnosis of acute dengue virus infection': 1, 'Comparison of nonstructural protein-1 antigen detection by rapid and enzyme-linked immunosorbent assay test and its correlation with polymerase chain reaction for early diagnosis of dengue': 1, 'Kinetics of chikungunya infections during an outbreak in Southern Thailand': 1, \"Emergence of chikungunya in Moonlapamok and Khong districts, Champassak province,the Lao People's Democratic Republic\": 1, 'An analysis of fevers of unknown origin in American soldiers in Vietnam': 1, 'Incidence of dengue and chikungunya viruses in mosquitoes and human patients in border provinces of Vietnam': 1, 'Evidence of previous but not current transmission of chikungunya virus in southern and central Vietnam: results from a systematic review and a seroprevalence study in four locations': 1, 'An overview of mosquito vectors of Zika virus': 1, 'Current status, challenges and perspectives in the development of vaccines against yellow fever, dengue, Zika and chikungunya viruses': 2, 'Fetal Zika virus infection in Vietnam': 1, 'Zika virus disease in traveler returning from Vietnam to Israel': 1, 'Detection of Zika virus in a traveller from Vietnam to Japan': 1, 'Zika beyond the Americas: travelers as sentinels of Zika virus transmission. A GeoSentinel analysis': 1, 'Zika virus infection in Vietnam: current epidemic, strain origin, spreading risk, and perspective': 1, 'Causes of non-malarial fever in Laos: a prospective study': 1, 'National surveillance for influenza and influenza-like illness in Vietnam': 2, 'The global impact of influenza on morbidity and mortality': 1, 'Treating influenza with antibiotics': 1, 'Vaccines against influenza WHO position paper': 1, 'Epidemiology and seasonality of respiratory tract virus infections in the tropics': 2, 'Epidemiology of acute respiratory infections in children of developing countries': 1, 'Gas-forming pyogenic liver abscess: a world review': 1, 'Causes of acute, undifferentiated, febrile illness in rural Thailand: results of a prospective observational study': 1, 'Acute undifferentiated fever in India: a multicentre study of aaetiology and diagnostic accuracy': 1, 'Causes of non-malarial febrile illness in outpatients in Tanzania': 1, 'Acute undifferentiated febrile illness in adult hospitalized patients: the disease spectrum and diagnostic predictors -an experience from a tertiary care hospital in South India': 1, 'Laboratory diagnosis of rickettsioses: current approaches to diagnosis of old and new rickettsial diseases': 2, 'Emerging rickettsioses of the Thai-Myanmar border': 1, 'Public health measures to slow community spread of COVID-19': 1, 'COVID-19 coronavirus pandemic': 1, 'Estimation of COVID-19 outbreak size in Italy': 1, 'Correcting under-reported COVID-19 case numbers': 1, 'Plaque formation and isolation of pure lines with poliomyelitis viruses': 1, 'Improvements in methods for calculating virus titer estimates from TCID50 and plaque assays': 2, 'Calculating HIV-1 infectious titre using a virtual TCID(50) method': 2, 'A simple and rapid Hepatitis A Virus (HAV) titration assay based on antibiotic resistance of infected cells: evaluation of the HAV neutralization potency of human immune globulin preparations': 2, 'Titration of human coronaviruses, HcoV-229E and HCoV-OC43, by an indirect immunoperoxidase assay': 3, 'A rapid method for immunotitration of influenza viruses using flow cytometry': 3, 'Production of glycoproteindeleted rabies viruses for monosynaptic tracing and high-level gene expression in neurons': 2, 'Rapid titration of adenoviral infectivity by flow cytometry in batch culture of infected HEK293 cells': 3, 'Rapid method for SV40 titration': 2, 'Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors': 2, 'Error assessment in recombinant baculovirus titration: evaluation of different methods': 3, 'Rapid titration of viruses by flow cytometry': 3, 'A flow cytometry-based immuno-titration assay for rapid and accurate titer determination of modified vaccinia Ankara virus vectors': 1, 'SLAM (CDw150) is a cellular receptor for measles virus': 1, 'End-point dilution and plaque assay methods for titration of cricket paralysis virus in cultured Drosophila cells': 1, 'A European collaborative study to assess the proficiency of laboratory estimates of potency of live measles, mumps and rubella tri-valent vaccines': 1, 'Identification of two amino acids in the hemagglutinin glycoprotein of measles virus (MV) that govern hemadsorption, HeLa cell fusion, and CD46 downregulation: phenotypic markers that differentiate vaccine and wild-type MV strains': 1, 'CD46-mediated measles virus entry: a first key to host-range specificity': 1, 'Efficient major histocompatibility complex class IIrestricted presentation of measles virus relies on hemagglutinin-mediated targeting to its cellular receptor human CD46 expressed by murine B cells': 1, 'In vitro antiviral activity of dehydroepiandrosterone and its synthetic derivatives against vesicular stomatitis virus': 1, 'Oncolysis of Hepatic Metastasis of Colorectal Cancer by Recombinant Vesicular Stomatitis Virus in Immune-Competent Mice': 1, 'Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage': 1, 'Characterization of the behavior of functional viral genomes during the early steps of human immunodeficiency virus type 1 infection': 1, 'SIVSM/HIV-2 Vpx proteins promote retroviral escape from a proteasomedependent restriction pathway present in human dendritic cells': 1, 'Identification of a methylated oligoribonucleotide as a potent inhibitor of HIV-1 reverse transcription complex': 1, 'Potency estimation of measles, mumps and rubella trivalent vaccines with quantitative PCR infectivity assay': 1, 'Estimation of the number of infectious measles viruses in live virus vaccines using quantitative real-time PCR': 1, 'Quantitative Measurement of Varicella-Zoster Virus Infection by Semiautomated Flow Cytometry': 1, 'COVID-19 in solid organ transplant recipients: initial report from the US epicenter': 1, 'SARS-CoV-2 infection in children': 1, 'COVID-19 associated hepatitis complicating recent living donor liver transplantation': 1, 'Protective effects of intravenous immunoglobulin and antimicrobial agents on acute pneumonia in leukopenic mice': 1, 'Illuminating viral infections in the nervous system': 1, 'Innate STAT1-dependent genomic response of neurons to the antiviral cytokine alpha interferon': 1, 'Immune responses to RNA-virus infections of the CNS': 1, 'Neurons under viral attack: Victims or warriors?': 1, 'Fatal fulminant pan-meningopolioencephalitis due to West Nile virus': 2, 'Long-term cognitive sequelae of acyclovir-treated herpes simplex encephalitis': 1, 'Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival': 1, 'Beta interferon controls West Nile virus infection and pathogenesis in mice': 1, 'Systemic distribution of West Nile virus infection: postmortem immunohistochemical study of six cases': 1, 'Inhibitor of κB kinase epsilon (IKK(epsilon)), STAT1, and IFIT2 proteins define novel innate immune effector pathway against West Nile virus infection': 1, 'A diverse range of gene products are effectors of the type I interferon antiviral response': 1, 'Interferon regulatory factor-1 (IRF-1) shapes both innate and CD8(+) T cell immune responses against West Nile virus infection': 1, 'Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300': 1, 'Cooperation of Stat2 and p300/CBP in signalling induced by interferonalpha': 1, 'Direct suppression of Stat1 function during adenoviral infection': 1, 'A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis': 1, 'An activity-regulated microRNA controls dendritic plasticity by downregulating p250GAP': 1, 'miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator': 1, 'MicroRNAs Show Mutually Exclusive Expression Patterns in the Brain of Adult Male Rats': 1, 'A MicroRNA Feedback Circuit in Midbrain Dopamine Neurons': 1, 'Cerebellar granule cells as a model to study mechanisms of neuronal apoptosis or survival in vivo and in vitro': 1, 'The history of the development of the cerebellar examination': 1, 'Age-dependent resistance to lethal alphavirus encephalitis in mice: analysis of gene expression in the central nervous system and identification of a novel interferon-inducible protective gene, mouse ISG12': 1, 'Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication': 1, 'The proinflammatory cytokine-induced IRG1 protein associates with mitochondria': 2, 'Mitoxosome: a mitochondrial platform for cross-talk between cellular stress and antiviral signaling': 1, 'The interferon-inducible gene viperin restricts West Nile virus pathogenesis': 1, 'Phosphorylation of immunity-related GTPases by a Toxoplasma gondii-secreted kinase promotes macrophage survival and virulence': 1, 'Phosphorylation of mouse immunity-related GTPase (IRG) resistance proteins is an evasion strategy for virulent Toxoplasma gondii': 1, 'Localized recrudescence of Toxoplasma infections in the central nervous system of immunocompromised mice assessed by in vivo bioluminescence imaging': 1, 'The changing pattern of human immunodeficiency virus-associated cerebral toxoplasmosis: a study of 46 postmortem cases': 1, 'Virulent Toxoplasma gondii evade immunity-related GTPase-mediated parasite vacuole disruption within primed macrophages': 1, 'Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genes': 1, 'Regulation of interferon and Toll-like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms': 1, 'Unbiased reconstruction of a mammalian transcriptional network mediating pathogen responses': 1, 'Histone H3 lysine 9 di-methylation as an epigenetic signature of the interferon response': 1, 'Ordered recruitment of chromatin modifying and general transcription factors to the IFN-beta promoter': 1, 'Virus infection leads to localized hyperacetylation of histones H3 and H4 at the IFN-beta promoter': 1, 'Inhibition of histone deacetylation induces constitutive derepression of the beta interferon promoter and confers antiviral activity': 1, 'Positive and Negative Regulation of the Innate Antiviral Response and Beta Interferon Gene Expression by Deacetylation': 1, 'Negative and Positive Regulation of Gene Expression by Mouse Histone Deacetylase 1': 1, 'Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis': 1, 'Infection and injury of neurons by West Nile encephalitis virus': 1, 'Structural racism and health inequities in the USA: evidence and interventions': 1, 'Built environment issues in unserved and underserved African-American neighborhoods in North Carolina': 1, 'Relationship between race and community water and sewer service in North Carolina': 2, 'Racial disparities in access to community water supply service in Wake County, North Carolina': 2, 'Public infrastructure disparities and the microbiological and chemical safety of drinking and surface water supplies in a community bordering a landfill': 1, 'Utility rates & schedules: Apex, NC -official website, www.apexnc.org/241/Utility-Rates-Schedules': 1, 'Environmental Protection Agency. Climate impacts on water resources': 1, 'Disparities in water and sewer services in North Carolina: an analysis of the decisionmaking process': 2, 'Municipal underbounding: annexation and racial exclusion in small southern towns': 1, 'A sensitive and specific antigen detection assay for Middle East respiratory syndrome coronavirus': 3, 'Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea': 2, 'Case report: detection of the Middle East respiratory syndrome corona virus (MERS-CoV) in nasal secretions of a dead human': 2, 'Contact investigation of a case of human novel coronavirus infection treated in a German hospital': 1, 'Reverse transcriptase loop-mediated isothermal amplification for the detection of feline coronavirus': 1, 'Development of fluorescent reverse transcription loop-mediated isothermal amplification (RT-LAMP) using quenching probes for the detection of the Middle East respiratory syndrome coronavirus': 1, 'Methods for rapid virus identification and quantification': 3, 'A conformation-dependent neutralizing monoclonal antibody specifically targeting receptorbinding domain in Middle East respiratory syndrome coronavirus spike protein': 1, 'Piezoelectric immunosensor for SARS-associated coronavirus in sputum': 1, 'Detection of severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in human serum using a localized surface plasmon coupled fluorescence fiber-optic biosensor': 1, 'An isothermal, labelfree, and rapid one-step RNA amplification/detection assay for diagnosis of respiratory viral infections': 1, 'A highly sensitive molecular detection platform for robust and facile diagnosis of Middle East Respiratory Syndrome (MERS) Corona Virus': 2, 'An amplified electrochemical immunosensor based on in situ-produced 1-naphthol as electroactive substance and graphene oxide and Pt nanoparticles functionalized CeO2 nanocomposites as signal enhancer': 1, 'Miniaturized biosensor for avian influenza virus detection': 1, 'A multi-virus detectable microfluidic electrochemical immunosensor for simultaneous detection of H1N1, H5N1, and H7N9 virus using ZnO nanorods for sensitivity enhancement': 1, 'Electrochemical detection of the oligomerization of PB1-F2 influenza a virus protein in infected cells': 1, 'Silver nanoparticles coated graphene electrochemical sensor for the ultrasensitive analysis of avian influenza virus H7': 1, 'Bifunctional magnetic nanobeads for sensitive detection of avian influenza A (H7N9) virus based on immunomagnetic separation and enzyme-induced metallization': 1, 'Label-free detection of influenza viruses using a reduced graphene oxide-based electrochemical immunosensor integrated with a microfluidic platform': 1, 'An ultrasensitive electrochemical DNA biosensor based on graphene/Au nanorod/ polythionine for human papillomavirus DNA detection': 1, 'Gold nanoparticle-based electrochemical biosensors': 1, 'Gold nanoparticles: preparation, properties, and applications in bionanotechnology': 3, 'Immunosensor based on electrodeposition of goldnanoparticles and ionic liquid composite for detection of Salmonella pullorum': 2, 'Multiplexed detection of DOCK8, PGM3 and STAT3 proteins for the diagnosis of Hyper-Immunoglobulin E syndrome using gold nanoparticles-based immunosensor array platform': 2, 'Aptamer-based label-free electrochemical biosensor array for the detection of total and glycated hemoglobin in human whole blood': 2, 'Competitive voltammetric morphine immunosensor using a gold nanoparticle decorated graphene electrode': 2, 'Electrochemical impedance immunosensor based on gold nanoparticles-protein G for the detection of cancer marker epidermal growth factor receptor in human plasma and brain tissue': 1, 'Electrochemical impedance spectroscopy detection of lysozyme based on electrodeposited gold nanoparticles': 1, 'Temperature-sensitive mutants of mouse hepatitis virus produce a high incidence of demyelination': 1, 'Demyelination produced by wild-type and temperature-sensitive mutants of mouse hepatitis virus type 4 (JHM). ICN-UCLA Syrnp': 1, 'Stolkin, and D. Gray. 1978. Tetanus toxin: a cell surface marker for neurons in culture': 2, 'Morphological and biochemical maturation of neurones cultured in the absence of glial cells': 1, 'Galactocerebroside is a specific cellsurface antigenic marker for oligodendrocytes in culture': 1, 'Effect of chronic viral infection on the immune system. I. Comparison of the immune responsiveness of mice chronically infected with LCM virus with that of noninfected mice': 1, 'Pathogenesis of murine cytomegalovirus infection: the macrophage as a permissive cell for cytomegalovirus infection, replication and latency': 1, 'Handbook of Experimental Immunology': 1, 'Immunolabeling studies of mouse spinal cord infected with mouse hepatitis virus': 1, 'Pathogenesis of chronic disease associated with persistent lymphocytic choriomeningitis viral infection. I. Relationship of antibody production to disease in neonatally-infected mice': 2, 'Immunohistochemical study of allergic encephalomyelitis': 3, 'General principles underlying laboratory diagnosis of viral infections. Computation of 50 percent endpoints': 1, 'Mouse macrophages as host cells for the mouse hepatitis virus and the genetic basis of their susceptibility': 2, 'Macrophages genetically resistant to mouse hepatitis virus converted in vitro to susceptible macrophages': 1, 'The cellular nature of genetic susceptibility to a virus': 1, 'In vitro interaction of mouse hepatitis virus and macrophages from genetically resistant mice. I. Adsorption of virus and growth curves': 2, 'Congenic strains of mice susceptible and resistant to mouse hepatitis virus': 1, 'In vitro interaction of mouse hepatitis virus and macrophages from genetically resi.stant mice. II. Biological characterization of a variant virus MHV (C3H) isolated from stocks of MHV(PRI)': 1, 'Correlation of persistent mouse hepatitis virus (MHV-3) infection with its effect on mouse macrophage cultures': 3, 'Neuropathologic effects of persistent infection of mice by mouse hepatitis virus': 2, 'Genetic study of mouse sensitivity to MHV3 infection: influence of the tt-2 complex': 1, 'Frelinger. t978. Resistance to fatal central nervous system disease by mouse hepatitis virus, strain JHM. I. Genetic analysis': 1, 'Virus-induced diabetes mellitus. Genetically determined host differences in the replication of encephalomyocarditis virus in pancreatic beta cells': 1, 'Cellular basis for susceptibility to mouse cytomegalovirus: evidence from tracheal organ culture': 1, 'Biological properties of avian coronavirus RNA': 1, 'identification of a new membrane-associated polypeptide specified by the coronavirus infectious bronchitis virus': 6, 'An improved filamentous helper phage for generating single-stranded plasmid DNA': 1, 'Construction of a new family of high efficiency bacterial expression vectors: Identification of cDNA clones coding for human liver proteins': 3, 'Coronavirus leader-RNA-primed transcription: An alternative mechanism to RNA splicing': 1, 'Coronavirus multiplication: Location of genes for virion proteins on the avian infectious bronchitis virus genome': 1, 'Coronavirus MHV-JHM mRNA 5 has a sequence arrangement which potentially allows translation of a second, downstream, open reading frame': 1, 'Coronavirus statics': 1, 'Disrupt. Protein-Protein Interfaces': 1, 'Molecular Dynamics Simulations Related to SARS-CoV-2': 1, 'Viral channel forming proteins-modeling the target': 1, 'Ion channels as antivirus targets': 1, 'Viral proteins function as ion channels': 2, 'Chinese herbs combined with Western medicine for severe acute respiratory syndrome (SARS)': 1, 'Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction': 5, 'Antiotensin-converting enzyme 2: a functional receptor for SARS coronavirus': 1, 'Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor': 2, 'A193-amino-acid fragment of the SARS corona virus S protein efficiently binds angiotensin-converting enzyme 2': 2, 'Characterisation of the 3a protein of SARS-associated coronavirus in infected vero E6 cells and SARS patients': 1, 'Use of frog eggs and oocytes for the study of messenger RNA and its translation in living cells': 1, 'Oogenesis in \"Xenopus laevis\" (Daudin): I. stages of oocyte development in laboratory maintained animals': 1, 'Plaque assay and improved yield of human coronaviruses in a human rhabdomycosarcoma cell line': 1, 'Human and bovine coronaviruss recognize sialic acid-containing receptors similar to those of influenza C viruses': 1, 'A conserved basic loop in hepatitis C virus p7 protein is required for amantadine-sensitive ion channel activity in mammalian cells but is dispensible for localization to mitochondria': 1, 'Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers': 1, 'Placebo-controlled trial of 400 mg amantadine combined with peginterferon alfa-2a and ribavirin for 48 weeks in chronic hepatitis C virus-1 infection': 1, 'Intracellular proton conductance of the hepatitis C virus p7 protein and its contribution to infectious virus production': 2, 'Granulopoiesis and granules of human neutrophils': 2, 'Neutrophils: new insights and open questions': 1, 'Neutrophil granules: a library of innate immunity proteins': 1, 'Neutrophils, from marrow to microbes': 1, 'Targeting of proteins to granule subsets is determined by timing and not by sorting: the specific granule protein NGAL is localized to azurophil granules when expressed in HL-60 cells': 1, 'Developmental analysis of bone marrow neutrophils reveals populations specialized in expansion, trafficking, and effector functions': 2, 'Dynamics of transcription regulation in human bone marrow myeloid differentiation to mature blood neutrophils': 2, \"What's your age again? Determination of human neutrophil half-lives revisited\": 1, 'Neutrophils instruct homeostatic and pathological states in naive tissues': 3, 'Circadian expression of migratory factors establishes lineagespecific signatures that guide the homing of leukocyte subsets to tissues': 1, 'A neutrophil timer coordinates immune defense and vascular protection': 18, 'Contribution of neutrophils to acute lung injury': 2, 'Neutrophils and their Fcγ receptors are essential in a mouse model of transfusion-related acute lung injury': 1, 'Neutrophils scan for activated platelets to initiate inflammation': 4, 'The acute respiratory distress syndrome: pathogenesis and treatment': 1, 'Rhythmic modulation of the hematopoietic niche through neutrophil clearance': 2, 'Neutrophil mobilization via plerixafor-mediated CXCR4 inhibition arises from lung demargination and blockade of neutrophil homing to the bone marrow': 2, 'Neutrophil ageing is regulated by the microbiome': 1, 'Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans': 1, 'Myeloid-specific deletion of Mcl-1 yields severely neutropenic mice that survive and breed in homozygous form': 1, 'Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury': 1, 'Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury': 2, 'Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury': 2, 'Extracellular DNA traps are associated with the pathogenesis of TRALI in humans and mice': 2, 'Pathophysiology of transfusionrelated acute lung injury': 1, 'Stabilized imaging of immune surveillance in the mouse lung': 2, 'Circadian variation in the frequency of onset of acute myocardial infarction': 1, 'Circadian control of the immune system': 1, 'Circadian variations of infarct size in acute myocardial infarction': 2, 'Acute respiratory distress syndrome in mechanically ventilated patients with community-acquired pneumonia': 2, 'Neutrophil-derived serine proteases modulate innate immune responses': 1, 'Neutrophil serine proteases: specific regulators of inflammation': 1, 'Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth': 1, 'Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase': 1, 'The role of CD18-mediated adhesion in neutrophil sequestration induced by infusion of activated plasma in rabbits': 1, 'The lung is a host defense niche for immediate neutrophilmediated vascular protection': 1, 'Thrombosis as an intravascular effector of innate immunity': 1, 'Host DNases prevent vascular occlusion by neutrophil extracellular traps': 1, 'General statistical framework for quantitative proteomics by stable isotope labeling': 1, 'A novel systems-biology algorithm for the analysis of coordinated protein responses using quantitative proteomics': 1, 'SanXoT: a modular and versatile package for the quantitative analysis of high-throughput proteomics experiments': 3, 'PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps': 1, 'Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19)': 2, 'ESHRE. ESHRE guidance on recommencing ART treatments': 1, 'Patient management and clinical recommendations during the coronavirus (COVID-19) pandemic': 1, 'best practice guidelines for reintroduction of routine fertility treatments during the COVID-19 pandemic': 2, 'Fertility care during the COVID-19 pandemic: guiding principles to assist Canadian ART clinics to resume services and care': 1, 'European Centre for Disease Prevention and Control. Contact tracing: public health management of persons, including healthcare workers, having had contact with COVID-19 cases in the European Union -second update': 1, 'Deaths in healthcare workers due to COVID-19: the need for robust data and analysis': 1, 'European Centre for Disease Prevention and Control. COVID-19 situation update worldwide, as of 16': 1, 'COVID-19) screening tool': 1, 'Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. Sci China Life Sci': 1, 'Diagnosis of the coronavirus disease (COVID-19): rRT-PCR or CT?': 1, 'NHS. Check if you have coronavirus symptoms': 1, 'Coronavirus disease-2019: is fever an adequate screening for the returning travelers': 1, 'Impact of coronavirus outbreak on NO 2 pollution assessed using TROPOMI and OMI observations': 1, 'Lockdown for CoViD-2019 in Milan: What are the effects on air quality?': 1, 'Spatial-Temporal Analysis on Spring Festival Travel Rush in China Based on Multisource Big Data': 1, 'Impact of anthropogenic emission on air quality over a megacity -revealed from an intensive atmospheric campaign during the Chinese Spring Festival': 1, 'Characterization and source identification of fine particulate matter in urban Beijing during the 2015 Spring Festival': 1, 'Air pollution \"holiday effect\" resulting from the Chinese New Year': 1, 'The effects of firework regulation on air quality and public health during the Chinese Spring Festival from 2013 to 2017 in a Chinese megacity': 1, 'Science Objectives of the Ozone Monitoring Instrument': 3, 'A new stratospheric and tropospheric NO 2 retrieval algorithm for nadir-viewing satellite instruments: applications to OMI': 1, 'A space-based, high-resolution view of notable changes in urban NOx pollution around the world': 1, 'S5P Mission Performance Centre Nitrogen Dioxide': 3, 'A physics-based approach to oversample multi-satellite, multispecies observations to a common grid': 4, 'Formaldehyde (HCHO) As a Hazardous Air Pollutant: Mapping Surface Air Concentrations from Satellite and Inferring Cancer Risks in the United States': 1, 'Effect of changing NO&amp': 1, 'Tropospheric NO 2 vertical column densities retrieved from ground-based MAX-DOAS measurements at Shangdianzi regional atmospheric background station in China': 1, 'Bats: Important reservoir hosts of emerging viruses': 5, 'Transcriptome sequencing and annotation for the Jamaican fruit bat (Artibeus jamaicensis)': 5, 'Bats prove to be rich reservoirs for emerging viruses': 1, 'Emerging diseases in chiroptera: Why bats?': 1, 'Bat white-nose syndrome: An emerging fungal pathogen? Science': 1, 'An emerging disease causes regional population collapse of a common North American bat species': 1, 'Geomyces destructans sp. nov. associated with bat white-nose syndrome': 1, 'Bartonella species in bat flies (Diptera: Nycteribiidae) from western Africa': 1, 'Global distribution and genetic diversity of Bartonella in bat flies (Hippoboscoidea, Streblidae, Nycteribiidae)': 1, 'Serologic survey of Eptesicus fuscus from Georgia, U.S.A. for Rickettsia and Borrelia and laboratory transmission of a Rickettsia by bat ticks': 1, 'Diseases and causes of death in European bats: Dynamics in disease susceptibility and infection rates': 1, 'Diseases in free-ranging bats from Germany': 1, 'Yersinia species isolated from bats': 1, 'Pathogenesis of experimental histoplasmosis in the bat, Artibeus lituratus': 1, 'Bats Without Borders: Long-distance movements and implications for disease risk management': 1, 'Isolation of multiple novel paramyxoviruses from pteropid bat urine': 2, 'Detection and phylogenetic analysis of group 1 coronaviruses in South American bats': 1, 'Novel astroviruses in insectivorous bats': 1, 'Evidence for retrovirus and paramyxovirus infection of multiple bat species in China': 2, 'Hantaviruses: Rediscovery and new beginnings': 1, 'Agricultural intensification, priming for persistence and the emergence of Nipah virus: A lethal bat-borne zoonosis': 1, 'A framework for the study of zoonotic disease emergence and its drivers: Spillover of bat pathogens as a case study': 1, 'Viral mechanisms of immune evasion': 1, 'The interferon antiviral response: From viral invasion to evasion': 1, 'Host evasion by emerging paramyxoviruses: Hendra virus and Nipah virus V proteins inhibit interferon signaling': 1, 'Henipaviruses Employ a Multifaceted approach to evade the antiviral interferon response': 2, 'Identification of the nuclear export signal and STAT-binding domains of the Nipah virus V protein reveals mechanisms underlying interferon evasion': 2, 'Nipah virus V protein evades alpha and gamma interferons by preventing STAT1 and STAT2 activation and nuclear accumulation': 1, 'Nipah virus V and W proteins have a common STAT1-binding domain yet inhibit STAT1 activation from the cytoplasmic and nuclear compartments, respectively': 1, 'Differential lymphocyte and antibody responses in deer mice infected with Sin Nombre hantavirus or Andes hantavirus': 2, 'Pteropid bats are confirmed as the reservoir hosts of henipaviruses: A comprehensive experimental study of virus transmission': 1, 'Oral shedding of Marburg virus in experimentally infected Egyptian fruit bats (Rousettus Aegyptiacus)': 1, 'Virological and serological findings in Rousettus aegyptiacus experimentally inoculated with vero cells-adapted hogan strain of Marburg virus': 1, 'A comparison of bats and rodents as reservoirs of zoonotic viruses: Are bats special?': 1, \"Mass extinctions, biodiversity and mitochondrial function: Are bats 'special' as reservoirs for emerging viruses?\": 2, 'Experimental infection model for Sin Nombre hantavirus in the deer mouse (Peromyscus maniculatus)': 1, 'Persistent Sin Nombre virus infection in the deer mouse (Peromyscus maniculatus) model: Sites of replication and strand-specific expression': 1, 'Experimental infection of the cane mouse Zygodontomys brevicauda (family Muridae) with Guanarito virus (Arenaviridae), the etiologic agent of Venezuelan hemorrhagic fever': 1, 'Experimental infection with Puumala virus, the etiologic agent of nephropathia epidemica, in bank voles (Clethrionomys glareolus)': 1, 'Regulatory T cells enhance persistence of the zoonotic pathogen Seoul virus in its reservoir host': 1, 'Regulatory T cell-like responses in deer mice persistently infected with Sin Nombre virus': 1, 'The other rabies viruses: The emergence and importance of lyssaviruses from bats and other vertebrates': 1, 'Bats, emerging infectious diseases, and the rabies paradigm revisited': 1, 'Host immunity to repeated rabies virus infection in big brown bats': 1, 'Susceptibility and pathogenesis of little brown bats (Myotis lucifugus) to heterologous and homologous rabies viruses': 2, 'Tacaribe virus, a new agent isolated from Artibeus bats and mosquitos in Trinidad, West Indies': 1, 'Tacaribe virus causes fatal infection of an ostensible reservoir host, the Jamaican fruit bat': 1, 'Structural basis for receptor recognition by New World hemorrhagic fever arenaviruses': 1, 'Phylogeny of New World arenaviruses based on the complete coding sequences of the small genomic segment identified an evolutionary lineage produced by intrasegmental recombination': 1, 'Mammalian Species: Artibeus jamaicensis': 1, 'Australian Animal Health Laboratory': 1, 'Discovery of an ebolavirus-like filovirus in europe': 1, 'Seroepidemiology of selected alphaviruses and flaviviruses in bats in Trinidad': 1, 'Isolation and phylogenetic characterization of bat astroviruses in southern China': 1, 'Host switching in lyssavirus history from the Chiroptera to the Carnivora orders': 1, 'Genetic constraints and the adaptive evolution of rabies virus in nature': 1, 'Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation': 1, 'Endothelial-specific knockdown of interleukin-1 (IL-1) type 1 receptor differentially alters CNS responses to IL-1 depending on its route of administration': 1, 'Deletion of prostaglandin e2 synthesizing enzymes in brain endothelial cells attenuates inflammatory Fever': 1, 'Immunoglobulin heavy chain diversity in Pteropid bats: Evidence for a diverse and highly specific antigen binding repertoire': 2, 'Molecular characterisation of RIG-I-like helicases in the black flying fox, Pteropus alecto': 2, 'Cloning, expression and antiviral activity of IFNgamma from the Australian fruit bat, Pteropus alecto': 3, 'Interferon production and signaling pathways are antagonized during henipavirus infection of fruit bat cell lines': 2, 'Purification and characterisation of immunoglobulins from the Australian black flying fox (Pteropus alecto) using anti-fab affinity chromatography reveals the low abundance of IgA': 1, 'Proteomics informed by transcriptomics reveals Hendra virus sensitizes bat cells to TRAIL mediated apoptosis': 2, 'Type III IFN receptor expression and functional characterisation in the pteropid bat, Pteropus alecto': 1, 'Bat Mx1 and Oas1, but not Pkr are highly induced by bat interferon and viral infection': 2, 'Antiviral immune responses of bats: A review': 3, 'What ecologists can tell virologists': 1, \"What's the damage? The impact of pathogens on pathways that maintain host genome integrity\": 1, 'Toll-like receptors': 2, 'Innate immunity: The virtues of a nonclonal system of recognition': 1, 'Nucleic acid recognition by the innate immune system': 1, 'NOD-like receptors: Role in innate immunity and inflammatory disease': 1, 'Molecular characterisation of Toll-like receptors in the black flying fox Pteropus alecto': 1, 'Molecular cloning and expression analysis of bat toll-like receptors 3, 7 and 9': 1, 'Structure of the human type-I interferon gene cluster determined from a YAC clone contig': 1, 'Type I interferon reaction to viral infection in interferon-competent, immortalized cell lines from the African fruit bat Eidolon helvum': 1, '28, IL-29 and their class II cytokine receptor IL-28R': 1, 'Type III IFNs in pteropid bats: Differential expression patterns provide evidence for distinct roles in antiviral immunity': 2, 'Plaque forming cell assay for antibody secreting cells in the bat Pteropus giganteus': 1, 'Immunofluorescence analysis of immunoglobulin bearing lymphocytes in the Indian fruit bat: Pteropus giganteus': 1, 'In vitro analysis of delayed immune response in a bat, Pteropus giganteus: Process of con-A mediated activation': 1, 'Analysis of immunocompetent cells in the bat, Pteropus giganteus: Isolation and scanning electron microscopic characterization': 1, 'The little brown bat, M. lucifugus, displays a highly diverse V H, D H and J H repertoire but little evidence of somatic hypermutation': 1, 'The two suborders of chiropterans have the canonical heavy-chain immunoglobulin (Ig) gene repertoire of eutherian mammals': 1, 'De novo derivation of proteomes from transcriptomes for transcript and protein identification': 1, 'Functional analysis of Rousettus aegyptiacus \"signal transducer and activator of transcription 1\" (STAT1)': 1, 'Marburg virus evades interferon responses by a mechanism distinct from ebola virus': 1, 'Field guide to next-generation DNA sequencers': 1, 'Control of pro-angiogenic cytokine mRNA half-life in cancer: The role of AU-rich elements and associated proteins': 1, 'De novo transcript sequence reconstruction from RNA-seq using the Trinity platform for reference generation and analysis': 1, 'Oases: Robust de novo RNA-seq assembly across the dynamic range of expression levels': 1, 'Differential expression analysis for sequence count data': 1, 'Count-based differential expression analysis of RNA sequencing data using R and Bioconductor': 1, 'RSEM: Accurate transcript quantification from RNA-Seq data with or without a reference genome': 1, 'RNA-eXpress annotates novel transcript features in RNA-seq data': 1, 'Database for Annotation, Visualization, and Integrated Discovery': 1, 'A knowledge base of biologic pathways and processes': 1, 'A cytoscape plug-in for exploring and visualizing reactome': 1, 'Expression profiling of lymph node cells from deer mice infected with Andes virus': 2, 'Lipids at the interface of virus-host interactions': 1, 'Multifaceted roles for lipids in viral infection': 1, 'Metabolic pathways in immune cell activation and quiescence': 1, 'An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow': 1, 'Generation of competent bone marrow-derived antigen presenting cells from the deer mouse (Peromyscus maniculatus)': 1, 'A package for performing multiple sequence alignment on a microcomputer': 1, 'World gastroenterology organization global guidelines on obesity': 1, 'The Netherlands epidemiology and demography compression of morbidity research group. Obesity in adulthood and its consequences for life expectancy: a life-table analysis': 2, 'Body-mass index and cause-specific mortality in 900000 adults: collaborative analyses of 57 prospective studies': 1, 'Bariatric surgery. A systematic review and meta-analysis': 1, 'The impacts of super obesity versus morbid obesity on respiratory mechanics and simple hemodynamic parameters during bariatric surgery': 1, 'Intraoperative ventilatory strategies for prevention of pulmonar atelectasis in obese patients undergoing laparoscopic bariatric surgery': 3, 'Ventilation strategies in obese patients undergoing surgery: a quantitative systematic review and meta-analysis': 4, 'Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated': 3, 'Bariatric Surgery in ClassI Obesity {accessed 21': 1, 'Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement': 1, 'Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated': 1, 'Pressurecontrolled ventilation improves oxygenation during laparoscopic obesity surgery compared with volume-controlled ventilation': 4, 'Recruitment of lung volume during surgery neither affects the postoperative spirometry nor the risk of hypoxaemia after laparoscopic gastric bypass in morbidly obese patients: a randomized controlled study': 6, 'Noninvasive ventilation and alveolar recruitment maneuver improve respiratory function during and after intubation of morbidly obese patients': 1, 'Equal ratio ventilation (1:1) improves arterial oxygenation during laparoscopic bariatric surgery: a crossover study': 2, 'Impact of alveolar recruitment maneuver in the postoperative period of Videolaparoscopic bariatric surgery': 1, 'Alveolar recruitment and arterial Desflurance concentration during bariatric surgery': 4, 'The effects of the alveolar recruitment maneuver and positive endexpiratory pressure on arterial oxygenation during laparoscopic bariatric surgery': 5, 'Use of positive pressure in pre and intraoperative of bariatric surgery and its effect on the time of extubation': 1, 'Prevention of atelectasis in morbidly obese oatients during general anestesia and paralysis: a computerized tomography study': 4, 'Analysis of the effects of the alveolar recruitment maneuver on blood oxygenation during bariatric surgery': 2, 'Comparison of volume-controlled and pressure-controlled ventilation during laparoscopic gastric banding in morbidly obese patients': 3, 'Effective ventilation strategies for obese patients undergoing bariatric surgery a literature review: a literature review': 1, 'An official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine clinical practice guideline: mechanical ventilation in adult patients with acute respiratory distress syndrome': 3, 'Higher vs lower positive endexpiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis': 1, 'Effects of pressurecontrolled with different I:E ratios versus volume-controlled ventilation on respiratory mechanics, gas exchange, and hemodynamics in patients with adult respiratory distress syndrome': 1, 'Effects of inverse ratio ventilation versus positive end-expiratory pressure on gas exchange and gastric intramucosal PCO2 and pH under constant mean airway pressure in acute respiratory distress syndrome': 1, 'Improved oxygenation and lower peak airway pressure in severe adult respiratory distress syndrome: treatment with inverse ratio ventilation': 1, 'Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysis': 1, 'Neonatal, postneonatal, childhood, and under-5 mortality for 187 countries, 1970-2010: a systematic analysis of progress towards millennium development goal 4': 3, 'World health statistics 2010: World Health Organization': 1, 'Seasonal influenza in adults and children-diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America': 1, 'Predicting the distribution of under-five deaths by cause in countries without adequate vital registration systems': 1, 'Child death review teams: a vital component of child protection': 1, 'Global initiatives for improving hospital care for children: state of the art and future prospects': 1, 'Hospital care for children in developing countries: clinical guidelines and the need for evidence': 1, 'The differentiation of the health situation in European postcommunist countries after 1990': 1, 'New WHO guidelines on emergency triage assessment and treatment': 1, 'Childhood mortality in children emergency Centre of the Lagos University teaching hospital': 2, 'Child health in complex emergencies': 3, 'Improved triage and emergency care for children reduces inpatient mortality in a resource-constrained setting': 2, 'Global use of the WHO pocket book of hospital care for children. Paediatrics and International Child health': 3, 'Morbidity and mortality pattern of admissions into the emergency Paediatric unit of University of Abuja Teaching Hospital': 1, 'The epidemiological profile of pediatric patients admitted to the general intensive care unit in an ethiopian university hospital': 1, 'Decreased pediatric hospital mortality after an intervention to improve emergency care in Lilongwe': 1, 'Prevalence and burden of diseases presenting to a general pediatrics ward in Gondar, Ethiopia': 4, 'The mortality of patients in a pediatric emergency department at a tertiary medical center in China: an observational study': 6, 'Pattern and outcome of admissions at the children emergency room at the Federal Teaching Hospital Abakaliki': 7, 'An audit of paediatric mortality patterns in a Nigerian teaching hospital': 4, \"Under-five mortality pattern and associated risk factors: a case-control study at the Princess Marie Louise Children's Hospital in\": 7, 'How well do mothers and caregivers prepare oral rehydration solution': 2, 'Integrated community case management of childhood illness in Ethiopia: implementation strength and quality of care': 2, 'Child mortality rate in Ethiopia': 1, 'Neonatal mortality in Ethiopia: trends and determinants': 1, 'Can we achieve millennium development goal 4? New analysis of country trends and forecasts of under-5 mortality to': 2, 'Demographic and mortality analysis of hospitalized children at a referral hospital in Addis Ababa': 4, 'Pattern and outcome of postneonatal pediatric emergencies in Nnamdi Azikiwe University teaching hospital': 1, 'Sociodemographic determinants of mortality in hospitalized under-five children at a secondary health Care Centre in the Niger Delta': 1, 'Correction: care seeking behaviour for children with suspected pneumonia in countries in sub-Saharan Africa with high pneumonia mortality': 1, \"Prevalence of childhood illness and mothers'/caregivers' care seeking behavior in Bahir Dar, Ethiopia: a descriptive community based cross sectional study\": 1, 'Morbidity and mortality of childhood illnesses at the emergency paediatric unit of the University of Benin Teaching Hospital': 1, 'A five-year review of childhood mortality at the university college hospital, Ibadan': 1, 'Modifiable factors for prevention of childhood mortality': 1, 'Protecting health from climate change: connecting science, policy and people': 1, 'Global burden of childhood pneumonia and diarrhoea': 1, 'Low contribution of health extension workers in identification of persons with presumptive pulmonary tuberculosis in Ethiopian Somali region pastoralists': 1, \"A qualitative assessment of health extension workers' relationships with the community and health sector in Ethiopia: opportunities for enhancing maternal health performance\": 1, 'Social-environmental influences on the occurrence of neonatal tetanus in some riverine communities in Nigeria': 1, 'Care seeking behaviour for children with suspected pneumonia in countries in sub-Saharan Africa with high pneumonia mortality': 1, 'Priority actions for the non-communicable disease crisis': 1, 'The magnitude of under-five emergencies in a resource-poor environment of a rural Hospital in Eastern Nigeria: implication for strengthening the house-hold and Community-integrated Management of Childhood Illnesses': 1, 'Serious childhood problems in countries with limited resources': 1, 'Excess child mortality after discharge from hospital in Kilifi, Kenya: a retrospective cohort analysis': 2, 'Diarrhoea: why children are still dying and what can be done': 1, 'Undernutrition as an underlying cause of child deaths associated with diarrhea, pneumonia, malaria, and measles': 1, 'Risk correlates of diarrhea in children under 5 years of age in slums of Bankura, West Bengal': 1, 'Global, regional, and national causes of child mortality in 2008: a systematic analysis': 1, 'Risk factors for death among children less than 5 years old hospitalized with diarrhea in rural western Kenya': 1, 'Approach to Nutrition Programming in the East Asia and Pacifc Region': 1, 'COVID-19 publications: Database coverage, citations, readers, tweets, news, Facebook walls': 1, 'Opportunistic infections of mice and rats: Jacoby and Lindsey revisited': 2, 'Diagnostic testing of mouse and rat colonies for infectious agents': 1, 'Prevalence of naturally occurring viral infections, Mycoplasma pulmonis and Clostridium piliforme in laboratory rodents in Western Europe screened from': 2, 'STAT1-dependent innate immunity to a Norwalk-like virus': 1, 'Development of a microsphere-based serologic multiplexed fluorescent immunoassay and a reverse transcriptase PCR assay to detect murine norovirus 1 infection in mice': 1, 'Mouse Norovirus (MNV): erste Untersuchungsergebnisse (Abstract) 44. GV-SOLAS Annual Meeting': 1, 'Genetic diversity and recombination of murine noroviruses in immunocompromised mice': 1, 'Prevalence of mouse norovirus (MNV) in a large breeding and experimental mouse facility. (Abstract) 10th FELASA Symposium': 1, 'Detection of infectious agents in laboratory rodents: Traditional and molecular techniques': 2, 'Guidance on the transport of laboratory animals': 1, 'Efficacy of disinfectants against MVM-and MNV-contaminated surfaces': 1, 'Resynchronization of the circadian corticosterone rhythm after a light/dark shift in juvenile and adult mice': 1, 'Establishing an appropriate period of acclimatization following transportation of laboratory animals': 1, 'Genome cryopreservation: A valuable contribution to mammalian genetic research': 1, 'Federation of International Mouse Resources: Global networking of resource centers': 1, 'Three-dimensional structure of the zona pellucida': 1, 'Biology and structure of the zona pellucida: A target for immunocontraception': 1, 'Constructing the mammalian egg zona pellucida: Some new pieces of an old puzzle': 1, 'Design and analysis of research on infectious disease transmission by embryos': 1, 'Development of normal mice by in vitro fertilization': 1, 'Production of normal young following transfer of mouse embryos obtained by in vitro fertilization using cryopreserved spermatozoa': 1, 'Murine cytomegalovirus infects spermatogenic cells': 1, 'Epididymis is a principal site of retrovirus expression in the mouse': 1, 'Detection of mouse parvovirus in Mus musculus gametes, embryos, and ovarian tissues by polymerase chain reaction assay': 4, 'Transmission of mouse minute virus (MVM) but not mouse hepatitis virus (MHV) following embryo transfer with experimentally exposed in vivo-derived embryos': 3, 'Production of virus-free seronegative pups from murine embryos arising from in vitro fertilization with mice minute virus-exposed spermatozoa': 2, 'The developmental ability of vitrified oocytes from different mouse strains assessed by parthenogenetic activation and intracytoplasmic sperm injection': 1, 'Live births after autologous transplant of cryopreserved mouse ovaries': 1, 'Fertility of mice receiving vitrified adult mouse ovaries': 1, 'Late replication in an Xautosome translocation in the mouse: Correlation with genetic inactivation and evidence for selective effects during embryogenesis': 1, 'Rescue of a transgenic mouse line by transplantation of a frozen-thawed ovary obtained postmortem': 1, 'Studies of the mechanism of spontaneous germline ecotropic provirus acquisition in mice': 1, 'Tissue distribution and duration of mouse hepatitis virus in naturally infected immunocompetent ICR (CD-1) and immunodeficient athymic nude-nu mouse strains used for ovarian transplantation and in vitro fertilization': 1, 'Helicobacter typhlonius was detected in the sex organs of three mouse strains but did not transmit vertically': 1, 'Effect of viruses on early mammalian development. I. Action of Mengo encephalitis virus on mouse ova cultivated in vitro': 1, 'Effect of viruses on early mammalian development. III. Further studies concerning the interaction of Mengo encephalitis virus with mouse ova': 1, 'Passage of mengovirus through the zona pellucida of the mouse morula': 1, 'Immunofluorescence study of the carrier state and mechanism of vertical transmission in lymphocytic choriomeningitis virus infection in mice': 1, 'The effectiveness of trypsin treatment to remove Sendai virus adhering to the zona pellucida of mouse preimplantation embryos': 2, 'The effect of experimental infection of mouse preimplantation embryos with paramyxovirus Sendai': 1, 'Sendai (parainfluenza 1) infection of mouse eggs': 1, 'Survey of embryonic stem cells for murine infective agents': 1, 'Replication of murine coronaviruses in mouse embryonic stem cell lines in vitro': 2, 'Maintenance of pluripotency in mouse embryonic stem cells persistently infected with murine coronavirus': 2, 'Recommendations for the health monitoring of rodent and rabbit colonies in breeding and experimental units': 1, 'Risk assessment of mouse hepatitis virus infection via in vitro fertilization and embryo transfer by the use of zona-intact and laser-microdissected oocytes': 1, 'Elimination of Sendai (parainfluenza type 1) virus infection from mice by embryo transfer': 1, 'Pathogenicity of mouse hepatitis virus for preimplantation mouse embryos': 1, 'Rederivation of inbred strains of mice by means of embryo transfer': 1, 'Rederivation of mice by means of in vitro fertilization and embryo transfer': 1, 'Rederivation of transgenic and genetargeted mice by embryo transfer': 1, 'Microbiological monitoring of laboratory mice and biocontainment in individually ventilated cages: A field study': 2, 'Efficacy of three microbiological monitoring methods in a ventilated cage rack': 1, 'A positive, individually ventilated caging system: A local barrier system to protect both animals and personnel': 1, 'Effectiveness of pressurized individually ventilated (PIV) cages in reducing transmission of pneumonia virus of mice (PVM) (abstr)': 1, 'Evaluation of isolator caging systems for protection of mice against challenge with mouse hepatitis virus': 1, 'Isolator rodent caging systems (state of the art): A critical view': 2, 'Elimination of mouse allergens in the working environment: Assessment of individually ventilated cage systems and ventilated cabinets in the containment of mouse allergens': 1, 'Virus PCR assay panels: An alternative to the mouse antibody production test': 1, 'Comparison of the sensitivity of in vivo antibody production tests with in vitro PCR-based methods to detect infectious contamination of biological materials': 1, 'Polymerase chain reaction (PCR) testing of biological materials for rodent pathogens as an alternative to the mouse antibody production (MAP) test. (Abstract) 9th FELASA Symposium': 1, 'Mouse antibody production test: Can we do without it?': 1, \"FELASA guidelines for education of specialists in laboratory animal science (Category D): Report of the Federation of Laboratory Animal Science Association's Working Group on Education of Specialists (Category D) accepted by the FELASA Board of Management\": 1, 'Recognizing and diagnosing postweaning multisystemic wasting syndrome (PMWS). Swine Health Production': 1, 'Isolation of circovirus from lesions of pigs with postweaning multisystemic wasting syndrome': 1, 'Changes in CD4 + , CD8 + , CD4 + CD8 + , and immunoglobulin M-positive peripheral blood mononuclear cells of postweaning multisystemic wasting syndrome-affected pigs and age-matched uninfected wasted and healthy pigs correlate with lesions and porcine circovirus type 2 load in lymphoid tissues': 2, 'Immunosupression in postweaning multisystemic wasting syndrome affected pigs': 1, 'Serum antibodies to porcine circovirus type 1 and type 2 in pigs with and without PMWS': 1, 'Lack of an effect of a commercial vaccine adjuvant on the development of postweaning multisystemic wasting syndrome (PMWS) in porcine circovirus type 2 (PCV2) experimentally infected conventional pigs': 1, 'Pathological, immunohistochemical, and in-situ hybridization studies of natural cases of postweaning multisystemic wasting syndrome (PMWS) in pigs': 1, 'Cytokine profiles of peripheral blood mononuclear cells of pigs suffering from postweaning multisystemic wasting syndrome in response to mitogen, superantigen or recall viral antigens': 4, 'Cytokine mRNA expression profiles in lymphoid tissues of pigs naturally affected by postweaning multisystemic wasting syndrome': 1, 'Association of lymphopenia with porcine circovirus type 2 induced postweaning multisystemic wasting syndrome (PMWS)': 1, 'Viral wasting syndrome of swine: experimental reproduction of postweaning multisystemic wasting syndrome in gnotobiotic swine by coinfection with porcine circovirus 2 and porcine parvovirus': 1, 'PCR detection of porcine circovirus type 2 (PCV2) DNA in blood, tonsillar and faecal swabs from experimentally infected pigs': 1, 'Comparison of porcine circovirus type 2 load in serum quantified by a real time PCR in postweaning multisystemic wasting syndrome and dermatitis and nephropathy syndrome naturally affected pigs': 1, 'Immune responses of pigs after experimental infection with a European strain of Porcine reproductive and respiratory syndrome virus': 1, 'Experimental inoculation of conventional pigs with porcine reproductive and respiratory syndrome virus and porcine circovirus 2': 1, 'Experimental reproduction of postweaning multisystemic wasting syndrome in cesarean-derived, colostrum-deprived piglets inoculated with porcine circovirus type 2 (PCV2): investigation of quantitative PCV2 distribution and antibody responses': 1, 'Cytokine and C-reactive protein profiles induced by porcine circovirus type 2 experimental infection in 3-week-old piglets': 1, 'Systemic cytokine profile in feeder pigs suffering from natural postweaning multisystemic wasting syndrome (PMWS) as determined by semiquantitative RT-PCR and flow cytometric intracellular cytokine detection': 1, 'Evolution and tinkering': 1, 'Paradoxical interplay of viral and cellular functions': 1, 'Components of fitness become effectively neutral in equilibrium populations': 3, 'Quantitative aspects of the spread of footand-mouth disease': 1, 'Immunological parameters of Togavirus disease syndromes': 1, 'Viral dynamics in human immunodeficiency virus type 1 infection': 2, 'A single amino acid substitution in nonstructural protein 3A can mediate adaptation of foot-and-mouth disease virus to the Guinea pig': 2, 'Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy': 2, 'Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1': 7, 'Influenza viruses': 1, 'Viral shedding patterns of children with influenza B infection': 1, 'Contact residues and predicted structure of the reovirus type 3-receptor interaction': 2, 'Using metagenomics to characterize an expanding virosphere': 1, 'Functions of replicating RNA in cells infected by RNA bacteriophages': 1, 'Pliovirus RNA replication': 1, 'Possible unifying mechanism of picornavirus genome replication': 1, \"Efficiency of incorporation and chain termination determines the inhibition potency of 2'-modified nucleotide analogs against hepatitis C virus polymerase\": 1, 'HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy': 1, 'Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection': 1, 'Time to hit HIV, early and hard': 1, 'HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time': 1, 'A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo': 1, 'Kinetics of acute hepatitis B virus infection in humans': 1, 'Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection': 2, 'Genetic identity, biological phenotype, and evolutionary pathways of transmitted/ founder viruses in acute and early HIV-1 infection': 1, 'Increase of virus yields and releases of Borna disease virus from persistently infected cells': 1, 'Contribution of LCMV towards deciphering biology of quasispecies in vivo': 3, 'Bottleneck-mediated quasispecies restriction during spread of an RNA virus from inoculation site to brain': 2, 'Evolution of mammalian and avian bornaviruses': 1, 'Development of a new Sindbis virus transducing system and its characterization in three Culicine mosquitoes and two Lepidopteran species': 1, 'Trans-packaged West Nile virus-like particles: infectious properties in vitro and in infected mosquito vectors': 1, 'Effect of bottlenecking on evolution of the nonstructural protein 3 gene of hepatitis C virus during sexually transmitted acute resolving infection': 1, 'Analysis of genetic bottlenecks during horizontal transmission of Cucumber mosaic virus': 2, 'Multiple host barriers restrict poliovirus trafficking in mice': 1, 'Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon': 2, 'Sequential bottlenecks drive viral evolution in early acute hepatitis C virus infection': 1, 'Viral quasispecies evolution. Microbiol': 2, 'Arboviral bottlenecks and challenges to maintaining diversity and fitness during mosquito transmission': 3, 'Assessment of experimental and natural viral aerosols': 1, 'The red queen reigns in the kingdom of RNA viruses': 1, 'Global epidemiology of hepatitis C virus infection': 1, 'Evolutionary basis of codon usage and nucleotide composition bias in vertebrate DNA viruses': 2, 'Contribution of a multifunctional polymerase region of foot-and-mouth disease virus to lethal mutagenesis': 2, 'Genetic bottlenecks reduce population variation in an experimental RNA virus population': 1, 'Estimation of the number of virus particles transmitted by an insect vector': 1, 'Estimation of the effective number of founders that initiate an infection after aphid transmission of a multipartite plant virus': 1, 'Contact transmission of Tobacco mosaic virus: a quantitative analysis of parameters relevant for virus evolution': 1, 'Narrow bottlenecks affect Pea seedborne mosaic virus populations during vertical seed transmission but not during leaf colonization': 1, 'Intra-and interhost evolutionary dynamics of equine influenza virus': 1, 'Dynamic viral dissemination in mice infected with yellow fever virus strain 17D': 1, 'Fundamental concepts in genetics: effective population size and patterns of molecular evolution and variation': 1, 'Genetic estimates of contemporary effective population size: what can they tell us about the importance of genetic stochasticity for wild population persistence?': 4, 'Fifteen years later: hard and soft selection sweeps confirm a large population number for HIV in vivo': 1, 'Biological implications of picornavirus fidelity mutants': 2, 'Evasion of superinfection exclusion and elimination of primary viral RNA by an adapted strain of hepatitis C virus': 1, 'A positively selected mutation in the WNV 2K peptide confers resistance to superinfection exclusion in vivo. Virology 464e465, 228e232': 2, 'The Evolutionary Biology of Viruses': 2, 'Molecular Basis of Virus Evolution': 2, 'Quasispecies and RNA Virus Evolution: Principles and Consequences': 1, 'Detection of genome-scale ordered RNA structure (GORS) in genomes of positive-stranded RNA viruses: implications for virus evolution and host persistence': 1, 'Developmental constraints and evolution': 1, 'Leeway and constraints in the forced evolution of a regulatory RNA helix': 1, 'RNA pseudoknots': 1, \"Large deletions in the 5'-untranslated region of foot-and-mouth disease virus of serotype C\": 1, 'RNA-protein interactions in regulation of picornavirus RNA translation': 1, 'Identification of an essential region for internal initiation of translation in the aphthovirus internal ribosome entry site and implications for viral evolution': 1, 'A single amino acid substitution in the V1 loop of human immunodeficiency virus type 1 gp120 alters cellular tropism': 2, 'Synonymous codon bias is related to gene length in Escherichia coli: selection for translational accuracy?': 1, 'The three-dimensional structure of foot-and-mouth disease virus at 2.9 Å resolution': 2, 'Structure of the major antigenic loop of foot-and-mouth disease virus complexed with a neutralizing antibody: direct involvement of the Arg-Gly-Asp motif in the interaction': 3, 'Foot-and-Mouth Disease Virus: Current Research and Emerging Trends': 1, 'Evolution of the capsid protein genes of foot-and-mouth disease virus: antigenic variation without accumulation of amino acid substitutions over six decades': 1, 'Distinct repertoire of antigenic variants of foot-andmouth disease virus in the presence or absence of immune selection': 2, 'Antibody recognition of picornaviruses and escape from neutralization: a structural view': 1, 'Complexity theory and the no free lunch theorem': 1, 'Naturally selecting solutions: the use of genetic algorithms in bioinformatics': 1, 'Use of uniform designs in combination with neural networks for viral infection process development': 1, 'Co-optimization free lunches: tractability of optimal black-box algorithms for maximizing expected utility': 1, 'Biological and biomedical implications of the coevolution of pathogens and their hosts': 2, 'Ancient co-speciation of simian foamy viruses and primates': 1, 'Viruses and the Evolution of Life': 1, 'A working hypothesisdvirus resistance development as an indicator of specific antiviral activity': 1, 'The leader proteinase of footand-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response': 1, 'Emergence of a drug-dependent human immunodeficiency virus type 1 variant during therapy with the T20 fusion inhibitor': 1, 'Inhibition of pyrimidine biosynthesis pathway suppresses viral growth through innate immunity': 1, 'Different types of secondary information in the genetic code': 1, 'Steps towards Life': 1, 'Biased codon usage near intron-exon junctions: selection on splicing enhancers, splice-site recognition or something else?': 1, 'Codon bias as a factor in regulating expression via translation rate in the human genome': 1, 'Mutation-selection models of codon substitution and their use to estimate selective strengths on codon usage': 1, 'Modulation of poliovirus replicative fitness in HeLa cells by deoptimization of synonymous codon usage in the capsid region': 1, 'Reduction of the rate of poliovirus protein synthesis through large-scale codon deoptimization causes attenuation by lowering specific infectivity': 1, 'Virus attenuation by genome-scale changes in codon pair bias': 1, 'Identification of amino acid residues critical for the anti-interferon activity of the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus': 3, 'Attenuation of human respiratory syncytial virus by genome-scale codon-pair deoptimization': 1, 'Influenza A virus attenuation by codon deoptimization of the NS gene for vaccine development': 1, 'Development of live-attenuated arenavirus vaccines based on codon deoptimization': 1, 'Zika virus attenuation by codon pair deoptimization induces sterilizing immunity in mouse models': 1, 'The Phylogenetic Handbook. A Practical Approach to DNA and Protein Phylogeny': 4, 'Hepatitis A virus adaptation to cellular shutoff is driven by dynamic adjustments of codon usage and results in the selection of populations with altered capsids': 1, 'Codon biases and viral fitness': 1, 'A new evolutionary law': 1, 'Red queen dynamics of protein translation': 1, 'A condition-specific codon optimization approach for improved heterologous gene expression in Saccharomyces cerevisiae': 1, 'Attenuation of RNA viruses by redirecting their evolution in sequence space': 1, 'Monitoring and redirecting virus evolution': 1, 'Ultra-deep pyrosequencing detects conserved genomic sites and quantifies linkage of drugresistant amino acid changes in the hepatitis B virus genome': 1, 'Exposing synonymous mutations': 1, 'Mathematical modeling of evolution. Solved and open problems': 1, 'Evolution of cell recognition by viruses: a source of biological novelty with medical implications': 5, 'The role of cellular adhesion molecules in virus attachment and entry': 2, 'Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily': 1, 'Receptors': 2, 'Host-selected amino acid changes at the sialic acid binding pocket of the parvovirus capsid modulate cell binding affinity and determine virulence': 2, 'Biochemical characterization of poliomavirusreceptor interactions': 1, 'Quantitative expression analysis of HHV-6 cell receptor CD46 on cells of human cord blood, peripheral blood and G-CSF mobilised leukapheresis cells': 1, 'Viruses and viral proteins': 1, 'Nectin-like interactions between poliovirus and its receptor trigger conformational changes associated with cell entry': 2, 'Cyclical adaptation of measles virus quasispecies to epithelial and lymphocytic cells: to V, or not to V': 1, 'Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin': 1, 'Structure and receptor binding preferences of recombinant human A(H3N2) virus hemagglutinins': 1, 'Host restriction in the productive cycle of avian polyomavirus budgerigar fledgling disease virus type 3 depends on a single amino acid change in the common region of structural proteins VP2/VP3': 1, 'A single-amino-acid change in murine norovirus NS1/2 is sufficient for colonic tropism and persistence': 1, 'A single amino acid change in the murine leukemia virus capsid gene responsible for the Fv1(nr) phenotype': 1, 'Single amino acid changes can influence titer, heparin binding, and tissue tropism in different adeno-associated virus serotypes': 1, 'A single mutation within the V3 envelope neutralization domain of feline immunodeficiency virus determines its tropism for CRFK cells': 1, 'A single amino acid substitution in the transmembrane envelope glycoprotein of feline immunodeficiency virus alters cellular tropism': 1, 'Expanded host cell tropism and cytopathic properties of feline immunodeficiency virus strain PPR subsequent to passage through interleukin-2-independent T cells': 1, 'Host range mutant of human immunodeficiency virus type 1: modification of cell tropism by a single point mutation at the neutralization epitope in the env gene': 1, 'Three classes of cell surface receptors for alphaherpesvirus entry': 2, 'Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity': 1, 'Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates': 1, 'Poliovirus variants selected on mutant receptor-expressing cells identify capsid residues that expand receptor recognition': 1, 'Mechanism of altered Sindbis virus neurovirulence associated with a singleamino-acid change in the E2 Glycoprotein': 1, 'A single mutation in the E2 glycoprotein important for neurovirulence influences binding of sindbis virus to neuroblastoma cells': 1, 'Cell recognition by foot-and-mouth disease virus that lacks the RGD integrin-binding motif: flexibility in aphthovirus receptor usage': 3, 'Expansion of host-cell tropism of foot-and-mouth disease virus despite replication in a constant environment': 2, 'Differences in affinity of binding of lymphocytic choriomeningitis virus strains to the cellular receptor alpha-dystroglycan correlate with viral tropism and disease kinetics': 1, 'Parvovirus host range, cell tropism and evolution': 1, 'A single amino acid in the adenovirus type 37 fiber confers binding to human conjunctival cells': 1, 'Change in coreceptor use correlates with disease progression in HIV-1-infected individuals': 1, 'Isolation of primary HIV-1 that target CD8þ T lymphocytes using CD8 as a receptor': 1, 'Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants': 1, 'Shift of clinical human immunodeficiency virus type 1 isolates from X4 to R5 and prevention of emergence of the syncytium-inducing phenotype by blockade of CXCR4': 1, 'Variations of coxsackievirus B3 capsid primary structure, ligands, and stability are selected for in a coxsackievirus and adenovirus receptor-limited environment': 1, 'Evolution of the equine infectious anemia virus long terminal repeat during the alteration of cell tropism': 1, 'HIV-1 clade promoters strongly influence spatial and temporal dynamics of viral replication in vivo': 2, 'Clade-specific differences in active viral replication and compartmentalization': 2, 'Dengue virus RNA structure specialization facilitates host adaptation. PLoS Pathog. 11, e1004604. Virgin, H.W., 2014. The virome in mammalian physiology and disease': 1, 'Dengue virus genomic variation associated with mosquito adaptation defines the pattern of viral non-coding RNAs and fitness in human cells': 2, 'Population mixing promotes arms race host-parasite coevolution': 1, 'Mutual information in protein multiple sequence alignments reveals two classes of coevolving positions': 1, 'Annotating protein functional residues by coupling highthroughput fitness profile and homologous-structure analysis': 1, 'Covariation of mutations in the V3 loop of human immunodeficiency virus type 1 envelope protein: an information theoretic analysis': 1, 'Virion structure': 1, 'Evolution subverting essentiality: dispensability of the cell attachment Arg-Gly-Asp motif in multiply passaged foot-and-mouth disease virus': 1, 'Perturbations in the surface structure of A22 Iraq foot-and-mouth disease virus accompanying coupled changes in host cell specificity and antigenicity': 2, 'Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle': 1, 'The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex': 1, 'A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants': 1, 'Evidence of the coevolution of antigenicity and host cell tropism of foot-and-mouth disease virus in vivo': 1, 'Structural changes in the haemagglutinin which accompany egg adaptation of an influenza A(H1N1) virus': 1, 'Preferential selection of receptor-binding variants of influenza virus hemagglutinin by the neutralizing antibody repertoire of transgenic mice expressing a human immunoglobulin mu minigene': 1, 'Selection of antigenically distinct variants of influenza C viruses by the host cell': 1, 'Characterization of H2 influenza virus hemagglutinin with monoclonal antibodies: influence of receptor specificity': 1, 'Human norovirus epitope D plasticity allows escape from antibody immunity without loss of capacity for binding cellular ligands': 2, 'Adeno-associated virus serotype 1 (AAV1)-and AAV5-antibody complex structures reveal evolutionary commonalities in parvovirus antigenic reactivity': 1, 'Identification of a putative cellular receptor for bovine herpesvirus 1': 1, 'Identification of a 56 kDa putative bovine herpesvirus 1 cellular receptor by anti-idiotype antibodies': 1, 'Identification of cell surface receptors for the 86-kilodalton glycoprotein of human cytomegalovirus': 1, 'Anti-idiotype antibodies that mimic gp86 of human cytomegalovirus inhibit viral fusion but not attachment': 1, 'Anti-idiotypic antibodies mimicking glycoprotein D of herpes simplex virus identify a cellular protein required for virus spread from cell to cell and virus-induced polykaryocytosis': 1, 'The major neutralizing antigenic site on herpes simplex virus glycoprotein D overlaps a receptor-binding domain': 1, 'Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus': 1, 'PreS1-specific binding proteins as potential receptors for hepatitis B virus in human hepatocytes': 1, \"Spontaneous development of anti-hepatitis B virus envelope (anti-idiotypic) antibodies in animals immunized with human liver endonexin II or with the F(ab')2 fragment of anti-human liver endonexin II immunoglobulin G: evidence for a receptor-ligandlike relationship between small hepatitis B surface antigen and endonexin II\": 1, 'Fibronectin of human liver sinusoids binds hepatitis B virus: identification by an anti-idiotypic antibody bearing the internal image of the pre-S2 domain': 1, 'Interaction between duck hepatitis B virus and a 170-kilodalton cellular protein is mediated through a neutralizing epitope of the pre-S region and occurs during viral infection': 1, 'Characterization of a 120-Kilodalton pre-S-binding protein as a candidate duck hepatitis B virus receptor': 1, 'Poliovirus host range is determined by a short amino acid sequence in neutralization antigenic site I': 1, 'Canyon rim residues, including antigenic determinants, modulate serotype-specific binding of polioviruses to mutants of the poliovirus receptor': 1, 'Three-dimensional structure of a mouse-adapted type 2/type 1 poliovirus chimera': 1, 'Mutational analysis of a neutralization epitope on the dengue type 2 virus (DEN2) envelope protein: monoclonal antibody resistant DEN2/DEN4 chimeras exhibit reduced mouse neurovirulence': 2, \"A neutralization site of DA strain of Theiler's murine encephalomyelitis virus important for disease phenotype\": 1, \"Adaptation of Theiler's virus to L929 cells: mutations in the putative receptor binding site on the capsid map to neutralization sites and modulate viral persistence\": 1, 'Recent structural solutions for antibody neutralization of viruses': 1, 'Functional and neutralization profile of seven overlapping antigenic sites on the HN glycoprotein of Newcastle disease virus: monoclonal antibodies to some sites prevent viral attachment': 1, 'Evidence from the anti-idiotypic network that the acetylcholine receptor is a rabies virus receptor': 1, 'Identification of the cell surface receptor for bovine viral diarrhoea virus by using anti-idiotypic antibodies': 1, 'A 50 kDa membrane protein from bovine kidney cells is a putative receptor for bovine viral diarrhea virus (BVDV)': 1, 'Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis': 1, 'Neutralization and fusion inhibition activities of monoclonal antibodies specific for the S1 subunit of the spike protein of neurovirulent murine coronavirus JHMV c1-2 variant': 1, 'Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies': 1, 'Identification of a putative alphavirus receptor on mouse neural cells': 1, 'Antiidiotypic antibodies as probes for the Sindbis virus receptor': 1, 'Host-cell receptors for Sindbis virus': 1, 'Putative receptor binding sites on alphaviruses as visualized by cryoelectron microscopy': 1, 'Isolation and biochemical characterization of the mammalian reovirus type 3 cell-surface receptor': 1, 'Anti-idiotypic antibody identifies the cellular receptor of reovirus type 3': 1, 'Sequences of the cell-attachment sites of reovirus type 3 and its anti-idiotypic/antireceptor antibody: modeling of their three-dimensional structures': 1, 'Development and use of antireceptor antibodies to study interaction of mammalian reovirus type 3 with its cell surface receptor': 1, 'VP7: an attachment protein of bluetongue virus for cellular receptors in Culicoides variipennis': 1, 'Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution': 1, 'Antigenic variation of clade 2.1 H5N1 virus is determined by a few amino acid substitutions immediately adjacent to the receptor binding site': 1, 'Structural comparison of two strains of foot-and-mouth disease virus subtype O1 and a laboratory antigenic variant': 1, 'The structure and antigenicity of a type C foot-and-mouth disease virus': 1, 'Rapid evolution of virus sequences in intrinsically disordered protein regions': 1, 'Innate antiviral immune signaling, viral evasion and modulation by HIV-1': 1, 'Viruses and the type I interferon antiviral system: induction and evasion': 1, 'Viruses and interferon: a fight for supremacy': 1, 'HIV-1 Nef: a master manipulator of the membrane trafficking machinery mediating immune evasion': 1, 'Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant': 1, 'Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus': 2, 'Escape of human immunodeficiency virus from immune control': 1, 'Viral persistence in vivo through selection of neutralizing antibody-escape variants': 2, 'Rapid selection of genetic and antigenic variants of foot-and-mouth disease virus during persistence in cattle': 1, 'Rapid evolution of the neutralizing antibody response to HIV type 1 infection': 1, 'Quasispecies: Concepts and Implications for Virology': 2, 'Non-random escape pathways from a broadly neutralizing human monoclonal antibody map to a highly conserved region on the hepatitis C virus E2 glycoprotein encompassing amino acids 412e423': 1, 'Response of hepatitis C virus to long-term passage in the presence of alpha interferon: multiple mutations and a common phenotype': 2, 'Molecular basis of interferon resistance in hepatitis C virus': 2, 'Quasispecies dynamics and clinical significance of HCV antiviral resistance': 1, 'Interferon induction as a quasispecies marker of vesicular stomatitis virus populations': 1, 'Increased fidelity reduces poliovirus fitness under selective pressure in mice': 2, 'Molecular dissection of bluetongue virus': 1, 'The Picornaviruses': 1, 'Molecular basis for a lack of correlation between viral fitness and cell killing capacity': 1, 'Involvement of a joker mutation in a polymerase-independent lethal mutagenesis escape mechanism': 2, 'Multifunctionality of a picornavirus polymerase domain: nuclear localization signal is involved in nucleotide recognition': 1, 'Arbovirus evolution': 2, 'Dengue and dengue hemorrhagic fever: its history and resurgence as a global public health problem': 1, 'Focus on molecular plant-nematode and plant-insect interactions': 1, 'Deceptive chemical signals induced by a plant virus attract insect vectors to inferior hosts': 1, 'Viral manipulation of plant stress responses and host interactions with insects': 1, 'Virus factories of cauliflower mosaic virus are virion reservoirs that engage actively in vector transmission': 1, 'Cell-Surface Peptidases in Health and Disease': 2, 'Inactivation of thyrotropin-releasing hormone (TRH) by the hormonally regulated TRH-degrading ectoenzyme: a potential regulator of TRH-signals?': 1, 'Cloning and characterization of a novel insulin-regulated membrane aminopeptidase from Glut4 vesicles': 1, 'Aminopeptidase-B in the rat testes: isolation, functional properties and cellular localization in the seminiferous tubules': 1, 'Leukotriene A4 hydrolase: an epoxide hydrolase with peptidase activity': 1, 'Puromycin-sensitive aminopeptidase. Sequence analysis, expression, and functional characterization': 2, 'Thyroid hormones rapidly and stringently regulate the messenger RNA levels of the thyrotropinreleasing hormone (TRH) receptor and the TRH-degrading ectoenzyme': 1, 'Molecular Cloning: a Laboratory Manual': 1, 'PROSITE: a dictionary of sites and patterns in proteins': 1, 'Protein database searches for multiple alignments': 1, 'FACS-optimized mutants of the green fluorescent protein (GFP)': 1, 'Fluorometric measurement of alkaline phosphatase and aminopeptidase activities in the order of 10(-14) mole': 1, 'Human aminopeptidase N is encoded by 20 exons': 1, 'The mouse BP-1 gene: structure, chromosomal localization, and regulation of expression by type I interferons and interleukin-7': 1, 'Human TRH-degrading ectoenzyme cDNA cloning, functional expression, genomic structure and chromosomal assignment': 2, 'Structural features in eukaryotic mRNAs that modulate the initiation of translation': 1, 'Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites': 1, 'A unique signature identifies a family of zinc-dependent metallopeptidases': 1, 'Characterization of Glu350 as a critical residue involved in the N-terminal amine binding site of aminopeptidase N (EC 3.4.11.2): insights into its mechanism of action': 1, 'A tyrosine residue essential for catalytic activity in aminopeptidase A': 1, 'Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro': 1, 'l-leucinethiol: a potent inhibitor of leucine aminopeptidase': 1, 'Proteins of the kidney microvillar membrane. Enzymic and molecular properties of aminopeptidase W': 1, 'Cellular reorganisation of membrane peptidases in Wallerian degeneration of pig peripheral nerve': 1, 'A novel neuron-specific aminopeptidase in rat brain synaptosomes. Its identification, purification, and characterization': 1, 'X-ray crystallographic determination of the structure of bovine lens leucine aminopeptidase complexed with amastatin: formulation of a catalytic mechanism featuring a gem-diolate transition state': 1, 'Handbook of Proteolytic Enzymes': 2, 'Crystalline leucine aminopeptidase from lens (alpha-aminoacyl-peptide hydrolase': 1, 'Structural and immunological evidence for the identity of prolyl aminopeptidase with leucyl aminopeptidase': 1, 'Identification of the thyrotropinreleasing-hormone-degrading ectoenzyme as a metallopeptidase': 1, 'Astacus protease: a zinc metalloenzyme': 1, 'Comparison of the soluble and membrane-bound forms of the puromycin-sensitive enkephalin-degrading aminopeptidases from rat': 1, 'Are there neuropeptidespecific peptidases?': 1, 'Beware: Gastrointestinal symptoms can be a manifestation of COVID-19': 2, 'Guidance for cardiac electrophysiology during the coronavirus (COVID-19) pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology': 2, 'COVID-19 Coronavirus Pandemic': 1, 'Impact of coronavirus disease 2019 (COVID-19) outbreak on ST-segment-elevation myocardial infarction care in Hong Kong': 2, 'Secondary impact of the COVID-19 pandemic on patients with heart failure': 2, \"Heart failure in the COVID-19 pandemic: Where has all New York's congestion gone?\": 1, 'Overcoming the bottleneck to widespread testing: A rapid review of nucleic acid testing approaches for COVID-19 detection': 2, 'Virological assessment of hospitalized patients with COVID-2019': 1, 'Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)': 2, 'Role of serology in the COVID-19 pandemic': 1, 'Can smartphone wireless ECGs be used to accurately assess ECG intervals in pediatrics? A comparison of mobile health monitoring to standard 12-lead ECG': 1, 'QTC intervals can be assessed with the AliveCor heart monitor in patients on dofetilide for atrial fibrillation': 1, 'Anosmia and ageusia as primary symptoms of COVID-19': 1, 'Vascular skin symptoms in COVID-19: A French observational study': 1, 'Hyperinflammatory shock in children during COVID-19 pandemic': 1, 'HRS Expert Consensus Statement on remote interrogation and monitoring for cardiovascular implantable electronic devices': 1, 'Use of remote monitoring of newly implanted cardioverterdefibrillators: Insights from the patient related determinants of ICD remote monitoring (PREDICT RM) study': 2, 'Impact of remote monitoring on clinical events and associated health care utilization: A nationwide assessment': 1, 'Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: The ALTITUDE survival study': 1, 'Virus interference. I. The interferon': 1, 'Synthesis in E. coli of a polypeptide with human leukocyte interferon activity': 1, 'IFN-tau: a novel subtype I IFN1. Structural characteristics, nonubiquitous expression, structure-function relationships, a pregnancy hormonal embryonic signal and cross-species therapeutic potentialities': 1, 'Interferon-kappa, a novel type I interferon expressed in human keratinocytes': 1, 'Diversity and relatedness among the type I interferons': 2, 'Circulating virus, interferon and antibody after vaccination with the 17-D strain of yellow-fever virus': 1, 'Cellular responses to interferon-gamma': 2, 'Three-dimensional structure of recombinant human interferon-gamma': 1, 'Cloning of a new type II cytokine receptor activating signal transducer and activator of transcription (STAT)1, STAT2 and STAT3': 1, 'IL-28, IL-29 and their class II cytokine receptor IL-28R': 1, 'Evasion of intracellular host defence by hepatitis C virus': 2, 'Interferons and apoptosis': 1, 'Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo': 1, 'IL-28 and IL-29: newcomers to the interferon family': 1, 'Cell type-specific involvement of RIG-I in antiviral response': 1, 'TLRs, NLRs and RLRs: a trinity of pathogen sensors that cooperate in innate immunity': 1, 'Antiviral innate immunity pathways': 2, 'TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity': 1, 'NF-kappaB and the immune response': 1, 'IRF-7 is the master regulator of type-I interferon-dependent immune responses': 1, 'Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes': 1, 'Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling': 1, 'A novel c-Jun-dependent signal transduction pathway necessary for the transcriptional activation of interferon gamma response genes': 1, 'Interferon modulation of cellular microRNAs as an antiviral mechanism': 1, 'Interferons and their actions': 1, 'Noncytolytic control of viral infections by the innate and adaptive immune response': 1, 'Distinct functions of IRF-3 and IRF-7 in IFN-alpha gene regulation and control of anti-tumor activity in primary macrophages': 1, 'Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts)': 1, 'Development of pegylated interferons for the treatment of chronic hepatitis C': 1, 'Antiviral activity of CHO-SS cellderived human omega interferon and other human interferons against HCV RNA replicons and related viruses': 1, 'A Phase I/II study evaluating escalating doses of recombinant human albumininterferon-alpha fusion protein in chronic hepatitis C patients who have failed previous interferon-alpha-based therapy': 2, 'Pharmacokinetic and pharmacodynamic studies of a human serum albumininterferon-alpha fusion protein in cynomolgus monkeys': 1, 'Evolution of a cytokine using DNA family shuffling': 1, 'Therapy of hepatitis C: consensus interferon trials': 1, 'The biologic activity and molecular characterization of a novel synthetic interferon-alpha species, consensus interferon': 1, 'A comparison of interferon-Con1 with natural recombinant interferons-alpha: antiviral, antiproliferative, and natural killer-inducing activities': 1, 'Durable sustained virological response after treatment with peginterferon alfa-2a (Pegasys) alone or in combination with ribavirin (Copegus): 5-year follow-up and the criteria for a cure': 1, '10-Year follow-up after interferon-alpha therapy for chronic hepatitis C': 1, 'National Institutes of Health Consensus Development Conference Panel statement: management of hepatitis C': 1, 'Optimal therapy of hepatitis C': 1, 'A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C': 1, 'Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide': 1, 'Antiviral action of ribavirin in chronic hepatitis C': 1, 'Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alpha-2a plus ribavirin combination': 2, 'A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C': 1, 'Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C': 2, 'Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus': 2, 'EASL International Consensus Conference on hepatitis C. Paris': 1, 'National Institutes of Health Consensus Development Conference statement: management of hepatitis C': 1, 'Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection': 5, 'Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose': 6, 'Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial': 5, 'Population pharmacokinetic and pharmacodynamic analysis of ribavirin in patients with chronic hepatitis C': 1, 'Ribavirin dosing in chronic hepatitis C: application of population pharmacokinetic-pharmacodynamic models': 1, 'High-dose ribavirin in combination with standard dose peginterferon for treatment of patients with chronic hepatitis C': 2, 'Predicting sustained virological response and anaemia in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) plus ribavirin': 1, 'Strategies for managing anemia in hepatitis C patients undergoing antiviral therapy': 1, 'Improved sustained virological response (SVR) rates with higher, fixed doses of peginterferon alfa-2a (40 kD) (Pegasys) plus ribavirin (RBV) (Copegus) in patients with \"difficult-to-treat': 1, 'Weight-based ribavirin dosing (WBD) increases sustained viral response (SVR) in patients with chronic hepatitis C (CHC): final results of the WIN-R study, a US community-based trial': 1, 'Therapy of hepatitis C: from empiricism to eradication': 1, 'The early HCV RNA dynamics in patients with acute hepatitis C treated with pegylated interferon-alpha2b': 2, 'Treatment of acute hepatitis C with interferon alfa-2b': 2, 'Efficacy of a 24-week course of PEG-interferon alpha-2b monotherapy in patients with acute hepatitis C after failure of spontaneous clearance': 1, 'Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II study': 1, 'A short course of pegylated interferon-alpha in acute HCV hepatitis': 2, 'Intravenous recombinant interferon-beta versus interferon-alpha-2b and ribavirin in combination for short-term treatment of chronic hepatitis C patients not responding to interferon-alpha': 1, 'Multicenter randomized, controlled study of intramuscular administration of interferon-beta for the treatment of chronic hepatitis C': 1, 'A pilot study of recombinant interferon beta-1a for the treatment of chronic hepatitis C': 1, 'Intravenous natural beta-interferon in white patients with chronic hepatitis C who are nonresponders to alpha-interferon': 1, 'Alpha but not beta interferon is useful in chronic active hepatitis due to hepatitis C virus. A prospective, double-blind, randomized study': 1, 'Combination therapy with interferon-alpha and ribavirin as immunomodulators in patients with chronic hepatitis C': 1, 'High viral eradication with a daily 12-week natural interferon-beta treatment regimen in chronic hepatitis C patients with low viral load': 1, 'Anti-viral actions and viral dynamics in the early phase of three different regimens of interferon treatment for chronic hepatitis C: differences between the twice-daily administration of interferon-beta treatment and the combination therapy with interferon-alpha plus ribavirin': 1, 'Open-labeled study of omega interferon in previously untreated HCVinfected patients': 1, 'HCV RNA results from a Phase II, randomized, open-labeled study of omega interferon (IFN) with or without ribavirin in IFN-naive genotype 1 chronic HCV patients': 1, 'Phase 2 study of omega interferon alone or in combination with ribavirin in subjects with chronic hepatitis C genotype-1 infection': 1, 'Interferons alpha, beta, gamma each inhibit hepatitis C virus replication at the level of internal ribosome entry site-mediated translation': 1, 'Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs': 1, 'Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons': 1, 'Pilot study of interferon gamma for chronic hepatitis C': 1, 'Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics': 1, 'A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patients': 1, 'Consensus interferon versus interferon-alpha 2b plus ribavirin in patients with relapsing HCV infection': 1, 'Consensus interferon and ribavirin for patients with chronic hepatitis C and failure of previous interferon-alpha therapy': 1, 'High dose consensus interferon in nonresponders to interferon alpha-2b and ribavirin with chronic hepatitis C': 1, 'Antiviral response of HCV genotype 1 to consensus interferon and ribavirin versus pegylated interferon and ribavirin': 1, 'The hepatitis C virus life cycle as a target for new antiviral therapies': 3, 'Results of an interim analysis of a Phase II study of telaprevir (VX-950) with peginterferon alfa-2a and ribavirin in previously untreated subjects with hepatitis C': 1, 'Dynamic HCV genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevir (VX-950)': 1, 'Valopicitabine (NM283), alone or with peg-interferon, compared to peginterferon/ribavirin (PEGIFN/RBV) retreatment in hepatitis C patients with prior non-response to PEGIFN/RBV: week 24 results': 1, 'Antiviral activity of the non-nucleoside polymerase inhibitor, HCV-796, in combination with pagylated interferon alfa-2b in treatment-naive patients with chronic HCV': 1, 'Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection': 1, 'Consensus statement (long version)': 2, 'A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update': 1, 'Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update': 1, 'Chronic hepatitis B': 1, 'Pilot study of recombinant human alpha-interferon for chronic type B hepatitis': 1, '48 weeks pegylated interferon alpha-2a is superior to 24 weeks of pegylated interferon alpha-2b in achieving hepatitis B e antigen seroconversion in chronic hepatitis B infection': 2, 'A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum': 3, 'Long-term suppression of hepatitis B e antigen-negative chronic hepatitis B by 24-month interferon therapy': 2, 'Effect of alphainterferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A metaanalysis': 1, 'Long-term follow-up of patients with chronic hepatitis B treated with interferon alfa': 1, 'Long-term follow-up of chronic hepatitis B patients treated with interferon alfa': 1, 'Longterm follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B': 2, 'Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B': 1, 'Long term effect of alpha interferon in children with chronic hepatitis B': 1, 'Delayed clearance of serum HBsAg in compensated cirrhosis B: relation to interferon alpha therapy and disease prognosis': 1, 'Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B': 2, 'Interferon alpha treatment and retreatment of hepatitis B e antigen-negative chronic hepatitis B': 2, 'Anti-HBe-positive chronic hepatitis B with HBV-DNA in the serum response to a 6-month course of lymphoblastoid interferon': 1, 'The long-term outcome of interferon-alpha treated and untreated patients with HBeAg-negative chronic hepatitis B': 1, 'Long-term results of interferon alpha monotherapy in patients with HBeAg-negative chronic hepatitis B': 1, 'Retreatment of chronic hepatitis B e antigen-positive patients with recombinant interferon alfa-2a': 1, 'Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B': 2, 'Treatment with Peg-interferon alpha-2b for HBeAg-positive chronic hepatitis B: HBsAg loss is associated with HBV genotype': 2, 'Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial': 4, 'Pegylated interferon alfa-2b monotherapy and pegylated interferon alfa-2b plus lamivudine combination therapy for patients with hepatitis B virus E antigen-negative chronic hepatitis B': 3, 'Genotype B and younger patient age associated with better response to lowdose therapy: a trial with pegylated/nonpegylated interferon-alpha-2b for hepatitis B e antigenpositive patients with chronic hepatitis B in China': 3, 'Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B': 2, 'Successful treatment with peginterferon alfa-2b of HBeAg-positive HBV non-responders to standard interferon or lamivudine': 1, 'The effect of pegylated interferon-alpha on the treatment of lamivudine resistant chronic HBeAg positive hepatitis B virus infection': 1, 'Long-term efficacy of interferon alpha-2b and lamivudine in combination compared to lamivudine monotherapy in patients with chronic hepatitis B. An Italian multicenter, randomized trial': 1, 'Interferon-lamivudine combination is no better than lamivudine alone in anti-HBe-positive chronic hepatitis B': 1, 'Lamivudine vs lamivudine and interferon combination treatment of HBeAg(-) chronic hepatitis B': 1, 'Combination of alpha-interferon with lamivudine reduces viral breakthrough during long-term therapy': 1, 'Lamivudine/interferon combination therapy in anti-HBe positive chronic hepatitis B patients: a controlled pilot study': 1, 'Peg-interferon improves liver histology in patients with HBeAg-positive chronic hepatitis B: no additional benefit of combination with lamivudine': 1, 'Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B': 1, 'Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients': 1, 'Effect of lowering HBV DNA levels by initial antiviral therapy before adding immunomodulator on treatment of chronic hepatitis B': 2, 'Lamivudine/pegylated interferon alfa-2b sequential combination therapy compared with lamivudine monotherapy in HBeAg-negative chronic hepatitis B': 1, 'Sequential treatment with lamivudine and interferon-alpha monotherapies in hepatitis B e antigennegative Chinese patients and its suppression of lamivudine-resistant mutations': 1, 'A pilot study of long-term weekly interferon-beta administration for chronic hepatitis B': 1, 'Lamivudine and IFN-beta sequential therapy in HBe antigen-positive patients with chronic hepatitis B virus genotype C infection': 1, 'A pilot study of beta-interferon for treatment of patients with chronic hepatitis B who failed to respond to alpha-interferon': 1, 'Effect of interferon-lambda on replication of hepatitis B virus in human hepatoma cells': 1, 'Inhibition of hepatitis B virus DNA replicative intermediate forms by recombinant interferon-gamma': 1, 'Effect of interferon-gamma on hepatic fibrosis in chronic hepatitis B virus infection: a randomized controlled study': 1, 'Chronic hepatitis D: a vanishing disease? An Italian multicenter study': 1, 'Rapidly progressive HBsAg-positive hepatitis in Italy. The role of hepatitis delta virus infection': 1, 'Treatment of chronic hepatitis D with interferon alfa-2a': 1, 'The French experience of treatment of chronic type D hepatitis with a 12-month course of interferon alpha-2B. Results of a randomized controlled trial': 1, 'Treatment of chronic hepatitis D virus infection with low and high doses of interferon-alpha 2a: utility of polymerase chain reaction in monitoring antiviral response': 1, 'A randomized controlled trial of a 12-month course of recombinant human interferon-alpha in chronic delta (type D) hepatitis: a multicenter Italian study': 1, 'Treatment of hepatitis D': 1, 'Resolution of chronic delta hepatitis after 12 years of interferon alfa therapy': 1, 'Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up': 2, 'Treatment of chronic hepatitis delta with pegylated interferon-alpha2b': 1, 'Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta': 3, 'Hepatitis D virus': 1, 'Ribavirin treatment for chronic hepatitis D: a pilot study': 1, 'Two-year interferon therapy with or without ribavirin in chronic delta hepatitis': 1, 'Alpha interferon and ribavirin combination therapy of chronic hepatitis D': 1, 'Lamivudine for chronic delta hepatitis': 1, 'Lamivudine therapy in chronic delta hepatitis: a multicentre randomized-controlled pilot study': 1, 'Efficacy of interferon alpha-2b and lamivudine combination treatment in comparison to interferon alpha-2b alone in chronic delta hepatitis: a randomized trial': 1, 'Lamivudine-high dose interferon combination therapy for chronic hepatitis B patients co-infected with the hepatitis D virus': 1, 'A multicenter randomized study comparing the efficacy of pegylated interferon-alpha-2a plus adefovir dipivoxil versus pegyated interferon-alpha-2a plus placebo versus adefovir dipivoxil for the treatment of chronic hepatitis delta hepatitis: the HEP-NET/International Delta Hepatitis Intervention Trial (HID-IT)': 1, 'Recombinant human interferon alfa-A suppresses HTLV-III replication in vitro': 1, 'Alpha interferon suppresses virion but not soluble human immunodeficiency virus antigen production in chronically infected T-lymphocytic cells': 1, 'Loss of infectivity by progeny virus from alpha interferon-treated human immunodeficiency virus type 1-infected T cells is associated with defective assembly of envelope gp120': 1, 'Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines': 1, 'Specific inhibition of viral protein synthesis in HIVinfected cells in response to interferon treatment': 1, 'Regulation of HIV replication in infected monocytes by IFN-alpha. Mechanisms for viral restriction': 1, 'Interferons in HIV and related diseases': 1, 'Zidovudine plus interferon-alpha versus zidovudine alone in HIV-infected symptomatic or asymptomatic persons with CD4+ cell counts > 150 × 10(6)/L: results of the Zidon trial': 1, 'Safety and antiviral activity of combination therapy with zidovudine, zalcitabine, and two doses of interferon-alpha2a in patients with HIV': 1, 'Phase II, randomized, open-label, community-based trial to compare the safety and activity of combination therapy with recombinant interferon-alpha2b and zidovudine versus zidovudine alone in patients with asymptomatic to mildly symptomatic HIV infection': 1, 'Combined zidovudine and interferon-alpha 2a therapy in children with acquired immune deficiency syndrome': 1, \"Complete clinical and virological remission of refractory HIV-related Kaposi's sarcoma with pegylated interferon alpha\": 1, 'Treatment of condylomata acuminata with pegylated interferon alfa-2b in HIV-infected patients': 1, 'Early control of HIV replication in primary HIV-1 infection treated with antiretroviral drugs and pegylated IFN alpha: results from the Primoferon A (ANRS 086) Study': 1, 'Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients': 1, 'The preventive effect of human interferon-alpha on influenza infection; modification of clinical manifestations of influenza in children in a closed community': 1, 'Use of interferon-alpha in patients with West Nile encephalitis: report of 2 cases': 1, 'Successful treatment of West Nile virus infection after approximately 3 weeks into the disease course': 1, 'Wellferon\") prophylaxis against rhinovirus and influenza virus in volunteers': 1, 'Effect of interferon-alpha2b therapy on St. Louis viral meningoencephalitis: clinical and laboratory results of a pilot study': 2, 'Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV)': 1, 'Increased sensitivity of SARS-coronavirus to a combination of human type I and type II interferons': 1, 'Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial': 2, 'What Skills Should be Included when Assessing Health Literacy?': 2, 'WHO. Global Report on Diabetes Executive Summary': 2, 'Indicators in KSA': 2, 'The impact of obesity related websites on decision making among students in Saudi Arabia': 1, 'Measuring functional, communicative, and critical health literacy among diabetic patients': 3, 'A framework for characterizing eHealth literacy demands and barriers': 2, 'Developing a new scale for e-health literacy': 2, 'Health literacy as a public health goal: a challenge for contemporary health education and communication strategies into the 21st century. Health Promot Int': 3, 'Health literacy as a learning outcome in schools': 3, 'The association of medical exposure and media literacy with adolescent alcohol and tobacco use': 2, 'Health-literacy-sensitive diabetes self-management interventions: a systematic review and meta-analysis. World Views Evid based': 1, 'Measuring health literacy in individuals with diabetes: a systematic review and evaluation of available measures': 4, 'eHealth literacy interventions for older adults: a systematic review of the literature': 3, 'Measuring health literacy: a pilot study of a new skills-based instrument': 1, \"Experimenting on the impact of learning methods and information presentation channels on older adults' e-health literacy\": 1, 'Older adults, e-health literacy, and collaborative learning: an experimental study': 2, 'Development and validation of Chinese Health Literacy Scale for Diabetes': 1, \"Health literacy and anesthesia: patients' knowledge of anesthesiologist roles and information desired in the preoperative visit\": 1, 'From solving a health problem to achieving quality of life: redefining eHealth literacy': 1, 'Health status and health services in the occupied Palestinian territory': 1, 'Report of the WHO -China Joint Mission on Coronavirus Disease 2019 (COVID-19)': 1, 'A brief review of antiviral drugs evaluated in registered clinical trials for COVID-19. medRxiv. Epub ahead of print 18': 2, 'WHO launches global megatrial of the four most promising coronavirus treatments. Science Magazine 2020': 2, 'Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model': 1, 'Evaluation of immunomodulators, interferons and known in vitro SARS-CoV inhibitors for inhibition of SARS-CoV replication in BALB/c mice': 1, 'Of chloroquine and COVID-19': 1, 'the PALM Writing Group. A randomized, controlled trial of Ebola virus disease therapeutics': 1, 'Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430': 1, 'Treatment with lopinavir/ritonavir or interferon-b1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset': 1, 'Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study': 1, 'Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen': 1, 'Combination therapy with lopinavir/ritonavir, ribavirin and interferon-a for Middle East respiratory syndrome': 1, 'Case of the index patient who caused tertiary transmission of coronavirus disease 2019 in Korea: the application of lopinavir/ritonavir for the treatment of COVID-19 pneumonia monitored by quantitative RT-PCR': 1, 'Role of human hypoxanthine guanine phosphoribosyltransferase in activation of the antiviral agent': 1, 'Favipiravir as a potential countermeasure against neglected and emerging RNA viruses': 2, 'Experimental treatment with favipiravir for COVID-19: an open-label control study. Engineering. Epub ahead of print': 1, 'Arbidol as a broadspectrum antiviral: an update': 1, 'Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan': 1, 'Why tocilizumab could be an effective treatment for severe COVID-19': 1, \"WHO Director-General's Opening Remarks At The Media Briefing On\": 1, 'Genomic characterisation and epidemiology of 2019 novel. Forthcoming': 1, 'Infection Prevention and Control of Epidemic-and Pandemic-Prone Acute Respiratory Infections in Health Care': 1, 'Clinical characteristics of coronavirus disease 2019 in China: NEJM': 1, 'Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention': 1, 'China Kadoorie Biobank Consortium. The burden of hypertension and associated risk for cardiovascular mortality in China': 1, 'Diabetes in China: epidemiology and genetic risk factors and their clinical utility in personalized medication': 1, 'Chronic obstructive pulmonary disease in China: a nationwide prevalence study': 1, 'Adult Obesity Facts': 1, \"America's Health Rankings. 2020. Explore Health Measures\": 1, \"America's Health Rankings. 2020. Explore Health Measures In Louisiana | 2019 Annual Report\": 1, 'Opinion | Why Coronavirus Is Killing African-Americans More Than Others': 1, 'Hospitalization and mortality among black patients and white patients with Covid-19': 1, 'Racial health disparities and Covid-19 -caution and context': 1, 'Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020. (cytokine storm link': 1, 'Recommendations for investigational COVID-19 convalescent plasma. FDA; 2020': 1, 'COVID-19 survivors needed to donate blood plasma': 1, 'CHEST -export citations': 1, 'Observational study of hydroxychloroquine in hospitalized patients with Covid-19': 1, 'Emerging marine diseases -Climate links and anthropogenic factors': 3, 'Worldwide outbreaks of a transmissible, life-threatening tumor in endangered marine turtles are not due to recent herpesvirus mutations': 3, 'Fibropapillomatosis of marine turtles': 2, 'Bacteraemia in free-ranging Hawaiian green turtles Chelonia mydas with fibropapillomatosis': 1, 'Altered in vitro immune responses in green turtles (Chelonia mydas) with fibropapillomatosis': 1, 'Temporal relationships for cold-like illnesses and otitis media in sibling pairs': 1, 'Sites of rhinovirus recovery after point inoculation of the upper airway': 1, 'Hand-to-hand transmission of rhinovirus colds': 5, 'Effect of route of inoculation on experimental respiratory viral disease in volunteers and evidence for airborne transmission': 1, 'Mechanisms of transmission of rhinovirus infections': 4, 'Inoculation of human volunteers with a strain of virus isolated from a common cold': 1, 'Relation between naturally acquired immunity and infectivity of two rhinoviruses in volunteers': 1, 'Experiments on the spread of colds. 1. Laboratory studies on the dispersal of nasal secretion': 1, 'Production of tracheobronchitis in volunteers with rhinovirus in a small-particle aerosol': 1, 'Rhinovirus infections in an industrial population. IV. Infections within families of employees during two fall peaks of respiratory illness': 1, 'Rhinovirus transmission: one if by air, two if by hand': 1, 'An investigation of the possible transmission of rhinovirus colds through indirect contact': 5, 'Survival of human rhinovirus type 14 dried onto nonporous inanimate surfaces: effect of relative humidity and suspending medium': 1, 'Near disappearance of rhinovirus along a fomite transmission chain': 1, 'Role of infectious secretions in the transmission of rhinovirus': 2, 'Quantitative rhinovirus shedding patterns in volunteers': 1, 'Survival of influenza virus on human fingers': 5, 'An RNA replication-center assay for high content image-based quantifications of human rhinovirus and coxsackievirus infections': 1, 'Potential role of hands in the spread of respiratory viral infections: studies with human parainfluenza virus 3 and rhinovirus 14': 3, 'Interruption of experimental rhinovirus transmission': 1, 'Efficacy of organic acids in hand cleansers for prevention of rhinovirus infections': 1, 'COVID-19) in the U.S. Centers for Disease Control and Prevention': 1, 'Using search engine data as a tool to predict syphilis': 1, 'COVID-19). Centers for Disease Control and Prevention': 1, 'Wearable sensors for remote health monitoring': 1, 'Telehealth: mapping the evidence for patient outcomes from systematic reviews': 1, 'Emerging infectious diseases in Southeast Asia: regional challenges to control': 1, 'Evaluation of a new rapid influenza A diagnostic test for detection of pandemic (H1N1) 2009 and seasonal influenza A virus': 1, 'Plaque assay and primary isolation of influenza A viruses in an established line of canine kidney cells (MDCK) in the presence of trypsin': 1, 'Universal primer set for the full-length amplification of all influenza A viruses': 1, 'Universal influenza B virus genomic amplification facilitates sequencing, diagnostics, and reverse genetics': 1, 'Molecular epidemiology and phylogenetic analyses of influenza B virus in Thailand during': 1, 'Integrated sentinel surveillance linking genetic, antigenic, and epidemiologic monitoring of influenza vaccineevirus relatedness and effectiveness during the 2013e2014 influenza season': 1, 'European Centre for Disease Prevention and Control. Influenza virus characterisation, summary Europe': 2, 'Differential diagnosis of pandemic (H1N1) 2009 infection by detection of haemagglutinin with an enzyme-linked immunoassay': 1, 'Optimal sampling sites and methods for detection of pathogens possibly causing community-acquired lower respiratory tract infections': 1, 'Evaluation of the Quidel QuickVue test for detection of influenza A and B viruses in the pediatric emergency medicine setting by use of three specimen collection methods': 1, 'A rapid test for the detection of influenza A virus including pandemic influenza A/H1N1': 1, 'Antigenic variation of the human influenza A (H3N2) virus during the 2014e2015 winter season': 1, 'The global antigenic diversity of swine influenza A viruses': 1, 'The contrasting phylodynamics of human influenza B viruses': 1, 'Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan': 2, 'Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China': 1, 'Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China': 2, 'Hospitalization for ambulatory-care-sensitive conditions in Taiwan following the SARS outbreak: a population-based interrupted time series study': 3, 'SARS: epidemiology': 2, 'Clinical outcomes of current medical approaches for Middle East respiratory syndrome: a systematic review and meta-analysis': 2, 'Secular trends in all-cause and cause-specific mortality rates in people with diabetes in Hong Kong, 2001-2016: a retrospective cohort study': 1, 'Factors determining the appearance of glucose in upper and lower respiratory tract secretions': 1, 'Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China': 2, 'V 21/04/1983 in Cass. Pen': 5, 'Censimento nazionale sulla molluschicoltura': 6, 'Evidence for interspecies transmission of oyster herpesvirus in marine bivalves': 1, 'Factors influencing in vitro killing of bacteria by hemocytes of the eastern oyster (Crassostrea virginica)': 1, 'Humoral defense factors in marine bivalves': 1, 'Cellular defense mechanisms of oysters and mussels': 1, 'The inter-relationships of bivalve hemocytes': 1, 'In vitro production of superoxide and nitric oxide (as nitrite and nitrate) in M. galloprovincialis hemocytes upon incubation with PMA or laminarin or during yeast phagocytosis': 1, 'Reactive Oxygen Species and antimicrobial defenses of invertebrates: a bivalve model': 2, 'Interaction of phagocytosed Bonamia sp. with hemocytes of oysters T iostrea chilensis': 1, 'Perkinsus marinus susceptibility and defense-related activities in eastern oysters C. virginica: temperature effects': 1, 'Applications and pitfalls of stress proteins in biomonitoring': 1, \"Ottime potenzialità per l'allevamento bufalino in Italia\": 4, 'Su alcune patologie riscontrate in ostriche piatte (Ostrea edulis) provenienti da banco naturale': 1, 'Presenza di Bonamia ostreae in ostriche piatte (Ostrea edulis) del Nord Adriatico': 1, 'Presenza di Perkinsus in vongole veraci (Ruditapes philippinarum) allevate nel Nord-Est Italia': 1, 'Perkinsus, a protistan threat to bivalve culture in the Mediterranean basin': 1, 'Comparative studies on the superovulatory effect of PMSG and FSH in the water buffalo (Bubalus bubalis). T heriogenology': 2, 'On-growing of the carpet-shell clam (T apes decussatus) (L.): two years experience in Venice Lagoon': 1, 'Pathologies found in molluscs from Apulian coasts, Southern Italy. 5th International Colloquium on Pathology in Marine Aquaculture': 1, 'Perkinsus sp. nei bivalvi dal Reno a Cesenatico': 1, 'Monitoring of infections by Protozoa of the genera Nematopsis, Perkinsus and Porospora in the smooth venus clam Callista chione from the North-Western Adriatica Sea (Italy)': 1, 'Occurrence of Vibrio spp. In sea fish, shrimps and bivalve molluscs harvested from Adriatic sea': 1, 'Detection of hepatitis A virus in mussels from different sources marketed in Puglia region (South Italy)': 1, 'Viruses and bivalve shellfish': 1, 'Bivalve molluscs as vectors of human enteric viruses. Microbiologie Aliments Nutrition': 3, 'Incidence of and risk factors for hepatitis A in Italy: Public Health indications from a 10-year surveillance': 1, 'Les intoxications des animaux domestiques: bilan du CNITV 1999. T hèse de doctorat vétérinaire': 1, \"Glyphosate toxicosis in domestic animals: a survey from the data of the Centre National d'Informations Toxicologiques Vétérinaires\": 2, 'Benzodiazepine poisoning in companion animals': 1, 'Permethrin toxicity in cats': 1, 'Ivermectin toxicity in an Australian Shepherd dog with the MDR1 mutation associated with ivermectin sensitivity in Collies': 1, 'Mechanisms for selective toxicity of fipronil insecticide and its sulfone metabolite and desulfinyl photoproduct': 1, 'Pericardial effusion and cardiac tamponade secondary to brodifacoum toxicosis in a dog': 1, 'Sémiologie et diagnostic différentiel des intoxications par les convulsivants chez les carnivores domestiques, Recueil de Médecine Vétérinaire': 1, 'Tossicologia veterinaria: descrizione di un caso in un fagiano': 1, 'Association between surges of follicle-stimulating hormone and the emergence of follicular waves in heifers': 1, 'Reproductive programs in dairy herds': 1, 'Concepts for regulation of corpus luteum function by the conceptus and ovarian follicles to improve fertility': 1, 'Synchronization rate, size of the ovulatory follicle, and pregnancy rate after synchronization of ovulation beginning on different days of the estrous cycle in lactating dairy cows': 2, 'Evaluation of timed insemination using a gonadotropin-releasing hormone agonist in lactating dairy cows': 2, 'Effect of human chorionic gonadotropin on luteal function and reproductive performance of high producing lactating Holstein dairy cows': 1, 'Reproductive management of lactating dairy cows using synchronization of ovulation': 1, 'Effect of duration of dominance of the ovulatory follicle on onset of estrus and fertility in heifers': 1, 'Effects of presynchronization and bovine somatotropin on pregnancy rates to a timed artificial insemination protocol in lactating dairy cows': 1, 'Use of estradiol cypionate in a pre-synchronized timed artificial insemination program for lactating dairy cows': 2, 'Timed artificial insemination (TAI) with estradiol cypionate (ECP) or insemination at detected estrus in lactating dairy cows': 1, 'Practical aspects of IVM-IVF in cattle': 1, 'Bovine embryo technologies. T heriogenology': 1, 'Disruption of bovine oocytes and preimplantation embryos by urea and acidic pH': 1, 'Effect of elevated systemic concentrations of ammonia and urea on the metabolite and ionic composition of oviductal fluid in cattle': 1, 'Development of immature bovine oocytes into viable embryos in vitro': 1, 'Factors influencing oocyte and embryo quality in cattle': 2, 'Bovine follicular development and its effect on the in vitro competence of oocytes': 1, 'Effects of repeated ultrasound-guided transvaginal follicular aspiration on bovine oocyte recovery and subsequent follicular development': 1, 'Kinetics of oocyte maturation and subsequent development of IVF, parthenogenetic, and NT bovine embryos after meiotic inhibition with roscovitine': 2, 'La relazione cane-proprietario: Indagine nel contesto urbano e rurale di Padova': 2, 'A new role for typical products in modern retails': 2, 'La spesa domestica per i prodotti tipici nel': 1, 'Sviluppo del mercato della Mozzarella di Bufala. Proceedings I Congresso Nazionale sull': 1, 'Market situation for buffalo milk products': 1, 'La filiera della mozzarella di bufala: un laboratorio dello sviluppo locale. L a Questione Agraria': 1, 'La produzione della carne bufalina in Italia': 1, \"Studio comparativo fra bufali e bovini sulla qualità della carne. I. caratteristiche mioreologiche all'età di 20 settimane\": 1, 'Influence of the feeding programme on growth dynamics of buffalo young bulls until 16 months of age': 1, 'Influence of different rationing scheme on the growth performance of young buffalo bulls': 1, 'Produzione del vitello bufalino a carne bianca alimentato con due diversi tipi di latte. Nota II: qualità della carne': 3, \"Chemical-nutritional characteristics of meat produced by young buffalo bulls. Proceeding of the XXXI International Symposium of Zoothecny ''Role of animal products on animal health\": 2, \"Prove comparative fra vitelli bovini e bufalini. V. Composizione acidica del grasso di varia localizzazione in animali di 28 settimane di età. Annali dell 'Istituto Sperimentale per la Zootecnia\": 1, 'Developments in the understanding of the pathophysiology of the urethral sphincter mechanism incompetence in the bitch': 2, 'Association in bitches between breed, size, neutering and docking, and acquired urinary incontinence due to incompetence of the urethral sphincter mechanism. T he Veterinary Record': 2, 'Effect of hormones on urethral sensitivity to phenylephrine in normal and incontinent dogs': 1, 'Sex hormones and the female urinary tract': 1, 'Acquired urinary incontinence in bitches: its incidence and relationship to neutering practices': 1, 'Incontinentia urinae bei der kastrierten hü ndin: häufigkeit und rassedisposition': 1, 'Comparison of long-term effects of ovariectomy versus ovariohysterectomy in bitches': 1, 'Nef rologia ed urologia del cane e del gatto': 1, 'Actin-binding properties and colocalization with actin during spermiogenesis of mammalian sperm calicin': 1, 'Actin polymerization in boar spermatozoa: fertilization is reduced with use of cytochalasin D. Molecular Reproduction and Development': 1, 'An antiactin monoclonal antibody inhibits the zona pellucida-induced acrosome reaction and hyperactivated motility of human sperm': 1, 'Influence of progesterone on boar sperm capacitation': 1, 'Sperm exocytosis reconstructed in a cell-free system: evidence for the involvement of phospholipase C and actin filaments in membrane fusion': 1, 'Preliminary study of the ultrasonographic diagnosis of pregnancy and fetal development in the dog': 1, 'Studies on canine pregnancy using B-mode ultrasound: Development of the conceptus and determination of gestational age': 1, 'Ultrasonographic appearance of the uterus, placenta, fetus, and fetal membranes throughout accurately timed pregnancy in Beagles': 1, 'Estudio ecográfico de la gestatió n en cánidos': 1, 'Observation of the growth process of a beagle embryo and fetus by ultrasound': 1, 'Determination of gestational age in medium and small size bitches using ultrasonographic fetal measurements': 2, 'Establishment of the prediction table of parturition day with ultrasonography in small pet dogs': 1, 'Ultrasonographic identification of fetal brain structures during pregnancy in the dog': 1, 'Morphometric studies of the bovine uterus: microscopic lesion and retrospective reproductive history': 1, 'Raffronto tra parametri istologici e livelli di mediatori chimici della flogosi in biopsie endometriali di bovine ipofertili': 2, 'Evaluation of mast cells in calf and heifer uteri': 3, 'Bovine mast cells: distribution, density, heterogeneity, and influence of fixation techniques': 1, 'Alternative solutions to hCG induction of ovulation in the mare': 1, 'The development of antibodies to human chorionic gonadotrophin following its repeated injection in the cyclic mare': 1, 'Uses of LHRH and analogues in the mare': 1, 'Advancing the time of ovulation in the mare with a short-term implant releasing the GnRH analogue deslorelin': 1, 'Use of the GnRH analogue desloreline acetate in a slow-release implant to accelerate ovulation in oestrus mares': 1, 'Use of buserelin to induce ovulation in cyclic mares': 2, 'Use of hCG, GnRH agonist or REFERENCES': 1, 'Restoration of fertility to oophorectomized sheep by ovarian autografts stored at −196 degrees': 2, 'Transplantation of cryopreserved fetal ovarian tissue to adult recipients in mice': 1, 'Ovarian tissue cryopreservation and transplantation: preliminary findings and implications for cancer patients': 1, 'In vitro development of sheep preantral follicles': 1, 'Current perspective on primordial follicle cryopreservation and culture for reproductive medicine': 1, 'Growth and differentiation of small ovarian follicles in mammals: problems and perspective': 1, 'In-vitro growth of murine pre-antral follicles after isolation from cryopreserved ovarian tissue': 1, 'Discharge of impulses in motor nerve fibres. The frequency of discharge in reflex and voluntary contraction': 2, 'Personalities in female domesticated pigs: behavioural and physiological indications': 1, 'Individual behavioural and physiological strategies in pigs': 3, 'Individual variation in the behaviour of pigs -Noise or functional coping strategies?': 1, 'Individual behavioural characteristics in pigs and their impact on production': 1, \"Caratterizzazione della reazione al backtest nel suinetto presvezzamento: correlazioni con l'accrescimento corporeo\": 1, 'One hundred and one new simple sequence repeatbased markers for the canine genome': 2, 'A new method of paternity testing for dogs, based on microsatellite sequences, T he Veterinary Record': 1, 'Use of canine microsatellite polymorphisms in forensic examinations': 1, 'Three polymorphic canine microsatellites': 1, 'Eighteen canine microsatellites': 1, 'A class of highly polymorphic tetranucleotide repeats for canine genetic mapping': 1, 'Nine canine microsatellites': 1, 'Identification and characterization of a set of 100 tri-and dinucleotide microsatellites in the canine genome': 1, 'Neurotrophins: roles in neuronal development and function': 1, 'Expression of TrkB neurotrophin receptor during T cell development. Role of brain derived neurotrophic factor in immature thymocyte survival': 2, 'Neurotrophin actions during the development of the peripheral nervous system': 2, 'Nerve growth factor: a neurotrophin with activity on cells of the immune system': 2, 'TrkA is necessary for the normal development of the murine thymus': 1, 'Interleukin-6 and interleukin-6 receptor mRNA expression in rat central nervous system': 1, 'Phenotypic knockout of nerve growth factor in adult transgenic mice reveals severe deficits in basal forebrain cholinergic neurons, cell death in the spleen, and skeletal muscle dystrophy': 1, 'Concerned about use of BST in dairy cattle': 1, 'La posizione dei comitati scientifici della U.E. sulla somatotropina bovina ricombinante': 1, 'Radioimmunoassay for insulin-like growth factor-I: solutions to some potential problems and pitfalls': 1, 'Synapse-independent and synapse-dependent apoptosis of 200 cerebellar granule cells in postnatal rabbits occur at two subsequent but partly overlapping developmental stages': 1, 'Caspase 6 activity initiate caspase 3 activation in cerebellar granular cell apoptosis': 1, 'The world according to PARP': 1, 'Molecular characterization of mitochondrial apoptosis-inducing factor': 1, 'Human skeletal muscle fibres: molecular and functional diversity': 1, 'Specificity of different anti-myosin heavy chain antibodies in bovine muscle': 1, 'Sequencing of the 2a, 2x and slow isoforms of the bovine myosin heavy chain and the different expression among muscles': 1, 'Enhanced electrophoretic separation and resolution of myosin heavy chains in mammalian and avian skeletal muscles': 1, 'Fibre types in extraocular muscles: a new myosin isoform in the fast fibres': 1, 'Differences in molecular structure among porcine myosin heavy chain 2a, 2x and 2b isoforms': 1, 'Improving the safety of embryo technologies: possible role of genomic imprinting': 1, 'Concentration of cyclic AMP during the maturation of pig oocyte in vivo and in vitro': 1, 'Developmental competence of pig oocyte matured and fertilized in vitro': 1, 'Demethylation of the zygotic paternal genome': 1, \"Accommodation of vascularized xenografts: 212 expression of ''protective genes'' by donor endothelial cells in a host Th2 cytokine environment\": 1, 'Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis': 1, 'Angiogenic growth factors in the pathophysiology of a murine model of acute lung injury': 1, 'Ghrelin is a growthhormone-releasing acylated peptide from stomach': 3, 'Immunocytochemical observation of ghrelin-containing neurons in the rat arcuate nucleus': 1, 'Ghrelin, a novel ghrowth hormone-releasing acylated peptide is 215 synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans': 3, 'Kidney produces a novel acylated peptide, ghrelin': 1, 'A-like cells in the rat stomach contain ghrelin and do not operate under gastrin control': 1, 'Ghrelin, a novel placental-derived hormone': 1, 'Immunoistochemical localization and biochemical characterization of ghrelin in the brain and stomach of the frog Rana esculenta': 2, 'V 10/01/1987 in Cass. Pen': 1, '11/07/1992 in Giust': 2, 'Manuale di Diritto Penale, p.s., II, Milano 11. Cass. Pen. Sez. V, 24/10/1980 in Cass': 3, 'Gastric endocrine cells: types, function and growth': 1, 'Nutritional modulation of somatotropic axiscytokine relationships in cattle: a brief review': 1, 'Alterazioni della funzionalità epatica nel puerperio e conseguenze sulla fertilità della bovina': 1, 'Dry matter intake reduction before calving in dairy cows: relationship with immune system and metabolism conditions. 53rd Meeting European Association Animal Production': 1, 'Commissione valutazione alimenti. Valutazione degli alimenti di interesse zootecnico. Analisi chimica': 1, 'Metodi di analisi per la valutazione degli alimenti di impiego zootecnico': 2, \"Recherche d'une méthode d'estimation de la production laitière des femelles ovines et bovines pendant la phase d'allaitement\": 1, 'Tecniche di alimentazione delle pecore e stima del valore energetico e proteico degli alimenti': 1, 'Ochratoxin A in food and feed: occurrence, legislation and mode of action': 1, 'Commercial aspects of oocyte retrieval and in vitro fertilization (IVF) for embryo production in problem cows': 1, 'Bovine and buffalo in vitro embryo production using oocytes derived from abattoir ovaries or collected by transvaginal follicle aspiration': 5, 'In vitro maturation, fertilization and development of follicular oocytes from buffalo (Bubalus bubalis)': 1, 'Effect of cysteamine during in vitro maturation on buffalo embryo development': 2, 'In vitro fertilization in buffalo and birth of first ever IVF buffalo calf': 1, 'In vitro production and transfer of embryos in buffaloes': 1, 'Pregnancies established after transferring embryos yielded by Ovum Pick-up and in vitro embryo production in Italian buffalo cows': 1, 'Embryo production by Ovum pick-up in water buffalo': 2, 'Cryopreservation of in vitro produced buffalo and bovine embryos by vitrification': 2, 'Mammary cancer prevention by conjugated dienoic derivative of linoleic acid': 1, 'Mechanisms for conjugated linoleic acid-mediated reduction in fat deposition': 1, 'Conjugated linoleic acid and atherosclerosis in rabbits': 1, 'Influence of dietary conjugated linoleic acid on growth, meat quality, lipogenesis, plasma leptin and physiological variables of lipid metabolism in rabbits': 1, 'Conjugated linoleic acid modulates tissue levels of chemical mediators and immunoglobulins in rats': 2, 'Effects of dietary conjugated linoleic acid in nursery pigs of dirty and clean environments on growth, empty body composition, and immune competence': 1, 'Effects of dietary conjugated linoleic acid on some aspecific immune parameters and acute phase protein in weaned piglets': 1, 'Immunological quantitation of antigens by single radial immunodiffusion': 1, 'Dietary 244 conjugated linoleic acid (CLA) influence immune response in suckling and weanling piglets': 2, 'The acquisition of passive immunity in the new-born piglet': 1, 'The influence of nonspecific immunostimulation of pregnant sows on the immunological value of colostrum': 1, 'Confronto tra bufale con differente resa alla caseificazione': 1, 'Proposta di un modello matematico per il pagamento del latte di bufala secondo qualità': 1, 'Ispezione degli alimenti di origine animale': 1, 'Determination of organophosphorus pesticides in whole/chocolate/skim-milk and infant formula using SPE with capilary GC-NPD. Food and Drug Administration L aboratory Information Bulletin ORA n': 1, 'Optimized method for the determination of organophosphorus pesticides in meat and fatty matrices': 2, 'Cit': 1, 'Ricerca di Clostridium Perfringens in Pesci Marini': 1, \"Indagine sulle batteriemie in spigole e orate d'allevamento. Atti Aassociazione Italiana VeterinariIgienisti\": 2, 'Virus enterici veicolati da alimenti': 1, 'Improved detection of human enteric viruses in foods by RT-PCR': 1, 'Microbial purification of shellfish: a review of depuration and relaying': 1, 'Valutazioni microbiologiche di carni bovine e suine macinate': 1, 'Valutazione microbiologica di carni macinate e preparazioni di carne': 3, 'Valutazioni microbiologiche di carni trite e preparazioni di carni ai sensi del D.P.R. 309/98': 1, 'Isolamento di salmonelle da alimenti di origine animale nel biennio 1997-1998': 1, 'Salmonella contamination of minced meat and meat products. Atti X Congresso Nazionale Associazione Italiana Veterinari Igienisti': 1, 'Microbiological hazard of fresh pork sausages: result of a 1-year study': 1, 'Salmonella in slaughter pig: prevalence, serotypes and critical control points during slaughter in two slaughterhouses': 1, \"T homson's Special Veterinary Pathology\": 1, \"Tumori dell'apparato urinario\": 1, 'T he medical impact of antimicrobical use in food animals': 2, 'Urinary tract neoplasms in dogs and cats. T he Compendium on Continuing Education for the Practicing Veterinarian': 1, 'Neoplasms of the canine urinary bladder': 1, 'Histological T yping of Urinary Bladder T umours -W HO International Histological Classification of T umours': 1, 'Effect of aflatoxins on tocopherol and retinol concentrations in growing barrows': 1, 'Sottopopolazioni linfocitarie nel sangue periferico di suinetti da 1 a 10 settimane di età': 1, 'Immunotossicità da aflatossine in scrofe gravide': 1, 'Immunotoxicological effects on piglets of feeding sows diets containing aflatoxins. T he Veterinary Record': 1, 'Atti Società Italiana Patologia Allevamento Ovini Caprini': 1, 'Influence of three types of farm management on the seroprevalence of Q fever as assessed by an indirect immunofluorescence assay': 1, 'Epidemiological survey of Q fever on dogs in an area of the Southern Italian Appennines and correlations with leishmaniosis and rickettsiosis': 1, 'The detection of Coxiella from ovin genital swabs, milk and fecal samples by the use of single touchdowm polymerase chain reaction': 1, 'Diagnosis of Q fever': 1, 'Betanodavirus infections of teleost fish: a review': 1, 'Family Nodaviridae': 1, 'Analisi del gene della proteina del capside in Nodavirus proveniente da un cefalo (L iza ramada) di allevamento': 1, 'Sea bream Sparus aurata, an asymptomatic contagious fish host for nodavirus': 1, 'Genomic classification of fish nodaviruses by phylogenetic analysis of the coat protein gene': 1, 'High permissivity of the fish cell line SSN-1 for piscine nodaviruses': 1, 'Production of transgenic rabbits, sheep and pigs by microinjection': 1, 'Establishment and characterization of two new pig cell lines for use in virological diagnostic laboratories': 1, 'Search for cross species transmission of porcine endogenous retrovirus in patients treated with living pig tissue': 1, 'Presenza di retrovirus endogeni in colture cellulari di origine suina e determinazione della eventuale trasmissione in sistemi cellulari di primati': 1, 'Antiretroviral agents inhibit infection of human cells by porcine endogenous retroviruses': 1, 'Susceptibility of the porcine endogenous retrovirus to reverse transcript and protease inhibitors': 1, 'Identification of three distinct antigenic sites in parapoxvirus. Archives of V irology': 1, 'Infectious Diseases of the dog and cat': 1, 'PCR detection and molecular identification of Chlamydiaceae species': 1, 'Vascular permeability factor/vascular endothelial growth factor, microvascular hypermeability, and angiogenesis': 1, 'What is the evidence that tumors are angiogenesis-dependent?': 1, \"Endothelial cell proliferation in prostatic carcinoma and prostatic hyperplasia: correlation with Gleason's score, microvessel density, and epithelial cell proliferation\": 1, 'Tumour angiogenesis': 1, 'Tumoral vascularity as a prognostic factor in cancer patients: the evidence continues to grow': 1, 'Expression of vascular endothelial growth factor in basal cell tumours and in squamous cell carcinomas of canine skin': 1, 'Angiogenesisi in squamous cell carcinomas of canine skin: an immunohistochemical and quantitative analysis': 1, 'Expression of vascular endothelial growth factor in canine mammary tumors': 1, 'The association between tumour progression and vascularity in the oral mucosa': 1, 'The same prion protein cause vCJD and BSE': 1, 'The immunobiology of TSE diseases': 1, 'Immunization with amyloid-beta attenuates Alzheimer disease-like pathology in the PDAPP mouse': 1, 'Immunization delays the onset of prion disease in mice': 1, 'Drug therapy in human and experimental transmissible spongiform encephalopathy': 1, \"and C is for Clioquinol' -the AbetaCs of Alzheimer's disease. T rends in Neurosciences\": 1, \"Metal chelation as a potential therapy for Alzheimer's disease\": 1, 'CP 55,940 protects against ischemia-induced electroencephalographic flattening and hyperlocomotion in Mongolian gerbils': 1, 'Polydeoxyribonucleotide (defibrotide) protects against post-ischemic behavioral, electroencephalographic and neuronal damage in the gerbil': 1, 'Keys to the Cestode Parasites of Vertebrates': 1, 'Parassiti in medicina veterinaria': 1, \"L 'esame coprologico nella diagnosi delle elmintiasi, seconda edizione\": 1, 'T oxoplasma gondii: from animals to humans': 1, 'Fauna parassitaria gastro-intestinale del gatto nelle Città di Bologna': 1, 'Patologia respiratoria animale': 1, \"Casi di micobatteriosi in pesci rossi d'acquario\": 6, \"Isolamento e tipizzazione di micobatteri in pesci tropicali d'allevamento\": 1, 'Mycobacteriosis and Nocardiosis': 3, 'A systemic mycobacteriosis in the European sea bass Dicentrarchus labrax cultured in Eilat (Red Sea)': 1, 'Mycobacterial infection in farmed turbot Scophthalmus maximus': 1, 'Profilassi delle zoonosi di origine ittica': 1, 'Phylogenetic analysis of small ruminant lentiviruses': 1, 'Genomic heterogeneity of small ruminant lentiviruses: existence of heterogeneous populations in sheep and of the same lentiviral genotypes in sheep and goats. Archive of V irology': 1, 'Genetic heterogeneity of small ruminant lentiviruses involves immunodominant epitope of capsid antigen and affects sensititity of single-strain-based immunoassay': 4, 'Antigenic crossreactivity between caprine arthritis-encephalitis, visna and progressive pneumonia viruses involves all virion-associated proteins and glycoproteins': 1, 'MEGA2: molecular evolutionary genetics analysis software': 1, 'The neighbor-joining method: a new method for reconstructing phylogenetic trees': 1, 'Characterization of the immunodominant crossreacting epitope of visna maedi virus and caprine arthritis-encephalitis virus capsid antigen': 2, 'A new sensitive serological assay for the detection of lentivirus infections in small ruminant': 1, 'Expression in Escherichia coli and sequencing of the coding region for the capsid protein of Dutch maedi-visna virus strain ZZV 1050: Application of recombinant protein in enzyme-linked immunosorbent assay for the detection of caprine and ovine lentiviruses': 1, 'Canine diabetes mellitus: a retrospective survey': 4, 'Familiar canine diabetes mellitus': 4, 'Canine immune-mediated diabetes mellitus: a case report': 2, 'A genome-wide search for human type 1 diebetes susceptibility genes': 1, 'Evaluation of secondary haemostasis in canine leishmaniasis': 1, 'Evaluation of primary haemostasis in canine leishmaniasis': 1, 'Study of haemostatic disorders in experimentally induced leishmaniasis in Beagle dogs': 1, 'Platelet aggregation response in canine leishmaniasis': 1, 'Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate': 1, 'Medroxyprogesterone acetate increases anthracyclines uptake in chronic lymphatic leukemia cells: role of nitric oxide and lipid peroxidation': 1, 'Microplate superoxide dismutase assay employing a nonenzymatic superoxide generator': 1, 'Role of superoxide in deoxyribonucleic acid strand scission': 1, 'Reevaluation of the importance of polymorphic HLA class II alleles and amino acids in the susceptibility of individuals of different populations to type I diabetes': 1, 'Inheritance of diabetes mellitus in Keeshond dogs': 2, 'Familial insulin-dependent diabetes mellitus in Samoyed dogs': 1, 'Diabetes mellitus in a colony of golden retrievers': 1, 'Epizootiologic patterns of diabetes mellitus in dogs': 2, 'Breed distribution of dogs with diabetes mellitus admitted to a tertiary care facility': 3, 'Understanding the pathophysiology of congenital heart defects': 1, 'A single major-gene defect underlying cardiac conotruncal malformations interferes with myocardial growth during embryonic development: studies in the CTD line of keeshond dogs': 1, 'Tetralogy of Fallot in a cat': 1, \"Schalm's veterinary haematology\": 1, 'Polycythemia and tetralogy of Fallot in a cat': 1, 'Recommendations for standards in transthoracic two-dimensional echocardiography in the dog and cat': 1, 'Echocardiography': 1, 'Causes and prevalence of cardiovascular disease': 1, 'Observation on breed and sex in relation to canine heart valve incompetence': 1, 'Observation on the effect of age on the severity of heart valve lesion in the dog': 1, 'Primary acquired mitral insufficiency in adult large breed dogs': 1, 'Unusual aspects of mitral valve disease in the dog': 1, 'Evaluation of four 2-dimensional echocardiographic methods for assessing left atrial size dogs': 1, 'Echocardiographic and echo-Doppler examination in the European wolf (Canis lupus L': 1, \"Anestesia degli animali ''insoliti'' -II Anestesia nei rettili\": 2, 'The medical care of iguanas and other common pet lizards. Veterinary Clinics of North America': 1, 'British Small Animal Veterinary Association: Manual of Exotic Pets': 1, 'Elementi di anestesia degli animali esotici e selvatici': 1, 'Anti-cardiolipin': 1, 'Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4': 1, 'A review of antiphospholipid syndrome': 1, 'Antiphospholipid antibodies in pediatrics': 1, 'Quantitation of bovine cytokine mRNA in milk cells of healthy cattle by real-time TaqMan PCR': 2, 'Detection of proinflammatory and regulatory cytokines in bovine millk using RT-PCR': 1, 'Chemotactic activities in non-mastitic and mastitic mammary secretions: Presence of Interleukin-8 in mastitic but not non-mastitic secretions': 1, 'Cytokines in mammary lymph and milk during endotoxin-induced bovine mastitis': 1, 'A high prevalence of feline leishmaniasis in southern Italy': 1, 'Efficacy of metronidazole-spiramycin combined therapy in the treatment of canine leishmanisis': 1, 'A review of the treatment of canine leishmaniasis': 1, 'Comparison of direct and indirect (oscillometric) measurements of arterial blood pressure in conscious dogs': 1, \"Monitoraggio della pressione sanguigna con metodi non invasivi e trattamento dell'ipertensione\": 1, 'A clinical evaluation of blood pressure through noninvasive measurement using the oscillometric procedure in conscious dogs': 3, 'T ossicologia Veterinaria': 2, 'Effects of the mycotoxin ochratoxin A and some of its metabolites on the human cell line THP-1. T oxicology': 1, 'Aspergillus carbonarius as the main source of ochratoxin A contamination in dried vine fruits from the Spanish market': 1, \"Pituitary Pars Intermedia Dysfunction (Equine Cushing's like Disease)\": 1, 'Equine pituitary adenoma: a functional and morphological study': 1, \"Problems in the diagnosis of pituitary adenoma (Cushing's syndrome) in horses\": 1, 'Equine pituitary tumors': 1, \"Pituitary Adenomas: Equine Cushing's Diseases\": 2, 'Evaluation of thyroid, adrenal and pituitary function': 1, \"Equine Cushing's disease\": 1, 'Prospective clinical evaluation of serum cardiac troponin T in dogs admitted to a veterinary teaching hospital': 2, 'Cardiac troponin T is a sensitive, specific biomarker of cardiac injury in laboratory animals': 1, 'Deficiencies of myocardial troponin-T and creatine kinase MB isoenzyme in dogs with idiopathic dilated cardiomyopathy': 1, 'L e Metodologie Posturali in Funzione Educativa e Rieducativa': 2, 'Sensazione Somatica': 2, 'Pied, É quilibre & Posture. Editions Frison-Roche': 1, 'Basi del Metodo di Rieducazione Posturale Globale': 1, 'Uso di una piattaforma biomeccanica nel programma di riabilitazione di pazienti canini ortopedici e neurologici': 1, 'Classification of peptidases': 2, 'Cysteine proteases and their inhibitors': 3, 'Structural studies of cysteine proteases and their inhibitors': 1, 'Enzyme Catalysis in Organic Synthesis': 1, 'Structure of papain refined at 1.65Å resolution': 2, 'A necessery modification to the preparation of papain from any high-quality latex of Carica papaya and evidence for structural integrity of the enzyme produced by traditional methods': 1, 'Catalytic mechanism in papain family of cysteine peptidases': 1, 'On the size of the active site in proteases': 1, 'Revised definition of substrate sites of papain-like cysteine proteases': 1, 'The cysteine proteinases of the pine apple plant': 1, \"Preparation of fully active ficin from Ficus glabrata by covalent chromatography and characterization of its active centre by using 2,2'-dipyridyl disulphide as a reactivity probe\": 1, 'Thiol-dependent cathepsins: Pathophysiological implications and recent advances in inhibitor design': 1, 'Human and parasitic papain-like cysteine proteases: their role in physiology and pathology and recent developments in inhibitor design': 4, 'Enzymatic hydrolysis of food proteins': 2, 'The state of enzyme biotechnology in the fish processing industry': 2, 'Industrial enzymes': 2, 'Industrial enzymes and their application': 1, 'Molecular and biotechnological aspects of microbial proteases': 1, 'Industrial use of enzymes': 1, 'Enzymes from fish and aquatic invertebrates and their application in the food industry': 1, 'Role of muscle endopeptidases and their inhibitors in meat tenderness': 2, 'Enzymatic protein hydrolysates in human nutrition': 3, 'Enzymes in industry. Production and application': 1, 'Enzymes from higher eukaryotes for industrial biocatalysis': 1, 'Beer stabilization with papain': 1, 'Endoproteases of barley and malt': 1, 'Modification of wheat flour with bromelain and baking hypoallergenic bread with added ingredients': 1, 'Enzymatic hydrolysis of atlantic cod (Gadus morhua L.) viscera': 1, 'Functional characteristics of egg white solids obtained from papain treated albumen': 1, 'Hydrophobicity, solubility, and emulsifying properties of soy protein peptides prepared by papain modification and ultrafiltration': 1, 'Preparation and characterization of papain-modified sesame (Sesamum indicum L.) protein isolates': 1, 'Physicochemical and functional properties of whey protein as affected by limited papain proteolysis and selective ultrafiltration': 1, 'The role of the proteasome, and cathepsins B, L, H and D in ostrich meat tenderization': 1, 'Effect of the addition of papain on the dry fermented sausage proteolysis': 1, 'Contribution of started cultures to the proteolytic process of a fermented non-dried whole muscle ham product': 1, 'Proteinase inhibitors': 1, 'Heat induced softening of surimi gel by proteinases': 1, 'Chicken plasma protein: Proteinase inhibitory activity and its effect on surimi gel properties': 1, 'Use of hydrolysate-based products in special medical diets': 1, 'The use of enzyme-digested soybean residue for feeding common carp': 1, 'Chitosan-based dietary foods': 1, 'Biochemistry of chitinases': 1, 'Chitosan chemistry and pharmaceutical perspectives': 1, 'Preparation and characterization of low molecular weight chitosan and chito-oligomers by a commercial enzyme': 1, 'Characterization of a chitosanase isolated from a commercial ficin preparation': 1, 'Purification and characterization of hydrolase with chitinase and chitosanase activity from commercial steam bromelain': 1, 'Protein recovery from slaughterhouse wastes': 1, 'Fractionation and enzymatic hydrolysis of soluble protein present in waste from soy processing': 1, 'Addition effects of bovine blood globin and sodium caseinate on the characteristics of raw and cooked ham pate': 1, 'Utilization of cod backbone by biochemical fractionation': 1, 'Production of tuna waste hydrolysates by a commercial neutral protease preparation': 1, 'Carotenoprotein from tropical brown shrimp shell waste by enzymatic process': 1, 'Biodegradation of polyester-amides using a pure strain of micro-organisms or papain I. Model compounds': 1, 'Biodegradation of polyurethane: a review': 1, 'Biodegradation of poly(vinyl alcohol) based materials': 1, 'Silicate enhancement enzymatic dehairing: a new lime-sulfite-free process for cowhides': 1, 'Degumming of silk fabric with several proteases': 1, 'Papain catalysed hydantoin hydrolysis in the synthesis of amino acids': 1, 'Biologically active peptides and enzymatic approaches to their production': 1, 'Towards new anticancer drugs: a decade of advances in synthesis of camptothecins and related alkaloids': 1, 'Sustainable enzymatic preparation of polyaspartate using bacterial protease': 1, 'Chromatographic fractionation and characterization of the active platelet aggregation inhibitory factor from bromelain': 1, 'Use of bromelain proteases for inhibiting blood coagulation': 1, 'Effect of etodolac on prostaglandin E2 biosynthesis, active oxygen generation and bradykinin formation': 1, 'Proteolytic enzymes and amylase induce cytokine production in human peripheral blood mononuclear cells in vivo': 1, 'Bromelain protease F9 reduces the CD44 mediated adhesion of human peripheral blood limphocytes to human umbilical vein endothelial cells': 1, 'Safety and efficacy of proteolytic enzyme for enzymatic burn debridement: a preliminary report': 1, 'Antimetastatic effect of bromelain with or without its proteolytic and anticoagulant activity': 1, 'Effect of bromelain on serum and tissue levels of amoxycyllin': 1, 'The action of papain and bromelain on the uterus': 1, 'Comparative trial of Nutrizym in chronic pancreatic insufficiency': 1, 'A double -blind crossover study of a plant proteolytic enzyme in oral surgery': 1, 'Bromelain: its use in prevention and treatment of cardiovascular disease, present status': 2, 'Bromelain: a literature review and discussion of its therapeutic applications': 1, 'In vitro tissue-digesting properties of krill enzymes compared with fibrinolysin/DNAse, papain and placebo': 1, 'Papain and other constituents of Carica papaya L': 1, 'Comparison of intervertebral disc disease treatment by chymopapain injection and open surgery': 2, 'Allergic reactions, including asthma, to the pineapple protease bromelain following occupational exposure': 1, 'Respiratory hazards from papain': 1, 'Papain-induced asthma-physiological and immunological features': 1, 'A six-month study of the evolution of papain-induced emphysema in the dog': 1, 'Induction of osteoarthrosis in the guinea pig knee by papain. Oral Surg': 1, 'Chymopapain-past and present, future? Cli': 1, 'Two anaphylactic deaths after chemonucleolysis': 1, 'Hemorrhagic complications after the lumbar injection of chymopapain': 1, 'Peripheral nerve injury by chymopapain injection': 1, 'Intervertebral disk-space infection after chymopapain injection': 1, 'Expression of cathepsin B, D and L protein in juvenile idiopathic arthritis': 1, 'Viral proteases': 1, 'Papain-like protease 2 (PLP2) from severe acute respiratory syndrome coronavirus (SARS-CoV): expression, purification characterization and inhibition': 1, 'Statins for the prevention and treatment of acute lung injury and acute respiratory distress syndrome:a systematic review and meta-analysis': 1, 'Regulators of endothelial and epithelial barrier integrity and function in acute lung injury': 1, 'Pharmacological therapies for pediatric and neonatal ALI/ARDS: an evidence-based review': 1, 'Lung injury in acute pancreatitis:mechanisms underlying augmented secondary injury': 1, 'Phospholipase A2 subclasses in acute respiratory distress syndrome': 1, 'Polydatin up-regulates Clara cell secretory protein to suppress phospholipase A2 of lung induced by LPS in vivo and in vitro': 2, 'Potential role of claracellprotein, an endogenous phospholipase A2 inhibitor, in acute lung injury': 1, 'Inhibition of calcium-independent phospholipase A2 prevents inflammatory mediator production in pulmonary microvascular endothelium': 1, 'Phospholipase A2 inhibitors as potential therapeutic agents for the treatment of inflammatory diseases': 1, 'Airway regeneration:the role of the Clara cell secretory protein and the cells that express it': 1, 'CCAAT/enhancer-binding protein β: its role in breast cancer and associations with receptor tyrosine kinases': 1, 'Regulation of mouse chondrocyte differentiation by CCAAT/enhancerbinding proteins': 1, 'Differential expression of CCAAT enhancer binding protein family in rat alveolar epithelial cell proliferation and in acute lung injury': 1, 'Role of cdk2 in the sequential phosphorylation/activation of C/EBPβ during adipocyte differentiation': 3, 'Repression of the long noncoding RNA-LET by histone deacetylase 3 contributes to hypoxia-mediated metastasis': 1, '3-Hydroxykynurenine transaminase identity with alanine glyoxylate transaminase. A probable detoxification protein in Aedes aegypti': 1, 'RIPK3 restricts viral pathogenesis via cell death-independent Neuroinflammation': 1, 'C/EBP β (CEBPB) protein binding to the C/EBP | CRE DNA 8-mer TTGC | GTCA is inhibited by 5hmC and enhanced by 5mC, 5fC, and 5caC in the CG dinucleotide': 1, 'Quercetin represses apolipoprotein B expression by inhibiting the transcriptional activity of C/EBP β': 1, 'CCAAT-enhancer binding protein (C/EBP) β regulates insulin-like growth factor (IGF) 1 expression in porcine liver during prenatal and postnatal development': 1, 'C/EBP β regulates P2X7 receptor expression in response to glucose challenge in intestinal epithelial cells': 1, 'C/EBP α and C/EBP δ activate the Clara cell secretory protein gene through interaction with two adjacent C/EBP-Binding sites': 1, 'Induction of secreted type IIA phospholipase A2 gene transcription by interleukin-1β. Role of C/EBP factors': 1, 'C/EBP-homologous protein (CHOP) in vascular smooth muscle cells regulates their proliferation in aortic explants and atherosclerotic lesions': 1, 'Modular organization of SARS coronavirus nucleocapsid protein': 1, 'Nucleocapsid amino acids 211 to 254, in particular, tetrad glutamines, are essential for the interaction between the nucleocapsid and membrane proteins of SARS-associated coronavirus': 1, 'Mass spectrometric characterization of proteins from the sars virus: a preliminary report': 1, 'SARS-CoV nucleocapsid protein binds to hUbc9, a ubiquitin conjugating enzyme of the sumoylation system': 2, 'The severe acute respiratory syndrome coronavirus nucleocapsid protein is phosphorylated and localizes in the cytoplasm by 14-3-3-mediated translocation': 2, 'Intracellular localization of the severe acute respiratory syndrome coronavirus nucleocapsid protein: absence of nucleolar accumulation during infection and after expression as a recombinant protein in vero cells': 1, 'Nuclear/nucleolar localization properties of C-terminal nucleocapsid protein of SARS coronavirus': 1, 'Structure of the N-terminal RNAbinding domain of the SARS CoV nucleocapsid protein': 1, 'Structure of the SARS coronavirus nucleocapsid protein RNA-binding dimerization domain suggests a mechanism for helical packaging of viral RNA': 1, 'Carboxyl terminus of severe acute respiratory syndrome coronavirus nucleocapsid protein: self-association analysis and nucleic acid binding characterization': 1, 'Assembly of severe acute respiratory syndrome coronavirus RNA packaging signal into virus-like particles is nucleocapsid dependent': 2, 'Analysis of multimerization of the SARS coronavirus nucleocapsid protein': 1, 'Recombinant severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein forms a dimer through its C-terminal domain': 1, 'SR-rich motif plays a pivotal role in recombinant SARS coronavirus nucleocapsid protein multimerization': 1, 'The nucleocapsid protein of severe acute respiratory syndrome-coronavirus inhibits the activity of cyclincyclin-dependent kinase complex and blocks S phase progression in mammalian cells': 1, 'Potent inhibition of SARSassociated coronavirus (SCOV) infection and replication by type I interferons (IFNalpha/beta) but not by type II interferon (IFN-gamma)': 1, 'Nucleocapsid protein of SARS-CoV activates the expression of cyclooxygenase-2 by binding directly to regulatory elements for nuclear factor-kappa B and CCAAT/enhancer binding protein': 1, 'Activation of AP-1 signal transduction pathway by SARS coronavirus nucleocapsid protein': 1, 'SARS-CoV nucleocapsid protein induced apoptosis of COS-1 mediated by the mitochondrial pathway': 1, 'Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid': 1, 'Nucleocapsid protein as early diagnostic marker for SARS': 1, 'Sumoylation of the nucleocapsid protein of severe acute respiratory syndrome coronavirus': 1, 'Generation of human antibody fragments recognizing distinct epitopes of the nucleocapsid (N) SARS-CoV protein using a phage display approach': 1, 'Characterization and application of monoclonal antibodies against N protein of SARS-coronavirus': 1, 'The C-terminal portion of the nucleocapsid protein demonstrates SARS-CoVantigenicity': 1, 'Characterization of monoclonal antibody against SARS coronavirus nucleocapsid antigen and development of an antigen capture ELISA': 2, 'Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus spike polypeptide enzyme-linked immunosorbent assay (ELISA) and SARS coronavirus nucleocapsid protein ELISA for serodiagnosis of SARS coronavirus pneumonia': 3, 'Immunofluorescence assay for detection of the nucleocapsid antigen of the severe acute respiratory syndrome (SARS)-associated coronavirus in cells derived from throat wash samples of patients with SARS': 1, 'Copious production of SARS-CoV nucleocapsid protein employing codon optimized synthetic gene': 1, 'Recombinant nucleocapsid protein-based IgG enzyme-linked immunosorbent assay for the serological diagnosis of SARS': 1, 'High-yield expression of recombinant SARS coronavirus nucleocapsid protein in methylotrophic yeast Pichia pastoris': 1, 'Extremely low exposure of a community to severe acute respiratory syndrome coronavirus: false seropositivity due to use of bacterially derived antigens': 1, 'Naturally occurring anti-Escherichia coli protein antibodies in the sera of healthy humans cause analytical interference in a recombinant nucleocapsid protein-based enzyme-linked immunosorbent assay for serodiagnosis of severe acute respiratory syndrome': 1, 'Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus': 2, 'Use of the COOH portion of the nucleocapsid protein in an antigen-capturing enzyme-linked immunosorbent assay for specific and sensitive detection of severe acute respiratory syndrome coronavirus': 1, 'Antigenic and cellular localisation analysis of the severe acute respiratory syndrome coronavirus nucleocapsid protein using monoclonal antibodies': 1, 'SARS exposure and emergency department workers': 1, 'Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARSassociated coronavirus': 1, 'Recombinant truncated nucleocapsid protein as antigen in a novel immunoglobulin M capture enzyme-linked immunosorbent assay for diagnosis of severe acute respiratory syndrome coronavirus infection': 1, 'Direct sequencing of SARScoronavirus S and N genes from clinical specimens shows limited variation': 1, 'Protective humoral responses to severe acute respiratory syndrome-associated coronavirus: implications for the design of an effective protein-based vaccine': 1, 'SARS patients-derived human recombinant antibodies to S and M proteins efficiently neutralize SARScoronavirus infectivity': 1, 'Induction of SARS-nucleoproteinspecific immune response by use of DNA vaccine': 2, 'Immune responses with DNA vaccines encoded different gene fragments of severe acute respiratory syndrome coronavirus in BALB/c mice': 1, 'Immune responses against SARScoronavirus nucleocapsid protein induced by DNA vaccine': 1, 'Immunological characterizations of the nucleocapsid protein based SARS vaccine candidates': 1, 'Identification and characterization of dominant helper T-cell epitopes in the nucleocapsid protein of severe acute respiratory syndrome coronavirus': 1, 'Expression of SARS-coronavirus nucleocapsid protein in Escherichia coli and Lactococcus lactis for serodiagnosis and mucosal vaccination': 1, 'Activation of NF-kappaB by the full-length nucleocapsid protein of the SARS coronavirus': 1, 'Ecology of prokaryotic viruses': 1, 'Here a virus, there a virus, everywhere the same virus?': 1, 'Elution and inactivation of bacteriophages on soil and cation-exchange resin': 1, 'Interaction between bacteriophage PBS1 and clay minerals and transduction of Bacillus subtilis by clay-phage complexes': 2, 'Are viruses driving microbial diversification and diversity?': 1, 'Interaction between viruses and clays in static and dynamic batch systems': 1, 'Fate and transport of viruses in porous media': 1, 'Ecology of viruses in soils: past, present and future perspectives': 1, 'Bacteriophage phi 6: a unique virus having a lipid-containing membrane and a genome composed of three dsRNA segments': 1, 'Packaging, replication and recombination of the segmented genome of bacteriophage F6 and its relatives': 1, 'Modification of the interaction between Escherichia coli and bacteriophage in saline sediment': 1, 'Effect of clay particle size on clay-Escherichia coli-bacteriophage interactions': 1, 'Effect of proteins on reovirus adsorption to clay minerals': 1, 'Enhancement of bacteriophage φX-174 plaques by homoionic clay minerals': 1, 'Transduction of Escherichia coli by bacteriophage P1 in soil': 1, 'Clay minerals protect bacteriophage PBS1 of Bacillus subtilis against inactivation and loss of transducing ability by UV radiation': 2, 'Adsorption of reovirus to clay minerals: effects of cation-exchange capacity, cation saturation, and surface area': 3, 'Specificity of virus adsorption to clay minerals': 2, 'Differential adsorption of occluded and nonoccluded insect-pathogenic viruses to soil-forming minerals': 1, 'Particle-associated viruses in water: impacts on disinfection processes': 1, 'Interactions between viruses and goethite during saturated flow: effects of solution pH, carbonate, and phosphate': 2, 'Effects of pH, ionic strength, dissolved organic matter, and flow rate on the co-transport of MS2 bacteriophages with kaolinite in gravel aquifer media': 1, 'Deposition kinetics of MS2 bacteriophages on clay mineral surfaces': 1, 'Deposition and aggregation kinetics of rotavirus in divalent cation solutions': 1, 'Adsorption of coliphages T1 and T7 to clay minerals': 1, 'Adsorption of bacteriophages on clay minerals': 1, 'Theory of the stability of strongly charged lyophobic sols and of the adhesion of strongly charged particles in solution of electrolytes': 1, 'Theory of the stability of lyophobic colloids': 1, 'Analysis of bacteriophage inactivation and its attenuation by adsorption onto colloidal particles by batch agitation techniques': 1, 'Forces dictating colloidal interactions between viruses and soil': 1, 'X-ray diffraction and the identification and analysis of clay minerals': 1, 'Bacteriophage phi 6 envelope elucidated by chemical cross-linking, immunodetection, and cryoelectron microscopy': 2, 'The isoelectric points of some strains of tobacco mosaic virus': 1, 'Electron microscopy of bacteriophage phi 6 nucleocapsid: two-dimensional image analysis': 1, 'Influence of cations on aggregation rates in Mg-Montmorillonite': 1, 'NIH image to ImageJ: 25 years of image analysis': 1, 'Attachment of bacteriophages MS2 and fX174 onto kaolinite and montmorillonite: extended-DLVO interactions': 1, 'Production of a polyhedral particle in Escherichia coli from a cDNA copy of the large genomic segment of bacteriophage phi 6': 1, 'Hepatitis B infection and primary liver cancer': 2, 'The treatment of chronic viral hepatitis': 1, 'A review of the case for hepatitis B vaccination of high-risk adults': 1, 'The Fgl2/fibroleukin prothrombase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis': 2, 'Network-based drug repurposing for novel coronavirus 2019-nCoV/ SARS-CoV-2': 1, 'An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice': 1, 'Identification of potential treatments for COVID-19 through artificial intelligence-enabled phenomic analysis of human cells infected with SARS-CoV-2. bioRxiv': 1, 'COVID-19 Map -Johns Hopkins Coronavirus': 1, 'SMILES. 2. Algorithm for generation of unique SMILES notation': 1, 'DrugBank 5.0: A major update to the DrugBank database for': 1, 'Drugbank Database': 1, 'DrugCentral: Online drug compendium': 1, 'Antiviral Candidate Compounds <https : / / www': 1, 'Lit -A Collection of Literature Extracted Small Molecules to Speed Identification of COVID-19 Therapeutics 2020': 1, 'Quantum chemistry structures and properties of 134 kilo molecules': 2, 'QM9 Dataset': 2, 'The Harvard organic photovoltaic dataset': 1, '/ articles / HOPV15_Dataset/1610063> (2020)': 1, 'PubChem substance and compound databases': 2, 'PubChem National Library of Medicine <https : / / pubchem': 1, 'The Drug Repurposing Hub: A next-generation drug library and information resource': 1, 'Synthetically Accessible Virtual Inventory (SAVI)': 1, 'Synthetically Accessible Virtual Inventory Database': 1, 'SureChEMBL: a large-scale, chemically annotated patent document database': 1, 'SureChEMBL Open Patent Data <https': 1, 'Open Babel: An open chemical toolbox': 1, 'Molecular Feature Extraction Pipeline Tools': 2, 'Mordred: A molecular descriptor calculator': 1, 'Visualizing data using t-SNE': 1, 'Recent enhancements and future plans in XSEDE16 Conference on Diversity, Big Data, and Science at Scale': 1, 'Exascale applications: Skin in the game': 1, 'Pervasive parallel programming in Python in 28th International Symposium on High-Performance Parallel and Distributed Computing': 1, 'Serverless supercomputing: High performance function as a service for science': 1, 'A data ecosystem to support machine learning in materials science': 1, 'The Materials Data Facility: Data services to advance materials science research': 1, 'Creating training data for scientific named entity recognition with minimal human': 1, 'COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses': 1, 'COVID-19 Data Repository by the Center for Systems Science and Engineering (CSSE)': 5, 'Help seeking behavior and the Internet: A national survey': 1, 'Trends of infodemiology studies: a scoping review': 2, 'Global Digital Overview. DataReportal. Accessed': 3, 'Infodemiology and infoveillance: Scoping review': 3, 'The application of internet-based sources for public health surveillance (infoveillance): Systematic review': 3, 'Google trends: A web-based tool for real-time surveillance of disease outbreaks': 1, 'The Use of Google Trends in Health Care Research: A Systematic Review': 5, 'Rapid Decline in Online Search Queries for Hip and Knee Arthroplasties Concurrent With the COVID-19 Pandemic': 2, 'Analysis of dermatologic conditions in Turkey and Italy by using Google Trends analysis in the era of the COVID 19 pandemic': 1, 'Google Trends: Opportunities and limitations in health and health policy research. Health Policy': 2, 'Google Trends in Infodemiology and Infoveillance: Methodology Framework': 1, 'Silver lining of COVID-19: Heightened global interest in pneumococcal and influenza vaccines': 1, 'Assessing the methods, tools, and statistical approaches in Google trends research: Systematic review': 1, 'Association of the COVID-19 pandemic with Internet Search Volumes: A Google TrendsTM Analysis': 1, 'Predicting COVID-19 Incidence Through Analysis of Google Trends Data in Iran: Data Mining and Deep Learning Pilot Study': 1, 'Scoping review on search queries and social media for disease surveillance: A chronology of innovation': 1, 'Communicable diseases in the South-East Asia Region of the World Health Organization: Towards a more effective response': 1, 'second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)': 1, \"World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19\": 1, 'Estimating the number of infections and the impact of nonpharmaceutical interventions on COVID-19 in 11 European countries. Imperial College London': 1, 'Infection fatality rate of SARS-CoV-2 infection in a German community with a super-spreading event': 1, 'Repeated seroprevalence of anti-SARS-CoV-2 IgG antibodies in a population-based sample': 1, 'SARS-CoV-2: Prevalence of antibodies in Jersey': 1, 'Vorläufiges Ergebnis und Schlussfolgerungen der COVID-19 Case-Cluster-Study (Gemeinde Gangelt)': 1, 'Loss of Smell and Taste in 2013 European Patients With Mild to Moderate COVID-19': 1, 'Serology-based tests for COVID-19': 2, 'Advice on the use of point-of-care immunodiagnostic tests for COVID-19: scientific brief': 3, 'National Ambulatory Medical Care Survey: 2005 summary': 1, 'Chronic cough due to acute bronchitis: ACCP evidencebased clinical practice guidelines': 4, 'Effects of naproxen on experimental rhinovirus colds: a randomized, double-blind, controlled trial': 1, 'Antibiotics for acute bronchitis': 1, 'Antibiotics for exacerbations of chronic obstructive pulmonary disease': 1, 'Antivirals for influenza in healthy adults: systematic review': 1, 'Hospitalizing influenza in adults': 1, 'Infectious mononucleosis': 1, 'Hepatosplenomegaly in infectious mononucleosis, assessed by ultrasonic scanning': 1, 'Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults': 1, 'A pooled analysis of the effect of condoms in preventing HSV-2 acquisition': 2, 'Consistent condom use is associated with lower prevalence of human papillomavirus infection in men': 1, 'The limited value of signs and symptoms in the diagnosis of vaginal infections': 1, 'Accuracy of the clinical diagnosis of vaginitis compared with a DNA probe laboratory standard': 1, 'The effectiveness of a clinical practice guideline for the management of presumed uncomplicated urinary tract infection in women': 1, 'Recurrent cystitis in non-pregnant women': 1, 'Urinary tract infection in children': 1, 'Screening for asymptomatic bacteriuria in pregnancy: a decision and cost analysis': 1, 'American Geriatric Society. Guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults': 1, 'Asymptomatic bacteriuria: when to screen and when to treat': 1, 'Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women': 2, 'A randomized trial to evaluate effectiveness and cost effectiveness of naturopathic cranberry products as prophylaxis against urinary tract infection in women': 1, 'Tick-borne diseases': 4, 'Tick-borne diseases in the United States': 4, 'The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis': 1, 'double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection': 1, 'Diagnostic accuracy of the physical examination and imaging tests for osteomyelitis underlying diabetic foot ulcers: meta-analysis': 1, 'Deep tissue biopsy vs. superficial swab culture monitoring in the microbiological assessment of limb-threatening diabetic foot infection': 1, 'Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: concordance with ulcer swab cultures': 1, 'Antibiotic prophylaxis for mammalian bites (Cochrane Review)': 1, \"Mandell, Douglas, and B ennett's Principles and Practices of Infectious Diseases\": 1, 'Spontaneous bacterial peritonitis: diagnosis, treatment and prevention': 1, 'Review article: the utility of reagent strips in the diagnosis of infected ascites in cirrhotic patients': 1, 'Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis': 1, 'A comprehensive evidence-based approach to fever of unknown origin': 1, 'Members of Veterans Affairs Hepatitis C Resource Center Program. Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program': 1, 'Brain abscess': 1, 'Practice guidelines for the management of bacterial meningitis': 3, 'The management of encephalitis: clinical practice guidelines of the Infectious Disease Society of America': 1, 'A comparison of vancomycin and metronidazole for the treatment of Clostridium difficileassociated diarrhea, stratified by disease severity': 1, 'Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis': 1, 'Diagnosis, management and treatment of hepatitis C: an update': 2, 'Prevention of infective endocarditis: guidelines from the American Health Association. Circulation': 2, 'ACC/AHA 2008 guideline update on valvular heart disease: focused update on infective endocarditis': 1, 'Infective endocarditis: diagnosis, antimicrobial therapy, and complications': 1, 'Prescription of antibiotics for prophylaxis to prevent bacterial endocarditis': 1, 'Emergence and pandemic potential of swine-origin H1N1 influenza virus': 2, 'Triple-reassortant swine influenza A (H1) in humans in the United States': 1, 'Novel swine-origin influenza A virus in humans: another pandemic knocking at the door': 1, 'Rapid multiplex reverse transcription-PCR typing of influenza A and B virus, and subtyping of influenza A virus into H1': 1, 'Switching gears for an influenza pandemic: validation of a duplex reverse transcriptase PCR assay for simultaneous detection and confirmatory identification of pandemic (H1N1) 2009 influenza virus': 1, 'Rapid-test sensitivity for novel swine-origin influenza A (H1N1) virus in humans': 1, 'Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreak': 1, 'Detection of loop-mediated isothermal amplification reaction by turbidity derived from magnesium pyrophosphate formation': 1, 'Accelerated reaction by loop-mediated isothermal amplification using loop primers': 2, 'Evaluation of four real-time PCR assays for detection of influenza A(H1N1) viruses': 1, 'Discrepant analysis: how can we test a test?': 1, 'Monitoring of viable airborne SARS virus in ambient air': 1, 'Bioaerosol health effects and exposure assessment: Progress and prospects': 1, 'How can air filters contribute to better IAQ': 1, 'Bacterial and fungal aerosol in indoor environment in Upper Silesia': 1, 'Control of aerosol contaminants in indoor air: Combining the particle concentration reduction with microbial inactivation': 6, 'Biological agent inactivation in a flowing air stream by photocatalysis': 3, 'Effectiveness of titanium dioxide photocatalyst filters for controlling bioaerosols': 8, 'Inactivation of microorganisms on the photocatalytic surfaces in air': 3, 'Enhanced photocatalytic inactivation of bacterial spores on surfaces in air': 2, 'Effect of negative air ionization on airborne transmission of Newcastle disease virus': 2, 'Bactericidal effect of negative and positive ions generated in nitrogen on Escherichia coli': 3, 'Heterogeneous photocatalytic oxidation of trichloroethylene and toluene mixtures in air: Kinetic promotion and inhibition, time-dependent catalyst activity': 2, 'Decomposition of gas-phase toluene by the combination of ozone and photocatalytic oxidation process (TiO 2 /UV, TiO 2 /UV/O 3 , and UV/O 3 )': 3, 'Different inactivation behaviors of MS-2 phage and Escherichia coli in TiO 2 photocatalytic disinfection': 3, 'Photoelectrocatalytic and photocatalytic disinfection of E. coli suspensions by titanium dioxide': 1, 'Photocatalytic inactivation of phage Q by immobilized titanium dioxide mediated photocatalyst': 1, 'Bactericidal and detoxification effects of TiO 2 thin film photocatalysts': 3, 'Bactericidal activity of photocatalytic TiO 2 reaction: Toward an understanding of it killing mechanism': 2, 'Enhanced photocatalytic disinfection of indoor air': 3, 'Unipolar ion emission enhances respiratory protection against fine and ultrafine particles': 1, 'Interaction of ozone and negative air ions to control micro-organisms': 2, 'Effectiveness of indoor air cleaning with corona ionizers': 1, 'Removal of fine and ultrafine particles from indoor air environments by the unipolar ion emission': 1, 'Evaluation of ionic air purifiers for reducing aerosol exposure in confined indoor spaces': 1, 'Aerosol removal by unipolar ionization in indoor environments': 2, 'Pressure inactivation kinetics of bacteriophage lambda Ci 857': 1, 'Microbiology-a laboratory manual': 2, 'Evaluation of eight bioaerosol samplers challenged with aerosols of free bacteria': 1, 'Collection efficiencies of aerosol samplers for virus-containing aerosols': 2, 'Sampling methodologies and dosage assessment techniques for submicrometre and ultrafine virus aerosol particles': 1, 'Principles and procedures of statistics: A biometrical approach': 1, 'Aerosol technology properties, behavior, and measurement of airborn particles': 1, 'Particle reentrainment from fibrous filters': 1, 'Bovine serum albumin observed by infrared spectrometry. II. Hydration mechanisms and interaction configurations of embedded H 2 O molecules': 1, 'Effect of wall surface materials on deposition of particles with the aid of negative air ions': 1, 'Influence of humidity on variation of ion mobility with life time in atmospheric air': 1, 'Chemical composition of small atmospheric ions near the ground': 1, 'Negative air ionisation and the production of hydrogen peroxide': 1, 'Negative air ions as a source of superoxide': 1, 'Bactericidal action of the reactive species produced by gas-discharge nonthermal plasma at atmospheric pressure: A review': 1, 'Inhibition of microbial growth using negative air ions': 2, 'Mineralization of bacterial cell mass on a photocatalytic surface in air': 1, \"The doctor's master\": 1, 'Public health ethics: mapping the domain': 1, 'Ethics in the time of COVID: what remains the same and what is different': 1, 'Fair allocation of scarce resources in the time of Covid-19': 3, 'A framework for rationing ventilators and critical care beds during the Covid-19 pandemic': 1, 'Who should receive life-support during a public health emergency? Using ethical principles to improve allocation decisions': 2, 'Ethics guidelines on COVID-19 triage -an emerging international consensus': 1, 'Too many patients … a framework to guide statewide allocation of scarce mechanical ventilation during disasters': 1, 'Setting Limits: Medical Goals in an Aging Society': 1, 'Ethical Framework for Health Care Institutions Responding to Novel Coronavirus SARS-CoV-2 (COVID-19) with Guidelines for Institutional Ethics Services Responding to COVID-19: Managing Uncertainty, Safeguarding Communities, Guiding Practice. Garrison, NY: The Hastings Center': 1, 'New treatments for influenza': 1, 'Amantadine resistance among highly pathogenic avian influenza viruses (H5N1) isolated from India': 1, 'Potential human adaptation mutation of influenza A(H5N1) virus': 1, 'A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9': 1, 'A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captoprilinsensitive carboxypeptidase': 1, 'Angiotensin II type 1 receptor antagonists in animal models of vascular, cardiac, metabolic and renal disease': 1, 'Angiotensin II type 2 receptor (AT2R) in renal and cardiovascular disease': 1, 'Role of the ACE2/angiotensin 1-7 axis of the renin-angiotensin system in heart failure': 1, 'Angiotensinconverting enzyme 2 is an essential regulator of heart function': 1, 'Chronic kidney disease: cardiac and renal angiotensin-converting enzyme (ACE) 2 expression in rats after subtotal nephrectomy and the effect of ACE inhibition': 1, 'ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation': 1, 'Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections': 6, 'Angiotensin II receptor blocker as a novel therapy in acute lung injury induced by avian influenza A H5N1 virus infection in mouse': 1, 'Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus': 1, 'Angiotensin-converting enzyme 2 in lung diseases': 1, 'Angiotensin-converting enzyme 2 prevents lipopolysaccharide-induced rat acute lung injury via suppressing the ERK1/2 and NF-kappaB signaling pathways': 2, 'The correlation between inflammatory injury induced by LPS and RAS in EpH4-Ev cells': 1, 'Angiotensin-converting enzyme 2 activator diminazene aceturate prevents lipopolysaccharide-induced inflammation by inhibiting MAPK and NF-kappaB pathways in human retinal pigment epithelium': 1, 'MicroRNAs: small RNAs with a big role in gene regulation': 1, 'MicroRNA therapeutics: discovering novel targets and developing specific therapy': 2, 'Drug target miRNAs: chances and challenges': 2, 'Angiotensin-converting enzyme 2 is subject to post-transcriptional regulation by miR-421': 2, 'miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance': 1, 'Effect of avian influenza A H5N1 infection on the expression of microRNA-141 in human respiratory epithelial cells': 1, 'Activated protein C ameliorates LPS-induced acute kidney injury and downregulates renal INOS and angiotensin 2': 1, 'Mesenchymal stem cells overexpressing angiotensin-converting enzyme 2 rescue lipopolysaccharide-induced lung injury': 1, 'The role of respiratory viruses in the etiology of bacterial pneumonia: an ecological perspective': 1, 'Acute respiratory distress syndrome and pneumonia: a comprehensive review of clinical data': 2, 'Angiotensin II formation and endothelin clearance in ARDS patients in supine and prone positions': 1, 'Modulation of NF-kappaB signalling by microbial pathogens': 1, 'NF-kappaB in immunobiology': 1, 'NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses': 1, 'NF-kappaB p65-dependent transactivation of miRNA genes following Cryptosporidium parvum infection stimulates epithelial cell immune responses': 1, 'DNA damage induces NF-kappaB-dependent microRNA-21 up-regulation and promotes breast cancer cell invasion': 1, 'NF-kappaB signaling differentially regulates influenza virus RNA synthesis': 2, 'Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon': 2, 'Acute respiratory distress syndrome induced by avian influenza A (H5N1) virus in mice': 2, 'An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals': 1, 'Clinical characteristics of 26 human cases of highly pathogenic avian influenza A (H5N1) virus infection in China': 1, 'Avian influenza A (H5N1) infection in humans': 1, 'Suppression of the antiviral response by an influenza histone mimic': 1, 'Influenza virus non-structural protein NS1: interferon antagonism and beyond': 1, 'Differential effects of NS1 proteins of human pandemic H1N1/2009, avian highly pathogenic H5N1, and low pathogenic H5N2 influenza A viruses on cellular pre-mRNA polyadenylation and mRNA translation': 1, 'Regulation of miR-200c/141 expression by intergenic DNA-looping and transcriptional readthrough': 1, 'Downregulation of angiotensin-converting enzyme 2 by the neuraminidase protein of influenza A (H1N1) virus': 1, 'Influenza virus-induced NF-kappaB-dependent gene expression is mediated by overexpression of viral proteins and involves oxidative radicals and activation of IkappaB kinase': 1, 'FAT10 is critical in influenza A virus replication by inhibiting type I IFN': 1, 'MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations': 1, 'Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3': 1, 'Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components': 1, 'NF-kappaB regulation in the immune system': 1, 'Effects of an angiotensin-converting enzyme inhibitor-based regimen on pneumonia risk': 1, 'Populationbased study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumonia-related outcomes': 1, 'The correlation between miR-200c and the severity of interstitial lung disease associated with different connective tissue diseases': 1, 'miR-429 regulates alveolar macrophage inflammatory cytokine production and is involved in LPS-induced acute lung injury': 1, 'Neuraminidase of influenza A virus binds lysosome-associated membrane proteins directly and induces lysosome rupture': 1, 'Olfactory and gustatory dysfunctions as a clinical presentation of mildto-moderate forms of the coronavirus disease (COVID-19): a multicenter European study': 4, 'Clinical and epidemiological characteristics of 1,420 European patients with mild-to-moderate coronavirus disease 2019': 1, 'COVID-19 anosmia reporting tool: initial findings. Otolaryngol Head Neck Surg': 1, 'Self-reported olfactory loss associates with outpatient clinical course in COVID-19. Int Forum Allergy Rhinol': 2, 'Smell dysfunction: a biomarker for COVID-19. Int Forum Allergy Rhinol': 1, 'Clinical Management of Severe Acute Respiratory Infection When Novel Coronavirus (2019-nCoV) Infection is Suspected: Interim Guidance': 1, 'Psychometric and clinimetric validity of the 20-item Sino-nasal outcome test (SNOT-20)': 1, 'Contemporary assessment of the prevalence of smell and taste problems in adults': 2, 'Normative data for the \"Sniffin\\' Sticks\" including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3,000 subjects': 1, 'Identification of viruses in patients with postviral olfactory dysfunction': 1, 'The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients': 1, 'World Health Organization. Mental health: Suicide data': 2, 'Suicide in developing countries (1): frequency, distribution, and association with socioeconomic indicators': 2, 'Suicide, suicide attempts, and suicidal ideation': 3, \"Kaplan & Sadock's synopsis of psychiatry: behavioral sciences/ clinical psychiatry\": 1, 'Self-directed violence surveillance: Uniform definitions and recommended data elements (version 1.0)': 1, 'Definitions: Self-directed violence': 1, 'Cross-national prevalence and risk factors for suicidal ideation, plans and attempts': 4, 'Twelve-month prevalence of and risk factors for suicide attempts in the world health organization world mental health surveys': 2, 'AIDS/HIV infection, comorbid psychiatric illness, and risk for subsequent suicide: a nationwide register linkage study': 1, 'HIV-infected mental health patients: characteristics and comparison with HIV-infected patients from the general population and non-infected mental health patients': 2, 'Trauma, mental health, distrust, and stigma among HIV-positive persons: implications for effective care': 2, 'The changing profile of mental health problems in people with HIV': 2, 'Comparison of depression and anxiety between HIV-positive and HIV-negative people': 1, 'Higher depression and anxiety rates with HIV across ART and viral load categories': 1, 'Prevalence of depression or depressive symptoms among people living with HIV/AIDS in China: a systematic review and meta-analysis': 1, 'HIV and mental health: an overview of research from India': 1, 'Depression and its associated factors among people living with HIV/AIDS: can it affect their quality of life?': 3, 'What is the relevance of mental health to HIV/AIDS care and treatment programs in developing countries? A systematic review': 2, 'Mental disorder and the outcome of HIV/AIDS in low-income and middle-income countries: a systematic review': 2, 'Prevalence and associated factors of suicidal ideation and attempt among people living with HIV/AIDS at Zewditu memorial hospital': 5, 'HIV-infection as a self-reported risk factor for attempted suicide in South Africa': 4, 'Suicidality, clinical depression, and anxiety disorders are highly prevalent in men who have sex with men in Mumbai, India: findings from a community-recruited sample': 1, 'HIV infection and mental health: suicidal behaviour -systematic review': 1, 'Suicide in HIV-infected individuals and the general population in Switzerland': 1, 'Efavirenz induces depressive-like behaviour, increased stress response and changes in the immune response in rats': 1, 'Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data': 2, 'Psychological autopsy studies of suicide: a systematic review': 1, 'Suicide prevention: the urgent need in developing countries': 1, 'CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV epidemiology research study': 1, 'Efficacy of group psychotherapy to reduce depressive symptoms among HIV-infected individuals: a systematic review and meta-analysis': 1, 'A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals': 1, \"Meta-analysis of cognitive-behavioral interventions on HIV-positive persons' mental health and immune functioning\": 1, 'Management of psychiatric disorders in patients infected with human immunodeficiency virus': 1, 'New Country Classifications | Data: The World Bank Group': 1, 'Suicidal ideation and suicide attempt among Indonesian adolescent students': 1, 'A quarter of Indonesians have experienced suicidal thoughts: YouGov': 1, 'Correlates of suicidal ideation among HIV-positive persons': 1, 'Prevalence of suicidal ideation and associated factors among HIV-positive MSM in Anhui, China': 2, 'Suicidal ideation, attempt, and determining factors among HIV/AIDS patients': 7, 'Prevalence and risk factors for lifetime suicide ideation, plan and attempt in Chinese men who have sex with men': 1, 'The world mental health (WMH) survey initiative version of the World Health Organization (WHO) composite international diagnostic interview (CIDI)': 1, 'Standardization and normalization of SCL-90 scores as a psychometric instrument. Thesis. Jakarta: Universitas Indonesia': 1, 'Hopelessness, depression and suicidal ideation in HIV-positive persons': 2, 'Evaluating anxiety and depression in HIV-infected patients': 1, 'Screening clinical depression in HIV-seropositive patients using the hospital anxiety and depression scale': 1, 'Prevalence of depression in people living with HIV/ AIDS undergoing ART and factors associated with it': 2, 'Depression in HIV infected patients: a review': 2, 'Anxiety and depression amongst patients enrolled in a public sector antiretroviral treatment programme in South Africa: a cross-sectional study': 1, 'Prevalence and correlates of depression and anxiety among patients with HIV on-follow up at alert hospital': 1, 'HIV-related stigma: implications for symptoms of anxiety and depression among Malawian women': 1, 'HIV and depression -a systematic review of interventions': 1, 'Identification of suicidal ideation and prevention of suicidal behaviour in the elderly': 1, 'Women with HIV: gender violence and suicidal ideation': 2, 'Laporan perkembangan HIV AIDS & infeksi menular seksual tahun 2018': 1, 'Depression and suicide risk among HIV positive individuals attending an out patient HIV/Aids clinic of a Nigerian tertiary health institution': 3, 'The changing relation between mortality and level of economic development': 1, 'A qualitative study on the stigma experienced by people with mental health problems and epilepsy in the Philippines': 1, 'HIVrelated stigma, isolation, discrimination, and serostatus disclosure: a global survey of 2035 HIV-infected adults': 1, 'Poor CD4 count is a predictor of untreated depression in human immunodeficiency virus-positive African-Americans': 1, 'Cognitive vulnerability for depression in HIV': 1, 'Frailty among HIV-1 infected adults under antiretroviral therapy in Indonesia': 1, 'Depression and CD4 cell count among persons with HIV infection in Uganda': 2, 'Adverse effects of highly active antiretroviral therapy in developing countries': 1, 'Neuropsychiatric side effects of efavirenz therapy': 2, 'Long-term neuropsychiatric disorders on efavirenz-based approaches: quality of life, psychologic issues, and adherence': 1, 'Improvement of depression and anxiety after discontinuation of long-term efavirenz treatment': 1, 'Implications of efavirenz for neuropsychiatry: a review': 1, 'Efavirenz and the CNS: what we already know and questions that need to be answered': 1, 'Associated factors of suicidal thoughts in HIV-positive individuals': 2, 'Depression and suicidal ideation among HIV-infected adults receiving efavirenz versus nevirapine in Uganda: a prospective cohort study': 2, 'Long-term efficacy and tolerance of efavirenz-and nevirapine-containing regimens in adult HIV type 1 Senegalese patients': 1, 'Predictors of major depression in recently diagnosed patients with HIV/AIDS in South Africa': 1, 'Perceived family support, depression, and suicidal ideation among people living with HIV/AIDS: a cross-sectional study in the Kathmandu Valley': 1, 'Clinical characteristics of critical patients with pandemic influenza A (H1N1) virus infection in Chengdu': 1, 'A (H1N1) pdm09 HA D222 variants associated with severity and mortality in patients during a second wave in Mexico': 1, 'Adaption of seasonal H1N1 influenza virus in mice': 1, 'Adaptive mutations that occurred during circulation in humans of H1N1 influenza virus in the 2009 pandemic enhance virulence in mice': 1, 'Naturally occurring single mutations in Ebola virus observably impact infectivity': 1, 'Mutations associated with severity of the pandemic influenza A(H1N1)pdm09 in humans: a systematic review and meta-analysis of epidemiological evidence': 1, 'A novel antigenic variant of Canine Parvovirus from a Vietnamese dog': 1, 'First detection of canine parvovirus type 2c in pups with haemorrhagic enteritis in Spain': 1, 'Western European epidemiological survey for parvovirus and coronavirus infections in dogs': 1, 'Canine parvovirus 2c infection in central Portugal': 1, 'Parasitology, virology, and serology of free-ranging coyotes (Canis Latrans) from Central Georgia': 1, 'Occurrence of canine parvovirus type 2c in the United States': 1, 'Typing of canine parvovirus strains circulating in Brazil between': 1, 'Characterization of Canine Parvovirus 2 variants circulating in Greece': 1, 'Clinical and virological findings in pups naturally infected by canine parvovirus type 2 Glu-426 mutant': 2, 'Comparison of three rapid commercial Canine parvovirus antigen detection tests with electron microscopy and polymerase chain reaction': 3, 'Canine Parvovirus infection: which diagnostic test for virus?': 6, 'A real-time PCR assay for rapid detection and quantitation of canine parvovirus type 2 in the feces of dogs': 4, 'Rapid method utilizing the polymerase chain reaction for detection of canine parvovirus in feces of diarrheic dogs': 1, 'Effects of canine parvovirus strain variations on diagnostic test results and clinical management of enteritis in dogs': 1, 'Evaluation of an in-clinic assay for the diagnosis of canine parvovirus': 1, 'Characterization of a nonhemagglutinating mutant of canine parvovirus': 1, 'Characterization of a canine parvovirus strain isolated from an adult dog': 1, 'Long-term viremia and fecal shedding in pups after modified-live canine parvovirus vaccination': 1, 'The airway epithelium: Soldier in the fight against respiratory viruses': 1, 'Discovery of modulators of HIV-1 infection from the human peptidome': 1, 'A peptide inhibitor of cytomegalovirus infection from human hemofiltrate': 1, 'Short-term monotherapy in HIV-infected patients with a virus entry inhibitor against the gp41 fusion peptide': 1, 'A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike': 1, 'Structure and variation of human α1-antitrypsin': 1, 'Simultaneous Treatment of Human Bronchial Epithelial Cells with Serine and Cysteine Protease Inhibitors Prevents Severe Acute Respiratory Syndrome Coronavirus Entry': 1, 'Characterization and treatment of SARS-CoV-2 in nasal and bronchial human airway epithelia': 1, 'Remdesivir but not famotidine inhibits SARS-CoV-2 replication in human pluripotent stem cell-derived intestinal organoids': 1, 'Dishevelled controls apical docking and planar polarization of basal bodies in ciliated epithelial cells': 1, 'Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV2-Priming Protease TMPRSS2': 1, 'Molecular architecture of the bipartite fusion loops of vesicular stomatitis virus glycoprotein G, a class III viral fusion protein': 1, 'Alpha 1 antitrypsin content in the serum, alveolar macrophages, and alveolar lavage fluid of smoking and nonsmoking normal subjects': 1, 'Biochemical Efficacy and Safety of Monthly Augmentation Therapy for Alpha 1-antitrypsin Deficiency': 1, 'A Vesicular Stomatitis Virus Replicon-Based Bioassay for the Rapid and Sensitive Determination of Multi-Species Type I Interferon': 1, 'Data-driven discovery and validation of circulating blood-based biomarkers associated with prevalent atrial fibrillation': 3, 'The Danish Health Authority, COVID-19 outbreak in Denmark': 1, 'Reduced rate of hospital admissions for ACS during New-onset atrial fibrillation': 2, 'The Covid-19 pandemic and the incidence of acute myocardial infarction': 2, 'Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study': 1, 'Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study': 1, 'ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS': 1, 'The Danish National Patient Registry: a review of content, data quality, and research potential': 2, 'The Danish Civil Registration System as a tool in epidemiology': 1, 'The Danish National Prescription Registry': 1, 'Danish education registers': 1, 'Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study': 2, 'Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation': 1, 'Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: The Swedish Atrial Fibrillation cohort study': 1, 'R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing': 1, 'Screening for atrial fibrillation': 1, 'Substantial differences in initiation of oral anticoagulant therapy and clinical outcome among non-valvular atrial fibrillation patients treated in inpatient and outpatient settings': 2, 'Delayed access or provision of care in Italy resulting from fear of COVID-19': 1, 'Integrating new approaches to atrial fibrillation management': 1, 'The US Center for Disease Control and Prevention, COVIDView, Pneumonia and influenza mortality Report': 1, 'Sanchis-Gomar F. Health risks and potential remedies during prolonged lockdowns for coronavirus disease 2019 (COVID-19)': 1, 'Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry': 1, 'Pitfalls of statistical hypothesis testing: type I and type II errors': 1, 'Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis': 1, 'Introduction to meta-analysis': 1, 'Addressing the Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Hematopoietic Cell Transplantation: Learning Networks as a Means for Sharing Best Practices': 1, 'Pitfalls of judgment during the COVID-19 pandemic': 1, \"COVID-19 FAQ's in Pediatric Cardiac Surgery\": 1, 'Resource Allocation and Decision Making for Pediatric and Congenital Cardiac Catheterization During the Novel Coronavirus SARS-CoV-2 (COVID-19) Pandemic: A U.S. Multi-Institutional Perspective': 1, 'COVID-19: Crisis Management in Congenital Heart Surgery. The Annals of thoracic surgery': 2, 'Considerations for Triaging Elective Cases in Children with Cardiac Disease in a Time of Crisis': 1, 'Lessons from SARS: a retrospective study of outpatient care during an infectious disease outbreak': 1, 'Effects of Response to 2014-2015 Ebola Outbreak on Deaths from Malaria, HIV/AIDS, and Tuberculosis, West Africa': 2, 'Regulation of macroautophagy by mTOR and Beclin 1 complexes': 5, 'Molecular mechanism and regulation of autophagy': 3, 'Signalling and autophagy regulation in health, aging and disease': 1, 'Autophagy fights disease through cellular self-digestion': 1, 'Vesicular trafficking and autophagosome formation': 1, 'Autophagy: process and function': 1, 'The late stages of autophagy: how does the end begin?': 1, 'Autophagosomes: biogenesis from scratch?': 1, 'Autophagosome formation: core machinery and adaptations': 1, 'Toward unraveling membrane biogenesis in mammalian autophagy': 1, 'Regulation and role of autophagy in mammalian cells': 1, 'Unveiling the roles of autophagy in innate and adaptive immunity': 3, 'Autophagy and antigen presentation': 1, 'Eating the enemy within: autophagy in infectious diseases': 2, 'Immune surveillance of intracellular pathogens via autophagy': 1, 'Autophagy genes in immunity': 1, 'Autophagy and signaling: their role in cell survival and cell death': 1, 'Autophagic and apoptotic response to stress signals in mammalian cells': 1, 'Autophagic cell death: the story of a misnomer': 1, 'Self-eating and self-killing: crosstalk between autophagy and apoptosis': 1, 'Does autophagy have a license to kill mammalian cells?': 2, 'Thinking globally and acting locally with TOR': 1, 'Regulation of targets of mTOR (mammalian target of rapamycin) signalling by intracellular amino acid availability': 1, 'ER stress (PERK/eIF2alpha phosphorylation) mediates the polyglutamine-induced LC3 conversion, an essential step for autophagy formation': 2, 'Regulation of starvation-and virus-induced autophagy by the eIF2alpha kinase signaling pathway': 3, 'PKR-dependent autophagic degradation of herpes simplex virus type 1': 4, 'Autophagy in innate and adaptive immunity': 1, 'Regulation of autophagy by cytoplasmic p53': 1, 'Amino acids interfere with the ERK1/2-dependent control of macroautophagy by controlling the activation of Raf-1 in human colon cancer HT-29 cells': 1, 'Roles of the Akt/mTOR/p70S6K and ERK1/2 signaling pathways in curcumin-induced autophagy': 1, 'A non-canonical MEK/ERK signaling pathway regulates autophagy via regulating Beclin 1': 1, 'Dependence of hepatocytic autophagy on intracellularly sequestered calcium': 1, 'Connecting endoplasmic reticulum stress to autophagy by unfolded protein response and calcium': 1, 'Regulation of autophagy by NFkappaB transcription factor and reactives oxygen species': 1, 'NF-kappaB activation represses tumor necrosis factor-alpha-induced autophagy': 1, 'Differential effects of endoplasmic reticulum stress-induced autophagy on cell survival': 1, 'Autophagy is activated for cell survival after endoplasmic reticulum stress': 1, 'Endoplasmic reticulum stress triggers autophagy': 1, 'Methods for monitoring autophagy': 1, 'Modification of intracellular membrane structures for virus replication': 1, 'Endoplasmic reticulum and Golgi complex: contributions to, and turnover by': 1, 'Association of polioviral proteins of the P2 genomic region with the viral replication complex and virus-induced membrane synthesis as visualized by electron microscopic immunocytochemistry and autoradiography': 1, 'Cellular COPII proteins are involved in production of the vesicles that form the poliovirus replication complex': 1, 'Cellular origin and ultrastructure of membranes induced during poliovirus infection': 1, 'Remodeling the endoplasmic reticulum by poliovirus infection and by individual viral proteins: an autophagy-like origin for virus-induced vesicles': 1, 'Subversion of cellular autophagosomal machinery by RNA viruses': 1, 'Modification of cellular autophagy protein LC3 by poliovirus': 1, 'Hijacking components of the cellular secretory pathway for replication of poliovirus RNA': 1, 'Role of microtubules in extracellular release of poliovirus': 1, 'Autophagosome supports coxsackievirus B3 replication in host cells': 1, 'Coxsackievirus B4 uses autophagy for replication after calpain activation in rat primary neurons': 1, 'Co-localization of constituents of the dengue virus translation and replication machinery with amphisomes': 2, 'Hepatitis C virus genotype 1a growth and induction of autophagy': 1, 'The autophagy machinery is required to initiate hepatitis C virus replication': 2, 'Knockdown of autophagy-related gene decreases the production of infectious hepatitis C virus particles': 2, 'Autophagy pathway intersects with HIV-1 biosynthesis and regulates viral yields in macrophages': 2, 'Induction of autophagy does not affect human rhinovirus type 2 production': 1, 'Coronavirus replication does not require the autophagy gene ATG5': 4, 'Cellular autophagy machinery is not required for vaccinia virus replication and maturation': 1, 'Aggresomes and autophagy generate sites for virus replication': 1, 'Autophagy defends cells against invading group A Streptococcus': 1, 'Escape of intracellular Shigella from autophagy': 1, 'Autophagy is an immediate macrophage response to Legionella pneumophila': 1, 'Yersinia pestis can reside in autophagosomes and avoid xenophagy in murine macrophages by preventing vacuole acidification': 1, 'Cellular autophagy: surrender, avoidance and subversion by microorganisms': 1, 'Eating oneself and uninvited guests: autophagy-related pathways in cellular defense': 1, 'Aggresomes and pericentriolar sites of virus assembly: cellular defense or viral design?': 1, 'Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-interacting protein': 3, 'HSV-1 ICP34.5 confers neurovirulence by targeting the Beclin 1 autophagy protein': 5, 'Xenophagy in herpes simplex virus replication and pathogenesis': 2, 'Analysis of the role of autophagy in replication of herpes simplex virus in cell culture': 1, 'The Atg5 Atg12 conjugate associates with innate antiviral immune responses': 3, \"Herpes simplex virus type 1 and Alzheimer's disease: the autophagy connection\": 1, 'Autophagy and viral neurovirulence': 1, 'Disruption of neuronal autophagy by infected microglia results in neurodegeneration': 1, 'CXCR3 activation by lentivirus infection suppresses neuronal autophagy: neuroprotective effects of antiretroviral therapy': 1, 'The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase': 1, 'Endogenous MHC class II processing of a viral nuclear antigen after autophagy': 1, 'Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes': 2, 'Autophagy within the antigen donor cell facilitates efficient antigen cross-priming of virus-specific CD8+ T cells': 1, 'Signaling pathways activated by microorganisms': 1, 'Autophagydependent viral recognition by plasmacytoid dendritic cells': 2, 'Viral recognition by Toll-like receptors': 1, 'Murine retroviruses activate B cells via interaction with toll-like receptor 4': 1, 'Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus': 1, 'Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis': 1, 'Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2': 1, 'Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling': 1, 'Absence of autophagy results in reactive oxygen species-dependent amplification of RLR signaling': 1, 'Autophagy in cell death: an innocent convict?': 2, 'Inhibition of macroautophagy triggers apoptosis': 1, 'Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes': 1, 'Autophagy: dual roles in life and death?': 1, 'Autophagy and cell death': 1, 'The role of autophagy in cancer development and response to therapy': 1, 'Autophagy in tumour suppression and promotion': 1, 'Life and death partners: apoptosis, autophagy and the cross-talk between them': 1, 'Control of autophagy by oncogenes and tumor suppressor genes': 1, 'Anti-and pro-tumor functions of autophagy': 1, 'Survival of parvovirus B19-infected cells by cellular autophagy': 1, 'Hepatitis B virus X protein sensitizes cells to starvation-induced autophagy via upregulation of beclin 1 expression': 1, 'Genes encoding Pir51, Beclin 1, RbAp48 and aldolase b are up or down-regulated in human primary hepatocellular carcinoma': 1, 'HBx gene of hepatitis B virus induces liver cancer in transgenic mice': 1, 'Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene': 1, 'Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor': 1, 'Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy': 2, 'Structural and biochemical bases for the inhibition of autophagy and apoptosis by viral BCL-2 of murine gamma-herpesvirus 68': 1, \"Molecular piracy of Kaposi's sarcoma associated herpesvirus\": 1, \"Kaposi's sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coin?\": 1, 'Autophagy is involved in T cell death after binding of HIV-1 envelope proteins to CXCR4': 3, 'Autophagy and CD4+ T lymphocyte destruction by HIV-1': 1, 'HIV and CXCR4 in a kiss of autophagic death': 1, 'Autophagy regulates programmed cell death during the plant innate immune response': 1, 'Oncolytic adenoviral mutants induce a novel mode of programmed cell death in ovarian cancer': 2, 'Delta-24-RGD in combination with RAD001 induces enhanced anti-glioma effect via autophagic cell death': 1, 'Autophagic cell death of malignant glioma cells induced by a conditionally replicating adenovirus': 1, 'Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell death': 1, 'Mre11 inhibition by oncolytic adenovirus associates with autophagy and underlies synergy with ionizing radiation': 1, 'Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo': 1, 'Autophagy-inducing agents augment the antitumor effect of telerase-selve oncolytic adenovirus OBP-405 on glioblastoma cells': 1, 'Differential role of autophagy in CD4 T cells and macrophages during X4 and R5 HIV-1 infection': 1, 'Human immunodeficiency virus type-1 infection inhibits autophagy': 1, 'Trends in infectious disease mortality in the United States during the 20th century': 1, 'Studies of the community and family: acute respiratory illness and infection': 1, 'National disease burden of respiratory viruses detected in children by polymerase chain reaction': 1, 'Respiratory virus infections': 1, 'Persistent symptomless human metapneumovirus infection in hematopoietic stem cell transplant recipients': 1, 'Epidemiology of human metapneumovirus': 1, 'Detection and pathogenicity of human metapneumovirus respiratory infection in pediatric Italian patients during winter-spring season': 3, 'An outbreak of severe respiratory tract infection due to human metapneumovirus in a long-term care facility': 3, 'Clinical impact and diagnosis of human metapneumovirus infections': 1, 'Human bocavirus -a novel parvovirus to infect humans': 1, 'A newly identified bocavirus species in human stoll': 1, 'Human Bocaviruses are highly diverse, dispersed, recombination prone, and prevalent in enteric infections': 1, 'Human metapneumovirus associated with respiratory tract infections in a 3-year study of nasal swabs from infants in Italy': 1, 'Human metapneumovirus infections cause similar symptoms and clinical severity as respiratory syncytial virus infections': 1, 'Comparison of human metapneumovirus, respiratory syncytial virus and influenza A virus lower respiratory tract infections in hospitalized young children': 1, 'Human bocavirus in children with acute asthma': 1, 'Role of emerging respiratory viruses in children with severe acute wheezing': 1, 'Human bocavirus in Italian patients with respiratory diseases': 2, 'Prolonged detection of human bocavirus DNA in nasopharyngeal aspirates of children with respiratory tract disease': 1, 'Frequency of human bocavirus (HBoV) infection among children with febrile respiratory symptoms in Argentina, Nicaragua and Peru': 1, 'Phylogenetic analysis of human bocavirus (hBoV) detected from children with acute respiratory infection in Japan': 1, 'Changing circulation rate of human metapneumovirus strains and types among hospitalized pediatric patients during three consecutive winterspring seasons': 1, 'Co-circulation of genetically distinct human metapneumovirus and human bocavirus strains in young children with respiratory tract infections in Italy': 3, 'Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratorytract infections in all age groups': 1, 'Sequence analysis of the N, P, M and F genes of Canadian human metapneumovirus strains': 2, 'Development of three multiplex RT-PCR assays for the detection of 12 respiratory RNA viruses': 1, 'Epidemiological survey of human metapneumovirus infection in a large pediatric tertiary care center': 1, 'Human metapneumovirus-associated respiratory tract infections in the Republic of Ireland during the influenza season of': 1, 'Epidemiological and phylogenic study of human Metapneumovirus infections during three consecutive outbreaks in Normandy. France': 3, 'Human metapneumovirus infection in a hematopoietic stem cell transplant recipient with relapsed multiple myeloma and rapidly progressing lung cancer': 1, 'Human metapneumovirus infection in young children hospitalized with acute respiratory tract disease: virologic and clinical features': 3, 'Prevalence and clinical and molecular characterization of human metapneumovirus in children with acute respiratory infection in China': 1, 'Prospective study of human metapneumovirus infection: diagnosis, typing and virus quantification in nasopharyngeal secretions from pediatric patients': 1, 'Comparison of human metapneumovirus genotypes from the province of Bolzano in northern Italy with strains from surrounding regions in Italy and Austria': 1, 'Association between high nasopharyngeal viral load and disease severity in children with human metapneumovirus infection': 1, 'Co-circulating genetically divergent A2 human metapneumovirus strains among children in southern Taiwan': 1, 'Human metapneumovirus genetic variability': 1, 'Genetic variability of human metapneumovirus infection: evidence of a shift in viral genotype without a change in illness': 1, 'Genetic diversity of human metapneumovirus over 4 consecutive years in Australia': 1, 'Epidemiology and genetic variability of human Metapneumovirus during a 4-year-long study in southeastern Brazil': 1, 'Coinfection of human metapneumovirus with adenovirus or respiratory syncytial virus among children in Japan': 1, 'Frequency of detection of picornaviruses and seven other respiratory pathogens in infants': 1, 'Detection of new respiratory viruses in hospitalized infants with bronchiolitis: a three-year prospective study': 1, 'Correlation between bocavirus infection and humoral response, and co-infection with other respiratory viruses in children with acute respiratory infection': 1, 'Human metapneumovirus infections in young and elderly adults': 1, 'Human metapneumovirus infections in adults: another piece of the puzzle': 1, 'Low prevalence of human metapneumovirus and human bocavirus in adult immunocompromised high risk patients suspected to suffer from Pneumocystis pneumonia': 1, 'Frequency and clinical relevance of human bocavirus infection in acute exacerbations of chronic obstructive pulmonary disease': 1, 'Detection of Human Bocavirus in bronchoalveolar lavage from Italian adult patients': 1, 'Moral injury': 1, 'Managing mental health challenges faced by healthcare workers during covid-19 pandemic': 1, 'Radiotherapy Treatment Review: A Prospective Evaluation of Concordance between Clinical Specialist Radiation Therapist and Radiation Oncologist in Patient Assessments': 1, 'What evidence is there on the effectiveness of different models of delivering urgent care? A rapid review': 1, 'Long-term cognitive impairment after acute respiratory distress syndrome: a review of clinical impact and pathophysiological mechanisms': 1, 'Neuropsychological sequelae and impaired health status in survivors of severe acute respiratory distress syndrome': 1, 'Harmful effects of mechanical ventilation on neurocognitive functions': 1, 'Favorable neurocognitive outcome with low tidal volume ventilation after cardiac arrest': 3, \"Acute neuropathological consequences of short-term mechanical ventilation in wild-type and Alzheimer's disease mice\": 1, 'Clinical phenotypes of delirium during critical illness and severity of subsequent long-term cognitive impairment: a prospective cohort study': 1, 'A multi-faceted strategy to reduce ventilation-associated mortality in brain-injured patients. The BI-VILI project: a nationwide quality improvement project': 1, 'Viral replicase gene products suffice for coronavirus discontinuous transcription': 1, 'Future trends and consumer lifestyles with regard to meat consumption': 4, 'Development of Plant Proteins in the European Union': 4, 'Understanding attitudes towards reducing meat consumption for environmental reasons. A qualitative synthesis review': 4, 'Future protein supply and demand: Strategies and factors influencing a sustainable equilibrium': 4, 'Food Consumption-Animal Based Protein': 2, 'Association of changes in red meat consumption with total and cause specific mortality among US women and men: Two prospective cohort studies': 3, 'Q&A on the Carcinogenicity of the Consumption of Red Meat and Processed Meat': 3, 'From traditional knowledge to novel adaptations of transhumant pastoralists the in face of new challenges in North Patagonia': 1, 'High nature value mountain farming systems in Europe: Case studies from the Atlantic Pyrenees, France and the Kerry Uplands, Ireland': 1, 'Informe Nacional del Ovino y Caprino': 1, 'The interactions between the structure of the food supply and the impact of livestock production on the environment. A multivariate analysis for understanding the differences and the analogies across European Union countries': 1, \"Why don't consumers buy organic lamb meat? A Spanish case study\": 4, 'The quality labelling as a food-safety indicator for beef and lamb': 4, 'Influence of quality labels on the formation of preferences of lamb meat consumers. A Spanish case study': 8, 'Acceptability of lamb meat from different producing systems and ageing time to German, Spanish and British consumers': 3, 'Factors associated with the purchase of designation of origin lamb meat': 4, 'Aspects of quality related to the consumption and production of lamb meat. Consumers versus producers': 2, 'Preference structure for lamb meat consumers. A Spanish case study': 7, 'Consumer attitudes towards meat consumption in spain with special reference to quality marks and kid meat': 1, 'Labelling information demanded by European consumers and relationships with purchasing motives, quality and safety of meat': 1, \"Consumer's purchasing intention for lamb meat affected by country of origin, feeding system and meat price: A conjoint study in Spain, France and United Kingdom\": 8, 'Preferences for lamb meat: A choice experiment for Spanish consumers': 3, 'Pathways to increase consumer trust in meat as a safe and wholesome food': 1, 'Extrinsic attributes of red meat as indicators of quality in Europe: An application for market segmentation': 2, 'Aduriz, I. The Argentine Crisis and its Impact on Household Welfare; Economic Commission for Latin America and the Caribbean': 1, 'Personality influences on consumption: Insights from the asian economic crisis': 4, 'From consumerism to guilt: Economic crisis and discourses about consumption in Spain': 2, 'Psychological health before, during, and after an economic crisis: Results from Indonesia': 2, 'Are recessions good for your health?': 1, 'Was the economic crisis of 2008 good for Icelanders? Impact on health behaviors': 1, 'Social inequalities in following official guidelines on healthy diet during the period of economic crisis in Spain': 4, 'Recomposition and levelling of consumption expenditures across four economic shocks in Russia': 1, \"The impact of the Greek crisis on the consumers' behaviour: Some initial evidences?\": 3, 'Consumption dynamics during recession and recovery: A learning journey': 3, 'Are consumers more rational and informed purchasers during recession periods? The role of Private Labels and retailing strategies': 3, 'Consumer perception of fresh meat quality: A framework for analysis': 1, 'Control of fresh meat quality through manipulation of muscle fiber characteristics': 1, 'Testing the Abbreviated Food Technology Neophobia Scale and its relation to satisfaction with food-related life in university students': 1, 'Analyzing the US retail wine market using price and consumer segmentation models': 1, 'Alimentario en España': 1, 'A comparison of modified atmosphere and vacuum skin packing for the storage of red meats': 2, 'Shelf life extension and microbiological safety of fresh meat-A review': 4, 'Use of dietary rosemary diterpenes to inhibit rancid volatiles in lamb meat packed under protective atmosphere': 2, 'Display life of sheep meats retail packaged under atmospheres of various volumes and compositions': 2, 'Actitudes de compra y consumo de carne de cordero. Estudio comparativo de consumidores en Zaragoza y Castellón': 3, 'Mathematical models of vaccination': 2, 'Emerg Epidemics Manag Control': 1, 'Numerical study of SARS epidemic model with the inclusion of diffusion in the system': 2, 'A multi-stage compartmental model for HIV-infected individuals: I waiting time approach': 1, 'Sree Hari Rao V. Modeling the spread of bird flu and predicting outbreak diversity': 1, 'Dynamics of a new strain of the H1N1 influenza a virus incorporating the effects of repetitive contacts': 1, 'Mathematical analysis of an age-structured model for malaria transmission dynamics': 1, 'Mathematical analysis of a three-strain tuberculosis transmission model': 1, 'Transmission dynamics of methicillin-resistant Staphylococcus aureus in a medical intensive care unit': 1, 'Modeling and analysis of a marine bacteriophage infection': 1, 'Global stability for an epidemic model with applications to feline infectious peritonitis and tuberculosis': 3, 'Dynamics of continuous and discrete time siv models of Gonorrhea transmission': 1, 'A new mathematical model of syphilis': 1, 'Mathematical Epidemiology of Infectious Disease: Model building, analysis and interpretation': 1, 'An epidemic model with delay and a nonlinear incidence rate': 3, 'Some epidemic models with nonlinear incidence': 3, 'Dynamical behaviour of epidemiological models with nonlinear incidence rates': 1, 'Estimation of the parameters of an infectious disease model using neural networks': 1, 'Analysis of a SIR model with bilinear incidence rate': 1, 'Global asymptotic stability of a delayed SEIRS epidemic model with saturation incidence': 1, 'Global stability for SIR and SEIR epidemic models with nonlinear incidence rate': 2, 'Global stability of a SIR epidemic model with constant immigration': 2, 'Stability analysis of a time delayed epidemic model with nonlinear incidence rate': 1, 'Local stability of a SIR model and effect of time delay': 2, 'Global behaviour of a SIR epidemic model with time delay': 1, 'Stability analysis of a delayed SIR epidemic model with stage structure and nonlinear analysis': 1, 'Global stability of a delayed SIR epidemic model with density dependent birth and death rates': 1, 'Three species food-chain models with mutual interference and time delays': 4, 'A stochastic model for epidemics based on renewal equation': 1, 'Stability analysis of a stochastic SIR epidemic model with specific nonlinear incidence rate': 1, 'A stochastic differential equation SIS epidemic model': 1, 'Epidemics in two competing species': 2, 'Nonlinear oscillations in epidemic models': 1, 'Stability and bifurcation analysis in a delayed SIR model': 5, 'A Lyapunov function and global properties for SIR and SEIR epidemiological models with nonlinear incidence': 2, 'A stochastic model for early HIV-I population dynamics': 1, 'Modeling diseases with latency and relapse': 1, 'Influence of nonlinear incidence rates upon the behaviour of SIRS epidemiological models': 1, 'A simple noise model with memory for biological systems': 2, 'Nonmonotonic behavior of spatiotemporal pattern formation in a noisy Lotka-Volterra system': 1, 'Dynamics of two competing species in the presence of Levy noise sources': 1, 'Environmental metal pollution considered as noise: effects on the spatial distribution of benthic forminifera in two coastal marine areas of Sicily(Southern Italy)': 1, 'Predictive dynamics: modeling for virological surveillance and clinical management of dengue': 2, 'A new intelligence-based approach for computer-aided diagnosis of dengue fever': 1, 'Dynamics models of infectious diseases. Non vector-borne diseases': 1, 'Largest-ever outbreak of Ebola virus disease thrusts experimental therapies vaccines into spotlight': 1, 'A simple stochastic model for an epidemic: numerical experiments with Matlab': 1, 'Stability criteria for a system involving two time delays': 1, 'persistence and extinction in predator -prey system with discrete and continuous time delays': 2, 'Simplified analytical stability test for systems with commensurate time delays': 2, 'Stability of differential systems involving time lags': 1, 'Solving DDEs in MATLAB': 1, \"Essai d'une nouvelle analyse de la mortalite causee par la petite verole\": 1, 'Infectious Diseases of Humans': 10, 'On epidemic disease in England-The evidence of variability and persistency of type': 2, 'The Interpretation of Periodicity in Disease Prevalence': 1, 'Recurrent outbreaks of measles, chickenpox, and mumps': 1, 'Tail risk of contagious diseases': 1, 'Anderson, Pediatric hospitalizations for croup (laryngotracheobronchitis): biennial increases associated with human parainfluenza virus 1 epidemics': 1, 'Epidemics and percolation in small-world networks': 3, 'An Experimental Study of the Small World Problem': 1, \"Collective dynamics of 'smallworld' networks\": 3, 'Mean-Field Solution of the Small-World Network Model': 5, 'Mean-Field and Anomalous Behavior on a Small-World Network': 1, 'Phase Structure of Driven Quantum Systems': 1, 'Discrete Time Crystals: Rigidity, Criticality, and Realizations': 1, 'Equilibration and order in quantum Floquet matter': 1, 'Modeling spontaneous breaking of time-translation symmetry': 1, 'Observation of discrete time-crystalline order in a disordered dipolar many-body system': 1, 'Observation of a discrete time crystal': 1, 'Discrete time-crystalline order in cavity and circuit qed systems': 1, 'Period-n discrete time crystals and quasicrystals with ultracold bosons': 1, 'Long-Range Prethermal Phases of Nonequilibrium Matter': 1, 'Classical discrete time crystals': 4, 'Bistability and time crystals in long-ranged directed percolation': 3, 'Classical stochastic discrete time crystals': 3, 'Complex and Adaptive Dynamical Systems': 1, 'Stability of temporally periodic states of classical many-body systems': 1, 'Prime number selection of cycles in a predator-prey model': 1, 'Small World Effect in an Epidemiological Model': 1, 'Absence of Quantum Time Crystals': 1, 'Functional role of type I and type II interferons in antiviral defense': 1, 'Interferon-inducible effector mechanisms in cellautonomous immunity': 1, 'The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus': 3, 'The interferon-stimulated gene Ifitm3zrestricts West Nile virus infection and pathogenesis': 1, 'Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms': 1, 'Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus': 1, 'The IFITM proteins inhibit HIV-1 infection': 1, 'IFITMs restrict the replication of multiple pathogenic viruses': 1, 'IFITM3 restricts the morbidity and mortality associated with influenza': 1, 'Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals': 1, 'Early hypercytokinemia is associated with interferoninduced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection': 1, 'Antiviral protection by IFITM3 in vivo': 1, 'IFITM3 restricts influenza A virus entry by blocking the formation of fusion pores following virus-endosome hemifusion': 3, 'A membrane topology model for human interferon inducible transmembrane protein 1': 1, 'The N-terminal region of IFITM3 modulates its antiviral activity by regulating IFITM3 cellular localization': 2, 'Identification of an endocytic signal essential for the antiviral action of IFITM3': 1, 'Phosphorylation of the antiviral protein IFITM3 dually regulates its endocytosis and ubiquitination': 1, 'Regulation of the trafficking and antiviral activity of IFITM3 by post-translational modifications': 1, 'Palmitoylome profiling reveals S-palmitoylationdependent antiviral activity of IFITM3': 2, 'Mass-tag labeling reveals site-specific and endogenous levels of protein S-fatty acylation': 2, 'S-Palmitoylation and ubiquitination differentially regulate interferon-induced transmembrane protein 3 (IFITM3)-mediated resistance to influenza virus': 5, 'IFITM3 inhibits influenza A virus infection by preventing cytosolic entry': 1, 'Functional involvement of interferon-inducible transmembrane proteins in antiviral immunity': 2, 'IFITM proteins restrict viral membrane hemifusion': 1, 'Interferon-induced transmembrane protein 3 blocks fusion of sensitive but not resistant viruses by partitioning into virus-carrying endosomes': 1, 'UBXN1 interferes with rig-I-like receptor-mediated antiviral immune response by targeting MAVS': 2, 'IFITM3 requires an amphipathic helix for antiviral activity': 1, 'IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread': 2, 'IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity': 1, 'IFITM proteins inhibit HIV-1 protein synthesis': 1, 'The broad-spectrum antiviral functions of IFIT and IFITM proteins': 1, 'IFITM3 directly engages and shuttles incoming virus particles to lysosomes': 2, 'Site-specific bioorthogonal labeling for fluorescence imaging of intracellular proteins in living cells': 5, 'Expanding the genetic code': 1, 'Expanding and reprogramming the genetic code': 1, 'The CD225 domain of IFITM3 is required for both IFITM protein association and inhibition of influenza A virus and dengue virus replication': 3, 'ZMPSTE24 defends against influenza and other pathogenic viruses': 1, 'A proteininteraction network of interferon-stimulated genes extends the innate immune system landscape': 2, 'The assembly of membrane proteins into complexes': 1, 'Photocrosslinkers illuminate interactions in living cells': 1, 'Photocrosslinking approaches to interactome mapping': 1, 'Bifunctional fatty acid chemical reporter for analyzing S-palmitoylated membrane protein-protein interactions in mammalian cells': 1, 'Protein photo-cross-linking in mammalian cells by site-specific incorporation of a photoreactive amino acid': 1, 'Genetically encoding an aliphatic diazirine for protein photocrosslinking': 1, 'Genetically encoded photoaffinity histone marks': 1, 'Genetically encoded protein photocrosslinker with a transferable mass spectrometry-identifiable label': 1, 'Quantitative and comparative profiling of protease substrates through a genetically encoded multifunctional photocrosslinker': 1, 'A chemical proteomics approach to reveal direct protein-protein interactions in living cells': 1, 'Ligand-free palladium-mediated site-specific protein labeling inside Gram-negative bacterial pathogens': 2, 'Emerging functions of the VCP/p97': 1, 'The AAA+ ATPase p97, a cellular multitool': 4, \"A mighty ''protein extractor'' of the cell: structure and function of the p97/CDC48 ATPase. Front\": 2, 'E3 ubiquitin ligase NEDD4 promotes influenza virus infection by decreasing levels of the antiviral protein IFITM3': 2, 'IFITM3 inhibits virus-triggered induction of type I interferon by mediating autophagosome-dependent degradation of IRF3': 1, 'IFITM proteins inhibit placental syncytiotrophoblast formation and promote fetal demise': 1, 'Interferon-induced transmembrane proteins inhibit cell fusion mediated by trophoblast syncytins': 2, 'IFITM3 promotes hepatocellular carcinoma invasion and metastasis by regulating MMP9 through p38/MAPK signaling': 1, 'mTOR inhibitors lower an intrinsic barrier to virus infection mediated by IFITM3': 1, 'Substrate processing by the Cdc48 ATPase complex is initiated by ubiquitin unfolding': 1, 'A CRISPR toolbox to study virus-host interactions': 1, 'Endolysosomal sorting of ubiquitylated caveolin-1 is regulated by VCP and UBXD1 and impaired by VCP disease mutations': 1, 'modulating ERGIC-53 trafficking': 1, 'VCP/p97 cooperates with YOD1, UBXD1 and PLAA to drive clearance of ruptured lysosomes by autophagy': 1, 'Genome-wide RNAi screen identifies SEC61A and VCP as conserved regulators of sindbis virus entry': 1, 'Influenza virus-host interactome screen as a platform for antiviral drug development': 1, 'Multiple UBXN family members inhibit retrovirus and lentivirus production and canonical NFkB signaling by stabilizing IkBa': 1, 'Identification of NMS-873, an allosteric and specific p97 inhibitor, as a broad antiviral against both influenza A and B viruses': 1, 'A non-canonical role of the p97 complex in RIG-I antiviral signaling': 1, 'A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC)': 1, 'Branching Processes with Biological Applications': 4, 'Strong approximations for epidemic models': 5, 'Mathematical Tools for Understanding Infectious Disease Dynamics': 2, 'Optimal vaccination policies for stochastic epidemics among a population of households': 2, 'Probability and random processes': 2, 'Random graph dynamics': 1, 'Using data on social contacts to estimate age-specific transmission parameters for respiratory-spread infectious agents': 5, 'On the formulation and analysis of general deterministic structured population models. I. Linear theory': 2, 'Epidemics with two levels of mixing': 1, 'Reproduction numbers for epidemic models with households and other social structures II: comparisons and implications for vaccination': 5, 'Reproduction numbers for epidemic models with households and other social structures. I. Definition and calculation of R 0': 5, 'Problems in accessing health care NDHS/National Population Commission': 1, 'Statistical Yearbook of Sweden': 1, 'WHO Ebola Response Team. Ebola virus disease in West Africa − the first 9 months of the epidemic and forward projections': 1, 'Stanford Large Network Dataset Collection': 4, 'The igraph software package for complex network research': 1, 'Neurochemistry and neuropharmacology of emesis -the role of serotonin': 5, 'Role of serotonin in gastrointestinal motility and irritable bowel syndrome': 2, 'Serotonin and GI clinical disorders': 8, 'A new method for visualization of gut mucosal cells, describing the enterochromaffin cell in the rat gastrointestinal tract': 3, 'Serotonin activates dendritic cell function in the context of gut inflammation': 2, 'The role of serotonin and its receptors in activation of immune responses and inflammation': 2, 'Pathology of US porcine epidemic diarrhea virus strain PC21A in gnotobiotic pigs': 6, 'Differential protein analysis of IPEC-J2 cells infected with porcine epidemic diarrhea virus pandemic and classical strains elucidates the pathogenesis of infection': 2, 'The role of IL-22 in viral infections: paradigms and paradoxes': 1, 'Cytokine responses in gnotobiotic pigs after infection with virulent or attenuated human rotavirus': 2, 'Divergent immunomodulating effects of probiotics on T cell responses to oral attenuated human rotavirus vaccine and virulent human rotavirus infection in a neonatal gnotobiotic piglet disease model': 2, 'Altered pathogenesis of porcine respiratory coronavirus in pigs due to immunosuppressive effects of dexamethasone: implications for corticosteroid use in treatment of severe acute respiratory syndrome coronavirus': 2, 'Characterization of porcine epidemic diarrhea virus isolate US/ Iowa/18984/2013 infection in 1-day-old cesarean-derived colostrum-deprived piglets': 2, 'Anorexia of infection: current prospects': 1, 'The intestinal immunoendocrine axis: novel cross-talk between enteroendocrine cells and the immune system during infection and inflammatory disease': 1, 'Renewal of enterochromaffin cells in the rat caecum': 1, 'Coronavirus genome structure and replication': 1, 'Family Coronaviridae': 1, 'Coronavirus diversity, phylogeny and, jumping': 1, 'Coronavirus host range expansion and Middle East respiratory syndrome coronavirus emergence: biochemical mechanisms and evolutionary perspectives': 1, 'Mutation rates among RNA viruses': 1, 'Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human': 1, 'Bovine respiratory coronavirus': 3, 'Serological and molecular evidence that canine respiratory coronavirus is circulating in Italy': 1, 'Isolation and sequence analysis of canine respiratory coronavirus': 1, 'Molecular characterization of a canine respiratory coronavirus strain detected in Italy': 1, 'Biological and genetic characterization of a hemagglutinating coronavirus isolated from a diarrhoeic child': 2, 'Enteric disease in postweaned beef calves associated with Bovine coronavirus clade 2': 1, 'Bovine coronavirus associated syndromes': 1, 'Rotaviral and coronaviral diarrhea': 1, 'Fatal winter dysentery with severe anemia in an adult cow': 1, 'Isolation of respiratory bovine coronavirus, other cytocidal viruses, and Pasteurella spp from cattle involved in two natural outbreaks of shipping fever': 1, 'Severe outbreak of bovine coronavirus infection in dairy cattle during the warmer season': 1, 'A longitudinal study of bovine coronavirus enteric and respiratory infections in dairy calves in two herds in Ohio': 1, 'Respiratory disease associated with bovine coronavirus infection in cattle herds in Southern Italy': 1, 'Bovine coronavirus infection in Ontario 1990-1991': 1, 'Revision of the Family Coronaviridae. Taxonomic Proposal of the Coronavirus Study Group to the ICTV Executive Committee': 1, 'Molecular epidemiology of human coronavirus OC43 reveals evolution of different genotypes over time and recent emergence of a novel genotype due to natural recombination': 1, 'Isolation and characterization of a novel Betacoronavirus subgroup A coronavirus, rabbit coronavirus HKU14, from domestic rabbits': 1, 'Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event': 1, 'Evolutionary history of the closely related group 2 coronaviruses: porcine hemagglutinating encephalomyelitis virus, bovine coronavirus, and human coronavirus OC43': 1, 'Isolation of coronaviruses antigenically indistinguishable from bovine coronavirus from wild ruminants with diarrhea': 7, 'Biologic, antigenic, and full-length genomic characterization of a bovine-like coronavirus isolated from a giraffe': 4, 'Situation and perspectives of buffalo in the world': 1, 'Detection of coronavirus antigen in fecal samples obtained from newborn buffalo calves': 1, 'Some viral agents associated with neonatal calf diarrhea': 1, 'Rota and/or coronavirus infections in newborn buffalo calves in Upper Egypt': 1, 'Epidemiological studies on diarrhea in cattle newborn calves fed on colostrum from vaccinated and control-pregnant cows. Trinational Animal Health Research Project (TAHRP), 2nd Annual Workshop': 1, 'The Tri-national Animal Health Research Project (TAHRP) -Project No. 398-0158.21. Final Evaluation Report. United States Agency for International Development': 1, 'Biological and genetic analysis of a bovine-like coronavirus isolated from water buffalo (Bubalus bubalis) calves': 1, 'Characterisation of bubaline coronavirus strains associated with gastroenteritis in water buffalo (Bubalus bubalis) calves': 1, 'Enteric coronaviruslike particles in sheep': 1, 'Role of Salmonella arizonae and other infective agents in enteric disease of lambs': 2, 'Intestinal coronavirus-like particles in sheep with diarrhoea': 1, 'Diagnosis of coronavirus in sheep in Valdivia province, Xth Region': 2, 'Role of enteric pathogens in the aetiology of neonatal diarrhoea in lambs and goat kids in Spain': 2, 'Observations and immunohistochemical detection of Coronavirus, Cryptosporidium parvum and Giardia intestinalis in neonatal diarrhoea in lambs and kids': 2, 'Serum antibodies to bovine coronavirus in Swedish sheep': 1, 'Serosurveillance of viral diseases in Korean native goats (Capra hircus)': 1, 'Family Camelidae (Camels)': 1, 'Ecology of feral camels in Australia. Managing the impacts of feral camels in Australia: a new way of doing business (DKCRC Report 47). Alice Springs: Desert Knowledge Cooperative Research Centre': 1, 'What connects llamas and alpacas, vicunas, and guanacos? Available at www.thoughtco.com/llama-and-alpaca-domestication-history-170646': 1, 'Identification of a novel coronavirus possibly associated with acute respiratory syndrome in alpacas': 4, 'Effect on performance of weanling alpacas following treatments against gastro-intestinal parasites': 1, 'World distribution of alpacas': 1, 'Risk factors for MERS coronavirus infection in dromedary camels in': 1, 'Identification and characterization of a novel alpaca respiratory coronavirus most closely related to the human coronavirus 229E': 3, 'Potential pathogens in feces from unweaned llamas and alpacas with diarrhea': 1, 'Diarrhea in llama and alpaca crias': 1, 'Comparison of genomic and predicted amino acid sequences of respiratory and enteric bovine coronaviruses isolated from the same animal with fatal shipping pneumonia': 1, 'Analysis of the genome sequence of an alpaca coronavirus': 1, 'Rapid detection of rotavirus and coronavirus in alpaca crias (Vicugna pacos) with diarrhea in the Cusco region': 1, 'Outbreak of diarrhea among preweaning alpacas (Vicugna pacos) in the southern Peruvian highland': 1, 'Detection of an antigenic group 2 coronavirus in an adult alpaca with enteritis': 1, 'Types of deer around the world': 1, 'A brief review of infectious and parasitic diseases of wapiti, with emphasis on western Canada and the northwestern United States': 2, 'Serological evidence of some bovine viruses in the caribou (Rangifer tarandus caribou) in Quebec': 2, 'Elk diseases survey in western Canada and northwestern United States': 2, 'Isolation and characterization of a coronavirus from elk calves with diarrhea': 3, 'Production, characterization, and uses of monoclonal antibodies against recombinant nucleoprotein of elk coronavirus': 2, 'Bovine-like coronaviruses isolated from four species of captive wild ruminants are homologous to bovine coronaviruses, based on complete genomic sequences': 3, 'Prevalence of eight bovine viruses in sika deer (Cervus nippon yesoensis) in Japan': 2, 'Detection of bovine coronavirus in nasal swab of noncaptive wild water deer': 2, 'Pathogens in water deer (Hydropotes inermis) in South Korea': 1, 'Identification of coronaviruses in exotic species of Bovidae': 5, 'Viral, parasitic and prion diseases of farmed deer and bison': 1, 'Diseases of Bison': 1, 'Detection and characterization of bovine-like coronaviruses from four species of zoo ruminants': 6, 'Health status of reintroduced wood bison (Bison bison athabascae): assessing the conservation value of an isolated population in Northwestern Canada': 1, 'Bovine coronavirus isolation and cultivation in continuous cell lines': 1, 'Giraffes must be listed as endangered, conservationists formally tell US. Guardian News and Media': 1, 'The IUCN Red List of Threatened Species': 1, 'Blood: pathophysiology': 6, 'Disorders of hemostasis and thrombosis': 6, 'Massive intravascular hemolysis in septicemia caused by Clostridium perfringens': 1, 'Hematological emergencies and transfusion medicine': 1, 'Disseminated intravascular coagulation in association with cavitary tuberculosis': 2, 'Endotoxemia in horses. A review of cellular and humoral mediators involved in its pathogenesis': 2, 'Disseminated intravascular coagulation in rabbits induced by administration of endotoxin or tissue factor: effect of anti-tissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activity': 1, 'Endotoxininduced hematologic and blood chemical changes in ponies: effect of flunixin meglumine, dexamethasone, and prednisolone': 1, 'Disorders of blood coagulation': 1, 'Medical and surgical management of multiple organ infarctions secondary to bacterial endocarditis in a dog': 1, 'Acute mastitis and disseminated intravascular coagulopathy caused by Pasteurella haemolytica in a cow': 1, 'Escherichia coli associated endotoxemia in dogs with parvovirus infection': 1, 'Hematological changes in calves exposed to a mixture of lipopolysaccharide and crude leukotoxin of Pasteurella haernolytica': 1, 'A case of disseminated intravascular coagulation (DIC) in a cow with endometritis and fetal death': 4, 'Disseminated intravascular coagulation in fowls after experimentally induced acute salmonellosis': 1, 'Polymorphonuclear neutrophil leukocyte function in clinical bovine patients and in cows with or without Staphylococcus aureus mastitis': 1, 'A severe case of acute suppurative dermatitis with disseminated intravascular coagulation in a dog': 1, 'Epitopic diversity of African swine fever virus': 1, 'Infectious canine hepatitis and canine acidophil cell hepatitis': 1, 'Feline panleukopenia. In: Greene CE (ed) Infectious diseases of the dog and cat. WB Saunders, Philadelphia': 1, \"Vaccination against and immune response to viral haemorrhagic disease of rabbits: a review of research in the People's Republic of China\": 1, 'Viruses and hemostasis': 1, 'Rabbit haemorrhagic disease virus: a calicivirus with differences': 1, 'Pathogenesis of haemorrhages in Trypanosoma vivax infection in cattle. 1. Disseminated intravascular coagulation': 1, 'Pathogenesis and aetiology of anaemia in trypanosomiasis with special reference to T. brucei and T. evansi': 1, 'Veterinary medicine': 1, 'Hematologic and coagulation abnormalities in acute bovine sarcocystosis': 1, 'Hemostatic alterations in pigs fed sublethal doses of Sarcocystis rniescheriana': 1, 'distal polyneuropathy after canine heartworm disease therapy complicated by disseminated intravascular coagulation': 1, 'Disseminated intravascular coagulation associated with heartworm disease in the dog': 1, 'Heartworm disease 224 R. R. de Gopegui et al. manifested by encophalomyelitis and myositis in a dog': 1, 'Use and regulation of blood clotting mechanisms': 1, 'Blood dyscrasias affecting the surgical patienthemostatic and thrombotic disorders': 1, 'Basic concepts of hemostasis and thrombosis': 1, 'Haemostasis and parturition re-visited; comparative profiles in mammals': 1, 'Amniotic fluid contains tissue factor, a potent initiator of coagulation': 1, 'A comparison study of phospholipids in human, goat and chick amniotic fluid': 1, 'Placental emboli from a fetus papyraceousm': 1, \"Obstetric hysterectomy: Ramathibodi's experience 1969-1987\": 2, 'Intravascular coagulation in relation to pregnancy and delivery': 1, 'Acute renal failure following necrosis of a myoma in the puerperium': 1, 'Clinical implication of disseminated intravascular coagulation': 3, 'Blood coagulation and its disorders in the dog': 1, 'ed) Textbook of veterinary internal medicine': 1, \"Clinical aspects of disseminated intravascular coagulation: a clinician's point of view\": 1, 'Vascular disorders associated with thrombohemorrhagic phenomena': 1, 'Disseminated intravascular coagulation: clinical/ laboratory correlation': 3, 'Disorders of blood coagulation and microcirculation in diabetics': 1, 'Pathogenesis of diabetic microangiopathy: an overview': 1, 'Platelets and neoplasia': 2, 'Hemostatic abnormalities in dogs with hemangiosarcoma': 2, 'Evaluation of hemostatic defects secondary to vascular tumors in dogs: 11 cases (1983-1988)': 2, 'disseminated intravascular coagulation associated with neoplasia': 2, 'Characterization of anemias associated with neoplasia in small animals': 3, 'Microangiopathic hemolytic anemia associated with radiation-induced hemangiosarcomas': 4, 'Human colorectal adenocarcinoma cells: differential nitric oxide synthesis determines their ability to aggregate platelets': 1, 'Animal tumor procoagulants: registry of the Subcommittee on Haemostasis and Malignancy of the Scientific and Standardization Committee, International Society of Thrombosis and Hameostasis': 1, 'The inhibition of platelet aggregation of metastatic H-ras-transformed 10T1/2 fibroblasts with castanospermine, an N-linked glycoprotein processing inhibitor': 1, 'Studies on the mechanism of synthesis and release of the procoagulant activity from leukaemic cells': 1, 'Evidence of a tumor proteinase in blood coagulation': 1, 'The regulation of hemostasis: the protein C system': 1, 'Coagulation abnormalities associated with neoplasia': 2, 'Antithrombin III and hepatocelhilar carcinoma': 1, 'Evidence of a warfarin-sensitive cancer procoagulant in V2 carcinoma': 1, 'A polypeptide factor produced by fibrosarcoma cells that induces endothelial tissue factor and ehnhances the procoagulant rsponse to tumor necrosis factor/cachectin': 2, 'Soluble factor in normal tissues that stimulates high-molecular-weight sialoglycoprotein production by human colon carcinoma cells': 1, 'Tissue factor released from leukemic cells': 1, 'Disseminated intravascular coagulation in a dog with thoracic neoplasia': 2, 'Oncologic emergencies in small animals. Part 1. Chemotherapy related and hematologic emergencies': 2, 'Cellular and secreted tumor plasminogen activator: the effects of NaCI': 1, 'Piasminogen activator content of human tumor and adjacent normal tissue measured with fibrin and non-fibrin assays': 1, 'Screening of human and animal tissue cell cultures as potential producers of plasminogen activator': 1, 'Plasminogen activators and cancer': 1, 'Hemostasis and disorders of coagulation': 1, 'Hypocomplementemia associated with naturally occurring lymphosarcoma in pet cats': 1, 'Isolation and characterization of feline C3 and evidence for the immune complex pathogenesis of feline infectious peritonitis': 1, 'Prediction of survival or death of patients in a state of severe shock': 2, 'Coagulation abnormalities in traumatic shock': 2, 'Mechanism of traumatic shock': 1, 'A new treatment for traumatic shock and ARDS': 1, 'Disseminated intravascular coagulopathy (DIC) in a cow with left displaced abomasum, metritis, and mastitis': 2, 'Disseminated intravascular coagulation during surgery for scoliosis': 1, 'Surgical complications. In: Slatter DH (ed) Textbook of small animal surgery': 1, 'The effects of administration of drugs influencing during treatment of patients with burns': 1, 'Alteration in coagulation and fibrinolysis after burn injury and significance of anticoagulation therapy using heparin and antithrombin III concentrate': 1, 'Selected anatomic burn pathology review for clihicians and pathologists': 1, 'Disseminated intravascular coagulation in the early stage after severe burn: the role of excessive thrombin generation': 1, 'Multi-organ damage in exertional heat stroke': 1, 'Disseminated intravascular coagulation following Echis carinatus venom in dogs: effects of a synthetic thrombin inhibitor': 1, 'Fibrinolysis as a feature of disseminated intravas': 1, 'Severe systematic reactions to Hymenoptera stings in three dogs': 1, 'Role of the kallikreinkinin system in human pancreatitis': 1, 'Exocrine pancreatic disease': 1, 'Release of immunoreactive canine leukocyte elastase normally and in endotoxin and pancreatitis shock': 1, 'Hemostatic disorders: coagulopathies and thrombotic disorders. In: Ettinger SJ (ed) Textbook of veterinary internal medicine': 2, 'The pathogenesis of accelerated fibrinolysis in liver cirrhosis: a critical role for tissue plasminogen activator inhibitors': 1, 'Disseminated intravascular coagulation in dogs with aflatoxicosis': 1, 'Coagulation defects of aflatoxin intoxicated rabbits': 1, 'Disorders of hemostasis and coagulation': 1, 'Mechanisms of the platelet aggregation induced by activated neutrophils and inhibitory effect of specific PAF receptor agonists': 1, 'Possible involvement of cytokines in diffuse intravascular coagulation and thrombosis': 2, 'Expression of coagulant activity in human platelets: release of membranous vesicles providing platelet factor 1 and platelet factor 3': 1, 'Structural biology, cellular interactions and pathophisiology of the contact system': 1, 'Studies on the inflammatory-coagulant axis in the baboon response to E. coil: regulatory roles of proteins C, S, C4bBP and of inhibitors of tissue factor': 2, 'Severe, acute disseminated intravascular coagulation. A reappraisal of its pathophysiology, clinical significance and therapy, based on 47 patients': 2, 'Pathophysiologic and biochemical events in disseminated intravascular coagulation: dysregulation of procoagulant and anticoagulant pathways': 8, 'Immune complex-induced disseminated intravascular coagulation (DIC). An experimental study': 1, 'Activation of the protein C pathway in acute sepsis': 2, 'Human dermal mast cells contain and release tumor necrosis factor o~, which induces endothelial leukocyte adhesion molecule E': 1, 'Microparticle generation during in vitro platelet activation by anti-CD9 murine monoclonal antibodies': 2, 'Thrombin induces platelet adhesion to endothelial cells': 1, 'Quantitative platelet disorders': 1, 'Extensive Ciq-complement initiated iysis of human platelets by IgG subclass murine monoclonal antibodies to the CD9 antigen': 1, 'Diseases of the hematopoietic and hemolymphatic systems': 5, 'Recognition and management of disseminated intravascular coagulation in horses': 4, 'Etiology, diagnosis, and treatment of recovery room bleeding/hemorrhage': 1, 'Intravascular coagulopathies associated with alimentary-induced acute laminitis in the pony': 1, 'Antithrombin III activity in horses with large colon torsion': 1, 'Disseminated intravascular coagulation and related syndromes: a clinical review': 5, 'Clinical significance of intravascular coagulation': 1, 'Hemostatic abnormalities in equine colic': 1, 'The course of disseminated intravascular coagulation is predicted by changes in thrombinantithrombin III complex levels -is there any difference between treatment with standard heparin or low-molecular-weight heparin?': 1, 'Diagnostic application of thrombotic markers': 2, 'Plasma levels of sohible fibrin in patients with malignancy-associated disseminated intravascular coagulation': 1, ') coagulation, fibrinolysis, and kinin generation in adult cats': 1, 'Studies on production of antithrombin II with special reference to endotoxin-induced DIC in dogs': 1, 'Pathophysiology of antithrombin III deficiency': 3, 'Antithrombin III, protein C, and protein S. Naturally occurring anticoagulant proteins': 1, 'Antithrombin III determination in horses. Reference values and acquired antithrombin III deficiency': 1, 'Evaluation of antithrombin-III activity as a coindicator of disseminated intravascular coagulation in cats with induced feline infectious peritonitis virus infection': 2, 'Activation of the coagulation cascade in severe falciparum malaria through the intrinsic pathway': 1, 'Thromboelastography as an aid to regional anesthesia: preliminary communication': 1, 'Thromboelastography used to monitor a dog with disseminated intravascular coagulation': 1, 'Trasplante hep,-itico ortot6pico por hemangioma cavernoso gigante y sindrome de Kasabach-Merritt': 1, 'Disseminated intravascular coagulation in children: diagnosis, management and outcome': 1, 'Leberpathologie im Rahmen des HELLP-Syndroms': 1, 'Rational therapy in disseminated intravascular coagulation': 5, 'Clinical significance of endothelial damage markers in essential mixed cryoglobulinemia': 1, 'Markers for endothelial injury, clotting and platelet activation in preeclampsia': 1, 'Plasma fibronectin concentrations in dogs with disseminated intravascular coagulation': 1, 'Treatment of disseminated intravascular coagulation with low molecular weight heparin. Research Group of FR-860 on DIC in Japan': 1, 'Influence of hiridun on the consumption of antithrombin III in experimental DIC': 1, 'Gabexate as a therapy for disseminated intravascular coagulation': 1, 'Hirudin in disseminated intravascular coagulation': 1, 'Microcirculatory disturbances in endotoxin-induced disseminated intravascular coagulation. The effects of heparin and gabexate mesilate on locomotive and metabolic changes of neutrophils': 1, 'Effects of DX-9065a, an orally active, newly synthesized and specific inhibitor of factor Xa, against experimental disseminated intravascular coagulation in rats': 1, 'Hemostatic defects associated with two infusion rates of dextran 70 in dogs': 1, 'Evaluation of hemostatic analytes after use of hypertonic saline solution combined with colloids for resuscitation of dogs with hypovolemia': 1, 'Effect of aspirin on local prostaglandin production and serotonin accumulation in a canine model with coronary cyclic flow variatins or thrombosis': 1, 'Actions and interactions of antithrombin and heparin': 1, 'Disseminated intravascular coagulation with multiple arterial thromboses responding to antithrombin-III concentrate infusion': 1, 'Disseminated intravascular coagulation associated with colic in 23 horses (1984-1989)': 1, 'Disseminated Intravascular Coagulation (DIC) Disseminated Intravascular Thrombosis (DIT) Consumption Coagulopathy (CC)': 1, 'Disseminated intravascular coagulation and blood component therapy': 1, 'Antithrobin III concentrates -are they clinically useful?': 1, 'Prevention of severe bleeding by tranexamic acid in a patient with disseminated intravascular coagulation': 1, 'Effect of dietary alpha-lineolenic acid on endotoxin-induced production of tumor necrosis factor by peritoneal macrophages in horses': 1, 'The weather factor. How nature has changed history': 1, 'The economics of climate change: The Stern review': 4, 'Some Like it Warm, First Things': 1, 'The impact of global warming on agriculture: A Ricardian approach': 2, 'The impact of global warming on U.S. agriculture: An econometric analysis of optimal growing conditions': 2, 'A Ricardian model of climate change in Canada': 2, 'A regional analysis of climate change impacts on Canadian agriculture': 1, 'Positive mathematical programming': 1, 'Agricultural and environmental policy models: Calibration, estimation and optimization . Manuscript (209 pp). Agricultural & Resource Economics': 1, 'The forest and agricultural sector optimization model (FASOM): Model structure and policy applications': 1, 'World agriculture and climate change: Economic adaptations': 3, 'Agricultural adaptation to climate change: Issues of long-run sustainability (Agric. Econ': 1, 'Global warming and agriculture: Impact estimates by country': 2, 'Climate change reconsidered: 2009 Report of the Nongovernmental International Panel on Climate Change (NIPCC)': 2, 'Super freakonomics: Global cooling, patriotic prostitutes, and why suicide bombers should buy life insurance': 3, 'A review of WTA/WTP studies': 1, 'Polar bear population forecasts: A publicpolicy forecasting audit': 2, 'Guns, germs and steel': 1, 'Barents Sea drift ice characteristics': 3, 'Early 20th century arctic warming in retrospect': 1, 'Science and civilization in China': 1, 'Past rates of climate change in the Arctic': 1, 'Working Group I contribution to the fourth assessment report of the Intergovernmental Panel on Climate Change': 1, 'A 20th century acceleration in global sea-level rise': 1, 'Constraints on future sea-level rise from past sea-level change': 1, 'Retraction: Constraints on future sea-level rise from past sea-level change': 1, 'Non-annular atmospheric circulation change induced by stratospheric ozone depletion and its role in the recent increase of Antarctic Sea ice extent': 1, 'The sea-level conundrum: Case studies from palaeo-archives': 2, 'A tropical cyclone data tape for the eastern and central North Paci fi c Basins, 1949-1983: Contents, limitations, and uses (NOAA Technical Memorandum NWS NHC 25, 17 pp)': 1, 'Econometric analysis': 2, 'Human contribution to more-intense precipitation extremes': 2, 'Anthropogenic greenhouse gas contribution to fl ood risk in England and Wales in autumn 2000': 2, 'Changes in precipitation extremes in the Hawaiian Islands in a warming climate': 1, 'Observed characteristics of hail size in four regions in China during 1980-2005': 1, 'A 450 year record of Spring-Summer fl ood layers in annually laminated sediments from Lake Ammersee (Southern Germany)': 1, 'Mosquito. A natural history of our most persistent and deadliest foe': 2, 'Climate change and global malaria recession': 3, 'DDT and DDE: Sources of exposure and how to avoid them (NAES #52031334, 6 pp)': 1, 'Birds on the rise': 1, 'Causes of bald eagle mortality': 1, 'Pesticide residues in eagles': 1, 'Residues of organochlorine pesticides and polychlorinated biphenyls and autopsy data for bald eagles': 1, 'Residues of organochlorine pesticides, polychlorinated biphenyls, and mercury and autopsy data for bald eagles': 1, \"Solutions for the world's biggest problems: Costs and bene fi ts\": 2, \"Cool it. The skeptical environmentalist's guide to global warming\": 1, 'Health and amenity effects of global warming': 1, 'What to do about climate change': 2, \"Is climate change the 'de fi ning challenge of our age\": 4, 'The amenity value of Italian culture': 1, 'Impact of climate change on tourist demand': 1, 'The impact of climate change on tourism in Germany, the UK and Ireland: A simulation study': 1, 'A production function approach to the GDP-temperature relationship': 1, 'To slow or not to slow: The economics of the greenhouse effect': 2, 'Managing the global commons: The economics of climate change': 4, 'Weighing the options of global warming policies': 5, 'Warming the world. Economic models of global warming': 3, 'McCarl GAMS user guide. Version 22': 1, 'Climate change': 2, 'Global crises, global solutions': 1, 'A review of the \"Stern review on the economics of climate change': 1, 'Country-speci fi c market impacts of climate change': 1, 'Accompanying notes and documentation on development of DICE-2007 model: Notes on DICE-2007.delta.v8 as of': 3, 'The Hartwell paper: A new direction for climate policy after the crash of': 8, 'Climate policy and the optimal balance between mitigation, adaptation and unavoided damage': 1, 'Estimates of damage costs of climate change': 1, 'The marginal damage costs of carbon dioxide emissions: An assessment of the uncertainties': 1, 'Forest management, conservation and global timber markets': 1, \"Solutions for the world's biggest problems. Costs and bene fi ts\": 2, 'Optimal environmental taxation in the presence of other taxes: General-equilibrium analysis': 1, 'Learning about environmental damage: Implications for emissions trading': 1, 'Optimal early action on greenhouse has emissions': 1, 'A critique of the Stern report': 2, 'The Stern review of the economics of climate change: A comment': 1, 'High-resolution carbon dioxide concentration record 650,000-800,000 years before present': 1, 'Positive feedback between global warming and atmospheric CO2 concentration inferred from past climate change': 1, 'Carbon-cycle feedbacks increase the likelihood of a warmer future': 1, 'Missing feedbacks, asymmetric uncertainties, and the underestimation of future warming': 1, 'The simple economics of Easter Island: A Ricardo-Malthus model of renewable resource use': 1, 'The climate change learning curve': 1, 'Better not to have been. The harm of coming into existence': 1, 'Green dragon: Dominion not death': 1, 'Albedo enhancement by stratospheric sulfur injections: A contribution to resolve a policy dilemma': 1, 'The incredible economics of geoengineering': 1, 'The coming global climate-technology revolution': 1, 'Follicular helper CD4 T cells (T FH )': 2, 'T cells and follicular dendritic cells in germinal center B-cell formation and selection': 1, 'Emerging concepts on T follicular helper cell dynamics in HIV infection': 1, 'Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation': 1, 'Bcl6 mediates the development of T follicular helper cells': 1, 'Lineage specification and heterogeneity of T follicular helper cells': 1, 'Phosphoinositide 3-kinase activity in T cells regulates the magnitude of the germinal center reaction': 1, 'Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter': 1, 'CD4 T follicular helper cell dynamics during SIV infection': 2, 'CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract': 1, 'Molecular epidemiology of the heterosexual HIV-1 transmission in Kunming, Yunnan Province of China suggests origin from the local IDU epidemic': 1, 'Rapid onset of intestinal epithelial barrier dysfunction in primary human immunodeficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration': 1, 'Lymphoid follicles are generated in high-grade cervical dysplasia and have differing characteristics depending on HIV status': 2, 'Cell-mediated immunity to HIV in the female reproductive tract': 2, 'Mucosal immunity: induction, dissemination, and effector functions': 2, 'Expression of HLA class II molecules in humanized NOD.Rag1KO.IL2RgcKO mice is critical for development and function of human T and B cells': 1, 'IL-7 induces expression and activation of integrin alpha4beta7 promoting naive T-cell homing to the intestinal mucosa': 2, 'HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor': 1, 'Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production': 2, 'Induction of ICOS+ CXCR3+ CXCR5+ TH cells correlates with antibody responses to influenza vaccination': 1, 'Loss of circulating CD4 T cells with B cell helper function during chronic HIV infection': 2, 'Human circulating PD-(+ )1CXCR3(-)CXCR5(+ ) memory T FH cells are highly functional and correlate with broadly neutralizing HIV antibody responses': 2, 'Expansion of HIV-specific T follicular helper cells in chronic HIV infection': 2, 'Inadequate T follicular cell help impairs B cell immunity during HIV infection': 3, 'T follicular helper (T FH ) cells in normal and dysregulated immune responses': 1, 'The integrin alpha4beta7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1': 1, 'CRTAM controls residency of gut CD4+ CD8+ T cells in the steady state and maintenance of gut CD4+ Th17 during parasitic infection': 1, 'An important regulatory role for CD4+ CD8 alpha alpha T cells in the intestinal epithelial layer in the prevention of inflammatory bowel disease': 1, 'Positive selection of mC46-expressing CD4+ T cells and maintenance of virus specific immunity in a primate AIDS model': 1, 'Peripheral CD4(+ )CD8(+ ) T cells are differentiated effector memory cells with antiviral functions': 1, 'CD4CD8alphaalpha lymphocytes, a novel human regulatory T cell subset induced by colonic bacteria and deficient in patients with inflammatory bowel disease': 1, 'CD4+ CD8+ double positive (DP) T cells in health and disease': 1, 'Transcriptional reprogramming of mature CD4(+ ) helper T cells generates distinct MHC class II-restricted cytotoxic T lymphocytes': 1, 'How can HIV-type-1-Env immunogenicity be improved to facilitate antibody-based vaccine development?': 1, 'Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1': 1, 'Target cell type-dependent modulation of human immunodeficiency virus type 1 capsid disassembly by cyclophilin A': 1, 'Probing the HIV-1 genomic RNA trafficking pathway and dimerization by genetic recombination and single virion analyses': 1, 'Enhancing SIV-specific immunity in vivo by PD-1 blockade': 1, 'Activation phenotype, rather than central-or effector-memory phenotype, predicts the recall efficacy of memory CD8+ T cells': 1, 'Chemokine receptor expression identifies Pre-T helper (Th)1, Pre-Th2, and nonpolarized cells among human CD4+ central memory T cells': 1, 'Identification of a T cell chemotactic factor in the cerebrospinal fluid of HIV-1-infected individuals as interferongamma inducible protein 10': 1, 'CXCR3 directs antigen-specific effector CD4+ T cell migration to the lung during parainfluenza virus infection': 1, 'CXCR3 deficiency increases susceptibility to genital herpes simplex virus type 2 infection: Uncoupling of CD8+ T-cell effector function but not migration': 1, 'CD8(+ ) T lymphocyte mobilization to virus-infected tissue requires CD4(+ ) T-cell help': 1, 'Peripheral blood CCR4+ CCR6+ and CXCR3+ CCR6+ CD4+ T cells are highly permissive to HIV-1 infection': 1, 'Reduced T(H)1/T(H)17 CD4 T-cell numbers are associated with impaired purified protein derivative-specific cytokine responses in patients with HIV-1 infection': 1, 'Establishment of HIV-1 latency in resting CD4+ T cells depends on chemokine-induced changes in the actin cytoskeleton': 1, 'HIV-1 expressing the envelopes of transmitted/founder or control/reference viruses have similar infection patterns of CD4 T-cells in human cervical tissue ex vivo': 1, 'An anti-phosphoinositide-specific monoclonal antibody that neutralizes HIV-1 infection of human monocytederived macrophages': 1, 'Identification of a broad-spectrum antiviral small molecule against severe acute respiratory syndrome coronavirus and Ebola, Hendra, and Nipah viruses by using a novel high-throughput screening assay': 1, 'Human monoclonal antibodies against highly conserved HR1 and HR2 domains of the SARS-CoV spike protein are more broadly neutralizing': 1, 'A functional henipavirus envelope glycoprotein pseudotyped lentivirus assay system': 1, 'Pneumonia of unknown etiology in Wuhan, China: Potential for international spread via commercial air travel': 2, 'The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health-The latest 2019 novel coronavirus outbreak in Wuhan': 3, 'Laboratory testing of human suspected cases of novel coronavirus (nCoV) infection: Interim guidance': 1, 'Surveillance case definitions for human infection with novel coronavirus (nCoV): Interim guidance v1': 1, 'COVID-19 Spike-host cell receptor GRP78 binding site prediction': 1, 'A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin': 1, 'Zika viral polymerase inhibition using anti-HCV drugs both in market and under clinical trials': 1, 'Zika virus: Novel Guanosine Derivatives revealed strong binding and possible inhibition of the polymerase': 2, 'Novel guanosine derivatives as anti-HCV NS5b polymerase: A QSAR and molecular docking study': 4, 'Molecular modeling comparison of the performance of NS5b polymerase inhibitor (PSI-7977) on prevalent HCV genotypes': 1, 'IDX-184 is a superior HCV directacting anti-viral drug: A QSAR study': 2, 'Molecular Modeling and Docking revealed superiority of IDX-184 as HCV polymerase Inhibitor': 2, 'Applications of Computer-Aided Approaches in The Development of Hepatitis C Antiviral Agents': 1, 'The mechanism of action of T7 DNA polymerase': 1, 'Molecular docking revealed the binding of nucleotide/side inhibitors to Zika viral polymerase solved structures': 1, 'Moroccan Medicinal plants as inhibitors of COVID-19: Computational investigations': 1, 'Novel Guanosine Derivatives against MERS CoV polymerase: An in silico perspective': 1, 'Drug repurposing for coronavirus (COVID-19): In silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes': 1, 'Reverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: An in silico study': 1, 'In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel': 1, 'Targeting SARS-CoV-2: A systematic drug repurposing approach to identify promising': 1, 'Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach': 1, 'Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19': 1, 'Peptide-like and small-molecule inhibitors against Covid-19': 1, 'In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain)': 1, 'Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study': 5, 'Structural properties of metal-free apometallothioneins': 1, \"Molecular mechanics. The MM3 force field for hydrocarbons. 3. The van der Waals' potentials and crystal data for aliphatic and aromatic hydrocarbons\": 1, 'Optimization of parameters for semiempirical methods V: Modification of NDDO approximations and application to 70 elements': 2, 'Molecular modelling: Principles and applications': 1, 'SWISS-MODEL: Modelling protein tertiary and quaternary structure using evolutionary information': 1, 'Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected: Interim guidance': 1, 'Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors': 1, 'VERIFY3D: Assessment of protein models with three-dimensional profiles': 1, 'Errors in protein structures': 1, 'Deviations from standard atomic volumes as a quality measure for protein crystal structures': 1, 'AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR': 1, 'Structural analysis and verification server website': 1, 'Scalable molecular dynamics with NAMD': 1, 'Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K': 1, 'Molecular dynamics simulation revealed binding of nucleotide inhibitors to ZIKV polymerase over 444 nanoseconds': 1, 'Molecular dynamics and docking reveal the potency of novel GTP derivatives against RNA dependent RNA polymerase of genotype 4a HCV': 1, 'Recognition of the gluconeogenic enzyme, Pck1, via the Gid4 E3 ligase: An in silico perspective': 1, 'UCSF Chimera-A visualization system for exploratory research and analysis': 1, 'AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading': 1, 'PLIP: Fully automated protein-ligand interaction profiler': 1, 'Remdesivir as a possible therapeutic option for the COVID-19. Travel Medicine and Infectious Disease': 1, 'Ongoing clinical trials for the management of the COVID-19 pandemic': 1, 'COVID-19 infection: origin, transmission, and characteristics of human coronaviruses': 2, 'The outbreak of COVID-19: An overview': 1, 'Laboratory testing for coronavirus disease ( COVID-19) in suspected human cases: interim guidance': 2, 'Evolving status of the 2019 novel coronavirus Infection: proposal of conventional serologic assays for disease diagnosis and infection monitoring': 3, 'Nigeria population (2020) live -Countrymeters': 1, 'Some control measures may lead to more transmissions': 3, 'Real estimates of mortality following COVID-19 infection. The Lancet infectious diseases': 1, \"Alzheimer's Disease International\": 1, 'High anxiety calls for innovation in digital mental health': 2, 'Digital Mental Health and COVID-19: Using Technology Today to Accelerate the Curve on Access and Quality Tomorrow': 3, 'Virtual health care in the era of COVID-19. The Lancet': 2, 'The largest human cognitive performance dataset reveals insights into the effects of lifestyle factors and aging': 3, 'A Consensus on the Brain Training Industry from the Scientific Community. Max Planck Institute for Human Development and Stanford Center on Longevity': 3, 'Controversies in Computerized Cognitive Training': 3, \"Do 'brain training' programs work?\": 4, 'Putting brain training to the test': 3, 'The Effect of an Online Cognitive Training Package in Healthy Older Adults: An Online Randomized Controlled Trial': 3, 'Effect of computerised cognitive training on cognitive outcomes in mild cognitive impairment: a systematic review and meta-analysis': 5, 'The ACTIVE study: study overview and major findings': 4, 'Ten-year effects of the advanced cognitive training for independent and vital elderly cognitive training trial on cognition and everyday functioning in older adults': 4, 'Computerized Cognitive Training in Cognitively Healthy Older Adults: A Systematic Review and Meta-Analysis of Effect Modifiers': 5, 'The Study of Mental and Resistance Training (SMART) Study-Resistance Training and/or Cognitive Training in Mild Cognitive Impairment: A Randomized, Double-Blind, Double-Sham Controlled Trial': 4, 'Augmenting Computerized Cognitive Training With Vortioxetine for Age-Related Cognitive Decline: A Randomized Controlled Trial': 1, 'Effects of Combined Physical and Cognitive Exercises on Cognition and Mobility in Patients With Mild Cognitive Impairment: A Randomized Clinical Trial': 3, 'A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. The Lancet': 1, 'Software as a Medical Device (SaMD). U.S. Food and Drug Administration': 2, 'The emerging world of digital therapeutics': 1, 'Developing Software Precertification Program. US Food and Drug Administration': 2, 'Cognitive training and neuroplasticity in MCI: protocol for a 2-site blinded randomized controlled treatment trial': 1, 'Aggregating Multiple Real-World Data Sources using a Patient-Centered Health Data Sharing Platform: an 8-week Cohort Study among Patients Undergoing Bariatric Surgery or Catheter Ablation of Atrial Fibrillation': 1, 'Exposure to airborne microorganisms, dust and endotoxin during processing of peppermint and chamomile herbs on farms': 1, 'Endemic work-related febrile respiratory illness among construction workers': 1, 'Bioaerosol health effects and exposure assessment: progress and prospects': 2, 'Quantitative analysis of bacterial aerosols in two different dental clinic environments': 4, 'Aerosols and splatter in dentistry: a brief review of the literature and infection control implications': 7, 'Airborne microorganisms collected in a preclinical dental laboratory': 2, 'Studies on dental aerobiology. I. Bacterial aerosols generated during dental procedures': 4, 'Microbiological evaluation of dental unit water systems in general dental practice in Europe': 1, 'Biofi lm problems in dental unit water systems and its practical control': 1, 'Evaluation of environmental bacterial contamination and procedures to control cross infection in a sample of Italian dental surgeries': 1, 'A cross sectional study of water quality from dental unit water lines in dental practices in the West of Scotland': 1, 'Detecting Legionella pneumophila in water systems: a comparison of various dental units': 1, 'Airborne spread of disease -the implications for dentistry': 1, 'Aerosol Technology: Properties, Behavior, and Measurement of Airborne Particles': 1, 'Suggested bacteriological standards for air in ultraclean operating room': 1, 'Convalescent plasma to treat COVID-19: possibilities and challenges': 3, 'The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) -China': 1, 'Use of convalescent plasma therapy in SARS patients in Hong Kong': 1, 'Treatment with convalescent plasma for influenza A (H5N1) infection': 1, 'Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection': 1, 'Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience': 1, 'The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis': 1, 'Evaluation of convalescent plasma for Ebola virus disease in Guinea': 1, 'Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV': 1, 'For the PROCESS group. The PROCESS 2018 statement: updating consensus preferred reporting of CasE series in surgery (PROCESS) guidelines': 1, 'Convalescent plasma as a potential therapy for COVID-19': 1, 'Covid-19: FDA approves use of convalescent plasma to treat critically ill patients': 1, 'Time, clocks, and the ordering of events in a distributed system': 3, 'An optimal algorithm for mutual exclusion in computer networks': 2, 'A tree-based algorithm for distributed mutual exclusion': 2, 'A distributed solution to the k -out of-M resources allocation problem': 2, 'A Distributed Token-Based Algorithm for the Dynamic Resource Allocation Problem': 3, 'Reducing synchronization cost in distributed multi-resource allocation problem': 4, 'Versatile, scalable, and accurate simulation of distributed applications and platforms': 3, 'The drinking philosophers problem': 4, 'ETSI GS NFV-MAN 001 V1.1.1 Network Functions Virtualisation (NFV)': 1, 'Network Functions Virtualisation (NFV) Use Cases': 2, 'Service Function Chaining (SFC) Architecture': 1, 'Network slicing to enable scalability and flexibility in 5G mobile networks': 1, 'Resource management in clouds: survey and research challenges': 1, 'Comparing VM-placement algorithms for on-demand clouds': 1, 'Generalized resource allocation for the cloud': 1, 'Cloud computing reference model: the modelling of service availability based on application profile and resource allocation': 1, 'Redundant virtual machine placement for fault-tolerant consolidated server clusters': 1, 'Supporting security requirements for resource management in cloud computing': 1, 'Solution of a problem in concurrent programming control': 1, 'A log (N) distributed mutual exclusion algorithm based on path reversal': 1, 'A distributed mutual exclusion algorithm': 1, 'A dining philosophers algorithm with polynomial response time': 1, 'The complexity of flowshop and jobshop scheduling -mathematics of operations research': 1, 'Hierarchical ordering of sequential processes': 2, 'An efficient solution to the drinking philosophers problem and its extensions': 2, 'Token based solutions to m resources allocation problem': 1, 'The internet topology zoo': 1, 'A note on two problems in connexion with graphs': 1, 'A N algorithm for mutual exclusion in decentralized systems': 1, 'Identification of diseased calves by use of data from automatic milk feeders': 7, 'Automated measurement of changes in feeding behaviour of milk fed calves associated with illness': 8, 'Technical note: Evaluation of data loggers for measuring lying behavior in dairy calves': 2, 'Behaviour of dairy calves after a low dose of bacterial endotoxin': 2, \"What is the relationship between level of infection and 'sickness behaviour' in cattle\": 1, 'Behavioural and physiological responses of calves to dehorning by heat cauterization with or without local anaesthesia': 4, 'The effect of meloxicam on behavior and pain sensitivity of dairy calves following cautery dehorning with a local anesthetic': 2, 'Development and performance evaluation of calf diarrhoea pathogen nucleic acid purification and detection workflow': 1, 'Brief communicatION: The use of infrared thermography and feeding behaviour for early disease detection in New Zealand dairy calves': 2, 'Short communication: Automated detection of behavioral changes from respiratory disease in pre-weaned calves': 3, 'Addressing the pain associated with disbudding and dehorning in cattle': 2, 'Reducing pain after dehorning in calves': 1, 'Biological basis of the behavior of sick animals. Neurosci': 1, 'Effect of castration and dehorning singularly or combined on the behavior and physiology of Holstein calves': 1, 'Pain and pessimism: Dairy calves exhibit negative judgement bias following hot-iron disbudding': 1, 'Effect of analgesia and antiinflammatory treatment on weight gain and milk intake of dairy calves after disbudding': 1, 'Effects of ad libitum milk intake on dairy calves': 1, 'Effects of a local anaesthetic and a nonsteroidal anti-inflammatory analgesic on the behavioural responses of calves to dehorning': 1, 'Effects of regional analgesia and/or a non-steroidal anti-inflammatory analgesic on the acute cortisol response to dehorning in calves': 1, 'Improving breeding efficiency for quality and yield of sweet potato': 1, 'Orange fleshed sweet potato (Ipomoea batatas L.) varieties evaluated with respect to growth parameters at Jimma in Southwestern Ethiopia': 1, 'Antimutagenecity of mono-, di-, and tricaffeoylquinic acid derivatives isolated from sweet potato (Impomoae batatas L) leaf': 2, 'Effect of age at short removal on tuber and shoot yields at harvest of five sweet potato (Ipomoea batatas (L) Lam) cultivars': 1, 'Nutritive evaluation on chemical components of leaves, stalks and stems of sweet potatoes (Ipomoea batatas poir)': 1, 'Sweet potato leaves: properties and synergistic interactions that promote health and prevent disease': 1, 'Growth suppression of human cancer cells by polyphenolics from sweetpotato (Ipomoea batatas L) leaves': 1, 'Improved metabolic control by Ipomoea batatas (Caiapo) is associated with increased adiponectin and decreased fibrinogen levels in type 2 diabetic subjects': 1, 'The Effect of Different Shade Levels on Growth and Tuber Yield of Sweet Potato: I. Plant Development': 1, 'Mulch and irrigation effects on plant-water relations and performance of cassava and sweet potato': 1, 'Water-deficit tolerant identification in sweet potato genotypes (Ipomoea batatas (L.) Lam.) in vegetative using multivariate physiological indices': 1, 'Farming of vegetables in space-limited environments': 1, 'On the impact of haze on the yield of photovoltaic systems in Singapore': 1, 'ASEAN and transbourndary haze pollution in Southeast Asia': 1, 'Nitrate accumulation, productivity and photosynthesis of temperate butter head lettuce under different nitrate availabilities and growth irradiances. The Open Hortic': 1, 'CAM plasticity in epiphytic tropical orchid species responding to environmental stress': 2, 'Quality of supplementary LED lighting effects on growth and photosynthesis of two different Lactuca recombinant inbred lines (RILs) grown in a tropical greenhouse': 2, 'Nitrate accumulation, productivity and photosynthesis of Brassica alboglabra grown under low light with supplemental LED lighting in the tropical greenhouse': 1, 'Advanced guide to hydroponics': 1, 'A modern tool for classical plant growth analysis': 1, 'The spectral determination of chlorophylls a and b, as well as carotenoids, using various solvents with spectrophotometers of different resolution': 1, 'The rate coefficient of repair of photosystem II after photoinactivation': 1, 'The half-life of the cytochrome bf complex in leaves of pea plants after transfer from moderately-high growth light to low light': 3, 'Further studies on quantifying photosystem II in vivo by flash-induced oxygen yield from leaf discs': 1, 'The influence of light intensity and leaf. movement on photosynthesis characteristics and carbon balance of soybean': 4, 'Thylakoid membrane organisation in sun/shade acclimation': 1, 'Photosynthetic acclimation of plants to growth irradiance: the relative importance of specific leaf area and nitrogen partitioning in maximizing carbon gain': 2, 'Photosynthetic responses of sun-and shade-grown barley leaves to high light: is the lower PSII connectivity in shade leaves associated with protection against excess of light?': 2, 'The role of xanthophyll cycle carotenoids in the protection of photosynthesis': 1, 'Biosynthesis, accumulation and emission of carotenoids, alphatocopherol, plastoquinone, and isoprene in leaves under high photosynthetic irradiance': 1, 'The roles of carotenoids in photosystem II of higher plants': 1, 'Carotenoids and photosynthesis': 1, 'Photoinhibition\" of Heliconia under natural tropical conditions-Importance of leaf orientation for light interception and leaf temperature': 1, 'Effects of growth and measurement light intensities on temperature dependence of CO2 assimilation rate in tobacco leaves': 2, 'Effect of interactions between light intensity and red-to-far-red ratio on the photosynthesis of soybean leaves under shade condition': 1, 'Adaptation of the thylakoid membranes of pea chloroplasts to light intensities. II. Regulation of electron transport capacities, electron carriers, coupling factor (CF1) activity and rates of photosynthesis': 1, 'Photosynthetic responses of Pisum sativum to an increase in irradiance during growth. II. Thylakoid membrane components': 1, 'The stoichiometries of supramolecular complexes in thylakoid membranes from spinach chloroplasts': 1, 'Acclimation of barley to changes in light intensity: photosynthetic electron transport activity and components': 1, 'Regulation of the photosynthetic apparatus under fluctuating growth light': 2, 'Fractional control of photosynthesis by the QB protein, the cytochrome f/b6 complex and other components of the photosynthetic apparatus': 1, 'Photosynthetic parameters of wild-type and Cytb6/f deficient transgenic tobacco studied by CO2 uptake and transmittance at 800 nm': 1, 'Irradiance and phenotype: comparative eco-development of sun and shade leaves in relation to photosynthetic CO2 diffusion': 3, 'Temperature acclimation of photosynthesis and related changes in photosystem II electron transport in winter wheat': 1, 'Temperature acclimation of photosynthesis: mechanisms involved in the changes in temperature dependence of photosynthetic rate': 1, 'Responses of stomatal conductance to light, humidity and temperature in winter wheat and barley grown at three concentrations of carbon dioxide in the field': 1, 'Guard cell photosynthesis and stomatal function': 1, 'Physiological responses of cucumber seedlings under different blue and red photon flux ratios using LEDs': 1, 'Leaf morphology, photosynthetic performance, chlorophyll fluorescence, stomatal development of lettuce (Lactuca sativa L.) exposed to different ratios of red light to blue light': 1, 'Biomass allocation to leaves, stems and roots: meta-analyses of interspecific variation and environmental control': 1, 'The effect of growth irradiance on leaf anatomy and photosynthesis in Acer species differing in light demand': 1, 'Sun leaves up-regulate the photorespiratory pathway to maintain a high rate of CO2 assimilation in tobacco': 4, 'Photosynthetic control of electron transport and the regulation of gene expression': 1, 'Glycine decarboxylase controls photosynthesis and plant growth': 1, 'Multigene manipulation of photosynthetic carbon assimilation increases CO2 fixation and biomass yield in tobacco': 1, 'Singapore sets 30% goal for home-grown food by 2030. The Straits Times': 1, 'Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial': 1, 'Colorectal liver metastases: a critical review of state of the art': 1, 'Stereotactic body radiotherapy for colorectal cancer liver metastases: a systematic review': 1, 'SARS-CoV-2 was already spreading in France in late': 1, 'Gastrointestinal manifestations of COVID-19': 1, 'SARS-CoV-2 from faeces to wastewater treatment: What do we know? A review': 1, 'Detection of SARS-CoV-2 in Fecal Samples from Patients with Asymptomatic and Mild COVID-19 in Korea': 2, 'Genomic Epidemiology of SARS-CoV-2 in Guangdong Province': 2, 'Presence of SARS-Coronavirus-2 in sewage': 2, 'SARS-CoV-2 Titers in Wastewater Are Higher than Expected from Clinically Confirmed Cases. mSystems': 4, 'Temporal detection and phylogenetic assessment of SARS-CoV-2 in municipal wastewater': 1, 'First detection of SARS-CoV-2 RNA in wastewater in North America: A study in Louisiana, USA': 2, 'MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms': 1, 'Verification of analytical methods for GMO testing when implementing interlaboratory validated methods. EUR 29015 EN, Publication Office of the European Union': 2, 'Detection of SARS-CoV-2 in wastewater in Japan by multiple molecular assays-implication for wastewater-based epidemiology (WBE). medRxiv preprint': 1, 'First Data-Set on SARS-CoV-2 Detection for Istanbul Wastewaters in Turkey. medRxiv preprint': 1, 'Regressing SARS-CoV-2 sewage measurements onto COVID-19 burden in the population: a proof-of-concept for quantitative environmental surveillance': 1, 'Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06': 1, 'Temporal signal and the evolutionary rate of 2019 n-CoV using 47 genomes collected by': 1, 'Phylodynamic analysis of SARS-CoV-2 | Update': 1, 'Analytical sensitivity and efficiency comparisons of SARS-COV-2 qRT-PCR primer-probe sets': 1, 'Report 5: Phylogenetic analysis of SARS-CoV-2. Imperial College London': 1, 'Emergence of genomic diversity and recurrent mutations in SARS-CoV-2. Infection': 1, 'Descriptive epidemiology of morbidity and mortality in Minnesota dairy heifer calves': 1, 'Health status of preweaned dairy heifers in the United States': 1, 'Risk factors associated with diarrhoea in newborn calves': 4, \"Influence des conditions d'élevage sur la fréquence des diarrhées de veau nouveau-nés et sur l'efficacité de leur traitement par voie orale\": 2, 'Dairy calf management, morbidity and mortality in Ontario Holstein herds': 2, 'Use of epidemiologic principles to identify risk factors associated with the development of diarrhoea in calves in five beef herds': 1, 'Effects of housing and colostrum feeding on serum immunoglobulins, growth, and fecal scores of Jersey calves': 1, \"L'activité vétérinaire passée au peigne fin\": 1, 'Regression analysis of multivariate incomplete failure time data by modelling marginal distributions': 3, 'The impact of heterogeneity in individual frailty on the dynamics of mortality': 2, 'Testing for centre effects in multi-center survival studies: a Monte Carlo comparison of fixed and random effects tests': 1, 'Serum gamma-glutamyl-transferase activity and protein concentration at birth and after suckling in calves with adequate and inadequate passive transfer of immunoglobulin': 2, 'Regression models and life tables (with discussion)': 1, 'Multivariate regression analyses for categorical data': 1, 'On the variance of asymptotically normal estimators from complex surveys': 1, 'Survival models for heterogeneous populations derived from stable distributions': 1, 'Frailty models for survival data': 1, 'True and spurious duration dependance: the identifiability of the proportional hazard model': 1, 'Pattern of diarrhoea in newborn beef calves in south-west France': 2, 'É levages des veaux et risque d emortalité et de troubles de santé en exploitations laitires': 1, 'Bovine Medicine: Calf Diarrhoea': 1, \"Objectivation de la propreté des vaches laitires et des stabulations: l'indice de propreté\": 1, 'Prediction of calf mortality by use of test for passive transfer of colostral immunoglobulin': 1, \"L'ambiance dans les btiments d'élevages bovins: méthodes pour le diagnostic de l'ambiance dans les btiments d'élevages bovins\": 1, 'Management of Health. British Library Cataloguing in Publication Data': 1, 'Risk factors for mortality from diarrhoea in beef calves in Alberta': 2, 'Management practices and risk factors for morbidity and mortality in Minnesota dairy calves': 1, 'Ultraprecision machining of polymers': 5, 'Cryogenic Machining of PDMS Fluidic Channel Using Shrinkage Compensation and Surface Roughness Control': 4, 'Micromachining of soft polymer material applying cryogenic cooling': 4, 'The effect of workpiece cooling on the machining of biomedical grade polymers': 4, 'Investigation of Turning Elastomers Assisted with Cryogenic Cooling': 4, 'Cryogenic Machining of Polymeric Biomaterials: An Intraocular Lens Case Study': 1, 'Analysis of tool wear in cryogenic turning of electron beam melted Ti6Al4V': 1, 'A comparison of cryogenic and high pressure emulsion cooling technologies on tool life and chip morphology in Ti-6Al-4V cutting': 1, 'Temperature effects on the Ti6Al4V machinability using cooled gaseous nitrogen in semi-finishing turning': 2, 'The ATHAS database on heat capacities of polymers': 1, 'Realtime surface defect detection and the traceable measurement of defect depth in 3D': 1, 'Adiabatic shear band formation as a result of cryogenic CNC machining of elastomers': 1, 'Current and Potential Applications of Cryogenic Treated Polymers': 1, 'On the Feasibility of Using Cryo-Treatment as a Tool to Enhance the Abrasive Wear Behaviour of Solid-Lubricated Polymeric Composites': 1, 'Suicide in women': 1, 'Global, regional, and national burden of suicide mortality 1990 to 2016: Systematic analysis for the global burden of disease study': 1, 'The gendered landscape of suicide: Masculinities, emotions and culture': 2, 'All across the United States, the coronavirus is killing more men than women, data show. The Washington Post': 1, \"Suicidal behavior and coronavirus (COVID-19): Insights from Durkheim's sociology of suicide\": 1, 'COVID 2019-suicides: a global psychological pandemic': 2, 'COVID-19 suicides in Pakistan, dying off not COVID-19 fear but poverty? -The forthcoming economic challenges for a developing country': 2, 'COVID-19-related suicides in Bangladesh due to lockdown and economic factors: Case study evidence from media reports': 1, 'Dislocating masculinity: Gender, power and anthropology': 1, 'Hegemonic masculinities: Rethinking the concept': 1, 'Masculinity and suicidal thinking': 1, 'Men and suicide prevention: A scoping review': 1, \"A review of men's health and masculinity\": 2, \"Masculinity and perceived normative health behaviors as predictors of men's health behaviors\": 1, 'Behavioral factors associated with disease, injury, and death among men: Evidence and implications for prevention': 1, 'Young people, gender and suicide': 1, 'Suicidal action, emotional expression, and the performance of masculinities': 1, \"Constructions of masculinity and their influence on men's well-being: A theory of gender and health\": 1, \"Suicidality in men-practical issues, challenges, solutions. The Journal of Men's Health and Gender\": 1, 'Help-seeking patterns and attitudes to treatment amongst men who attempted suicide': 1, 'Suicide and hegemonic masculinity in Australian men': 2, 'Suicide mortality and coronavirus disease 2019-a perfect storm': 3, 'Suicide prevention during the COVID-19 outbreak': 3, 'Keep socially (but not physically) connected and carry on: Preventing suicide in the age of COVID-19': 3, 'Men, masculinity, violence and care in times of COVID-19': 1, 'Using social media networks to engage men in conversations on masculinity and suicide: Content analysis of Man Up Facebook campaign data': 1, 'Suicide: A 15-year review of the sociological literature part I: Cultural and economic factors': 1, 'Sociological autopsy: An integrated approach to the study of men': 1, 'Young men, masculinities, and suicide': 1, 'Suicide among men in Ghana: The burden of masculinity': 1, 'COVID-19, unemployment, and suicide': 1, 'Suicide risk and prevention during the COVID-19 pandemic. The Lancet Psychiatry': 3, 'Zur kenntnis der antifermentativen, lytischen and agglutinieren wirkungen des blutserums und der lymphe. Zentralblatt Bakteriol': 2, 'Non-human primates in HIV research: Achievements, limits and alternatives': 2, 'The cytopathic effects of vervet monkey viruses': 3, 'Antigenic comparisons of two new rotaviruses from rhesus monkeys': 2, 'Development of a rotavirus-shedding model in rhesus macaques, using a homologous wild-type rotavirus of a new P genotype': 9, 'A rotavirus strain isolated from pig-tailed macaque (Macaca nemestrina) with diarrhea bears a P6 [1]: G8 specificity': 2, 'Characterization of a rhesus monkey calicivirus representing a new genus of Caliciviridae': 3, 'Detection of norovirus-, sapovirus-and rhesus enteric calicivirus-specific antibodies in captive juvenile macaques': 4, 'Genetic diversity and histo-blood group antigen interactions of rhesus enteric caliciviruses': 2, 'Recovery of infectious virus by transfection of in vitro-generated RNA from Tulane calicivirus cDNA': 2, 'Simian rotaviruses possess divergent gene constellations that originated from interspecies transmission and reassortment': 3, 'Rotavirus infection in African non-human primates': 1, 'Detection of viral agents in fecal specimens of monkeys with diarrhea': 2, 'Rotarix (RIX4414): An oral human rotavirus vaccine': 1, 'The pentavalent rotavirus vaccine': 1, 'Expression of IfnIr1 on intestinal epithelial cells is critical to the antiviral effects of interferon lambda against Norovirus and Reovirus': 2, 'Defining T-cell-mediated immune responses in rotavirus-infected juvenile rhesus macaques': 2, 'Susceptibility of non-human primate species to infection by simian rotavirus SA-11': 2, 'Rotavirus infection of human cholangiocytes parallels the murine model of biliary atresia': 1, 'Rhesus rotavirus VP4 sequence-specific activation of mononuclear cells is associated with cholangiopathy in murine biliary atresia': 1, 'The SRL peptide of rotavirus VP4 protein governs cholangiocyte infection and the murine model of biliary atresia': 3, 'Broad blockade antibody responses in human volunteers after immunization with a multivalent norovirus VLP candidate vaccine: Immunological analyses from a phase I clinical trial': 1, 'A working model of how noroviruses infect the intestine': 1, 'Inhibition of human norovirus by a viral polymerase inhibitor in the B cell culture system and in the mouse model': 1, 'Human noroviruses: Recent advances in a 50-year history': 1, 'Interferon lambda (IFN-λ) efficiently blocks norovirus transmission in a mouse model': 1, 'Targetting macrophage-and intestinal epithelial cell-specific microRNAs against norovirus restricts replication in vivo': 1, 'Human organoidcultures: Transformative new tools for human virus studies': 1, 'Calicivirus from novel Recovirus genogroup in human diarrhea': 2, 'Enteric bacteria promote human and mouse norovirus infection of B cells': 2, 'Identification of a novel cellular target and a co-factor for norovirus infection-B cells & commensal bacteria': 1, 'Chimpanzees as an animal model for human norovirus infection and vaccine development': 2, 'rhesus macaques with primate enteric caliciviruses': 2, 'Dietary gluten-induced gut dysbiosis is accompanied by selective upregulation of microRNAs with intestinal tight junction and bacteria-binding motifs in rhesus macaque model of celiac disease': 1, 'Natural Norovirus infections in rhesus macaques': 2, 'A longitudinal-study of dominance in an outdoor colony of domestic rats': 1, \"The laboratory rat: Relating its age with human's\": 1, 'Serological detection of adenoviruses in non-human primates maintained in a colony in Kenya': 1, 'A diverse group of small circular ssDNA viral genomes in human and non-human primate stools': 1, '17 natural infections in rhesus monkeys': 1, 'Case-control comparison of enteric viromes in captive rhesus macaques with acute or idiopathic chronic diarrhea': 1, 'The enteric virome in inflammatory bowel disease': 1, 'SIV infection-mediated changes in gastrointestinal bacterial microbiome and virome are associated with immunodeficiency and prevented by vaccination': 1, 'Assessment of the gorilla gut virome in association with natural simian immunodeficiency virus infection': 2, 'Destabilization of the gut microbiome marks the end-stage of simian immunodeficiency virus infection in wild chimpanzees': 2, 'Transmission of equine influenza virus to dogs': 2, 'Transmission of avian influenza virus (H3N2) to dogs': 1, 'Influenza A virus (H3N8) in dogs with respiratory disease': 3, 'Influenza virus infection in racing greyhounds': 1, 'Infection of dogs with equine influenza virus: evidence for transmission from horses during the Australian outbreak': 1, 'Influenza viruses in adult dogs raised in rural and urban areas in the state of Sao Paulo': 2, 'Seroprevalence and risk factors for canine H3N8 influenza virus exposure in household dogs in Colorado': 4, 'Transmission of canine influenza virus (H3N8) among susceptible dogs': 1, 'Adaptive pathways of zoonotic influenza viruses: from exposure to establishment in humans': 1, 'Natural and experimental infection of dogs with pandemic H1N1/2009 influenza virus': 1, 'Serologic evidence of pandemic (H1N1) 2009 infection in dogs': 3, 'A novel reassortant canine H3N1 influenza virus between pandemic H1N1 and canine H3N2 influenza viruses in Korea': 2, 'Point seroprevalence of canine influenza virus H3N8 in dogs participating in a flyball tournament in Pennsylvania': 1, 'Serological diagnosis of influenza by haemagglutination inhibition testing; in: WHO Global Influenza Surveillance Network': 1, 'Diagnostic application of H3N8-specific equine influenza real-time reverse transcription polymerase chain reaction assays for the detection of Canine influenza virus in clinical specimens': 1, 'One-step real-time RT-PCR for pandemic influenza A virus (H1N1) 2009 matrix gene detection in swine samples': 1, 'Diagnostic performance of the canine Influenza A Virus subtype H3N8 hemagglutination inhibition assay': 1, 'A sero-survey of subtype H3 influenza A virus infection in dogs and cats in Japan': 1, 'A serological survey of canine respiratory coronavirus and canine influenza virus in Korean dogs': 1, 'Serologic prevalence of antibodies against canine influenza virus (H3N8) in dogs in a metropolitan animal shelter': 1, 'Serological survey in dogs and cats for influenza A(H1N1)pdm09 in Germany': 1, 'Seroprevalence of antibodies to influenza A/H1N1/2009 among transmission risk groups after the second wave in Mexico, by a virus-free ELISA method': 1, 'Clinical and epidemiological features of 2009 pandemic H1N1 influenza differ slightly according to seroprevalence status during the second wave in the general population in Mexico': 1, 'Characterization of an H3N2 canine influenza virus isolated from Tibetan mastiffs in China': 1, 'World Health Organization, Global Alliance for Vaccines and Immunization (GAVI) Fact sheet 169': 3, 'The value of vaccination: A global perspective': 2, 'Poxvirus viability and signatures in historical relics': 1, 'Edward Jenner and the history of smallpox and vaccination': 3, 'Understanding Modern Vaccines: Perspectives in Vaccinology': 3, 'Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases': 2, 'Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic': 3, 'Vaccines: Past, present and future': 4, 'Influenza and vaccine development: A continued battle': 1, 'World Health Oranisation, The relathionship between persisting spinal paralysis and poliomyelites vaccine -results of a ten-year enquiry': 1, 'Clinical reactogenicity of intradermal bacille Calmette-Guerin vaccination': 1, 'The new pentavalent rotavirus vaccine composed of bovine (strain WC3)-human rotavirus reassortants': 1, \"Dengue type 4 virus mutants containing deletions in the 3' noncoding region of the RNA genome: Analysis of growth restriction in cell culture and altered viremia pattern and immunogenicity in rhesus monkeys\": 1, 'Reduction of the rate of poliovirus protein synthesis through largescale codon deoptimization causes attenuation of viral virulence by lowering specific infectivity': 1, 'Active and passive immunity, vaccine types, excipients and licensing': 1, 'Vaccines and vaccination in historical perspective': 1, 'Immunogenicity of the recombinant GenHevac B Pasteur vaccine against hepatitis B in chronic uremic patients': 1, 'Hepatitis B vaccines prepared from yeast by recombinant DNA techniques: Memorandum from a WHO meeting': 1, 'FluBlok, a next generation influenza vaccine manufactured in insect cells': 1, 'Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development': 1, 'Virus-like particles-universal molecular toolboxes': 2, 'Virus-like particles: Passport to immune recognition': 1, 'DNA vaccines: An historical perspective and view to the future': 2, 'West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays': 1, 'Comprehensive gene expression profiling following DNA vaccination of rainbow trout against infectious hematopoietic necrosis virus': 1, 'Virus-like particle-based vaccines against hepatitis C virus infection': 1, 'Improved characteristics and protective efficacy in an animal model of E. coli-derived recombinant double-layered rotavirus virus-like particles': 1, 'The prospects and challenges of universal vaccines for influenza': 1, 'Analytical technologies for influenza virus-like particle candidate vaccines: Challenges and emerging approaches': 1, 'Chimeric hepatitis E virus-like particle as a carrier for oral-delivery': 2, 'Selfadjuvanting modular virus-like particles for mucosal vaccination against group A streptococcus (GAS)': 1, 'Chimeric derivatives of hepatitis B virus core particles carrying major epitopes of the rubella virus E1 glycoprotein': 1, 'Combinatorial approach to hepadnavirus-like particle vaccine design': 1, 'Efficacy of RG1-VLP vaccination against infections with genital and cutaneous human papillomaviruses': 1, 'Generation of HIV-1 virus-like particles expressing different HIV-1 glycoproteins': 1, 'A novel platform for virus-like particle-display of flaviviral envelope domain III: Induction of Dengue and West Nile virus neutralizing antibodies': 1, 'Production of retroviral vectors: Review. Curr': 1, 'A prime-boost strategy using virus-like particles pseudotyped for HCV proteins triggers broadly neutralizing antibodies in macaques': 3, 'Down-regulation of CD81 tetraspanin in human cells producing retroviral-based particles: Tailoring vector composition': 2, 'Downregulation of CD81 in human cells producing HCV-E1/E2 retroVLPs': 2, 'Production and immunogenicity of chimeric virus-like particles containing porcine reproductive and respiratory syndrome virus GP5 protein': 1, 'Targeted transduction patterns in the mouse brain by lentivirus vectors pseudotyped with VSV, Ebola, Mokola, LCMV, or MuLV envelope proteins': 2, 'Assembly and immunological properties of a bivalent virus-like particle (VLP) for avian influenza and Newcastle disease': 1, 'Antibody quality and protection from lethal Ebola virus challenge in nonhuman primates immunized with rabies virus based bivalent vaccine': 1, 'Placebocontrolled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection': 1, 'Induction of neutralizing antibodies against human immunodeficiency virus type 1 primary isolates by Gag-Env pseudovirion immunization': 1, 'Glycated AAV vectors: Chemical redirection of viral tissue tropism': 1, 'Development of the nanobody display technology to target lentiviral vectors to antigen-presenting cells': 1, 'Adenoviral targeting using genetically incorporated camelid single variable domains': 1, 'Cell selective targeting of a simian virus 40 virus-like particle conjugated to epidermal growth factor': 1, 'Self-assembled viruslike particles from rotavirus structural protein VP6 for targeted drug delivery': 1, 'Combination of doxorubicinbased chemotherapy and polyethylenimine/p53 gene therapy for the treatment of lung cancer using porous PLGA microparticles': 1, 'Recombinant retrovirus-derived virus-like particle-based vaccines induce hepatitis C virus-specific cellular and neutralizing immune responses in mice': 2, 'Multiple tandem copies of conserved gp41 epitopes incorporated in gag virus-like particles elicit systemic and mucosal antibodies in an optimized heterologous vector delivery regimen': 2, 'Intranasal immunization with influenza VLPs incorporating membrane-anchored flagellin induces strong heterosubtypic protection': 1, 'MLV based viral-like-particles for delivery of toxic proteins and nuclear transcription factors': 1, 'Efficient in vitro gene delivery by hybrid biopolymer/virus nanobiovectors': 1, 'Encapsulation of adenovirus serotype 5 in anionic lecithin liposomes using a bead-based immunoprecipitation technique enhances transfection efficiency': 1, 'Polyethyleneimine is a potent systemic adjuvant for glycoprotein antigens': 1, 'Viruslike particles and alpha-galactosylceramide form a self-adjuvanting composite particle that elicits anti-tumor responses': 1, 'Rabies virus glycoprotein and immune response pattern using recombinant protein or recombinant RNA viral vectors': 1, 'Can an immune-regulatory vaccine prevent HIV infection?': 1, 'Rational design of immunostimulatory siRNAs': 1, 'Protection and antibody response caused by turkey herpesvirus vector Newcastle disease vaccine': 1, 'Recombinant adenovirus induces maturation of dendritic cells via an NF-kappaB-dependent pathway': 1, 'Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand': 1, 'Novel adenovirus vector-based vaccines for HIV-1': 1, 'DNA vaccines encoding retrovirus-based virus-like particles induce efficient immune responses without adjuvant': 1, 'DNA vaccines expressing retrovirus-like particles are efficient immunogens to induce neutralizing antibodies': 2, 'Efficacy of DNA vaccines forming e7 recombinant retroviral virus-like particles for the treatment of human papillomavirus-induced cancers': 1, 'Increased immunogenicity of a DNA-launched Venezuelan equine encephalitis virus-based replicon DNA vaccine': 1, 'Cross-protective immunity to influenza A viruses': 1, 'A universal flu vaccine': 1, 'Impact of cross-protective vaccines on epidemiological and evolutionary dynamics of influenza': 2, 'Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody': 1, 'Prevalence of cross-reactive HIV-1-neutralizing activity in HIV-1-infected patients with rapid or slow disease progression': 1, 'Antibodies in HIV-1 vaccine development and therapy': 1, 'Immunogen design for HIV-1 and influenza': 1, 'Definition of a conserved immunodominant domain on hepatitis C virus E2 glycoprotein by neutralizing human monoclonal antibodies': 1, 'Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge': 1, 'Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33': 1, 'Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2': 1, 'Hepatitis C virus E2 envelope glycoprotein core structure': 1, 'Animal models for HCV study': 1, 'Polio and Nobel prizes: Looking back 50 years': 1, 'Polio and rabies vaccines produced in continuous cell lines: A reality for Vero cell line': 1, 'Heterogeneity of the tumorigenic phenotype expressed by Madin-Darby canine kidney cells': 1, 'Trivalent MDCK cell culturederived influenza vaccine Optaflu (Novartis Vaccines)': 1, 'Recombinant trivalent influenza vaccine (flublok ® ): A review of its use in the prevention of seasonal influenza in adults': 1, 'Cell lines derived from human tumors for vaccine manufacture in: FDA Briefing Document -Vaccines and Related Biological Products Advisory Committee Meeting': 1, 'Middle East respiratory syndrome coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group': 1, 'Cellular targets for improved manufacturing of virus-based-biopharmaceuticals': 3, 'Characteristics of a human cell line transformed by DNA from human adenovirus type 5': 1, 'Immortalization by gene transfection': 1, 'Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrence': 1, 'Characterization of 911: A new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors': 1, 'A cell line for high-yield production of E1-deleted adenovirus vectors without the emergence of replication-competent virus': 1, 'Efficient transformation of primary human amniocytes by E1 functions of Ad5: Generation of new cell lines for adenoviral vector production': 1, 'Adenoviral producer cells': 1, 'CAP, a new human suspension cell line for influenza virus production': 1, 'Suitability of PER.C6 cells to generate epidemic and pandemic influenza vaccine strains by reverse genetics': 1, 'An avian cell line designed for production of highly attenuated viruses': 2, 'Comparison between hepatitis B surface antigen (HBsAg) particles derived from mammalian cells (CHO) and yeast cells (Hansenula polymorpha): Composition, structure and immunogenicity': 1, 'Rabies virus-like particles expressed in HEK293 cells': 1, 'Generation and characterization of a new mammalian cell line continuously expressing virus-like particles of Japanese encephalitis virus for a subunit vaccine candidate': 2, 'Recombinant protein vaccines produced in insect cells': 1, 'Thirty years of baculovirus-insect cell protein expression: From dark horse to mainstream technology': 1, 'Flipasemediated cassette exchange in Sf9 insect cells for stable gene expression': 1, 'HIV-Gag VLPs presenting trimeric HIV-1 gp140 spikes constitutively expressed in stable double transfected insect cell line': 1, 'Engineering of baculovirus vectors for the manufacture of virionfree biopharmaceuticals': 1, 'Conversion of MDCK cell line to suspension culture by transfecting with human siat7e gene and its application for influenza virus production': 2, 'Application of microarrays to identify and characterize genes involved in attachment dependence in HeLa cells': 1, 'High yield production of influenza virus in Madin Darby canine kidney (MDCK) cells with stable knockdown of IRF7': 1, 'Establishment of cell lines with increased susceptibility to EV71/CA16 by stable overexpression of SCARB2': 1, 'Identification of host proteins associated with retroviral vector particles by proteomic analysis of highly purified vector preparations': 1, 'Coronaviruses Hijack the LC3-I-positive EDEMosomes, ER-derived vesicles exporting short-lived ERAD regulators, for replication': 6, 'Involvement of autophagy in coronavirus replication': 2, 'Induction of autophagy enhances porcine reproductive and respiratory syndrome virus replication': 3, 'Autophagy sustains the replication of porcine reproductive and respiratory virus in host cells': 3, 'Porcine reproductive and respiratory syndrome virus induces autophagy to promote virus replication': 3, 'Severe acute respiratory syndrome coronavirus replication is severely impaired by MG132 due to proteasome-independent inhibition of M-calpain': 3, 'An autophagy-independent role for LC3 in equine arteritis virus replication': 6, 'The Interaction between Nidovirales and Autophagy Components': 3, 'Equine torovirus (BEV) induces caspase-mediated apoptosis in infected cells': 4, 'Ultrastructural characterization of membranous torovirus replication factories': 4, 'New insights on the structure and morphogenesis of Berne virus': 1, 'LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing': 2, 'p62/SQSTM1 Binds Directly to Atg8/LC3 to Facilitate Degradation of Ubiquitinated Protein Aggregates by': 4, 'Sigma-1 Receptor Regulates Early Steps of Viral RNA Replication at the Onset of Hepatitis C Virus Infection': 2, 'A Third-Generation Lentivirus Vector with a Conditional Packaging System': 1, 'Functional specificity of the mammalian Beclin-Vps34 PI 3-kinase complex in macroautophagy versus endocytosis and lysosomal enzyme trafficking': 1, 'Protein Kinase PKR Plays a Stimulus-and Virus-Dependent Role in Apoptotic Death and Virus Multiplication in Human Cells': 1, 'A guided tour into subcellular colocalization analysis in light microscopy': 1, 'Calcium Phosphate Transfection': 1, 'Discordance of UPR signaling by ATF6 and Ire1p-XBP1 with levels of target transcripts': 2, 'Interplay between the cellular autophagy machinery and positive-stranded RNA viruses': 2, 'How positive-strand RNA viruses benefit from autophagosome maturation': 2, 'The Parkinson-associated protein PINK1 interacts with Beclin1 and promotes autophagy': 1, 'Autophagosome-lysosome fusion depends on the pH in acidic compartments in CHO cells': 1, 'The phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated rat hepatocytes': 1, 'Microtubule-associated protein 1 light chain 3 alpha (LC3)-associated phagocytosis is required for the efficient clearance of dead cells': 1, '3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes': 1, 'Degradation of short and long lived proteins in isolated rat liver lysosomes. Effects of pH, temperature, and proteolytic inhibitors': 1, 'Inhibition of the lysosomal pathway of protein degradation in isolated rat hepatocytes by ammonia, methylamine, chloroquine and leupeptin. European journal of biochemistry / FEBS': 1, 'Dengue Virus Inhibition of Autophagic Flux and Dependency of Viral Replication on Proteasomal Degradation of the Autophagy Receptor p62': 1, 'Intracellular vesicle acidification promotes maturation of infectious poliovirus particles': 1, 'Ubiquitination and selective autophagy': 1, 'The Role of the Selective Adaptor p62 and Ubiquitin-Like Proteins in Autophagy': 3, 'p62 links the autophagy pathway and the ubiqutin-proteasome system upon ubiquitinated protein degradation': 2, 'Cleaning up in the endoplasmic reticulum: ubiquitin in charge': 2, 'ER-associated degradation: Protein quality control and beyond': 1, 'XBP1 mRNA Is Induced by ATF6 and Spliced by IRE1 in Response to ER Stress to Produce a Highly Active Transcription Factor': 1, 'Viruses and the autophagy machinery': 1, 'Viruses and autophagy': 1, 'Autophagy and Viruses: Adversaries or Allies': 1, 'Manipulation or capitulation: virus interactions with autophagy. Microbes and infection / Institut Pasteur': 1, 'Autophagy: The multi-purpose bridge in viral infections and host cells': 1, 'Open Reading Frame 1a-Encoded Subunits of the Arterivirus Replicase Induce Endoplasmic Reticulum-Derived Double-Membrane Vesicles Which Carry the Viral Replication Complex': 1, 'Ultrastructural characterization of SARS coronavirus': 1, 'RNA Replication of Mouse Hepatitis Virus Takes Place at Double-Membrane Vesicles': 1, 'Infectious bronchitis virus generates spherules from zippered endoplasmic reticulum membranes': 1, 'Ultrastructural characterization of arterivirus replication structures: reshaping the endoplasmic reticulum to accommodate viral RNA synthesis': 1, 'Qualitative and quantitative ultrastructural analysis of the membrane rearrangements induced by coronavirus': 1, 'SARS-Coronavirus Replication Is Supported by a Reticulovesicular Network of Modified Endoplasmic Reticulum': 1, 'Coronavirus nsp6 proteins generate autophagosomes from the endoplasmic reticulum via an omegasome intermediate': 1, 'Visualizing the autophagy pathway in avian cells and its application to studying infectious bronchitis virus': 1, 'ERAD and ERAD tuning: disposal of cargo and of ERAD regulators from the mammalian ER': 1, 'Segregation and rapid turnover of EDEM1 by an autophagy-like mechanism modulates standard ERAD and folding activities': 1, 'Morphogenesis of Berne virus (proposed family Toroviridae)': 1, 'Cargo recognition and trafficking in selective autophagy': 1, 'Coronavirus infection, ER stress, apoptosis and innate immunity': 1}\n"
          ],
          "name": "stdout"
        },
        {
          "output_type": "stream",
          "text": [
            "/usr/local/lib/python3.6/dist-packages/ipykernel_launcher.py:13: SettingWithCopyWarning: \n",
            "A value is trying to be set on a copy of a slice from a DataFrame.\n",
            "Try using .loc[row_indexer,col_indexer] = value instead\n",
            "\n",
            "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
            "  del sys.path[0]\n"
          ],
          "name": "stderr"
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "hxhBtC9DtJsZ",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 760
        },
        "outputId": "d1d3a0ad-3957-4fc6-98f0-c611e6a81a04"
      },
      "source": [
        "#Getting Seaborn Style for Pandas Plots\n",
        "top_n=50\n",
        "sns.set()       \n",
        "new_df[0:top_n].reset_index().plot(\n",
        "    x = 'title', \n",
        "    y = 'no. of times cited', \n",
        "    kind='bar', \n",
        "    legend = False,\n",
        "    width=0.6,\n",
        "    figsize=(20,8)\n",
        ")\n",
        "plt.ylabel(\"Number of times cited\")\n",
        "plt.xlabel(\"Paper\")\n",
        "plt.title(\"No. of citations of top \"+format(top_n)+\" papers\")\n",
        "plt.gca().yaxis.grid(linestyle=':')"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "image/png": "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\n",
            "text/plain": [
              "<Figure size 1440x576 with 1 Axes>"
            ]
          },
          "metadata": {
            "tags": []
          }
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "X1XjOKQZuKId"
      },
      "source": [
        "#pip install export_saved_model"
      ],
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "54SonHtfIrWU"
      },
      "source": [
        "spark.stop()"
      ],
      "execution_count": null,
      "outputs": []
    }
  ]
}